PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chikwana, VM; Stec, B; Lee, BWK; de Crecy-Lagard, V; Iwata-Reuyl, D; Swairjo, MA				Chikwana, Vimbai M.; Stec, Boguslaw; Lee, Bobby W. K.; de Crecy-Lagard, Valerie; Iwata-Reuyl, Dirk; Swairjo, Manal A.			Structural Basis of Biological Nitrile Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUEUOSINE-BIOSYNTHESIS; ENZYME; MECHANISM; QUEF; OXIDOREDUCTASE; CYCLOHYDROLASE; NITROGENASE; REFINEMENT; FOLD	The enzyme QueF catalyzes the reduction of the nitrile group of 7-cyano-7-deazaguanine (preQ(0)) to 7-aminomethyl-7-deazaguanine (preQ(1)), the only nitrile reduction reaction known in biology. We describe here two crystal structures of Bacillus subtilis QueF, one of the wild-type enzyme in complex with the substrate preQ(0), trapped as a covalent thioimide, a putative intermediate in the reaction, and the second of the C55A mutant in complex with the substrate preQ(0) bound noncovalently. The QueF enzyme forms an asymmetric tunnel-fold homodecamer of two head-to-head facing pentameric subunits, harboring 10 active sites at the intersubunit interfaces. In both structures, a preQ(0) molecule is bound at eight sites, and in the wild-type enzyme, it forms a thioimide covalent linkage to the catalytic residue Cys-55. Both structural and transient kinetic data show that preQ(0) binding, not thioimide formation, induces a large conformational change in and closure of the active site. Based on these data, we propose a mechanism for the activation of the Cys-55 nucleophile and subsequent hydride transfer.	[Chikwana, Vimbai M.; Lee, Bobby W. K.; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Stec, Boguslaw] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Swairjo, Manal A.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA	Portland State University; Sanford Burnham Prebys Medical Discovery Institute; State University System of Florida; University of Florida; Western University of Health Sciences	Iwata-Reuyl, D (corresponding author), Portland State Univ, Dept Chem, POB 751, Portland, OR 97207 USA.	iwatard@pdx.edu; mswairjo@westernu.edu	Swairjo, Manal/AAR-9137-2021; de Crecy-Lagard, Valerie/AAN-8995-2020	Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [GM70641]; Department of Energy, the National Institutes of Health; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, the National Institutes of Health; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM70641 (to D. I. R. and V. d. C. L.).; We thank Drs. A. Gonzalez and B. Sankaran for preliminary work on x-ray data collection, K. Shah for preliminary work on QueF crystals, Dr. P. Kuzmic for helpful discussions on data analysis with DynaFit, and Prof. A. Osterman for general support. The Stanford Synchrotron Research Laboratory Structural Molecular Biology Program is supported by the Department of Energy, the National Institutes of Health, and the National Institute of General Medical Sciences.	Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Cole J. L., 2012, HETEROANALYSIS VERSI; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher K, 2006, BIOCHEMISTRY-US, V45, P4190, DOI 10.1021/bi0514109; Hayes D. B., 2012, SEDNTERP VERSION 2 4; HWANG JC, 1972, BIOCHIM BIOPHYS ACTA, V283, P339, DOI 10.1016/0005-2728(72)90250-2; Iwata-Reuyl D, 2009, DNA RNA MODIFICATION, P379; Kim Y, 2010, J MOL BIOL, V404, P127, DOI 10.1016/j.jmb.2010.09.042; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKADA N, 1979, J BIOL CHEM, V254, P3067; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Retailleau P, 2004, ACTA CRYSTALLOGR D, V60, P453, DOI 10.1107/S0907444903029718; Sankaran B, 2009, J BACTERIOL, V191, P6936, DOI 10.1128/JB.00287-09; STEVENSON DE, 1990, FEBS LETT, V277, P112, DOI 10.1016/0014-5793(90)80821-Y; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Swairjo MA, 2005, ACTA CRYSTALLOGR F, V61, P945, DOI 10.1107/S1744309105029246; Tanaka Y, 2005, J BIOCHEM, V138, P263, DOI 10.1093/jb/mvi120; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102	24	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30560	30570		10.1074/jbc.M112.388538	http://dx.doi.org/10.1074/jbc.M112.388538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787148	Green Published, hybrid			2022-12-25	WOS:000308579800048
J	Schroeder, J; Nakagawa, S; Cleasby, IR; Burke, T				Schroeder, Julia; Nakagawa, Shinichi; Cleasby, Ian R.; Burke, Terry			Passerine Birds Breeding under Chronic Noise Experience Reduced Fitness	PLOS ONE			English	Article							HOUSE SPARROWS; ENVIRONMENTAL NOISE; RESPONSIVENESS; BLACKBIRD; SUCCESS; IMPACT; CALLS; SIZE; SEX	Background: Fitness in birds has been shown to be negatively associated with anthropogenic noise, but the underlying mechanisms remain obscure. It is however crucial to understand the mechanisms of how urban noise impinges on fitness to obtain a better understanding of the role of chronic noise in urban ecology. Here, we examine three hypotheses on how noise might reduce reproductive output in passerine birds: (H1) by impairing mate choice, (H2) by reducing territory quality and (H3) by impeding chick development. Methodology/Principal Findings: We used long-term data from an island population of house sparrows, Passer domesticus, in which we can precisely estimate fitness. We found that nests in an area affected by the noise from large generators produced fewer young, of lower body mass, and fewer recruits, even when we corrected statistically for parental genetic quality using a cross-fostering set-up, supporting H3. Also, individual females provided their young with food less often when they bred in the noisy area compared to breeding attempts by the same females elsewhere. Furthermore, we show that females reacted flexibly to increased noise levels by adjusting their provisioning rate in the short term, which suggests that noise may be a causal factor that reduces reproductive output. We rejected H1 and H2 because nestbox occupancy, parental body mass, age and reproductive investment did not differ significantly between noisy and quiet areas. Conclusions/Significance: Our results suggest a previously undescribed mechanism to explain how environmental noise can reduce fitness in passerine birds: by acoustically masking parent-offspring communication. More importantly, using a cross-fostering set-up, our results demonstrate that birds breeding in a noisy environment experience significant fitness costs. Chronic noise is omnipresent around human habitation and may produces similar fitness consequences in a wide range of urban bird species.	[Schroeder, Julia; Nakagawa, Shinichi; Cleasby, Ian R.; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, New Zealand; [Nakagawa, Shinichi] Max Planck Inst Ornithol, Seewiesen, Germany	University of Sheffield; University of Otago; Max Planck Society	Schroeder, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	julia.schroeder@gmail.com	Burke, Terry/B-3196-2011; Schroeder, Julia/B-1436-2010; Nakagawa, Shinichi/B-5571-2011	Burke, Terry/0000-0003-3848-1244; Schroeder, Julia/0000-0002-4136-843X; Nakagawa, Shinichi/0000-0002-7765-5182	NERC(Natural Environment Research Council) [NE/F00607/1]; Humbolt Fellowship; Natural Environment Research Council [NE/F006071/1] Funding Source: researchfish; NERC [NE/F006071/1] Funding Source: UKRI	NERC(Natural Environment Research Council)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Humbolt Fellowship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the grant NE/F00607/1 from NERC(Natural Environment Research Council) to TB, and SN was supported by a Humbolt Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Burford JE, 1998, ANIM BEHAV, V56, P555, DOI 10.1006/anbe.1998.0830; Burke T., 1984, THESIS U NOTTINGHAM; Cleasby IR, 2010, BIOL J LINN SOC, V101, P680, DOI 10.1111/j.1095-8312.2010.01515.x; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; Francis CD, 2011, P ROY SOC B-BIOL SCI, V278, P2025, DOI 10.1098/rspb.2010.1847; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gelman A., 2007, DATA ANAL USING REGR; Grodzinski U, 2007, P R SOC B, V274, P2449, DOI 10.1098/rspb.2007.0658; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hole DG, 2002, NATURE, V418, P931, DOI 10.1038/418931a; Hu Y, 2010, ANIM BEHAV, V79, P863, DOI 10.1016/j.anbehav.2009.12.036; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Leonard ML, 2012, BIOL LETTERS, V8, P530, DOI 10.1098/rsbl.2012.0032; Leonard ML, 2005, P ROY SOC B-BIOL SCI, V272, P651, DOI 10.1098/rspb.2004.3021; Leonard ML, 2001, BEHAV ECOL SOCIOBIOL, V49, P170, DOI 10.1007/s002650000290; Nakagawa S, 2007, J EVOLUTION BIOL, V20, P1674, DOI 10.1111/j.1420-9101.2007.01403.x; Nakagawa S, 2008, J AVIAN BIOL, V39, P222, DOI 10.1111/j.2008.0908-8857.04171.x; Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; Ockendon N, 2009, BEHAV ECOL, V20, P305, DOI 10.1093/beheco/arp006; Peach WJ, 2008, ANIM CONSERV, V11, P493, DOI 10.1111/j.1469-1795.2008.00209.x; Price K, 1998, ANIM BEHAV, V56, P571, DOI 10.1006/anbe.1998.0832; Quinn JL, 2006, J AVIAN BIOL, V37, P601; Reijnen R, 1996, BIOL CONSERV, V75, P255, DOI 10.1016/0006-3207(95)00074-7; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; Schroeder J, 2012, J EVOLUTION BIOL, V25, P149, DOI 10.1111/j.1420-9101.2011.02412.x; Schroeder J, 2011, J AVIAN BIOL, V42, P271, DOI 10.1111/j.1600-048X.2010.05271.x; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Summers-Smith J.D., 1963, THE HOUSE SPARROW; Swaddle JP, 2007, ANIM BEHAV, V74, P363, DOI 10.1016/j.anbehav.2007.01.004; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006	36	110	110	3	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39200	10.1371/journal.pone.0039200	http://dx.doi.org/10.1371/journal.pone.0039200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808028	gold, Green Accepted, Green Published			2022-12-25	WOS:000306362400008
J	Yoshibori, M; Yorimitsu, T; Sato, K				Yoshibori, Mariko; Yorimitsu, Tomohiro; Sato, Ken			Involvement of the Penta-EF-Hand Protein Pef1p in the Ca2+-Dependent Regulation of COPII Subunit Assembly in Saccharomyces cerevisiae	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES; ALG-2 INTERACTS; GTP HYDROLYSIS; COAT PROTEINS; ER; MEMBRANE; COMPLEX; VISUALIZATION; ORGANIZATION	Although it is well established that the coat protein complex II (COPII) mediates the transport of proteins and lipids from the endoplasmic reticulum (ER) to the Golgi apparatus, the regulation of the vesicular transport event and the mechanisms that act to counterbalance the vesicle flow between the ER and Golgi are poorly understood. In this study, we present data indicating that the penta-EF-hand Ca2+-binding protein Pef1p directly interacts with the COPII coat subunit Sec31p and regulates COPII assembly in Saccharomyces cerevisiae. ALG-2, a mammalian homolog of Pef1p, has been shown to interact with Sec31A in a Ca2+-dependent manner and to have a role in stabilizing the association of the Sec13/31 complex with the membrane. However, Pef1p displayed reversed Ca2+ dependence for Sec13/31p association; only the Ca2+-free form of Pef1p bound to the Sec13/31p complex. In addition, the influence on COPII coat assembly also appeared to be reversed; Pef1p binding acted as a kinetic inhibitor to delay Sec13/31p recruitment. Our results provide further evidence for a linkage between Ca2+-dependent signaling and ER-to-Golgi trafficking, but its mechanism of action in yeast seems to be different from the mechanism reported for its mammalian homolog ALG-2.	[Yoshibori, Mariko; Yorimitsu, Tomohiro; Sato, Ken] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Yoshibori, M (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	kensato@bio.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); MEXT:Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT); Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT:Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS) (TY and KS), and in part by the Targeted Proteins Research Program from MEXT:Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Kodera C, 2011, TRAFFIC, V12, P591, DOI 10.1111/j.1600-0854.2011.01173.x; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lee TH, 1999, MOL BIOL CELL, V10, P1445, DOI 10.1091/mbc.10.5.1445; Lu ZM, 2001, MOL BIOL CELL, V12, P795, DOI 10.1091/mbc.12.4.795; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Okamoto M, 2012, J CELL SCI IN PRESS; ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Sato K, 2004, J BIOL CHEM, V279, P1330, DOI 10.1074/jbc.C300457200; Satoh H, 2002, BBA-PROTEINS PROTEOM, V1600, P61, DOI 10.1016/S1570-9639(02)00445-4; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Vernarecci S, 2007, MOL MICROBIOL, V65, P1122, DOI 10.1111/j.1365-2958.2007.05852.x; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; WAHL M, 1992, J CELL PHYSIOL, V150, P593, DOI 10.1002/jcp.1041500321; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yorimitsu T, 2012, MOL BIOL CE IN PRESS, P23; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	42	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40765	10.1371/journal.pone.0040765	http://dx.doi.org/10.1371/journal.pone.0040765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792405	gold, Green Submitted, Green Published			2022-12-25	WOS:000306362400100
J	Gao, C; Qiu, JH; Ma, CQ; Xu, P				Gao, Chao; Qiu, Jianhua; Ma, Cuiqing; Xu, Ping			Efficient Production of Pyruvate from DL-Lactate by the Lactate-Utilizing Strain Pseudomonas stutzeri SDM	PLOS ONE			English	Article							LACTIC-ACID; BIOTECHNOLOGICAL ROUTES; ESCHERICHIA-COLI; BIOCATALYST; MEMBRANE; OXIDASE; (R)-LACTATE; CATALYST; GLUCOSE; BIOMASS	Background: The platform chemical lactate is currently produced mainly through the fermentation of sugars presented in biomass. Besides the synthesis of biodegradable polylactate, lactate is also viewed as a feedstock for the green chemistry of the future. Pyruvate, another important platform chemical, can be produced from lactate through biocatalysis. Methodology/Principal Findings: It was established that whole cells of Pseudomonas stutzeri SDM catalyze lactate oxidation with lactate-induced NAD-independent lactate dehydrogenases (iLDHs) through the inherent electron transfer chain. Unlike the lactate oxidation processes observed in previous reports, the mechanism underlying lactate oxidation described in the present study excluded the costliness of the cofactor regeneration step and production of the byproduct hydrogen peroxide. Conclusions/Significance: Biocatalysis conditions were optimized by using the cheap DL-lactate as the substrate and whole cells of the lactate-utilizing P. stutzeri SDM as catalyst. Under optimal conditions, the biocatalytic process produced pyruvate at a high concentration (48.4 g l(-1)) and a high yield (98%). The bioconversion system provides a promising alternative for the green production of pyruvate.	[Gao, Chao; Qiu, Jianhua; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn		Ma, Cuiqing/0000-0002-7468-1027; Gao, Chao/0000-0002-5205-0670	National Natural Science Foundation of China [31000014, 31170052]; Research Fund for the Doctoral Program of Higher Education of China [20090131110036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The work was supported by the National Natural Science Foundation of China (31000014 and 31170052), and by the Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20090131110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 1997, APPL CATAL A-GEN, V150, P13, DOI 10.1016/S0926-860X(96)00295-5; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; BUTO S, 1994, BIOTECHNOL BIOENG, V44, P1288, DOI 10.1002/bit.260441104; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Cooper B, 1989, DE patent, Patent No. 3733157; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Distel KA, 2005, BIORESOURCE TECHNOL, V96, P617, DOI 10.1016/j.biortech.2004.06.005; DIXON NM, 1989, BIOELECTROCH BIOENER, V21, P245, DOI 10.1016/0302-4598(89)85004-4; Eisenberg A, 1997, J MOL CATAL B-ENZYM, V2, P223, DOI 10.1016/S1381-1177(96)00021-5; Gao C, 2009, BIORESOURCE TECHNOL, V100, P1878, DOI 10.1016/j.biortech.2008.09.053; Gao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036519; Gao C, 2012, J BACTERIOL, V194, P2687, DOI 10.1128/JB.06579-11; Gao C, 2011, BIOTECHNOL ADV, V29, P930, DOI 10.1016/j.biotechadv.2011.07.022; Gao CA, 2011, BIORESOURCE TECHNOL, V102, P4595, DOI 10.1016/j.biortech.2011.01.003; Gao C, 2010, PROCESS BIOCHEM, V45, P1912, DOI 10.1016/j.procbio.2010.05.029; Gao C, 2010, APPL ENVIRON MICROB, V76, P1679, DOI 10.1128/AEM.02470-09; Gu JS, 2002, J MOL CATAL B-ENZYM, V18, P299, DOI 10.1016/S1381-1177(02)00110-8; Hao JR, 2007, BIOTECHNOL LETT, V29, P105, DOI 10.1007/s10529-006-9204-6; Hekmat D, 1999, ENZYME MICROB TECH, V24, P471, DOI 10.1016/S0141-0229(98)00135-5; Jiang TY, 2012, J BACTERIOL, V194, P894, DOI 10.1128/JB.06478-11; John RP, 2007, APPL MICROBIOL BIOT, V74, P524, DOI 10.1007/s00253-006-0779-6; Li Y, 2002, APPL MICROBIOL BIOT, V60, P101, DOI [10.1007/s0253-002-1064-y, 10.1007/s00253-002-1064-y]; Li Y, 2001, APPL MICROBIOL BIOT, V57, P451, DOI 10.1007/s002530100804; Liu ZQ, 2010, PROCESS BIOCHEM, V45, P1632, DOI 10.1016/j.procbio.2010.06.012; Ma CQ, 2004, APPL MICROBIOL BIOT, V66, P34, DOI 10.1007/s00253-004-1646-y; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Miyazaki M, 2001, CHEM COMMUN, P1800, DOI 10.1039/b104873m; Ogawa J, 2001, J MOL CATAL B-ENZYM, V11, P355, DOI 10.1016/S1381-1177(00)00024-2; Qin JY, 2010, BIORESOURCE TECHNOL, V101, P7570, DOI 10.1016/j.biortech.2010.04.037; SCHINSCHEL C, 1993, J BIOTECHNOL, V31, P191, DOI 10.1016/0168-1656(93)90160-O; Stottmeister U, 2005, J IND MICROBIOL BIOT, V32, P651, DOI 10.1007/s10295-005-0254-x; van Maris AJA, 2004, APPL ENVIRON MICROB, V70, P159, DOI 10.1128/AEM.70.1.159-166.2004; Xu P, 2008, J BIOSCI BIOENG, V105, P169, DOI 10.1263/jbb.105.169; Zelic B, 2004, BIOTECHNOL BIOENG, V85, P638, DOI 10.1002/bit.10820	35	7	8	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40755	10.1371/journal.pone.0040755	http://dx.doi.org/10.1371/journal.pone.0040755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792404	Green Submitted, Green Published, gold			2022-12-25	WOS:000306354700066
J	Kim, SM; Kim, YG; Jeong, KH; Lee, SH; Lee, TW; Ihm, CG; Moon, JY				Kim, Su-Mi; Kim, Yang-Gyun; Jeong, Kyung-Hwan; Lee, Sang-Ho; Lee, Tae-Won; Ihm, Chun-Gyoo; Moon, Ju-Young			Angiotensin II-Induced Mitochondrial Nox4 Is a Major Endogenous Source of Oxidative Stress in Kidney Tubular Cells	PLOS ONE			English	Article							NAD(P)H OXIDASE; ENDOTHELIAL-CELLS; EXPRESSION; LOCALIZATION; DYSFUNCTION; APOPTOSIS; HYPERTENSION; ACTIVATION; DISEASE; RATS	Angiotensin II (Ang II)-induced activation of nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase leads to increased production of reactive oxygen species (ROS), an important intracellular second messenger in renal disease. Recent findings suggest that Ang II induces mitochondrial depolarization and further amplifies mitochondrial generation of ROS. We examined the hypothesis that ROS injury mediated by Ang II-induced mitochondrial Nox4 plays a pivotal role in mitochondrial dysfunction in tubular cells and is related to cell survival. In addition, we assessed whether angiotensin (1-7) peptide (Ang-(1-7)) was able to counteract Ang II-induced ROS-mediated cellular injury. Cultured NRK-52E cells were stimulated with 10(-6) M Ang II for 24 h with or without Ang-(1-7) or apocynin. Ang II simulated mitochondrial Nox4 and resulted in the abrupt production of mitochondrial superoxide (O-2(-)) and hydrogen peroxide (H2O2). Ang II also induced depolarization of the mitochondrial membrane potential, and cytosolic secretion of cytochrome C and apoptosis-inducing factor (AIF). Ang-(1-7) attenuated Ang II-induced mitochondrial Nox4 expression and apoptosis, and its effect was comparable to that of the NAD(P) H oxidase inhibitor. These findings suggest that Ang II-induced activation of mitochondrial Nox4 is an important endogenous source of ROS, and is related to cell survival. The ACE2-Ang-(1-7)-Mas receptor axis should be investigated further as a novel target of Ang II-mediated ROS injury.	[Kim, Su-Mi; Kim, Yang-Gyun; Lee, Sang-Ho; Moon, Ju-Young] Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp Gangdong, Dept Internal Med,Div Nephrol, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital	Kim, SM (corresponding author), Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp Gangdong, Dept Internal Med,Div Nephrol, Seoul, South Korea.	jymoon@khu.ac.kr	/W-5371-2019; KIM, YANG GYUN/AAI-9821-2020	KIM, YANG GYUN/0000-0002-3497-5514	Kyung Hee University [KHU-20100722]	Kyung Hee University	This work was supported by a grant from the Kyung Hee University in 2010 (KHU-20100722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Benter IF, 2008, AM J NEPHROL, V28, P25, DOI 10.1159/000108758; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Ferrario CM, 1997, HYPERTENSION, V30, P535, DOI 10.1161/01.HYP.30.3.535; Gallagher PE, 2008, AM J PHYSIOL-CELL PH, V295, pC1169, DOI 10.1152/ajpcell.00145.2008; Gava E, 2009, NEPHROL DIAL TRANSPL, V24, P1766, DOI 10.1093/ndt/gfn736; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Graham S, 2011, AM J PHYSIOL-CELL PH, V301, pC304, DOI 10.1152/ajpcell.00014.2011; Guzik TJ, 2006, ARTERIOSCL THROM VAS, V26, P333, DOI 10.1161/01.ATV.0000196651.64776.51; Gwathmey TM, 2010, HYPERTENSION, V55, P166, DOI 10.1161/HYPERTENSIONAHA.109.141622; Hampton MB, 1998, ANN NY ACAD SCI, V854, P328, DOI 10.1111/j.1749-6632.1998.tb09913.x; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Iyer SN, 2000, J CARDIOVASC PHARM, V36, P109, DOI 10.1097/00005344-200007000-00015; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Liao Xin-xue, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1345; Moon JY, 2011, AM J PHYSIOL-RENAL, V300, pF1271, DOI 10.1152/ajprenal.00065.2010; NAKAMOTO H, 1995, HYPERTENSION, V25, P796, DOI 10.1161/01.HYP.25.4.796; Nakamura S, 2003, AM J PHYSIOL-REG I, V284, pR164, DOI 10.1152/ajpregu.00210.2002; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Ruiz-Ortega M, 1998, NEPHROL DIAL TRANSPL, V13, P886, DOI 10.1093/ndt/13.4.886; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y; Stegbauer J, 2011, BRIT J PHARMACOL, V163, P974, DOI 10.1111/j.1476-5381.2011.01295.x; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	34	79	81	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39739	10.1371/journal.pone.0039739	http://dx.doi.org/10.1371/journal.pone.0039739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808054	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700018
J	Forbes, HJ; Doyle, AM; Maganja, K; Changalucha, J; Weiss, HA; Ross, DA; Hayes, RJ				Forbes, Harriet J.; Doyle, Aoife M.; Maganja, Kaballa; Changalucha, John; Weiss, Helen A.; Ross, David A.; Hayes, Richard J.			Rapid Increase in Prevalence of Male Circumcision in Rural Tanzania in the Absence of a Promotional Campaign	PLOS ONE			English	Article							SEXUAL HEALTH INTERVENTION; HIV PREVENTION; MWANZA REGION; INFECTION; MEN; RISK; TRIAL; DESIGN; KENYA	Objectives: To estimate the prevalence of circumcision among young men in rural Mwanza, North-Western Tanzania, and document trends in circumcision prevalence over time. To investigate associations of circumcision with socio-demographic characteristics, reported sexual behaviours and sexually transmitted infections (STIs). Design: A cross-sectional survey in communities which had previously participated in a cluster-randomized trial of an adolescent sexual health intervention that did not include male circumcision in 20 rural communities. Methods: In 2007/08, 7300 young men (age 16-23 years) were interviewed and examined by a clinician. The prevalence of circumcision by age was compared with data collected during the trial in 1998-2002. Odds ratios (OR) and 95% confidence intervals (CI) for the association of circumcision with socio-demographic characteristics, reported sexual behaviours and with HIV and other STIs were estimated using multivariable conditional logistic regression. Results: The prevalence of male circumcision was 40.6%, and age-specific prevalence had more than doubled since 2001/2002. Circumcised men reported less risky sexual behaviours, being more likely to report having ever used a condom (adjusted OR=2.62, 95% CI: 2.32-2.95). Men circumcised before sexual debut were at reduced risk of being HIV seropositive compared with non-circumcised men (adjusted OR=0.50, 95% CI: 0.25-0.97), and also had reduced risks of HSV-2 infection and genital ulcer syndrome in the past 12 months compared with non-circumcised men. Conclusions: There was a steep increase in circumcision prevalence between 2001/02 and 2007/08 in the absence of a promotional campaign. Circumcised men reported safer sexual practices than non-circumcised men and had lower prevalence of HIV and HSV-2 infection.	[Forbes, Harriet J.; Doyle, Aoife M.; Weiss, Helen A.; Ross, David A.; Hayes, Richard J.] London Sch Hyg & Trop Med, London WC1, England; [Maganja, Kaballa; Changalucha, John] Mwanza Ctr, Natl Inst Med Res, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Forbes, HJ (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	harriet.forbes@lshtm.ac.uk	Doyle, Aoife/AAX-3525-2020; weiss, helen/ABC-7823-2021	Doyle, Aoife/0000-0002-3305-7738; weiss, helen/0000-0003-3547-7936; Hayes, Richard/0000-0002-1729-9892; Forbes, Harriet/0000-0001-6888-2212	European Commission; UK Department for International Development, and Irish Aid; Medical Research Council of Great Britain; United Nations Joint Programme on HIV/AIDS (UNAIDS); Medical Research Council [G0700837, G0902121] Funding Source: researchfish; MRC [G0902121, G0700837] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department for International Development, and Irish Aid; Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Nations Joint Programme on HIV/AIDS (UNAIDS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MEMA kwa Vijana Trial was a collaboration between the London School of Hygiene & Tropical Medicine (LSHTM), the Tanzanian National Institute for Medical Research (NIMR), the African Medical and Research Foundation (AMREF), and the Ministries of Health and Social Welfare and of Education and Vocational Training of the Government of Tanzania. It was supported by grants from the European Commission, the UK Department for International Development, and Irish Aid, with additional funding support from the Medical Research Council of Great Britain and The United Nations Joint Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, 19 C RETR OPP INF CR; Bailey RC, 1999, J ACQ IMMUN DEF SYND, V22, P294; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; DFID Dfid, 2010, ROLL OUT AD MAL CIRC; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Nnko S, 2001, SEX TRANSM DIS, V28, P214, DOI 10.1097/00007435-200104000-00005; Obasi AI, 2006, AIDS CARE, V18, P311, DOI 10.1080/09540120500161983; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Sobngwi-Tambekou J, 2009, SEX TRANSM INFECT, V85, P116, DOI 10.1136/sti.2008.032334; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tanzania Commission for AIDS Dar es Salaam TaNBoSDeS Tanzania and ORC Macro Calverton Maryland USA, 2005, TANZ HIV AIDS IND SU; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; *UNAIDS WHO, 2007, NEW DAT MAL CIRC HIV; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; Wambura M, 2009, SITUATION ANAL MALE; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Weiss HA, 2008, TROP MED INT HEALTH, V13, P1054, DOI 10.1111/j.1365-3156.2008.02107.x; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40507	10.1371/journal.pone.0040507	http://dx.doi.org/10.1371/journal.pone.0040507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792359	gold, Green Published, Green Accepted			2022-12-25	WOS:000306461800100
J	Meng, S; Cao, JT; Wang, LS; Zhou, Q; Li, YG; Shen, CX; Zhang, XP; Wang, CQ				Meng, Shu; Cao, JiaTian; Wang, LianSheng; Zhou, Qing; Li, YiGang; Shen, ChengXing; Zhang, XiaoPing; Wang, ChangQian			MicroRNA 107 Partly Inhibits Endothelial Progenitor Cells Differentiation via HIF-1 beta	PLOS ONE			English	Article							GENE-EXPRESSION; HYPOXIA; ANGIOGENESIS; CANCER; NEOVASCULARIZATION; DEHYDROGENASE; INACTIVATION; SIGNATURE; SYNTHASE; PATHWAY	Endothelial progenitor cells (EPCs) play an important role in tissue repair after ischemic heart disease. In particular, the recovery of endothelial function is reliant on the ability and rate of EPCs differentiate into mature endothelial cells. The present study evaluated the effect of microRNA 107 (miR-107) on the mechanism of EPCs differentiation. EPCs were isolated from rats' bone marrow and miR-107 expression of EPCs in hypoxic and normoxic conditions were measured by real-time qualitative PCR. CD31 was analyzed by flow cytometry and eNOS was examined by real-time qualitative PCR and western blotting and these were used as markers of EPC differentiation. In order to reveal the mechanism, we used miR107 inhibitor and lentiviral vector expressing a short hairpin RNA (shRNA) that targets miR-107 and hypoxia-inducible factor-1 beta (HIF-1 beta) to alter miR107 and HIF-1 beta expression. MiR-107 expression were increased in EPCs under hypoxic conditions. Up-regulation of miR-107 partly suppressed the EPCs differentiation induced in hypoxia, while down-regulation of miR-107 promoted EPC differentiation. HIF-1 beta was the target. This study indicated that miR-107 was up-regulated in hypoxia to prevent EPCs differentiation via its target HIF-1 beta. The physiological mechanisms of miR-107 must be evaluated if it is to be used as a potential anti-ischemia therapeutic regime.	[Meng, Shu; Zhou, Qing; Li, YiGang; Shen, ChengXing] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China; [Cao, JiaTian; Wang, ChangQian] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China; [Wang, LianSheng] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Lab Med, Shanghai 200030, Peoples R China; [Zhang, XiaoPing] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Nucl Med, Shangha, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Wang, CQ (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China.	changqianwang@163.com			National Natural Science Foundation of China [30971436]; Shanghai Committee of Science and Technology of China [09XD1403100, 09JC1410600, 10JC1408900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology of China	This project was supported by National Natural Science Foundation of China (Grant No. 30971436 URL: http://www.nsfc.gov.cn/Portal0/default152.htm), the Shanghai Committee of Science and Technology of China (Grant No. 09XD1403100, 09JC1410600 and 10JC1408900 URL: http://www.stcsm.gov.cn/structure/index.htmnd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen EY, 2001, CANCER RES, V61, P2429; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gou X, 2011, ASIAN J ANDROL, V13, P332, DOI 10.1038/aja.2010.116; Jiang M, 2006, J VASC RES, V43, P511, DOI 10.1159/000095964; Jiang Meng, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P565; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Ma FX, 2006, J LIPID RES, V47, P1227, DOI 10.1194/jlr.M500507-JLR200; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weir L, 2011, BBA-MOL CELL RES, V1813, P60, DOI 10.1016/j.bbamcr.2010.11.014; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Zundel W, 2000, GENE DEV, V14, P391	29	42	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40323	10.1371/journal.pone.0040323	http://dx.doi.org/10.1371/journal.pone.0040323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792280	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800069
J	Zeck, A; Regula, JT; Larraillet, V; Mautz, B; Popp, O; Gopfert, U; Wiegeshoff, F; Vollertsen, UEE; Gorr, IH; Koll, H; Papadimitriou, A				Zeck, Anne; Regula, Joerg Thomas; Larraillet, Vincent; Mautz, Bjoern; Popp, Oliver; Goepfert, Ulrich; Wiegeshoff, Frank; Vollertsen, Ulrike E. E.; Gorr, Ingo H.; Koll, Hans; Papadimitriou, Apollon			Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; MISINCORPORATION; HETEROGENEITY; THERAPEUTICS	Sequence variants in recombinant biopharmaceuticals may have a relevant and unpredictable impact on clinical safety and efficacy. Hence, their sensitive analysis is important throughout bioprocess development. The two stage analytical approach presented here provides a quick multi clone comparison of candidate production cell lines as a first stage, followed by an in-depth analysis including identification and quantitation of aberrant sequence variants of selected clones as a second stage. We show that the differential analysis is a suitable tool for sensitive and fast batch to batch comparison of recombinant proteins. The optimized approach allows for detection of not only single amino acid substitutions in unmodified peptides, but also substitutions in posttranslational modified peptides such as glycopeptides, for detection of truncated or elongated sequence variants as well as double amino acid substitutions or substitution with amino acid structural isomers within one peptide. In two case studies we were able to detect sequence variants of different origin down to a sub percentage level. One of the sequence variants (Thr -> Asn) could be correlated to a cytosine to adenine substitution at DNA(desoxyribonucleic acid) level. In the second case we were able to correlate the sub percentage substitution (Phe -> Tyr) to amino acid limitation in the chemically defined fermentation medium.	[Zeck, Anne; Regula, Joerg Thomas; Larraillet, Vincent; Mautz, Bjoern; Popp, Oliver; Goepfert, Ulrich; Wiegeshoff, Frank; Vollertsen, Ulrike E. E.; Gorr, Ingo H.; Koll, Hans; Papadimitriou, Apollon] Roche Diagnost GmbH, Biol Res Pharma Res & Early Dev, Penzberg, Germany	Roche Holding	Zeck, A (corresponding author), Inst Univ Tuebingen, NMI Nat & Med Sci, Reutlingen, Germany.	anne.zeck@nmi.de		Regula, Joerg Thomas/0000-0002-7343-1077				Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Dorai H, 2007, BIOPROCESS INT, P66; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Gineikiene E, 2009, EXPERT REV MOL DIAGN, V9, P817, DOI [10.1586/erm.09.66, 10.1586/ERM.09.66]; Guo DL, 2010, BIOTECHNOL BIOENG, V107, P163, DOI 10.1002/bit.22780; Gurer-Orhan H, 2006, BIOCHEM J, V395, P277, DOI 10.1042/BJ20051964; HARRIS RJ, 1993, BIO-TECHNOL, V11, P1293; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Khetan A, 2010, BIOTECHNOL BIOENG, V107, P116, DOI 10.1002/bit.22771; Klipcan L, 2009, P NATL ACAD SCI USA, V106, P11045, DOI 10.1073/pnas.0905212106; Kotia RB, 2010, ANAL BIOCHEM, V399, P190, DOI 10.1016/j.ab.2010.01.008; Listgarten J, 2005, MOL CELL PROTEOMICS, V4, P419, DOI 10.1074/mcp.R500005-MCP200; Omasa T, 2010, BIOPROC BIOSYST ENG, V33, P117, DOI 10.1007/s00449-009-0351-8; Que A, 2010, BIOPROCESS INT, V8, P52; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Ronaghi M, 2007, PHARMACOGENOMICS, V8, P1437, DOI 10.2217/14622416.8.10.1437; Samaranayake H, 2009, ANN MED, V41, P322, DOI 10.1080/07853890802698842; SCORER CA, 1991, NUCLEIC ACIDS RES, V19, P3511, DOI 10.1093/nar/19.13.3511; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wen DY, 2009, J BIOL CHEM, V284, P32686, DOI 10.1074/jbc.M109.059360; Woodward C, 2010, HIGH SPEED AMINO ACI, p[1, 5]; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yang Y, 2010, MABS-AUSTIN, V2, P285, DOI 10.4161/mabs.2.3.11718; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h	27	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40328	10.1371/journal.pone.0040328	http://dx.doi.org/10.1371/journal.pone.0040328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792284	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800071
J	Hone, DWE; Tischlinger, H; Frey, E; Roper, M				Hone, David W. E.; Tischlinger, Helmut; Frey, Eberhard; Roeper, Martin			A New Non-Pterodactyloid Pterosaur from the Late Jurassic of Southern Germany	PLOS ONE			English	Article							LIMESTONE; EVOLUTION; EXTENT; FLIGHT; CHINA	Background: The `Solnhofen Limestone' beds of the Southern Franconian Alb, Bavaria, southern Germany, have for centuries yielded important pterosaur specimens, most notably of the genera Pterodactylus and Rhamphorhynchus. Here we describe a new genus of non-pterodactyloid pterosaur based on an extremely well preserved fossil of a young juvenile: Bellubrunnus rothgaengeri (gen. et sp. nov.). Methodology/Principal Findings: The specimen was examined firsthand by all authors. Additional investigation and photography under UV light to reveal details of the bones not easily seen under normal lighting regimes was completed. Conclusions/Significance: This taxon heralds from a newly explored locality that is older than the classic Solnhofen beds. While similar to Rhamphorhynchus, the new taxon differs in the number of teeth, shape of the humerus and femur, and limb proportions. Unlike other derived non-pterodacytyloids, Bellubrunnus lacks elongate chevrons and zygapophyses in the tail, and unlike all other known pterosaurs, the wingtips are curved anteriorly, potentially giving it a unique flight profile.	[Hone, David W. E.] Univ Coll Dublin, Dept Biol & Environm Sci, Dublin 2, Ireland; [Frey, Eberhard] Staatl Museum Naturkunde Karlsruhe, Karlsruhe, Germany; [Roeper, Martin] Museum Solnhofen, Solnhofen, Germany	University College Dublin	Hone, DWE (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	dwe_hone@yahoo.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824				Andres B, 2010, J VERTEBR PALEONTOL, V30, P163, DOI 10.1080/02724630903409220; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Bennett S. Christopher, 2000, Historical Biology, V14, P255; Bennett SC, 1996, J VERTEBR PALEONTOL, V16, P432, DOI 10.1080/02724634.1996.10011332; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Carpenter K., 2003, SPECIAL PUBLICATIONS, V217, P45; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Colbert E. H., 1969, American Museum Novitates, VNo. 2370, P1; Dyke GJ, 2009, J EVOLUTION BIOL, V22, P890, DOI 10.1111/j.1420-9101.2008.01682.x; Elgin RA, 2011, ACTA PALAEONTOL POL, V56, P99, DOI 10.4202/app.2009.0145; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; FRICKHINGER K.A., 1994, FOSSILIEN SOLNHOFEN; Gasparini Z, 2004, PALAEONTOLOGY, V47, P919, DOI 10.1111/j.0031-0239.2004.00399.x; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Jenkins Farish A. Jr., 2001, Bulletin of the Museum of Comparative Zoology, V156, P151; Kaup J, 1834, ISIS, V3, P311; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Lu JC, 2012, ZOOTAXA, P1; Lu JC, 2011, ACTA GEOL SIN-ENGL, V85, P507, DOI 10.1111/j.1755-6724.2011.00444.x; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Lu JC, 2009, ACTA GEOL SIN-ENGL, V83, P189, DOI 10.1111/j.1755-6724.2009.00062.x; Muller M, 1961, ERLANG GEOL ABH; Padian K, 2008, SPEC PAP PALAEONTOL, P5; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Roper M, 1998, ACTA ALBERTINA RATIS, V50, P77; Roper M, 2005, ZITTELIANA, V26, P57; ROPER M., 1996, PLATTENKALKE BRUNN L; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Seeley H.G., 1870, ORNITHOSAURIA ELEMEN, P135; Tischlinger H., 2005, ZITTELIANA B, V26, P26; Tischlinger H., 2002, ARCHAEOPTERYX, V20, P1; Tischlinger H., 2010, ACTA GEOSCIENTICA SI, V31, P62; Tischlinger Helmut, 2005, Archaeopteryx, V23, P33; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P132; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176	42	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39312	10.1371/journal.pone.0039312	http://dx.doi.org/10.1371/journal.pone.0039312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792168	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300006
J	Inoue, M; Inoue, K; Akimoto, K				Inoue, Machiko; Inoue, Kazuo; Akimoto, Kimihiko			Effects of Age and Sex in the Diagnosis of Type 2 Diabetes Using Glycated Haemoglobin in Japan: The Yuport Medical Checkup Centre Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; A1C-BASED DIAGNOSIS; CARDIOVASCULAR RISK; HBA(1C); INDIVIDUALS; PREVALENCE; CRITERIA; IMPACT; MELLITUS; HBA1C	Background: We examined how the prevalence of individuals diagnosed with diabetes differs by age and sex using the diagnostic criteria of fasting plasma glucose (FPG) and/or glycated haemoglobin (HbA1c) in a large Japanese population. Methods: We conducted a cross-sectional study using a dataset of 33,959 people (16,869 men and 17,090 women) without known diabetes who underwent health checkups from 1998 to 2006. We divided the age range of the participants into six groups of similar numbers. We compared the prevalence of diabetes using the criteria of FPG >= 7.0 mmol/l (126 mg/dl), HbA1c >= 48 mmol/mol (6.5%), or both, in men and women in each age group. Results: Men had higher prevalence of diabetes than women using the criterion of either FPG or HbA1c (7.5% men vs. 3.4% women, P<0.001), or both (4.3% men vs. 1.8% women, P<0.001). HbA1c increased steadily in women through the six age groups. In the oldest group (>= 66 years), the proportion of women among those diagnosed with diabetes was as high as 42.3% (215/508) using the criterion of either FPG or HbA1c, and 41.6% (116/279) using both criteria. Conclusions: Using either FPG or HbA1c, the prevalence of people diagnosed with diabetes would almost double compared to using the criterion of both scores, and this would include more elderly women than men. The impact of introducing HbA1c for diabetes diagnosis should be considered in terms of age and sex.	[Inoue, Machiko] Teikyo Univ, Sch Med, Dept Community Med, Tokyo 173, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Akimoto, Kimihiko] Akimoto Occupat Hlth Consultant Off, Tokyo, Japan	Teikyo University; Teikyo University	Inoue, M (corresponding author), Teikyo Univ, Sch Med, Dept Community Med, Tokyo 173, Japan.	machiko-inoue@umin.ac.jp	Inoue, Machiko/T-4884-2019	Inoue, Machiko/0000-0002-0799-5894				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Buell C, 2007, DIABETES CARE, V30, P2233, DOI 10.2337/dc07-0585; Carrera T, 1998, DIABETES CARE, V21, P2193, DOI 10.2337/diacare.21.12.2193; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Cohen RM, 2010, J CLIN ENDOCR METAB, V95, P5203, DOI 10.1210/jc.2010-2352; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; HASHIMOTO Y, 1995, DIABETES CARE, V18, P1337, DOI 10.2337/diacare.18.10.1337; Heianza Y, 2012, DIABETES RES CLIN PR, V95, P283, DOI 10.1016/j.diabres.2011.10.024; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; Inoue K, 2012, DIABETIC MED, V29, pE75, DOI 10.1111/j.1464-5491.2011.03536.x; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Kim CH, 2011, DIABETES RES CLIN PR, V91, pE8, DOI 10.1016/j.diabres.2010.09.025; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Kuzuya T, 1999, J JPN DIAB SOC, V42, P385; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Mostafa SA, 2010, DIABETIC MED, V27, P762, DOI 10.1111/j.1464-5491.2010.03015.x; Motta M, 2006, ARCH GERONTOL GERIAT, V42, P101, DOI 10.1016/j.archger.2005.05.001; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988; Yates AP, 2002, DIABETIC MED, V19, P254, DOI 10.1046/j.1464-5491.2002.00644.x	30	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40375	10.1371/journal.pone.0040375	http://dx.doi.org/10.1371/journal.pone.0040375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792294	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300060
J	Li, XY; Wang, X; Zhang, SP; Liu, DW; Duan, YX; Dong, W				Li, Xiaoyan; Wang, Xue; Zhang, Shaopeng; Liu, Dawei; Duan, Yuxi; Dong, Wei			Identification of Soybean MicroRNAs Involved in Soybean Cyst Nematode Infection by Deep Sequencing	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; MEDICAGO-TRUNCATULA; SMALL RNAS; REGULATED MICRORNAS; EXPRESSION ANALYSIS; NODULE DEVELOPMENT; RESPONSIVE MIRNAS; TARGET GENES; GENOME; RESISTANCE	Soybean cyst nematode (SCN), Heterodera glycines, is the most devastating pathogen of soybean worldwide. MicroRNAs (miRNAs) are a class of small, non-coding RNAs that are known to play important role in plant stress response. However, there are few reports profiling the miRNA expression patterns during pathogen stress. We sequenced four small RNA libraries from two soybean cultivar (Hairbin xiaoheidou, SCN race 3 resistant, Liaodou 10, SCN race 3 susceptible) that grown under un-inoculated and SCN-inoculated soil. Small RNAs were mapped to soybean genome sequence, 364 known soybean miRNA genes were identified in total. In addition, 21 potential miRNA candidates were identified. Comparative analysis of miRNA profiling indicated 101 miRNAs belong to 40 families were SCN-responsive. We also found 20 miRNAs with different express pattern even between two cultivars of the same species. These findings suggest that miRNA paly important role in soybean response to SCN and have important implications for further identification of miRNAs under pathogen stress.	[Li, Xiaoyan; Zhang, Shaopeng] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Li, Xiaoyan; Zhang, Shaopeng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Xue; Liu, Dawei; Duan, Yuxi] Shenyang Agr Univ, Nematol Inst No China, Shenyang, Peoples R China; [Dong, Wei] Beijing Genom Inst, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shenyang Agricultural University; Beijing Genomics Institute (BGI)	Li, XY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	duanyx6407@163.com; dongw@genomics.org.cn			National Natural Science Foundation of China [30392100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (grant numbers 30392100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P103, DOI 10.1007/978-94-007-0434-3_6; Alkharouf NW, 2006, PLANTA, V224, P838, DOI 10.1007/s00425-006-0270-8; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; [Anonymous], PHYSL PLANTARUM, V138, P226; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen L, 2011, PLANTA; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo N, 2011, GENOME, V54, P954, DOI [10.1139/g11-050, 10.1139/G11-050]; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Hewezi T, 2008, MOL PLANT MICROBE IN, V21, P1622, DOI 10.1094/MPMI-21-12-1622; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jones-Rhoades MW, 2011, PLANT MOL BIOL; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Klink VP, 2007, PLANTA, V226, P1389, DOI 10.1007/s00425-007-0581-4; Krol J, 2010, NATURE REV GENETICS; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li H, 2010, PLANT PHYSIOL, V153, P1759, DOI 10.1104/pp.110.156950; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li XY, 2011, CHINESE SCI BULL, V56, P1904, DOI 10.1007/s11434-011-4510-3; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramsay K, 2006, MOL PLANT PATHOL, V7, P429, DOI 10.1111/j.1364-3703.2006.00348.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simon SA, 2009, PLANT PHYSIOL, V151, P1002, DOI 10.1104/pp.109.144345; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Thiebaut F, 2011, PLANT CELL ENV; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wrather J. A, 2009, EFFECTS DIS SOYBEAN; Zeng HQ, 2010, J PLANT PHYSIOL, V167, P1289, DOI 10.1016/j.jplph.2010.04.017; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	66	92	102	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39650	10.1371/journal.pone.0039650	http://dx.doi.org/10.1371/journal.pone.0039650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22802924	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800056
J	Maussion, G; Yang, J; Yerko, V; Barker, P; Mechawar, N; Ernst, C; Turecki, G				Maussion, Gilles; Yang, Jennie; Yerko, Volodymyr; Barker, Philip; Mechawar, Naguib; Ernst, Carl; Turecki, Gustavo			Regulation of a Truncated Form of Tropomyosin-Related Kinase B (TrkB) by Hsa-miR-185*in Frontal Cortex of Suicide Completers	PLOS ONE			English	Article							MICRORNA BIOGENESIS; PASSENGER STRAND; MENTAL-HEALTH; NEW-BRUNSWICK; EXPRESSION; RISK; MICROPROCESSOR; METHYLATION; DYSFUNCTION; DEPRESSION	Background: TrkB-T1 is a BDNF receptor lacking a tyrosine kinase domain that is highly expressed in astrocytes and regulates BDNF-evoked calcium transients. Previous studies indicate that downregulation of TrkB-T1 in frontal cortex may be involved in neurobiological processes underlying suicide. Methods: In a microarray screening study (N = 8), we interrogated all known microRNA in the frontal cortex of suicide completers with low expression of TrkB-T1 and normal controls. These findings were validated and followed up in a larger sample of cases and controls (N = 55). Functional analyses included microRNA silencing, microRNA overexpression and luciferase assays to investigate specificity and to validate interactions between differentially expressed microRNA and TrkB-T1. Results: MicroRNAs Hsa-miR-185* and Hsa-miR-491-3p were upregulated in suicide completers with low expression of TrkB.T1 (P-nominal: 9.10(-5) and 1.8.10(-4) respectively; FDR-corrected p = 0.031). Bioinformatic analyses revealed five putative binding sites for the DiGeorge syndrome linked microRNA Hsa-miR-185* in the 3'UTR of TrkB-T1, but none for Hsa-miR-491-3P. The increase of Hsa-miR-185* in frontal cortex of suicide completers was validated then confirmed in a larger, randomly selected group of suicide completers, where an inverse correlation between Hsa-miR-185* and TrkB-T1 expression was observed (R = -0.439; p = 0.001). Silencing and overexpression studies performed in human cell lines confirmed the inverse relationship between hsa-mir-185* and trkB-T1 expression. Luciferase assays demonstrated that Hsa-miR-185* binds to sequences in the 39UTR of TrkB-T1. Conclusion: These results suggest that an increase of Hsa-miR-185* expression levels regulates, at least in part, the TrkB-T1 decrease observed in the frontal cortex of suicide completers and further implicate the 22q11 region in psychopathology.	[Maussion, Gilles; Yang, Jennie; Yerko, Volodymyr; Mechawar, Naguib; Ernst, Carl; Turecki, Gustavo] McGill Univ, Douglas Hosp Res Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Barker, Philip] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University; McGill University	Maussion, G (corresponding author), McGill Univ, Douglas Hosp Res Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Maussion, Gilles/AAA-2027-2021; Turecki, Gustavo/K-5100-2015	Maussion, Gilles/0000-0001-5785-6238; Turecki, Gustavo/0000-0003-4075-2736	CIHR (Canadian Institutes of Health Research) [MOP 84291, MOP 93775]; AFSP (American Foundation for Suicide Prevention); FRSQ-INSERM (Institut national de la sante et de la recherche medicale, France)	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); AFSP (American Foundation for Suicide Prevention); FRSQ-INSERM (Institut national de la sante et de la recherche medicale, France)	This work was supported by CIHR (Canadian Institutes of Health Research) grants MOP 84291 and MOP 93775 and an AFSP Distinguished Scientist Award (American Foundation for Suicide Prevention) to GT. GM holds a fellowship from the FRSQ-INSERM program (Institut national de la sante et de la recherche medicale, France). CE is the Canada Research Chair in Psychiatric Genetics and is partially funded by a Young Investigator grant from the American Foundation of Suicide Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Beezhold KJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Boelle PY, 1999, LANCET, V353, P1364, DOI 10.1016/S0140-6736(05)74363-4; Cao Wen, 2005, Journal of Applied Genetics, V46, P217; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Christensen M, 2009, NEUROSCI LETT, V466, P55, DOI 10.1016/j.neulet.2009.04.043; Drury GL, 2010, J BIOL CHEM, V285, P31130, DOI 10.1074/jbc.M110.137919; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Duguay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026430; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Dwivedi Y, 2010, ANN MED, V42, P87, DOI 10.3109/07853890903485730; Ernst C, 2009, MOL PSYCHIATR, V14, P830, DOI 10.1038/mp.2009.35; Ernst C, 2011, BIOL PSYCHIAT, V70, P312, DOI 10.1016/j.biopsych.2011.03.038; Ernst C, 2009, ARCH GEN PSYCHIAT, V66, P22, DOI 10.1001/archpsyc.66.1.22; George Ajish D, 2006, RNA Biol, V3, P57; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Horie T, 2010, CARDIOVASC RES, V87, P656, DOI 10.1093/cvr/cvq148; Hoven CW, 2010, EUR PSYCHIAT; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lesage A, 2008, CAN J PSYCHIAT, V53, P671, DOI 10.1177/070674370805301006; Mai JK, 2007, ATLAS HUMAN BRAIN, P280; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Mazan-Mamczarz Krystyna, 2007, Cancer Genomics & Proteomics, V4, P233; Miguel-Hidalgo JJ, 2010, J AFFECT DISORDERS, V127, P230, DOI 10.1016/j.jad.2010.06.003; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morton S, 2006, BIOCHEM J, V399, P265, DOI 10.1042/BJ20060681; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okasha A, 1999, CLIN PSYCHOL REV, V19, P917, DOI 10.1016/S0272-7358(99)00003-3; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rossbach M, 2010, CURR MOL MED, V10, P361, DOI 10.2174/156652410791317048; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Seguin M, 2006, CAN J PSYCHIAT, V51, P581, DOI 10.1177/070674370605100906; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Valentine GW, 2009, BIOCHEM PHARMACOL, V78, P431, DOI 10.1016/j.bcp.2009.04.008; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Weinberg MS, 2009, HUM MOL GENET, V18, pR27, DOI 10.1093/hmg/ddp070; World Health Organisation, 2009, COUNTR REP	68	56	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39301	10.1371/journal.pone.0039301	http://dx.doi.org/10.1371/journal.pone.0039301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	22802923	Green Published, Green Submitted, gold			2022-12-25	WOS:000305781700027
J	Watanabe, S; Takahashi, N; Uchida, H; Wakasugi, K				Watanabe, Seiji; Takahashi, Nozomu; Uchida, Hiroyuki; Wakasugi, Keisuke			Human Neuroglobin Functions as an Oxidative Stress-responsive Sensor for Neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PROTECTS PC12 CELLS; LIPID RAFTS; OXYGEN; SURFACE; GLOBIN; IDENTIFICATION; ACTIVATION; G-ALPHA(O); RESISTANT	Mammalian neuroglobin (Ngb) protects neuronal cells under conditions of oxidative stress. The mechanism underlying this function is only partly understood. Here, we report that human Ngb exists in lipid rafts only during oxidative stress and that lipid rafts are crucial for neuroprotection by Ngb. The ferrous oxygen-bound form of Ngb, which exists under normoxia, is converted to the ferric bis-His conformation during oxidative stress, inducing large tertiary structural changes. We clarified that ferric bis-His Ngb, but not ferrous ligand-bound Ngb, specifically binds to flotillin-1, a lipid raft microdomain-associated protein, as well as to alpha-subunits of heterotrimeric G proteins (G alpha(i/o)). Moreover, we found that human ferric bis-His Ngb acts as a guanine nucleotide dissociation inhibitor for G alpha(i/o) that has been modified by oxidative stress. In addition, our data shows that Ngb inhibits the decrease in cAMP concentration that occurs under oxidative stress, leading to protection against cell death. Furthermore, by using a mutated Ngb protein that cannot form the bis-His conformation, we demonstrate that the oxidative stress-induced structural changes of human Ngb are essential for its neuroprotective activity.	[Watanabe, Seiji; Takahashi, Nozomu; Uchida, Hiroyuki; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Wakasugi, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	wakasugi@bio.c.u-tokyo.ac.jp	Wakasugi, Keisuke/AAQ-1642-2020	Wakasugi, Keisuke/0000-0002-8408-5616; Watanabe, Seiji/0000-0001-8038-7919	PRESTO program of Japan Science and Technology (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan [23117704]; JSPS	PRESTO program of Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the PRESTO program of Japan Science and Technology (JST) (to K. W.) and a Grant-in-Aid 23117704 for Scientific Research (to K. W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the JSPS Research Fellowships for Young Scientists.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Anselmi M, 2007, BIOPHYS J, V93, P434, DOI 10.1529/biophysj.106.099648; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kim SY, 2008, J BIOL CHEM, V283, P1350, DOI 10.1074/jbc.M702344200; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nienhaus K, 2007, IUBMB LIFE, V59, P490, DOI 10.1080/15216540601188538; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2002, J BIOL CHEM, V277, P9036, DOI 10.1074/jbc.M107392200; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Quinton TM, 2005, J THROMB HAEMOST, V3, P1036, DOI 10.1111/j.1538-7836.2005.01325.x; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stuermer CAO, 2010, TRENDS CELL BIOL, V20, P6, DOI 10.1016/j.tcb.2009.10.003; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; Uno T, 2004, J BIOL CHEM, V279, P5886, DOI 10.1074/jbc.M311748200; Wakasugi K, 2005, ANN NY ACAD SCI, V1053, P220, DOI 10.1196/annals.1344.020; Wakasugi K, 2005, BIOCHEM BIOPH RES CO, V330, P591, DOI 10.1016/j.bbrc.2005.03.021; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P2943, DOI 10.1021/bi0477539; Wakasugi K, 2004, BIOCHEM BIOPH RES CO, V318, P453, DOI 10.1016/j.bbrc.2004.04.045; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wakasugi K., 2011, AM J NEUROPROTEC NEU, V3, P42; Wakasugi K, 2011, MAR GENOM, V4, P137, DOI 10.1016/j.margen.2011.03.001; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P5266, DOI 10.1021/bi800286m; Watanabe S, 2008, BIOCHEM BIOPH RES CO, V369, P695, DOI 10.1016/j.bbrc.2008.02.089; Watanabe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016808; Watanabe S, 2010, FEBS LETT, V584, P2467, DOI 10.1016/j.febslet.2010.04.054; Yang B., 2006, FASEB J, V20, pE688; Yuyama K, 2007, J BIOL CHEM, V282, P26392, DOI 10.1074/jbc.M705046200; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479	55	45	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30128	30138		10.1074/jbc.M112.373381	http://dx.doi.org/10.1074/jbc.M112.373381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787149	Green Published, hybrid			2022-12-25	WOS:000308579800008
J	Rose, MV; Kimaro, G; Nissen, TN; Kroidl, I; Hoelscher, M; Bygbjerg, IC; Mfinanga, SG; Ravn, P				Rose, Michala V.; Kimaro, Godfather; Nissen, Thomas N.; Kroidl, Inge; Hoelscher, Michael; Bygbjerg, Ib C.; Mfinanga, Sayoki G.; Ravn, Pernille			QuantiFERON (R)-TB Gold In-Tube Performance for Diagnosing Active Tuberculosis in Children and Adults in a High Burden Setting	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; SOUTH-AFRICAN CHILDREN; PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; INFECTION; MALNUTRITION; HIV; ANERGY; TESTS; AGE	Aim: To determine whether QuantiFERON (R)-TB Gold In-Tube (QFT) can contribute to the diagnosis of active tuberculosis (TB) in children in a high-burden setting and to assess the performance of QFT and tuberculin skin test (TST) in a prospective cohort of TB suspect children compared to adults with confirmed TB in Tanzania. Methods: Sensitivity and specificity of QFT and TST for diagnosing active TB as well as indeterminate QFT rates and IFN-gamma levels were assessed in 211 TB suspect children in a Tanzanian district hospital and contrasted in 90 adults with confirmed pulmonary TB. Results: Sensitivity of QFT and TST in children with confirmed TB was 19% (5/27) and 6% (2/31) respectively. In adults sensitivity of QFT and TST was 84% (73/87) and 85% (63/74). The QFT indeterminate rate in children and adults was 27% and 3%. Median levels of IFN-gamma were lower in children than adults, particularly children <2 years and HIV infected. An indeterminate result was associated with age <2 years but not malnutrition or HIV status. Overall childhood mortality was 19% and associated with an indeterminate QFT result at baseline. Conclusion: QFT and TST showed poor performance and a surprisingly low sensitivity in children. In contrast the performance in Tanzanian adults was good and comparable to performance in high-income countries. Indeterminate results in children were associated with young age and increased mortality. Neither test can be recommended for diagnosing active TB in children with immature or impaired immunity in a high-burden setting.	[Rose, Michala V.; Bygbjerg, Ib C.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Rose, Michala V.; Nissen, Thomas N.] Hvidovre Univ Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark; [Kimaro, Godfather; Mfinanga, Sayoki G.] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [Kroidl, Inge] NIMR Mbeya Med Res Programme, Mbeya, Tanzania; [Kroidl, Inge; Hoelscher, Michael] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; [Ravn, Pernille] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; National Institute of Medical Research; University of Munich; University of Southern Denmark; Odense University Hospital	Rose, MV (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	michala.rose@gmail.com	Hoelscher, Michael/D-3436-2012	Nissen, Thomas Norrelykke/0000-0001-8565-9629; Bygbjerg, Ib/0000-0001-9100-2754	KNCV Tuberculosis Foundation; Reinholdt Jorck's Fund; Cluster in International Health; Justesen's Fund; Danish Research Council; Danish International Development Assistance [74-08-UHH DANIDA]	KNCV Tuberculosis Foundation; Reinholdt Jorck's Fund; Cluster in International Health; Justesen's Fund; Danish Research Council(Det Frie Forskningsrad (DFF)); Danish International Development Assistance	The study was financially supported by the KNCV Tuberculosis Foundation, Reinholdt Jorck's Fund, Cluster in International Health, Justesen's Fund, Danish Research Council and Danish International Development Assistance (74-08-UHH DANIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004220; [Anonymous], 2006, WHOHTMTB2006371; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Bjerrum S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-6; Cattamanchi A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-75; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Du Toit G, 2002, INT J TUBERC LUNG D, V6, P814; European Centre for Disease Prevention and Control, 2011, US INT GAMM REL ASS; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hamm DM, 2009, J INFECT DIS, V199, P1583, DOI 10.1086/598950; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hoffmann M, 2010, EUR INFECT DIS, V4, P23; Jaspan HB, 2006, AIDS, V20, P483, DOI 10.1097/01.aids.0000210602.40267.60; Lewinsohn DA, 2010, CURR OPIN PEDIATR, V22, P71, DOI 10.1097/MOP.0b013e3283350301; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Lighter J, 2009, PEDIATRICS, V123, P30, DOI 10.1542/peds.2007-3618; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2010, INFECT DIS CLIN N AM, V24, P727, DOI 10.1016/j.idc.2010.04.004; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mbago F, 2010, ANN TB LEPROSY REPOR; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Muheza District Council, 2010, MUH DISTR COUNC REP; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2009, PEDIATRICS, V123, P38, DOI 10.1542/peds.2008-0611; Pai M, 2005, AM J RESP CRIT CARE, V172, P519, DOI 10.1164/rccm.2506003; Pelly TF, 2005, INT J TUBERC LUNG D, V9, P977; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Tatala S R, 2008, Tanzan J Health Res, V10, P189; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; van Rheenen P, 2002, TROP MED INT HEALTH, V7, P435, DOI 10.1046/j.1365-3156.2002.00882.x; World Health Organization, 2011, US TUB INT GAMM REL; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	37	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e37851	10.1371/journal.pone.0037851	http://dx.doi.org/10.1371/journal.pone.0037851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808002	Green Published, Green Submitted, gold			2022-12-25	WOS:000306366400003
J	Benz, J; Sendlmeier, C; Barends, TRM; Meinhart, A				Benz, Juliane; Sendlmeier, Christina; Barends, Thomas R. M.; Meinhart, Anton			Structural Insights into the Effector - Immunity System Tse1/Tsi1 from Pseudomonas aeruginosa	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; PROGRAMMED CELL-DEATH; VI SECRETION; ESCHERICHIA-COLI; BACTERIAL; PROTEIN; MECHANISM; FAMILY; CRYSTALLOGRAPHY; SUPERFAMILY	During an interbacterial battle, the type-6-secretion-system (T6SS) of the human pathogen Pseudomonas aeruginosa injects the peptidoglycan(PG)-hydrolase Tse1 into the periplasm of Gram-negative enemy cells and induces their lysis. However, for its own benefit, P. aeruginosa produces and transports the immunity-protein Tsi1 into its own periplasm where in prevents accidental exo- and endogenous intoxication. Here we present the high-resolution X-ray crystal structure of the lytic enzyme Tse1 and describe the mechanism by which Tse1 cleaves the gamma-D-glutamyl-L-meso-diaminopimelic acid amide bond of crosslinked PG. Tse1 belongs to the superfamily of N1pC/P60 peptidases but is unique among described members of this family of which the structure was described, since it is a single domain protein without any putative localization domain. Most importantly, we present the crystal structure of Tse1 bound to its immunity-protein Tsi1 as well and describe the mechanism of enzyme inhibition. Tsi1 occludes the active site of Tse1 and abolishes its enzyme activity by forming a hydrogen bond to a catalytically important histidine residue in Tse1. Based on our structural findings in combination with a bioinfomatic approach we also identified a related system in Burkholderia phytofirmans. Not only do our findings point to a common catalytic mechanism of the Tse1 PG-hydrolases, but we can also show that it is distinct from other members of this superfamily. Furthermore, we provide strong evidence that the mechanism of enzyme inhibition between Tsi1 orthologues is conserved. This work is the first structural description of an entire effector/immunity pair injected by the T6SS system. Moreover, it is also the first example of a member of the N1pC/P60 superfamily which becomes inhibited upon binding to its cognate immunity protein.	[Benz, Juliane; Sendlmeier, Christina; Barends, Thomas R. M.; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany	Max Planck Society	Benz, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany.	anton.meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014		Max Planck Society; Chica and Heinz Schaller Foundation	Max Planck Society(Max Planck Society); Chica and Heinz Schaller Foundation	This study was financially supported by the Max Planck Society and the Chica and Heinz Schaller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Cramer WA, 1999, NAT STRUCT BIOL, V6, P295, DOI 10.1038/7520; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fu ZB, 2007, J BACTERIOL, V189, P8871, DOI 10.1128/JB.01272-07; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; HARTLEY RW, 1973, J BIOL CHEM, V248, P5624; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; James R, 2002, BIOCHIMIE, V84, P381, DOI 10.1016/S0300-9084(02)01450-5; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Meng W, 2010, J MED CHEM, V53, P5620, DOI 10.1021/jm100634a; Miranda JJL, 2003, PROTEIN SCI, V12, P73, DOI 10.1110/ps.0224203; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nakajima Y, 2008, J BACTERIOL, V190, P7819, DOI 10.1128/JB.02010-07; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Papadakos G, 2012, Q REV BIOPHYS, V45, P57, DOI 10.1017/S0033583511000114; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Sudmeier JL, 2003, J AM CHEM SOC, V125, P8430, DOI 10.1021/ja034072c; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Zou TT, 2012, J MOL BIOL, V417, P351, DOI 10.1016/j.jmb.2012.01.040	64	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40453	10.1371/journal.pone.0040453	http://dx.doi.org/10.1371/journal.pone.0040453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792331	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800088
J	Mpyet, C; Lass, BD; Yahaya, HB; Solomon, AW				Mpyet, Caleb; Lass, Barka David; Yahaya, Hadi B.; Solomon, Anthony W.			Prevalence of and Risk Factors for Trachoma in Kano State, Nigeria	PLOS ONE			English	Article							VISUAL IMPAIRMENT; MUSCA-SORBENS; VECTOR	Background: In northern Nigeria, trachoma is an important public health problem, but there are currently few population-based data on prevalence of disease and no formal trachoma control programs. Methodology / Principal Findings: In Kano state, Nigeria, we conducted a population-based cross-sectional survey using multistage cluster random sampling, combining examination for clinical signs of trachoma and application of questionnaires assessing potential household-level risk factors. A total of 4491 people were examined in 40 clusters, of whom 1572 were aged 1-9 years, and 2407 (53.6%) were female. In 1-9 year-olds, the prevalence of trachomatous inflammation-follicular (TF) was 17.5% (95% CI: 15.7-19.5%). In a multivariate model, independent risk factors for active trachoma were the presence of flies on the face (OR 1.98, 95% CI 1.30-3.02); a dirty face (OR 2.45, 95% CI 1.85-3.25) and presence of animal dung within the compound of residence (OR 3.46, 95% CI 1.62-7.41). The prevalence of trachomatous trichiasis in persons aged >= 15years was 10.9% (95% CI: 9.7-12.2%). Trichiasis was significantly more common in adult females than in adult males. Conclusion/Significance: There is an urgent need for a trachoma control program in Kano state, with emphasis given to provision of good quality trichiasis surgery. Particular effort will need to be made to identify women with trichiasis and engage them with appropriate services while also taking steps to secure azithromycin for mass treatment and ensuring personal and environmental hygiene.	[Mpyet, Caleb] Jos Univ Teaching Hosp, Dept Ophthalmol, Jos, Nigeria; [Lass, Barka David] Bingham Univ Teaching Hosp, Dept Ophthalmol, Jos, Nigeria; [Yahaya, Hadi B.] Murtala Mohammed Specialist Hosp, Dept Ophthalmol, Kano, Nigeria; [Solomon, Anthony W.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Mpyet, C (corresponding author), Jos Univ Teaching Hosp, Dept Ophthalmol, Jos, Nigeria.	mpyetc@yahoo.com		Solomon, Anthony/0000-0001-7101-6649	CBM Vision2020 Support Program, Jos, Nigeria; National Institute for Health Research [CL-2009-20-001] Funding Source: researchfish	CBM Vision2020 Support Program, Jos, Nigeria; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by CBM Vision2020 Support Program, Jos, Nigeria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu L, 2002, Niger J Med, V11, P108; Abdull MM, 2009, INVEST OPHTH VIS SCI, V50, P4114, DOI 10.1167/iovs.09-3507; Emerson PM, 2000, T ROY SOC TROP MED H, V94, P28, DOI 10.1016/S0035-9203(00)90427-9; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; Jip NF, 2008, OPHTHAL EPIDEMIOL, V15, P294, DOI 10.1080/09286580802256542; Kalua K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009067; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Miller K, 2004, BRIT J OPHTHALMOL, V88, P750, DOI 10.1136/bjo.2003.038661; Mpyet C, 2008, OPHTHAL EPIDEMIOL, V15, P303, DOI 10.1080/09286580802237633; Office S.I.N.S, 2009, REPORT 2009 POPULATI; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schemann JF, 2003, T ROY SOC TROP MED H, V97, P63, DOI 10.1016/S0035-9203(03)90025-3; Solomon AW, 2006, TRACHOMA CONTROL GUI; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; West S, 2004, BRIT J OPHTHALMOL, V88, P1368, DOI 10.1136/bjo.2004.041657; World Health Assembly, 1998, 51 WORLD HLTH ASS GE	17	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40421	10.1371/journal.pone.0040421	http://dx.doi.org/10.1371/journal.pone.0040421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792311	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000306461800080
J	Park, JH; Darvin, P; Lim, EJ; Joung, YH; Hong, DY; Park, EU; Park, SH; Choi, SK; Moon, ES; Cho, BW; Park, KD; Lee, HK; Kim, MJ; Park, DS; Chung, IM; Yang, YM				Park, Jin Hee; Darvin, Pramod; Lim, Eun Joung; Joung, Youn Hee; Hong, Dae Young; Park, Eui U.; Park, Seung Hwa; Choi, Soo Keun; Moon, Eon-Soo; Cho, Byung Wook; Park, Kyung Do; Lee, Hak Kyo; Kim, Myong-Jo; Park, Dong-Sik; Chung, Ill-Min; Yang, Young Mok			Hwanggeumchal sorghum Induces Cell Cycle Arrest, and Suppresses Tumor Growth and Metastasis through Jak2/STAT Pathways in Breast Cancer Xenografts	PLOS ONE			English	Article							FACTOR-I RECEPTOR; SIGNAL TRANSDUCER; IGF-1 EXPRESSION; KINASE-ACTIVITY; HYPOXIA; APOPTOSIS; STAT5B; ACTIVATOR; PROTEIN; PHASE	Background: Cancer is one of the highly virulent diseases known to humankind with a high mortality rate. Breast cancer is the most common cancer in women worldwide. Sorghum is a principal cereal food in many parts of the world, and is critical in folk medicine of Asia and Africa. In the present study, we analyzed the effects of HSE in metastatic breast cancer. Methodology/Principal Findings: Preliminary studies conducted on MDA-MB 231 and MCF-7 xenograft models showed tumor growth suppression by HSE. Western blotting studies conducted both in vivo and in vitro to check the effect of HSE in Jak/STAT pathways. Anti-metastatic effects of HSE were confirmed using both MDA-MB 231 and MCF-7 metastatic animal models. These studies showed that HSE can modulate Jak/STAT pathways, and it hindered the STAT5b/IGF-1R and STAT3/VEGF pathways not only by down-regulating the expression of these signal molecules and but also by preventing their phosphorylation. The expression of angiogenic factors like VEGF, VEGF-R2 and cell cycle regulators like cyclin D, cyclin E, and pRb were found down-regulated by HSE. In addition, it also targets Brk, p53, and HIF-1 alpha for anti-cancer effects. HSE induced G1 phase arrest and migration inhibition in MDA-MB 231 cells. The metastasis of breast cancer to the lungs also found blocked by HSE in the metastatic animal model. Conclusions/Significance: Usage of HS as a dietary supplement is an inexpensive natural cancer therapy, without any side effects. We strongly recommend the use of HS as an edible therapeutic agent as it possesses tumor suppression, migration inhibition, and anti-metastatic effects on breast cancer.	[Park, Jin Hee; Darvin, Pramod; Lim, Eun Joung; Joung, Youn Hee; Yang, Young Mok] Konkuk Univ, Sch Med, Dept Pathol, Seoul, South Korea; [Park, Jin Hee; Darvin, Pramod; Lim, Eun Joung; Joung, Youn Hee; Yang, Young Mok] Konkuk Univ, Inst Biomed Sci & Technol, Seoul, South Korea; [Hong, Dae Young] Konkuk Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Park, Eui U.] Konkuk Univ, Sch Med, Dept Forens Med, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Sch Med, Dept Anat, Seoul, South Korea; [Choi, Soo Keun] Kyung Hee Univ, Coll Hotel & Tourism Management, Dept Culinary & Serv Management, Seoul, South Korea; [Moon, Eon-Soo] Konkuk Univ, Sch Med, Dept Internal Med, Chungju, South Korea; [Cho, Byung Wook] Pusan Natl Univ, Coll Life Sci, Dept Anim Sci, Pusan 609735, South Korea; [Park, Kyung Do; Lee, Hak Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea; [Kim, Myong-Jo] Kangwon Natl Univ, Dept Appl Plant Sci, Chunchon, South Korea; [Park, Dong-Sik] Rural Dev Adm, Suwon, South Korea; [Chung, Ill-Min] Konkuk Univ, Dept Appl Life Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Kyung Hee University; Konkuk University; Konkuk University Medical Center; Pusan National University; Hankyong National University; Kangwon National University; Rural Development Administration (RDA); Konkuk University	Park, JH (corresponding author), Konkuk Univ, Sch Med, Dept Pathol, Glocal Campus, Seoul, South Korea.	ymyang@kku.ac.kr	Darvin, Pramod/M-1730-2019	Darvin, Pramod/0000-0003-3746-109X; Kim, Myong Jo/0000-0003-4378-4071	Next generation BioGreen 21 Programs [PJ0081062011]; Biogreen 21 programs, Rural Development Administration, South Korea [PJ006457]	Next generation BioGreen 21 Programs; Biogreen 21 programs, Rural Development Administration, South Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Next generation BioGreen 21 Programs (No. PJ0081062011), and partially supported by Biogreen 21 programs (No. PJ006457), Rural Development Administration, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awika JM, 2004, PHYTOCHEMISTRY, V65, P1199, DOI 10.1016/j.phytochem.2004.04.001; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; BARTKOVA J, 1994, J PATHOL, V172, P237, DOI 10.1002/path.1711720303; BASERGA R, 1994, CELL, V79, P927, DOI 10.1016/0092-8674(94)90023-X; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341; Carr TP, 2005, J NUTR, V135, P2236, DOI 10.1093/jn/135.9.2236; Chen WJ, 2003, BIOCHEM PHARMACOL, V65, P1777, DOI 10.1016/S0006-2952(03)00156-4; Cho SH, 2000, FASEB J, V14, pA249; Chung IM, 2011, IMMUNOPHARM IMMUNOT, V33, P447, DOI 10.3109/08923973.2010.532804; Chung IM, 2004, KOREAN SOC CROP SCI, V8, P5; Dal Monte M, 2007, INVEST OPHTH VIS SCI, V48, P3480; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Friedman M, 2007, J AGR FOOD CHEM, V55, P243, DOI 10.1021/jf062276h; Funamoto M, 2000, J BIOL CHEM, V275, P10561, DOI 10.1074/jbc.275.14.10561; Girnita L, 2000, CANCER RES, V60, P5278; Gupta K, 2005, POSTGRAD MED J, V81, P236, DOI 10.1136/pgmj.2004.023309; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Himpe E, 2009, BIOFACTORS, V35, P76, DOI 10.1002/biof.20; Huang CS, 1998, CANCER RES, V58, P4102; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Joung YH, 2005, EXP MOL MED, V37, P353, DOI 10.1038/emm.2005.45; Joung YH, 2008, INT J ONCOL, V33, P477, DOI 10.3892/ijo_00000030; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kil HY, 2009, FOOD CHEM, V115, P1234, DOI 10.1016/j.foodchem.2009.01.032; Kurmasheva RT, 2006, BBA-REV CANCER, V1766, P1, DOI 10.1016/j.bbcan.2006.05.003; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee MY, 2006, BREAST, V15, P187, DOI 10.1016/j.breast.2005.05.005; Lim EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033361; Lim EJ, 2010, INT J ONCOL, V36, P1243, DOI 10.3892/ijo_00000608; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mo HB, 1999, J NUTR, V129, P804, DOI 10.1093/jn/129.4.804; Morrissey PA, 1998, INT DAIRY J, V8, P463, DOI 10.1016/S0958-6946(98)00070-3; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Resnik JL, 1998, CANCER RES, V58, P1159; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Ryu HS, 2008, KOREAN J NUTR, V19, P176; SENGER DR, 1986, CANCER RES, V46, P5629; Takahashi H, 2000, BIOCHEM BIOPH RES CO, V267, P388, DOI 10.1006/bbrc.1999.1931; Terman BI, 2001, EINSTEIN Q J BIOL ME, V18, P59; Thomas R, 2009, PROSTATE, V69, P263, DOI 10.1002/pros.20885; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tweardy D, 2011, J CLIN ONCOL, V29, P2443, DOI 10.1200/JCO.2010.34.2014; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WARNER TF, 1988, MED HYPOTHESES, V26, P99, DOI 10.1016/0306-9877(88)90060-6; Werner H, 2006, TRENDS ENDOCRIN MET, V17, P236, DOI 10.1016/j.tem.2006.06.007; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yang LY, 2009, J AGR FOOD CHEM, V57, P1797, DOI 10.1021/jf8035066; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162	58	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40531	10.1371/journal.pone.0040531	http://dx.doi.org/10.1371/journal.pone.0040531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792362	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800103
J	Sivik, T; Gunnarsson, C; Fornander, T; Nordenskjold, B; Skoog, L; Stal, O; Jansson, A				Sivik, Tove; Gunnarsson, Cecilia; Fornander, Tommy; Nordenskjold, Bo; Skoog, Lambert; Stal, Olle; Jansson, Agneta			17 beta-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer	PLOS ONE			English	Article							ADJUVANT TAMOXIFEN; PROGNOSTIC MARKER; POSTMENOPAUSAL; DEHYDROGENASES; AMPLIFICATION; INHIBITORS; EXPRESSION; HSD17B1	Introduction: 17 beta-hydroxysteroid dehydrogenases (17 beta HSDs) are important enzymes regulating the pool of bioactive steroids in the breast. The current study was undertaken in order to evaluate implications of 17 beta HSD14 in breast cancer, measuring 17 beta HSD14 protein expression in breast tumours. Methods: An antibody targeting the 17 beta HSD14 antigen was generated and validated using HSD17B14-transfected cells and a peptide-neutralising assay. Tissue microarrays with tumours from 912 post-menopausal women diagnosed with lymph node-negative breast cancer, and randomised to adjuvant tamoxifen or no endocrine treatment, were analysed for 17 beta HSD14 protein expression with immunohistochemistry. Results: Results were obtained from 847 tumours. Patients with oestrogen positive tumours with high 17 beta HSD14 expression had fewer local recurrences when treated with tamoxifen (HR 0.38; 95% C.I. 0.19-0.77, p = 0.007) compared to patients with lower tumoural 17 beta HSD14 expression, for whom tamoxifen did not reduce the number of local recurrences (HR 1.19; 95% C.I. 0.54-2.59; p = 0.66). No prognostic importance of 17 beta HSD14 was seen for systemically untreated patients. Conclusions: Using a highly specific validated antibody for immunohistochemical analysis of a large number of breast tumours, we have shown that tumoural expression levels of 17 beta HSD14 can predict the outcome of adjuvant tamoxifen treatment in terms of local recurrence-free survival in patients with lymph node-negative ER+ breast cancer. The results need be verified to confirm any clinical relevance.	[Sivik, Tove; Nordenskjold, Bo; Stal, Olle; Jansson, Agneta] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden; [Gunnarsson, Cecilia] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Clin Genet, Linkoping, Sweden; [Gunnarsson, Cecilia; Nordenskjold, Bo; Stal, Olle] Cty Council Ostergotland, Linkoping, Sweden; [Fornander, Tommy; Skoog, Lambert] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Linkoping University; Linkoping University; City Council Ostergotland; Karolinska Institutet	Sivik, T (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden.	tove.sivik@liu.se	Gunnarsson, Cecilia/ABD-9170-2021		Swedish Cancer Society; Swedish Research Council [K2008-54X-20639-01-3]; Olle Engkvist Byggmastare Foundation; Cancer and Allergy Foundation; Percy Falk's Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Olle Engkvist Byggmastare Foundation; Cancer and Allergy Foundation; Percy Falk's Foundation	The study was supported by grants from the Swedish Cancer Society, Swedish Research Council (K2008-54X-20639-01-3), Olle Engkvist Byggmastare Foundation, The Cancer and Allergy Foundation and Percy Falk's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Gunnarsson C, 2003, ONCOGENE, V22, P34, DOI 10.1038/sj.onc.1206078; Gunnarsson C, 2001, CANCER RES, V61, P8448; Gunnarsson C, 2008, BREAST CANCER RES TR, V108, P35, DOI 10.1007/s10549-007-9579-7; IINO Y, 1991, BRIT J CANCER, V64, P1019, DOI 10.1038/bjc.1991.457; Jansson A, 2009, CLIN CANCER RES, V15, P3610, DOI 10.1158/1078-0432.CCR-08-2599; Jansson AK, 2006, CANCER RES, V66, P11471, DOI 10.1158/0008-5472.CAN-06-1448; Khoshnoud MR, 2011, BREAST CANC RES TREA; Labrie F, 1995, ANN NY ACAD SCI, V774, P16, DOI 10.1111/j.1749-6632.1995.tb17369.x; LONNING PE, 1990, J STEROID BIOCHEM, V35, P355, DOI 10.1016/0022-4731(90)90241-J; Lukacik P, 2007, BIOCHEM J, V402, P419, DOI 10.1042/BJ20061319; Oduwole OO, 2004, CANCER RES, V64, P7604, DOI 10.1158/0008-5472.CAN-04-0446; Pasqualini JR, 2009, MATURITAS, V62, P343, DOI 10.1016/j.maturitas.2008.12.008; Rutqvist LE, 2007, ACTA ONCOL, V46, P133, DOI 10.1080/02841860601034834; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900	18	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40568	10.1371/journal.pone.0040568	http://dx.doi.org/10.1371/journal.pone.0040568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792371	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800107
J	van der Heijden, K; Petersen, JM; Dubilier, N; Borowski, C				van der Heijden, Karina; Petersen, Jillian M.; Dubilier, Nicole; Borowski, Christian			Genetic Connectivity between North and South Mid-Atlantic Ridge Chemosynthetic Bivalves and Their Symbionts	PLOS ONE			English	Article							SEA HYDROTHERMAL VENT; SHRIMP RIMICARIS-EXOCULATA; EVOLUTIONARY RELATIONSHIPS; ENDOSYMBIOTIC BACTERIA; VESICOMYIDAE BIVALVIA; LARVAL DISPERSAL; MUSSELS BIVALVIA; DUAL SYMBIOSIS; FRACTURE-ZONE; HYBRID ZONE	Transform faults are geological structures that interrupt the continuity of mid-ocean ridges and can act as dispersal barriers for hydrothermal vent organisms. In the equatorial Atlantic Ocean, it has been hypothesized that long transform faults impede gene flow between the northern and the southern Mid-Atlantic Ridge (MAR) and disconnect a northern from a southern biogeographic province. To test if there is a barrier effect in the equatorial Atlantic, we examined phylogenetic relationships of chemosynthetic bivalves and their bacterial symbionts from the recently discovered southern MAR hydrothermal vents at 5 degrees S and 9 degrees S. We examined Bathymodiolus spp. mussels and Abyssogena southwardae clams using the mitochondrial cytochrome c oxidase subunit I (COI) gene as a phylogenetic marker for the hosts and the bacterial 16S rRNA gene as a marker for the symbionts. Bathymodiolus spp. from the two southern sites were genetically divergent from the northern MAR species B. azoricus and B. puteoserpentis but all four host lineages form a monophyletic group indicating that they radiated after divergence from their northern Atlantic sister group, the B. boomerang species complex. This suggests dispersal of Bathymodiolus species from north to south across the equatorial belt. 16S rRNA genealogies of chemoautotrophic and methanotrophic symbionts of Bathymodiolus spp. were inconsistent and did not match the host COI genealogy indicating disconnected biogeography patterns. The vesicomyid clam Abyssogena southwardae from 5 degrees S shared an identical COI haplotype with A. southwardae from the Logatchev vent field on the northern MAR and their symbionts shared identical 16S phylotypes, suggesting gene flow across the Equator. Our results indicate genetic connectivity between the northern and southern MAR and suggest that a strict dispersal barrier does not exist.	[van der Heijden, Karina; Petersen, Jillian M.; Dubilier, Nicole; Borowski, Christian] Max Planck Inst Marine Microbiol, Symbiosis Grp, Bremen, Germany	Max Planck Society	van der Heijden, K (corresponding author), Max Planck Inst Marine Microbiol, Symbiosis Grp, Bremen, Germany.	cborowsk@mpi-bremen.de	Petersen, Jillian/GVU-6351-2022; Petersen, Jillian/K-6066-2015; Dubilier, Nicole/I-8203-2018	Dubilier, Nicole/0000-0002-9394-825X; Petersen, Jillian/0000-0002-9852-3445	German Research Foundation (DFG) within the framework of the Program SPP 1144 "From Mantle to the Ocean: Energy-Material- and Life-Cycles at Spreading Axes'' [BO2500/2-1]; DFG Cluster of Excellence "The Ocean in the Earth System'' at MARUM, Bremen; Max Planck Society	German Research Foundation (DFG) within the framework of the Program SPP 1144 "From Mantle to the Ocean: Energy-Material- and Life-Cycles at Spreading Axes''(German Research Foundation (DFG)); DFG Cluster of Excellence "The Ocean in the Earth System'' at MARUM, Bremen; Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding was granted through the German Research Foundation (DFG, project no. BO2500/2-1) within the framework of the Program SPP 1144 "From Mantle to the Ocean: Energy-Material- and Life-Cycles at Spreading Axes'', the DFG Cluster of Excellence "The Ocean in the Earth System'' at MARUM, Bremen, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; Bulgheresi S, 2011, ISME J, V5, P986, DOI 10.1038/ismej.2010.198; CANNAT M, 1991, J GEODYN, V13, P97, DOI 10.1016/0264-3707(91)90034-C; CARY SC, 1993, P NATL ACAD SCI USA, V90, P5695, DOI 10.1073/pnas.90.12.5695; DeChaine EG, 2006, ENVIRON MICROBIOL, V8, P1902, DOI 10.1111/j.1462-2920.2005.01113.x; Dekov V, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005526; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; ENDOW K, 1990, MAR ECOL PROG SER, V64, P309, DOI 10.3354/meps064309; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; German CR, 2008, EARTH PLANET SC LETT, V273, P332, DOI 10.1016/j.epsl.2008.06.048; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; Haase KM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001509; Haase KM, 2009, MAR GEOL, V266, P52, DOI 10.1016/j.margeo.2009.07.012; HEEZEN BC, 1964, DEEP-SEA RES, V11, P11, DOI 10.1016/0011-7471(64)91079-4; Hein J., 1999, EXPLOR MIN GEOL, V8, P299; Hurtado LA, 2003, APPL ENVIRON MICROB, V69, P2058, DOI 10.1128/AEM.69.4.2058-2064.2003; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; JOLLIVET D, 1995, HEREDITY, V74, P376, DOI 10.1038/hdy.1995.56; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Krylova EM, 2010, J MOLLUS STUD, V76, P107, DOI 10.1093/mollus/eyp052; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Le Pennec M, 1988, J SHELLFISH RES, V7, P483; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; LUTZ RA, 1984, SCIENCE, V226, P1451, DOI 10.1126/science.226.4681.1451; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Mercier H, 1998, J PHYS OCEANOGR, V28, P779, DOI 10.1175/1520-0485(1998)028<0779:TOBWIT>2.0.CO;2; Miyazaki JI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010363; Mullineaux LS, 2002, CAH BIOL MAR, V43, P281; MULLINEAUX LS, 1995, GEOPHYS MONOGR SER, V91, P408; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Peek AS, 2000, J MOL EVOL, V50, P141, DOI 10.1007/s002399910016; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Peek AS, 1998, MOL BIOL EVOL, V15, P1514, DOI 10.1093/oxfordjournals.molbev.a025879; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Petersen JM, 2009, ENV MICROBIOL REP, V1, P319, DOI 10.1111/j.1758-2229.2009.00081.x; Plouviez S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-220; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; Shank T, 2004, OCEANUS, V42, P78; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Smith CR, 1998, CAH BIOL MAR, V39, P345; Stewart FJ, 2008, MOL BIOL EVOL, V25, P673, DOI 10.1093/molbev/msn010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Tyler PA, 2003, HYDROBIOLOGIA, V503, P9, DOI 10.1023/B:HYDR.0000008492.53394.6b; Tyler PA, 2002, OCEANOL ACTA, V25, P227, DOI 10.1016/S0399-1784(02)01202-1; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Won Y, 2003, MOL ECOL, V12, P169, DOI 10.1046/j.1365-294X.2003.01726.x; Won YJ, 2002, CAH BIOL MAR, V43, P387; Won YJ, 2003, APPL ENVIRON MICROB, V69, P6785, DOI 10.1128/AEM.69.11.6785-6792.2003; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2	73	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39994	10.1371/journal.pone.0039994	http://dx.doi.org/10.1371/journal.pone.0039994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792208	gold, Green Submitted, Green Published			2022-12-25	WOS:000306461800030
J	Xiao, B; Huang, YS; Zhang, LZ; Lin, ZB; Wang, GF				Xiao, Bin; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu			Growth, Structure and Spectroscopic Characterization of Nd3+-Doped KBaGd(WO4)(3) Crystal with a Disordered Structure	PLOS ONE			English	Article							OPTICAL SPECTROSCOPY; ND-YAG; LASER; INTENSITIES; ABSORPTION	The undoped and the Nd3+:KBaGd(WO4)(3) crystals were grown by the top seeded solution growth (TSSG) method from a flux of K2W2O7. The structure of the pure crystal was determined by the single-crystal X-ray diffraction method. It crystallizes in the monoclinic symmetry with space group C2/c. In the structure, K+ and Ba2+ ions share the same 8f site with occupancy of 0.464 and 0.536, respectively. The investigation of spectral properties of Nd3+: KBaGd(WO4)(3) crystal indicates that it exhibits broad absorption and emission bands, which are attributed to locally disordered environments around the Nd3+ centers. The broad absorption band is suitable for diode laser pumping.	[Xiao, Bin; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu] Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China; [Xiao, Bin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, B (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China.	wgf@ms.fjirsm.ac.cn		Xiao, Bin/0000-0001-8512-0340	National Natural Science Foundation of China [61108054]; National Natural Science Foundation of Fujian Province [2011J01376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work is supported by the National Natural Science Foundation of China (No. 61108054) and the National Natural Science Foundation of Fujian Province (No. 2011J01376), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULL BF, 1982, IEEE J QUANTUM ELECT, V18, P925, DOI 10.1109/JQE.1982.1071611; BELRUSS V, 1971, MATER RES BULL, V6, P899, DOI 10.1016/0025-5408(71)90068-7; Cano-Torres JM, 2006, J OPT SOC AM B, V23, P2494, DOI 10.1364/JOSAB.23.002494; Cascales C, 2005, OPT MATER, V27, P1672, DOI 10.1016/j.optmat.2004.11.051; Cavalli E, 1999, J OPT SOC AM B, V16, P1958, DOI 10.1364/JOSAB.16.001958; Chen YJ, 2004, CHEM PHYS LETT, V397, P282, DOI 10.1016/j.cplett.2004.09.002; Garcia-Cortes A, 2008, APPL PHYS B-LASERS O, V91, P507, DOI 10.1007/s00340-008-3041-3; GIESEN A, 1994, APPL PHYS B-LASERS O, V58, P365, DOI 10.1007/BF01081875; Huang XY, 2009, J ALLOY COMPD, V468, P321, DOI 10.1016/j.jallcom.2007.12.091; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; Kaminsky W, 2007, J APPL CRYSTALLOGR, V40, P382, DOI 10.1107/S0021889807003986; Korotkov AS, 2010, J PHYS CHEM SOLIDS, V71, P958, DOI 10.1016/j.jpcs.2010.04.002; Li H, 2010, CRYSTENGCOMM, V12, P1307, DOI 10.1039/b914641e; Li H, 2009, J ALLOY COMPD, V478, P484, DOI 10.1016/j.jallcom.2008.11.079; Lu J, 2000, APPL PHYS B-LASERS O, V71, P469, DOI 10.1007/s003400000394; Meng XM, 2011, CRYSTENGCOMM, V13, P4069, DOI 10.1039/c0ce00922a; Minassian A, 2003, APPL PHYS B-LASERS O, V76, P341, DOI 10.1007/s00340-003-1095-9; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; Pujol MC, 1999, APPL PHYS B-LASERS O, V68, P187, DOI 10.1007/s003400050605; RAZEGHI M, 1994, NATURE, V369, P631, DOI 10.1038/369631a0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Song J, 1999, APPL OPTICS, V38, P5158, DOI 10.1364/AO.38.005158; Wang CQ, 2000, APPL PHYS B-LASERS O, V70, P769, DOI 10.1007/PL00021132; Zhou W.-L., 1997, OSA Trends in Optics and Photonics Series. Vol.10 Advanced Solid State Lasers. From the Topical Meeting, P451; Zhu HM, 2007, J OPT SOC AM B, V24, P2659, DOI 10.1364/JOSAB.24.002659	25	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40229	10.1371/journal.pone.0040229	http://dx.doi.org/10.1371/journal.pone.0040229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792248	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800053
J	Zhang, ZY; Ye, WM; Qian, Y; Zheng, ZG; Huang, XH; Hu, G				Zhang, Zhaoyang; Ye, Weiming; Qian, Yu; Zheng, Zhigang; Huang, Xuhui; Hu, Gang			Chaotic Motifs in Gene Regulatory Networks	PLOS ONE			English	Article							NEGATIVE FEEDBACK LOOPS; BELOUSOV-ZHABOTINSKY REACTION; PEROXIDASE-OXIDASE REACTION; DETERMINISTIC CHAOS; ESCHERICHIA-COLI; COMPLEX DYNAMICS; BUILDING-BLOCKS; TIM PROTEINS; MODEL; OSCILLATIONS	Chaos should occur often in gene regulatory networks (GRNs) which have been widely described by nonlinear coupled ordinary differential equations, if their dimensions are no less than 3. It is therefore puzzling that chaos has never been reported in GRNs in nature and is also extremely rare in models of GRNs. On the other hand, the topic of motifs has attracted great attention in studying biological networks, and network motifs are suggested to be elementary building blocks that carry out some key functions in the network. In this paper, chaotic motifs (subnetworks with chaos) in GRNs are systematically investigated. The conclusion is that: (i) chaos can only appear through competitions between different oscillatory modes with rivaling intensities. Conditions required for chaotic GRNs are found to be very strict, which make chaotic GRNs extremely rare. (ii) Chaotic motifs are explored as the simplest few-node structures capable of producing chaos, and serve as the intrinsic source of chaos of random few-node GRNs. Several optimal motifs causing chaos with atypically high probability are figured out. (iii) Moreover, we discovered that a number of special oscillators can never produce chaos. These structures bring some advantages on rhythmic functions and may help us understand the robustness of diverse biological rhythms. (iv) The methods of dominant phase-advanced driving (DPAD) and DPAD time fraction are proposed to quantitatively identify chaotic motifs and to explain the origin of chaotic behaviors in GRNs.	[Zhang, Zhaoyang; Ye, Weiming; Zheng, Zhigang; Huang, Xuhui; Hu, Gang] Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China; [Ye, Weiming] Beijing Normal Univ, Sch Management, Beijing 100875, Peoples R China; [Qian, Yu] Baoji Univ Arts & Sci, Nonlinear Res Inst, Baoji, Peoples R China	Beijing Normal University; Beijing Normal University; Baoji University of Arts & Sciences	Zhang, ZY (corresponding author), Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China.	hxhoneness@gmail.com; ganghu@bnu.edu.cn	Qian, Yu/A-7862-2012	huang, xu hui/0000-0003-1477-9572; Zheng, Zhigang/0000-0002-1421-0442	National Natural Science Foundation of China [10975015, 11174034, 11105003]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China under Grant No. 10975015, 11174034 and 11105003 and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; BRONNIKOVA TV, 1995, J PHYS CHEM-US, V99, P9309, DOI 10.1021/j100023a001; DECROLY O, 1982, P NATL ACAD SCI-BIOL, V79, P6917, DOI 10.1073/pnas.79.22.6917; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; Goldbeter A., 1996, BIOCH OSCILLATIONS C; GYORGYI L, 1992, NATURE, V355, P808, DOI 10.1038/355808a0; GYORGYI L, 1989, J CHEM PHYS, V91, P6131, DOI 10.1063/1.457432; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hauser MJB, 1997, J PHYS CHEM B, V101, P5075, DOI 10.1021/jp9707549; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; Kappler K, 2003, SIGNAL PROCESS, V83, P789, DOI 10.1016/S0165-1684(02)00479-6; Kobayashi Y, 2010, EUR PHYS J B, V76, P167, DOI 10.1140/epjb/e2010-00200-9; LARTER R, 1991, PHILOS T ROY SOC A, V337, P291, DOI 10.1098/rsta.1991.0124; Leloup JC, 1999, J THEOR BIOL, V198, P445, DOI 10.1006/jtbi.1999.0924; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; OLSEN LF, 1977, NATURE, V267, P177, DOI 10.1038/267177a0; Otto ER, 1977, B MATH BIOL, V39, P275; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pigolotti S, 2007, P NATL ACAD SCI USA, V104, P6533, DOI 10.1073/pnas.0610759104; Pigolotti S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088701; Qian Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036101; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Suguna C, 1999, PHYS REV E, V60, P5943, DOI 10.1103/PhysRevE.60.5943; Svetoslav N, 2009, CHAOS SOLITON FRACT, V42, P385; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Ye WM, 2010, PHYS LETT A, V374, P2521, DOI 10.1016/j.physleta.2010.04.015; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Zhang DM, 1993, CHAOS, V3, P723, DOI 10.1063/1.165933; Zhigulin VP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.238701	42	32	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39355	10.1371/journal.pone.0039355	http://dx.doi.org/10.1371/journal.pone.0039355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792171	gold, Green Submitted, Green Published			2022-12-25	WOS:000306461800009
J	Quesada, A; Vargas, F; Montoro-Molina, S; O'Valle, F; Rodriguez-Martinez, MD; Osuna, A; Prieto, I; Ramirez, M; Wangensteen, R				Quesada, Andres; Vargas, Felix; Montoro-Molina, Sebastian; O'Valle, Francisco; Dolores Rodriguez-Martinez, Maria; Osuna, Antonio; Prieto, Isabel; Ramirez, Manuel; Wangensteen, Rosemary			Urinary Aminopeptidase Activities as Early and Predictive Biomarkers of Renal Dysfunction in Cisplatin-Treated Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ALANINE AMINOPEPTIDASE; THYROID-DISORDERS; DIAGNOSTIC-VALUE; TUBULAR INJURY; NEPHROTOXICITY; ENZYMURIA; MARKER; MICROALBUMINURIA; GLUCOSAMINIDASE	This study analyzes the fluorimetric determination of alanyl- (Ala), glutamyl- (Glu), leucyl-cystinyl- (Cys) and aspartyl-aminopeptidase (AspAp) urinary enzymatic activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats. Male Wistar rats (n = 8 each group) received a single subcutaneous injection of either saline or cisplatin 3.5 or 7 mg/kg, and urine samples were taken at 0, 1, 2, 3 and 14 days after treatment. In urine samples we determined Ala, Glu, Cys and AspAp activities, proteinuria, N-acetyl-beta-D-glucosaminidase (NAG), albumin, and neutrophil gelatinase-associated lipocalin (NGAL). Plasma creatinine, creatinine clearance and renal morphological variables were measured at the end of the experiment. CysAp, NAG and albumin were increased 48 hours after treatment in the cisplatin 3.5 mg/kg treated group. At 24 hours, all urinary aminopeptidase activities and albuminuria were significantly increased in the cisplatin 7 mg/kg treated group. Aminopeptidase urinary activities correlated (p<0.011; r(2)>0.259) with plasma creatinine, creatinine clearance and/or kidney weight/body weight ratio at the end of the experiment and they could be considered as predictive biomarkers of renal injury severity. ROC-AUC analysis was made to study their sensitivity and specificity to distinguish between treated and untreated rats at day 1. All aminopeptidase activities showed an AUC>0.633. We conclude that Ala, Cys, Glu and AspAp enzymatic activities are early and predictive urinary biomarkers of the renal dysfunction induced by cisplatin. These determinations can be very useful in the prognostic and diagnostic of renal dysfunction in preclinical research and clinical practice.	[Quesada, Andres; Montoro-Molina, Sebastian; Prieto, Isabel; Ramirez, Manuel; Wangensteen, Rosemary] Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain; [Vargas, Felix] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain; [O'Valle, Francisco; Dolores Rodriguez-Martinez, Maria] Univ Granada, IBIMER Granada, Fac Med, Dept Anat Patol, E-18071 Granada, Spain; [Osuna, Antonio] Hosp Virgen de las Nieves, Serv Nefrol, Granada, Spain	Universidad de Jaen; University of Granada; University of Granada; Hospital Universitario Virgen de las Nieves	Quesada, A (corresponding author), Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain.	rwangens@ujaen.es	OValle, Francisco/AAA-9151-2019; Prieto, Isabel/H-7463-2015; Osuna, Antonio/H-1896-2015; Wangensteen, Rosemary/M-9856-2015	Prieto, Isabel/0000-0003-0624-9504; Wangensteen, Rosemary/0000-0001-7161-9925; Quesada, Andres/0000-0002-9584-5756; Montoro-Molina, Sebastian/0000-0003-3683-3357	University of Jaen [R1/12/2010/66]; Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal) [REDinREN RD06/0016/0017, RD07/0016/2008]; "FEDER una manera de hacer Europa"	University of Jaen; Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal); "FEDER una manera de hacer Europa"	This study was supported by a grant (R1/12/2010/66) from the University of Jaen with the participation of Caja Rural of Jaen, and from the Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal, REDinREN RD06/0016/0017 and RD07/0016/2008), "FEDER una manera de hacer Europa." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiston AL, 2011, REGUL PEPTIDES, V166, P83, DOI 10.1016/j.regpep.2010.09.003; Bazzi C, 2002, NEPHROL DIAL TRANSPL, V17, P1890, DOI 10.1093/ndt/17.11.1890; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Eng J, 2006, ROC ANAL WEB BASED C; Glassock RJ, 2010, CURR HYPERTENS REP, V12, P364, DOI 10.1007/s11906-010-0133-3; Holdt B, 2008, CLIN CHEM LAB MED, V46, P537, DOI 10.1515/CCLM.2008.103; Inselmann G, 2003, MYCOSES, V46, P169, DOI 10.1046/j.1439-0507.2003.00856.x; Kawai Y, 2009, J PHARMACOL SCI, V111, P433, DOI 10.1254/jphs.09185FP; KENNY AJ, 1982, PHYSIOL REV, V62, P91, DOI 10.1152/physrev.1982.62.1.91; Kuzniar J, 2006, INT UROL NEPHROL, V38, P753, DOI 10.1007/s11255-006-0052-z; Lazarevic G, 2007, RENAL FAILURE, V29, P199, DOI 10.1080/08860220601098870; Lisowska-Myjak B, 2010, BLOOD PURIFICAT, V29, P357, DOI 10.1159/000309421; Marchewka Z, 2009, TRANSPL P, V41, P1660, DOI 10.1016/j.transproceed.2009.01.116; Masseroli M, 1998, LAB INVEST, V78, P511; Mitic B, 2008, RENAL FAILURE, V30, P896, DOI 10.1080/08860220802359048; Molitoris BA, 2007, J AM SOC NEPHROL, V18, P1992, DOI 10.1681/ASN.2007050567; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Naghibi B, 2007, J NEPHROL, V20, P482; Perez-Abud R, 2011, AM J PHYSIOL-ENDOC M, V301, pE281, DOI 10.1152/ajpendo.00690.2010; PETERS JE, 1972, CLIN CHIM ACTA, V37, P213, DOI 10.1016/0009-8981(72)90436-6; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; SAFIRSTEIN R, 1987, INT J ANDROL, V10, P325, DOI 10.1111/j.1365-2605.1987.tb00200.x; Segarra AB, 2006, HORM METAB RES, V38, P48, DOI 10.1055/s-2006-924978; SONG LJ, 1994, AM J PHYSIOL-RENAL, V267, pF546, DOI 10.1152/ajprenal.1994.267.4.F546; Spasovski D, 2011, CLIN LAB, V57, P305; SWEAT F, 1964, ARCH PATHOL, V78, P69; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; WINSTON JA, 1985, AM J PHYSIOL, V249, pF490, DOI 10.1152/ajprenal.1985.249.4.F490; Yang CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/759313; Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624	33	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40402	10.1371/journal.pone.0040402	http://dx.doi.org/10.1371/journal.pone.0040402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792302	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300063
J	Takazawa, T; Croft, GF; Amoroso, MW; Studer, L; Wichterle, H; MacDermott, AB				Takazawa, Tomonori; Croft, Gist F.; Amoroso, Mackenzie W.; Studer, Lorenz; Wichterle, Hynek; MacDermott, Amy B.			Maturation of Spinal Motor Neurons Derived from Human Embryonic Stem Cells	PLOS ONE			English	Article							SPIKE-FREQUENCY ADAPTATION; IN-VITRO; DIRECTED DIFFERENTIATION; GENIOGLOSSAL MOTONEURONS; HORSERADISH-PEROXIDASE; QUANTITATIVE-ANALYSIS; PHRENIC MOTONEURONS; FIRING PROPERTIES; RAT; CORD	Our understanding of motor neuron biology in humans is derived mainly from investigation of human postmortem tissue and more indirectly from live animal models such as rodents. Thus generation of motor neurons from human embryonic stem cells and human induced pluripotent stem cells is an important new approach to model motor neuron function. To be useful models of human motor neuron function, cells generated in vitro should develop mature properties that are the hallmarks of motor neurons in vivo such as elaborated neuronal processes and mature electrophysiological characteristics. Here we have investigated changes in morphological and electrophysiological properties associated with maturation of neurons differentiated from human embryonic stem cells expressing GFP driven by a motor neuron specific reporter (Hb9::GFP) in culture. We observed maturation in cellular morphology seen as more complex neurite outgrowth and increased soma area over time. Electrophysiological changes included decreasing input resistance and increasing action potential firing frequency over 13 days in vitro. Furthermore, these human embryonic stem cell derived motor neurons acquired two physiological characteristics that are thought to underpin motor neuron integrated function in motor circuits; spike frequency adaptation and rebound action potential firing. These findings show that human embryonic stem cell derived motor neurons develop functional characteristics typical of spinal motor neurons in vivo and suggest that they are a relevant and useful platform for studying motor neuron development and function and for modeling motor neuron diseases.	[Takazawa, Tomonori; MacDermott, Amy B.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek; MacDermott, Amy B.] Columbia Univ, Dept Neurosci, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek] Columbia Univ, Dept Pathol, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek] Columbia Univ, Dept Neurol, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY USA; [Croft, Gist F.; Wichterle, Hynek] Columbia Univ, Columbia Stem Cell Initiat, New York, NY USA; [Takazawa, Tomonori; Croft, Gist F.; Amoroso, Mackenzie W.; Wichterle, Hynek; MacDermott, Amy B.] Jenifer Estess Lab Stem Cell Res, Project ALS, New York, NY USA; [Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center	Takazawa, T (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.	abm1@columbia.edu	Studer, Lorenz/ABH-1491-2021; Takazawa, Tomonori/H-9332-2019	Studer, Lorenz/0000-0003-0741-7987; Takazawa, Tomonori/0000-0002-0119-3532; Croft, Gist/0000-0002-9721-0148; Mathis, Mackenzie/0000-0001-7368-4456; Wichterle, Hynek/0000-0002-7817-0080	Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research; P2 ALS; NYSTEM [CO24415]; Dr. Leigh G. Cascarilla Post-Doctoral Fellowships in Stem Cell Research; National Institutes of Health [1RC2NS069395]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069395] Funding Source: NIH RePORTER	Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research; P2 ALS; NYSTEM; Dr. Leigh G. Cascarilla Post-Doctoral Fellowships in Stem Cell Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research; P2 ALS; NYSTEM grant CO24415; The Dr. Leigh G. Cascarilla Post-Doctoral Fellowships in Stem Cell Research; National Institutes of Health 1RC2NS069395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 2001, DEV HUMAN SPINAL COR; Bertrand S, 1998, J NEUROPHYSIOL, V79, P342, DOI 10.1152/jn.1998.79.1.342; Brownstone RM, 2006, PROG NEUROBIOL, V78, P156, DOI 10.1016/j.pneurobio.2006.04.002; Brownstone RM, 2011, J NEUROPHYSIOL, V105, P1045, DOI 10.1152/jn.00411.2010; Burke RE, 1996, J COMP NEUROL, V372, P465; CAMERON WE, 1985, J COMP NEUROL, V231, P91, DOI 10.1002/cne.902310108; Carrascal L, 2005, BRAIN RES REV, V49, P377, DOI 10.1016/j.brainresrev.2005.02.003; CULLHEIM S, 1987, J COMP NEUROL, V255, P68, DOI 10.1002/cne.902550106; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Gao BX, 1998, J NEUROPHYSIOL, V80, P3047, DOI 10.1152/jn.1998.80.6.3047; Gorman RB, 2005, J COMP PHYSIOL A, V191, P583, DOI 10.1007/s00359-005-0612-1; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P911, DOI 10.1113/jphysiol.1963.sp007230; Hinckley CA, 2005, J NEUROPHYSIOL, V93, P1439, DOI 10.1152/jn.00647.2004; Kuo JJ, 2004, J NEUROPHYSIOL, V91, P571, DOI 10.1152/jn.00665.2003; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li Y, 2005, J COMP NEUROL, V483, P304, DOI 10.1002/cne.20438; MACDERMOTT AB, 1986, DEV BIOL, V113, P317, DOI 10.1016/0012-1606(86)90167-3; Manuel M, 2009, J NEUROSCI, V29, P11246, DOI 10.1523/JNEUROSCI.3260-09.2009; Martin-Caraballo M, 2001, J NEUROBIOL, V46, P231, DOI 10.1002/1097-4695(200103)46:4<231::AID-NEU1005>3.0.CO;2-U; Martin-Caraballo M, 1999, J NEUROPHYSIOL, V81, P1365, DOI 10.1152/jn.1999.81.3.1365; Meehan CF, 2010, J NEUROPHYSIOL, V103, P2599, DOI 10.1152/jn.00668.2009; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Miles GB, 2005, J PHYSIOL-LONDON, V566, P519, DOI 10.1113/jphysiol.2005.086033; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; NUNEZABADES PA, 1995, J COMP NEUROL, V353, P129, DOI 10.1002/cne.903530112; NUNEZABADES PA, 1993, J NEUROPHYSIOL, V70, P1401, DOI 10.1152/jn.1993.70.4.1401; Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Placantonakis Dimitris G, 2009, Clin Neurosurg, V56, P125; Powers RK, 1999, J PHYSIOL-PARIS, V93, P101, DOI 10.1016/S0928-4257(99)80141-7; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; ROBERTS A, 1990, EUR J NEUROSCI, V2, P11, DOI 10.1111/j.1460-9568.1990.tb00377.x; ROSE PK, 1985, J COMP NEUROL, V239, P89, DOI 10.1002/cne.902390108; SINGH RN, 2005, EXP NEUROL, V196, P224, DOI DOI 10.1016/J.EXPNEUROL.2005.06.021; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; STEIN RB, 1979, BRAIN RES, V175, P372, DOI 10.1016/0006-8993(79)91019-9; Takazawa T, 2004, J NEUROPHYSIOL, V92, P3106, DOI 10.1152/jn.00494.2004; VIANA F, 1994, NEUROSCIENCE, V59, P131, DOI 10.1016/0306-4522(94)90105-8; VIANA F, 1993, J NEUROPHYSIOL, V69, P2137, DOI 10.1152/jn.1993.69.6.2137; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; ZISKINDCONHAIM L, 1988, DEV BIOL, V128, P21, DOI 10.1016/0012-1606(88)90262-X	44	53	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40154	10.1371/journal.pone.0040154	http://dx.doi.org/10.1371/journal.pone.0040154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802953	Green Submitted, gold, Green Published			2022-12-25	WOS:000306186900027
J	Berger, CE; Qian, YJ; Liu, G; Chen, HW; Chen, XB				Berger, Crystal E.; Qian, Yingjuan; Liu, Gang; Chen, Hongwu; Chen, Xinbin			p53, a Target of Estrogen Receptor (ER) alpha, Modulates DNA Damage-induced Growth Suppression in ER-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADJUVANT ENDOCRINE THERAPY; HISTOLOGIC GRADE; GENE-EXPRESSION; BINDING; ACTIVATION; BETA; TRANSCRIPTION; MUTATIONS; SEQUENCE; ELEMENT	In response to genotoxic stress, the p53 tumor suppressor induces target genes for cell cycle arrest, apoptosis, and DNA repair. Although p53 is the most commonly mutated gene in all human cancers, it is only mutated in about 20% of breast cancers. 70% of all breast cancer cases are estrogen receptor (ER)positive and express ER alpha. ER-positive breast cancer generally indicates good patient prognosis and treatment responsiveness with antiestrogens, such as tamoxifen. However, ER-positive breast cancer patients can experience loss or a reduction in ER alpha, which is associated with aggressive tumor growth, increased invasiveness, poor prognosis, and loss of p53 function. Consistent with this, we found that p53 is a target gene of ER alpha. Specifically, we found that knockdown of ER alpha decreases expression of p53 and its downstream targets, MDM2 and p21. In addition, we found that ER alpha activates p53 transcription via binding to estrogen response element half-sites within the p53 promoter. Moreover, we found that loss of ER alpha desensitizes, whereas ectopic expression of ER alpha sensitizes, breast cancer cells to DNA damage-induced growth suppression in a p53-dependent manner. Altogether, this study provides an insight into a feedback loop between ER alpha and p53 and a biological role of p53 in the DNA damage response in ER-positive breast cancers.	[Berger, Crystal E.; Qian, Yingjuan; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA; [Liu, Gang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Chen, Hongwu] Univ Calif Davis, UC Davis Canc Ctr Basic Sci, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis	Qian, YJ (corresponding author), Univ Calif Davis, Comparat Oncol Lab, 2128A Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.	yqian@ucdavis.edu; xbchen@ucdavis.edu		Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633	National Institutes of Health [CA076069]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant CA076069.	Agrawal A, 2006, EXP MOL PATHOL, V81, P115, DOI 10.1016/j.yexmp.2006.07.001; AITKEN SC, 1985, CANCER RES, V45, P1611; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Allegra J C, 1980, Recent Results Cancer Res, V71, P20; Angeloni SV, 2004, J ENDOCRINOL, V180, P497, DOI 10.1677/joe.0.1800497; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Barkhem Tomas, 2004, Am J Pharmacogenomics, V4, P19, DOI 10.2165/00129785-200404010-00003; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fernandez-Cuesta L, 2011, BREAST CANCER RES TR, V125, P35, DOI 10.1007/s10549-010-0819-x; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; Gretarsdottir S, 1996, BRIT J CANCER, V74, P555, DOI 10.1038/bjc.1996.400; Gu GW, 2012, J CELL PHYSIOL, V227, P3363, DOI 10.1002/jcp.24035; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Huang J, 2005, MOL ENDOCRINOL, V19, P2696, DOI 10.1210/me.2005-0120; HUBAY CA, 1985, J STEROID BIOCHEM, V23, P1147, DOI 10.1016/0022-4731(85)90034-2; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Leygue E, 1998, CANCER RES, V58, P3197; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; PARKER MG, 1993, ANN NY ACAD SCI, V684, P119, DOI 10.1111/j.1749-6632.1993.tb32276.x; PARL FF, 1984, CANCER, V54, P2237, DOI 10.1002/1097-0142(19841115)54:10<2237::AID-CNCR2820541029>3.0.CO;2-V; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Qian YJ, 2012, P NATL ACAD SCI USA, V109, P11300, DOI 10.1073/pnas.1203185109; Qian YJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207241; Qin CH, 2002, MOL ENDOCRINOL, V16, P1793, DOI 10.1210/me.2002-0006; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; SASA M, 1994, J SURG ONCOL, V56, P46, DOI 10.1002/jso.2930560110; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Shirley SH, 2009, CANCER RES, V69, P3405, DOI 10.1158/0008-5472.CAN-08-3628; SLUYSER M, 1974, CANCER RES, V34, P3253; STANFORD JL, 1986, EPIDEMIOL REV, V8, P42, DOI 10.1093/oxfordjournals.epirev.a036295; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Thompson AM, 2010, J PATHOL, V220, P401, DOI 10.1002/path.2674; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Velculescu VE, 1996, CLIN CHEM, V42, P858; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yu CL, 1997, BIOCHEM BIOPH RES CO, V239, P617, DOI 10.1006/bbrc.1997.7522; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	68	52	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30117	30127		10.1074/jbc.M112.367326	http://dx.doi.org/10.1074/jbc.M112.367326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787161	Green Published, hybrid			2022-12-25	WOS:000308579800007
J	Ray, S; Taylor, M; Banerjee, T; Tatulian, SA; Teter, K				Ray, Supriyo; Taylor, Michael; Banerjee, Tuhina; Tatulian, Suren A.; Teter, Ken			Lipid Rafts Alter the Stability and Activity of the Cholera Toxin A1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; INTESTINAL MICROVILLUS MEMBRANE; CHO-CELLS RESISTANT; ENDOPLASMIC-RETICULUM; A(1) DOMAIN; RETRO-TRANSLOCATION; SIGNAL-TRANSDUCTION; THERMAL-STABILITY; SHIGA TOXIN; C-TERMINUS	Cholera toxin (CT) travels from the cell surface to the endoplasmic reticulum (ER) as an AB holotoxin. ER-specific conditions then promote the dissociation of the catalytic CTA1 subunit from the rest of the toxin. CTA1 is held in a stable conformation by its assembly in the CT holotoxin, but the dissociated CTA1 subunit is an unstable protein that spontaneously assumes a disordered state at physiological temperature. This unfolding event triggers the ER-to-cytosol translocation of CTA1 through the quality control mechanism of ER-associated degradation. The translocated pool of CTA1 must regain a folded, active structure to modify its G protein target which is located in lipid rafts at the cytoplasmic face of the plasma membrane. Here, we report that lipid rafts place disordered CTA1 in a functional conformation. The hydrophobic C-terminal domain of CTA1 is essential for binding to the plasma membrane and lipid rafts. These interactions inhibit the temperature-induced unfolding of CTA1. Moreover, lipid rafts could promote a gain of structure in the disordered, 37 degrees C conformation of CTA1. This gain of structure corresponded to a gain of function: whereas CTA1 by itself exhibited minimal in vitro activity at 37 degrees C, exposure to lipid rafts resulted in substantial toxin activity at 37 degrees C. In vivo, the disruption of lipid rafts with filipin substantially reduced the activity of cytosolic CTA1. Lipid rafts thus exhibit a chaperone-like function that returns disordered CTA1 to an active state and is required for the optimal in vivo activity of CTA1.	[Ray, Supriyo; Taylor, Michael; Banerjee, Tuhina; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Teter, K (corresponding author), 12722 Res Pkwy, Orlando, FL 32826 USA.	kteter@mail.ucf.edu	Ray, Supriyo/L-1020-2019	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI073783 (to K. T.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Boon JM, 2002, MED RES REV, V22, P251, DOI 10.1002/med.10009; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; D'Antuono C, 2000, ARCH BIOCHEM BIOPHYS, V382, P39, DOI 10.1006/abbi.2000.1979; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Debnath D, 2003, BIOCHEM BIOPH RES CO, V301, P979, DOI 10.1016/S0006-291X(03)00066-4; Delaunay JL, 2008, BBA-BIOMEMBRANES, V1778, P105, DOI 10.1016/j.bbamem.2007.09.017; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; FORSTNER GG, 1968, BIOCHEM J, V106, P381, DOI 10.1042/bj1060381; FORSTNER GG, 1968, BIOCHEM J, V109, P51, DOI 10.1042/bj1090051; Frazier ML, 2007, BIOPHYS J, V92, P2422, DOI 10.1529/biophysj.106.100107; GOINS B, 1988, BIOCHEMISTRY-US, V27, P2046, DOI 10.1021/bi00406a035; Grzybek M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005053; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Kamata K, 2008, AM J HEMATOL, V83, P371, DOI 10.1002/ajh.21126; KASSIS S, 1982, J BIOL CHEM, V257, P2148; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; Lavigne P, 1998, J MOL BIOL, V281, P165, DOI 10.1006/jmbi.1998.1914; LENCER WI, 1987, INFECT IMMUN, V55, P3126, DOI 10.1128/IAI.55.12.3126-3130.1987; Liang W, 2000, J ANIM SCI, V78, P2329; LITMAN BJ, 1975, BIOCHIM BIOPHYS ACTA, V394, P166, DOI 10.1016/0005-2736(75)90254-0; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Menikh A, 1997, BIOCHEMISTRY-US, V36, P15865, DOI 10.1021/bi970944+; Mills SE, 2003, J ANIM SCI, V81, P122; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; PROULX P, 1991, BIOCHIM BIOPHYS ACTA, V1071, P255, DOI 10.1016/0304-4157(91)90016-P; Qin S, 2004, J MOL BIOL, V344, P71, DOI 10.1016/j.jmb.2004.09.034; Ray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023692; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Saleh MT, 1996, BIOCHEMISTRY-US, V35, P9325, DOI 10.1021/bi960177z; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SCHROEDER F, 1995, MOL MEMBR BIOL, V12, P113, DOI 10.3109/09687689509038505; SOMAN G, 1986, BIOCHEMISTRY-US, V25, P4113, DOI 10.1021/bi00362a019; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; SUREWICZ WK, 1990, BIOCHEMISTRY-US, V29, P8106, DOI 10.1021/bi00487a017; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor ME, 2011, APPL MATH SCI, V116, P1, DOI 10.1007/978-1-4419-7052-7_1; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Waheed AA, 1998, LIPIDS, V33, P1093, DOI 10.1007/s11745-998-0310-y; WELSH CF, 1994, MOL CELL BIOCHEM, V138, P157, DOI 10.1007/BF00928458; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wolf AA, 2002, J BIOL CHEM, V277, P16249, DOI 10.1074/jbc.M109834200	66	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30395	30405		10.1074/jbc.M112.385575	http://dx.doi.org/10.1074/jbc.M112.385575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787142	Green Published, hybrid			2022-12-25	WOS:000308579800032
J	Zhang, X; Zhang, Z; Cheng, JW; Li, M; Wang, W; Xu, WR; Wang, H; Zhang, RW				Zhang, Xu; Zhang, Zhuo; Cheng, Jianwen; Li, Mao; Wang, Wei; Xu, Wenrong; Wang, Hui; Zhang, Ruiwen			Transcription Factor NFAT1 Activates the mdm2 Oncogene Independent of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PANCREATIC-CANCER; NUCLEAR FACTOR; T-CELLS; C-MYC; PATHWAY; GROWTH; CALCINEURIN; EXPRESSION; INDUCTION	Although the MDM2-p53 interaction has been well documented, MDM2 overexpression is observed in human cancers with little or no functional p53, suggesting that mdm2 expression is regulated by mechanisms independent of p53. Dysregulation of NFAT signaling is associated with malignant transformation and cancer development and progression. In this study, we demonstrate that the human mdm2 P2 promoter contains a consensus binding site for the NFAT1 transcription factor. NFAT1 directly binds the mdm2 P2 promoter in vitro and in vivo, resulting in the up-regulation of mdm2 transcription. Enforced expression of NFAT1 results in an elevated MDM2 protein level and reduces p53 activation and function in response to DNA damage. Both NFAT1 and MDM2 are highly expressed in human hepatocellular carcinoma tissues, compared with adjacent normal liver tissues. There is a positive correlation between the NFAT1 and MDM2 levels in tumor tissues. The novel function of NFAT1 in the control of MDM2 expression provides a basis for future investigations of the role of NFAT1 in cancer development, progression, and therapy.	[Zhang, Xu; Wang, Wei; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA; [Zhang, Xu; Wang, Wei; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Sch Pharm, Amarillo, TX 79106 USA; [Zhang, Xu; Xu, Wenrong] Jiangsu Univ, Affiliated Hosp, Ctr Clin Lab, Sch Med Sci & Lab Med, Zhenjiang 212001, Jiangsu, Peoples R China; [Zhang, Zhuo; Li, Mao] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Cheng, Jianwen] Fudan Univ, Zhong Shan Hosp, Dept Liver Surg, Shanghai 200032, Peoples R China; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Jiangsu University; University of Alabama System; University of Alabama Birmingham; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, RW (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, 1300 Coulter Dr, Amarillo, TX 79106 USA.	ruiwen.zhang@ttuhsc.edu			National Institutes of Health [R01 CA112029, R01 CA121211]; Susan G. Komen Foundation [BCTR0707731]; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; Science and Technology Commission of Shanghai Municipality [08391910800, 10391902100]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants R01 CA112029 and R01 CA121211. This work was also supported by Susan G. Komen Foundation Grant BCTR0707731 (to R. Z.).; Supported by the One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation Grants 30870513, 31070680, 91029715, and 81025017; Ministry of Science and Technology of China Grant 2007CB947100; and Science and Technology Commission of Shanghai Municipality Grants 08391910800 and 10391902100.	Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Busuttil V, 2010, P NATL ACAD SCI USA, V107, P18061, DOI 10.1073/pnas.1006163107; Chebel A, 2009, J BIOL CHEM, V284, P35725, DOI 10.1074/jbc.M109.009183; Chen Zhao-Li, 2011, Chin J Cancer, V30, P62; CORDONCARDO C, 1994, CANCER RES, V54, P794; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Gerlach K., 2012, CANC RES; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li M, 2005, CANCER RES, V65, P8200, DOI 10.1158/0008-5472.CAN-05-1302; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Maxeiner JH, 2009, CANCER RES, V69, P3069, DOI 10.1158/0008-5472.CAN-08-1678; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Truong AHL, 2005, ONCOGENE, V24, P962, DOI 10.1038/sj.onc.1208323; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yang GH, 2008, ONCOLOGIST, V13, P1155, DOI 10.1634/theoncologist.2008-0081; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200	40	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30468	30476		10.1074/jbc.M112.373738	http://dx.doi.org/10.1074/jbc.M112.373738			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787160	hybrid, Green Published			2022-12-25	WOS:000308579800039
J	Wu, KC; Cui, JY; Klaassen, CD				Wu, Kai Connie; Cui, Julia Yue; Klaassen, Curtis D.			Effect of Graded Nrf2 Activation on Phase-I and -II Drug Metabolizing Enzymes and Transporters in Mouse Liver	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; GLUTATHIONE-S-TRANSFERASE; XENOBIOTIC TRANSPORTERS; SUBSTRATE-SPECIFICITY; KEAP1-KNOCKDOWN MICE; ALDEHYDE REDUCTASE; BILIARY-EXCRETION; CELLULAR DEFENSE; MESSENGER-RNA; GENE BATTERY	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that induces a battery of cytoprotective genes in response to oxidative/electrophilic stress. Kelch-like ECH associating protein 1 (Keap1) sequesters Nrf2 in the cytosol. The purpose of this study was to investigate the role of Nrf2 in regulating the mRNA of genes encoding drug metabolizing enzymes and xenobiotic transporters. Microarray analysis was performed in livers of Nrf2-null, wild-type, Keap1-knockdown mice with increased Nrf2 activation, and Keap1-hepatocyte knockout mice with maximum Nrf2 activation. In general, Nrf2 did not have a marked effect on uptake transporters, but the mRNAs of organic anion transporting polypeptide 1a1, sodium taurocholate cotransporting polypeptide, and organic anion transporter 2 were decreased with Nrf2 activation. The effect of Nrf2 on cytochrome P450 (Cyp) genes was minimal, with only Cyp2a5, Cyp2c50, Cyp2c54, and Cyp2g1 increased, and Cyp2u1 decreased with enhanced Nrf2 activation. However, Nrf2 increased mRNA of many other phase-I enzymes, such as aldo-keto reductases, carbonyl reductases, and aldehyde dehydrogenase 1. Many genes involved in phase-II drug metabolism were induced by Nrf2, including glutathione S-transferases, UDP-glucuronosyltransferases, and UDP-glucuronic acid synthesis enzymes. Efflux transporters, such as multidrug resistance-associated proteins, breast cancer resistant protein, as well as ATP-binding cassette g5 and g8 were induced by Nrf2. In conclusion, Nrf2 markedly alters hepatic mRNA of a large number of drug metabolizing enzymes and xenobiotic transporters, and thus Nrf2 plays a central role in xenobiotic metabolism and detoxification.	[Wu, Kai Connie; Cui, Julia Yue; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Wu, KC (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	cklaasse@kumc.edu	Wu, Kai/I-2202-2013		National Institutes of Health [DK-081461, ES-009716, RR-021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported by National Institutes of Health grants DK-081461, ES-009716, and RR-021940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Bakar A, 2007, DRUG METAB DISPOS, V35, P787, DOI 10.1124/dmd.106.014423; Alnouti Y, 2008, TOXICOL SCI, V101, P51, DOI 10.1093/toxsci/kfm280; Anwar-Mohamed A, 2011, TOXICOL IN VITRO, V25, P785, DOI 10.1016/j.tiv.2011.01.014; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cheng QQ, 2011, J BIOCHEM MOL TOXIC, V25, P320, DOI 10.1002/jbt.20392; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; Ebert B, 2010, BIOCHEMISTRY-US, V49, P8499, DOI 10.1021/bi100814d; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Gardner R, 2004, TOXICOL LETT, V148, P65, DOI 10.1016/j.toxlet.2003.12.056; Gu J, 1998, J PHARMACOL EXP THER, V285, P1287; Hinshelwood A, 2002, FEBS LETT, V523, P213, DOI 10.1016/S0014-5793(02)02982-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; Jansen PJ, 2006, BBA-MOL CELL BIOL L, V1761, P445, DOI 10.1016/j.bbalip.2006.03.015; Kassner N, 2008, DRUG METAB DISPOS, V36, P2113, DOI 10.1124/dmd.108.022251; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Klaassen CD, 2008, TOXICOL SCI, V101, P186, DOI 10.1093/toxsci/kfm214; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lamsa V, 2010, CHEM RES TOXICOL, V23, P977, DOI 10.1021/tx100084c; Lu H, 2010, TOXICOL SCI, V118, P380, DOI 10.1093/toxsci/kfq280; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Maher JM, 2007, HEPATOLOGY, V46, P1597, DOI 10.1002/hep.21831; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; MCLELLAN LI, 1994, BIOCHEM J, V300, P117, DOI 10.1042/bj3000117; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Nishinaka T, 2005, J PHARMACOL SCI, V97, P43, DOI 10.1254/jphs.FP0040404; Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435; Nunoya K, 1995, XENOBIOTICA, V25, P1283, DOI 10.3109/00498259509061917; Okada K, 2008, AM J PHYSIOL-GASTR L, V295, pG735, DOI 10.1152/ajpgi.90321.2008; Pilka ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007113; Reisman SA, 2009, TOXICOL SCI, V109, P24, DOI 10.1093/toxsci/kfp045; Reisman SA, 2009, TOXICOL SCI, V109, P31, DOI 10.1093/toxsci/kfp047; Reisman SA, 2009, BIOCHEM PHARMACOL, V77, P1273, DOI 10.1016/j.bcp.2008.12.028; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Short DM, 2006, TOXICOL APPL PHARM, V210, P163, DOI 10.1016/j.taap.2005.09.017; Singh S, 2010, INT J BIOCHEM CELL B, V42, P1105, DOI 10.1016/j.biocel.2010.01.022; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Yokota SI, 2010, BIOCH PHARM; Zamek-Gliszczynski MJ, 2006, MOL PHARMACOL, V70, P2127, DOI 10.1124/mol.106.026955	49	99	102	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39006	10.1371/journal.pone.0039006	http://dx.doi.org/10.1371/journal.pone.0039006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808024	Green Published, Green Submitted, gold			2022-12-25	WOS:000306366400007
J	Comeros-Raynal, MT; Choat, JH; Polidoro, BA; Clements, KD; Abesamis, R; Craig, MT; Lazuardi, ME; McIlwain, J; Muljadi, A; Myers, RF; Nanola, CL; Pardede, S; Rocha, LA; Russell, B; Sanciangco, JC; Stockwell, B; Harwell, H; Carpenter, KE				Comeros-Raynal, Mia T.; Choat, John Howard; Polidoro, Beth A.; Clements, Kendall D.; Abesamis, Rene; Craig, Matthew T.; Lazuardi, Muhammad Erdi; McIlwain, Jennifer; Muljadi, Andreas; Myers, Robert F.; Nanola, Cleto L., Jr.; Pardede, Shinta; Rocha, Luiz A.; Russell, Barry; Sanciangco, Jonnell C.; Stockwell, Brian; Harwell, Heather; Carpenter, Kent E.			The Likelihood of Extinction of Iconic and Dominant Herbivores and Detritivores of Coral Reefs: The Parrotfishes and Surgeonfishes	PLOS ONE			English	Article							IUCN RED LIST; CLIMATE-CHANGE; PHASE-SHIFTS; HABITAT DEGRADATION; MARINE RESERVE; BOLBOMETOPON-MURICATUM; STOPLIGHT PARROTFISH; EVOLUTIONARY HISTORY; CHEILINUS-UNDULATUS; NUTRITIONAL ECOLOGY	Parrotfishes and surgeonfishes perform important functional roles in the dynamics of coral reef systems. This is a consequence of their varied feeding behaviors ranging from targeted consumption of living plant material (primarily surgeonfishes) to feeding on detrital aggregates that are either scraped from the reef surface or excavated from the deeper reef substratum (primarily parrotfishes). Increased fishing pressure and widespread habitat destruction have led to population declines for several species of these two groups. Species-specific data on global distribution, population status, life history characteristics, and major threats were compiled for each of the 179 known species of parrotfishes and surgeonfishes to determine the likelihood of extinction of each species under the Categories and Criteria of the IUCN Red List of Threatened Species. Due in part to the extensive distributions of most species and the life history traits exhibited in these two families, only three (1.7%) of the species are listed at an elevated risk of global extinction. The majority of the parrotfishes and surgeonfishes (86%) are listed as Least Concern, 10% are listed as Data Deficient and 1% are listed as Near Threatened. The risk of localized extinction, however, is higher in some areas, particularly in the Coral Triangle region. The relatively low proportion of species globally listed in threatened Categories is highly encouraging, and some conservation successes are attributed to concentrated conservation efforts. However, with the growing realization of man's profound impact on the planet, conservation actions such as improved marine reserve networks, more stringent fishing regulations, and continued monitoring of the population status at the species and community levels are imperative for the prevention of species loss in these groups of important and iconic coral reef fishes.	[Comeros-Raynal, Mia T.; Polidoro, Beth A.; Sanciangco, Jonnell C.; Harwell, Heather; Carpenter, Kent E.] Old Dominion Univ, IUCN Species Programme, SSC Marine Biodivers Unit Global Marine Species A, Norfolk, VA 23529 USA; [Choat, John Howard] James Cook Univ, Sch Marine Biol & Aquaculture, Townsville, Qld 4811, Australia; [Clements, Kendall D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Abesamis, Rene] Silliman Univ, Dumaguete, Negros Oriental, Philippines; [Craig, Matthew T.] Univ San Diego, Dept Marine Sci & Environm Studies, San Diego, CA 92110 USA; [Lazuardi, Muhammad Erdi] Conservat Int, Denpasar, Bali, Indonesia; [McIlwain, Jennifer] Curtin Univ Technol, Dept Environm & Agr, Perth, WA, Australia; [Muljadi, Andreas] Coral Triangle Ctr, Sanur, Bali, Indonesia; [Myers, Robert F.] Coral Graph, Wellington, FL USA; [Nanola, Cleto L., Jr.] Univ Philippines Mindanao, Coll Sci & Math, Davao, Philippines; [Pardede, Shinta] Wildlife Conservat Soc, Indonesia Marine Program, Bogor, Jawa Barat, Indonesia; [Rocha, Luiz A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Russell, Barry] Charles Darwin Univ, Arafura Timor Res Facil C, Sch Environm & Life Sci, Brinkin, NT, Australia	Old Dominion University; James Cook University; University of Auckland; Silliman University; University of San Diego; Conservation International - Indonesia; Curtin University; University of the Philippines System; University of the Philippines Mindanao; Wildlife Conservation Society - Indonesia; California Academy of Sciences; Charles Darwin University	Comeros-Raynal, MT (corresponding author), Old Dominion Univ, IUCN Species Programme, SSC Marine Biodivers Unit Global Marine Species A, Norfolk, VA 23529 USA.	mcome003@odu.edu	Rocha, Luiz/T-6326-2019; Rocha, Luiz/C-5107-2011; Abesamis, Rene A./AAE-1917-2022; McIlwain, Jennifer L/J-9179-2012	Abesamis, Rene A./0000-0001-7456-1415; McIlwain, Jennifer L/0000-0002-7790-5081; Clements, Kendall/0000-0001-8512-5977; Lazuardi, Muhammad Erdi/0000-0001-8964-8898; Rocha, Luiz/0000-0003-4011-569X; Comeros-Raynal, Mia Theresa/0000-0002-5087-8984; Sanciangco, Jonnell Cueto/0000-0001-8268-3180	New Hampshire Charitable Foundation	New Hampshire Charitable Foundation	This research was supported by core funding from Tom Haas and the New Hampshire Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Allen GR, 2002, ENVIRON BIOL FISH, V65, P209, DOI 10.1023/A:1020093012502; [Anonymous], 2005, STATE CORAL REEF ECO; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Aswani S, 2004, ENVIRON CONSERV, V31, P1; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barber PH, 2006, EVOLUTION, V60, P1825; Bellwood DR, 2011, CORAL REEFS, V30, P549, DOI 10.1007/s00338-011-0738-2; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bernal MA, 2011, ZOOTAXA, P63; Breslauer G., 1991, DUAL CITY RESTRUCTUR, P3, DOI DOI 10.4095/134069; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Burke L., 2011, REEFS RISK REVISITED; Burkepile DE, 2011, CORAL REEFS, V30, P351, DOI 10.1007/s00338-011-0726-6; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; BUTLER JN, 1993, ENVIRONMENT, V35, P6, DOI 10.1080/00139157.1993.9929067; Caicos GoTa, 2011, FISHERIES PROTECTION, P3; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carpenter KE, 2010, J MAR BIOL, V2011, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cesar H., 2003, EC WORLDWIDE CORAL R; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Choat JH, 2006, MAR ECOL PROG SER, V318, P237, DOI 10.3354/meps318237; Choat J.H., 1991, P120; Choat JH, 2003, MAR ECOL PROG SER, V246, P265, DOI 10.3354/meps246265; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 2009, CHLORURUS BLEEKERI I; Claisse JT, 2009, MAR ECOL PROG SER, V389, P245, DOI 10.3354/meps08114; Clements KD, 2004, MOL PHYLOGENET EVOL, V32, P575, DOI 10.1016/j.ympev.2004.02.003; CLEMENTS KD, 1995, PHYSIOL ZOOL, V68, P355, DOI 10.1086/physzool.68.3.30163774; CLEMENTS KD, 1994, J COMP PHYSIOL B, V164, P372, DOI 10.1007/BF00302552; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Colin PL, 2012, REEF FISH SPAWNING A, P526; Council CFM, 2010, 2010 CAR ANN CAT 622; Crossman DJ, 2005, MAR ECOL PROG SER, V296, P129, DOI 10.3354/meps296129; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; Debrot D., 2008, P 60 GULF CAR FISH I, P335; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; Donaldson TJ, 2004, ENVIRON BIOL FISH, V70, P373, DOI 10.1023/B:EBFI.0000035509.89614.1e; Dulvy Nicholas K., 2009, P129; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Ferreira B, 2008, SCARUS TRISPINOSUS I; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Ferreira CE, 2008, SCARUS GUACAMAIA IUC; Ferreira CEL, 2005, CORAL REEFS, V24, P128, DOI 10.1007/s00338-004-0459-x; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gillett R., 2006, SPEARFISHING PACIFIC; Gochfeld DJ, 2010, MAR ECOL PROG SER, V398, P137, DOI 10.3354/meps08302; Graham NAJ, 2005, CORAL REEFS, V24, P118, DOI 10.1007/s00338-004-0466-y; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Green A.L., 2009, MONITORING FUNCTIONA; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamilton R., 2003, PUTTING FISHERS KNOW, P68; Hamilton RJ, 2008, CORAL REEFS, V27, P153, DOI 10.1007/s00338-007-0304-0; Hamilton RJ, 2012, FISH FISHERIES SERIE, P490; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; IUCN, 2003, GUID APPL IUCN RED L; (IUCN) IUfCoN, 2012, CLASS SCHEM VERS 3 0; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 1999, CONSERV BIOL, V13, P1466, DOI 10.1046/j.1523-1739.1999.98324.x; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Kronen M, 2012, OCEAN COAST MANAGE, V55, P63, DOI 10.1016/j.ocecoaman.2011.07.011; Lavides MN, 2009, ENVIRON CONSERV, V36, P235, DOI 10.1017/S0376892909990385; Lawson GL, 1999, ENVIRON BIOL FISH, V54, P19, DOI 10.1023/A:1007477527663; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCormick MI, 2010, CORAL REEFS, V29, P537, DOI 10.1007/s00338-010-0620-7; McManus JW, 2000, ICES J MAR SCI, V57, P572, DOI 10.1006/jmsc.2000.0720; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Montero R, 2009, FISHERIES NASSAU GRO; Mountfort DO, 2002, APPL ENVIRON MICROB, V68, P1374, DOI 10.1128/AEM.68.3.1374-1380.2002; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Mumby PJ, 2012, MARINE ECOLOGY PROGR, V445; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Nanola CL, 2011, ENVIRON BIOL FISH, V90, P405, DOI 10.1007/s10641-010-9750-6; Nelson JS, 1984, FISHES WORLD; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Parenti Paolo, 2011, Smithiana Bulletin, P29; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Polidoro BA, 2012, MAR ECOL PROG SER, V448, P93, DOI 10.3354/meps09545; Polidoro BA, 2011, J MARINE BIOL, V2011, P14; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2004, CORAL REEFS, V23, P352, DOI 10.1007/s00338-004-0394-x; Randall J.E., 2001, SURGEONFISHES HAWAII; Reeson PH, 1983, ICLARM STUD REV, P178; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Rhodes KL, 2008, CORAL REEFS, V27, P443, DOI 10.1007/s00338-007-0331-x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; ROBERTSON DR, 1992, MAR BIOL, V114, P527, DOI 10.1007/BF00357250; ROBERTSON DR, 1988, MAR BIOL, V97, P495, DOI 10.1007/BF00391045; Rocha LA, 2012, ZOOTAXA, P61; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rotjan RD, 2005, MAR ECOL PROG SER, V305, P193, DOI 10.3354/meps305193; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Sabater MG, 2009, REV FISH SCI, V17, P318, DOI 10.1080/10641260802702872; Sabetian A., 2010, PARROTFISH FISHERIES; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Sadovy Y, 2012, FISH FISHER IN PRESS; Sadovy Yvonne J., 2002, P391, DOI 10.1016/B978-012615185-5/50023-2; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stevenson TC, 2011, ICES J MAR SCI, V68, P813, DOI 10.1093/icesjms/fsr020; Stockwell B, 2009, MAR ECOL PROG SER, V389, P1, DOI 10.3354/meps08150; Streelman JT, 2002, EVOLUTION, V56, P961; Subcommittee ISaP, 2011, GUID US IUCN RED LIS; Tissot Brian N., 2004, Pacific Science, V58, P175, DOI 10.1353/psc.2004.0024; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; To AWL, 2009, FISH FISH, V10, P396, DOI 10.1111/j.1467-2979.2009.00326.x; Tolimieri N, 1998, B MAR SCI, V62, P253; UNEP/WCMC, 2010, GLOB DISTR COR REEFS; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P419, DOI 10.1666/0094-8373(2000)026<0419:DHATAO>2.0.CO;2; Walsh W, 2010, REPORT FINDINGS RECO; (WDPA) WDoPA, 2010, PROT AR EXTR 2010 WO; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CORAL REEFS W; WILKINSON C, 2002, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W; Wilkinson CR, 1998, STATUS CORAL REEFS W; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	159	46	50	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39825	10.1371/journal.pone.0039825	http://dx.doi.org/10.1371/journal.pone.0039825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808066	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000306362400022
J	Kim, S; Parks, CG; Xu, ZL; Carswell, G; DeRoo, LA; Sandler, DP; Taylor, JA				Kim, Sangmi; Parks, Christine G.; Xu, Zongli; Carswell, Gleta; DeRoo, Lisa A.; Sandler, Dale P.; Taylor, Jack A.			Association between Genetic Variants in DNA and Histone Methylation and Telomere Length	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPIGENETIC REGULATION; METHYLTRANSFERASE BHMT; BETAINE-HOMOCYSTEINE; OXIDATIVE STRESS; ARGININE; LOCUS; RISK; DISEASE; SNP	Telomere length, a biomarker of aging and age-related diseases, exhibits wide variation between individuals. Common genetic variation may explain some of the individual differences in telomere length. To date, however, only a few genetic variants have been identified in the previous genome-wide association studies. As emerging data suggest epigenetic regulation of telomere length, we investigated 72 single nucleotide polymorphisms (SNPs) in 46 genes that involve DNA and histone methylation as well as telomerase and telomere-binding proteins and DNA damage response. Genotyping and quantification of telomere length were performed in blood samples from 989 non-Hispanic white participants of the Sister Study, a prospective cohort of women aged 35-74 years. The association of each SNP with logarithmically-transformed relative telomere length was estimated using multivariate linear regression. Six SNPs were associated with relative telomere length in blood cells with p-values<0.05 (uncorrected for multiple comparisons). The minor alleles of BHMT rs3733890 G>A (p = 0.041), MTRR rs2966952 C>T (p = 0.002) and EHMT2 rs558702 G>A (p = 0.008) were associated with shorter telomeres, while minor alleles of ATM rs1801516 G>A (p = 0.031), MTR rs1805087 A>G (p = 0.038) and PRMT8 rs12299470 G>A (p = 0.019) were associated with longer telomeres. Five of these SNPs are located in genes coding for proteins involved in DNA and histone methylation. Our results are consistent with recent findings that chromatin structure is epigenetically regulated and may influence the genomic integrity of telomeric region and telomere length maintenance. Larger studies with greater coverage of the genes implicated in DNA methylation and histone modifications are warranted to replicate these findings.	[Kim, Sangmi] Georgia Hlth Sci Univ, Ctr Canc, Sect Hematol Oncol, Dept Med, Augusta, GA USA; [Kim, Sangmi; Parks, Christine G.; Xu, Zongli; DeRoo, Lisa A.; Sandler, Dale P.; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA; [Xu, Zongli; Carswell, Gleta; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC USA	University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kim, S (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, Sect Hematol Oncol, Dept Med, Augusta, GA USA.	sankim@georgiahealth.edu; taylor@niehs.nih.gov	taylor, jack a/C-7154-2019	taylor, jack a/0000-0001-5303-6398; Sandler, Dale/0000-0002-6776-0018; xu, zongli/0000-0002-9034-8902; Parks, Christine/0000-0002-5734-3456	National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES044005, Z01 ES049033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044005, ZIAES049033, ZICES102546, ZIAES049032] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES044005 and Z01 ES049033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harmon DL, 1999, GENET EPIDEMIOL, V17, P298, DOI 10.1002/(SICI)1098-2272(199911)17:4<298::AID-GEPI5>3.0.CO;2-V; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Jin GF, 2010, CANCER-AM CANCER SOC, V116, P5700, DOI 10.1002/cncr.25301; Kim S, 2011, CANCER CAUSE CONTROL, V22, P1061, DOI 10.1007/s10552-011-9778-8; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li F, 2008, MOL GENET METAB, V94, P326, DOI 10.1016/j.ymgme.2008.03.013; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mirabello L, 2010, HUM MUTAT, V31, P1050, DOI 10.1002/humu.21314; Mitchell TRH, 2009, MOL CELL BIOL, V29, P4918, DOI 10.1128/MCB.00009-09; Mostowska A, 2010, EUR J ORAL SCI, V118, P325, DOI 10.1111/j.1600-0722.2010.00757.x; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Paul L, 2009, J NUTR; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Simarro M, 2010, BIOCHEM BIOPH RES CO, V401, P440, DOI 10.1016/j.bbrc.2010.09.075; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stancheva I, 2005, BIOCHEM CELL BIOL, V83, P385, DOI 10.1139/o05-043; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Vera E, 2008, ONCOGENE, V27, P6817, DOI 10.1038/onc.2008.289; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Weinberg CR, 2007, AM J EPIDEMIOL, V166, P447, DOI 10.1093/aje/kwm097; Weisberg IS, 2003, ATHEROSCLEROSIS, V167, P205, DOI 10.1016/S0021-9150(03)00010-8; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	48	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40504	10.1371/journal.pone.0040504	http://dx.doi.org/10.1371/journal.pone.0040504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792358	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400065
J	Monttinen, HAM; Ravantti, JJ; Poranen, MM				Monttinen, Heli A. M.; Ravantti, Janne J.; Poranen, Minna M.			Evidence for a Non-Catalytic Ion-Binding Site in Multiple RNA-Dependent RNA Polymerases	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DE-NOVO INITIATION; GDD SEQUENCE MOTIF; DNA-POLYMERASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; REVERSE-TRANSCRIPTASE; ACID-RESIDUES	A high-affinity divalent cation-binding site located proximal to the catalytic center has been identified in several RNA-dependent RNA polymerases (RdRps), but the characteristics of such a site have not been systematically studied. Here, all available polymerase structures that follow the hand-like structural motif were screened for the presence of a divalent cation close to the catalytic site but distinct from catalytic metal ions. Such non-catalytic ions were found in all RNA virus families for which there were high-resolution RdRp structures available. Bound ions were always located in structurally similar locations at an approximate 6-angstrom distance from the catalytic site. Furthermore, the second aspartate residue in the highly conserved GDD sequence was found to be involved in the coordination of the bound ion in all viral RdRps studied. These results suggest that a non-catalytic ion-binding site is conserved across positive-sense, single-stranded, and double-stranded RNA viruses. Interestingly, a non-catalytic ion was also observed in a similar position in the reverse transcriptase of the human immunodeficiency virus. Moreover, two members of the DNA-dependent DNA polymerase B family displayed an ion at a comparable distance from the catalytic site, but the position was clearly distinct from the non-catalytic ion-binding sites of RdRps.	[Monttinen, Heli A. M.; Ravantti, Janne J.; Poranen, Minna M.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Ravantti, Janne J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; University of Helsinki	Monttinen, HAM (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	minna.poranen@helsinki.fi		Poranen, Minna/0000-0002-4775-3670; Monttinen, Heli/0000-0003-2461-0690; Ravantti, Janne/0000-0002-8578-7230	Academy of Finland [250113, 256069]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants from the Academy of Finland (grant number 250113 and 256069; www.aka.fi) and Sigrid Juselius Foundation (www.sigridjuselius.fi) to MMP. HAMM is a fellow of the Viikki Doctoral Programme in Molecular Biosciences (http://www.helsinki.fi/vgsb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui-Ismaili MH, 2000, J HUMAN VIROL, V3, P306; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans RJ, 2008, P NATL ACAD SCI USA, V105, P20695, DOI 10.1073/pnas.0809989106; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JABLONSKI SA, 1995, J VIROL, V69, P1532, DOI 10.1128/JVI.69.3.1532-1539.1995; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurila MRL, 2005, J GEN VIROL, V86, P521, DOI 10.1099/vir.0.80492-0; LAZCANO A, 1988, J MOL EVOL, V27, P365, DOI 10.1007/BF02101199; Lee JH, 2011, J GEN VIROL, V92, P1607, DOI 10.1099/vir.0.031104-0; Leon PE, 1998, J MOL EVOL, V47, P122, DOI 10.1007/PL00006368; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poranen MM, 2008, NUCLEIC ACIDS RES, V36, P6633, DOI 10.1093/nar/gkn632; Ranjith-Kumar CT, 2003, VIROLOGY, V312, P270, DOI 10.1016/S0042-6822(03)00247-2; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Salgado PS, 2004, STRUCTURE, V12, P307, DOI 10.1016/j.str.2004.01.012; SANKAR S, 1992, J BIOL CHEM, V267, P10168; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Takeshita D, 2010, P NATL ACAD SCI USA, V107, P15733, DOI 10.1073/pnas.1006559107; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Valverde-Garduno V, 1998, J MOL EVOL, V47, P73, DOI 10.1007/PL00006364; Vazquez AL, 2000, J VIROL, V74, P3888, DOI 10.1128/JVI.74.8.3888-3891.2000; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wright S, 2012, J VIROL, V86, P2837, DOI 10.1128/JVI.05168-11; Yang HY, 2003, J VIROL, V77, P1195, DOI 10.1128/JVI.77.2.1195-1203.2003; Yang HY, 2001, J VIROL, V75, P11088, DOI 10.1128/JVI.75.22.11088-11095.2001; Yi GH, 2003, EUR J BIOCHEM, V270, P4952, DOI 10.1046/j.1432-1033.2003.03897.x; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	57	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40581	10.1371/journal.pone.0040581	http://dx.doi.org/10.1371/journal.pone.0040581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792374	gold, Green Published			2022-12-25	WOS:000306362400072
J	El-Keredy, A; Schleyer, M; Konig, C; Ekim, A; Gerber, B				El-Keredy, Amira; Schleyer, Michael; Koenig, Christian; Ekim, Aslihan; Gerber, Bertram			Behavioural Analyses of Quinine Processing in Choice, Feeding and Learning of Larval Drosophila	PLOS ONE			English	Article							BITTER TASTE; MELANOGASTER; RECEPTORS; REWARD; ORGANIZATION; ARCHITECTURE; PERCEPTION; SYSTEM; SMELL; MODEL	Gustatory stimuli can support both immediate reflexive behaviour, such as choice and feeding, and can drive internal reinforcement in associative learning. For larval Drosophila, we here provide a first systematic behavioural analysis of these functions with respect to quinine as a study case of a substance which humans report as "tasting bitter''. We describe the dose-effect functions for these different kinds of behaviour and find that a half-maximal effect of quinine to suppress feeding needs substantially higher quinine concentrations (2.0 mM) than is the case for internal reinforcement (0.6 mM). Interestingly, in previous studies (Niewalda et al. 2008, Schipanski et al 2008) we had found the reverse for sodium chloride and fructose/sucrose, such that dose-effect functions for those tastants were shifted towards lower concentrations for feeding as compared to reinforcement, arguing that the differences in dose-effect function between these behaviours do not reflect artefacts of the types of assay used. The current results regarding quinine thus provide a starting point to investigate how the gustatory system is organized on the cellular and/or molecular level to result in different behavioural tuning curves towards a bitter tastant.	[El-Keredy, Amira; Schleyer, Michael; Ekim, Aslihan; Gerber, Bertram] Univ Wurzburg, Wurzburg, Germany; [El-Keredy, Amira] Tanta Univ, Tanta, Egypt; [Schleyer, Michael; Koenig, Christian; Gerber, Bertram] Univ Leipzig, Leipzig, Germany; [Ekim, Aslihan] Bilkent Univ, Ankara, Turkey; [Gerber, Bertram] Leibniz Inst Neurobiol, Magdeburg, Germany; [Gerber, Bertram] Univ Magdeburg, D-39106 Magdeburg, Germany	University of Wurzburg; Egyptian Knowledge Bank (EKB); Tanta University; Leipzig University; Ihsan Dogramaci Bilkent University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	El-Keredy, A (corresponding author), Univ Wurzburg, Wurzburg, Germany.	bertram.gerber@lin-magdeburg.de		Schleyer, Michael/0000-0001-8020-1483; Gerber, Bertram/0000-0003-3003-0051; Konig, Christian/0000-0001-6033-8255	PhD fellowship of the Studienstiftung des Deutschen Volkes; Channel System Program of the Egyptian Ministry of Higher Education; German Federal Ministry of Science and Technology (Bernstein Network Insect inspired robotics); Heisenberg Fellow of the Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft (SPP 1392 Integrative analyses of olfaction)	PhD fellowship of the Studienstiftung des Deutschen Volkes; Channel System Program of the Egyptian Ministry of Higher Education; German Federal Ministry of Science and Technology (Bernstein Network Insect inspired robotics); Heisenberg Fellow of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (SPP 1392 Integrative analyses of olfaction)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (SPP 1392 Integrative analyses of olfaction [to BG]), by a PhD fellowship of the Studienstiftung des Deutschen Volkes (to MS), by the Channel System Program of the Egyptian Ministry of Higher Education (to AEK), and by the German Federal Ministry of Science and Technology (Bernstein Network Insect inspired robotics [to BG]). BG is a Heisenberg Fellow of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cobb Matthew, 2009, SEB Experimental Biology Series, V63, P1; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Gerber B, 2009, RESULTS PROBL CELL D; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gerber B, 2006, P ROY SOC B-BIOL SCI, V273, P2965, DOI 10.1098/rspb.2006.3673; Hammer M, 1998, LEARN MEMORY, V5, P146; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Hendel T, 2005, J COMP PHYSIOL A, V191, P265, DOI 10.1007/s00359-004-0574-8; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kwon JY, 2011, J NEUROSCI, V31, P15300, DOI 10.1523/JNEUROSCI.3363-11.2011; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Niewalda T, 2008, CHEM SENSES, V33, P685, DOI 10.1093/chemse/bjn037; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Russell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020100; Saumweber T, 2011, CHEM SENSES, V36, P223, DOI 10.1093/chemse/bjq128; Schipanski A, 2008, CHEM SENSES, V33, P563, DOI 10.1093/chemse/bjn024; Schleyer M, 2011, LEARN MEMORY, V18, P639, DOI 10.1101/lm.2163411; Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001	36	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40525	10.1371/journal.pone.0040525	http://dx.doi.org/10.1371/journal.pone.0040525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802964	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500052
J	Burd, BJ; Macdonald, TA; van Roodselaar, A				Burd, Brenda J.; Macdonald, Tara A.; van Roodselaar, Albert			Towards Predicting Basin-Wide Invertebrate Organic Biomass and Production in Marine Sediments from a Coastal Sea	PLOS ONE			English	Article							BENTHIC SECONDARY PRODUCTION; FREE DRY-WEIGHT; CONTINENTAL-SLOPE; BRITISH-COLUMBIA; ENERGY-TRANSFER; STANDING STOCK; WADDEN SEA; STRAIT; MEIOFAUNA; GEORGIA	Detailed knowledge of environmental conditions is required to understand faunal production in coastal seas with topographic and hydrographic complexity. We test the hypothesis that organic biomass and production of subtidal sediment invertebrates throughout the Strait of Georgia, west coast of Canada, can be predicted by depth, substrate type and organic flux modified to reflect lability and age of material. A basin-wide database of biological, geochemical and flux data was analysed using an empirical production/ biomass (P/B) model to test this hypothesis. This analysis is unique in the spatial extent and detail of P/B and concurrent environmental measurements over a temperate coastal region. Modified organic flux was the most important predictor of organic biomass and production. Depth and substrate type were secondary modifiers. Between 69-74% of variability in biomass and production could be explained by the combined environmental factors. Organisms <1 mm were important contributors to biomass and production primarily in shallow, sandy sediments, where high P/B values were found despite low organic flux. Low biomass, production, and P/B values were found in the deep, northern basin and mainland fjords, which had silty sediments, low organic flux, low biomass of organisms <1 mm, and dominance by large, slow-growing macrofauna. In the highest organic flux and biomass areas near the Fraser River discharge, production did not increase beyond moderate flux levels. Although highly productive, this area had low P/B. Clearly, food input is insufficient to explain the complex patterns in faunal production revealed here. Additional environmental factors (depth, substrate type and unmeasured factors) are important modifiers of these patterns. Potential reasons for the above patterns are explored, along with a discussion of unmeasured factors possibly responsible for unexplained (30%) variance in biomass and production. We now have the tools for basin-wide first-order estimates of sediment invertebrate production.	[Burd, Brenda J.; Macdonald, Tara A.] Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [van Roodselaar, Albert] Metro Vancouver, Kingsway Burnaby, BC, Canada	Fisheries & Oceans Canada	Burd, BJ (corresponding author), Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada.	burdb@dfo-mpo.gc.ca			Metro Vancouver	Metro Vancouver	This work is part of the Strait of Georgia Ambient Monitoring Program, which is a collaborative research program with two partners: Fisheries and Oceans Canada and Metro Vancouver (formerly the Greater Vancouver Regional District). Metro Vancouver supplied all the funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller JY, 2002, DEEP-SEA RES PT II, V49, P4599, DOI 10.1016/S0967-0645(02)00131-5; ALONGI D, 1998, COASTAL ECOSYSTEM PR; Altenbach AV, 2001, J FORAMIN RES, V31, P79, DOI 10.2113/0310079; ASMUS H, 1982, NETH J SEA RES, V16, P403, DOI 10.1016/0077-7579(82)90046-1; BANSE K, 1980, ECOL MONOGR, V50, P355, DOI 10.2307/2937256; Barrie J, 2008, GEORGIA BASIN GEOHAZ; Berkenbusch K, 2011, MAR ECOL PROG SER, V425, P79, DOI 10.3354/meps09014; Beukema J, 1983, INVERTEBRATES WADDEN, P134; BREY T, 1986, MEERESFORSCHUNG, V31, P52; Brey T, 1998, J EXP MAR BIOL ECOL, V231, P191, DOI 10.1016/S0022-0981(98)00060-4; BREY T, 2004, POPULATION DYNAMICS; Brey T., 2001, POPULATION DYNAMICS; Burd BJ, 2008, MAR ENVIRON RES, V66, pS3, DOI 10.1016/j.marenvres.2008.09.004; Burd BJ, 2008, MAR ENVIRON RES, V66, pS62, DOI 10.1016/j.marenvres.2008.08.009; Burd BJ, 2009, 2859 FISH AQ SCI, V2859; CARPENTER R, 1981, GEOCHIM COSMOCHIM AC, V45, P1155, DOI 10.1016/0016-7037(81)90139-3; Clarke A, 2008, MAR ECOL PROG SER, V369, P25, DOI 10.3354/meps07670; Coull BC, 1999, AUST J ECOL, V24, P327, DOI 10.1046/j.1442-9993.1999.00979.x; Cusson M, 2005, MAR ECOL PROG SER, V297, P1, DOI 10.3354/meps297001; Danovaro R, 2002, MAR ECOL PROG SER, V234, P95, DOI 10.3354/meps234095; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2007, MAR BIOL, V152, P339, DOI 10.1007/s00227-007-0696-y; Davenne E, 2001, WATER PROPERTIES STR; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; DEKKER R, 1989, NETH J SEA RES, V23, P57, DOI 10.1016/0077-7579(89)90043-4; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dinn P, 2011, THESIS U VICTORIA; Dolbeth M, 2005, J EXP MAR BIOL ECOL, V326, P115, DOI 10.1016/j.jembe.2005.05.010; ELLISON RL, 1984, HYDROBIOLOGIA, V109, P131, DOI 10.1007/BF00011572; EVANS S, 1983, MAR ECOL PROG SER, V10, P147, DOI 10.3354/meps010147; Galeron J, 2000, MAR ECOL PROG SER, V197, P121, DOI 10.3354/meps197121; GERLACH SA, 1971, OECOLOGIA, V6, P176, DOI 10.1007/BF00345719; GERLACH SA, 1978, OECOLOGIA, V33, P55, DOI 10.1007/BF00376996; Gobas F.A., 2001, PERSISTENT ORGANIC P, P145, DOI [10.1007/978-1-4615-1571-5_6, DOI 10.1007/978-1-4615-1571-5_6]; Gobas FAPC, 1998, ENVIRON SCI TECHNOL, V32, P2442, DOI 10.1021/es980022+; GORDON K, 1997, THESIS U BRIT COLUMB; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; Heip C, 2003, MARINE SCIENCE FRONTIERS FOR EUROPE, P289; Hill PR, 2008, MAR ENVIRON RES, V66, pS39, DOI 10.1016/j.marenvres.2008.09.003; Hua Er, 2010, Journal of Ocean University of China, V9, P279, DOI 10.1007/s11802-010-1726-9; Isaaks E.H., 1989, APPL GEOSTATISTICS; Johannessen SC, 2012, MAR POLLUT BULL, V64, P675, DOI 10.1016/j.marpolbul.2012.01.026; Johannessen SC, 2009, CLIM RES, V40, P1, DOI 10.3354/cr00819; Johannessen SC, 2008, MAR ENVIRON RES, V66, pS1, DOI 10.1016/j.marenvres.2008.10.001; Johannessen SC, 2005, ENVIRON SCI TECHNOL, V39, P4361, DOI 10.1021/es040535i; Johannessen SC, 2005, MAR GEOL, V216, P59, DOI 10.1016/j.margeo.2005.01.004; Johnson NA, 2007, DEEP-SEA RES PT I, V54, P1350, DOI 10.1016/j.dsr.2007.04.011; Jumars P.A., 1989, Elsevier Oceanography Series, V47, P349; LEUVEN RSEW, 1985, HYDROBIOLOGIA, V127, P151, DOI 10.1007/BF00004193; LEVINGS CD, 1983, CAN J FISH AQUAT SCI, V40, P1120, DOI 10.1139/f83-131; Li J, 1997, FUND APPL NEMATOL, V20, P487; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LLANSO RJ, 1998, PUBLICATION WASHINGT; Maar M, 2011, J MARINE SYST, V85, P57, DOI 10.1016/j.jmarsys.2010.11.006; Macdonald RW, 2008, MAR ENVIRON RES, V66, pS87, DOI 10.1016/j.marenvres.2008.08.001; Macdonald T, 2011, MARINE ECOLOGY PROGR, V445, P129; Macdonald TA, 2010, 2874 FISH AQ SCI, V2874; Manini E, 2002, CHEM ECOL, V18, P155, DOI 10.1080/02757540212682; Masson D, 2002, ESTUAR COAST SHELF S, V54, P115, DOI 10.1006/ecss.2001.0833; Nilsen M, 2006, MAR ECOL PROG SER, V321, P67, DOI 10.3354/meps321067; PROBERT PK, 1986, NEW ZEAL J MAR FRESH, V20, P407, DOI 10.1080/00288330.1986.9516160; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Ricciardi A, 1998, MAR ECOL PROG SER, V163, P245, DOI 10.3354/meps163245; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; SCHWINGHAMER P, 1986, MAR ECOL PROG SER, V31, P131, DOI 10.3354/meps031131; Seitz RD, 2009, J EXP MAR BIOL ECOL, V381, pS4, DOI 10.1016/j.jembe.2009.07.004; SHIRAYAMA Y, 1984, OCEANOL ACTA, V7, P113; Smith CR, 1997, DEEP-SEA RES PT II, V44, P2295, DOI 10.1016/S0967-0645(97)00022-2; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Soltwedel T, 1996, J MAR BIOL ASSOC UK, V76, P327, DOI 10.1017/S0025315400030587; Stucchi D, 2009, LONG TERM TRENDS DEE; Tagliapietra D, 2007, HYDROBIOLOGIA, V588, P205, DOI 10.1007/s10750-007-0663-0; Thatje S, 1999, POLAR BIOL, V22, P31; THOMSON RE, 1981, CANADIAN SPECIAL PUB, V56, P235; TUMBIOLO ML, 1994, MAR ECOL PROG SER, V114, P165, DOI 10.3354/meps114165; Vanaverbeke J, 1997, J SEA RES, V38, P93, DOI 10.1016/S1385-1101(97)00038-5; Vanden Berghe E, 2009, MAR ECOL PROG SER, V382, P225, DOI 10.3354/meps07826; Vandepitte L, 2010, HYDROBIOLOGIA, V644, P1, DOI 10.1007/s10750-010-0108-z; Vinogradov M, 1983, SEA, P123; VRANKEN G, 1986, HYDROBIOLOGIA, V135, P193, DOI 10.1007/BF00006530; VRANKEN G, 1986, OPHELIA, V26, P429, DOI 10.1080/00785326.1986.10422004; WARWICK RM, 1984, OECOLOGIA, V61, P32, DOI 10.1007/BF00379085; WESSA P, 2010, FREE STAT SOFTWARE; WIGLEY RL, 1964, LIMNOL OCEANOGR, V9, P485, DOI 10.4319/lo.1964.9.4.0485; WITTE JI, 1984, MAR ECOL PROG SER, V14, P129, DOI 10.3354/meps014129; WRIGHT CA, 2008, STRAIT GEORGIA AMBIE	89	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40295	10.1371/journal.pone.0040295	http://dx.doi.org/10.1371/journal.pone.0040295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792267	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800063
J	Crespo-Enriquez, I; Partanen, J; Martinez, S; Echevarria, D				Crespo-Enriquez, Ivan; Partanen, Juha; Martinez, Salvador; Echevarria, Diego			Fgf8-Related Secondary Organizers Exert Different Polarizing Planar Instructions along the Mouse Anterior Neural Tube	PLOS ONE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; MORPHOGEN GRADIENT; ISTHMIC ORGANIZER; SIGNALING PATHWAYS; EXPRESSION DOMAINS; SPROUTY PROTEINS; FGF8; GENE; BRAIN; GBX2	Early brain patterning depends on proper arrangement of positional information. This information is given by gradients of secreted signaling molecules (morphogens) detected by individual cells within the responding tissue, leading to specific fate decisions. Here we report that the morphogen FGF8 exerts initially a differential signal activity along the E9.5 mouse neural tube. We demonstrate that this polarizing activity codes by RAS-regulated ERK1/2 signaling and depends on the topographical location of the secondary organizers: the isthmic organizer (IsO) and the anterior neural ridge (anr) but not on zona limitans intrathalamica (zli). Our results suggest that Sprouty2, a negative modulator of RAS/ERK pathway, is important for regulating Fgf8 morphogenetic signal activity by controlling Fgf8-induced signaling pathways and positional information during early brain development.	[Crespo-Enriquez, Ivan; Martinez, Salvador; Echevarria, Diego] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante, Spain; [Partanen, Juha] Univ Helsinki, Div Genet, Dept Biosci, Helsinki, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Helsinki	Crespo-Enriquez, I (corresponding author), Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante, Spain.	diegoaza@umh.es	Echevarria, Diego/E-6386-2016; Echevarria, Diego/P-7391-2019; Enriquez, Ivan Crespo/N-4949-2019; Mratinez, Salvador/L-4896-2014	Echevarria, Diego/0000-0002-0938-7470; Echevarria, Diego/0000-0002-0938-7470; Enriquez, Ivan Crespo/0000-0003-2967-4554; Mratinez, Salvador/0000-0002-9320-4103; Martinez, Salvador/0000-0002-2910-8926; Partanen, Juha/0000-0001-8850-4825	Spanish Government [BFU2008-00588, SAF 2008-01004]; Consolider-Ingenio [CSD2007-00023]; Spanish Government Fellowship [FPI-BES 2006-12420M]	Spanish Government(Spanish GovernmentEuropean Commission); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Government Fellowship	This work was supported by national grants from the Spanish Government BFU2008-00588, SAF 2008-01004 and Consolider-Ingenio CSD2007-00023. ICE was supported by a Spanish Government Fellowship FPI-BES 2006-12420M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon F, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-61; Aroca P, 2005, BRAIN RES REV, V49, P179, DOI 10.1016/j.brainresrev.2004.12.031; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Blak AA, 2007, DEV BIOL, V303, P231, DOI 10.1016/j.ydbio.2006.11.008; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Christen B, 1999, DEVELOPMENT, V126, P119; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Echevarria D, 2005, DEV BIOL, V277, P114, DOI 10.1016/j.ydbio.2004.09.011; Echevarria D, 2001, INT J DEV BIOL, V45, P895; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gabay L, 1997, DEVELOPMENT, V124, P3535; Garda AL, 2001, MECH DEVELOP, V101, P111, DOI 10.1016/S0925-4773(00)00567-0; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Jukkola T, 2006, DEV BIOL, V297, P141, DOI 10.1016/j.ydbio.2006.05.002; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Lahti L, 2011, DEV BIOL, V349, P270, DOI 10.1016/j.ydbio.2010.11.008; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Lin W, 2005, GENESIS, V41, P110, DOI 10.1002/gene.20103; Lin W, 2002, MECH DEVELOP, V113, P163, DOI 10.1016/S0925-4773(02)00018-7; Liu AM, 1999, DEVELOPMENT, V126, P4827; Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; MARIN F, 1994, DEV BIOL, V163, P19, DOI 10.1006/dbio.1994.1120; Martinez S, 2001, INT J DEV BIOL, V45, P367; Mason I, 2000, BIOCHEM CELL BIOL, V78, P577, DOI 10.1139/bcb-78-5-577; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; MEINHARDT H, 1984, Journal of Embryology and Experimental Morphology, V83, P289; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nakamura H, 2008, DEV GROWTH DIFFER, V50, pS113, DOI 10.1111/j.1440-169X.2008.00995.x; Nowak M, 2011, NAT CELL BIOL, V13, P153, DOI 10.1038/ncb2155; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Partanen J, 2007, J NEUROCHEM, V101, P1185, DOI 10.1111/j.1471-4159.2007.04463.x; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Raible F, 2004, TRENDS NEUROSCI, V27, P727, DOI 10.1016/j.tins.2004.10.003; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Sato T, 2004, DEV GROWTH DIFFER, V46, P487; Sato T, 2001, DEVELOPMENT, V128, P2461; Sato T, 2009, DEVELOPMENT, V136, P3617, DOI 10.1242/dev.041210; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shinya M, 2001, DEVELOPMENT, V128, P4153; Smith TG, 2006, FEBS LETT, V580, P4242, DOI 10.1016/j.febslet.2006.06.081; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Suzuki A, 2012, DEV GROWTH DIFFER, V54, P463, DOI 10.1111/j.1440-169X.2012.01332.x; Suzuki-Hirano A, 2010, DEV BIOL, V337, P284, DOI 10.1016/j.ydbio.2009.10.044; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392; Trokovic R, 2005, DEV BIOL, V278, P428, DOI 10.1016/j.ydbio.2004.11.024; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; Vieira C, 2006, NEUROSCIENCE, V137, P7, DOI 10.1016/j.neuroscience.2005.09.017; Vieira C, 2010, INT J DEV BIOL, V54, P7, DOI 10.1387/ijdb.092853cv; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Yu TA, 2011, DEVELOPMENT, V138, P2957, DOI 10.1242/dev.063784	79	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39977	10.1371/journal.pone.0039977	http://dx.doi.org/10.1371/journal.pone.0039977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792203	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800028
J	Frisch, D; Cottenie, K; Badosa, A; Green, AJ				Frisch, Dagmar; Cottenie, Karl; Badosa, Anna; Green, Andy J.			Strong Spatial Influence on Colonization Rates in a Pioneer Zooplankton Metacommunity	PLOS ONE			English	Article							HIGH DISPERSAL CAPACITY; AQUATIC INVERTEBRATES; TEMPORARY WETLANDS; COPEPODS; COMMUNITIES; PATTERNS; WIND; HYDROPERIOD; MECHANISMS; RICHNESS	The magnitude of community-wide dispersal is central to metacommunity models, yet dispersal is notoriously difficult to quantify in passive and cryptic dispersers such as many freshwater invertebrates. By overcoming the problem of quantifying dispersal rates, colonization rates into new habitats can provide a useful estimate of the magnitude of effective dispersal. Here we study the influence of spatial and local processes on colonization rates into new ponds that indicate differential dispersal limitation of major zooplankton taxa, with important implications for metacommunity dynamics. We identify regional and local factors that affect zooplankton colonization rates and spatial patterns in a large-scale experimental system. Our study differs from others in the unique setup of the experimental pond area by which we were able to test spatial and environmental variables at a large spatial scale. We quantified colonization rates separately for the Copepoda, Cladocera and Rotifera from samples collected over a period of 21 months in 48 newly constructed temporary ponds of 0.18-2.95 ha distributed in a restored wetland area of 2,700 ha in Donana National Park, Southern Spain. Species richness upon initial sampling of new ponds was about one third of that in reference ponds, although the rate of detection of new species from thereon were not significantly different, probably owing to high turnover in the dynamic, temporary reference ponds. Environmental heterogeneity had no detectable effect on colonization rates in new ponds. In contrast, connectivity, space (based on latitude and longitude) and surface area were key determinants of colonization rates for copepods and cladocerans. This suggests dispersal limitation in cladocerans and copepods, but not in rotifers, possibly due to differences in propagule size and abundance.	[Frisch, Dagmar] Univ Oklahoma, Biol Stn, Kingston, OK USA; [Cottenie, Karl] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Frisch, Dagmar; Badosa, Anna; Green, Andy J.] Donana Biol Stn EBD CSIC, Dept Wetland Ecol, Seville, Spain	University of Oklahoma System; University of Oklahoma - Norman; University of Guelph; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Frisch, D (corresponding author), Univ Oklahoma, Biol Stn, Kingston, OK USA.	dfrisch@sistern.net	Badosa, Anna/AAD-4016-2019; Frisch, Dagmar/F-6363-2012; Green, Andy J/A-5189-2008; Frisch, Dagmar/AAE-9499-2019	Green, Andy J/0000-0002-1268-4951; Frisch, Dagmar/0000-0001-9310-2230; Cottenie, Karl/0000-0001-9498-8483	Ministerio de Educacion y Ciencia; Spanish Ministerio de Medio Ambiente Donana restoration project; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [P06-RNM-02431]; European Science Foundation (Eurodiversity programme BIOPOOL project)	Ministerio de Educacion y Ciencia(Spanish Government); Spanish Ministerio de Medio Ambiente Donana restoration project; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); European Science Foundation (Eurodiversity programme BIOPOOL project)	The authors are grateful to Arantza Arechederra for her invaluable assistance with fieldwork and zooplankton analysis. Additional help in the field was provided by Ernesto Garcia, Ana Carvajal and Marta Sanchez. DF was supported partly via a postdoctoral fellowship from the Ministerio de Educacion y Ciencia. Additional funding was provided by the Spanish Ministerio de Medio Ambiente Donana 2005 restoration project, by the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (project P06-RNM-02431) and by the European Science Foundation (Eurodiversity programme BIOPOOL project).; DF was supported partly via a postdoctoral fellowship from the Ministerio de Educacion y Ciencia. Additional funding was provided by the Spanish Ministerio de Medio Ambiente Donana 2005 restoration project, by the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (project P06-RNM-02431) and by the European Science Foundation (Eurodiversity programme BIOPOOL project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2007, OECOLOGIA, V153, P135, DOI 10.1007/s00442-007-0704-4; Alonso M., 1996, CRUSTACEA BRANCHIOPO; Badosa A, 2010, HYDROBIOLOGIA, V654, P67, DOI 10.1007/s10750-010-0370-0; Bartholme S, 2005, LIMNOL OCEANOGR, V50, P923, DOI 10.4319/lo.2005.50.3.0923; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brochet AL, 2010, HYDROBIOLOGIA, V637, P255, DOI 10.1007/s10750-009-9975-6; BUCKLEY RC, 1986, J BIOGEOGR, V13, P69, DOI 10.2307/2844850; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Cohen GM, 2003, OIKOS, V103, P603, DOI 10.1034/j.1600-0706.2003.12660.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Dussart B, 1969, COPEPODES EAUX CONTI, DOI DOI 10.1007/s00442-010-1847-2; Dussart B, 1967, COPEPODES EAUX CONTI; Einsle U, 1993, CRUSTACEA COPEPODA C, P208; Espinar JL, 2009, AQUAT ECOL, V43, P323, DOI 10.1007/s10452-007-9162-7; Fahd K, 2009, HYDROBIOLOGIA, V634, P219, DOI 10.1007/s10750-009-9889-3; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Frisch D, 2006, HYDROBIOLOGIA, V556, P327, DOI 10.1007/s10750-005-1305-z; Frisch D, 2005, FRESHWATER BIOL, V50, P323, DOI 10.1111/j.1365-2427.2004.01321.x; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Frisch D, 2007, FUND APPL LIMNOL, V168, P289, DOI 10.1127/1863-9135/2007/0168-0289; Frisch D, 2009, HYDROBIOLOGIA, V624, P115, DOI 10.1007/s10750-008-9672-x; Gray DK, 2011, ECOL APPL, V21, P1241, DOI 10.1890/10-0364.1; Guadagnin DL, 2007, BIODIVERS CONSERV, V16, P1231, DOI 10.1007/s10531-006-9127-5; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Hovestadt T, 2005, DIVERS DISTRIB, V11, P333, DOI 10.1111/j.1366-9516.2005.00161.x; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jenkins DG, 2007, GLOBAL ECOL BIOGEOGR, V16, P415, DOI 10.1111/j.1466-8238.2007.00312.x; Jenkins DG, 1998, ECOL MONOGR, V68, P421, DOI 10.1890/0012-9615(1998)068[0421:DSCDIS]2.0.CO;2; Jenkins DG, 1998, HYDROBIOLOGIA, V387, P15, DOI 10.1023/A:1017080029317; Koste W, 1978, ROTATORIA RADERTIERE; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lindo Z, 2008, OIKOS, V117, P1856, DOI 10.1111/j.1600-0706.2008.16920.x; Louette G, 2005, ECOLOGY, V86, P353, DOI 10.1890/04-0403; Louette G, 2008, FRESHWATER BIOL, V53, P2309, DOI 10.1111/j.1365-2427.2008.02052.x; MAC ARTHUR ROBERT H., 1967; MCCORMICK PV, 1988, T AM MICROSC SOC, V107, P259, DOI 10.2307/3226502; Michels E, 2001, MOL ECOL, V10, P1929, DOI 10.1046/j.1365-294X.2001.01340.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Resetarits WJ, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P374; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Santamaria L, 2005, DONANA AGUA BIOSFERA, P313; Sarnelle O, 2004, LIMNOL OCEANOGR, V49, P1382, DOI 10.4319/lo.2004.49.4_part_2.1382; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Shurin JB, 2000, ECOLOGY, V81, P3074, DOI 10.2307/177402; Silver CA, 2012, ACTA OECOL, V39, P1, DOI 10.1016/j.actao.2011.10.001; Vanschoenwinkel B, 2008, FRESHWATER BIOL, V53, P2264, DOI 10.1111/j.1365-2427.2008.02071.x; Vanschoenwinkel B, 2008, ECOGRAPHY, V31, P567, DOI 10.1111/j.0906-7590.2008.05442.x; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Waterkeyn A, 2008, FRESHWATER BIOL, V53, P1808, DOI 10.1111/j.1365-2427.2008.02005.x; Waterkeyn A, 2010, AQUAT CONSERV, V20, P580, DOI 10.1002/aqc.1122	64	71	72	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40205	10.1371/journal.pone.0040205	http://dx.doi.org/10.1371/journal.pone.0040205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792241	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800049
J	Okada, K; Angkawidjaja, C; Koga, Y; Takano, K; Kanaya, S				Okada, Ken; Angkawidjaja, Clement; Koga, Yuichi; Takano, Kazufumi; Kanaya, Shigenori			Characteristic Features of Kynurenine Aminotransferase Allosterically Regulated by (Alpha)-Ketoglutarate in Cooperation with Kynurenine	PLOS ONE			English	Article							PYROCOCCUS-HORIKOSHII OT3; CRYSTAL-STRUCTURE; II HOMOLOG; ACID; SCHIZOPHRENIA	Kynurenine aminotransferase from Pyrococcus horikoshii OT3 (PhKAT), which is a homodimeric protein, catalyzes the conversion of kynurenine (KYN) to kynurenic acid (KYNA). We analyzed the transaminase reaction mechanisms of this protein with pyridoxal-5'-phosphate (PLP), KYN and alpha-ketoglutaric acid (2OG) or oxaloacetic acid (OXA). 2OG significantly inhibited KAT activities in kinetic analyses, suggesting that a KYNA biosynthesis is allosterically regulated by 2OG. Its inhibitions evidently were unlocked by KYN. 2OG and KYN functioned as an inhibitor and activator in response to changes in the concentrations of KYN and 2OG, respectively. The affinities of one subunit for PLP or 2OG were different from that of the other subunit, as confirmed by spectrophotometry and isothermal titration calorimetry, suggesting that the difference of affinities between subunits might play a role in regulations of the KAT reaction. Moreover, we identified two active and allosteric sites in the crystal structure of PhKAT-2OG complexes. The crystal structure of PhKAT in complex with four 2OGs demonstrates that two 2OGs in allosteric sites are effector molecules which inhibit the KYNA productions. Thus, the combined data lead to the conclusion that PhKAT probably is regulated by allosteric control machineries, with 2OG as the allosteric inhibitor.	[Okada, Ken; Angkawidjaja, Clement; Koga, Yuichi; Takano, Kazufumi; Kanaya, Shigenori] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Osaka, Japan; [Takano, Kazufumi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST)	Okada, K (corresponding author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Osaka, Japan.	okadak@mls.eng.osaka-u.ac.jp		Takano, Kazufumi/0000-0002-7548-7314; Angkawidjaja, Clement/0000-0002-5019-2536	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21380065]; Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan	This work was supported in part by a grant (21380065) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by an Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Chon H, 2005, PROTEINS, V61, P685, DOI 10.1002/prot.20614; Chon H, 2005, ACTA CRYSTALLOGR F, V61, P319, DOI 10.1107/S1744309105005269; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erhardt S, 2003, ADV EXP MED BIOL, V527, P155; Han Q, 2008, J BIOL CHEM, V283, P3567, DOI 10.1074/jbc.M708358200; Han Q, 2008, BIOCHEMISTRY-US, V47, P1622, DOI 10.1021/bi701800j; Han QA, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-19; Han Q, 2010, CELL MOL LIFE SCI, V67, P353, DOI 10.1007/s00018-009-0166-4; Hartai Z, 2007, NEUROCHEM INT, V50, P308, DOI 10.1016/j.neuint.2006.08.012; Kawarabayasi Y, 1998, DNA Res, V5, P147, DOI 10.1093/dnares/5.2.147; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rossi F, 2004, J BIOL CHEM, V279, P50214, DOI 10.1074/jbc.M409291200; Rossi F, 2008, J BIOL CHEM, V283, P3559, DOI 10.1074/jbc.M707925200; Rossi F, 2008, CURR OPIN STRUC BIOL, V18, P748, DOI 10.1016/j.sbi.2008.09.009; TOBES MC, 1977, J BIOL CHEM, V252, P4591; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wogulis M, 2008, BIOCHEMISTRY-US, V47, P1608, DOI 10.1021/bi701172v; Wu HQ, 2010, J MOL NEUROSCI, V40, P204, DOI 10.1007/s12031-009-9235-2	22	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40307	10.1371/journal.pone.0040307	http://dx.doi.org/10.1371/journal.pone.0040307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792273	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800067
J	Hosp, J; Sagane, Y; Danks, G; Thompson, EM				Hosp, Julia; Sagane, Yoshimasa; Danks, Gemma; Thompson, Eric M.			The Evolving Proteome of a Complex Extracellular Matrix, the Oikopleura House	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CELLULOSE SYNTHASE; 3-DIMENSIONAL STRUCTURE; PHYLOGENETIC ANALYSIS; DIOICA; PREDICTION; SECRETION; PROTEINS; CHORDATE; APPENDICULARIAN	Extracellular matrices regulate biological processes at the level of cells, tissues, and in some cases, entire multicellular organisms. The subphylum Urochordata exemplifies the latter case, where animals are partially or completely enclosed in "houses" or "tunics". Despite this common strategy, we show that the house proteome of the appendicularian, Oikopleura, has very little in common with the proteome of the sister class, ascidian, Ciona. Of 80 identified house proteins (oikosins), similar to half lack domain modules or similarity to known proteins, suggesting de novo appearance in appendicularians. Gene duplication has been important in generating almost 1/3 of the current oikosin complement, with serial duplications up to 8 paralogs in one family. Expression pattern analyses revealed that individual oikosins are produced from specific fields of cells within the secretory epithelium, but in some cases, migrate up to at least 20 cell diameters in extracellular space to combine in defined house structures. Interestingly, peroxidasin and secretory phospholipase A(2) domains, implicated in innate immune defence are secreted from the anlage associated with the food-concentrating filter, suggesting that this extra-organismal structure may play, in part, such a role in Oikopleura. We also show that sulfation of proteoglycans is required for the hydration and inflation of pre-house rudiments into functional houses. Though correct proportioning in the production of oikosins would seem important in repetitive assembly of the complex house structure, the genomic organization of oikosin loci appears incompatible with common enhancers or locus control regions exerting such a coordinate regulatory role. Thus, though all tunicates employ extracellular matrices based on a cellulose scaffold as a defining feature of the subphylum, they have evolved radically different protein compositions associated with this common underlying structural theme.	[Hosp, Julia; Sagane, Yoshimasa; Danks, Gemma; Thompson, Eric M.] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Danks, Gemma] Univ Bergen, Computat Biol Unit, Bergen, Norway; [Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Hosp, J (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway.	Eric.Thompson@sars.uib.no	Sagane, Yoshimasa/C-7635-2013; Sagane, Yoshimasa/AAG-5543-2019	Sagane, Yoshimasa/0000-0002-7815-3141; Danks, Gemma/0000-0001-7004-0065	Norwegian Research Council FUGE [17541/S10]	Norwegian Research Council FUGE(Research Council of Norway)	This work was supported by Norwegian Research Council FUGE grant 17541/S10. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DEIBEL D, 1985, MAR ECOL PROG SER, V27, P79, DOI 10.3354/meps027079; Denoeud F, 2010, SCIENCE, V330, P1381, DOI 10.1126/science.1194167; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong CH, 2011, FISH SHELLFISH IMMUN, V30, P1223, DOI 10.1016/j.fsi.2011.04.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FENAUX R, 1986, ZOOMORPHOLOGY, V106, P224, DOI 10.1007/BF00312043; Ganot P, 2002, DEV BIOL, V252, P59, DOI 10.1006/dbio.2002.0834; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Koehler CJ, 2009, J PROTEOME RES, V8, P4333, DOI 10.1021/pr900425n; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; Matthysse AG, 2004, P NATL ACAD SCI USA, V101, P986, DOI 10.1073/pnas.0303623101; Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; Sagane Y, 2011, CELL MOL LIFE SCI, V68, P1611, DOI 10.1007/s00018-010-0547-8; Sagane Y, 2010, DEVELOPMENT, V137, P1483, DOI 10.1242/dev.044503; Schneppenheim R, 2011, J THROMB HAEMOST, V9, P209, DOI 10.1111/j.1538-7836.2011.04324.x; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Spada F, 2001, J BIOL CHEM, V276, P20624, DOI 10.1074/jbc.M100438200; Spada F, 2007, BIOL CELL, V99, P273, DOI 10.1042/BC20060124; Thompson EM, 2001, DEV BIOL, V238, P260, DOI 10.1006/dbio.2001.0414; Thompson EM, 2005, RESPONSE MARINE ECOS, P89; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troedsson C, 2009, J PLANKTON RES, V31, P1453, DOI 10.1093/plankt/fbp085; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	48	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40172	10.1371/journal.pone.0040172	http://dx.doi.org/10.1371/journal.pone.0040172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792236	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300034
J	Otero-Muras, I; Banga, JR; Alonso, AA				Otero-Muras, Irene; Banga, Julio R.; Alonso, Antonio A.			Characterizing Multistationarity Regimes in Biochemical Reaction Networks	PLOS ONE			English	Article							CHEMICAL-REACTION NETWORKS; MULTIPLE EQUILIBRIA; SYSTEMS BIOLOGY; OPTIMIZATION; BISTABILITY; BIFURCATION; KINETICS; SWITCH; MULTISTABILITY; HYSTERESIS	Switch like responses appear as common strategies in the regulation of cellular systems. Here we present a method to characterize bistable regimes in biochemical reaction networks that can be of use to both direct and reverse engineering of biological switches. In the design of a synthetic biological switch, it is important to study the capability for bistability of the underlying biochemical network structure. Chemical Reaction Network Theory (CRNT) may help at this level to decide whether a given network has the capacity for multiple positive equilibria, based on their structural properties. However, in order to build a working switch, we also need to ensure that the bistability property is robust, by studying the conditions leading to the existence of two different steady states. In the reverse engineering of biological switches, knowledge collected about the bistable regimes of the underlying potential model structures can contribute at the model identification stage to a drastic reduction of the feasible region in the parameter space of search. In this work, we make use and extend previous results of the CRNT, aiming not only to discriminate whether a biochemical reaction network can exhibit multiple steady states, but also to determine the regions within the whole space of parameters capable of producing multistationarity. To that purpose we present and justify a condition on the parameters of biochemical networks for the appearance of multistationarity, and propose an efficient and reliable computational method to check its satisfaction through the parameter space.	[Otero-Muras, Irene] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Zurich, Switzerland; [Banga, Julio R.; Alonso, Antonio A.] Spanish Natl Res Council, CSIC, Inst Invest Marinas, BioProc Engn Grp, Vigo, Spain	Swiss Federal Institutes of Technology Domain; ETH Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Otero-Muras, I (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Zurich, Switzerland.	antonio@iim.csic.es	Otero-Muras, Irene/K-3832-2014; Banga, Julio R./ABD-8629-2020; Banga, Julio R./A-8388-2008	Otero-Muras, Irene/0000-0003-2895-997X; Banga, Julio R./0000-0002-4245-0320; Banga, Julio R./0000-0002-4245-0320; Alonso, Antonio/0000-0001-8203-1799	Spanish government, Ministry of Science and Innovation [DPI2008-06880-C03-02, DPI2004-07444-C04-03]; Xunta de Galicia [PGIDIT02-PXIC40209PN]; Consejo Superior de Investigaciones CientA-ficas [PIE-201170E018]	Spanish government, Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Consejo Superior de Investigaciones CientA-ficas	Funding provided by Spanish government, Ministry of Science and Innovation project MultiSysBio (ref. DPI2008-06880-C03-02) and DPI2004-07444-C04-03, Xunta de Galicia (PGIDIT02-PXIC40209PN). Consejo Superior de Investigaciones CientA-ficas intramural project BioREDES (ref. PIE-201170E018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Angeli D, 2007, MATH BIOSCI, V210, P598, DOI 10.1016/j.mbs.2007.07.003; Bailey JE, 2001, NAT BIOTECHNOL, V19, P503, DOI 10.1038/89204; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Bishop LM, 2010, BIOPHYS J, V98, P1, DOI 10.1016/j.bpj.2009.09.055; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Chickarmane V, 2005, BIOINFORMATICS, V21, P3688, DOI 10.1093/bioinformatics/bti603; Conradi C, 2005, IEE P SYST BIOL, V152, P243, DOI 10.1049/ip-syb:20050045; Conradi C, 2007, P NATL ACAD SCI USA, V104, P19175, DOI 10.1073/pnas.0705731104; Craciun G, 2005, SIAM J APPL MATH, V65, P1526, DOI 10.1137/S0036139904440278; Craciun G, 2006, SIAM J APPL MATH, V66, P1321, DOI 10.1137/050634177; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Csendes T, 2008, OPTIM LETT, V2, P445, DOI 10.1007/s11590-007-0072-3; EDELSTEIN BB, 1970, J THEOR BIOL, V29, P57, DOI 10.1016/0022-5193(70)90118-9; Egea JA, 2007, J GLOBAL OPTIM, V37, P481, DOI 10.1007/s10898-006-9075-3; FEINBERG M, 1987, CHEM ENG SCI, V42, P2229, DOI 10.1016/0009-2509(87)80099-4; FEINBERG M, 1974, CHEM ENG SCI, V29, P775, DOI 10.1016/0009-2509(74)80195-8; FEINBERG M, 1977, ARCH RATION MECH AN, V66, P83, DOI 10.1007/BF00250853; Feinberg M., 1979, LECT CHEM REACTION N; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Govaerts W, 2003, P 2003 ACM S APPL CO, P161; Granvilliers L, 2006, ACM T MATH SOFTWARE, V32, P138, DOI 10.1145/1132973.1132980; HORN F, 1972, ARCH RATION MECH AN, V47, P81; HORN F, 1972, ARCH RATION MECH AN, V49, P172; HUANG S, 2005, COMPUTATIONAL SYSTEM; Jaulin L., 2001, APPL INTERVAL ANAL; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lu J, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-11; Moore RE., 1988, RELIABILITY COMPUTIN; Otero-Muras I, 2008, SYST CONTROL LETT, V57, P554, DOI 10.1016/j.sysconle.2007.12.003; Otero-Muras I, 2009, BIOTECHNOL PROGR, V25, P619, DOI 10.1002/btpr.112; Pal L, 2009, OPTIM METHOD SOFTW, V24, P749, DOI 10.1080/10556780902753395; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pedamallu CS, 2011, INT J MODEL IDENTIF, V14, P133, DOI 10.1504/IJMIC.2011.042347; Ross J, 1999, ANNU REV PHYS CHEM, V50, P51, DOI 10.1146/annurev.physchem.50.1.51; Rump S, 1999, DEV RELIABLE COMPUTI, P77, DOI DOI 10.1007/978-94-017-1247-7; Saez-Rodriguez J, 2008, IET SYST BIOL, V2, P80, DOI 10.1049/iet-syb:20070012; Schreiber I, 2003, J PHYS CHEM A, V107, P9846, DOI 10.1021/jp035310t; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Vlad MO, 2006, DETERMINATION COMPLE; Wang YC, 2011, BMC SYST BIOL, V5, DOI [10.1186/1752-0509-5-S1-S6, 10.1186/1752-0509-5-S1-S1]; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19	46	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39194	10.1371/journal.pone.0039194	http://dx.doi.org/10.1371/journal.pone.0039194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802936	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900010
J	Pan, Y; Zhang, Q; Atsaves, V; Yang, H; Claret, FX				Pan, Y.; Zhang, Q.; Atsaves, V.; Yang, H.; Claret, F. X.			Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways	ONCOGENE			English	Article						nasopharyngeal carcinoma; Epstein-Barr virus-associated malignancy; cisplatin; ultraviolet radiation; ionizing radiation; RPPA	DOMAIN-BINDING PROTEIN-1; CELL-CYCLE CHECKPOINTS; HOMOLOGOUS RECOMBINATION; RAD51 PROTEIN; ACTIVATION; EXPRESSION; CISPLATIN; INHIBITION; OVEREXPRESSION; CONTRIBUTES	Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-associated malignancy most common in East Asia and Africa. Radiotherapy and cisplatin-based chemotherapy are the main treatment options. Unfortunately, disease response to concurrent chemoradiotherapy varies among patients with NPC, and many cases are resistant to cisplatin. Increased DNA damage repair is one of the mechanisms contributing to this resistance. Jab1/CSN5 is a multifunctional protein that participates in controlling cell proliferation and the stability of multiple proteins. Jab1 overexpression has been found to correlate with poor prognosis in several tumor types. However, the biological significance of Jab1 activity in response to cancer treatment is unclear. In this study, we used three NPC cell lines (CNE1, CNE2 and HONE1) to investigate the hypothesis that Jab1 positively regulates the DNA repair protein Rad51 and, in turn, cellular response to treatment with DNA-damaging agents such as cisplatin, ionizing radiation (IR) and ultraviolet (UV) radiation. We found that Jab1 was overexpressed in two relatively cisplatin-, IR- and UV-resistant NPC cell lines, and knocking down its expression conferred sensitivity to cisplatin, IR and UV radiation. By contrast, exogenous Jab1 expression enhanced the resistance of NPC cells to cisplatin, IR and UV radiation. Moreover, we provide a mechanism by which Jab1 positively regulated Rad51 through p53-dependent pathway, and increased ectopic expression of Rad51 conferred cellular resistance to cisplatin, IR and UV radiation in Jab1-deficient cells. Taken together, our findings suggest that Jab1 has an important role in the cellular response to cisplatin and irradiation by regulating DNA damage and repair pathways. Therefore, Jab1 is a novel biomarker for predicting the outcome of patients with NPC who are treated with DNA-damaging agents.	[Pan, Y.; Zhang, Q.; Atsaves, V.; Claret, F. X.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Pan, Y.; Yang, H.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510275, Guangdong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University	Claret, FX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	fxclaret@mdanderson.org	atsaves, vasileios/ABA-1599-2021; Claret, Francois X/R-2104-2016; Pan, Yunbao/J-9016-2013	Claret, Francois X/0000-0003-4629-6495; Pan, Yunbao/0000-0002-6311-2945; atsaves, vasileios/0000-0002-9234-4657	China Scholarship Council [2010638087]; National Cancer Institute [RO1-CA90853]; NCI Cancer Center Support Grant [CA16672]; National Natural Science Foundation of China [81071837, 30670627]; Natural Science Foundation of Guangdong Province, China [9251008901000005, 06021210]; Scientific and Technological Project of Guangdong, China [2008A030201009, 2010B050700016]; NATIONAL CANCER INSTITUTE [R01CA090853, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Scientific and Technological Project of Guangdong, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Zahid H Siddik, Do Youn Oh for helpful discussions and Ronald Glaser for kindly providing HONE1 cells. This work was supported by a fellowship from the China Scholarship Council (2010638087 to YP) and a grant from the National Cancer Institute (RO1-CA90853 to FXC). The University of Texas MD Anderson Functional Proteomics Core Facility is supported by an NCI Cancer Center Support Grant (CA16672); the National Natural Science Foundation of China (81071837; 30670627); Natural Science Foundation of Guangdong Province, China (9251008901000005; 06021210) and Scientific and Technological Project of Guangdong, China (2008A030201009; 2010B050700016 to HY). We thank Kate J Newberry and Sunita Patterson for editing the manuscript.	Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Cheung BW, 2005, CANCER RES, V65, P1450, DOI 10.1158/0008-5472.CAN-04-0567; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Cruet-Hennequart S, 2009, CELL CYCLE, V8, P3039; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Dmitrieva NI, 2011, P NATL ACAD SCI USA, V108, P20796, DOI 10.1073/pnas.1114677108; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng ZZ, 2010, CANCER LETT, V297, P190, DOI 10.1016/j.canlet.2010.05.011; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Kouvaraki MA, 2006, CANCER RES, V66, P8581, DOI 10.1158/0008-5472.CAN-06-0975; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Le QT, 2003, INT J RADIAT ONCOL, V56, P1046, DOI 10.1016/S0360-3016(03)00117-2; Lee JH, 2010, ONCOGENE, V29, P1431, DOI 10.1038/onc.2009.438; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Ma W, 2012, ONCOGENE, V31, P1024, DOI 10.1038/onc.2011.300; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Pabla N, 2011, J BIOL CHEM, V286, P10411, DOI 10.1074/jbc.M110.210989; Pan YB, 2012, CANCER RES, V72, P1890, DOI 10.1158/0008-5472.CAN-11-3472; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Raderschall E, 2002, CANCER RES, V62, P219; Rassidakis GZ, 2003, CLIN CANCER RES, V9, P1121; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Russell JS, 2003, CANCER RES, V63, P7377; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yip KW, 2005, CLIN CANCER RES, V11, P8131, DOI 10.1158/1078-0432.CCR-05-1266; Zhang QX, 2005, FEBS LETT, V579, P3932, DOI 10.1016/j.febslet.2005.06.012	44	57	60	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2756	2766		10.1038/onc.2012.294	http://dx.doi.org/10.1038/onc.2012.294			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22797071	Green Accepted			2022-12-25	WOS:000319808000007
J	Mignot, I; Pecqueur, L; Dorleans, A; Karuppasamy, M; Ravelli, RBG; Dreier, B; Pluckthun, A; Knossow, M; Gigant, B				Mignot, Ingrid; Pecqueur, Ludovic; Dorleans, Audrey; Karuppasamy, Manikandan; Ravelli, Raimond B. G.; Dreier, Birgit; Plueckthun, Andreas; Knossow, Marcel; Gigant, Benoit			Design and Characterization of Modular Scaffolds for Tubulin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATHMIN FAMILY PROTEINS; MICROTUBULE; COMPLEX; RECOGNIZE; ALIGNMENT; DYNAMICS; BIND; CAPS	In cells, microtubule dynamics is regulated by stabilizing and destabilizing factors. Whereas proteins in both categories have been identified, their mechanism of action is rarely understood at the molecular level. This is due in part to the difficulties faced in structural approaches to obtain atomic models when tubulin is involved. Here, we design and characterize new stathmin-like domain (SLD) proteins that sequester tubulins in numbers different from two, the number of tubulins bound by stathmin or by the SLD of RB3, two stathmin family members that have been extensively studied. We established rules for the design of tight tubulin-SLD assemblies and applied them to complexes containing one to four tubulin heterodimers. Biochemical and structural experiments showed that the engineered SLDs behaved as expected. The new SLDs will be tools for structural studies of microtubule regulation. The larger complexes will be useful for cryo-electron microscopy, whereas crystallography or nuclear magnetic resonance will benefit from the 1: 1 tubulin-SLD assembly. Finally, our results provide new insight into SLD function, suggesting that a major effect of these phosphorylatable proteins is the programmed release of sequestered tubulin for microtubule assembly at the specific cellular locations of members of the stathmin family.	[Mignot, Ingrid; Pecqueur, Ludovic; Dorleans, Audrey; Knossow, Marcel; Gigant, Benoit] CNRS, LEBS, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Karuppasamy, Manikandan; Ravelli, Raimond B. G.] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Dreier, Birgit; Plueckthun, Andreas] Univ Zurich, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zurich	Gigant, B (corresponding author), CNRS, LEBS, Ctr Rech Gif, Bat 34,1 Av Terrasse, F-91198 Gif Sur Yvette, France.	gigant@lebs.cnrs-gif.fr	Plückthun, Andreas/C-2746-2009; Karuppasamy, Manikandan/D-2053-2014	Plückthun, Andreas/0000-0003-4191-5306; Ravelli, Raimond/0000-0001-6056-5888; Gigant, Benoit/0000-0002-5946-6759; Pecqueur, Ludovic/0000-0002-0396-699X	Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale [DEQ20081213979]; Netherlands Organisation For Scientific Research [016.072.321]; Agence Nationale de la Recherche [ANR-09-BLAN-0071]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Netherlands Organisation For Scientific Research(Netherlands Organization for Scientific Research (NWO)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche Grant ANR-09-BLAN-0071 and the Fondation pour la Recherche Medicale Grant DEQ20081213979.; Supported by The Netherlands Organisation For Scientific Research, Project 016.072.321.	Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; Bricogne G., 2011, BUSTER VERSION 2 8 0; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charbaut E, 2002, FEBS LETT, V529, P341, DOI 10.1016/S0014-5793(02)03421-X; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Cormier A, 2009, J BIOL CHEM, V284, P6909, DOI 10.1074/jbc.M808249200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dorleans Audrey, 2007, Methods Mol Med, V137, P235, DOI 10.1007/978-1-59745-442-1_16; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Frank J, 2006, 3 DIMENSIONAL ELECT, P139; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastritis PL, 2011, PROTEIN SCI, V20, P482, DOI 10.1002/pro.580; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krouglova T, 2003, FEBS LETT, V546, P365, DOI 10.1016/S0014-5793(03)00636-7; Lachkar S, 2010, J BIOL CHEM, V285, P11667, DOI 10.1074/jbc.M109.096727; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Segerman B, 2000, J BIOL CHEM, V275, P35759, DOI 10.1074/jbc.M005875200; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221	45	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31085	31094		10.1074/jbc.M112.383869	http://dx.doi.org/10.1074/jbc.M112.383869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22791712	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000308791300021
J	Santostefano, KE; Hamazaki, T; Pardo, CE; Kladde, MP; Terada, N				Santostefano, Katherine E.; Hamazaki, Takashi; Pardo, Carolina E.; Kladde, Michael P.; Terada, Naohiro			Fibroblast Growth Factor Receptor 2 Homodimerization Rapidly Reduces Transcription of the Pluripotency Gene Nanog without Dissociation of Activating Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE ENDODERM; CELLS; METHYLATION; CHROMATIN; EPIBLAST; ELEMENT	Nanog or Gata6-positive cells co-exist and are convertible within the inner cell mass of murine blastocysts and embryonic stem (ES) cells. Previous studies demonstrate fibroblast growth factor receptor 2 (FGFR2) triggers Nanog gene down-regulation and differentiation to primitive endoderm (PE); however, the underlying mechanisms responsible for reversible and fluctuating cell fate are poorly understood. Using an inducible FGFR2 dimerization system in ES cells, we demonstrate that FGFR2 activation rapidly down-regulated Nanog gene transcription through activation of the Mek pathway and subsequently differentiated ES cells into PE cells. FGFR2 rather selectively repressed the Nanog gene with minimal effect on other pluripotency genes, including Oct4 and Sox2. We determined the Nanog promoter region containing minimum Oct4/Sox2 binding sites was sufficient for this transcriptional down-regulation by FGFR2, when the reporter transgenes were integrated with insulators. Of interest, FGFR2-mediated Nanog transcriptional reduction occurred without dissociation of RNA polymerase II, p300, Oct4, Sox2, and Tet1 from the Nanog proximal promoter region and with no increase in repressive histone methylation marks or DNA methylation, implying the gene repression is in the early and transient phase. Furthermore, addition of a specific FGFR inhibitor readily reversed this Nanog repression status. These findings illustrate well how FGFR2 induces rapid but reversible Nanog repression within ES cells.	[Santostefano, Katherine E.; Hamazaki, Takashi; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; [Pardo, Carolina E.; Kladde, Michael P.] Univ Florida, Coll Med, Dept Biochem, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Terada, N (corresponding author), Univ Florida, Coll Med, Dept Pathol, POB 100275, Gainesville, FL 32610 USA.	terada@pathology.ufl.edu			National Institutes of Health [DK059699, GM091238, T32 CA009126]; NATIONAL CANCER INSTITUTE [R01CA155390, T32CA009126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants DK059699 and GM091238 (to N. T.).; Recipient of Predoctoral Fellowship T32 CA009126 from the National Institutes of Health.	Alfa RW, 2009, J NEUROSCI RES, V87, P2624, DOI 10.1002/jnr.22101; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Brower JV, 2009, BBA-GENE REGUL MECH, V1789, P198, DOI 10.1016/j.bbagrm.2008.12.005; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Darst RP, 2012, METHODS MOL BIOL, V833, P125, DOI 10.1007/978-1-61779-477-3_9; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Kwiatkowski BA, 2008, J CELL PHYSIOL, V215, P803, DOI 10.1002/jcp.21365; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Xian W, 2009, CANCER RES, V69, P2244, DOI 10.1158/0008-5472.CAN-08-3398; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138	32	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30507	30517		10.1074/jbc.M112.388181	http://dx.doi.org/10.1074/jbc.M112.388181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787153	Green Published, hybrid			2022-12-25	WOS:000308579800043
J	Lisa-Santamaria, P; Jimenez, A; Revuelta, JL				Lisa-Santamaria, Patricia; Jimenez, Alberto; Revuelta, Jose L.			The Protein Factor-arrest 11 (Far11) Is Essential for the Toxicity of Human Caspase-10 in Yeast and Participates in the Regulation of Autophagy and the DNA Damage Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATG1 KINASE COMPLEX; SACCHAROMYCES-CEREVISIAE; FAMILY PROTEINS; APOPTOSIS; PHOSPHORYLATION; IDENTIFICATION; PATHWAYS; DEATH; TOR; CROSSTALK	The heterologous expression of human caspase-10 in Saccharomyces cerevisiae induces a lethal phenotype, which includes some hallmarks of apoptosis and autophagy, alterations in the intra-S checkpoint, and cell death. To determine the cellular processes and pathways that are responsible of the caspase-10-induced cell death we have designed a loss-of-function screening system to identify genes that are essential for the lethal phenotype. We observed that the ER-Golgi-localized family of proteins Far, MAPK signaling, the autophagy machinery, and several kinases and phosphatases are essential for caspase-10 toxicity. We also found that the expression of caspase-10 elicits a simultaneous activation of the MAP kinases Fus3, Kss1, and Slt2. Furthermore, the protein Far11, which is a target of MAP kinases, is essential for the dephosphorylation of Atg13 and, consequently, for the induction of autophagy. In addition, Far11 participates in the regulation of the DNA damage response through the dephosphorylation of Rad53. Finally, we have also demonstrated that Far11 is able to physically interact with the phosphatases Pph21, Pph22, and Pph3. Overall, our results indicate that the expression of human caspase-10 in S. cerevisiae activates an intracellular death signal that depends on the Far protein complex and that Far11 may function as a regulator subunit of phosphatases in different processes, thus representing a mechanistic link between them.	[Jimenez, Alberto] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37007 Salamanca, Spain; Univ Salamanca, CSIC, Dept Microbiol & Genet, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca	Jimenez, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.	alji@usal.es; revuelta@usal.es	Revuelta, Jose Luis/ABG-1502-2020; Jiménez, Alberto/A-6234-2009; Revuelta, Jose L/C-2324-2012	Revuelta, Jose Luis/0000-0001-7838-5308; Jiménez, Alberto/0000-0003-3685-6479; Revuelta, Jose L/0000-0001-7838-5308	Junta de Castilla y Leon Grants [SA008B08, GR147]; Ministerio de Ciencia y Innovacion [BIO2008-00194]; FPU predoctoral fellowship from Spanish Ministerio de Educacion y Ciencia	Junta de Castilla y Leon Grants(Junta de Castilla y Leon); Ministerio de Ciencia y Innovacion(Spanish Government); FPU predoctoral fellowship from Spanish Ministerio de Educacion y Ciencia(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG))	This work was supported in part by Junta de Castilla y Leon Grants SA008B08 (to A. J.) and GR147 (to J. L. R.) and Ministerio de Ciencia y Innovacion Grant BIO2008-00194.; Recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educacion y Ciencia.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Braun RJ, 2010, TRENDS BIOCHEM SCI, V35, P135, DOI 10.1016/j.tibs.2009.10.005; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giorgini F, 2006, METHOD ENZYMOL, V412, P201, DOI 10.1016/S0076-6879(06)12013-3; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Greenwood MT, 2010, CELL DEATH DIFFER, V17, P737, DOI 10.1038/cdd.2009.177; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Jimenez A, 2007, YEAST, V24, P481, DOI 10.1002/yea.1483; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lisa-Santamaria P, 2009, BBA-MOL CELL RES, V1793, P561, DOI 10.1016/j.bbamcr.2008.12.016; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puryer MA, 2006, APOPTOSIS, V11, P509, DOI 10.1007/s10495-006-5114-2; Rodriguez-Pachon JM, 2002, J BIOL CHEM, V277, P27094, DOI 10.1074/jbc.M201527200; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stephan JS, 2010, AUTOPHAGY, V6, P294, DOI 10.4161/auto.6.2.11129; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	56	12	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29636	29647		10.1074/jbc.M112.344192	http://dx.doi.org/10.1074/jbc.M112.344192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782902	hybrid, Green Published			2022-12-25	WOS:000308286900039
J	Li, YX; Wang, F; Zhang, XY; Qi, Z; Tang, MX; Szeto, C; Li, Y; Zhang, HY; Chen, XW				Li, Yingxin; Wang, Fang; Zhang, Xiaoying; Qi, Zhao; Tang, Mingxin; Szeto, Christopher; Li, Ying; Zhang, Hongyu; Chen, Xiongwen			beta-Adrenergic Stimulation Increases Cav3.1 Activity in Cardiac Myocytes through Protein Kinase A	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; SMOOTH-MUSCLE CELLS; CA2+ CHANNELS; VENTRICULAR MYOCYTES; ATRIAL CELLS; MODULATION; PHYSIOLOGY; NEURONS; MICE	The T-type Ca2+ channel (TTCC) plays important roles in cellular excitability and Ca2+ regulation. In the heart, TTCC is found in the sinoatrial nodal (SAN) and conduction cells. Cav3.1 encodes one of the three types of TTCCs. To date, there is no report regarding the regulation of Cav3.1 by beta-adrenergic agonists, which is the topic of this study. Ventricular myocytes (VMs) from Cav3.1 double transgenic (TG) mice and SAN cells from wild type, Cav3.1 knockout, or Cav3.2 knockout mice were used to study beta-adrenergic regulation of overexpressed or native Cav3.1-mediated T-type Ca2+ current (ICa-T(3.1)). ICa-T(3.1) was not found in control VMs but was robust in all examined TG-VMs. A b-adrenergic agonist (isoproterenol, ISO) and a cyclic AMP analog (dibutyryl-cAMP) significantly increased ICa-T(3.1) as well as ICa-L in TG-VMs at both physiological and room temperatures. The ISO effect on ICa-L and ICa-T in TG myocytes was blocked by H89, a PKA inhibitor. ICa-T was detected in control wildtype SAN cells but not in Cav3.1 knockout SAN cells, indicating the identity of ICa-T in normal SAN cells is mediated by Cav3.1. Real-time PCR confirmed the presence of Cav3.1 mRNA but not mRNAs of Cav3.2 and Cav3.3 in the SAN. ICa-T in SAN cells from wild type or Cav3.2 knockout mice was significantly increased by ISO, suggesting native Cav3.1 channels can be upregulated by the beta-adrenergic (beta-AR) system. In conclusion, b-adrenergic stimulation increases ICa-T(3.1) in cardiomyocytes, which is mediated by the cAMP/PKA pathway. The upregulation of ICa-T(3.1) by the b-adrenergic system could play important roles in cellular functions involving Cav3.1.	[Li, Yingxin; Wang, Fang; Zhang, Xiaoying; Qi, Zhao; Tang, Mingxin; Szeto, Christopher; Li, Ying; Zhang, Hongyu; Chen, Xiongwen] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA; [Li, Yingxin; Wang, Fang; Zhang, Xiaoying; Qi, Zhao; Tang, Mingxin; Szeto, Christopher; Li, Ying; Zhang, Hongyu; Chen, Xiongwen] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Li, Ying] Third Mil Med Univ, Inst Burn Res, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Army Medical University	Li, YX (corresponding author), Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA.	xchen001@temple.edu	Chen, Xiongwen/D-5988-2012	Chen, Xiongwen/0000-0002-3829-5815	National Institutes of Health [R01-HL088243]; American Heart Association [0730347N, 09PRE2260943]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (R01-HL088243 to X.C.) and American Heart Association (SDG Grant 0730347N to X.C. and Predoctoral Fellowship 09PRE2260943 to Y.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P. J., 2007, V45, P215; AKAIKE N, 1991, COMP BIOCHEM PHYS C, V98, P31; Alvarez JL, 1996, J PHYSIOL-LONDON, V491, P321, DOI 10.1113/jphysiol.1996.sp021218; ALVAREZ JL, 1992, J GEN PHYSIOL, V100, P519, DOI 10.1085/jgp.100.3.519; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BENHAM CD, 1988, J PHYSIOL-LONDON, V404, P767, DOI 10.1113/jphysiol.1988.sp017318; Chemin J, 2007, J BIOL CHEM, V282, P32710, DOI 10.1074/jbc.M702746200; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chen XW, 2002, CIRC RES, V91, P517, DOI 10.1161/01.RES.0000033988.13062.7C; FISHER R, 1990, J NEUROPHYSIOL, V64, P1291, DOI 10.1152/jn.1990.64.4.1291; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Huc S, 2009, BBA-MOL CELL RES, V1793, P947, DOI 10.1016/j.bbamcr.2008.11.003; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; Lenglet S, 2002, ENDOCR RES, V28, P651, DOI 10.1081/ERC-120016981; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Metrich M, 2009, PHARMACOL REP, V61, P146, DOI 10.1016/S1734-1140(09)70017-9; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nilius B, 2006, CELL CALCIUM, V40, P81, DOI 10.1016/j.ceca.2006.04.011; NUSS HB, 1993, CIRC RES, V73, P777, DOI 10.1161/01.RES.73.4.777; Perez-Reyes E, 2006, CNS NEUROL DISORD-DR, V5, P605, DOI 10.2174/187152706779025508; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2006, CELL CALCIUM, V40, P89, DOI 10.1016/j.ceca.2006.04.012; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shuba YM, 2008, CHANNELS, V2, P299, DOI 10.4161/chan.2.4.6577; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39965	10.1371/journal.pone.0039965	http://dx.doi.org/10.1371/journal.pone.0039965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808078	gold, Green Submitted, Green Published			2022-12-25	WOS:000306406700016
J	Avva, J; Weis, MC; Sramkoski, RM; Sreenath, N; Jacobberger, JW				Avva, Jayant; Weis, Michael C.; Sramkoski, R. Michael; Sreenath, N.; Jacobberger, James W.			Dynamic Expression Profiles from Static Cytometry Data: Component Fitting and Conversion to Relative, "Same Scale'' Values	PLOS ONE			English	Article							HUMAN CYCLIN B1; CELL-CYCLE; HISTONE H3; AURORA-B; GENE-EXPRESSION; FLOW-CYTOMETRY; PHOSPHORYLATION; LOCALIZATION; MODEL	Background: Cytometry of asynchronous proliferating cell populations produces data with an extractable time-based feature embedded in the frequency of clustered, correlated events. Here, we present a specific case of general methodology for calculating dynamic expression profiles of epitopes that oscillate during the cell cycle and conversion of these values to the same scale. Methods: Samples of K562 cells from one population were labeled by direct and indirect antibody methods for cyclins A2 and B1 and phospho-S10-histone H3. The same indirect antibody was used for both cyclins. Directly stained samples were counter-stained with 496-diamidino-2-phenylindole and indirectly stained samples with propidium to label DNA. The S phase cyclin expressions from indirect assays were used to scale the expression of the cyclins of the multi-variate direct assay. Boolean gating and two dimensional, sequential regions set on bivariate displays of the directly conjugated sample data were used to untangle and isolate unique, unambiguous expression values of the cyclins along the four-dimensional data path through the cell cycle. The median values of cyclins A2 and B1 from each region were correlated with the frequency of events within each region. Results: The sequential runs of data were plotted as continuous multi-line linear equations of the form y = [(y(i+1)-y(i))/(x(i+1)-x(i))]x+y(i)-[(y(i+1)-y(i))/(x(i+1)-x(i))]x(i) (line between points (x(i),y(i)) and (x(i+1), y(i+1))) to capture the dynamic expression profile of the two cyclins. Conclusions: This specific approach demonstrates the general methodology and provides a rule set from which the cell cycle expression of any other epitopes could be measured and calculated. These expression profiles are the "state variable'' outputs, useful for calibrating mathematical cell cycle models.	[Avva, Jayant; Weis, Michael C.; Sreenath, N.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Sramkoski, R. Michael; Jacobberger, James W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Avva, J (corresponding author), Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA.	jwj@case.edu	Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	National Cancer Institute [R01CA73413, P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA073413] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants (R01CA73413 to James W. Jacobberger) and (P30CA43703 to Stanton Gerson at Case Comprehensive Cancer Center Core Facility Support), both from the National Cancer Institute (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avva J, 2011, METHODS MOL BIOL, V717, P171, DOI 10.1007/978-1-61779-024-9_10; Bagwell CB, 1993, CLIN FLOW CYTOMETRY, P635; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; Becker M, 2010, CELL CYCLE, V9, P1360, DOI 10.4161/cc.9.7.11177; Conradie R, 2010, FEBS J, V277, P357, DOI 10.1111/j.1742-4658.2009.07473.x; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Csikasz-Nagy A, 2009, BRIEF BIOINFORM, V10, P424, DOI 10.1093/bib/bbp005; Erlandsson F, 2000, EXP CELL RES, V259, P86, DOI 10.1006/excr.2000.4889; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; Frisa PS, 2000, CYTOMETRY, V39, P79, DOI 10.1002/(SICI)1097-0320(20000101)39:1<79::AID-CYTO11>3.0.CO;2-3; GONG JP, 1995, CELL GROWTH DIFFER, V6, P1485; Gray JW, 1990, FLOW CYTOMETRY CELL; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jacobberger JW, 2008, CYTOM PART A, V73A, P5, DOI 10.1002/cyto.a.20501; Jacobberger JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030870; Jacobberger JW, 2011, METHODS MOL BIOL, V699, P229, DOI 10.1007/978-1-61737-950-5_11; JACOBBERGER JW, 1986, CYTOMETRY, V7, P356, DOI 10.1002/cyto.990070410; Jacobberger JW, 2003, CYTOM PART A, V54A, P75, DOI 10.1002/cyto.a.10063; Jacobberger JW, 1999, CYTOMETRY, V35, P284, DOI 10.1002/(SICI)1097-0320(19990301)35:3<284::AID-CYTO12>3.0.CO;2-K; Juan G, 1999, EXP CELL RES, V246, P212, DOI 10.1006/excr.1998.4283; Koseoglu MM, 2010, CELL CYCLE, V9, P3857, DOI 10.4161/cc.9.19.13300; LOZZIO CB, 1973, J NATL CANCER I, V50, P535, DOI 10.1093/jnci/50.2.535; Monier K, 2007, J CELL SCI, V120, P101, DOI 10.1242/jcs.03326; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pines J, 2009, MOL CELL, V34, P135, DOI 10.1016/j.molcel.2009.04.006; Scrittori L, 2005, MOL BIOL CELL, V16, P292, DOI 10.1091/mbc.E04-06-0447; Singhania R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001077; Viallard JF, 1999, EXP CELL RES, V247, P208, DOI 10.1006/excr.1998.4352; Viallard JF, 2000, CYTOMETRY, V39, P117, DOI 10.1002/(SICI)1097-0320(20000201)39:2<117::AID-CYTO4>3.3.CO;2-R; WALKER PMB, 1954, J EXP BIOL, V31, P8; Weis MC, 2011, THESIS CASE W RESERV, P189	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e38275	10.1371/journal.pone.0038275	http://dx.doi.org/10.1371/journal.pone.0038275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808005	Green Published, Green Submitted, gold			2022-12-25	WOS:000306366400004
J	Chen, YY; Chang, JR; Huang, WF; Kuo, SC; Su, IJ; Sun, JR; Chiueh, TS; Huang, TS; Chen, YS; Dou, HY				Chen, Yih-Yuan; Chang, Jia-Ru; Huang, Wei-Feng; Kuo, Shu-Chen; Su, Ih-Jen; Sun, Jun-Ren; Chiueh, Tzong-Shi; Huang, Tsi-Shu; Chen, Yao-Shen; Dou, Horng-Yunn			Genetic Diversity of the Mycobacterium tuberculosis Beijing Family Based on SNP and VNTR Typing Profiles in Asian Countries	PLOS ONE			English	Article							POPULATION-STRUCTURE ANALYSIS; MOLECULAR EPIDEMIOLOGY; VARIABLE-NUMBER; EAST-ASIA; STRAINS; GENOTYPE; EVOLUTIONARY; SUBLINEAGES; RESISTANCE; RUSSIA	The Mycobacterium tuberculosis (MTB) Beijing strain is highly virulent, drug resistant, and endemic over Asia. To explore the genetic diversity of this family in several different regions of eastern Asia, 338 Beijing strains collected in Taiwan (Republic of China) were analyzed by mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing and compared with published MIRU-VNTR profiles and by the Hunter-Gaston diversity index (HGDI) of Beijing strains from Japan and South Korea. The results revealed that VNTR2163b (HGDI>0.6) and five other loci (VNTR424, VNTR4052, VNTR1955, VNTR4156 and VNTR 2996; HGDI>0.3) could be used to discriminate the Beijing strains in a given geographic region. Analysis based on the number of VNTR repeats showed three VNTRs (VNTR424, 3192, and 1955) to be phylogenetically informative loci. In addition, to determine the geographic variation of sequence types in MTB populations, we also compared sequence type (ST) data of our strains with published ST profiles of Beijing strains from Japan and Thailand. ST10, ST22, and ST19 were found to be prevalent in Taiwan (82%) and Thailand (92%). Furthermore, classification of Beijing sublineages as ancient or modern in Taiwan was found to depend on the repeat number of VNTR424. Finally, phylogenetic relationships of MTB isolates in Taiwan, South Korea, and Japan were revealed by a minimum spanning tree based on MIRU-VNTR genotyping. In this topology, the MIRU-VNTR genotypes of the respective clusters were tightly correlated to other genotypic characters. These results are consistent with the hypothesis that clonal evolution of these MTB lineages has occurred.	[Chen, Yih-Yuan; Chang, Jia-Ru; Huang, Wei-Feng; Kuo, Shu-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Triserv Gen Hosp, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Natl Def Med Ctr, Taipei, Taiwan; [Huang, Tsi-Shu; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Dou, Horng-Yunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	National Health Research Institutes - Taiwan; Tri-Service General Hospital; National Defense Medical Center; Kaohsiung Veterans General Hospital; Taipei Medical University	Chen, YY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Dou, horng-yunn/F-1966-2015; Su, Ih-Jen/B-2655-2010; Kuo, Shu-Chen/G-9108-2011; Dou, Horng-Yunn/B-2652-2010	Chen, Yih-Yuan/0000-0001-9507-291X; Sun, jun-ren/0000-0002-8769-9170	National Health Research Institutes; National Science Council, Taiwan [NSC 100-3111-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by grants from the National Health Research Institutes and National Science Council (NSC 100-3111-B-400-001), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Chang JR, 2011, CLIN MICROBIOL INFEC, V17, P1391, DOI 10.1111/j.1469-0691.2010.03436.x; Dou HY, 2008, INFECT GENET EVOL, V8, P323, DOI 10.1016/j.meegid.2008.02.003; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Dou HY, 2011, INT J EVOL BIOL, V2011; Faksri K, 2011, INFECT GENET EVOL, V11, P1142, DOI 10.1016/j.meegid.2011.04.007; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Hanekom M, 2007, J CLIN MICROBIOL, V45, P2263, DOI 10.1128/JCM.02354-06; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Milan SJ, 2004, J CLIN MICROBIOL, V42, P1064, DOI 10.1128/JCM.42.3.1064-1068.2004; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P1504, DOI 10.1128/JCM.40.4.1504-1507.2002; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Schurch AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028365; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wada T, 2009, INFECT GENET EVOL, V9, P921, DOI 10.1016/j.meegid.2009.06.012; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007	33	29	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39792	10.1371/journal.pone.0039792	http://dx.doi.org/10.1371/journal.pone.0039792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808061	Green Submitted, Green Published, gold			2022-12-25	WOS:000306366400012
J	Shao, L; Zheng, H; Jia, FJ; Wang, HQ; Liu, L; Sun, Q; An, MY; Zhang, XH; Wen, H				Shao, Li; Zheng, Hong; Jia, Feng-Ju; Wang, Hui-Qin; Liu, Li; Sun, Qi; An, Meng-Ying; Zhang, Xiu-Hua; Wen, Hao			Methods of Patient Warming during Abdominal Surgery	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; NORMOTHERMIA; HYPOTHERMIA	Background: Keeping abdominal surgery patients warm is common and warming methods are needed in power outages during natural disasters. We aimed to evaluate the efficacy of low-cost, low-power warming methods for maintaining normothermia in abdominal surgery patients. Methods: Patients (n = 160) scheduled for elective abdominal surgery were included in this prospective clinical study. Five warming methods were applied: heated blood transfusion/fluid infusion vs. unheated; wrapping patients vs. not wrapping; applying moist dressings, heated or not; surgical field rinse heated or not; and applying heating blankets or not. Patients' nasopharyngeal and rectal temperatures were recorded to evaluate warming efficacy. Significant differences were found in mean temperatures of warmed patients compared to those not warmed. Results: When we compared temperatures of abdominal surgery patient groups receiving three specific warming methods with temperatures of control groups not receiving these methods, significant differences were revealed in temperatures maintained during the surgeries between the warmed groups and controls. Discussion: The value of maintaining normothermia in patients undergoing abdominal surgery under general anesthesia is accepted. Three effective economical and practically applicable warming methods are combined body wrapping and heating blanket; combined body wrapping, heated moist dressings, and heating blanket; combined body wrapping, heated moist dressings, and warmed surgical rinse fluid, with or without heating blanket. These methods are practically applicable when low-cost method is indeed needed.	[Shao, Li; Jia, Feng-Ju; Wang, Hui-Qin; Liu, Li; An, Meng-Ying; Zhang, Xiu-Hua] Xinjiang Med Univ, Teaching Hosp 1, Dept Operat Room, Urumqi, Xinjiang Uygur, Peoples R China; [Wen, Hao] Xinjiang Med Univ, Teaching Hosp 1, Dept Surg, Urumqi, Xinjiang Uygur, Peoples R China; [Zheng, Hong] Xinjiang Med Univ, Teaching Hosp 1, Dept Anesthesiol, Urumqi, Xinjiang Uygur, Peoples R China; [Sun, Qi] Xinjiang Med Univ, Teaching Hosp 1, Dept Stat Counseling, Urumqi, Xinjiang Uygur, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Shao, L (corresponding author), Xinjiang Med Univ, Teaching Hosp 1, Dept Operat Room, Urumqi, Xinjiang Uygur, Peoples R China.	dr.wenhao@163.com	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022					Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; FRANK SM, 1993, ANESTHESIOLOGY, V78, P468, DOI 10.1097/00000542-199303000-00010; HARLING DW, 1995, ANAESTHESIA, V50, P659; Hervey GR, 1988, TXB PHYSL, P510; Hirvonen EA, 2011, EUR J ANAESTH, V28, P376, DOI 10.1097/EJA.0b013e328340507d; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Liu XY, 2003, ANESTHESIOLOGY, V23, P712; Moran D S, 2001, Harefuah, V140, P1078; Park H, 2007, J KOREAN ACAD NURS, V37, P1061; Putzu Marta, 2007, Acta Biomed, V78, P163; Sessler DI, 1997, ANN NY ACAD SCI, V813, P757, DOI 10.1111/j.1749-6632.1997.tb51779.x; Sessler DI, 2001, ANESTHESIOLOGY, V95, P531, DOI 10.1097/00000542-200108000-00040; Sheng ZR, 1996, CLIN ANESTHESIOLOGY; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Wong PF, 2007, BRIT J SURG, V94, P421, DOI 10.1002/bjs.5631	15	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39622	10.1371/journal.pone.0039622	http://dx.doi.org/10.1371/journal.pone.0039622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808045	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400015
J	Saiz, H; Alados, CL				Saiz, Hugo; Alados, Concepcion L.			Changes in Semi-Arid Plant Species Associations along a Livestock Grazing Gradient	PLOS ONE			English	Article							POSITIVE INTERACTIONS; SPATIAL-PATTERNS; FACILITATION NETWORKS; COMPETITION; COMMUNITIES; VEGETATION; DESERT; DYNAMICS; SHRUB; ENVIRONMENTS	In semi-arid ecosystems, vegetation is heterogeneously distributed, with plant species often associating in patches. These associations between species are not constant, but depend on the particular response of each species to environmental factors. Here, we investigated how plant species associations change in response to livestock grazing in a semi-arid ecosystem, Cabo de Gata-Nijar Natural Park in South East Spain. We established linear point-intercept transects at four sites with different grazing intensity, and recorded all species at each point. We investigated plant associations by comparing the number of times that each pair of species occurred at the same spatial point (co-occurrences), with the expected number of times based on species abundances. We also assessed associations for each shrub and grass species by considering all their pairs of associations and for the whole plant community by considering all pairs of associations on each site. At all sites, the plant community had a negative pattern of association, with fewer co-occurrences than expected. Negative association in the plant community increased at maximum grazing intensity. Most species associated as expected, particularly grass species, and positive associations were most important at intermediate grazing intensities. No species changed its type of association along the grazing gradient. We conclude that in the present plant community, grazing-resistant species compete among themselves and segregate in space. Some shrub species act as refuges for grazing-sensitive species that benefit from being spatially associated with shrub species, particularly at intermediate grazing intensities where positive associations were highest. At high grazing intensity, these shrubs can no longer persist and positive associations decrease due to the disappearance of refuges. Spatial associations between plant species and their response to grazing help identify the factors that organize plant communities, and may contribute to improving management of semi-arid ecosystems.	[Saiz, Hugo; Alados, Concepcion L.] CSIC, Inst Pirenaico Ecol, Dept Biodiversidad & Restaurac, Grp Conservac Biodiversidad, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Saiz, H (corresponding author), CSIC, Inst Pirenaico Ecol, Dept Biodiversidad & Restaurac, Grp Conservac Biodiversidad, Zaragoza, Spain.	hsaiz@ipe.csic.es	Saiz, Hugo/K-8724-2014; Alados, Concepción L/K-8085-2014	Saiz, Hugo/0000-0002-7568-2996; Alados, Concepción L/0000-0002-6227-861X	Spanish Ministry of Science and Innovation [CGL2008-0065]; National Research Council of Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Research Council of Spain	The study was made possible by the financial support of CEBCE project Ref. CGL2008-0065 of the Spanish Ministry of Science and Innovation, and grant JAEPre from the National Research Council of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Alados CL, 2006, BIOL J LINN SOC, V87, P103, DOI 10.1111/j.1095-8312.2006.00559.x; Alados CL, 2003, ECOL MODEL, V163, P1, DOI 10.1016/S0304-3800(02)00294-6; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; Barot S, 1999, ECOLOGY, V80, P1987, DOI 10.1890/0012-9658(1999)080[1987:DOASPT]2.0.CO;2; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bisigato AJ, 1997, J ARID ENVIRON, V36, P639, DOI 10.1006/jare.1996.0247; Brooker R, 2005, OIKOS, V109, P63, DOI 10.1111/j.0030-1299.2005.13557.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Casper BB, 1996, OECOLOGIA, V106, P144, DOI 10.1007/BF00328593; Cavieres L, 2002, J VEG SCI, V13, P547, DOI 10.1111/j.1654-1103.2002.tb02081.x; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Engel EC, 2008, PLANT ECOL, V195, P77, DOI 10.1007/s11258-007-9300-2; Escudero A, 2005, J VEG SCI, V16, P383, DOI 10.1111/j.1654-1103.2005.tb02377.x; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Holt AR, 2002, BASIC APPL ECOL, V3, P1, DOI 10.1078/1439-1791-00083; Maestre FT, 2005, PLANT ECOL, V179, P133, DOI 10.1007/s11258-004-4641-6; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; MCAULIFFE JR, 1988, AM NAT, V131, P459, DOI 10.1086/284802; MCNAUGHTON SJ, 1986, AM NAT, V128, P765, DOI 10.1086/284602; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Navarro T, 2009, CANDOLLEA, V64, P69; NIERING WA, 1963, SCIENCE, V142, P15, DOI 10.1126/science.142.3588.15; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oyonarte C., 1999, CARTOGRAFIA DELIMITA; Passera C, 1999, THESIS U GRANADA GRA; Peinado M, 1992, FLORA VEGETATIO MUND; Pugnaire FI, 2011, J ARID ENVIRON, V75, P1310, DOI 10.1016/j.jaridenv.2011.01.016; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Rees M, 1996, AM NAT, V147, P1, DOI 10.1086/285837; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROBLES AB, 1995, J ARID ENVIRON, V30, P191, DOI 10.1016/S0140-1963(05)80070-9; Smit C, 2007, OECOLOGIA, V152, P265, DOI 10.1007/s00442-006-0650-6; Smit C, 2009, J ECOL, V97, P1215, DOI 10.1111/j.1365-2745.2009.01555.x; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tirado R, 2005, OIKOS, V111, P437, DOI 10.1111/j.1600-0706.2005.14094.x; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Verdu M, 2011, OIKOS, V120, P1351, DOI 10.1111/j.1600-0706.2011.19477.x	46	49	49	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40551	10.1371/journal.pone.0040551	http://dx.doi.org/10.1371/journal.pone.0040551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792367	Green Published, gold			2022-12-25	WOS:000306354700059
J	Bian, CJ; Wu, R; Cho, K; Yu, XC				Bian, Chunjing; Wu, Rong; Cho, Kathleen; Yu, Xiaochun			Loss of BRCA1-A Complex Function in RAP80 Null Tumor Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HUMAN OVARIAN; CANCER SUSCEPTIBILITY; TARGETS BRCA1; BREAST; PROTEIN; MUTATIONS; BINDING; PALB2; BRIP1	Receptor Associated Protein 80 (RAP80) is a subunit of the BRCA1-A complex and targets BRCA1 to DNA damage sites in response to DNA double strand breaks. Since mutations of BRCA1 are associated with familial ovarian cancers, we screened 26 ovarian cancer-derived cell lines for RAP80 mutations and found that TOV-21G cells harbor a RAP80 mutation (c.1107G>A). This mutation generates a stop codon at Trp369, which deletes the partial AIR region and the C-terminal zinc fingers of RAP80. Interestingly, both the mutant and wild type alleles of RAP80 lose their expression due to promoter hypermethylation, suggesting that TOV-21G is a RAP80-null cell line. In these cells, not only is the BRCA1-A complex disrupted, but the relocation of the remaining subunits in the BRCA1-A complex including BRCA1, CCDC98, NBA1, BRCC36 and BRE is significantly suppressed. Moreover, TOV-21G cells are hypersensitive to ionizing radiation, which is due to the compromised DNA damage repair capacity in these cells. Reconstitution of TOV-21G cells with wild type RAP80 rescues these cellular defects in response to DNA damage. Thus, our results demonstrate that RAP80 is a scaffold protein in the BRCA1-A complex. Identification of TOV-21G as a RAP80 null tumor cell line will be very useful for the study of the molecular mechanism in DNA damage response.	[Bian, Chunjing; Cho, Kathleen; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Wu, Rong; Cho, Kathleen] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bian, CJ (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	kathcho@umich.edu; xiayu@umich.edu		Cho, Kathleen/0000-0003-0500-9998	American Cancer Society [RSG-08-125-01-CCG]; United States National Institutes of Health [CA132755, CA130899]; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society (RSG-08-125-01-CCG to X.Y.) and the United States National Institutes of Health (CA132755 and CA130899 to X.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Akbari MR, 2009, BREAST CANCER RES TR, V113, P377, DOI 10.1007/s10549-008-9938-z; American Cancer Society, 2007, GLOBAL CANC FACTS FI; BUICK RN, 1985, CANCER RES, V45, P3668; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Dansonka-Mieszkowska A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-20; De Nicolo A, 2008, CLIN CANCER RES, V14, P4672, DOI 10.1158/1078-0432.CCR-08-0087; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Kato M, 2000, J HUM GENET, V45, P133, DOI 10.1007/s100380050199; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Luo MP, 1997, GYNECOL ONCOL, V67, P277, DOI 10.1006/gyno.1997.4880; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Pylkas K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-146; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rauh-Adelmann C, 2000, MOL CARCINOGEN, V28, P236, DOI 10.1002/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Velicescu M, 2003, CANCER RES, V63, P5813; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wong MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/s10549-011-1443-0; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	42	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40406	10.1371/journal.pone.0040406	http://dx.doi.org/10.1371/journal.pone.0040406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792303	Green Submitted, gold, Green Published			2022-12-25	WOS:000306461800077
J	Porter, NM; Bohannon, JH; Curran-Rauhut, M; Buechel, HM; Dowling, ALS; Brewer, LD; Popovic, J; Thibault, V; Kraner, SD; Chen, KC; Blalock, EM				Porter, Nada M.; Bohannon, Julia H.; Curran-Rauhut, Meredith; Buechel, Heather M.; Dowling, Amy L. S.; Brewer, Lawrence D.; Popovic, Jelena; Thibault, Veronique; Kraner, Susan D.; Chen, Kuey Chu; Blalock, Eric M.			Hippocampal CA1 Transcriptional Profile of Sleep Deprivation: Relation to Aging and Stress	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AGE-RELATED-CHANGES; SLOW-WAVE SLEEP; ALZHEIMERS-DISEASE; GENE-EXPRESSION; GLUCOSE-METABOLISM; MECHANISMS; HOMER1A; WAKE; BIOINFORMATICS	Background: Many aging changes seem similar to those elicited by sleep-deprivation and psychosocial stress. Further, sleep architecture changes with age suggest an age-related loss of sleep. Here, we hypothesized that sleep deprivation in young subjects would elicit both stress and aging-like transcriptional responses. Methodology/Principal Findings: F344 rats were divided into control and sleep deprivation groups. Body weight, adrenal weight, corticosterone level and hippocampal CA1 transcriptional profiles were measured. A second group of animals was exposed to novel environment stress (NES), and their hippocampal transcriptional profiles measured. A third cohort exposed to control or SD was used to validate transcriptional results with Western blots. Microarray results were statistically contrasted with prior transcriptional studies. Microarray results pointed to sleep pressure signaling and macromolecular synthesis disruptions in the hippocampal CA1 region. Animals exposed to NES recapitulated nearly one third of the SD transcriptional profile. However, the SD -aging relationship was more complex. Compared to aging, SD profiles influenced a significant subset of genes. mRNA associated with neurogenesis and energy pathways showed agreement between aging and SD, while immune, glial, and macromolecular synthesis pathways showed SD profiles that opposed those seen in aging. Conclusions/Significance: We conclude that although NES and SD exert similar transcriptional changes, selective presynaptic release machinery and Homer1 expression changes are seen in SD. Among other changes, the marked decrease in Homer1 expression with age may represent an important divergence between young and aged brain response to SD. Based on this, it seems reasonable to conclude that therapeutic strategies designed to promote sleep in young subjects may have off-target effects in the aged. Finally, this work identifies presynaptic vesicular release and intercellular adhesion molecular signatures as novel therapeutic targets to counter effects of SD in young subjects.	[Porter, Nada M.; Buechel, Heather M.; Brewer, Lawrence D.; Popovic, Jelena; Thibault, Veronique; Chen, Kuey Chu; Blalock, Eric M.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Bohannon, Julia H.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Curran-Rauhut, Meredith] Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA; [Dowling, Amy L. S.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Kraner, Susan D.] Wright State Univ, Dept Neurosci Cell Biol Physiol, Dayton, OH 45435 USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; Dickinson College; University of Kentucky; University System of Ohio; Wright State University Dayton	Porter, NM (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	emblal@uky.edu		Kraner, Susan/0000-0002-1062-4007	DARPA; NIH [NIA AG10836, NIA AG037868]; NATIONAL INSTITUTE ON AGING [P01AG010836, R01AG037868] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a DARPA sub-contract, and NIH grants NIA AG10836 and NIA AG037868. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, approval from DARPA was required to allow public access to microarray data.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Ancoli-Israel S, 2006, AM J GERIAT PSYCHIAT, V14, P95, DOI 10.1097/01.JGP.0000196627.12010.d1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avidan Alon Y, 2003, Clin Cornerstone, V5, P51, DOI 10.1016/S1098-3597(03)90035-4; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blalock EM, 2003, J NEUROSCI, V23, P3807; Blalock EM, 2011, J CHEM NEUROANATOMY; Blalock EM, 2012, J UROLOGY, V187, P725, DOI 10.1016/j.juro.2011.09.142; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Born J, 2010, WORLD J BIOL PSYCHIA, V11, P16, DOI 10.3109/15622971003637637; BOWERSOX SS, 1984, SLEEP, V7, P380, DOI 10.1093/sleep/7.4.380; Boyle J, 2011, J PSYCHOPHARMACOLOGY; Buechel HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018387; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Cai AH, 1997, AM J PHYSIOL-REG I, V273, pR1764, DOI 10.1152/ajpregu.1997.273.5.R1764; Cho YW, 2011, SEIZURE-EUR J EPILEP, V20, P336, DOI 10.1016/j.seizure.2011.01.006; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; Christian LM, 2011, PSYCHONEUROENDOCRINO, V36, P1495, DOI 10.1016/j.psyneuen.2011.04.003; Cirelli C, 2006, J NEUROCHEM, V98, P1632, DOI 10.1111/j.1471-4159.2006.04058.x; Clement P, 2003, NEUROSCIENCE, V116, P863, DOI 10.1016/S0306-4522(02)00761-3; COENEN AML, 1985, PHYSIOL BEHAV, V35, P501, DOI 10.1016/0031-9384(85)90130-1; Conti B, 2007, MOL PSYCHIATR, V12, P167, DOI 10.1038/sj.mp.4001897; Diekelmann S, 2011, NAT NEUROSCI; ELDRIDGE JC, 1989, J NEUROSCI, V9, P3237; ELEFTHERIOU BE, 1975, GERONTOLOGY, V21, P21, DOI 10.1159/000212027; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Florian C, 2011, J NEUROSCI, V31, P6956, DOI 10.1523/JNEUROSCI.5761-10.2011; Garrido P, 2011, AGING DIS, V2, P80; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hampson RE, 2009, PSYCHOPHARMACOLOGY, V202, P355, DOI 10.1007/s00213-008-1360-z; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Hughes Timothy R, 2009, J Biol, V8, P3, DOI 10.1186/jbiol104; Hursh SR, 2004, AVIAT SPACE ENVIR MD, V75, pA44; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kelly MJ, 2008, MOL CELL ENDOCRINOL, V290, P14, DOI 10.1016/j.mce.2008.04.014; Kitka T, 2009, BEHAV BRAIN RES, V205, P482, DOI 10.1016/j.bbr.2009.08.004; Kryger M, 2004, GERIATRICS-US, V59, P24; Landfield PW, 2007, CURR ALZHEIMER RES, V4, P205, DOI 10.2174/156720507780362083; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Mackiewicz M, 2008, ANN NY ACAD SCI, V1129, P335, DOI 10.1196/annals.1417.030; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Mariani E, 2007, J ALZHEIMERS DIS, V12, P23; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Monjan Andrew A, 2010, Front Neurol, V1, P124, DOI 10.3389/fneur.2010.00124; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; Nelson SE, 2004, NEUROSCI LETT, V367, P105, DOI 10.1016/j.neulet.2004.05.089; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Snedecor GW, 1967, STATISTICAL METHODS, P199; Sohrabji F, 2006, ENDOCRINE, V29, P191, DOI 10.1385/ENDO:29:2:191; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Suchecki D, 2000, PHYSIOL BEHAV, V68, P309, DOI 10.1016/S0031-9384(99)00181-X; Takeuchi T, 2002, BEHAV BRAIN RES, V136, P193, DOI 10.1016/S0166-4328(02)00123-7; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Thompson CL, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00165; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tornatore Jane B, 2003, Am J Alzheimers Dis Other Demen, V18, P240, DOI 10.1177/153331750301800413; Tractenberg RE, 2005, J SLEEP RES, V14, P177, DOI 10.1111/j.1365-2869.2005.00445.x; Van Cauter E, 1998, HORM RES, V49, P147, DOI 10.1159/000023162; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Weinert D, 2000, CHRONOBIOL INT, V17, P261, DOI 10.1081/CBI-100101048; Youngblood BD, 1997, PHYSIOL BEHAV, V61, P249, DOI 10.1016/S0031-9384(96)00363-0; Zhdanova IV, 2011, J BIOL RHYTHM, V26, P149, DOI 10.1177/0748730410395849	86	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40128	10.1371/journal.pone.0040128	http://dx.doi.org/10.1371/journal.pone.0040128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792227	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300028
J	Tang, JS; Liao, YH; Zhou, B; Tan, CL; Liu, WQ; Wang, D; Liu, TQ; Hao, W; Tan, LW; Chen, XG				Tang, Jinsong; Liao, Yanhui; Zhou, Bing; Tan, Changliang; Liu, Weiqing; Wang, Dong; Liu, Tieqiao; Hao, Wei; Tan, Liwen; Chen, Xiaogang			Decrease in Temporal Gyrus Gray Matter Volume in First-Episode, Early Onset Schizophrenia: An MRI Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SYNDROME SCALE PANSS; BRAIN MORPHOLOGY; MACAQUE MONKEYS; 1ST EPISODE; PSYCHOSIS; DEFICITS; ADOLESCENTS; CHILDHOOD; DURATION	Background: Loss of gray matter has been previously found in early-onset schizophrenic patients. However, there are no consistent findings between studies due to different methods used to measure grey matter volume/density and influences of confounding factors. Methods: The volume of gray matter (GM) was measured in 29 first episode early-onset schizophrenia (EOS) and 34 well-matched healthy controls by using voxel-based morphometry (VBM). Psychotic symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS). The correlations between the GM volume and PANSS scores, age of psychosis onset, duration of psychosis, and chlorpromazine (CPZ) equivalent value were investigated. Results: Relative to healthy subjects, the patients with first episode EOS showed significantly lower GM volume in the left middle and superior temporal gyrus. The loss of GM volume negatively correlated with PANSS-positive symptoms (p = 0.002), but not with PANSS-negative symptoms, PANSS-general psychopathology, and PANSS-total score. No significant correlation was found between GM volume and age of psychosis onset, duration of psychosis, and CPZ equivalent value. Conclusion: Patients with first episode EOS have evidence of reduced GM in the left middle and superior temporal gyrus. Structural abnormalities in the left middle and superior temporal gyrus may contribute to the pathophysiology of schizophrenia.	[Tang, Jinsong; Liao, Yanhui; Liu, Weiqing; Wang, Dong; Liu, Tieqiao; Hao, Wei; Tan, Liwen; Chen, Xiaogang] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China; [Zhou, Bing; Tan, Changliang] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tang, JS (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China.	chenxghn@gmail.com	Liao, Yanhui/L-1590-2016; liu, tieqiao/GSE-2327-2022	Liao, Yanhui/0000-0003-4735-3252; 	Natural Science Foundation of China [30900486, 81100996, 81130020]; National Key Basic Research and Development Program (973) [2012CB517904, 2009CB522007]; National Key Technology R&D Program of China [2012BAI01B07]; Central Colleges Basic Scientific Research Operating Expenses [2011QNZT170]; Specialized Research Fund for the Doctoral Program of Higher Education [20110162120013]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Central Colleges Basic Scientific Research Operating Expenses; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the Natural Science Foundation of China (Grant No. 30900486 to JT, 81100996 to YL, 81130020 to WH), the National Key Basic Research and Development Program (973) (Grant No. 2012CB517904 to XC, 2009CB522007 to WH), National Key Technology R&D Program in the 12th Five-Year Plan of China (2012BAI01B07 to WH), Central Colleges Basic Scientific Research Operating Expenses (2011QNZT170 to YL), and Specialized Research Fund for the Doctoral Program of Higher Education (20110162120013 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2006, AM J MED GENET B, V141B, P513, DOI 10.1002/ajmg.b.30338; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; Arango C, 2012, ARCH GEN PSYCHIAT, V69, P16, DOI 10.1001/archgenpsychiatry.2011.150; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bangalore SS, 2009, NEUROREPORT, V20, P729, DOI 10.1097/WNR.0b013e32832ae501; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Emsley R, 2003, SCHIZOPHR RES, V61, P47, DOI 10.1016/S0920-9964(02)00302-X; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2007, ARCH GEN PSYCHIAT, V64, P772, DOI 10.1001/archpsyc.64.7.772; Ho BC, 2003, AM J PSYCHIAT, V160, P142, DOI 10.1176/appi.ajp.160.1.142; Hoff AL, 2000, AM J PSYCHIAT, V157, P1824, DOI 10.1176/appi.ajp.157.11.1824; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honea RA, 2008, BIOL PSYCHIAT, V63, P465, DOI 10.1016/j.biopsych.2007.05.027; Janssen J, 2008, J AM ACAD CHILD PSY, V47, P1311, DOI 10.1097/CHI.0b013e318184ff48; Jung WH, 2010, J KOREAN MED SCI, V25, P1700, DOI 10.3346/jkms.2010.25.12.1700; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keshavan MS, 1998, J PSYCHIAT RES, V32, P161, DOI 10.1016/S0022-3956(97)00038-1; Kong XJ, 2011, J PSYCHIATR NEUROSCI, V36, P120, DOI 10.1503/jpn.100041; Konopaske GT, 2008, BIOL PSYCHIAT, V63, P759, DOI 10.1016/j.biopsych.2007.08.018; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Kumra S, 2012, J AM ACAD CHILD PSY, V51, P171, DOI 10.1016/j.jaac.2011.11.001; Kyriakopoulos M, 2008, BIOL PSYCHIAT, V63, P519, DOI 10.1016/j.biopsych.2007.05.021; Pagsberg AK, 2007, J NEURAL TRANSM, V114, P489, DOI 10.1007/s00702-006-0573-8; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; Schultz SK, 1999, LANCET, V353, P1425, DOI 10.1016/S0140-6736(98)07549-7; Schumacher A, 2006, CURR TOP MICROBIOL, V310, P81; Skelly LR, 2008, SCHIZOPHR RES, V98, P157, DOI 10.1016/j.schres.2007.10.009; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Tang JS, 2010, BRAIN RES, V1343, P199, DOI 10.1016/j.brainres.2010.04.083; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Tsuang Ming T, 2004, World Psychiatry, V3, P73; Velakoulis D, 2002, SCHIZOPHR RES, V57, P43, DOI 10.1016/S0920-9964(01)00307-3; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25	36	34	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40247	10.1371/journal.pone.0040247	http://dx.doi.org/10.1371/journal.pone.0040247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802957	gold, Green Submitted, Green Published			2022-12-25	WOS:000306186900031
J	Xu, H; Yang, F; Sun, Y; Yuan, Y; Cheng, H; Wei, ZQ; Li, SY; Cheng, T; Brann, D; Wang, RM				Xu, Hong; Yang, Fang; Sun, Ying; Yuan, Yuan; Cheng, Hua; Wei, Zhongqiu; Li, Shuyu; Cheng, Tan; Brann, Darrell; Wang, Ruimin			A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ASPARTYL-LYSYL-PROLINE; RADIATION-INDUCED PNEUMONOPATHY; SERUM RESPONSE FACTOR; BETA TGF-BETA; PULMONARY-FIBROSIS; RECEPTOR BLOCKER; EXPRESSION; FIBROBLASTS; ACTIVATION	Background: Myofibroblast differentiation, characterized by alpha-smooth muscle actin (alpha-SMA) expression, is a key process in organ fibrosis, and is induced by TGF-beta. Here we examined whether an anti-fibrotic agent, N-acetyl-seryl-aspartyllysylproline (Ac-SDKP), can regulate induction of TGF-beta signaling and myofibroblast differentiation as a potential key component of its anti-fibrotic mechanism in vivo and in vitro. Methodology/Principal Findings: Rat pulmonary fibroblasts were cultured in vitro and divided to 4 groups 1) control; 2) TGF-beta 1; 3) TGF-beta 1+ LY364947; 4) TGF-beta 1+ Ac-SDKP. For in vivo studies, six groups of animals were utilized 1) control 4w; 2) silicotic 4w; 3) control 8w; 4) silicotic 8w; 5) Ac-SDKP post-treatment; 6) Ac-SDKP pre-treatment. SiO2 powders were douched in the trachea of rat to make the silicotic model. Myofibroblast differentiation was measured by examining expression of alpha-SMA, as well as expression of serum response factor (SRF), a key regulator of myofibroblast differentiation. The expressions of collagen, TGF-beta 1 and RAS signaling were also assessed. The results revealed that TGF-beta 1 strongly induced myofibroblast differentiation and collagen synthesis in vitro, and that pre-treatment with Ac-SDKP markedly attenuated myofibroblast activation, as well as induction of TGF-beta 1 and its receptor. Similar results were observed in vivo in the pathologically relevant rat model of silicosis. Ac-SDKP treatment in vivo strongly attenuated 1) silicosis-induced increased expressions of TGF-beta 1 and RAS signaling, 2) myofibroblast differentiation as indicated by a robust decrease of SRF and alpha-SMA-positive myofibroblast localization in siliconic nodules in the lung, 3) collagen deposition. Conclusion/Significance: The results of the present study suggest a novel mechanism of action for Ac-SDKP's beneficial effect in silicosis, which involves attenuation of TGF-beta 1 and its receptors, SRF and Ang II type 1 receptor (AT1) expression, collagen deposition and myofibroblast differentiation. The results further suggest that therapies targeting myofibroblast differentiation may have therapeutic efficacy in treatment of silicosis of the lung.	[Xu, Hong; Yang, Fang; Cheng, Tan] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Yang, Fang; Sun, Ying; Yuan, Yuan; Cheng, Hua; Wei, Zhongqiu; Li, Shuyu; Wang, Ruimin] Hebei United Univ, Med Res Ctr, Tangshan, Peoples R China; [Brann, Darrell] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA	Hebei Medical University; North China University of Science & Technology; University System of Georgia; Augusta University	Xu, H (corresponding author), Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China.	fangyang02@sohu.com	Xu, Hong/ABC-2923-2021	Xu, Hong/0000-0002-3655-3833	National Natural Science Foundation of China [81072254]; Hebei Province Natural Science Foundation of China [C2011401024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Natural Science Foundation of China(Natural Science Foundation of Hebei Province)	This work was funded by the National Natural Science Foundation of China (No. 81072254) and Hebei Province Natural Science Foundation of China (No. C2011401024); http://159.226.244.22/portal/Proj_List.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Azizi M, 1996, J CLIN INVEST, V97, P839, DOI 10.1172/JCI118484; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Chen W, 2001, OCCUP ENVIRON MED, V58, P31, DOI 10.1136/oem.58.1.31; Chou HC, 2012, J PHARMACOL EXP THER, V340, P169, DOI 10.1124/jpet.111.186288; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao XR, 2009, EUR J PHARMACOL, V606, P115, DOI 10.1016/j.ejphar.2008.12.049; Gauldie J, 1999, CURR TOPICS PATHOL, V93, P35; Health Mo, 2011, 2010 PREV WORK SIT O; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Horn A, 2012, ANN RHEUM DIS; Jagirdar J, 1996, AM J RESP CRIT CARE, V154, P1076, DOI 10.1164/ajrccm.154.4.8887610; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KUMAR CC, 1995, J BIOCHEM-TOKYO, V118, P1285, DOI 10.1093/oxfordjournals.jbchem.a125020; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Molteni A, 2007, CURR PHARM DESIGN, V13, P1307, DOI 10.2174/138161207780618777; Moltenti A, 2000, INT J RADIAT BIOL, V76, P523, DOI 10.1080/095530000138538; Omata M, 2006, J AM SOC NEPHROL, V17, P674, DOI 10.1681/ASN.2005040385; Pereira RM, 2009, WORLD J GASTROENTERO, V15, P2579, DOI 10.3748/wjg.15.2579; Perret-Guillaume C, 2009, J HYPERTENS, V27, pS3, DOI 10.1097/01.hjh.0000354511.14086.f1; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Sopel MJ, 2011, LAB INVEST, V91, P565, DOI 10.1038/labinvest.2010.190; Sun Y, 2010, LIFE SCI, V87, P232, DOI 10.1016/j.lfs.2010.06.016; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas CR, 2010, ENVIRON HEALTH INSIG, V4, P21; Usuki J, 2012, J NIPPON MED SCH, V79, P46, DOI 10.1272/jnms.79.46; Xu Hong, 2009, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V25, P283; Yan Jing-Bo, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P401; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; Yang F, 2011, XIAN DAI YU FANG YI, V38, P4930; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531	39	71	80	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40301	10.1371/journal.pone.0040301	http://dx.doi.org/10.1371/journal.pone.0040301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802960	Green Published, gold, Green Submitted			2022-12-25	WOS:000306186900034
J	Dong, YS; Zhang, LJ; Zhang, S; Bai, YP; Chen, HY; Sun, XX; Yong, WD; Li, W; Colvin, SC; Rhodes, SJ; Shou, WN; Zhang, ZY				Dong, Yuanshu; Zhang, Lujuan; Zhang, Sheng; Bai, Yunpeng; Chen, Hanying; Sun, Xiaoxin; Yong, Weidong; Li, Wei; Colvin, Stephanie C.; Rhodes, Simon J.; Shou, Weinian; Zhang, Zhong-Yin			Phosphatase of Regenerating Liver 2 (PRL2) Is Essential for Placental Development by Down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and Activating Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; TUMOR-SUPPRESSOR; CELL-MIGRATION; GLYCOGEN CELLS; INVASION; METASTASIS; EXPRESSION; STABILITY; BINDING	The PRL (phosphatase of regenerating liver) phosphatases are implicated in the control of cell proliferation and invasion. Aberrant PRL expression is associated with progression and metastasis of multiple cancers. However, the specific in vivo function of the PRLs remains elusive. Here we show that deletion of PRL2, the most ubiquitously expressed PRL family member, leads to impaired placental development and retarded growth at both embryonic and adult stages. Ablation of PRL2 inactivates Akt and blocks glycogen cell proliferation, resulting in reduced spongiotrophoblast and decidual layers in the placenta. These structural defects cause placental hypotrophy and insufficiency, leading to fetal growth retardation. We demonstrate that the tumor suppressor PTEN is elevated in PRL2-deficient placenta. Biochemical analyses indicate that PRL2 promotes Akt activation by down-regulating PTEN through the proteasome pathway. This study provides the first evidence that PRL2 is required for extra-embryonic development and associates the oncogenic properties of PRL2 with its ability to negatively regulate PTEN, thereby activating the PI3K-Akt pathway.	[Dong, Yuanshu; Zhang, Lujuan; Zhang, Sheng; Bai, Yunpeng; Shou, Weinian; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Hanying; Sun, Xiaoxin; Yong, Weidong; Li, Wei; Shou, Weinian] Indiana Univ Sch Med, Riley Heart Res Ctr, Dept Pediat, Indianapolis, IN 46202 USA; [Colvin, Stephanie C.; Rhodes, Simon J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu			National Institutes of Health [CA69202, HL85098, HD42024]; Indiana University Collaborative Research Grant (IUCRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042024] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092, P01HL085098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Collaborative Research Grant (IUCRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69202 (to Z. Y. Z.), HL85098 (to W. S.), and HD42024 (to S. J. R.). This work was also supported by an Indiana University Collaborative Research Grant (IUCRG) pilot grant.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Dackor J, 2009, GENETICS, V183, P207, DOI 10.1534/genetics.109.104372; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Dumaual CM, 2006, J HISTOCHEM CYTOCHEM, V54, P1401, DOI 10.1369/jhc.6A7019.2006; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Franco D, 2001, EUR J MORPHOL, V39, P169, DOI 10.1076/ejom.39.3.169.4670; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lopez MF, 1996, ENDOCRINOLOGY, V137, P2100, DOI 10.1210/en.137.5.2100; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Okada T, 1996, BIOCHEM J, V317, P475, DOI 10.1042/bj3170475; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; Wang Q, 2002, CANCER LETT, V175, P63, DOI 10.1016/S0304-3835(01)00703-0; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Werner SR, 2003, CANCER LETT, V202, P201, DOI 10.1016/S0304-3835(03)00517-2; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhao ZY, 1996, GENOMICS, V35, P172, DOI 10.1006/geno.1996.0336	36	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32172	32179		10.1074/jbc.M112.393462	http://dx.doi.org/10.1074/jbc.M112.393462			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22791713	Green Published, hybrid			2022-12-25	WOS:000309059400054
J	Petrushanko, IY; Yakushev, S; Mitkevich, VA; Kamanina, YV; Ziganshin, RH; Meng, XY; Anashkina, AA; Makhro, A; Lopina, OD; Gassmann, M; Makarov, AA; Bogdanova, A				Petrushanko, Irina Yu.; Yakushev, Sergej; Mitkevich, Vladimir A.; Kamanina, Yuliya V.; Ziganshin, Rustam H.; Meng, Xianyu; Anashkina, Anastasiya A.; Makhro, Asya; Lopina, Olga D.; Gassmann, Max; Makarov, Alexander A.; Bogdanova, Anna			S-Glutathionylation of the Na,K-ATPase Catalytic alpha Subunit Is a Determinant of the Enzyme Redox Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSIBLE OXIDATIVE MODIFICATION; OXYGEN-INDUCED REGULATION; NA-K-ATPASE; CARDIAC MYOCYTES; PUMP; INHIBITION; CYSTEINE; GLUTATHIOLATION; NITROSYLATION; NA+,K+-ATPASE	Na,K-ATPase is highly sensitive to changes in the redox state, and yet the mechanisms of its redox sensitivity remain unclear. We have explored the possible involvement of S-glutathionylation of the catalytic alpha subunit in redox-induced responses. For the first time, the presence of S-glutathionylated cysteine residues was shown in the alpha subunit in duck salt glands, rabbit kidneys, and rat myocardium. Exposure of the Na, K-ATPase to oxidized glutathione (GSSG) resulted in an increase in the number of S-glutathionylated cysteine residues. Increase in S-glutathionylation was associated with dose- and time-dependent suppression of the enzyme function up to its complete inhibition. The enzyme inhibition concurred with S-glutathionylation of the Cys-454, -458, -459, and -244. Upon binding of glutathione to these cysteines, the enzyme was unable to interact with adenine nucleotides. Inhibition of the Na, K-ATPase by GSSG did not occur in the presence of ATP at concentrations above 0.5 mM. Deglutathionylation of the alpha subunit catalyzed by glutaredoxin or dithiothreitol resulted in restoration of the Na,K-ATPase activity. Oxidation of regulatory cysteines made them inaccessible for glutathionylation but had no profound effect on the enzyme activity. Regulatory S-glutathionylation of the alpha subunit was induced in rat myocardium in response to hypoxia and was associated with oxidative stress and ATP depletion. S-Glutathionylation was followed by suppression of the Na, K-ATPase activity. The rat alpha 2 isoform was more sensitive to GSSG than the alpha 1 isoform. Our findings imply that regulatory S-glutathionylation of the catalytic subunit plays a key role in the redox-induced regulation of Na,K-ATPase activity.	[Petrushanko, Irina Yu.; Mitkevich, Vladimir A.; Anashkina, Anastasiya A.; Makarov, Alexander A.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 11999, Russia; [Bogdanova, Anna] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, CH-8057 Zurich, Switzerland; [Yakushev, Sergej; Makhro, Asya; Gassmann, Max; Bogdanova, Anna] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Kamanina, Yuliya V.; Meng, Xianyu; Lopina, Olga D.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119234, Russia; [Ziganshin, Rustam H.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Makarov, AA (corresponding author), RAS, VA Engelhardt Mol Biol Inst, 32 Vavilova St, Moscow 119991, Russia.	aamakarov@eimb.ru; annab@access.uzh.ch	Lopina, Olga/ABE-6918-2021; Bogdanova, Anna Yu/M-1977-2017; Makarov, Alexander/P-5279-2016; Ziganshin, Rustam/Q-7445-2016; Mitkevich, Vladimir A/M-3897-2017; Anashkina, Anastasia/E-6078-2016; Mitkevich, Vladimir/AAA-4160-2022	Lopina, Olga/0000-0001-9608-0196; Bogdanova, Anna Yu/0000-0003-0502-5381; Ziganshin, Rustam/0000-0002-7931-519X; Mitkevich, Vladimir A/0000-0002-1517-1983; Anashkina, Anastasia/0000-0003-1763-300X; Mitkevich, Vladimir/0000-0002-1517-1983; Gassmann, Max/0000-0003-2750-8878	Swiss Academy of Sciences [112449, 310030_124970/1]; Forschungskredit scholarship; Russian Foundation for Basic Research [07-04-01355, 08-04-01321]; Molecular and Cellular Biology Program of the Russian Academy of Sciences; Russian Federal Program [16.512.11.2280]	Swiss Academy of Sciences; Forschungskredit scholarship; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cellular Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Federal Program	This work was supported by Swiss Academy of Sciences Grants 112449 and 310030_124970/1 (to A. B.), a Forschungskredit scholarship (to S. Y.), Russian Foundation for Basic Research Grants 07-04-01355 (to I. P.) and 08-04-01321 (to O. L.), the Molecular and Cellular Biology Program of the Russian Academy of Sciences, and by Russian Federal Program Contract 16.512.11.2280 (to A. M. and I. P.).	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bogdanova A., 2006, CURR ENZYME INHIBITI, V2, P37, DOI [10.2174/157340806775473490, DOI 10.2174/157340806775473490]; Bogdanova AY, 2003, J MEMBRANE BIOL, V195, P33, DOI 10.1007/s00232-003-2042-8; CAPPEL RE, 1986, J BIOL CHEM, V261, P5385; Cappiello M, 1996, J BIOL CHEM, V271, P33539, DOI 10.1074/jbc.271.52.33539; Cortes A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Fuller W, 2003, CARDIOVASC RES, V57, P1044, DOI 10.1016/S0008-6363(02)00810-6; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; Grycova L, 2009, BBA-BIOMEMBRANES, V1788, P1081, DOI 10.1016/j.bbamem.2009.02.004; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; KANEKO M, 1989, AM J PHYSIOL, V257, pH804, DOI 10.1152/ajpheart.1989.257.3.H804; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Komniski MS, 2011, AM J PHYSIOL-HEART C, V300, pH1645, DOI 10.1152/ajpheart.00220.2010; Kurella EG, 1999, CELL MOL NEUROBIOL, V19, P133, DOI 10.1023/A:1006976810642; Lancel S, 2009, CIRC RES, V104, P720, DOI 10.1161/CIRCRESAHA.108.188441; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mitkevich VA, 2006, NUCLEIC ACIDS RES, V34, P3947, DOI 10.1093/nar/gkl549; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Petrushanko I, 2006, AM J PHYSIOL-REG I, V290, pR916, DOI 10.1152/ajpregu.00038.2005; Petrushanko IY, 2007, J GEN PHYSIOL, V130, P389, DOI 10.1085/jgp.200709783; Rasmussen HH, 2010, TRENDS CARDIOVAS MED, V20, P85, DOI 10.1016/j.tcm.2010.06.002; RATHBUN WB, 1969, ANAL BIOCHEM, V28, P436, DOI 10.1016/0003-2697(69)90198-5; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi HLG, 2000, BBA-BIOMEMBRANES, V1464, P177, DOI 10.1016/S0005-2736(99)00245-X; SMITH TW, 1988, METHOD ENZYMOL, V156, P46; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; XIE Z, 1995, BIOCHEM BIOPH RES CO, V207, P155, DOI 10.1006/bbrc.1995.1166; Xu KY, 1997, ANN NY ACAD SCI, V834, P680, DOI 10.1111/j.1749-6632.1997.tb52349.x	39	85	90	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32195	32205		10.1074/jbc.M112.391094	http://dx.doi.org/10.1074/jbc.M112.391094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22798075	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000309059400056
J	Szekeres, M; Nadasy, GL; Turu, G; Soltesz-Katona, E; Toth, ZE; Balla, A; Catt, KJ; Hunyady, L				Szekeres, Maria; Nadasy, Gyoergy L.; Turu, Gabor; Soltesz-Katona, Eszter; Toth, Zsuzsanna E.; Balla, Andras; Catt, Kevin J.; Hunyady, Laszlo			Angiotensin II Induces Vascular Endocannabinoid Release, Which Attenuates Its Vasoconstrictor Effect via CB1 Cannabinoid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CARDIOVASCULAR PHARMACOLOGY; NITRIC-OXIDE; RAT AORTA; CORONARY; MECHANISMS; RESISTANCE; REACTIVITY; ARTERY; VASORELAXATION	In the vascular system angiotensin II (Ang II) causes vasoconstriction via the activation of type 1 angiotensin receptors. Earlier reports have shown that in cellular expression systems diacylglycerol produced during type 1 angiotensin receptor signaling can be converted to 2-arachidonoylglycerol, an important endocannabinoid. Because activation of CB1 cannabinoid receptors (CB1R) induces vasodilation and reduces blood pressure, we have tested the hypothesis that Ang II-induced 2-arachidonoylglycerol release can modulate its vasoconstrictor action in vascular tissue. Rat and mouse skeletal muscle arterioles and mouse saphenous arteries were isolated, pressurized, and subjected to microangiometry. Vascular expression of CB1R was demonstrated using Western blot and RT-PCR. In accordance with the functional relevance of these receptors WIN55212, a CB1R agonist, caused vasodilation, which was absent in CB1R knock-out mice. Inhibition of CB(1)Rs using O2050, a neutral antagonist, enhanced the vasoconstrictor effect of Ang II in wild type but not in CB1R knock-out mice. Inverse agonists of CB1R (SR141716 and AM251) and inhibition of diacylglycerol lipase using tetrahydrolipstatin also augmented the Ang II-induced vasoconstriction, suggesting that endocannabinoid release modulates this process via CB1R activation. This effect was independent of nitric-oxide synthase activity and endothelial function. These data demonstrate that Ang II stimulates vascular endocannabinoid formation, which attenuates its vasoconstrictor effect, suggesting that endocannabinoid release from the vascular wall and CB1R activation reduces the vasoconstrictor and hypertensive effects of Ang II.	[Hunyady, Laszlo] Semmelweis Univ, Fac Med, Dept Physiol, H-1444 Budapest, Hungary; [Nadasy, Gyoergy L.] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1444 Budapest, Hungary; [Toth, Zsuzsanna E.] Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, H-1444 Budapest, Hungary; [Balla, Andras; Hunyady, Laszlo] Semmelweis Univ, Lab Mol Physiol, H-1444 Budapest, Hungary; Hungarian Acad Sci, H-1444 Budapest, Hungary; [Catt, Kevin J.] NICHD, Sect Hormonal Regulat, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, POB 259, H-1444 Budapest, Hungary.	Hunyady@eok.sote.hu	Toth, Zsuzsanna/U-2579-2019; Soltész-Katona, Eszter/H-1897-2019	Soltész-Katona, Eszter/0000-0002-9054-740X; Turu, Gabor/0000-0002-4421-3812; Balla, Andras/0000-0002-6450-2793	Hungarian National Science Foundation [OTKA NK-100883, NK-72661, OTKA TO32019]; Hungarian Ministry of National Resources [ETT 495/09]; National Development Agency, Hungary [TAMOP 4.2.1.B-09/1/KMR-2010-0001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000184] Funding Source: NIH RePORTER	Hungarian National Science Foundation; Hungarian Ministry of National Resources; National Development Agency, Hungary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Hungarian National Science Foundation (OTKA NK-100883, NK-72661, OTKA TO32019), Hungarian Ministry of National Resources (ETT 495/09), and from the National Development Agency, Hungary (TAMOP 4.2.1.B-09/1/KMR-2010-0001).	Bagi Z, 2006, LUPUS, V15, P326, DOI 10.1191/0961203306lu2297oa; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Begg M, 2003, J BIOL CHEM, V278, P46188, DOI 10.1074/jbc.M307258200; Chataigneau T, 1998, BRIT J PHARMACOL, V123, P968, DOI 10.1038/sj.bjp.0701690; Daly CJ, 2010, BRIT J PHARMACOL, V159, P787, DOI 10.1111/j.1476-5381.2009.00608.x; Dannert MT, 2007, VASC PHARMACOL, V46, P16, DOI 10.1016/j.vph.2006.06.005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gauthier KM, 2005, AM J PHYSIOL-HEART C, V288, pH1344, DOI 10.1152/ajpheart.00537.2004; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; Gyombolai P, 2012, MOL CELL ENDOCRINOL, V353, P29, DOI 10.1016/j.mce.2011.10.011; Haendeler J, 2000, REGUL PEPTIDES, V95, P1, DOI 10.1016/S0167-0115(00)00133-6; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hiley CR, 2009, J CARDIOVASC PHARM, V53, P267, DOI 10.1097/FJC.0b013e318192671d; Hillard CJ, 2000, J PHARMACOL EXP THER, V294, P27; Hogestatt ED, 2002, PROSTAG LEUKOTR ESS, V66, P343, DOI 10.1054/plef.2001.0346; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Lopez-Miranda V, 2008, CURR VASC PHARMACOL, V6, P335, DOI 10.2174/157016108785909706; Massett MP, 2002, AM J PHYSIOL-HEART C, V283, pH2282, DOI 10.1152/ajpheart.00544.2002; Mechoulam R, 1998, EUR J PHARMACOL, V362, pR1, DOI 10.1016/S0014-2999(98)00777-8; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nadasy GL, 2001, MICROVASC RES, V61, P282, DOI 10.1006/mvre.2000.2297; Niederhoffer N, 2003, N-S ARCH PHARMACOL, V367, P434, DOI 10.1007/s00210-003-0755-y; O'Sullivan SE, 2007, J PHARMACOL EXP THER, V321, P663, DOI 10.1124/jpet.106.116566; O'Sullivan SE, 2004, BRIT J PHARMACOL, V142, P435, DOI 10.1038/sj.bjp.0705810; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Phillips SA, 2006, J APPL PHYSIOL, V100, P1117, DOI 10.1152/japplphysiol.00994.2005; Quignard JF, 2001, J BIOL CHEM, V276, P32545, DOI 10.1074/jbc.M102582200; Rademacher DJ, 2005, AM J PHYSIOL-HEART C, V288, pH2694, DOI 10.1152/ajpheart.00978.2004; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Randall MD, 2002, PHARMACOL THERAPEUT, V95, P191, DOI 10.1016/S0163-7258(02)00258-9; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; SUN D, 1994, AM J PHYSIOL, V266, pH1177, DOI 10.1152/ajpheart.1994.266.3.H1177; Szekeres M, 2004, J CARDIOVASC PHARM, V43, P242, DOI 10.1097/00005344-200402000-00012; Szekeres M, 2001, J CARDIOVASC PHARM, V38, P584, DOI 10.1097/00005344-200110000-00011; Szekeres M, 2010, ENDOCRINOLOGY, V151, P1695, DOI 10.1210/en.2009-1060; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Turu G, 2009, J BIOL CHEM, V284, P16914, DOI 10.1074/jbc.M109.003681; Varbiro S, 2000, J HYPERTENS, V18, P1587, DOI 10.1097/00004872-200018110-00009; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Weber DS, 2001, AM J PHYSIOL-HEART C, V280, pH2196, DOI 10.1152/ajpheart.2001.280.5.H2196; White R, 2001, BRIT J PHARMACOL, V134, P921, DOI 10.1038/sj.bjp.0704333; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	50	40	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31540	31550		10.1074/jbc.M112.346296	http://dx.doi.org/10.1074/jbc.M112.346296			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22787147	hybrid, Green Published			2022-12-25	WOS:000308791300066
J	Nakagawa, N; Manya, H; Toda, T; Endo, T; Oka, S				Nakagawa, Naoki; Manya, Hiroshi; Toda, Tatsushi; Endo, Tamao; Oka, Shogo			Human Natural Killer-1 Sulfotransferase (HNK-1ST)-induced Sulfate Transfer Regulates Laminin-binding Glycans on alpha-Dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; CARBOHYDRATE EPITOPE HNK-1; WALKER-WARBURG-SYNDROME; CELL-ADHESION MOLECULE; SKELETAL-MUSCLE; O-GLYCAN; ABNORMAL GLYCOSYLATION; GLYCOPROTEIN COMPLEX; GLUCURONIC-ACID; MELANOMA-CELLS	Retinoic acid (RA) is a well established anti-tumor agent inducing differentiation in various cancer cells. Recently, a robust up-regulation of human natural killer-1 sulfotransferase (HNK-1ST) was found in several subsets of melanoma cells during RA-mediated differentiation. However, the molecular mechanism underlying the tumor suppression mediated by HNK-1ST remains unclear. Here, we show that HNK-1ST changed the glycosylation state and reduced the ligand binding activity of alpha-dystroglycan (alpha-DG) in RA-treated S91 melanoma cells, which contributed to an attenuation of cell migration. Knockdown of HNK-1ST restored the glycosylation of alpha-DG and the migration of RA-treated S91 cells, indicating that HNK-1ST functions through glycans on alpha-DG. Using CHO-K1 cells, we provide direct evidence that HNK-1ST but not other homologous sulfotransferases (C4ST1 and GalNAc4ST1) suppresses the glycosylation of alpha-DG. The activity-abolished mutant of HNK-1ST did not show the alpha-DG-modulating function, indicating that the sulfotransferase activity of HNK-1ST is essential. Finally, the HNK-1ST-dependent incorporation of [S-35]sulfate groups was detected on alpha-DG. These findings suggest a novel role for HNK-1ST as a tumor suppressor controlling the functional glycans on alpha-DG and the importance of sulfate transfer in the glycosylation of alpha-DG.	[Nakagawa, Naoki; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Tokyo 1730015, Japan; [Manya, Hiroshi; Endo, Tamao] Inst Gerontol, Tokyo 1730015, Japan; [Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan	Kyoto University; Tokyo Metropolitan Institute of Gerontology; Kobe University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Manya, Hiroshi/0000-0003-1573-9177	Japan Society for the Promotion of Science [23659153]; Ministry of Education, Culture, Sports, Science and Technology [23110006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Challenging Exploratory Research 23659153 (to S. O.) from Japan Society for the Promotion of Science and for Scientific Research on Innovative Areas and Grant 23110006 (to S. O.) from Ministry of Education, Culture, Sports, Science and Technology.	ARIGA T, 1987, J BIOL CHEM, V262, P848; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Casado JG, 2008, TUMOR BIOL, V29, P304, DOI 10.1159/000156707; Chiba A, 1997, J BIOL CHEM, V272, P2156; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Girard JP, 1998, FASEB J, V12, P603, DOI 10.1096/fasebj.12.7.603; Hakomori S, 1996, CANCER RES, V56, P5309; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Meany Danni L, 2011, Clin Proteomics, V8, P7, DOI 10.1186/1559-0275-8-7; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; MOOY CM, 1995, HUM PATHOL, V26, P1185, DOI 10.1016/0046-8177(95)90191-4; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Nakagawa N, 2011, BIOCHEM BIOPH RES CO, V415, P109, DOI 10.1016/j.bbrc.2011.10.023; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okuda T, 2000, J BIOL CHEM, V275, P40605, DOI 10.1074/jbc.M007983200; Ong E, 1999, J BIOL CHEM, V274, P25608, DOI 10.1074/jbc.274.36.25608; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Spanjaard RA, 1997, J BIOL CHEM, V272, P18990, DOI 10.1074/jbc.272.30.18990; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Thies A, 2004, J PATHOL, V203, P933, DOI 10.1002/path.1595; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhao XS, 2009, CANCER RES, V69, P5218, DOI 10.1158/0008-5472.CAN-09-0705	53	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30823	30832		10.1074/jbc.M112.363036	http://dx.doi.org/10.1074/jbc.M112.363036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22801424	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000308579800070
J	Schaub, RE; Poole, SJ; Garza-Sanchez, F; Benbow, S; Hayes, CS				Schaub, Ryan E.; Poole, Stephen J.; Garza-Sanchez, Fernando; Benbow, Sarah; Hayes, Christopher S.			Proteobacterial ArfA Peptides Are Synthesized from Non-stop Messenger RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANS-TRANSLATION; ESCHERICHIA-COLI; RIBOSOME-RESCUE; STOP CODONS; A-SITE; BACILLUS-SUBTILIS; RIBONUCLEASE-III; TAGGED PROTEINS; QUALITY-CONTROL; TAGGING SYSTEM	The translation of non-stop mRNA (which lack in-frame stop codons) represents a significant quality control problem for all organisms. In eubacteria, the transfer-messenger RNA (tmRNA) system facilitates recycling of stalled ribosomes from non-stop mRNA in a process termed trans-translation or ribosome rescue. During rescue, the nascent chain is tagged with the tmRNA-encoded ssrA peptide, which promotes polypeptide degradation after release from the stalled ribosome. Escherichia coli possesses an additional ribosome rescue pathway mediated by the ArfA peptide. The E. coli arfA message contains a hairpin structure that is cleaved by RNase III to produce a non-stop transcript. Therefore, ArfA levels are controlled by tmRNA through ssrA-peptide tagging and proteolysis. Here, we examine whether ArfA homologues from other bacteria are also regulated by RNase III and tmRNA. We searched 431 arfA coding sequences for mRNA secondary structures and found that 82.8% of the transcripts contain predicted hairpins in their 3'-coding regions. The arfA hairpins from Haemophilus influenzae, Proteus mirabilis, Vibrio fischeri, and Pasteurella multocida are all cleaved by RNase III as predicted, whereas the hairpin from Neisseria gonorrhoeae functions as an intrinsic transcription terminator to generate non-stop mRNA. Each ArfA homologue is ssrA-tagged and degraded when expressed in wild-type E. coli cells, but accumulates in mutants lacking tmRNA. Together, these findings show that ArfA synthesis from non-stop mRNA is a conserved mechanism to regulate the alternative ribosome rescue pathway. This strategy ensures that ArfA homologues are only deployed when the tmRNA system is incapacitated or overwhelmed by stalled ribosomes.	[Schaub, Ryan E.; Poole, Stephen J.; Garza-Sanchez, Fernando; Benbow, Sarah; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu			National Institutes of Health [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078634.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Baranov PV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-28; Barends S, 2011, WIRES RNA, V2, P233, DOI 10.1002/wrna.48; BECKWITH JR, 1966, J MOL BIOL, V19, P254, DOI 10.1016/S0022-2836(66)80003-7; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Felden B, 2011, RNA BIOL, V8, P440, DOI 10.4161/rna.8.3.15387; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kobayashi K, 2008, MICROBIOL-SGM, V154, P54, DOI 10.1099/mic.0.2007/011783-0; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; OH BK, 1991, MOL GEN GENET, V229, P52, DOI 10.1007/BF00264212; Pertzev AV, 2006, NUCLEIC ACIDS RES, V34, P3708, DOI 10.1093/nar/gkl459; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sundermeier TR, 2007, J BIOL CHEM, V282, P34779, DOI 10.1074/jbc.M707256200; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Wiegert T, 2001, J BACTERIOL, V183, P3885, DOI 10.1128/JB.183.13.3885-3889.2001; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Zhang KJ, 1997, P NATL ACAD SCI USA, V94, P13437, DOI 10.1073/pnas.94.25.13437	43	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29765	29775		10.1074/jbc.M112.374074	http://dx.doi.org/10.1074/jbc.M112.374074			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22791716	hybrid, Green Published			2022-12-25	WOS:000308286900052
J	Qiu, XY				Qiu, Xiangyun			Heat Induced Capsid Disassembly and DNA Release of Bacteriophage lambda	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; VIRAL CAPSIDS; VIRUS MATURATION; PHAGE; INACTIVATION; TRANSITION; STABILITY; MECHANISM; DYNAMICS	Successive structural changes of bacteriophage lambda upon heating were characterized with quantitative experimental methods. In the commonly used Tris-Mg buffer, differential scanning calorimetry measurements first established that the protein capsid of l phage melts at 87 degrees C and its genomic DNA melts at 91 degrees C. Interestingly, prior to the capsid melting, lambda DNA was found to escape out of the capsid and subject to DNase digestion above similar to 68 degrees C, as concluded from light scattering, UV absorption, and electron microscopy studies. Further investigations indicated distinct temperature-dependent behaviors of the three phage proteins. Around 68 degrees C, disruption of the tail first occurs and leads to the escape of lambda DNA; above the capsid melting temperature of 87 degrees C, the auxiliary protein gpD of the phage head remains soluble in solution and resists centrifugal sedimentation, whereas the major capsid protein gpE is easily precipitated and likely exists as aggregates.	George Washington Univ, Dept Phys, Washington, DC 20052 USA	George Washington University	Qiu, XY (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.	xqiu@gwu.edu			George Washington University	George Washington University	This work is supported by the George Washington University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; BLAKE RD, 1979, BIOPOLYMERS, V18, P3089, DOI 10.1002/bip.1979.360181214; Blake RD, 1998, NUCLEIC ACIDS RES, V26, P3323, DOI 10.1093/nar/26.14.3323; BUCHWALD M, 1970, VIROLOGY, V42, P375, DOI 10.1016/0042-6822(70)90281-3; CASJENS SR, 1974, J MOL BIOL, V88, P535, DOI 10.1016/0022-2836(74)90500-2; Catalano C.E., 2005, VIRAL GENOME PACKAGI; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; Duda RL, 2009, J MOL BIOL, V391, P471, DOI 10.1016/j.jmb.2009.06.035; Duguid JG, 1996, BIOPHYS J, V71, P3350, DOI 10.1016/S0006-3495(96)79528-0; DYSON RD, 1967, VIROLOGY, V33, P559, DOI 10.1016/0042-6822(67)90055-4; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fane BA, 2003, ADV PROTEIN CHEM, V64, P259; FEISS M, 1977, VIROLOGY, V77, P281, DOI 10.1016/0042-6822(77)90425-1; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Hendrix R, 1983, COLD SPRING HARBOR M; Hendrix RW, 2005, ADV VIRUS RES, V64, P1, DOI 10.1016/S0065-3527(05)64001-8; Hirneisen KA, 2010, COMPR REV FOOD SCI F, V9, P3, DOI 10.1111/j.1541-4337.2009.00092.x; Ivanovska I, 2007, P NATL ACAD SCI USA, V104, P9603, DOI 10.1073/pnas.0703166104; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kawai Y, 1999, J GEN APPL MICROBIOL, V45, P135, DOI 10.2323/jgam.45.135; Knobler CM, 2009, ANNU REV PHYS CHEM, V60, P367, DOI 10.1146/annurev.physchem.59.032607.093728; Los Marcin, 2004, Journal of Applied Genetics, V45, P111; Muller-Merbach M, 2005, J DAIRY RES, V72, P281, DOI 10.1017/S0022029905000725; Muller-Merbach M, 2005, INT DAIRY J; MURIALDO H, 1991, ANNU REV BIOCHEM, V60, P125; Odijk T, 2004, PHILOS T R SOC A, V362, P1497, DOI 10.1098/rsta.2004.1385; Panja D, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045006; Petrov AS, 2008, BIOPHYS J, V95, P497, DOI 10.1529/biophysj.108.131797; Purohit PK, 2003, P NATL ACAD SCI USA, V100, P3173, DOI 10.1073/pnas.0737893100; Qiu XY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028102; Reddy VS, 2005, ADV VIRUS RES, V64, P45, DOI 10.1016/S0065-3527(05)64003-1; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; STURTEVANT JM, 1987, ANNU REV PHYS CHEM, V38, P463, DOI 10.1146/annurev.pc.38.100187.002335; WIDOM J, 1983, J MOL BIOL, V171, P419, DOI 10.1016/0022-2836(83)90038-4; Zandi R, 2004, P NATL ACAD SCI USA, V101, P15556, DOI 10.1073/pnas.0405844101	40	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39793	10.1371/journal.pone.0039793	http://dx.doi.org/10.1371/journal.pone.0039793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808062	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400019
J	Richards, FM; Tape, CJ; Jodrell, DI; Murphy, G				Richards, Frances M.; Tape, Christopher J.; Jodrell, Duncan I.; Murphy, Gillian			Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; UP-REGULATED EXPRESSION; CONVERTING-ENZYME; BREAST-CANCER; PHASE-III; ALPHA INHIBITOR; FAMILY-MEMBERS; FACTOR TNF; ADAM17; ACTIVATION	ADAM 17 (TNF-alpha converting enzyme, TACE) is a potential target for cancer therapy, but the small molecule inhibitors reported to date are not specific to this ADAM family member. This membrane-bound metalloproteinase is responsible for ectodomain shedding of pathologically significant substrates including TNF-alpha and EGFR ligands. The aim of this study was to evaluate the pharmacokinetics, pharmacodynamics and anti-tumour efficacy of the first specific inhibitor, an anti-human ADAM17 IgG antibody, clone D1(A12). We used intraperitoneal xenografts of the human ovarian cancer cell line IGROV1-Luc in Balb/c nude mice, chosen because it was previously reported that growth of these xenografts is inhibited by knock-down of TNF-alpha. In vitro, 200 nM D1(A12) inhibited shedding of ADAM17 substrates TNF-alpha, TNFR1-alpha, TGF-alpha, amphiregulin (AREG), HB-EGF and IL-6R alpha, from IGROV1-Luc cells, (4.7 nM IC50 for TNF-alpha shedding). In IGROV1-Luc xenografts in vivo, D1(A12) IgG showed pharmacokinetic properties suitable for efficacy studies, with a single i.p. dose of 10 mg/kg D1(A12) sufficient to maintain IgG plasma and ascites fluid concentrations above 100 nM for more than 7 days. The plasma half life was 8.6 days. Next, an efficacy study was performed, dosing D1(A12) or anti-human TNF-alpha antibody infliximab at 10 mg/kg q7d, quantifying IGROV1-Luc tumour burden by bioluminescence. D1(A12) IgG showed a significant reduction in tumour growth (p = 0.005), 56% of vehicle control. Surprisingly, D1(A12) did not reduce the concentration of circulating human TNF-alpha, suggesting that another enzyme may compensate for inhibition of ADAM17 in vivo (but not in vitro). However, D1(A12) did show clear pharmacodynamic effects in the mice, with significant inhibition of shedding from tumour of ADAM17 substrates TNFR1-alpha, AREG, and TGF-alpha (4-15-fold reductions, p<0.0001 for all three). Thus, D1(A12) has anti-ADAM17 activity in vivo, inhibits shedding of EGFR ligands and has potential for use in EGF ligand-dependent tumours.	[Richards, Frances M.; Jodrell, Duncan I.] Univ Cambridge, Pharmacol & Drug Dev Grp, Canc Res UK Cambridge Res Inst, Cambridge, England; [Richards, Frances M.; Tape, Christopher J.; Jodrell, Duncan I.; Murphy, Gillian] Univ Cambridge, Dept Oncol, Cambridge, England; [Tape, Christopher J.; Murphy, Gillian] Univ Cambridge, Proteases & Tumour Microenvironm Grp, Canc Res UK Cambridge Res Inst, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Richards, FM (corresponding author), Univ Cambridge, Pharmacol & Drug Dev Grp, Canc Res UK Cambridge Res Inst, Cambridge, England.	frances.richards@cancer.org.uk		Tape, Christopher/0000-0003-4712-2737	Cancer Research UK [C96/A8333]; Hutchison-Whampoa Ltd.; Cancer Research UK [15678] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Hutchison-Whampoa Ltd.; Cancer Research UK(Cancer Research UK)	The research work in this study was funded by Cancer Research UK (www.cancerresearchuk.org), grant number C96/A8333. Prof. Murphy's Chair was funded by a charitable donation to the Univerity of Cambridge by Hutchison-Whampoa Ltd. She is not an employee of Hutchison Whampoa, and Hutchison Whampoa have no commercial interests in any of the authors' research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanious H, 2011, BLOOD, V117, P6237, DOI 10.1182/blood-2010-10-313940; Baumgart A, 2010, CANCER RES, V70, P5368, DOI 10.1158/0008-5472.CAN-09-3763; BENARD J, 1985, CANCER RES, V45, P4970; Bissett D, 2005, J CLIN ONCOL, V23, P842, DOI 10.1200/JCO.2005.03.170; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brown ER, 2008, ANN ONCOL, V19, P1340, DOI 10.1093/annonc/mdn054; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Georgopoulos S, 1996, J INFLAMM, V46, P86; Ghetie V, 2004, CANC DRUG DISC DEV, P475; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hassan MI, 1999, ANTICANCER RES, V19, P5657; Heath EI, 2001, CANCER CHEMOTH PHARM, V48, P269, DOI 10.1007/s002800100330; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Hirte H, 2006, GYNECOL ONCOL, V102, P300, DOI 10.1016/j.ygyno.2005.12.020; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; KENNEL SJ, 1991, CANCER RES, V51, P1529; Kornfeld JW, 2011, BRIT J CANCER, V104, P138, DOI 10.1038/sj.bjc.6606017; Kulbe H, 2011, CANC RES; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kyula JN, 2010, CLIN CANCER RES, V16, P3378, DOI 10.1158/1078-0432.CCR-10-0014; Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Lin P., 2011, MOL CELL BIOCH; Madhusudan S, 2005, J CLIN ONCOL, V23, P5950, DOI 10.1200/JCO.2005.04.127; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Mezyk-Kopec R, 2009, CYTOKINE, V46, P309, DOI 10.1016/j.cyto.2009.03.002; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; Narita D, 2012, ACTA HISTOCHEM, V114, P131, DOI 10.1016/j.acthis.2011.03.009; NAYLOR MS, 1993, J CLIN INVEST, V91, P2194, DOI 10.1172/JCI116446; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Qian MX, 2007, DRUG METAB DISPOS, V35, P1916, DOI 10.1124/dmd.107.015933; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Salako MA, 2011, MOL THER, V19, P490, DOI 10.1038/mt.2010.247; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schmuck R, 2011, AM J PATHOL, V178, P1792, DOI 10.1016/j.ajpath.2010.12.043; Sinnathamby G, 2011, CLIN EXP IMMUNOL, V163, P324, DOI 10.1111/j.1365-2249.2010.04298.x; Sparano JA, 2004, J CLIN ONCOL, V22, P4683, DOI 10.1200/JCO.2004.08.054; Stokes A, 2010, CLIN CANCER RES, V16, P2022, DOI 10.1158/1078-0432.CCR-09-2525; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Thabet MM, 2006, CURR OPIN INVEST DR, V7, P1014; Van Schaeybroeck S, 2011, CANCER RES, V71, P1071, DOI 10.1158/0008-5472.CAN-10-0714; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zheng X, 2011, MOL CARCINOG; Zheng X, 2009, CANCER BIOL THER, V8, P1045, DOI 10.4161/cbt.8.11.8539; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	61	62	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40597	10.1371/journal.pone.0040597	http://dx.doi.org/10.1371/journal.pone.0040597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792380	gold, Green Submitted, Green Published			2022-12-25	WOS:000306362400078
J	Wang, ZG; Zhang, ZQ; Jiao, Q; Liao, W; Chen, GH; Sun, KJ; Shen, LF; Wang, MX; Li, K; Liu, YJ; Lu, GM				Wang, Zhengge; Zhang, Zhiqiang; Jiao, Qing; Liao, Wei; Chen, Guanghui; Sun, Kangjian; Shen, Lianfang; Wang, Maoxue; Li, Kai; Liu, Yijun; Lu, Guangming			Impairments of Thalamic Nuclei in Idiopathic Generalized Epilepsy Revealed by a Study Combining Morphological and Functional Connectivity MRI	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; STRUCTURAL CONNECTIVITY; ABSENCE SEIZURES; BASAL GANGLIA; GLOBAL SIGNAL; STATE; NETWORKS; CORTEX; LOBE; EEG	Objective: Neuroimaging evidence suggested that the thalamic nuclei may play different roles in the progress of idiopathic generalized epilepsy (IGE). This study aimed to demonstrate the alterations in morphometry and functional connectivity in the thalamic nuclei in IGE. Methods: Fifty-two patients with IGE characterized by generalized tonic-clonic seizures and 67 healthy controls were involved in the study. The three-dimensional high-resolution T1-weighted MRI data were acquired for voxel-based morphometry (VBM) analysis, and resting-state blood-oxygenation level functional MRI data were acquired for functional connectivity analysis. The thalamic nuclei of bilateral medial dorsal nucleus (MDN) and pulvinar, as detected with decreased gray matter volumes in patients with IGE through VBM analysis, were selected as seed regions for functional connectivity analysis. Results: Different alteration patterns were found in functional connectivity of the thalamic nuclei with decreased gray matter volumes in IGE. Seeding at the MDN, decreased connectivity in the bilateral orbital frontal cortex, caudate nucleus, putamen and amygdala were found in the patients (P<0.05 with correction). However, seeding at the pulvinar, no significant alteration of functional connectivity was found in the patients (P<0.05 with correction). Conclusions: Some specific impairment of thalamic nuclei in IGE was identified using morphological and functional connectivity MRI approaches. These findings may strongly support the different involvement of the thalamocortical networks in IGE.	[Wang, Zhengge; Zhang, Zhiqiang; Jiao, Qing; Shen, Lianfang; Wang, Maoxue; Lu, Guangming] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China; [Chen, Guanghui] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Sun, Kangjian] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Li, Kai] Suzhou Univ, Dept Pharmacol, Suzhou 215006, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	Nanjing University; Nanjing University; Nanjing University; Hangzhou Normal University; Hangzhou Normal University; Soochow University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wang, ZG (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China.	cjr.luguangming@vip.163.com			Natural Science Foundation of China [30800264, 30971019, 90820006, 81020108022, 61035006]; Key Program [10Z026, BWS11J063]; Grants for Young Scholars in Jinling Hospital [Q2008063, 2011060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program; Grants for Young Scholars in Jinling Hospital	This work was supported by Natural Science Foundation of China (Grant nos. 30800264, 30971019, 90820006, 81020108022 and 61035006); Key Program (Grant nos. 10Z026, BWS11J063); and Grants for Young Scholars in Jinling Hospital (Grant nos. Q2008063, 2011060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelu-Paz R, 2008, J PSYCHIATR NEUROSCI, V33, P489; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bai XX, 2010, J NEUROSCI, V30, P5884, DOI 10.1523/JNEUROSCI.5101-09.2010; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bernhardt BC, 2009, NEUROIMAGE, V46, P373, DOI 10.1016/j.neuroimage.2009.01.055; Boyd JG, 2010, NEUROLOGY, V74, P1003, DOI 10.1212/WNL.0b013e3181d5dc4f; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Deransart C, 2002, EPILEPTIC DISORD, V4, pS61; Deransart C, 1998, EPILEPSY RES, V32, P213, DOI 10.1016/S0920-1211(98)00053-9; Eckert U, 2011, HUM BRAIN MAPP; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Hodaie M, 2006, BRAIN RES, V1115, P1, DOI 10.1016/j.brainres.2006.07.085; Huang W, 2011, J NEURORADIOLOGY, V38, P298, DOI 10.1016/j.neurad.2010.12.007; Kato K, 2008, NEUROL MED-CHIR, V48, P285, DOI 10.2176/nmc.48.285; Lehericy S, 2002, EPILEPTIC DISORD, V4, pS23; Liao W., 2010, PLOS ONE, V5; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Luo C, 2011, HUM BRAIN MAPP; Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x; Mattson RH, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s.2.3.x; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Moeller F, 2011, EPILEPSIA, V52, P515, DOI 10.1111/j.1528-1167.2010.02938.x; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Pulsipher DT, 2011, NEUROLOGY, V76, P28, DOI 10.1212/WNL.0b013e318203e8f3; Rosenberg DS, 2006, EPILEPSIA, V47, P98, DOI 10.1111/j.1528-1167.2006.00375.x; Song M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017294; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Strigaro G, 2012, EPILEPSIA; Tyvaert L, 2009, NEUROLOGY, V73, P2018, DOI 10.1212/WNL.0b013e3181c55d02; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Yasuda CL, 2010, EXPERT REV NEUROTHER, V10, P975, DOI 10.1586/ERN.10.63; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhang ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028817; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	44	51	54	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39701	10.1371/journal.pone.0039701	http://dx.doi.org/10.1371/journal.pone.0039701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808050	gold, Green Submitted, Green Published			2022-12-25	WOS:000306362400016
J	Zheng, YL; Huo, DZ; Zhang, J; Yoshimatsu, TF; Niu, Q; Olopade, OI				Zheng, Yonglan; Huo, Dezheng; Zhang, Jing; Yoshimatsu, Toshio F.; Niu, Qun; Olopade, Olufunmilayo I.			Microsatellites in the Estrogen Receptor (ESR1, ESR2) and Androgen Receptor (AR) Genes and Breast Cancer Risk in African American and Nigerian Women	PLOS ONE			English	Article							CAG REPEAT POLYMORPHISM; SUSCEPTIBILITY LOCI; BREAST/OVARIAN CANCER; MUTATION CARRIERS; NO ASSOCIATION; ALPHA GENE; LENGTH; POPULATION; EXON-1; BETA	Genetic variants in hormone receptor genes may be crucial predisposing factors for breast cancer, and microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes have been suggested to play a role. We studied 258 African-American (AA) women with breast cancer and 259 hospital-based controls, as well as 349 Nigerian (NG) female breast cancer patients and 296 community controls. Three microsatellites, ESR1_TA, ESR2_CA and AR_CAG, in the ESR1, ESR2 and AR genes, respectively, were genotyped. Their repeat lengths were then analyzed as continuous and dichotomous variables. Analyses of continuous variables showed no association with breast cancer risk in either AA or NG at ESR1_TA; AA cases had shorter repeats in the long allele of ESR2_CA than AA controls (Mann-Whitney P = 0.036; logistic regression P = 0.04, OR = 0.91, 95% CI 0.83-1.00), whereas NG patients had longer repeats in the short allele than NG controls (Mann-Whitney P = 0.0018; logistic regression P = 0.04, OR = 1.06, 95% CI 1.00-1.11); and AA cases carried longer repeats in the short allele of AR_CAG than AA controls (Mann-Whitney P = 0.038; logistic regression P = 0.03, OR = 1.08, 95% CI 1.01-1.15). When allele sizes were categorized as dichotomous variables, we discovered that women with two long alleles of ESR2_CA had increased risk of breast cancer (OR = 1.38, 95% CI 1.10-1.74; P = 0.006). This is the first study to investigate these three microsatellites in hormonal receptor genes in relation to breast cancer risk in an indigenous African population. After adjusting for multiple-testing, our findings suggest that ESR2_CA is associated with breast cancer risk in Nigerian women, whereas ESR1_TA and AR_CAG seem to have no association with the disease among African American or Nigerian women.	[Zheng, Yonglan; Zhang, Jing; Yoshimatsu, Toshio F.; Niu, Qun; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, Chicago, IL 60637 USA; [Huo, Dezheng] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Zheng, YL (corresponding author), Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, 5841 S Maryland Ave, Chicago, IL 60637 USA.	folopade@medicine.bsd.uchicago.edu	Yoshimatsu, Toshio F./HDN-6928-2022; Zheng, Yonglan/C-4236-2011; Zheng, Yonglan/O-4112-2019	Yoshimatsu, Toshio F./0000-0003-2674-8159; Zheng, Yonglan/0000-0001-6597-7072	National Cancer Institute at the National Institutes of Health [R01 CA142996-01, P50 CA125183]; Entertainment Industry Foundation; Falk Medical Research Trust; Susan G. Komen for the Cure; NATIONAL CANCER INSTITUTE [R01CA142996, P50CA125183] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Entertainment Industry Foundation; Falk Medical Research Trust; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute at the National Institutes of Health (R01 CA142996-01 and P50 CA125183), the Entertainment Industry Foundation, the Falk Medical Research Trust, and Susan G. Komen for the Cure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, INT J CANCER, V126, P2935, DOI 10.1002/ijc.24892; Anghel A, 2006, J CANCER RES CLIN, V132, P727, DOI 10.1007/s00432-006-0121-9; Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; BERNSTEIN L, 1993, EPIDEMIOL REV, V15, P48, DOI 10.1093/oxfordjournals.epirev.a036116; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Calvo RM, 2000, J CLIN ENDOCR METAB, V85, P1735, DOI 10.1210/jc.85.4.1735; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Chintamani, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-64; Cox DG, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1602; Dagan E, 2002, EUR J HUM GENET, V10, P724, DOI 10.1038/sj.ejhg.5200880; Dunning AM, 1999, CARCINOGENESIS, V20, P2131, DOI 10.1093/carcin/20.11.2131; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Elhaji YA, 2001, BREAST CANCER RES TR, V70, P109, DOI 10.1023/A:1012942910375; Forsti A, 2003, BREAST CANCER RES TR, V79, P409, DOI 10.1023/A:1024020609833; Fytili P, 2005, CLIN GENET, V68, P268, DOI 10.1111/j.1399-0004.2005.00495.x; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Giguere Y, 2001, CANCER RES, V61, P5869; Gilbert Samuel F, 2011, Breast Dis, V33, P17, DOI 10.3233/BD-2010-0323; Gilbert SF, 2011, BREAST CANCER RES TR, V129, P575, DOI 10.1007/s10549-011-1510-6; Given HF, 2000, EUR J CANCER, V36, P533, DOI 10.1016/S0959-8049(99)00310-X; Gonzalez A, 2007, EUR J CANCER, V43, P2373, DOI 10.1016/j.ejca.2007.07.001; Haiman CA, 2002, CANCER RES, V62, P1045; Hankinson Susan E., 2010, Hormones & Cancer, V1, P2, DOI 10.1007/s12672-009-0003-0; Hietala M, 2011, MOL GENET METAB, V102, P82, DOI 10.1016/j.ymgme.2010.09.006; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Iobagiu C, 2006, BREAST CANCER RES TR, V95, P153, DOI 10.1007/s10549-005-9060-4; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kadouri L, 2001, BRIT J CANCER, V85, P36, DOI 10.1054/bjoc.2001.1777; Kristiansen M, 2002, J MED GENET, V39, P30, DOI 10.1136/jmg.39.1.30; Lamp M, 2011, GYNECOL ENDOCRINOL, V27, P425, DOI 10.3109/09513590.2010.495434; Liede A, 2003, CANCER EPIDEM BIOMAR, V12, P848; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; MacLean HE, 2004, BREAST CANCER RES TR, V88, P239, DOI 10.1007/s10549-004-0781-6; Maggiolini M, 1999, CANCER RES, V59, P4864; Mehdipour P, 2011, BREAST J, V17, P39, DOI 10.1111/j.1524-4741.2010.01031.x; Menin C, 2001, CANCER LETT, V168, P31, DOI 10.1016/S0304-3835(01)00473-6; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Rajender S, 2011, BREAST CANCER RES TR, V127, P751, DOI 10.1007/s10549-010-1263-7; Rebbeck TR, 1999, AM J HUM GENET, V64, P1371, DOI 10.1086/302366; Russo J, 2004, TRENDS ENDOCRIN MET, V15, P211, DOI 10.1016/j.tem.2004.05.007; Sakoda LC, 2011, CANCER EPIDEMIOL, V35, P48, DOI 10.1016/j.canep.2010.08.005; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slattery ML, 2007, BREAST CANCER RES TR, V105, P327, DOI 10.1007/s10549-006-9453-z; Spurdle AB, 2005, BREAST CANCER RES, V7, pR176, DOI 10.1186/bcr971; Spurdle AB, 1999, JNCI-J NATL CANCER I, V91, P961, DOI 10.1093/jnci/91.11.961; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Suter NM, 2003, CANCER EPIDEM BIOMAR, V12, P127; Syrjakoski K, 2003, BREAST CANCER RES TR, V77, P167, DOI 10.1023/A:1021369508561; Tsezou A, 2008, BREAST, V17, P159, DOI 10.1016/j.breast.2007.08.007; Wang W, 2005, CANCER EPIDEM BIOMAR, V14, P2990, DOI 10.1158/1055-9965.EPI-05-0310; Wedren S, 2004, BREAST CANCER RES, V6, pR437, DOI 10.1186/bcr811; Wedren S, 2007, CANCER EPIDEM BIOMAR, V16, P1775, DOI 10.1158/1055-9965.EPI-06-1096; Wu MH, 2008, EUR J CANCER PREV, V17, P317, DOI 10.1097/CEJ.0b013e3282f75e7f; Young IE, 2000, J MED GENET, V37, P139, DOI 10.1136/jmg.37.2.139; Yu H, 2000, BREAST CANCER RES TR, V59, P153, DOI 10.1023/A:1006356502820; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	57	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40494	10.1371/journal.pone.0040494	http://dx.doi.org/10.1371/journal.pone.0040494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792352	Green Submitted, gold, Green Published			2022-12-25	WOS:000306362400063
J	Morales, J; Gunther, G; Zanocco, AL; Lemp, E				Morales, Javier; Guenther, German; Zanocco, Antonio L.; Lemp, Else			Singlet Oxygen Reactions with Flavonoids. A Theoretical - Experimental Study	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; CHEMICAL-REACTIVITY; QUENCHING REACTION; CHEMISTRY; FOOD	Detection of singlet oxygen emission, lambda(max) = 1270 nm, following laser excitation and steady-state methods were employed to measure the total reaction rate constant, k(T), and the reactive reaction rate constant, k(r), for the reaction between singlet oxygen and several flavonoids. Values of k(T) determined in deuterated water, ranging from 2.4x10(7) M(-1)s(-1) to 13.4x10(7) M(-1)s(-1), for rutin and morin, respectively, and the values measured for k(r), ranging from 2.8x10(5) M(-1)s(-1) to 65.7x10(5) M(-1)s(-1) for kaempferol and morin, respectively, being epicatechin and catechin chemically unreactive. These results indicate that all the studied flavonoids are good quenchers of singlet oxygen and could be valuable antioxidants in systems under oxidative stress, in particular if a flavonoid-rich diet was previously consumed. Analysis of the dependence of rate constant values with molecular structure in terms of global descriptors and condensed Fukui functions, resulting from electronic structure calculations, supports the formation of a charge transfer exciplex in all studied reactions. The fraction of exciplex giving reaction products evolves through a hydroperoxide and/or an endoperoxide intermediate produced by singlet oxygen attack on the double bond of the ring C of the flavonoid.	[Morales, Javier] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias & Tecnol Farmaceut, Santiago, Chile; [Guenther, German; Zanocco, Antonio L.; Lemp, Else] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fis Quim, Santiago, Chile	Universidad de Chile; Universidad de Chile	Morales, J (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias & Tecnol Farmaceut, Santiago, Chile.	elemp@ciq.uchile.cl	Gunther, German/I-1028-2013	Gunther, German/0000-0002-4733-8426; Morales Valenzuela, Javier Eduardo/0000-0002-9880-2567; ZANOCCO, ANTONIO/0000-0002-6521-5382	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090267]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico grant 1090267. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker EM, 2004, EUR FOOD RES TECHNOL, V219, P561, DOI 10.1007/s00217-004-1012-4; Bodamyali T, 2000, PROG INFLAM RES, P11; Briviba K, 1997, BIOL CHEM, V378, P1259; Briviba K, 2000, METHOD ENZYMOL, V319, P222; Castro-Olivares R, 2009, J PHOTOCH PHOTOBIO A, V207, P160, DOI 10.1016/j.jphotochem.2009.05.012; Chamorro E, 2005, J CHEM PHYS, V123; Contreras RR, 1999, CHEM PHYS LETT, V304, P405, DOI 10.1016/S0009-2614(99)00325-5; Cren-Olive C, 2002, J AM CHEM SOC, V124, P14027, DOI 10.1021/ja0262434; Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13&lt;1925::AID-JSFA714&gt;3.0.CO;2-4; Frisch M. J., 2009, GAUSSIAN 09 REVISION; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; Galleano M, 2010, ARCH BIOCHEM BIOPHYS, V501, P23, DOI 10.1016/j.abb.2010.04.005; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; HALLIWELL B, 1995, BIOCHEM PHARMACOL, V49, P1341, DOI 10.1016/0006-2952(95)00088-H; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Hulten LM, 1999, FREE RADICAL BIO MED, V27, P1203; Kawanishi S, 2002, FREE RADICAL BIO MED, V32, P822, DOI 10.1016/S0891-5849(02)00779-7; Manach C, 1998, FEBS LETT, V426, P331, DOI 10.1016/S0014-5793(98)00367-6; MATSUURA T, 1970, TETRAHEDRON, V26, P435, DOI 10.1016/S0040-4020(01)97840-8; Mendoza-Wilson AM, 2006, J MOL STRUC-THEOCHEM, V761, P97, DOI 10.1016/j.theochem.2006.01.001; Mendoza-Wilson AM, 2005, J MOL STRUC-THEOCHEM, V716, P67, DOI 10.1016/j.theochem.2004.10.083; Mukai K, 2005, FREE RADICAL BIO MED, V39, P752, DOI 10.1016/j.freeradbiomed.2005.04.027; Nagai S, 2005, J PHYS CHEM B, V109, P4234, DOI 10.1021/jp0451389; Parr R. G., 1989, INT SERIES MONOGRAPH, V16; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; Payan-Gomez SA, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-12; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Roginsky V, 2005, FOOD CHEM, V92, P235, DOI 10.1016/j.foodchem.2004.08.004; Sachidanandam K, 2005, CARDIOVASC DRUG REV, V23, P115; Sies H, 2010, ARCH BIOCHEM BIOPHYS, V501, P2, DOI 10.1016/j.abb.2010.04.006; Stief TW, 2003, MED HYPOTHESES, V60, P567, DOI 10.1016/S0306-9877(03)00026-4; Tiznado W, 2005, J PHYS CHEM A, V109, P3220, DOI 10.1021/jp0450787; TOURNAIRE C, 1993, J PHOTOCH PHOTOBIO B, V19, P205, DOI 10.1016/1011-1344(93)87086-3	35	46	48	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40548	10.1371/journal.pone.0040548	http://dx.doi.org/10.1371/journal.pone.0040548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802966	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500054
J	Gill, RS; Lee, TF; Liu, JQ; Chaudhary, H; Brocks, DR; Bigam, DL; Cheung, PY				Gill, Richdeep S.; Lee, Tze-Fun; Liu, Jiang-Qin; Chaudhary, Hetal; Brocks, Dion R.; Bigam, David L.; Cheung, Po-Yin			Cyclosporine Treatment Reduces Oxygen Free Radical Generation and Oxidative Stress in the Brain of Hypoxia-Reoxygenated Newborn Piglets	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; N-ACETYLCYSTEINE IMPROVES; ISCHEMIC ENCEPHALOPATHY; DOSE-RESPONSE; CELL-DEATH; 100-PERCENT OXYGEN; CEREBRAL HYPOXIA; INJURY; NIM811; RATS	Oxygen free radicals have been implicated in the pathogenesis of hypoxic-ischemic encephalopathy. It has previously been shown in traumatic brain injury animal models that treatment with cyclosporine reduces brain injury. However, the potential neuroprotective effect of cyclosporine in asphyxiated neonates has yet to be fully studied. Using an acute newborn swine model of hypoxia-reoxygenation, we evaluated the effects of cyclosporine on the brain, focusing on hydrogen peroxide (H2O2) production and markers of oxidative stress. Piglets (1-4 d, 1.4-2.5 kg) were block-randomized into three hypoxia-reoxygenation experimental groups (2 h hypoxia followed by 4 h reoxygenation)(n = 8/group). At 5 min after reoxygenation, piglets were given either i.v. saline (placebo, controls) or cyclosporine (2.5 or 10 mg/kg i.v. bolus) in a blinded-randomized fashion. An additional sham-operated group (n = 4) underwent no hypoxia-reoxygenation. Systemic hemodynamics, carotid arterial blood flow (transit-time ultrasonic probe), cerebral cortical H2O2 production (electrochemical sensor), cerebral tissue glutathione (ELISA) and cytosolic cytochrome-c (western blot) levels were examined. Hypoxic piglets had cardiogenic shock (cardiac output 40-48% of baseline), hypotension (mean arterial pressure 27-31 mmHg) and acidosis (pH 7.04) at the end of 2 h of hypoxia. Post-resuscitation cyclosporine treatment, particularly the higher dose (10 mg/kg), significantly attenuated the increase in cortical H2O2 concentration during reoxygenation, and was associated with lower cerebral oxidized glutathione levels. Furthermore, cyclosporine treatment significantly attenuated the increase in cortical cytochrome-c and lactate levels. Carotid blood arterial flow was similar among groups during reoxygenation. Conclusively, post-resuscitation administration of cyclosporine significantly attenuates H2O2 production and minimizes oxidative stress in newborn piglets following hypoxia-reoxygenation.	[Gill, Richdeep S.; Bigam, David L.; Cheung, Po-Yin] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Lee, Tze-Fun; Liu, Jiang-Qin; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Chaudhary, Hetal; Brocks, Dion R.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	University of Alberta; University of Alberta; University of Alberta	Gill, RS (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	poyin@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health Research [MOP53116]; Women and Children's Health Research Institute at the University of Alberta; Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada; Alberta Innovates Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute at the University of Alberta; Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada; Alberta Innovates Health Solutions	This work was supported by Canadian Institutes of Health Research, MOP53116, www.cihr-irsc.ca, the Women and Children's Health Research Institute at the University of Alberta, www.wchri.srv.ualberta.ca (operating funds), the Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada and the Alberta Innovates Health Solutions (salary awards to Dr. Richdeep S. Gill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri B, 1999, ACT NEUR S, V75, P21; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; dos Santos AB, 2009, TOXICON, V54, P16, DOI 10.1016/j.toxicon.2009.03.004; Frantseva MV, 2001, FREE RADICAL BIO MED, V31, P1216, DOI 10.1016/S0891-5849(01)00705-5; Gratton R, 1996, J SOC GYNECOL INVEST, V3, P60, DOI 10.1016/1071-5576(95)00047-X; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Jacobs SE, 2010, J PAEDIATR CHILD H, V46, P568, DOI 10.1111/j.1440-1754.2010.01880.x; Jacobson J, 2002, J CELL SCI, V115, P1175; Johnson ST, 2007, SHOCK, V28, P484, DOI 10.1097/shk.0b013e31804f775d; Joynt C, 2009, SHOCK, V31, P292, DOI 10.1097/SHK.0b013e31817fd752; Kanduru SV, 2010, BIOMED CHROMATOGR, V24, P148, DOI 10.1002/bmc.1263; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kutzsche S, 1999, BIOL NEONATE, V76, P153, DOI 10.1159/000014155; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lee TF, 2008, INTENS CARE MED, V34, P190, DOI 10.1007/s00134-007-0880-z; Leger PL, 2011, EXP NEUROL, V230, P58, DOI 10.1016/j.expneurol.2010.06.009; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; Martin LJ, 1997, J COMP NEUROL, V377, P262, DOI 10.1002/(SICI)1096-9861(19970113)377:2<262::AID-CNE8>3.0.CO;2-1; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Nakai A, 2004, PEDIATR NEUROL, V30, P247, DOI 10.1016/j.pediatrneurol.2003.09.006; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Pacheco-Lopez G, 2012, INT J NEUROPSYCHOPH, V5, P1; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; Puka-Sundvall M, 2001, DEV NEUROSCI-BASEL, V23, P192, DOI 10.1159/000046142; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rodrigo J, 2005, FREE RADICAL BIO MED, V39, P26, DOI 10.1016/j.freeradbiomed.2005.02.010; Segawa D, 1998, J THORAC CARDIOV SUR, V115, P925, DOI 10.1016/S0022-5223(98)70375-7; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Vannucci RC, 2000, AM J PERINAT, V17, P113, DOI 10.1055/s-2000-9293; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zuckerman SL, 1992, HEART CIRC PHYSL, V35, pH2198	40	10	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40471	10.1371/journal.pone.0040471	http://dx.doi.org/10.1371/journal.pone.0040471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792343	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700054
J	Lee, WT; Lin, MH; Lee, EJ; Hung, YC; Tai, SH; Chen, HY; Chen, TY; Wu, TS				Lee, Wei-Ting; Lin, Miao-Hui; Lee, E-Jian; Hung, Yu-Chang; Tai, Shih-Huang; Chen, Hung-Yi; Chen, Tsung-Ying; Wu, Tian-Shung			Magnolol Reduces Glutamate-Induced Neuronal Excitotoxicity and Protects against Permanent Focal Cerebral Ischemia Up to 4 Hours	PLOS ONE			English	Article							STROKE-INDUCED EPILEPSY; IN-VITRO MODEL; INDUCED EPILEPTOGENESIS; DOSE-RESPONSE; RATS; CALCIUM; INJURY; NEUROPROTECTION; NEUROTOXICITY; OFFICINALIS	Neuroprotective efficacy of magnolol, 5,5'-dially-2,2'-dihydroxydiphenyl, was investigated in a model of stroke and cultured neurons exposed to glutamate-induced excitotoxicity. Rats were subjected to permanent middle cerebral artery occlusion (pMCAO). Magnolol or vehicle was administered intraperitoneally, at 1 hr pre-insult or 1-6 hrs post-insult. Brain infarction was measured upon sacrifice. Relative to controls, animals pre-treated with magnolol (50-200 mg/kg) had significant infarct volume reductions by 30.9-37.8% and improved neurobehavioral outcomes (P<0.05, respectively). Delayed treatment with magnolol (100 mg/kg) also protected against ischemic brain damage and improved neurobehavioral scores, even when administered up to 4 hrs post-insult (P < 0.05, respectively). Additionally, magnolol (0.1 mu M) effectively attenuated the rises of intracellular Ca2+ levels, [Ca2+](i), in cultured neurons exposed to glutamate. Consequently, magnolol (0.1-1 mu M) significantly attenuated glutamate-induced cytotoxicity and cell swelling (P<0.05). Thus, magnolol offers neuroprotection against permanent focal cerebral ischemia with a therapeutic window of 4 hrs. This neuroprotection may be, partly, mediated by its ability to limit the glutamate-induced excitotoxicity.	[Lee, Wei-Ting; Lee, E-Jian; Hung, Yu-Chang; Tai, Shih-Huang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Neurophysiol Lab,Neurosurg Serv,Dept Surg, Tainan 70101, Taiwan; [Lee, Wei-Ting] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Lin, Miao-Hui] Natl Univ Tainan, Dept Early Childhood Educ, Tainan, Taiwan; [Chen, Hung-Yi] China Med Univ, Inst Pharm, Taichung, Taiwan; [Chen, Tsung-Ying] Buddhist Tzu Chi Gen Hosp, Hualien, Taiwan; [Chen, Tsung-Ying] Buddhist Tzu Chi Univ, Dept Anesthesiol, Hualien, Taiwan; [Wu, Tian-Shung] Natl Cheng Kung Univ, Inst Chem, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National University Tainan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; National Cheng Kung University	Lee, WT (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Neurophysiol Lab,Neurosurg Serv,Dept Surg, Tainan 70101, Taiwan.	ejian@mail.ncku.edu.tw		Chen, Tsung-Ying/0000-0002-2029-5550	National Cheng Kung University Hospital (NCKUH) [90-039]; National Science Council of Taiwan (NSC) [99-2314-B-006-022-MY3]	National Cheng Kung University Hospital (NCKUH); National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Cheng Kung University Hospital (NCKUH No. 90-039) and the National Science Council of Taiwan (NSC No. 99-2314-B-006-022-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CP, 2003, CLIN EXP PHARMACOL P, V30, P387, DOI 10.1046/j.1440-1681.2003.03847.x; Chen HY, 2009, PHYTOMEDICINE, V16, P976, DOI 10.1016/j.phymed.2009.03.001; Chen HY, 2009, J PINEAL RES, V47, P260, DOI 10.1111/j.1600-079X.2009.00709.x; Chen TY, 2012, CRIT CARE MED, V40, P532, DOI 10.1097/CCM.0b013e31822f0b08; Chen TY, 2011, CRIT CARE MED, V39, P1130, DOI 10.1097/CCM.0b013e31820a9442; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clemens JA, 2000, FREE RADICAL BIO MED, V28, P1526, DOI 10.1016/S0891-5849(00)00258-6; DeLorenzo RJ, 2007, INT REV NEUROBIOL, V81, P59, DOI 10.1016/S0074-7742(06)81005-6; Fan J, 2010, J NEUROCHEM, V115, P1045, DOI 10.1111/j.1471-4159.2010.06994.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HATFIELD RH, 1992, EUR J PHARMACOL, V216, P1, DOI 10.1016/0014-2999(92)90201-E; Hedrick MS, 2005, J EXP BIOL, V208, P681, DOI 10.1242/jeb.01436; Hsieh MT, 1998, CLIN EXP PHARMACOL P, V25, P813, DOI 10.1111/j.1440-1681.1998.tb02158.x; Lee EJ, 2009, EXP NEUROL, V217, P74, DOI 10.1016/j.expneurol.2009.01.019; Lee EJ, 2009, NEUROCHEM RES, V34, P1157, DOI 10.1007/s11064-008-9892-5; Lee EJ, 2005, FREE RADICAL BIO MED, V39, P495, DOI 10.1016/j.freeradbiomed.2005.04.004; Lee EJ, 2002, J NEUROSCI RES, V68, P636, DOI 10.1002/jnr.10251; Lee MM, 1998, NEUROREPORT, V9, P3451, DOI 10.1097/00001756-199810260-00021; Lin SP, 2011, PLANTA MED, V77, P1800, DOI 10.1055/s-0030-1271159; Lin YR, 2006, EUR J PHARMACOL, V537, P64, DOI 10.1016/j.ejphar.2006.03.035; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Ritz MF, 2008, BRAIN RES, V1239, P226, DOI 10.1016/j.brainres.2008.08.073; Sun DA, 2001, STROKE, V32, P2344, DOI 10.1161/hs1001.097242; Tai SH, 2011, J PINEAL RES, V50, P292, DOI 10.1111/j.1600-079X.2010.00839.x; Tai SH, 2010, J PINEAL RES, V49, P332, DOI 10.1111/j.1600-079X.2010.00797.x; TENG CM, 1990, LIFE SCI, V47, P1153, DOI 10.1016/0024-3205(90)90176-R; WATANABE K, 1983, PLANTA MED, V49, P103, DOI 10.1055/s-2007-969825; WILLIAMS DA, 1990, CELL CALCIUM, V11, P75, DOI 10.1016/0143-4160(90)90061-X; Yanamoto H, 2001, STROKE, V32, P232, DOI 10.1161/01.STR.32.1.232; Zhang M, 2010, NEUROSCIENCE, V166, P1083, DOI 10.1016/j.neuroscience.2010.01.030	32	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39952	10.1371/journal.pone.0039952	http://dx.doi.org/10.1371/journal.pone.0039952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808077	Green Submitted, gold, Green Published			2022-12-25	WOS:000306354700020
J	Villeger, S; Miranda, JR; Hernandez, DF; Mouillot, D				Villeger, Sebastien; Ramos Miranda, Julia; Flores Hernandez, Domingo; Mouillot, David			Low Functional beta-Diversity Despite High Taxonomic beta-Diversity among Tropical Estuarine Fish Communities	PLOS ONE			English	Article							SPECIES RICHNESS; PHYLOGENETIC STRUCTURE; NULL MODELS; ASSEMBLAGES; CONGRUENCE; CHALLENGES; CALIFORNIA; GRADIENTS; TURNOVER; PATTERNS	The concept of beta-diversity, defined as dissimilarity among communities, has been widely used to investigate biodiversity patterns and community assembly rules. However, in ecosystems with high taxonomic beta-diversity, due to marked environmental gradients, the level of functional beta-diversity among communities is largely overlooked while it may reveal processes shaping community structure. Here, decomposing biodiversity indices into alpha (local) and gamma (regional) components, we estimated taxonomic and functional beta-diversity among tropical estuarine fish communities, through space and time. We found extremely low functional beta-diversity values among fish communities (<1.5%) despite high dissimilarity in species composition and species dominance. Additionally, in contrast to the high alpha and gamma taxonomic diversities, alpha and gamma functional diversities were very close to the minimal value. These patterns were caused by two dominant functional groups which maintained a similar functional structure over space and time, despite the strong dissimilarity in taxonomic structure along environmental gradients. Our findings suggest that taxonomic and functional beta-diversity deserve to be quantified simultaneously since these two facets can show contrasting patterns and the differences can in turn shed light on community assembly rules.	[Villeger, Sebastien] Univ Toulouse 3, Lab Evolut & Diversite Biol, F-31062 Toulouse, France; [Ramos Miranda, Julia; Flores Hernandez, Domingo] Univ Autonoma Campeche, Ctr Ecol Pesquerias & Oceanog Golfo Mexico, Campeche, Mexico; [Mouillot, David] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Mouillot, David] Univ Montpellier 2, Montpellier, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; James Cook University; Universite de Montpellier	Villeger, S (corresponding author), Univ Toulouse 3, Lab Evolut & Diversite Biol, F-31062 Toulouse, France.	sebastien.villeger@univ-tlse3.fr	Villéger, Sébastien/AAW-9949-2021; Villéger, Sébastien/C-6272-2011	Villéger, Sébastien/0000-0002-2362-7178; Villéger, Sébastien/0000-0002-2362-7178	PICS-CNRS program; ANR project "BIODIVNEK"; CONACYT grant; Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; EU project BIOFRESH [Nu226874]	PICS-CNRS program; ANR project "BIODIVNEK"(French National Research Agency (ANR)); CONACYT grant(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); EU project BIOFRESH	This study was partially funded by a PICS-CNRS program and by the ANR project "BIODIVNEK". JRM and DFH benefited from a CONACYT grant. DM was supported by Marie Curie International Outgoing Fellowship (FISHECO) IOF-GA-2009-236316. SV was supported by the EU project BIOFRESH (7th Framework European program, Contract Nu226874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Blaber SJM, 2002, J FISH BIOL, V61, P1, DOI 10.1006/jfbi.2002.2063; Boyle KS, 2006, MAR ECOL PROG SER, V319, P65, DOI 10.3354/meps319065; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; David LT, 1998, CONT SHELF RES, V18, P1057, DOI 10.1016/S0278-4343(98)00033-8; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dumay O, 2004, J FISH BIOL, V64, P970, DOI 10.1111/j.1095-8649.2004.00365.x; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Irz P, 2007, GLOBAL ECOL BIOGEOGR, V16, P350, DOI 10.1111/j.1466-8238.2006.00290.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krasnov BR, 2010, INT J PARASITOL, V40, P807, DOI 10.1016/j.ijpara.2009.12.002; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mason NWH, 2007, OECOLOGIA, V153, P441, DOI 10.1007/s00442-007-0727-x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Munkemuller T, 2012, ECOGRAPHY IN PRESS; Pavoine S, 2009, ECOL LETT, V12, P898, DOI [10.1111/j.1461-0248.2009.01348.x, 10.1111/j.1461-0248.2009.01344.x]; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Qian H, 2009, ECOGRAPHY, V32, P553, DOI 10.1111/j.1600-0587.2008.05755.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; Sokol ER, 2011, AM NAT, V177, P630, DOI 10.1086/659625; Sosa-Lopez A, 2007, MAR ECOL PROG SER, V342, P217, DOI 10.3354/meps342217; Sosa-Lopez A, 2007, J BIOGEOGR, V34, P52, DOI 10.1111/j.1365-2699.2006.01588.x; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; SWENSON NG, 2010, P BIOL SCI, V0278; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Villeger S, 2008, J ECOL, V96, P845, DOI 10.1111/j.1365-2745.2007.01351.x; Villeger S, 2008, MAR ECOL PROG SER, V364, P135, DOI 10.3354/meps07471; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046	47	99	103	7	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40679	10.1371/journal.pone.0040679	http://dx.doi.org/10.1371/journal.pone.0040679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792395	Green Published, Green Accepted, gold			2022-12-25	WOS:000306354700063
J	Xu, W; Lan, Q; Chen, MG; Chen, H; Zhu, N; Zhou, XH; Wang, J; Fan, HM; Yan, CS; Kuang, JL; Warburton, D; Togbe, D; Ryffel, B; Zheng, SG; Shi, W				Xu, Wei; Lan, Qin; Chen, Maogen; Chen, Hui; Zhu, Ning; Zhou, Xiaohui; Wang, Julie; Fan, Huimin; Yan, Chun-Song; Kuang, Jiu-Long; Warburton, David; Togbe, Dieudonnee; Ryffel, Bernhard; Zheng, Song-Guo; Shi, Wei			Adoptive Transfer of Induced-Treg Cells Effectively Attenuates Murine Airway Allergic Inflammation	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; CUTTING EDGE; EX-VIVO; ASTHMA; FOXP3; SUPPRESS; DISEASE; IL-2	Both nature and induced regulatory T (Treg) lymphocytes are potent regulators of autoimmune and allergic disorders. Defects in endogenous Treg cells have been reported in patients with allergic asthma, suggesting that disrupted Treg cell-mediated immunological regulation may play an important role in airway allergic inflammation. In order to determine whether adoptive transfer of induced Treg cells generated in vitro can be used as an effective therapeutic approach to suppress airway allergic inflammation, exogenously induced Treg cells were infused into ovalbumin-sensitized mice prior to or during intranasal ovalbumin challenge. The results showed that adoptive transfer of induced Treg cells prior to allergen challenge markedly reduced airway hyperresponsiveness, eosinophil recruitment, mucus hyper-production, airway remodeling, and IgE levels. This effect was associated with increase of Treg cells (CD4(+)FoxP3(+)) and decrease of dendritic cells in the draining lymph nodes, and with reduction of Th1, Th2, and Th17 cell response as compared to the controls. Moreover, adoptive transfer of induced Treg cells during allergen challenge also effectively attenuate airway inflammation and improve airway function, which are comparable to those by natural Treg cell infusion. Therefore, adoptive transfer of in vitro induced Treg cells may be a promising therapeutic approach to prevent and treat severe asthma.	[Xu, Wei; Chen, Hui; Warburton, David; Shi, Wei] Childrens Hosp Los Angeles, Dept Surg, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Lan, Qin; Chen, Maogen; Zhu, Ning; Zhou, Xiaohui; Wang, Julie; Zheng, Song-Guo] Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA; [Lan, Qin; Zhou, Xiaohui; Fan, Huimin] Tongji Univ, Inst Immunol, Shanghai E Hosp, Shanghai 200092, Peoples R China; [Xu, Wei; Yan, Chun-Song; Kuang, Jiu-Long] Nanchang Univ, Dept Resp Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Togbe, Dieudonnee; Ryffel, Bernhard] Univ Orleans, Orleans, France; [Togbe, Dieudonnee; Ryffel, Bernhard] CNRS, F-45071 Orleans, France	Children's Hospital Los Angeles; University of Southern California; Tongji University; Nanchang University; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS)	Xu, W (corresponding author), Childrens Hosp Los Angeles, Dept Surg, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	szheng@usc.edu; wshi@chla.usc.edu	Warburton, David/AAD-5709-2020; Maogen, Chen/AAN-1551-2021; Togbe, Dieudonnee/AAE-1135-2020	Maogen, Chen/0000-0001-9319-5334; Togbe, Dieudonnee/0000-0001-6658-414X	National Institutes of Health (NIH) [HL109932, HL068597]; Webb Foundation [(WS)NIH AR059103]; American College of Rheumatology; Arthritis Foundation; California Institute of Regenerative Medicine Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109932, R01HL068597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Webb Foundation; American College of Rheumatology(General Electric); Arthritis Foundation; California Institute of Regenerative Medicine Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institutes of Health (NIH) HL109932 and HL068597, and Webb Foundation grant (WS)NIH AR059103, the American College of Rheumatology (Within Our Reach) and the Arthritis Foundation (SGZ). California Institute of Regenerative Medicine Training Grant (WX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2000, AM J RESP CRIT CARE, V162, P2295, DOI 10.1164/ajrccm.162.6.9912001; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Discombe G, 1946, LANCET, V1, P195; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fantini MC, 2006, GUT, V55, P671, DOI 10.1136/gut.2005.072801; Godebu E, 2008, J IMMUNOL, V181, P1798, DOI 10.4049/jimmunol.181.3.1798; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Larche M, 2007, CHEST, V132, P1007, DOI 10.1378/chest.06-2434; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Nguyen KD, 2009, J ALLERGY CLIN IMMUN, V123, P933, DOI 10.1016/j.jaci.2008.11.037; Richards IM, 1996, AM J PHYSIOL-LUNG C, V271, pL267, DOI 10.1152/ajplung.1996.271.2.L267; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; van Oosterhout AJM, 2005, EUR RESPIR J, V26, P918, DOI 10.1183/09031936.05.00011205; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Xue KY, 2007, J HUAZHONG U SCI-MED, V27, P31, DOI 10.1007/s11596-007-0109-y; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XH, 2010, J MOL CELL BIOL, V2, P164, DOI 10.1093/jmcb/mjq007	33	73	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40314	10.1371/journal.pone.0040314	http://dx.doi.org/10.1371/journal.pone.0040314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792275	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700035
J	Currylow, AF; MacGowan, BJ; Williams, RN				Currylow, Andrea F.; MacGowan, Brian J.; Williams, Rod N.			Short-Term Forest Management Effects on a Long-Lived Ectotherm	PLOS ONE			English	Article							TURTLES TERRAPENE-CAROLINA; AGED TIMBER HARVEST; BOX TURTLES; HOME-RANGE; AMPHIBIAN POPULATIONS; HABITAT FRAGMENTATION; MOVEMENT; REPTILES; THERMOREGULATION; TEMPERATURE	Timber harvesting has been shown to have both positive and negative effects on forest dwelling species. We examined the immediate effects of timber harvests (clearcuts and group selection openings) on ectotherm behavior, using the eastern box turtle as a model. We monitored the movement and thermal ecology of 50 adult box turtles using radiotelemetry from May-October for two years prior to, and two years following scheduled timber harvests in the Central Hardwoods Region of the U. S. Annual home ranges (7.45 ha, 100% MCP) did not differ in any year or in response to timber harvests, but were 33% larger than previous estimates (range 0.47-187.67 ha). Distance of daily movements decreased post-harvest (from 22 m +/- 1.2 m to 15 m +/- 0.9 m) whereas thermal optima increased (from 23 +/- 1 degrees C to 25 +/- 1 degrees C). Microclimatic conditions varied by habitat type, but monthly average temperatures were warmer in harvested areas by as much as 13 degrees C. Animals that used harvest openings were exposed to extreme monthly average temperatures (similar to 40 degrees C). As a result, the animals made shorter and more frequent movements in and out of the harvest areas while maintaining 9% higher body temperatures. This experimental design coupled with radiotelemetry and behavioral observation of a wild ectotherm population prior to and in response to anthropogenic habitat alteration is the first of its kind. Our results indicate that even in a relatively contiguous forested landscape with small-scale timber harvests, there are local effects on the thermal ecology of ectotherms. Ultimately, the results of this research can benefit the conservation and management of temperature-dependent species by informing effects of timber management across landscapes amid changing climates.	[Currylow, Andrea F.; MacGowan, Brian J.; Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Currylow, AF (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	a.currylow@gmail.com	Currylow, Andrea/J-5506-2014	Currylow, Andrea/0000-0003-1631-8964	Indiana Division of Forestry Grant [E-9-6-A558]; IDNR Division of Fish and Wildlife; Wildlife Diversity Section; State Wildlife Improvement Grant [E2-08-WDS15]	Indiana Division of Forestry Grant; IDNR Division of Fish and Wildlife; Wildlife Diversity Section; State Wildlife Improvement Grant	Funding for the project was provided by the Indiana Division of Forestry Grant #E-9-6-A558 and IDNR Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement Grant #E2-08-WDS15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Allard HA, 1935, SCI MON, V41, P325; ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Bayless JW, 1984, HOME RANGE STUDIES E; Bernstein NP, 2005, AM MIDL NAT, V153, P370, DOI 10.1674/0003-0031(2005)153[0370:TEOOOB]2.0.CO;2; BLEM CR, 1986, COMP BIOCHEM PHYS A, V85, P563, DOI 10.1016/0300-9629(86)90447-0; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; BRATTSTROM BH, 1965, AM MIDL NAT, V73, P376, DOI 10.2307/2423461; Breshears DD, 1998, INT J PLANT SCI, V159, P1010, DOI 10.1086/314083; BROOKS RJ, 1991, CAN J ZOOL, V69, P1314, DOI 10.1139/z91-185; Cadenasso ML, 2001, CONSERV BIOL, V15, P91, DOI 10.1046/j.1523-1739.2001.99309.x; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; CONGDON JD, 1989, J HERPETOL, V23, P179, DOI 10.2307/1564027; Crawford JA, 2008, ANIM CONSERV, V11, P369, DOI 10.1111/j.1469-1795.2008.00191.x; Cunnington GM, 2008, ECOSCIENCE, V15, P472, DOI 10.2980/15-4-3140; Currylow AF, 2011, AM MIDL NAT, V165, P143, DOI 10.1674/0003-0031-165.1.143; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; do Amaral JPS, 2002, CAN J ZOOL, V80, P934, DOI 10.1139/Z02-070; DODD CK, 2001, N AM BOX TURTLES NAT; Dolbeer RA, 1969, ASB B, V16; Donaldson BM, 2005, J HERPETOL, V39, P278, DOI 10.1670/0022-1511(2005)039[0278:AHURTH]2.0.CO;2; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; ERNST C H, 1974, Transactions of the Kentucky Academy of Science, V35, P27; ESRI, 2009, ARCGIS DESKTOP 9; Ferner JW, 2007, REV MARKING INDIVIDU; Fox S.F., 2003, LIZARD SOCIAL BEHAV; Fredericksen TS, 2000, J FOREST, V98, P4; Garcia JDD, 2007, BIODIVERS CONSERV, V16, P2949, DOI 10.1007/s10531-007-9154-x; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gibbs JP, 2005, CONSERV BIOL, V19, P552, DOI 10.1111/j.1523-1739.2005.000155.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Gitzen RA, 2007, FOREST ECOL MANAG, V251, P142, DOI 10.1016/j.foreco.2007.05.028; Goldstein MI, 2005, J WILDLIFE MANAGE, V69, P525, DOI 10.2193/0022-541X(2005)069[0525:SRORAA]2.0.CO;2; GOULD E, 1957, BIOL BULL, V112, P336, DOI 10.2307/1539126; Gram WK, 2003, CONSERV BIOL, V17, P1324, DOI 10.1046/j.1523-1739.2003.02171.x; Hallgren-Scaffidi L, 1986, HABITAT HOME RANGE P; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hocking DJ, 2008, J HERPETOL, V42, P689, DOI 10.1670/07-294R1.1; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; HUTCHISON VICTOR H., 1966, HERPETOLOGIA, V22, P32; Iglay RB, 2007, J HERPETOL, V41, P102, DOI 10.1670/0022-1511(2007)41[102:EBTTCC]2.0.CO;2; Kalb RA, NO FOREST E IN PRESS; Kipp RL, 2003, NESTING ECOLOGY E BO; Kroll JC, 1973, COMP PHYSL ECOLOGY E; MacGowan BJ, 2004, TURTLES INDIANA; MADDEN R. C., 1975, THESIS CITY U NEW YO; Marchand MN, 2004, CONSERV BIOL, V18, P758, DOI 10.1111/j.1523-1739.2004.00019.x; McLeod RF, 1998, AM MIDL NAT, V139, P164, DOI 10.1674/0003-0031(1998)139[0164:ROHCTF]2.0.CO;2; NICHOLS J. T., 1939, COPEIA, V1939, P125, DOI 10.2307/1436804; Nieuwolt PM, 1996, HERPETOLOGICA, V52, P487; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Penick DN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P57, DOI 10.1086/339219; Perison D, 1997, FOREST ECOL MANAG, V90, P171, DOI 10.1016/S0378-1127(96)03896-0; Peterman WE, 2009, FOREST ECOL MANAG, V257, P8, DOI 10.1016/j.foreco.2008.08.011; PETERSON CC, 1987, J HERPETOL, V21, P16, DOI 10.2307/1564372; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; Quinn DP, 2008, RADIO TELEMETRIC STU; R Development Core Team, 2009, R FDN STAT COMP; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; Rittenhouse TAG, 2009, CAN J ZOOL, V87, P618, DOI 10.1139/Z09-049; Rittenhouse TAG, 2009, ECOLOGY, V90, P1620, DOI 10.1890/08-0326.1; Rodgers AR, 2005, HRE HOME RANGE EXTEN; ROSE F L, 1975, Herpetologica, V31, P448; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; SAS Institute Inc, 2008, JMP 8 0; SAS Institute Inc, 2007, SAS ONLINEDOC 9 2; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schwartz C.W., 1974, 3 TOED BOX TURTLE CE; Schwartz ER, 1984, 3 TOED BOX TURTLE 2; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Sepulveda M, 2008, J THERM BIOL, V33, P141, DOI 10.1016/j.jtherbio.2007.07.002; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Steen DA, 2006, ANIM CONSERV, V9, P269, DOI 10.1111/j.1469-1795.2006.00032.x; STICKEL LF, 1950, ECOL MONOGR, V20, P353, DOI 10.2307/1943570; STICKEL LF, 1989, J HERPETOL, V23, P40, DOI 10.2307/1564314; STRANG CA, 1983, J HERPETOL, V17, P43, DOI 10.2307/1563779; Summerville K, 2010, ECOLOGICAL APPL; Summerville KS, 2009, FOREST ECOL MANAG, V259, P8, DOI 10.1016/j.foreco.2009.09.033; Todd BD, 2008, CONSERV BIOL, V22, P753, DOI 10.1111/j.1523-1739.2008.00916.x; Tozetti AM, 2010, HERPETOL J, V20, P277; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Weiss JA, 2009, DEMOGRAPHICS ACTIVIT; WILLIAMS EC, 1987, HERPETOLOGICA, V43, P328; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	86	33	33	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40473	10.1371/journal.pone.0040473	http://dx.doi.org/10.1371/journal.pone.0040473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792344	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800093
J	Deleuze, V; El-Hajj, R; Chalhoub, E; Dohet, C; Pinet, V; Couttet, P; Mathieu, D				Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Couttet, Philippe; Mathieu, Daniele			Angiopoietin-2 Is a Direct Transcriptional Target of TAL1, LYL1 and LMO2 in Endothelial Cells	PLOS ONE			English	Article							ADULT HEMATOPOIETIC STEM; GENOME-WIDE ANALYSIS; LOOP-HELIX PROTEINS; VASCULAR DEVELOPMENT; DNA-BINDING; EXPRESSION; SCL; SCL/TAL-1; ANGIOGENESIS; LEUKEMIA	The two related basic helix-loop-helix, TAL1 and LYL1, and their cofactor LIM-only-2 protein (LMO2) are present in blood and endothelial cells. While their crucial role in early hematopoiesis is well established, their function in endothelial cells and especially in angiogenesis is less understood. Here, we identified ANGIOPOIETIN-2 (ANG-2), which encodes a major regulator of angiogenesis, as a direct transcriptional target of TAL1, LYL1 and LMO2. Knockdown of any of the three transcription factors in human blood and lymphatic endothelial cells caused ANG-2 mRNA and protein down-regulation. Transient transfections showed that the full activity of the ANG-2 promoter required the integrity of a highly conserved Ebox-GATA composite element. Accordingly, chromatin immunoprecipitation assays demonstrated that TAL1, LYL1, LMO2 and GATA2 occupied this region of ANG-2 promoter in human endothelial cells. Furthermore, we showed that LMO2 played a central role in assembling TAL1-E47, LYL1-LYL1 or/and LYL1-TAL1 dimers with GATA2. The resulting complexes were able to activate endogenous ANG-2 expression in endothelial cells as well as in non-endothelial cells. Finally, we showed that ANG-2 gene activation during angiogenesis concurred with the up-regulation of TAL1 and LMO2. Altogether, we identified ANG-2 as a bona fide target gene of LMO2-complexes with TAL1 and/or LYL1, highlighting a new function of the three hematopoietic factors in the endothelial lineage.	[Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Mathieu, Daniele] CNRS, Inst Genet Mol Montpellier, UMR 5535, Montpellier, France; [Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Mathieu, Daniele] Univ Montpellier 2, Montpellier, France; [Deleuze, Virginie; El-Hajj, Rawan; Chalhoub, Elias; Dohet, Christiane; Pinet, Valerie; Mathieu, Daniele] Univ Montpellier I, Montpellier, France; [Couttet, Philippe] Sanger Inst, Cambridge, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Wellcome Trust Sanger Institute	Deleuze, V (corresponding author), CNRS, Inst Genet Mol Montpellier, UMR 5535, Montpellier, France.	daniele.mathieu@igmm.cnrs.fr	PINET, Valérie/G-6085-2012; Couttet, Philippe/AAH-5489-2019; Mathieu, Daniele/G-6092-2012	PINET, Valérie/0000-0002-4044-6440; Couttet, Philippe/0000-0002-5255-6647; Deleuze-Marques, Virginie/0000-0001-9872-1946	"Ligue Regionale contre le Cancer" (Herault, France); "Conseil National de Recherche scientifique" (Libanon); "Association pour la Recherche sur le Cancer" (ARC, France); CNRS; INSERM; Association pour la Recherche sur le Cancer (ARC, FRANCE); Agence Nationale pour la Recherche (ANR-MNP, France); ROCHE-SAS (Neuilly-sur-Seine, FRANCE); ROCHE-SAS (France)	"Ligue Regionale contre le Cancer" (Herault, France); "Conseil National de Recherche scientifique" (Libanon); "Association pour la Recherche sur le Cancer" (ARC, France)(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC, FRANCE)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche (ANR-MNP, France)(French National Research Agency (ANR)); ROCHE-SAS (Neuilly-sur-Seine, FRANCE); ROCHE-SAS (France)	R.H. was successively supported by the "Ligue Regionale contre le Cancer" (Herault, France), the "Conseil National de Recherche scientifique" (Libanon), and the "Association pour la Recherche sur le Cancer" (ARC, France). V.D. and C.D. are supported by CNRS. D.M. and V.P. are supported by INSERM. This work was funded by grants from the Association pour la Recherche sur le Cancer (ARC, FRANCE) and Agence Nationale pour la Recherche (ANR-MNP, France), and an award from ROCHE-SAS (Neuilly-sur-Seine, FRANCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received awards from ROCHE-SAS (France) for this study. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bresnick EH, 2012, NUCL ACIDS RES; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chetty R, 1997, J PATHOL, V181, P311, DOI 10.1002/(SICI)1096-9896(199703)181:3<311::AID-PATH775>3.0.CO;2-B; Coffelt SB, 2010, CANC RES, V70; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gering M, 2003, DEVELOPMENT, V130, P6187, DOI 10.1242/dev.00875; Giroux S, 2007, GENE EXPR PATTERNS, V7, P215, DOI 10.1016/j.modgep.2006.10.004; Gratzinger D, 2009, AM J CLIN PATHOL, V131, P264, DOI 10.1309/AJCP5FP3NAXAXRJE; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jang C, 2009, ARTERIOSCL THROM VAS, V29, P401, DOI 10.1161/ATVBAHA.108.172676; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Kappel A, 2000, BLOOD, V96, P3078; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Lazrak M, 2004, J CELL SCI, V117, P1161, DOI 10.1242/jcs.00969; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lecuyer E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703939200; Lewis CE, 2011, CANCER CELL, V19, P431, DOI 10.1016/j.ccr.2011.03.016; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; Patterson LJ, 2005, BLOOD, V105, P3502, DOI 10.1182/blood-2004-09-3547; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Pirot N, 2010, BLOOD, V115, P5270, DOI 10.1182/blood-2010-03-275651; Porcher C, 1999, DEVELOPMENT, V126, P4603; PULFORD K, 1995, BLOOD, V85, P675, DOI 10.1182/blood.V85.3.675.bloodjournal853675; Schlaeger TM, 2004, MOL CELL BIOL, V24, P7491, DOI 10.1128/MCB.24.17.7491-7502.2004; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Tang T, 2006, J PATHOL, V210, P121, DOI 10.1002/path.2028; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wozniak RJ, 2008, MOL CELL BIOL, V28, P6681, DOI 10.1128/MCB.01061-08; Yamada Y, 2002, ONCOGENE, V21, P1309, DOI 10.1038/sj.onc.1205285; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	55	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40484	10.1371/journal.pone.0040484	http://dx.doi.org/10.1371/journal.pone.0040484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792348	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800095
J	Gagnaire, J; Dauwalder, O; Boisset, S; Khau, D; Freydiere, AM; Ader, F; Bes, M; Lina, G; Tristan, A; Reverdy, ME; Marchand, A; Geissmann, T; Benito, Y; Durand, G; Charrier, JP; Etienne, J; Welker, M; Van Belkum, A; Vandenesch, F				Gagnaire, Julie; Dauwalder, Olivier; Boisset, Sandrine; Khau, David; Freydiere, Anne-Marie; Ader, Florence; Bes, Michele; Lina, Gerard; Tristan, Anne; Reverdy, Marie-Elisabeth; Marchand, Adrienne; Geissmann, Thomas; Benito, Yvonne; Durand, Geraldine; Charrier, Jean-Philippe; Etienne, Jerome; Welker, Martin; Van Belkum, Alex; Vandenesch, Francois			Detection of Staphylococcus aureus Delta-Toxin Production by Whole-Cell MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							GENE REGULATOR AGR; DESORPTION IONIZATION-TIME; QUORUM-SENSING SYSTEM; REDUCED SUSCEPTIBILITY; ROUTINE IDENTIFICATION; RESISTANT; VANCOMYCIN; STRAINS; VIRULENCE; DYSFUNCTION	The aim of the present study was to detect the Staphylococcus aureus delta-toxin using Whole-Cell (WC) Matrix Assisted Laser Desorption Ionization - Time-of-Flight (MALDI-TOF) mass spectrometry (MS), correlate delta-toxin expression with accessory gene regulator (agr) status, and assess the prevalence of agr deficiency in clinical isolates with and without resistance to methicillin and glycopeptides. The position of the delta-toxin peak in the mass spectrum was identified using purified delta-toxin and isogenic wild type and mutant strains for agr-rnaIII, which encodes delta-toxin. Correlation between delta-toxin production and agr RNAIII expression was assessed by northern blotting. A series of 168 consecutive clinical isolates and 23 unrelated glycopeptide-intermediate S. aureus strains (GISA/heterogeneous GISA) were then tested by WC-MALDI-TOF MS. The delta-toxin peak was detected at 3005 +/- 5 Thomson, as expected for the naturally formylated delta toxin, or at 3035 +/- 5 Thomson for its G10S variant. Multivariate analysis showed that chronicity of S. aureus infection and glycopeptide resistance were significantly associated with delta-toxin deficiency (p = 0.048; CI 95%: 1.01-10.24; p = 0.023; CI 95%: 1.20-12.76, respectively). In conclusion, the S. aureus delta-toxin was identified in the WC-MALDI-TOF MS spectrum generated during routine identification procedures. Consequently, agr status can potentially predict infectious complications and rationalise application of novel virulence factor-based therapies.	[Gagnaire, Julie; Dauwalder, Olivier; Boisset, Sandrine; Khau, David; Freydiere, Anne-Marie; Bes, Michele; Lina, Gerard; Tristan, Anne; Reverdy, Marie-Elisabeth; Benito, Yvonne; Etienne, Jerome; Vandenesch, Francois] Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Ctr Biol & Pathol E, Bron, France; [Dauwalder, Olivier; Boisset, Sandrine; Lina, Gerard; Tristan, Anne; Geissmann, Thomas; Benito, Yvonne; Etienne, Jerome; Vandenesch, Francois] Univ Lyon, Lyon, France; [Dauwalder, Olivier; Boisset, Sandrine; Ader, Florence; Bes, Michele; Lina, Gerard; Tristan, Anne; Geissmann, Thomas; Benito, Yvonne; Etienne, Jerome; Vandenesch, Francois] INSERM, Bacterial Pathogenesis & Innate Immun Lab, U851, F-69008 Lyon, France; [Ader, Florence] Hosp Civils Lyon, Serv Malad Infect, Lyon, France; [Marchand, Adrienne] Univ Poitiers, CNRS, IBMIG, Lab Chim & Microbiol Eau,UMR 6008,UFR Sci Fondame, Poitiers, France; [Durand, Geraldine; Welker, Martin; Van Belkum, Alex] bioMerieux SA, Microbiol Res & Dev Unit, La Balme Les Grottes, France; [Charrier, Jean-Philippe] bioMerieux SA, Technol Res Dept, Technol Platform, Marcy Letoile, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; bioMerieux	Gagnaire, J (corresponding author), Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Ctr Biol & Pathol E, Bron, France.	francois.vandenesch@univ-lyon1.fr	TRISTAN, Anne/GSN-8306-2022; Boisset, Sandrine SB/D-8144-2014; Lina, Gerard J/L-9352-2014; Vandenesch, Francois/C-7209-2014; ADER, Florence/M-7619-2014; Geissmann, Thomas/L-9432-2014; Tristan, Anne/L-9464-2014; Charrier, Jean-Philippe/E-3998-2013; DAUWALDER, Olivier/L-9619-2014	TRISTAN, Anne/0000-0001-9471-2655; Boisset, Sandrine SB/0000-0001-8717-8749; Vandenesch, Francois/0000-0001-9412-7106; Geissmann, Thomas/0000-0001-5734-5489; Welker, Martin/0000-0001-9819-6264; DAUWALDER, Olivier/0000-0003-1722-1582; ADER, Florence/0000-0002-4778-4338; Charrier, Jean-Philippe/0000-0001-5769-1189; Lina, Gerard/0000-0002-9236-7998				Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Benito Y, 1998, J BACTERIOL, V180, P5780, DOI 10.1128/JB.180.21.5780-5783.1998; Bergeron M, 2011, EUR J CLIN MICROBIOL, V30, P343, DOI 10.1007/s10096-010-1091-z; Bittar F, 2009, INT J ANTIMICROB AG, V34, P467, DOI 10.1016/j.ijantimicag.2009.03.017; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Cafiso V, 2012, J CLIN MICROBIOL, V50, P1742, DOI 10.1128/JCM.06307-11; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; Dauwalder O, 2010, INT J ANTIMICROB AG, V36, P193, DOI 10.1016/j.ijantimicag.2010.04.005; Dumitrescu O, 2011, ANTIMICROB AGENTS CH, V55, P3261, DOI 10.1128/AAC.01401-10; Fagerquist CK, 2009, APPL ENVIRON MICROB, V75, P4341, DOI 10.1128/AEM.00079-09; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Harigaya Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-287; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; JANZON L, 1989, MOL GEN GENET, V219, P480, DOI 10.1007/BF00259623; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEVINE DP, 1991, ANN INTERN MED, V115, P674, DOI 10.7326/0003-4819-115-9-674; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/383271; Marchand A, 2011, PEPTIDES, V32, P845, DOI 10.1016/j.peptides.2011.01.025; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Otto M, 2000, BIOTECHNIQUES, V28, P1088, DOI 10.2144/00286bm07; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Tsuji BT, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-20; van Belkum A, 2012, J CLIN MICROBIOL, V50, P1513, DOI 10.1128/JCM.00420-12; Verdon J, 2009, PEPTIDES, V30, P817, DOI 10.1016/j.peptides.2008.12.017; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Walsh TR, 2001, J CLIN MICROBIOL, V39, P2439, DOI 10.1128/JCM.39.7.2439-2444.2001; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399	51	45	52	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40660	10.1371/journal.pone.0040660	http://dx.doi.org/10.1371/journal.pone.0040660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792394	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800115
J	Kazenwadel, J; Secker, GA; Betterman, KL; Harvey, NL				Kazenwadel, Jan; Secker, Genevieve A.; Betterman, Kelly L.; Harvey, Natasha L.			In Vitro Assays Using Primary Embryonic Mouse Lymphatic Endothelial Cells Uncover Key Roles for FGFR1 Signalling in Lymphangiogenesis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; THORACIC-DUCT; INTERSTITIAL FLOW; TISSUE-CULTURE; STEM-CELLS; EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; BLOOD; LINE	Despite the importance of blood vessels and lymphatic vessels during development and disease, the signalling pathways underpinning vessel construction remain poorly characterised. Primary mouse endothelial cells have traditionally proven difficult to culture and as a consequence, few assays have been developed to dissect gene function and signal transduction pathways in these cells ex vivo. Having established methodology for the purification, short-term culture and transfection of primary blood (BEC) and lymphatic (LEC) vascular endothelial cells isolated from embryonic mouse skin, we sought to optimise robust assays able to measure embryonic LEC proliferation, migration and three-dimensional tube forming ability in vitro. In the course of developing these assays using the pro-lymphangiogenic growth factors FGF2 and VEGF-C, we identified previously unrecognised roles for FGFR1 signalling in lymphangiogenesis. The small molecule FGF receptor tyrosine kinase inhibitor SU5402, but not inhibitors of VEGFR-2 (SU5416) or VEGFR-3 (MAZ51), inhibited FGF2 mediated LEC proliferation, demonstrating that FGF2 promotes proliferation directly via FGF receptors and independently of VEGF receptors in primary embryonic LEC. Further investigation revealed that FGFR1 was by far the predominant FGF receptor expressed by primary embryonic LEC and correspondingly, siRNA-mediated FGFR1 knockdown abrogated FGF2 mediated LEC proliferation. While FGF2 potently promoted LEC proliferation and migration, three dimensional tube formation assays revealed that VEGF-C primarily promoted LEC sprouting and elongation, illustrating that FGF2 and VEGF-C play distinct, cooperative roles in lymphatic vascular morphogenesis. These assays therefore provide useful tools able to dissect gene function in cellular events important for lymphangiogenesis and implicate FGFR1 as a key player in developmental lymphangiogenesis in vivo.	[Kazenwadel, Jan; Secker, Genevieve A.; Betterman, Kelly L.; Harvey, Natasha L.] SA Pathol, Ctr Canc Biol, Div Haematol, Adelaide, SA, Australia; [Betterman, Kelly L.; Harvey, Natasha L.] Univ Adelaide, Sch Med, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide	Kazenwadel, J (corresponding author), SA Pathol, Ctr Canc Biol, Div Haematol, Adelaide, SA, Australia.	natasha.harvey@health.sa.gov.au	Kazenwadel, Jan/E-6620-2012	Kazenwadel, Jan/0000-0001-6216-3444; Harvey, Natasha/0000-0001-9839-8966; Secker, Genevieve/0000-0002-5109-3222	National Health and Medical Research Council of Australia [626959]; Cancer Council South Australia; MedVet Pty Ltd Research Fellowship; National Breast Cancer Foundation PhD Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council South Australia(Cancer Council South Australia); MedVet Pty Ltd Research Fellowship; National Breast Cancer Foundation PhD Scholarship	This work was supported by grants from the National Health and Medical Research Council of Australia (Project Grant 626959, NLH) and Cancer Council South Australia (NLH), a MedVet Pty Ltd Research Fellowship (NLH) and National Breast Cancer Foundation PhD Scholarship (KLB) (http://www.nhmrc.gov.au/, http://www.cancersa.org.au/aspx/home.aspx, http://www.nationalbreastcancer.org/, http://www.medvet.com.au/corporate/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; BORRON P, 1994, LYMPHOLOGY, V27, P6; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOWMAN CA, 1984, LYMPHOLOGY, V17, P15; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; DJONEIDI M, 1991, MICROCIRC ENDOTH LYM, V7, P161; Fong TAT, 1999, CANCER RES, V59, P99; GNEPP DR, 1985, IN VITRO CELL DEV B, V21, P200, DOI 10.1007/BF02620930; Grand EK, 2004, LEUKEMIA, V18, P962, DOI 10.1038/sj.leu.2403347; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; JOHNSTON MG, 1984, IN VITRO CELL DEV B, V20, P566; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Kono T, 2006, ARTERIOSCL THROM VAS, V26, P2070, DOI 10.1161/01.ATV.0000225770.57219.b0; Kreuger J, 2006, ARTERIOSCL THROM VAS, V26, P1073, DOI 10.1161/01.ATV.0000217610.58032.b7; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Liersch R, 2006, BLOOD, V107, P1214, DOI 10.1182/blood-2005-08-3400; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancardi S, 1999, EXP CELL RES, V246, P368, DOI 10.1006/excr.1998.4270; Matsuo M, 2006, CELL TISSUE RES, V326, P749, DOI 10.1007/s00441-006-0229-x; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002; NICOSIA RF, 1987, IN VITRO CELL DEV B, V23, P167; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; PEPPER MS, 1994, EXP CELL RES, V210, P298, DOI 10.1006/excr.1994.1042; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shayan R, 2007, GROWTH FACTORS, V25, P417, DOI 10.1080/08977190801932550; Shin JW, 2006, MOL BIOL CELL, V17, P576, DOI 10.1091/mbc.E05-04-0368; Sironi M, 2006, CELL TISSUE RES, V325, P91, DOI 10.1007/s00441-006-0171-y; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; WAY D, 1987, IN VITRO CELL DEV B, V23, P647, DOI 10.1007/BF02621074; Yamaguchi T, 2008, FEBS J, V275, P1988, DOI 10.1111/j.1742-4658.2008.06353.x; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	43	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40497	10.1371/journal.pone.0040497	http://dx.doi.org/10.1371/journal.pone.0040497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792354	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000306461800098
J	Lin, YP; Yang, CY; Liao, CC; Yu, WC; Chi, CW; Lin, CH				Lin, Yao-Ping; Yang, Chih-Yu; Liao, Chen-Chung; Yu, Wen-Chung; Chi, Chin-Wen; Lin, Chao-Hsiung			Plasma Protein Characteristics of Long-Term Hemodialysis Survivors	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; CLUSTERIN/APOLIPOPROTEIN-J; PROTEOMIC ANALYSIS; GC-GLOBULIN; DIALYSIS; DISEASE; ACTIVATION; MECHANISMS; STRESS; ALPHA(1)-ANTITRYPSIN	Hemodialysis (HD) patients are under recurrent circulatory stress, and hemodialysis has a high mortality rate. The characteristics of plasma proteomes in patients surviving long-term HD remain obscure, as well as the potential biomarkers in predicting prognoses. This study reports the proteome analyses of patient plasma from non-diabetic long-term HD (LHD, dialysis vintage 14.9 +/- 4.1 years, n = 6) and the age/sex/uremic etiology-comparable short-term HD (SHD, dialysis vintage 5.3 +/- 2.9 years, n = 6) using 2-DE and mass spectrometry. In addition, a 4-year longitudinal follow-up of 60 non-diabetic HD patients was subsequently conducted to analyze the baseline plasma proteins by ELISA in predicting prognosis. Compared to the SHD, the LHD survivors had increased plasma vitamin D binding proteins (DBP) and decreased clusterin, apolipoprotein A-IV, haptoglobin, hemopexin, complement factors B and H, and altered isoforms of alpha 1-antitrypsin and fibrinogen gamma. During the 45.7 +/- 15 months for follow-up of the 60 HD patient cases, 16 patients died. Kaplan-Meier analysis demonstrated that HD patients with the lowest tertile of the baseline plasma DBP level have a significantly higher mortality rate. Multivariate Cox regression analysis further indicated that DBP is an independent predictor of mortality. In summary, the altered plasma proteins in LHD implicated accelerated atherosclerosis, defective antioxidative activity, increased inflammation/infection, and organ dysfunction. Furthermore, lower baseline plasma DBP in HD patients is related to mortality. The results suggest that the proteomic approach could help discover the potential biomarker in HD prognoses.	[Lin, Yao-Ping; Yang, Chih-Yu] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Lin, Yao-Ping; Yang, Chih-Yu; Yu, Wen-Chung] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Liao, Chen-Chung; Lin, Chao-Hsiung] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan; [Chi, Chin-Wen; Lin, Chao-Hsiung] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genom Sci, Taipei 112, Taiwan; [Lin, Chao-Hsiung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Lin, YP (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.	chlin2@ym.edu.tw	Yang, Chih-Yu/AAR-6147-2020	Yang, Chih-Yu/0000-0001-9899-3159; LIN, CHAO-HSIUNG/0000-0001-6344-271X	National Science Council in Taiwan [NSC 93-2314-B-075-044, NSC96-2317-B-010-001, NSC98-2311-B-010-003-MY3]; Taipei Veterans General Hospital in Taiwan [VGH 95DHA0100584, VGH 95DHA0100695, VGHUST100-G7-5-1]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital in Taiwan	This work was supported in part by grants (NSC 93-2314-B-075-044, NSC96-2317-B-010-001, and NSC98-2311-B-010-003-MY3) from the National Science Council in Taiwan and grants (VGH 95DHA0100584, VGH 95DHA0100695, and VGHUST100-G7-5-1) from the Taipei Veterans General Hospital in Taiwan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borawski J, 2003, RENAL FAILURE, V25, P589, DOI 10.1081/JDI-120022550; Chu JG, 2001, CLIN CHIM ACTA, V311, P95, DOI 10.1016/S0009-8981(01)00585-X; Clark WR, 2002, J AM SOC NEPHROL, V13, pS41; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Daemen MARC, 2000, CIRCULATION, V102, P1420, DOI 10.1161/01.CIR.102.12.1420; Dahl B, 2003, CRIT CARE MED, V31, P152, DOI 10.1097/00003246-200301000-00024; Dihazi H, 2008, PROTEOM CLIN APPL, V2, P1167, DOI 10.1002/prca.200780143; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Gotch FA, 2000, BLOOD PURIFICAT, V18, P276, DOI 10.1159/000014449; Hallbauer J, 2010, PROTEOM CLIN APPL, V4, P953, DOI 10.1002/prca.201000051; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Horl WH, 2002, J AM SOC NEPHROL, V13, pS62; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Jofre R, 2006, J AM SOC NEPHROL, V17, pS274, DOI 10.1681/ASN.2006080926; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kim CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009065; Kronenberg F, 2000, J AM COLL CARDIOL, V36, P751, DOI 10.1016/S0735-1097(00)00775-0; Langlois RG, 2004, AM J NEPHROL, V24, P268, DOI 10.1159/000077409; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin YP, 2002, KIDNEY INT, V62, P1828, DOI 10.1046/j.1523-1755.2002.00610.x; Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138; Mateos-Caceres PJ, 2004, J AM COLL CARDIOL, V44, P1578, DOI 10.1016/j.jacc.2004.06.073; McIntyre CW, 2010, SEMIN DIALYSIS, V23, P449, DOI 10.1111/j.1525-139X.2010.00782.x; McVoy LA, 2005, J IMMUNOL, V175, P4754, DOI 10.4049/jimmunol.175.7.4754; Michelis R, 2003, NEPHROL DIAL TRANSPL, V18, P924, DOI 10.1093/ndt/gfg031; Mosesson MW, 2003, J THROMB HAEMOST, V1, P231, DOI 10.1046/j.1538-7836.2003.00063.x; Petropoulou C, 2001, FEBS LETT, V509, P287, DOI 10.1016/S0014-5793(01)03150-7; Pitteri SJ, 2010, CANCER RES, V70, P8598, DOI 10.1158/0008-5472.CAN-10-1676; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Schiodt FV, 1996, HEPATOLOGY, V23, P713, DOI 10.1002/hep.510230409; Silver J, 1999, KIDNEY INT, V56, pS2, DOI 10.1046/j.1523-1755.1999.07310.x; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Thongboonkerd V, 2009, CLIN SCI, V116, P721, DOI 10.1042/CS20080478; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Unruh ML, 2005, AM J KIDNEY DIS, V46, P1107, DOI 10.1053/j.ajkd.2005.09.002; Urbich C, 2000, CIRCULATION, V101, P352, DOI 10.1161/01.CIR.101.4.352; Weissinger EM, 2006, PROTEOMICS, V6, P993, DOI 10.1002/pmic.200500210; Witko-Sarsat W, 2003, KIDNEY INT, V64, P82, DOI 10.1046/j.1523-1755.2003.00044.x; Yamamoto N, 1996, J IMMUNOL, V157, P1744	41	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40232	10.1371/journal.pone.0040232	http://dx.doi.org/10.1371/journal.pone.0040232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792249	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800054
J	Menoret, A; Kumar, S; Vella, AT				Menoret, Antoine; Kumar, Sanjeev; Vella, Anthony T.			Cytochrome b5 and Cytokeratin 17 Are Biomarkers in Bronchoalveolar Fluid Signifying Onset of Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; STAPHYLOCOCCAL-ENTEROTOXIN-B; VON-WILLEBRAND-FACTOR; CLINICAL-OUTCOMES; T-CELLS; IN-VIVO; PLASMA; B(5); PROTEIN; MICE	Acute lung injury (ALI) is characterized by pulmonary edema and acute inflammation leading to pulmonary dysfunction and potentially death. Early medical intervention may ameliorate the severity of ALI, but unfortunately, there are no reliable biomarkers for early diagnosis. We screened for biomarkers in a mouse model of ALI. In this model, inhalation of S. aureus enterotoxin A causes increased capillary permeability, cell damage, and increase protein and cytokine concentration in the lungs. We set out to find predictive biomarkers of ALI in bronchoalveolar lavage (BAL) fluid before the onset of clinical manifestations. A cutting edge proteomic approach was used to compare BAL fluid harvested 16 h post S. aureus enterotoxin A inhalation versus BAL fluid from vehicle alone treated mice. The proteomic PF 2D platform permitted comparative analysis of proteomic maps and mass spectrometry identified cytochrome b5 and cytokeratin 17 in BAL fluid of mice challenged with S. aureus enterotoxin A. Validation of cytochrome b5 showed tropic expression in epithelial cells of the bronchioles. Importantly, S. aureus enterotoxin A inhalation significantly decreased cytochrome b5 during the onset of lung injury. Validation of cytokeratin 17 showed ubiquitous expression in lung tissue and increased presence in BAL fluid after S. aureus enterotoxin A inhalation. Therefore, these new biomarkers may be predictive of ALI onset in patients and could provide insight regarding the basis of lung injury and inflammation.	[Menoret, Antoine; Kumar, Sanjeev; Vella, Anthony T.] Univ Connecticut, Ctr Hlth, Farmington, CT USA	University of Connecticut	Menoret, A (corresponding author), Univ Connecticut, Ctr Hlth, Farmington, CT USA.	vella@uchc.edu		Kumar, Sanjeev/0000-0002-4454-9914	National Institutes of Health [PO1 AI056172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health PO1 AI056172 project 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, Chem Immunol Allergy, V93, P214, DOI 10.1159/000100897; Bajaj MS, 1999, INTENS CARE MED, V25, P1259, DOI 10.1007/s001340050097; Barre O, 2006, PROTEOMICS, V6, P5096, DOI 10.1002/pmic.200600074; Beckhove P, 2010, J CLIN INVEST, V120, P2230, DOI 10.1172/JCI37646; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Calfee CS, 2011, CRIT CARE MED, V39, P711, DOI 10.1097/CCM.0b013e318207ec3c; Cheng IW, 2003, CRIT CARE MED, V31, P20, DOI 10.1097/00003246-200301000-00003; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Durr UHN, 2007, BBA-BIOMEMBRANES, V1768, P3235, DOI 10.1016/j.bbamem.2007.08.007; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Engstrom G, 2009, THORAX, V64, P211, DOI 10.1136/thx.2008.102079; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Gaggar A, 2006, CLIN CHIM ACTA, V372, P24, DOI 10.1016/j.cca.2006.04.019; GIORDANO SJ, 1993, BIOCHIM BIOPHYS ACTA, V1172, P95, DOI 10.1016/0167-4781(93)90274-H; Han SG, 2008, INHAL TOXICOL, V20, P391, DOI 10.1080/08958370801904014 ; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0; Ishizaka A, 2004, AM J PHYSIOL-LUNG C, V286, pL1088, DOI 10.1152/ajplung.00420.2002; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim ST, 2011, AM J RHINOL ALLERGY, V25, P19, DOI 10.2500/ajra.2011.25.3564; Kropski JA, 2009, CHEST, V135, P1440, DOI 10.1378/chest.08-2465; Kuebler WM, 2011, CRIT CARE MED, V39, P207, DOI 10.1097/CCM.0b013e318202e669; LeClaire RD, 1996, TOXICOL PATHOL, V24, P619, DOI 10.1177/019262339602400513; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; Lee HJ, 2008, PROTEOMICS, V8, P3371, DOI 10.1002/pmic.200800111; Levitt Joseph E, 2009, J Intensive Care Med, V24, P151, DOI 10.1177/0885066609332603; Lombard N, 2002, ENDOCR RES, V28, P485, DOI 10.1081/ERC-120016827; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Menoret A, 2009, J IMMUNOL, V183, P7489, DOI 10.4049/jimmunol.0901414; Miyakawa H, 2002, EUR RESPIR J, V19, P447, DOI 10.1183/09031936.02.00265902; Muralimohan G, 2008, J IMMUNOL, V181, P3698, DOI 10.4049/jimmunol.181.5.3698; Nakanishi M, 2007, PROTEOM CLIN APPL, V1, P1660, DOI 10.1002/prca.200700545; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Rieder SA, 2011, INFECT IMMUN, V79, P3141, DOI 10.1128/IAI.00177-11; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; TENHOLDER MF, 1991, CHEST, V100, P1385, DOI 10.1378/chest.100.5.1385; Tesfaigzi Y, 2001, RESP PHYSIOL, V128, P79, DOI 10.1016/S0034-5687(01)00267-5; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287; Thomas Damien, 2007, Chem Immunol Allergy, V93, P24, DOI 10.1159/000100856; Tripathi A, 2005, AM J RHINOL, V19, P327, DOI 10.1177/194589240501900401; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC	52	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40184	10.1371/journal.pone.0040184	http://dx.doi.org/10.1371/journal.pone.0040184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792238	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800047
J	Saha, D; Fetzner, R; Burkhardt, B; Podlech, J; Metzler, M; Dang, H; Lawrence, C; Fischer, R				Saha, Debjani; Fetzner, Ramona; Burkhardt, Britta; Podlech, Joachim; Metzler, Manfred; Dang, Ha; Lawrence, Christopher; Fischer, Reinhard			Identification of a Polyketide Synthase Required for Alternariol (AOH) and Alternariol-9-Methyl Ether (AME) Formation in Alternaria alternata	PLOS ONE			English	Article							SECONDARY METABOLISM; MYCOTOXIN PRODUCTION; O-METHYLTRANSFERASE; GENE; BIOSYNTHESIS; TOXINS; PROTEINS; NITROGEN; ENCODES; BIOLOGY	Alternaria alternata produces more than 60 secondary metabolites, among which alternariol (AOH) and alternariol-9-methyl ether (AME) are important mycotoxins. Whereas the toxicology of these two polyketide-based compounds has been studied, nothing is known about the genetics of their biosynthesis. One of the postulated core enzymes in the biosynthesis of AOH and AME is polyketide synthase (PKS). In a draft genome sequence of A. alternata we identified 10 putative PKS-encoding genes. The timing of the expression of two PKS genes, pksJ and pksH, correlated with the production of AOH and AME. The PksJ and PksH proteins are predicted to be 2222 and 2821 amino acids in length, respectively. They are both iterative type I reducing polyketide synthases. PksJ harbors a peroxisomal targeting sequence at the C-terminus, suggesting that the biosynthesis occurs at least partly in these organelles. In the vicinity of pksJ we found a transcriptional regulator, altR, involved in pksJ induction and a putative methyl transferase, possibly responsible for AME formation. Downregulation of pksJ and altR caused a large decrease of alternariol formation, suggesting that PksJ is the polyketide synthase required for the postulated Claisen condensations during the biosynthesis. No other enzymes appeared to be required. PksH downregulation affected pksJ expression and thus caused an indirect effect on AOH production.	[Saha, Debjani; Fetzner, Ramona; Fischer, Reinhard] KIT, Inst Appl Biosci, Dept Microbiol, Karlsruhe, Germany; [Burkhardt, Britta; Metzler, Manfred] KIT, Inst Appl Biosci, Dept Food Chem, Karlsruhe, Germany; [Podlech, Joachim] KIT, Inst Organ Chem, Karlsruhe, Germany; [Dang, Ha; Lawrence, Christopher] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Blacksburg, VA USA	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Virginia Polytechnic Institute & State University	Saha, D (corresponding author), KIT, Inst Appl Biosci, Dept Microbiol, South Campus, Karlsruhe, Germany.	reinhard.fischer@bio.uka.de	Fischer, Reinhard/I-1220-2016	Fischer, Reinhard/0000-0002-6704-2569	Humboldt Society; Baden Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Karlsruhe Institute of Technology (KIT); Direct For Biological Sciences [0918298] Funding Source: National Science Foundation	Humboldt Society(Alexander von Humboldt Foundation); Baden Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology (KIT); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Humboldt Society and the Baden Wurttemberg Stiftung. D.S. is a Humboldt fellow. The authors thank Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Karlsruhe Institute of Technology (KIT) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Y, 2011, J AGR FOOD CHEM, V59, P6360, DOI 10.1021/jf201516f; Akamatsu H, 1999, CURR GENET, V35, P647, DOI 10.1007/s002940050464; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Brugger EM, 2006, TOXICOL LETT, V164, P221, DOI 10.1016/j.toxlet.2006.01.001; Brzonkalik K, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-28; Brzonkalik K, 2011, INT J FOOD MICROBIOL, V147, P120, DOI 10.1016/j.ijfoodmicro.2011.03.016; Burkhardt Britta, 2009, Mycotoxin Res, V25, P149, DOI 10.1007/s12550-009-0022-2; Cho YR, 2006, MOL PLANT MICROBE IN, V19, P7, DOI 10.1094/MPMI-19-0007; Covert SF, 2001, MYCOL RES, V105, P259, DOI 10.1017/S0953756201003872; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; DASENBROCK J, 1987, J CHEM SOC CHEM COMM, P1235, DOI 10.1039/c39870001235; Fehr M, 2009, MOL NUTR FOOD RES, V53, P441, DOI 10.1002/mnfr.200700379; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; GATENBEC.S, 1965, ACTA CHEM SCAND, V19, P65, DOI 10.3891/acta.chem.scand.19-0065; Gulder TA, 2012, TOP CURR CHEM, P1, DOI DOI 10.1038/JA.2013.125; HARRIS TM, 1977, J AM CHEM SOC, V99, P1631, DOI 10.1021/ja00447a058; HILTUNEN M, 1992, EXP MYCOL, V16, P44, DOI 10.1016/0147-5975(92)90040-X; Imazaki A, 2010, EUKARYOT CELL, V9, P682, DOI 10.1128/EC.00369-09; Kelkar HS, 1996, APPL ENVIRON MICROB, V62, P4296, DOI 10.1128/AEM.62.11.4296-4298.1996; Kelkar HS, 1997, J BIOL CHEM, V272, P1589, DOI 10.1074/jbc.272.3.1589; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; KIMURA N, 1993, J BACTERIOL, V175, P4427, DOI 10.1128/JB.175.14.4427-4435.1993; Koch K, 2005, J ORG CHEM, V70, P3275, DOI 10.1021/jo050075r; LIU GT, 1992, CHINESE MED J-PEKING, V105, P394; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Miyamoto Y, 2008, MOL PLANT MICROBE IN, V21, P1591, DOI 10.1094/MPMI-21-12-1591; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; NISHIMURA S, 1983, ANNU REV PHYTOPATHOL, V21, P87, DOI 10.1146/annurev.py.21.090183.000511; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; OTANI H, 1995, CAN J BOT, V73, pS453, DOI 10.1139/b95-282; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; PERO R W, 1973, Environmental Health Perspectives, V4, P87, DOI 10.2307/3428185; Pfeiffer E, 2007, MOL NUTR FOOD RES, V51, P307, DOI 10.1002/mnfr.200600237; Reyes-Dominguez Y, 2012, FUNGAL GENET BIOL, V49, P39, DOI 10.1016/j.fgb.2011.11.002; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Sambrook J., 1999, MOL CLONING LAB MANU; Schmidt-Heydt M, 2007, INT J FOOD MICROBIOL, V117, P131, DOI 10.1016/j.ijfoodmicro.2007.01.014; Scott PM, 2001, J AOAC INT, V84, P1809; SIMPSON TJ, 1987, NAT PROD REP, V4, P339, DOI 10.1039/np9870400339; Sprote P, 2009, EUKARYOT CELL, V8, P421, DOI 10.1128/EC.00374-08; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; THOMAS R, 1961, BIOCHEM J, V80, P234, DOI 10.1042/bj0800234; TRAIL F, 1995, MICROBIOL-UK, V141, P755, DOI 10.1099/13500872-141-4-755; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214	53	65	71	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40564	10.1371/journal.pone.0040564	http://dx.doi.org/10.1371/journal.pone.0040564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792370	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800106
J	Sakamoto, M; Ruta, M				Sakamoto, Manabu; Ruta, Marcello			Convergence and Divergence in the Evolution of Cat Skulls: Temporal and Spatial Patterns of Morphological Diversity	PLOS ONE			English	Article							LATE-MIOCENE; FELIDAE; CARNIVORA; PHYLOGENY; SIZE; MAMMALIA; PERFORMANCE; ALLOMETRY; RADIATION; REVISION	Background: Studies of biological shape evolution are greatly enhanced when framed in a phylogenetic perspective. Inclusion of fossils amplifies the scope of macroevolutionary research, offers a deep-time perspective on tempo and mode of radiations, and elucidates life-trait changes. We explore the evolution of skull shape in felids (cats) through morphometric analyses of linear variables, phylogenetic comparative methods, and a new cladistic study of saber-toothed cats. Methodology/Principal Findings: A new phylogenetic analysis supports the monophyly of saber-toothed cats (Machairodontinae) exclusive of Felinae and some basal felids, but does not support the monophyly of various saber-toothed tribes and genera. We quantified skull shape variation in 34 extant and 18 extinct species using size-adjusted linear variables. These distinguish taxonomic group membership with high accuracy. Patterns of morphospace occupation are consistent with previous analyses, for example, in showing a size gradient along the primary axis of shape variation and a separation between large and small-medium cats. By combining the new phylogeny with a molecular tree of extant Felinae, we built a chronophylomorphospace (a phylogeny superimposed onto a two-dimensional morphospace through time). The evolutionary history of cats was characterized by two major episodes of morphological divergence, one marking the separation between saber-toothed and modern cats, the other marking the split between large and small-medium cats. Conclusions/Significance: Ancestors of large cats in the `Panthera' lineage tend to occupy, at a much later stage, morphospace regions previously occupied by saber-toothed cats. The latter radiated out into new morphospace regions peripheral to those of extant large cats. The separation between large and small-medium cats was marked by considerable morphologically divergent trajectories early in feline evolution. A chronophylomorphospace has wider applications in reconstructing temporal transitions across two-dimensional trait spaces, can be used in ecophenotypical and functional diversity studies, and may reveal novel patterns of morphospace occupation.	[Sakamoto, Manabu; Ruta, Marcello] Univ Bristol, Sch Earth Sci, Bristol, Avon, England	University of Bristol	Sakamoto, M (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	m.sakamoto@bristol.ac.uk	; Sakamoto, Manabu/F-6690-2010	Ruta, Marcello/0000-0002-6151-0704; Sakamoto, Manabu/0000-0001-6447-406X	BBSRC [BB/H007954/1]; Biotechnology and Biological Sciences Research Council [BB/H007954/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC (http://www.bbsrc.ac.uk/) grant BB/H007954/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D., 2011, RGL 3D VISUALIZATION; Barnett R, 2005, CURR BIOL, V15, pR589, DOI 10.1016/j.cub.2005.07.052; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bookstein F. L., 1985, MORPHOMETRICS EVOLUT; Brusatte SL, 2012, J EVOLUTION BIOL, V25, P365, DOI 10.1111/j.1420-9101.2011.02427.x; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Burger J, 2004, MOL PHYLOGENET EVOL, V30, P841, DOI 10.1016/j.ympev.2003.07.020; Christiansen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002807; Christiansen P, 2008, CLADISTICS, V24, P977, DOI 10.1111/j.1096-0031.2008.00226.x; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Deng T, 2006, GEODIVERSITAS, V28, P499; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Geraads D, 2004, NEUES JAHRB GEOL P-M, P95; Goloboff P, 2008, CLADISTICS, V24, P91; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Leidy J, 1872, P ACAD NAT SCI PHILA, V24, P38; Liu Li-Ping, 2008, Vertebrata Palasiatica, V46, P124; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Meachen-Samuels J, 2009, BIOL J LINN SOC, V96, P784, DOI 10.1111/j.1095-8312.2008.01169.x; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Core Development Team, 2011, R LANG ENV STAT COMP; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; Rohlf F. James, 2002, VVolume 64, P175; Rothwell T, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)403<0001:PSONAP>2.0.CO;2; Roussiakis SJ, 2006, GEOBIOS-LYON, V39, P563, DOI 10.1016/j.geobios.2005.04.002; Sakamoto M, 2010, J EVOLUTION BIOL, V23, P463, DOI 10.1111/j.1420-9101.2009.01922.x; Sakamoto M, 2010, P ROY SOC B-BIOL SCI, V277, P3327, DOI 10.1098/rspb.2010.0794; Salesa MJ, 2012, J SYST PALAEONTOL, V10, P87, DOI 10.1080/14772019.2011.566584; Salesa MJ, 2010, PALAEONTOLOGY, V53, P1369, DOI 10.1111/j.1475-4983.2010.01013.x; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; SEYMOUR K, 1993, MORPHOLOGICAL CHANGE IN QUATERNARY MAMMALS OF NORTH AMERICA, P343, DOI 10.1017/CBO9780511565052.014; Sicuro FL, 2011, BIOL J LINN SOC, V103, P176, DOI 10.1111/j.1095-8312.2011.01636.x; Sicuro FL, 2011, ZOOL J LINN SOC-LOND, V161, P414, DOI 10.1111/j.1096-3642.2010.00636.x; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Stayton CT, 2006, PALAEONTOLOGY, V49, P307, DOI 10.1111/j.1475-4983.2006.00523.x; Stone JR, 2003, ACTA ZOOL-STOCKHOLM, V84, P63, DOI 10.1046/j.1463-6395.2003.00131.x; Sunquist ME, 2002, WILD CATS WORLD; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Turner A., 1997, BIG CATS THEIR FOSSI; WERDELIN L, 1981, ANN ZOOL FENN, V18, P37; WERDELIN L, 1983, BIOL J LINN SOC, V19, P375, DOI 10.1111/j.1095-8312.1983.tb00793.x; Werdelin L, 2001, ZOOL J LINN SOC-LOND, V132, P147, DOI 10.1006/zjls.2000.0260; WERDELIN L, 1996, CARNIVORE BEHAV ECOL, V2, P582; Werdelin Lars, 2010, P59; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532	57	42	43	1	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39752	10.1371/journal.pone.0039752	http://dx.doi.org/10.1371/journal.pone.0039752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792186	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000306461800017
J	Huang, GH; Garretson, TA; Cheng, XH; Holztrager, MS; Li, SJ; Wang, X; Cheng, XW				Huang, Guo-Hua; Garretson, Tyler A.; Cheng, Xin-Hua; Holztrager, Maria S.; Li, Shun-Ji; Wang, Xing; Cheng, Xiao-Wen			Phylogenetic Position and Replication Kinetics of Heliothis virescens Ascovirus 3h (HvAV-3h) Isolated from Spodoptera exigua	PLOS ONE			English	Article							DIADROMUS-PULCHELLUS ASCOVIRUS; DNA INSECT VIRUS; HOST-RANGE; FRUGIPERDA LEPIDOPTERA; APOPTOSIS; SEQUENCE; HISTOPATHOLOGY; ORGANIZATION; HYMENOPTERA; BACULOVIRUS	Insect-specific ascoviruses with a circular genome are distributed in the USA, France, Australia and Indonesia. Here, we report the first ascovirus isolation from Spodoptera exigua in Hunan, China. DNA-DNA hybridization to published ascoviruses demonstrated that the new China ascovirus isolate is a variant of Heliothis virescens ascovirus 3a (HvAV-3a), thus named HvAV-3h. We investigated the phylogenetic position, cell infection, vesicle production and viral DNA replication kinetics of HvAV-3h, as well as its host-ranges. The major capsid protein (MCP) gene and the delta DNA polymerase (DNA po1) gene of HvAV-3h were sequenced and compared with the available ascovirus isolates for phylogenetic analysis. This shows a close relationship with HvAV-3g, originally isolated from Indonesia, HvAV-3e from Australia and HvAV-3c from United States. HvAV-3h infection induced vesicle production in the SeE1 cells derived from S. exigua and Sf9 cells derived from S. frugiperda, resulting in more vesicles generated in Sf9 than SeE1. Viral DNA replication kinetics of HvAV-3h also demonstrated a difference between the two cell lines tested. HvAV-3h could readily infect three important insect pests Helicoverpa armigera (Hubner), Spodoptera exigua (Hubner) and Spodoptera litura (Fabricius) from two genera in different subfamilies with high mortalities.	[Huang, Guo-Hua; Li, Shun-Ji; Wang, Xing; Cheng, Xiao-Wen] Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Garretson, Tyler A.; Cheng, Xin-Hua; Holztrager, Maria S.; Cheng, Xiao-Wen] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	Hunan Agricultural University; University System of Ohio; Miami University	Huang, GH (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.	chengx@muohio.edu		Garretson, Tyler/0000-0001-6799-0350	National Department Public Benefit Research Foundation [200903017]	National Department Public Benefit Research Foundation	This study was supported by National Department Public Benefit Research Foundation (no. 200903017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2006, ARCH VIROL, V151, P1689, DOI 10.1007/s00705-006-0762-7; Asgari S, 2007, VIRUS RES, V128, P99, DOI 10.1016/j.virusres.2007.04.020; Asgari S, 2007, J GEN VIROL, V88, P1120, DOI 10.1099/vir.0.82651-0; Bideshi DK, 2006, J VIROL, V80, P11791, DOI 10.1128/JVI.01639-06; Bideshi DK, 2010, INSECT VIROLOGY, P3; Bideshi DK, 2005, GENE DEV, V19, P1416, DOI 10.1101/gad.1300205; Bigot Y, 1997, J GEN VIROL, V78, P1149, DOI 10.1099/0022-1317-78-5-1149; Bigot Y, 1997, J GEN VIROL, V78, P1139, DOI 10.1099/0022-1317-78-5-1139; Bigot Y., 2011, VIRAL TAXONOMY 9 REP, V3rd ed., P147, DOI [10.1016/B978-0-12-384684-6.00011-2, DOI 10.1016/B978-0-12-384684-6.00011-2]; Bigot Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006397; CARNER GR, 1983, J INVERTEBR PATHOL, V41, P238, DOI 10.1016/0022-2011(83)90224-0; Cheng XW, 1999, J GEN VIROL, V80, P1537, DOI 10.1099/0022-1317-80-6-1537; Cheng XW, 2005, J INVERTEBR PATHOL, V89, P193, DOI 10.1016/j.jip.2005.06.011; Cheng XW, 2003, BIOTECHNIQUES, V34, P1162, DOI 10.2144/03346bm08; Cheng XW, 2000, J GEN VIROL, V81, P3083, DOI 10.1099/0022-1317-81-12-3083; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DELIUS H, 1984, J VIROL, V49, P609, DOI 10.1128/JVI.49.2.609-614.1984; FEDERICI BA, 1990, J INVERTEBR PATHOL, V56, P300, DOI 10.1016/0022-2011(90)90116-N; FEDERICI BA, 1983, P NATL ACAD SCI-BIOL, V80, P7664, DOI 10.1073/pnas.80.24.7664; FEDERICI BA, 1982, J INVERTEBR PATHOL, V40, P41, DOI 10.1016/0022-2011(82)90035-0; Federici BA, 1999, VIRUS TAXONOMY; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goodman CL, 2001, IN VITRO CELL DEV-AN, V37, P367, DOI 10.1007/BF02577573; GOVINDARAJAN R, 1990, J INVERTEBR PATHOL, V56, P291, DOI 10.1016/0022-2011(90)90115-M; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; HAMM JJ, 1985, ENVIRON ENTOMOL, V14, P258, DOI 10.1093/ee/14.3.258; Hamm JJ, 1998, J INVERTEBR PATHOL, V72, P138, DOI 10.1006/jipa.1998.4763; HAMM JJ, 1986, FLA ENTOMOL, V69, P524, DOI 10.2307/3495385; HUDSON JS, 1981, P S E ELECT MICROSC, V4, P27; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Mitchell E.R., 1979, P386; Nei M., 2000, Molecular evolution and phylogenetics.; Newton IR, 2003, BIOL CHARACTERISATIO; Oppenheimer DI, 1997, ARCH VIROL, V142, P2107, DOI 10.1007/s007050050229; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Peterson MW, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-7; SKALITER R, 1994, P NATL ACAD SCI USA, V91, P10665, DOI 10.1073/pnas.91.22.10665; Stadelbacher EA, 1979, 37 ANN P EL MICR SOC, P52; Stasiak K, 2000, J GEN VIROL, V81, P3059, DOI 10.1099/0022-1317-81-12-3059; Stasiak K, 2005, J INSECT PHYSIOL, V51, P103, DOI 10.1016/j.jinsphys.2004.07.004; Stasiak K, 2003, J GEN VIROL, V84, P2999, DOI 10.1099/vir.0.19290-0; Swofford DL, 2002, PAUP PHYLEGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillman PG, 2004, ENVIRON ENTOMOL, V33, P633, DOI 10.1603/0046-225X-33.3.633; Wang LH, 2008, J GEN VIROL, V89, P1402, DOI 10.1099/vir.0.2008/000695-0; Wang LH, 2006, VIROLOGY, V354, P167, DOI 10.1016/j.virol.2006.06.029; Xue JL, 2011, J GEN VIROL, V92, P2797, DOI 10.1099/vir.0.035733-0	49	32	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40225	10.1371/journal.pone.0040225	http://dx.doi.org/10.1371/journal.pone.0040225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792245	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300038
J	Weigel, KJ; Rues, L; Doyle, EJ; Buchheit, CL; Wood, JG; Gallagher, RJ; Kelly, LE; Radel, JD; Bradley, KA; LeVine, SM				Weigel, Kelsey J.; Rues, Laura; Doyle, Edward J.; Buchheit, Cassandra L.; Wood, John G.; Gallagher, Ryan J.; Kelly, Laura E.; Radel, Jeffrey D.; Bradley, Kenneth A.; LeVine, Steven M.			Rapid Vascular Responses to Anthrax Lethal Toxin in Mice Containing a Segment of Chromosome 11 from the CAST/Ei Strain on a C57BL/6 Genetic Background	PLOS ONE			English	Article							MAP-KINASE-KINASE; TISSUE FACTOR; PROTECTIVE ANTIGEN; NEUTROPHIL RECRUITMENT; INTERFERON-GAMMA; FACTOR CLEAVES; STERNE STRAIN; IFN-GAMMA; CELLS; SUSCEPTIBILITY	Host allelic variation controls the response to B. anthracis and the disease course of anthrax. Mouse strains with macrophages that are responsive to anthrax lethal toxin (LT) show resistance to infection while mouse strains with LT non-responsive macrophages succumb more readily. B6.CAST.11M mice have a region of chromosome 11 from the CAST/Ei strain (a LT responsive strain) introgressed onto a LT non-responsive C57BL/6J genetic background. Previously, B6.CAST.11M mice were found to exhibit a rapid inflammatory reaction to LT termed the early response phenotype (ERP), and displayed greater resistance to B. anthracis infection compared to C57BL/6J mice. Several ERP features (e.g., bloat, hypothermia, labored breathing, dilated pinnae vessels) suggested vascular involvement. To test this, Evan's blue was used to assess vessel leakage and intravital microscopy was used to monitor microvascular blood flow. Increased vascular leakage was observed in lungs of B6.CAST.11M mice compared to C57BL/6J mice 1 hour after systemic administration of LT. Capillary blood flow was reduced in the small intestine mesentery without concomitant leukocyte emigration following systemic or topical application of LT, the latter suggesting a localized tissue mechanism in this response. Since LT activates the Nlrp1b inflammasome in B6.CAST.11M mice, the roles of inflammasome products, IL-1 beta and IL-18, were examined. Topical application to the mesentery of IL-1 beta but not IL-18 revealed pronounced slowing of blood flow in B6.CAST.11M mice that was not present in C57BL/6J mice. A neutralizing anti-IL-1 beta antibody suppressed the slowing of blood flow induced by LT, indicating a role for IL-1 beta in the response. Besides allelic differences controlling Nlrp1b inflammasome activation by LT observed previously, evidence presented here suggests that an additional genetic determinant(s) could regulate the vascular response to IL-1 beta. These results demonstrate that vessel leakage and alterations to blood flow are part of the rapid response in mice resistant to B. anthracis infection.	[Weigel, Kelsey J.; Rues, Laura; Doyle, Edward J.; Buchheit, Cassandra L.; Wood, John G.; Gallagher, Ryan J.; Kelly, Laura E.; LeVine, Steven M.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Weigel, Kelsey J.; Rues, Laura; Doyle, Edward J.; Buchheit, Cassandra L.; Kelly, Laura E.] Rockhurst Univ, Kansas City, MO USA; [Wood, John G.] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66103 USA; [Radel, Jeffrey D.] Univ Kansas, Med Ctr, Dept Occupat Therapy Educ, Kansas City, KS 66103 USA; [Bradley, Kenneth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles	Weigel, KJ (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	slevine@kumc.edu		Gorsuch, Cassandra/0000-0002-6993-6910	National Institutes of Health [AI077791]; NICHD Center Grant [HD 02528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077791, R01AI077791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD Center Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health Grant AI077791 (to KAB and SML) and a NICHD Center Grant (HD 02528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEALL FA, 1966, J INFECT DIS, V116, P377, DOI 10.1093/infdis/116.3.377; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2010, CELL HOST MICROBE, V8, P394, DOI 10.1016/j.chom.2010.10.011; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; BURKE JF, 1958, J PATHOL BACTERIOL, V76, P1, DOI 10.1002/path.1700760102; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; Dao T, 1998, J IMMUNOL, V161, P2217; Davis RC, 2007, GENOMICS, V90, P306, DOI 10.1016/j.ygeno.2007.05.009; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Dumas EK, 2011, TOXINS, V3, P1111, DOI 10.3390/toxins3091111; Elazar S, 2010, VET RES, V41, DOI 10.1051/vetres/2009058; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; Fantuzzi G, 1998, BLOOD, V91, P2118, DOI 10.1182/blood.V91.6.2118.2118_2118_2125; Finigan JH, 2009, AM J PHYSIOL-LUNG C, V296, pL1002, DOI 10.1152/ajplung.90555.2008; FISH DC, 1968, J INFECT DIS, V118, P114, DOI 10.1093/infdis/118.1.114; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ganter CG, 2006, MINERVA ANESTESIOL, V72, P21; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gozes Y, 2006, INFECT IMMUN, V74, P1266, DOI 10.1128/IAI.74.2.1266-1272.2006; Gray H., 1918, ANATOMY HUMAN BODY, V20th; Hack C E, 1994, Prog Clin Biol Res, V388, P335; Hack C Erik, 2003, Contrib Microbiol, V10, P18; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kalns J, 2002, BIOCHEM BIOPH RES CO, V292, P41, DOI 10.1006/bbrc.2002.6626; Kawa K, 2010, INT IMMUNOL, V22, P157, DOI 10.1093/intimm/dxp122; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; KLEIN F, 1962, SCIENCE, V138, P1331, DOI 10.1126/science.138.3547.1331; KLEIN F, 1967, P SOC EXP BIOL MED, V124, P678; KLEIN F, 1966, J INFECT DIS, V116, P123, DOI 10.1093/infdis/116.2.123; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.039; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Levi M, 2012, NETH J MED, V70, P114; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McAllister RD, 2003, AM J PATHOL, V163, P1735, DOI 10.1016/S0002-9440(10)63532-8; McColl SR, 1999, J IMMUNOL, V163, P2829; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Monroe DM, 1996, BLOOD COAGUL FIBRIN, V7, P459, DOI 10.1097/00001721-199606000-00005; Netea MG, 2000, J IMMUNOL, V164, P2644, DOI 10.4049/jimmunol.164.5.2644; Niatsetskaya Z, 2010, ANTIOXID REDOX SIGN, V12, P435, DOI 10.1089/ars.2009.2800; Norman KE, 2003, BLOOD, V101, P921, DOI 10.1182/blood-2001-12-0190; Ovanesov MV, 2005, J THROMB HAEMOST, V3, P321, DOI 10.1111/j.1538-7836.2005.01128.x; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; Rao LVM, 2004, J THROMB HAEMOST, V2, P530, DOI 10.1111/j.1538-7933.2004.00629.x; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; SAKLATVALA J, 1993, FEBS LETT, V334, P189, DOI 10.1016/0014-5793(93)81709-9; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Shikama Y, 2011, INNATE IMMUN-LONDON, V17, P3, DOI 10.1177/1753425909347508; Singh Y, 1999, INFECT IMMUN, V67, P1853; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Steiner DRS, 2001, J APPL PHYSIOL, V91, P1160, DOI 10.1152/jappl.2001.91.3.1160; Stroher U, 2001, J VIROL, V75, P11025, DOI 10.1128/JVI.75.22.11025-11033.2001; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Sutherland AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7702; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takahashi H, 2006, J LEUKOCYTE BIOL, V79, P789, DOI 10.1189/jlb.0705372; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Terra J, 2010, THESIS U CALIFORNIA; Terra JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002469; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Vandenbroucke RE, 2011, EMBO MOL MED, V3, P367, DOI 10.1002/emmm.201100146; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; WELKOS SL, 1989, MICROB PATHOGENESIS, V7, P15, DOI 10.1016/0882-4010(89)90108-3; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WILHELM DL, 1962, PHARMACOL REV, V14, P251; Wood JG, 2000, J APPL PHYSIOL, V89, P1561, DOI 10.1152/jappl.2000.89.4.1561; Xin LJ, 2007, INFECT IMMUN, V75, P5018, DOI 10.1128/IAI.00499-07; Zhu P, 1998, BIOCHEM J, V330, P975, DOI 10.1042/bj3300975; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	91	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40126	10.1371/journal.pone.0040126	http://dx.doi.org/10.1371/journal.pone.0040126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792226	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300027
J	Chiu, HW; Fang, WH; Chen, YL; Wu, MD; Yuan, GF; Ho, SY; Wang, YJ				Chiu, Hui-Wen; Fang, Wen-Hung; Chen, Yen-Lin; Wu, Ming-Der; Yuan, Gwo-Fang; Ho, Sheng-Yow; Wang, Ying-Jan			Monascuspiloin Enhances the Radiation Sensitivity of Human Prostate Cancer Cells by Stimulating Endoplasmic Reticulum Stress and Inducing Autophagy	PLOS ONE			English	Article							RED YEAST RICE; DNA-DAMAGE; COMBINATION TREATMENT; PANCREATIC-CANCER; ARSENIC TRIOXIDE; IN-VITRO; APOPTOSIS; RADIOTHERAPY; INHIBITION; INDUCTION	Prostate cancer is a very common cancer among males. Traditional treatments for prostate cancer have limited efficacy; therefore, new therapeutic strategies and/or new adjuvant drugs must be explored. Red yeast rice (RYR) is a traditional food spice made in Asia by fermenting white rice with Monascus purpureus Went yeast. Accumulating evidence indicates that RYR has antitumor activity. In this study, PC-3 cells (human prostate cancer cells) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with monascuspiloin (MP, a yellow pigment isolated from Monascus pilosus M93-fermented rice) and to determine the underlying mechanisms of these effects in vitro and in vivo. We found that IR combined with MP showed increased therapeutic efficacy when compared with either treatment alone in PC-3 cells. In addition, the combined treatment enhanced DNA damage and endoplasmic reticulum (ER) stress. The combined treatment induced primarily autophagy in PC-3 cells, and the cell death that was induced by the combined treatment was chiefly the result of inhibition of the Akt/mTOR signaling pathways. In an in vivo study, the combination treatment showed greater anti-tumor growth effects. These novel findings suggest that the combined treatment could be a potential therapeutic strategy for prostate cancer.	[Chiu, Hui-Wen; Fang, Wen-Hung; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Yen-Lin; Wu, Ming-Der; Yuan, Gwo-Fang] BCRC, Food Ind Res & Dev Inst, Hsinchu, Taiwan; [Ho, Sheng-Yow] Sinlau Christian Hosp, Dept Radiat Oncol, Tainan, Taiwan	National Cheng Kung University	Chiu, HW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	shengho@seed.net.tw; yjwang@mail.ncku.edu.tw			Food Industry Research and Development Institute; Ministry of Economic Affairs [101-EC-17-A-01-04-0525]; National Science Council, Taiwan [NSC 100-2314-B-006 -055]; Sinlau Christian Hospital, Tainan, Taiwan; Food and Drug Administration, Department, Executive Yuan [DOH101-FDA-41301]; Aim for the Top University Project	Food Industry Research and Development Institute; Ministry of Economic Affairs; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Sinlau Christian Hospital, Tainan, Taiwan; Food and Drug Administration, Department, Executive Yuan; Aim for the Top University Project	This study was supported by the Food Industry Research and Development Institute and the financial support (101-EC-17-A-01-04-0525) of the Ministry of Economic Affairs, the National Science Council, Taiwan (NSC 100-2314-B-006 -055), the Sinlau Christian Hospital, Tainan, Taiwan, Food and Drug Administration, Department, Executive Yuan (DOH101-FDA-41301) and Aim for the Top University Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Attard G, 2006, BRIT J CANCER, V95, P767, DOI 10.1038/sj.bjc.6603223; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burdak-Rothkamm S, 2009, EUR J PHARMACOL, V625, P151, DOI 10.1016/j.ejphar.2009.09.068; CHEN XP, 1987, J TRADIT MED, V5, P61; Cheng Yan, 2011, World J Biol Chem, V2, P226, DOI 10.4331/wjbc.v2.i10.226; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Dai Y, 2011, AM J CANCER RES, V1, P128; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; DiPaola RS, 2001, HEMATOL ONCOL CLIN N, V15, P509, DOI 10.1016/S0889-8588(05)70229-X; He L, 2009, FEBS LETT, V583, P903, DOI 10.1016/j.febslet.2009.02.002; Hong MY, 2008, J NUTR BIOCHEM, V19, P448, DOI 10.1016/j.jnutbio.2007.05.012; Hong MY, 2011, CANCER PREV RES, V4, P608, DOI 10.1158/1940-6207.CAPR-10-0219; Hong MY, 2008, J MED FOOD, V11, P657, DOI 10.1089/jmf.2007.0702; Hsu WH, 2012, APPL MICROBIOL BIOTE; Karnak D, 2010, CURR DRUG TARGETS, V11, P699, DOI 10.2174/138945010791170888; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee CL, 2008, APPL MICROBIOL BIOT, V79, P829, DOI 10.1007/s00253-008-1480-8; Li X, 2012, MOL CELL BIOCH; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; Martinkova L, 1999, FOOD ADDIT CONTAM, V16, P15, DOI 10.1080/026520399284280; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McArt DG, 2010, MUTAGENESIS, V25, P299, DOI 10.1093/mutage/geq006; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Mukubou H, 2010, INT J ONCOL, V37, P821, DOI 10.3892/ijo_00000732; OSBORNE CK, 1987, EUR J CANCER CLIN ON, V23, P1189; Paglin S, 2001, CANCER RES, V61, P439; Palayoor ST, 1997, RADIAT RES, V148, P105, DOI 10.2307/3579566; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Sanchez C, 2009, PROSTATE, V69, P1448, DOI 10.1002/pros.20991; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Shin SW, 2012, BBA-MOL CELL RES, V1823, P451, DOI 10.1016/j.bbamcr.2011.10.014; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Viola G, 2012, BIOCHEM PHARMACOL, V83, P16, DOI 10.1016/j.bcp.2011.09.017; Wu CT, 2007, ENDOCR-RELAT CANCER, V14, P633, DOI 10.1677/ERC-07-0073; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663	41	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40462	10.1371/journal.pone.0040462	http://dx.doi.org/10.1371/journal.pone.0040462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802963	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900036
J	Kim, SJ; Nian, C; Karunakaran, S; Clee, SM; Isales, CM; McIntosh, CHS				Kim, Su-Jin; Nian, Cuilan; Karunakaran, Subashini; Clee, Susanne M.; Isales, Carlos M.; McIntosh, Christopher H. S.			GIP-Overexpressing Mice Demonstrate Reduced Diet-Induced Obesity and Steatosis, and Improved Glucose Homeostasis	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GASTRIC-INHIBITORY POLYPEPTIDE; RECEPTOR KNOCKOUT MICE; HIGH-FAT DIET; MITOCHONDRIAL BIOGENESIS; SYNAPTIC PLASTICITY; ENERGY-EXPENDITURE; TRANSGENIC MICE; ADIPOSE-TISSUE; LIPOPROTEIN-LIPASE	Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone that potentiates glucose-stimulated insulin secretion during a meal. Since GIP has also been shown to exert beta-cell prosurvival and adipocyte lipogenic effects in rodents, both GIP receptor agonists and antagonists have been considered as potential therapeutics in type 2 diabetes (T2DM). In the present study, we tested the hypothesis that chronically elevating GIP levels in a transgenic (Tg) mouse model would increase adipose tissue expansion and exert beneficial effects on glucose homeostasis. In contrast, although GIP Tg mice demonstrated enhanced b-cell function, resulting in improved glucose tolerance and insulin sensitivity, they exhibited reduced diet-induced obesity. Adipose tissue macrophage infiltration and hepatic steatosis were both greatly reduced, and a number of genes involved in lipid metabolism/inflammatory signaling pathways were found to be down-regulated. Reduced adiposity in GIP Tg mice was associated with decreased energy intake, involving overexpression of hypothalamic GIP. Together, these studies suggest that, in the context of over-nutrition, transgenic GIP overexpression has the potential to improve hepatic and adipocyte function as well as glucose homeostasis.	[Kim, Su-Jin; Nian, Cuilan; Karunakaran, Subashini; Clee, Susanne M.; McIntosh, Christopher H. S.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Kim, Su-Jin; Nian, Cuilan; Karunakaran, Subashini; Clee, Susanne M.; McIntosh, Christopher H. S.] Univ British Columbia, Diabet Res Grp, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Isales, Carlos M.] Georgia Hlth Sci Univ, Dept Orthopaed Surg, Augusta, GA USA; [Isales, Carlos M.] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA USA	University of British Columbia; University of British Columbia; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kim, SJ (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada.	mcintoch@mail.ubc.ca	Clee, Susanne/AAC-4278-2020; Isales, Carlos/J-9902-2013; Clee, Susanne/F-7312-2010	Isales, Carlos/0000-0002-4480-3484; Clee, Susanne/0000-0001-7946-688X	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR)	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	These studies were generously supported by funding to CHSM from the Canadian Diabetes Association (CDA) and the Canadian Institutes of Health Research (CIHR), and to SMC from the CDA. SMC holds a Canada Research Chair in the Genetics of Obesity and Diabetes and is a Michael Smith Foundation for Health Research (MSFHR) scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Andrews Zane B, 2010, Curr Aging Sci, V3, P102; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Ding KH, 2006, PEPTIDES, V27, P2750, DOI 10.1016/j.peptides.2006.05.011; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007; Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Gault VA, 2011, J ENDOCRINOL, V208, P265, DOI 10.1530/JOE-10-0419; Getty-Kaushik L, 2006, OBESITY, V14, P1124, DOI 10.1038/oby.2006.129; Gniuli D, 2010, DIABETOLOGIA, V53, P2233, DOI 10.1007/s00125-010-1830-9; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hawke Z, 2009, J NEUROSCI, V29, P14828, DOI 10.1523/JNEUROSCI.1526-09.2009; Hinke SA, 2002, DIABETES, V51, P652, DOI 10.2337/diabetes.51.3.652; Hinke SA, 2000, J ENDOCRINOL, V165, P281, DOI 10.1677/joe.0.1650281; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin N, 2006, PEPTIDES, V27, P893, DOI 10.1016/j.peptides.2005.08.003; Irwin N, 2009, DIABETOLOGIA, V52, P1724, DOI 10.1007/s00125-009-1422-8; Irwin N, 2010, EXPERT OPIN INV DRUG, V19, P1039, DOI 10.1517/13543784.2010.513381; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kerr BD, 2009, BIOCHEM PHARMACOL, V78, P1008, DOI 10.1016/j.bcp.2009.05.037; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim SJ, 2007, J BIOL CHEM, V282, P34139, DOI 10.1074/jbc.M704896200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kim SJ, 2011, J LIPID RES, V52, P759, DOI 10.1194/jlr.M012203; Kim SJ, 2010, J LIPID RES, V51, P3145, DOI 10.1194/jlr.M006841; Kohlstedt K, 2011, BASIC RES CARDIOL, V106, P205, DOI 10.1007/s00395-010-0137-9; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; McIntosh CHS, 2010, VITAM HORM, V84, P21, DOI [10.1016/S0083-6729(10)84016-6, 10.1016/B978-0-12-381517-0.00002-3]; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; McIntosh CHS, 1999, ENDOCRINOLOGY, V140, P398, DOI 10.1210/en.140.1.398; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mohammad S, 2011, J BIOL CHEM, V286, P43062, DOI 10.1074/jbc.M111.289009; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nyberg J, 2007, J NEUROSCI RES, V85, P2099, DOI 10.1002/jnr.21349; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; Porter DW, 2011, EUR J PHARMACOL, V650, P688, DOI 10.1016/j.ejphar.2010.10.059; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Widenmaier SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009590; Xie D, 2007, BONE, V40, P1352, DOI 10.1016/j.bone.2007.01.007; Ye JM, 2004, DIABETOLOGIA, V47, P1306, DOI 10.1007/s00125-004-1436-1	55	96	105	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40156	10.1371/journal.pone.0040156	http://dx.doi.org/10.1371/journal.pone.0040156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802954	Green Published, gold, Green Submitted			2022-12-25	WOS:000306186900028
J	Das, S; Bryan, K; Buckley, PG; Piskareva, O; Bray, IM; Foley, N; Ryan, J; Lynch, J; Creevey, L; Fay, J; Prenter, S; Koster, J; van Sluis, P; Versteeg, R; Eggert, A; Schulte, JH; Schramm, A; Mestdagh, P; Vandesompele, J; Speleman, F; Stallings, RL				Das, S.; Bryan, K.; Buckley, P. G.; Piskareva, O.; Bray, I. M.; Foley, N.; Ryan, J.; Lynch, J.; Creevey, L.; Fay, J.; Prenter, S.; Koster, J.; van Sluis, P.; Versteeg, R.; Eggert, A.; Schulte, J. H.; Schramm, A.; Mestdagh, P.; Vandesompele, J.; Speleman, F.; Stallings, R. L.			Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs	ONCOGENE			English	Article						miRNA; methylation; tumor suppressor; neuroblastoma; SOX2	TUMOR-SUPPRESSOR; PROMOTES TRANSFORMATION; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; RETINOIC ACID; EXPRESSION; METHYLATION; GENE; DIFFERENTIATION; PATTERNS	MicroRNAs (miRNAs) contribute to the pathogenesis of many forms of cancer, including the pediatric cancer neuroblastoma, but the underlying mechanisms leading to altered miRNA expression are often unknown. Here, a novel integrated approach for analyzing DNA methylation coupled with miRNA and mRNA expression data sets identified 67 epigenetically regulated miRNA in neuroblastoma. A large proportion (42%) of these miRNAs was associated with poor patient survival when underexpressed in tumors. Moreover, we demonstrate that this panel of epigenetically silenced miRNAs targets a large set of genes that are overexpressed in tumors from patients with poor survival in a highly redundant manner. The genes targeted by the epigenetically regulated miRNAs are enriched for a number of biological processes, including regulation of cell differentiation. Functional studies involving ectopic overexpression of several of the epigenetically silenced miRNAs had a negative impact on neuroblastoma cell viability, providing further support to the concept that inactivation of these miRNAs is important for neuroblastoma disease pathogenesis. One locus, miR-340, induced either differentiation or apoptosis in a cell context dependent manner, indicating a tumor suppressive function for this miRNA. Intriguingly, it was determined that miR-340 is upregulated by demethylation of an upstream genomic region that occurs during the process of neuroblastoma cell differentiation induced by all-trans retinoic acid (ATRA). Further biological studies of miR-340 revealed that it directly represses the SOX2 transcription factor by targeting of its 30-untranslated region, explaining the mechanism by which SOX2 is downregulated by ATRA. Although SOX2 contributes to the maintenance of stem cells in an undifferentiated state, we demonstrate that miR-340-mediated downregulation of SOX2 is not required for ATRA induced differentiation to occur. In summary, our results exemplify the dynamic nature of the miRNA epigenome and identify a remarkable network of miRNA/mRNA interactions that significantly contribute to neuroblastoma disease pathogenesis.	[Das, S.; Bryan, K.; Buckley, P. G.; Piskareva, O.; Bray, I. M.; Foley, N.; Ryan, J.; Lynch, J.; Creevey, L.; Fay, J.; Prenter, S.; Stallings, R. L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Das, S.; Bryan, K.; Buckley, P. G.; Piskareva, O.; Bray, I. M.; Foley, N.; Ryan, J.; Lynch, J.; Creevey, L.; Fay, J.; Prenter, S.; Stallings, R. L.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Koster, J.; van Sluis, P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Eggert, A.; Schulte, J. H.; Schramm, A.] Univ Childrens Hosp, Essen, Germany; [Mestdagh, P.; Vandesompele, J.; Speleman, F.] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Amsterdam; Academic Medical Center Amsterdam; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ghent University; Ghent University Hospital	Stallings, RL (corresponding author), Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, York House,York St, Dublin 2, Ireland.	rstallings@rcsi.ie	Versteeg, Rogier/AAQ-1765-2020; Vandesompele, Jo/W-3411-2018; Eggert, Angelika/AAE-6907-2022; Schulte, Johannes H/G-3981-2010; Schulte, Johannes H./V-2474-2018; Koster, Jan/C-5934-2008; Schramm, Alexander/G-5688-2010; Stallings, Raymond/A-7213-2008; speleman, frank/AAR-5184-2020	Vandesompele, Jo/0000-0001-6274-0184; Eggert, Angelika/0000-0003-3476-8184; Koster, Jan/0000-0002-0890-7585; Schramm, Alexander/0000-0001-7670-7529; speleman, frank/0000-0002-6628-8559; Versteeg, Rogier/0000-0001-7172-0388; Fay, Joanna/0000-0001-6294-2886; Mestdagh, Pieter/0000-0001-7821-9684; Schulte, Johannes Hubertus/0000-0003-0671-1201; Bryan, Kenneth/0000-0002-9550-8354	Science Foundation Ireland [07/IN.1/B1776]; Children's Medical and Research Foundation; NIH [5R01CA127496]; NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from Science Foundation Ireland (07/IN.1/B1776), Children's Medical and Research Foundation and NIH (5R01CA127496).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Buckley PG, 2011, INT J CANCER, V128, P2296, DOI 10.1002/ijc.25584; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Das S, 2010, CANCER RES, V70, P7874, DOI 10.1158/0008-5472.CAN-10-1534; Decock A, 2011, EPIGENETICS-US, V6, P962, DOI 10.4161/epi.6.8.16516; Gomez-Mateo MD, 2011, GENE CHROMOSOME CANC, V50, P374, DOI 10.1002/gcc.20859; Dudziec E, 2011, CLIN CANCER RES, V17, P1287, DOI 10.1158/1078-0432.CCR-10-2017; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Foley NH, 2011, CELL DEATH DIFFER, V18, P1089, DOI 10.1038/cdd.2010.172; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Girgert R, 1997, J NEURO-ONCOL, V31, P93, DOI 10.1023/A:1005789516322; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoebeeck J, 2009, CANCER LETT, V273, P336, DOI 10.1016/j.canlet.2008.08.019; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lopez-Serra P., 2011, ONCOGENE; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; SIDELL N, 1982, J NATL CANCER I, V68, P589; Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136; Stallings RL, 2011, SEMIN CANC BIOL; Stevanovic M, 2003, MOL BIOL REP, V30, P127, DOI 10.1023/A:1023961009869; Tivnan A, 2010, ANTICANCER RES, V30, P4391; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang QW, 2007, CLIN CANCER RES, V13, P3191, DOI 10.1158/1078-0432.CCR-06-2846; Yang QW, 2004, CANCER RES, V64, P4531, DOI 10.1158/0008-5472.CAN-04-0956; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147	56	65	68	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2013	32	24					2927	2936		10.1038/onc.2012.311	http://dx.doi.org/10.1038/onc.2012.311			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22797059	Green Accepted			2022-12-25	WOS:000320369700003
J	Krajewska, M; Heijink, AM; Bisselink, YJWM; Seinstra, RI; Sillje, HHW; de Vries, EGE; van Vugt, MATM				Krajewska, M.; Heijink, A. M.; Bisselink, Y. J. W. M.; Seinstra, R. I.; Sillje, H. H. W.; de Vries, E. G. E.; van Vugt, M. A. T. M.			Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination	ONCOGENE			English	Article						Wee1; homologous recombination; DNA repair; cell cycle checkpoint; MK-1775	CYCLIN-DEPENDENT KINASES; DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND-BREAK; CELL-CYCLE; END RESECTION; REGULATORY MECHANISM; MAMMALIAN-CELLS; REPAIR; PHOSPHORYLATION; RECOVERY	In response to DNA breaks, the 'DNA damage response' provokes a cell cycle arrest to facilitate DNA repair. Recent findings have indicated that cells can respond to DNA damage throughout the cell cycle, except during mitosis. Specifically, various mitotic kinases, including Cdk1, Aurora A and Plk1, were shown to inactivate key DNA damage checkpoint proteins when cells enter mitosis. Aberrant activation of mitotic kinases during interphase could therefore modulate cellular responses to DNA damage. In this study, our aim was to determine how aberrant activation of Cdk1 affects the cellular responses to DNA damage. We used Wee1 inhibition, using MK-1775, to force Cdk1 activation, which did not cause cytotoxicity in non-transformed cells. Instead, it accelerated mitotic entry and caused radio sensitization in p53-defective cancer cells, but not in p53-proficient cancer cells. Interestingly, we showed that Wee1 inhibition leads to elevation of Cdk1 activity in interphase cells. When we subsequently analyzed DNA damage responses in cells with forced Cdk1 activation, we observed a marked reduction of 53BP1 at sites of DNA damage along with an increase in g-H2AX staining after irradiation, indicative of defective DNA repair. Indeed, when DNA repair was analyzed using in vivo endonuclease-induced homologous recombination (HR) assays, compromised DNA repair after Wee1 inhibition was confirmed. This defect in HR was accompanied by increased phosphorylation of BRCA2 at the Cdk1 phosphorylation site S3291. Taken together, our results indicate that Wee1 inhibition leads to forced Cdk1 activation in interphase cells, which interferes with normal DNA damage responses.	[Krajewska, M.; Heijink, A. M.; Bisselink, Y. J. W. M.; Seinstra, R. I.; de Vries, E. G. E.; van Vugt, M. A. T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9713 GZ Groningen, Netherlands; [Sillje, H. H. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 GZ Groningen, Netherlands	University of Groningen; University of Groningen	van Vugt, MATM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	m.vugt@umcg.nl	Krajewska, Malgorzata/AAH-1158-2021	Heijink, Anne Margriet/0000-0001-9229-0575; Krajewska, Malgorzata/0000-0002-2243-5924; de Vries, Elisabeth/0000-0002-8949-7425	NWO-VENI grant [916.76.062]	NWO-VENI grant	This work was supported by a NWO-VENI grant (916.76.062) to MATMVV. We thank Drs Maria Jasin, Jeff Parvin, Reuven Agami, James Ferrell Jr and Vera Gorbunova for generously supplying materials, Dr Gerben Vader for critically reading the manuscript and members of the Medical Oncology laboratory for helpful discussions.	Adams Bret R, 2010, Aging (Albany NY), V2, P582; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Crescenzi E, 2005, CLIN CANCER RES, V11, P8158, DOI 10.1158/1078-0432.CCR-05-1042; Dominguez-Kelly R, 2011, J CELL BIOL, V194, P567, DOI 10.1083/jcb.201101047; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; HARPER JW, 1993, CELL, V75, P805; Hirai H, 2010, CANCER BIOL THER, V9, P514, DOI 10.4161/cbt.9.7.11115; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Leijen S, 2010, CURR CLIN PHARMACOL, V5, P186, DOI 10.2174/157488410791498824; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PARVIN J, 2011, J VIS EXP, V48, pE2468; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Scully R, 2005, ONCOGENE, V24, P2871, DOI 10.1038/sj.onc.1208609; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van Vugt MATM, 2010, CELL CYCLE, V9, P2097, DOI 10.4161/cc.9.11.11840; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	41	92	93	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 13	2013	32	24					3001	3008		10.1038/onc.2012.296	http://dx.doi.org/10.1038/onc.2012.296			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22797065				2022-12-25	WOS:000320369700010
J	Ezponda, T; Popovic, R; Shah, MY; Martinez-Garcia, E; Zheng, Y; Min, DJ; Will, C; Neri, A; Kelleher, NL; Yu, J; Licht, JD				Ezponda, T.; Popovic, R.; Shah, M. Y.; Martinez-Garcia, E.; Zheng, Y.; Min, D-J; Will, C.; Neri, A.; Kelleher, N. L.; Yu, J.; Licht, J. D.			The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer	ONCOGENE			English	Article						MMSET; histone methylation; epithelial-mesenchymal transition; invasion; prostate cancer	MULTIPLE-MYELOMA; GENE-EXPRESSION; MODIFICATION PATTERNS; UP-REGULATION; PREDICT RISK; MMSET; PROTEIN; CLASSIFICATION; IDENTIFICATION; CHARACTERIZES	Epigenetic deregulation of gene expression has a role in the initiation and progression of prostate cancer (PCa). The histone methyltransferase MMSET/WHSC1 (Multiple Myeloma SET domain) is overexpressed in a number of metastatic tumors, but its mechanism of action has not been defined. In this work, we found that PCa cell lines expressed significantly higher levels of MMSET compared with immortalized, non-transformed prostate cells. Knockdown experiments showed that, in metastatic PCa cell lines, dimethylation of lysine 36 and trimethylation of lysine 27 on histone H3 (H3K36me2 and H3K27me3, respectively) depended on MMSET expression, whereas depletion of MMSET in benign prostatic cells did not affect chromatin modifications. Knockdown of MMSET in DU145 and PC-3 tumor cells decreased cell proliferation, colony formation in soft agar and strikingly diminished cell migration and invasion. Conversely, overexpression of MMSET in immortalized, non-transformed RWPE-1 cells promoted cell migration and invasion, accompanied by an epithelial-mesenchymal transition (EMT). Among a panel of EMT-promoting genes analyzed, TWIST1 expression was strongly activated in response to MMSET. Chromatin immunoprecipitation analysis demonstrated that MMSET binds to the TWIST1 locus and leads to an increase in H3K36me2, suggesting a direct role of MMSET in the regulation of this gene. Depletion of TWIST1 in MMSET-overexpressing RWPE-1 cells blocked cell invasion and EMT, indicating that TWIST1 was a critical target of MMSET, responsible for the acquisition of an invasive phenotype. Collectively, these data suggest that MMSET has a role in PCa pathogenesis and progression through epigenetic regulation of metastasis-related genes.	[Ezponda, T.; Popovic, R.; Shah, M. Y.; Martinez-Garcia, E.; Min, D-J; Will, C.; Kelleher, N. L.; Yu, J.; Licht, J. D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zheng, Y.; Kelleher, N. L.] Northwestern Univ, Dept Chem, Dept Mol Biosci, Evanston, IL USA; [Zheng, Y.; Kelleher, N. L.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [Neri, A.] Univ Milan, Dept Med Sci, Fdn Ist Ricovero & Cura Carattere Sci Policlin, Hematol Ctr Trapianti Midollo Osseo 1, Milan, Italy	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University; University of Milan	Licht, JD (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Feinberg Sch Med, Lurie 5-123,303 E Super St, Chicago, IL 60611 USA.	j-licht@northwestern.edu	Neri, Antonino/I-9690-2014; Licht, Jonathan/AAL-9184-2020; Ezponda, Teresa/AAA-5040-2020; Zheng, Yupeng/B-3782-2014; Licht, Jonathan/L-4239-2019	Neri, Antonino/0000-0001-9047-5912; Licht, Jonathan/0000-0002-3942-1369; Ezponda, Teresa/0000-0003-3682-7125; Zheng, Yupeng/0000-0002-3351-5161	Fundacion Alfonso Martin Escudero fellowship; Ruth Kirschstein National Research Service Award [F32HL099177]; Associazione Italiana Ricerca sul Cancro (AIRC); NIH [K99/R00CA129565]; U.S. Department of Defense [W81XWH-09-1-0193]; American Cancer Society [RSG-12-085-01, R01GM067193, RO1CA123204]; Leukemia and Lymphoma Society Specialized Center of Research Award; Physical Sciences Oncology Center grant [U54CA143869]; NATIONAL CANCER INSTITUTE [R01CA123204, U54CA143869, K99CA129565, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL099177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067193] Funding Source: NIH RePORTER	Fundacion Alfonso Martin Escudero fellowship; Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society Specialized Center of Research Award(Leukemia and Lymphoma Society); Physical Sciences Oncology Center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Fundacion Alfonso Martin Escudero fellowship (T.E.), a Ruth Kirschstein National Research Service Award F32HL099177 (R.P.), the Associazione Italiana Ricerca sul Cancro (AIRC) (A.N.), NIH K99/R00CA129565 (J.Y.), the U.S. Department of Defense W81XWH-09-1-0193 (J.Y.), a Research Scholar Award RSG-12-085-01 from the American Cancer Society (J.Y.), R01GM067193 (N.L.K.), RO1CA123204 (J.D.L.) a Leukemia and Lymphoma Society Specialized Center of Research Award (J.D.L.) and Physical Sciences Oncology Center grant U54CA143869 (J.D.L. and N.L.K.).	Agnelli L, 2005, J CLIN ONCOL, V23, P7296, DOI 10.1200/JCO.2005.01.3870; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bianco-Miotto T, CANC EPIDEMIOL BIOMA, V19, P2611; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Daigle SR, CANC CELL, V20, P53; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garlisi CG, 2001, AM J RESP CELL MOL, V24, P90, DOI 10.1165/ajrcmb.24.1.4224; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hudlebusch HR, CLIN CANC RES, V17, P2919; Hudlebusch HR, CANC RES, V71, P4226; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kassambara A, 2009, BIOCHEM BIOPH RES CO, V379, P840, DOI 10.1016/j.bbrc.2008.12.093; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li J, 2008, NEURO-ONCOLOGY, V10, P45, DOI 10.1215/15228517-2007-036; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Lombardi L, 2007, GENE CHROMOSOME CANC, V46, P226, DOI 10.1002/gcc.20404; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Morishita M, 2011, BBA-REV CANCER, V1816, P158, DOI 10.1016/j.bbcan.2011.05.004; Okabe H, 2001, CANCER RES, V61, P2129; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Schulz WA, 2006, J CELL MOL MED, V10, P100, DOI 10.1111/j.1582-4934.2006.tb00293.x; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyokawa G, 2011, NEOPLASIA, V13, P887, DOI 10.1593/neo.11048; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143	52	95	103	1	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2013	32	23					2882	2890		10.1038/onc.2012.297	http://dx.doi.org/10.1038/onc.2012.297			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22797064	Green Accepted			2022-12-25	WOS:000320369100008
J	Del Vecchio, CA; Giacomini, CP; Vogel, H; Jensen, KC; Florio, T; Merlo, A; Pollack, JR; Wong, AJ				Del Vecchio, C. A.; Giacomini, C. P.; Vogel, H.; Jensen, K. C.; Florio, T.; Merlo, A.; Pollack, J. R.; Wong, A. J.			EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms	ONCOGENE			English	Article						EGFRvIII; glioblastoma; HDAC; methylation; amplification	GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITORS; TUMOR-INITIATING CELLS; TRICHOSTATIN-A; IN-VIVO; LUNG CARCINOMAS; HDAC INHIBITORS; BREAST-CANCER; VALPROIC ACID; BRAIN-TUMORS	Amplification and rearrangements of the epidermal growth factor receptor (EGFR) gene are frequently found in glioblastoma multiforme (GBM). The most common variant is EGFR variant III (EGFRvIII). Research suggests that EGFRvIII could be a marker for a cancer stem cell or tumor-initiating population. If amplification and rearrangement are early events in tumorigenesis, this implies that they should be preserved throughout the tumor. However, in primary GBM, EGFRvIII expression is focal and sporadic. Unexpectedly, we found EGFR amplification and rearrangement throughout the tumor, including regions with no EGFRvIII expression, suggesting that mechanisms exist to modulate EGFRvIII expression even in the presence of high gene amplification. To study this phenomenon, we characterized three GBM cell lines with endogenous EGFRvIII. EGFRvIII expression was heterogeneous, with both positive and negative populations maintaining the genetic alterations, akin to primary tumors. Furthermore, EGFRvIII defined a hierarchy where EGFRvIII-positive cells gave rise to additional positive and negative cells. Only cells that had recently lost EGFRvIII expression could re-express EGFRvIII, providing an important buffer for maintaining EGFRvIII-positive cell numbers. Epigenetic mechanisms had a role in maintaining heterogeneous EGFRvIII expression. Demethylation induced a 20-60% increase in the percentage of EGFRvIII-positive cells, indicating that some cells could re-express EGFRvIII. Surprisingly, inhibition of histone deacetylation resulted in a 50-80% reduction in EGFRvIII expression. Collectively, this data demonstrates that EGFR amplification and rearrangement are early events in tumorigenesis and EGFRvIII follows a model of hierarchical expression. Furthermore, EGFRvIII expression is restricted by epigenetic mechanisms, suggesting that drugs that modulate the epigenome might be used successfully in glioblastoma tumors.	[Del Vecchio, C. A.; Wong, A. J.] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA; [Del Vecchio, C. A.; Giacomini, C. P.; Pollack, J. R.; Wong, A. J.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Giacomini, C. P.; Vogel, H.; Jensen, K. C.; Pollack, J. R.] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Jensen, K. C.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Florio, T.] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; [Merlo, A.] Univ Basel, Lab Mol Neurooncol, Dept Clin & Biol Sci, Basel, Switzerland	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Genoa; University of Basel	Wong, AJ (corresponding author), Stanford Univ, Med Ctr, Dept Neurosurg, Canc Biol Program, 1201 Welch Rd,MSLS P108, Stanford, CA 94305 USA.	ajwong@stanford.edu	Florio, Tullio/A-2211-2012; FLORIO, TULLIO/ABG-3182-2020	Florio, Tullio/0000-0002-2394-996X; Vogel, Otto Hannes/0000-0002-0960-3508; Del Vecchio Fitz, Catherine/0000-0002-9554-411X; Jensen, Kristin/0000-0003-1177-9104	National Defense Science and Engineering Graduate Research Fellowship; National Science Foundation Graduate Research Fellowship; NIH [CA124832, RC2 CA14891]; Lucille Packard Children's Foundation; National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA124832, R01CA069495, RC2CA148491] Funding Source: NIH RePORTER	National Defense Science and Engineering Graduate Research Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille Packard Children's Foundation; National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Neethan Lobo, Dr Siddhartha Mitra, Dr A Hunter Shain and the Stanford FACS facility for technical advice. Additionally, we thank Dana Bangs and Dr Athena Cherry at the Stanford Cytogenetics Laboratory for their assistance with FISH staining and analysis. This work was supported by the National Defense Science and Engineering Graduate Research Fellowship, the National Science Foundation Graduate Research Fellowship, NIH Grants CA124832, RC2 CA14891, the Lucille Packard Children's Foundation and a research grant from the National Brain Tumor Foundation.	Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bialer M, 2007, NEUROTHERAPEUTICS, V4, P130, DOI 10.1016/j.nurt.2006.11.007; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; BIGNER SH, 1990, CANCER RES, V50, P8017; Camphausen K, 2005, INT J CANCER, V114, P380, DOI 10.1002/ijc.20774; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; DEPALAZZO IEG, 1993, CANCER RES, V53, P3217; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Jones G, 2001, CANCER RES, V61, P4978; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; Nagane M, 2001, J NEUROSURG, V95, P472, DOI 10.3171/jns.2001.95.3.0472; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Olapade-Olaopa EO, 2000, BRIT J CANCER, V82, P186; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Shabason JE, 2011, J CELL MOL MED, V15, P2735, DOI 10.1111/j.1582-4934.2011.01296.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Solomon DA, 2009, CANCER RES, V69, P5630, DOI 10.1158/0008-5472.CAN-09-1055; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Svechnikova I, 2008, INT J ONCOL, V32, P821; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tang CK, 2000, CANCER RES, V60, P3081; Thomas C, 2001, ACTA NEUROPATHOL, V101, P605; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; VONHOFF DD, 1991, CANCER RES, V51, P6273; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Witusik-Perkowska M, 2011, J NEURO-ONCOL, V102, P395, DOI 10.1007/s11060-010-0352-0; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; WONG AJ, 2008, J CLIN ONCOL S, V26, P2002; YAMAZAKI H, 1988, MOL CELL BIOL, V8, P1816, DOI 10.1128/MCB.8.4.1816; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	45	80	82	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2013	32	21					2670	2681		10.1038/onc.2012.280	http://dx.doi.org/10.1038/onc.2012.280			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FH	22797070	Bronze			2022-12-25	WOS:000319806700008
J	Albrecht, DW; Herdendorf, TJ; Nelson, SW				Albrecht, Dustin W.; Herdendorf, Timothy J.; Nelson, Scott W.			Disruption of the Bacteriophage T4 Mre11 Dimer Interface Reveals a Two-state Mechanism for Exonuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CRYSTAL-STRUCTURE; HOMOLOGOUS RECOMBINATION; DNA-REPLICATION; ATP HYDROLYSIS; PROTEINS; INSIGHTS; ENZYME; EXO1	The Mre11-Rad50 (MR) complex is a central player in DNA repair and is implicated in the processing of DNA ends caused by double strand breaks. Recent crystal structures of the MR complex suggest that several conformational rearrangements occur during its ATP hydrolysis cycle. A comparison of the Mre11 dimer interface from these structures suggests that the interface is dynamic in nature and may adopt several different arrangements. To probe the functional significance of the Mre11 dimer interface, we have generated and characterized a dimer disruption Mre11 mutant (L101D-Mre11). Although L101D-Mre11 binds to Rad50 and dsDNA with affinity comparable with the wild-type enzyme, it does not activate the ATP hydrolysis activity of Rad50, suggesting that the allosteric communication between Mre11 and Rad50 has been interrupted. Additionally, the dsDNA exonuclease activity of the L101D-MR complex has been reduced by 10-fold under conditions where processive exonuclease activity is required. However, we unexpectedly found that under steady state conditions, the nuclease activity of the L101D-MR complex is significantly greater than that of the wild-type complex. Based on steady state and single-turnover nuclease assays, we have assigned the rate-determining step of the steady state nuclease reaction to be the productive assembly of the complex at the dsDNA end. Together, our data suggest that the Mre11 dimer interface adopts at least two different states during the exonuclease reaction.	[Albrecht, Dustin W.; Herdendorf, Timothy J.; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu			Carver Trust Young Investigator Grant [10-3603]; Iowa State University institutional support; National Science Foundation Grant [MCB-1121693]; Div Of Molecular and Cellular Bioscience [1121693] Funding Source: National Science Foundation	Carver Trust Young Investigator Grant; Iowa State University institutional support; National Science Foundation Grant(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Carver Trust Young Investigator Grant 10-3603 (to S.W.N.), Iowa State University institutional support (to S.W.N.), and National Science Foundation Grant MCB-1121693 (to S.W.N.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Das D, 2010, J MOL BIOL, V397, P647, DOI 10.1016/j.jmb.2010.01.049; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Herdendorf TJ, 2011, BIOCHEMISTRY-US, V50, P6030, DOI 10.1021/bi200184w; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; KREUZER KN, 1988, J BIOL CHEM, V263, P11366; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Majka J, 2012, J BIOL CHEM, V287, P2328, DOI 10.1074/jbc.M111.307041; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	40	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31371	31381		10.1074/jbc.M112.392316	http://dx.doi.org/10.1074/jbc.M112.392316			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22798142	Green Published, hybrid			2022-12-25	WOS:000308791300048
J	Hartmann, J; Tran, TV; Kaudeer, J; Oberle, K; Herrmann, J; Quagliano, I; Abel, T; Cohnen, A; Gatterdam, V; Jacobs, A; Wollscheid, B; Tampe, R; Watzl, C; Diefenbach, A; Koch, J				Hartmann, Jessica; Thuy-Van Tran; Kaudeer, Janina; Oberle, Karin; Herrmann, Julia; Quagliano, Isabell; Abel, Tobias; Cohnen, Andre; Gatterdam, Volker; Jacobs, Andrea; Wollscheid, Bernd; Tampe, Robert; Watzl, Carsten; Diefenbach, Andreas; Koch, Joachim			The Stalk Domain and the Glycosylation Status of the Activating Natural Killer Cell Receptor NKp30 Are Important for Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-ASSOCIATED TRANSCRIPT-3; VIRUS-INFECTED CELLS; HEPARAN-SULFATE; DENDRITIC CELLS; NK CELLS; CYTOTOXICITY RECEPTORS; SURFACE-MOLECULE; TUMOR; RECOGNITION; NKP46	The natural cytotoxicity receptors are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. The human natural cytotoxicity receptor family comprises the three type I membrane proteins NKp30, NKp44, and NKp46. Especially NKp30 is critical for the cytotoxicity of NK cells against different targets including tumor, virus-infected, and immature dendritic cells. Although the crystal structure of NKp30 was recently solved (Li, Y., Wang, Q., and Mariuzza, R. A. (2011) J. Exp. Med. 208, 703-714; Joyce, M. G., Tran, P., Zhuravleva, M. A., Jaw, J., Colonna, M., and Sun, P. D. (2011) Proc. Natl. Acad. Sci. U.S.A. 108, 6223-6228), a key question, how NKp30 recognizes several non-related ligands, remains unclear. Therefore, we investigated the parameters that impact ligand recognition of NKp30. Based on various NKp30-hIgG1-Fc fusion proteins, which were optimized for minimal background binding to cellular Fc gamma receptors, we identified the flexible stalk region of NKp30 as an important but so far neglected module for ligand recognition and related signaling of the corresponding full-length receptor proteins. Moreover, we found that the ectodomain of NKp30 is N-linked glycosylated at three different sites. Mutational analyses revealed differential binding affinities and signaling capacities of mono-, di-, or triglycosylated NKp30, suggesting that the degree of glycosylation could provide a switch to modulate the ligand binding properties of NKp30 and NK cell cytotoxicity.	[Hartmann, Jessica; Thuy-Van Tran; Kaudeer, Janina; Herrmann, Julia; Quagliano, Isabell; Koch, Joachim] Inst Biomed Res, D-60596 Frankfurt, Germany; [Oberle, Karin; Diefenbach, Andreas] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Abel, Tobias] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Cohnen, Andre; Watzl, Carsten] Leibniz Res Ctr Working Environm & Human Factors, IfADo, D-44139 Dortmund, Germany; [Gatterdam, Volker; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Jacobs, Andrea; Wollscheid, Bernd] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Freiburg; Paul Ehrlich Institute; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Goethe University Frankfurt; Swiss Federal Institutes of Technology Domain; ETH Zurich	Koch, J (corresponding author), Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	joachim.koch@em.uni-frankfurt.de	Diefenbach, Andreas/T-2589-2018; Wollscheid, Bernd/E-8909-2010; Tampé, Robert/H-2953-2015; Hartmann, Jessica/AAL-8849-2021; Watzl, Carsten/B-4911-2013	Diefenbach, Andreas/0000-0002-9176-9530; Wollscheid, Bernd/0000-0002-3923-1610; Tampé, Robert/0000-0002-0403-2160; Hartmann, Jessica/0000-0001-9372-8954; Watzl, Carsten/0000-0001-5195-0995; Gatterdam, Volker/0000-0001-7078-9885	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/17.004]; German Federal Ministry of Health (Bundesministerium fur Gesundheit); Ministry of Higher Education, Research and the Arts of the State of Hessen (Hessisches Ministerium fur Wissenschaft und Kunst)	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst; German Federal Ministry of Health (Bundesministerium fur Gesundheit); Ministry of Higher Education, Research and the Arts of the State of Hessen (Hessisches Ministerium fur Wissenschaft und Kunst)	This work was supported in part by grants from the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) Center for Cell and Gene Therapy Frankfurt funded by Hessisches Ministerium fur Wissenschaft und Kunst funding reference number III L 4-518/17.004 (2010).; We thank Alexander Steinle for critical review of the manuscript and helpful discussions. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (Bundesministerium fur Gesundheit) and the Ministry of Higher Education, Research and the Arts of the State of Hessen (Hessisches Ministerium fur Wissenschaft und Kunst).	Andersen PS, 2001, J BIOL CHEM, V276, P49125, DOI 10.1074/jbc.M109396200; ANDERSON CL, 1982, J EXP MED, V156, P1794, DOI 10.1084/jem.156.6.1794; Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biassoni Roberto, 2009, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1410s84; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Byrd A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001339; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Funke J, 2011, AIDS REV, V13, P67; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hershkovitz O, 2008, GLYCOBIOLOGY, V18, P28, DOI 10.1093/glycob/cwm125; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Jarahian M, 2009, J VIROL, V83, P8108, DOI 10.1128/JVI.00211-09; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Joyce MG, 2011, P NATL ACAD SCI USA, V108, P6223, DOI 10.1073/pnas.1100622108; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; McCann FE, 2002, IMMUNOL REV, V189, P179, DOI 10.1034/j.1600-065X.2002.18915.x; MCCOOL D, 1985, J IMMUNOL, V135, P1975; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Ponnampalam AP, 2008, EUR J IMMUNOL, V38, P216, DOI 10.1002/eji.200636429; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Sivori S, 2000, J NEUROIMMUNOL, V107, P220, DOI 10.1016/S0165-5728(00)00221-6; Srivastava BIS, 2006, LEUKEMIA RES, V30, P37, DOI 10.1016/j.leukres.2005.06.020; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Warren HS, 2005, J IMMUNOL, V175, P207, DOI 10.4049/jimmunol.175.1.207; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923; Zheng XX, 1999, J IMMUNOL, V163, P4041	53	31	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31527	31539		10.1074/jbc.M111.304238	http://dx.doi.org/10.1074/jbc.M111.304238			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807449	Green Published, hybrid			2022-12-25	WOS:000308791300065
J	Lu, YL; Kwan, AH; Jeffries, CM; Guss, JM; Trewhella, J				Lu, Yanling; Kwan, Ann H.; Jeffries, Cy M.; Guss, J. Mitchell; Trewhella, Jill			The Motif of Human Cardiac Myosin-binding Protein C Is Required for Its Ca2+-dependent Interaction with Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; RAY-SCATTERING REVEALS; TARGET RECOGNITION; REGULATORY DOMAIN; PHOSPHORYLATION; MUSCLE; MUTATIONS; COMPLEX; IDENTIFICATION	The N-terminal modules of cardiac myosin-binding protein C (cMyBP-C) play a regulatory role in mediating interactions between myosin and actin during heart muscle contraction. The so-called "motif," located between the second and third immunoglobulin modules of the cardiac isoform, is believed to modulate contractility via an "on-off" phosphorylation-dependent tether to myosin Delta S2. Here we report a novel Ca2+-dependent interaction between the motif and calmodulin (CaM) based on the results of a combined fluorescence, NMR, and light and x-ray scattering study. We show that constructs of cMyBP-C containing the motif bind to Ca2+/CaM with a moderate affinity (K-D similar to 10 mu M), which is similar to the affinity previously determined for myosin Delta S2. However, unlike the interaction with myosin Delta S2, the Ca2+/CaM interaction is unaffected by substitution with a triphosphorylated motif mimic. Further, Ca2+/CaM interacts with the highly conserved residues (Glu(319)-Lys(341)) toward the C-terminal end of the motif. Consistent with the Ca2+ dependence, the binding of CaM to the motif is mediated via the hydrophobic clefts within the N- and C-lobes that are known to become more exposed upon Ca2+ binding. Overall, Ca2+/CaM engages with the motif in an extended clamp configuration as opposed to the collapsed binding mode often observed in other CaM-protein interactions. Our results suggest that CaM may act as a structural conduit that links cMyBP-C with Ca2+ signaling pathways to help coordinate phosphorylation events and synchronize the multiple interactions between cMyBP-C, myosin, and actin during the heart muscle contraction.	[Lu, Yanling; Kwan, Ann H.; Jeffries, Cy M.; Guss, J. Mitchell; Trewhella, Jill] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Trewhella, J (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08, Sydney, NSW 2006, Australia.	Jill.Trewhella@sydney.edu.au	Guss, Jules Mitchell/N-1387-2019	Guss, Jules Mitchell/0000-0003-4259-6079; /0000-0002-8718-7343; Kwan, Ann/0000-0002-1506-2226; Trewhella, Jill/0000-0002-8555-6766	Australian Research Council [DP120103841]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP120103841.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Andre I, 2004, BIOPHYS J, V87, P1929, DOI 10.1529/biophysj.104.040998; BLUMENTHAL DK, 1988, BIOCHEM BIOPH RES CO, V156, P860, DOI 10.1016/S0006-291X(88)80923-9; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Cheng LH, 2003, CIRCULATION, V108, P90; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Govada L, 2008, J MOL BIOL, V378, P387, DOI 10.1016/j.jmb.2008.02.044; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; Howarth JW, 2012, J BIOL CHEM, V287, P8254, DOI 10.1074/jbc.M111.309591; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2011, J MOL BIOL, V414, P735, DOI 10.1016/j.jmb.2011.10.029; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Kelly M, 2009, CIRC-CARDIOVASC GENE, V2, P182, DOI 10.1161/CIRCGENETICS.108.836478; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Koster S, 2011, J BIOL CHEM, V286, P40954, DOI 10.1074/jbc.M111.286906; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Lu YL, 2011, J MOL BIOL, V413, P908, DOI 10.1016/j.jmb.2011.09.026; Lu YL, 2011, BIOPOLYMERS, V95, P505, DOI 10.1002/bip.21624; Matsushima N, 2000, BIOCHEM J, V347, P211, DOI 10.1042/0264-6021:3470211; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Muino PL, 2009, J PHYS CHEM B, V113, P2572, DOI 10.1021/jp711513b; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; Oakley CE, 2007, INT J BIOCHEM CELL B, V39, P2161, DOI 10.1016/j.biocel.2006.12.008; Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; SCHLENDER KK, 1991, J BIOL CHEM, V266, P2811; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stull JT, 2011, ARCH BIOCHEM BIOPHYS, V510, P120, DOI 10.1016/j.abb.2011.01.017; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tong CW, 2004, J PHYSIOL-LONDON, V558, P927, DOI 10.1113/jphysiol.2004.062539; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Weljie AM, 2000, PROTEIN ENG, V13, P59, DOI 10.1093/protein/13.1.59; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	61	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31596	31607		10.1074/jbc.M112.383299	http://dx.doi.org/10.1074/jbc.M112.383299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801425	Green Published, hybrid			2022-12-25	WOS:000308791300071
J	Vats, A; Singh, AK; Mukherjee, R; Chopra, T; Ravindran, MS; Mohanty, D; Chatterji, D; Reyrat, JM; Gokhale, RS				Vats, Archana; Singh, Anil Kumar; Mukherjee, Raju; Chopra, Tarun; Ravindran, Madhu Sudhan; Mohanty, Debasisa; Chatterji, Dipankar; Reyrat, Jean-Marc; Gokhale, Rajesh S.			Retrobiosynthetic Approach Delineates the Biosynthetic Pathway and the Structure of the Acyl Chain of Mycobacterial Glycopeptidolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; POLYKETIDE SYNTHASES; FATTY-ACIDS; SMEGMATIS; IDENTIFICATION; TUBERCULOSIS; SURFACE; LIPIDS; METHYLTRANSFERASE; CONSTRUCTION	Glycopeptidolipids (GPLs) are dominant cell surface molecules present in several non-tuberculous and opportunistic mycobacterial species. GPLs from Mycobacterium smegmatis are composed of a lipopeptide core unit consisting of a modified C-26-C-34 fatty acyl chain that is linked to a tetrapeptide (Phe-Thr-Ala-alaninol). The hydroxyl groups of threonine and terminal alaninol are further modified by glycosylations. Although chemical structures have been reported for 16 GPLs from diverse mycobacteria, there is still ambiguity in identifying the exact position of the hydroxyl group on the fatty acyl chain. Moreover, the enzymes involved in the biosynthesis of the fatty acyl component are unknown. In this study we show that a bimodular polyketide synthase in conjunction with a fatty acyl-AMP ligase dictates the synthesis of fatty acyl chain of GPL. Based on genetic, biochemical, and structural investigations, we determine that the hydroxyl group is present at the C-5 position of the fatty acyl component. Our retrobiosynthetic approach has provided a means to understand the biosynthesis of GPLs and also resolve the long-standing debate on the accurate structure of mycobacterial GPLs.	[Vats, Archana; Gokhale, Rajesh S.] CSIR Inst Genom & Integrat Biol, Delhi 110007, India; [Singh, Anil Kumar; Reyrat, Jean-Marc] Univ Paris 05, Fac Med Paris Descartes, INSERM, U570, F-75730 Paris 15, France; [Singh, Anil Kumar] CSIR NE Inst Sci & Technol, Dept Biotechnol, Jorhat 785006, Assam, India; [Mukherjee, Raju; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Vats, Archana; Chopra, Tarun; Ravindran, Madhu Sudhan; Mohanty, Debasisa; Gokhale, Rajesh S.] Natl Inst Immunol, New Delhi 110067, India; [Gokhale, Rajesh S.] Jawarharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Gokhale, RS (corresponding author), CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.	rsg@igib.res.in	Ravindran, Madhu Sudhan/I-5325-2019; Mohanty, Debasisa/A-1428-2009	Ravindran, Madhu Sudhan/0000-0001-7450-2001; Chatterji, Dipankar/0000-0002-9985-0632; MOHANTY, DEBASISA/0000-0002-3374-0588	Le Centre Indo-Francais Pour la Recherche Avancee (CEFIPRA)/Indo-French Centre for the Promotion of Advanced Research (IFCPAR) [3403-03]; Department of Biotechnology, Government of India; CEFIPRA/IFCPAR	Le Centre Indo-Francais Pour la Recherche Avancee (CEFIPRA)/Indo-French Centre for the Promotion of Advanced Research (IFCPAR); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CEFIPRA/IFCPAR	This work was supported by Le Centre Indo-Francais Pour la Recherche Avancee (CEFIPRA)/Indo-French Centre for the Promotion of Advanced Research (IFCPAR) Grant 3403-03 (to J.-M. R. and R. S. G.); Supported by a Department of Biotechnology, Government of India, post-doctoral fellowship.; Supported by CEFIPRA/IFCPAR.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Aspinall GO, 1995, ADV CARBOHYD CHEM BI, V51, P169, DOI 10.1016/S0065-2318(08)60194-8; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; BRENNAN PJ, 1979, J BIOL CHEM, V254, P4205; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chopra T, 2008, PLOS BIOL, V6, P1584, DOI 10.1371/journal.pbio.0060163; Deshayes C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r20; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p; Griffiths WJ, 2001, BIOCHEM J, V355, P545, DOI 10.1042/bj3550545; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jeevarajah D, 2002, MICROBIOL-SGM, V148, P3079, DOI 10.1099/00221287-148-10-3079; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; KHOO KH, 1995, CARBOHYD RES, V276, P449, DOI 10.1016/0008-6215(95)00184-U; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; MARIN LML, 1991, BIOCHEMISTRY-US, V30, P10536, DOI 10.1021/bi00107a024; Medjahed H, 2009, APPL ENVIRON MICROB, V75, P1331, DOI 10.1128/AEM.01914-08; Miyamoto Y, 2006, J BACTERIOL, V188, P86, DOI 10.1128/JB.188.1.86-95.2006; Mohanty D, 2011, TUBERCULOSIS, V91, P448, DOI 10.1016/j.tube.2011.04.006; Mukherjee R, 2005, MICROBIOL-SGM, V151, P2385, DOI 10.1099/mic.0.27908-0; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Ojha AK, 2002, MICROBIOL-SGM, V148, P3039, DOI 10.1099/00221287-148-10-3039; Patterson JH, 2000, J BIOL CHEM, V275, P24900, DOI 10.1074/jbc.M000147200; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Prod'hom G, 1998, FEMS MICROBIOL LETT, V158, P75, DOI 10.1111/j.1574-6968.1998.tb12803.x; Recht J, 2001, Acta Cient Venez, V52 Suppl 1, P45; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; SMITH DONALD W., 1960, NATURE, V186, P887, DOI 10.1038/186887a0; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; Stinear TP, 2005, J BACTERIOL, V187, P1668, DOI 10.1128/JB.187.5.1668-1676.2005; Tang YY, 2006, BIOCHEMISTRY-US, V45, P14085, DOI 10.1021/bi061187v; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Villeneuve C, 2003, J BIOL CHEM, V278, P51291, DOI 10.1074/jbc.M306554200; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8	43	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30677	30687		10.1074/jbc.M112.384966	http://dx.doi.org/10.1074/jbc.M112.384966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798073	hybrid, Green Published			2022-12-25	WOS:000308579800057
J	Liu, C; Zhang, X; Huang, F; Yang, B; Li, J; Liu, BF; Luo, HH; Zhang, P; Zhang, H				Liu, Chao; Zhang, Xue; Huang, Feng; Yang, Bin; Li, Jun; Liu, Bingfeng; Luo, Haihua; Zhang, Ping; Zhang, Hui			APOBEC3G Inhibits MicroRNA-mediated Repression of Translation by Interfering with the Interaction between Argonaute-2 and MOV10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; REVERSE TRANSCRIPTION; PROTEIN-SYNTHESIS; STRESS GRANULES; 7SL RNA; DROSOPHILA; GW182; BIOGENESIS; COMPLEXES; FAMILY	The apolipoprotein-B-mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G or A3G) is a potent restrictive factor for human immunodeficiency virus type 1 (HIV-1) and many other retroviruses. It belongs to the cytidine deaminase family. Recent studies have shown that A3G significantly inhibits microRNA (miRNA)-mediated repression of translation. However, the mechanism underlying this action must be clarified. In this report, we have demonstrated that A3G counteracts miRNA-mediated repression of translation by inhibiting the interaction between moloney leukemia virus 10 (MOV10) protein and Argonaute-2 (AGO2), causing either abnormal assembly or abnormal maturation of miRNA-inducing silencing complex (miRISC). Through a series of MOV10 deletions, we found that A3G binds to a domain at the C terminus in MOV10, where it competitively inhibits the binding of AGO2 to that same domain. The interaction between A3G and MOV10 relies on its association with a small RNA named 7SL RNA. The A3G mutant W127L, which is unable to bind to 7SL RNA, shows significantly incapability to counteract the miRNA-mediated repression of translation. Our data demonstrate a novel mechanism involved in the regulation of miRISC activity. Although both A3G and MOV10 belong to the interferon antiviral system and inhibit HIV-1 and other retroviruses, their opposing effects on the cellular miRNA activity suggest that they play much more complicated regulatory roles in various cellular functions.	[Liu, Chao; Zhang, Xue; Huang, Feng; Li, Jun; Liu, Bingfeng; Luo, Haihua; Zhang, Ping; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Chao; Zhang, Xue; Huang, Feng; Li, Jun; Liu, Bingfeng; Luo, Haihua; Zhang, Ping; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Yang, Bin; Zhang, Hui] Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, Philadelphia, PA 19107 USA	Sun Yat Sen University; Sun Yat Sen University; Jefferson University	Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China.	chaoliulc@yahoo.com.cn; hz08043@gmail.com		Li, Jun/0000-0002-2611-8918	National Institutes of Health [AI078812]; Guangdong Innovative Research Team Program [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; Natural Science Foundation of China [30972620, 81101255]; Natural Science Foundation of Guangdong [9251008901000022, 10451008901004204]; Research Fund for the Doctoral Program of Higher Education of China [20090171110083, 20100171120056]; China Postdoctoral Science Foundation [20100470045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guangdong Innovative Research Team Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, National Institutes of Health Grant AI078812 (to H. Z.), Guangdong Innovative Research Team Program (2009010058), National Basic Research Program of China (973 Program, 2010CB912202), Natural Science Foundation of China (30972620, 81101255), Natural Science Foundation of Guangdong (9251008901000022, 10451008901004204), Research Fund for the Doctoral Program of Higher Education of China (20090171110083, 20100171120056), and China Postdoctoral Science Foundation (20100470045).	Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mary C, 2010, RNA, V16, P969, DOI 10.1261/rna.2040410; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Pei YF, 2009, J THEOR BIOL, V261, P17, DOI 10.1016/j.jtbi.2009.07.022; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Tian CJ, 2007, NUCLEIC ACIDS RES, V35, P7288, DOI 10.1093/nar/gkm816; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; WOLIN SL, 1983, CELL, V32, P735, DOI 10.1016/0092-8674(83)90059-4; Yang SC, 2001, J BIOL CHEM, V276, P4889, DOI 10.1074/jbc.M004895200; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519	44	41	45	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29373	29383		10.1074/jbc.M112.354001	http://dx.doi.org/10.1074/jbc.M112.354001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22791714	hybrid, Green Published			2022-12-25	WOS:000308286900016
J	Wu, CS; Yen, CJ; Chou, RH; Li, ST; Huang, WC; Ren, CT; Wu, CY; Yu, YL				Wu, Chen-Shiou; Yen, Chia-Jui; Chou, Ruey-Hwang; Li, Shiou-Ting; Huang, Wei-Chien; Ren, Chien-Tai; Wu, Chung-Yi; Yu, Yung-Luen			Cancer-Associated Carbohydrate Antigens as Potential Biomarkers for Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B VIRUS; LIVER-CANCER; ALTERED GLYCOSYLATION; ALPHA-FETOPROTEIN; CELL-MIGRATION; GLOBO-H; SERUM; ANTIBODIES; OLIGOSACCHARIDES; GLYCOPROTEINS	Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, developing the early, high-sensitivity diagnostic biomarkers to prevent HCC is urgently needed. Serum a-fetoprotein (AFP), the clinical biomarker in current use, is elevated in only similar to 60% of patients with HCC; therefore, identification of additional biomarkers is expected to have a significant impact on public health. In this study, we used glycan microarray analysis to explore the potential diagnostic value of several cancer-associated carbohydrate antigens (CACAs) as biomarkers for HCC. We used glycan microarray analysis with 58 different glycan analogs for quantitative comparison of 593 human serum samples (293 HCC samples; 133 chronic hepatitis B virus (HBV) infection samples, 134 chronic hepatitis C virus (HCV) infection samples, and 33 healthy donor samples) to explore the diagnostic possibility of serum antibody changes as biomarkers for HCC. Serum concentrations of anti-disialosyl galactosyl globoside (DSGG), anti-fucosyl GM1 and anti-Gb2 were significantly higher in patients with HCC than in chronic HBV infection individuals not in chronic HCV infection patients. Overall, in our study population, the biomarker candidates DSGG, fucosyl GM1 and Gb2 of CACAs achieved better predictive sensitivity than AFP. We identified potential biomarkers suitable for early detection of HCC. Glycan microarray analysis provides a powerful tool for high-sensitivity and high-throughput detection of serum antibodies against CACAs, which may be valuable serum biomarkers for the early detection of persons at high risk for HCC.	[Wu, Chen-Shiou; Huang, Wei-Chien; Wu, Chung-Yi; Yu, Yung-Luen] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ Hosp, Div Hematol Oncol, Dept Internal Med, Tainan 70428, Taiwan; [Wu, Chen-Shiou; Li, Shiou-Ting; Ren, Chien-Tai; Wu, Chung-Yi] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chou, Ruey-Hwang; Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Academia Sinica - Taiwan; Asia University Taiwan	Wu, CS (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan.	cyiwu@gate.sinica.edu.tw; ylyu@mail.cmu.edu.tw	Wu, Chung-Yi/K-8334-2018; Chou, Ruey-Hwang/K-8541-2013; Huang, Wei-Chien/H-3126-2019; Huang, Wei-Chien/D-1740-2012	Chou, Ruey-Hwang/0000-0002-2297-2180; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Wu, Chen-Shiou/0000-0003-0791-1483	National Science Council of Taiwan [NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC100-2321-B-039-004]; University of Texas MD Anderson-China Medical University; Hospital Sister Institution Fund [DMR-101-115]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); University of Texas MD Anderson-China Medical University(China Medical University); Hospital Sister Institution Fund	This work was supported by National Science Council of Taiwan grants NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC100-2321-B-039-004, and The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund DMR-101-115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Brandlein S, 2003, CANCER RES, V63, P7995; BREZICKA FT, 1989, CANCER RES, V49, P1300; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; CAPORASO N, 1991, J HEPATOL, V12, P367, DOI 10.1016/0168-8278(91)90841-X; Chandrasekaran EV, 2001, GLYCOBIOLOGY, V11, P353, DOI 10.1093/glycob/11.5.353; CHEN DS, 1984, GASTROENTEROLOGY, V86, P1404; Chen L, 2010, ANN SURG ONCOL, V17, P2518, DOI 10.1245/s10434-010-1038-8; de Leoz MLA, 2008, DIS MARKERS, V25, P243, DOI 10.1155/2008/515318; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ElRefaie A, 1996, J HEPATOL, V24, P277, DOI 10.1016/S0168-8278(96)80005-5; Filmus Jorge, 2004, Mol Diagn, V8, P207, DOI 10.2165/00066982-200408040-00002; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Henry CJ, 2005, CLIN CANCER RES, V11, P751; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Lattova E, 2009, RAPID COMMUN MASS SP, V23, P2983, DOI 10.1002/rcm.4202; Liaw YF, 2005, SEMIN LIVER DIS, V25, P40, DOI 10.1055/s-2005-915649; Liaw YF, 2005, J CLIN VIROL, V34, pS143, DOI 10.1016/S1386-6532(05)80025-3; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Marrero J. A., 2005, CLIN LIVER DIS, V9, pvi; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Marrero Jorge A, 2005, Clin Liver Dis, V9, P235, DOI 10.1016/j.cld.2004.12.006; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; Nealen ML, 2001, CIRC RES, V88, P438; Ouerfelli O, 2005, EXPERT REV VACCINES, V4, P677, DOI 10.1586/14760584.4.5.677; Pang RWC, 2008, ANN SURG ONCOL, V15, P962, DOI 10.1245/s10434-007-9730-z; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Satoh M, 1996, CANCER RES, V56, P1932; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521; Stanley P, 2002, BBA-GEN SUBJECTS, V1573, P363, DOI 10.1016/S0304-4165(02)00404-X; Tseng SY, 2008, CHEM-ASIAN J, V3, P1395, DOI 10.1002/asia.200800154; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wands J, 2007, NEW ENGL J MED, V357, P1974, DOI 10.1056/NEJMcibr075652; Wang CC, 2008, P NATL ACAD SCI USA, V105, P11661, DOI 10.1073/pnas.0804923105; Wu CY, 2009, ORG BIOMOL CHEM, V7, P2247, DOI 10.1039/b902510n; Wu LH, 2010, GLYCOBIOLOGY, V20, P215, DOI 10.1093/glycob/cwp168; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	44	41	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39466	10.1371/journal.pone.0039466	http://dx.doi.org/10.1371/journal.pone.0039466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808038	Green Submitted, Green Published, gold			2022-12-25	WOS:000306406700009
J	Redondo, CM; Gago-Dominguez, M; Ponte, SM; Castelo, ME; Jiang, XJ; Garcia, AA; Fernandez, MP; Tome, MA; Fraga, M; Gude, F; Martinez, ME; Garzon, VM; Carracedo, A; Castelao, JE				Redondo, Carmen M.; Gago-Dominguez, Manuela; Miranda Ponte, Sara; Enguix Castelo, Manuel; Jiang, Xuejuan; Alonso Garcia, Ana; Pena Fernandez, Maite; Ausencia Tome, Maria; Fraga, Maximo; Gude, Francisco; Elena Martinez, Maria; Munoz Garzon, Victor; Carracedo, Angel; Esteban Castelao, J.			Breast Feeding, Parity and Breast Cancer Subtypes in a Spanish Cohort	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR STATUS; AFRICAN-AMERICAN WOMEN; HISPANIC WHITE WOMEN; SAN-LUIS VALLEY; RISK-FACTORS; ESTROGEN-RECEPTOR; MATERNAL RECALL; CLINICAL PRESENTATION; RACIAL/ETHNIC GROUPS; MOLECULAR ANALYSIS	Background: Differences in the incidence and outcome of breast cancer among Hispanic women compared with white women are well documented and are likely explained by ethnic differences in genetic composition, lifestyle, or environmental exposures. Methodolgy/Principal Findings: A population-based study was conducted in Galicia, Spain. A total of 510 women diagnosed with operable invasive breast cancer between 1997 and 2010 participated in the study. Data on demographics, breast cancer risk factors, and clinico-pathological characteristics were collected. The different breast cancer tumor subtypes were compared on their clinico-pathological characteristics and risk factor profiles, particularly reproductive variables and breastfeeding. Among the 501 breast cancer patients (with known ER and PR receptors), 85% were ER+/PR+ and 15% were ER-&PR-. Among the 405 breast cancer with known ER, PR and HER2 status, 71% were ER+/PR+/HER2- (luminal A), 14% were ER+/PR+/HER2+ (luminal B), 10% were ER-/PR-/HER2- (triple negative breast cancer, TNBC), and 5% were ER-/PR-/HER2+ (non-luminal). A lifetime breastfeeding period equal to or longer than 7 months was less frequent in case patients with TNBC (OR = 0.25, 95% CI = 0.08-0.68) compared to luminal A breast cancers. Both a low (2 or fewer pregnancies) and a high (3-4 pregnancies) number of pregnancies combined with a long breastfeeding period were associated with reduced odds of TNBC compared with luminal A breast cancer, although the association seemed to be slightly more pronounced among women with a low number of pregnancies (OR = 0.09, 95% CI = 0.005-0.54). Conclusions/Significance: In case-case analyses with the luminal A cases as the reference group, we observed a lower proportion of TNBC among women who breastfed 7 or more months. The combination of longer breastfeeding duration and lower parity seemed to further reduce the odds of having a TNBC compared to a luminal A breast cancer.	[Redondo, Carmen M.; Miranda Ponte, Sara; Esteban Castelao, J.] Complejo Hosp Univ Vigo, Genom Med Grp, Oncol & Genet Unit, Vigo, Spain; [Gago-Dominguez, Manuela; Carracedo, Angel] Complejo Hosp Univ Santiago, IDIS, Genom Med Grp, Galician Fdn Genom Med, Santiago De Compostela, Spain; [Enguix Castelo, Manuel; Munoz Garzon, Victor] Complejo Hosp Univ Vigo, Dept Radiotherapy, Vigo, Spain; [Jiang, Xuejuan] Univ So Calif, Ophtalmol & Prevent Med Dept, Los Angeles, CA USA; [Alonso Garcia, Ana] Hosp Univ Cent Asturias, Dept Radiotherapy, Oviedo, Spain; [Pena Fernandez, Maite] Complejo Hosp Univ Santiago, Ginecol Dept, Santiago De Compostela, Spain; [Ausencia Tome, Maria] Complejo Hosp Univ Santiago, Dept Endocrinol, Santiago De Compostela, Spain; [Fraga, Maximo] Complejo Hosp Univ Santiago, Dept Pathol, Santiago De Compostela, Spain; [Gude, Francisco] Complejo Hosp Univ Santiago, Clin Epidemiol Unit, Santiago De Compostela, Spain; [Elena Martinez, Maria] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo; University of Southern California; Central University Hospital Asturias; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; University of California System; University of California San Diego	Redondo, CM (corresponding author), Complejo Hosp Univ Vigo, Genom Med Grp, Oncol & Genet Unit, Vigo, Spain.	carmen.redondo.marey@sergas.es	Fraga, Máximo/AAC-9417-2020; Carracedo, Angel/D-4257-2012; Gago-Dominguez, Manuela/AAP-6611-2021	Carracedo, Angel/0000-0003-1085-8986; Redondo, Carmen M./0000-0003-4971-2861; Castelao, Jose E/0000-0001-7110-1376; Fraga Rodriguez, Maximo/0000-0001-6185-9562; Gago, Manuela/0000-0001-6713-4351	Programa Grupos Emergentes EMERCIII, Instituto de Salud Carlos III, Cancer Genetics Unit Complejo Hospitalario Universitario de Vigo, Spain	Programa Grupos Emergentes EMERCIII, Instituto de Salud Carlos III, Cancer Genetics Unit Complejo Hospitalario Universitario de Vigo, Spain	Programa Grupos Emergentes EMERCIII, Instituto de Salud Carlos III, Cancer Genetics Unit Complejo Hospitalario Universitario de Vigo, Spain (IP: JEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Franco M, 2001, AM J HUM GENET, V69, P268; Chakraborty Bandana M., 1999, Ethnicity and Disease, V9, P278; Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220; Chu KC, 2001, CANCER, V92, P37, DOI 10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Diez O, 1998, HUM GENET, V103, P707, DOI 10.1007/s004390050895; Diez O, 1999, BRIT J CANCER, V79, P1302, DOI 10.1038/sj.bjc.6690208; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; ELLIS IO, 2003, WHO CLASSIFICATION T, P9; FRIERSON HF, 1995, AM J CLIN PATHOL, V103, P195; Galicia Xd, 2001, XUNTA GALICIA, P456; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Hausauer AK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1839; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Lapham SJ, 1993, L136 CPH ETHN HISP B; LAUNER LJ, 1992, J EPIDEMIOL COMMUN H, V46, P203, DOI 10.1136/jech.46.3.203; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Ma HY, 2010, CANCER RES, V70, P575, DOI 10.1158/0008-5472.CAN-09-3460; Martinez ME, 2010, CANCER EPIDEM BIOMAR, V19, P2710, DOI 10.1158/1055-9965.EPI-10-0742; Martinez ME, 2010, HEALTH, V2, P1040, DOI DOI 10.4236/HEALTH.2010.29153; Mew NA, 2002, CLIN GENET, V62, P151, DOI 10.1034/j.1399-0004.2002.620208.x; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mullineaux LG, 2003, CANCER-AM CANCER SOC, V98, P597, DOI 10.1002/cncr.11533; Osorio A, 1998, CANCER LETT, V123, P153, DOI 10.1016/S0304-3835(97)00416-3; Osorio A, 2000, BRIT J CANCER, V82, P1266, DOI 10.1054/bjoc.1999.1089; Palmer JR, 2011, CANCER EPIDEM BIOMAR, V20, P1883, DOI 10.1158/1055-9965.EPI-11-0465; Patel TA, 2010, ONCOLOGIST, V15, P466, DOI 10.1634/theoncologist.2010-0004; Phipps AI, 2008, CANCER-AM CANCER SOC, V113, P1521, DOI 10.1002/cncr.23786; Phipps AI, 2011, JNCI-J NATL CANCER I, V103, P470, DOI 10.1093/jnci/djr030; Promislow JHE, 2005, AM J EPIDEMIOL, V161, P289, DOI 10.1093/aje/kwi044; Blesa JR, 2000, HUM MUTAT, V15, P381, DOI 10.1002/(SICI)1098-1004(200004)15:4<381::AID-HUMU14>3.0.CO;2-H; Sans M, 2000, HUM BIOL, V72, P155; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Shetterly SM, 1998, AM J EPIDEMIOL, V147, P1019, DOI 10.1093/oxfordjournals.aje.a009395; Shinde SS, 2010, CANCER-AM CANCER SOC, V116, P4933, DOI 10.1002/cncr.25443; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Trivers KF, 2009, CANCER CAUSE CONTROL, V20, P1071, DOI 10.1007/s10552-009-9331-1; Watlington AT, 2007, CANCER, V109, P2093, DOI 10.1002/cncr.22640; Vega A, 2002, ANN HUM GENET, V66, P29, DOI 10.1017/S0003480001001014; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Wojcik Barbara E, 2003, Breast J, V9, P175, DOI 10.1046/j.1524-4741.2003.09308.x; Xing P, 2010, MED ONCOL, V27, P926, DOI 10.1007/s12032-009-9308-7; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806	48	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40543	10.1371/journal.pone.0040543	http://dx.doi.org/10.1371/journal.pone.0040543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792365	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400068
J	von Glehn, F; Jarius, S; de Oliveira, ACP; Brandao, CO; Farias, AS; Damasceno, A; Casseb, J; Moraes, AS; Longhini, ALF; Wandinger, KP; Damasceno, BP; Wildemann, B; Santos, LMB				von Glehn, Felipe; Jarius, Sven; Penalva de Oliveira, Augusto C.; Brandao, Carlos Otavio; Farias, Alessandro S.; Damasceno, Alfredo; Casseb, Jorge; Moraes, Adriel S.; Longhini, Ana Leda F.; Wandinger, Klaus-Peter; Damasceno, Benito P.; Wildemann, Brigitte; Santos, Leonilda M. B.			Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; VIRUS TYPE-I; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; 1-ASSOCIATED MYELOPATHY; BRAZILIAN PATIENTS; INFECTION; NEURITIS	Introduction: The seroprevalence of human T-cell leukemia virus type 1 (HTLV-1) is very high among Brazilians (similar to 1:200). HTLV-1 associated myelopathy or tropical spastic paraparesis (HAM/TSP) is the most common neurological complication of HTLV-1 infection. HAM/TSP can present with an acute/subacute form of longitudinally extensive myelitis, which can be confused with lesions seen in aquaporin-4 antibody (AQP4-Ab) positive neuromyelitis optica spectrum disorders (NMOSD) on MRI. Moreover, clinical attacks in patients with NMOSD have been shown to be preceded by viral infections in around 30% of cases. Objective: To evaluate the frequency of AQP4-Ab in patients with HAM/TSP. To evaluate the frequency of HTLV-1 infection in patients with NMOSD. Patients and Methods: 23 Brazilian patients with HAM/TSP, 20 asymptomatic HTLV-1+ serostatus patients, and 34 with NMOSD were tested for AQP4-Ab using a standardized recombinant cell based assay. In addition, all patients were tested for HTLV-1 by ELISA and Western blotting. Results: 20/34 NMOSD patients were positive for AQP4-Ab but none of the HAM/TSP patients and none of the asymptomatic HTLV-1 infected individuals. Conversely, all AQP4-Ab-positive NMOSD patients were negative for HTLV-1 antibodies. One patient with HAM/TSP developed optic neuritis in addition to subacute LETM; this patient was AQP4-Ab negative as well. Patients were found to be predominantly female and of African descent both in the NMOSD and in the HAM/TSP group; Osame scale and expanded disability status scale scores did not differ significantly between the two groups. Conclusions: Our results argue both against a role of antibodies to AQP4 in the pathogenesis of HAM/TSP and against an association between HTLV-1 infection and the development of AQP4-Ab. Moreover, the absence of HTLV-1 in all patients with NMOSD suggests that HTLV-1 is not a common trigger of acute attacks in patients with AQP4-Ab positive NMOSD in populations with high HTLV-1 seroprevalence.	[von Glehn, Felipe; Brandao, Carlos Otavio; Farias, Alessandro S.; Moraes, Adriel S.; Longhini, Ana Leda F.; Santos, Leonilda M. B.] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Neuroimmunol Unit, Campinas, SP, Brazil; [von Glehn, Felipe; Brandao, Carlos Otavio; Damasceno, Alfredo; Damasceno, Benito P.] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil; [Jarius, Sven; Wildemann, Brigitte] Heidelberg Univ, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany; [Penalva de Oliveira, Augusto C.] Univ Estadual Campinas, Dept Internal Med, Neuroinfect Dis Unit, Campinas, SP, Brazil; [Penalva de Oliveira, Augusto C.; Casseb, Jorge] Emilio Ribas Inst Infectol, Dept Neurol, Sao Paulo, Brazil; [Wandinger, Klaus-Peter] Euroimmun, Inst Expt Immunol, Lubeck, Germany	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Ruprecht Karls University Heidelberg; Universidade Estadual de Campinas; EUROIMMUN	von Glehn, F (corresponding author), Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Neuroimmunol Unit, Campinas, SP, Brazil.	fglehn@terra.com.br; leonilda@unicamp.br	Farias, Alessandro/C-6879-2012; Damasceno, Alfredo/D-8137-2016; Moraes, Adriel S/F-1259-2013; Farias, Alessandro/AAH-2228-2020; casseb, jorge/X-5219-2019; BRANDÃO, CARLOS OTÁVIO CO/M-3152-2014; von Glehn, Felipe/C-5970-2012	Farias, Alessandro/0000-0001-6759-1819; Moraes, Adriel S/0000-0002-9365-573X; Farias, Alessandro/0000-0001-6759-1819; casseb, jorge/0000-0002-4553-2559; BRANDÃO, CARLOS OTÁVIO CO/0000-0002-4898-5916; von Glehn, Felipe/0000-0002-1004-7641; Damasceno, Alfredo/0000-0002-7919-3989	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Bayer Schering Healthcare; Merck Serono; Abbott Bristol; Abbott GSK	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Bayer Schering Healthcare; Merck Serono(Merck & Company); Abbott Bristol; Abbott GSK	This study received financial support from the Brazilian government agencies FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -www.fapesp.br/en) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - www.capes.gov.br). The work of S.J. and B. W. was supported by research grants from Bayer Schering Healthcare and from Merck Serono. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of S.J. and B. W. was supported by research grants from Bayer Schering Healthcare and from Merck Serono. A.C.P.O. received consulting fees from - Abbott & Bristol and speaking fees from Abbott & GSK. K. P. W. is an employee of Euroimmun, Luebeck, Germany. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adoni T, 2010, MULT SCLER J, V16, P81, DOI 10.1177/1352458509353651; Bergamaschi R, 2004, MULT SCLER J, V10, P2, DOI 10.1191/1352458504ms988oa; Brito JCD, 2003, ARQ NEURO-PSIQUIAT, V61, P816, DOI 10.1590/S0004-282X2003000500021; Cabre P, 2001, NEUROLOGY, V56, P507, DOI 10.1212/WNL.56.4.507; Casseb J, 2008, J MED VIROL, V80, P392, DOI 10.1002/jmv.21111; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; Haines JL, 2002, HUM MOL GENET, V11, P2251; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kanamori Y, 2011, NEUROLOGY, V77, P652, DOI 10.1212/WNL.0b013e318229e694; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kasahata N, 2003, ARCH NEUROL-CHICAGO, V60, P873, DOI 10.1001/archneur.60.6.873; Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Koga M, 2009, INTERNAL MED, V48, P1157, DOI 10.2169/internalmedicine.48.1989; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lana-Peixoto M A, 1992, Arq Neuropsiquiatr, V50, P419; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; MATSUMOTO M, 1990, AM J TROP MED HYG, V42, P365, DOI 10.4269/ajtmh.1990.42.365; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555; Olindo S, 2010, J CLIN NEUROSCI, V17, P1449, DOI 10.1016/j.jocn.2009.12.024; OSAME M, 1986, LANCET, V1, P1031; Papais-Alvarenga RM, 2002, J NEUROL NEUROSUR PS, V73, P429, DOI 10.1136/jnnp.73.4.429; Petzold A, 2010, J NEUROL NEUROSUR PS, V81, P109, DOI 10.1136/jnnp.2008.146894; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; WHO, 1989, SCI GROUP HTLV I INF, P4; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2007, NEUROLOGIST, V13, P2, DOI 10.1097/01.nrl.0000250927.21903.f8; Wingerchuk DM, 2009, J NEUROL SCI, V286, P18, DOI 10.1016/j.jns.2009.08.045; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yoshida Y, 1998, OPHTHALMOLOGICA, V212, P73, DOI 10.1159/000027246	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39372	10.1371/journal.pone.0039372	http://dx.doi.org/10.1371/journal.pone.0039372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808032	Green Published, gold, Green Submitted			2022-12-25	WOS:000306355500009
J	Fusco, C; Micale, L; Egorov, M; Monti, M; D'Addetta, EV; Augello, B; Cozzolino, F; Calcagni, A; Fontana, A; Polishchuk, RS; Didelot, G; Reymond, A; Pucci, P; Merla, G				Fusco, Carmela; Micale, Lucia; Egorov, Mikhail; Monti, Maria; D'Addetta, Ester Valentina; Augello, Bartolomeo; Cozzolino, Flora; Calcagni, Alessia; Fontana, Andrea; Polishchuk, Roman S.; Didelot, Gerard; Reymond, Alexandre; Pucci, Piero; Merla, Giuseppe			The E3-Ubiquitin Ligase TRIM50 Interacts with HDAC6 and p62, and Promotes the Sequestration and Clearance of Ubiquitinated Proteins into the Aggresome	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; MASS-SPECTROMETRY; AUTOPHAGY; DEGRADATION; HUNTINGTIN; DISEASE; STRESS; CANCER; CELLS; MICE	In this study we report that, in response to proteasome inhibition, the E3-Ubiquitin ligase TRIM50 localizes to and promotes the recruitment and aggregation of polyubiquitinated proteins to the aggresome. Using Hdac6-deficient mouse embryo fibroblasts (MEF) we show that this localization is mediated by the histone deacetylase 6, HDAC6. Whereas Trim50-deficient MEFs allow pinpointing that the TRIM50 ubiquitin-ligase regulates the clearance of polyubiquitinated proteins localized to the aggresome. Finally we demonstrate that TRIM50 colocalizes, interacts with and increases the level of p62, a multifunctional adaptor protein implicated in various cellular processes including the autophagy clearance of polyubiquitinated protein aggregates. We speculate that when the proteasome activity is impaired, TRIM50 fails to drive its substrates to the proteasome-mediated degradation, and promotes their storage in the aggresome for successive clearance.	[Fusco, Carmela; Micale, Lucia; D'Addetta, Ester Valentina; Augello, Bartolomeo; Calcagni, Alessia; Merla, Giuseppe] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Egorov, Mikhail; Polishchuk, Roman S.] Telethon Inst Genet & Med, Naples, Italy; [Monti, Maria; Cozzolino, Flora; Pucci, Piero] Univ Naples Federico II, CEINGE Adv Biotechnol, Naples, Italy; [Monti, Maria; Cozzolino, Flora; Pucci, Piero] Univ Naples Federico II, Dept Organ Chem & Biochem, Naples, Italy; [Fontana, Andrea] IRCCS Casa Sollievo Sofferenza, Biostat Unit, San Giovanni Rotondo, Italy; [Didelot, Gerard; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	IRCCS Casa Sollievo Della Sofferenza; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; IRCCS Casa Sollievo Della Sofferenza; University of Lausanne	Fusco, C (corresponding author), IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy.	g.merla@operapadrepio.it	Kutalik, Zoltan/HHZ-5697-2022; Calcagni, Alessia/AAB-7918-2021; cozzolino, flora/AAA-3155-2022; Fusco, Carmela/H-2964-2016; Micale, Lucia/K-3909-2016; Fontana, Andrea/J-8584-2016; Augello, Bartolomeo/B-1927-2017; merla, giuseppe/K-4627-2012; MONTI, Maria/J-2816-2018	Kutalik, Zoltan/0000-0001-8285-7523; Calcagni, Alessia/0000-0002-1946-5815; Fusco, Carmela/0000-0001-7794-6046; Fontana, Andrea/0000-0002-6660-5315; Augello, Bartolomeo/0000-0001-7475-6976; merla, giuseppe/0000-0001-5078-928X; MONTI, Maria/0000-0002-7775-7154; Micale, Lucia/0000-0003-3604-194X; cozzolino, flora/0000-0002-4648-8107; Polishchuk, Roman/0000-0002-7698-1955; Reymond, Alexandre/0000-0003-1030-8327; PUCCI, Pietro/0000-0002-5885-1495	MIUR FIRB Project Italian Human ProteomeNet [RBRN07BMCT]; Jerome Lejeune Foundation; Ricerca Corrente; Italian Ministry of Health; "5x1000" voluntary contributions; Fondazione Banca del Monte di Foggia "Domenico Siniscalco Ceci"; Italian Telethon Foundation [GGP06122]; Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale; European Commission anEUploidy Integrated Project [037627]; Swiss National Science Foundation; Telethon Electron Microscopy Core Facility (Telethon Grant) [GFP08001]	MIUR FIRB Project Italian Human ProteomeNet; Jerome Lejeune Foundation; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Italian Ministry of Health(Ministry of Health, Italy); "5x1000" voluntary contributions; Fondazione Banca del Monte di Foggia "Domenico Siniscalco Ceci"; Italian Telethon Foundation(Fondazione Telethon); Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale(Ministry of Foreign Affairs and International Cooperation (Italy)); European Commission anEUploidy Integrated Project(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Telethon Electron Microscopy Core Facility (Telethon Grant)(Fondazione Telethon)	This work was in part supported by grants from the MIUR FIRB Project Italian Human ProteomeNet RBRN07BMCT to PP, Jerome Lejeune Foundation, the Ricerca Corrente 2010 funding granted by the Italian Ministry of Health, the "5x1000" voluntary contributions, the Fondazione Banca del Monte di Foggia "Domenico Siniscalco Ceci", the Italian Telethon Foundation (Grant #GGP06122) and with the contribution of Ministero degli Affari Esteri, Direzione Generale per la Promozione e la Cooperazione Culturale (2009-2010) to GM; the European Commission anEUploidy Integrated Project (grant 037627), the Jerome Lejeune Foundation, the Swiss National Science Foundation to AR. We acknowledge the Telethon Electron Microscopy Core Facility (Telethon Grant #GFP08001) for the help with the electron microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Chernorudskiy AL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-126; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Egorov MV, 2009, MOL BIOL CELL, V20, P2413, DOI 10.1091/mbc.E08-11-1136; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gozal YM, 2009, J PROTEOME RES, V8, P5069, DOI 10.1021/pr900474t; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Ichimura Y, 2010, SEMIN IMMUNOPATHOL, V32, P431, DOI 10.1007/s00281-010-0220-1; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luciani A, 2010, NAT CELL BIOL; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Merla G, 2010, HUM GENET; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Micale L, 2008, EUR J HUM GENET, V16, P1038, DOI 10.1038/ejhg.2008.68; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song CC, 2008, TOXICOL APPL PHARM, V228, P351, DOI 10.1016/j.taap.2007.12.026; Takashima A, 2001, Curr Protoc Cell Biol, VChapter 2, DOI 10.1002/0471143030.cb0201s00; Vasilescu J, 2005, J PROTEOME RES, V4, P2192, DOI 10.1021/pr050265i; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	42	63	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40440	10.1371/journal.pone.0040440	http://dx.doi.org/10.1371/journal.pone.0040440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792322	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700049
J	Weber, KL; Doucet, M; Shaner, A; Hsu, N; Huang, D; Fogel, J; Kominsky, SL				Weber, Kristy L.; Doucet, Michele; Shaner, Adam; Hsu, Nigel; Huang, David; Fogel, Jenna; Kominsky, Scott L.			MIP-1 delta Activates NFATc1 and Enhances Osteoclastogenesis: Involvement of Both PLC gamma 2 and NF kappa B Signaling	PLOS ONE			English	Article							INFLAMMATORY PROTEIN 1-ALPHA; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; RHEUMATOID-ARTHRITIS; STIMULATING FACTOR; MYELOMA CELLS; EXPRESSION; DIFFERENTIATION; INHIBITION; CHEMOKINE	Pathological bone resorption is a source of significant morbidity in diseases affecting the skeleton such as rheumatoid arthritis, periodontitis, and cancer metastasis to bone. Evidence indicates that elevated levels of inflammatory mediators such as IL-1, IL-6, and TNF-alpha play a role in this process by promoting the formation of bone-resorbing osteoclasts. Additionally, current studies have identified inflammatory chemokines of the macrophage inflammatory protein (MIP) family as potential mediators of pathological bone resorption, where both MIP-1 alpha and -3 alpha have been shown to enhance osteoclast (OCL) development. In this study we provide evidence that MIP-1 delta, whose expression is associated with renal cell carcinoma bone metastasis and rheumatoid arthritis, enhances OCL formation in vitro via a direct effect on OCL precursors. Consistent with this ability, exposure of OCL precursors to MIP-1 delta resulted in the activation of PLC gamma 2 and NF-kappa B, two signaling pathways known to regulate OCL differentiation. Moreover, MIP-1 delta induced expression and nuclear translocation of NFATc1, a master regulator of osteoclastogenesis, which was dependent on activation of both the PLC gamma 2 and NF kappa B signaling pathways. Lastly, consistent with in vitro studies, in vivo administration of MIP-1 delta significantly increased OCL number and resorption area as determined using a murine calvarial bone resorption model. Taken together, these data highlight the potential of MIP-1 delta as a mediator of pathological bone resorption and provide insight into the molecular mechanism through which MIP-1 delta enhances osteoclastogenesis.	[Weber, Kristy L.; Doucet, Michele; Shaner, Adam; Hsu, Nigel; Huang, David; Fogel, Jenna; Kominsky, Scott L.] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Weber, KL (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA.	kominsc@jhmi.edu	Doucet, Michele/A-8551-2013		National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR056373]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056373] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Award Number R21AR056373 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Arthritis and Musculoskeletal and Skin Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATAILLE R, 1992, INT J CLIN LAB RES, V21, P283, DOI 10.1007/BF02591662; Bendre MS, 2005, CANCER RES, V65, P11001, DOI 10.1158/0008-5472.CAN-05-2630; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Choi SJ, 2001, J CLIN INVEST, V108, P1833, DOI 10.1172/JCI13116; Choi SJ, 2000, BLOOD, V96, P671; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; Gladue RP, 2010, CURR TOP MED CHEM, V10, P1268; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hosokawa Y, 2007, CLIN EXP IMMUNOL, V149, P146, DOI 10.1111/j.1365-2249.2007.03398.x; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V142, P285, DOI 10.1111/j.1365-2249.2005.02912.x; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Lisignoli G, 2007, J CELL PHYSIOL, V210, P798, DOI 10.1002/jcp.20905; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Maruyama T, 2010, J BONE MINER RES, V25, P1058, DOI 10.1359/jbmr.091032; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; O'Brien CA, 2000, J CELL BIOCHEM, V79, P532, DOI 10.1002/1097-4644(20001215)79:4<532::AID-JCB20>3.0.CO;2-U; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; UY HL, 1995, J BONE MINER RES, V10, P295; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Victoriano AFB, 2006, ANTIMICROB AGENTS CH, V50, P547, DOI 10.1128/AAC.50.2.547-555.2006; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40799	10.1371/journal.pone.0040799	http://dx.doi.org/10.1371/journal.pone.0040799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792407	Green Submitted, Green Published, gold			2022-12-25	WOS:000306354700067
J	Loehr, J; Leinonen, T; Herczeg, G; O'Hara, RB; Merila, J				Loehr, John; Leinonen, Tuomas; Herczeg, Gabor; O'Hara, Robert B.; Merila, Juha			Heritability of Asymmetry and Lateral Plate Number in the Threespine Stickleback	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DEVELOPMENTAL STABILITY; DIRECTIONAL ASYMMETRY; DROSOPHILA-MELANOGASTER; MERISTIC CHARACTERS; SELECTION; EVOLUTION; POPULATIONS; GENETICS; FITNESS	The estimation of individual fitness and quality are important elements of evolutionary ecological research. Over the past six decades, there has been great interest in using fluctuating asymmetry (FA) to represent individual quality, yet, serious technical problems have hampered efforts to estimate the heritability of FA, which, in turn, has limited progress in the investigation of FA from an evolutionary perspective. Here we estimate the heritability of number of lateral plates, their FA and directional asymmetry (DA) in threespine stickleback, Gasterosteus aculeatus. By (i) using a meristic trait and (ii) basing our calculations on a large half-sib design experiment involving 2,079 offspring from 84 families, we overcame many of the difficulties faced by earlier FA studies. Both lateral plate number and FA in lateral plates were heritable (h(2)=0.46 and 0.21, respectively), even after controlling for marker genotypes linked to EDA (the major locus influencing plate number). Likewise, DA in lateral plates was heritable h(2)=0.23). The additive genetic component of FA in lateral plates makes it a prime candidate for further investigation into the evolutionary implications of FA and the genetic underpinnings of developmental instability. This discovery in an evolutionary model species holds the possibility to invigorate the study of FA from an evolutionary perspective.	[Loehr, John; Leinonen, Tuomas; Herczeg, Gabor; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Loehr, John] Univ Helsinki, Lammi Biol Stn, Lammi, Finland; [O'Hara, Robert B.] Univ Helsinki, Dept Math & Stat, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Loehr, J (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008; O'Hara, Bob/A-7499-2008; Herczeg, Gabor/AAZ-1661-2021; Herczeg, Gábor/AAF-9978-2020	Merila, Juha/0000-0001-9614-0072; O'Hara, Bob/0000-0001-9737-3724; Herczeg, Gabor/0000-0003-0441-342X; 	Academy of Finland [108601, 118673, 213491]; Ministry of Education; LOEWE program of Hesse's Ministry of Higher Education, Research and the Arts	Academy of Finland(Academy of Finland); Ministry of Education; LOEWE program of Hesse's Ministry of Higher Education, Research and the Arts	This work was supported by the Academy of Finland (www.aka.fi; grant nos. 108601, 118673 and 213491), the LUOVA graduate school funded by the Ministry of Education (TL), and the LOEWE program of Hesse's Ministry of Higher Education, Research and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Badyaev AV, 2000, ECOLOGY, V81, P336, DOI 10.1890/0012-9658(2000)081[0336:SADSVR]2.0.CO;2; BELL MA, 1981, EVOLUTION, V35, P67, DOI 10.1111/j.1558-5646.1981.tb04859.x; Bell MA, 2010, ENVIRON BIOL FISH, V89, P189, DOI 10.1007/s10641-010-9712-z; Bergstrom CA, 2003, EVOLUTION, V57, P2128; Bergstrom CA, 2000, BEHAVIOUR, V137, P1097, DOI 10.1163/156853900502457; Bjorklund M, 1997, ANN ZOOL FENN, V34, P133; BRADLEY BP, 1980, GENETICS, V95, P1033; Cano JM, 2006, MOL ECOL, V15, P4613, DOI 10.1111/j.1365-294X.2006.03099.x; Carter Ashley J R, 2009, Int J Evol Biol, V2010, P759159, DOI 10.4061/2009/759159; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; COYNE JA, 1987, J HERED, V78, P119, DOI 10.1093/oxfordjournals.jhered.a110329; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Duan W, 2001, J HERED, V92, P392, DOI 10.1093/jhered/92.5.392; Fuller Rebecca C., 2003, P157; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GIBSON JB, 1974, HEREDITY, V33, P293, DOI 10.1038/hdy.1974.95; HAGEN DW, 1973, HEREDITY, V30, P303, DOI 10.1038/hdy.1973.40; HAGEN DW, 1973, HEREDITY, V31, P75, DOI 10.1038/hdy.1973.59; Herczeg G, 2005, AMPHIBIA-REPTILIA, V26, P422, DOI 10.1163/156853805774408540; Hermida M, 2002, CAN J ZOOL, V80, P532, DOI 10.1139/Z02-022; Leamy L, 1997, J EVOLUTION BIOL, V10, P21; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Leamy LJ, 1997, EVOLUTION, V51, P957, DOI 10.2307/2411169; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Leung B, 1996, ECOSCIENCE, V3, P400, DOI 10.1080/11956860.1996.11682357; Lynch M., 1998, GENETICS ANAL QUANTI; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; MATHER K, 1953, HEREDITY, V7, P297, DOI 10.1038/hdy.1953.41; MERILA J, 1995, SYST BIOL, V44, P97, DOI 10.2307/2413486; Moller A.P., 1997, ASYMMETRY DEV STABIL; Moller AP, 1997, J EVOLUTION BIOL, V10, P1, DOI 10.1007/s000360050001; MOODIE GEE, 1976, SYST ZOOL, V25, P49, DOI 10.2307/2412778; Nakagawa S, 2008, TRENDS ECOL EVOL, V23, P592, DOI 10.1016/j.tree.2008.06.014; Palmer AR, 1999, AM NAT, V154, P220, DOI 10.1086/303223; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pelabon C, 2006, J EVOLUTION BIOL, V19, P764, DOI 10.1111/j.1420-9101.2005.01054.x; Pelabon C, 2010, EVOLUTION, V64, P1912, DOI 10.1111/j.1558-5646.2010.00979.x; Pritchard JR, 2001, EVOL ECOL RES, V3, P209; REEVE ECR, 1960, GENET RES, V1, P151, DOI 10.1017/S0016672300000148; Reimchen TE, 2001, BIOL J LINN SOC, V73, P51, DOI 10.1006/bijl.2001.0523; REIMCHEN TE, 1992, EVOLUTION, V46, P1224, DOI 10.1111/j.1558-5646.1992.tb00631.x; Reimchen TE, 2009, EVOLUTION, V63, P115, DOI 10.1111/j.1558-5646.2008.00520.x; SCHEINER SM, 1991, J EVOLUTION BIOL, V4, P51, DOI 10.1046/j.1420-9101.1991.4010051.x; SWAIN DP, 1987, AM NAT, V129, P761, DOI 10.1086/284671; Thornhill R, 1999, AM NAT, V154, P234, DOI 10.1086/303233; TUINSTRA EJ, 1990, P ROY SOC B-BIOL SCI, V241, P146, DOI 10.1098/rspb.1990.0078; Van Dongen S, 2007, EVOLUTION, V61, P1033, DOI 10.1111/j.1558-5646.2007.00096.x; VANVALEN L, 1962, EVOLUTION, V16, P125; Whitlock M, 1996, P ROY SOC B-BIOL SCI, V263, P849, DOI 10.1098/rspb.1996.0125	57	21	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39843	10.1371/journal.pone.0039843	http://dx.doi.org/10.1371/journal.pone.0039843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792190	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800021
J	Xu, BZ; Obata, Y; Cao, F; Taketo, T				Xu, Baozeng; Obata, Yayoi; Cao, Feng; Taketo, Teruko			The Presence of the Y-Chromosome, Not the Absence of the Second X-Chromosome, Alters the mRNA Levels Stored in the Fully Grown XY Mouse Oocyte	PLOS ONE			English	Article							OVARIAN FOLLICULAR DEVELOPMENT; RENIN-ANGIOTENSIN SYSTEM; GENE-EXPRESSION; EMBRYONIC-DEVELOPMENT; LINKED INHIBITOR; GERM-CELLS; SEX; TRANSLATION; FERTILIZATION; PROTEIN	The oocytes of B6.Y-TIR sex-reversed female mouse mature in culture but fail to develop after fertilization because of their cytoplasmic defects. To identify the defective components, we compared the gene expression profiles between the fully-grown oocytes of B6.Y-TIR (XY) females and those of their XX littermates by cDNA microarray. 173 genes were found to be higher and 485 genes were lower in XY oocytes than in XX oocytes by at least 2-fold. We compared the transcript levels of selected genes by RT-PCR in XY and XX oocytes, as well as in XO oocytes missing paternal X-chromosomes. All genes tested showed comparable transcript levels between XX and XO oocytes, indicating that mRNA accumulation is well adjusted in XO oocytes. By contrast, in addition to Y-encoded genes, many genes showed significantly different transcript levels in XY oocytes. We speculate that the presence of the Y-chromosome, rather than the absence of the second X-chromosome, caused dramatic changes in the gene expression profile in the XY fully-grown oocyte.	[Xu, Baozeng; Taketo, Teruko] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Xu, Baozeng; Taketo, Teruko] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Obata, Yayoi; Cao, Feng] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan	McGill University; McGill University; Tokyo University of Agriculture	Xu, BZ (corresponding author), McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada.	teruko.taketo@mcgill.ca		Taketo, Teruko/0000-0002-7077-3768	Canadian Institutes of Health Research fund [MOP 86567]	Canadian Institutes of Health Research fund(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research fund granted to TT (MOP 86567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Alton M, 2008, REPRODUCTION, V135, P241, DOI 10.1530/REP-07-0383; Amleh A, 1996, DEV BIOL, V178, P263, DOI 10.1006/dbio.1996.0217; Amleh A, 2000, DEV BIOL, V219, P277, DOI 10.1006/dbio.1999.9600; Baarends WM, 1999, MOL CELL ENDOCRINOL, V151, P5, DOI 10.1016/S0303-7207(99)00060-X; Baumann C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001137; Bebington C, 2001, HUM REPROD UPDATE, V7, P102, DOI 10.1093/humupd/7.1.102; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; De La Fuente R, 2004, DEV BIOL, V272, P1, DOI 10.1016/j.ydbio.2003.12.012; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Ditton HJ, 2004, HUM MOL GENET, V13, P2333, DOI 10.1093/hmg/ddh240; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; KAPLAN G, 1982, J EXP ZOOL, V220, P361, DOI 10.1002/jez.1402200311; Kawamura K, 2003, DEV BIOL, V256, P331, DOI 10.1016/S0012-1606(02)00135-5; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KELLER SA, 1990, GENE DEV, V4, P1316, DOI 10.1101/gad.4.8.1316; Kim J, 2009, ENDOCRINOLOGY, V150, P3392, DOI 10.1210/en.2008-0948; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; LANE PW, 1990, J HERED, V81, P43, DOI 10.1093/oxfordjournals.jhered.a110923; Lee CH, 2001, GENESIS, V30, P7, DOI 10.1002/gene.1026; Lee J, 2004, MOL HUM REPROD, V10, P259, DOI 10.1093/molehr/gah037; Lee SH, 2010, FOOD CHEM TOXICOL, V48, P2633, DOI 10.1016/j.fct.2010.06.032; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; LIGHTMAN A, 1987, AM J OBSTET GYNECOL, V156, P808, DOI 10.1016/0002-9378(87)90336-X; Malapeira J, 2011, ONCOGENE, V30, P1912, DOI 10.1038/onc.2010.565; MANGIA F, 1975, DEV BIOL, V45, P211, DOI 10.1016/0012-1606(75)90061-5; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Morita Y, 2000, ANN NY ACAD SCI, V905, P209; NAGAMINE CM, 1990, GENE DEV, V4, P63, DOI 10.1101/gad.4.1.63; NAGAMINE CM, 1987, DIFFERENTIATION, V33, P223, DOI 10.1111/j.1432-0436.1987.tb01561.x; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; Obata Y, 2008, P NATL ACAD SCI USA, V105, P13918, DOI 10.1073/pnas.0802680105; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Oh B, 2000, DEVELOPMENT, V127, P3795; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; PLACHOT M, 1988, HUM REPROD, V3, P125, DOI 10.1093/oxfordjournals.humrep.a136644; Potireddy S, 2006, DEV BIOL, V298, P155, DOI 10.1016/j.ydbio.2006.06.024; ROLLER RJ, 1989, DEVELOPMENT, V106, P251; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Stutz A, 1998, GENE DEV, V12, P2535, DOI 10.1101/gad.12.16.2535; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; TAKETOHOSOTANI T, 1989, DEVELOPMENT, V107, P95; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Turner JMA, 2000, CHROMOSOMA, V109, P426, DOI 10.1007/s004120000097; Vanderhyden BC, 1997, BIOL REPROD, V57, P641, DOI 10.1095/biolreprod57.3.641; Villemure M, 2007, DEV BIOL, V301, P1, DOI 10.1016/j.ydbio.2006.10.034; Wang YF, 2002, ENDOCRINOLOGY, V143, P2732, DOI 10.1210/en.143.7.2732; Wong J, 2000, BIOL REPROD, V63, P756, DOI 10.1095/biolreprod63.3.756; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; YOSHIMURA Y, 1994, J CLIN INVEST, V93, P180, DOI 10.1172/JCI116943; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218; ZWINGMAN T, 1993, P NATL ACAD SCI USA, V90, P814, DOI 10.1073/pnas.90.3.814	67	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40481	10.1371/journal.pone.0040481	http://dx.doi.org/10.1371/journal.pone.0040481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792347	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800094
J	Chiu, JKH; Chen, YPP				Chiu, Jimmy Ka Ho; Chen, Yi-Ping Phoebe			Conformational Features of Topologically Classified RNA Secondary Structures	PLOS ONE			English	Article							INCLUDING PSEUDOKNOTS; NONCODING RNAS; STRUCTURE PREDICTION; PARTITION-FUNCTION; RIBOSOMAL-RNA; ALGORITHM; THERMODYNAMICS; PROBABILITIES; INFORMATION	Background: Current RNA secondary structure prediction approaches predict prevalent pseudoknots such as the H-pseudoknot and kissing hairpin. The number of possible structures increases drastically when more complex pseudoknots are considered, thus leading to computational limitations. On the other hand, the enormous population of possible structures means not all of them appear in real RNA molecules. Therefore, it is of interest to understand how many of them really exist and the reasons for their preferred existence over the others, as any new findings revealed by this study might enhance the capability of future structure prediction algorithms for more accurate prediction of complex pseudoknots. Methodology/Principal Findings: A novel algorithm was devised to estimate the exact number of structural possibilities for a pseudoknot constructed with a specified number of base pair stems. Then, topological classification was applied to classify RNA pseudoknotted structures from data in the RNA STRAND database. By showing the vast possibilities and the real population, it is clear that most of these plausible complex pseudoknots are not observed. Moreover, from these classified motifs that exist in nature, some features were identified for further investigation. It was found that some features are related to helical stacking. Other features are still left open to discover underlying tertiary interactions. Conclusions: Results from topological classification suggest that complex pseudoknots are usually some well-known motifs that are themselves complex or the interaction results of some special motifs. Heuristics can be proposed to predict the essential parts of these complex motifs, even if the required thermodynamic parameters are currently unknown.	[Chiu, Jimmy Ka Ho; Chen, Yi-Ping Phoebe] La Trobe Univ, Dept Comp Sci & Comp Engn, Melbourne, Vic, Australia	La Trobe University	Chiu, JKH (corresponding author), La Trobe Univ, Dept Comp Sci & Comp Engn, Melbourne, Vic, Australia.	phoebe.chen@latrobe.edu.au	Chen, Yi-Ping Phoebe/B-8844-2008	Chen, Yi-Ping Phoebe/0000-0002-4122-3767				Akutsu T, 2000, DISCRETE APPL MATH, V104, P45, DOI 10.1016/S0166-218X(00)00186-4; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Andersen ES, 2006, NUCLEIC ACIDS RES, V34, pD163, DOI 10.1093/nar/gkj142; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bon M, 2008, J MOL BIOL, V379, P900, DOI 10.1016/j.jmb.2008.04.033; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Chen QF, 2011, IEEE T BIO-MED ENG, V58, P1528, DOI 10.1109/TBME.2010.2090043; Chen QF, 2009, IEEE T KNOWL DATA EN, V21, P974, DOI 10.1109/TKDE.2008.231; Chen WYC, 2007, T AM MATH SOC, V359, P1555; Chen WYC, 2009, P NATL ACAD SCI USA, V106, P22061, DOI 10.1073/pnas.0907269106; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Jiang MH, 2010, J COMPUT BIOL, V17, P915, DOI 10.1089/cmb.2009.0119; Lee KS, 1997, J MOL BIOL, V269, P732, DOI 10.1006/jmbi.1997.1092; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Reidys CM, 2011, BIOINFORMATICS, V27, P1076, DOI 10.1093/bioinformatics/btr090; Reiter NJ, 2011, CURR OPIN STRUC BIOL, V21, P319, DOI 10.1016/j.sbi.2011.03.003; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rodland EA, 2006, J COMPUT BIOL, V13, P1197, DOI 10.1089/cmb.2006.13.1197; Sperschneider J, 2011, RNA, V17, P27, DOI 10.1261/rna.2394511; Steinberg SV, 2007, RNA, V13, P1036, DOI 10.1261/rna.495207; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Theis C, 2010, LECT N BIOINFORMAT, V6293, P52, DOI 10.1007/978-3-642-15294-8_5; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; van Batenburg FHD, 2001, NUCLEIC ACIDS RES, V29, P194, DOI 10.1093/nar/29.1.194; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	37	8	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39907	10.1371/journal.pone.0039907	http://dx.doi.org/10.1371/journal.pone.0039907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792195	Green Published, gold			2022-12-25	WOS:000306436300013
J	Gervan, P; Gombos, F; Kovacs, I				Gervan, Patricia; Gombos, Ferenc; Kovacs, Ilona			Perceptual Learning in Williams Syndrome: Looking Beyond Averages	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; OBSTRUCTIVE SLEEP-APNEA; DOWN-SYNDROME; HPC-1/SYNTAXIN 1A; VISUAL-CORTEX; RETT-SYNDROME; CHILDREN; NEUROANATOMY; ABNORMALITIES; INTEGRATION	Williams Syndrome is a genetically determined neurodevelopmental disorder characterized by an uneven cognitive profile and surprisingly large neurobehavioral differences among individuals. Previous studies have already shown different forms of memory deficiencies and learning difficulties in WS. Here we studied the capacity of WS subjects to improve their performance in a basic visual task. We employed a contour integration paradigm that addresses occipital visual function, and analyzed the initial (i.e. baseline) and after-learning performance of WS individuals. Instead of pooling the very inhomogeneous results of WS subjects together, we evaluated individual performance by expressing it in terms of the deviation from the average performance of the group of typically developing subjects of similar age. This approach helped us to reveal information about the possible origins of poor performance of WS subjects in contour integration. Although the majority of WS individuals showed both reduced baseline and reduced learning performance, individual analysis also revealed a dissociation between baseline and learning capacity in several WS subjects. In spite of impaired initial contour integration performance, some WS individuals presented learning capacity comparable to learning in the typically developing population, and vice versa, poor learning was also observed in subjects with high initial performance levels. These data indicate a dissociation between factors determining initial performance and perceptual learning.	[Gervan, Patricia; Gombos, Ferenc; Kovacs, Ilona] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary	Budapest University of Technology & Economics	Gervan, P (corresponding author), Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary.	pgervan@cogsci.bme.hu	Kovacs, Ilona/A-2372-2009	Kovacs, Ilona/0000-0002-1772-2697; Gervan, Patricia/0000-0001-5603-1912	OTKA (Hungarian Scientific Research Fund) [NF60806, TAMOP-4.2.2.B-10/1'2010-0009]	OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by OTKA (Hungarian Scientific Research Fund) NF60806 and TAMOP-4.2.2.B-10/1'2010-0009 (Social Renewal Operational Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2002, J NEUROSCI, V22, P8633; Arens R, 1998, J PEDIATR-US, V133, P670, DOI 10.1016/S0022-3476(98)70110-6; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Ashkenas J, 1996, AM J HUM GENET, V59, P756; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U., 1988, LANGUAGE DEV EXCEPTI, P177; Bodizs R, 2012, RES DEV DISABIL, V33, P153, DOI 10.1016/j.ridd.2011.09.004; Botta A, 1999, J MED GENET, V36, P478; Botta A, 1999, GENOMICS, V62, P525, DOI 10.1006/geno.1999.5987; BURKHALTER A, 1993, CEREB CORTEX, V3, P476, DOI 10.1093/cercor/3.5.476; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Carter JC, 2008, AM J NEURORADIOL, V29, P436, DOI 10.3174/ajnr.A0857; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Chisum HJ, 2004, NEURAL NETWORKS, V17, P681, DOI 10.1016/j.neunet.2004.05.002; de Miguel-Diaz J, 2003, SLEEP, V26, P1006, DOI 10.1093/sleep/26.8.1006; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Didden R, 2001, RES DEV DISABIL, V22, P255, DOI 10.1016/S0891-4222(01)00071-3; Dyken ME, 2003, ARCH PEDIAT ADOL MED, V157, P655, DOI 10.1001/archpedi.157.7.655; Epstein CJ., 2001, METABOLIC MOL BASES, V8th ed, P1223; Ewen Joshua B, 2005, Semin Pediatr Neurol, V12, P229, DOI 10.1016/j.spen.2005.12.005; Facon B, 2011, RES DEV DISABIL, V32, P2134, DOI 10.1016/j.ridd.2011.07.029; Galaburda AM, 2000, J COGNITIVE NEUROSCI, V12, P74, DOI 10.1162/089892900561995; Galaburda AM, 2002, ARCH NEUROL-CHICAGO, V59, P1461, DOI 10.1001/archneur.59.9.1461; Gao MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010292; Gervan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025572; Gervan P, 2010, J VISION, V10, DOI 10.1167/10.6.24; Gombos F, 2011, J INTELL DISABIL RES, V55, P255, DOI 10.1111/j.1365-2788.2010.01354.x; Harvey MT, 2002, INT J DEV NEUROSCI, V20, P443, DOI 10.1016/S0736-5748(02)00008-4; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jarrold C, 2007, CORTEX, V43, P233, DOI 10.1016/S0010-9452(08)70478-7; JORGENSEN OS, 1990, J NEUROL SCI, V98, P63; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kovacs I, 1996, BEHAV BRAIN RES, V82, P1, DOI 10.1016/S0166-4328(97)81103-5; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Kozma P, 2002, 2 ANN M VIS SCI SOC; Kozma-Wiebe P, 2006, COMPUT HUM BEHAV, V22, P971, DOI 10.1016/j.chb.2004.03.017; Kronk R, 2010, SLEEP, V33, P679, DOI 10.1093/sleep/33.5.679; Mandolesi L, 2009, INT J DEV NEUROSCI, V27, P205, DOI 10.1016/j.ijdevneu.2009.01.004; MARCUS CL, 1991, PEDIATRICS, V88, P132; McKendrick AM, 2010, J VISION, V10, DOI 10.1167/10.2.1; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Nakayama T, 1998, CYTOGENET CELL GENET, V82, P49, DOI 10.1159/000015063; Pennington BF, 2001, DEV COGN NEUROSCI, P149; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; REISS AL, 1994, NEUROLOGY, V44, P1317, DOI 10.1212/WNL.44.7.1317; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; Roudaia E, 2008, VISION RES, V48, P2767, DOI 10.1016/j.visres.2008.07.026; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; SPITZ HH, 1982, MERRILL PALMER QUART, V28, P167; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; Temudo T, 2009, BRAIN DEV-JPN, V31, P46, DOI 10.1016/j.braindev.2008.05.003; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; Vicari S, 1996, CORTEX, V32, P503, DOI 10.1016/S0010-9452(96)80007-4; Vicari S, 2003, DEV MED CHILD NEUROL, V45, P269, DOI 10.1017/S0012162203000513; WANG PP, 1994, J CLIN EXP NEUROPSYC, V16, P317, DOI 10.1080/01688639408402641; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WEIS S, 1991, AM J NEURORADIOL, V12, P1207; Young D, 2007, BRAIN DEV-JPN, V29, P609, DOI 10.1016/j.braindev.2007.04.001	66	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40282	10.1371/journal.pone.0040282	http://dx.doi.org/10.1371/journal.pone.0040282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974LI	22792262	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300045
J	Griffin, MDW; Billakanti, JM; Wason, A; Keller, S; Mertens, HDT; Atkinson, SC; Dobson, RCJ; Perugini, MA; Gerrard, JA; Pearce, FG				Griffin, Michael D. W.; Billakanti, Jagan M.; Wason, Akshita; Keller, Sabrina; Mertens, Haydyn D. T.; Atkinson, Sarah C.; Dobson, Renwick C. J.; Perugini, Matthew A.; Gerrard, Juliet A.; Pearce, Frederick Grant			Characterisation of the First Enzymes Committed to Lysine Biosynthesis in Arabidopsis thaliana	PLOS ONE			English	Article							DIHYDRODIPICOLINATE SYNTHASE; ESCHERICHIA-COLI; BIOLOGICAL MACROMOLECULES; 3-DIMENSIONAL STRUCTURE; PARTIAL-PURIFICATION; QUATERNARY STRUCTURE; SOLUTION SCATTERING; AMINO-ACIDS; REDUCTASE; RESOLUTION	In plants, the lysine biosynthetic pathway is an attractive target for both the development of herbicides and increasing the nutritional value of crops given that lysine is a limiting amino acid in cereals. Dihydrodipicolinate synthase (DHDPS) and dihydrodipicolinate reductase (DHDPR) catalyse the first two committed steps of lysine biosynthesis. Here, we carry out for the first time a comprehensive characterisation of the structure and activity of both DHDPS and DHDPR from Arabidopsis thaliana. The A. thaliana DHDPS enzyme (At-DHDPS2) has similar activity to the bacterial form of the enzyme, but is more strongly allosterically inhibited by (S)-lysine. Structural studies of At-DHDPS2 show (S)-lysine bound at a cleft between two monomers, highlighting the allosteric site; however, unlike previous studies, binding is not accompanied by conformational changes, suggesting that binding may cause changes in protein dynamics rather than large conformation changes. DHDPR from A. thaliana (At-DHDPR2) has similar specificity for both NADH and NADPH during catalysis, and has tighter binding of substrate than has previously been reported. While all known bacterial DHDPR enzymes have a tetrameric structure, analytical ultracentrifugation, and scattering data unequivocally show that At-DHDPR2 exists as a dimer in solution. The exact arrangement of the dimeric protein is as yet unknown, but ab initio modelling of x-ray scattering data is consistent with an elongated structure in solution, which does not correspond to any of the possible dimeric pairings observed in the X-ray crystal structure of DHDPR from other organisms. This increased knowledge of the structure and function of plant lysine biosynthetic enzymes will aid future work aimed at improving primary production.	[Griffin, Michael D. W.; Atkinson, Sarah C.; Dobson, Renwick C. J.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Billakanti, Jagan M.; Wason, Akshita; Keller, Sabrina; Dobson, Renwick C. J.; Gerrard, Juliet A.; Pearce, Frederick Grant] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Billakanti, Jagan M.; Wason, Akshita; Keller, Sabrina; Dobson, Renwick C. J.; Gerrard, Juliet A.; Pearce, Frederick Grant] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Billakanti, Jagan M.; Gerrard, Juliet A.] Ind Res Ltd, Lower Hutt, New Zealand; [Mertens, Haydyn D. T.] Australian Synchrotron, Melbourne, Vic, Australia; [Atkinson, Sarah C.; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia	University of Melbourne; University of Canterbury; University of Canterbury; Callaghan Innovation; La Trobe University	Griffin, MDW (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia.	grant.pearce@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Atkinson, Sarah/0000-0002-3518-9785; BILLAKANTI, JAGANMOHAN/0000-0002-8763-8036; Griffin, Michael/0000-0001-9845-7735; Pearce, Frederick/0000-0002-2683-0331; Mertens, Haydyn/0000-0002-5664-744X	Defense Threat Reduction Agency [W911NF-07-1-0073, AB07CBT004]; Foundation of Research, Science and Technology; New Zealand Synchrotron Group	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Foundation of Research, Science and Technology; New Zealand Synchrotron Group	This work was supported in part by the Defense Threat Reduction Agency (W911NF-07-1-0073 and AB07CBT004) and in part by the Foundation of Research, Science and Technology. Travel to the Australian Synchrotron was funded by the New Zealand Synchrotron Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SC, 2012, PLOS ONE UNPUB; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Blickling S, 1997, BIOL CHEM, V378, P207; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Cirilli M, 2003, BIOCHEMISTRY-US, V42, P10644, DOI 10.1021/bi030044v; Craciun A, 2000, FEBS LETT, V487, P234, DOI 10.1016/S0014-5793(00)02303-6; DEREPPE C, 1992, PLANT PHYSIOL, V98, P813, DOI 10.1104/pp.98.3.813; Devenish SRA, 2010, J MED CHEM, V53, P4808, DOI 10.1021/jm100349s; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, BIOCHEM J, V377, P757, DOI 10.1042/bj20031389; Dobson RCJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020439; Dommaraju S, 2010, ACTA CRYSTALLOGR F, V66, P57, DOI 10.1107/S1744309109047964; Dommaraju SR, 2011, ARCH BIOCHEM BIOPHYS, V512, P167, DOI 10.1016/j.abb.2011.06.006; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRISCH DA, 1991, PLANT PHYSIOL, V96, P444, DOI 10.1104/pp.96.2.444; Frizzi A, 2008, PLANT BIOTECHNOL J, V6, P13, DOI 10.1111/j.1467-7652.2007.00290.x; Galili G, 2002, ANNU REV PLANT BIOL, V53, P27, DOI 10.1146/annurev.arplant.53.091401.110929; GHISLAIN M, 1990, PLANTA, V180, P480, DOI 10.1007/BF02411444; Girish TS, 2011, FEBS LETT, V585, P2561, DOI 10.1016/j.febslet.2011.07.021; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Griffin MDW, 2011, ACTA CRYSTALLOGR F, V67, P1386, DOI 10.1107/S1744309111033276; Griffin MDW, 2010, ARCH BIOCHEM BIOPHYS, V494, P58, DOI 10.1016/j.abb.2009.11.014; Hudson AO, 2005, BBA-GEN SUBJECTS, V1721, P27, DOI 10.1016/j.bbagen.2004.09.008; Jander G, 2010, MOL PLANT, V3, P54, DOI 10.1093/mp/ssp104; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaur N, 2011, INT J BIOL MACROMOL, V48, P779, DOI 10.1016/j.ijbiomac.2011.03.002; Kiefer F, 2009, NUCL ACIDS RES, V37; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMPAISAL R, 1989, AGR BIOL CHEM TOKYO, V53, P355, DOI 10.1080/00021369.1989.10869297; KUMPAISAL R, 1987, PLANT PHYSIOL, V85, P145, DOI 10.1104/pp.85.1.145; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MATTHEWS BF, 1978, PLANTA, V141, P315, DOI 10.1007/BF00388350; Pearce FG, 2008, BIOCHEMISTRY-US, V47, P12108, DOI 10.1021/bi801094t; Pearce FG, 2008, J BIOCHEM, V143, P617, DOI 10.1093/jb/mvn012; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Pearce FG, 2011, BIOCH BIOPHYS ACTA; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Reddy S, 1996, BIOCHEMISTRY-US, V35, P13924; REDDY SG, 1995, BIOCHEMISTRY-US, V34, P3492, DOI 10.1021/bi00011a002; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Roberts SJ, 2003, BIOORG MED CHEM LETT, V13, P265, DOI 10.1016/S0960-894X(02)00923-X; Sarrobert C, 2000, PLANT J, V24, P357, DOI 10.1046/j.1365-313x.2000.00884.x; SCAPIN G, 1995, BIOCHEMISTRY-US, V34, P3502, DOI 10.1021/bi00011a003; Scapin G, 1997, BIOCHEMISTRY-US, V36, P15081, DOI 10.1021/bi9719915; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Shimizu H, 2007, PLANT J, V52, P539, DOI 10.1111/j.1365-313X.2007.03256.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TYAGI VVS, 1983, PLANT PHYSIOL, V73, P687, DOI 10.1104/pp.73.3.687; Ufaz S, 2008, PLANT PHYSIOL, V147, P954, DOI 10.1104/pp.108.118091; Vauterin M, 1999, PLANT MOL BIOL, V39, P695, DOI 10.1023/A:1006132428623; WALLSGROVE RM, 1981, PHYTOCHEMISTRY, V20, P2651, DOI 10.1016/0031-9422(81)85261-2	62	37	38	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40318	10.1371/journal.pone.0040318	http://dx.doi.org/10.1371/journal.pone.0040318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792278	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300053
J	Krueger, C; King, MR; Krueger, F; Branco, MR; Osborne, CS; Niakan, KK; Higgins, MJ; Reik, W				Krueger, Christel; King, Michelle R.; Krueger, Felix; Branco, Miguel R.; Osborne, Cameron S.; Niakan, Kathy K.; Higgins, Michael J.; Reik, Wolf			Pairing of Homologous Regions in the Mouse Genome Is Associated with Transcription but Not Imprinting Status	PLOS ONE			English	Article							REPRESSIVE HISTONE METHYLATION; ORDER CHROMATIN ARRANGEMENTS; STRAND BREAK REPAIR; HEAVY-CHAIN LOCUS; GENE-EXPRESSION; 3D STRUCTURE; RECOMBINATION; MAINTENANCE; DOMAIN; TRANS	Although somatic homologous pairing is common in Drosophila it is not generally observed in mammalian cells. However, a number of regions have recently been shown to come into close proximity with their homologous allele, and it has been proposed that pairing might be involved in the establishment or maintenance of monoallelic expression. Here, we investigate the pairing properties of various imprinted and non-imprinted regions in mouse tissues and ES cells. We find by allele-specific 4C-Seq and DNA FISH that the Kcnq1 imprinted region displays frequent pairing but that this is not dependent on monoallelic expression. We demonstrate that pairing involves larger chromosomal regions and that the two chromosome territories come close together. Frequent pairing is not associated with imprinted status or DNA repair, but is influenced by chromosomal location and transcription. We propose that homologous pairing is not exclusive to specialised regions or specific functional events, and speculate that it provides the cell with the opportunity of trans-allelic effects on gene regulation.	[Krueger, Christel; King, Michelle R.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge, England; [Krueger, Felix] Babraham Inst, Bioinformat Grp, Cambridge, England; [Branco, Miguel R.] Imperial Coll Sch Med, Genome Funct Grp, MRC, Ctr Clin Sci, London, England; [Osborne, Cameron S.] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Niakan, Kathy K.; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Niakan, Kathy K.] Univ Cambridge, Dept Physiol Dev & Neurosci, Anne McLaren Lab Regenerat Med, Cambridge, England; [Higgins, Michael J.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Cambridge; Roswell Park Cancer Institute	Krueger, C (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	christel.krueger@babraham.ac.uk; wolf.reik@bbsrc.ac.uk	Osborne, Cameron/N-1398-2017; Branco, Miguel/H-9509-2019; Reik, Wolf/I-6794-2012; Krueger, Felix/J-3340-2019	Osborne, Cameron/0000-0003-4126-2499; Branco, Miguel/0000-0001-9447-1548; Krueger, Felix/0000-0002-5513-3324; Reik, Wolf/0000-0003-0216-9881; Krueger, Christel/0000-0001-5601-598X; Niakan, Kathy/0000-0003-1646-4734	BBSRC [BB/H088071/1]; MRC [G0700760]; Wellcome Trust [095645/Z/11/Z]; EU through EpiGeneSys; EU through Blueprint; DFG [KR 3317/2-1]; CTR; NCI/NIH [2RO1 CA089426]; BBSRC [BB/H008071/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S119, BBS/E/B/0000C214, BB/H008071/1] Funding Source: researchfish; Medical Research Council [G0700760] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA089426] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EU through EpiGeneSys; EU through Blueprint; DFG(German Research Foundation (DFG)); CTR; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the BBSRC, grant BB/H088071/1 (www.bbsrc.ac.uk), MRC, grant G0700760 (www.mrc.ac.uk), Wellcome Trust, grant 095645/Z/11/Z (www.wellcome.ac.uk) and the EU through EpiGeneSys (www.epigenesys.eu) and Blueprint (www.blueprint-epigenome.eu). C. K. was funded by the DFG, personal fellowship KR 3317/2-1 (www.dfg.de) and CTR, personal short term fellowship (www.trophoblast.cam.ac.uk). M.J.H. received funding through grant NCI/NIH 2RO1 CA089426 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Anguera MC, 2006, COLD SPRING HARB SYM, V71, P429, DOI 10.1101/sqb.2006.71.012; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Brideau CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013784; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cope NF, 2009, COLD SPRING HARB PRO; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Duvillie B, 1998, GENOMICS, V47, P52, DOI 10.1006/geno.1997.5070; Fitzpatrick GV, 2007, MOL CELL BIOL, V27, P2636, DOI 10.1128/MCB.02036-06; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Heride C, 2010, J CELL SCI, V123, P4063, DOI 10.1242/jcs.066498; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hu JF, 1997, J BIOL CHEM, V272, P20715, DOI 10.1074/jbc.272.33.20715; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Koeman JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000176; Kozubek S, 2002, CHROMOSOMA, V111, P321, DOI 10.1007/s00412-002-0210-8; Landers M, 2005, NUCLEIC ACIDS RES, V33, P3976, DOI 10.1093/nar/gki705; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meguro-Horike M, 2011, HUM MOL GENET, V20, P3798, DOI 10.1093/hmg/ddr298; Moynahan ME, 1997, P NATL ACAD SCI USA, V94, P8988, DOI 10.1073/pnas.94.17.8988; Nagele RG, 2001, J CELL SCI, V114, P377; Nagy A., 2003, MANIPULATING MOUSE E; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Peltomaki P, 2012, EXP CELL RES, V318, P299, DOI 10.1016/j.yexcr.2011.12.001; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Stout K, 1999, CHROMOSOME RES, V7, P323, DOI 10.1023/A:1009287111661; Teller K, 2007, P NATL ACAD SCI USA, V104, P14970, DOI 10.1073/pnas.0704285104; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Xu M, 2008, BBA-MOL CELL RES, V1783, P2155, DOI 10.1016/j.bbamcr.2008.07.013; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	53	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38983	10.1371/journal.pone.0038983	http://dx.doi.org/10.1371/journal.pone.0038983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802932	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900006
J	Eiseler, T; Kohler, C; Nimmagadda, SC; Jamali, A; Funk, N; Joodi, G; Storz, P; Seufferlein, T				Eiseler, Tim; Koehler, Conny; Nimmagadda, Subbaiah Chary; Jamali, Arsia; Funk, Nancy; Joodi, Golsa; Storz, Peter; Seufferlein, Thomas			Protein Kinase D1 Mediates Anchorage-dependent and -independent Growth of Tumor Cells via the Zinc Finger Transcription Factor Snail1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER; CYCLIN D1; MESENCHYMAL TRANSITION; MITOTIC COMMITMENT; DNA-SYNTHESIS; E-CADHERIN; AURORA-A; PKC-MU; PHOSPHORYLATION; PROLIFERATION	We here identify protein kinase D1 (PKD1) as a major regulator of anchorage-dependent and -independent growth of cancer cells controlled via the transcription factor Snail1. Using FRET, we demonstrate that PKD1, but not PKD2, efficiently interacts with Snail1 in nuclei. PKD1 phosphorylates Snail1 at Ser-11. There was no change in the nucleocytoplasmic distribution of Snail1 using wild type Snail1 and Ser-11 phosphosite mutants in different tumor cells. Regardless of its phosphorylation status or following co-expression of constitutively active PKD, Snail1 was predominantly localized to cell nuclei. We also identify a novel mechanism of PKD1-mediated regulation of Snail1 transcriptional activity in tumor cells. The interaction of the co-repressors histone deacetylases 1 and 2 as well as lysyl oxidase-like protein 3 with Snail1 was impaired when Snail1 was not phosphorylated at Ser-11, which led to reduced Snail1-associated histone deacetylase activity. Additionally, lysyl oxidase-like protein 3 expression was up-regulated by ectopic PKD1 expression, implying a synergistic regulation of Snail1-driven transcription. Ectopic expression of PKD1 also up-regulated proliferation markers such as Cyclin D1 and Ajuba. Accordingly, Snail1 and its phosphorylation at Ser-11 were required and sufficient to control PKD1-mediated anchorage-independent growth and anchorage-dependent proliferation of different tumor cells. In conclusion, our data show that PKD1 is crucial to support growth of tumor cells via Snail1.	[Eiseler, Tim; Seufferlein, Thomas] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Eiseler, Tim; Koehler, Conny; Nimmagadda, Subbaiah Chary; Jamali, Arsia; Funk, Nancy; Joodi, Golsa] Univ Halle Wittenberg, Univ Clin Halle, Dept Internal Med 1, D-06120 Halle, Saale, Germany; [Jamali, Arsia; Joodi, Golsa] Univ Tehran Med Sci, Student Sci Res Ctr, Tehran 1417613151, Iran; [Storz, Peter] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Ulm University; Martin Luther University Halle Wittenberg; Tehran University of Medical Sciences; Mayo Clinic	Seufferlein, T (corresponding author), Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Germany.	thomas.seufferlein@uniklinik-ulm.de	Seufferlein, Thomas TW/P-7147-2018	Joodi, Golsa/0000-0002-6371-433X	National Institutes of Health [R01CA140182, R01GM86435]; Deutsche Krebshilfe [109222]; Wilhelm-Roux-Program [FKZ 23/19, FKZ 23/08]; Florida Department of Health Bankhead-Coley Cancer Research Program [FLA07BN-08]; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [NGFN plus/PKB-01GS08209-4]; NATIONAL CANCER INSTITUTE [R01CA140182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Roux-Program; Florida Department of Health Bankhead-Coley Cancer Research Program; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA140182 and R01GM86435 (to P. S.). This work was also supported by Deutsche Krebshilfe Grant 109222, Wilhelm-Roux-Program Grants FKZ 23/19 and FKZ 23/08 (to T. E.), Florida Department of Health Bankhead-Coley Cancer Research Program Grant FLA07BN-08 (to P. S.), and German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) Grant NGFN plus/PKB-01GS08209-4 (to T. S.).	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Dodd ME, 2005, J INVEST DERMATOL, V125, P294, DOI 10.1111/j.0022-202X.2005.23780.x; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Guha S, 2002, CANCER RES, V62, P1632; Guha S, 2010, BIOCHEM PHARMACOL, V80, P1946, DOI 10.1016/j.bcp.2010.07.002; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jackson LN, 2006, BIOCHEM BIOPH RES CO, V348, P945, DOI 10.1016/j.bbrc.2006.07.142; Kimura Masashi, 2005, Gan To Kagaku Ryoho, V32, P1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Ouyang WM, 2007, J CELL BIOCHEM, V101, P969, DOI 10.1002/jcb.21279; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prigent C, 2003, CELL, V114, P531, DOI 10.1016/S0092-8674(03)00685-8; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Seufferlein T, 2002, J GASTROINTEST CANC, V31, P15, DOI 10.1385/IJGC:31:1-3:15; Van Lint J, 2002, INT J BIOCHEM CELL B, V34, P577, DOI 10.1016/S1357-2725(01)00163-7; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1653; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zwijsen RML, 1996, MOL CELL BIOL, V16, P2554	40	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32367	32380		10.1074/jbc.M112.370999	http://dx.doi.org/10.1074/jbc.M112.370999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22791710	Green Published, hybrid			2022-12-25	WOS:000309168300008
J	Goh, LL; Manser, E				Goh, Liuh Ling; Manser, Ed			The GTPase-deficient Rnd Proteins Are Stabilized by Their Effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; ORNITHINE DECARBOXYLASE; PROTEASOMAL DEGRADATION; MEDIATES DEGRADATION; ACTIVATING PROTEIN; P190 RHOGAP; IN-VIVO; R-RAS; RHOE; BINDING	Rnd proteins are Rho family GTP-binding proteins with cellular functions that antagonize RhoA signaling. We recently described a new Rnd3 effector Syx, also named PLEKHG5, that interacts with Rnds via a Raf1-like "Ras-binding domain." Syx is a multidomain RhoGEF that participates in early zebrafish development. Here we demonstrated that Rnd1, Rnd2, and Rnd3 stability is acutely dependent on interaction with their effectors such as Syx or p190 RhoGAP. Although Rnd3 turnover is blocked by treatment of cells with MG132, we provide evidence that such turnover is mediated indirectly by effects on the Rnd3 effectors, rather than on Rnd3 itself, which is not significantly ubiquitinated. The minimal regions of Syx and p190 RhoGAP that bind Rnd3 are not sequence-related but have similar effects. We have identified features that allow for Rnd3 turnover including a conserved Lys-45 close to the switch I region and the C-terminal membrane-binding domain of Rnd3, which cannot be substituted by the equivalent Cdc42 CAAX sequence. By contrast, an effector binding-defective mutant of Rnd3 when overexpressed undergoes turnover at normal rates. Interestingly the activity of the RhoA-regulated kinase ROCK stimulates Rnd3 turnover. This study suggests that Rnd proteins are regulated through feedback mechanisms in cells where the level of effectors and RhoA activity influence the stability of Rnd proteins. This effector feedback behavior is analogous to the ability of ACK1 and PAK1 to prolong the lifetime of the active GTP-bound state of Cdc42 and Rac1.	[Goh, Liuh Ling; Manser, Ed] Inst Med Biol, Rho GTPases Signaling Grp, Singapore 138648, Singapore; [Manser, Ed] Astar Neurosci Res Partnership, Small G Prot Signaling & Kinases Grp, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR)	Manser, E (corresponding author), Inst Med Biol, Rho GTPases Signaling Grp, 8A Biomed Grove,06-06 Immunos Bldg, Singapore 138648, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020					Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bonet R, 2009, J MOL BIOL, V389, P230, DOI 10.1016/j.jmb.2009.04.035; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Fiegen D, 2002, FEBS LETT, V525, P100, DOI 10.1016/S0014-5793(02)03094-6; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Foster R, 1996, MOL CELL BIOL, V16, P2689; GLASS JR, 1987, J CELL PHYSIOL, V130, P133, DOI 10.1002/jcp.1041300119; Goda T, 2009, DEV DYNAM, V238, P2867, DOI 10.1002/dvdy.22099; Goh LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012409; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Karkkainen S, 2010, FEBS LETT, V584, P3867, DOI 10.1016/j.febslet.2010.07.060; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Komander D, 2008, EMBO J, V27, P3175, DOI 10.1038/emboj.2008.226; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2012, MOL BIOL CELL, V23, P1593, DOI 10.1091/mbc.E11-11-0900; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Ryan K. R., 2012, J CELL SCI, DOI 10/1242/jcs.101931; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Tyburczy ME, 2010, AM J PATHOL, V176, P1878, DOI 10.2353/ajpath.2010.090950; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Villalonga P, 2009, J BIOL CHEM, V284, P35287, DOI 10.1074/jbc.M109.050120; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Xie C, 2011, J BIOL CHEM, V286, P35933, DOI 10.1074/jbc.M111.270199; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	58	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31311	31320		10.1074/jbc.M111.327056	http://dx.doi.org/10.1074/jbc.M111.327056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807448	hybrid, Green Published			2022-12-25	WOS:000308791300042
J	Jaenecke, I; Boissel, JP; Lemke, M; Rupp, J; Gasnier, B; Closs, EI				Jaenecke, Isabel; Boissel, Jean-Paul; Lemke, Matthias; Rupp, Johanna; Gasnier, Bruno; Closs, Ellen I.			A Chimera Carrying the Functional Domain of the Orphan Protein SLC7A14 in the Backbone of SLC7A2 Mediates Trans-stimulated Arginine Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; CYSTINOSIS; CYSTEAMINE; LYSOSOMES; MEMBRANE; SUBUNIT; CATS	In human skin fibroblasts, a lysosomal transport system specific for cationic amino acids has been described and named system c. We asked if SLC7A14 (solute carrier family 7 member A14), an orphan protein assigned to the SLC7 subfamily of cationic amino acid transporters (CATs) due to sequence homology, may represent system c. Fusion proteins between SLC7A14 and enhanced GFP localized to intracellular vesicles, co-staining with the lysosomal marker LysoTracker (R). To perform transport studies, we first tried to redirect SLC7A14 to the plasma membrane (by mutating putative lysosomal targeting motifs) but without success. We then created a chimera carrying the backbone of human (h) CAT-2 and the protein domain of SLC7A14 corresponding to the so-called "functional domain" of the hCAT proteins, a protein stretch of 81 amino acids that determines the apparent substrate affinity, sensitivity to trans-stimulation, and (as revealed in this study) pH dependence. The chimera mediated arginine transport and exhibited characteristics similar but not identical to hCAT-2A (the low affinity hCAT-2 isoform). Western blot and microscopic analyses confirmed localization of the chimera in the plasma membrane of Xenopus laevis oocytes. Noticeably, arginine transport by the hCAT-2/SLC7A14 chimera was pH-dependent, trans-stimulated, and inhibited by alpha-trimethyl-L-lysine, properties assigned to lysosomal transport system c in human skin fibroblasts. Expression analysis showed strong expression of SLC7A14 mRNA in these cells. Taken together, these data strongly suggest that SLC7A14 is a lysosomal transporter for cationic amino acids.	[Gasnier, Bruno] Univ Paris 05, CNRS, UMR 8192, F-75006 Paris, France; [Jaenecke, Isabel; Boissel, Jean-Paul; Lemke, Matthias; Rupp, Johanna; Closs, Ellen I.] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-55131 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Johannes Gutenberg University of Mainz	Closs, EI (corresponding author), Univ Med Ctr Mainz, Dept Pharmacol, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	closs@uni-mainz.de	Closs, Ellen/ABD-5217-2020; Gasnier, Bruno/AAD-9124-2022	Closs, Ellen/0000-0002-9505-2289; Gasnier, Bruno/0000-0003-4458-6296	Deutsche Forschungsgemeinschaft (DFG) [Cl 100/4-3]; Cystinosis Research Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cystinosis Research Foundation	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant Cl 100/4-3 (to E. I. C.) and a Cystinosis Research Foundation common grant (to B. G. and E. I. C.).	Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Closs EI, 1997, BIOCHEMISTRY-US, V36, P6462, DOI 10.1021/bi962829p; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Habermeier A, 2003, J BIOL CHEM, V278, P19492, DOI 10.1074/jbc.M210254200; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Levtchenko EN, 2006, PEDIATR NEPHROL, V21, P110, DOI 10.1007/s00467-005-2052-0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; PISONI RL, 1987, J BIOL CHEM, V262, P15011; PISONI RL, 1985, J BIOL CHEM, V260, P4791; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Rotmann A, 2007, AM J PHYSIOL-CELL PH, V292, pC2259, DOI 10.1152/ajpcell.00323.2006; SCHULMAN JD, 1969, SCIENCE, V166, P1152, DOI 10.1126/science.166.3909.1152; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Terry J., 2002, PHARM J, V269, P615; Vekony N, 2001, BIOCHEMISTRY-US, V40, P12387, DOI 10.1021/bi011345c; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wolf S, 2002, BIOCHEM J, V364, P767, DOI 10.1042/BJ20020084	19	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30853	30860		10.1074/jbc.M112.350322	http://dx.doi.org/10.1074/jbc.M112.350322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787143	hybrid, Green Published			2022-12-25	WOS:000308579800073
J	Wu, Q; DiBona, VL; Bernard, LP; Zhang, HY				Wu, Qian; DiBona, Victoria L.; Bernard, Laura P.; Zhang, Huaye			The Polarity Protein Partitioning-defective 1 (PAR-1) Regulates Dendritic Spine Morphogenesis through Phosphorylating Postsynaptic Density Protein 95 (PSD-95)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE; LOCALIZATION; DROSOPHILA; MAINTENANCE; DISORDERS; PATHOLOGY; BAZOOKA; GENES; MARK	The polarity protein PAR-1 plays an essential role in many cellular contexts, including embryogenesis, asymmetric cell division, directional migration, and epithelial morphogenesis. Despite its known importance in different cellular processes, the role of PAR-1 in neuronal morphogenesis is less well understood. In particular, its role in the morphogenesis of dendritic spines, which are sites of excitatory synaptic inputs, has been unclear. Here, we show that PAR-1 is required for normal spine morphogenesis in hippocampal neurons. We further show that PAR-1 functions through phosphorylating the synaptic scaffolding protein PSD-95 in this process. Phosphorylation at a conserved serine residue in the KXGS motif in PSD-95 regulates spine morphogenesis, and a phosphomimetic mutant of this site can rescue the defects of kinase-dead PAR-1. Together, our findings uncover a role of PAR-1 in spine morphogenesis in hippocampal neurons through phosphorylating PSD-95.	[Wu, Qian; DiBona, Victoria L.; Bernard, Laura P.; Zhang, Huaye] UMDNJ Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, HY (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane W, Piscataway, NJ 08854 USA.	zhang29@umdnj.edu			National Institutes of Health [NS065183]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065183, K99NS065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS065183 (to H. Z.). This work was also supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (to H. Z.).	Bayraktar J, 2006, J CELL SCI, V119, P711, DOI 10.1242/jcs.02789; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hayashi K, 2011, J NEUROSCI, V31, P12094, DOI 10.1523/JNEUROSCI.0751-11.2011; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Krahn MP, 2009, DEV CELL, V16, P901, DOI 10.1016/j.devcel.2009.04.011; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Segu L, 2008, NEUROBIOL AGING, V29, P231, DOI 10.1016/j.neurobiolaging.2006.10.014; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016	24	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30781	30788		10.1074/jbc.M112.351452	http://dx.doi.org/10.1074/jbc.M112.351452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807451	Green Published, hybrid			2022-12-25	WOS:000308579800066
J	Williams, PT				Williams, Paul T.			Non-Exchangeability of Running vs. Other Exercise in Their Association with Adiposity, and Its Implications for Public Health Recommendations	PLOS ONE			English	Article							OF-SPORTS-MEDICINE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; ENERGY-EXPENDITURE; BODY FATNESS; OBESITY; ADULTS; AGE; PREVENTION; INTENSITY	Purpose: Current physical activity recommendations assume that different activities can be exchanged to produce the same weight-control benefits so long as total energy expended remains the same (exchangeability premise). To this end, they recommend calculating energy expenditure as the product of the time spent performing each activity and the activity's metabolic equivalents (MET), which may be summed to achieve target levels. The validity of the exchangeability premise was assessed using data from the National Runners' Health Study. Methods: Physical activity dose was compared to body mass index (BMI) and body circumferences in 33,374 runners who reported usual distance run and pace, and usual times spent running and other exercises per week. MET hours per day (METhr/d) from running was computed from: a) time and intensity, and b) reported distance run (1.02 MET.hours per km). Results: When computed from time and intensity, the declines (slope +/- SE) per METhr/d were significantly greater (P<10(-15)) for running than non-running exercise for BMI (slopes +/- SE, male: -0.12 +/- 0.00 vs. 0.00 +/- 0.00; female: -0.12 +/- 0.00 vs. -0.01 +/- 0.01 kg/m(2) per METhr/d) and waist circumference (male: 20.2860.01 vs. -0.07 +/- 0.01; female: -0.31 +/- 0.01 vs. -0.05 +/- 0.01 cm per METhr/d). Reported METhr/d of running was 38% to 43% greater when calculated from time and intensity than distance. Moreover, the declines per METhr/d run were significantly greater when estimated from reported distance for BMI (males: -0.29 +/- 0.01; females: -0.27 +/- 0.01 kg/m(2) per METhr/d) and waist circumference (males: -0.67 +/- 0.02; females: -0.69 +/- 0.02 cm per METhr/d) than when computed from time and intensity (cited above). Conclusion: The exchangeability premise was not supported for running vs. non-running exercise. Moreover, distance-based running prescriptions may provide better weight control than time-based prescriptions for running or other activities. Additional longitudinal studies and randomized clinical trials are required to verify these results prospectively.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung, and Blood Institute [HL094717]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grant HL094717 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Albarracin D, 2009, OBESITY, V17, P1451, DOI 10.1038/oby.2009.16; Andrade AM, 2010, PATIENT EDUC COUNS, V79, P320, DOI 10.1016/j.pec.2010.01.006; [Anonymous], 1998, OBES RES S, V2, p51s; Baker C. W., 2000, Physical activity and obesity, P311; Broom DR, 2009, AM J PHYSIOL-REG I, V296, pR29, DOI 10.1152/ajpregu.90706.2008; Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Goran MI, 2001, PEDIATR CLIN N AM, V48, P931, DOI 10.1016/S0031-3955(05)70349-7; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Institute of Medicine, 2005, DIET REF INT EN CARB, P880; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; LENNON D, 1985, INT J OBESITY, V9, P39; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Martins C, 2008, INT J OBESITY, V32, P1337, DOI 10.1038/ijo.2008.98; Martins C, 2007, BRIT J NUTR, V98, P834, DOI 10.1017/S000711450774922X; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; O'Rahilly S, 2008, DIABETES, V57, P2905, DOI 10.2337/db08-0210; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pendleton VR, 2002, INT J EAT DISORDER, V31, P172, DOI 10.1002/eat.10010; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ratcliff L, 2011, INT J SPORT NUTR EXE, V21, P11, DOI 10.1123/ijsnem.21.1.11; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; The Centers for Disease Control and Prevention (CDC), 2010, MMWR-MORBID MORTAL W, V57, P1297; TREMBLAY A, 1990, AM J CLIN NUTR, V51, P153, DOI 10.1093/ajcn/51.2.153; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2010, AM J PREV MED, V39, pE13, DOI 10.1016/j.amepre.2010.05.017; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; US Department of Health and Human Services, 1999, PHYS ACT HLTH REP SU; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams PT, 2008, OBESITY, V16, P102, DOI 10.1038/oby.2007.5; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2009, OBESITY, V17, P1428, DOI 10.1038/oby.2008.680; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2012, MED SCI SPO IN PRESS; Yoshioka M, 2001, INT J OBESITY, V25, P332, DOI 10.1038/sj.ijo.0801554	41	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e36360	10.1371/journal.pone.0036360	http://dx.doi.org/10.1371/journal.pone.0036360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808000	Green Submitted, Green Published, gold			2022-12-25	WOS:000306406700003
J	Fang, XY; Lang, YJ; Wang, YX; Mo, W; Wei, HH; Xie, JH; Yu, M				Fang, Xiaoyun; Lang, Yongjiang; Wang, Yuxiong; Mo, Wei; Wei, Huanhuan; Xie, Jianhui; Yu, Min			Shp2 Activates Fyn and Ras to Regulate RBL-2H3 Mast Cell Activation following Fc epsilon RI Aggregation	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; AFFINITY IGE RECEPTOR; SIGNALING PATHWAY; NOONAN SYNDROME; NEGATIVE REGULATION; KINASE; GAB2; SYK; RELEASE; PTPN11	The protein-tyrosine phosphatase (PTP) Shp2 has been implicated in many immunoreceptor signaling pathways, but its role in immunoreceptor Fc epsilon RI signaling, which leads to the activation of mast cells and blood basophils, is still largely undefined. Using Shp2 knockdown RBL-2H3 (RBL) mast cells, we here reported that Shp2 is required for the activation of RBL cells induced by Fc epsilon RI. Fc epsilon RI-evoked degranulation, calcium mobilization, and synthesis of cytokine transcripts (IL-1 beta, IL-10, and monocyte chemoattractant protein 1 (MCP-1)) were reduced in Shp2 knockdown RBL cells. Signaling regulatory mechanism investigation using immunoblotting, immunoprecipitation, and GST pull-down assay reveals that the down-regulation of Shp2 expression in RBL cells leads to decreased activities of Fyn, PLC gamma, JNK, p38MAPK, and Ras/Erk1/2 after Fc epsilon RI aggregation. Further studies suggest that Paxillin phosphoryaltion was also impaired, but PAG phosphorylation was normal after Fc epsilon RI stimulation as a consequence of the inhibition of Shp2 expression in RBL cells. Collectively, our data strongly indicate that Shp2 is essential for the activation of RBL cells in response to Fc epsilon RI aggregation. Shp2 regulates this process through Fyn and Ras with no involvement of PAG. In addition, we identify Paxillin as an indirect substrate of Shp2 in Fc epsilon RI-initiated signaling of RBL cells.	[Fang, Xiaoyun; Lang, Yongjiang; Wang, Yuxiong; Mo, Wei; Wei, Huanhuan; Yu, Min] Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Mol Med, Shanghai 200433, Peoples R China; [Xie, Jianhui] Fudan Univ, Ctr Gene Res, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Fang, Xiaoyun; Lang, Yongjiang; Wang, Yuxiong; Mo, Wei; Wei, Huanhuan; Xie, Jianhui; Yu, Min] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Fang, XY (corresponding author), Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Mol Med, Shanghai 200433, Peoples R China.	jhxie@fudan.edu.cn; minyu@shmu.edu.cn			National Natural Science Foundation of China [30870565, 81171912]; The Key Program of New Drug Innovation; Ministry of Science and Technology of China [2009ZX09503-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Key Program of New Drug Innovation; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (No.30870565 and 81171912) and The Key Program of New Drug Innovation, Ministry of Science and Technology of China (2009ZX09503-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Araki T, 2009, P NATL ACAD SCI USA, V106, P4736, DOI 10.1073/pnas.0810053106; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Binder G, 2009, HORM RES, V71, P64, DOI 10.1159/000192439; Costello PS, 1996, ONCOGENE, V13, P2595; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; EISEMAN E, 1992, NATURE, V355, P78; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Furumoto Y, 2005, NOVART FDN SYMP, V271, P47; Furumoto Y, 2005, NOVART FDN SYMP, V271, P95; Furumoto Yasuko, 2005, Novartis Found Symp, V271, P39; Futami M, 2011, BLOOD, V118, P1077, DOI 10.1182/blood-2009-12-261636; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Hong H, 2007, BLOOD, V110, P2511, DOI 10.1182/blood-2007-01-066092; Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Kambayashi T, 2009, IMMUNOL REV, V232, P99, DOI 10.1111/j.1600-065X.2009.00825.x; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 2006, TRENDS IMMUNOL, V27, P88, DOI 10.1016/j.it.2005.11.008; Li L, 2011, BLOOD, V118, P1504, DOI 10.1182/blood-2010-06-288910; McPherson VA, 2009, J IMMUNOL, V183, P4940, DOI 10.4049/jimmunol.0900702; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naal RMZG, 2004, BIOSENS BIOELECTRON, V20, P791, DOI 10.1016/j.bios.2004.03.017; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishida K, 2011, J IMMUNOL, V187, P932, DOI 10.4049/jimmunol.1100360; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; Pan Y, 2010, DEVELOPMENT, V137, P1085, DOI 10.1242/dev.042820; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Tang H, 1999, J BIOL CHEM, V274, P12401, DOI 10.1074/jbc.274.18.12401; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Xu RZ, 2005, BLOOD, V106, P3142, DOI 10.1182/blood-2004-10-4057; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang WJ, 2009, J BIOL CHEM, V284, P22353, DOI 10.1074/jbc.M109.020495	55	14	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40566	10.1371/journal.pone.0040566	http://dx.doi.org/10.1371/journal.pone.0040566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802969	Green Published, gold, Green Submitted			2022-12-25	WOS:000306355500059
J	Yamamoto, S; Miyazaki, M; Iwano, T; Kitazawa, S				Yamamoto, Shinya; Miyazaki, Makoto; Iwano, Takayuki; Kitazawa, Shigeru			Bayesian Calibration of Simultaneity in Audiovisual Temporal Order Judgments	PLOS ONE			English	Article							AUDITORY-VISUAL INTERACTION; SUPERIOR COLLICULUS; PERCEPTION; RECALIBRATION; CORTEX; ASYNCHRONY; STIMULI; INTEGRATION; NEURONS; VISION	After repeated exposures to two successive audiovisual stimuli presented in one frequent order, participants eventually perceive a pair separated by some lag time in the same order as occurring simultaneously (lag adaptation). In contrast, we previously found that perceptual changes occurred in the opposite direction in response to tactile stimuli, conforming to Bayesian integration theory (Bayesian calibration). We further showed, in theory, that the effect of Bayesian calibration cannot be observed when the lag adaptation was fully operational. This led to the hypothesis that Bayesian calibration affects judgments regarding the order of audiovisual stimuli, but that this effect is concealed behind the lag adaptation mechanism. In the present study, we showed that lag adaptation is pitch-insensitive using two sounds at 1046 and 1480 Hz. This enabled us to cancel lag adaptation by associating one pitch with sound-first stimuli and the other with light-first stimuli. When we presented each type of stimulus (high-or low-tone) in a different block, the point of simultaneity shifted to "sound-first" for the pitch associated with sound-first stimuli, and to "light-first" for the pitch associated with light-first stimuli. These results are consistent with lag adaptation. In contrast, when we delivered each type of stimulus in a randomized order, the point of simultaneity shifted to "light-first" for the pitch associated with sound-first stimuli, and to "sound-first" for the pitch associated with light-first stimuli. The results clearly show that Bayesian calibration is pitch-specific and is at work behind pitch-insensitive lag adaptation during temporal order judgment of audiovisual stimuli.	[Yamamoto, Shinya; Iwano, Takayuki; Kitazawa, Shigeru] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Miyazaki, Makoto] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan; [Iwano, Takayuki; Kitazawa, Shigeru] Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Ctr Informat & Neural Networks, Osaka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Yamaguchi University; Juntendo University; Osaka University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Yamamoto, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan.	yamamoto-s@aist.go.jp	Iwano, Takayuki/N-6112-2016; Yamamoto, Shinya/S-3134-2016	Iwano, Takayuki/0000-0001-8173-8901; Yamamoto, Shinya/0000-0002-0505-8848	Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18020037, 23680029]; MEXT [21670004, 18200024, 21240029]	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was partly supported by the Special Coordination Funds for Promoting Science and Technology, a Grant-in-Aid for Scientific Research on Priority Areas (System study on higher-order brain functions) (#18020037), and a Grant-in-Aid for Young Scientists (A) (#23680029) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to S.Y., a Grant-in-Aid for Young Scientists (S) (#21670004) from MEXT to M. M., and a Grant-in-Aid for Scientific Research (A) (#18200024, and #21240029) from MEXT to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; ALLON N, 1978, BRAIN RES, V159, P321, DOI 10.1016/0006-8993(78)90538-3; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bieser A, 1998, EXP BRAIN RES, V122, P139, DOI 10.1007/s002210050501; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Guo K, 2004, VISION RES, V44, P2349, DOI 10.1016/j.visres.2004.04.014; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2005, EXP BRAIN RES, V166, P465, DOI 10.1007/s00221-005-2386-7; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Heron J, 2012, EXP BRAIN RES, V218, P477, DOI 10.1007/s00221-012-3038-3; Heron J, 2007, J VISION, V7, DOI 10.1167/7.13.5; HIRSCH JA, 1985, J NEUROPHYSIOL, V53, P726, DOI 10.1152/jn.1985.53.3.726; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Keetels M, 2008, NEUROSCI LETT, V430, P130, DOI 10.1016/j.neulet.2007.10.044; Keetels M, 2008, PERCEPT PSYCHOPHYS, V70, P765, DOI 10.3758/PP.70.5.765; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kersten D, 1997, PERCEPTION, V26, P171, DOI 10.1068/p260171; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LOE PR, 1969, ELECTROEN CLIN NEURO, V26, P395, DOI 10.1016/0013-4694(69)90089-3; Machulla TK, 2012, EXP BRAIN RES, V217, P89, DOI 10.1007/s00221-011-2976-5; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Navarra J, 2007, NEUROSCI LETT, V413, P72, DOI 10.1016/j.neulet.2006.11.027; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Sato Y, 2009, ARTIF LIFE ROBOT, V14, P289, DOI 10.1007/s10015-009-0675-0; Sato Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019377; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Takahashi K, 2008, NEUROREPORT, V19, P319, DOI 10.1097/WNR.0b013e3282f4f039; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; WALKER JT, 1981, PERCEPT PSYCHOPHYS, V29, P475, DOI 10.3758/BF03207361; WALKER JT, 1979, PERCEPT PSYCHOPHYS, V26, P241, DOI 10.3758/BF03199875; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	42	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40379	10.1371/journal.pone.0040379	http://dx.doi.org/10.1371/journal.pone.0040379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792297	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700041
J	Grimley, R; Polyakova, O; Vamathevan, J; McKenary, J; Hayes, B; Patel, C; Smith, J; Bridges, A; Fosberry, A; Bhardwaja, A; Mouzon, B; Chung, CW; Barrett, N; Richmond, N; Modha, S; Solari, R				Grimley, Rachel; Polyakova, Oxana; Vamathevan, Jessica; McKenary, Joanne; Hayes, Brian; Patel, Champa; Smith, Janet; Bridges, Angela; Fosberry, Andrew; Bhardwaja, Anshu; Mouzon, Bernadette; Chung, Chun-Wa; Barrett, Nathalie; Richmond, Nicola; Modha, Sundip; Solari, Roberto			Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NF kappa B Responses	PLOS ONE			English	Article							PROTEIN DEACETYLASES; GENE-EXPRESSION; SIR2; CHROMATIN; SPECIFICITY; MECHANISM; SUBSTRATE; REPAIR; CELLS; ASSAY	SIRT6 is involved in inflammation, aging and metabolism potentially by modulating the functions of both NF kappa B and HIF1 alpha. Since it is possible to make small molecule activators and inhibitors of Sirtuins we wished to establish biochemical and cellular assays both to assist in drug discovery efforts and to validate whether SIRT6 represents a valid drug target for these indications. We confirmed in cellular assays that SIRT6 can deacetylate acetylated-histone H3 lysine 9 (H3K9Ac), however this deacetylase activity is unusually low in biochemical assays. In an effort to develop alternative assay formats we observed that SIRT6 overexpression had no influence on TNF alpha induced nuclear translocation of NFkB, nor did it have an effect on nuclear mobility of RelA/p65. In an effort to identify a gene expression profile that could be used to identify a SIRT6 readout we conducted genome-wide expression studies. We observed that overexpression of SIRT6 had little influence on NF kappa B-dependent genes, but overexpression of the catalytically inactive mutant affected gene expression in developmental pathways.	[Grimley, Rachel; Polyakova, Oxana; McKenary, Joanne; Patel, Champa; Bridges, Angela; Fosberry, Andrew; Bhardwaja, Anshu; Mouzon, Bernadette; Chung, Chun-Wa; Barrett, Nathalie; Richmond, Nicola; Modha, Sundip] GlaxoSmithKline, Platform Technol Sci, Stevenage, Herts, England; [Vamathevan, Jessica] GlaxoSmithKline, Computat Biol, Stevenage, Herts, England; [Vamathevan, Jessica; Hayes, Brian; Smith, Janet; Solari, Roberto] GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Grimley, R (corresponding author), GlaxoSmithKline, Platform Technol Sci, Gunnels Wood Rd, Stevenage, Herts, England.	roberto.2.solari@gsk.com		Vamathevan, Jessica/0000-0003-2016-9754				Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; French JB, 2008, BIOCHEMISTRY-US, V47, P10227, DOI 10.1021/bi800767t; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; MacNee W, 2009, BIOCHEM SOC T, V37, P819, DOI 10.1042/BST0370819; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marcotte PA, 2004, ANAL BIOCHEM, V332, P90, DOI 10.1016/j.ab.2004.05.039; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; McDonagh T, 2005, METHODS, V36, P346, DOI 10.1016/j.ymeth.2005.03.005; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Schaaf MJM, 2006, J BIOL CHEM, V281, P22409, DOI 10.1074/jbc.M511086200; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	30	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39847	10.1371/journal.pone.0039847	http://dx.doi.org/10.1371/journal.pone.0039847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792191	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800022
J	Saulle, E; Guerriero, R; Petronelli, A; Coppotelli, E; Gabbianelli, M; Morsilli, O; Spinello, I; Pelosi, E; Castelli, G; Testa, U; Coppola, S				Saulle, Ernestina; Guerriero, Raffaella; Petronelli, Alessia; Coppotelli, Elena; Gabbianelli, Marco; Morsilli, Ornella; Spinello, Isabella; Pelosi, Elvira; Castelli, Germana; Testa, Ugo; Coppola, Simona			Autocrine Role of Angiopoietins during Megakaryocytic Differentiation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; THROMBOPOIETIN; EXPRESSION; CELLS; RELEASE; BLOOD; IDENTIFICATION; PROLIFERATION; PROTEINS; LEUKEMIA	The tyrosine kinase Tie-2 and its ligands Angiopoietins (Angs) transduce critical signals for angiogenesis in endothelial cells. This receptor and Ang-1 are coexpressed in hematopoietic stem cells and in a subset of megakaryocytes, though a possible role of angiopoietins in megakaryocytic differentiation/proliferation remains to be demonstrated. To investigate a possible effect of Ang-1/Ang-2 on megakaryocytic proliferation/differentiation we have used both normal CD34(+) cells induced to megakaryocytic differentiation and the UT7 cells engineered to express the thrombopoietin receptor (TPOR, also known as c-mpl, UT7/mpl). Our results indicate that Ang-1/Ang-2 may have a role in megakaryopoiesis. Particularly, Ang-2 is predominantly produced and released by immature normal megakaryocytic cells and by undifferentiated UT7/mpl cells and slightly stimulated TPO-induced cell proliferation. Ang-1 production is markedly induced during megakaryocytic differentiation/maturation and potentiated TPO-driven megakaryocytic differentiation. Blocking endogenously released angiopoietins partially inhibited megakaryocytic differentiation, particularly for that concerns the process of polyploidization. According to these data it is suggested that an autocrine angiopoietin/Tie-2 loop controls megakaryocytic proliferation and differentiation.	[Saulle, Ernestina; Guerriero, Raffaella; Petronelli, Alessia; Coppotelli, Elena; Gabbianelli, Marco; Morsilli, Ornella; Spinello, Isabella; Pelosi, Elvira; Castelli, Germana; Testa, Ugo; Coppola, Simona] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Coppola, Simona] Ist Super Sanita, Natl Ctr Rare Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Saulle, E (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	ugo.testa@iss.it; simona.coppola@iss.it	Saulle, Ernestina/AAE-4654-2021; SAULLE, ERNESTINA/J-8834-2016; Gabbianelli, Marco/O-1210-2017; pelosi, elvira/J-7298-2016; Coppola, Simona/A-6638-2015; Testa, Ugo/J-6472-2016; SPINELLO, ISABELLA/J-8779-2016; Guerriero, Raffaella/O-1219-2017; castelli, germana/J-7244-2016	Gabbianelli, Marco/0000-0002-7824-780X; pelosi, elvira/0000-0002-3043-6249; Coppola, Simona/0000-0001-7851-9409; Testa, Ugo/0000-0001-7900-8942; castelli, germana/0000-0002-3593-1230; saulle, ernestina/0000-0001-6681-6887	FIRC (Federazione Italiana Ricerca sul Cancro, Milano, Italy) fellowship; Italian Health Ministery; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	FIRC (Federazione Italiana Ricerca sul Cancro, Milano, Italy) fellowship(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministery; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Dr. Petronelli was supported by a FIRC (Federazione Italiana Ricerca sul Cancro, Milano, Italy) fellowship. This study was supported by a grant from the Italian Health Ministery to Dr. Testa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Batard P, 1996, BLOOD, V87, P2212, DOI 10.1182/blood.V87.6.2212.bloodjournal8762212; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bobik R, 1998, FEBS LETT, V423, P10, DOI 10.1016/S0014-5793(98)00056-8; Bornstein R, 2001, BRIT J HAEMATOL, V114, P458, DOI 10.1046/j.1365-2141.2001.02954.x; Brizzi MF, 1999, CIRC RES, V84, P785; Cardier JE, 1998, BLOOD, V91, P923, DOI 10.1182/blood.V91.3.923.923_923_929; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casella I, 2003, BLOOD, V101, P1316, DOI 10.1182/blood-2002-07-2184; Coppola S, 2006, CELL DEATH DIFFER, V13, P61, DOI 10.1038/sj.cdd.4401698; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DUMONT DJ, 1993, ONCOGENE, V8, P1293; Garcia J, 2001, MOL CELL BIOL, V21, P2659, DOI 10.1128/MCB.21.8.2659-2670.2001; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gomei Y, 2010, EXP HEMATOL, V38, P82, DOI 10.1016/j.exphem.2009.11.007; GUERRIERO R, 1995, BLOOD, V86, P3725, DOI 10.1182/blood.V86.10.3725.bloodjournal86103725; Guerriero R, 2006, J CELL SCI, V119, P744, DOI 10.1242/jcs.02784; Huang YQ, 2000, BLOOD, V95, P1993, DOI 10.1182/blood.V95.6.1993; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kanda S, 2005, CANCER RES, V65, P6820, DOI 10.1158/0008-5472.CAN-05-0522; Li JJ, 2001, THROMB HAEMOSTASIS, V85, P204, DOI 10.1055/s-0037-1615677; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Neagoe PE, 2009, GROWTH FACTORS, V27, P335, DOI 10.3109/08977190903155043; Ohsaka A, 2009, BIOCHEM BIOPH RES CO, V390, P1171, DOI 10.1016/j.bbrc.2009.10.110; PARTANEN J, 1990, P NATL ACAD SCI USA, V87, P8913, DOI 10.1073/pnas.87.22.8913; Porteu F, 1996, MOL CELL BIOL, V16, P2473; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Riccioni R, 2007, STEM CELLS, V25, P1862, DOI 10.1634/stemcells.2006-0700; Rosa AI, 2010, J NEUROSCI, V30, P4573, DOI 10.1523/JNEUROSCI.5597-09.2010; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; Schubert SY, 2011, ARTERIOSCLE IN PRESS; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Singh H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029319; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Yaun HT, 2009, MOL CELL BIOL, V29, P29011; Zetterberg E, 2003, BRIT J HAEMATOL, V121, P497, DOI 10.1046/j.1365-2141.2003.04289.x	44	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39796	10.1371/journal.pone.0039796	http://dx.doi.org/10.1371/journal.pone.0039796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792187	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800018
J	Song, NN; Zhang, GH; Geng, WY; Liu, ZB; Jin, WZ; Li, L; Cao, YX; Zhu, DN; Yu, J; Shen, LL				Song, Nana; Zhang, Guihong; Geng, Wenye; Liu, Zibing; Jin, Weizhong; Li, Li; Cao, Yinxiang; Zhu, Danian; Yu, Jerry; Shen, Linlin			Acid Sensing Ion Channel 1 in Lateral Hypothalamus Contributes to Breathing Control	PLOS ONE			English	Article							PROTON-GATED CHANNELS; OREXIN KNOCKOUT MICE; SENSORY NEURONS; HYPERCAPNIC CHEMOREFLEX; NERVOUS-SYSTEM; DIURNAL CYCLE; ACTIVE PERIOD; NA+ CHANNEL; RAT; WAKEFULNESS	Acid-sensing ion channels (ASICs) are present in neurons and may contribute to chemoreception. Among six subunits of ASICs, ASIC1 is mainly expressed in the central nervous system. Recently, multiple sites in the brain including the lateral hypothalamus (LH) have been found to be sensitive to extracellular acidification. Since LH contains orexin neurons and innervates the medulla respiratory center, we hypothesize that ASIC1 is expressed on the orexin neuron and contributes to acid-induced increase in respiratory drive. To test this hypothesis, we used double immunofluorescence to determine whether ASIC1 is expressed on orexin neurons in the LH, and assessed integrated phrenic nerve discharge (iPND) in intact rats in response to acidification of the LH. We found that ASIC1 was co-localized with orexinA in the LH. Microinjection of acidified artificial cerebrospinal fluid increased the amplitude of iPND by 70% (pH 7.4 v.s. pH 6.5:1.05 +/- 0.12 v.s. 1.70 +/- 0.10, n = 6, P<0.001) and increased the respiratory drive (peak amplitude of iPND/inspiratory time, PA/Ti) by 40% (1.10 +/- 0.23 v.s. 1.50 +/- 0.38, P<0.05). This stimulatory effect was abolished by blocking ASIC1 with a nonselective inhibitor (amiloride 10 mM), a selective inhibitor (PcTX1, 10 nM) or by damaging orexin neurons in the LH. Current results support our hypothesis that the orexin neuron in the LH can exert an excitation on respiration via ASIC1 during local acidosis. Since central acidification is involved in breathing dysfunction in a variety of pulmonary diseases, understanding its underlying mechanism may improve patient management.	[Song, Nana; Zhang, Guihong; Geng, Wenye; Liu, Zibing; Jin, Weizhong; Li, Li; Cao, Yinxiang; Zhu, Danian; Yu, Jerry; Shen, Linlin] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yu, Jerry] Univ Louisville, Dept Pulm Med, Louisville, KY 40292 USA	Fudan University; University of Louisville	Song, NN (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	llshen@shmu.edu.cn			National Natural Science Foundation of China [81070001, 30670771]; Science and Technology Commission of Shanghai Municipality [09JC1402100]; Shanghai Leading Academic Discipline Project [B112]; Shanghai MICCAI (Medical Image Computing and Computer Assisted Intervention) Key laboratory [06DZ22103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai MICCAI (Medical Image Computing and Computer Assisted Intervention) Key laboratory	This work was supported by National Natural Science Foundation of China (NO.81070001, NO.30670771) URL: http://www.nsfc.gov.cn; Science and Technology Commission of Shanghai Municipality (09JC1402100) URL: http://www.stcsm.gov.cn; Shanghai Leading Academic Discipline Project (B112) URL: http://www.shmec.gov.cn and Shanghai MICCAI (Medical Image Computing and Computer Assisted Intervention) Key laboratory (06DZ22103) URL: http://www.fudan.edu.cn/new_research/mainlab.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Berquin P, 2000, BRAIN RES, V857, P30, DOI 10.1016/S0006-8993(99)02304-5; [曹性玲 CAO Xing-ling], 2009, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V40, P662; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dias MB, 2010, RESP PHYSIOL NEUROBI, V170, P96, DOI 10.1016/j.resp.2009.12.002; Dias MB, 2009, J PHYSIOL-LONDON, V587, P2059, DOI 10.1113/jphysiol.2008.168260; Dong X, 2011, ACTA PHYSIOL, V201, P97, DOI 10.1111/j.1748-1716.2010.02207.x; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Fung SJ, 2001, BRAIN RES, V903, P257, DOI 10.1016/S0006-8993(01)02318-6; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Guyenet PG, 2005, J NEUROSCI, V25, P8938, DOI 10.1523/JNEUROSCI.2415-05.2005; Han F, 2011, SLEEP BIOL RHYTHMS, V9, P44, DOI 10.1111/j.1479-8425.2010.00467.x; Hildebrand MS, 2004, HEARING RES, V190, P149, DOI 10.1016/S0378-5955(04)00015-2; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; Kc P, 2002, RESP PHYSIOL, V129, P289, DOI 10.1016/S0034-5687(01)00321-8; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Krout KE, 2005, BRAIN RES, V1050, P199, DOI 10.1016/j.brainres.2005.04.090; Kuwaki T, 2010, RESP PHYSIOL NEUROBI, V173, P223, DOI 10.1016/j.resp.2010.02.006; Li AH, 2010, J PHYSIOL-LONDON, V588, P2935, DOI 10.1113/jphysiol.2010.191288; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Liu ZB, 2010, CLIN EXP PHARMACOL P, V37, P963, DOI 10.1111/j.1440-1681.2010.05411.x; Meng QY, 2009, NEUROSCIENCE, V159, P1126, DOI 10.1016/j.neuroscience.2009.01.069; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Nakamura A, 2007, J APPL PHYSIOL, V102, P241, DOI 10.1152/japplphysiol.00679.2006; Peng BG, 2004, J NEUROSCI, V24, P10167, DOI 10.1523/JNEUROSCI.3196-04.2004; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REDGATE ES, 1958, AM J PHYSIOL, V193, P189, DOI 10.1152/ajplegacy.1958.193.1.189; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sunanaga J, 2009, RESP PHYSIOL NEUROBI, V166, P184, DOI 10.1016/j.resp.2009.03.006; Tanaka M, 2008, AM J PHYSIOL-REG I, V294, pR477, DOI 10.1152/ajpregu.00633.2007; Ugawa S, 2003, J NEUROSCI, V23, P3616; von der Goltz C, 2011, HORM BEHAV, V60, P644, DOI 10.1016/j.yhbeh.2011.08.017; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang W, 2007, NEUROSCIENCE, V145, P631, DOI 10.1016/j.neuroscience.2006.12.009; Watson C, 2006, RAT BRAIN STEREOTAXI; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Young JK, 2005, J APPL PHYSIOL, V98, P1387, DOI 10.1152/japplphysiol.00914.2004; Yuan FL, 2010, MOL CELL BIOCHEM, V340, P153, DOI 10.1007/s11010-010-0412-y; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	54	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39982	10.1371/journal.pone.0039982	http://dx.doi.org/10.1371/journal.pone.0039982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792205	gold, Green Submitted, Green Published			2022-12-25	WOS:000306461800029
J	Zhou, X; Li, C; Xu, WT; Chen, JC				Zhou, Xiang; Li, Chao; Xu, Weiting; Chen, Jianchang			Trimetazidine Protects against Smoking-Induced Left Ventricular Remodeling via Attenuating Oxidative Stress, Apoptosis, and Inflammation	PLOS ONE			English	Article							HEART-FAILURE; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE; CARDIOMYOCYTE APOPTOSIS; DILATED CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CARDIAC FIBROBLASTS; TOBACCO-SMOKE; DYSFUNCTION	Trimetazidine, a piperazine derivative used as an anti-anginal agent, improves myocardial glucose utilization through inhibition of fatty acid metabolism. The present study was designed to investigate whether trimetazidine has the protective effects against smoking-induced left ventricular remodeling in rats. In this study, Wistar rats were randomly divided into 3 groups: smoking group (exposed to cigarette smoke), trimetazidine group (exposed to cigarette smoke and treated with trimetazidine), and control group. The echocardiographic and morphometric data indicated that trimetazidine has protective effects against smoking-induced left ventricular remodeling. Oxidative stress was evaluated by detecting malondialdehyde, superoxide dismutase, and glutathione peroxidase in the supernatant of left ventricular tissue. Cardiomyocyte apoptotic rate was determined by flow cytometry with Annexin V/PI staining. Gene expression and serum levels of inflammatory markers, including interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha, were deteced by quantitative real-time PCR and enzyme-linked immunosorbent assay. Our results suggested that trimetazidine could significantly reduce smoking-induced oxidative stress, apoptosis, and inflammation. In conclusion, our study demonstrates that trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.	[Zhou, Xiang; Xu, Weiting; Chen, Jianchang] Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Peoples R China; [Li, Chao] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China	Soochow University - China; University of Hong Kong	Zhou, X (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Peoples R China.	zhou-xiang@suda.edu.cn			academic research grants of the Second Affiliated Hospital of Soochow University	academic research grants of the Second Affiliated Hospital of Soochow University	This study was supported by the academic research grants of the Second Affiliated Hospital of Soochow University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2003, J AM COLL CARDIOL, V41, P753, DOI 10.1016/S0735-1097(02)02959-5; Abbate A, 2002, J CELL PHYSIOL, V193, P145, DOI 10.1002/jcp.10174; Bertomeu-Gonzalez V, 2006, AM J CARDIOL, V98, p19J, DOI 10.1016/j.amjcard.2006.07.005; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Castardeli E, 2007, EUR J HEART FAIL, V9, P1081, DOI 10.1016/j.ejheart.2007.09.004; Castardeli Édson, 2005, Arq. Bras. Cardiol., V84, P320, DOI 10.1590/S0066-782X2005000400009; Chandrashekhar Y, 2005, Curr Heart Fail Rep, V2, P18, DOI 10.1007/s11897-005-0003-5; Cheng TH, 2003, J AM COLL CARDIOL, V42, P1845, DOI 10.1016/j.jacc.2003.06.010; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Di Napoli P, 2005, HEART, V91, P161, DOI 10.1136/hrt.2003.031310; FANTINI E, 1994, J MOL CELL CARDIOL, V26, P949, DOI 10.1006/jmcc.1994.1116; Fragasso G, 2006, EUR HEART J, V27, P942, DOI 10.1093/eurheartj/ehi816; Fragasso G, 2006, J AM COLL CARDIOL, V48, P992, DOI 10.1016/j.jacc.2006.03.060; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gu LZ, 2008, EUR J HEART FAIL, V10, P1057, DOI 10.1016/j.ejheart.2008.08.009; Haustein KO, 1999, INT J CLIN PHARM TH, V37, P76; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Ibe W, 2007, EUR J HEART FAIL, V9, P160, DOI 10.1016/j.ejheart.2006.06.002; Kameda K, 2003, EUR HEART J, V24, P2180, DOI 10.1016/j.ehj.2003.09.022; Khan M, 2010, J PHARMACOL EXP THER, V333, P421, DOI 10.1124/jpet.109.165175; LAKIER JB, 1992, AM J MED, V93, pS8, DOI 10.1016/0002-9343(92)90620-Q; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord KC, 2010, CARDIOVASC RES, V87, P111, DOI 10.1093/cvr/cvq043; MARIDONNEAUPARINI I, 1985, BRIT J CLIN PHARMACO, V20, P148, DOI 10.1111/j.1365-2125.1985.tb05047.x; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park KH, 2010, AM J CARDIOL, V105, P1723, DOI 10.1016/j.amjcard.2010.01.351; Rosen BD, 2006, J AM COLL CARDIOL, V47, P1150, DOI 10.1016/j.jacc.2005.08.078; Sabri A, 2003, ANTIOXID REDOX SIGN, V5, P731, DOI 10.1089/152308603770380034; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; SUN Y, 1988, CLIN CHEM, V34, P497; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thrainsdottir IS, 2004, J CARDIOVASC PHARM, V44, P101, DOI 10.1097/00005344-200407000-00014; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	43	38	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40424	10.1371/journal.pone.0040424	http://dx.doi.org/10.1371/journal.pone.0040424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792312	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800081
J	Cao, LY; Dai, C; Li, ZJ; Fan, Z; Song, Y; Wu, YL; Cao, ZJ; Li, WX				Cao, Luyang; Dai, Chao; Li, Zhongjie; Fan, Zheng; Song, Yu; Wu, Yingliang; Cao, Zhijian; Li, Wenxin			Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; FUNCTIONAL-CHARACTERIZATION; ANTIBIOTIC-RESISTANCE	BmKn2 is an antimicrobial peptide (AMP) characterized from the venom of scorpion Mesobuthus martensii Karsch by our group. In this study, Kn2-7 was derived from BmKn2 to improve the antibacterial activity and decrease hemolytic activity. Kn2-7 showed increased inhibitory activity against both Gram-positive bacteria and Gram-negative bacteria. Moreover, Kn2-7 exhibited higher antibacterial activity against clinical antibiotic-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA). In addition, the topical use of Kn2-7 effectively protected the skin of mice from infection in an S. aureus mouse skin infection model. Kn2-7 exerted its antibacterial activity via a bactericidal mechanism. Kn2-7 killed S. aureus and E. coli rapidly by binding to the lipoteichoic acid (LTA) in the S. aureus cell wall and the lipopolysaccharides (LPS) in the E. coli cell wall, respectively. Finally, the hemolytic activity of Kn2-7 was significantly decreased, compared to the wild-type peptide BmKn2. Taken together, the Kn2-7 peptide can be developed as a topical therapeutic agent for treating bacterial infections.	[Cao, Luyang; Dai, Chao; Li, Zhongjie; Fan, Zheng; Song, Yu; Wu, Yingliang; Cao, Zhijian; Li, Wenxin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Cao, LY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn; liwxlab@whu.edu.cn	Dai, Chao/I-6913-2012		Natural Science Foundation of China (NSFC) [31071942]; China Specific Project for Developing New Drugs [2009ZX09103-612, 2011ZX09102-001-32]; National Basic Research Program of China [2010CB529800, 2010CB530100]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Specific Project for Developing New Drugs; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from Natural Science Foundation of China (NSFC) (No. 31071942), the China Specific Project for Developing New Drugs (Nos. 2009ZX09103-612 and 2011ZX09102-001-32), and the National Basic Research Program of China (Nos. 2010CB529800 and 2010CB530100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Chen YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034947; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Fan SZ, 2010, CANCER LETT, V291, P158, DOI 10.1016/j.canlet.2009.10.011; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; Hebert C, 2011, INFECT DIS CLIN N AM, V25, P181, DOI 10.1016/j.idc.2010.11.006; Hou Z, 2011, J INFECT DIS, V203, P273, DOI 10.1093/infdis/jiq029; Ippolito G, 2010, INT J INFECT DIS, V14, pS7, DOI 10.1016/j.ijid.2010.05.003; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kirillov L V, 1976, Dev Biol Stand, V32, P203; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Paulmann M, 2012, J BIOL CHEM     1224; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; Yuan WY, 2010, PEPTIDES, V31, P22, DOI 10.1016/j.peptides.2009.10.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zhao ZH, 2009, ANTIMICROB AGENTS CH, V53, P3472, DOI 10.1128/AAC.01436-08	29	72	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40135	10.1371/journal.pone.0040135	http://dx.doi.org/10.1371/journal.pone.0040135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792229	Green Submitted, gold, Green Published			2022-12-25	WOS:000306436300030
J	Gehrau, RC; Archer, KJ; Mas, VR; Maluf, DG				Gehrau, Ricardo C.; Archer, Kellie J.; Mas, Valeria R.; Maluf, Daniel G.			Molecular Profiles of HCV Cirrhotic Tissues Derived in a Panel of Markers with Clinical Utility for Hepatocellular Carcinoma Surveillance	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DNA-DAMAGE; LIVER-TRANSPLANTATION; GROWTH ARREST; UNITED-STATES; REPAIR; CARCINOGENESIS; EPIDEMIOLOGY; INFECTION; GENES	Background: Early hepatocellular carcinoma (HCC) detection is difficult because low accuracy of surveillance tests. Genome-wide analyses were performed using HCV-cirrhosis with HCC to identify predictive signatures. Methodology/Principal Findings: Cirrhotic liver tissue was collected from 107 HCV-infected patients with diagnosis of HCC at pre-transplantation and confirmed in explanted livers. Study groups included: 1) microarray hybridization set (n = 80) including patients without (woHCC = 45) and with (wHCC = 24) HCC, and with incidental HCC (iHCC = 11); 2) independent validation set (n = 27; woHCC = 16, wHCC = 11). Pairwise comparisons were performed using moderated t-test. FDR < 1% was considered significant. L-1-penalized logistic regression model was fit for woHCC and wHCC microarrays, and tested against iHCC. Prediction model genes were validated in independent set by qPCR. The genomic profile was associated with genetic disorders and cancer focused on gene expression, cell cycle and cell death. Molecular profile analysis revealed cell cycle progression and arrest at G2/M, but progressing to mitosis; unregulated DNA damage check-points, and apoptosis. The prediction model included 17 molecules demonstrated 98.6% of accuracy and correctly classified 6 out of 11 undiagnosed iHCC cases. The best model performed even better in the additional independent set. Conclusions/Significances: The molecular analysis of HCV-cirrhotic tissue conducted to a prediction model with good performance and high potential for HCC surveillance.	[Gehrau, Ricardo C.; Mas, Valeria R.; Maluf, Daniel G.] Univ Virginia, Dept Surg, Transplant Div, Charlottesville, VA 22903 USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	University of Virginia; Virginia Commonwealth University; Virginia Commonwealth University	Gehrau, RC (corresponding author), Univ Virginia, Dept Surg, Transplant Div, Charlottesville, VA 22903 USA.	DGM9Y@hscmail.mcc.virginia.edu		Archer, Kellie/0000-0003-1555-5781	NIH-NCI [P30 CA016059]; NIH [N01-DK-7-0004/HHSN267200700004C]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part, by funding from NIH-NCI Cancer Center Support Grant P30 CA016059. Pathologic human livers were obtained through the Liver Tissue Cell Distribution System, which was funded by NIH Contract #N01-DK-7-0004/HHSN267200700004C. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; [Anonymous], 2011, SURV VIR HEP US; Archer KJ, 2010, BRIEF BIOINFORM, V11, P244, DOI 10.1093/bib/bbp055; Archer KJ, 2009, CANCER EPIDEM BIOMAR, V18, P2929, DOI 10.1158/1055-9965.EPI-09-0767; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruix J, 2006, ONCOGENE, V25, P3848, DOI 10.1038/sj.onc.1209548; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fartoux L, 2011, CLIN RES HEPATOL GAS, V35, pS21, DOI 10.1016/S2210-7401(11)70004-3; Fujita N, 2008, J VIRAL HEPATITIS, V15, P498, DOI 10.1111/j.1365-2893.2008.00972.x; Gehrau R, 2011, EXPERT REV GASTROENT, V5, P539, DOI [10.1586/egh.11.48, 10.1586/EGH.11.48]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Jakate S, 2010, AM J SURG PATHOL, V34, P935, DOI 10.1097/PAS.0b013e3181ddf52f; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Kershenobich D, 2011, LIVER INT, V31, P4, DOI 10.1111/j.1478-3231.2011.02535.x; Khalid SS, 2011, HEPATOL INT, V5, P782, DOI 10.1007/s12072-011-9252-4; Kim DY, 2011, ONCOLOGY-BASEL, V81, P56, DOI 10.1159/000333261; Kim TK, 2011, ABDOM IMAGING, V36, P244, DOI 10.1007/s00261-011-9686-0; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lee JM, 2011, ABDOM IMAGING, V36, P282, DOI 10.1007/s00261-011-9692-2; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Llovet JM, 2006, SEMIN LIVER DIS, V26, P248, DOI 10.1055/s-2006-947296; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Machida K, 2009, J VIROL, V83, P12590, DOI 10.1128/JVI.02643-08; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mas VR, 2004, LIVER TRANSPLANT, V10, P607, DOI 10.1002/lt.20118; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Mohd-Ismail NK, 2009, J VIROL, V83, P9993, DOI 10.1128/JVI.00509-09; Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x; Park M. Y., 2011, GLMPATH L1 REGULARIZ; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qiu WH, 2003, AM J PATHOL, V162, P1961, DOI 10.1016/S0002-9440(10)64329-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Utsunomiya T, 2010, J GASTROENTEROL, V45, P146, DOI 10.1007/s00535-009-0164-1; Washburn K, 2010, TRANSPLANT REV-ORLAN, V24, P11, DOI 10.1016/j.trre.2009.10.002; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yamashita T, 2011, J GASTROEN HEPATOL, V26, P960, DOI 10.1111/j.1440-1746.2011.06723.x; Zheng SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-62	44	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40275	10.1371/journal.pone.0040275	http://dx.doi.org/10.1371/journal.pone.0040275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792259	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300043
J	Sabbir, MG; Prieditis, H; Ravinsky, E; Mowat, MRA				Sabbir, Mohammad Golam; Prieditis, Heather; Ravinsky, Esther; Mowat, Michael R. A.			The Role of Dlc1 Isoform 2 in K-Ras2(G12D) Induced Thymic Cancer	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; TUMOR-SUPPRESSOR GENE; CELL-CYCLE ARREST; HEPATOCELLULAR-CARCINOMA; SKIN CARCINOGENESIS; CPG ISLAND; K-RAS; RHO; EXPRESSION; MOUSE	The Deleted in liver cancer one (Dlc1) tumor suppressor gene encodes a RhoGTPase activating protein (RhoGAP). The Dlc1 gene has multiple transcriptional isoforms and we have previously established a mouse strain containing a gene trap (gt) insertion, which specifically reduces the expression of the 6.1 kb isoform (isoform 2). This gene trapped allele when homozygous results in embryonic lethality and the heterozygous gene trapped mice do not show an increased incidence of cancers, suggesting that cooperating oncogenic changes may be required for transformation. In the present work, we have studied the in vivo cooperation between oncogenic K-Ras2 and Dlc1 genes in tumourigenesis. We have observed an increase in invasive thymic cancers, including both thymomas and lymphomas, resulting in significantly shortened life spans in mice heterozygous for the gt Dlc1 allele and an inducible LSL-K-Ras2(G12D) allele compared with the LSL-K-Ras2(G12D) only mice. The heterozygous mice showed a high degree of metastasis in the lung. We have found tumour specific selective hypermethylation of the Dlc1 isoform 2 promoter and reduction of the corresponding protein expression in thymic lymphoma (TL) and thymic epithelial carcinoma (TEC) derived from the thymic tumours. The Dlc1 deficient thymic lymphoma cell lines exhibited increased trans-endothelial cell migration. TEC cell lines also exhibited increased stress fiber formation and Rho activity. Introduction of the three Dlc1 isoforms tagged with GFP into these cells resulted in different morphological changes. These results suggest that loss of expression of only isoform 2 may be sufficient for the development of thymic tumors and metastasis.	[Sabbir, Mohammad Golam; Prieditis, Heather; Mowat, Michael R. A.] CancerCare Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada; [Sabbir, Mohammad Golam; Mowat, Michael R. A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Ravinsky, Esther] Hlth Sci Ctr, Dept Pathol, Winnipeg, MB, Canada	CancerCare Manitoba Foundation; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Sabbir, MG (corresponding author), CancerCare Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada.	mmowat@cc.umanitoba.ca	Sabbir, Mohammad/AAG-6238-2019		Cancer Research Society Inc.; CancerCare Manitoba Foundation Inc.	Cancer Research Society Inc.; CancerCare Manitoba Foundation Inc.	This study was supported with grants from Cancer Research Society Inc. (http://www.src-crs.ca/en-CA) and CancerCare Manitoba Foundation Inc. (http://www.cancercarefdn.mb.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; BERNATZ PE, 1961, J THORAC CARDIOV SUR, V42, P424; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bryan JN, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-73; Costello PS, 2000, J EXP MED, V192, P77, DOI 10.1084/jem.192.1.77; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; DELLAGI K, 1987, CANCER RES, V47, P1170; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dooley J, 2007, DEV DYNAM, V236, P3459, DOI 10.1002/dvdy.21364; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Durkin ME, 2002, GENE, V288, P119, DOI 10.1016/S0378-1119(02)00462-6; Gomez J, 1997, EUR J IMMUNOL, V27, P2793, DOI 10.1002/eji.1830271108; HEATH JP, 1983, J CELL SCI, V60, P331; HICKS GG, 1991, MOL CELL BIOL, V11, P1344, DOI 10.1128/MCB.11.3.1344; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; HORII A, 1993, HUM MOL GENET, V2, P283, DOI 10.1093/hmg/2.3.283; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jackson RJ, 2003, CANCER RES, V63, P3021; Jackson RJ, 2002, ONCOGENE, V21, P8486, DOI 10.1038/sj.onc.1205946; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; KOHL NE, 1987, ONCOGENE, V2, P41; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Low JSW, 2011, ONCOGENE, V30, P1923, DOI 10.1038/onc.2010.576; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Ng IOL, 2000, CANCER RES, V60, P6581; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Rohnelt RK, 1997, INT IMMUNOL, V9, P435, DOI 10.1093/intimm/9.3.435; Sabbir MG, 2006, INT J EXP PATHOL, V87, P151; Sabbir MG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-17; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Song Li-jie, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P428; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Vielkind S, 2005, J IMMUNOL, V175, P350, DOI 10.4049/jimmunol.175.1.350; Wang Y, 1996, P NATL ACAD SCI USA, V93, P3932, DOI 10.1073/pnas.93.9.3932; Weinberg WC, 1999, CANCER RES, V59, P2050; Wong CM, 2003, CANCER RES, V63, P7646; Woodside DG, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-2; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zheng SQL, 2003, MUTAT RES-FUND MOL M, V528, P45, DOI 10.1016/S0027-5107(03)00081-2	56	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40302	10.1371/journal.pone.0040302	http://dx.doi.org/10.1371/journal.pone.0040302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792269	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300050
J	Park-Windhol, C; Zhang, P; Zhu, M; Su, JL; Chaves, L; Maldonado, AE; King, ME; Rickey, L; Cullen, D; Mende, U				Park-Windhol, Cindy; Zhang, Peng; Zhu, Ming; Su, Jialin; Chaves, Leonard, Jr.; Maldonado, Angel E.; King, Michelle E.; Rickey, Lisa; Cullen, Darragh; Mende, Ulrike			Gq/11-Mediated Signaling and Hypertrophy in Mice with Cardiac-Specific Transgenic Expression of Regulator of G-Protein Signaling 2	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PROGNOSTIC IMPLICATIONS; TRANSITION-STATE; C BETA; HEART; ACTIVATION; RGS2; KINASE; DYSFUNCTION; PALMITOYLATION	Cardiac hypertrophy is a well-established risk factor for cardiovascular morbidity and mortality. Activation of G(q/11)-mediated signaling is required for pressure overload-induced cardiomyocyte (CM) hypertrophy to develop. We previously showed that among Regulators of G protein Signaling, RGS2 selectively inhibits G(q/11) signaling and its hypertrophic effects in isolated CM. In this study, we generated transgenic mice with CM-specific, conditional RGS2 expression (dTG) to investigate whether RGS2 overexpression can be used to attenuate G(q/11)-mediated signaling and hypertrophy in vivo. Transverse aortic constriction (TAC) induced a comparable rise in ventricular mass and ANF expression and corresponding hemodynamic changes in dTG compared to wild types (WT), regardless of the TAC duration (1-8 wks) and timing of RGS2 expression (from birth or adulthood). Inhibition of endothelin-1-induced G(q/11)-mediated phospholipase C beta activity in ventricles and atrial appendages indicated functionality of transgenic RGS2. However, the inhibitory effect of transgenic RGS2 on G(q/11)mediated PLC beta activation differed between ventricles and atria: (i) in sham-operated dTG mice the magnitude of the inhibitory effect was less pronounced in ventricles than in atria, and (ii) after TAC, negative regulation of G(q/11) signaling was absent in ventricles but fully preserved in atria. Neither difference could be explained by differences in expression levels, including marked RGS2 downregulation after TAC in left ventricle and atrium. Counter-regulatory changes in other G(q/11)regulating RGS proteins (RGS4, RGS5, RGS6) and random insertion were also excluded as potential causes. Taken together, despite ample evidence for a role of RGS2 in negatively regulating G(q/11) signaling and hypertrophy in CM, CM-specific RGS2 overexpression in transgenic mice in vivo did not lead to attenuate ventricular G(q/11)-mediated signaling and hypertrophy in response to pressure overload. Furthermore, our study suggests chamber-specific differences in the regulation of RGS2 functionality and potential future utility of the new transgenic model in mitigating G(q/11) signaling in the atria in vivo.	[Park-Windhol, Cindy; Zhang, Peng; Zhu, Ming; Su, Jialin; Chaves, Leonard, Jr.; Maldonado, Angel E.; King, Michelle E.; Rickey, Lisa; Mende, Ulrike] Brown Univ, Rhode Isl Hosp, Div Cardiol, Cardiovasc Res Ctr, Providence, RI 02903 USA; [Park-Windhol, Cindy; Zhang, Peng; Zhu, Ming; Su, Jialin; Chaves, Leonard, Jr.; Maldonado, Angel E.; King, Michelle E.; Rickey, Lisa; Mende, Ulrike] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Park-Windhol, Cindy; Rickey, Lisa] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Cullen, Darragh] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cardiac Muscle Res Lab, Boston, MA 02115 USA; [Cullen, Darragh] Harvard Univ, Sch Med, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Park-Windhol, C (corresponding author), Brown Univ, Rhode Isl Hosp, Div Cardiol, Cardiovasc Res Ctr, Providence, RI 02903 USA.	ulrike_mende@brown.edu			National Heart Lung and Blood Institute [HL-80127]; American Heart Association (AHA) [0740098N, 09PRE2170075]; Brown University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080127] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); Brown University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart Lung and Blood Institute (HL-80127 to UM) and the American Heart Association (AHA) (0740098N to UM), an AHA predoctoral fellowship award [09PRE2170075 to CP] and an undergraduate teaching and research assistant award from Brown University (to LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bootman MD, 2006, J CELL SCI, V119, P3915, DOI 10.1242/jcs.03223; Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; Chakir K, 2011, J MOL CELL CARDIOL, V50, P1000, DOI 10.1016/j.yjmcc.2011.01.015; Cingolani OH, 2011, AM J PHYSIOL-HEART C, V301, pH2198, DOI 10.1152/ajpheart.00781.2011; Cunningham ML, 2001, J BIOL CHEM, V276, P5438, DOI 10.1074/jbc.M007699200; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Genomics of Cardiovascular Development Adaptation and Remodeling, GEN CARD DEV AD REM; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Hill JA, 2002, J BIOL CHEM, V277, P10251, DOI 10.1074/jbc.M110722200; Hirose M, 2009, HEART RHYTHM, V6, P78, DOI 10.1016/j.hrthm.2008.10.018; Jones TLZ, 2004, METHOD ENZYMOL, V389, P33; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Leenders JJ, 2011, J MOL CELL CARDIOL, V51, P156, DOI 10.1016/j.yjmcc.2011.04.017; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; McCloskey DT, 2005, PHYSIOL GENOMICS, V22, P118, DOI 10.1152/physiolgenomics.00016.2005; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Nattel S, 2009, HEART RHYTHM, V6, P85, DOI 10.1016/j.hrthm.2008.11.028; Ni JQ, 2006, INT J BIOCHEM CELL B, V38, P2209, DOI 10.1016/j.biocel.2006.06.015; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Rogers JH, 2001, J MOL CELL CARDIOL, V33, P209, DOI 10.1006/jmcc.2000.1307; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sheridan DJ, 2000, CARDIOVASC RES, V47, P133, DOI 10.1016/S0008-6363(00)00065-1; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Vinet L, 2008, AM J PHYSIOL-HEART C, V295, pH352, DOI 10.1152/ajpheart.01101.2007; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Woodcock EA, 2009, J MOL CELL CARDIOL, V47, P676, DOI 10.1016/j.yjmcc.2009.08.020; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zhang P, 2011, CIRC RES, V109, P320, DOI 10.1161/CIRCRESAHA.110.231423; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	56	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40048	10.1371/journal.pone.0040048	http://dx.doi.org/10.1371/journal.pone.0040048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802950	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900024
J	Romeo, Y; Moreau, J; Zindy, PJ; Saba-El-Leil, M; Lavoie, G; Dandachi, F; Baptissart, M; Borden, KLB; Meloche, S; Roux, PP				Romeo, Y.; Moreau, J.; Zindy, P-J; Saba-El-Leil, M.; Lavoie, G.; Dandachi, F.; Baptissart, M.; Borden, K. L. B.; Meloche, S.; Roux, P. P.			RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth	ONCOGENE			English	Article						Melanoma; BRAF; MAPK; RSK; mTOR	PROTEIN-KINASE PATHWAY; INITIATION-FACTOR 4E; TRANSLATION INITIATION; B-RAF; DEPENDENT TRANSLATION; MOLECULAR-MECHANISMS; TUBEROUS SCLEROSIS; CELL-PROLIFERATION; S6 KINASE; PHOSPHORYLATION	The Ras/mitogen-activated protein kinase (MAPK) signalling cascade regulates various biological functions, including cell growth, proliferation and survival. As such, this pathway is often deregulated in cancer, including melanomas, which frequently harbour activating mutations in the NRAS and BRAF oncogenes. Hyperactive MAPK signalling is known to promote protein synthesis, but the mechanisms by which this occurs remain poorly understood. Here, we show that expression of oncogenic forms of Ras and Raf promotes the constitutive activation of the mammalian target of rapamycin (mTOR). Using pharmacological inhibitors and RNA interference, we find that the MAPK-activated protein kinase RSK (p90 ribosomal S6 kinase) is partly required for these effects. Using melanoma cell lines carrying activating BRAF mutations, we show that ERK/RSK signalling regulates assembly of the translation initiation complex and polysome formation, as well as the translation of growth-related messenger RNAs containing a 50-terminal oligopyrimidine (TOP) motif. Accordingly, we find that RSK inhibition abrogates tumour growth in mice. Our findings indicate that RSK may be a valuable therapeutic target for the treatment of tumours characterized by deregulated MAPK signalling, such as melanoma.	[Romeo, Y.; Moreau, J.; Zindy, P-J; Saba-El-Leil, M.; Lavoie, G.; Dandachi, F.; Baptissart, M.; Borden, K. L. B.; Meloche, S.; Roux, P. P.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Borden, K. L. B.; Roux, P. P.] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Meloche, S.] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Roux, PP (corresponding author), Univ Montreal, IRIC Univ Montreal, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	philippe.roux@umontreal.ca	Romeo, Yves/AAC-1669-2021; Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250	Canadian Cancer Society Research Institute; Cancer Research Society; Natural Sciences and Engineering Research Council of Canada; Human Frontier Science Programme (HFSP); FRSQ; NATIONAL CANCER INSTITUTE [R01CA080728, R01CA098571] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Human Frontier Science Programme (HFSP)(Human Frontier Science Program); FRSQ(Fonds de la Recherche en Sante du Quebec); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Cancer Society Research Institute (PPR), the Cancer Research Society (PPR and SM), and the Natural Sciences and Engineering Research Council of Canada (PPR). We thank Dr Nahum Sonenberg for the phospho-4E-BP1 antibody. PP Roux holds a Canada Research Chair in Signal Transduction and Proteomics and a Career Development Award from the Human Frontier Science Programme (HFSP). K Borden and S Meloche hold Canada Research Chairs in Molecular Biology of the Cell Nucleus, and in Cellular Signalling, respectively. IRIC core facilities are supported by the FRSQ.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Eisenmann KM, 2003, CANCER RES, V63, P8330; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gaestel M, 2008, FRONT BIOSCI, V13, P6050, DOI 10.2741/3136; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; O'Reilly KE, 2009, CLIN CANCER RES, V15, P2872, DOI 10.1158/1078-0432.CCR-08-2336; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Romeo Y, 2011, EXPERT OPIN THER TAR, V15, P5, DOI 10.1517/14728222.2010.531014; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Scheier B, 2011, IMMUNOTHERAPY-UK, V3, P1461, DOI [10.2217/IMT.11.136, 10.2217/imt.11.136]; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamashita R, 2008, NUCLEIC ACIDS RES, V36, P3707, DOI 10.1093/nar/gkn248; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	50	43	43	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2013	32	24					2917	2926		10.1038/onc.2012.312	http://dx.doi.org/10.1038/onc.2012.312			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22797077	Green Accepted			2022-12-25	WOS:000320369700002
J	Koese, M; Rentero, C; Kota, BP; Hoque, M; Cairns, R; Wood, P; de Muga, SV; Reverter, M; Alvarez-Guaita, A; Monastyrskaya, K; Hughes, WE; Swarbrick, A; Tebar, F; Daly, RJ; Enrich, C; Grewal, T				Koese, M.; Rentero, C.; Kota, B. P.; Hoque, M.; Cairns, R.; Wood, P.; Vila de Muga, S.; Reverter, M.; Alvarez-Guaita, A.; Monastyrskaya, K.; Hughes, W. E.; Swarbrick, A.; Tebar, F.; Daly, R. J.; Enrich, C.; Grewal, T.			Annexin A6 is a scaffold for PKC alpha to promote EGFR inactivation	ONCOGENE			English	Article						annexin A6; scaffold; PKC alpha; EGF receptor	EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; FACTOR RECEPTOR PHOSPHORYLATION; INTRACELLULAR TRAFFICKING; CHOLESTEROL TRANSPORT; MEMBRANE-BINDING; CARCINOMA-CELLS; 79 AKAP79; CANCER; VI	Protein kinase C alpha (PKC alpha) can phosphorylate the epidermal growth factor receptor (EGFR) at threonine 654 (T654) to inhibit EGFR tyrosine phosphorylation (pY-EGFR) and the associated activation of downstream effectors. However, upregulation of PKC alpha in a large variety of cancers is not associated with EGFR inactivation, and factors determining the potential of PKC alpha to downregulate EGFR are yet unknown. Here, we show that ectopic expression of annexin A6 (AnxA6), a member of the Ca2+ and phospholipid-binding annexins, strongly reduces pY-EGFR levels while augmenting EGFR T654 phosphorylation in EGFR overexpressing A431, head and neck and breast cancer cell lines. Reduced EGFR activation in AnxA6 expressing A431 cells is associated with reduced EGFR internalization and degradation. RNA interference (RNAi)-mediated PKC alpha knockdown in AnxA6 expressing A431 cells reduces T654-EGFR phosphorylation, but restores EGFR tyrosine phosphorylation, clonogenic growth and EGFR degradation. These findings correlate with AnxA6 interacting with EGFR, and elevated AnxA6 levels promoting PKC alpha membrane association and interaction with EGFR. Stable expression of the cytosolic N-terminal mutant AnxA6(1-175), which cannot promote PKC alpha membrane recruitment, does not increase T654-EGFR phosphorylation or the association of PKC alpha with EGFR. AnxA6 overexpression does not inhibit tyrosine phosphorylation of the T654A EGFR mutant, which cannot be phosphorylated by PKC alpha. Most strikingly, stable plasma membrane anchoring of AnxA6 is sufficient to recruit PKC alpha even in the absence of EGF or Ca2+. In summary, AnxA6 is a new PKC alpha scaffold to promote PKC alpha-mediated EGFR inactivation through increased membrane targeting of PKC alpha and EGFR/PKC alpha complex formation.	[Koese, M.; Kota, B. P.; Hoque, M.; Cairns, R.; Wood, P.; Grewal, T.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Rentero, C.; Vila de Muga, S.; Reverter, M.; Alvarez-Guaita, A.; Tebar, F.; Enrich, C.] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, IDIBAPS, Barcelona 08036, Spain; [Monastyrskaya, K.] Univ Bern, Dept Clin Res, Urol Res Lab, Bern, Switzerland; [Hughes, W. E.; Swarbrick, A.; Daly, R. J.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	University of Sydney; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Bern; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Enrich, C (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cellular, Casanova 143, Barcelona 08036, Spain.	enrich@ub.edu; thomas.grewal@sydney.edu.au	Rentero Alfonso, Carles/L-4430-2017; Hoque, Monira/AAN-5715-2020; Köse, Meryem/K-7399-2013; Tebar, Francesc/H-1498-2015; Swarbrick, Alexander/E-6107-2010	Rentero Alfonso, Carles/0000-0003-4684-0278; Köse, Meryem/0000-0002-3391-3418; Tebar, Francesc/0000-0002-9522-9726; Swarbrick, Alexander/0000-0002-3051-5676; Hughes, William/0000-0002-7149-3987; Alvarez-Guaita, Anna/0000-0002-9248-2275; Enrich, Carlos/0000-0003-0382-2993; Daly, Roger/0000-0002-5739-8027; Grewal, Thomas/0000-0002-7937-8887; Monastyrskaya, Katia/0000-0003-2042-1139; Cairns, Rose/0000-0002-8946-5079	National Health and Medical Research Council of Australia (NHMRC) [510293, 510294]; University of Sydney [2010-02681]; Consolider-Ingenio from Ministerio de Innovacion, Ciencia y Tecnologia [CSD2009-00016]; Fundacio Marato TV3 (Barcelona, Spain) [PI040236]; NHMRC; National Heart Foundation (NHF)/NHMRC postgraduate scholarship; Beatriu de Pinos fellowship (Generalitat de Catalunya); Ministerio de Educacion y Ciencia, Spain; Ministerio de Innovacion, Ciencia y Tecnologia; Cancer Institute NSW; National Breast Cancer Foundation; (FPI mobility Program) at the laboratory of TG (Sydney, Australia);  [BFU2009-10335];  [BFU2009-13526]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Consolider-Ingenio from Ministerio de Innovacion, Ciencia y Tecnologia; Fundacio Marato TV3 (Barcelona, Spain); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation (NHF)/NHMRC postgraduate scholarship; Beatriu de Pinos fellowship (Generalitat de Catalunya)(Generalitat de Catalunya); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Ministerio de Innovacion, Ciencia y Tecnologia; Cancer Institute NSW; National Breast Cancer Foundation; (FPI mobility Program) at the laboratory of TG (Sydney, Australia); ; 	This study was supported by grants to TG from the National Health and Medical Research Council of Australia (NHMRC; 510293, 510294) and the University of Sydney (2010-02681). CE is supported by BFU2009-10335, Consolider-Ingenio CSD2009-00016 from Ministerio de Innovacion, Ciencia y Tecnologia and PI040236 from Fundacio Marato TV3 (Barcelona, Spain). FT is supported by BFU2009-13526. RJD and AS would like to acknowledge funding from the NHMRC. PW is a recipient of a co-funded National Heart Foundation (NHF)/NHMRC postgraduate scholarship. CR is grateful to the Beatriu de Pinos fellowship (Generalitat de Catalunya). SV is thankful to Ministerio de Educacion y Ciencia, Spain, (FPI mobility Program) for a short-term fellowship at the laboratory of TG (Sydney, Australia). MR and AA are supported by fellowships from Ministerio de Innovacion, Ciencia y Tecnologia. AS is supported by Early Career Fellowships from the Cancer Institute NSW and the National Breast Cancer Foundation.	Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Assender JW, 2007, J CLIN PATHOL, V60, P1216, DOI 10.1136/jcp.2006.041616; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; BOWEN S, 1991, J BIOL CHEM, V266, P1162; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Collazos A, 2011, BIOCHEM J, V438, P535, DOI 10.1042/BJ20110521; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Davis AJ, 1996, J BIOL CHEM, V271, P24333, DOI 10.1074/jbc.271.40.24333; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P4080, DOI 10.1073/pnas.82.12.4080; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; Dubois T, 1996, BBA-MOL CELL RES, V1313, P290, DOI 10.1016/0167-4889(96)00102-4; Enrich C, 2011, BBA-MOL CELL RES, V1813, P935, DOI 10.1016/j.bbamcr.2010.09.015; FABBRO D, 1986, CANCER RES, V46, P2720; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Frankel LB, 2007, BREAST CANCER RES TR, V104, P165, DOI 10.1007/s10549-006-9399-1; Freye-Minks C, 2003, BIOCHEMISTRY-US, V42, P620, DOI 10.1021/bi026742h; FRIEDMAN B, 1989, P NATL ACAD SCI USA, V86, P812, DOI 10.1073/pnas.86.3.812; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, CURR SIGNAL TRANSD T, V1, P147, DOI 10.2174/157436206777012066; Grewal T, 2010, INT J BIOCHEM CELL B, V42, P580, DOI 10.1016/j.biocel.2009.12.020; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; IWASHITA S, 1984, J BIOL CHEM, V259, P2559; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Johannsdottir HK, 2006, INT J CANCER, V119, P1052, DOI 10.1002/ijc.21934; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim J, 2011, ONCOGENE, V30, P323, DOI 10.1038/onc.2010.415; KING CS, 1986, J BIOL CHEM, V261, P73; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; LUND KA, 1990, J BIOL CHEM, V265, P20517; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Minashima T, 2012, J BIOL CHEM, V287, P14803, DOI 10.1074/jbc.M111.297861; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; MORRISON P, 1993, J BIOL CHEM, V268, P15536; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Pierga JY, 2007, BRIT J CANCER, V96, P341, DOI 10.1038/sj.bjc.6603483; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Podszywalow-Bartnicka P, 2010, J CELL BIOCHEM, V111, P168, DOI 10.1002/jcb.22685; Pons M, 2001, FEBS LETT, V501, P69, DOI 10.1016/S0014-5793(01)02635-7; Prevostel C, 2000, J CELL SCI, V113, P2575; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; RON D, 1994, J BIOL CHEM, V269, P21395; Sakwe AM, 2011, EXP CELL RES, V317, P823, DOI 10.1016/j.yexcr.2010.12.008; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; Schmitz-Peiffer C, 1998, BIOCHEM J, V330, P675, DOI 10.1042/bj3300675; SMYTHE E, 1994, J CELL BIOL, V124, P301, DOI 10.1083/jcb.124.3.301; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Stewart JR, 2005, MOL CANCER THER, V4, P726, DOI 10.1158/1535-7163.MCT-05-0013; Strzelecka-Kiliszek A, 2008, J CELL BIOCHEM, V104, P418, DOI 10.1002/jcb.21632; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; THEOBALD J, 1995, BRIT J CANCER, V71, P786, DOI 10.1038/bjc.1995.152; Timpson P, 2007, CANCER RES, V67, P9304, DOI 10.1158/0008-5472.CAN-07-0798; Tonetti DA, 2003, BRIT J CANCER, V88, P1400, DOI 10.1038/sj.bjc.6600923; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Xu TR, 2004, FEBS LETT, V570, P20, DOI 10.1016/j.febslet.2004.05.080	74	48	50	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2013	32	23					2858	2872		10.1038/onc.2012.303	http://dx.doi.org/10.1038/onc.2012.303			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22797061				2022-12-25	WOS:000320369100006
J	Popovic, A; Wu, B; Arrowsmith, CH; Edwards, AM; Davidson, AR; Maxwell, KL				Popovic, Ana; Wu, Bin; Arrowsmith, Cheryl H.; Edwards, Aled M.; Davidson, Alan R.; Maxwell, Karen L.			Structural and Biochemical Characterization of Phage lambda FI Protein (gpFI) Reveals a Novel Mechanism of DNA Packaging Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDIMENSIONAL NMR METHODS; BACTERIOPHAGE-LAMBDA; HEAD MORPHOGENESIS; BACILLUS-SUBTILIS; GENE-PRODUCT; DOMAINS; INVITRO; SYSTEM; GENOME; IDENTIFICATION	One of the final steps in the morphogenetic pathway of phage lambda is the packaging of a single genome into a preformed empty head structure. In addition to the terminase enzyme, the packaging chaperone, FI protein (gpFI), is required for efficient DNA packaging. In this study, we demonstrate an interaction between gpFI and the major head protein, gpE. Amino acid substitutions in gpFI that reduced the strength of this interaction also decreased the biological activity of gpFI, implying that this head binding activity is essential for the function of gpFI. We also show that gpFI is a two-domain protein, and the C-terminal domain is responsible for the head binding activity. Using nuclear magnetic resonance spectroscopy, we determined the three-dimensional structure of the C-terminal domain and characterized the helical nature of the N-terminal domain. Through structural comparisons, we were able to identify two previously unannotated prophage-encoded proteins with tertiary structures similar to gpFI, although they lack significant pairwise sequence identity. Sequence analysis of these diverse homologues led us to identify related proteins in a variety of myo- and siphophages, revealing that gpFI function has a more highly conserved role in phage morphogenesis than was previously appreciated. Finally, we present a novel model for the mechanism of gpFI chaperone activity in the DNA packaging reaction of phage lambda.	[Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Popovic, Ana; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Edwards, Aled M.; Davidson, Alan R.; Maxwell, Karen L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wu, Bin; Arrowsmith, Cheryl H.; Edwards, Aled M.] Ontario Canc Inst, Div Canc Genom & Prote, Toronto, ON M5G 2M9, Canada; [Wu, Bin; Arrowsmith, Cheryl H.] Univ Toronto, Dept Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Maxwell, KL (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St,Rm 508, Toronto, ON M5S 3E1, Canada.	karen.maxwell@utoronto.ca	Popovic, Ana/AAF-8508-2021	Popovic, Ana/0000-0003-0137-7400; Edwards, Aled/0000-0002-4782-6016; Maxwell, Karen/0000-0002-0211-5480; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research [MOP-6279, MOP-77680]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Quebec Ministere de la Recherche en Science et Technologie; McGill University	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Quebec Ministere de la Recherche en Science et Technologie; McGill University	This work was supported in part by Canadian Institutes for Health Research Operating Grants MOP-6279 (to K. L. M. and A. M. E.) and MOP-77680 (to A. R. D.) and by the Natural Sciences and Engineering Research Council of Canada (to C. H. A.).; We thank Diane Bona for technical assistance, Mike Feiss for the gift of the gpFI antibody, Gabe Lander for providing the coordinates of Protein Data Bank code 3BQW modeled into the lambda prohead cryoelectron density, Jonathan Lukin and Tara Sprules for NMR data collection, and Paul Sadowski and Lisa Pell for critical reading of the manuscript. NMR experiments were recorded at the Quebec/Eastern Canada High Field NMR Facility, supported by grants from the Canada Foundation for Innovation, the Quebec Ministere de la Recherche en Science et Technologie, and McGill University.	BECKER A, 1977, VIROLOGY, V78, P291, DOI 10.1016/0042-6822(77)90100-3; BECKER A, 1990, J BACTERIOL, V172, P2819, DOI 10.1128/jb.172.6.2819-2824.1990; BECKER A, 1988, J MOL BIOL, V199, P597, DOI 10.1016/0022-2836(88)90304-X; Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067; CATALANO CE, 1995, BIOCHEMISTRY-US, V34, P10036, DOI 10.1021/bi00031a027; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIDSON A, 1987, VIROLOGY, V161, P305, DOI 10.1016/0042-6822(87)90122-X; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; FEISS M, 1988, VIROLOGY, V167, P323, DOI 10.1016/0042-6822(88)90090-6; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Fraser JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/j.jmb.2006.03.043; Goddard T. D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HOHN B, 1975, J MOL BIOL, V98, P93, DOI 10.1016/S0022-2836(75)80103-3; HOHN T, 1975, J MOL BIOL, V98, P107, DOI 10.1016/S0022-2836(75)80104-5; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HWANG Y, 1995, VIROLOGY, V211, P367, DOI 10.1006/viro.1995.1419; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KATSURA I, 1986, J MOL BIOL, V190, P577, DOI 10.1016/0022-2836(86)90243-3; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Kilcher S, 2010, J BACTERIOL, V192, P5441, DOI 10.1128/JB.00709-10; Krogh S, 1996, MICROBIOL-UK, V142, P2031, DOI 10.1099/13500872-142-8-2031; Kumaraswami M, 2011, J BIOL CHEM, V286, P35852, DOI 10.1074/jbc.M111.269860; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; MURIALDO H, 1991, ANNU REV BIOCHEM, V60, P125; MURIALDO H, 1978, MICROBIOL REV, V42, P529, DOI 10.1128/MMBR.42.3.529-576.1978; Murialdo H, 1997, MOL MICROBIOL, V24, P341, DOI 10.1046/j.1365-2958.1997.3321698.x; MURIALDO H, 1981, J MOL BIOL, V145, P375, DOI 10.1016/0022-2836(81)90211-4; Murialdo H, 1997, MOL MICROBIOL, V24, P937, DOI 10.1046/j.1365-2958.1997.4011769.x; MURIALDO H, 1972, VIROLOGY, V48, P785, DOI 10.1016/0042-6822(72)90162-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; OKAMOTO K, 1968, J MOL BIOL, V34, P429, DOI 10.1016/0022-2836(68)90170-8; OKAMOTO K, 1968, J MOL BIOL, V34, P413, DOI 10.1016/0022-2836(68)90169-1; Rajagopala SV, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-213; RAY P, 1975, VIROLOGY, V64, P247, DOI 10.1016/0042-6822(75)90096-3; Sippy J, 2004, MOL MICROBIOL, V52, P501, DOI 10.1111/j.1365-2958.2004.03990.x; STEENSMA HY, 1978, A VAN LEEUW J MICROB, V44, P353, DOI 10.1007/BF00394312; Suzuki R, 2009, PROTEINS, V75, P336, DOI 10.1002/prot.22243; WITKIEWICZ H, 1986, BIOSCIENCE REP, V6, P103, DOI 10.1007/BF01145185; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zimmer M, 2003, MOL MICROBIOL, V50, P303, DOI 10.1046/j.1365-2958.2003.03684.x	44	6	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32085	32095		10.1074/jbc.M112.378349	http://dx.doi.org/10.1074/jbc.M112.378349			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22801427	hybrid, Green Published			2022-12-25	WOS:000309059400046
J	Dehmer, M; Tsoy, YR				Dehmer, Matthias; Tsoy, Yury Robertovich			The Quality of Zero Bounds for Complex Polynomials	PLOS ONE			English	Article								In this paper, we evaluate the quality of zero bounds on the moduli of univariate complex polynomials. We select classical and recently developed bounds and evaluate their quality by using several sets of complex polynomials. As the quality of priori bounds has not been investigated thoroughly, our results can be useful to find optimal bounds to locate the zeros of complex polynomials.	[Tsoy, Yury Robertovich] Tomsk Polytech Univ, Dept Comp Engn, Tomsk, Russia	Tomsk Polytechnic University		matthias.dehmer@umit.at						Dehmer M., 2006, J INEQUALITIES PURE, V7; Dehmer M., 2004, ANAL THEORIE POLYNOM; Dehmer M, 2011, APPL MATH COMPUT, V218, P4128, DOI 10.1016/j.amc.2011.09.043; DEUTSCH E, 1981, AM MATH MON, V88, P205, DOI 10.2307/2320474; Heitzinger W, 1985, PRAXIS NICHTLINEARER; Jain V. K., 1986, Journal of Mathematical and Physical Sciences, V20, P259; JOYAL A, 1967, CAN MATH BULLETIN, V10, P53, DOI 10.4153/CMB-1967-006-3; Kalantari B, 2005, MATH COMPUT, V74, P841; Kojima J, 1914, TOHOKU MATH J, V5, P54; Kuniyeda M, 1916, B AM MATH SOC, V8, P167; Marden M, 1966, MATH SURVEYS AM MATH, V3; McNamee JM, 2005, P 17 IMACS WORLD C P; Mignotte M., 1999, POLYNOMIALS ALGORITH; Milovanovic G.V., 1994, TOPICS POLYNOMIALS E; Obreschkoff N, 1963, HOCHSCHULBUCHER MATH, V55; Prasolov V. V, 2004, ALGORITHM COMP MATH; Rahman Q.I., 2002, ANAL THEORY POLYNOMI	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39537	10.1371/journal.pone.0039537	http://dx.doi.org/10.1371/journal.pone.0039537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808042	Green Published, gold			2022-12-25	WOS:000306366400010
J	Alvarado, A; Garcillan-Barcia, MP; de la Cruz, F				Alvarado, Andres; Pilar Garcillan-Barcia, M.; de la Cruz, Fernando			A Degenerate Primer MOB Typing (DPMT) Method to Classify Gamma-Proteobacterial Plasmids in Clinical and Environmental Settings	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; HYBRID OLIGONUCLEOTIDE PRIMERS; KLEBSIELLA-PNEUMONIAE STRAINS; PROTEIN SECONDARY STRUCTURE; HOST-RANGE PLASMIDS; ESCHERICHIA-COLI; INCX PLASMID; CONJUGATIVE RELAXASE; RESISTANCE PLASMIDS; NUCLEOTIDE-SEQUENCE	Transmissible plasmids are responsible for the spread of genetic determinants, such as antibiotic resistance or virulence traits, causing a large ecological and epidemiological impact. Transmissible plasmids, either conjugative or mobilizable, have in common the presence of a relaxase gene. Relaxases were previously classified in six protein families according to their phylogeny. Degenerate primers hybridizing to coding sequences of conserved amino acid motifs were designed to amplify related relaxase genes from gamma-Proteobacterial plasmids. Specificity and sensitivity of a selected set of 19 primer pairs were first tested using a collection of 33 reference relaxases, representing the diversity of gamma-Proteobacterial plasmids. The validated set was then applied to the analysis of two plasmid collections obtained from clinical isolates. The relaxase screening method, which we call "Degenerate Primer MOB Typing" or DPMT, detected not only most known Inc/Rep groups, but also a plethora of plasmids not previously assigned to any Inc group or Rep-type.	[Alvarado, Andres] Univ Cantabria, Dept Biol Mol, Consejo Super Invest Cient, SODERCAN, E-39005 Santander, Spain; Univ Cantabria, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient, SODERCAN, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Alvarado, A (corresponding author), Univ Cantabria, Dept Biol Mol, Consejo Super Invest Cient, SODERCAN, E-39005 Santander, Spain.	delacruz@unican.es	Garcillán-Barcia, María Pilar/G-5812-2016; de la Cruz, Fernando/L-2812-2014	Garcillán-Barcia, María Pilar/0000-0001-7058-5428; de la Cruz, Fernando/0000-0003-4758-6857	Spanish Ministry of Education [BFU2008-00995/BMC]; RETICS research network, Instituto de Salud Carlos III, Spanish Ministry of Health [RD06/0008/1012]; European VII Framework Program [248919/FP7-ICT-2009-4]; I Plan Regional de I+D+i de Cantabria [20-1-2007]; Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Education(Spanish Government); RETICS research network, Instituto de Salud Carlos III, Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European VII Framework Program; I Plan Regional de I+D+i de Cantabria; Consejo Superior de Investigaciones Cientificas	This work was supported by Spanish Ministry of Education (www.mec.es) (BFU2008-00995/BMC), RETICS research network, Instituto de Salud Carlos III, Spanish Ministry of Health (www.msps.es) (RD06/0008/1012) and grant no 248919/FP7-ICT-2009-4 from the European VII Framework Program (http://cordis.europa.eu/fp7/home_en.html). AA was partially funded by the I Plan Regional de I+D+i de Cantabria (Ref. 20-1-2007). MPGB was funded by a JAE-Doc_2009 postdoctoral contract from Consejo Superior de Investigaciones Cientificas (www.csic.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRES I, 1984, PLASMID, V11, P96, DOI 10.1016/0147-619X(84)90012-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; AUSTIN S, 1990, CELL, V60, P351, DOI 10.1016/0092-8674(90)90584-2; Bahl MI, 2009, PLASMID, V62, P134, DOI 10.1016/j.plasmid.2009.05.004; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Boer R, 2006, J MOL BIOL, V358, P857, DOI 10.1016/j.jmb.2006.02.018; BRADLEY DE, 1982, PLASMID, V7, P95, DOI 10.1016/0147-619X(82)90031-2; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Camps Manel, 2010, Recent Pat DNA Gene Seq, V4, P58; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Coelho A, 2012, INT J ANTIMICROB AG, V39, P514, DOI 10.1016/j.ijantimicag.2012.01.006; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; DATTA N, 1971, NATURE, V234, P222, DOI 10.1038/234222a0; Datta S, 2003, STRUCTURE, V11, P1369, DOI 10.1016/j.str.2003.10.001; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Ejrnaes K, 2011, VIRULENCE, V2, P528, DOI 10.4161/viru.2.6.18189; Elhani D, 2010, CLIN MICROBIOL INFEC, V16, P157, DOI 10.1111/j.1469-0691.2009.03057.x; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2010, J ANTIMICROB CHEMOTH, V65, P1155, DOI 10.1093/jac/dkq101; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gardner MN, 2004, MICROBIOL-SGM, V150, P1797, DOI 10.1099/mic.0.26951-0; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gotz A, 1996, APPL ENVIRON MICROB, V62, P2621; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Greated A, 1999, MICROBIOL-SGM, V145, P3003, DOI 10.1099/00221287-145-11-3003; Gstalder ME, 2003, RES MICROBIOL, V154, P499, DOI 10.1016/S0923-2508(03)00143-8; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; HEDGES RW, 1975, MOL GEN GENET, V140, P289, DOI 10.1007/BF00267320; Heuer H, 2009, ENV MICROBIOL, V11, P937; Heuer H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00002; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2009, METHODS MOL BIOL, V551, P27, DOI 10.1007/978-1-60327-999-4_3; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Krasowiak R, 2002, FEMS MICROBIOL ECOL, V42, P217, DOI 10.1111/j.1574-6941.2002.tb01011.x; Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100; LOPEZ J, 1989, GENE, V78, P183, DOI 10.1016/0378-1119(89)90327-2; Mata C, 2012, J ANTIMICROB CHEMOTH, V67, P115, DOI 10.1093/jac/dkr412; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; Morant Marc, 2002, BMC Plant Biol, V2, P7, DOI 10.1186/1471-2229-2-7; NIKOLETTI S, 1988, J BACTERIOL, V170, P1311, DOI 10.1128/jb.170.3.1311-1318.1988; Novais A, 2010, 20 EUR C CLIN MICR I; Novais A, 2007, ANTIMICROB AGENTS CH, V51, P796, DOI 10.1128/AAC.01070-06; Novais A, 2006, ANTIMICROB AGENTS CH, V50, P2741, DOI 10.1128/AAC.00274-06; Novais A, 2010, ANTIMICROB AGENTS CH, V54, P825, DOI 10.1128/AAC.00959-09; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; NUGENT ME, 1981, J GEN MICROBIOL, V126, P305; Nunez B, 2001, MOL MICROBIOL, V39, P1088, DOI 10.1046/j.1365-2958.2001.02308.x; Oliver A, 2005, ANTIMICROB AGENTS CH, V49, P1567, DOI 10.1128/AAC.49.4.1567-1571.2005; Pedrosa A, 2008, 18 EUR C CLIN MICR I; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Garcillan-Barcia MP, 2011, FEMS MICROBIOL REV, V35, P936, DOI 10.1111/j.1574-6976.2011.00291.x; PRASZKIER J, 1991, J BACTERIOL, V173, P2393, DOI 10.1128/JB.173.7.2393-2397.1991; Provencher C, 2003, APPL ENVIRON MICROB, V69, P3299, DOI 10.1128/AEM.69.6.3299-3307.2003; Rose TM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-20; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Schluter A, 2007, APPL ENVIRON MICROB, V73, P1952, DOI 10.1128/AEM.02159-06; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Sesma A, 1998, APPL ENVIRON MICROB, V64, P3948; Sirichote P, 2010, J CLIN MICROBIOL, V48, P883, DOI 10.1128/JCM.01792-09; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Sobecky PA, 1997, APPL ENVIRON MICROB, V63, P888, DOI 10.1128/AEM.63.3.888-895.1997; Sobecky PA, 1998, APPL ENVIRON MICROB, V64, P2822; STALKER DM, 1985, PLASMID, V14, P245, DOI 10.1016/0147-619X(85)90008-3; Taylor DE, 2004, PLASMID BIOLOGY, P473; Tietze E, 1998, PLASMID, V39, P165, DOI 10.1006/plas.1998.1343; Toleman MA, 2011, FEMS MICROBIOL REV, V35, P912, DOI 10.1111/j.1574-6976.2011.00294.x; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; van Elsas JD, 1998, APPL ENVIRON MICROB, V64, P880; Varsaki A, 2003, MOL MICROBIOL, V48, P481, DOI 10.1046/j.1365-2958.2003.03441.x; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Zong ZY, 2011, J MED MICROBIOL, V60, P435, DOI 10.1099/jmm.0.026997-0	83	57	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40438	10.1371/journal.pone.0040438	http://dx.doi.org/10.1371/journal.pone.0040438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792321	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400054
J	Kniffin, KM; Wansink, B				Kniffin, Kevin M.; Wansink, Brian			It's Not Just Lunch: Extra-Pair Commensality Can Trigger Sexual Jealousy	PLOS ONE			English	Article								Do people believe that sharing food might involve sharing more than just food? To investigate this, participants were asked to rate how jealous they (Study 1) - or their best friend (Study 2) - would be if their current romantic partner were contacted by an ex-romantic partner and subsequently engaged in an array of food- and drink-based activities. We consistently find - across both men and women - that meals elicit more jealousy than face-to-face interactions that do not involve eating, such as having coffee. These findings suggest that people generally presume that sharing a meal enhances cooperation. In the context of romantic pairs, we find that participants are attuned to relationship risks that extra-pair commensality can present. For romantic partners left out of a meal, we find a common view that lunch, for example, is not "just lunch."	[Kniffin, Kevin M.; Wansink, Brian] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14853 USA	Cornell University	Kniffin, KM (corresponding author), Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14853 USA.	kmk276@cornell.edu						Amiraian D, 2009, APPETITE, V52, P226, DOI 10.1016/j.appet.2008.07.005; Amiraian DE, 2009, APPETITE, V53, P226, DOI 10.1016/j.appet.2009.06.012; Bove CF, 2003, APPETITE, V40, P25, DOI 10.1016/S0195-6663(02)00147-2; BUSS DM, 1992, PSYCHOL SCI, V3, P251, DOI 10.1111/j.1467-9280.1992.tb00038.x; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; DeScioli P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005802; DeSteno D, 2002, J PERS SOC PSYCHOL, V83, P1103, DOI 10.1037//0022-3514.83.5.1103; Frank R.H, 2013, FALLING RISING INEQU, DOI DOI 10.1525/9780520957435; Harris CR, 2000, J PERS SOC PSYCHOL, V78, P1082, DOI 10.1037//0022-3514.78.6.1082; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Kniffin Kevin M., 2009, Journal of Bioeconomics, V11, P23, DOI 10.1007/s10818-009-9056-y; Kniffin KM, 2010, GROUP ORGAN MANAGE, V35, P150, DOI 10.1177/1059601109360390; Kniffin KM, 2005, HUM NATURE-INT BIOS, V16, P278, DOI 10.1007/s12110-005-1011-6; Kniffin KM, 2004, EVOL HUM BEHAV, V25, P88, DOI 10.1016/S1090-5138(04)00006-6; O'Gorman R, 2009, P ROY SOC B-BIOL SCI, V276, P323, DOI 10.1098/rspb.2008.1082; Shackelford TK, 2007, CURR DIR PSYCHOL SCI, V16, P47, DOI 10.1111/j.1467-8721.2007.00473.x; Sobal J, 2003, APPETITE, V41, P181, DOI 10.1016/S0195-6663(03)00078-3; Solnick SJ, 2012, INJURY PREV, V18, P259, DOI 10.1136/injuryprev-2011-040117; Wang XT, 2010, PSYCHOL SCI, V21, P183, DOI 10.1177/0956797609358096; Wansink, 2006, MINDLESS EATING WHY; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wilson DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027826; Wrangham RW, 2009, CATCHING FIRE COOKIN; Young ME, 2009, APPETITE, V53, P268, DOI 10.1016/j.appet.2009.07.021	25	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40445	10.1371/journal.pone.0040445	http://dx.doi.org/10.1371/journal.pone.0040445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973LU	22792327	gold, Green Published			2022-12-25	WOS:000306362400055
J	Zhu, B; Peng, RH; Fu, XY; Jin, XF; Zhao, W; Xu, J; Han, HJ; Gao, JJ; Xu, ZS; Bian, L; Yao, QH				Zhu, Bo; Peng, Ri-He; Fu, Xiao-Yan; Jin, Xiao-Fen; Zhao, Wei; Xu, Jing; Han, Hong-Juan; Gao, Jian-Jie; Xu, Zhi-Sheng; Bian, Lin; Yao, Quan-Hong			Enhanced Transformation of TNT by Arabidopsis Plants Expressing an Old Yellow Enzyme	PLOS ONE			English	Article							2,4,6-TRINITROTOLUENE; PHYTOREMEDIATION; DETOXIFICATION; THALIANA; DROUGHT; WATER	2,4,6-Trinitrotoluene (TNT) is released in nature from manufacturing or demilitarization facilities, as well as after the firing or detonation of munitions or leakage from explosive remnants of war. Environmental contamination by TNT is associated with human health risks, necessitating the development of cost-effective remediation techniques. The lack of affordable and effective cleanup technologies for explosives contamination requires the development of better processes. In this study, we present a system for TNT phytoremediation by overexpressing the old yellow enzyme (OYE3) gene from Saccharomyces cerevisiae. The resulting transgenic Arabidopsis plants demonstrated significantly enhanced TNT tolerances and a strikingly higher capacity to remove TNT from their media. The current work indicates that S. cerevisiae OYE3 overexpression in Arabidopsis is an efficient method for the phytoremoval and degradation of TNT. Our findings have the potential to provide a suitable remediation strategy for sites contaminated by TNT.	[Zhu, Bo; Peng, Ri-He; Fu, Xiao-Yan; Jin, Xiao-Fen; Zhao, Wei; Xu, Jing; Han, Hong-Juan; Gao, Jian-Jie; Yao, Quan-Hong] Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China; [Xu, Zhi-Sheng] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Bian, Lin] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China	Shanghai Academy of Agricultural Sciences; Nanjing Agricultural University; Yangzhou University	Zhu, B (corresponding author), Shanghai Acad Agr Sci, Agrobiotechnol Res Ctr, Shanghai, Peoples R China.	yaoquanhong_sh@yahoo.com.cn			Hi-tech Research and Development Program (863) of China [2008AA10Z401]; Shanghai Natural Science Foundation [11ZR1432600]; Development Fund of Shanghai Academy of Agricultural Sciences	Hi-tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Development Fund of Shanghai Academy of Agricultural Sciences	The research was supported by Hi-tech Research and Development Program (863) of China (2008AA10Z401) and Shanghai Natural Science Foundation (11ZR1432600) and the Development Fund of Shanghai Academy of Agricultural Sciences [Nongkefa 2011(11)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TA, 1994, ACS S SERIES, V63; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Begcy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023776; Beynon ER, 2009, PLANT PHYSIOL, V151, P253, DOI 10.1104/pp.109.141598; Bhadra R, 1999, ENVIRON SCI TECHNOL, V33, P446, DOI 10.1021/es980635m; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; CUNNINGHAM SD, 1995, TRENDS BIOTECHNOL, V13, P393, DOI 10.1016/S0167-7799(00)88987-8; CUNNINGHAM SD, 1993, IN VITRO CELL DEV-PL, V29P, P207, DOI 10.1007/BF02632036; ETNIER EL, 1989, REGUL TOXICOL PHARM, V9, P147, DOI 10.1016/0273-2300(89)90032-9; French CE, 1999, NAT BIOTECHNOL, V17, P491, DOI 10.1038/8673; Hannink NK, 2007, INT J PHYTOREMEDIAT, V9, P385, DOI 10.1080/15226510701603916; Koss G, 1989, BUNDESGESUNDHEITSBLA, V32; LEVSEN K, 1993, ACTA HYDROCH HYDROB, V21, P153, DOI 10.1002/aheh.19930210304; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Luo Zhi-yong, 2001, Hunan Yike Daxue Xuebao, V26, P178; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; Pandey JS, 2000, MELB AUSTR P CSRA, P545; Pavlostathis SG, 1998, ENVIRON TOXICOL CHEM, V17, P2266, DOI [10.1002/etc.5620171117, 10.1897/1551-5028(1998)017&lt;2266:TOTBTA&gt;2.3.CO;2]; Peng R.H., 2001, ACTA PHYTOPHYSIOL SI, V27, P55; Pennington JC, 2002, THERMOCHIM ACTA, V384, P163, DOI 10.1016/S0040-6031(01)00801-2; Peuke AD, 2005, EMBO REP, V6, P497, DOI 10.1038/sj.embor.7400445; Spain JC, 2000, BIODEGRADATION OF NITROAROMATIC COMPOUNDS AND EXPLOSIVES, P1; Suresh B, 2004, CRIT REV BIOTECHNOL, V24, P97, DOI 10.1080/07388550490493627; Theorell H, 1935, BIOCHEM Z, V279, P463; Thompson PL, 1998, ENVIRON SCI TECHNOL, V32, P975, DOI 10.1021/es970799n; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Warburg O, 1932, NATURWISSENSCHAFTEN, V20, P980, DOI 10.1007/BF01504728; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; WON WD, 1976, APPL ENVIRON MICROB, V31, P576, DOI 10.1128/AEM.31.4.576-580.1976; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x	35	15	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39861	10.1371/journal.pone.0039861	http://dx.doi.org/10.1371/journal.pone.0039861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808068	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400023
J	Matisziw, TC; Grubesic, TH; Guo, JY				Matisziw, Timothy C.; Grubesic, Tony H.; Guo, Junyu			Robustness Elasticity in Complex Networks	PLOS ONE			English	Article							INFRASTRUCTURE; VULNERABILITY; EMERGENCE; DYNAMICS; SUPPORT; SCIENCE	Network robustness refers to a network's resilience to stress or damage. Given that most networks are inherently dynamic, with changing topology, loads, and operational states, their robustness is also likely subject to change. However, in most analyses of network structure, it is assumed that interaction among nodes has no effect on robustness. To investigate the hypothesis that network robustness is not sensitive or elastic to the level of interaction (or flow) among network nodes, this paper explores the impacts of network disruption, namely arc deletion, over a temporal sequence of observed nodal interactions for a large Internet backbone system. In particular, a mathematical programming approach is used to identify exact bounds on robustness to arc deletion for each epoch of nodal interaction. Elasticity of the identified bounds relative to the magnitude of arc deletion is assessed. Results indicate that system robustness can be highly elastic to spatial and temporal variations in nodal interactions within complex systems. Further, the presence of this elasticity provides evidence that a failure to account for nodal interaction can confound characterizations of complex networked systems.	[Matisziw, Timothy C.; Guo, Junyu] Univ Missouri, Dept Civil & Environm Engn, Columbia, MO 65211 USA; [Matisziw, Timothy C.] Univ Missouri, Dept Geog, Columbia, MO USA; [Matisziw, Timothy C.] Univ Missouri, Inst Informat, Columbia, MO USA; [Grubesic, Tony H.] Drexel Univ, Coll Informat Sci & Technol, Geog Informat Syst & Spatial Anal Lab, Philadelphia, PA 19104 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Drexel University	Matisziw, TC (corresponding author), Univ Missouri, Dept Civil & Environm Engn, Columbia, MO 65211 USA.	matisziwt@missouri.edu	Matisziw, Timothy/N-9105-2016	Matisziw, Timothy/0000-0003-2159-4904; Grubesic, Tony/0000-0003-4517-586X	National Science Foundation [0908030, 0718091]; National Academies Keck Futures Initiative [CS05]	National Science Foundation(National Science Foundation (NSF)); National Academies Keck Futures Initiative	This research is supported in part by the National Science Foundation (0908030 and 0718091). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. Portions of this work are also supported by the National Academies Keck Futures Initiative Complex Systems grant CS05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alderson DL, 2008, OPER RES, V56, P1047, DOI 10.1287/opre.1080.0606; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Caldarelli G., 2007, SCALE FREE NETWORKS; Church RL, 2004, ANN ASSOC AM GEOGR, V94, P491, DOI 10.1111/j.1467-8306.2004.00410.x; D'Souza RM, 2007, P NATL ACAD SCI USA, V104, P6112, DOI 10.1073/pnas.0606779104; de Menezes MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068701; Deville Yves, 2003, Briefings in Bioinformatics, V4, P246, DOI 10.1093/bib/4.3.246; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Fotheringham A.S., 1989, SPATIAL INTERACTION; Grubesic TH, 2008, INT REGIONAL SCI REV, V31, P88, DOI 10.1177/0160017607308679; Grubesic TH, 2011, J URBAN TECHNOL, V18, P51, DOI 10.1080/10630732.2011.578409; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kumar R, 2000, ANN IEEE SYMP FOUND, P57, DOI 10.1109/SFCS.2000.892065; Kurant M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036114; LAND AH, 1960, ECONOMETRICA, V28, P497, DOI 10.2307/1910129; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lerner AP, 1933, REV ECON STUD, V1, P226; Matisziw TC, 2009, COMPUT OPER RES, V36, P16, DOI 10.1016/j.cor.2007.09.004; Matisziw TC, 2009, ANN REGIONAL SCI, V43, P307, DOI 10.1007/s00168-008-0235-x; Matisziw TC, 2009, LANDSCAPE ECOL, V24, P89, DOI 10.1007/s10980-008-9282-z; Meloni S, 2009, P NATL ACAD SCI USA, V106, P16897, DOI 10.1073/pnas.0907121106; Murray AT, 2008, GROWTH CHANGE, V39, P573, DOI 10.1111/j.1468-2257.2008.00447.x; Myung YS, 2004, EUR J OPER RES, V156, P579, DOI 10.1016/S0377-2217(03)00135-8; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Rinaldi SA, 2001, IEEE CONTR SYST MAG, V21, P11, DOI 10.1109/37.969131; Saavedra S, 2008, P NATL ACAD SCI USA, V105, P16466, DOI 10.1073/pnas.0804740105; Shen S, 2011, NETWORKS, DOI 10-1002/net.20464; Snediker DE, 2008, DECIS SUPPORT SYST, V44, P954, DOI 10.1016/j.dss.2007.11.003; Snijders TAB, 2001, SOCIOL METHODOL, V31, P361, DOI 10.1111/0081-1750.00099; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Willinger W., 2009, NOT AM MATH SOC, V56, P586; WOLLMER R, 1964, OPER RES, V12, P934, DOI 10.1287/opre.12.6.934	40	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39788	10.1371/journal.pone.0039788	http://dx.doi.org/10.1371/journal.pone.0039788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973JD	22808060	Green Published, gold, Green Submitted			2022-12-25	WOS:000306355500014
J	Michels, L; Luchinger, R; Koenig, T; Martin, E; Brandeis, D				Michels, Lars; Luechinger, Rafael; Koenig, Thomas; Martin, Ernst; Brandeis, Daniel			Developmental Changes of BOLD Signal Correlations with Global Human EEG Power and Synchronization during Working Memory	PLOS ONE			English	Article							SCHOOL-AGE CHILDREN; DEFAULT-MODE; PHASE SYNCHRONIZATION; ALPHA OSCILLATIONS; THETA-OSCILLATIONS; BRAIN ACTIVITY; HUMAN ELECTROENCEPHALOGRAM; NEURONAL SYNCHRONY; PARIETAL CORTEX; FREQUENCY BANDS	In humans, theta band (5-7 Hz) power typically increases when performing cognitively demanding working memory (WM) tasks, and simultaneous EEG-fMRI recordings have revealed an inverse relationship between theta power and the BOLD (blood oxygen level dependent) signal in the default mode network during WM. However, synchronization also plays a fundamental role in cognitive processing, and the level of theta and higher frequency band synchronization is modulated during WM. Yet, little is known about the link between BOLD, EEG power, and EEG synchronization during WM, and how these measures develop with human brain maturation or relate to behavioral changes. We examined EEG-BOLD signal correlations from 18 young adults and 15 school-aged children for age-dependent effects during a load-modulated Sternberg WM task. Frontal load (in-)dependent EEG theta power was significantly enhanced in children compared to adults, while adults showed stronger fMRI load effects. Children demonstrated a stronger negative correlation between global theta power and the BOLD signal in the default mode network relative to adults. Therefore, we conclude that theta power mediates the suppression of a task-irrelevant network. We further conclude that children suppress this network even more than adults, probably from an increased level of task-preparedness to compensate for not fully mature cognitive functions, reflected in lower response accuracy and increased reaction time. In contrast to power, correlations between instantaneous theta global field synchronization and the BOLD signal were exclusively positive in both age groups but only significant in adults in the frontal-parietal and posterior cingulate cortices. Furthermore, theta synchronization was weaker in children and was -in contrast to EEG power- positively correlated with response accuracy in both age groups. In summary we conclude that theta EEG-BOLD signal correlations differ between spectral power and synchronization and that these opposite correlations with different distributions undergo similar and significant neuronal developments with brain maturation.	[Michels, Lars; Martin, Ernst] Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland; [Michels, Lars] Univ Zurich Hosp, Inst Neuroradiol, CH-8091 Zurich, Switzerland; [Luechinger, Rafael; Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Koenig, Thomas] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Martin, Ernst; Brandeis, Daniel] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Brandeis, Daniel] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelberg, Germany	University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Bern; University Hospital of Bern; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Michels, L (corresponding author), Univ Childrens Hosp, Ctr MR Res, Zurich, Switzerland.	lars.michels@kispi.uzh.ch	Koenig, Thomas/F-6454-2010; Michels, Lars/X-6939-2018; Koenig, Thomas/ABD-2278-2020	Koenig, Thomas/0000-0002-1472-4638; Koenig, Thomas/0000-0002-1472-4638; Michels, Lars/0000-0003-3750-1100	University Research Priority Program "Integrative Human Physiology"	University Research Priority Program "Integrative Human Physiology"	This work was supported by the University Research Priority Program "Integrative Human Physiology" ("Linking the major system markers for typical and atypical brain development: a multimodal imaging and spectroscopy study" and "Thalamocortical interaction in brain state regulation during normal development and in epilepsy") at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P2252, DOI 10.1016/j.clinph.2004.05.004; Basar E, 1997, BIOL CYBERN, V76, P471, DOI 10.1007/s004220050360; Bell MA, 2002, PSYCHOPHYSIOLOGY, V39, P450, DOI 10.1017/S0048577201393174; Bell MA, 2007, DEV NEUROPSYCHOL, V31, P21, DOI 10.1207/s15326942dn3101_2; Benjamini Y., 1995, J R STAT SOC, V57, P289, DOI [10.1111/j.2517-6161.1995.tb02031.x, DOI 10.1111/J.2517-6161.1995.TB02031.X]; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; CASEY BJ, 1995, NEUROIMAGE, V2, P221, DOI 10.1006/nimg.1995.1029; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doesburg SM, 2010, EXP BRAIN RES, V201, P719, DOI 10.1007/s00221-009-2086-9; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Etherington SJ, 2011, J NEUROSCI, V31, P9526, DOI 10.1523/JNEUROSCI.0458-11.2011; Ewald A, 2012, NEUROIMAGE, V60, P476, DOI 10.1016/j.neuroimage.2011.11.084; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Feinberg I, 2011, SLEEP, V34, P325, DOI 10.1093/sleep/34.3.325; Feldman DE, 2000, NAT NEUROSCI, V3, P303, DOI 10.1038/73849; Fernandez T, 1998, NEUROREPORT, V9, P3681; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Finn AS, 2010, J NEUROSCI, V30, P11062, DOI 10.1523/JNEUROSCI.6266-09.2010; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Frei E, 2001, HUM BRAIN MAPP, V14, P152, DOI 10.1002/hbm.1049; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P100, DOI 10.1016/0013-4694(88)90205-2; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; Grieve PG, 2003, CLIN NEUROPHYSIOL, V114, P1594, DOI 10.1016/S1388-2457(03)00122-6; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hestrin S, 2005, NAT NEUROSCI, V8, P1283, DOI 10.1038/nn1005-1283; INGVAR DH, 1976, ELECTROEN CLIN NEURO, V41, P268, DOI 10.1016/0013-4694(76)90119-X; INGVAR DH, 1979, PHARMAKOPSYCH NEURO, V12, P200, DOI 10.1055/s-0028-1094611; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jensen O, 2006, NEUROSCIENCE, V139, P237, DOI 10.1016/j.neuroscience.2005.06.004; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 1998, J NEUROSCI, V18, P10688; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Koenig T, 2001, NEUROIMAGE, V14, P383, DOI 10.1006/nimg.2001.0825; Koenig T, 2001, SCHIZOPHR RES, V50, P55, DOI 10.1016/S0920-9964(00)00154-7; Koenig T, 2009, ELECT NEUROIMAGING, P145, DOI DOI 10.1017/CBO9780511596889.009; Krause CM, 2007, NEUROREPORT, V18, P213, DOI 10.1097/WNR.0b013e3280148ea0; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luchinger R, 2011, NEUROIMAGE; Luchinger R, 2012, NEUROIMAGE, V60, P1426, DOI 10.1016/j.neuroimage.2012.01.031; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meltzer JA, 2007, CLIN NEUROPHYSIOL, V118, P2419, DOI 10.1016/j.clinph.2007.07.023; Michels L, 2010, BRAIN TOPOGR; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; NAGATA K, 1988, Brain Topography, V1, P97, DOI 10.1007/BF01129174; Nelson C.A., 2001, HDB DEV COGNITIVE NE; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; O'Hare ED, 2008, NEUROIMAGE, V42, P1678, DOI 10.1016/j.neuroimage.2008.05.057; Olesen PJ, 2007, CEREB CORTEX, V17, P1047, DOI 10.1093/cercor/bhl0l4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Pugnetti L, 2010, INT J NEUROSCI, V120, P88, DOI 10.3109/00207450903436346; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Sammer G, 2007, HUM BRAIN MAPP, V28, P793, DOI 10.1002/hbm.20309; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; Sauseng P, 2002, NEUROSCI LETT, V324, P121, DOI 10.1016/S0304-3940(02)00225-2; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Scherf KS, 2006, J COGNITIVE NEUROSCI, V18, P1045, DOI 10.1162/jocn.2006.18.7.1045; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Supekar K, 2010, NEUROIMAGE; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wackermann J, 1998, ELECTROEN CLIN NEURO, V107, P415, DOI 10.1016/S0013-4694(98)00090-X; Wu X, 2007, NEUROIMAGE, V35, P1654, DOI 10.1016/j.neuroimage.2007.02.011; Yordanova J, 1996, NEUROREPORT, V8, P277, DOI 10.1097/00001756-199612200-00055; Yordanova J, 1997, INT J PSYCHOPHYSIOL, V26, P411, DOI 10.1016/S0167-8760(97)00779-4; Yordanova J, 1996, INT J NEUROSCI, V85, P155, DOI 10.3109/00207459608986360; Yordanova JY, 1996, ELECTROEN CLIN NEURO, V99, P527	115	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39447	10.1371/journal.pone.0039447	http://dx.doi.org/10.1371/journal.pone.0039447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792176	Green Accepted, Green Published, gold			2022-12-25	WOS:000306461800013
J	Pandelova, I; Figueroa, M; Wilhelm, LJ; Manning, VA; Mankaney, AN; Mockler, TC; Ciuffetti, LM				Pandelova, Iovanna; Figueroa, Melania; Wilhelm, Larry J.; Manning, Viola A.; Mankaney, Aakash N.; Mockler, Todd C.; Ciuffetti, Lynda M.			Host-Selective Toxins of Pyrenophora tritici-repentis Induce Common Responses Associated with Host Susceptibility	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TAN SPOT; PTR TOXA; GENE-EXPRESSION; MICROARRAY ANALYSIS; CHLOROSIS TOXIN; POWDERY MILDEW; JASMONIC ACID; CAUSAL AGENT; WHEAT	Pyrenophora tritici-repentis (Ptr), a necrotrophic fungus and the causal agent of tan spot of wheat, produces one or a combination of host-selective toxins (HSTs) necessary for disease development. The two most studied toxins produced by Ptr, Ptr ToxA (ToxA) and Ptr ToxB (ToxB), are proteins that cause necrotic or chlorotic symptoms respectively. Investigation of host responses induced by HSTs provides better insight into the nature of the host susceptibility. Microarray analysis of ToxA has provided evidence that it can elicit responses similar to those associated with defense. In order to evaluate whether there are consistent host responses associated with susceptibility, a similar analysis of ToxB-induced changes in the same sensitive cultivar was conducted. Comparative analysis of ToxA-and ToxB-induced transcriptional changes showed that similar groups of genes encoding WRKY transcription factors, RLKs, PRs, components of the phenylpropanoid and jasmonic acid pathways are activated. ROS accumulation and photosystem dysfunction proved to be common mechanism-of-action for these toxins. Despite similarities in defense responses, transcriptional and biochemical responses as well as symptom development occur more rapidly for ToxA compared to ToxB, which could be explained by differences in perception as well as by differences in activation of a specific process, for example, ethylene biosynthesis in ToxA treatment. Results of this study suggest that perception of HSTs will result in activation of defense responses as part of a susceptible interaction and further supports the hypothesis that necrotrophic fungi exploit defense responses in order to induce cell death.	[Pandelova, Iovanna; Figueroa, Melania; Wilhelm, Larry J.; Manning, Viola A.; Mankaney, Aakash N.; Mockler, Todd C.; Ciuffetti, Lynda M.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Pandelova, Iovanna; Figueroa, Melania; Wilhelm, Larry J.; Manning, Viola A.; Mankaney, Aakash N.; Mockler, Todd C.; Ciuffetti, Lynda M.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Figueroa, Melania] Oregon State Univ, USDA, ARS, Forage Seed & Cereal Res Unit, Corvallis, OR 97331 USA; [Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Oregon State University; Oregon State University; Oregon State University; United States Department of Agriculture (USDA); Donald Danforth Plant Science Center	Pandelova, I (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	ciuffetL@science.oregonstate.edu	Mockler, Todd C/L-2609-2013; Figueroa, Melania/AAI-8692-2021; Figueroa, Melania/R-7696-2017	Mockler, Todd C/0000-0002-0462-5775; Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X	National Research Initiative Microbial Biology: Microbial Associations with Plants Program of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES) [2006-55600-16619]; Agriculture and Food Research Initiative Competitive Grants Program [2010-65108-20548]; SIDA National Institute of Food and Agriculture	National Research Initiative Microbial Biology: Microbial Associations with Plants Program of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES); Agriculture and Food Research Initiative Competitive Grants Program; SIDA National Institute of Food and Agriculture	This project was supported by the National Research Initiative Microbial Biology: Microbial Associations with Plants Program of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES, grant#:2006-55600-16619) and in part by the Agriculture and Food Research Initiative Competitive Grants Program grant #:2010-65108-20548) from the SIDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari TB, 2009, MOL PLANT MICROBE IN, V22, P1056, DOI 10.1094/MPMI-22-9-1056; Anderson JA, 1999, PHYTOPATHOLOGY, V89, P293, DOI 10.1094/PHYTO.1999.89.4.293; Andrie RA, 2007, PHYTOPATHOLOGY, V97, P694, DOI 10.1094/PHYTO-97-6-0694; BALLANCE GM, 1989, PHYSIOL MOL PLANT P, V35, P203, DOI 10.1016/0885-5765(89)90051-9; Ballance GM, 1996, MOL PLANT PATHOL; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENNETT FGA, 1984, PLANT PATHOL, V33, P279, DOI 10.1111/j.1365-3059.1984.tb01324.x; Betts MF, 2011, PHYSIOL MOL PLANT P, V75, P138, DOI 10.1016/j.pmpp.2011.03.002; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boddu J, 2007, MOL PLANT MICROBE IN, V20, P1364, DOI 10.1094/MPMI-20-11-1364; Boyle C, 2006, PLANT PATHOL, V55, P82, DOI 10.1111/j.1365-3059.2005.01281.x; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Ciuffetti LM, 1998, CAN J PLANT PATHOL, V20, P421, DOI 10.1080/07060669809500415; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; Cosgrove DJ, 2001, CURR BIOL, V11, pR558, DOI 10.1016/S0960-9822(01)00342-6; De Wolf ED, 1998, CAN J PLANT PATHOL, V20, P349, DOI 10.1080/07060669809500404; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Faris JD, 1996, PHYTOPATHOLOGY, V86, P459, DOI 10.1094/Phyto-86-459; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Frick UB, 2002, PLANTA, V216, P83, DOI 10.1007/s00425-002-0887-1; Friesen TL, 2008, PLANT PHYSIOL, V146, P682, DOI 10.1104/pp.107.108761; Friesen TL, 2004, THEOR APPL GENET, V109, P464, DOI 10.1007/s00122-004-1678-9; Gamba FM, 1998, CAN J PLANT PATHOL, V20, P401, DOI 10.1080/07060669809500411; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; HAGBORG WAF, 1970, CAN J BOTANY, V48, P1135, DOI 10.1139/b70-165; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Kim YM, 2010, PROTEOMICS, V10, P2911, DOI 10.1002/pmic.200900670; Kwon CY, 1998, PHYSIOL MOL PLANT P, V52, P201, DOI 10.1006/pmpp.1998.0151; Lamari L, 2005, PHYTOPATHOLOGY, V95, P144, DOI 10.1094/PHYTO-95-0144; Lamari L, 2003, PHYTOPATHOLOGY, V93, P391, DOI 10.1094/PHYTO.2003.93.4.391; LAMARI L, 1991, PHYTOPATHOLOGY, V81, P1092, DOI 10.1094/Phyto-81-1092; Lamari L, 1995, CAN J PLANT PATHOL, V17, P312, DOI 10.1080/07060669509500668; Lamari L, 2010, CAN J PLANT PATHOL, V32, P4, DOI 10.1080/07060661003594117; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Mahalingam R, 1999, MOL PLANT MICROBE IN, V12, P490, DOI 10.1094/MPMI.1999.12.6.490; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Manning VA, 2004, MOL PLANT MICROBE IN, V17, P491, DOI 10.1094/MPMI.2004.17.5.491; Manning VA, 2008, MOL PLANT MICROBE IN, V21, P315, DOI 10.1094/MPMI-21-3-0315; Manning VA, 2009, MOL PLANT MICROBE IN, V22, P665, DOI 10.1094/MPMI-22-6-0665; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Martinez JP, 2001, MOL PLANT MICROBE IN, V14, P675, DOI 10.1094/MPMI.2001.14.5.675; MUELLER MJ, 1993, P NATL ACAD SCI USA, V90, P7490, DOI 10.1073/pnas.90.16.7490; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; OROLAZA NP, 1995, PHYTOPATHOLOGY, V85, P1282, DOI 10.1094/Phyto-85-1282; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Perello A, 2003, CROP PROT, V22, P157, DOI 10.1016/S0261-2194(02)00140-0; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; REINBOTHE S, 1994, P NATL ACAD SCI USA, V91, P7012, DOI 10.1073/pnas.91.15.7012; REINBOTHE S, 1993, EMBO J, V12, P1505, DOI 10.1002/j.1460-2075.1993.tb05794.x; REINBOTHE S, 1994, PLANT CELL, V6, P1197, DOI 10.1105/tpc.6.9.1197; Rickauer M, 1997, PLANTA, V202, P155, DOI 10.1007/s004250050114; Saad HA, 2008, CORNEA, V27, P818, DOI 10.1097/ICO.0b013e3181705ca2; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Sarma GN, 2005, PLANT CELL, V17, P3190, DOI 10.1105/tpc.105.034918; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stock WS, 1996, GENOME, V39, P598, DOI 10.1139/g96-075; Strelkov S, 1998, DEV PLANT PATHOL, V13, P137; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Strelkov SE, 2003, CAN J PLANT PATHOL, V25, P339; Strelkov SE, 1998, CAN J PLANT PATHOL, V20, P428, DOI 10.1080/07060669809500417; Strelkov SE, 1999, MOL PLANT MICROBE IN, V12, P728, DOI 10.1094/MPMI.1999.12.8.728; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; TOMAS A, 1990, MOL PLANT MICROBE IN, V3, P221, DOI 10.1094/MPMI-3-221; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TUORI RP, 1995, MOL PLANT MICROBE IN, V8, P41, DOI 10.1094/MPMI-8-0041; Tuori RP, 2000, MOL PLANT MICROBE IN, V13, P456, DOI 10.1094/MPMI.2000.13.4.456; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Van Breusegem F, 2008, PLANT PHYSIOL, V147, P978, DOI 10.1104/pp.108.122325; VANWEES S, 2002, ARABIDOPSIS LAB MANU, P86; Vincent D, 2012, MOL PLANT PATHOL, V13, P467, DOI 10.1111/j.1364-3703.2011.00763.x; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Weise, 1987, COMPENDIUM WHEAT DIS, P42; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wi SJ, 2010, MOL CELLS, V30, P37, DOI 10.1007/s10059-010-0086-z; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z; Zhang HF, 1997, PHYTOPATHOLOGY, V87, P154, DOI 10.1094/PHYTO.1997.87.2.154; Zhang LR, 2008, PLANT CELL PHYSIOL, V49, P1092, DOI 10.1093/pcp/pcn086; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	97	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40240	10.1371/journal.pone.0040240	http://dx.doi.org/10.1371/journal.pone.0040240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792250	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800055
J	Silva, LP; Vanzile, M; Bavari, S; Aman, JMJ; Schriemer, DC				Silva, Leslie P.; Vanzile, Michael; Bavari, Sina; Aman, J. M. Javad; Schriemer, David C.			Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails	PLOS ONE			English	Article							POSTEXPOSURE PROTECTION; NONHUMAN-PRIMATES; RNA; OLIGOMERIZATION; GLYCOPROTEIN; ASSOCIATION; PARTICLES; DISCOVERY; GENOME; TSG101	The matrix protein VP40 coordinates numerous functions in the viral life cycle of the Ebola virus. These range from the regulation of viral transcription to morphogenesis, packaging and budding of mature virions. Similar to the matrix proteins of other nonsegmented, negative-strand RNA viruses, VP40 proceeds through intermediate states of assembly (e.g. octamers) but it remains unclear how these intermediates are coordinated with the various stages of the life cycle. In this study, we investigate the molecular basis of synchronization as governed by VP40. Hydrogen/deuterium exchange mass spectrometry was used to follow induced structural and conformational changes in VP40. Together with computational modeling, we demonstrate that both extreme N and C terminal tail regions stabilize the monomeric state through a direct association. The tails appear to function as a latch, released upon a specific molecular trigger such as RNA ligation. We propose that triggered release of the tails permits the coordination of late-stage events in the viral life cycle, at the inner membrane of the host cell. Specifically, N-tail release exposes the L-domain motifs PTAP/PPEY to the transport and budding complexes, whereas triggered C-tail release could improve association with the site of budding.	[Silva, Leslie P.; Schriemer, David C.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Vanzile, Michael; Bavari, Sina; Aman, J. M. Javad] USA, Med Res Inst Infect Dis, Frederick, MD USA	University of Calgary	Silva, LP (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	dschriem@ucalgary.ca	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635	Alberta Innovates - Health Solutions; Defense Threat Reduction Agency [JSTO-CBD project] [44.10022-08-RD-B]; Defense Threat Reduction Agency TMTI (Transformational Medical Technologies Initiative) project [0048-09-RD-T]	Alberta Innovates - Health Solutions; Defense Threat Reduction Agency [JSTO-CBD project]; Defense Threat Reduction Agency TMTI (Transformational Medical Technologies Initiative) project	The work was supported in part by grants from Alberta Innovates - Health Solutions, the Defense Threat Reduction Agency [JSTO-CBD project 44.10022-08-RD-B and TMTI (Transformational Medical Technologies Initiative) project 0048-09-RD-T]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Chalmers MJ, 2011, INT J MASS SPECTROM, V302, P59, DOI 10.1016/j.ijms.2010.08.002; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Halfmann P, 2008, P NATL ACAD SCI USA, V105, P1129, DOI 10.1073/pnas.0708057105; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; He J, 2009, VIRUSES-BASEL, V1, P441, DOI 10.3390/v1030441; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Hoenen T, 2012, EXPERT OPIN BIOL THE; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Johnson RF, 2006, J VIROL, V80, P5135, DOI 10.1128/JVI.01857-05; Kortepeter MG, 2008, EMERG INFECT DIS, V14, P881, DOI 10.3201/eid1406.071489; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Pigott DC, 2005, CRIT CARE CLIN, V21, P765, DOI 10.1016/j.ccc.2005.06.007; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Reynard O, 2011, J INFECT DIS, V204, pS884, DOI 10.1093/infdis/jir359; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Schmitt AP, 2004, CURR TOP MICROBIOL, V283, P145; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Slysz GW, 2008, ANAL CHEM, V80, P7004, DOI 10.1021/ac800897q; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2005, EXPERT REV VACCINES, V4, P429, DOI 10.1586/14760584.4.3.429; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837	39	22	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39978	10.1371/journal.pone.0039978	http://dx.doi.org/10.1371/journal.pone.0039978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792204	Green Submitted, gold, Green Published			2022-12-25	WOS:000306436300018
J	Weinstein, SJ; Peters, U; Ahn, J; Friesen, MD; Riboli, E; Hayes, RB; Albanes, D				Weinstein, Stephanie J.; Peters, Ulrike; Ahn, Jiyoung; Friesen, Marlin D.; Riboli, Elio; Hayes, Richard B.; Albanes, Demetrius			Serum alpha-Tocopherol and gamma-Tocopherol Concentrations and Prostate Cancer Risk in the PLCO Screening Trial: A Nested Case-Control Study	PLOS ONE			English	Article							DIETARY VITAMIN-E; OMEGA-HYDROXYLASE PATHWAY; BETA-CAROTENE; SUPPLEMENTATION; RETINOL; ASSOCIATION; PREVENTION; SELENIUM; MICRONUTRIENTS; MEN	Background: Vitamin E compounds exhibit prostate cancer preventive properties experimentally, but serologic investigations of tocopherols, and randomized controlled trials of supplementation in particular, have been inconsistent. Many studies suggest protective effects among smokers and for aggressive prostate cancer, however. Methods: We conducted a nested case-control study of serum alpha-tocopherol and gamma-tocopherol and prostate cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, with 680 prostate cancer cases and 824 frequency-matched controls. Multivariate-adjusted, conditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CIs) for tocopherol quintiles. Results: Serum alpha-tocopherol and gamma-tocopherol were inversely correlated (r = -0.24, p < 0.0001). Higher serum alpha-tocopherol was associated with significantly lower prostate cancer risk (OR for the highest vs. lowest quintile = 0.63, 95% CI 0.44-0.92, p-trend 0.05). By contrast, risk was non-significantly elevated among men with higher gamma-tocopherol concentrations (OR for the highest vs. lowest quintile = 1.35, 95% CI 0.92-1.97, p-trend 0.41). The inverse association between prostate cancer and alpha-tocopherol was restricted to current and recently former smokers, but was only slightly stronger for aggressive disease. By contrast, the increased risk for higher gamma-tocopherol was more pronounced for less aggressive cancers. Conclusions: Our findings indicate higher alpha-tocopherol status is associated with decreased risk of developing prostate cancer, particularly among smokers. Although two recent controlled trials did not substantiate an earlier finding of lower prostate cancer incidence and mortality in response to supplementation with a relatively low dose of a-tocopherol, higher a-tocopherol status may be beneficial with respect to prostate cancer risk among smokers. Determining what stage of prostate cancer development is impacted by vitamin E, the underlying mechanisms, and how smoking modifies the association, is needed for a more complete understanding of the vitamin E-prostate cancer relation.	[Weinstein, Stephanie J.; Albanes, Demetrius] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Peters, Ulrike] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Ahn, Jiyoung; Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA; [Friesen, Marlin D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol, London, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; New York University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London	Weinstein, SJ (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	weinstes@mail.nih.gov; daa@nih.gov	Weinstein, Stephanie J/P-1627-2017; Albanes, Demetrius/B-9749-2015	Weinstein, Stephanie J/0000-0002-3834-1535; Riboli, Elio/0000-0001-6795-6080; Hayes, Richard/0000-0002-0918-661X; Ahn, Jiyoung/0000-0002-2900-2304	Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services (DHHS)	Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services (DHHS)	This research was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services (DHHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; [Anonymous], 1994, Ann Epidemiol, V4, P1, DOI 10.1016/1047-2797(94)90036-1; [Anonymous], 1997, AJCC CANC STAGING MA; Brigelius-Flohe R, 2002, AM J CLIN NUTR, V76, P703, DOI 10.1093/ajcn/76.4.703; Bruno RS, 2005, J NUTR, V135, P671, DOI 10.1093/jn/135.4.671; Bruno RS, 2005, AM J CLIN NUTR, V81, P95; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Cheng TYD, 2011, J NUTR, V141, P1731, DOI 10.3945/jn.111.141713; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Comstock GW, 2001, CANCER EPIDEM BIOMAR, V10, P65; Eichholzer M, 1996, INT J CANCER, V66, P145, DOI 10.1002/(SICI)1097-0215(19960410)66:2&lt;145::AID-IJC1&gt;3.0.CO;2-2; Fleshner NE, 2002, UROL CLIN N AM, V29, P107, DOI 10.1016/S0094-0143(02)00023-X; Ford ES, 2006, AM J CLIN NUTR, V84, P375; Gann PH, 2009, JAMA-J AM MED ASSOC, V301, P102, DOI 10.1001/jama.2008.863; Gann PH, 1999, CANCER RES, V59, P1225; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Gill JK, 2009, CANCER CAUSE CONTROL, V20, P1161, DOI 10.1007/s10552-009-9304-4; Goodman GE, 2003, CANCER EPIDEM BIOMAR, V12, P518; HANDELMAN GJ, 1985, J NUTR, V115, P807, DOI 10.1093/jn/115.6.807; Hartman TJ, 2001, PROSTATE, V46, P33, DOI 10.1002/1097-0045(200101)46:1&lt;33::AID-PROS1005&gt;3.0.CO;2-6; HAYES RB, 1988, CANCER-AM CANCER SOC, V62, P2021, DOI 10.1002/1097-0142(19881101)62:9<2021::AID-CNCR2820620925>3.0.CO;2-R; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Helzlsouer KJ, 2000, J NATL CANCER I, V92, P2018, DOI 10.1093/jnci/92.24.2018; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; Jiang Q, 2000, P NATL ACAD SCI USA, V97, P11494, DOI 10.1073/pnas.200357097; Key TJ, 2007, AM J CLIN NUTR, V86, P672, DOI 10.1093/ajcn/86.3.672; Kirsh VA, 2006, JNCI-J NATL CANCER I, V98, P245, DOI 10.1093/jnci/djj050; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; KNEKT P, 1988, AM J EPIDEMIOL, V127, P28, DOI 10.1093/oxfordjournals.aje.a114788; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Major JM, 2011, HUM MOL GENET; Meyer F, 2005, INT J CANCER, V116, P182, DOI 10.1002/ijc.21058; Mondu AM, 2011, J NUTR, V141, P2030, DOI 10.3945/jn.111.143669; Mondul AM, 2011, CANCER CAUSE CONTROL, V22, P827, DOI 10.1007/s10552-011-9753-4; Moyad M A, 1999, Semin Urol Oncol, V17, P85; Ni J, 2003, BIOCHEM BIOPH RES CO, V300, P357, DOI 10.1016/S0006-291X(02)02851-6; Nomura AMY, 1997, CANCER EPIDEM BIOMAR, V6, P487; Parker RS, 2004, ANN NY ACAD SCI, V1031, P13, DOI 10.1196/annals.1331.002; Peters U, 2008, CANCER CAUSE CONTROL, V19, P75, DOI 10.1007/s10552-007-9072-y; Peters U, 2007, CANCER EPIDEM BIOMAR, V16, P962, DOI 10.1158/1055-9965.EPI-06-0861; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Rodriguez C, 2004, CANCER EPIDEM BIOMAR, V13, P378; Rossini A, 2008, PHARMACOGENOMICS, V9, P1737, DOI 10.2217/14622416.9.11.1737; Rothman K., 1998, MODERN EPIDEMIOLOGY; Saldeen K, 2005, NUTR RES, V25, P877, DOI 10.1016/j.nutres.2005.09.019; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Steghens JP, 1997, J CHROMATOGR B, V694, P71, DOI 10.1016/S0378-4347(97)00140-0; Stram DO, 2006, CANCER CAUSE CONTROL, V17, P1193, DOI 10.1007/s10552-006-0064-0; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Traber M.G., 1999, MODERN NUTR HLTH DIS, V9th, P347; Traber MG, 2010, MOL NUTR FOOD RES, V54, P661, DOI 10.1002/mnfr.200900440; Venkateswaran V, 2010, NAT REV UROL, V7, P442, DOI 10.1038/nrurol.2010.102; Wagner KH, 2004, ANN NUTR METAB, V48, P169, DOI 10.1159/000079555; Watters JL, 2009, CANCER RES, V69, P3833, DOI 10.1158/0008-5472.CAN-08-4640; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Weinstein SJ, 2007, CANCER EPIDEM BIOMAR, V16, P1253, DOI 10.1158/1055-9965.EPI-06-1084; Woodson K, 2002, ANTICANCER RES, V22, P375; Wright ME, 2007, CANCER EPIDEM BIOMAR, V16, P1128, DOI 10.1158/1055-9965.EPI-06-1071; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P7408, DOI 10.1073/pnas.102014399	63	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40204	10.1371/journal.pone.0040204	http://dx.doi.org/10.1371/journal.pone.0040204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792240	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300035
J	Roh, M; Zhang, Y; Murakami, Y; Thanos, A; Lee, SC; Vavvas, DG; Benowitz, LI; Miller, JW				Roh, Miin; Zhang, Yan; Murakami, Yusuke; Thanos, Aristomenis; Lee, Sung Chul; Vavvas, Demetrios G.; Benowitz, Larry I.; Miller, Joan W.			Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-alpha (TNF-alpha), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; MOUSE MODEL; FLUORESCEIN LEAKAGE; ACTIVATED MICROGLIA; ALZHEIMERS-DISEASE; NEURONAL DEATH; OPTIC DISC; EXPRESSION; ISCHEMIA	Background: Visual loss in glaucoma is associated with pathological changes in retinal ganglion cell (RGC) axons and a slow decline in the RGC population. Age and elevated intraocular pressure (IOP) are the main risk factors for glaucomatous loss of vision. Several studies have implicated the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) as a link between elevated IOP and RGC death, but the cellular source of TNF-alpha and its causative role in RGC death remain uncertain. Here, using a rat model of glaucoma, we investigated the source of elevated TNF-alpha and examined whether Etanercept, a TNF-alpha blocker that is in common clinical use for other indications, is protective against RGC death. Methodology/Principal Findings: Episcleral vein cauterization (EVC) caused intraocular pressure (IOP) to be elevated for at least 28 days. IOP elevation resulted in a dramatic increase in TNF-alpha levels within a few days, axonal degeneration, and a 38% loss of RGCs by 4 weeks. Immunostaining coupled with confocal microscopy showed that OHT induced robust induction of TNF-alpha in Iba-1-positive microglia around the optic nerve head (ONH). Despite persistent elevation of IOP, Etanercept reduced microglial activation, TNF-alpha levels, axon degeneration in the optic nerve, and the loss of RGCs. Conclusions/Significance: Ocular hypertension (OHT) triggers an inflammatory response characterized by the appearance of activated microglia around the ONH that express TNF-alpha. Blocking TNF-alpha activity with a clinically approved agent inhibits this microglial response and prevents axonal degeneration and loss of RGCs. These findings suggest a new treatment strategy for glaucoma using TNF-alpha antagonists or suppressors of inflammation.	[Roh, Miin; Zhang, Yan; Murakami, Yusuke; Thanos, Aristomenis; Vavvas, Demetrios G.; Miller, Joan W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02215 USA; [Roh, Miin; Zhang, Yan; Murakami, Yusuke; Thanos, Aristomenis; Vavvas, Demetrios G.; Miller, Joan W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Retina Serv,Dept Ophthalmol, Boston, MA USA; [Roh, Miin; Lee, Sung Chul] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul, South Korea; [Benowitz, Larry I.] Harvard Univ, Sch Med, Labs Neurosci Res Neurosurg, Boston, MA USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Dept Surg, FM Kirby Neurobiol Ctr,Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, FM Kirby Neurobiol Ctr,Childrens Hosp, Boston, MA USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Yonsei University; Yonsei University Health System; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Roh, M (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02215 USA.	larry.benowitz@childrens.harvard.edu; joan_miller@meei.harvard.edu		Benowitz, Larry/0000-0002-0277-7222; Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478; Roh, Miin/0000-0003-3346-754X	Neovascular Research Fund; Bacardi Fund; Research to Prevent Blindness Foundation; Lions Eye Research Fund; Onassis Foundation; Fight For Sight; Harvard Ophthalmology Department; National Eye Institute [EY014104, EY05690]; NATIONAL EYE INSTITUTE [P30EY014104, R01EY005690] Funding Source: NIH RePORTER	Neovascular Research Fund; Bacardi Fund; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Lions Eye Research Fund; Onassis Foundation; Fight For Sight; Harvard Ophthalmology Department; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Neovascular Research Fund (JM, MR), the Bacardi Fund (DV), the Research to Prevent Blindness Foundation (DV), the Lions Eye Research Fund (DV), the Onassis Foundation (DV), a Fight For Sight Grant-in-Aid (DV), the Harvard Ophthalmology Department (DV), and National Eye Institute grants EY014104 (JM) and EY05690 (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend O, 2005, GRAEF ARCH CLIN EXP, V243, P659, DOI 10.1007/s00417-004-1092-7; Avunduk MC, 2004, EXP EYE RES, V79, P357, DOI 10.1016/j.exer.2004.06.001; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chen YN, 2007, BRAIN RES, V1148, P28, DOI 10.1016/j.brainres.2007.02.027; Chung HS, 1999, SURV OPHTHALMOL, V43, pS43, DOI 10.1016/S0039-6257(99)00050-8; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Fischer F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-120; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Harms AS, 2012, GLIA, V60, P189, DOI 10.1002/glia.21254; Harms AS, 2011, MOL THER, V19, P46, DOI 10.1038/mt.2010.217; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hernandez M R, 1993, J Glaucoma, V2, P50; Sande PH, 2008, AM J PATHOL, V173, P1702, DOI 10.2353/ajpath.2008.080518; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kaur C, 2008, CLIN OPHTHALMOL, V2, P879, DOI 10.2147/opth.s3361; Kreutz MR, 2004, EUR J NEUROSCI, V19, P247, DOI 10.1111/j.1460-9568.2004.03087.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; Mangan BG, 2007, VET OPHTHALMOL, V10, P117, DOI 10.1111/j.1463-5224.2007.00585.x; Marina N, 2010, NAT PROTOC, V5, P1642, DOI 10.1038/nprot.2010.128; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Moreland LW, 2000, J RHEUMATOL, V27, P601; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nanda S, 2004, EXPERT OPIN PHARMACO, V5, P1175, DOI 10.1517/eoph.5.5.1175.31081; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Plange N, 2010, OPHTHAL PHYSL OPT, V30, P315, DOI 10.1111/j.1475-1313.2010.00717.x; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Ramiro S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008886.pub2; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; Schmidt KG, 2004, OPHTHALMOLOGE, V101, P1071, DOI 10.1007/s00347-004-1131-0; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Siu AW, 2002, EXP EYE RES, V75, P401, DOI 10.1006/exer.2002.2029; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P705, DOI 10.1167/iovs.06-0810; Tochel C M, 2005, BMC Ophthalmol, V5, P22, DOI 10.1186/1471-2415-5-22; Trichonas G, 2010, INVEST OPHTH VIS SCI, V51, P1677, DOI 10.1167/iovs.09-4193; Uchihara T, 1997, STROKE, V28, P1948, DOI 10.1161/01.STR.28.10.1948; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666, DOI 10.1001/archopht.118.5.666; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	65	144	150	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40065	10.1371/journal.pone.0040065	http://dx.doi.org/10.1371/journal.pone.0040065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802951	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900025
J	Ma, JC; Tang, WK; Esser, L; Pastan, I; Xia, D				Ma, Jichun; Tang, Wai Kwan; Esser, Lothar; Pastan, Ira; Xia, Di			Recognition of Mesothelin by the Therapeutic Antibody MORAb-009 STRUCTURAL AND MECHANISTIC INSIGHTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-REPLACEMENT; MONOCLONAL-ANTIBODY; EXPRESSION; ADENOCARCINOMAS; PANCREAS; AFFINITY; BINDING; CLONING	Mesothelin is a tumor differentiation antigen that is highly expressed in many epithelial cancers, with limited expression in normal human tissues. Binding of mesothelin on normal mesothelial cells lining the pleura or peritoneum to the tumor-associated cancer antigen 125 (CA-125) can lead to heterotypic cell adhesion and tumor metastasis within the pleural and peritoneal cavities. This binding can be prevented by MORAb-009, a humanized monoclonal antibody against mesothelin currently under clinical trials. Weshow here that MORAb-009 recognizes a non-linear epitope that is contained in the first 64-residue fragment of the mesothelin. We further demonstrate that the recognition is independent of glycosylation state of the protein but sensitive to the loss of a disulfide bond linking residues Cys-7 and Cys-31. The crystal structure of the complex between the mesothelin N-terminal fragment and Fab of MORAb-009 at 2.6 angstrom resolution reveals an epitope encompassing multiple secondary structural elements of the mesothelin, including residues from helix alpha 1, the loops linking helices alpha 1 and alpha 2, and between helices alpha 4 and alpha 5. The mesothelin fragment has a compact, right-handed superhelix structure consisting of five short helices and connecting loops. A residue essential for complex formation has been identified as Phe-22, which projects its side chain into a hydrophobic niche formed on the antibody recognition surface upon antigen-antibody contact. The overlapping binding footprints of both the monoclonal antibody and the cancer antigen CA-125 explains the therapeutic effect and provides a basis for further antibody improvement.	[Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xia, D (corresponding author), 37 Convent Dr,Bldg 37,Rm 2122C, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Tang, Wai Kwan/A-6158-2012; pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270	Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; Cooperative Research and Development Agreement CRADA with Morphotek; NATIONAL CANCER INSTITUTE [ZIABC010600, ZIABC008753, ZIABC010319] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cooperative Research and Development Agreement CRADA with Morphotek; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. This work was also supported by a Cooperative Research and Development Agreement CRADA with Morphotek.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Argani P, 2001, CLIN CANCER RES, V7, P3862; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Bateman AC, 1997, HISTOPATHOLOGY, V30, P49, DOI 10.1046/j.1365-2559.1996.d01-562.x; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan Raffit, 2007, Cancer Immun, V7, P20; Hassan R, 2010, LUNG CANCER, V68, P455, DOI 10.1016/j.lungcan.2009.07.016; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma JC, 2008, J APPL CRYSTALLOGR, V41, P1150, DOI 10.1107/S0021889808033797; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ordonez NG, 2003, MODERN PATHOL, V16, P192, DOI 10.1097/01.MP.0000056981.16578.C3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Sathyanarayana BK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-1; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Sundberg E. J., 2004, MOL BIOL B CELLS, VVII, P491; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yen MJ, 2006, CLIN CANCER RES, V12, P827, DOI 10.1158/1078-0432.CCR-05-1397; Zhang YJ, 2006, CLIN CANCER RES, V12, P4695, DOI 10.1158/1078-0432.CCR-06-0346	33	23	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33123	33131		10.1074/jbc.M112.381756	http://dx.doi.org/10.1074/jbc.M112.381756			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22787150	Green Published, hybrid			2022-12-25	WOS:000309602100004
J	Perez-Berna, AJ; Ortega-Esteban, A; Menendez-Conejero, R; Winkler, DC; Menendez, M; Steven, AC; Flint, SJ; de Pablo, PJ; San Martin, C				Perez-Berna, Ana J.; Ortega-Esteban, Alvaro; Menendez-Conejero, Rosa; Winkler, Dennis C.; Menendez, Margarita; Steven, Alasdair C.; Flint, S. Jane; de Pablo, Pedro J.; San Martin, Carmen			The Role of Capsid Maturation on Adenovirus Priming for Sequential Uncoating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; VIRAL-DNA; VIRUS ENTRY; CELL ENTRY; TYPE-2; STABILITY; MICROSCOPY; TRANSPORT; PROTEASE; RECONSTRUCTIONS	Adenovirus assembly concludes with proteolytic processing of several capsid and core proteins. Immature virions containing precursor proteins lack infectivity because they cannot properly uncoat, becoming trapped in early endosomes. Structural studies have shown that precursors increase the network of interactions maintaining virion integrity. Using different biophysical techniques to analyze capsid disruption in vitro, we show that immature virions are more stable than the mature ones under a variety of stress conditions and that maturation primes adenovirus for highly cooperative DNA release. Cryoelectron tomography reveals that under mildly acidic conditions mimicking the early endosome, mature virions release pentons and peripheral core contents. At higher stress levels, both mature and immature capsids crack open. The virus core is completely released from cracked capsids in mature virions, but it remains connected to shell fragments in the immature particle. The extra stability of immature adenovirus does not equate with greater rigidity, because in nanoindentation assays immature virions exhibit greater elasticity than the mature particles. Our results have implications for the role of proteolytic maturation in adenovirus assembly and uncoating. Precursor proteins favor assembly by establishing stable interactions with the appropriate curvature and preventing premature ejection of contents by tightly sealing the capsid vertices. Upon maturation, core organization is looser, particularly at the periphery, and interactions preserving capsid curvature are weakened. The capsid becomes brittle, and pentons are more easily released. Based on these results, we hypothesize that changes in core compaction during maturation may increase capsid internal pressure to trigger proper uncoating of adenovirus.	[Perez-Berna, Ana J.; Menendez-Conejero, Rosa; San Martin, Carmen] Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Macromol Struct, E-28049 Madrid, Spain; [Ortega-Esteban, Alvaro; de Pablo, Pedro J.] Univ Autonoma Madrid, Dept Condensed Matter Phys, E-28049 Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Menendez, Margarita] CIBER Enfermedades Resp, Madrid 28006, Spain; [Winkler, Dennis C.; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Flint, S. Jane] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Princeton University	San Martin, C (corresponding author), Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Macromol Struct, Darwin 3, E-28049 Madrid, Spain.	carmen@cnb.csic.es	Perez-Berna, Ana/G-2789-2016; Menendez, Margarita/M-1795-2014; de Pablo, Pedro/L-9392-2014; Ortega-Esteban, Alvaro/M-7458-2015; San Martín, Carmen/A-4074-2010	Menendez, Margarita/0000-0002-3267-4443; de Pablo, Pedro/0000-0003-2386-3186; Ortega-Esteban, Alvaro/0000-0001-9642-0568; San Martín, Carmen/0000-0001-9799-175X; Perez-Berna, Ana/0000-0003-4145-532X; Winkler, Dennis/0000-0003-1445-6554	National Institutes of Health [GM037705, AI1058172]; Ministry of Science and Innovation of Spain [BFU2010-16382/BMC, MAT2008-02533, PIB2010US-00233, FIS2011-29493, FIS2010-10552-E, FIS2011-16090-E, BFU2009-10052]; Local Madrid Government [P2009/MAT-1467]; Juan de la Cierva Postdoctoral Contract from the Ministry of Science and Innovation of Spain [JCI-2009-05187]; Spain CSIC Travel Grant [PA1002892]; Ministry of Education of Spain; Instituto de Salud Carlos III of Spain [FI08/00035]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Local Madrid Government; Juan de la Cierva Postdoctoral Contract from the Ministry of Science and Innovation of Spain; Spain CSIC Travel Grant; Ministry of Education of Spain(Spanish Government); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM037705 and AI1058172 (to S. J. F.). This work was also supported by Ministry of Science and Innovation of Spain Grants BFU2010-16382/BMC (to C. S. M.), MAT2008-02533, PIB2010US-00233, and FIS2011-29493 (to P. J. P.), FIS2010-10552-E and FIS2011-16090-E (to C. S. M. and P. J. P.), and BFU2009-10052 (to M. M.), and by Local Madrid Government Grant P2009/MAT-1467 (to P. J. P.).; Recipient of Juan de la Cierva Postdoctoral Contract JCI-2009-05187 from the Ministry of Science and Innovation of Spain and recipient of additional support from Spain CSIC Travel Grant PA1002892.; Recipient of FPU predoctoral fellowship from the Ministry of Education of Spain.; Recipient of Predoctoral Fellowship FI08/00035 from the Instituto de Salud Carlos III of Spain.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Baclayon M, 2011, NANO LETT, V11, P4865, DOI 10.1021/nl202699r; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Carreira A, 2004, J BIOL CHEM, V279, P6517, DOI 10.1074/jbc.M307662200; CHATTERJEE PK, 1985, J VIROL, V55, P379, DOI 10.1128/JVI.55.2.379-386.1985; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; CHROBOCZEK J, 1992, VIROLOGY, V186, P280, DOI 10.1016/0042-6822(92)90082-Z; COTTEN M, 1995, VIROLOGY, V213, P494, DOI 10.1006/viro.1995.0022; de Pablo PJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.098101; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; Greber UF, 1996, EMBO J, V15, P1766, DOI 10.1002/j.1460-2075.1996.tb00525.x; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; HANNAN C, 1983, INTERVIROLOGY, V19, P213, DOI 10.1159/000149363; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Huang RK, 2011, J MOL BIOL, V408, P541, DOI 10.1016/j.jmb.2011.01.016; Ihnat PM, 2005, BBA-GEN SUBJECTS, V1726, P138, DOI 10.1016/j.bbagen.2005.06.006; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leen AM, 2005, BRIT J HAEMATOL, V128, P135, DOI 10.1111/j.1365-2141.2004.05218.x; Lindert S, 2009, J VIROL, V83, P11491, DOI 10.1128/JVI.01214-09; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Ortega-Esteban A, 2012, ULTRAMICROSCOPY, V114, P56, DOI 10.1016/j.ultramic.2012.01.007; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; RANCOURT C, 1995, VIROLOGY, V209, P167, DOI 10.1006/viro.1995.1240; Rexroad J, 2006, J PHARM SCI-US, V95, P237, DOI 10.1002/jps.20496; Rexroad J, 2003, J PHARM SCI, V92, P665, DOI 10.1002/jps.10340; Rexroad J, 2006, J PHARM SCI-US, V95, P1469, DOI 10.1002/jps.20617; Roos WH, 2012, P NATL ACAD SCI USA, V109, P2342, DOI 10.1073/pnas.1109590109; Roos WH, 2009, P NATL ACAD SCI USA, V106, P9673, DOI 10.1073/pnas.0901514106; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Martin CS, 2012, VIRUSES-BASEL, V4, P847, DOI 10.3390/v4050847; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2009, STRUCTURE, V17, P1563, DOI 10.1016/j.str.2009.10.009; Seki T, 2002, J VIROL, V76, P1100, DOI 10.1128/JVI.76.3.1100-1108.2002; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; Singh R, 2009, TRENDS BIOTECHNOL, V27, P220, DOI 10.1016/j.tibtech.2009.01.003; Smith JG, 2010, CURR TOP MICROBIOL, V343, P195, DOI 10.1007/82_2010_16; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Teschke CM, 2003, BIOPHYS J, V84, P2585, DOI 10.1016/S0006-3495(03)75063-2; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; Weber J. M., 1999, MED INTELL UNIT, P79; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wodrich H, 2003, EMBO J, V22, P6245, DOI 10.1093/emboj/cdg614; Zandi R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021917; Zink M, 2009, BIOPHYS J, V96, P1350, DOI 10.1016/j.bpj.2008.11.028	65	70	73	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31582	31595		10.1074/jbc.M112.389957	http://dx.doi.org/10.1074/jbc.M112.389957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22791715	Green Published, hybrid			2022-12-25	WOS:000308791300070
J	Tokutsu, R; Kato, N; Bui, KH; Ishikawa, T; Minagawa, J				Tokutsu, Ryutaro; Kato, Nobuyasu; Bui, Khanh Huy; Ishikawa, Takashi; Minagawa, Jun			Revisiting the Supramolecular Organization of Photosystem II in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; OXYGEN-EVOLVING COMPLEX; ELECTRON-MICROSCOPY; STATE TRANSITIONS; THYLAKOID MEMBRANE; GREEN PLANTS; IN-VIVO; CRYSTAL-STRUCTURE; GRANA MEMBRANES; 16-KDA PROTEINS	Photosystem II (PSII) is a multiprotein complex that splits water and initiates electron transfer in photosynthesis. The central part of PSII, the PSII core, is surrounded by light-harvesting complex II proteins (LHCIIs). In higher plants, two or three LHCII trimers are seen on each side of the PSII core whereas only one is seen in the corresponding positions in Chlamydomonas reinhardtii, probably due to the absence of CP24, a minor monomeric LHCII. Here, we re-examined the supramolecular organization of the C. reinhardtii PSII-LHCII supercomplex by determining the effect of different solubilizing detergents. When we solubilized the thylakoid membranes with n-dodecyl-beta-D-maltoside (beta-DM) or n-dodecyl-alpha-D-maltoside (alpha-DM) and subjected them to gel filtration, we observed a clear difference in molecular mass. The alpha-DM-solubilized PSII-LHCII supercomplex bound twice more LHCII than the beta-DM-solubilized supercomplex and retained higher oxygen-evolving activity. Single-particle image analysis from electron micrographs of the alpha-DM-solubilized and negatively stained supercomplex revealed that the PSII-LHCII supercomplex had a novel supramolecular organization, with three LHCII trimers attached to each side of the core.	[Tokutsu, Ryutaro; Minagawa, Jun] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Kato, Nobuyasu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Bui, Khanh Huy; Ishikawa, Takashi] ETH, Dept Biol, CH-8093 Zurich, Switzerland	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Hokkaido University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Minagawa, J (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Environm Photobiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	minagawa@nibb.ac.jp	Tokutsu, Ryutaro/GRF-0208-2022; Ishikawa, Takashi/E-5023-2017; Tokutsu, Ryutaro/V-7596-2019	Ishikawa, Takashi/0000-0002-1976-7477; Tokutsu, Ryutaro/0000-0003-2037-255X; Bui, Khanh Huy/0000-0001-8231-3016; Minagawa, Jun/0000-0002-3028-3203; Bui, Khanh Huy/0000-0003-2814-9889	Japan Society for the Promotion of Science [21001384]; Council for Science and Technology [GS026]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology	This work was in part supported by the Japan Society for the Promotion of Science through Research Fellowship for Young Scientists 21001384 to (R. T.) and Funding Program for Next Generation World-Leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy Grant GS026 (to J. M.).	Bertos NR, 1998, J PHYCOL, V34, P1009, DOI 10.1046/j.1529-8817.1998.341009.x; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Boekema EJ, 1998, EUR J BIOCHEM, V252, P268, DOI 10.1046/j.1432-1327.1998.2520268.x; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOODENOUGH UW, 1969, PLANT PHYSIOL, V44, P990, DOI 10.1104/pp.44.7.990; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; HARAUZ G, 1988, METHOD ENZYMOL, V164, P35; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Nicholson WV, 1996, BIOCHEM J, V315, P543, DOI 10.1042/bj3150543; Nicholson WV, 1996, BIOSCIENCE REP, V16, P159, DOI 10.1007/BF01206204; Nield J, 2000, J BIOL CHEM, V275, P27940; Nield J, 2000, NAT STRUCT BIOL, V7, P44; ONO T, 1984, FEBS LETT, V168, P281, DOI 10.1016/0014-5793(84)80263-X; ONO TA, 1983, FEBS LETT, V164, P255, DOI 10.1016/0014-5793(83)80297-X; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Penczek PA, 1996, ULTRAMICROSCOPY, V63, P205, DOI 10.1016/0304-3991(96)00037-X; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Sugiura M, 1998, FEBS LETT, V426, P140, DOI 10.1016/S0014-5793(98)00328-7; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; Tokutsu R, 2009, J BIOL CHEM, V284, P7777, DOI 10.1074/jbc.M809360200; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; WRIGLEY NG, 1968, J ULTRA MOL STRUCT R, V24, P454, DOI 10.1016/S0022-5320(68)80048-6; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x	47	72	72	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31574	31581		10.1074/jbc.M111.331991	http://dx.doi.org/10.1074/jbc.M111.331991			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801422	Green Published, hybrid			2022-12-25	WOS:000308791300069
J	Zhao, ZH; Hong, W; Zeng, ZY; Wu, YL; Hu, KH; Tian, XH; Li, WX; Cao, ZJ				Zhao, Zhenhuan; Hong, Wei; Zeng, Zhengyang; Wu, Yingliang; Hu, Kanghong; Tian, Xiaohui; Li, Wenxin; Cao, Zhijian			Mucroporin-M1 Inhibits Hepatitis B Virus Replication by Activating the Mitogen-activated Protein Kinase (MAPK) Pathway and Down-regulating HNF4 alpha in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 4-ALPHA; FACTOR 4 ALPHA; GENE-EXPRESSION; ANTIMICROBIAL PEPTIDES; TRANSCRIPTION FACTORS; 3 BETA; INFECTION; VENOM; PROMOTER; RECEPTORS	Hepatitis B virus (HBV) is a noncytopathic human hepadnavirus that causes acute, chronic hepatitis and hepatocellular carcinoma (HCC). As the clinical utility of current therapies is limited, new anti-HBV agents and sources for such agents are still highly sought after. Here, we report that Mucroporin-M1, a scorpion venom-derived peptide, reduces the amount of extracellular HBsAg, HBeAg, and HBV DNA productions of HepG2.2.15 cells in a dose-dependent manner and inhibits HBV capsid DNA, HBV intracellular RNA replication intermediates and the HBV Core protein in the cytoplasm of HepG2.2.15 cells. Using a mouse model of HBV infection, we found that HBV replication was significantly inhibited by intravenous injection of the Mucroporin-M1 peptide. This inhibitory activity was due to a reduction in HBV promoter activity caused by a decrease in the binding of HNF4 alpha to the precore/core promoter region. Furthermore, we confirmed that Mucroporin-M1 could selectively activate mitogen-activated protein kinases (MAPKs) and lead to the down-regulation of HNF4 alpha expression, which explains the decreased binding of HNF4 alpha to the HBV promoter. Moreover, when the protein phosphorylation activity of the MAPK pathway was inhibited, both HNF4 alpha expression and HBV replication recovered. Finally, we proved that treatment with the Mucroporin-M1 peptide increased phosphorylation of the MAPK proteins in HBV-harboring mice. These results implicate Mucroporin-M1 peptide can activate the MAPK pathway and then reduce the expression of HNF4 alpha, resulting in the inhibition of HBV replication in vitro and in vivo. Our work also opens new doors to discovering novel anti-HBV agents or sources.	[Zhao, Zhenhuan; Hong, Wei; Zeng, Zhengyang; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Hu, Kanghong; Tian, Xiaohui] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; zjcao@whu.edu.cn	Hong, Wei/AAJ-6912-2020; Hu, Kanghong/AAL-3011-2020	Hong, Wei/0000-0001-7410-4679	National Key Basic Research Program in China [2010CB529800, 2010CB530100]; National Natural Science Foundation of China [31071942, 30971500]; China Specific Project for Developing New Drugs [2011ZX09401-302, 2011ZX09102-001-32]; Fundamental Research Funds for the Central Universities of China [1102001]	National Key Basic Research Program in China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Specific Project for Developing New Drugs; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Key Basic Research Program in China (2010CB529800 and 2010CB530100), National Natural Science Foundation of China (31071942 and 30971500), China Specific Project for Developing New Drugs (2011ZX09401-302 and 2011ZX09102-001-32), and Fundamental Research Funds for the Central Universities of China (1102001).	Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Chen EQ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-23; Chen HS, 2009, J PAIN, V10, P201, DOI 10.1016/j.jpain.2008.08.011; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Fan Z, 2011, ANTIMICROB AGENTS CH, V55, P5220, DOI 10.1128/AAC.00369-11; Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Ishida H, 2000, J VIROL, V74, P1241, DOI 10.1128/JVI.74.3.1241-1251.2000; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kovalchuk LV, 2007, ADV EXP MED BIOL, V601, P369; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005489; Li QL, 2011, PEPTIDES, V32, P1518, DOI 10.1016/j.peptides.2011.05.015; Li Ying, 2005, Antiviral Chemistry & Chemotherapy, V16, P193; Long Y, 2009, J VIRAL HEPATITIS, V16, P537, DOI 10.1111/j.1365-2893.2009.01089.x; Lorin C, 2005, VIROLOGY, V334, P264, DOI 10.1016/j.virol.2005.02.002; McGibbon Emily, 2012, Morbidity and Mortality Weekly Report, V61, P6; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Torres HA, 2012, NAT REV CLIN ONCOL, V9, P156, DOI 10.1038/nrclinonc.2012.1; VanCompernolle SE, 2005, J VIROL, V79, P11598, DOI 10.1128/JVI.79.18.11598-11606.2005; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wang ZY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-128; Yan R, 2011, PEPTIDES, V32, P11, DOI 10.1016/j.peptides.2010.10.008; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Ying CX, 2007, P NATL ACAD SCI USA, V104, P8526, DOI 10.1073/pnas.0609883104; Yu XM, 2003, J VIROL, V77, P2489, DOI 10.1128/JVI.77.4.2489-2499.2003; Zheng YY, 2004, J VIROL, V78, P6908, DOI 10.1128/JVI.78.13.6908-6914.2004; Zheng YY, 2003, J VIROL, V77, P7707, DOI 10.1128/JVI.77.14.7707-7712.2003	39	48	55	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30181	30190		10.1074/jbc.M112.370312	http://dx.doi.org/10.1074/jbc.M112.370312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22791717	Green Published, hybrid			2022-12-25	WOS:000308579800013
J	Fang, CK; Chen, HW; Chiang, IT; Chen, CC; Liao, JF; Su, TP; Tung, CY; Uchitomi, Y; Hwang, JJ				Fang, Chun-Kai; Chen, Hong-Wen; Chiang, I-Tsang; Chen, Chia-Chieh; Liao, Jyh-Fei; Su, Ton-Ping; Tung, Chieh-Yin; Uchitomi, Yosuke; Hwang, Jeng-Jong			Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System	PLOS ONE			English	Article							TAIL SUSPENSION TEST; QUALITY-OF-LIFE; MAJOR DEPRESSION; CANCER-PATIENTS; HEALTHY-VOLUNTEERS; COLORECTAL-CANCER; COLON-CARCINOMA; ANTIDEPRESSANTS; MICE; INTERLEUKIN-12	To study the tumor inhibition effect of mirtazapine, a drug for patients with depression, CT26/luc colon carcinoma-bearing animal model was used. BALB/c mice were randomly divided into six groups: two groups without tumors, i.e. wild-type (no drug) and drug (mirtazapine), and four groups with tumors, i.e. never (no drug), always (pre-drug, i.e. drug treatment before tumor inoculation and throughout the experiment), concurrent (simultaneously tumor inoculation and drug treatment throughout the experiment), and after (post-drug, i.e. drug treatment after tumor inoculation and throughout the experiment). The "psychiatric" conditions of mice were observed from the immobility time with tail suspension and spontaneous motor activity post tumor inoculation. Significant increase of serum interlukin-12 (sIL-12) and the inhibition of tumor growth were found in mirtazapine-treated mice (always, concurrent, and after) as compared with that of never. In addition, interferon-gamma level and immunocompetent infiltrating CD4+/CD8+ T cells in the tumors of mirtazapine-treated, tumor-bearing mice were significantly higher as compared with that of never. Tumor necrosis factor-alpha (TNF-alpha) expressions, on the contrary, are decreased in the mirtazapine-treated, tumor-bearing mice as compared with that of never. Ex vivo autoradiography with [I-123] ADAM, a radiopharmaceutical for serotonin transporter, also confirms the similar results. Notably, better survival rates and intervals were also found in mirtazapine-treated mice. These findings, however, were not observed in the immunodeficient mice. Our results suggest that tumor growth inhibition by mirtazapine in CT26/luc colon carcinoma-bearing mice may be due to the alteration of the tumor microenvironment, which involves the activation of the immune response and the recovery of serotonin level.	[Fang, Chun-Kai; Chiang, I-Tsang; Tung, Chieh-Yin; Hwang, Jeng-Jong] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Fang, Chun-Kai] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Fang, Chun-Kai] Mackay Mem Hosp, Suicide Prevent Ctr, Taipei, Taiwan; [Chen, Hong-Wen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Hong-Wen] Mackay Mem Hosp, Hosp Palliat Care Ctr, Taipei, Taiwan; [Chen, Chia-Chieh] Inst Nucl Energy Res, Tao Yuan, Taiwan; [Liao, Jyh-Fei] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Su, Ton-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Uchitomi, Yosuke] Okayama Univ, Dept Neuropsychiat, Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Institute of Nuclear Energy Research - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Okayama University	Fang, CK (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	jjhwang@ym.edu.tw	Uchitomi, Yosuke/E-1463-2015		National Science Council, Taiwan [NSC100-2314-B-010-016]; University System of Taiwan [VGHUST98-P6-39]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); University System of Taiwan	This work was supported by grants from the National Science Council, Taiwan (NSC100-2314-B-010-016), and the University System of Taiwan (VGHUST98-P6-39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDUL N, 1995, J UROLOGY, V154, P247, DOI 10.1016/S0022-5347(01)67288-4; Anttila SAK, 2001, CNS DRUG REV, V7, P249; Arimochi H, 2006, EUR J PHARMACOL, V541, P17, DOI 10.1016/j.ejphar.2006.04.053; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cankurtaran ES, 2008, SUPPORT CARE CANCER, V16, P1291, DOI 10.1007/s00520-008-0425-1; Chow TH, 2008, NUCL MED BIOL, V35, P623, DOI 10.1016/j.nucmedbio.2008.04.001; Chow TH, 2009, J NUCL MED, V50, P2073, DOI 10.2967/jnumed.109.063503; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dazzi L, 2002, SYNAPSE, V43, P70, DOI 10.1002/syn.10024; De Berardis D, 2010, INT J IMMUNOPATH PH, V23, P417, DOI 10.1177/039463201002300204; Frick LR, 2008, BIOCHEM PHARMACOL, V75, P1817, DOI 10.1016/j.bcp.2008.01.015; Gil-Ad I, 2008, INT J ONCOL, V33, P277, DOI 10.3892/ijo_00000007; Gu T, 2010, CANCER RES, V70, P129, DOI 10.1158/0008-5472.CAN-09-3170; Heyes MP, 1997, BIOCHEM J, V326, P351, DOI 10.1042/bj3260351; Kast RE, 2007, EUR J CANCER CARE, V16, P351, DOI 10.1111/j.1365-2354.2006.00760.x; Kast RE, 2001, SUPPORT CARE CANCER, V9, P469, DOI 10.1007/s005200000215; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; Kim SW, 2008, PSYCHIAT CLIN NEUROS, V62, P75, DOI 10.1111/j.1440-1819.2007.01778.x; Kim YK, 2002, MOL PSYCHIATR, V7, P1107, DOI 10.1038/sj.mp.4001084; Kraus T, 2002, PHARMACOPSYCHIATRY, V35, P220, DOI 10.1055/s-2002-36390; Kubera M, 2006, PHARMACOL BIOCHEM BE, V85, P813, DOI 10.1016/j.pbb.2006.11.017; Lee KM, 2006, INT IMMUNOPHARMACOL, V6, P1298, DOI 10.1016/j.intimp.2006.03.015; Lin KH, 2002, NUCL MED BIOL, V29, P643, DOI 10.1016/S0969-8051(02)00323-2; Lin KJ, 2004, J NUCL MED, V45, P673; Lopez MC, 2000, J GEN VIROL, V81, P1175, DOI 10.1099/0022-1317-81-5-1175; Lutgendorf SK, 2010, J CLIN ONCOL, V28, P4094, DOI 10.1200/JCO.2009.26.9357; Maes M, 1999, NEUROPSYCHOPHARMACOL, V20, P370, DOI 10.1016/S0893-133X(98)00088-8; Marek GJ, 2003, NEUROPSYCHOPHARMACOL, V28, P402, DOI 10.1038/sj.npp.1300057; Miovic M, 2007, CANCER-AM CANCER SOC, V110, P1665, DOI 10.1002/cncr.22980; Moreno-Smith M, 2011, CLIN CANCER RES, V17, P3649, DOI 10.1158/1078-0432.CCR-10-2441; Mortarini R, 2000, CANCER RES, V60, P3559; Muller N, 2007, NERVENARZT, V78, P1261, DOI 10.1007/s00115-007-2311-3; Pan CC, 2006, CHINESE J PHYSIOL, V49, P290; Qi H, 2009, J NEURO-ONCOL, V94, P367, DOI 10.1007/s11060-009-9887-3; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Rakhit A, 1999, CLIN PHARMACOL THER, V65, P615, DOI 10.1016/S0009-9236(99)90083-8; Reich M, 2008, CURR OPIN ONCOL, V20, P353, DOI 10.1097/CCO.0b013e3282fc734b; Riechelmann RP, 2010, AM J HOSP PALLIAT ME, V27, P106, DOI 10.1177/1049909109345685; Rogoz Z, 2005, J PHYSIOL PHARMACOL, V56, P661; Rosetti M, 2006, J Exp Ther Oncol, V6, P23; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stockler MR, 2007, LANCET ONCOL, V8, P603, DOI 10.1016/S1470-2045(07)70148-1; Sutcigil L, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/76396; Szuster-Ciesielska A, 2003, POL J PHARMACOL, V55, P353; Theobald DE, 2002, J PAIN SYMPTOM MANAG, V23, P442, DOI 10.1016/S0885-3924(02)00381-0; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsai HC, 2009, PROG NEURO-PSYCHOPH, V33, P711, DOI 10.1016/j.pnpbp.2009.03.018; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Xu WN, 2006, LANCET ONCOL, V7, P301, DOI 10.1016/S1470-2045(06)70622-2	49	28	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e38886	10.1371/journal.pone.0038886	http://dx.doi.org/10.1371/journal.pone.0038886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808019	Green Published, Green Submitted, gold			2022-12-25	WOS:000306406700005
J	Hershey, T; Lugar, HM; Shimony, JS; Rutlin, J; Koller, JM; Perantie, DC; Paciorkowski, AR; Eisenstein, SA; Permutt, MA				Hershey, Tamara; Lugar, Heather M.; Shimony, Joshua S.; Rutlin, Jerrel; Koller, Jonathan M.; Perantie, Dana C.; Paciorkowski, Alex R.; Eisenstein, Sarah A.; Permutt, M. Alan		Washington Univ Wolfram Study Grp	Early Brain Vulnerability in Wolfram Syndrome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; VOXEL-BASED MORPHOMETRY; SYNDROME DIABETES-INSIPIDUS; SURFACE-BASED ANALYSIS; CEREBRAL WHITE-MATTER; BONE-MINERAL DENSITY; OPTIC ATROPHY; CHEMICAL CHAPERONES; INTRACRANIAL VOLUME; CORTICAL THICKNESS	Wolfram Syndrome (WFS) is a rare autosomal recessive disease characterized by insulin-dependent diabetes mellitus, optic nerve atrophy, diabetes insipidus, deafness, and neurological dysfunction leading to death in mid-adulthood. WFS is caused by mutations in the WFS1 gene, which lead to endoplasmic reticulum (ER) stress-mediated cell death. Case studies have found widespread brain atrophy in late stage WFS. However, it is not known when in the disease course these brain abnormalities arise, and whether there is differential vulnerability across brain regions and tissue classes. To address this limitation, we quantified regional brain abnormalities across multiple imaging modalities in a cohort of young patients in relatively early stages of WFS. Children and young adults with WFS were evaluated with neurological, cognitive and structural magnetic resonance imaging measures. Compared to normative data, the WFS group had intact cognition, significant anxiety and depression, and gait abnormalities. Compared to healthy and type 1 diabetic control groups, the WFS group had smaller intracranial volume and preferentially affected gray matter volume and white matter microstructural integrity in the brainstem, cerebellum and optic radiations. Abnormalities were detected in even the youngest patients with mildest symptoms, and some measures did not follow the typical age-dependent developmental trajectory. These results establish that WFS is associated with smaller intracranial volume with specific abnormalities in the brainstem and cerebellum, even at the earliest stage of clinical symptoms. This pattern of abnormalities suggests that WFS has a pronounced impact on early brain development in addition to later neurodegenerative effects, representing a significant new insight into the WFS disease process. Longitudinal studies will be critical for confirming and expanding our understanding of the impact of ER stress dysregulation on brain development.	[Hershey, Tamara; Lugar, Heather M.; Rutlin, Jerrel; Koller, Jonathan M.; Perantie, Dana C.; Eisenstein, Sarah A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hershey, Tamara] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Hershey, Tamara; Shimony, Joshua S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Permutt, M. Alan] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Paciorkowski, Alex R.] Washington Univ, Dept Neurol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hershey, T (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	tammy@npg.wustl.edu		Hershey, Tamara/0000-0001-7549-0698	Washington University; American Diabetes Association; George Decker and Julio V. Santiago Pediatric Diabetes Research Fund; Mallinckrodt Institute of Radiology Pilot Fund; National Institutes of Health [DK016746-39, DK064832, NCRR 1S10RR022984-01A1, UL1 RR024992, MH064769]; National Headache Foundation; McDonnell Center for Systems Neuroscience Small Grants Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070855] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022984, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016746, R01DK064832, P30DK020579, R37DK016746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064769] Funding Source: NIH RePORTER	Washington University; American Diabetes Association(American Diabetes Association); George Decker and Julio V. Santiago Pediatric Diabetes Research Fund; Mallinckrodt Institute of Radiology Pilot Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Headache Foundation; McDonnell Center for Systems Neuroscience Small Grants Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Jack and J. T. Snow Fund at Washington University, the American Diabetes Association, the George Decker and Julio V. Santiago Pediatric Diabetes Research Fund, the Mallinckrodt Institute of Radiology Pilot Fund, and the National Institutes of Health [grant numbers DK016746-39 to MAP, DK064832, NCRR 1S10RR022984-01A1 and UL1 RR024992]. Drs. Deanna Barch, Joan Luby, Kelly Botteron, Tammie Benzinger and Soe Mar provided access to many of the control subject scans. These scans were supported by the National Headache Foundation, the McDonnell Center for Systems Neuroscience Small Grants Program, and the National Institutes of Health [grant number MH064769]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Akiyama M, 2009, DIABETOLOGIA, V52, P653, DOI 10.1007/s00125-009-1270-6; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Barkovich AJ, 2009, BRAIN, V132, P3199, DOI 10.1093/brain/awp247; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Barrett TG, 1997, EYE, V11, P882, DOI 10.1038/eye.1997.226; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bjorntorp P, 2000, MATTER WHITE MATTER, P325; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; CARSON MJ, 1977, AM J DIS CHILD, V131, P1382, DOI 10.1001/archpedi.1977.02120250064010; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; D'Annunzio G, 2008, DIABETES CARE, V31, P1743, DOI 10.2337/dc08-0178; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Ferguson SC, 2003, DIABETES, V52, P149, DOI 10.2337/diabetes.52.1.149; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Fridlund A., 1994, CALIFORNIA VERBAL LE; Galluzzi P, 1999, NEURORADIOLOGY, V41, P729, DOI 10.1007/s002340050832; Genis D, 1997, ACTA NEUROPATHOL, V93, P426, DOI 10.1007/s004010050635; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; GREGORIOS JB, 1989, J NEUROPATH EXP NEUR, V48, P308, DOI 10.1097/00005072-198905000-00028; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Hilson JB, 2009, ACTA NEUROPATHOL, V118, P415, DOI 10.1007/s00401-009-0546-8; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; JACKSON MJ, 1994, DIABETES CARE, V17, P728, DOI 10.2337/diacare.17.7.728; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; KEHL O, 1982, SCHWEIZ MED WSCHR, V112, P348; Kerbrat A, 2012, NEUROLOGY, V78, P194, DOI 10.1212/WNL.0b013e318240799a; KHARDORI R, 1983, DIABETES CARE, V6, P67, DOI 10.2337/diacare.6.1.67; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee NJ, 2009, BRAIN RES, V1276, P77, DOI 10.1016/j.brainres.2009.04.027; Limperopoulos C, 2006, CURR OPIN PEDIATR, V18, P621, DOI 10.1097/MOP.0b013e32801080e8; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Macey PM, 2011, CEREB CORTEX; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Meda SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031913; Moorhead TWJ, 2005, NEUROIMAGE, V28, P544, DOI 10.1016/j.neuroimage.2005.04.045; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nickl-Jockschat T, 2009, NEUROCASE, V15, P47, DOI 10.1080/13554790802613009; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Pakdemirli E, 2005, Australas Radiol, V49, P189, DOI 10.1111/j.1440-1673.2005.01420.x; Perantie DC, 2007, DIABETES CARE, V30, P2331, DOI 10.2337/dc07-0351; Perantie DC, 2011, DIABETES, V60, P3006, DOI 10.2337/db11-0589; Pereira JB, 2011, HUM BRAIN MAPP; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220; Raud S, 2009, NEUROSCI LETT, V460, P138, DOI 10.1016/j.neulet.2009.05.054; REUHL KR, 1991, NEUROTOXICOLOGY, V12, P341; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Rigoli L, 2011, CLIN GENET, V79, P103, DOI 10.1111/j.1399-0004.2010.01522.x; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Scheel C, 2011, NEUROIMAGE, V58, P391, DOI 10.1016/j.neuroimage.2011.06.040; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Scolding NJ, 1996, ANN NEUROL, V39, P352, DOI 10.1002/ana.410390312; Sgouros S, 1999, J NEUROSURG, V91, P610, DOI 10.3171/jns.1999.91.4.0610; Shannon P, 1999, ACTA NEUROPATHOL, V98, P304, DOI 10.1007/s004010051084; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Sierra C, 2002, J HYPERTENS, V20, P519, DOI 10.1097/00004872-200203000-00028; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Wessels AM, 2006, DIABETOLOGIA, V49, P2474, DOI 10.1007/s00125-006-0283-7; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Woods BT, 2005, SCHIZOPHR RES, V73, P221, DOI 10.1016/j.schres.2004.05.014; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamamoto H, 2006, EXP EYE RES, V83, P1303, DOI 10.1016/j.exer.2006.06.010	101	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40604	10.1371/journal.pone.0040604	http://dx.doi.org/10.1371/journal.pone.0040604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792385	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400082
J	Schmidt, F; van den Eijnden, M; Gobert, RP; Saborio, GP; Carboni, S; Alliod, C; Pouly, S; Staugaitis, SM; Dutta, R; Trapp, B; van Huijsduijnen, RH				Schmidt, Fanny; van den Eijnden, Monique; Gobert, Rosanna Pescini; Saborio, Gabriela P.; Carboni, Susanna; Alliod, Chantal; Pouly, Sandrine; Staugaitis, Susan M.; Dutta, Ranjan; Trapp, Bruce; van Huijsduijnen, Rob Hooft			Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GROWTH-FACTOR RECEPTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ELEMENT-BINDING PROTEIN; MULTIPLE-SCLEROSIS; PRECURSOR CELLS; CNS REMYELINATION; PROGENITOR CELLS; MYELIN FORMATION; SORTING NEXIN-6	Multiple sclerosis (MS) is a neuroinflammatory disease characterized by a progressive loss of myelin and a failure of oligodendrocyte (OL)-mediated remyelination, particularly in the progressive phases of the disease. An improved understanding of the signaling mechanisms that control differentiation of OL precursors may lead to the identification of new therapeutic targets for remyelination in MS. About 100 mammalian Protein Tyrosine Phosphatases (PTPs) are known, many of which are involved in signaling both in health and disease. We have undertaken a systematic genomic approach to evaluate PTP gene activity in multiple sclerosis autopsies and in related in vivo and in vitro models of the disease. This effort led to the identification of Dusp15/VHY, a PTP previously believed to be expressed only in testis, as being transcriptionally regulated during OL differentiation and in MS lesions. Subsequent RNA interference studies revealed that Dusp15/VHY is a key regulator of OL differentiation. Finally, we identified PDGFR-beta and SNX6 as novel and specific Dusp15 substrates, providing an indication as to how this PTP might exert control over OL differentiation.	[Schmidt, Fanny; van den Eijnden, Monique; Gobert, Rosanna Pescini; Saborio, Gabriela P.; Carboni, Susanna; Alliod, Chantal; Pouly, Sandrine; van Huijsduijnen, Rob Hooft] Merck Serono SA, Geneva, Switzerland; [Staugaitis, Susan M.; Dutta, Ranjan; Trapp, Bruce] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA	Merck KGaA; EMD Serono Inc.; Cleveland Clinic Foundation	Schmidt, F (corresponding author), Merck Serono SA, Geneva, Switzerland.	rob.hooft@merckgroup.com	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Pescini Gobert, Rosanna/0000-0002-2434-7530	European Union Research Training Network [MRTN-CT-2006-035830]; National Institute of Neurological Disorders and Stroke (NINDS) [NS38667, NS35058]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038667, R01NS035058, P50NS038667] Funding Source: NIH RePORTER	European Union Research Training Network(European Commission); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	FS, MvdE and RHvH received funding from the European Union Research Training Network MRTN-CT-2006-035830. The study is supported by the National Institute of Neurological Disorders and Stroke (NINDS). NS38667 and NS35058 (SMS, RD and BT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, J BIOL CHEM, V279, P32586, DOI 10.1074/jbc.M403442200; Appolloni I, 2009, INT J CANCER, V124, P2251, DOI 10.1002/ijc.24206; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Bourikas D, 2010, MOL CELL NEUROSCI, V45, P363, DOI 10.1016/j.mcn.2010.07.009; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Eng LF, 1996, NEUROCHEM RES, V21, P511, DOI 10.1007/BF02527717; Espejo C, 2005, NEUROSCIENCE, V132, P1135, DOI 10.1016/j.neuroscience.2005.01.057; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fyffe-Maricich SL, 2011, J NEUROSCI, V31, P843, DOI 10.1523/JNEUROSCI.3239-10.2011; Gobert RP, 2009, J BIOL CHEM, V284, P11385, DOI 10.1074/jbc.M807241200; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0; Hao XB, 2011, CELL SIGNAL, V23, P935, DOI 10.1016/j.cellsig.2011.01.022; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hildreth KL, 2004, J BIOL CHEM, V279, P41775, DOI 10.1074/jbc.M403274200; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kim M, 2010, FEBS LETT, V584, P3923, DOI 10.1016/j.febslet.2010.08.034; Kippert A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-40; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Lafrenaye AD, 2010, J NEUROCHEM, V115, P269, DOI 10.1111/j.1471-4159.2010.06926.x; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; LUBETZKI C, 1993, P NATL ACAD SCI USA, V90, P6820, DOI 10.1073/pnas.90.14.6820; Massa PT, 2000, GLIA, V29, P376, DOI 10.1002/(SICI)1098-1136(20000215)29:4<376::AID-GLIA8>3.3.CO;2-J; Matesanz F, 2005, J NEUROL, V252, P994, DOI 10.1007/s00415-005-0795-y; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Morris PG, 2010, TARGET ONCOL, V5, P193, DOI 10.1007/s11523-010-0160-7; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Oya T, 2002, GLIA, V38, P303, DOI 10.1002/glia.10074; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Pereira GB, 2011, J NEUROSCI RES, V89, P1070, DOI 10.1002/jnr.22625; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; Schwertassek U, 2010, FEBS J, V277, P2463, DOI 10.1111/j.1742-4658.2010.07661.x; Selvaraju R, 2004, MOL CELL NEUROSCI, V25, P707, DOI 10.1016/j.mcn.2003.12.014; Shiga H, 2005, NEUROSCI RES, V53, P436, DOI 10.1016/j.neures.2005.09.004; Shiga H, 2005, J NEUROSCI RES, V80, P767, DOI 10.1002/jnr.20513; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; SMITS A, 1993, EUR J NEUROSCI, V5, P986, DOI 10.1111/j.1460-9568.1993.tb00950.x; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Storch MK, 1996, NEUROSCIENCE, V71, P885, DOI 10.1016/0306-4522(95)00476-9; Syed YA, 2011, J NEUROSCI, V31, P3719, DOI 10.1523/JNEUROSCI.4930-10.2011; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Torisu R, 2011, BRAIN TUMOR PATHOL, V28, P33, DOI 10.1007/s10014-010-0006-0; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu JH, 2005, J BIOL CHEM, V280, P31027, DOI 10.1074/jbc.M501473200; Yamazaki T, 2009, J PERIPHER NERV SYST, V14, P165, DOI 10.1111/j.1529-8027.2009.00228.x	70	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40457	10.1371/journal.pone.0040457	http://dx.doi.org/10.1371/journal.pone.0040457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792334	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400057
J	Barisone, GA; Ngo, T; Tran, M; Cortes, D; Shahi, MH; Nguyen, TV; Perez-Lanza, D; Matayasuwan, W; Diaz, E				Barisone, Gustavo A.; Tin Ngo; Martin Tran; Cortes, Daniel; Shahi, Mehdi H.; Tuong-Vi Nguyen; Perez-Lanza, Daniel; Matayasuwan, Wanna; Diaz, Elva			Role of MXD3 in Proliferation of DAOY Human Medulloblastoma Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; PRECURSOR PROLIFERATION; INDUCED APOPTOSIS; GENE-EXPRESSION; SONIC HEDGEHOG; MAD FAMILY; IN-VIVO; MYC; DIFFERENTIATION; GROWTH	A subset of medulloblastomas, the most common brain tumor in children, is hypothesized to originate from granule neuron precursors (GNPs) in which the sonic hedgehog (SHH) pathway is over-activated. MXD3, a basic helix-look-helix zipper transcription factor of the MAD family, has been reported to be upregulated during postnatal cerebellar development and to promote GNP proliferation and MYCN expression. Mxd3 is upregulated in mouse models of medulloblastoma as well as in human medulloblastomas. Therefore, we hypothesize that MXD3 plays a role in the cellular events that lead to medulloblastoma biogenesis. In agreement with its proliferative role in GNPs, MXD3 knock-down in DAOY cells resulted in decreased proliferation. Sustained overexpression of MXD3 resulted in decreased cell numbers due to increased apoptosis and cell cycle arrest. Structure-function analysis revealed that the Sin3 interacting domain, the basic domain, and binding to E-boxes are essential for this activity. Microarray-based expression analysis indicated up-regulation of 84 genes and down-regulation of 47 genes. Potential direct MXD3 target genes were identified by ChIP-chip. Our results suggest that MXD3 is necessary for DAOY medulloblastoma cell proliferation. However, increased level and/or duration of MXD3 expression ultimately reduces cell numbers via increased cell death and cell cycle arrest.	[Barisone, Gustavo A.; Tin Ngo; Martin Tran; Cortes, Daniel; Shahi, Mehdi H.; Tuong-Vi Nguyen; Perez-Lanza, Daniel; Matayasuwan, Wanna; Diaz, Elva] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Barisone, GA (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.	ediaz@ucdavis.edu			James S. McDonnell Foundation [220020074.01]; National Institutes of Health [DP2 OD006479-01]; California Institute of Regenerative Medicine; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006479] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants to ED. from the James S. McDonnell Foundation (220020074.01) and the National Institutes of Health Director's New Innovator Award Program (DP2 OD006479-01) and by a postdoctoral fellowship to GAB from the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Amin MA, 2007, BIOCHEM BIOPH RES CO, V360, P320, DOI 10.1016/j.bbrc.2007.06.092; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Barisone GA, 2008, CELL CYCLE, V7, P423, DOI 10.4161/cc.7.4.5413; Barrio S, 2011, J CLIN PATHOL; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Chen XR, 2010, WORLD J GASTROENTERO, V16, P1409, DOI 10.3748/wjg.v16.i11.1409; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; COLLINS VP, 1995, GLIA, V15, P289, DOI 10.1002/glia.440150309; CROUCH DH, 1993, ONCOGENE, V8, P1849; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; EISENMAN RE, 2006, MYC MAX MAD TRANSCRI; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FISHER F, 1993, EMBO J, V12, P5075, DOI 10.1002/j.1460-2075.1993.tb06201.x; Foley KP, 1998, EMBO J, V17, P774, DOI 10.1093/emboj/17.3.774; Fox EJ, 2001, BIOCHEM J, V359, P361, DOI 10.1042/0264-6021:3590361; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gore Y, 2010, MOL BIOL CELL, V21, P1864, DOI 10.1091/mbc.E09-09-0813; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; Komashko VM, 2008, GENOME RES, V18, P521, DOI 10.1101/gr.074609.107; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; McCabe MG, 2006, J NEUROPATH EXP NEUR, V65, P549, DOI 10.1097/00005072-200606000-00003; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Migheli A, 1999, AM J PATHOL, V155, P365, DOI 10.1016/S0002-9440(10)65133-4; Nair SK, 2006, CURR TOP MICROBIOL, V302, P123; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nasir A, 2011, PANCREAS, V40, P627, DOI 10.1097/MPA.0b013e3182152bda; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Piya S, 2011, MOL CANC RES; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Queva C, 1998, ONCOGENE, V16, P967, DOI 10.1038/sj.onc.1201611; Queva C, 2001, MOL CELL BIOL, V21, P703, DOI 10.1128/MCB.21.3.703-712.2001; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sibella-Arguelles C, 2001, CR ACAD SCI III-VIE, V324, P365, DOI 10.1016/S0764-4469(00)01300-7; Steiger D, 2008, NAT GENET, V40, P1084, DOI 10.1038/ng.178; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Yun JS, 2007, MOL CELL BIOL, V27, P8178, DOI 10.1128/MCB.00656-06	50	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38508	10.1371/journal.pone.0038508	http://dx.doi.org/10.1371/journal.pone.0038508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808009	Green Published, gold			2022-12-25	WOS:000306355500004
J	Tchinda, GG; Atashili, J; Achidi, EA; Kamga, HL; Njunda, AL; Ndumbe, PM				Tchinda, Gervais Gouana; Atashili, Julius; Achidi, Eric A.; Kamga, Henri L.; Njunda, Anna L.; Ndumbe, Peter M.			Impact of Malaria on Hematological Parameters in People Living with HIV/AIDS Attending the Laquintinie Hospital in Douala, Cameroon	PLOS ONE			English	Article							INFECTION; HIV	Background: People living with HIV/AIDS (PLWHA) frequently have abnormal blood counts including anemia, leucopenia and thrombocytopenia. The role of infection with plasmodia on these hematological parameters in PLWHA is not well known. In this study we compared selected hematological parameters between malaria positive and negative PLWHA. Methods: We conducted a cross-sectional study of PLWHA attending the Douala Laquintinie hospital. After obtaining consent, demographic and clinical data were obtained via a standardized questionnaire. Blood samples collected for hematological assays were run using an automated full blood counter. Malaria parasitaemia was determined by blood smear microscopy. Results: A total of 238 adult PLWHA were enrolled, 48.3% of who were on antiretroviral therapy and 24.8% of whom had malaria parasitaemia. The respective mean (+/- SD) of hemoglobin level, RBC count, WBC count, platelet count, lymphocyte count and CD4+ T cell counts in malaria co-infected patients versus non-infected patients were: 10.8(+/- 1.9) g/dl versus 11.4(+/- 2.0) g/dl; 3,745,254(+/- 793,353) cells/mu l versus 3,888,966(+/- 648,195) cells/mu l; 4,403(+/- 1,534) cells/mu l versus 4,920(+/- 1,922) cells/mu l; 216,051(+/- 93,884) cells/mu l versus 226,792(+/- 98,664) cells/mu l; 1,846(+/- 711) cells/mu l versus 2,052(+/- 845) cells/mu l and 245(+/- 195) cells/mu l versus 301(+/- 211) cells/mu l. All these means were not statistically significantly different from each other. Conclusion: There was no significant difference in studied hematological parameters between malaria positive and negative PLWHA. These data suggest little or no impact of malaria infection. Hematological anomalies in PLWHA in this area need not be necessarily attributed to malaria. These need to be further investigated to identify and treat other potential causes.	[Tchinda, Gervais Gouana; Achidi, Eric A.; Kamga, Henri L.; Njunda, Anna L.] Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, Cameroon; [Atashili, Julius] Univ Buea, Fac Hlth Sci, Dept Publ Hlth & Hyg, Buea, Cameroon; [Ndumbe, Peter M.] Univ Buea, Fac Hlth Sci, Dept Biomed Sci, Buea, Cameroon		Tchinda, GG (corresponding author), Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, Cameroon.	atashili@yahoo.ie			European and Developing Countries Trial Partnership (EDCTP)	European and Developing Countries Trial Partnership (EDCTP)	Dr. Atashili, Dr. Achidi and Dr. Ndumbe's work was partially supported by a grant from the European and Developing Countries Trial Partnership (EDCTP) to the Central African Network against Tuberculosis AIDS and Malaria (CANTAM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili Suresh Venkata Satya, 2008, Turk J Haematol, V25, P13; Audu R. A., 2005, Annals of African Medicine, V4, P10; Bashawri LAM, 2002, ANN SAUDI MED, V22, P372, DOI 10.5144/0256-4947.2002.372; Cheesbrougu M, 2006, DISTRICT LAB PRACTIC, V2nd, P319; Erhabor O, 2006, NIGERIAN J MED, V15; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Goselle ON, 2009, J VECTOR DIS, V46, P205; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; MULLER O, 1990, T ROY SOC TROP MED H, V84, P336, DOI 10.1016/0035-9203(90)90306-Y; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nkuo-Akenji T, 2008, AJAR-AFR J AIDS RES, V7, P229, DOI 10.2989/AJAR.2008.7.2.8.525; Richards MW, 1998, AM J TROP MED HYG, V59, P859, DOI 10.4269/ajtmh.1998.59.859; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Van Geertruyden JP, 2006, JAIDS-J ACQ IMM DEF, V43, P363; WHO, 2011, WORLD MALARIA REPORT 2011, P1	17	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40553	10.1371/journal.pone.0040553	http://dx.doi.org/10.1371/journal.pone.0040553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802967	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500055
J	Scartozzi, M; Loretelli, C; Galizia, E; Mandolesi, A; Pistelli, M; Bittoni, A; Giampieri, R; Faloppi, L; Bianconi, M; Del Prete, M; Bianchi, F; Belvederesi, L; Bearzi, I; Cascinu, S				Scartozzi, Mario; Loretelli, Cristian; Galizia, Eva; Mandolesi, Alessandra; Pistelli, Mirco; Bittoni, Alessandro; Giampieri, Riccardo; Faloppi, Luca; Bianconi, Maristella; Del Prete, Michela; Bianchi, Francesca; Belvederesi, Laura; Bearzi, Italo; Cascinu, Stefano			Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients	PLOS ONE			English	Article							PERITONEAL CARCINOMATOSIS; GENE; EXPRESSION; POLYMORPHISMS; ASSOCIATION; CELLS; ADENOCARCINOMA; ANGIOGENESIS; CHEMOTHERAPY; MECHANISMS	In radically resected gastric cancer the possibility to predict the site of relapse could be clinically relevant for the selection of post-surgical management. We previously showed that specific tumour integrins genotypes are independently associated with either peritoneal or hematogenous metastases (ITGA and ITGV). Recently VEGF and VEGF-R polymorphisms have been demonstrated to potentially affect tumour angiogenesis and the metastatic process in gastric cancer. We then investigated the role of VEGFs and VEGF-R genotyping in determining either peritoneal carcinosis or hematogenous metastases in radically resected gastric cancer patients. Tumour genotyping for integrins (ITGA and ITGV) was also performed according to our previous findings. Genotyping for VEGF-A, VEGF-C, VEGFR-1,2,3 and ITGA and ITGV was carried out on pT4a radically resected gastric tumours recurring with either peritoneal-only carcinosis or hematogenous metastases. 101 patients fulfilled the inclusion criteria: 57 with peritoneal carcinomatosis only and 44 with hematogenous spread only. At multivariate analysis, intestinal histology and the AC genotype of rs699947 (VEGFA) showed to independently correlate with hematogenous metastases (p = 0.0008 and 0.008 respectively), whereas diffuse histology and the AA genotype of rs2269772 (ITGA) independently correlated with peritoneal-only diffusion (p = <0.0001 and 0.03 respectively). Our results seem to indicate that combining information from genotyping of rs699947 (VEGFA, AC), rs2269772 (ITGA, AA) and tumour histology could allow clinicians to individuate gastric cancer at high risk for recurrence either with peritoneal or hematogenous metastases. The selection tool deriving from this analysis may allow an optimal use of the available treatment strategies in these patients.	[Scartozzi, Mario; Giampieri, Riccardo; Cascinu, Stefano] Univ Politecn Marche, Clin Oncol Med, AO Osped Riuniti, Ancona, Italy; [Loretelli, Cristian; Bianchi, Francesca; Belvederesi, Laura] Univ Politecn Marche, Ctr Regionale Genet Oncol, AO Osped Riuniti, Ancona, Italy; [Galizia, Eva] Osped Profili, Fabriano, Italy; [Pistelli, Mirco; Bittoni, Alessandro; Faloppi, Luca; Bianconi, Maristella; Del Prete, Michela] Univ Politecn Marche, Scuola Specializzaz Oncol, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Scartozzi, M (corresponding author), Univ Politecn Marche, Clin Oncol Med, AO Osped Riuniti, Ancona, Italy.	marioscartozzi@gmail.com	Cascinu, Stefano/G-2399-2017; Cascinu, Stefano/AAN-1923-2020; Loretelli, Cristian/AAO-7678-2020; Faloppi, Luca/K-1030-2016	Cascinu, Stefano/0000-0003-2215-0731; Faloppi, Luca/0000-0003-3689-3085; Loretelli, Cristian/0000-0002-7583-8540; SCARTOZZI, MARIO/0000-0001-5977-5546; Bianconi, Maristella/0000-0003-3475-2529; Pistelli, Mirco/0000-0002-9289-8537				Bando E, 1999, AM J SURG, V178, P256, DOI 10.1016/S0002-9610(99)00162-2; Bozzetti F, 2008, J SURG ONCOL, V98, P273, DOI 10.1002/jso.21052; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carter AM, 2002, THROMB HAEMOSTASIS, V87, P846, DOI 10.1055/s-0037-1613095; Ceelen WP, 2009, LANCET ONCOL, V10, P72, DOI 10.1016/S1470-2045(08)70335-8; Chen MH, 2011, PHARMACOGENOMICS J, V11, P227, DOI 10.1038/tpj.2010.48; Day DA, 1998, J ENDOCRINOL, V157, P361, DOI 10.1677/joe.0.1570361; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Formento JL, 2009, PHARMACOGENOMICS, V10, P1277, DOI [10.2217/pgs.09.54, 10.2217/PGS.09.54]; Fujiwara Y, 2007, GASTRIC CANCER, V10, P197, DOI 10.1007/s10120-007-0436-5; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Glehen O, 2004, LANCET ONCOL, V5, P219, DOI 10.1016/S1470-2045(04)01425-1; Hansen TF, 2011, PHARMACOGENOMICS J, V11, P53, DOI 10.1038/tpj.2010.4; Hansen TF, 2010, VIRCHOWS ARCH, V456, P251, DOI 10.1007/s00428-009-0878-8; Hesketh J, 2004, BIOCHEM SOC T, V32, P990, DOI 10.1042/BST0320990; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang JL, 2004, HUM MOL GENET, V13, P2691, DOI 10.1093/hmg/ddh279; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kim JG, 2007, ANN ONCOL, V18, P1030, DOI 10.1093/annonc/mdm085; Kitadai Y, 2010, J ONCOL, V2010, DOI 10.1155/2010/468725; Kodama M, 2008, CLIN CANCER RES, V14, P7205, DOI 10.1158/1078-0432.CCR-08-0818; Krippl P, 2003, INT J CANCER, V106, P468, DOI 10.1002/ijc.11238; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Scartozzi M, 2011, ANN ONCOL, V22, P897, DOI 10.1093/annonc/mdq542; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Smyth SS, 2002, J CELL BIOL, V158, P17, DOI 10.1083/jcb.200202100; Takahashi Y, 1996, CLIN CANCER RES, V2, P1679; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Yamamoto S, 1998, PATHOL INT, V48, P499, DOI 10.1111/j.1440-1827.1998.tb03940.x; Yan TD, 2007, ANN SURG ONCOL, V14, P2702, DOI 10.1245/s10434-007-9487-4; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhao R, 2010, CANCER LETT, V287, P150, DOI 10.1016/j.canlet.2009.06.006	35	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38192	10.1371/journal.pone.0038192	http://dx.doi.org/10.1371/journal.pone.0038192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808003	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700001
J	Chang, XL; Nick, P				Chang, Xiaoli; Nick, Peter			Defence Signalling Triggered by Flg22 and Harpin Is Integrated into a Different Stilbene Output in Vitis Cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; ACTIVATED PROTEIN-KINASE; DISEASE RESISTANCE; GENE-EXPRESSION; OXIDATIVE BURST; HYDROGEN-PEROXIDE; BOTRYTIS-CINEREA; HOST-DEFENSE; PLANT; ARABIDOPSIS	Plants can activate defence to pathogen attack by two layers of innate immunity: basal immunity triggered by pathogen-associated molecular pattern (PAMP) triggered immunity (PTI) and effector-triggered immunity (ETI) linked with programmed cell death. Flg22 and Harpin are evolutionary distinct bacterial PAMPs. We have previously shown that Harpin triggers hypersensitive cell death mimicking ETI in Vitis rupestris, but not in the Vitis vinifera cultivar 'Pinot Noir'. In contrast, the bacterial PAMP flg22 activating PTI does not trigger cell death. To get insight into the defence signalling triggered by flg22 and Harpin, we compared cellular responses upon flg22 and Harpin treatment in the two Vitis cell lines. We found that extracellular alkalinisation was blocked by inhibition of calcium influx, and modulated by pharmacological manipulation of the cytoskeleton and mitogen-activated protein kinase activity with quantitative differences between cell lines and type of PAMPs. In addition, an oxidative burst was detected that was much stronger and faster in response to Harpin as compared to flg22. In V. rupestris, both flg22 and Harpin induced transcripts of defence-related genes including stilbene synthase, microtubule disintegration and actin bundling in a similar way, whereas they differed in V. vinifera cv. 'Pinot Noir'. In contrast to Harpin, flg22 failed to trigger significant levels of the stilbene trans-resveratrol, and did not induce hypersensitive cell death even in the highly responsive V. rupestris. We discuss these data in a model, where flg22- and Harpin-triggered defence shares a part of early signal components, but differs in perception, oxidative burst, and integration into a qualitatively different stilbene output, such that for flg22 a basal PTI is elicited in both cell lines, while Harpin induces cell death mimicking an ETI-like pattern of defence.	[Chang, Xiaoli; Nick, Peter] Karlsruhe Inst Technol, Inst Bot 1, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Chang, XL (corresponding author), Karlsruhe Inst Technol, Inst Bot 1, Karlsruhe, Germany.	chang.xiaoli@bio.uni-karlsruhe.de						Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Adrian M, 1997, J CHEM ECOL, V23, P1689, DOI 10.1023/B:JOEC.0000006444.79951.75; Aslam SN, 2009, MOL PLANT PATHOL, V10, P375, DOI [10.1111/j.1364-3703.2009.00537.x, 10.1111/J.1364-3703.2009.00537.X]; Aziz A, 2004, PLANTA, V218, P767, DOI 10.1007/s00425-003-1153-x; BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Belhadj A, 2008, PLANT PHYSIOL BIOCH, V46, P493, DOI 10.1016/j.plaphy.2007.12.001; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bruno G, 2006, PHYSIOL MOL PLANT P, V69, P182, DOI 10.1016/j.pmpp.2007.04.006; Casagrande K, 2011, PLANTA, V234, P1097, DOI 10.1007/s00425-011-1461-5; Celimene CC, 2001, PHYTOCHEMISTRY, V56, P161, DOI 10.1016/S0031-9422(00)00384-8; Chang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026405; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Di Gaspero G, 2003, MOL GENET GENOMICS, V269, P612, DOI 10.1007/s00438-003-0884-5; DING JP, 1993, PLANT J, V3, P83, DOI 10.1111/j.1365-313X.1993.tb00013.x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; Haapalainen M, 2011, MOL PLANT PATHOL, V12, P151, DOI 10.1111/j.1364-3703.2010.00655.x; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hohenberger P, 2011, BBA-BIOMEMBRANES, V1808, P2304, DOI 10.1016/j.bbamem.2011.05.019; Holley SR, 2003, PLANT PHYSIOL, V132, P1728, DOI 10.1104/pp.103.024414; Ichinose Y, 2001, PLANT PHYSIOL BIOCH, V39, P771, DOI 10.1016/S0981-9428(01)01300-6; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Komis G, 2011, CURR OPIN PLANT BIOL, V14, P650, DOI 10.1016/j.pbi.2011.07.008; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; Lai ZB, 2011, PLANT J, V66, P953, DOI 10.1111/j.1365-313X.2011.04553.x; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LANGCAKE P, 1981, PHYSIOL PLANT PATHOL, V18, P213; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Maisch J, 2007, PLANT PHYSIOL, V143, P1695, DOI 10.1104/pp.106.094052; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nick P, 2011, SIGNAL COMMUN PLANTS, P53, DOI 10.1007/978-3-642-19091-9_3; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 1999, CELL MOL LIFE SCI, V55, P167, DOI 10.1007/s000180050283; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Pezet R, 2004, PHYSIOL MOL PLANT P, V65, P297, DOI 10.1016/j.pmpp.2005.03.002; Pezet R, 2004, VITIS, V43, P145; Poinssot B, 2003, MOL PLANT MICROBE IN, V16, P553, DOI 10.1094/MPMI.2003.16.6.553; Qiao F, 2010, J EXP BOT, V61, P4021, DOI 10.1093/jxb/erq221; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Tampakaki AP, 2010, ANNU REV PHYTOPATHOL, V48, P347, DOI 10.1146/annurev-phyto-073009-114407; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TROPF S, 1994, J MOL EVOL, V38, P610; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Vandelle E, 2006, MOL PLANT MICROBE IN, V19, P429, DOI 10.1094/MPMI-19-0429; Wang SH, 2011, PLANT CELL, V23, P3412, DOI 10.1105/tpc.111.089920; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Yalamanchili RD, 2002, J BIOL CHEM, V277, P28424, DOI 10.1074/jbc.M203844200; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	81	46	47	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40446	10.1371/journal.pone.0040446	http://dx.doi.org/10.1371/journal.pone.0040446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792328	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800087
J	Kuo, YJ; Tsuang, FY; Sun, JS; Lin, CH; Chen, CH; Li, JY; Huang, YC; Chen, WY; Yeh, CB; Shyu, JF				Kuo, Yi-Jie; Tsuang, Fon-Yih; Sun, Jui-Sheng; Lin, Chi-Hung; Chen, Chia-Hsien; Li, Jia-Ying; Huang, Yi-Chian; Chen, Wei-Yu; Yeh, Chin-Bin; Shyu, Jia-Fwu			Calcitonin Inhibits SDCP-Induced Osteoclast Apoptosis and Increases Its Efficacy in a Rat Model of Osteoporosis	PLOS ONE			English	Article							SINTERED DICALCIUM PYROPHOSPHATE; MOLECULAR-MECHANISMS; OVARIECTOMIZED RATS; SALMON-CALCITONIN; BONE-FORMATION; IN-VITRO; BISPHOSPHONATES; METABOLISM; SURVIVAL; OSTEOBLASTS	Introduction: Treatment for osteoporosis commonly includes the use of bisphosphonates. Serious side effects of these drugs are caused by the inhibition of bone resorption as a result of osteoclast apoptosis. Treatment using calcitonin along with bisphosphonates overcomes these side-effects in some patients. Calcitonin is known to inhibit bone resorption without reducing the number of osteoclasts and is thought to prolong osteoclast survival through the inhibition of apoptosis. Further understanding of how calcitonin inhibits apoptosis could prove useful to the development of alternative treatment regimens for osteoporosis. This study aimed to analyze the mechanism by which calcitonin influences osteoclast apoptosis induced by a bisphosphate analog, sintered dicalcium pyrophosphate (SDCP), and to determine the effects of co-treatment with calcitonin and SDCP on apoptotic signaling in osteoclasts. Methods: Isolated osteoclasts were treated with CT, SDCP or both for 48 h. Osteoclast apoptosis assays, pit formation assays, and tartrate-resistant acid phosphatase (TRAP) staining were performed. Using an osteoporosis rat model, ovariectomized (OVX) rats received calcitonin, SDCP, or calcitonin + SDCP. The microarchitecture of the fifth lumbar trabecular bone was investigated, and histomorphometric and biochemical analyses were performed. Results: Calcitonin inhibited SDCP-induced apoptosis in primary osteoclast cultures, increased Bcl-2 and Erk activity, and decreased Mcl-1 activity. Calcitonin prevented decreased osteoclast survival but not resorption induced by SDCP. Histomorphometric analysis of the tibia revealed increased bone formation, and microcomputed tomography of the fifth lumbar vertebrate showed an additive effect of calcitonin and SDCP on bone volume. Finally, analysis of the serum bone markers CTX-I and P1NP suggests that the increased bone volume induced by co-treatment with calcitonin and SDCP may be due to decreased bone resorption and increased bone formation. Conclusions: Calcitonin reduces SDCP-induced osteoclast apoptosis and increases its efficacy in an in vivo model of osteoporosis.	[Kuo, Yi-Jie] Taipei Med Univ Hosp, Dept Orthopaed, Taipei, Taiwan; [Kuo, Yi-Jie] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Sun, Jui-Sheng] Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Hsinchu, Taiwan; [Sun, Jui-Sheng] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Chi-Hung; Chen, Chia-Hsien] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Li, Jia-Ying; Chen, Wei-Yu; Shyu, Jia-Fwu] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Huang, Yi-Chian] Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei 112, Taiwan; [Yeh, Chin-Bin; Shyu, Jia-Fwu] Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; National Yang Ming Chiao Tung University; National Defense Medical Center; National Yang Ming Chiao Tung University; Tri-Service General Hospital	Kuo, YJ (corresponding author), Taipei Med Univ Hosp, Dept Orthopaed, Taipei, Taiwan.	jiafwu.shyu@msa.hinet.net		Tsuang, Fon-Yih/0000-0001-5797-1885; SUN, JUI-SHENG/0000-0001-5142-8777	National Defense Medical Center of Medical Research Grants [DOD-100-C-11-02]; Tri-Service General Hospital of Medical Research Grants [TSGH-C99-011-12-S03]	National Defense Medical Center of Medical Research Grants; Tri-Service General Hospital of Medical Research Grants	This work was funded by National Defense Medical Center of Medical Research Grants (DOD-100-C-11-02) and Tri-Service General Hospital of Medical Research Grants (TSGH-C99-011-12-S03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; CHAMBERS TJ, 1984, J ENDOCRINOL, V102, P281, DOI 10.1677/joe.0.1020281; Davey RA, 2005, J BONE MINER METAB, V23, P359, DOI 10.1007/s00774-005-0613-8; Davey RA, 2008, J BONE MINER RES, V23, P1182, DOI 10.1359/JBMR.080310; de Paula FJA, 2010, HORM METAB RES, V42, P299, DOI 10.1055/s-0030-1248255; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Furuichi H, 2000, BIOL PHARM BULL, V23, P946; Gallagher JC, 2010, MATURITAS, V65, P301, DOI 10.1016/j.maturitas.2010.01.002; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; Horne WC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P221, DOI 10.1016/B978-0-12-373884-4.00031-8; Huebner AK, 2008, ARCH BIOCHEM BIOPHYS, V473, P210, DOI 10.1016/j.abb.2008.02.013; Huebner AK, 2006, J BONE MINER RES, V21, P1924, DOI 10.1359/JBMR.060820; Iwamoto Jun, 2009, Ther Clin Risk Manag, V5, P499; Kanaoka K, 2000, ENDOCRINOLOGY, V141, P2995, DOI 10.1210/en.141.8.2995; Karsdal MA, 2008, BIODRUGS, V22, P137, DOI 10.2165/00063030-200822030-00001; Lin CL, 1996, GASTROENTEROLOGY, V111, P1263, DOI 10.1053/gast.1996.v111.pm8898640; LIN FH, 1995, BIOMATERIALS, V16, P793, DOI 10.1016/0142-9612(95)99642-Y; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mochizuki K, 2000, J BONE MINER METAB, V18, P194, DOI 10.1007/s007740070020; Ogawa K, 2005, J BONE MINER METAB, V23, P351, DOI 10.1007/s00774-005-0612-9; Ozoran K., 2007, APLAR J RHEUMATOL, V10, P17; Penolazzi L, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-59; Rogers MJ, 2011, BONE, V49, P34, DOI 10.1016/j.bone.2010.11.008; Rogers MJ, 1999, BONE, V24, p73S, DOI 10.1016/S8756-3282(99)00070-8; Selander KS, 1996, MOL CELL ENDOCRINOL, V122, P119, DOI 10.1016/0303-7207(96)03870-1; Shyu JF, 2007, BONE, V40, P1329, DOI 10.1016/j.bone.2007.01.014; Stern PH, 2007, J CELL BIOCHEM, V101, P1087, DOI 10.1002/jcb.21311; Sun JS, 1999, ARTIF ORGANS, V23, P331, DOI 10.1046/j.1525-1594.1999.06235.x; Sun JS, 2003, J BIOMED MATER RES A, V64A, P616, DOI 10.1002/jbm.a.10439; Sun JS, 2002, J BIOMED MATER RES, V59, P246, DOI 10.1002/jbm.1238; Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N; Sutherland KA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2681; Tanaka S, 2010, ADV EXP MED BIOL, V658, P111, DOI 10.1007/978-1-4419-1050-9_12; Woodrow JP, 2006, ENDOCRINOLOGY, V147, P4010, DOI 10.1210/en.2005-1616; ZAIDI M, 1990, J ENDOCRINOL INVEST, V13, P119, DOI 10.1007/BF03349520	41	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40272	10.1371/journal.pone.0040272	http://dx.doi.org/10.1371/journal.pone.0040272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792258	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800059
J	van't Hoog, AH; Meme, HK; Laserson, KF; Agaya, JA; Muchiri, BG; Githui, WA; Odeny, LO; Marston, BJ; Borgdorff, MW				van't Hoog, Anna H.; Meme, Helen K.; Laserson, Kayla F.; Agaya, Janet A.; Muchiri, Benson G.; Githui, Willie A.; Odeny, Lazarus O.; Marston, Barbara J.; Borgdorff, Martien W.			Screening Strategies for Tuberculosis Prevalence Surveys: The Value of Chest Radiography and Symptoms	PLOS ONE			English	Article							INFECTIOUS TUBERCULOSIS; PULMONARY TUBERCULOSIS; TRIBAL POPULATION; BURDEN; HIV; COMMUNITY; DIAGNOSIS; HARARE; YIELD; INDIA	Background: We conducted a tuberculosis (TB) prevalence survey and evaluated the screening methods used in our survey, to assess if screening in TB prevalence surveys could be simplified, and to assess the accuracy of screening algorithms that may be applicable for active case finding. Methods: All participants with a positive screen on either a symptom questionnaire, chest radiography (CXR) and/or sputum smear microscopy submitted sputum for culture. HIV status was obtained from prevalent cases. We estimated the accuracy of modified screening strategies with bacteriologically confirmed TB as the gold standard, and compared these with other survey reports. We also assessed whether sequential rather than parallel application of symptom, CXR and HIV screening would substantially reduce the number of participants requiring CXR and/or sputum culture. Results: Presence of any abnormality on CXR had 94% (95%CI 88-98) sensitivity (92% in HIV-infected and 100% in HIV-uninfected) and 73% (95%CI 68-77) specificity. Symptom screening combinations had significantly lower sensitivity than CXR except for 'any TB symptom' which had 90% (95%CI 84-95) sensitivity (96% in HIV-infected and 82% in HIV-uninfected) and 32% (95%CI 30-34) specificity. Smear microscopy did not yield additional suspects, thus the combined symptom/CXR screen applied in the survey had 100% (95%CI 97-100) sensitivity. Specificity was 65% (95%CI 61-68). Sequential application of first a symptom screen for 'any symptom', followed by CXR-evaluation and different suspect criteria depending on HIV status would result in the largest reduction of the need for CXR and sputum culture, approximately 36%, but would underestimate prevalence by 11%. Conclusion: CXR screening alone had higher accuracy compared to symptom screening alone. Combined CXR and symptom screening had the highest sensitivity and remains important for suspect identification in TB prevalence surveys in settings where bacteriological sputum examination of all participants is not feasible.	[van't Hoog, Anna H.; Laserson, Kayla F.; Agaya, Janet A.; Muchiri, Benson G.; Odeny, Lazarus O.] Kenya Govt Med Res Ctr, Ctr Dis Control Res & Publ Hlth Collaborat, Kisumu, Kenya; [van't Hoog, Anna H.; Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Meme, Helen K.; Githui, Willie A.] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya; [Laserson, Kayla F.; Marston, Barbara J.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA	Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	van't Hoog, AH (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control Res & Publ Hlth Collaborat, Kisumu, Kenya.	a.h.vanthoog@amc.uva.nl	Odeny, Lazarus/CAF-6591-2022		US President's Emergency Plan For AIDS Relief; United States Agency for International Development through John's Hopkins University; Gates Foundation	US President's Emergency Plan For AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development through John's Hopkins University(United States Agency for International Development (USAID)); Gates Foundation(Bill & Melinda Gates Foundation)	Support provided by The US President's Emergency Plan For AIDS Relief; www.pepfar.gov, United States Agency for International Development through John's Hopkins University and protocol development was also supported by the Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Churchyard GJ, 2010, AIDS, V24, pS19, DOI 10.1097/01.aids.0000391018.72542.46; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Datta M, 2001, INT J TUBERC LUNG D, V5, P240; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P343; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Marciniuk DD, 1999, CHEST, V115, P445, DOI 10.1378/chest.115.2.445; Ministry of Health Kingdom of Cambodia, 2002, REP NAT TB PREV SURV; Ministry of Health of the People's Republic of China, 2004, REP NAT RAND SURV EP; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Murhekar MV, 2004, B WORLD HEALTH ORGAN, V82, P836; National AIDS/STI Control Programme (NASCOP) Kenya, 2009, 2007 KEN AIDS IND SU; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; OCONNOR GT, 1994, AM J RESP CRIT CARE, V149, pS21, DOI 10.1164/ajrccm/149.2_Pt_2.S21; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P611; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Sebhatu M, 2007, B WORLD HEALTH ORGAN, V85, P593, DOI 10.2471/BLT.06.038604; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Tupasi TE, 2009, INT J TUBERC LUNG D, V13, P1224; van der Werf MJ, 2008, INT J TUBERC LUNG D, V12, P1255; van Ginneken B, 2009, EUR J RADIOL, V72, P226, DOI 10.1016/j.ejrad.2009.05.061; van Leth F, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P58, DOI 10.5588/ijtld.10.0417; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 1998, LAB SERV TUB CONTR 3; World Health Organization, 2007, ASS TB PREV POP BAS; World Health Organization, 2009, WHOHTMTB2009419, P2; World Health Organization (WHO), 2009, WHOHTMTB2009426; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	44	71	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e38691	10.1371/journal.pone.0038691	http://dx.doi.org/10.1371/journal.pone.0038691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792158	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800004
J	Soares, MC; Bshary, R; Mendonca, R; Grutter, AS; Oliveira, RF				Soares, Marta C.; Bshary, Redouan; Mendonca, Rute; Grutter, Alexandra S.; Oliveira, Rui F.			Arginine Vasotocin Regulation of Interspecific Cooperative Behaviour in a Cleaner Fish	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SOCIAL-BEHAVIOR; LABROIDES-DIMIDIATUS; VASOPRESSIN; AGGRESSION; COURTSHIP; MODULATION; MECHANISMS; EVOLUTION; ISOTOCIN	In an interspecific cooperative context, individuals must be prepared to tolerate close interactive proximity to other species but also need to be able to respond to relevant social stimuli in the most appropriate manner. The neuropeptides vasopressin and oxytocin and their non-mammalian homologues have been implicated in the evolution of sociality and in the regulation of social behaviour across vertebrates. However, little is known about the underlying physiological mechanisms of interspecific cooperative interactions. In interspecific cleaning mutualisms, interactions functionally resemble most intraspecific social interactions. Here we provide the first empirical evidence that arginine vasotocin (AVT), a non-mammalian homologue of arginine vasopressin (AVP), plays a critical role as moderator of interspecific behaviour in the best studied and ubiquitous marine cleaning mutualism involving the Indo-Pacific bluestreak cleaner wrasse Labroides dimidiatus. Exogenous administration of AVT caused a substantial decrease of most interspecific cleaning activities, without similarly affecting the expression of conspecific directed behaviour, which suggests a differential effect of AVT on cleaning behaviour and not a general effect on social behaviour. Furthermore, the AVP-V1a receptor antagonist (manning compound) induced a higher likelihood for cleaners to engage in cleaning interactions and also to increase their levels of dishonesty towards clients. The present findings extend the knowledge of neuropeptide effects on social interactions beyond the study of their influence on conspecific social behaviour. Our evidence demonstrates that AVT pathways might play a pivotal role in the regulation of interspecific cooperative behaviour and conspecific social behaviour among stabilized pairs of cleaner fish. Moreover, our results suggest that the role of AVT as a neurochemical regulator of social behaviour may have been co-opted in the evolution of cooperative behaviour in an interspecific context, a hypothesis that is amenable to further testing on the potential direct central mechanism involved.	[Soares, Marta C.; Mendonca, Rute; Oliveira, Rui F.] ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal; [Soares, Marta C.; Bshary, Redouan] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Grutter, Alexandra S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Oliveira, Rui F.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	Instituto Superior Psicologia Aplicada (ISPA); University of Neuchatel; University of Queensland; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Soares, MC (corresponding author), ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal.	msoares@ispa.pt	Soares, Marta/GSM-7143-2022; Oliveira, Rui/A-3581-2013; Grutter, Alexandra S/J-2737-2013; Soares, Marta C/J-4448-2013; Soares, Marta/J-4448-2013	Soares, Marta/0000-0002-5213-2377; Oliveira, Rui/0000-0003-1528-618X; Grutter, Alexandra S/0000-0003-1688-2821; Soares, Marta C/0000-0002-5213-2377; Soares, Marta/0000-0001-5304-3424; Mendonca, Rute/0000-0001-7290-3901; Bshary, Redouan/0000-0001-7198-8472	Fundacao para a Ciencia e Tecnologia [PTDC/MAR/105276/2008]; Swiss Science Foundation	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Swiss Science Foundation(Swiss National Science Foundation (SNSF))	This study was financed by a grant provided by Fundacao para a Ciencia e Tecnologia (PTDC/MAR/105276/2008) (financing MCS and RM) and by the Swiss Science Foundation (grant to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Reagan E., 2005, HORMONES ANIMAL SOCI; Balment RJ, 2006, GEN COMP ENDOCR, V147, P9, DOI 10.1016/j.ygcen.2005.12.022; Bastian J, 2001, J EXP BIOL, V204, P1909; BERNSTEI.JJ, 1965, EXP NEUROL, V11, P464, DOI 10.1016/0014-4886(65)90060-9; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R., 2011, FISH COGNITION BEHAV, P277; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Bshary R, 2011, ETHOLOGY, V117, P246, DOI 10.1111/j.1439-0310.2010.01872.x; Bshary Redouan, 2008, P563; Bundgaard M, 2008, GLIA, V56, P699, DOI 10.1002/glia.20642; Burbach JPH, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3055; Carneiro LA, 2003, FISH PHYSIOL BIOCHEM, V28, P241, DOI 10.1023/B:FISH.0000030542.31395.8a; Cheney KL, 2008, BEHAV ECOL, V19, P1063, DOI 10.1093/beheco/arn067; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Cote IM, 1998, J FISH BIOL, V53, P256, DOI 10.1111/j.1095-8649.1998.tb01031.x; CUSHMAN JH, 1991, TRENDS ECOL EVOL, V6, P193, DOI 10.1016/0169-5347(91)90213-H; de Kloet ER, 2010, EUR J PHARMACOL, V626, P18, DOI 10.1016/j.ejphar.2009.10.017; Dewan AK, 2011, HORM BEHAV, V59, P56, DOI 10.1016/j.yhbeh.2010.10.002; DICKMAN CR, 1992, TRENDS ECOL EVOL, V7, P194, DOI 10.1016/0169-5347(92)90072-J; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Feder HM, 1966, CLEANING SYMBIOSIS M; Feifel D, 2009, NEUROPSYCHOPHARMACOL, V34, P2011, DOI 10.1038/npp.2009.15; Goodson JL, 2010, CURR OPIN NEUROBIOL, V20, P784, DOI 10.1016/j.conb.2010.08.020; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2004, CURR BIOL, V14, P1080, DOI 10.1016/j.cub.2004.05.048; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Grutter AS, 1997, COPEIA, P346, DOI 10.2307/1447754; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Lema SC, 2004, HORM BEHAV, V46, P628, DOI 10.1016/j.yhbeh.2004.07.003; Lema SC, 2010, MAR FRESHW BEHAV PHY, V43, P257, DOI 10.1080/10236244.2010.498632; Lema SC, 2010, MOL CELL ENDOCRINOL, V321, P215, DOI 10.1016/j.mce.2010.02.015; LENKE R, 1988, BEHAV BRAIN RES, V27, P73, DOI 10.1016/0166-4328(88)90110-6; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Manning M, 2008, PROGR BRAIN RES, V170; McEwen Barbara B, 2004, Adv Pharmacol, V50, P531; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Robertson D.R., 1974, STUDY ETHOLOGY REPRO; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; Santangelo N, 2006, P ROY SOC B-BIOL SCI, V273, P3085, DOI 10.1098/rspb.2006.3683; Santangelo N, 2010, BRAIN BEHAV EVOLUT, V75, P282, DOI 10.1159/000316867; Semsar K, 2004, HORM BEHAV, V45, P345, DOI 10.1016/j.yhbeh.2004.01.003; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Soares MC, 2008, ETHOLOGY, V114, P209, DOI 10.1111/j.1439-0310.2007.01471.x; Soares MC, 2010, PHILOS T R SOC B, V365, P2737, DOI 10.1098/rstb.2010.0151; Tebbich S, 2002, ANIM COGN, V5, P139, DOI 10.1007/s10071-002-0141-z; Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Young LJ, 2008, RES PERSPECT END INT, P57, DOI 10.1007/978-3-540-79288-8_5	61	36	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39583	10.1371/journal.pone.0039583	http://dx.doi.org/10.1371/journal.pone.0039583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802939	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900013
J	Kerkhofs, S; Dubois, V; De Gendt, K; Helsen, C; Clinckemalie, L; Spans, L; Schuit, F; Boonen, S; Vanderschueren, D; Saunders, PTK; Verhoeven, G; Claessens, F				Kerkhofs, Stefanie; Dubois, Vanessa; De Gendt, Karel; Helsen, Christine; Clinckemalie, Liesbeth; Spans, Lien; Schuit, Frans; Boonen, Steven; Vanderschueren, Dirk; Saunders, Philippa T. K.; Verhoeven, Guido; Claessens, Frank			A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5 alpha reductase II gene	FASEB JOURNAL			English	Article						sperm maturation; male fertility; androgen receptor; binding site; Srd5 alpha 2	DIFFERENTIAL DNA-BINDING; CARBONIC-ANHYDRASE; RECEPTOR-BINDING; EXPRESSION; RAT; KNOCKOUT; MICE; TRANSCRIPTOME; TESTOSTERONE; RECOGNITION	The androgen receptor (AR) recognizes two types of DNA elements that are dimers of 5'-AGAACA-3'-like hexamers, either organized as inverted or direct repeats. We developed a mouse model [(specificity affecting AR knock-in (SPARKI)] in which the AR DNA-binding domain was mutated such that it lost binding to direct repeats but not to inverted elements. The impaired fertility of the male SPARKI mice correlates with the reduced motility of the spermatozoa, a characteristic that is developed during transit through the epididymis. Comparative transcriptome analyses revealed that the expression of 39 genes is changed in SPARKI epididymis. Remarkably, the expression of the steroid 5 alpha-reductase type II (Srd5 alpha 2) gene, which metabolizes testosterone into the more potent dihydrotestosterone, is reduced 4-fold in SPARKI vs. wild type. The comparison of the SPARKI phenotype with that of Srd5 alpha 2-knockout mice shows, however, that the reduced Srd5 alpha 2 expression cannot explain all defects of the SPARKI epididymis. Moreover, we describe three new selective androgen response elements (AREs), which control the androgen responsiveness of the Srd5 alpha 2 gene. We conclude that the SPARKI model can be considered a knockout model for AR functioning via selective AREs and that this has a dramatic effect on sperm maturation in the epididymis.-Kerkhofs, S., Dubois, V., De Gendt, K., Helsen, C., Clinckemalie, L., Spans, L., Schuit, F., Boonen, S., Vanderschueren, D., Saunders, P. T. K., Verhoeven, G., Claessens, F. A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5 alpha reductase II gene. FASEB J. 26, 4360-4372 (2012). www.fasebj.org	[Kerkhofs, Stefanie; Dubois, Vanessa; Helsen, Christine; Clinckemalie, Liesbeth; Spans, Lien; Claessens, Frank] Katholieke Univ Leuven, Mol Endocrinol Lab, Dept Cellular & Mol Med, B-3000 Louvain, Belgium; [De Gendt, Karel; Boonen, Steven; Vanderschueren, Dirk; Verhoeven, Guido] Katholieke Univ Leuven, Div Clin & Expt Endocrinol, B-3000 Louvain, Belgium; [Schuit, Frans] Katholieke Univ Leuven, Dept Cellular & Mol Med, Gene Express Unit, B-3000 Louvain, Belgium; [Saunders, Philippa T. K.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland	KU Leuven; KU Leuven; KU Leuven; University of Edinburgh	Claessens, F (corresponding author), Katholieke Univ Leuven, Mol Endocrinol Lab, Dept Cellular & Mol Med, Campus Gasthuisberg O&N1,POB 901,Herestr 49, B-3000 Louvain, Belgium.	frank.claessens@med.kuleuven.be	Claessens, Frank/M-8565-2016; Dubois, Vanessa/ABF-9551-2021; De Gendt, Karel/A-6332-2009; Saunders, Philippa TK/C-7489-2013	Claessens, Frank/0000-0002-8676-7709; Dubois, Vanessa/0000-0001-8894-2980; Saunders, Philippa TK/0000-0001-9051-9380; vanderschueren, dirk/0000-0003-1395-0104; Helsen, Christine/0000-0003-1048-2798	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; MRC [G1100356, G1002033] Funding Source: UKRI; Medical Research Council [G1002033, G1100356] Funding Source: researchfish	Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. K.D.G. is holder of a postdoctoral fellowship of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. L.C. is holder of a doctoral fellowship of the Agentschap voor Innovatie door Wetenschap en Technologie. V.D. is holder of a doctoral fellowship of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. S.B. is senior clinical investigator of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen and holder of the Leuven University Chair in Gerontology and Geriatrics. The authors thank R. Bollen and H. Debruyn for their excellent technical assistance and their colleagues of the Molecular Endocrinology Laboratory for helpful discussions. The authors thank Dr. Diane M. Robins (University of Michigan Medical School, Ann Arbor, MI, USA) for the kind gift of the AR and GR expression plasmids. The authors thank Dr. Carl Spiessens and his coworkers for the help with the sperm analyses. The authors declare no conflicts of interest.	ADLER AJ, 1992, P NATL ACAD SCI USA, V89, P11660, DOI 10.1073/pnas.89.24.11660; Barfield JP, 2005, BIOL REPROD, V72, P1275, DOI 10.1095/biolreprod.104.038448; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Cooper TG, 2007, ASIAN J ANDROL, V9, P533, DOI 10.1111/j.1745-7262.2007.00285.x; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; DEVOS P, 1993, MOL CELL ENDOCRINOL, V90, pR11, DOI 10.1016/0303-7207(93)90160-L; Ekstedt E, 2004, J MOL HISTOL, V35, P167; Ezer NRB, 2002, ANDROGENIC REGULATIO; Haelens A, 2003, BIOCHEM J, V369, P141, DOI 10.1042/BJ20020912; Helsen C, 2012, MOL CELL ENDOCRINOL, V348, P411, DOI 10.1016/j.mce.2011.07.025; Henderson NA, 2006, J ENDOCRINOL, V190, P779, DOI 10.1677/joe.1.06862; Hermo L., 2002, EPIDIDYMAL CELL TYPE; Hinton BT, 1995, REPROD FERT DEVELOP, V7, P731, DOI 10.1071/RD9950731; Hsia N, 2004, BIOL REPROD, V70, P448, DOI 10.1095/biolreprod.103.021493; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Itoh M, 1999, J ANDROL, V20, P551; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Jervis KM, 2001, BIOL REPROD, V65, P696, DOI 10.1095/biolreprod65.3.696; Jin Y, 2001, BEST PRACT RES CL EN, V15, P79, DOI 10.1053/beem.2001.0120; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Jones RC, 1999, INT J ANDROL, V22, P57; KAUNISTO K, 1995, BIOL REPROD, V52, P1350, DOI 10.1095/biolreprod52.6.1350; Kobayashi T, 2007, FEBS LETT, V581, P3157, DOI 10.1016/j.febslet.2007.05.081; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Mahendroo MS, 2001, ENDOCRINOLOGY, V142, P4652, DOI 10.1210/en.142.11.4652; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Nef S, 2000, GENE DEV, V14, P3075, DOI 10.1101/gad.843800; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Schauwaers K, 2007, P NATL ACAD SCI USA, V104, P4961, DOI 10.1073/pnas.0610814104; Scheller A, 1998, J BIOL CHEM, V273, P24216, DOI 10.1074/jbc.273.37.24216; Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515; Snyder EM, 2009, BIOL REPROD, V81, P707, DOI 10.1095/biolreprod.109.079053; Tanner TM, 2010, CELL MOL LIFE SCI, V67, P1919, DOI 10.1007/s00018-010-0302-1; Thimon V, 2007, MOL HUM REPROD, V13, P691, DOI 10.1093/molehr/gam051; TOTH M, 1982, ENDOKRINOLOGIE, V80, P163; TURNER TT, 1995, J ANDROL, V16, P292; Turner TT, 2003, REPRODUCTION, V125, P871, DOI 10.1530/reprod/125.6.871; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Vanderschueren D, 2000, ENDOCRINOLOGY, V141, P1642, DOI 10.1210/en.141.5.1642; Venken K, 2005, J BONE MINER RES, V20, P2138, DOI 10.1359/JBMR.050811; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298; Verrijdt G, 2002, J BIOL CHEM, V277, P35191, DOI 10.1074/jbc.M205928200; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yeung CH, 2000, BIOL REPROD, V63, P612, DOI 10.1095/biolreprod63.2.612	53	19	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4360	4372		10.1096/fj.11-202283	http://dx.doi.org/10.1096/fj.11-202283			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22798427				2022-12-25	WOS:000309704000040
J	Nakayama, Y; Nakamura, N; Oki, S; Wakabayashi, M; Ishihama, Y; Miyake, A; Itoh, N; Kurosaka, A				Nakayama, Yoshiaki; Nakamura, Naosuke; Oki, Sayoko; Wakabayashi, Masaki; Ishihama, Yasushi; Miyake, Ayumi; Itoh, Nobuyuki; Kurosaka, Akira			A Putative Polypeptide N-Acetylgalactosaminyltransferase/Williams-Beuren Syndrome Chromosome Region 17 (WBSCR17) Regulates Lamellipodium Formation and Macropinocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GALNAC; CELL-ADHESION; GLYCOSYLATION; EXPRESSION; IDENTIFICATION; GENE; PROLIFERATION; VISUALIZATION; TRAFFICKING; COMPLETION	We previously identified a novel polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) gene, which is designated Williams-Beuren syndrome chromosome region 17 (WBSCR17) because it is located in the chromosomal flanking region of the Williams-Beuren syndrome deletion. Recent genome-scale analysis of HEK293T cells treated with a high concentration of N-acetylglucosamine (GlcNAc) demonstrated that WBSCR17 was one of the up-regulated genes possibly involved in endocytosis (Lau, K. S., Khan, S., and Dennis, J. W. (2008) Genome-scale identification of UDP-GlcNAc-dependent pathways. Proteomics 8, 3294-3302). To assess its roles, we first expressed recombinant WBSCR17 in COS7 cells and demonstrated that it was N-glycosylated and localized mainly in the Golgi apparatus, as is the case for the other GalNAc-Ts. Assay of recombinant WBSCR17 expressed in insect cells showed very low activity toward typical mucin peptide substrates. We then suppressed the expression of endogenous WBSCR17 in HEK293T cells using siRNAs and observed phenotypic changes of the knockdown cells with reduced lamellipodium formation, altered O-glycan profiles, and unusual accumulation of glycoconjugates in the late endosomes/lysosomes. Analyses of endocytic pathways revealed that macropinocytosis, but neither clathrin-nor caveolin-dependent endocytosis, was elevated in the knockdown cells. This was further supported by the findings that the overexpression of recombinant WBSCR17 stimulated lamellipodium formation, altered O-glycosylation, and inhibited macropinocytosis. WBSCR17 therefore plays important roles in lamellipodium formation and the regulation of macropinocytosis as well as lysosomes. Our study suggests that a subset of O-glycosylation produced by WBSCR17 controls dynamic membrane trafficking, probably between the cell surface and the late endosomes through macropinocytosis, in response to the nutrient concentration as exemplified by environmental GlcNAc.	[Nakayama, Yoshiaki; Nakamura, Naosuke; Oki, Sayoko; Kurosaka, Akira] Kyoto Sangyo Univ, Lab Neuroglycobiol, Dept Mol Sci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan; [Wakabayashi, Masaki; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular BioAnal, Sakyo Ku, Kyoto 6068501, Japan; [Miyake, Ayumi; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto 6068501, Japan	Kyoto Sangyo University; Kyoto University; Kyoto University	Kurosaka, A (corresponding author), Kyoto Sangyo Univ, Lab Neuroglycobiol, Dept Mol Sci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan.	kurosaka@cc.kyoto-su.ac.jp	Ishihama, Yasushi/B-3101-2016	Ishihama, Yasushi/0000-0001-7714-203X; Nakayama, Yoshiaki/0000-0003-2187-3292	Japan Society for the Promotion of Science [24110516, 23770159]; Private University Strategic Research Foundation Support Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Private University Strategic Research Foundation Support Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This work was in part supported by Grants-in-Aid for Scientific Research on Innovative Areas 24110516 (to Y. N.), and for Young Scientists (B) 23770159 (to Y. N.), the Protein 3000 Project from the Japan Society for the Promotion of Science (to A. K.), and the Private University Strategic Research Foundation Support Program (to A. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; CANTZ M, 1990, J INHERIT METAB DIS, V13, P523, DOI 10.1007/BF01799510; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Elhammer AP, 1999, GLYCOCONJUGATE J, V16, P171, DOI 10.1023/A:1026465232149; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; Gerloni M, 2005, J IMMUNOL, V175, P6551, DOI 10.4049/jimmunol.175.10.6551; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Hisatsune A, 2009, BIOCHEM BIOPH RES CO, V388, P677, DOI 10.1016/j.bbrc.2009.08.059; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kabayama H, 2011, J NEUROSCI, V31, P7357, DOI 10.1523/JNEUROSCI.2718-10.2011; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Lau KS, 2008, PROTEOMICS, V8, P3294, DOI 10.1002/pmic.200800208; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Nakamura N, 2005, BIOL PHARM BULL, V28, P429, DOI 10.1248/bpb.28.429; OGATA S, 1992, CANCER RES, V52, P5971; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Rottger S, 1998, J CELL SCI, V111, P45; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tenno M, 2007, FEBS J, V274, P6037, DOI 10.1111/j.1742-4658.2007.06124.x; Ulloa F, 2003, J BIOL CHEM, V278, P12374, DOI 10.1074/jbc.M211909200; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145	39	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32222	32235		10.1074/jbc.M112.370932	http://dx.doi.org/10.1074/jbc.M112.370932			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22787146	hybrid, Green Published			2022-12-25	WOS:000309059400059
J	Bai, FW; Asojo, OA; Cirillo, P; Ciustea, M; Ledizet, M; Aristoff, PA; Leng, L; Koski, RA; Powell, TJ; Bucala, R; Anthony, KG				Bai, Fengwei; Asojo, Oluwatoyin A.; Cirillo, Pier; Ciustea, Mihai; Ledizet, Michel; Aristoff, Paul A.; Leng, Lin; Koski, Raymond A.; Powell, Thomas J.; Bucala, Richard; Anthony, Karen G.			A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RHEUMATOID-ARTHRITIS; REGULATORY ROLE; FACTOR GENE; MATRIX METALLOPROTEINASES; TAUTOMERASE INHIBITORS; SYNOVIAL FIBROBLASTS; CRYSTAL-STRUCTURE; DISCOVERY; REVEALS	Macrophage migration inhibitory factor (MIF) is a catalytic cytokine and an upstream mediator of the inflammatory pathway. MIF has broad regulatory properties, dysregulation of which has been implicated in the pathology of multiple immunological diseases. Inhibition of MIF activity with small molecules has proven beneficial in a number of disease models. Known small molecule MIF inhibitors typically bind in the tautomerase site of the MIF trimer, often covalently modifying the catalytic proline. Allosteric MIF inhibitors, particularly those that associate with the protein by noncovalent interactions, could reveal novel ways to block MIF activity for therapeutic benefit and serve as chemical probes to elucidate the structural basis for the diverse regulatory properties of MIF. In this study, we report the identification and functional characterization of a novel allosteric MIF inhibitor. Identified from a high throughput screening effort, this sulfonated azo compound termed p425 strongly inhibited the ability of MIF to tautomerize 4-hydroxyphenyl pyruvate. Furthermore, p425 blocked the interaction of MIF with its receptor, CD74, and interfered with the pro-inflammatory activities of the cytokine. Structural studies revealed a unique mode of binding for p425, with a single molecule of the inhibitor occupying the interface of two MIF trimers. The inhibitor binds MIF mainly on the protein surface through hydrophobic interactions that are stabilized by hydrogen bonding with four highly specific residues from three different monomers. The mode of p425 binding reveals a unique way to block the activity of the cytokine for potential therapeutic benefit in MIF-associated diseases.	[Bai, Fengwei; Cirillo, Pier; Ciustea, Mihai; Ledizet, Michel; Aristoff, Paul A.; Koski, Raymond A.; Powell, Thomas J.; Anthony, Karen G.] L2 Diagnost LLC, New Haven, CT 06511 USA; [Asojo, Oluwatoyin A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; [Bai, Fengwei] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Powell, Thomas J.] Artificial Cell Technol, New Haven, CT 06511 USA; [Asojo, Oluwatoyin A.] Baylor Coll Med, Dept Pediat & Trop Med, Houston, TX 77030 USA	University of Nebraska System; University of Nebraska Medical Center; Yale University; University of Southern Mississippi; Baylor College of Medicine	Anthony, KG (corresponding author), L2 Diagnost LLC, 300 George St,Ste 309, New Haven, CT 06511 USA.	Karen.Anthony@L2dx.com	Asojo, Oluwatoyin/H-1324-2019	Asojo, Oluwatoyin/0000-0002-4043-2700; Leng, Lin/0000-0002-0605-358X	National Institutes of Health from the NIAMS [1R43AR056908]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR056908, R01AR050498] Funding Source: NIH RePORTER	National Institutes of Health from the NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R43AR056908 from the NIAMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ainola MM, 2005, CLIN EXP RHEUMATOL, V23, P644; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cherepkova OA, 2004, NEUROCHEM RES, V29, P1399, DOI 10.1023/B:NERE.0000026403.06238.73; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396; Crichlow GV, 2009, BIOCHEMISTRY-US, V48, P132, DOI 10.1021/bi8014423; Dabideen DR, 2007, J MED CHEM, V50, P1993, DOI 10.1021/jm061477+; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Gregersen PK, 2003, ARTHRITIS RHEUM-US, V48, P1171, DOI 10.1002/art.10880; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jorgensen WL, 2010, BIOORG MED CHEM LETT, V20, P7033, DOI 10.1016/j.bmcl.2010.09.118; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Kleemann R, 1998, FEBS LETT, V430, P191, DOI 10.1016/S0014-5793(98)00654-1; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Konttinen YT, 1999, ANN RHEUM DIS, V58, P691, DOI 10.1136/ard.58.11.691; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lolis E, 1996, P ASSOC AM PHYSICIAN, V108, P415; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lolis Elias, 2001, Current Opinion in Pharmacology, V1, P662, DOI 10.1016/S1471-4892(01)00112-6; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Mitchell RA, 2000, SEMIN CANCER BIOL, V10, P359, DOI 10.1006/scbi.2000.0328; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nguyen MT, 2003, J BIOL CHEM, V278, P33654, DOI 10.1074/jbc.M301735200; Nunez C, 2007, GENES IMMUN, V8, P168, DOI 10.1038/sj.gene.6364365; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Orita M, 2001, J MED CHEM, V44, P540, DOI 10.1021/jm000386o; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Ouertatani-Sakouhi H, 2009, BIOCHEMISTRY-US, V48, P9858, DOI 10.1021/bi900957e; Pakozdi A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2021; Pinto DJP, 1996, BIOORG MED CHEM LETT, V6, P2907, DOI 10.1016/S0960-894X(96)00513-6; Poelarends GJ, 2008, CELL MOL LIFE SCI, V65, P3606, DOI 10.1007/s00018-008-8285-x; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115; ROSETH S, 1995, J NEUROCHEM, V65, P96; Sanchez E, 2006, GENES IMMUN, V7, P433, DOI 10.1038/sj.gene.6364310; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Soares TA, 2002, BIOPOLYMERS, V65, P313, DOI 10.1002/bip.10252; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Sun HW, 1996, PROTEIN ENG, V9, P631, DOI 10.1093/protein/9.8.631; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; XU Q, 1992, J BIOL CHEM, V267, P11968; Xue CB, 1997, J MED CHEM, V40, P2064, DOI 10.1021/jm960799i; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	76	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30653	30663		10.1074/jbc.M112.385583	http://dx.doi.org/10.1074/jbc.M112.385583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22782901	hybrid, Green Published			2022-12-25	WOS:000308579800055
J	Keogh, JS; Noble, DWA; Wilson, EE; Whiting, MJ				Keogh, J. Scott; Noble, Daniel W. A.; Wilson, Eleanor E.; Whiting, Martin J.			Activity Predicts Male Reproductive Success in a Polygynous Lizard	PLOS ONE			English	Article							SEXUAL SELECTION; MULTIPLE PATERNITY; BEHAVIOR	Activity patterns and social interactions play a key role in determining reproductive success, although this is poorly understood for species that lack overt social behaviour. We used genetic paternity analysis to quantify both multiple paternity and the relative roles of activity and social behaviour in determining reproductive success in a nondescript Australian lizard. During the breeding season we intensively followed and recorded the behaviour of a group of seven males and 13 females in a naturalistic outdoor enclosure to examine the relative roles of body size, activity and social interactions in determining male fertilization success. We found multiple paternity in 42% of clutches. No single behaviour was a significant predictor of male fertilization success in isolation, but male-female association, interactions and courtship explained 41% of the variation in male fertilization success. Males with the highest number of offspring sired invested heavily in interacting with females but spent very little time in interactions with males. These same males also sired offspring from more clutches. When taken collectively, an index of overall male activity, including locomotion and all social interactions, significantly explained 81% of the variation in the total number of offspring sired and 90% of the variation in the number of clutches in which males sired offspring. We suggest that the most successful male strategy is a form of endurance rivalry in which active mate searching and interactions with females have the greatest fitness benefits.	[Keogh, J. Scott; Wilson, Eleanor E.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Noble, Daniel W. A.; Whiting, Martin J.] Macquarie Univ, Div Brain Behav & Evolut, Dept Biol Sci, Sydney, NSW 2109, Australia	Australian National University; Macquarie University	Keogh, JS (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	scott.keogh@anu.edu.au	Keogh, Scott/C-8441-2009; Noble, Daniel/H-6214-2013; Whiting, Martin J./E-2999-2010	Keogh, Scott/0000-0002-1373-6186; Noble, Daniel/0000-0001-9460-8743; Whiting, Martin J./0000-0002-4662-0227	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council to JSK. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Baird TA, 2007, BEHAV ECOL, V18, P1146, DOI 10.1093/beheco/arm092; Borges-Landaez PA, 2003, J HERPETOL, V37, P592, DOI 10.1670/26-02N; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Head ML, 2005, ACTA ETHOL, V8, P79, DOI 10.1007/s10211-005-0003-1; Hoglund J, 1995, MONOGRAPHS BEHAV ECO; IMS RA, 1988, NATURE, V335, P541, DOI 10.1038/335541a0; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Lane JE, 2008, ANIM BEHAV, V75, P1927, DOI 10.1016/j.anbehav.2007.10.038; Lane JE, 2009, J ANIM ECOL, V78, P296, DOI 10.1111/j.1365-2656.2008.01502.x; Morrison SF, 2002, MOL ECOL, V11, P535, DOI 10.1046/j.0962-1083.2002.01450.x; Murphy CG, 1998, EVOLUTION, V52, P8, DOI 10.1111/j.1558-5646.1998.tb05133.x; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Olsson M, 2000, P ROY SOC B-BIOL SCI, V267, P2339, DOI 10.1098/rspb.2000.1289; Olsson M, 2011, EVOLUTION, V65, P3323, DOI 10.1111/j.1558-5646.2011.01387.x; Olsson M, 2011, EVOLUTION, V65, P574, DOI 10.1111/j.1558-5646.2010.01152.x; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; Salvador A, 2008, BEHAV ECOL, V19, P169, DOI 10.1093/beheco/arm118; Scott IAW, 2001, MOL ECOL NOTES, V1, P28, DOI 10.1046/j.1471-8278.2000.00011.x; Stapley J, 2005, BEHAV ECOL, V16, P514, DOI 10.1093/beheco/ari019; Stapley J, 2004, ANIM BEHAV, V68, P841, DOI 10.1016/j.anbehav.2004.02.008; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Whiting MJ, 2003, LIZARD SOCIAL BEHAVIOR, P47	26	27	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38856	10.1371/journal.pone.0038856	http://dx.doi.org/10.1371/journal.pone.0038856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808016	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400006
J	Ryan, MM; Ryan, B; Kyrke-Smith, M; Logan, B; Tate, WP; Abraham, WC; Williams, JM				Ryan, Margaret M.; Ryan, Brigid; Kyrke-Smith, Madeleine; Logan, Barbara; Tate, Warren P.; Abraham, Wickliffe C.; Williams, Joanna M.			Temporal Profiling of Gene Networks Associated with the Late Phase of Long-Term Potentiation In Vivo	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; DENTATE GYRUS; HISTONE MODIFICATIONS; GLUTAMATE-RECEPTOR; NEURITE OUTGROWTH; BEHAVING RATS; EXPRESSION	Long-term potentiation (LTP) is widely accepted as a cellular mechanism underlying memory processes. It is well established that LTP persistence is strongly dependent on activation of constitutive and inducible transcription factors, but there is limited information regarding the downstream gene networks and controlling elements that coalesce to stabilise LTP. To identify these gene networks, we used Affymetrix RAT230.2 microarrays to detect genes regulated 5 h and 24 h (n = 5) after LTP induction at perforant path synapses in the dentate gyrus of awake adult rats. The functional relationships of the differentially expressed genes were examined using DAVID and Ingenuity Pathway Analysis, and compared with our previous data derived 20 min post-LTP induction in vivo. This analysis showed that LTP-related genes are predominantly upregulated at 5 h but that there is pronounced downregulation of gene expression at 24 h after LTP induction. Analysis of the structure of the networks and canonical pathways predicted a regulation of calcium dynamics via G-protein coupled receptors, dendritogenesis and neurogenesis at the 5 h time-point. By 24 h neurotrophin-NFKB driven pathways of neuronal growth were identified. The temporal shift in gene expression appears to be mediated by regulation of protein synthesis, ubiquitination and time-dependent regulation of specific microRNA and histone deacetylase expression. Together this programme of genomic responses, marked by both homeostatic and growth pathways, is likely to be critical for the consolidation of LTP in vivo.	[Ryan, Margaret M.; Ryan, Brigid; Kyrke-Smith, Madeleine; Logan, Barbara; Tate, Warren P.; Abraham, Wickliffe C.; Williams, Joanna M.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Ryan, Margaret M.; Ryan, Brigid; Kyrke-Smith, Madeleine; Williams, Joanna M.] Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Ryan, Margaret M.; Tate, Warren P.] Otago Sch Med Sci, Dept Biochem, Dunedin, New Zealand; [Logan, Barbara; Abraham, Wickliffe C.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Ryan, MM (corresponding author), Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand.	joanna.williams@anatomy.otago.ac.nz		Tate, Warren/0000-0002-6971-7734	The Royal Society of New Zealand Marsden Fund [03-UOO-118]; University of Otago Grants Committee	The Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Otago Grants Committee	The Royal Society of New Zealand Marsden Fund; Grant number 03-UOO-118. University of Otago Grants Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2003, NEUROSCIENTIST, V9, P463, DOI 10.1177/1073858403259119; Abraham WC, 2002, J NEUROSCI, V22, P9626; Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bramham CR, 1996, J COMP NEUROL, V368, P371; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Cheyne JE, 2008, MOL CELL NEUROSCI, V37, P432, DOI 10.1016/j.mcn.2007.10.015; Dong E, 2003, P NATL ACAD SCI USA, V100, P5479, DOI 10.1073/pnas.1031602100; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Errington ML, 2003, PHILOS T ROY SOC B, V358, P675, DOI 10.1098/rstb.2002.1251; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jurado S, 2010, EMBO J, V29, P2827, DOI 10.1038/emboj.2010.160; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Leone V, 2011, MOL ENDOCRINOL, V25, P1819, DOI 10.1210/me.2011-0014; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Lisman J., 2006, SCI STKE, V2006, pr; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; LYNCH MA, 1994, NEUROSCIENCE, V60, P1, DOI 10.1016/0306-4522(94)90197-X; Ma Q, 2008, CELL SIGNAL, V20, P1044, DOI 10.1016/j.cellsig.2008.01.015; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Mikl M, 2010, J COMP PHYSIOL A, V196, P321, DOI 10.1007/s00359-010-0520-x; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nishimura H, 2003, J NEUROCHEM, V85, P1216, DOI 10.1046/j.1471-4159.2003.01760.x; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park CS, 2006, J BIOL CHEM, V281, P30195, DOI 10.1074/jbc.M605876200; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pincheira R, 2009, EMBO J, V28, P261, DOI 10.1038/emboj.2008.274; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Ryan MM, 2011, HIPPOCAMPUS, V21, P541, DOI 10.1002/hipo.20770; Saba R., 2010, BRAIN RES; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SMIRNOVA T, 1993, SCIENCE, V262, P433, DOI 10.1126/science.8105538; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yellajoshyula D, 2011, P NATL ACAD SCI USA, V108, P3294, DOI 10.1073/pnas.1012053108; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	67	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40538	10.1371/journal.pone.0040538	http://dx.doi.org/10.1371/journal.pone.0040538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802965	gold, Green Published, Green Submitted			2022-12-25	WOS:000306355500053
J	Van der Burg, E; Olivers, CNL; Theeuwes, J				Van der Burg, Erik; Olivers, Christian N. L.; Theeuwes, Jan			The Attentional Window Modulates Capture by Audiovisual Events	PLOS ONE			English	Article							ABRUPT VISUAL ONSETS; SELECTIVE ATTENTION; SEARCH; COLOR; SOUND; ENHANCEMENT; INTEGRATION; SYNCHRONY; TACTILE; SIZE	Visual search is markedly improved when a target color change is synchronized with a spatially non-informative auditory signal. This "pip and pop" effect is an automatic process as even a distractor captures attention when accompanied by a tone. Previous studies investigating visual attention have indicated that automatic capture is susceptible to the size of the attentional window. The present study investigated whether the pip and pop effect is modulated by the extent to which participants divide their attention across the visual field We show that participants were better in detecting a synchronized audiovisual event when they divided their attention across the visual field relative to a condition in which they focused their attention. We argue that audiovisual capture is reduced under focused conditions relative to distributed settings.	[Van der Burg, Erik; Olivers, Christian N. L.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Van der Burg, E (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	e.van.der.burg@psy.vu.nl	Theeuwes, Jan/ABF-3771-2020; Theeuwes, Jan/B-6862-2008	Theeuwes, Jan/0000-0002-5849-7721; Olivers, Christian/0000-0001-7470-5378	NWO-VIDI [452-06-007]	NWO-VIDI(Netherlands Organization for Scientific Research (NWO))	This research was supported by a NWO-VIDI grant (452-06-007) to CNLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Alsius A, 2007, EXP BRAIN RES, V183, P399, DOI 10.1007/s00221-007-1110-1; Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Belopolsky AV, 2010, NO CAPTURE OUTSIDE A; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; de Boer-Schellekens L, 2012, EXP BRAIN RES, V216, P243, DOI 10.1007/s00221-011-2926-2; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Hernandez M, 2010, ATTEN PERCEPT PSYCHO, V72, P963, DOI 10.3758/APP.72.4.963; Matusz PJ, 2011, PSYCHON B REV, V18, P904, DOI 10.3758/s13423-011-0131-8; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Ngo MK, 2010, ATTEN PERCEPT PSYCHO, V72, P1654, DOI 10.3758/APP.72.6.1654; Olivers CNL, 2008, BRAIN RES, V1242, P191, DOI 10.1016/j.brainres.2008.01.070; Perrott DR, 1996, HUM FACTORS, V38, P702, DOI 10.1518/001872096778827260; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Shams L, 2010, PHYS LIFE REV, V7, P269, DOI 10.1016/j.plrev.2010.04.006; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Spence C, 2007, ACOUST SCI TECHNOL, V28, P61, DOI 10.1250/ast.28.61; Staufenbiel SM, 2011, EXP BRAIN RES, V213, P457, DOI 10.1007/s00221-011-2797-6; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; THEEUWES J, 1994, PERCEPTION, V23, P429, DOI 10.1068/p230429; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; Van der Burg E, 2010, ACTA PSYCHOL, V134, P198, DOI 10.1016/j.actpsy.2010.01.010; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	41	20	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39137	10.1371/journal.pone.0039137	http://dx.doi.org/10.1371/journal.pone.0039137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	973JD	22808027	gold, Green Published, Green Submitted			2022-12-25	WOS:000306355500007
J	Auliff, AM; Balu, B; Chen, NH; O'Neil, MT; Cheng, Q; Adams, JH				Auliff, Alyson M.; Balu, Bharath; Chen, Nanhua; O'Neil, Michael T.; Cheng, Qin; Adams, John H.			Functional Analysis of Plasmodium vivax Dihydrofolate Reductase-Thymidylate Synthase Genes through Stable Transformation of Plasmodium falciparum	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; SULFADOXINE-PYRIMETHAMINE; IN-VITRO; MALARIA PARASITE; ANTIFOLATE RESISTANCE; THERAPEUTIC RESPONSE; CHLOROQUINE; MUTATIONS; ANTIMALARIAL; TRANSFECTION	Mechanisms of drug resistance in Plasmodium vivax have been difficult to study partially because of the difficulties in culturing the parasite in vitro. This hampers monitoring drug resistance and research to develop or evaluate new drugs. There is an urgent need for a novel method to study mechanisms of P. vivax drug resistance. In this paper we report the development and application of the first Plasmodium falciparum expression system to stably express P. vivax dhfr-ts alleles. We used the piggyBac transposition system for the rapid integration of wild-type, single mutant (117N) and quadruple mutant (57L/58R/61M/117T) pvdhfr-ts alleles into the P. falciparum genome. The majority (81%) of the integrations occurred in non-coding regions of the genome; however, the levels of pvdhfr transcription driven by the P. falciparum dhfr promoter were not different between integrants of non-coding and coding regions. The integrated quadruple pvdhfr mutant allele was much less susceptible to antifolates than the wild-type and single mutant pvdhfr alleles. The resistance phenotype was stable without drug pressure. All the integrated clones were susceptible to the novel antifolate JPC-2067. Therefore, the piggyBac expression system provides a novel and important tool to investigate drug resistance mechanisms and gene functions in P. vivax.	[Auliff, Alyson M.; Chen, Nanhua; Cheng, Qin] Australian Army Malaria Inst, Drug Resistance & Diagnost Dept, Enoggera, Qld, Australia; [Auliff, Alyson M.; Cheng, Qin] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Balu, Bharath; Adams, John H.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [O'Neil, Michael T.] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA	QIMR Berghofer Medical Research Institute; University of Queensland; State University System of Florida; University of South Florida; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Auliff, AM (corresponding author), Australian Army Malaria Inst, Drug Resistance & Diagnost Dept, Enoggera, Qld, Australia.	qin.cheng@defence.gov.au; jadams3@health.usf.edu	Adams, John/G-1800-2015; Adams, John H./ABB-8458-2020; Cheng, Qin/AAO-2198-2020	Adams, John/0000-0003-3707-7979; Adams, John H./0000-0003-3707-7979; Cheng, Qin/0000-0001-7776-4437	National Institutes of Health [R21AI070888, R01AI033656]; Australian American Fulbright Scholarship; Chief of Army Scholarship; ARC/NHMRC Parasitology Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094973, R21AI070888, R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian American Fulbright Scholarship; Chief of Army Scholarship; ARC/NHMRC Parasitology Network(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by National Institutes of Health grants R21AI070888 and R01AI033656 (JHA). AMA received travel awards from the Australian American Fulbright Scholarship (2009), Chief of Army Scholarship (2009) and ARC/NHMRC Parasitology Network travel scholarship (2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additonal external funding received for this study.	Alam MT, 2007, ANTIMICROB AGENTS CH, V51, P857, DOI 10.1128/AAC.01200-06; Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67, DOI 10.1590/S0037-86821999000100013; Arnold C, 1991, PCR Methods Appl, V1, P39; Auliff A, 2006, AM J TROP MED HYG, V75, P617, DOI 10.4269/ajtmh.2006.75.617; Auliff AM, 2010, ANTIMICROB AGENTS CH, V54, P3927, DOI 10.1128/AAC.00628-10; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2007, INT J PARASITOL, V37, P1, DOI 10.1016/j.ijpara.2006.10.001; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bhattacharjee S, 2008, BLOOD, V111, P2418, DOI 10.1182/blood-2007-09-115279; CANFIELD CJ, 1993, AM J TROP MED HYG, V49, P121, DOI 10.4269/ajtmh.1993.49.121; Canfield CJ, 1986, WHO MONOGR SER, V99; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; COATNEY GR, 1963, AM J TROP MED HYG, V12, P121, DOI 10.4269/ajtmh.1963.12.121; DARLOW B, 1982, AM J TROP MED HYG, V31, P10, DOI 10.4269/ajtmh.1982.31.10; de Pecoulas PE, 1998, GENE, V211, P177, DOI 10.1016/S0378-1119(98)00118-8; de Pecoulas PE, 1998, MOL BIOCHEM PARASIT, V92, P265, DOI 10.1016/S0166-6851(97)00247-8; DOBERSTYN EB, 1979, T ROY SOC TROP MED H, V73, P15, DOI 10.1016/0035-9203(79)90121-4; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Edstein MD, 1997, ANTIMICROB AGENTS CH, V41, P2300, DOI 10.1128/AAC.41.10.2300; Edstein MD, 2007, J ANTIMICROB CHEMOTH, V60, P811, DOI 10.1093/jac/dkm280; Fryauff DJ, 1998, AM J TROP MED HYG, V59, P513, DOI 10.4269/ajtmh.1998.59.513; Goldberg DE, 2010, TRENDS PARASITOL; Hastings MD, 2005, ANTIMICROB AGENTS CH, V49, P733, DOI 10.1128/AAC.49.2.733-740.2005; Hastings MD, 2004, J INFECT DIS, V189, P744, DOI 10.1086/381397; Hastings MD, 2002, P NATL ACAD SCI USA, V99, P13137, DOI 10.1073/pnas.182295999; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Imwong M, 2003, ANTIMICROB AGENTS CH, V47, P1514, DOI 10.1128/AAC.47.5.1514-1521.2003; Imwong M, 2001, ANTIMICROB AGENTS CH, V45, P3122, DOI 10.1128/AAC.45.11.3122-3127.2001; Kurcer MA, 2004, ANN TROP MED PARASIT, V98, P447, DOI 10.1179/000349804225021343; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leartsakulpanich U, 2002, MOL BIOCHEM PARASIT, V119, P63, DOI 10.1016/S0166-6851(01)00402-9; Liu YG, 1998, PLANT MOL BIOL REP, V16, P175, DOI 10.1023/A:1007420918645; Maher SP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-222; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nirmalan N, 2004, MOL BIOCHEM PARASIT, V136, P63, DOI 10.1016/j.molbiopara.2004.02.013; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; O'Neil MT, 2007, J INFECT DIS, V196, P467, DOI 10.1086/519286; Peters W, 1998, ADV PARASIT, V41, P1, DOI 10.1016/S0065-308X(08)60421-2; Pfahler JM, 2006, MOL BIOCHEM PARASIT, V149, P99, DOI 10.1016/j.molbiopara.2006.03.018; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phillips EJ, 1996, CLIN INFECT DIS, V23, P1171, DOI 10.1093/clinids/23.5.1171; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P1680, DOI 10.1128/AAC.44.6.1680-1685.2000; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Sa JM, 2006, MOL BIOCHEM PARASIT, V150, P219, DOI 10.1016/j.molbiopara.2006.08.006; Shearer TW, 2005, J MED CHEM, V48, P2805, DOI 10.1021/jm049683+; Somsak V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-291; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Tamez PA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000118; Tjitra E, 2002, ANTIMICROB AGENTS CH, V46, P3947, DOI 10.1128/AAC.46.12.3947-3953.2002; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; Young M. D., 1959, Bulletin of the World Health Organization, V20, P27; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	62	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40416	10.1371/journal.pone.0040416	http://dx.doi.org/10.1371/journal.pone.0040416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792308	Green Submitted, Green Published, gold			2022-12-25	WOS:000306354700044
J	Cento, V; Mirabelli, C; Salpini, R; Dimonte, S; Artese, A; Costa, G; Mercurio, F; Svicher, V; Parrotta, L; Bertoli, A; Ciotti, M; Di Paolo, D; Sarrecchia, C; Andreoni, M; Alcaro, S; Angelico, M; Perno, CF; Ceccherini-Silberstein, F				Cento, Valeria; Mirabelli, Carmen; Salpini, Romina; Dimonte, Salvatore; Artese, Anna; Costa, Giosue; Mercurio, Fabio; Svicher, Valentina; Parrotta, Lucia; Bertoli, Ada; Ciotti, Marco; Di Paolo, Daniele; Sarrecchia, Cesare; Andreoni, Massimo; Alcaro, Stefano; Angelico, Mario; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca			HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; DRUG-RESISTANCE; GENETIC BARRIER; NS3/4A PROTEASE; PEGINTERFERON ALPHA-2B; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; TELAPREVIR; REPLICATION; BOCEPREVIR	Background: Because of the extreme genetic variability of hepatitis C virus (HCV), we analyzed whether specific HCV-genotypes are differently prone to develop resistance to linear and macrocyclic protease-inhibitors (PIs). Methods: The study includes 1568 NS3-protease sequences, isolated from PI-naive patients infected with HCV-genotypes 1a (N=621), 1b (N=474), 2 (N=72), 3 (N=268), 4 (N=54)5 (N=6), and 6 (N=73). Genetic-barrier was calculated as the sum of nucleotide-transitions (score=1) and/or nucleotide-transversions (score=2.5) required for drug-resistance-mutations emergence. Forty-three mutations associated with PIs-resistance were analyzed (36A/M/L/G-41R-43S/V-54A/S/V-55A-Q80K/R/L/H/G-109K-138T-155K/Q/T/I/M/S/G/L-156T/V/G/S-158I-168A/H/T/V/E/I/G/N/Y-170A/T-175L). Structural analyses on NS3-protease and on putative RNA-models have been also performed. Results: Overall, NS3-protease was moderately conserved, with 85/181 (47.0%) amino-acids showing <1% variability. The catalytic-triad (H57-D81-S139) and 6/13 resistance-associated positions (Q41-F43-R109-R155-A156-V158) were fully conserved (variability <= 1%). Structural-analysis highlighted that most of the NS3-residues involved in drug-stabilization were highly conserved, while 7 PI-resistance residues, together with selected residues located in proximity of the PI-binding pocket, were highly variable among HCV-genotypes. Four resistance-mutations (80K/G-36L-175L)were found as natural polymorphisms in selected genotypes (80K present in 41.6% HCV-1a, 100% of HCV-5 and 20.6% HCV-6; 80G present in 94.4% HCV-2; 36L present in 100% HCV-3-5 and >94% HCV-2-4; 175L present in 100% HCV-1a-3-5 and >97% HCV-2-4). Furthermore, HCV-3 specifically showed non-conservative polymorphisms (R123T-D168Q) at two drug-interacting positions. Regardless of HCV-genotype, 13 PIs resistance-mutations were associated with low genetic-barrier, requiring only 1 nucleotide-substitution (41R-43S/V-54A-55A-80R-156V/T: score=1; 54S-138T-156S/G-168E/H: score=2.5). By contrast, by using HCV-1b as reference genotype, nucleotide-heterogeneity led to a lower genetic-barrier for the development of some drug-resistance-mutations in HCV-1a (36M-155G/I/K/M/S/T-170T), HCV-2 (36M-80K-155G/I/K/S/T-170T), HCV-3 (155G/I/K/M/S/T-170T), HCV-4-6 (155I/S/L), and HCV-5 (80G-155G/I/K/M/S/T). Conclusions: The high degree of HCV genetic variability makes HCV-genotypes, and even subtypes, differently prone to the development of PIs resistance-mutations. Overall, this can account for different responsiveness of HCV-genotypes to PIs, with important clinical implications in tailoring individualized and appropriate regimens.	[Cento, Valeria; Mirabelli, Carmen; Salpini, Romina; Dimonte, Salvatore; Mercurio, Fabio; Svicher, Valentina; Perno, Carlo Federico; Ceccherini-Silberstein, Francesca] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Artese, Anna; Costa, Giosue; Parrotta, Lucia; Alcaro, Stefano] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Catanzaro, Italy; [Bertoli, Ada; Ciotti, Marco; Perno, Carlo Federico] Tor Vergata Univ Hosp, Complex Unit Mol Virol, Rome, Italy; [Di Paolo, Daniele; Angelico, Mario] Tor Vergata Univ Hosp, Dept Internal Med, Rome, Italy; [Sarrecchia, Cesare; Andreoni, Massimo] Tor Vergata Univ Hosp, Dept Publ Hlth, Rome, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata	Cento, V (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy.	ceccherini@med.uniroma2.it	Cento, Valeria/AAF-2607-2020; Salpini, Romina/ABE-4828-2021; Andreoni, Masimo/AAL-2214-2020; Di Maio, Velia Chiara/AGH-2628-2022; perno, carlo federico/O-1544-2016; Salpini, Romina/K-2170-2016; Mirabelli, Carmen/D-9441-2018; Cento, Valeria/K-6636-2012; Costa, Giosuè/K-8461-2016; Ceccherini-Silberstein, Francesca/K-4762-2016	Salpini, Romina/0000-0002-2488-2082; Salpini, Romina/0000-0002-2488-2082; Mirabelli, Carmen/0000-0002-4785-5482; Cento, Valeria/0000-0002-3272-4252; Costa, Giosuè/0000-0003-0947-9479; BERTOLI, ADA/0000-0003-0663-2503; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; ANGELICO, Mario/0000-0003-2883-9206; Andreoni, Massimo/0000-0002-3205-9758; ALCARO, Stefano/0000-0002-0437-358X; PERNO, CARLO FEDERICO/0000-0002-0825-5388; SVICHER, VALENTINA/0000-0002-2377-504X	Merck Sharp; Dohme; Italian National Institute of Health; Italian Ministry of Instruction, University and Research (MIUR) (Accordi di Programma) [RBAP11YS7K_001]; Progetto FILAS; Aviralia Foundation	Merck Sharp; Dohme; Italian National Institute of Health; Italian Ministry of Instruction, University and Research (MIUR) (Accordi di Programma)(Ministry of Education, Universities and Research (MIUR)); Progetto FILAS; Aviralia Foundation	This work was supported by an unrestricted educational grant from Merck Sharp and Dohme and by grants from the Italian National Institute of Health, the Italian Ministry of Instruction, University and Research (MIUR) (Accordi di Programma 2011: RBAP11YS7K_001), by the "Progetto FILAS" and Aviralia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro S, 2010, CHEMMEDCHEM, V5, P575, DOI 10.1002/cmdc.200900541; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Butt AA, 2012, CLIN INFECT DIS, V54, P96, DOI 10.1093/cid/cir774; Chase R, 2009, ANTIVIR RES, V84, P178, DOI 10.1016/j.antiviral.2009.09.003; Colson P, 2012, J CLIN VIROL, V53, P178, DOI 10.1016/j.jcv.2011.10.005; Dimonte S, 2012, INTERVIROLOGY, V55, P385, DOI 10.1159/000334696; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Ferenci P, 2011, ANTIVIR THER, V16, P1187, DOI 10.3851/IMP1934; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Fried M W, 2001, Clin Liver Dis, V5, P1009, DOI 10.1016/S1089-3261(05)70206-3; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Herrmann E, 2000, ANTIVIR THER, V5, P85; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Imhof I, 2011, HEPATOLOGY, V53, P1090, DOI 10.1002/hep.24172; Irshad M, 2008, REV MED VIROL, V19, DOI [10.1002/rmv.603, DOI 10.1002/RMV.603]; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kim JJ, 2012, AM J HEALTH-SYST PH, V69, P19, DOI 10.2146/ajhp110123; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lemke CT, 2011, J BIOL CHEM, V286, P11434, DOI 10.1074/jbc.M110.211417; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Lopez-Labrador FX, 2008, ANTIVIR THER, V13, P481; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Ortuso F, 2006, BIOINFORMATICS, V22, P1449, DOI 10.1093/bioinformatics/btl115; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Prongay AJ, 2007, J MED CHEM, V50, P2310, DOI 10.1021/jm060173k; Qiu P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp251; Reiser M, 2005, HEPATOLOGY, V41, P832, DOI 10.1002/hep.20612; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Svicher V, 2011, DIGEST LIVER DIS, V43, P975, DOI 10.1016/j.dld.2011.07.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Trimoulet P, 2011, HIV MED, V12, P506, DOI 10.1111/j.1468-1293.2011.00913.x; Vallet S, 2011, ANTIVIR THER, V16, P1093, DOI 10.3851/IMP1900; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; Verbinnen T, 2010, J VIROL, V84, P11124, DOI 10.1128/JVI.01217-10; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; World Health Organization (WHO) HCV Fact Sheet, 2011, WHO HCV FACT SHEET; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	74	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39652	10.1371/journal.pone.0039652	http://dx.doi.org/10.1371/journal.pone.0039652			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792183	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800015
J	Lee, M; Jun, SY; Yoon, BY; Song, S; Lee, K; Ha, NC				Lee, Minho; Jun, So-Young; Yoon, Bo-Young; Song, Saemee; Lee, Kangseok; Ha, Nam-Chul			Membrane Fusion Proteins of Type I Secretion System and Tripartite Efflux Pumps Share a Binding Motif for TolC in Gram-Negative Bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MULTIDRUG EFFLUX; HEMOLYSIN TRANSLOCATOR; PERIPLASMIC COMPONENT; TIP REGION; HLYD; IDENTIFICATION; TRANSPORTER; HAIRPIN	The Hly translocator complex of Escherichia coli catalyzes type I secretion of the toxin hemolysin A (HlyA). In this complex, HlyB is an inner membrane ABC (ATP Binding Cassette)-type transporter, TolC is an outer membrane channel protein, and HlyD is a periplasmic adaptor anchored in the inner membrane that bridges HlyB to TolC. This tripartite organization is reminiscent of that of drug efflux systems such as AcrA-AcrB-TolC and MacA-MacB-TolC of E. coli. We have previously shown the crucial role of conserved residues located at the hairpin tip region of AcrA and MacA adaptors during assembly of their cognate systems. In this study, we investigated the role of the putative tip region of HlyD using HlyD mutants with single amino acid substitutions at the conserved positions. In vivo and in vitro data show that all mutations abolished HlyD binding to TolC and resulted in the absence of HlyA secretion. Together, our results suggest that, similarly to AcrA and MacA, HlyD interacts with TolC in a tip-to-tip manner. A general model in which these conserved interactions induce opening of TolC during drug efflux and type I secretion is discussed.	[Lee, Minho; Song, Saemee; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Jun, So-Young; Yoon, Bo-Young; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Mfg Pharm, Pusan, South Korea	Chung Ang University; Pusan National University	Lee, M (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr	Lee, Minho/AAK-4109-2021	Lee, Minho/0000-0002-8404-5702	National Research Foundation of Korea [2010-0015298]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ009025]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea	This work was supported by grants 2010-0015298 from the National Research Foundation of Korea, and the Next-Generation BioGreen 21 Program (SSAC, grant#: PJ009025), Rural Development Administration, Republic of Korea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; COHEN SN, 1977, J BACTERIOL, V132, P734, DOI 10.1128/JB.132.2.734-737.1977; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; HOLLAND IB, 1990, J BIOENERG BIOMEMBR, V22, P473, DOI 10.1007/BF00763178; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; KENNY B, 1992, MOL MICROBIOL, V6, P1477, DOI 10.1111/j.1365-2958.1992.tb00868.x; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; MACKMAN N, 1984, MOL GEN GENET, V196, P129, DOI 10.1007/BF00334104; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Pimenta AL, 1999, MOL GEN GENET, V261, P122, DOI 10.1007/s004380050949; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; SCHULEIN R, 1992, MOL GEN GENET, V234, P155; SCHULEIN R, 1994, MOL GEN GENET, V245, P203; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2011, PROTEIN SCI, V20, P6, DOI 10.1002/pro.532; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; WANG RC, 1991, J MOL BIOL, V217, P441, DOI 10.1016/0022-2836(91)90748-U; WELCH RA, 1981, NATURE, V294, P665, DOI 10.1038/294665a0; Xu YB, 2012, J BIOL CHEM, V287, P11740, DOI 10.1074/jbc.M111.329375; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189	33	38	37	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40460	10.1371/journal.pone.0040460	http://dx.doi.org/10.1371/journal.pone.0040460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792337	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800090
J	Liu, XY; Wang, YJ; Shih, CK; Ren, D; Yang, D				Liu, Xingyue; Wang, Yongjie; Shih, Chungkun; Ren, Dong; Yang, Ding			Early Evolution and Historical Biogeography of Fishflies (Megaloptera: Chauliodinae): Implications from a Phylogeny Combining Fossil and Extant Taxa	PLOS ONE			English	Article							WEELE MEGALOPTERA; NEUROPTERIDA INSECTA; NEOCHAULIODES-WEELE; CORYDALIDAE; GENUS; VICARIANCE; CHINA; SYSTEMATICS; HEMISPHERE; DISPERSAL	Fishflies (Corydalidae: Chauliodinae) are one of the main groups of the basal holometabolous insect order Megaloptera, with ca. 130 species distributed worldwide. A number of genera from the Southern Hemisphere show remarkably disjunctive distributions and are considered to be the austral remnants or "living fossils'' of Gondwana. Hitherto, the evolutionary history of fishflies remains largely unexplored due to limited fossil record and incomplete knowledge of phylogenetic relationships. Here we describe two significant fossil species of fishflies, namely Eochauliodes striolatus gen. et sp. nov. and Jurochauliodes ponomarenkoi Wang & Zhang, 2010 (original designation for fossil larvae only), from the Middle Jurassic of Inner Mongolia, China. These fossils represent the earliest fishfly adults. Furthermore, we reconstruct the first phylogenetic hypothesis including all fossil and extant genera worldwide. Three main clades within Chauliodinae are recognized, i.e. the Dysmicohermes clade, the Protochauliodes clade, and the Archichauliodes clade. The phylogenetic and dispersal-vicariance (DIVA) analyses suggest Pangaean origin and global distribution of fishflies before the Middle Jurassic. The generic diversification of fishflies might have happened before the initial split of Pangaea, while some Gondwanan-originated clades were likely to be affected by the sequential breakup of Pangaea. The modern fauna of Asian fishflies were probably derived from their Gondwanan ancestor but not the direct descendents of the Mesozoic genera in Asia.	[Liu, Xingyue; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Wang, Yongjie; Shih, Chungkun; Ren, Dong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	China Agricultural University; Capital Normal University	Liu, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	rendong@mail.cnu.edu.cn; dyangcau@yahoo.com.cn	Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659	National Natural Science Foundation of People's Republic of China [31000973]; Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China [201178]; Science Foundation of Doctor Subjects, State Education Ministry of People's Republic of China [20090008120019]	National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Science Foundation of Doctor Subjects, State Education Ministry of People's Republic of China	This research was supported by the National Natural Science Foundation of People's Republic of China (No. 31000973 to XL), the Foundation for the Author of National Excellent Doctoral Dissertation of People's Republic of China (No. 201178 to XL), the Science Foundation of Doctor Subjects, State Education Ministry of People's Republic of China (No. 20090008120019 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS BA, 1988, J ULTRA MOL STRUCT R, V101, P185, DOI 10.1016/0889-1605(88)90008-0; Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Ansorge J, 2001, NEUES JAHRB GEOL P-M, P553; Ansorge J, 2005, ABSTR VORTR 2; Aspock Horst, 1998, Acta Zoologica Fennica, V209, P33; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; BRUNDIN L, 1967, ANNU REV ENTOMOL, V12, P149, DOI 10.1146/annurev.en.12.010167.001053; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Contreras-Ramos A, 1998, J N AM BENTHOL SOC, V17, P489, DOI 10.2307/1468368; Cox CB, 2000, MEM I OSWALDO CRUZ, V95, P509, DOI 10.1590/S0074-02762000000400012; Cranston PS, 2010, SYST ENTOMOL, V35, P636, DOI 10.1111/j.1365-3113.2010.00531.x; Engel MS, 2008, J KANSAS ENTOMOL SOC, V81, P188, DOI 10.2317/JKES-802.19.1; Esben-Petersen P., 1924, Annals of the South African Museum, V19, P151; Evans ED, 1972, THESIS OREGON STATES; FLINT O S JR, 1973, Revista Chilena de Entomologia, V7, P31; FLINT OLIVER S., 1965, PSYCHE J ENTOMOL [CAMBRIDGE MASSACHUSETTS], V72, P255; FLINT OS, 1983, ENTOMOL NEWS, V94, P15; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Gould Katherine R., 1998, American Journal of Botany, V85, P133; Grimaldi David, 2005, pi; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Hayashi F, 1995, THE NATURE INSECTS, V30, P15; Heilveil JS, 2006, MOL ECOL, V15, P1627, DOI 10.1111/j.1365-294X.2006.02876.x; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Kimmins D.E., 1954, Bulletin of the British Museum (Natural History) Entomology, V3, P417; Kukalova-Peck J., 1991, P141; Liu XY, 2006, ZOOL SCR, V35, P473, DOI 10.1111/j.1463-6409.2006.00240.x; Liu XY, 2008, SYST ENTOMOL, V33, P560, DOI 10.1111/j.1365-3113.2008.00429.x; Liu XY, 2007, ZOOTAXA, P29, DOI 10.11646/zootaxa.1511.1.3; Liu XY, 2006, SYST ENTOMOL, V31, P652, DOI 10.1111/j.1365-3113.2006.00346.x; Liu XY, 2011, ZOOTAXA, P23, DOI 10.11646/zootaxa.2981.1.2; Liu XY, 2011, ZOOTAXA, P1; Liu XY, 2010, ZOOTAXA, P33, DOI 10.11646/zootaxa.2692.1.2; Liu XY, 2010, EUR J ENTOMOL, V107, P425, DOI 10.14411/eje.2010.050; Liu XY, 2010, ANN ZOOL, V60, P109, DOI 10.3161/000345410X499597; Liu XY, 2006, ANN ZOOL, V56, P187; Liu XY, 2005, ENTOMOL SCI, V8, P293, DOI 10.1111/j.1479-8298.2005.00128.x; Liu XY, 2005, ZOOTAXA, P1; MADDISON DR, 2000, MACCLADE VERSION 4 0; New Timothy R., 1993, Handbuch der Zoologie (Berlin), V4, P1; PENNY ND, 1993, ENTOMOL NEWS, V104, P17; Penny ND, 1999, ENTOMOL NEWS, V110, P193; Pictet J.F., 1854, TRAITE PALEONTOLOGIE, V2, P301; PONOMARENKO A G, 1976, Entomologicheskoe Obozrenie, V55, P425; Ponomarenko A.G., 2002, HIST INSECTS, P176; Price BW, 2012, ZOOKEYS IN PRESS; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; Ren D., 2010, SILENT STORIES INSEC; RIEK E F, 1974, Palaeontologia Africana, V17, P19; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; SCOTESE CR, 1991, PALAEOGEOGR PALAEOCL, V87, P493, DOI 10.1016/0031-0182(91)90145-H; STYS P, 1990, BIOL REV, V65, P401, DOI 10.1111/j.1469-185X.1990.tb01232.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tan Jing-Jing, 2002, Acta Zootaxonomica Sinica, V27, P428; Theischinger G, 2000, AUSTR ALDERFLY LARVA, V29; Theischinger Gunther, 1999, Stapfia, V60, P85; Thomas DC, 2012, J BIOGEOGR, V39, P98, DOI 10.1111/j.1365-2699.2011.02596.x; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; van der Weele H.W, 1910, COLLECTIONS ZOOLOGIQ, V5, P1; van dersWeele H.W., 1909, NOTES LEYDEN MUSEUM, V30, P249; VEEVERS JJ, 1991, AUST J EARTH SCI, V38, P373, DOI 10.1080/08120099108727979; Wang B, 2010, J PALEONTOL, V84, P774, DOI 10.1666/09-162.1; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wichard Wilfried, 2003, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V87, P147; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; Yang D., 2010, FAUNA SINICA INSECTA, V51; Yu Y., 2011, RASP RECONSTRUCT ANC; [No title captured]	74	29	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40345	10.1371/journal.pone.0040345	http://dx.doi.org/10.1371/journal.pone.0040345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792287	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800072
J	Maezawa, Y; Binnie, M; Li, CJ; Thorner, P; Hui, CC; Alman, B; Taketo, MM; Quaggin, SE				Maezawa, Yoshiro; Binnie, Matthew; Li, Chengjin; Thorner, Paul; Hui, Chi-Chung; Alman, Benjamin; Taketo, Makoto Mark; Quaggin, Susan E.			A New Cre Driver Mouse Line, Tcf21/Pod1-Cre, Targets Metanephric Mesenchyme	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; BETA-CATENIN GENE; KIDNEY DEVELOPMENT; MAMMALIAN KIDNEY; TRANSGENIC MICE; HUMAN HOMOLOG; EXPRESSION; MUTATIONS; CELLS; POD1	Conditional gene targeting in mice has provided great insight into the role of gene function in kidney development and disease. Although a number of Cre-driver mouse strains already exist for the kidney, development of additional strains with unique expression patterns is needed. Here we report the generation and validation of a Tcf21/Pod1-Cre driver strain that expresses Cre recombinase throughout the condensing and stromal mesenchyme of developing kidneys and in their derivatives including epithelial components of the nephron and interstitial cells. To test the efficiency of this line, we crossed it to mice transgenic for either loss or gain of function beta-catenin conditional alleles. Mice with deletion of beta-catenin from Tcf21-expressing cells are born with hypoplastic kidneys, hydroureters and hydronephrosis. By contrast, Tcf21-Cre driven gain of function for beta-catenin in mice results in fused midline kidneys and hypoplastic kidneys. Finally, we report the first renal mesenchymal deletion of Patched1 (Ptch1), the receptor for sonic hedgehog (Shh), which results in renal cysts demonstrating a functional role of Shh signaling pathway in renal cystogensis. In summary, we report the generation and validation of a new Cre driver strain that provides robust excision in metanephric mesenchyme.	[Maezawa, Yoshiro; Li, Chengjin; Quaggin, Susan E.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Binnie, Matthew] Univ Toronto, St Michaels Hosp, Div Respirol, Toronto, ON M5B 1W8, Canada; [Thorner, Paul] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Hui, Chi-Chung; Alman, Benjamin] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Alman, Benjamin] Univ Toronto, Div Orthopaed Surg, Toronto, ON, Canada; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Quaggin, Susan E.] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada; [Quaggin, Susan E.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Kyoto University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Maezawa, Y (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	quaggin@lunenfeld.ca		Maezawa, Yoshiro/0000-0001-5567-9901	Canadian Institutes of Health Research [MOP62931];  [016002]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); 	This work was funded by Canadian Institutes of Health Research grants MOP62931, Terry Fox grant 016002 to S.E.Q. who holds the Gabor-Zellerman Chair in Renal Research, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Brault V, 2001, DEVELOPMENT, V128, P1253; Cain JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007313; Cui SY, 2005, J AM SOC NEPHROL, V16, P3247, DOI 10.1681/ASN.2005030278; Cui SY, 2003, DEV DYNAM, V226, P512, DOI 10.1002/dvdy.10244; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Li J, 2000, GENESIS, V26, P162, DOI 10.1002/(SICI)1526-968X(200002)26:2<162::AID-GENE21>3.0.CO;2-R; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; Maezawa Y, 2012, EMBRYOLOGY KIDNEY BR; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pietila I, DEV BIOL, V353, P50; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; Robyn J, 2008, CURRENT TOPICS DEV B, V84, P250; Shan JD, 2010, DIFFERENTIATION, V79, P57, DOI 10.1016/j.diff.2009.08.006; Srinivas S, 1999, DEV GENET, V24, P241; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tasouri E, 2011, CELL TISSUE RES, V345, P21, DOI 10.1007/s00441-011-1192-8; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Yu J, 2002, DEVELOPMENT, V129, P5301; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	36	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40547	10.1371/journal.pone.0040547	http://dx.doi.org/10.1371/journal.pone.0040547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792366	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800105
J	Padmanabhan, V; Khan, ZS; Solomon, DE; Armstrong, A; Rumbaugh, KP; Vanapalli, SA; Blawzdziewicz, J				Padmanabhan, Venkat; Khan, Zeina S.; Solomon, Deepak E.; Armstrong, Andrew; Rumbaugh, Kendra P.; Vanapalli, Siva A.; Blawzdziewicz, Jerzy			Locomotion of C. elegans: A Piecewise-Harmonic Curvature Representation of Nematode Behavior	PLOS ONE			English	Article							THERMAL-GRADIENT; CAENORHABDITIS; THERMOTAXIS; NEURONS; TOUCH	Caenorhabditis elegans, a free-living soil nematode, displays a rich variety of body shapes and trajectories during its undulatory locomotion in complex environments. Here we show that the individual body postures and entire trails of C. elegans have a simple analytical description in curvature representation. Our model is based on the assumption that the curvature wave is generated in the head segment of the worm body and propagates backwards. We have found that a simple harmonic function for the curvature can capture multiple worm shapes during the undulatory movement. The worm body trajectories can be well represented in terms of piecewise sinusoidal curvature with abrupt changes in amplitude, wavevector, and phase.	[Padmanabhan, Venkat] Texas Tech Univ, Venkat Padmanabhan Dept Mech Engn, Lubbock, TX 79409 USA; [Khan, Zeina S.] Texas Tech Univ, Zeina S Khan Dept Chem Engn, Lubbock, TX 79409 USA; [Solomon, Deepak E.] Texas Tech Univ, Deepak E Solomon Dept Chem Engn, Lubbock, TX 79409 USA; [Armstrong, Andrew] Texas Tech Univ, Hlth Sci Ctr, Andrew Armstrong Dept Surg, Lubbock, TX 79430 USA; [Rumbaugh, Kendra P.] Texas Tech Univ, Hlth Sci Ctr, Kendra P Rumbaugh Dept Surg, Lubbock, TX 79430 USA; [Vanapalli, Siva A.] Texas Tech Univ, Siva Vanapalli Dept Chem Engn, Lubbock, TX 79409 USA; [Blawzdziewicz, Jerzy] Texas Tech Univ, Jerzy Blawzdziewicz Dept Mech Engn, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Padmanabhan, V (corresponding author), Texas Tech Univ, Venkat Padmanabhan Dept Mech Engn, Lubbock, TX 79409 USA.	venkatram.padmanabhan@ttu.edu	Padmanabhan, Venkat/G-2798-2013		National Science Foundation (NSF) CAREER Award [1150836]; Howard Hughes Medical Institute (through the Undergraduate Science Education Program); NSF Grant [CBET 1059745]; Div Of Chem, Bioeng, Env, & Transp Sys [1059745] Funding Source: National Science Foundation	National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Howard Hughes Medical Institute (through the Undergraduate Science Education Program)(Howard Hughes Medical Institute); NSF Grant(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	SAV acknowledges National Science Foundation (NSF) CAREER Award Grant No.\ 1150836. KPR acknowledges the Howard Hughes Medical Institute (grant through the Undergraduate Science Education Program to Texas Tech University). This work was also supported by NSF Grant No.\ CBET 1059745 (JB,VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Berri S, 2009, HFSP J, V3, P186, DOI 10.2976/1.3082260; Boyle JH, 2008, LECT NOTES COMPUT SC, V4984, P37; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen B, 1986, P NATL ACAD SCI USA, V103, P4723; Fang-Yen C, 2010, P NATL ACAD SCI USA, V107, P20323, DOI 10.1073/pnas.1003016107; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; GRAY J, 1964, J EXP BIOL, V41, P135; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hart A., 2006, WORMBOOK, DOI [10.1895/wormbook.1.87.1, DOI 10.1895/WORMBOOK.1.87.1, 10.1895/wormbook.1.87.1.]; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Jung S, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3359611; Kaplan F, 2009, J CHEM ECOL, V35, P878, DOI 10.1007/s10886-009-9670-0; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Kim D, 2011, J EXP BIOL, V214, P1554, DOI 10.1242/jeb.052092; Majmudar T, 2012, J R SOC INTERFACE; Matsuoka T, 2008, J THEOR BIOL, V250, P230, DOI 10.1016/j.jtbi.2007.10.002; Nakazato K, 2009, J THEOR BIOL, V260, P56, DOI 10.1016/j.jtbi.2009.05.027; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Pierce-Shimomura JT, 2005, J EXP BIOL, V208, P4727, DOI 10.1242/jeb.01933; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Ramot D, 2008, J NEUROSCI, V28, P12546, DOI 10.1523/JNEUROSCI.2857-08.2008; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shen XN, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.208101; Shenoy VB, 2007, P NATL ACAD SCI USA, V104, P8229, DOI 10.1073/pnas.0702454104; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stiernagle Theresa, 2006, WormBook, P1; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Sznitman J, 2010, EXP MECH, V50, P1303, DOI 10.1007/s11340-010-9339-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhao BB, 2003, J NEUROSCI, V23, P5319	36	17	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40121	10.1371/journal.pone.0040121	http://dx.doi.org/10.1371/journal.pone.0040121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792224	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800042
J	Sanchez-Guerrero, E; Chen, E; Kockx, M; An, SW; Chong, BH; Khachigian, LM				Sanchez-Guerrero, Estella; Chen, Elya; Kockx, Maaike; An, Si-Wei; Chong, Beng H.; Khachigian, Levon M.			IL-1beta Signals through the EGF Receptor and Activates Egr-1 through MMP-ADAM	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR RECEPTOR; NEOINTIMAL HYPERPLASIA; EPITHELIAL-CELLS; GENE-EXPRESSION; RESPONSE GENE-1; TRANSACTIVATION; TRANSCRIPTION; ATHEROSCLEROSIS; MIGRATION	The immediate-early gene Egr-1 controls the inducible expression of many genes implicated in the pathogenesis of a range of vascular disorders, yet our understanding of the mechanisms controlling the rapid expression of this prototypic zinc finger transcription factor is poor. Here we show that Egr-1 expression induced by IL-1beta is dependent on metalloproteinases (MMP) and a disintegrin and a metalloproteinase (ADAM). Pharmacologic MMP/ADAM inhibitors and siRNA knockdown prevent IL-1beta induction of Egr-1. Further, IL-1beta activates Egr-1 via the epidermal growth factor receptor (EGFR). This is blocked by EGFR tyrosine kinase inhibition and EGFR knockdown. IL-1beta induction of Egr-1 expression is reduced in murine embryonic fibroblasts (mEFs) deficient in ADAM17 despite unbiased expression of EGFR and IL-1RI in ADAM17-deficient and wild-type mEFs. Finally, we show that IL-1beta-inducible wound repair after mechanical injury requires both EGFR and MMP/ADAM. This study reports for the first time that Egr-1 induction by IL-1beta involves EGFR and MMP/ADAM-dependent EGFR phosphorylation.	[Sanchez-Guerrero, Estella; Chen, Elya; Kockx, Maaike; An, Si-Wei; Chong, Beng H.; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia	University of New South Wales Sydney	Sanchez-Guerrero, E (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	L.Khachigian@unsw.edu.au	Khachigian, Levon/AAZ-7458-2020; Chong, Beng/AAE-2617-2019; Chong, Beng/AAM-9010-2021	Khachigian, Levon/0000-0003-3446-0323	National Health and Medical Research Council (NHMRC) of Australia; National Heart Foundation (NHF); Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation (NHF)(National Heart Foundation of Australia); Australian Research Council (ARC)(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia, National Heart Foundation (NHF) and Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Bhindi R, 2011, J PATHOL IN PRESS; Bhindi R, 2007, AM J PATHOL, V171, P1079, DOI 10.2353/ajpath.2007.070120; Bos M, 1997, CLIN CANCER RES, V3, P2099; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1; Chan HW, 2006, PULM PHARMACOL THER, V19, P74, DOI 10.1016/j.pupt.2005.04.005; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Day FL, 1999, J BIOL CHEM, V274, P23726, DOI 10.1074/jbc.274.34.23726; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fuentes LQ, 2008, CELL SIGNAL, V20, P1642, DOI 10.1016/j.cellsig.2008.05.009; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Howe CL, 2006, NEUROBIOL DIS, V23, P731, DOI 10.1016/j.nbd.2006.06.012; Isoda K, 2003, CIRCULATION, V108, P516, DOI 10.1161/01.CIR.0000085567.18648.21; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, pE35, DOI 10.1161/ATVBAHA.111.225623; Johnson TW, 2005, ARTERIOSCL THROM VAS, V25, P754, DOI 10.1161/01.ATV.0000157582.33180.a9; Keates S, 2005, GUT, V54, P1363, DOI 10.1136/gut.2005.066977; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Khachigian LM, 1997, ARTERIOSCL THROM VAS, V17, P2280, DOI 10.1161/01.ATV.17.10.2280; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P1660; LEMIRE JM, 1994, AM J PATHOL, V144, P1068; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Lowe HC, 2002, THROMB HAEMOSTASIS, V87, P134, DOI 10.1055/s-0037-1612956; Lowe HC, 2001, CIRC RES, V89, P670, DOI 10.1161/hh2001.097867; Luo X, 2009, ARTERIOSCL THROM VAS, V29, P1836, DOI 10.1161/ATVBAHA.109.189753; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; Mifune M, 2005, J BIOL CHEM, V280, P26592, DOI 10.1074/jbc.M502906200; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Ohtani K, 2004, GENE THER, V11, P126, DOI 10.1038/sj.gt.3302153; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Poncet N, 2011, CELL SIGNAL, V23, P572, DOI 10.1016/j.cellsig.2010.11.009; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Reddy ABM, 2009, ENDOCRINOLOGY, V150, P63, DOI 10.1210/en.2008-0677; Saito S, 2002, BIOCHEM BIOPH RES CO, V294, P1023, DOI 10.1016/S0006-291X(02)00595-8; Sanchez-Guerrero E, 2008, NUCLEIC ACIDS RES, V36, P1941, DOI 10.1093/nar/gkm923; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Takaguri A, 2011, HYPERTENSION, V57, P841, DOI 10.1161/HYPERTENSIONAHA.110.166892; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; Wang B, 2010, ARTERIOSCL THROM VAS, V30, P536, DOI 10.1161/ATVBAHA.109.193821; White KJ, 2011, J INVEST DERMATOL, V131, P435, DOI 10.1038/jid.2010.308; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298	51	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39811	10.1371/journal.pone.0039811	http://dx.doi.org/10.1371/journal.pone.0039811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792188	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800019
J	Sun, XM; Saito, M; Sato, Y; Chikata, T; Naruto, T; Ozawa, T; Kobayashi, E; Kishi, H; Muraguchi, A; Takiguchi, M				Sun, Xiaoming; Saito, Masumichi; Sato, Yoshinori; Chikata, Takayuki; Naruto, Takuya; Ozawa, Tatsuhiko; Kobayashi, Eiji; Kishi, Hiroyuki; Muraguchi, Atsushi; Takiguchi, Masafumi			Unbiased Analysis of TCR alpha/beta Chains at the Single-Cell Level in Human CD8(+) T-Cell Subsets	PLOS ONE			English	Article							ANTIGEN RECEPTOR GENES; V(D)J RECOMBINATION; GERMLINE TRANSCRIPTION; BETA-CHAINS; DIFFERENTIATION; REARRANGEMENT; RECOGNITION; PROMOTER; MEMORY; REPERTOIRE	T-cell receptor (TCR) alpha/beta chains are expressed on the surface of CD8(+) T-cells and have been implicated in antigen recognition, activation, and proliferation. However, the methods for characterization of human TCR alpha/beta chains have not been well established largely because of the complexity of their structures owing to the extensive genetic rearrangements that they undergo. Here we report the development of an integrated 5'-RACE and multiplex PCR method to amplify the full-length transcripts of TCRa/b at the single-cell level in human CD8+ subsets, including naive, central memory, early effector memory, late effector memory, and effector phenotypic cells. Using this method, with an approximately 47% and 62% of PCR success rate for TCR alpha and for TCR beta chains, respectively, we were able to analyze more than 1,000 reads of transcripts of each TCR chain. Our comprehensive analysis revealed the following: (1) chimeric rearrangements of TCR delta-alpha, (2) control of TCR alpha/beta transcription with multiple transcriptional initiation sites, (3) altered utilization of TCR alpha/beta chains in CD8(+) subsets, and (4) strong association between the clonal size of TCR alpha/beta chains and the effector phenotype of CD8(+) T-cells. Based on these findings, we conclude that our method is a useful tool to identify the dynamics of the TCR alpha/beta repertoire, and provides new insights into the study of human TCR alpha/beta chains.	[Sun, Xiaoming; Saito, Masumichi; Sato, Yoshinori; Chikata, Takayuki; Naruto, Takuya; Takiguchi, Masafumi] Kumamoto Univ, Ctr AIDS Res, Honjo, Kumamoto, Japan; [Ozawa, Tatsuhiko; Kobayashi, Eiji; Kishi, Hiroyuki; Muraguchi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan	Kumamoto University; University of Toyama	Sun, XM (corresponding author), Kumamoto Univ, Ctr AIDS Res, Honjo, Kumamoto, Japan.	masafumi@kumamoto-u.ac.jp	Sun, Xiaoming/H-9656-2019; Sato, Yoshinori/J-2497-2015; Takiguchi, Masafumi/E-7468-2013	Sun, Xiaoming/0000-0001-6266-6869; Sato, Yoshinori/0000-0001-8250-6598; Kobayashi, Eiji/0000-0002-7303-2797; Ozawa, Tatsuhiko/0000-0002-3112-452X; Chikata, Takayuki/0000-0001-8907-1320	Global COE program "Global Education and Research Center Aiming at the control of AIDS" [F13]	Global COE program "Global Education and Research Center Aiming at the control of AIDS"	This research was supported by the Global COE program "Global Education and Research Center Aiming at the control of AIDS'' (No. F13), launched as a project commissioned by the Ministry of Education, Science, Sports, and Culture, Japan (http://www.jsps.go.jp/english/e-globalcoe/01_outline.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SJ, 1988, P NATL ACAD SCI USA, V85, P3551, DOI 10.1073/pnas.85.10.3551; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deng XZ, 1998, J BIOL CHEM, V273, P23709, DOI 10.1074/jbc.273.37.23709; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GELLERT M, 1992, ANNU REV GENET, V26, P425, DOI 10.1146/annurev.ge.26.120192.002233; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GORSKI J, 1994, J IMMUNOL, V152, P5109; Guidotti LG, 1996, CURR OPIN IMMUNOL, V8, P478, DOI 10.1016/S0952-7915(96)80034-3; Hamrouni A, 2003, J EXP MED, V197, P601, DOI 10.1084/jem.20021945; Inlay M, 2003, CLIN IMMUNOL, V109, P29, DOI 10.1016/S1521-6616(03)00199-2; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KOBAYASHI Y, 1991, J IMMUNOL, V147, P3201; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; MIOSSEC C, 1990, J EXP MED, V171, P1171, DOI 10.1084/jem.171.4.1171; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; PADOVAN E, 1995, ANN NY ACAD SCI, V756, P66, DOI 10.1111/j.1749-6632.1995.tb44482.x; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Sikes ML, 1998, J IMMUNOL, V161, P1399; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Ueno T, 2003, EUR J IMMUNOL, V33, P2910, DOI 10.1002/eji.200324148; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90	37	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40386	10.1371/journal.pone.0040386	http://dx.doi.org/10.1371/journal.pone.0040386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792299	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800075
J	Lee, RHC; Tseng, TY; Wu, CYC; Chen, PY; Chen, MF; Kuo, JS; Lee, TJF				Lee, Reggie Hui-Chao; Tseng, Ting-Yi; Wu, Celeste Yin-Chieh; Chen, Po-Yi; Chen, Mei-Fang; Kuo, Jon-Son; Lee, Tony Jer-Fu			Memantine Inhibits alpha 3 beta 2-nAChRs-Mediated Nitrergic Neurogenic Vasodilation in Porcine Basilar Arteries	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SUPERIOR CERVICAL-GANGLION; LARGE CEREBRAL-ARTERIES; OPEN-CHANNEL BLOCKERS; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; ANTAGONIST MEMANTINE; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; BLOOD-FLOW	Memantine, an NMDA receptor antagonist used for treatment of Alzheimer's disease (AD), is known to block the nicotinic acetylcholine receptors (nAChRs) in the central nervous system (CNS). In the present study, we examined by wire myography if memantine inhibited alpha 3 beta 2-nAChRs located on cerebral perivascular sympathetic nerve terminals originating in the superior cervical ganglion (SCG), thus, leading to inhibition of nicotine-induced nitrergic neurogenic dilation of isolated porcine basilar arteries. Memantine concentration-dependently blocked nicotine-induced neurogenic dilation of endothelium-denuded basilar arteries without affecting that induced by transmural nerve stimulation, sodium nitroprusside, or isoproterenol. Furthermore, memantine significantly inhibited nicotine-elicited inward currents in Xenopous oocytes expressing alpha 3 beta 2-, alpha 7- or alpha 4 beta 2-nAChR, and nicotine-induced calcium influx in cultured rat SCG neurons. These results suggest that memantine is a non-specific antagonist for nAChR. By directly inhibiting alpha 4 beta 2-nAChRs located on the sympathetic nerve terminals, memantine blocks nicotine-induced neurogenic vasodilation of the porcine basilar arteries. This effect of memantine is expected to reduce the blood supply to the brain stem and possibly other brain regions, thus, decreasing its clinical efficacy in the treatment of Alzheimer's disease.	[Lee, Reggie Hui-Chao; Kuo, Jon-Son; Lee, Tony Jer-Fu] Tzu Chi Univ, Coll Med, Inst Med Sci, Hualien, Taiwan; [Tseng, Ting-Yi; Wu, Celeste Yin-Chieh; Chen, Po-Yi; Kuo, Jon-Son] Tzu Chi Univ, Coll Med, Inst Pharmacol & Toxicol, Hualien, Taiwan; [Lee, Tony Jer-Fu] Tzu Chi Univ, Coll Life Sci, Inst Life Sci, Hualien, Taiwan; [Lee, Reggie Hui-Chao; Tseng, Ting-Yi; Wu, Celeste Yin-Chieh; Chen, Po-Yi; Kuo, Jon-Son; Lee, Tony Jer-Fu] Tzu Chi Univ, Coll Life Sci, Ctr Vasc Med, Hualien, Taiwan; [Chen, Po-Yi; Chen, Mei-Fang] Buddhist Tzu Chi Gen Hosp, Dept Res, Hualien, Taiwan; [Lee, Tony Jer-Fu] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Tzu Chi University; Tzu Chi University; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Southern Illinois University System; Southern Illinois University	Lee, RHC (corresponding author), Tzu Chi Univ, Coll Med, Inst Med Sci, Hualien, Taiwan.	tlee@mail.tcu.edu.tw	Chen, Po-Yi/ABG-6350-2021	Lee, Reggie/0000-0001-6099-8333	Tzu Chi University [TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, TCRPP99006]; National Science Council of Taiwan [NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, NSC 100-2320-B-320-007-MY2]; Tzu Chi Foundation	Tzu Chi University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi Foundation	This study was supported by Tzu Chi University (http://eng.tcu.edu.tw/) (Grants TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, and TCRPP99006), National Science Council of Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp = 7) (NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, and NSC 100-2320-B-320-007-MY2), and Tzu Chi Foundation (http://tw.tzuchi.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Babic T, 1999, J NEUROL NEUROSUR PS, V67, P558, DOI 10.1136/jnnp.67.4.558; Brenner SR, 2008, NEUROLOGY, V70, P243, DOI 10.1212/01.wnl.0000299721.10189.fe; Brown DRP, 1996, J PSYCHIAT RES, V30, P109, DOI 10.1016/0022-3956(95)00032-1; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; Castellani RJ, 2006, ACTA NEUROPATHOL, V111, P503, DOI 10.1007/s00401-006-0071-y; CHEN FY, 1995, J PHARMACOL EXP THER, V273, P895; Chen MF, 2012, NEUROPHARMACOLOGY, V62, P1651, DOI 10.1016/j.neuropharm.2011.11.011; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Dogan A, 1999, ACTA NEUROCHIR, V141, P1107, DOI 10.1007/s007010050491; Doraiswamy P Murali, 2003, Psychopharmacol Bull, V37, P41; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Erb C, 1999, BIOCHEM PHARMACOL, V57, P681, DOI 10.1016/S0006-2952(98)00338-4; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hesselink MB, 1999, PHARMACEUT RES, V16, P637, DOI 10.1023/A:1018856020583; Hirsch C, 1997, DEMENT GERIATR COGN, V8, P98, DOI 10.1159/000106613; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jarvis B, 2003, DRUG AGING, V20, P465, DOI 10.2165/00002512-200320060-00005; KORNHUBER J, 1995, NEUROSCI LETT, V195, P137, DOI 10.1016/0304-3940(95)11785-U; Lee RHC, 2011, AM J PHYSIOL-HEART C, V301, pH344, DOI 10.1152/ajpheart.00172.2011; LEE TJF, 1976, CIRC RES, V39, P120, DOI 10.1161/01.RES.39.1.120; LEE TJF, 1981, CIRC RES, V49, P971, DOI 10.1161/01.RES.49.4.971; LEE TJF, 1982, J CEREBR BLOOD F MET, V2, P439, DOI 10.1038/jcbfm.1982.50; Lee TJF, 2000, AM J PHYSIOL-HEART C, V279, pH808, DOI 10.1152/ajpheart.2000.279.2.H808; Lin HW, 2008, P NATL ACAD SCI USA, V105, P19526, DOI 10.1073/pnas.0810262105; Long C, 2006, AM J PHYSIOL-HEART C, V291, pH202, DOI 10.1152/ajpheart.01192.2005; Maskell PD, 2003, BRIT J PHARMACOL, V140, P1313, DOI 10.1038/sj.bjp.0705559; MATHEW NT, 1974, STROKE, V5, P303, DOI 10.1161/01.STR.5.3.303; Mozayan M, 2006, J CEREBR BLOOD F MET, V26, P1562, DOI 10.1038/sj.jcbfm.9600310; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; RIVERA VM, 1974, J AM GERIATR SOC, V22, P397, DOI 10.1111/j.1532-5415.1974.tb05408.x; Rogawski MA, 2003, CNS DRUG REV, V9, P275, DOI 10.1111/j.1527-3458.2003.tb00254.x; Rogawski MA, 2000, AMINO ACIDS, V19, P133, DOI 10.1007/s007260070042; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Si ML, 2005, J CEREBR BLOOD F MET, V25, P1573, DOI 10.1038/sj.jcbfm.9600232; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Si ML, 2001, J PHARMACOL EXP THER, V298, P122; WELCH MJ, 1976, J NEUROL NEUROSUR PS, V39, P367, DOI 10.1136/jnnp.39.4.367; Yeh JJ, 2001, J NEUROCHEM, V79, P258, DOI 10.1046/j.1471-4159.2001.00545.x; Zhang W, 1998, J PHARMACOL EXP THER, V284, P790; Zhou YF, 2001, J NEUROBIOL, V46, P178, DOI 10.1002/1097-4695(20010215)46:3<178::AID-NEU1001>3.0.CO;2-C; Zhou YF, 1998, J NEUROBIOL, V34, P164, DOI 10.1002/(SICI)1097-4695(19980205)34:2<164::AID-NEU6>3.0.CO;2-0	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40326	10.1371/journal.pone.0040326	http://dx.doi.org/10.1371/journal.pone.0040326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792283	gold, Green Submitted, Green Published			2022-12-25	WOS:000306436300055
J	Takamoto, M; Kaburaki, T; Mabuchi, A; Araie, M; Amano, S; Aihara, M; Tomidokoro, A; Iwase, A; Mabuchi, F; Kashiwagi, K; Shirato, S; Yasuda, N; Kawashima, H; Nakajima, F; Numaga, J; Kawamura, Y; Sasaki, T; Tokunaga, K				Takamoto, Mitsuko; Kaburaki, Toshikatsu; Mabuchi, Akihiko; Araie, Makoto; Amano, Shiro; Aihara, Makoto; Tomidokoro, Atsuo; Iwase, Aiko; Mabuchi, Fumihiko; Kashiwagi, Kenji; Shirato, Shiroaki; Yasuda, Noriko; Kawashima, Hidetoshi; Nakajima, Fumiko; Numaga, Jiro; Kawamura, Yoshiya; Sasaki, Tsukasa; Tokunaga, Katsushi			Common Variants on Chromosome 9p21 Are Associated with Normal Tension Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; OPTIC-NERVE HEAD; NORMAL-PRESSURE GLAUCOMA; OCULAR HYPERTENSION; INTRAOCULAR-PRESSURE; GENETIC-VARIANTS; BLOOD-PRESSURE; TGF-BETA; JAPANESE POPULATION	Although intraocular pressure (IOP) is the most definitive cause of glaucoma, a subtype of open angle glaucoma (OAG) termed normal tension glaucoma (NTG), which occurs in spite of normal IOP, accounts for a large part of glaucoma cases, especially in Japan. To find common genetic variants contributing to NTG in Japanese patients, we conducted a genome-wide association study (GWAS). We performed the first screening for 531,009 autosomal SNPs with a discovery cohort of 286 cases and 557 controls, and then a second screening for the top 30 suggestive loci in an independent cohort of 183 cases and 514 controls. Our findings identified a significantly associated SNP; rs523096 [combined p-value = 7.40 x 10(-8), odds ratio (OR) = 2.00 with 95% confidence interval (CI) 1.55-2.58] located 10 kbp upstream of CDKN2B on chromosome 9p21. Moreover, analysis of another independent case- control set successfully replicated the results of the screening studies (combined values of all 3 stages p = 4.96 x 10(-11), OR = 2.13 with 95% CI 1.69-2.68). The SNPs near rs523096 were recently reported to be associated with OAG associated with elevated IOP in primary open-angle glaucoma (POAG), the predominant subtype of glaucoma in Caucasian populations. Our results revealed that the 9p21 locus is also associated with NTG in Japanese. In addition, we identified SNPs more strongly associated with NTG.	[Takamoto, Mitsuko; Kaburaki, Toshikatsu; Araie, Makoto; Amano, Shiro; Aihara, Makoto; Tomidokoro, Atsuo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Mabuchi, Akihiko; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Iwase, Aiko] Tajimi Municipal Hosp, Dept Ophthalmol, Gifu, Japan; [Iwase, Aiko] Tajimi Iwase Eye Clin, Gifu, Japan; [Mabuchi, Fumihiko; Kashiwagi, Kenji] Univ Yamanashi, Dept Ophthalmol, Tamaho, Yamanashi, Japan; [Shirato, Shiroaki] Shirato Eye Clin, Tokyo, Japan; [Yasuda, Noriko] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Tokyo, Japan; [Kawashima, Hidetoshi; Nakajima, Fumiko] Saitama Red Cross Hosp, Dept Ophthalmol, Saitama, Japan; [Nakajima, Fumiko] Showa Gen Hosp, Dept Ophthalmol, Tokyo, Japan; [Numaga, Jiro] Tokyo Metropolitan Geriatr Hosp, Dept Ophthalmol, Tokyo 173, Japan; [Kawamura, Yoshiya] Yokohama Clin, Dept Psychiat, Yokohama, Kanagawa, Japan; [Sasaki, Tsukasa] Univ Tokyo, Dept Phys & Hlth Educ, Grad Sch Educ, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Yamanashi; Tokyo Metropolitan Institute of Gerontology; University of Tokyo	Takamoto, M (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	mwatanabe-tky@umin.ac.jp	Kaburaki, Toshikatsu/AAH-7091-2020		Ministry of Education, Culture, Sports, Science, and Technology [20592033]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This project was funded by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (20592033) to Dr. Kaburaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1981, ARCH OPHTHALMOL-CHIC, V99, P1795, DOI 10.1001/archopht.1981.03930020669009; Allingham RR, 2005, SHIELDS TXB GLAUCOMA, Vxiii; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; ANDERSON DR, 1999, AUTOMATED STATIC PER, pR14; Aung T, 2002, HUM GENET, V110, P513, DOI 10.1007/s00439-002-0711-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barry CJ, 1997, AUST NZ J OPHTHALMOL, V25, P137, DOI 10.1111/j.1442-9071.1997.tb01295.x; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burdon KP, 2011, NAT GENET       0527; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; CHIHARA E, 1992, GRAEF ARCH CLIN EXP, V230, P511, DOI 10.1007/BF00181770; COFFEY M, 1993, BRIT J OPHTHALMOL, V77, P17, DOI 10.1136/bjo.77.1.17; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Cursiefen C, 2000, AM J OPHTHALMOL, V129, P102, DOI 10.1016/S0002-9394(99)00289-5; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Dong J, 2001, BRIT J OPHTHALMOL, V85, P56, DOI 10.1136/bjo.85.1.56; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Duenker N, 2005, INT REV CYTOL, V245, P17, DOI 10.1016/S0074-7696(05)45002-0; Eid TE, 1997, AM J OPHTHALMOL, V124, P805, DOI 10.1016/S0002-9394(14)71698-8; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Fan BJ, 2005, MOL VIS, V11, P625; Fuchshofer R, 2011, EXP EYE RES, V93, P165, DOI 10.1016/j.exer.2010.07.014; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; GLOSTER J, 1981, BRIT J OPHTHALMOL, V65, P452, DOI 10.1136/bjo.65.7.452; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARRIS A, 1994, AM J OPHTHALMOL, V118, P642, DOI 10.1016/S0002-9394(14)76579-1; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Joachim SC, 2005, GRAEF ARCH CLIN EXP, V243, P817, DOI 10.1007/s00417-004-1094-5; Junemann AGM, 2000, GRAEF ARCH CLIN EXP, V238, P306, DOI 10.1007/s004170050357; KAISER HJ, 1993, GRAEF ARCH CLIN EXP, V231, P677, DOI 10.1007/BF00919280; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kawamura Y, 2011, J HUM GENET, V56, P852, DOI 10.1038/jhg.2011.117; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kremmer S, 2001, CLIN EXP IMMUNOL, V125, P211, DOI 10.1046/j.1365-2249.2001.01578.x; Lam CY, 2006, J GLAUCOMA, V15, P218, DOI 10.1097/01.ijg.0000212217.19804.a7; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Mabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Meyer JH, 1996, BRIT J OPHTHALMOL, V80, P864, DOI 10.1136/bjo.80.10.864; Morgan-Davies J, 2004, BRIT J OPHTHALMOL, V88, P1299, DOI 10.1136/bjo.2003.036020; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; Ohsaka Y, 2010, BIOCHEM GENET, V48, P970, DOI 10.1007/s10528-010-9379-3; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Pena JDO, 1999, BRIT J OPHTHALMOL, V83, P209, DOI 10.1136/bjo.83.2.209; PHELPS CD, 1985, INVEST OPHTH VIS SCI, V26, P1105; Pho L, 2006, CURR OPIN ONCOL, V18, P173, DOI 10.1097/01.cco.0000208791.22442.09; Powell B, 2003, MOL VIS, V9, P460; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Riccadonna M, 2003, J GLAUCOMA, V12, P156, DOI 10.1097/00061198-200304000-00011; ROJANAPONGPUN P, 1993, BRIT J OPHTHALMOL, V77, P25, DOI 10.1136/bjo.77.1.25; ROMANO C, 1995, INVEST OPHTH VIS SCI, V36, P1968; Rotchford AP, 2003, OPHTHALMOLOGY, V110, P376, DOI 10.1016/S0161-6420(02)01568-3; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Schwenn O, 2002, BRIT J OPHTHALMOL, V86, P981, DOI 10.1136/bjo.86.9.981; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Sripriya S, 2006, MOL VIS, V12, P816; Tezel G, 1996, OPHTHALMOLOGY, V103, P2105, DOI 10.1016/S0161-6420(96)30382-5; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Trivedi RH, 2011, J OCUL PHARMACOL TH, V27, P477, DOI 10.1089/jop.2010.0100; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vickers JC, 2002, MOL VIS, V8, P389; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Woo SJ, 2003, BRIT J OPHTHALMOL, V87, P695, DOI 10.1136/bjo.87.6.695; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Wu LL, 2000, JPN J OPHTHALMOL, V44, P643, DOI 10.1016/S0021-5155(00)00275-6; YAMAGAMI J, 1992, GRAEF ARCH CLIN EXP, V230, P446, DOI 10.1007/BF00175931; YAMAZAKI Y, 1991, GRAEF ARCH CLIN EXP, V229, P517, DOI 10.1007/BF00203313	93	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40107	10.1371/journal.pone.0040107	http://dx.doi.org/10.1371/journal.pone.0040107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792221	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300025
J	Vercelli, CA; Aisemberg, J; Cella, M; Salazar, AI; Wolfson, ML; Franchi, AM				Vercelli, Claudia A.; Aisemberg, Julieta; Cella, Maximiliano; Salazar, Ana Ines; Wolfson, Manuel L.; Franchi, Ana M.			Opposite Effects of Methanandamide on Lipopolysaccharide-Induced Prostaglandin E2 and F2 alpha Synthesis in Uterine Explants from Pregnant Mice	PLOS ONE			English	Article							MYOMETRIAL SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHESIS; HUMAN DECIDUA VERA; ARACHIDONIC-ACID; ENDOCANNABINOID SYSTEM; ANANDAMIDE SYNTHESIS; FETAL MEMBRANES; DENDRITIC CELLS; RAT UTERUS; BIOSYNTHESIS	Prostaglandins (PG) are effective abortifacients and are important mediators of lipopolisaccharide (LPS)-induced embryonic resorption (ER). Besides, anandamide (AEA) has been described as one of the major endocannabinoids present in the uterus suggesting that it might play a role in reproduction. It has been reported that high levels of AEA are associated with pregnancy failure and that LPS increases AEA production. Also, it has been observed that AEA modulates PG production in different tissues. In this sense, we studied whether LPS-induced PG production is modulated by AEA and we also assessed the effect of this endocannabinoid on PG metabolism in an in vitro model. Uterine explants from BALB/c implantation sites were cultured in the presence of LPS plus cannabinoid receptor (CB) specific antagonists and PG production was assessed. Then, we studied the effect of exogenous AEA on different steps of PG metabolic pathway. We showed that AEA is involved in LPS-induced PG biosynthesis. Also, we observed that AEA exerts opposite effects on PGE(2) and PGF(2 alpha) biosynthesis, by inhibiting PGE(2) production and increasing PGF2a levels. We suggest that AEA could be involved in the mechanisms implicated in LPS-induced ER. A better understanding of how AEA could be affecting ER could help developing specific interventions to prevent this pathology.	[Vercelli, Claudia A.; Aisemberg, Julieta; Cella, Maximiliano; Salazar, Ana Ines; Wolfson, Manuel L.; Franchi, Ana M.] Univ Buenos Aires, Sch Med, Natl Res Council, Ctr Pharmacol & Bot Studies,Lab Physiopathol Preg, Buenos Aires, DF, Argentina	University of Buenos Aires	Vercelli, CA (corresponding author), Univ Buenos Aires, Sch Med, Natl Res Council, Ctr Pharmacol & Bot Studies,Lab Physiopathol Preg, Buenos Aires, DF, Argentina.	clauverce77@yahoo.com.ar		Wolfson, Manuel Luis/0000-0003-3433-1521	National Research Council [CONICET-PIP 2008-2204]; Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT - PICT 2006-2165]	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This study was supported by the National Research Council (CONICET-PIP 2008-2204) and by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT - PICT 2006-2165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; Chen P, 2005, MICROVASC RES, V69, P28, DOI 10.1016/j.mvr.2005.02.001; COX SM, 1988, AM J OBSTET GYNECOL, V159, P99, DOI 10.1016/0002-9378(88)90501-7; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; DIAZ S, 1994, J PHARMACOL EXP THER, V268, P1289; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Farina M, 2004, J STEROID BIOCHEM, V91, P211, DOI 10.1016/j.jsbmb.2004.05.001; Farina MG, 2006, PROSTAG OTH LIPID M, V79, P260, DOI 10.1016/j.prostaglandins.2006.02.004; GROSS TS, 1987, PROSTAG OTH LIPID M, V34, P903, DOI 10.1016/0090-6980(87)90070-0; GU W, 1990, PROSTAG LEUKOTR ESS, V40, P27, DOI 10.1016/0952-3278(90)90112-X; HANSEN HS, 1976, PROSTAGLANDINS, V12, P647, DOI 10.1016/0090-6980(76)90044-7; Hertelendy F, 2004, CURR PHARM DESIGN, V10, P2499, DOI 10.2174/1381612043383926; HORTA AEM, 1986, ANN RECH VET, V17, P395; Hunter SA, 1997, LIFE SCI, V60, P1563, DOI 10.1016/S0024-3205(97)00122-7; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kubota K, 2005, J ENDOCRINOL, V187, P339, DOI 10.1677/joe.1.06169; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; MICHALEK SM, 1980, J IMMUNOL, V125, P2220; Mitchell MD, 2008, AM J PHYSIOL-ENDOC M, V294, pE352, DOI 10.1152/ajpendo.00495.2007; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Navarrete CM, 2009, J NEUROCHEM, V109, P452, DOI 10.1111/j.1471-4159.2009.05966.x; NIESERT S, 1986, AM J OBSTET GYNECOL, V155, P1348, DOI 10.1016/0002-9378(86)90172-9; O'Banion MK, 2010, PROSTAG OTH LIPID M, V91, P113, DOI 10.1016/j.prostaglandins.2009.04.008; Paria BC, 2000, CHEM PHYS LIPIDS, V108, P211, DOI 10.1016/S0009-3084(00)00197-3; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHLEGEL W, 1984, FEBS LETT, V171, P141, DOI 10.1016/0014-5793(84)80475-5; SLAMA H, 1993, PROSTAGLANDINS, V45, P57, DOI 10.1016/0090-6980(93)90090-T; Slater DM, 2006, MOL HUM REPROD, V12, P89, DOI 10.1093/molehr/gal005; Someya A, 2002, EUR J PHARMACOL, V450, P131, DOI 10.1016/S0014-2999(02)02122-2; VANE JR, 1973, BRIT J PHARMACOL, V48, P629, DOI 10.1111/j.1476-5381.1973.tb08250.x; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Vercelli CA, 2009, PLACENTA, V30, P579, DOI 10.1016/j.placenta.2009.04.003; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Wang HB, 2007, PROSTAG OTH LIPID M, V83, P62, DOI 10.1016/j.prostaglandins.2006.09.009; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Winchester SK, 2002, ENDOCRINOLOGY, V143, P2593, DOI 10.1210/en.143.7.2593; WIQVIST N, 1983, ACTA OBSTET GYN SCAN, P23; Zerani M, 2007, REPRODUCTION, V133, P1005, DOI 10.1530/REP-06-0107	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39532	10.1371/journal.pone.0039532	http://dx.doi.org/10.1371/journal.pone.0039532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792180	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300009
J	Vidal, A; Zhang, QH; Medigue, C; Fabre, S; Clement, F				Vidal, Alexandre; Zhang, Qinghua; Medigue, Claire; Fabre, Stephane; Clement, Frederique			DynPeak: An Algorithm for Pulse Detection and Frequency Analysis in Hormonal Time Series	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; SECRETORY EVENTS; APPRAISAL; INSIGHTS; SIGNAL; SURGE; FSH; EWE	The endocrine control of the reproductive function is often studied from the analysis of luteinizing hormone (LH) pulsatile secretion by the pituitary gland. Whereas measurements in the cavernous sinus cumulate anatomical and technical difficulties, LH levels can be easily assessed from jugular blood. However, plasma levels result from a convolution process due to clearance effects when LH enters the general circulation. Simultaneous measurements comparing LH levels in the cavernous sinus and jugular blood have revealed clear differences in the pulse shape, the amplitude and the baseline. Besides, experimental sampling occurs at a relatively low frequency (typically every 10 min) with respect to LH highest frequency release (one pulse per hour) and the resulting LH measurements are noised by both experimental and assay errors. As a result, the pattern of plasma LH may be not so clearly pulsatile. Yet, reliable information on the InterPulse Intervals (IPI) is a prerequisite to study precisely the steroid feedback exerted on the pituitary level. Hence, there is a real need for robust IPI detection algorithms. In this article, we present an algorithm for the monitoring of LH pulse frequency, basing ourselves both on the available endocrinological knowledge on LH pulse (shape and duration with respect to the frequency regime) and synthetic LH data generated by a simple model. We make use of synthetic data to make clear some basic notions underlying our algorithmic choices. We focus on explaining how the process of sampling affects drastically the original pattern of secretion, and especially the amplitude of the detectable pulses. We then describe the algorithm in details and perform it on different sets of both synthetic and experimental LH time series. We further comment on how to diagnose possible outliers from the series of IPIs which is the main output of the algorithm.	[Vidal, Alexandre] Univ Evry Val dEssonne, Lab Anal & Probabil EA 2172, Evry, France; [Zhang, Qinghua] INRIA Rennes Bretagne Atlantique Res Ctr, Project Team SISYPHE, Rennes, France; [Medigue, Claire; Clement, Frederique] INRIA Paris Rocquencourt Res Ctr, Project Team SISYPHE, Le Chesnay, France; [Fabre, Stephane] Univ Tours, IFCE, Lab Physiol Reprod & Comportements, INRA Tours Res Ctr,UMR INRA 85,UMR CNRS 6175, Nouzilly, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Vidal, A (corresponding author), Univ Evry Val dEssonne, Lab Anal & Probabil EA 2172, Evry, France.	alexandre.vidal@univ-evry.fr	FABRE, Stéphane/AAQ-8400-2020; Fabre, Stéphane/ABC-1483-2020	FABRE, Stéphane/0000-0001-7350-9500; 	French National Institute for Research in Computer Science and Control	French National Institute for Research in Computer Science and Control	Large Scale Initiative Action REGATE: academic funding supported by the French National Institute for Research in Computer Science and Control. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird D T, 1981, J Reprod Fertil Suppl, V30, P119; BAIRD DT, 1981, BIOL REPROD, V24, P1013, DOI 10.1095/biolreprod24.5.1013; Clarke I, 2002, ENDOCRINOLOGY, V143, P117, DOI 10.1210/en.143.1.117; Drouilhet L, 2010, BIOL REPROD, V82, P815, DOI 10.1095/biolreprod.109.082065; Keenan DM, 2000, SIAM J APPL MATH, V61, P934, DOI 10.1137/S0036139998334718; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; MOENTER SM, 1992, ENDOCRINOLOGY, V130, P2978, DOI 10.1210/en.130.5.2978; MOENTER SM, 1990, ENDOCRINOLOGY, V127, P1375, DOI 10.1210/endo-127-3-1375; SOLLENBERGER MJ, 1990, J NEUROENDOCRINOL, V2, P845, DOI 10.1111/j.1365-2826.1990.tb00650.x; URBAN RJ, 1988, ENDOCR REV, V9, P3, DOI 10.1210/edrv-9-1-3; VELDHUIS JD, 1990, J NEUROENDOCRINOL, V2, P755, DOI 10.1111/j.1365-2826.1990.tb00638.x; Vidal A, 2009, PHILOS T R SOC A, V367, P4759, DOI 10.1098/rsta.2009.0136	12	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39001	10.1371/journal.pone.0039001	http://dx.doi.org/10.1371/journal.pone.0039001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802933	Green Submitted, gold, Green Published			2022-12-25	WOS:000306186900007
J	Bian, MJ; Liu, J; Hong, XQ; Yu, M; Huang, YF; Sheng, ZJ; Fei, J; Huang, F				Bian, Minjuan; Liu, Jie; Hong, Xiaoqi; Yu, Mei; Huang, Yufang; Sheng, Zhejin; Fei, Jian; Huang, Fang			Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice	PLOS ONE			English	Article							ALPHA-SYNUCLEIN AGGREGATION; UBIQUITIN-PROTEIN LIGASE; CELL-DEATH; RAT MODEL; MITOCHONDRIAL DYSFUNCTION; NEURONAL DEGENERATION; PINK1/PARKIN PATHWAY; OXIDATIVE DAMAGE; MOTOR DEFICITS; MOUSE MODEL	Mutations in the parkin gene are currently thought to be the most common cause of recessive familial Parkinsonism. Parkin functions as an E3 ligase to regulate protein turnover, and its function in mitochondrial quality control has been reported recently. Overexpression of parkin has been found to prevent neuronal degeneration under various conditions both in vivo and in vitro. Here, we generated a transgenic mouse model in which expression of wild type parkin was driven by neuron-specific enolase (NSE) promoter. We reported that both young and old parkin transgenic mice exhibited less reduction of striatal TH protein and number of TH positive neurons in the substantia nigra induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP), compared to wild type littermates. MPTP-induced mitochondrial impairment in the substantia nigra was improved in young parkin transgenic mice. Decreased striatal alpha-synuclein was demonstrated in old parkin transgenic mice. These results provide reliable evidence from the transgenic mouse model for parkin that overexpression of parkin may attenuate dopaminergic neurodegeneration induced by MPTP through protection of mitochondria and reduction of alpha-synuclein in the nigrostriatal pathway.	[Bian, Minjuan; Liu, Jie; Hong, Xiaoqi; Yu, Mei; Huang, Yufang; Huang, Fang] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sheng, Zhejin; Fei, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Huang, Fang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Bian, MJ (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	huangf@shmu.edu.cn			National Natural Science Foundation of China [90919004, 81171188]; Specialized Research Fund for the Doctoral Program of Higher Education [20110071110039]; Ministry of Science and Technology of China [2012CB966300, 2010CB945501, 2011CB965103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (90919004, 81171188); Specialized Research Fund for the Doctoral Program of Higher Education (20110071110039) and grants from the Ministry of Science and Technology of China (2012CB966300, 2010CB945501, 2011CB965103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bian MJ, 2008, ACTA BIOCH BIOPH SIN, V40, P505, DOI 10.1111/j.1745-7270.2008.00423.x; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Burke RE, 2004, NEUROLOGIST, V10, P75, DOI 10.1097/01.nrl.0000117822.90759.83; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Duvoisin R C, 1999, Adv Neurol, V80, P161; Dzaman-Serafin Sylwia, 2005, Pol Merkur Lekarski, V19, P215; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gegg ME, 2011, AUTOPHAGY, V7, P243, DOI 10.4161/auto.7.2.14332; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gibrat C, 2009, J NEUROCHEM, V109, P1469, DOI 10.1111/j.1471-4159.2009.06072.x; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hu JH, 2003, J NEUROSCI RES, V74, P614, DOI 10.1002/jnr.10780; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Le Couteur David G, 2002, Rev Environ Health, V17, P51; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liberatore GT, 1999, NAT MED, V5, P1403; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Manfredsson FP, 2007, EXP NEUROL, V207, P289, DOI 10.1016/j.expneurol.2007.06.019; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Mizuno Y, 1999, Adv Neurol, V80, P171; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Ulusoy A, 2008, EXP NEUROL, V212, P258, DOI 10.1016/j.expneurol.2008.04.026; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van Noort JM, 2008, J PATHOL, V214, P267, DOI 10.1002/path.2273; Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Xuan Q, 2011, J NEURAL TRANSM, V118, P1575, DOI 10.1007/s00702-011-0636-3; Yang LC, 1998, J NEUROSCI, V18, P8145; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	80	53	55	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39953	10.1371/journal.pone.0039953	http://dx.doi.org/10.1371/journal.pone.0039953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792139	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100151
J	Hakanson, M; Kobel, S; Lutolf, MP; Textor, M; Cukierman, E; Charnley, M				Hakanson, Maria; Kobel, Stefan; Lutolf, Matthias P.; Textor, Marcus; Cukierman, Edna; Charnley, Mirren			Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; BETA(1) INTEGRIN; PROGNOSTIC MARKER; RESISTANCE; TISSUE; APOPTOSIS; ADHESION; GROWTH; MICROENVIRONMENT; INHIBITOR	Background: Increasing evidence shows that the cancer microenvironment affects both tumorigenesis and the response of cancer to drug treatment. Therefore in vitro models that selectively reflect characteristics of the in vivo environment are greatly needed. Current methods allow us to screen the effect of extrinsic parameters such as matrix composition and to model the complex and three-dimensional (3D) cancer environment. However, 3D models that reflect characteristics of the in vivo environment are typically too complex and do not allow the separation of discrete extrinsic parameters. Methodology/Principal Findings: In this study we used a poly(ethylene glycol) (PEG) hydrogel-based microwell array to model breast cancer cell behavior in multilayer cell clusters that allows a rigorous control of the environment. The innovative array fabrication enables different matrix proteins to be integrated into the bottom surface of microwells. Thereby, extrinsic parameters including dimensionality, type of matrix coating and the extent of cell-cell adhesion could be independently studied. Our results suggest that cell to matrix interactions and increased cell-cell adhesion, at high cell density, induce independent effects on the response to Taxol in multilayer breast cancer cell clusters. In addition, comparing the levels of apoptosis and proliferation revealed that drug resistance mediated by cell-cell adhesion can be related to altered cell cycle regulation. Conversely, the matrix-dependent response to Taxol did not correlate with proliferation changes suggesting that cell death inhibition may be responsible for this effect. Conclusions/Significance: The application of the PEG hydrogel platform provided novel insight into the independent role of extrinsic parameters controlling drug response. The presented platform may not only become a useful tool for basic research related to the role of the cancer microenvironment but could also serve as a complementary platform for in vitro drug development.	[Hakanson, Maria; Textor, Marcus; Charnley, Mirren] Swiss Fed Inst Technol, Lab Surface Sci & Technol, BioInterface Grp, Zurich, Switzerland; [Kobel, Stefan; Lutolf, Matthias P.] EPF Lausanne, Lab Stem Cell Bioengn, Lausanne, Switzerland; [Cukierman, Edna] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Fox Chase Cancer Center	Hakanson, M (corresponding author), Swiss Fed Inst Technol, Lab Surface Sci & Technol, BioInterface Grp, Zurich, Switzerland.	edna.cukierman@fccc.edu; mirren.charnley@mat.ethz.ch	Textor, Marcus/A-6200-2012; Lutolf, Matthias P/E-5914-2010; Cukierman, Edna/A-3951-2013; cukierman, edna/AAU-8932-2020	Textor, Marcus/0000-0002-0178-1801; cukierman, edna/0000-0002-1452-9576; Charnley, Mirren/0000-0003-3845-9290	Competence Centre for Materials Science and Technoloy (CCMX); Swiss National Science Foundation (SNSF) [CR23I2_125290/1]; National Centers for Competence in Research (NCCR); National Institutes of Health/National Cancer Institute [CA113451]; NATIONAL CANCER INSTITUTE [R01CA113451] Funding Source: NIH RePORTER	Competence Centre for Materials Science and Technoloy (CCMX); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Centers for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Competence Centre for Materials Science and Technoloy (CCMX; www.ccmx.ch), the Swiss National Science Foundation (SNSF; www.snf.ch; grant number CR23I2_125290/1) and the National Centers for Competence in Research (NCCR; www.nccr.ch; Nano-P5, project 03) for their financial support of this work. The authors also acknowledge funds from National Institutes of Health/National Cancer Institute grant CA113451 (to EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 2003, EUR J CANCER, V39, P438, DOI 10.1016/S0959-8049(02)00732-3; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p; Cukierman E, 2012, CELL ADHESION MIGRAT, V6, px; Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Denys H, 2009, CURR PHARM DESIGN, V15, P1373, DOI 10.2174/138161209787846711; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gudjonsson T, 2003, METHODS, V30, P247, DOI 10.1016/S1046-2023(03)00031-8; Gupta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021494; Hakanson M., 2011, INTEGR BIOL, P1; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Hirtenlehner K, 2002, EUR CYTOKINE NETW, V13, P234; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ohbayashi M., 2008, Experimental Oncology, V30, P276; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y; Patel SR, 2001, CANCER, V92, P1347, DOI 10.1002/1097-0142(20010901)92:5<1347::AID-CNCR1456>3.0.CO;2-0; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; StCroix B, 1996, NAT MED, V2, P1204; Teicher BA, 2009, BIOCHEM PHARMACOL, V77, P1665, DOI 10.1016/j.bcp.2009.01.006; Vargas GA, 2009, BIOMARK MED, V3, P701, DOI 10.2217/BMM.09.74; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005; Zutter MM, 2007, ADV EXP MED BIOL, V608, P87	59	21	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40141	10.1371/journal.pone.0040141	http://dx.doi.org/10.1371/journal.pone.0040141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792141	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100215
J	Yoo, SM; Antonyak, MA; Cerione, RA				Yoo, Sungsoo M.; Antonyak, Marc A.; Cerione, Richard A.			The Adaptor Protein and Arf GTPase-activating Protein Cat-1/Git-1 Is Required for Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAXILLIN-KINASE-LINKER; EPIDERMAL-GROWTH-FACTOR; P21-ACTIVATED KINASE; TYROSINE PHOSPHORYLATION; FOCAL ADHESIONS; EXCHANGE FACTOR; LD4 MOTIF; GIT1; PIX; COMPLEX	Cat-1/Git-1 is a multifunctional protein that acts as a GTPase-activating protein (GAP) for Arf GTPases, as well as serves as a scaffold for a number of different signaling proteins. Cat-1 is best known for its role in regulating cell shape and promoting cell migration. However, whether Cat-1 might also contribute to cellular transformation is currently unknown. Here we show that similar to 95% of cervical tumor samples examined overexpress Cat-1, suggesting that the up-regulation of Cat-1 expression is a frequent occurrence in this type of cancer. We demonstrate further that knocking down Cat-1 from NIH3T3 fibroblasts expressing an activated form of Cdc42 (Cdc42 F28L), or from the human cervical carcinoma (HeLa) cell line, inhibits the ability of these cells to form colonies in soft agar, an in vitro measure of tumorgenicity. The requirement for Cat-1 when assaying the anchorage-independent growth of transformed fibroblasts and HeLa cells is dependent on its ability to bind paxillin, while being negatively impacted by its Arf-GAP activity. Moreover, the co-expression of Cat-1 and an activated form of Arf6 in fibroblasts was sufficient to induce their transformation. These findings highlight novel roles for Cat-1 and its interactions with the Arf GTPases and paxillin in oncogenic transformation.	[Yoo, Sungsoo M.; Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NIGMS NIH HHS [R01 GM047458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Santy LC, 2002, J BIOL CHEM, V277, P40185, DOI 10.1074/jbc.C200481200; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Tu SS, 2002, BIOCHEMISTRY-US, V41, P12350, DOI 10.1021/bi026167h; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Wade R, 2011, J BIOL CHEM, V286, P37932, DOI 10.1074/jbc.M111.294504; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Won H, 2011, NAT MED, V17, P566, DOI 10.1038/nm.2330; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yin GY, 2005, J BIOL CHEM, V280, P27705, DOI 10.1074/jbc.M502271200; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Yu JXA, 2009, MOL BIOL CELL, V20, P4706, DOI 10.1091/mbc.E09-07-0548; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	40	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31462	31470		10.1074/jbc.M112.353615	http://dx.doi.org/10.1074/jbc.M112.353615			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807447	Green Published, hybrid			2022-12-25	WOS:000308791300059
J	Lim, PJ; Chatterji, U; Cordek, D; Sharma, SD; Garcia-Rivera, JA; Cameron, CE; Lin, K; Targett-Adams, P; Gallay, PA				Lim, Precious J.; Chatterji, Udayan; Cordek, Daniel; Sharma, Suresh D.; Garcia-Rivera, Jose A.; Cameron, Craig E.; Lin, Kai; Targett-Adams, Paul; Gallay, Philippe A.			Correlation between NS5A Dimerization and Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; RNA REPLICATION; CYCLOSPORINE-A; CELL-CULTURE; MEMBRANE ASSOCIATION; DOMAIN; BINDING; CYCLOPHILIN; INHIBITORS; PARTICLES	Hepatitis C virus (HCV) is the main agent of acute and chronic liver diseases leading to cirrhosis and hepatocellular carcinoma. The current standard therapy has limited efficacy and serious side effects. Thus, the development of alternate therapies is of tremendous importance. HCV NS5A (nonstructural 5A protein) is a pleiotropic protein with key roles in HCV replication and cellular signaling pathways. Here we demonstrate that NS5A dimerization occurs through Domain I (amino acids 1-240). This interaction is not mediated by nucleic acids because benzonase, RNase, and DNase treatments do not prevent NS5A-NS5A interactions. Importantly, DTT abrogates NS5A-NS5A interactions but does not affect NS5A-cyclophilin A interactions. Other reducing agents such as tris(2-carboxyethyl) phosphine and 2-mercaptoethanol also abrogate NS5A-NS5A interactions, implying that disulfide bridges may play a role in this interaction. Cyclophilin inhibitors, cyclosporine A, and alisporivir and NS5A inhibitor BMS-790052 do not block NS5A dimerization, suggesting that their antiviral effects do not involve the disruption of NS5A-NS5A interactions. Four cysteines, Cys-39, Cys-57, Cys-59, and Cys-80, are critical for dimerization. Interestingly, the four cysteines have been proposed to form a zinc-binding motif. Supporting this notion, NS5A dimerization is greatly facilitated by Zn2+ but not by Mg2+ or Mn2+. Importantly, the four cysteines are vital not only for viral replication but also critical for NS5A binding to RNA, revealing a correlation between NS5A dimerization, RNA binding, and HCV replication. Altogether our data suggest that NS5A-NS5A dimerization and/or multimerization could represent a novel target for the development of HCV therapies.	[Gallay, Philippe A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Cordek, Daniel; Sharma, Suresh D.; Cameron, Craig E.] Penn State Univ, Philadelphia, PA 16802 USA; [Lin, Kai] Novartis Inst Biomed Res Inc, Cambridge, MA 02139 USA; [Targett-Adams, Paul] Pfizer Global Res & Dev, Sandwich CT13 9NJ, Kent, England	Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Novartis; Pfizer	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, IMM 9,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gallay@scripps.edu	Cordek, Daniel/A-3494-2013; SHARMA, Suresh/C-4431-2008; SHARMA, Suresh D./AAD-7723-2022	SHARMA, Suresh/0000-0002-8633-4145; SHARMA, Suresh D./0000-0002-8633-4145; Targett-Adams, Paul/0000-0003-4967-1668	U.S. Public Health Service [AI087746, GM089001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089001] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service Grants AI087746 (to P. A. G.) and GM089001 (to C. E. C.).	Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brass V, 2007, J VIROL, V81, P2745, DOI 10.1128/JVI.01279-06; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Di Bisceglie AM, 2002, HEPATOLOGY, V35, P224, DOI 10.1053/jhep.2002.30531; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Hwang J, 2010, J VIROL, V84, P12480, DOI 10.1128/JVI.01319-10; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lemm JA, 2011, ANTIMICROB AGENTS CH, V55, P3795, DOI 10.1128/AAC.00146-11; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Qiu DK, 2011, J GEN VIROL, V92, P2502, DOI 10.1099/vir.0.034801-0; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Waller H, 2010, J VIROL METHODS, V165, P202, DOI 10.1016/j.jviromet.2010.01.020; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	43	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30861	30873		10.1074/jbc.M112.376822	http://dx.doi.org/10.1074/jbc.M112.376822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22801423	Green Published, hybrid			2022-12-25	WOS:000308579800074
J	Miernikiewicz, P; Owczarek, B; Piotrowicz, A; Boczkowska, B; Rzewucka, K; Figura, G; Letarov, A; Kulikov, E; Kopciuch, A; Switala-Jelen, K; Oslizlo, A; Hodyra, K; Gubernator, J; Dabrowska, K				Miernikiewicz, Paulina; Owczarek, Barbara; Piotrowicz, Agnieszka; Boczkowska, Barbara; Rzewucka, Kamila; Figura, Grzegorz; Letarov, Andrey; Kulikov, Eugene; Kopciuch, Agnieszka; Switala-Jelen, Kinga; Oslizlo, Anna; Hodyra, Katarzyna; Gubernator, Jerzy; Dabrowska, Krystyna			Recombinant Expression and Purification of T4 Phage Hoc, Soc, gp23, gp24 Proteins in Native Conformations with Stability Studies	PLOS ONE			English	Article							BACTERIOPHAGE THERAPY	Understanding the biological activity of bacteriophage particles is essential for rational design of bacteriophages with defined pharmacokinetic parameters and to identify the mechanisms of immunobiological activities demonstrated for some bacteriophages. This work requires highly purified preparations of the individual phage structural proteins, possessing native conformation that is essential for their reactivity, and free of incompatible biologically active substances such as bacterial lipopolysaccharide (LPS). In this study we describe expression in E. coli and purification of four proteins forming the surface of the bacteriophage T4 head: gp23, gp24, gphoc and gpsoc. We optimized protein expression using a set of chaperones for effective production of soluble proteins in their native conformations. The assistance of chaperones was critical for production of soluble gp23 (chaperone gp31 of T4 phage) and of gpsoc (chaperone TF of E. coli). Phage head proteins were purified in native conditions by affinity chromatography and size-exclusion chromatography. Two-step LPS removal allowed immunological purity grade with the average endotoxin activity less than 1 unit per ml of protein preparation. The secondary structure and stability of the proteins were studied using circular dichroism (CD) spectrometry, which confirmed that highly purified proteins preserve their native conformations. In increasing concentration of a denaturant (guanidine hydrochloride), protein stability was proved to increase as follows: gpsoc, gp23, gphoc. The denaturation profile of gp24 protein showed independent domain unfolding with the most stable larger domain. The native purified recombinant phage proteins obtained in this work were shown to be suitable for immunological experiments in vivo and in vitro.	[Miernikiewicz, Paulina; Owczarek, Barbara; Piotrowicz, Agnieszka; Boczkowska, Barbara; Rzewucka, Kamila; Figura, Grzegorz; Kopciuch, Agnieszka; Switala-Jelen, Kinga; Oslizlo, Anna; Hodyra, Katarzyna; Dabrowska, Krystyna] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Letarov, Andrey; Kulikov, Eugene] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia; [Gubernator, Jerzy] Univ Wroclaw, Dept Lipids & Liposomes, Fac Biotechnol, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences; University of Wroclaw	Miernikiewicz, P (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland.	dabrok@iitd.pan.wroc.pl	Dragos, Anna/C-4541-2019; Letarov, Andrey V./AAD-1731-2022; Dragos, Anna/X-2245-2019	Dragos, Anna/0000-0003-4136-986X; Dragos, Anna/0000-0003-4136-986X; Figura, Grzegorz/0000-0002-2663-8112; Miernikiewicz, Paulina/0000-0003-4592-3741; Maciejewska, Barbara/0000-0002-4876-8743; Dabrowska, Krystyna/0000-0002-1518-3183; Kulikov, Eugene/0000-0002-9101-1543; Owczarek, Barbara/0000-0001-5658-1455	EU Structural Funds; Polish Ministry of Science [N N401 417236, 13-0089-06/2010]	EU Structural Funds; Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This work was supported by EU Structural Funds (Operational Programme Innovative Economy "Optimization of characteristics and preparation of bacteriophage preparations for therapeutic purposes") and the Polish Ministry of Science (grant nos. N N401 417236 and 13-0089-06/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Besley NA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2426344; Black Lindsay W., 1994, P218; Buczek O, 2002, PROTEIN SCI, V11, P924, DOI 10.1110/ps.4460102; Calmat S, 2009, BIOCHEMISTRY-US, V48, P11692, DOI 10.1021/bi9013962; Carlson Karin, 1994, P427; Chan BK, 2012, ADV APPL MICROBIOL, V78, P1, DOI 10.1016/B978-0-12-394805-2.00001-4; Dabrowska K, 2005, J APPL MICROBIOL, V98, P7, DOI 10.1111/j.1365-2672.2004.02422.x; Dabrowska K, 2007, ARCH MICROBIOL, V187, P489, DOI 10.1007/s00203-007-0216-y; DeClue AE, 2012, VET J, V192, P455, DOI 10.1016/j.tvjl.2011.09.001; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Fokine A, 2011, J VIROL, V85, P8141, DOI 10.1128/JVI.00847-11; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Georgopoulos Costa P., 1994, P213; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Gorski A, 2012, ADV VIRUS R IN PRESS; Hayashi Takaya, 2011, Nihon Rinsho Meneki Gakkai Kaishi, V34, P329; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Krisch HM, 2008, RES MICROBIOL, V159, P314, DOI 10.1016/j.resmic.2008.04.014; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Letarov A, 2009, J APPL MICROBIOL, V107, P1, DOI 10.1111/j.1365-2672.2009.04143.x; Letarov AV, 2010, ACTA NATURAE, V2, P60, DOI 10.32607/20758251-2010-2-1-60-71; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Oslizlo A, 2011, BMC BIOTECHNOL, V31, P11; Ren ZJ, 1998, GENE, V215, P439, DOI 10.1016/S0378-1119(98)00298-4; Robertson K, 2012, BIOCHEM BIOPH RES CO, V418, P537, DOI 10.1016/j.bbrc.2012.01.061; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; Stone R, 2002, SCIENCE, V298, P728, DOI 10.1126/science.298.5594.728; Sulakvelidze A, 2005, DRUG DISCOV TODAY, V10, P807, DOI 10.1016/S1359-6446(05)03441-0	32	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e38902	10.1371/journal.pone.0038902	http://dx.doi.org/10.1371/journal.pone.0038902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808021	Green Published, gold, Green Submitted			2022-12-25	WOS:000306406700006
J	Lindegren, M; Dakos, V; Groger, JP; Gardmark, A; Kornilovs, G; Otto, SA; Mollmann, C				Lindegren, Martin; Dakos, Vasilis; Groeger, Joachim P.; Gardmark, Anna; Kornilovs, Georgs; Otto, Saskia A.; Moellmann, Christian			Early Detection of Ecosystem Regime Shifts: A Multiple Method Evaluation for Management Application	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; LEADING INDICATOR; MARINE ECOSYSTEM; SLOWING-DOWN; CLIMATE; DYNAMICS; TIME; REORGANIZATION; ZOOPLANKTON; VARIABILITY	Critical transitions between alternative stable states have been shown to occur across an array of complex systems. While our ability to identify abrupt regime shifts in natural ecosystems has improved, detection of potential early-warning signals previous to such shifts is still very limited. Using real monitoring data of a key ecosystem component, we here apply multiple early-warning indicators in order to assess their ability to forewarn a major ecosystem regime shift in the Central Baltic Sea. We show that some indicators and methods can result in clear early-warning signals, while other methods may have limited utility in ecosystem-based management as they show no or weak potential for early-warning. We therefore propose a multiple method approach for early detection of ecosystem regime shifts in monitoring data that may be useful in informing timely management actions in the face of ecosystem change.	[Lindegren, Martin] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Lindegren, Martin] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Dakos, Vasilis] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Groeger, Joachim P.] Fed Res Inst Rural Areas Forestry & Fisheries, Inst Sea Fisheries, von Thunen Inst, Hamburg, Germany; [Groeger, Joachim P.] Univ Rostock, Inst Biosci, Rostock, Germany; [Gardmark, Anna] Swedish Univ Agr Sci, Inst Coastal Res, Dept Aquat Resources, Oregrund, Sweden; [Kornilovs, Georgs] Inst Food Safety Anim Hlth & Environm, Dept Fish Resources Res, Riga, Latvia; [Otto, Saskia A.; Moellmann, Christian] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany	University of California System; University of California San Diego; Scripps Institution of Oceanography; Technical University of Denmark; Wageningen University & Research; Johann Heinrich von Thunen Institute; University of Rostock; Swedish University of Agricultural Sciences; Institute of Food Safety, Animal Health & Environment "BIOR"; University of Hamburg	Lindegren, M (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mlindegren@ucsd.edu	Möllmann, Christian/M-8006-2019; Gårdmark, Anna/AAC-3909-2021; Möllmann, Christian/C-4788-2011	Möllmann, Christian/0000-0001-9161-6342; Dakos, Vasilis/0000-0001-8862-718X; Lindegren, Martin/0000-0002-9185-951X	European Research Council (ERC); BONUS-AMBER	European Research Council (ERC)(European Research Council (ERC)); BONUS-AMBER	VD was supported by an European Research Council (ERC) grant awarded to M. Scheffer and SAO by BONUS-AMBER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Carpenter SR, 2011, ECOLOGY, V92, P2196, DOI 10.1890/11-0716.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Donangelo R, 2010, INT J BIFURCAT CHAOS, V20, P315, DOI 10.1142/S0218127410025764; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Hansen FC, 2006, J PLANKTON RES, V28, P39, DOI 10.1093/plankt/fbi097; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Hewitt JE, 2010, MAR ECOL PROG SER, V413, P267, DOI 10.3354/meps08626; Hinrichsen HH, 2002, CAN J FISH AQUAT SCI, V59, P1858, DOI 10.1139/F02-149; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Link JS, 2009, PROG OCEANOGR, V81, P29, DOI 10.1016/j.pocean.2009.04.004; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2011, BIOL LETTERS, V7, P484, DOI 10.1098/rsbl.2010.1213; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Mollmann C, 2000, J PLANKTON RES, V22, P2015, DOI 10.1093/plankt/22.11.2015; Mollmann C, 2005, ICES J MAR SCI, V62, P1270, DOI 10.1016/j.icesjms.2005.04.021; Mollmann C, 2003, FISH OCEANOGR, V12, P360, DOI 10.1046/j.1365-2419.2003.00257.x; Renz J, 2006, MAR BIOL, V148, P567, DOI 10.1007/s00227-005-0103-5; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Trenkel VM, 2009, ECOL INDIC, V9, P732, DOI 10.1016/j.ecolind.2008.09.005; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Voss R, 2003, FISH RES, V63, P97, DOI 10.1016/S0165-7836(02)00282-5; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	37	65	66	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38410	10.1371/journal.pone.0038410	http://dx.doi.org/10.1371/journal.pone.0038410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808007	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000306355500002
J	Ruge, CA; Schaefer, UF; Herrmann, J; Kirch, J; Canadas, O; Echaide, M; Perez-Gil, J; Casals, C; Muller, R; Lehr, CM				Ruge, Christian A.; Schaefer, Ulrich F.; Herrmann, Jennifer; Kirch, Julian; Canadas, Olga; Echaide, Mercedes; Perez-Gil, Jesus; Casals, Cristina; Mueller, Rolf; Lehr, Claus-Michael			The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles	PLOS ONE			English	Article							PULMONARY SURFACTANT; PHYSICAL-PROPERTIES; TITANIUM-DIOXIDE; SP-A; AGGREGATION; COMPONENTS; OLIGOMERIZATION; PHOSPHOLIPIDS; RECOGNITION; ADSORPTION	The peripheral lungs are a potential entrance portal for nanoparticles into the human body due to their large surface area. The fact that nanoparticles can be deposited in the alveolar region of the lungs is of interest for pulmonary drug delivery strategies and is of equal importance for toxicological considerations. Therefore, a detailed understanding of nanoparticle interaction with the structures of this largest and most sensitive part of the lungs is important for both nanomedicine and nanotoxicology. Astonishingly, there is still little known about the bio-nano interactions that occur after nanoparticle deposition in the alveoli. In this study, we compared the effects of surfactant-associated protein A (SP-A) and D (SP-D) on the clearance of magnetite nanoparticles (mNP) with either more hydrophilic (starch) or hydrophobic (phosphatidylcholine) surface modification by an alveolar macrophage (AM) cell line (MH-S) using flow cytometry and confocal microscopy. Both proteins enhanced the AM uptake of mNP compared with pristine nanoparticles; for the hydrophilic ST-mNP, this effect was strongest with SP-D, whereas for the hydrophobic PL-mNP it was most pronounced with SP-A. Using gel electrophoretic and dynamic light scattering methods, we were able to demonstrate that the observed cellular effects were related to protein adsorption and to protein-mediated interference with the colloidal stability. Next, we investigated the influence of various surfactant lipids on nanoparticle uptake by AM because lipids are the major surfactant component. Synthetic surfactant lipid and isolated native surfactant preparations significantly modulated the effects exerted by SP-A and SP-D, respectively, resulting in comparable levels of macrophage interaction for both hydrophilic and hydrophobic nanoparticles. Our findings suggest that because of the interplay of both surfactant lipids and proteins, the AM clearance of nanoparticles is essentially the same, regardless of different intrinsic surface properties.	[Ruge, Christian A.; Schaefer, Ulrich F.; Kirch, Julian; Lehr, Claus-Michael] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-6600 Saarbrucken, Germany; [Herrmann, Jennifer; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-6600 Saarbrucken, Germany; [Canadas, Olga; Echaide, Mercedes; Perez-Gil, Jesus; Casals, Cristina] Univ Complutense, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Canadas, Olga; Casals, Cristina] Univ Complutense, CIBER Enfermedades Resp, E-28040 Madrid, Spain; [Herrmann, Jennifer; Mueller, Rolf; Lehr, Claus-Michael] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland HIPS, D-6600 Saarbrucken, Germany	Saarland University; Saarland University; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid; Helmholtz Association; Saarland University	Ruge, CA (corresponding author), Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-6600 Saarbrucken, Germany.	lehr@mx.uni-saarland.de	ECHAIDE, MERCEDES/I-1649-2015; Cañadas, Olga/G-3547-2015; Lehr, Claus-Michael/AAU-8117-2020; Casals, Cristina/H-4658-2015; Perez-Gil, Jesus/H-3102-2019; Müller, Rolf/B-1559-2008	ECHAIDE, MERCEDES/0000-0002-0836-0858; Cañadas, Olga/0000-0002-1932-3796; Lehr, Claus-Michael/0000-0002-5864-8462; Casals, Cristina/0000-0003-2696-0918; Perez-Gil, Jesus/0000-0003-3587-7147; Müller, Rolf/0000-0002-1042-5665; Herrmann, Jennifer/0000-0003-3398-9938	German Research Foundation (DFG) [PAK 367]; Spanish Ministry of Economy and Competitivity [BIO2009-09694, CSD2007-00010, SAF2009-07810]; Community of Madrid [S2009MAT-1507]; Instituto de Salud Carlos III [CIBERES-CB06/06/0002]	German Research Foundation (DFG)(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitivity(Spanish Government); Community of Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the German Research Foundation (DFG, PAK 367). ME and JPG acknowledge funding from Spanish Ministry of Economy and Competitivity (BIO2009-09694, CSD2007-00010) and Community of Madrid (S2009MAT-1507). OC and CC acknowledge funding from Spanish Ministry of Economy and Competitivity (SAF2009-07810) and Instituto de Salud Carlos III (CIBERES-CB06/06/0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; Bernhard W, 2000, AM J RESP CRIT CARE, V162, P1524, DOI 10.1164/ajrccm.162.4.9908104; Blanco O, 2007, EUR J PHARMACOL, V568, P1, DOI 10.1016/j.ejphar.2007.04.035; CASALS C, 1994, BIOCHEM SOC T, V22, pS370, DOI 10.1042/bst022370s; Casals C, 2001, PEDIATR PATHOL MOL M, V20, P249, DOI 10.1080/152279501750412216; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Erpenbeck VJ, 2005, AM J PHYSIOL-LUNG C, V288, pL692, DOI 10.1152/ajplung.00362.2004; Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Harishchandra RK, 2010, J R SOC INTERFACE, V7, pS15, DOI 10.1098/rsif.2009.0329.focus; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Jones BG, 2002, J PHARM PHARMACOL, V54, P1065, DOI 10.1211/002235702320266217; Kirch J, 2012, J CONTROL RELEASE, V159, P128, DOI 10.1016/j.jconrel.2011.12.015; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Muller RH, 1997, PHARMACEUT RES, V14, P18, DOI 10.1023/A:1012043131081; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Patton JS, 2007, NAT REV DRUG DISCOV, V6, P67, DOI 10.1038/nrd2153; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruano MLF, 2000, BIOCHEMISTRY-US, V39, P6529, DOI 10.1021/bi000188z; Ruge CA, 2011, NANOMED-NANOTECHNOL, V7, P690, DOI 10.1016/j.nano.2011.07.009; Sachan AK, 2012, ACS NANO, V6, P1677, DOI 10.1021/nn204657n; Saenz A, 2007, BIOPHYS J, V92, P482, DOI 10.1529/biophysj.106.090217; Saenz A, 2006, FEBS J, V273, P2515, DOI 10.1111/j.1742-4658.2006.05258.x; Sanchez-Barbero F, 2005, J BIOL CHEM, V280, P7659, DOI 10.1074/jbc.M410266200; Sanchez-Barbero F, 2007, BIOCHEM J, V406, P479, DOI 10.1042/BJ20070275; Schleh C, 2011, EUR J PHARM BIOPHARM, V77, P350, DOI 10.1016/j.ejpb.2010.12.025; Schleh C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-90; Schulze C, 2011, EUR J PHARM BIOPHARM, V77, P376, DOI 10.1016/j.ejpb.2010.10.013; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Stensballe A, 2004, RAPID COMMUN MASS SP, V18, P1721, DOI 10.1002/rcm.1542; Stringer B, 1996, AM J RESP CELL MOL, V14, P155, DOI 10.1165/ajrcmb.14.2.8630265; Sung JC, 2007, TRENDS BIOTECHNOL, V25, P563, DOI 10.1016/j.tibtech.2007.09.005; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Tino MJ, 1998, BBA-MOL BASIS DIS, V1408, P241, DOI 10.1016/S0925-4439(98)00071-4; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931	41	118	118	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40775	10.1371/journal.pone.0040775	http://dx.doi.org/10.1371/journal.pone.0040775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802970	Green Submitted, Green Published, gold			2022-12-25	WOS:000306355500081
J	Jin, CN; Rajabi, H; Pitroda, S; Li, AL; Kharbanda, A; Weichselbaum, R; Kufe, D				Jin, Caining; Rajabi, Hasan; Pitroda, Sean; Li, Ailing; Kharbanda, Akriti; Weichselbaum, Ralph; Kufe, Donald			Cooperative Interaction between the MUC1-C Oncoprotein and the Rab31 GTPase in Estrogen Receptor-Positive Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MAMMARY-GLAND; LUNG-CANCER; PREDICT; DIFFERENTIATION; TUMORIGENESIS; TRAFFICKING; CARCINOMAS; ACTIVATION; SURVIVAL	Rab31 is a member of the Ras superfamily of small GTPases that has been linked to poor outcomes in patients with breast cancer. The MUC1-C oncoprotein is aberrantly overexpressed in most human breast cancers and also confers a poor prognosis. The present results demonstrate that MUC1-C induces Rab31 expression in estrogen receptor positive (ER+) breast cancer cells. We show that MUC1-C forms a complex with estrogen receptor alpha (ER alpha) on the Rab31 promoter and activates Rab31 gene transcription in an estrogen-dependent manner. In turn, Rab31 contributes to the upregulation of MUC1-C abundance in breast cancer cells by attenuating degradation of MUC1-C in lysosomes. Expression of an inactive Rab31(S20N) mutant in nonmalignant breast epithelial cells confirmed that Rab31 regulates MUC1-C expression. The functional significance of the MUC1-C/Rab31 interaction is supported by the demonstration that Rab31 confers the formation of mammospheres by a MUC1-C-dependent mechanism. Analysis of microarray databases further showed that (i) Rab31 is expressed at higher levels in breast cancers as compared to that in normal breast tissues, (ii) MUC1+ and ER+ breast cancers have increased levels of Rab31 expression, and (iii) patients with Rab31-positive breast tumors have a significantly decreased ten-year overall survival as compared to those with Rab31-negative tumors. These findings indicate that MUC1-C and Rab31 function in an autoinductive loop that contributes to overexpression of MUC1-C in breast cancer cells.	[Jin, Caining; Rajabi, Hasan; Kharbanda, Akriti; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pitroda, Sean; Weichselbaum, Ralph] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Li, Ailing] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jin, CN (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu			National Cancer Institute [CA97098, CA42802, CA100707]; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA166480, R01CA097098, R01CA042802] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA97098, CA42802 and CA100707 awarded by the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Khodarev NN, 2009, CANCER RES, V69, P2833, DOI 10.1158/0008-5472.CAN-08-4513; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; Kotzsch M, 2008, BREAST CANCER RES TR, V111, P229, DOI 10.1007/s10549-007-9782-6; Kufe D, 2012, ONCOGENE IN PRESS; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Pitroda SP, 2009, P NATL ACAD SCI USA, V106, P5837, DOI 10.1073/pnas.0812029106; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Rodriguez-Gabin AG, 2010, J NEUROSCI RES, V88, P589, DOI 10.1002/jnr.22236; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030	30	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39432	10.1371/journal.pone.0039432	http://dx.doi.org/10.1371/journal.pone.0039432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792175	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700011
J	Liao, JH; Kuo, CI; Huang, YY; Lin, YC; Lin, YC; Yang, CY; Wu, WL; Chang, WH; Liaw, YC; Lin, LH; Chang, CI; Wu, SH				Liao, Jiahn-Haur; Kuo, Chiao-I; Huang, Ya-Yi; Lin, Yu-Ching; Lin, Yen-Chen; Yang, Chen-Yui; Wu, Wan-Ling; Chang, Wei-Hau; Liaw, Yen-Chywan; Lin, Li-Hua; Chang, Chung-I; Wu, Shih-Hsiung			A Lon-Like Protease with No ATP-Powered Unfolding Activity	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; LA; PROTEINS; SITES; PEPTIDES; CLEAVAGE; BINDING; AAA(+)	Lon proteases are a family of ATP-dependent proteases involved in protein quality control, with a unique proteolytic domain and an AAA(+) (ATPases associated with various cellular activities) module accommodated within a single polypeptide chain. They were classified into two types as either the ubiquitous soluble LonA or membrane-inserted archaeal LonB. In addition to the energy-dependent forms, a number of medically and ecologically important groups of bacteria encode a third type of Lon-like proteins in which the conserved proteolytic domain is fused to a large N-terminal fragment lacking canonical AAA(+) motifs. Here we showed that these Lon-like proteases formed a clade distinct from LonA and LonB. Characterization of one such Lon-like protease from Meiothermus taiwanensis indicated that it formed a hexameric assembly with a hollow chamber similar to LonA/B. The enzyme was devoid of ATPase activity but retained an ability to bind symmetrically six nucleotides per hexamer; accordingly, structure-based alignment suggested possible existence of a nonfunctional AAA-like domain. The enzyme degraded unstructured or unfolded protein and peptide substrates, but not well-folded proteins, in ATP-independent manner. These results highlight a new type of Lon proteases that may be involved in breakdown of excessive damage or unfolded proteins during stress conditions without consumption of energy.	[Liao, Jiahn-Haur; Kuo, Chiao-I; Lin, Yu-Ching; Lin, Li-Hua; Chang, Chung-I; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Huang, Ya-Yi] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Lin, Yen-Chen; Liaw, Yen-Chywan] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Yang, Chen-Yui; Wu, Wan-Ling; Chang, Chung-I; Wu, Shih-Hsiung] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Chang, Wei-Hau] Acad Sinica, Inst Chem, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Liao, JH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	chungi@gate.sinica.edu.tw; shwu@gate.sinica.edu.tw	Chang, Wei-Hau/F-1965-2015	Chang, Wei-Hau/0000-0002-2612-850X; Chang, Chung-I/0000-0003-0989-1228	Academia Sinica and the National Science Council Taipei, Taiwan [NSC99-2320-B-001-MY2, NSC 100-2811-M-001-056]	Academia Sinica and the National Science Council Taipei, Taiwan	This work was supported by Academia Sinica and the National Science Council (NSC99-2320-B-001-MY2; NSC 100-2811-M-001-056), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERIK AY, 1991, FEBS LETT, V287, P211, DOI 10.1016/0014-5793(91)80053-6; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Botos I, 2005, J MOL BIOL, V351, P144, DOI 10.1016/j.jmb.2005.06.008; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chen MY, 2002, INT J SYST EVOL MICR, V52, P1647, DOI 10.1099/00207713-52-5-1647; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Duman RE, 2010, J MOL BIOL, V401, P653, DOI 10.1016/j.jmb.2010.06.030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fukui T, 2002, J BACTERIOL, V184, P3689, DOI 10.1128/JB.184.13.3689-3698.2002; Garcia-Nafria J, 2010, PROTEIN SCI, V19, P987, DOI 10.1002/pro.376; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; GOLDBERG AL, 1985, J BIOL CHEM, V260, P2029; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Im YJ, 2004, J BIOL CHEM, V279, P53451, DOI 10.1074/jbc.M410437200; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Lee AYL, 2004, EUR J BIOCHEM, V271, P834, DOI 10.1111/j.1432-1033.2004.03988.x; Liao JH, 2010, BIOPHYS J, V98, P129, DOI 10.1016/j.bpj.2009.09.052; Maehara T, 2008, EXTREMOPHILES, V12, P285, DOI 10.1007/s00792-007-0129-3; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Neuwald AF, 1999, GENOME RES, V9, P27; Nishii W, 2005, FEBS LETT, V579, P6846, DOI 10.1016/j.febslet.2005.11.026; Nishii W, 2002, EUR J BIOCHEM, V269, P451, DOI 10.1046/j.0014-2956.2001.02668.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Park SC, 2006, MOL CELLS, V21, P129; Rotanova TV, 2004, EUR J BIOCHEM, V271, P4865, DOI 10.1111/j.1432-1033.2004.04452.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; Ward Donald E., 2002, Archaea, V1, P63, DOI 10.1155/2002/503191; WAXMAN L, 1985, J BIOL CHEM, V260, P2022; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070	40	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40226	10.1371/journal.pone.0040226	http://dx.doi.org/10.1371/journal.pone.0040226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792246	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800051
J	Majumdar, R; Dighe, RR				Majumdar, Ritankar; Dighe, Rajan R.			The Hinge Region of Human Thyroid-Stimulating Hormone (TSH) Receptor Operates as a Tunable Switch between Hormone Binding and Receptor Activation	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; PROTEIN-COUPLED RECEPTORS; LEUCINE-RICH DOMAIN; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODIES; ALPHA-SUBUNIT; NEGATIVE COOPERATIVITY; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION	The mechanism by which the hinge regions of glycoprotein hormone receptors couple hormone binding to activation of downstream effecters is not clearly understood. In the present study, agonistic (311.62) and antagonistic (311.87) monoclonal antibodies (MAbs) directed against the TSH receptor extracellular domain were used to elucidate role of the hinge region in receptor activation. MAb 311.62 which identifies the LRR/Cb-2 junction (aa 265-275), increased the affinity of TSHR for the hormone while concomitantly decreasing its efficacy, whereas MAb 311.87 recognizing LRR 7-9 (aa 201-259) acted as a non-competitive inhibitor of Thyroid stimulating hormone (TSH) binding. Binding of MAbs was sensitive to the conformational changes caused by the activating and inactivating mutations and exhibited differential effects on hormone binding and response of these mutants. By studying the effects of these MAbs on truncation and chimeric mutants of thyroid stimulating hormone receptor (TSHR), this study confirms the tethered inverse agonistic role played by the hinge region and maps the interactions between TSHR hinge region and exoloops responsible for maintenance of the receptor in its basal state. Mechanistic studies on the antibody-receptor interactions suggest that MAb 311.87 is an allosteric insurmountable antagonist and inhibits initiation of the hormone induced conformational changes in the hinge region, whereas MAb 311.62 acts as a partial agonist that recognizes a conformational epitope critical for coupling of hormone binding to receptor activation. The hinge region, probably in close proximity with the alpha-subunit in the hormone-receptor complex, acts as a tunable switch between hormone binding and receptor activation.	[Majumdar, Ritankar; Dighe, Rajan R.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Majumdar, R (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rdighe@mrdg.iisc.ernet.in	Majumdar, Ritankar/AAE-7249-2022	Majumdar, Ritankar/0000-0001-6624-0187	India Institute of Science	India Institute of Science	This work was financially supported by a scholarship from the India Institute of Science to RM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Ando T, 2004, ENDOCRINOLOGY, V145, P5185, DOI 10.1210/en.2004-0789; Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Chen CR, 2008, ENDOCRINOLOGY, V149, P3427, DOI 10.1210/en.2008-0207; Chen CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031973; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Costagliola S, 2004, MOL ENDOCRINOL, V18, P3020, DOI 10.1210/me.2004-0231; Costagliola S, 2002, BIOCHEM BIOPH RES CO, V299, P891, DOI 10.1016/S0006-291X(02)02762-6; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; Demarest JF, 2008, J CLIN PHARMACOL, V48, P1179, DOI 10.1177/0091270008322178; DIGHE RR, 1990, J IMMUNOL METHODS, V131, P229, DOI 10.1016/0022-1759(90)90194-Z; DIGHE RR, 1983, ARCH BIOCHEM BIOPHYS, V225, P490, DOI 10.1016/0003-9861(83)90058-9; DIGHE RR, 1990, MOL CELL ENDOCRINOL, V72, P63, DOI 10.1016/0303-7207(90)90240-9; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jeffreys J, 2002, THYROID, V12, P1051, DOI 10.1089/105072502321085144; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; KAUMANN AJ, 1982, N-S ARCH PHARMACOL, V318, P192, DOI 10.1007/BF00500480; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; Lin W, 2007, MOL CELL ENDOCRINOL, V260, P83, DOI 10.1016/j.mce.2006.06.012; Miguel RN, 2009, J MOL ENDOCRINOL, V42, P381, DOI 10.1677/JME-08-0152; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mizutori Y, 2009, J CLIN ENDOCR METAB, V94, P927, DOI 10.1210/jc.2008-2134; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1991, J CLIN INVEST, V88, P336, DOI 10.1172/JCI115297; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Nicholson LB, 1996, J MOL ENDOCRINOL, V16, P159, DOI 10.1677/jme.0.0160159; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; PANTEL J, 1993, BIOCHEM BIOPH RES CO, V195, P588, DOI 10.1006/bbrc.1993.2086; POWELLJONES CHJ, 1979, P NATL ACAD SCI USA, V76, P705, DOI 10.1073/pnas.76.2.705; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; RAPOPORT B, 1982, J CLIN ENDOCR METAB, V54, P1059, DOI 10.1210/jcem-54-5-1059; Roth KE, 1996, BIOCHEMISTRY-US, V35, P7928, DOI 10.1021/bi952566j; Saha S, 2010, METALLOMICS, V2, P754, DOI 10.1039/c0mt00028k; Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6; Sanders J, 1997, BAILLIERE CLIN ENDOC, V11, P451, DOI 10.1016/S0950-351X(97)80693-3; Sanders J, 2004, THYROID, V14, P560, DOI 10.1089/1050725041692918; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; Shepherd PS, 1999, MOL CELL ENDOCRINOL, V149, P197, DOI 10.1016/S0303-7207(98)00207-X; Smith BR, 2007, HOT THYROIDOLOGY; Strange PG, 2008, BRIT J PHARMACOL, V153, P1353, DOI 10.1038/sj.bjp.0707672; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WAYS JP, 1983, BIOCHEM J, V216, P423, DOI 10.1042/bj2160423; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797	66	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40291	10.1371/journal.pone.0040291	http://dx.doi.org/10.1371/journal.pone.0040291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792265	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000306461800062
J	Zhang, JD; Li, XB; Song, YY; Liu, J				Zhang, Jiedong; Li, Xiaobai; Song, Yiying; Liu, Jia			The Fusiform Face Area Is Engaged in Holistic, Not Parts-Based, Representation of Faces	PLOS ONE			English	Article							VOXEL PATTERN-ANALYSIS; SURFACE-BASED ANALYSIS; SPATIAL RELATIONS; CONFIGURAL INFORMATION; PERCEPTION; FEATURES; RECOGNITION; INVERSION; IDENTITY; WHOLES	Numerous studies with functional magnetic resonance imaging have shown that the fusiform face area (FFA) in the human brain plays a key role in face perception. Recent studies have found that both the featural information of faces (e.g., eyes, nose, and mouth) and the configural information of faces (i.e., spatial relation among features) are encoded in the FFA. However, little is known about whether the featural information is encoded independent of or combined with the configural information in the FFA. Here we used multi-voxel pattern analysis to examine holistic representation of faces in the FFA by correlating spatial patterns of activation with behavioral performance in discriminating face parts with face configurations either present or absent. Behaviorally, the absence of face configurations (versus presence) impaired discrimination of face parts, suggesting a holistic representation in the brain. Neurally, spatial patterns of activation in the FFA were more similar among correct than incorrect trials only when face parts were presented in a veridical face configuration. In contrast, spatial patterns of activation in the occipital face area, as well as the object-selective lateral occipital complex, were more similar among correct than incorrect trials regardless of the presence of veridical face configurations. This finding suggests that in the FFA faces are represented not on the basis of individual parts but in terms of the whole that emerges from the parts.	[Zhang, Jiedong; Li, Xiaobai; Song, Yiying; Liu, Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Jiedong; Li, Xiaobai; Song, Yiying; Liu, Jia] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Liu, Jia] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JD (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn		Liu, Jia/0000-0003-0383-0934	100 Talents Program of the Chinese Academy of Sciences; National Basic Research Program of China [2010CB833903, 2011CB505402]; Fundamental Research Funds for the Central Universities [2009SD-3]	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is funded by the 100 Talents Program of the Chinese Academy of Sciences, the National Basic Research Program of China (2010CB833903, 2011CB505402), and the Fundamental Research Funds for the Central Universities (2009SD-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Harris A, 2008, J COGNITIVE NEUROSCI, V20, P863, DOI 10.1162/jocn.2008.20509; Harris A, 2010, J NEUROPHYSIOL, V104, P336, DOI 10.1152/jn.00626.2009; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; HOSIE JA, 1988, PERCEPTION, V17, P461, DOI 10.1068/p170461; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; Liu J, 2010, J COGNITIVE NEUROSCI, V22, P203, DOI 10.1162/jocn.2009.21203; Maurer D, 2007, NEUROPSYCHOLOGIA, V45, P1438, DOI 10.1016/j.neuropsychologia.2006.11.016; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; McKone E, 2001, J EXP PSYCHOL HUMAN, V27, P573, DOI 10.1037/0096-1523.27.3.573; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Peelen MV, 2007, TRENDS COGN SCI, V11, P4, DOI 10.1016/j.tics.2006.10.009; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Raizada RDS, 2010, CEREB CORTEX, V20, P1, DOI 10.1093/cercor/bhp076; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; RHODES G, 1988, PERCEPTION, V17, P43, DOI 10.1068/p170043; Rhodes G, 2009, EUR J NEUROSCI, V30, P721, DOI 10.1111/j.1460-9568.2009.06861.x; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Rotshtein P, 2007, J COGNITIVE NEUROSCI, V19, P1435, DOI 10.1162/jocn.2007.19.9.1435; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schiltz C, 2010, J VISION, V10, DOI 10.1167/10.2.25; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; SERGENT J, 1984, BRIT J PSYCHOL, V75, P221, DOI 10.1111/j.2044-8295.1984.tb01895.x; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Williams MA, 2007, NAT NEUROSCI, V10, P685, DOI 10.1038/nn1900; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yovel G, 2008, PSYCHON B REV, V15, P933, DOI 10.3758/PBR.15.5.933; Zhu Q, 2011, J NEUROSCI, V31, P10323, DOI 10.1523/JNEUROSCI.0873-11.2011; Zhu Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006239	58	29	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40390	10.1371/journal.pone.0040390	http://dx.doi.org/10.1371/journal.pone.0040390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792301	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800076
J	Kolar, F; Fer, T; Stech, M; Travnicek, P; Duskova, E; Schonswetter, P; Suda, J				Kolar, Filip; Fer, Tomas; Stech, Milan; Travnicek, Pavel; Duskova, Eva; Schoenswetter, Peter; Suda, Jan			Bringing Together Evolution on Serpentine and Polyploidy: Spatiotemporal History of the Diploid-Tetraploid Complex of Knautia arvensis (Dipsacaceae)	PLOS ONE			English	Article							DACTYLIS-GLOMERATA L; POPULATION-STRUCTURE; MULTIPLE ORIGINS; FLOW-CYTOMETRY; GENE FLOW; ASTERACEAE; DIFFERENTIATION; RANUNCULACEAE; CONSEQUENCES; DIVERGENCE	Polyploidization is one of the leading forces in the evolution of land plants, providing opportunities for instant speciation and rapid gain of evolutionary novelties. Highly selective conditions of serpentine environments act as an important evolutionary trigger that can be involved in various speciation processes. Whereas the significance of both edaphic speciation on serpentine and polyploidy is widely acknowledged in plant evolution, the links between polyploid evolution and serpentine differentiation have not yet been examined. To fill this gap, we investigated the evolutionary history of the perennial herb Knautia arvensis (Dipsacaceae), a diploid-tetraploid complex that exhibits an intriguing pattern of ecogeographic differentiation. Using plastid DNA sequencing and AFLP genotyping of 336 previously cytotyped individuals from 40 populations from central Europe, we unravelled the patterns of genetic variation among the cytotypes and the edaphic types. Diploids showed the highest levels of genetic differentiation, likely as a result of long term persistence of several lineages in ecologically distinct refugia and/or independent immigration. Recurrent polyploidization, recorded in one serpentine island, seems to have opened new possibilities for the local serpentine genotype. Unlike diploids, the serpentine tetraploids were able to escape from the serpentine refugium and spread further; this was also attributable to hybridization with the neighbouring non-serpentine tetraploid lineages. The spatiotemporal history of K. arvensis allows tracing the interplay of polyploid evolution and ecological divergence on serpentine, resulting in a complex evolutionary pattern. Isolated serpentine outcrops can act as evolutionary capacitors, preserving distinct karyological and genetic diversity. The serpentine lineages, however, may not represent evolutionary `dead-ends' but rather dynamic systems with a potential to further influence the surrounding populations, e.g., via independent polyplodization and hybridization. The complex eco-geographical pattern together with the incidence of both primary and secondary diploid-tetraploid contact zones makes K. arvensis a unique system for addressing general questions of polyploid research.	[Kolar, Filip; Fer, Tomas; Travnicek, Pavel; Duskova, Eva; Suda, Jan] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Kolar, Filip; Travnicek, Pavel; Suda, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Stech, Milan] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Schoenswetter, Peter] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Innsbruck	Kolar, F (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	filip.kolar@gmail.com	Fér, Tomáš/A-9991-2008; Schönswetter, Peter/T-8241-2017; Stech, Milan/C-9805-2009; kolar, filip/E-3826-2012; Suda, Jan/D-3369-2013; Travnicek, Pavel/G-9028-2012	Fér, Tomáš/0000-0002-0126-3684; Schönswetter, Peter/0000-0001-9225-4566; kolar, filip/0000-0002-8793-7992; Suda, Jan/0000-0001-8964-9153; Travnicek, Pavel/0000-0002-5806-1645; Stech, Milan/0000-0002-2987-6052	Grant Agency of the Academy of Sciences of the Czech Republic [KJB601110627]; Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021620828, MSM6007665801]; Academy of Sciences of the Czech Republic [KJB600050812, AV0Z60050516]; Grant Agency of the Charles University [GAUK 261 211]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Charles University	This work was supported by the Grant Agency of the Academy of Sciences of the Czech Republic to JS and MS. (project number KJB601110627). Additional support was provided by the Ministry of Education, Youth and Sports of the Czech Republic (MSM 0021620828 and MSM6007665801), the Academy of Sciences of the Czech Republic (KJB600050812 and AV0Z60050516), and Grant Agency of the Charles University (GAUK 261 211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo N, 2010, NEW PHYTOL, V187, P1170, DOI 10.1111/j.1469-8137.2010.03328.x; Balao F, 2009, ANN BOT-LONDON, V104, P965, DOI 10.1093/aob/mcp182; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Breton Sintes S, 1974, ANN SCI NAT BOT BIOL, V12, P277; Breton Sintes S, 1975, ANNEE BIOL, V14, P45; BROCHMANN C, 1992, NORD J BOT, V12, P257, DOI 10.1111/j.1756-1051.1992.tb01303.x; Burnier J, 2009, MOL ECOL, V18, P3730, DOI 10.1111/j.1365-294X.2009.04281.x; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coulaud J, 1999, CAN J BOT, V77, P673, DOI 10.1139/b99-028; Duskova E, 2010, PRESLIA, V82, P127; DVORAKOVA M, 1988, Preslia (Prague), V60, P1; EHRENDORFER F., 1962, BER DEUTSCH BOT GESELL, V75, P137; EHRENDORFER F, 1981, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V102, P225; EHRENDORFER F., 1965, The genetics of colonizing species: Proc. 1st. Internat. Union biol. Sci., Asilomar, California., P331; Ehrendorfer F., 1980, Polyploidy. Biological relevance. Part I. Polyploidy and plant evolution., P45; Ehrendorfer F., 1976, FLORA EUROPAEA, V4, P60; Ehrendorfer F., 1962, OSTERR BOT Z, V109, P276; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FORDE MB, 1962, EVOLUTION, V16, P338, DOI 10.2307/2406283; HAHNE J, 1991, FLORA, V185, P17; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; JANKOVSKA V., 1980, PALAOGEOBOTANISCHE R; Kaplan Zdenek, 1998, Preslia (Prague), V70, P21; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Krahulcova A, 1998, FOLIA GEOBOT, V33, P87, DOI 10.1007/BF02914931; Krahulec F, 2006, PRESLIA, V78, P503; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; KRUCKEBERG A R, 1991, Aliso, V13, P225; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; KRUCKEBERG AR, 1967, BRITTONIA, V19, P133, DOI 10.2307/2805271; KRUCKEBERG AR, 1986, SYST BOT, V11, P455, DOI 10.2307/2419082; KRUCKEBERG AR, 1954, ECOLOGY, V35, P267, DOI 10.2307/1931126; Levin D. A, 2002, OX ECOL EV; Loureiro J, 2010, PRESLIA, V82, P3; Lozek V, 1973, PRIRODA CTVRTOHORACH; LUMARET R, 1987, OECOLOGIA, V73, P436, DOI 10.1007/BF00385262; Ma JX, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-100; MACEIRA NO, 1993, NEW PHYTOL, V124, P321, DOI 10.1111/j.1469-8137.1993.tb03822.x; Macnair MR, 1998, ENDLESS FORMS, P157; Mayer MS, 1999, SYST BOT, V24, P47, DOI 10.2307/2419385; MAYER MS, 1994, AM J BOT, V81, P1288, DOI 10.2307/2445405; MAYER MS, 1994, SYST BOT, V19, P557, DOI 10.2307/2419777; Moravec J., 2002, PREHLED VEGETACE CES; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Novak F. A., 1960, PRESLIA, V32, P1; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Petit C, 1999, TRENDS ECOL EVOL, V14, P306, DOI 10.1016/S0169-5347(99)01608-0; Pritchard JK, 2000, GENETICS, V155, P945; Proctor J, 1999, TRENDS ECOL EVOL, V14, P334, DOI 10.1016/S0169-5347(99)01698-5; Rajakaruna N, 2004, INT GEOL REV, V46, P471, DOI 10.2747/0020-6814.46.5.471; Rajakaruna N, 2003, NEW PHYTOL, V157, P93, DOI 10.1046/j.1469-8137.2003.00648.x; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2007, HEREDITY, V98, P143, DOI 10.1038/sj.hdy.6800912; Rejzkova E, 2008, BOT J LINN SOC, V158, P115, DOI 10.1111/j.1095-8339.2008.00826.x; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Segraves KA, 1999, MOL ECOL, V8, P253, DOI 10.1046/j.1365-294X.1999.00562.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Slovak M, 2009, J BIOGEOGR, V36, P372, DOI 10.1111/j.1365-2699.2008.02005.x; SOJAK J., 1960, PRESLIA [PRAHA], V32, P369; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; STEPANEK J, 1982, Folia Geobotanica and Phytotaxonomica, V17, P359; STEPANEK J, 1983, Preslia (Prague), V55, P1; STEPANEK J, 1997, KVETENA CESKE REPUBL, V6, P543; Stepanek J, 1989, STUDIE CSAV, p[25, 25]; Stuessy TF, 2004, AM J BOT, V91, P889, DOI 10.3732/ajb.91.6.889; Tribsch A, 2002, AM J BOT, V89, P2024, DOI 10.3732/ajb.89.12.2024; Weiss H, 2002, NEW PHYTOL, V156, P85, DOI 10.1046/j.1469-8137.2002.00500.x; WESTERBERGH A, 1992, EVOLUTION, V46, P1537, DOI 10.1111/j.1558-5646.1992.tb01143.x	83	48	49	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39988	10.1371/journal.pone.0039988	http://dx.doi.org/10.1371/journal.pone.0039988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792207	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300020
J	Tilney, PM; van Wyk, AE; van der Merwe, CF				Tilney, Patricia M.; van Wyk, Abraham E.; van der Merwe, Chris F.			Structural Evidence in Plectroniella armata (Rubiaceae) for Possible Material Exchange between Domatia and Mites	PLOS ONE			English	Article							PLANT CUTICLES; LEAF DOMATIA; ULTRASTRUCTURE; MUTUALISM; BARRIER; ANATOMY	Domatia are small structures on the lower surface of a leaf, usually taking the form of cavities, pouches, domes with an opening, or hairs (or a combination of these), and located in the axils between the main veins. They are found in many dicotyledons including certain members of the Rubiaceae. As part of an ongoing study of selected southern African members of the tribe Vanguerieae of this family, their structure in transverse section was investigated. In some taxa, such as Plectroniella armata, light microscopic (LM) observations revealed large numbers of stomata in the domatia as well as a number of channel-like structures extending across the cuticle toward the cavity of the domatia. The cuticle of the epidermis lining the domatia also appeared thicker than in other parts of the leaves. The epidermis in P. armata was also examined using transmission electron microscopy (TEM). Domatia have been shown to house mainly mites, many of which are predatory or fungivorous, in a symbiotic (mutualistic) relationship with the plant. To date, much research has focussed on the role of domatia in providing shelter for various organisms, their eggs and their young. However, the TEM study revealed the apparent "channels" and thick cuticle seen under LM to be electron dense non-cellulosic branching fibrils within pronounced, often closely spaced cuticular folds. The functional significance of these fibrils and folds requires further investigation. Folding of cell walls and membranes at ultrastructural level is usually functionally associated with an increased surface area to facilitate active exchange of compounds/metabolites. This may indicate that translocation of substances and/or other forms of communication is possible between the domatium and its inhabitants. This therefore suggests a far more active role for the leaf in the symbiotic relationship than was previously thought. More work is required to test such a possibility.	[Tilney, Patricia M.] Univ Johannesburg, Dept Bot & Plant Biotechnol, Johannesburg, South Africa; [van Wyk, Abraham E.] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa; [van der Merwe, Chris F.] Univ Pretoria, Lab Microscopy & Microanal, ZA-0002 Pretoria, South Africa	University of Johannesburg; University of Pretoria; University of Pretoria	Tilney, PM (corresponding author), Univ Johannesburg, Dept Bot & Plant Biotechnol, Auckland Pk, Johannesburg, South Africa.	pmtilney@uj.ac.za	van Wyk, Abraham/A-2181-2008	van Wyk, Abraham/0000-0002-0437-3272	National Research Foundation grant [NRF 273030]; University of Pretoria	National Research Foundation grant(National Research Foundation of Korea); University of Pretoria	The work was funded by a National Research Foundation grant (NRF 273030) awarded to PMT. AEVW and CFVDM were funded by the University of Pretoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluska F, 2006, COMMUNICATION IN PLANTS: NEURONAL ASPECTS OF PLANT LIFE, P19; Cortesero AM, 2000, BIOL CONTROL, V17, P35, DOI 10.1006/bcon.1999.0777; Moraes TMD, 2009, BIOCELL, V33, P155; DICKE M, 1988, NETH J ZOOL, V38, P148, DOI 10.1163/156854288X00111; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; Hamilton AG, 1896, P LINNAEAN SOC NEW S, V21, P758; HESSEIN N A, 1986, International Journal of Acarology, V12, P215; HUXLEY CR, 1978, NEW PHYTOL, V80, P231, DOI 10.1111/j.1469-8137.1978.tb02285.x; JACOBS M, 1966, K NED AKAD VAN WET-P, V69, P275; Kerstiens G, 2006, J EXP BOT, V57, P2493, DOI 10.1093/jxb/erl017; Kirkwood RC, 1999, PESTIC SCI, V55, P69, DOI 10.1002/(SICI)1096-9063(199901)55:1&lt;69::AID-PS860&gt;3.0.CO;2-H; Lundstrom AN, 1887, NOVA ACTA REGIAE S 3, V13, P1; Matos CHC, 2006, ENTOMOL EXP APPL, V118, P185, DOI 10.1111/j.1570-7458.2006.00381.x; Nepi Massimo, 2007, P129, DOI 10.1007/978-1-4020-5937-7_3; Nishida S, 2006, ANN BOT-LONDON, V97, P601, DOI 10.1093/aob/mcl009; ODOWD DJ, 1991, TRENDS ECOL EVOL, V6, P179, DOI 10.1016/0169-5347(91)90209-G; ODOWD DJ, 1989, BIOL J LINN SOC, V37, P191, DOI 10.1111/j.1095-8312.1989.tb01901.x; Radice S, 2003, PLANT SYST EVOL, V238, P23, DOI 10.1007/s00606-002-0279-9; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Romero GQ, 2011, BIOTA NEOTROP, V11, P27, DOI 10.1590/S1676-06032011000100002; Schonherr J, 2006, J EXP BOT, V57, P2471, DOI 10.1093/jxb/erj217; Stace C.A., 1965, B BRIT MUS NAT HIST, V4, P1; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Wilkinson HP, 1979, ANATOMY DICOTYLEDONS, V1, P132	24	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39984	10.1371/journal.pone.0039984	http://dx.doi.org/10.1371/journal.pone.0039984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792206	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300019
J	Virtue, S; Masoodi, M; Velagapudi, V; Tan, CY; Dale, M; Suorti, T; Slawik, M; Blount, M; Burling, K; Campbell, M; Eguchi, N; Medina-Gomez, G; Sethi, JK; Oresic, M; Urade, Y; Griffin, JL; Vidal-Puig, A				Virtue, Sam; Masoodi, Mojgan; Velagapudi, Vidya; Tan, Chong Yew; Dale, Martin; Suorti, Tapani; Slawik, Marc; Blount, Margaret; Burling, Keith; Campbell, Mark; Eguchi, Naomi; Medina-Gomez, Gema; Sethi, Jaswinder K.; Oresic, Matej; Urade, Yoshihiro; Griffin, Julian L.; Vidal-Puig, Antonio			Lipocalin Prostaglandin D Synthase and PPAR gamma 2 Coordinate to Regulate Carbohydrate and Lipid Metabolism In Vivo	PLOS ONE			English	Article							ADIPOSE-TISSUE EXPANDABILITY; DEPOT-SPECIFIC DIFFERENCES; FATTY-ACID-METABOLISM; P465L PPAR-GAMMA; INSULIN SENSITIVITY; GENE-EXPRESSION; WEIGHT-LOSS; MICE; OBESITY; LIPOTOXICITY	Mice lacking Peroxisome Proliferator-Activated Receptor gamma 2 (PPAR gamma 2) have unexpectedly normal glucose tolerance and mild insulin resistance. Mice lacking PPAR gamma 2 were found to have elevated levels of Lipocalin prostaglandin D synthase (L-PGDS) expression in BAT and subcutaneous white adipose tissue (WAT). To determine if induction of L-PGDS was compensating for a lack of PPAR gamma 2, we crossed L-PGDS KO mice to PPAR gamma 2 KO mice to generate Double Knock Out mice (DKO). Using DKO mice we demonstrated a requirement of L-PGDS for maintenance of subcutaneous WAT (scWAT) function. In scWAT, DKO mice had reduced expression of thermogenic genes, the de novo lipogenic program and the lipases ATGL and HSL. Despite the reduction in markers of lipolysis in scWAT, DKO mice had a normal metabolic rate and elevated serum FFA levels compared to L-PGDS KO alone. Analysis of intra-abdominal white adipose tissue (epididymal WAT) showed elevated expression of mRNA and protein markers of lipolysis in DKO mice, suggesting that DKO mice may become more reliant on intra-abdominal WAT to supply lipid for oxidation. This switch in depot utilisation from subcutaneous to epididymal white adipose tissue was associated with a worsening of whole organism metabolic function, with DKO mice being glucose intolerant, and having elevated serum triglyceride levels compared to any other genotype. Overall, L-PGDS and PPAR gamma 2 coordinate to regulate carbohydrate and lipid metabolism.	[Virtue, Sam; Tan, Chong Yew; Dale, Martin; Blount, Margaret; Burling, Keith; Campbell, Mark; Sethi, Jaswinder K.; Vidal-Puig, Antonio] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Cambridge, England; [Masoodi, Mojgan] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Velagapudi, Vidya; Suorti, Tapani; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Slawik, Marc] Endocrinol Diabet Univ Hosp, Dept Med Innenstadt, Munich, Germany; [Eguchi, Naomi; Urade, Yoshihiro] Osaka Biosci Inst, Osaka, Japan; [Medina-Gomez, Gema] Univ Rey Juan Carlos, Dept Bioquim Fisiol & Genet Mol, Madrid, Spain; [Griffin, Julian L.] Med Res Council Human Nutr Res, Dept Biochem, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; VTT Technical Research Center Finland; Universidad Rey Juan Carlos; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Virtue, S (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Cambridge, England.	sv234@medschl.cam.ac.uk; ajv22@medschl.cam.ac.uk	MASOODI, MOJGAN/P-1499-2019; Virtue, SAm/B-7578-2013; Oresic, Matej/K-7673-2016; Sethi, Jaswinder K./B-1413-2008; Medina-Gomez, Gema/CAF-4668-2022; Medina-Gomez, Gema/F-5667-2016; Medina-Gomez, Gema/CAI-1063-2022; Velagapudi, Vidya/L-7278-2015; Oresic, Matej/AAV-3978-2020	MASOODI, MOJGAN/0000-0001-9840-1731; Virtue, SAm/0000-0002-9545-5432; Oresic, Matej/0000-0002-2856-9165; Sethi, Jaswinder K./0000-0003-4157-0475; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Velagapudi, Vidya/0000-0002-8261-7164; Vidal-Puig, Antonio/0000-0003-4220-9577	Diabetes UK; EU HEPADIP FP6 (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome); The Medical Research Council Centre for Obesity Related Disorders; Medical Research Council; BBSRC [BB/H013539/2, BB/H013539/1] Funding Source: UKRI; MRC [MC_UP_A090_1006, G0802051] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013539/1, BB/H013539/2, JF16994] Funding Source: researchfish; British Heart Foundation [PG/10/38/28359] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006, G0802051, G0600717B] Funding Source: researchfish	Diabetes UK(Diabetes UK); EU HEPADIP FP6 (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome); The Medical Research Council Centre for Obesity Related Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Diabetes UK (www.diabetes.org.uk), EU HEPADIP FP6 (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome) (www.hepadip.org), The Medical Research Council Centre for Obesity Related Disorders (www.mrc-cord.org), and the Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2006, CURR PROTOC NEUROSCI, V9; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Basu A, 2001, AM J PHYSIOL-ENDOC M, V280, pE1000, DOI 10.1152/ajpendo.2001.280.6.E1000; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; Gray SL, 2006, DIABETES, V55, P2669, DOI 10.2337/db06-0389; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Laaksonen T, 2006, J AM CHEM SOC, V128, P14341, DOI 10.1021/ja064701t; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; Masoodi M, 2010, EXP DERMATOL, V19, P751, DOI 10.1111/j.1600-0625.2010.01098.x; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; O'Rourke RW, 2009, INT J OBESITY, V33, P978, DOI 10.1038/ijo.2009.133; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Quinkler M, 2006, GENE, V380, P137, DOI 10.1016/j.gene.2006.05.026; Ragolia L, 2005, J BIOL CHEM     1224; Rocha PM, 2008, METABOLISM, V57, P1315, DOI 10.1016/j.metabol.2008.01.003; Rodriguez-Cuenca S, 2012, FASEB J; Tan GD, 2008, J CLIN ENDOCR METAB, V93, P4462, DOI 10.1210/jc.2007-2356; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	36	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39512	10.1371/journal.pone.0039512	http://dx.doi.org/10.1371/journal.pone.0039512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792179	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300008
J	Willander, H; Presto, J; Askarieh, G; Biverstal, H; Frohm, B; Knight, SD; Johansson, J; Linse, S				Willander, Hanna; Presto, Jenny; Askarieh, Glareh; Biverstal, Henrik; Frohm, Birgitta; Knight, Stefan D.; Johansson, Jan; Linse, Sara			BRICHOS Domains Efficiently Delay Fibrillation of Amyloid beta-Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; A-BETA; EXTRACELLULAR CHAPERONE; POLYMERIC NANOPARTICLES; TRANSMEMBRANE SEGMENT; LUNG-DISEASE; TOXICITY; INHIBITION; DEMENTIA	Amyloid diseases such as Alzheimer, Parkinson, and prion diseases are associated with a specific form of protein mis-folding and aggregation into oligomers and fibrils rich in beta-sheet structure. The BRICHOS domain consisting of similar to 100 residues is found in membrane proteins associated with degenerative and proliferative disease, including lung fibrosis (surfactant protein C precursor; pro-SP-C) and familial dementia (Bri2). We find that recombinant BRICHOS domains from Bri2 and pro-SP-C prevent fibril formation of amyloid beta-peptides (A beta(40) and A beta(42)) far below the stoichiometric ratio. Kinetic experiments show that a main effect of BRICHOS is to prolong the lag time in a concentration-dependent, quantitative, and reproducible manner. An ongoing aggregation process is retarded if BRICHOS is added at any time during the lag phase, but it is too late to interfere at the end of the process. Results from circular dichroism and NMR spectroscopy, as well as analytical size exclusion chromatography, imply that A beta is maintained as an unstructured monomer during the extended lag phase in the presence of BRICHOS. Electron microscopy shows that although the process is delayed, typical amyloid fibrils are eventually formed also when BRICHOS is present. Structural BRICHOS models display a conserved array of tyrosine rings on a five-stranded beta-sheet, with inter-hydroxyl distances suited for hydrogen-bonding peptides in an extended beta-conformation. Our data imply that the inhibitory mechanism is reliant on BRICHOS interfering with molecular events during the lag phase.	[Willander, Hanna; Presto, Jenny; Johansson, Jan] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Willander, Hanna; Presto, Jenny; Biverstal, Henrik; Johansson, Jan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Dis Res Ctr, S-14186 Stockholm, Sweden; [Askarieh, Glareh; Knight, Stefan D.] Swedish Univ Agr Sci, Biomed Ctr, Uppsala BioCtr, Dept Mol Biol, SE-75124 Uppsala, Sweden; [Frohm, Birgitta; Linse, Sara] Lund Univ, Ctr Chem, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden	Swedish University of Agricultural Sciences; Karolinska Institutet; Swedish University of Agricultural Sciences; Lund University	Johansson, J (corresponding author), Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.	Janne.Johansson@ki.se; Sara.Linse@biochemistry.lu.se	Knight, Stefan/D-4315-2015	Presto, Jenny/0000-0001-5102-6815; Biverstal, Henrik/0000-0002-2097-7658; Knight, Stefan/0000-0002-7180-8758; Linse, Sara/0000-0001-9629-7109; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council.	Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Cabaleiro-Lago C, 2008, J AM CHEM SOC, V130, P15437, DOI 10.1021/ja8041806; Casals C, 2008, FEBS J, V275, P536, DOI 10.1111/j.1742-4658.2007.06220.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Danielsson J, 2006, MAGN RESON CHEM, V44, pS114, DOI 10.1002/mrc.1814; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; El-Agnaf O, 2004, PROTEIN PEPTIDE LETT, V11, P207, DOI 10.2174/0929866043407156; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fabrizi C, 2001, J NEUROCHEM, V78, P406, DOI 10.1046/j.1471-4159.2001.00419.x; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Johansson H, 2009, J MOL BIOL, V389, P227, DOI 10.1016/j.jmb.2009.04.021; Johansson H, 2006, J BIOL CHEM, V281, P21032, DOI 10.1074/jbc.M603001200; Johansson H, 2009, PROTEIN SCI, V18, P1175, DOI 10.1002/pro.123; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LINDAHL P, 1988, BIOCHEMISTRY-US, V27, P5074, DOI 10.1021/bi00414a019; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Marshall KE, 2009, BIOCHEM SOC T, V37, P671, DOI 10.1042/BST0370671; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nerelius C, 2009, BIOCHEMISTRY-US, V48, P3778, DOI 10.1021/bi900135c; Nerelius C, 2008, BIOCHEM J, V416, P201, DOI 10.1042/BJ20080981; Nilsson LNG, 2001, J NEUROSCI, V21, P1444, DOI 10.1523/JNEUROSCI.21-05-01444.2001; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; POWERS JM, 1981, J NEUROPATH EXP NEUR, V40, P592, DOI 10.1097/00005072-198111000-00002; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, ACTA NEUROPATHOL, V111, P139, DOI 10.1007/s00401-005-0030-z; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Xue WF, 2006, J MOL BIOL, V358, P1244, DOI 10.1016/j.jmb.2006.02.069; Yamin G, 2008, CURR PHARM DESIGN, V14, P3231, DOI 10.2174/138161208786404137; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	68	108	109	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31608	31617		10.1074/jbc.M112.393157	http://dx.doi.org/10.1074/jbc.M112.393157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801430	Green Published, hybrid			2022-12-25	WOS:000308791300072
J	Gao, H; Wu, XM; Sun, Y; Zhou, SH; Silberstein, LE; Zhu, ZL				Gao, Hong; Wu, Xiaoming; Sun, Yan; Zhou, Shuanhu; Silberstein, Leslie E.; Zhu, Zhenglun			Suppression of Homeobox Transcription Factor VentX Promotes Expansion of Human Hematopoietic Stem/Multipotent Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EX-VIVO EXPANSION; STEM-CELLS; SELF-RENEWAL; BETA-CATENIN; DIFFERENTIATION; PROLIFERATION; REPOPULATION; QUIESCENCE; XOM	Mechanisms that regulate proliferation and expansion of human hematopoietic stem/multipotent progenitor cells (HSC/MPPs) are targets of intensive investigations. Several cell intrinsic factors and signaling pathways have been implicated in the proliferation and differentiation of human HSC/MPPs. Nevertheless, expansion of human HSC/MPPs for clinical application remains a critical challenge. VentX is a human homeobox transcription factor that was recently identified as an anti-proliferation and pro-differentiation factor in human hematopoietic cells. Here, we report that VentX expression is up-regulated during ontogenesis of human hematopoietic cells. Strikingly, suppression of VentX expression led to significant expansion of HSC/MPPs ex vivo and a 20-fold increase in engraftment potential in the NOD/SCID/IL2R gamma 2(null) mouse model. VentX suppression helped preserve the HSC/MPP pools and promote clonogenicity of hematopoietic progenitor cells. Mechanistically, we show that VentX regulates critical cell cycle regulators and Wnt downstream genes previously implicated in HSC/MPP proliferation and expansion.	[Gao, Hong; Wu, Xiaoming; Zhu, Zhenglun] Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; [Zhou, Shuanhu] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Sun, Yan; Silberstein, Leslie E.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Zhu, ZL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Gastroenterol, 75 Francis St, Boston, MA 02115 USA.	zzhu@partners.org	Zhou, Shuanhu/Q-7137-2019; Zhou, Shuanhu/AAW-4405-2021	Zhou, Shuanhu/0000-0003-4745-5347	National Institutes of Health [1R03HD064617]; Department of Defense; American Cancer Society; Brigham and Women's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD064617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Brigham and Women's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by National Institutes of Health Grant 1R03HD064617, the Department of Defense, the American Cancer Society, and a research fund from Brigham and Women's Hospital. To whom correspondence should be addressed. Tel.: 617-732-5467; Fax: 617-730-5807; E-mail: zzhu@partners.org.	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Baena E, 2007, EXP HEMATOL, V35, P1333, DOI 10.1016/j.exphem.2007.05.015; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brunstein CG, 2006, ANNU REV MED, V57, P403, DOI 10.1146/annurev.med.57.051804.123642; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Istvanffy R, 2011, BLOOD, V118, P2712, DOI 10.1182/blood-2010-05-287235; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Ko KH, 2011, STEM CELLS, V29, P108, DOI 10.1002/stem.551; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Rawat VPS, 2010, P NATL ACAD SCI USA, V107, P16946, DOI 10.1073/pnas.1001878107; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Sorrentino BP, 2004, NAT REV IMMUNOL, V4, P878, DOI 10.1038/nri1487; Wu XM, 2011, J CLIN INVEST, V121, P2599, DOI 10.1172/JCI45556; Wu XM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206078; Yang YZ, 2007, CELL RES, V17, P307, DOI 10.1038/cr.2007.29; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	32	11	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29979	29987		10.1074/jbc.M112.383018	http://dx.doi.org/10.1074/jbc.M112.383018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22791709	hybrid, Green Published			2022-12-25	WOS:000308286900071
J	Isaakidis, P; Varghese, B; Mansoor, H; Cox, HS; Ladomirska, J; Saranchuk, P; Da Silva, E; Khan, S; Paryani, R; Udwadia, Z; Migliori, GB; Sotgiu, G; Reid, T				Isaakidis, Petros; Varghese, Bhanumati; Mansoor, Homa; Cox, Helen S.; Ladomirska, Joanna; Saranchuk, Peter; Da Silva, Esdras; Khan, Samsuddin; Paryani, Roma; Udwadia, Zarir; Migliori, Giovanni Battista; Sotgiu, Giovanni; Reid, Tony			Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; TREATMENT OUTCOMES; MDR-TB; HIV; METAANALYSIS; THERAPY	Background: Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings. Methods: Medecins Sans Frontieres (MSF) is supporting a community-based treatment program for drug-resistant tuberculosis in HIV-infected patients in a slum setting in Mumbai, India since 2007. Patients are being treated for both diseases and the management of AE is done on an outpatient basis whenever possible. Prospective data were analysed to determine the occurrence and nature of AE. Results: Between May 2007 and September 2011, 67 HIV/MDR-TB co-infected patients were being treated with anti-TB treatment and ART; 43.3% were female, median age was 35.5 years (Interquartile Range: 30.5-42) and the median duration of anti-TB treatment was 10 months (range 0.5-30). Overall, AE were common in this cohort: 71%, 63% and 40% of patients experienced one or more mild, moderate or severe AE, respectively. However, they were rarely life-threatening or debilitating. AE occurring most frequently included gastrointestinal symptoms (45% of patients), peripheral neuropathy (38%), hypothyroidism (32%), psychiatric symptoms (29%) and hypokalaemia (23%). Eleven patients were hospitalized for AE and one or more suspect drugs had to be permanently discontinued in 27 (40%). No AE led to indefinite suspension of an entire MDR-TB or ART regimen. Conclusions: AE occurred frequently in this Mumbai HIV/MDR-TB cohort but not more frequently than in non-HIV patients on similar anti-TB treatment. Most AE can be successfully managed on an outpatient basis through a community-based treatment program, even in a resource-limited setting. Concerns about severe AE in the management of co-infected patients are justified, however, they should not cause delays in the urgently needed rapid scale-up of antiretroviral therapy and second-line anti-TB treatment.	[Isaakidis, Petros; Varghese, Bhanumati; Mansoor, Homa; Ladomirska, Joanna; Da Silva, Esdras; Khan, Samsuddin; Paryani, Roma] Med Sans Frontieres, Mumbai, Maharashtra, India; [Cox, Helen S.; Saranchuk, Peter] Med Sans Frontieres, SAMU, Cape Town, South Africa; [Cox, Helen S.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Udwadia, Zarir] Parmanand Deepchand Hinduja Natl Hosp, Mumbai, Maharashtra, India; [Udwadia, Zarir] Med Res Ctr Hinduja, Mumbai, Maharashtra, India; [Migliori, Giovanni Battista] Fdn S Maugeri, World Hlth Org Collaborating Ctr TB & Lung Dis, Care & Res Inst, Tradate, Italy; [Sotgiu, Giovanni] Univ Sassari, Dept Biomed Sci, Epidemiol & Med Stat Unit, I-07100 Sassari, Italy; [Reid, Tony] Med Sans Frontieres, Opertat Res Unit, Brussels, Belgium	University of Cape Town; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; University of Sassari; Doctors Without Borders	Isaakidis, P (corresponding author), Med Sans Frontieres, Mumbai, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org	Sotgiu, Giovanni/N-1032-2017; Migliori, Giovanni Battista/AAB-8589-2020	Sotgiu, Giovanni/0000-0002-1600-4474; Migliori, Giovanni Battista/0000-0002-2597-574X; Isaakidis, Petros/0000-0002-7881-1554; Cox, Helen/0000-0002-6538-7192	Medecins Sans Frontieres	Medecins Sans Frontieres	Medecins Sans Frontieres private funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID PROGR MAN DRUG; Bhargava A, 2011, HYPOTHESIS, V9, pe7; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Duggal P, 2007, BMC EAR NOSE THROAT, V7, DOI 10.1186/1472-6815-7-5; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joseph P, 2011, INDIAN J MED RES, V133, P529; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; NUNN P, 1991, LANCET, V337, P627; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Palacios E, 2012, INT J TUBERC LUNG D, V16, P348, DOI 10.5588/ijtld.11.0473; Ramma LD, 2012, INT J TUBERC LUNG D, V16, P283, DOI 10.5588/ijtld.11.0712; Satti H, 2012, INT J TUBERC LUNG DI; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; Torre P, 2006, INT J AUDIOL, V45, P559, DOI 10.1080/14992020600860935; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2009, MAN MDR TB FIELD GUI	26	65	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40781	10.1371/journal.pone.0040781	http://dx.doi.org/10.1371/journal.pone.0040781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792406	Green Submitted, gold, Green Published			2022-12-25	WOS:000306362400101
J	Makvandi-Nejad, S; Hoffman, GE; Allen, JJ; Chu, E; Gu, E; Chandler, AM; Loredo, AI; Bellone, RR; Mezey, JG; Brooks, SA; Sutter, NB				Makvandi-Nejad, Shokouh; Hoffman, Gabriel E.; Allen, Jeremy J.; Chu, Erin; Gu, Esther; Chandler, Alyssa M.; Loredo, Ariel I.; Bellone, Rebecca R.; Mezey, Jason G.; Brooks, Samantha A.; Sutter, Nathan B.			Four Loci Explain 83% of Size Variation in the Horse	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADULT HEIGHT; BIOLOGICAL PATHWAYS; POPULATION; VARIANTS; TRAITS; DOGS; DIFFERENTIATION; IDENTIFICATION; GENES	Horse body size varies greatly due to intense selection within each breed. American Miniatures are less than one meter tall at the withers while Shires and Percherons can exceed two meters. The genetic basis for this variation is not known. We hypothesize that the breed population structure of the horse should simplify efforts to identify genes controlling size. In support of this, here we show with genome-wide association scans (GWAS) that genetic variation at just four loci can explain the great majority of horse size variation. Unlike humans, which are naturally reproducing and possess many genetic variants with weak effects on size, we show that horses, like other domestic mammals, carry just a small number of size loci with alleles of large effect. Furthermore, three of our horse size loci contain the LCORL, HMGA2 and ZFAT genes that have previously been found to control human height. The LCORL/NCAPG locus is also implicated in cattle growth and HMGA2 is associated with dog size. Extreme size diversification is a hallmark of domestication. Our results in the horse, complemented by the prior work in cattle and dog, serve to pinpoint those very few genes that have played major roles in the rapid evolution of size during domestication.	[Makvandi-Nejad, Shokouh; Allen, Jeremy J.; Chu, Erin; Gu, Esther; Chandler, Alyssa M.; Loredo, Ariel I.; Sutter, Nathan B.] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA; [Hoffman, Gabriel E.; Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Loredo, Ariel I.] La Sierra Univ, Dept Biol, Riverside, CA USA; [Bellone, Rebecca R.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Brooks, Samantha A.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; University of Tampa; Cornell University	Makvandi-Nejad, S (corresponding author), Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA.	nbs39@cornell.edu	Brooks, Samantha/ABD-5279-2020	Brooks, Samantha/0000-0002-4500-2689; Bellone, Rebecca/0000-0001-8838-7227; Allen, Jeremy/0000-0003-1224-4646	Cornell University Center for Vertebrate Genomics	Cornell University Center for Vertebrate Genomics	We thank the Cornell University Center for Vertebrate Genomics for grant support (NS and SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Brooks SA, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2010.02127.x; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Carty CL, 2011, HUM MOL GENET; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; Cleynen I, 2008, INT J ONCOL, V32, P289; Clutton-Brock J, 1999, NATURAL HIST MUSEUM, pviii; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hermann-Kleiter N, 2009, INT J DEV BIOL, V53, P983, DOI 10.1387/ijdb.072435nh; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Loughran G, 2005, ONCOGENE, V24, P6185, DOI 10.1038/sj.onc.1208772; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Perola M, 2011, BEST PRACT RES CL EN, V25, P19, DOI 10.1016/j.beem.2010.10.013; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Takeuchi F, 2009, J HUM GENET, V54, P749, DOI 10.1038/jhg.2009.99; Tsunoda T, 2010, P NATL ACAD SCI USA, V107, P14199, DOI 10.1073/pnas.1002494107; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Zheng ZY, 2012, ONCOGENE; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	37	133	144	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39929	10.1371/journal.pone.0039929	http://dx.doi.org/10.1371/journal.pone.0039929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808074	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400026
J	Yoshida, M; Takimoto, R; Murase, K; Sato, Y; Hirakawa, M; Tamura, F; Sato, T; Iyama, S; Osuga, T; Miyanishi, K; Takada, K; Hayashi, T; Kobune, M; Kato, J				Yoshida, Makoto; Takimoto, Rishu; Murase, Kazuyuki; Sato, Yasushi; Hirakawa, Masahiro; Tamura, Fumito; Sato, Tsutomu; Iyama, Satoshi; Osuga, Takahiro; Miyanishi, Koji; Takada, Kohichi; Hayashi, Tsuyoshi; Kobune, Masayoshi; Kato, Junji			Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE LECTIN; BINDING-SPECIFICITY; MONOCLONAL-ANTIBODY; ARMING ANTIBODIES; RAT-LIVER; PHASE-I; SERUM; LIPOSOMES; CARCINOMA; THERAPY	Owing to its aggressiveness and the lack of effective therapies, pancreatic ductal adenocarcinoma has a dismal prognosis. New strategies to improve treatment and survival are therefore urgently required. Numerous fucosylated antigens in sera serve as tumor markers for cancer detection and evaluation of treatment efficacy. Increased expression of fucosyltransferases has also been reported for pancreatic cancer. These enzymes accelerate malignant transformation through fucosylation of sialylated precursors, suggesting a crucial requirement for fucose by pancreatic cancer cells. With this in mind, we developed fucose-bound nanoparticles as vehicles for delivery of anticancer drugs specifically to cancer cells. L-fucose-bound liposomes containing Cy5.5 or Cisplatin were effectively delivered into CA19-9 expressing pancreatic cancer cells. Excess L-fucose decreased the efficiency of Cy5.5 introduction by L-fucose-bound liposomes, suggesting L-fucose-receptor-mediated delivery. Intravenously injected L-fucose-bound liposomes carrying Cisplatin were successfully delivered to pancreatic cancer cells, mediating efficient tumor growth inhibition as well as prolonging survival in mouse xenograft models. This modality represents a new strategy for pancreatic cancer cell-targeting therapy.	[Yoshida, Makoto; Takimoto, Rishu; Murase, Kazuyuki; Sato, Yasushi; Hirakawa, Masahiro; Tamura, Fumito; Sato, Tsutomu; Iyama, Satoshi; Osuga, Takahiro; Miyanishi, Koji; Takada, Kohichi; Hayashi, Tsuyoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido, Japan; [Yoshida, Makoto; Takimoto, Rishu; Hirakawa, Masahiro; Tamura, Fumito; Kato, Junji] Sapporo Med Univ, Grad Sch Med, Div Clin Oncol, Chuo Ku, Sapporo, Hokkaido, Japan; [Sato, Tsutomu; Kobune, Masayoshi] Sapporo Med Univ, Grad Sch Med, Div Mol Oncol, Chuo Ku, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Yoshida, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido, Japan.	jkato@sapmed.ac.jp	Iyama, Satoshi/AAA-6237-2019	Miyanishi, Koji/0000-0002-6466-3458; Sato, Yasushi/0000-0002-6776-4609	Ministry of Education, Science, Sports and Culture [21390231]; Grants-in-Aid for Scientific Research [24590985] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B), 21390231, 2009, to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALLEN TM, 1994, TRENDS PHARMACOL SCI, V15, P215, DOI 10.1016/0165-6147(94)90314-X; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Aubert M, 2000, INT J CANCER, V88, P558, DOI 10.1002/1097-0215(20001115)88:4<558::AID-IJC7>3.0.CO;2-B; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Damascelli B, 2001, CANCER, V92, P2592, DOI 10.1002/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Deyasi S K, 1975, Indian J Pathol Bacteriol, V18, P16; GUNN FJ, 1994, MOL MICROBIOL, V12, P799, DOI 10.1111/j.1365-2958.1994.tb01066.x; HAKOMORI S, 1983, JNCI-J NATL CANCER I, V71, P231; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P5696; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P7433; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P7440; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kawakami S, 2000, BBA-GEN SUBJECTS, V1524, P258, DOI 10.1016/S0304-4165(00)00163-X; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; KOPROWSKI H, 1981, SCIENCE, V212, P53, DOI 10.1126/science.6163212; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7426; Lima CMSR, 2002, CURR OPIN ONCOL, V14, P424, DOI 10.1097/01.CCO.0000020621.28068.04; MAGNANI JL, 1982, METHOD ENZYMOL, V83, P235; Mas E, 1998, GLYCOBIOLOGY, V8, P605, DOI 10.1093/glycob/8.6.605; Miyanishi K, 2008, JPN J CLIN ONCOL, V38, P268, DOI 10.1093/jjco/hyn015; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Moghimi SM, 2006, J LIPOSOME RES, V16, P167, DOI 10.1080/08982100600848801; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakao A, 1998, SEMIN SURG ONCOL, V15, P15, DOI 10.1002/(SICI)1098-2388(199807/08)15:1<15::AID-SSU4>3.3.CO;2-G; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Sagawa T, 2008, HEPATOLOGY, V48, P828, DOI 10.1002/hep.22420; SAKAI T, 1990, CLIN CHEM, V36, P474; Sawke NG, 2010, INDIAN J CANCER, V47, P452, DOI 10.4103/0019-509X.73549; SENIOR JH, 1987, CRC CR REV THER DRUG, V3, P123; Shore S, 2003, ALIMENT PHARM THER, V18, P1049, DOI 10.1111/j.1365-2036.2003.01781.x; Sturgeon CM, 2010, CLIN CHEM, V56, pE1, DOI 10.1373/clinchem.2009.133124; SUGANO K, 1988, JPN J CANCER RES, V79, P618, DOI 10.1111/j.1349-7006.1988.tb00031.x; Symon Z, 1999, CANCER, V86, P72, DOI 10.1002/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.3.CO;2-T; Tajiri M, 2008, GLYCOBIOLOGY, V18, P2, DOI 10.1093/glycob/cwm117; Tawada K, 2009, PANCREAS, V38, P30, DOI 10.1097/MPA.0b013e318183ff73; Tonetti M, 1998, BIOCHIMIE, V80, P923, DOI 10.1016/S0300-9084(00)88889-6; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Tsuchida A, 2003, J BIOL CHEM, V278, P22787, DOI 10.1074/jbc.M211034200; von Mehren M, 2003, ANNU REV MED, V54, P343, DOI 10.1146/annurev.med.54.101601.152442; Weiner LM, 2000, ONCOGENE, V19, P6144, DOI 10.1038/sj.onc.1204000; WIESE TJ, 1994, J BIOL CHEM, V269, P22705; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141	49	51	52	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39545	10.1371/journal.pone.0039545	http://dx.doi.org/10.1371/journal.pone.0039545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808043	gold, Green Submitted, Green Published			2022-12-25	WOS:000306362400014
J	Lavoz, C; Rodrigues-Diez, R; Benito-Martin, A; Rayego-Mateos, S; Rodrigues-Diez, RR; Alique, M; Ortiz, A; Mezzano, S; Egido, J; Ruiz-Ortega, M				Lavoz, Carolina; Rodrigues-Diez, Raquel; Benito-Martin, Alberto; Rayego-Mateos, Sandra; Rodrigues-Diez, Raul R.; Alique, Matilde; Ortiz, Alberto; Mezzano, Sergio; Egido, Jesus; Ruiz-Ortega, Marta			Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; TGF-BETA; DIABETIC-NEPHROPATHY; FIBROTIC RESPONSE; KIDNEY FIBROSIS; CELL FATE; EXPRESSION; FIBROBLASTS; TRANSDIFFERENTIATION	Recent studies have described that the Notch signaling pathway is activated in a wide range of renal diseases. Angiotensin II (AngII) plays a key role in the progression of kidney diseases. AngII contributes to renal fibrosis by upregulation of profibrotic factors, induction of epithelial mesenchymal transition and accumulation of extracellular matrix proteins. In cultured human tubular epithelial cells the Notch activation by transforming growth factor-beta 1 (TGF-beta 1) has been involved in epithelial mesenchymal transition. AngII mimics many profibrotic actions of TGF-beta 1. For these reasons, our aim was to investigate whether AngII could regulate the Notch/Jagged system in the kidney, and its potential role in AngII-induced responses. In cultured human tubular epithelial cells, TGF-beta 1, but not AngII, increased the Notch pathway-related gene expression, Jagged-1 synthesis, and caused nuclear translocation of the activated Notch. In podocytes and renal fibroblasts, AngII did not modulate the Notch pathway. In tubular epithelial cells, pharmacological Notch inhibition did not modify AngII-induced changes in epithelial mesenchymal markers, profibrotic factors and extracellular matrix proteins. Systemic infusion of AngII into rats for 2 weeks caused tubulointerstitial fibrosis, but did not upregulate renal expression of activated Notch-1 or Jagged-1, as observed in spontaneously hypertensive rats. Moreover, the Notch/Jagged system was not modulated by AngII type I receptor blockade in the model of unilateral ureteral obstruction in mice. These data clearly indicate that AngII does not regulate the Notch/Jagged signaling system in the kidney, in vivo and in vitro. Our findings showing that the Notch pathway is not involved in AngII-induced fibrosis could provide important information to understand the complex role of Notch system in the regulation of renal regeneration vs damage progression.	[Lavoz, Carolina; Rodrigues-Diez, Raquel; Rayego-Mateos, Sandra; Rodrigues-Diez, Raul R.; Alique, Matilde; Ruiz-Ortega, Marta] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain; [Benito-Martin, Alberto; Ortiz, Alberto] Univ Autonoma Madrid, Dialysis Unit, Fdn Jimenez Diaz, IIS, Madrid, Spain; [Mezzano, Sergio] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile	Autonomous University of Madrid; Autonomous University of Madrid; Fundacion Jimenez Diaz; Universidad Austral de Chile	Lavoz, C (corresponding author), Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain.	mruizo@fjd.es	Benito-Martin, Alberto/GLU-6164-2022; Alique, Matilde/I-1341-2016; Ortega, Marta Ruiz/AAN-2136-2020; Díez, Raquel Rodrigues/ABE-9703-2020; MATEOS, SANDRA RAYEGO/AAI-2123-2019; Ruiz-Ortega, Marta/D-3584-2012; ortiz, alberto/Y-7582-2018; Díez, Raúl R Rodrigues/G-8386-2017; ruiz-ortega, marta/D-3584-2012	Benito-Martin, Alberto/0000-0002-0700-3891; Alique, Matilde/0000-0002-7912-1133; Ortega, Marta Ruiz/0000-0002-1495-6535; Díez, Raquel Rodrigues/0000-0002-6348-1505; Ruiz-Ortega, Marta/0000-0002-1495-6535; ortiz, alberto/0000-0002-9805-9523; Rayego-Mateos, Sandra/0000-0001-6874-2359; Rodrigues Diez, Raul/0000-0002-2456-6709; ruiz-ortega, marta/0000-0002-1403-2690	Instituto de Salud Carlos III [PI081564, PI11/01854, PS09/00447, REDINREN ISCIII-RETIC RD06/0016/0004]; Sociedad Espanola de Nefrologia; Comunidad de Madrid [S2010/BMD-2321]; Agencia Espanola de Cooperacion Internacional [A/9571/07]; Fundacion Lilly; FONDECYT Chile [1080083, 1120480]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Sociedad Espanola de Nefrologia; Comunidad de Madrid(Comunidad de Madrid); Agencia Espanola de Cooperacion Internacional; Fundacion Lilly; FONDECYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grants from the Instituto de Salud Carlos III (PI081564, PI11/01854 and PS09/00447 and REDINREN ISCIII-RETIC RD06/0016/0004), Sociedad Espanola de Nefrologia, Comunidad de Madrid (S2010/BMD-2321), Agencia Espanola de Cooperacion Internacional (PCI Iberoamerica; A/9571/07), Fundacion Lilly, FONDECYT Chile 1080083 and 1120480. CL and RRD are fellows of ISCIII. Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boulos N, 2011, HYPERTENSION, V57, P1176, DOI 10.1161/HYPERTENSIONAHA.111.170746; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Challen GA, 2006, J AM SOC NEPHROL, V17, P1896, DOI 10.1681/ASN.2005111228; Chen L, 2006, ACTA PHARMACOL SIN, V27, P1029, DOI 10.1111/j.1745-7254.2006.00344.x; Daniel C, 2008, KIDNEY INT, V74, P551, DOI 10.1038/ki.2008.290; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Grego-Bessa J, 2004, CELL CYCLE, V3, P718; Gupta S, 2010, AM J PHYSIOL-RENAL, V298, pF209, DOI 10.1152/ajprenal.00451.2009; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kretzler M, 2008, NAT MED, V14, P246, DOI 10.1038/nm0308-246; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kwon SM, 2009, TRENDS CARDIOVAS MED, V19, P170, DOI 10.1016/j.tcm.2009.10.002; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lin CL, 2010, DIABETES, V59, P1915, DOI 10.2337/db09-0663; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; McCright B, 2001, DEVELOPMENT, V128, P491; McCright B, 2003, CURR OPIN NEPHROL HY, V12, P5, DOI 10.1097/00041552-200301000-00002; McLaughlin KA, 2000, DEV BIOL, V227, P567, DOI 10.1006/dbio.2000.9913; Morissey J, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017905.77985.4A; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Nyhan KC, 2010, BBA-MOL CELL RES, V1803, P1386, DOI 10.1016/j.bbamcr.2010.09.001; Ortiz A, 1997, J AM SOC NEPHROL, V8, P1845; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Diez RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014145; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ruperez M, 2003, CIRCULATION, V108, P1499, DOI 10.1161/01.CIR.0000089129.51288.BA; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sanchez-Nino MD, 2012, LAB INVEST, V92, P32, DOI 10.1038/labinvest.2011.138; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Walsh DW, 2008, BBA-MOL BASIS DIS, V1782, P10, DOI 10.1016/j.bbadis.2007.09.005; Waters AM, 2008, J AM SOC NEPHROL, V19, P1139, DOI 10.1681/ASN.2007050596; Weisberg AD, 2005, ARTERIOSCL THROM VAS, V25, P365, DOI 10.1161/01.ATV.0000152356.85791.52; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2008, FRONT BIOSCI, V13, P6991; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616	55	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40490	10.1371/journal.pone.0040490	http://dx.doi.org/10.1371/journal.pone.0040490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792351	Green Submitted, Green Published, gold			2022-12-25	WOS:000306354700056
J	Chen, LF; Vicente-Manzanares, M; Potvin-Trottier, L; Wiseman, PW; Horwitz, AR				Chen, Lingfeng; Vicente-Manzanares, Miguel; Potvin-Trottier, Laurent; Wiseman, Paul W.; Horwitz, Alan Rick			The Integrin-Ligand Interaction Regulates Adhesion and Migration through a Molecular Clutch	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; NONMUSCLE MYOSIN-II; CELL-MIGRATION; FOCAL ADHESIONS; FIBROSARCOMA CELLS; ACTIN-FILAMENTS; ALPHA-ACTININ; GROWTH-FACTOR; U2OS CELLS; PROTEINS	Adhesive and migratory behavior can be cell type, integrin, and substrate dependent. We have compared integrin and substrate differences using three integrin receptors: alpha 5 beta 1, alpha 6 beta 1, and alpha L beta 2 expressed in a common cell type, CHO center dot B2 cells, which lack integrin alpha subunits, as well as in different cell types that express one or more of these integrins. We find that CHO center dot B2 cells expressing either alpha 6 beta 1 or alpha L beta 2 integrins migrate and protrude faster and are more directionally persistent on laminin or ICAM-1, respectively, than CHO center dot B2 cells expressing alpha 5 beta 1 on fibronectin. Despite rapid adhesion maturation and the presence of large adhesions in both the alpha 6 beta 1- and alpha L beta 2-expressing cells, they display robust tyrosine phosphorylation. In addition, whereas myosin II regulates adhesion maturation and turnover, protrusion rates, and polarity in cells migrating on fibronectin, surprisingly, it does not have comparable effects in cells expressing alpha 6 beta 1 or alpha L beta 2. This apparent difference in the integration of myosin II activity, adhesion, and migration arises from alterations in the ligand-integrin-actin linkage (molecular clutch). The elongated adhesions in the protrusions of the alpha 6 beta 1-expressing cells on laminin or the alpha L beta 2-expressing cells on ICAM-1 display a novel, rapid retrograde flux of integrin; this was largely absent in the large adhesions in protrusions of alpha 5 beta 1-expressing cells on fibronectin. Furthermore, the force these adhesions exert on the substrate in protrusive regions is reduced compared to similar regions in alpha 5-expressing cells, and the adhesion strength is reduced. This suggests that intracellular forces are not efficiently transferred from actomyosin to the substratum due to altered adhesion strength, that is, avidity, affinity, or the ligand-integrin-actin interaction. Finally, we show that the migration of fast migrating leukocytes on fibronectin or ICAM-1 is also largely independent of myosin II; however, their adhesions are small and do not show retrograde fluxing suggesting other intrinsic factors determine their migration differences.	[Chen, Lingfeng; Vicente-Manzanares, Miguel; Horwitz, Alan Rick] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA; [Vicente-Manzanares, Miguel] Univ Autonoma Madrid, Sch Med, Hosp Princesa, Madrid, Spain; [Potvin-Trottier, Laurent; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada	University of Virginia; Autonomous University of Madrid; McGill University; McGill University	Chen, LF (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA.	Horwitz@virginia.edu	Potvin-Trottier, Laurent/AAL-3122-2021; Bustelo, Xose R./A-9526-2010; Vicente-Manzanares, Miguel/H-1010-2018	Potvin-Trottier, Laurent/0000-0001-7876-2820; Bustelo, Xose R./0000-0001-9398-6072; Vicente-Manzanares, Miguel/0000-0001-5943-3220	National Institutes of Health grants [GM23244]; Cell Migration Consortium [U54 GM064346]; Ramon y Cajal program from the Spanish Ministerio de Economia y Competividad (MINECO) [RYC-2010-06094]; Natural Sciences and Engineering Council of Canada (NSERC); Canadian Institutes of Health Research; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); NSERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244, U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Migration Consortium; Ramon y Cajal program from the Spanish Ministerio de Economia y Competividad (MINECO); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ARH was supported by National Institutes of Health grants GM23244 and the Cell Migration Consortium (U54 GM064346). MVM is supported by the Ramon y Cajal program (RYC-2010-06094) from the Spanish Ministerio de Economia y Competividad (MINECO). PWW acknowledges funding support from the Natural Sciences and Engineering Council of Canada (NSERC) and the Canadian Institutes of Health Research. LPT acknowledges fellowship support from Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) and NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuta AKH, 2009, BIOTECHNOL PROGR, V25, P227, DOI 10.1002/btpr.58; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1; Boudou T, 2009, BIORHEOLOGY, V46, P191, DOI 10.3233/BIR-2009-0540; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Chung J, 2004, MOL CELLS, V17, P203; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026; De Ruijter JE, 2001, TISSUE ENG, V7, P279, DOI 10.1089/10763270152044143; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Eddy RJ, 2000, J CELL SCI, V113, P1287; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lein PJ, 2001, CELL BIOL, V153, P1427; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Millius A, 2009, METHODS MOL BIOL, V571, P167, DOI 10.1007/978-1-60761-198-1_11; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PETERSEN NO, 1993, BIOPHYS J, V65, P1135, DOI 10.1016/S0006-3495(93)81173-1; Pigott R, 1993, ADHESION MOL, P74; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; RAMOS DM, 1991, INVAS METAST, V11, P125; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; ter Brugge PJ, 2002, J BIOMED MATER RES, V61, P399, DOI 10.1002/jbm.10172; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Vicente-Manzanares M, 2010, BIOCHEM BIOPH RES CO, V402, P537, DOI 10.1016/j.bbrc.2010.10.071; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vicente-Manzanares M, 2009, J CELL SCI, V122, P1473, DOI 10.1242/jcs.052894; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Waterman-Storer C, 2002, CURR PROTOC CELL BIO; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Xue W, 1997, CANCER RES, V57, P1682; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235; Ziyyat A, 2006, J CELL SCI, V119, P416, DOI 10.1242/jcs.02730	73	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40202	10.1371/journal.pone.0040202	http://dx.doi.org/10.1371/journal.pone.0040202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792239	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800048
J	Jarajapu, YPR; Cai, J; Yan, YQ; Calzi, SL; Kielczewski, JL; Hu, P; Shaw, LC; Firth, SM; Chan-Ling, T; Boulton, ME; Baxter, RC; Grant, MB				Jarajapu, Yagna P. R.; Cai, Jun; Yan, Yuanqing; Calzi, Sergio Li; Kielczewski, Jennifer L.; Hu, Ping; Shaw, Lynn C.; Firth, Sue M.; Chan-Ling, Tailoi; Boulton, Michael E.; Baxter, Robert C.; Grant, Maria B.			Protection of Blood Retinal Barrier and Systemic Vasculature by Insulin-Like Growth Factor Binding Protein-3	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BREAST-CANCER CELLS; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; SHEAR-STRESS; IGFBP-3; ACTIVATION; EXPRESSION; APOPTOSIS; PATHWAYS	Previously, we showed that insulin growth factor (IGF)-1 binding protein-3 (IGFBP-3), independent of IGF-1, reduces pathological angiogenesis in a mouse model of the oxygen-induced retinopathy (OIR). The current study evaluates novel endothelium-dependent functions of IGFBP-3 including blood retinal barrier (BRB) integrity and vasorelaxation. To evaluate vascular barrier function, either plasmid expressing IGFBP-3 under the regulation of an endothelial-specific promoter or a control plasmid was injected into the vitreous humor of mouse pups (P1) and compared to the non-injected eyes of the same pups undergoing standard OIR protocol. Prior to sacrifice, the mice were given an injection of horseradish peroxidase (HRP). IGFBP-3 plasmid-injected eyes displayed near-normal vessel morphology and enhanced vascular barrier function. Further, in vitro IGFBP-3 protects retinal endothelial cells from VEGF-induced loss of junctional integrity by antagonizing the dissociation of the junctional complexes. To assess the vasodilatory effects of IGFBP-3, rat posterior cerebral arteries were examined in vitro. Intraluminal IGFBP-3 decreased both pressure- and serotonin-induced constrictions by stimulating nitric oxide ( NO) release that were blocked by L-NAME or scavenger receptor-B1 neutralizing antibody (SRB1-Ab). Both wild-type and IGF-1-nonbinding mutant IGFBP-3 (IGFBP-3NB) stimulated eNOS activity/NO release to a similar extent in human microvascular endothelial cells (HMVECs). NO release was neither associated with an increase in intracellular calcium nor decreased by Ca2+/calmodulin-dependent protein kinase II (CamKII) blockade; however, dephosphorylation of eNOS-Thr(495) was observed. Phosphatidylinositol 3-kinase (PI3K) activity and Akt-Ser(473) phosphorylation were both increased by IGFBP-3 and selectively blocked by the SRB1-Ab or PI3K blocker LY294002. In conclusion, IGFBP-3 mediates protective effects on BRB integrity and mediates robust NO release to stimulate vasorelaxation via activation of SRB1. This response is IGF-1- and calcium-independent, but requires PI3K/Akt activation, suggesting that IGFBP-3 has novel protective effects on retinal and systemic vasculature and may be a therapeutic candidate for ocular complications such as diabetic retinopathy.	[Jarajapu, Yagna P. R.; Yan, Yuanqing; Calzi, Sergio Li; Kielczewski, Jennifer L.; Shaw, Lynn C.; Grant, Maria B.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Cai, Jun; Boulton, Michael E.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Hu, Ping; Chan-Ling, Tailoi] Univ Sydney, Bosch Inst, Discipline Anat, Sydney, NSW 2006, Australia; [Firth, Sue M.; Baxter, Robert C.] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Sydney; University of Sydney; Kolling Institute of Medical Research	Jarajapu, YPR (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.	grantma@ufl.edu	Baxter, Robert C/F-3927-2012; Chan-Ling, Tailoi/X-2718-2019; Chan-Ling, Tailoi/A-2177-2008	Baxter, Robert C/0000-0001-5061-2142; Chan-Ling, Tailoi/0000-0002-8225-3671	National Institutes of Health (NIH) [EY007739, EY012601, U01 HL087366, RO1 EY018358]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY007739, R01EY007739, R01EY018358, R01EY012601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants EY007739, EY012601 and U01 HL087366 to Dr. Grant and RO1 EY018358 to Dr. Boulton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; ChanLing T, 1997, MICROSC RES TECHNIQ, V36, P1; Domene H M, 2005, J Endocrinol Invest, V28, P43; El-Remessy AB, 2003, AM J PATHOL, V162, P1995, DOI 10.1016/S0002-9440(10)64332-5; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fu P, 2007, J BIOL CHEM, V282, P22298, DOI 10.1074/jbc.M703066200; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; HIRATA K, 1995, HYPERTENSION, V25, P180, DOI 10.1161/01.HYP.25.2.180; Hwa V, 1999, ACTA PAEDIATR, V88, P37, DOI 10.1111/j.1651-2227.1999.tb14349.x; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jarajapu YPR, 2002, AM J PHYSIOL-HEART C, V283, pH2234, DOI 10.1152/ajpheart.00624.2002; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Ju WK, 2001, NEUROREPORT, V12, P2405, DOI 10.1097/00001756-200108080-00024; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kielczewski JL, 2011, AM J PATHOL, V178, P1517, DOI 10.1016/j.ajpath.2010.12.031; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Koga T, 2008, CANCER LETT, V268, P82, DOI 10.1016/j.canlet.2008.03.030; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Lee WH, 1999, ENDOCRINE, V11, P181, DOI 10.1385/ENDO:11:2:181; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lu LJ, 2009, BRAIN RES, V1264, P104, DOI 10.1016/j.brainres.2009.01.043; Mishra S, 2004, CANCER RES, V64, P2516, DOI 10.1158/0008-5472.CAN-03-2877; Mohanraj LOY, 2010, ENDOCR REV, pS1035; OH Y, 1993, GROWTH REGULAT, V3, P84; Phillips LS, 1998, PROG NUCLEIC ACID RE, V60, P195, DOI 10.1016/S0079-6603(08)60894-6; Rosenfeld RG, 2000, GROWTH HORM IGF RES, V10, pS16, DOI 10.1016/S1096-6374(00)90007-8; Schedlich LJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P359, DOI 10.1016/j.abb.2007.06.013; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shaw LC, 2006, GENE THER, V13, P752, DOI 10.1038/sj.gt.3302718; Spoerri PE, 2006, MOL VIS, V12, P32; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2128; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; Yan XL, 2004, J BIOL CHEM, V279, P53232, DOI 10.1074/jbc.M409345200; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	53	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39398	10.1371/journal.pone.0039398	http://dx.doi.org/10.1371/journal.pone.0039398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792172	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800010
J	Liu, M; Wang, S; Sun, TG; Su, JG; Zhang, YX; Yue, JJ; Sun, ZW				Liu, Ming; Wang, Shuang; Sun, Tingguang; Su, Jiguo; Zhang, Yuanxing; Yue, Junjie; Sun, Zhiwei			Insight into the Structure, Dynamics and the Unfolding Property of Amylosucrases: Implications of Rational Engineering on Thermostability	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; NORMAL-MODE ANALYSIS; AMINO-ACID-SEQUENCE; MOLECULAR-DYNAMICS; NEISSERIA-POLYSACCHAREA; VIBRATIONAL DYNAMICS; SINGLE-PARAMETER; BINDING PROTEIN; MOTIONS; STABILITY	Amylosucrase (AS) is a kind of glucosyltransferases (E.C. 2.4.1.4) belonging to the Glycoside Hydrolase (GH) Family 13. In the presence of an activator polymer, in vitro, AS is able to catalyze the synthesis of an amylose-like polysaccharide composed of only alpha-1,4-linkages using sucrose as the only energy source. Unlike AS, other enzymes responsible for the synthesis of such amylose-like polymers require the addition of expensive nucleotide-activated sugars. These properties make AS an interesting enzyme for industrial applications. In this work, the structures and topology of the two AS were thoroughly investigated for the sake of explaining the reason why Deinococcus geothermalis amylosucrase (DgAS) is more stable than Neisseria polysaccharea amylosucrase (NpAS). Based on our results, there are two main factors that contribute to the superior thermostability of DgAS. On the one hand, DgAS holds some good structural features that may make positive contributions to the thermostability. On the other hand, the contacts among residues of DgAS are thought to be topologically more compact than those of NpAS. Furthermore, the dynamics and unfolding properties of the two AS were also explored by the gauss network model (GNM) and the anisotropic network model (ANM). According to the results of GNM and ANM, we have found that the two AS could exhibit a shear-like motion, which is probably associated with their functions. What is more, with the discovery of the unfolding pathway of the two AS, we can focus on the weak regions, and hence designing more appropriate mutations for the sake of thermostability engineering. Taking the results on structure, dynamics and unfolding properties of the two AS into consideration, we have predicted some novel mutants whose thermostability is possibly elevated, and hopefully these discoveries can be used as guides for our future work on rational design.	[Liu, Ming; Wang, Shuang; Yue, Junjie; Sun, Zhiwei] Beijing Inst Biotechnol, Beijing, Peoples R China; [Liu, Ming; Zhang, Yuanxing] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Liu, Ming] Genor Biopharma Co Ltd, Shanghai, Peoples R China; [Sun, Tingguang] Guangxi Univ Technol, Dept Biol & Chem Engn, Liuzhou, Peoples R China; [Su, Jiguo] Yanshan Univ, Coll Sci, Qinhuangdao, Peoples R China	East China University of Science & Technology; Guangxi University of Science & Technology; Yanshan University	Liu, M (corresponding author), Beijing Inst Biotechnol, Beijing, Peoples R China.	yxzhang@ecust.edu.cn; yue_junjie@126.com; szwyhhh@yahoo.com.cn		Yue, Junjie/0000-0002-2549-9261	National Natural Science Foundation of China [31170883]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by the National Natural Science Foundation of China 31170883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Albenne C, 2004, J BIOL CHEM, V279, P726, DOI 10.1074/jbc.M309891200; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bae E, 2008, P NATL ACAD SCI USA, V105, P9594, DOI 10.1073/pnas.0800938105; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Chennubhotla C, 2005, PHYS BIOL, V2, pS173, DOI 10.1088/1478-3975/2/4/S12; Cortes J, 2004, J COMPUT CHEM, V25, P956, DOI 10.1002/jcc.20021; de Montalk GP, 2000, FEMS MICROBIOL LETT, V186, P103; de Montalk GP, 2000, FEBS LETT, V471, P219, DOI 10.1016/S0014-5793(00)01406-X; De Montalk GP, 1999, J BACTERIOL, V181, P375; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; Emond S, 2008, FEMS MICROBIOL LETT, V285, P25, DOI 10.1111/j.1574-6968.2008.01204.x; Emond S, 2008, PROTEIN SCI, V17, P967, DOI 10.1110/ps.083492608; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Guerin F, 2012, J BIOL CHEM, V287, P6642, DOI 10.1074/jbc.M111.322917; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ha SJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1505, DOI 10.1271/bbb.80891; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; HEHRE EJ, 1946, J BIOL CHEM, V166, P777; HEHRE EJ, 1949, J BIOL CHEM, V177, P267; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hinsen K, 1999, J CHEM PHYS, V111, P10766, DOI 10.1063/1.480441; Isin B, 2002, BIOPHYS J, V82, P569, DOI 10.1016/S0006-3495(02)75422-2; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Jernigan RL, 1999, INT J QUANTUM CHEM, V75, P301, DOI 10.1002/(SICI)1097-461X(1999)75:3<301::AID-QUA19>3.0.CO;2-0; Keskin O, 2002, BIOPHYS J, V83, P663, DOI 10.1016/S0006-3495(02)75199-0; Kundu S, 2002, BIOPHYS J, V83, P723, DOI 10.1016/S0006-3495(02)75203-X; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Li GH, 2002, BIOPHYS J, V83, P2457, DOI 10.1016/S0006-3495(02)75257-0; Liu M, 2008, BIOPHYS CHEM, V138, P42, DOI 10.1016/j.bpc.2008.09.001; Liu M, 2008, BIOPHYS CHEM, V135, P19, DOI 10.1016/j.bpc.2008.02.017; Liu M, 2009, BIOPOLYMERS, V91, P700, DOI 10.1002/bip.21211; Loris R, 1999, PROTEINS, V36, P117, DOI 10.1002/(SICI)1097-0134(19990701)36:1<117::AID-PROT10>3.0.CO;2-H; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; MACKENZIE CR, 1978, CAN J MICROBIOL, V24, P357, DOI 10.1139/m78-060; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Micheletti C, 2004, PROTEINS, V55, P635, DOI 10.1002/prot.20049; Ming D, 2002, P NATL ACAD SCI USA, V99, P8620, DOI 10.1073/pnas.082148899; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; MUNOZ V, 1994, PROTEINS, V20, P301, DOI 10.1002/prot.340200403; NEMETHY G, 1966, J PHYS CHEM-US, V70, P998, DOI 10.1021/j100876a008; Petukhov M, 1999, PROTEIN SCI, V8, P1982, DOI 10.1110/ps.8.10.1982; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pizzut-Serin S, 2005, FEBS LETT, V579, P1405, DOI 10.1016/j.febslet.2004.12.097; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; PREISS J, 1973, ANN NY ACAD SCI, V210, P265, DOI 10.1111/j.1749-6632.1973.tb47578.x; RIOU JY, 1983, ANN INST PASTEUR MIC, VB134, P257, DOI 10.1016/S0769-2609(83)80038-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Skov LK, 2000, ACTA CRYSTALLOGR D, V56, P203, DOI 10.1107/S0907444999015887; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; Su JG, 2008, BIOPHYS J, V94, P4586, DOI 10.1529/biophysj.107.121665; Su JG, 2007, BIOPHYS J, V92, P1326, DOI 10.1529/biophysj.106.086512; Su JG, 2011, J BIOMOL STRUCT DYN, V29, P105, DOI 10.1080/07391102.2011.10507377; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Temiz NA, 2002, PROTEINS, V49, P61, DOI 10.1002/prot.10183; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; van der Veen BA, 2006, FEBS J, V273, P673, DOI 10.1111/j.1742-4658.2005.05076.x; Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005; Xu CY, 2003, J MOL BIOL, V333, P153, DOI 10.1016/j.jmb.2003.08.027; Xu XJ, 2011, J BIOMOL STRUCT DYN, V28, P717, DOI 10.1080/07391102.2011.10508601; Yennamalli RM, 2011, J BIOMOL STRUCT DYN, V29, P509, DOI 10.1080/07391102.2011.10507402	78	5	7	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40441	10.1371/journal.pone.0040441	http://dx.doi.org/10.1371/journal.pone.0040441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792323	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800085
J	Massimi, P; Zori, P; Roberts, S; Banks, L				Massimi, Paola; Zori, Patrizia; Roberts, Sally; Banks, Lawrence			Differential Regulation of Cell-Cell Contact, Invasion and Anoikis by hScrib and hDlg in Keratinocytes	PLOS ONE			English	Article							PAPILLOMAVIRUS E6 PROTEINS; LARGE TUMOR-SUPPRESSOR; DISCS LARGE; HUMAN HOMOLOG; POLARITY; EXPRESSION; TUMORIGENESIS; DEREGULATION; RECRUITMENT; MIGRATION	The components of the Scrib/Dlg tumour suppressor complex have complementary roles in Drosophila and loss of both proteins is a common event in many different human tumours. However no studies have directly addressed the respective contributions of loss of hScrib and hDlg in the same human cell background to cellular phenotypes associated with cell transformation. In human HaCaT keratinocytes we show that removal of hScrib greatly reduces cell-cell contact and cell-matrix interactions, and promotes an invasive phenotype. Conversely, in cells lacking hDlg1 cell-cell contacts are maintained and there are decreases in both cell growth and invasion. However, hDlg-depleted cells show increased resistance to a specialized form of apoptosis known as anoikis, to which cells lacking hScrib are highly susceptible. Thus whilst it has been widely assumed that hScrib and hDlg have complementary roles, these studies in fact demonstrate that hScrib and hDlg1 have distinct and opposing functions in human keratinocytes.	[Massimi, Paola; Zori, Patrizia; Banks, Lawrence] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Roberts, Sally] Univ Birmingham, Dept Canc Sci, Birmingham, W Midlands, England	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Birmingham	Massimi, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	banks@icgeb.org	Roberts, Sally/N-6143-2014	Roberts, Sally/0000-0003-4653-9442	Association for International Cancer Research; Wellcome Trust; Associazione italiana per la ricerca sul Cancro	Association for International Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Associazione italiana per la ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The work was supported by the Association for International Cancer Research, the Wellcome Trust and the Associazione italiana per la ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Cavatorta AL, 2004, INT J CANCER, V111, P373, DOI 10.1002/ijc.20275; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Lawrence DW, 2002, AM J PHYSIOL-CELL PH, V282, pC1235, DOI 10.1152/ajpcell.00288.2001; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Massimi P, 2008, EXP CELL RES, V314, P3306, DOI 10.1016/j.yexcr.2008.08.016; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Subbaiah VK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002543; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Watson RA, 2002, CARCINOGENESIS, V23, P1791, DOI 10.1093/carcin/23.11.1791; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40279	10.1371/journal.pone.0040279	http://dx.doi.org/10.1371/journal.pone.0040279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792261	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800061
J	Stiubea-Cohen, R; David, R; Neumann, Y; Krief, G; Deutsch, O; Zacks, B; Aframian, DJ; Palmon, A				Stiubea-Cohen, Raluca; David, Ran; Neumann, Yoav; Krief, Guy; Deutsch, Omer; Zacks, Batia; Aframian, Doron J.; Palmon, Aaron			Effect of Irradiation on Cell Transcriptome and Proteome of Rat Submandibular Salivary Glands	PLOS ONE			English	Article							MASS-SPECTROMETRY; NECK-CANCER; RADIATION-THERAPY; ALPHA-AMYLASE; GRAFT CELLS; IDENTIFICATION; HEAD; RADIOSENSITIVITY; POLYMORPHISMS; RADIOTHERAPY	Salivary glands (SGs) are irreversibly damaged by irradiation (IR) treatment in head and neck cancer patients. Here, we used an animal irradiation model to investigate and define the molecular mechanisms affecting SGs following IR, focusing on saliva proteome and global transcription profile of submandibular salivary gland (SSG) tissue. We show that saliva secretion was gradually reduced to 50% of its initial level 12 weeks post-IR. Saliva protein composition was further examined by proteomic analysis following mass spectrometry (MS) analysis that revealed proteins with reduced expression originating from SSGs and proteins with increased expression derived from the serum, both indicating salivary tissue damage. To examine alterations in mRNA expression levels microarray analysis was performed. We found significant alterations in 95 genes, including cell-cycle arrest genes, SG functional genes and a DNA repair gene. Tissue damage was seen by confocal immunofluorescence of alpha-amylase and c-Kit that showed an increase and decrease, respectively, in protein expression. This was coherent with real-time PCR results. This data indicates that IR damages the SSG cells' ability to produce and secrete saliva and proteins, and maintain the physiological barrier between serum and saliva. The damage does not heal due to cell-cycle arrest, which prevents tissue regeneration. Taken together, our results reveal a new insight into IR pathobiology.	[Stiubea-Cohen, Raluca; David, Ran; Neumann, Yoav; Krief, Guy; Deutsch, Omer; Zacks, Batia; Palmon, Aaron] Hebrew Univ Jerusalem, Inst Dent Sci, Fac Dent Med, Jerusalem, Israel; [Aframian, Doron J.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Oral Med, Salivary Gland Clin, Jerusalem, Israel; [Aframian, Doron J.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Oral Med, Saliva Diagnost Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Stiubea-Cohen, R (corresponding author), Hebrew Univ Jerusalem, Inst Dent Sci, Fac Dent Med, Jerusalem, Israel.	aharonp@ekmd.huji.ac.il			Tashtiot Foundation, Israeli Ministry of Science; Israel Science Foundation [1083/11]	Tashtiot Foundation, Israeli Ministry of Science; Israel Science Foundation(Israel Science Foundation)	This research was supported by the Tashtiot Foundation, Israeli Ministry of Science and by Israel Science Foundation grant no. 1083/11. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aframian DJ, 2004, TISSUE ENG, V10, P914, DOI 10.1089/1076327041348518; Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380; Azen EA, 1996, AM J HUM GENET, V58, P143; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan M, 2001, EUR J BIOCHEM, V268, P3423, DOI 10.1046/j.1432-1327.2001.02241.x; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Coppes RP, 2002, RADIOTHER ONCOL, V63, P321, DOI 10.1016/S0167-8140(02)00129-9; Cotrim AP, 2007, CLIN CANCER RES, V13, P4928, DOI 10.1158/1078-0432.CCR-07-0662; Cotroneo E, 2010, DIFFERENTIATION, V79, P120, DOI 10.1016/j.diff.2009.11.005; David R, 2008, TISSUE ENG PT A, V14, P331, DOI 10.1089/tea.2007.0122; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch O, 2008, ELECTROPHORESIS, V29, P4150, DOI 10.1002/elps.200800207; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P485, DOI 10.1177/154411130201300606; Eisbruch A, 2005, NAT CLIN PRACT ONCOL, V2, P34, DOI 10.1038/ncponc0058; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Hardt M, 2005, BIOCHEMISTRY-US, V44, P2885, DOI 10.1021/bi048176r; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirtz C, 2005, PROTEOMICS, V5, P4597, DOI 10.1002/pmic.200401316; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; KASHIMA HK, 1965, AMER J ROENTGENOL RA, V94, P271; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Munter MW, 2007, INT J RADIAT ONCOL, V67, P651, DOI 10.1016/j.ijrobp.2006.09.035; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; O'Connell AC, 1999, RADIAT RES, V151, P150, DOI 10.2307/3579765; Palmon A, 2012, METHODS, V56, P305, DOI 10.1016/j.ymeth.2011.10.002; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takagi K, 2003, RADIAT RES, V159, P351, DOI 10.1667/0033-7587(2003)159[0351:SOSIXI]2.0.CO;2; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Yaniv A, 2011, TISSUE ENG PART C-ME, V17, P69, DOI [10.1089/ten.tec.2010.0228, 10.1089/ten.TEC.2010.0228]; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zeilstra LJW, 2000, INT J RADIAT BIOL, V76, P419, DOI 10.1080/095530000138763; Zhang ZD, 2010, DNA REPAIR, V9, P558, DOI 10.1016/j.dnarep.2010.02.006; Zheng CY, 2011, CLIN CANCER RES, V17, P2842, DOI 10.1158/1078-0432.CCR-10-2982; Zhou J, 2009, TUMOR BIOL, V30, P130, DOI 10.1159/000225242	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40636	10.1371/journal.pone.0040636	http://dx.doi.org/10.1371/journal.pone.0040636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792391	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800112
J	Malinowsky, K; Raychaudhuri, M; Buchner, T; Thulke, S; Wolff, C; Hofler, H; Becker, KF; Avril, S				Malinowsky, Katharina; Raychaudhuri, Mithu; Buchner, Theresa; Thulke, Sabrina; Wolff, Claudia; Hoefler, Heinz; Becker, Karl-Friedrich; Avril, Stefanie			Common Protein Biomarkers Assessed by Reverse Phase Protein Arrays Show Considerable Intratumoral Heterogeneity in Breast Cancer Tissues	PLOS ONE			English	Article							FORMALIN-FIXED TISSUES; PLASMINOGEN-ACTIVATOR; INHIBITOR PAI-1; MICROARRAYS; CARCINOMA; AMPLIFICATION; EVOLUTION; SPECIMENS; DIAGNOSIS	Proteins are used as prognostic and predictive biomarkers in breast cancer. However, the variability of protein expression within the same tumor is not well studied. The aim of this study was to assess intratumoral heterogeneity in protein expression levels by reverse-phase-protein-arrays (RPPA) (i) within primary breast cancers and (ii) between axillary lymph node metastases from the same patient. Protein was extracted from 106 paraffin-embedded samples from 15 large (>= 3 cm) primary invasive breast cancers, including different zones within the primary tumor (peripheral, intermediate, central) as well as 2-5 axillary lymph node metastases in 8 cases. Expression of 35 proteins including 15 phosphorylated proteins representing the HER2, EGFR, and uPA/PAI-1 signaling pathways was assessed using reverse-phase-protein-arrays. All 35 proteins showed considerable intratumoral heterogeneity within primary breast cancers with a mean coefficient of variation (CV) of 31% (range 22-43%). There were no significant differences between phosphorylated (CV 32%) and non-phosphorylated proteins (CV 31%) and in the extent of intratumoral heterogeneity within a defined tumor zone (CV 28%, range18-38%) or between different tumor zones (CV 24%, range 17-38%). Lymph node metastases from the same patient showed a similar heterogeneity in protein expression (CV 27%, range 18-34%). In comparison, the variation amongst different patients was higher in primary tumors (CV 51%, range 29-98%) and lymph node metastases (CV 65%, range 40-146%). Several proteins showed significant differential expression between different tumor stages, grades, histological subtypes and hormone receptor status. Commonly used protein biomarkers of breast cancer, including proteins from HER2, uPA/PAI-1 and EGFR signaling pathways showed higher than previously reported intratumoral heterogeneity of expression levels both within primary breast cancers and between lymph node metastases from the same patient. Assessment of proteins as diagnostic or prognostic markers may require tumor sampling in several distinct locations to avoid sampling bias.	[Malinowsky, Katharina; Raychaudhuri, Mithu; Buchner, Theresa; Thulke, Sabrina; Wolff, Claudia; Hoefler, Heinz; Becker, Karl-Friedrich; Avril, Stefanie] Tech Univ Munich, Dept Pathol, Munich, Germany	Technical University of Munich	Malinowsky, K (corresponding author), Tech Univ Munich, Dept Pathol, Munich, Germany.	stefanie.avril@lrz.tum.de	Avril, Stefanie/J-6668-2016; Becker, Karl-Friedrich/D-3636-2015	Avril, Stefanie/0000-0002-3394-8733; Becker, Karl-Friedrich/0000-0002-6801-4498	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG) [SA1698/1-2]; NGFN (Nationales Genomforschungsnetz) Project of the BMBF (Bundesministerium fur Bildung und Forschung) [01GR0805]	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG)(German Research Foundation (DFG)); NGFN (Nationales Genomforschungsnetz) Project of the BMBF (Bundesministerium fur Bildung und Forschung)	This study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG;http://www.dfg.de/index.jsp) Grant No SA1698/1-2 and the NGFN (Nationales Genomforschungsnetz; http://www.ngfn.de) Project of the BMBF (Bundesministerium fur Bildung und Forschung) Grant No 01GR0805. Funding covered personnel costs (technicians) and consumables for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Berg D, 2011, APPL IMMUNOHISTO M M, V19, P300, DOI 10.1097/PAI.0b013e3182054f9f; Berg D, 2011, METHODS MOL BIOL, V785, P109, DOI 10.1007/978-1-61779-286-1_8; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Brunelli M, 2009, AM J CLIN PATHOL, V131, P678, DOI 10.1309/AJCP09VUTZWZXBMJ; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fujii H, 1996, CANCER RES, V56, P1493; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Glockner S, 2002, LAB INVEST, V82, P1419, DOI 10.1097/01.LAB.0000032371.16521.40; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; LONN U, 1994, INT J CANCER, V58, P40, DOI 10.1002/ijc.2910580108; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; Murphy CG, 2009, BIOL-TARGETS THER, V3, P289; Nassar A, 2010, APPL IMMUNOHISTO M M, V18, P433, DOI 10.1097/PAI.0b013e3181dddb20; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Raychaudhuri M, 2012, J MOL DIAGN IN PRESS; Schmitt M, 2008, BREAST CARE, V3, P3, DOI 10.1159/000151737; Shen CY, 2000, CANCER RES, V60, P3884; Shin SJ, 2006, INT J SURG PATHOL, V14, P279, DOI 10.1177/1066896906293055; Wolff C, 2011, METHODS MOL BIOL, V785, P123, DOI 10.1007/978-1-61779-286-1_9; Wolff C, 2011, J PATHOL, V223, P54, DOI 10.1002/path.2791; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485	28	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40285	10.1371/journal.pone.0040285	http://dx.doi.org/10.1371/journal.pone.0040285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792263	Green Submitted, gold, Green Published			2022-12-25	WOS:000306436300046
J	Markowitz, VM; Chen, IMA; Chu, K; Szeto, E; Palaniappan, K; Jacob, B; Ratner, A; Liolios, K; Pagani, I; Huntemann, M; Mavromatis, K; Ivanova, NN; Kyrpides, NC				Markowitz, Victor M.; Chen, I-Min A.; Chu, Ken; Szeto, Ernest; Palaniappan, Krishna; Jacob, Biju; Ratner, Anna; Liolios, Konstantinos; Pagani, Ioanna; Huntemann, Marcel; Mavromatis, Konstantinos; Ivanova, Natalia N.; Kyrpides, Nikos C.			IMG/M-HMP: A Metagenome Comparative Analysis System for the Human Microbiome Project	PLOS ONE			English	Article							IDENTIFICATION; RECOGNITION; SEQUENCES; DATABASE; GENES	The Integrated Microbial Genomes and Metagenomes (IMG/M) resource is a data management system that supports the analysis of sequence data from microbial communities in the integrated context of all publicly available draft and complete genomes from the three domains of life as well as a large number of plasmids and viruses. IMG/M currently contains thousands of genomes and metagenome samples with billions of genes. IMG/M-HMP is an IMG/M data mart serving the US National Institutes of Health (NIH) Human Microbiome Project (HMP), focussed on HMP generated metagenome datasets, and is one of the central resources provided from the HMP Data Analysis and Coordination Center (DACC). IMG/M-HMP is available at http://www.hmpdacc-resources.org/imgm_hmp/.	[Markowitz, Victor M.; Chen, I-Min A.; Chu, Ken; Szeto, Ernest; Palaniappan, Krishna; Jacob, Biju; Ratner, Anna] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA; [Liolios, Konstantinos; Pagani, Ioanna; Huntemann, Marcel; Mavromatis, Konstantinos; Ivanova, Natalia N.; Kyrpides, Nikos C.] Dept Energy Joint Genome Inst, Microbial Genom & Metagen Program, Walnut Creek, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Markowitz, VM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA.	vmmarkowitz@lbl.gov; nckyrpides@lbl.gov	Huntemann, Marcel/HCH-8928-2022; Kyrpides, Nikos C./A-6305-2014; Pagani, Ioanna/E-7390-2012	Huntemann, Marcel/0000-0002-1284-3748; Kyrpides, Nikos C./0000-0002-6131-0462; Mavrommatis, Konstantinos/0000-0003-4549-385X; Palaniappan, Krishnaveni/0000-0003-4484-7505; Ivanova, Natalia/0000-0002-5802-9485	Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy [DE-AC02-05CH11231]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. National Institutes of Health Data Analysis and Coordination Center [U01-HG004866]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004866] Funding Source: NIH RePORTER	Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Institutes of Health Data Analysis and Coordination Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work presented in this paper was supported by the Director, Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The IMG/M-HMP system is supported by the U.S. National Institutes of Health Data Analysis and Coordination Center contract U01-HG004866. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Hunter S., 2005, NUCLEIC ACIDS RES, V37, pD211; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Markowitz VM, 2012, NUCL ACID RES; Markowitz VM, 2012, NUCL ACID R IN PRESS; Mavromatis K, 2011, SIGS UNPUB; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Pagani I, 2012, NUCL ACIDS RES; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; The Human Microbiome Consortium, 2012, NATURE UNPUB; The Human Microbiome Jumpstart Reference Strains Consortium, 2010, SCIENCE, V328, P994; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	21	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40151	10.1371/journal.pone.0040151	http://dx.doi.org/10.1371/journal.pone.0040151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792232	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300032
J	Stawski, C; Geiser, F				Stawski, Clare; Geiser, Fritz			Will Temperature Effects or Phenotypic Plasticity Determine the Thermal Response of a Heterothermic Tropical Bat to Climate Change?	PLOS ONE			English	Article							BODY-TEMPERATURE; TORPOR; HIBERNATION; ENERGETICS; PHYSIOLOGY; BIRDS; THERMOREGULATION; EVOLUTION; PATTERNS; MAMMALS	The proportion of organisms exposed to warm conditions is predicted to increase during global warming. To better understand how bats might respond to climate change, we aimed to obtain the first data on how use of torpor, a crucial survival strategy of small bats, is affected by temperature in the tropics. Over two mild winters, tropical free-ranging bats (Nyctophilus bifax, 10 g, n = 13) used torpor on 95% of study days and were torpid for 33.5+/-18.8% of 113 days measured. Torpor duration was temperature-dependent and an increase in ambient temperature by the predicted 2 degrees C for the 21st century would decrease the time in torpor to 21.8%. However, comparisons among Nyctophilus populations show that regional phenotypic plasticity attenuates temperature effects on torpor patterns. Our data suggest that heterothermy is important for energy budgeting of bats even under warm conditions and that flexible torpor use will enhance bats' chance of survival during climate change.	[Stawski, Clare; Geiser, Fritz] Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia	University of New England	Stawski, C (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	clare.stawski@gmail.com	Geiser, Fritz/O-4175-2018; Stawski, Clare/E-2284-2011	Geiser, Fritz/0000-0001-7621-5049; Stawski, Clare/0000-0003-1714-0301	Australian Postgraduate Award; Bat Conservation International; Jagiellonian University; University of New England; Australian Research Council	Australian Postgraduate Award(Australian Government); Bat Conservation International; Jagiellonian University; University of New England; Australian Research Council(Australian Research Council)	Financial support was provided by an Australian Postgraduate Award, Bat Conservation International, Jagiellonian University and the University of New England to Clare Stawski and the Australian Research Council to Fritz Geiser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; Bartels W, 1998, J COMP PHYSIOL B, V168, P233, DOI 10.1007/s003600050141; Bieber C, 2009, NATURWISSENSCHAFTEN, V96, P165, DOI 10.1007/s00114-008-0471-z; Boyer BB, 1999, BIOSCIENCE, V49, P713, DOI 10.2307/1313595; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Canale CI, 2010, CLIM RES, V43, P135, DOI 10.3354/cr00897; CARPENTER FL, 1988, CONDOR, V90, P373, DOI 10.2307/1368565; Churchill S, 2008, AUSTR BATS, V2nd; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2001, J COMP PHYSIOL B, V171, P569; GEISER F, 1993, J COMP PHYSIOL B, V163, P133; Geiser Fritz, 2012, P109; Geiser F, 2011, INTEGR COMP BIOL, V51, P337, DOI 10.1093/icb/icr042; Geiser F, 2011, NATURWISSENSCHAFTEN, V98, P447, DOI 10.1007/s00114-011-0779-y; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; HEATH M, 1983, AM J PHYSIOL, V244, pR273, DOI 10.1152/ajpregu.1983.244.2.R273; Henshaw R.E., 1970, P188; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kelm DH, 2007, J COMP PHYSIOL B, V177, P667, DOI 10.1007/s00360-007-0164-5; Kortner G, 2000, OECOLOGIA, V123, P350, DOI 10.1007/s004420051021; Liow LH, 2009, AM NAT, V173, P264, DOI 10.1086/595756; Liu JN, 2011, J COMP PHYSIOL B, V181, P125, DOI 10.1007/s00360-010-0509-3; Lovegrove BG, 2008, J COMP PHYSIOL B, V178, P691, DOI 10.1007/s00360-008-0257-9; Maloney SK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P385, DOI 10.1086/316677; McKechnie AE, 2011, INTEGR COMP BIOL, V51, P349, DOI 10.1093/icb/icr035; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RICHARDS GC, 1989, AUST WILDLIFE RES, V16, P151; Riek A, 2012, J EXP BIOL, V215, P1552, DOI 10.1242/jeb.069559; Schmid J, 2009, NATURWISSENSCHAFTEN, V96, P609, DOI 10.1007/s00114-009-0515-z; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Speakman JR, 2003, BAT ECOLOGY, P430; Stawski Clare, 2012, P99; Stawski C, 2011, AM J PHYSIOL-REG I, V301, pR542, DOI 10.1152/ajpregu.00792.2010; Stawski C, 2010, NATURWISSENSCHAFTEN, V97, P29, DOI 10.1007/s00114-009-0606-x; Stawski C, 2009, J COMP PHYSIOL B, V179, P433, DOI 10.1007/s00360-008-0328-y; Toussaint DC, 2010, MAMM BIOL, V75, P466, DOI 10.1016/j.mambio.2009.06.001; Turbill C, 2003, PHYSIOL BIOCHEM ZOOL, V76, P868, DOI 10.1086/378915; Turbill C, 2008, J COMP PHYSIOL B, V178, P597, DOI 10.1007/s00360-007-0249-1; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; TWENTE JW, 1985, CAN J ZOOL, V63, P2955, DOI 10.1139/z85-443; Visser ME, 2012, NAT CLIM CHANGE, V2, P77, DOI 10.1038/nclimate1387; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Zervanos SM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P135, DOI 10.1086/648736	50	25	25	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40278	10.1371/journal.pone.0040278	http://dx.doi.org/10.1371/journal.pone.0040278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802959	gold, Green Submitted, Green Published			2022-12-25	WOS:000306186900033
J	Kappelmann, M; Kuphal, S; Meister, G; Vardimon, L; Bosserhoff, AK				Kappelmann, M.; Kuphal, S.; Meister, G.; Vardimon, L.; Bosserhoff, A-K			MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression	ONCOGENE			English	Article						malignant melanoma; miRNA; c-Jun; migration; post-transcriptionally; protein expression	CELL INVASION; TRANSCRIPTION FACTORS; MALIGNANT-MELANOMA; MESSENGER-RNAS; PROLIFERATION; GENE; AP-1; MELANOCYTES; MECHANISMS; REGIONS	A fundamental event in the development and progression of malignant melanoma is the deregulation of cancer-relevant transcription factors. We recently showed that c-Jun is a main regulator of tumor progression in melanoma and thus the most important member of the AP-1 transcription factor family for this disease. Interestingly, we revealed that c-Jun expression was regulated on the post-transcriptional level and therefore speculated that miRNAs could be involved in c-Jun regulation. We determined seed sequences for miR-125b and miR-527 in the coding region of c-Jun mRNA that hints at the direct involvement of miRNA-dependent regulation on the protein level. We found that the expression of miR-125b was significantly reduced in malignant melanoma cell lines and tissue samples compared with melanocytes, whereas miR-527 remained unchanged. In further functional experiments, treatment of melanoma cells with pre-miR-125b resulted in strong suppression of cellular proliferation and migration, supporting the role of miR-125b in melanoma. In addition, transfection of pre-miR-125b led to strong downregulation of c-Jun protein but not mRNA expression in melanoma cells. Luciferase assays using reporter plasmids containing the miR-125b seed sequence in the luciferase coding region confirmed the direct interaction with miR-125b. Furthermore, immunoprecipitation of Ago-2 revealed that c-Jun mRNA accumulated in the RNA-induced silencing complex after pre-miR-125b transfection in melanoma cells. In summary, we identified an important role for miR-125b in malignant melanoma. Moreover, we demonstrated post-transcriptional regulation of c-Jun by this miRNA and showed that c-Jun is a main mediator of the effects of miR-125b on melanoma cells.	[Kappelmann, M.; Kuphal, S.; Bosserhoff, A-K] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Meister, G.] Univ Regensburg, Inst Biochem, D-93053 Regensburg, Germany; [Vardimon, L.] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	University of Regensburg; University of Regensburg; Tel Aviv University	Bosserhoff, AK (corresponding author), Univ Regensburg, Inst Pathol, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	anja.bosserhoff@klinik.uni-regensburg.de	Kuphal, Silke/AAW-2702-2020; Bosserhoff, Anja/GNH-4801-2022	Bosserhoff, Anja/0000-0001-8147-394X; Kappelmann-Fenzl, Melanie/0000-0003-0312-1687	Melanoma Research Network of the Deutsche Krebshilfe e.V. (German Cancer Aid); DFG; Bavarian Ministry for education and science (BayGene); European Union; Bundesministerium fur Bildung und Forschung (BMBF, NGFN+)	Melanoma Research Network of the Deutsche Krebshilfe e.V. (German Cancer Aid)(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); Bavarian Ministry for education and science (BayGene); European Union(European Commission); Bundesministerium fur Bildung und Forschung (BMBF, NGFN+)(Federal Ministry of Education & Research (BMBF))	We would like to thank Lisa Ellmann for continuous assistance in cultivation. This work was supported by Melanoma Research Network of the Deutsche Krebshilfe e.V. (German Cancer Aid) and the DFG. GM is supported by grants from the Bavarian Ministry for education and science (BayGene), the European Union (ERC starting grant 'sRNAs', FP7 project 'ONCOMIRs') and the Bundesministerium fur Bildung und Forschung (BMBF, NGFN+).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braig S, 2013, ONCOGENE, V32, P837, DOI 10.1038/onc.2012.115; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Deng Y, 2011, INT J BIOL SCI, V7, P133, DOI 10.7150/ijbs.7.133; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Glud M, 2011, MELANOMA RES, V21, P253, DOI 10.1097/CMR.0b013e328345333b; Glud M, 2010, MELANOMA RES, V20, P479, DOI 10.1097/CMR.0b013e32833e32a1; Howell PM, 2010, OCHSNER J, V10, P83; Jacob K, 1998, MELANOMA RES, V8, P211, DOI 10.1097/00008390-199806000-00003; Janga SC, 2011, ADV EXP MED BIOL, V722, P59, DOI 10.1007/978-1-4614-0332-6_4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Katiyar S, 2010, MOL BIOL CELL, V21, P4264, DOI 10.1091/mbc.E10-08-0705; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Libermann TA, 2006, CURR GENE THER, V6, P17, DOI 10.2174/156652306775515501; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Papaconstantinou I, 2012, EUR J GASTROEN HEPAT, V24, P223, DOI 10.1097/MEG.0b013e3283505063; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Polak P, 2006, ONCOGENE, V25, P665, DOI 10.1038/sj.onc.1209114; Poser I, 2004, ONCOGENE, V23, P6115, DOI 10.1038/sj.onc.1207797; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Rothhammer T, 2005, CANCER RES, V65, P448; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Schmid R, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.78; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shoo BA, 2009, SEMIN CUTAN MED SURG, V28, P96, DOI 10.1016/j.sder.2009.04.005; Spangler B, 2011, PIGM CELL MELANOMA R, V24, P148, DOI 10.1111/j.1755-148X.2010.00787.x; Spangler B, 2012, INT J CANCER, V130, P2801, DOI 10.1002/ijc.26277; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Weiss C, 2004, CELL CYCLE, V3, P111; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	45	111	111	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2013	32	24					2984	2991		10.1038/onc.2012.307	http://dx.doi.org/10.1038/onc.2012.307			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22797068				2022-12-25	WOS:000320369700008
J	Benayoun, BA; Anttonen, M; L'Hote, D; Bailly-Bechet, M; Andersson, N; Heikinheimo, M; Veitia, RA				Benayoun, B. A.; Anttonen, M.; L'Hote, D.; Bailly-Bechet, M.; Andersson, N.; Heikinheimo, M.; Veitia, R. A.			Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation	ONCOGENE			English	Article						FOXL2; ovarian granulosa cell tumor; ovary; transcriptome	EXPRESSION; VISUALIZATION; HALLMARKS; STRESS	Ovarian granulosa cell tumors (OGCT) are the most frequent kind of sex cord-stromal tumors, and represent similar to 2-5% of all ovarian malignancies. OGCTs exist as two entities, juvenile and adult types, with specific clinical and pathological characteristics. The molecular pathogenesis of these tumors has just begun to be unraveled. Indeed, recent studies have indicated that mutation and/or misregulation of the key ovarian transcription factor FOXL2 has a role in OGCT formation, although the mechanisms remain unclear. To better understand the molecular characteristics of OGCT, we studied the transcriptomic profiles of ten human adult-type OGCT samples, as well as ethnically matched granulosa cell (GC) controls. We find that the OGCT samples analyzed herein exhibit several hallmarks of cancer, including increased expression of genes linked to cell proliferation, but decreased expression of those conferring sensitivity to cell death. Moreover, genes differentially expressed in OGCTs are significantly enriched for known FOXL2 target genes, consistently with the prevalence of FOXL2 somatic mutation in these tumors. Expression of these targets is altered in a way expected to promote malignant transformation, for instance, through induction of genes associated with faster cell cycling and downregulation of genes associated with cell death. Over time, such defects may be responsible at least partly for the malignant transformation of healthy GCs into OGCT. These insights into the molecular pathogenesis of OGCTs may open the way to new efforts in the development of more targeted therapeutic strategies for OGCT patients.	[Benayoun, B. A.; L'Hote, D.; Veitia, R. A.] Inst Jacques Monod, F-75251 Paris, France; [Benayoun, B. A.; L'Hote, D.; Veitia, R. A.] Univ Paris 07, Paris 13, France; [Anttonen, M.] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Anttonen, M.; Andersson, N.; Heikinheimo, M.] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Anttonen, M.; Andersson, N.; Heikinheimo, M.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Bailly-Bechet, M.] Univ Lyon, UMR 5558, CNRS, Laborat Biometrie & Biol Evolut, Villeurbanne, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Veitia, RA (corresponding author), Univ Paris 07, Batiment Buffon,15 Rue Helene Brion, Paris 13, France.	veitia.reiner@ijm.univ-paris-diderot.fr	Bailly-Bechet, Marc/B-6292-2012; Andersson, Noora/AAW-2030-2020; Benayoun, Bérénice A./K-7048-2012; LHOTE, David/AAD-5390-2020; L'Hote, David/L-2653-2017	Andersson, Noora/0000-0003-4708-7273; Benayoun, Bérénice A./0000-0002-7401-4777; L'Hote, David/0000-0001-5658-5018	AMN/Universite Paris Diderot-Paris 7; The Helsinki University Central Hospital Research Funds; Academy of Finland; Sigrid Juselius Foundation; Helsinki University Central Hospital; Universite Paris Diderot-Paris 7; CNRS; Universite Lyon 1; Institut Universitaire de France; Fondation pour la Recherche Medicale; Ligue Nationale Contre le Cancer (Comite de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer; Universite Paris VII; Fondation pour la Recherche Medicale (FRM)	AMN/Universite Paris Diderot-Paris 7; The Helsinki University Central Hospital Research Funds; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital; Universite Paris Diderot-Paris 7; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Lyon 1; Institut Universitaire de France; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Nationale Contre le Cancer (Comite de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer; Universite Paris VII; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	We thank Dr Ralf Butzow and Dr Unkila-Kallio for help and collection of the human OGCT samples. We thank Dr Denis Mestivier for his advice on clustering analysis of the OGCT microarray samples. BAB was funded by AMN/Universite Paris Diderot-Paris 7 fellowships. MA was funded by a grant from The Helsinki University Central Hospital Research Funds. NA and MH were funded by Academy of Finland, Sigrid Juselius Foundation and Helsinki University Central Hospital. DL was funded by Universite Paris Diderot-Paris 7. MBB was funded by CNRS and Universite Lyon 1. RAV was funded by Institut Universitaire de France, Fondation pour la Recherche Medicale, Ligue Nationale Contre le Cancer (Comite de Paris), Groupement d'Entreprises Francaises dans la Lutte contre le Cancer, CNRS and Universite Paris VII. This work was supported by grants from Fondation pour la Recherche Medicale (FRM), from The Helsinki University Central Hospital Research Funds and from Academy of Finland, Sigrid Juselius Foundation and Helsinki University Central Hospital.	Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2010, BBA-REV CANCER, V1805, P1, DOI 10.1016/j.bbcan.2009.09.002; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; East N, 2005, J OBSTET GYNAECOL CA, V27, P363, DOI 10.1016/S1701-2163(16)30464-9; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kalfa N, 2009, GENOME MED, V1, DOI 10.1186/gm81; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim MS, 2010, J PATHOL, V221, P147, DOI 10.1002/path.2688; Kyronlahti A, 2010, ENDOCR-RELAT CANCER, V17, P709, DOI 10.1677/ERC-10-0041; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Nagaraja AK, 2010, ENDOCRINOLOGY, V151, P4994, DOI 10.1210/en.2010-0428; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Pectasides D, 2008, CANCER TREAT REV, V34, P1, DOI 10.1016/j.ctrv.2007.08.007; Rishi AK, 1999, NUCLEIC ACIDS RES, V27, P3111, DOI 10.1093/nar/27.15.3111; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sambrook J, 2001, MOL CLONING LAB MANU; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	40	41	42	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2739	2746		10.1038/onc.2012.298	http://dx.doi.org/10.1038/onc.2012.298			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22797072				2022-12-25	WOS:000319808000005
J	Snow, JJ; Lee, MH; Verheyden, J; Kroll-Conner, PL; Kimble, J				Snow, J. J.; Lee, M-H; Verheyden, J.; Kroll-Conner, P. L.; Kimble, J.			C. elegans FOG-3/Tob can either promote or inhibit germline proliferation, depending on gene dosage and genetic context	ONCOGENE			English	Article						FOG-3; Tob/BTG; proliferation; tumor formation; germ cells; C. elegans	RNA-BINDING PROTEIN; MITOTIC REGION; EARLY EVENT; STEM-CELLS; TOB; PHOSPHORYLATION; EXPRESSION; FAMILY; FATE; BTG1	Vertebrate Tob/BTG proteins inhibit cell proliferation when overexpressed in tissue-culture cells, and they can function as tumor suppressors in mice. The single Caenorhabditis elegans Tob/BTG ortholog, FOG-3, by contrast, was identified from its loss-of-function phenotype as a regulator of sperm fate specification. Here we report that FOG-3 also regulates proliferation in the germline tissue. We first demonstrate that FOG-3 is a positive regulator of germline proliferation. Thus, fog-3 null mutants possess fewer germ cells than normal, a modest but reproducible decrease observed for each of two distinct fog-3 null alleles. A similar decrease also occurred in fog-3/+ heterozygotes, again for both fog-3 alleles, revealing a haplo-insufficient effect on proliferation. Therefore, FOG-3 normally promotes proliferation, and two copies of the fog-3 gene are required for this function. We next overexpressed FOG-3 by removal of FBF, the collective term for FBF-1 and FBF-2, two nearly identical PUF RNA-binding proteins. We find that overexpressed FOG-3 blocks proliferation in fbf-1 fbf-2 mutants; whereas germ cells stop dividing and instead differentiate in fbf-1 fbf-2 double mutants, they continue to proliferate in fog-3; fbf-1 fbf-2 triple mutants. Therefore, like its vertebrate Tob/BTG cousins, overexpressed FOG-3 is 'antiproliferative'. Indeed, some fog-3; fbf-1 fbf-2 mutants possess small tumors, suggesting that FOG-3 can act as a tumor suppressor. Finally, we show that FOG-3 and FBF work together to promote tumor formation in animals carrying oncogenic Notch mutations. A similar effect was not observed when germline tumors were induced by manipulation of other regulators; therefore, this FOG-3 tumor-promoting effect is context dependent. We conclude that FOG-3 can either promote or inhibit proliferation in a manner that is sensitive to both genetic context and gene dosage. The discovery of these FOG-3 effects on proliferation has implications for our understanding of vertebrate Tob/BTG proteins and their influence on normal development and tumorigenesis.	[Snow, J. J.; Kimble, J.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Lee, M-H; Kroll-Conner, P. L.; Kimble, J.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Verheyden, J.; Kimble, J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimble, J (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	jekimble@wisc.edu		Lee, Myon Hee/0000-0001-9020-2391	NIH [5T32GM007215, R01GM069454, 5F32GM095036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095036, R01GM069454, T32GM007215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Japanese consortium for generation of fog-3(tm4376) and the CGC for strains. We also thank members of the Kimble lab for helpful discussions, Laura Vanderploeg for help with figures and Anne Helsley for help preparing the manuscript. JJS was supported by NIH Training Grant 5T32GM007215 in Molecular Biosciences. JK is supported by NIH R01GM069454. JV is supported by NIH 5F32GM095036. JK is an investigator of the Howard Hughes Medical Institute.	Albrecht M, 2004, FEBS LETT, V569, P18, DOI 10.1016/j.febslet.2004.03.126; BARTON MK, 1987, GENETICS, V115, P107; Berry LW, 1997, DEVELOPMENT, V124, P925; BRENNER S, 1974, GENETICS, V77, P71; Busson M, 2005, ONCOGENE, V24, P1698, DOI 10.1038/sj.onc.1208373; Byrd DT, 2009, SEMIN CELL DEV BIOL, V20, P1107, DOI 10.1016/j.semcdb.2009.09.005; Chen PJ, 2000, DEV BIOL, V217, P77, DOI 10.1006/dbio.1999.9521; Cinquin O, 2010, P NATL ACAD SCI USA, V107, P2048, DOI 10.1073/pnas.0912704107; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; ELLIS RE, 1995, GENETICS, V139, P561; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ito Y, 2005, CANCER LETT, V220, P237, DOI 10.1016/j.canlet.2004.08.017; Iwanaga K, 2003, CANCER LETT, V202, P71, DOI 10.1016/j.canlet.2003.08.019; Jia SJ, 2007, DEV DYNAM, V236, P913, DOI 10.1002/dvdy.21092; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Kershner AM, 2010, P NATL ACAD SCI USA, V107, P3936, DOI 10.1073/pnas.1000495107; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Lamont LB, 2007, DEV DYNAM, V236, P871, DOI 10.1002/dvdy.21081; Lee MH, 2011, P NATL ACAD SCI USA, V108, P9125, DOI 10.1073/pnas.1106027108; Majid S, 2009, CARCINOGENESIS, V30, P662, DOI 10.1093/carcin/bgp042; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Podbilewicz B., 2006, WORMBOOK; Rodier A, 2001, ONCOGENE, V20, P2691, DOI 10.1038/sj.onc.1204398; Rodier A, 1999, EXP CELL RES, V249, P337, DOI 10.1006/excr.1999.4486; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Thompson BE, 2006, P NATL ACAD SCI USA, V103, P620, DOI 10.1073/pnas.0510264103; Thompson BE, 2005, DEVELOPMENT, V132, P3471, DOI 10.1242/dev.01921; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yanagie H, 2009, BIOMED PHARMACOTHER, V63, P275, DOI 10.1016/j.biopha.2008.04.010; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	41	10	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2013	32	21					2614	2621		10.1038/onc.2012.291	http://dx.doi.org/10.1038/onc.2012.291			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FH	22797076	Green Accepted			2022-12-25	WOS:000319806700002
J	Huitema, LFA; Renn, J; Logister, I; Gray, JK; Waltz, SE; Flik, G; Schulte-Merker, S				Huitema, Leonie F. A.; Renn, Joerg; Logister, Ive; Gray, Jerilyn K.; Waltz, Susan E.; Flik, Gert; Schulte-Merker, Stefan			Macrophage-stimulating protein and calcium homeostasis in zebrafish	FASEB JOURNAL			English	Article						msp; ron; mineralization; bone; osteogenesis; stanniocalcin	RECEPTOR TYROSINE KINASE; BONE-RESORPTION; GENE-PRODUCT; GROWTH; EXPRESSION; IDENTIFICATION; OSTEOBLASTS; ACTIVATION; RON; STANNIOCALCIN	To systematically identify novel gene functions essential for osteogenesis and skeletal mineralization, we performed a forward genetic mutagenesis screen in zebrafish and isolated a mutant that showed delayed skeletal mineralization. Analysis of the mutant phenotype in an osterix:nuclear-GFP transgenic background demonstrated that mutants contain osterix-expressing osteoblasts comparable to wild-type embryos. Positional cloning revealed a premature stop mutation in the macrophage-stimulating protein (msp) gene, predicted to result in a biologically inactive protein. Analysis of the embryonic expression pattern for the receptor for Msp, Ron, shows specific expression in the corpuscles of Stannius, a teleost-specific organ that produces stanniocalcin, a pivotal hormone in fish calcium homeostasis. Knockdown of Ron resulted in identical phenotypes as observed in msp mutants. Msp mutant embryos could be rescued by excess calcium. Consistent with a role for Msp/Ron in calcium homeostasis, calcium-regulating factors, such as pth1, pth2, stc1l, and trpv5/6 were significantly affected in msp mutant larvae. While Msp and Ron have previously been shown to play a critical role in a wide variety of biological processes, we introduce here the Msp/Ron signaling axis as a previously unappreciated player in calcium homeostasis and embryonic skeletal mineralization.-Huitema, L. F. A., Renn, J., Logister, I., Gray, J. K., Waltz, S. E., Flik, G., Schulte-Merker, S. Macrophage stimulating protein and calcium homeostasis in zebrafish. FASEB J. 26, 4092-4101 (2012). www.fasebj.org	[Huitema, Leonie F. A.; Logister, Ive; Schulte-Merker, Stefan] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Huitema, Leonie F. A.; Logister, Ive; Schulte-Merker, Stefan] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Huitema, Leonie F. A.; Logister, Ive; Schulte-Merker, Stefan] Ctr Biomed Genet, Utrecht, Netherlands; [Schulte-Merker, Stefan] Wageningen Univ, Expt Zool Grp, Wageningen, Netherlands; [Renn, Joerg] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Gray, Jerilyn K.; Waltz, Susan E.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Gray, Jerilyn K.; Waltz, Susan E.] Vet Hosp Med Ctr, Cincinnati, OH USA; [Flik, Gert] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Physiol, NL-6525 ED Nijmegen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Wageningen University & Research; National University of Singapore; University System of Ohio; University of Cincinnati; Radboud University Nijmegen	Schulte-Merker, S (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	s.schulte@hubrecht.eu	Flik, Gert/C-8229-2011	Flik, Gert/0000-0001-9285-7957; Waltz, Susan/0000-0003-3572-4642	Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture, and Science; NATIONAL CANCER INSTITUTE [R01CA125379] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000803] Funding Source: NIH RePORTER	Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture, and Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank the Tubingen 2000 screen consortium members for identifying the msp<SUP>t34230</SUP> mutant phenotype; this mutant was identified while S.S.-M. was working at Exelixis Deutschland GmbH (Tubingen, Germany). Many thanks also go to C. Hammond and J. Vanoevelen for editorial review and W. Atsma for calcium measurements. The authors acknowledge the Hubrecht Institute Imaging Center for expert advice on imaging. All members of the S.S.-M. laboratory are acknowledged for comments and scientific discussions. S.S.-M. gratefully recognizes the support of the Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture, and Science.	Bassett DI, 2003, DEV GENES EVOL, V213, P360, DOI 10.1007/s00427-003-0339-3; Bezerra JA, 1998, J CLIN INVEST, V101, P1175, DOI 10.1172/JCI1744; BEZERRA JA, 1993, HEPATOLOGY, V18, P394, DOI 10.1016/0270-9139(93)90024-H; Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165; Brand Michael, 2002, P7; Bushinsky DA, 2010, CLIN J AM SOC NEPHRO, V5, pS12, DOI 10.2215/CJN.05970809; FLIK G, 1995, FISH PHYSIOL, V14, P317; Flik Gert, 1995, Biochemistry and Molecular Biology of Fishes, V5, P251; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gerritsen ME, 2005, VITAM HORM, V70, P105, DOI 10.1016/S0083-6729(05)70004-2; Guerreiro PM, 2004, J EXP BIOL, V207, P645, DOI 10.1242/jeb.00765; Haffter P, 1996, DEVELOPMENT, V123, P1; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hogan BM, 2005, ENDOCRINOLOGY, V146, P547, DOI 10.1210/en.2004-0296; Hoshijima K, 2007, J ENDOCRINOL, V193, P481, DOI 10.1677/JOE-07-0003; Inohaya K, 2007, DEV DYNAM, V236, P3031, DOI 10.1002/dvdy.21329; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704; Lafont AG, 2011, J BONE MINER RES, V26, P1072, DOI 10.1002/jbmr.301; LEONARD EJ, 1978, EXP CELL RES, V114, P117, DOI 10.1016/0014-4827(78)90043-5; Mundy GR, 1999, CLIN CHEM, V45, P1347; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; Santoro MM, 1996, MOL CELL BIOL, V16, P7072; Schulte-Merker S., 2002, ZEBRAFISH PRACTICAL, P41; SHIMAMOTO A, 1993, FEBS LETT, V333, P61, DOI 10.1016/0014-5793(93)80375-5; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; Vanoevelen J, 2011, FASEB J, V25, P3197, DOI 10.1096/fj.11-183145; Varsamos S, 2005, COMP BIOCHEM PHYS A, V141, P401, DOI 10.1016/j.cbpb.2005.01.013; Varsamos S, 2002, ANAT EMBRYOL, V205, P203, DOI 10.1007/s00429-002-0231-3; WAGNER GF, 1991, MOL CELL ENDOCRINOL, V79, P129, DOI 10.1016/0303-7207(91)90103-Y; Waltz SE, 1997, J BIOL CHEM, V272, P30526, DOI 10.1074/jbc.272.48.30526; WANG MH, 1995, P NATL ACAD SCI USA, V92, P3933, DOI 10.1073/pnas.92.9.3933; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; WANG MH, 1994, J BIOL CHEM, V269, P13806; Wang MH, 1996, J CLIN INVEST, V97, P720, DOI 10.1172/JCI118470; WANG MH, 1994, J BIOL CHEM, V269, P3436; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446	46	15	16	0	103	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4092	4101		10.1096/fj.11-202663	http://dx.doi.org/10.1096/fj.11-202663			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22787265	Green Published			2022-12-25	WOS:000309704000016
J	van Weeghel, M; te Brinke, H; van Lenthe, H; Kulik, W; Minkler, PE; Stoll, MSK; Sass, JO; Janssen, U; Stoffel, W; Schwab, KO; Wanders, RJA; Hoppel, CL; Houten, SM				van Weeghel, Michel; te Brinke, Heleen; van Lenthe, Henk; Kulik, Wim; Minkler, Paul E.; Stoll, Maria S. K.; Sass, Joern Oliver; Janssen, Uwe; Stoffel, Wilhelm; Schwab, K. Otfried; Wanders, Ronald J. A.; Hoppel, Charles L.; Houten, Sander M.			Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids	FASEB JOURNAL			English	Article						mouse models; inherited metabolic disease	TANDEM MASS-SPECTROMETRY; BETA-OXIDATION; RAT-LIVER; DELTA-3,DELTA-2-ENOYL-COA ISOMERASE; 3-HYDROXYACYL-COA DEHYDROGENASE; 2-ENOYL-COA HYDRATASE; ZELLWEGER SYNDROME; ENZYME; MOUSE; FIBROBLASTS	Mitochondrial enoyl-CoA isomerase (ECI1) is an auxiliary enzyme involved in unsaturated fatty acid oxidation. In contrast to most of the other enzymes involved in fatty acid oxidation, a deficiency of ECI1 has yet to be identified in humans. We used wild-type (WT) and Eci1-deficient knockout (KO) mice to explore a potential presentation of human ECI1 deficiency. Upon food withdrawal, Eci1-deficient mice displayed normal blood beta-hydroxybutyrate levels (WT 1.09 mM vs. KO 1.10 mM), a trend to lower blood glucose levels (WT 4.58 mM vs. KO 3.87 mM, P=0.09) and elevated blood levels of unsaturated acylcarnitines, in particular C12:1 acylcarnitine (WT 0.03 mu M vs. KO 0.09 mu M, P<0.01). Feeding an olive oil-rich diet induced an even greater increase in C12: 1 acylcarnitine levels (WT 0.01 mu M vs. KO 0.04 mu M, P<0.01). Overall, the phenotypic presentation of Eci1-deficient mice is mild, possibly caused by the presence of a second enoyl-CoA isomerase (Eci2) in mitochondria. Knockdown of Eci2 in Eci1-deficient fibroblasts caused a more pronounced accumulation of C12: 1 acylcarnitine on incubation with unsaturated fatty acids (12-fold, P<0.05). We conclude that Eci2 compensates for Eci1 deficiency explaining the mild phenotype of Eci1-deficient mice. Hypoglycemia and accumulation of C12: 1 acylcarnitine might be diagnostic markers to identify ECI1 deficiency in humans.-van Weeghel, M., te Brinke, H., van Lenthe, H., Kulik, W., Minkler, P. E., Stoll, M. S. K., Sass, J. O., Janssen, U., Stoffel, W., Schwab, O. K., Wanders, R. J. A., Hoppel, C. L., Houten, S. M. Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids. FASEB J. 26, 4316-4326 (2012). www.fasebj.org	[van Weeghel, Michel; te Brinke, Heleen; van Lenthe, Henk; Kulik, Wim; Wanders, Ronald J. A.; Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis,Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Wanders, Ronald J. A.; Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Minkler, Paul E.; Stoll, Maria S. K.; Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Sass, Joern Oliver; Schwab, K. Otfried] Ctr Childrens Hosp Freiburg, Freiburg, Germany; [Sass, Joern Oliver] Univ Childrens Hosp Zurich, Dept Clin Chem & Biochem, Zurich, Switzerland; [Janssen, Uwe] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Stoffel, Wilhelm] Univ Cologne, Inst Biochem, Ctr Mol Med Cologne, Cluster Excellence Cellular Stress Response Aging, Cologne, Germany	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Case Western Reserve University; Case Western Reserve University; University Children's Hospital Zurich; Miltenyi Biotec; University of Cologne	Houten, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis F0 222, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.m.houten@amc.uva.nl	Houten, Sander/Y-3599-2019; van Weeghel, Michel/A-2766-2010	Houten, Sander/0000-0002-6167-9147; van Weeghel, Michel/0000-0002-4916-2866	Netherlands Organization for Scientific Research (VIDI) [016.086.336]; Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences, The Netherlands	Netherlands Organization for Scientific Research (VIDI)(Netherlands Organization for Scientific Research (NWO)); Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences, The Netherlands	The authors thank Dr. H. Schulz (Department of Chemistry, City College and Graduate School of the City University of New York, New York, NY, USA) for the generous gift of the polyclonal mouse Eci1 and Eci2 antibody, Dr. C. Argmann for critically reading the manuscript, W. Smit for the analysis of the fatty acid composition of the diet, and the employees of the Animal Research Institute (Amsterdam, The Netherlands) for technical assistance. This work was supported by the Netherlands Organization for Scientific Research (VIDI; grant 016.086.336 to S.M.H.) and the Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences, The Netherlands (to M.V.W.).	Bakermans AJ, 2011, CIRC-CARDIOVASC IMAG, V4, P558, DOI 10.1161/CIRCIMAGING.111.963751; Bergmeyer H. U., 1986, METHODS ENZYMATIC AN, V2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENDEL K, 1967, BIOCHIM BIOPHYS ACTA, V137, P98, DOI 10.1016/0005-2760(67)90012-4; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Cox KB, 2001, HUM MOL GENET, V10, P2069, DOI 10.1093/hmg/10.19.2069; Geisbrecht BV, 1999, J BIOL CHEM, V274, P21797, DOI 10.1074/jbc.274.31.21797; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; Ijlst L, 1998, J CLIN INVEST, V102, P527, DOI 10.1172/JCI2927; Janssen U, 2002, J BIOL CHEM, V277, P19579, DOI 10.1074/jbc.M110993200; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; MANNING NJ, 1990, J INHERIT METAB DIS, V13, P58, DOI 10.1007/BF01799333; Miinalainen IJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000543; Minkler P. E., 2011, J AM SOC MASS SPE S1, V22, P69; Minkler PE, 2008, CLIN CHEM, V54, P1451, DOI 10.1373/clinchem.2007.099226; MULLERNEWEN G, 1991, BIOL CHEM H-S, V372, P613, DOI 10.1515/bchm3.1991.372.2.613; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; PALOSAARI PM, 1991, J BIOL CHEM, V266, P10750; PALOSAARI PM, 1990, J BIOL CHEM, V265, P3347; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RASMUSSEN JT, 1990, BIOCHEM J, V265, P849, DOI 10.1042/bj2650849; Ren Y, 2003, J BIOL CHEM, V278, P111, DOI 10.1074/jbc.M209261200; SCHULZ H, 1987, TRENDS BIOCHEM SCI, V12, P403, DOI 10.1016/0968-0004(87)90196-4; Stoffel W, 1964, Hoppe Seylers Z Physiol Chem, V339, P167, DOI 10.1515/bchm2.1964.339.1.167; van Vlies N, 2007, MOL GENET METAB, V90, P24, DOI 10.1016/j.ymgme.2006.07.006; Ventura FV, 1999, CLIN CHIM ACTA, V281, P1, DOI 10.1016/S0009-8981(98)00188-0; Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745; WANDERS RJA, 1984, BIOCHEM BIOPH RES CO, V123, P1054, DOI 10.1016/S0006-291X(84)80240-5; WANDERS RJA, 1986, CLIN CHIM ACTA, V159, P1, DOI 10.1016/0009-8981(86)90160-9; Zhang DY, 2002, J BIOL CHEM, V277, P9127, DOI 10.1074/jbc.M112228200	32	33	33	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2012	26	10					4316	4326		10.1096/fj.12-206326	http://dx.doi.org/10.1096/fj.12-206326			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22782973				2022-12-25	WOS:000309704000036
J	Song, CH; Yang, SH; Park, E; Cho, SH; Gong, EY; Khadka, DB; Cho, WJ; Lee, K				Song, Chin-Hee; Yang, Su Hui; Park, Eunsook; Cho, Suk Hee; Gong, Eun-Yeung; Khadka, Daulat Bikram; Cho, Won-Jea; Lee, Keesook			Structure-based Virtual Screening and Identification of a Novel Androgen Receptor Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; LIGAND-DEPENDENT TRANSACTIVATION; NECROSIS-FACTOR-ALPHA; LNCAP CELLS; BINDING DOMAIN; IN-VIVO; TRANSCRIPTIONAL COACTIVATOR; NEOPLASTIC PROSTATE; DEPRIVATION THERAPY; CYPROTERONE-ACETATE	Hormonal therapies, mainly combinations of anti-androgens and androgen deprivation, have been the mainstay treatment for advanced prostate cancer because the androgen-androgen receptor (AR) system plays a pivotal role in the development and progression of prostate cancers. However, the emergence of androgen resistance, largely due to inefficient anti-hormone action, limits the therapeutic usefulness of these therapies. Here, we report that 6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide (DIMN) acts as a novel anti-androgenic compound that may be effective in the treatment of both androgen-dependent and androgen-independent prostate cancers. Through AR structure-based virtual screening using the FlexX docking model, fifty-four compounds were selected and further screened for AR antagonism via cell-based tests. One compound, DIMN, showed an antagonistic effect specific to AR with comparable potency to that of the classical AR antagonists, hydroxyflutamide and bicalutamide. Consistent with their anti-androgenic activity, DIMN inhibited the growth of androgen-dependent LNCaP prostate cancer cells. Interestingly, the compound also suppressed the growth of androgen-independent C4-2 and CWR22rv prostate cancer cells, which express a functional AR, but did not suppress the growth of the AR-negative prostate cancer cells PPC-1, DU145, and R3327-AT3.1. Taken together, the results suggest that the synthetic compound DIMN is a novel anti-androgen and strong candidate for useful therapeutic agent against early stage to advanced prostate cancer.	[Yang, Su Hui; Cho, Suk Hee; Khadka, Daulat Bikram; Cho, Won-Jea] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea; [Yang, Su Hui; Cho, Suk Hee; Khadka, Daulat Bikram; Cho, Won-Jea] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju 500757, South Korea; [Song, Chin-Hee; Park, Eunsook; Gong, Eun-Yeung; Lee, Keesook] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Cho, WJ (corresponding author), Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea.	wjcho@chonnam.ac.kr; klee@chonnam.ac.kr	Yang, Suhui/S-4240-2019	Yang, Suhui/0000-0003-3424-2692; Khadka, Daulat Bikram/0000-0002-6634-5824	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [NRF-2012R1A2A2A01008388, NRF-2011-0015551]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2012R1A2A2A01008388, NRF-2011-0015551).	Ai JK, 2009, MOL ENDOCRINOL, V23, P1963, DOI 10.1210/me.2009-0188; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Anderson J, 2003, BJU INT, V91, P455, DOI 10.1046/j.1464-410X.2003.04026.x; Axerio-Cilies P, 2011, J MED CHEM, V54, P6197, DOI 10.1021/jm200532b; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Butler LM, 2000, CANCER RES, V60, P5165; Chattopadhyay S, 2006, MOL ENDOCRINOL, V20, P984, DOI 10.1210/me.2005-0240; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Craft N, 1998, CANCER METAST REV, V17, P421, DOI 10.1023/A:1006141806801; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; CULIG Z, 1994, CANCER RES, V54, P5474; Eder Iris E, 2005, Future Oncol, V1, P93; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Furutani T, 2002, BIOCHEM BIOPH RES CO, V294, P779, DOI 10.1016/S0006-291X(02)00564-8; Gao WQ, 2006, PHARM RES-DORDR, V23, P1641, DOI 10.1007/s11095-006-9024-3; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P4315; Grigoryev DN, 2000, J STEROID BIOCHEM, V75, P1, DOI 10.1016/S0960-0760(00)00131-X; HAMANN LG, 1995, ANN NY ACAD SCI, V761, P383, DOI 10.1111/j.1749-6632.1995.tb31398.x; Hara T, 2003, CANCER RES, V63, P149; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hong CY, 2005, MOL ENDOCRINOL, V19, P2245, DOI 10.1210/me.2004-0400; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Jung ME, 2010, J MED CHEM, V53, P2779, DOI 10.1021/jm901488g; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; Kawata H, 2011, PROSTATE, V71, P1344, DOI 10.1002/pros.21351; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Kinoyama I, 2006, J MED CHEM, V49, P716, DOI 10.1021/jm050293c; Kinoyama I, 2005, CHEM PHARM BULL, V53, P402, DOI 10.1248/cpb.53.402; Kokontis JM, 1999, VITAM HORM, V55, P219; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V367, P481, DOI 10.1016/j.bbrc.2007.12.162; Lee SJ, 2004, MOL THER, V10, P1051, DOI 10.1016/j.ymthe.2004.08.028; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lee YS, 2002, BIOL REPROD, V67, P1580, DOI 10.1095/biolreprod.102.006155; Lefort M, 2005, UROL INT, V74, P301, DOI 10.1159/000084427; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Lu S, 2007, MOL CANCER THER, V6, P2057, DOI 10.1158/1535-7163.MCT-06-0735; Manin M, 2002, BIOCHEM J, V366, P729, DOI 10.1042/BJ20020585; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Mikhailova M, 2008, ADV EXP MED BIOL, V617, P397, DOI 10.1007/978-0-387-69080-3_38; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Miyamoto H, 1998, P NATL ACAD SCI USA, V95, P7379, DOI 10.1073/pnas.95.13.7379; Mohler ML, 2009, J MED CHEM, V52, P3597, DOI 10.1021/jm900280m; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; ONATE SA, 1995, SCIENCE, V270, P1354; Osguthorpe DJ, 2011, BIOCHEMISTRY-US, V50, P4105, DOI 10.1021/bi102059z; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POYET P, 1985, MOL CELL ENDOCRINOL, V42, P283, DOI 10.1016/0303-7207(85)90059-0; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Reid P, 1999, INVEST NEW DRUG, V17, P271, DOI 10.1023/A:1006344807086; Rodriguez-Berriguete G., 2012, J SIGNAL TRANSDUCT, V2012; Rowland JG, 2007, PROTEOMICS, V7, P47, DOI 10.1002/pmic.200600697; Salvati ME, 2005, BIOORG MED CHEM LETT, V15, P271, DOI 10.1016/j.bmcl.2004.10.085; SCHER HI, 1995, UROLOGY, V46, P142, DOI 10.1016/S0090-4295(99)80182-4; Setlur SR, 2005, ADV ANAT PATHOL, V12, P265, DOI 10.1097/01.pap.0000184179.50672.f7; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Soderholm AA, 2008, J CHEM INF MODEL, V48, P1882, DOI 10.1021/ci800149w; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Suh JH, 2008, J STEROID BIOCHEM, V112, P117, DOI 10.1016/j.jsbmb.2008.09.003; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Terouanne B, 2002, MOL CELL ENDOCRINOL, V198, P143, DOI 10.1016/S0303-7207(02)00377-5; Thalmann GN, 2000, PROSTATE, V44, P91; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang Y, 2008, ONCOGENE, V27, P7106, DOI 10.1038/onc.2008.318; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Wen Y, 2000, CANCER RES, V60, P6841; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; WILDING G, 1989, PROSTATE, V14, P103, DOI 10.1002/pros.2990140204; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043; Yang J, 2006, J PHARMACOL EXP THER, V317, P402, DOI 10.1124/jpet.105.094334; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yeh SY, 1998, P NATL ACAD SCI USA, V95, P5527, DOI 10.1073/pnas.95.10.5527; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817	97	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30769	30780		10.1074/jbc.M112.379107	http://dx.doi.org/10.1074/jbc.M112.379107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798067	hybrid, Green Published			2022-12-25	WOS:000308579800065
J	Kar, UK; Jiang, JN; Champion, CI; Salehi, S; Srivastava, M; Sharma, S; Rabizadeh, S; Niazi, K; Kickhoefer, V; Rome, LH; Kelly, KA				Kar, Upendra K.; Jiang, Janina; Champion, Cheryl I.; Salehi, Sahar; Srivastava, Minu; Sharma, Sherven; Rabizadeh, Shahrooz; Niazi, Kayvan; Kickhoefer, Valerie; Rome, Leonard H.; Kelly, Kathleen A.			Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice	PLOS ONE			English	Article							IN-VIVO; ANTIGEN PRESENTATION; CROSS-PRESENTATION; DELIVERY-SYSTEMS; DNA VACCINES; T-CELLS; PROTEIN; VIRUS; NANOPARTICLES; LOCALIZATION	Background: Modifications of adjuvants that induce cell-mediated over antibody-mediated immunity is desired for development of vaccines. Nanocapsules have been found to be viable adjuvants and are amenable to engineering for desired immune responses. We previously showed that natural nanocapsules called vaults can be genetically engineered to elicit Th1 immunity and protection from a mucosal bacterial infection. The purpose of our study was to characterize immunity produced in response to OVA within vault nanoparticles and compare it to another nanocarrier. Methodology and Principal Findings: We characterized immunity resulting from immunization with the model antigen, ovalbumin (OVA) encased in vault nanocapsules and liposomes. We measured OVA responsive CD8(+) and CD4(+) memory T cell responses, cytokine production and antibody titers in vitro and in vivo. We found that immunization with OVA contain in vaults induced a greater number of anti-OVA CD8(+) memory T cells and production of IFN gamma plus CD4(+) memory T cells. Also, modification of the vault body could change the immune response compared to OVA encased in liposomes. Conclusions/Significance: These experiments show that vault nanocapsules induced strong anti-OVA CD8(+) and CD4(+) T cell memory responses and modest antibody production, which markedly differed from the immune response induced by liposomes. We also found that the vault nanocapsule could be modified to change antibody isotypes in vivo. Thus it is possible to create a vault nanocapsule vaccine that can result in the unique combination of immunogen-responsive CD8(+) and CD4(+) T cell immunity coupled with an IgG1 response for future development of vault nanocapsule-based vaccines against antigens for human pathogens and cancer.	[Kar, Upendra K.; Kickhoefer, Valerie; Rome, Leonard H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Jiang, Janina; Champion, Cheryl I.; Salehi, Sahar; Kelly, Kathleen A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Srivastava, Minu; Sharma, Sherven] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Med Lab, Los Angeles, CA USA; [Rabizadeh, Shahrooz; Niazi, Kayvan] Univ Calif Los Angeles, Samueli Sch Engn, Dept Bioengn, Los Angeles, CA USA; [Rabizadeh, Shahrooz; Niazi, Kayvan; Kickhoefer, Valerie; Rome, Leonard H.; Kelly, Kathleen A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kar, UK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	kkelly@mednet.ucla.edu	Kar, Upendra K/H-5250-2012; Rome, Leonard H/E-8786-2016	Kar, Upendra K/0000-0003-4065-0860; Rome, Leonard H/0000-0002-1236-2063; Kickhoefer, Valerie/0000-0002-0048-0580	National Institutes of Health [AI026328]; Abraxis Bioscience, Inc [20090918]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026328, R21AI026328, R01AI079004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraxis Bioscience, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by the National Institutes of Health, AI026328 (Dr. Kelly), sponsored research award from Abraxis Bioscience, Inc (Dr. Kelly) and 20090918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 2010, TRENDS MOL MED, V16, P478, DOI 10.1016/j.molmed.2010.07.007; Andrews CD, 2012, MOL PHARMACEUTI 0406, P6; Assudani D, 2008, CANCER RES, V68, P9892, DOI 10.1158/0008-5472.CAN-08-3134; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Bolhassani A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-3; Brave A, 2007, MOL PHARMACEUT, V4, P18, DOI 10.1021/mp060098+; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Carstens MG, 2011, VACCINE, V29, P4761, DOI 10.1016/j.vaccine.2011.04.081; Champion CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005409; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; FERRARI C, 1992, J VIROL, V66, P2536, DOI 10.1128/JVI.66.4.2536-2540.1992; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Fritsche PJ, 2010, SWISS MED WKLY, V140, P238, DOI smw-12980; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Haglund K, 2002, J VIROL, V76, P7506, DOI 10.1128/JVI.76.15.7506-7517.2002; Han M, 2011, ACS NANO, V5, P6128, DOI 10.1021/nn2014613; Harnack U, 2010, ANTICANCER RES, V30, P3959; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Henriques AM, 2009, INT J PHARMACEUT, V377, P92, DOI 10.1016/j.ijpharm.2009.05.005; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Ingolotti M, 2010, EXPERT REV VACCINES, V9, P747, DOI 10.1586/ERV.10.57; Izquierdo MA, 1996, AM J PATHOL, V148, P877; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kar UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018758; Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2009, ACS NANO, V3, P27, DOI 10.1021/nn800638x; Kim C, 2010, IMMUNOLOGY, V131, P310, DOI 10.1111/j.1365-2567.2010.03338.x; Langridge W, 2010, CURR OPIN INVEST DR, V11, P919; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; McNeela EA, 2001, ADV DRUG DELIVER REV, V51, P43, DOI 10.1016/S0169-409X(01)00169-7; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; Mitchell DA, 1998, EUR J IMMUNOL, V28, P1923, DOI 10.1002/(SICI)1521-4141(199806)28:06<1923::AID-IMMU1923>3.0.CO;2-9; Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Moser M, 2001, IMMUNOBIOLOGY, V204, P551, DOI 10.1078/0171-2985-00092; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Ohlschlager P, 2011, INT J CANCER, V128, P473, DOI 10.1002/ijc.25344; Pathak Y., 2009, DRUG DELIVERY NANOPA, P1; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Poderycki MJ, 2006, BIOCHEMISTRY-US, V45, P12184, DOI 10.1021/bi0610552; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; Suprenant KA, 2002, BIOCHEMISTRY-US, V41, P14447, DOI 10.1021/bi026747e; Tiwari S, 2010, NANOMEDICINE-UK, V5, P1617, DOI [10.2217/nnm.10.128, 10.2217/NNM.10.128]; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Zhong ZH, 2010, INT J PHARMACEUT, V399, P156, DOI 10.1016/j.ijpharm.2010.07.053; Zhou F, 2010, INT REV IMMUNOL, V29, P56, DOI 10.3109/08830180903349644	53	31	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38553	10.1371/journal.pone.0038553	http://dx.doi.org/10.1371/journal.pone.0038553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808011	gold, Green Submitted, Green Published			2022-12-25	WOS:000306362400003
J	Nishiumi, S; Kobayashi, T; Ikeda, A; Yoshie, T; Kibi, M; Izumi, Y; Okuno, T; Hayashi, N; Kawano, S; Takenawa, T; Azuma, T; Yoshida, M				Nishiumi, Shin; Kobayashi, Takashi; Ikeda, Atsuki; Yoshie, Tomoo; Kibi, Megumi; Izumi, Yoshihiro; Okuno, Tatsuya; Hayashi, Nobuhide; Kawano, Seiji; Takenawa, Tadaomi; Azuma, Takeshi; Yoshida, Masaru			A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer	PLOS ONE			English	Article							AMINO-ACID; MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; PLASMA; COLON; CARCINOMA; IDENTIFY; GC/MS	Background: To improve the quality of life of colorectal cancer patients, it is important to establish new screening methods for early diagnosis of colorectal cancer. Methodology/Principal Findings: We performed serum metabolome analysis using gas-chromatography/mass-spectrometry (GC/MS). First, the accuracy of our GC/MS-based serum metabolomic analytical method was evaluated by calculating the RSD% values of serum levels of various metabolites. Second, the intra-day (morning, daytime, and night) and inter-day (among 3 days) variances of serum metabolite levels were examined. Then, serum metabolite levels were compared between colorectal cancer patients (N = 60; N = 12 for each stage from 0 to 4) and age-and sex-matched healthy volunteers (N = 60) as a training set. The metabolites whose levels displayed significant changes were subjected to multiple logistic regression analysis using the stepwise variable selection method, and a colorectal cancer prediction model was established. The prediction model was composed of 2-hydroxybutyrate, aspartic acid, kynurenine, and cystamine, and its AUC, sensitivity, specificity, and accuracy were 0.9097, 85.0%, 85.0%, and 85.0%, respectively, according to the training set data. In contrast, the sensitivity, specificity, and accuracy of CEA were 35.0%, 96.7%, and 65.8%, respectively, and those of CA19-9 were 16.7%, 100%, and 58.3%, respectively. The validity of the prediction model was confirmed using colorectal cancer patients (N = 59) and healthy volunteers (N = 63) as a validation set. At the validation set, the sensitivity, specificity, and accuracy of the prediction model were 83.1%, 81.0%, and 82.0%, respectively, and these values were almost the same as those obtained with the training set. In addition, the model displayed high sensitivity for detecting stage 0-2 colorectal cancer (82.8%). Conclusions/Significance: Our prediction model established via GC/MS-based serum metabolomic analysis is valuable for early detection of colorectal cancer and has the potential to become a novel screening test for colorectal cancer.	[Nishiumi, Shin; Kobayashi, Takashi; Ikeda, Atsuki; Yoshie, Tomoo; Kibi, Megumi; Izumi, Yoshihiro; Okuno, Tatsuya; Azuma, Takeshi; Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Hayashi, Nobuhide; Kawano, Seiji] Kobe Univ Hosp, Dept Clin Lab, Kobe, Hyogo, Japan; [Takenawa, Tadaomi; Yoshida, Masaru] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 657, Japan; [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Metabol Res, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Nishiumi, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan.	myoshida@med.kobe-u.ac.jp	Nishiumi, Shin/ABD-5775-2020; Okuno, Tatsuya/ABD-6927-2020; KOBAYASHI, Takashi/AAM-7549-2021	Nishiumi, Shin/0000-0003-2126-3013; KOBAYASHI, Takashi/0000-0002-9202-7643	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan; MEXT of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants for the Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (TK, TY, MK, TA, and MY); a Grant-in-Aid for Scientific Research on Innovative Areas from the MEXT of Japan (SN and TA); the Education Program for Specialized Clinicians in the Support Program for Improving Graduate School Education from the MEXT of Japan (AI); and Grants for project research (Development of fundamental technology for the analysis and evaluation of functional agricultural products and functional foods) from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan (MY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertini I, 2012, CANCER RES, V72, P356, DOI 10.1158/0008-5472.CAN-11-1543; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; DEMLING J, 1993, AMINO ACIDS, V5, P253, DOI 10.1007/BF00805988; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; Iob V, 1963, J SURG RES, V3, P85; KIKUCHI Y, 1985, ACTA OBSTET GYN SCAN, V64, P553, DOI 10.3109/00016348509156361; Kimura T, 2009, CURR OPIN CLIN NUTR, V12, P49, DOI 10.1097/MCO.0b013e3283169242; Lavie Lena, 2004, J Circadian Rhythms, V2, P5, DOI 10.1186/1740-3391-2-5; Matsuda T, 2010, JPN J CLIN ONCOL, V40, P1192, DOI 10.1093/jjco/hyq109; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; Nishiumi S, 2010, METABOLOMICS, V6, P518, DOI 10.1007/s11306-010-0224-9; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162; Rainesalo S, 2004, NEUROCHEM RES, V29, P319, DOI 10.1023/B:NERE.0000010461.34920.0c; Ritchie SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-13; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tagi T, 2010, J GASTROENTEROL, V45, P1201, DOI 10.1007/s00535-010-0279-4; Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Walczak K, 2011, SCAND J GASTROENTERO, V46, P903, DOI 10.3109/00365521.2011.579159; Yoshida M, 2012, J GASTROENTEROL, V47, P9, DOI 10.1007/s00535-011-0493-8	28	188	197	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40459	10.1371/journal.pone.0040459	http://dx.doi.org/10.1371/journal.pone.0040459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792336	gold, Green Published, Green Submitted			2022-12-25	WOS:000306362400059
J	Pang, S; Duan, LS; Liu, ZQ; Song, XY; Li, XF; Wang, CJ				Pang, Sen; Duan, Liusheng; Liu, Zhiqian; Song, Xiaoyu; Li, Xuefeng; Wang, Chengju			Co-Induction of a Glutathione-S-transferase, a Glutathione Transporter and an ABC Transporter in Maize by Xenobiotics	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; HERBICIDE RESISTANCE; DETOXIFICATION; DERIVATIVES; EXPRESSION; SAFENERS; ENZYMES; FAMILY; GENE	Glutathione conjugation reactions are one of the principal mechanisms that plants utilize to detoxify xenobiotics. The induction by four herbicides (2,4-D, atrazine, metolachlor and primisulfuron) and a herbicide safener (dichlormid) on the expression of three genes, ZmGST27, ZmGT1 and ZmMRP1, encoding respectively a glutathione-S-transferase, a glutathione transporter and an ATP-binding cassette (ABC) transporter was studied in maize. The results demonstrate that the inducing effect on gene expression varies with both chemicals and genes. The expression of ZmGST27 and ZmMRP1 was up-regulated by all five compounds, whereas that of ZmGT1 was increased by atrazine, metolachlor, primisulfuron and dichlormid, but not by 2,4-D. For all chemicals, the inducing effect was first detected on ZmGST27. The finding that ZmGT1 is activated alongside ZmGST27 and ZmMRP1 suggests that glutathione transporters are an important component in the xenobiotic detoxification system of plants.	[Pang, Sen; Duan, Liusheng] China Agr Univ, Engn Res Ctr Plant Growth Regulators, Minist Educ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Pang, Sen; Song, Xiaoyu; Li, Xuefeng; Wang, Chengju] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Liu, Zhiqian] Victorian AgriBiosci Ctr, Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia	China Agricultural University; China Agricultural University; Victorian Department of Environment & Primary Industries	Pang, S (corresponding author), China Agr Univ, Engn Res Ctr Plant Growth Regulators, Minist Educ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	lixuefeng2007@163.com; Wangchengju@cau.edu.cn	Duan, Liusheng/F-8954-2011	Duan, Liusheng/0000-0003-0323-9378	Chinese Universities Scientific Fund [2011JS001]	Chinese Universities Scientific Fund	This study was supported by Chinese Universities Scientific Fund (Project No. 2011JS001). The funders had no role in study design, data collection and analysis, decision to publish, or prepatation of the manuscript.	ALSCHER RG, 1989, PHYSIOL PLANTARUM, V77, P457, DOI 10.1111/j.1399-3054.1989.tb05667.x; ANDERSON MP, 1991, PLANT PHYSIOL, V96, P104, DOI 10.1104/pp.96.1.104; Basantani M, 2011, PESTIC BIOCHEM PHYS, V99, P111, DOI 10.1016/j.pestbp.2010.11.007; BRISTOL DW, 1977, J AGR FOOD CHEM, V25, P1308, DOI 10.1021/jf60214a008; Cagnac O, 2004, PLANT PHYSIOL, V135, P1378, DOI 10.1104/pp.104.039859; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; Del Buono D, 2006, PESTIC BIOCHEM PHYS, V85, P61, DOI 10.1016/j.pestbp.2005.09.006; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 1996, PESTIC BIOCHEM PHYS, V54, P96, DOI 10.1006/pest.1996.0013; GAILLARD C, 1994, FEBS LETT, V352, P219, DOI 10.1016/0014-5793(94)00961-9; Hatton PJ, 1996, PESTIC SCI, V46, P267, DOI 10.1002/(SICI)1096-9063(199603)46:3&lt;267::AID-PS347&gt;3.0.CO;2-N; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; JEPSON I, 1994, PLANT MOL BIOL, V26, P1855, DOI 10.1007/BF00019498; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Letouze A, 2003, AGRONOMIE, V23, P601, DOI 10.1051/agro:2003036; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; MILLER KD, 1994, PESTIC BIOCHEM PHYS, V48, P123, DOI 10.1006/pest.1994.1013; Pang S, 2012, J FOOD AGRIC ENVIRON, V10, P621; Pang S, 2010, PROG BIOCHEM BIOPHYS, V37, P1120, DOI 10.3724/SP.J.1206.2010.00188; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; Scarponi L, 2005, J AGR FOOD CHEM, V53, P2483, DOI 10.1021/jf047948n; Swarbreck D, 2003, GENE, V315, P153, DOI 10.1016/S0378-1119(03)00734-0; Theodoulou FL, 2003, PEST MANAG SCI, V59, P202, DOI 10.1002/ps.576; TIMMERMAN KP, 1989, PHYSIOL PLANTARUM, V77, P465, DOI 10.1111/j.1399-3054.1989.tb05668.x; Yuan JS, 2007, TRENDS PLANT SCI, V12, P6, DOI 10.1016/j.tplants.2006.11.001; Zhang MY, 2004, PLANT PHYSIOL, V134, P482, DOI 10.1104/pp.103.030940	29	25	27	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40712	10.1371/journal.pone.0040712	http://dx.doi.org/10.1371/journal.pone.0040712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792398	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400094
J	Andres, NL; Tesse, A; Regnault, V; Louis, H; Cattan, V; Thornton, SN; Labat, C; Kakou, A; Tual-Chalot, S; Faure, S; Challande, P; Osborne-Pellegrin, M; Martinez, MC; Lacolley, P; Andriantsitohaina, R				Andres, Natalia Lopez; Tesse, Angela; Regnault, Veronique; Louis, Huguette; Cattan, Valerie; Thornton, Simon N.; Labat, Carlos; Kakou, Agustine; Tual-Chalot, Simon; Faure, Sebastien; Challande, Pascale; Osborne-Pellegrin, Mary; Martinez, M. Carmen; Lacolley, Patrick; Andriantsitohaina, Ramaroson			Increased Microparticle Production and Impaired Microvascular Endothelial Function in Aldosterone-Salt-Treated Rats: Protective Effects of Polyphenols	PLOS ONE			English	Article							RED WINE POLYPHENOLS; SHED MEMBRANE-PARTICLES; NITRIC-OXIDE; CIRCULATING MICROPARTICLES; BLOOD-PRESSURE; IN-VIVO; HYPERTENSIVE PATIENTS; VASCULAR FUNCTION; ANGIOTENSIN-II; CELL APOPTOSIS	We aimed to characterize circulating microparticles in association with arterial stiffness, inflammation and endothelial dysfunction in aldosterone-salt-induced hypertension in rats and to investigate the preventive effects of red wine polyphenols. Uninephrectomized male Sprague-Dawley rats were treated with aldosterone-salt (1 mu g.h(-1)), with or without administration of either red wine polyphenols, Provinols (TM) (20 mg.kg(-1).day(-1)), or spironolactone (30 mg.kg(-1).day(-1)) for 4 weeks. Microparticles, arterial stiffness, nitric oxide (NO) spin trapping, and mesenteric arterial function were measured. Aldosterone-salt rats showed increased microparticle levels, including those originating from platelets, endothelium and erythrocytes. Hypertension resulted in enhanced aortic stiffness accompanied by increased circulating and aortic NO levels and an upregulation of aortic inducible NO-synthase, NF kappa B, superoxide anions and nitrotyrosine. Flow-induced dilatation was reduced in mesenteric arteries. These effects were prevented by spironolactone. Provinols (TM) did not reduce arterial stiffness or systolic hypertension but had effects similar to those of spironolactone on endothelial function assessed by flow-mediated vasodilatation, microparticle generation, aortic NO levels and oxidative stress and apoptosis in the vessel wall. Neither the contractile response nor endothelium-dependent relaxation in mesenteric arteries differed between groups. The in vivo effects of Provinols (TM) were not mediated by mineralocorticoid receptors or changes in shear stress. In conclusion, vascular remodelling and endothelial dysfunction in aldosterone-salt-mediated hypertension are associated with increased circulating microparticles. Polyphenols prevent the enhanced release of microparticles, macrovascular inflammation and oxidative stress, and microvascular endothelial dysfunction independently of blood pressure, shear stress and mineralocorticoid receptor activation in a model of hyperaldosteronism.	[Andres, Natalia Lopez; Regnault, Veronique; Louis, Huguette; Cattan, Valerie; Thornton, Simon N.; Labat, Carlos; Kakou, Agustine; Lacolley, Patrick] Nancy Univ, INSERM, U961, Nancy, France; [Tesse, Angela; Tual-Chalot, Simon; Faure, Sebastien; Martinez, M. Carmen; Andriantsitohaina, Ramaroson] Univ Nantes Angers Le Mans, INSERM, U1063, Angers, France; [Challande, Pascale] Univ Paris 06, CNRS, UMR 7190, Paris, France; [Osborne-Pellegrin, Mary] Paris Diderot Univ, INSERM, U698, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Andres, NL (corresponding author), Nancy Univ, INSERM, U961, Nancy, France.	ramaroson.andriantsitohaina@univ-angers.fr	ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; Lacolley, Patrick/G-3118-2013; Clere, Nicolas/K-4414-2015; Lopez-Andres, Natalia/B-1276-2017; REGNAULT, Veronique/AAY-1711-2020; Tesse, Angela/D-4803-2015; Labat, Carlos/F-7492-2010; Regnault, Veronique/H-9138-2016	Lopez-Andres, Natalia/0000-0003-3728-2606; REGNAULT, Veronique/0000-0001-6418-5022; Tesse, Angela/0000-0002-2153-4357; Labat, Carlos/0000-0002-5275-3405; Faure, Sebastien/0000-0001-7524-8295; andriantsitohaina, ramaroson/0000-0002-4770-3585; Tual-Chalot, Simon/0000-0002-9307-7175	Fondation de France [2005005375]; Agence Nationale de la Recherche	Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the "Fondation de France" (2005005375) and the "Agence Nationale de la Recherche". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Bernatova I, 2002, AM J PHYSIOL-HEART C, V282, pH942, DOI 10.1152/ajpheart.00724.2001; Boulanger CM, 2007, HYPERTENSION, V49, P902, DOI 10.1161/01.HYP.0000259667.22309.df; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; BRILLA CG, 1993, J MOL CELL CARDIOL, V25, P563, DOI 10.1006/jmcc.1993.1066; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Carlstrom M, 2007, HYPERTENSION, V49, P1342, DOI 10.1161/HYPERTENSIONAHA.107.087213; Chahed S, 2010, DIABETES, V59, P694, DOI 10.2337/db08-1524; Chalopin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008554; Di Zhang A, 2008, HYPERTENSION, V52, P1060, DOI 10.1161/HYPERTENSIONAHA.108.117531; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; GARWITZ ET, 1982, HYPERTENSION, V4, P374, DOI 10.1161/01.HYP.4.3.374; Huang W, 1998, CIRC RES, V82, P879; Jelic S, 2009, VASC HEALTH RISK MAN, V5, P909; Jeong Y, 2009, P NATL ACAD SCI USA, V106, P3782, DOI 10.1073/pnas.0804037106; Jimenez R, 2007, FREE RADICAL BIO MED, V43, P462, DOI 10.1016/j.freeradbiomed.2007.05.007; Kleschyov AL, 2007, J CHROMATOGR B, V851, P12, DOI 10.1016/j.jchromb.2006.10.006; Lacolley P, 2002, CIRCULATION, V106, P2848, DOI 10.1161/01.CIR.0000039328.33137.6C; Lijnen P, 1996, J CARDIOVASC PHARM, V27, P462, DOI 10.1097/00005344-199604000-00002; Lopez-Andres N, 2010, J HYPERTENS, V28, P1261, DOI 10.1097/HJH.0b013e328337fe42; Lopez-Sepulveda R, 2008, HYPERTENSION, V51, P1088, DOI 10.1161/HYPERTENSIONAHA.107.107672; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Martin S, 2003, BRIT J PHARMACOL, V139, P1095, DOI 10.1038/sj.bjp.0705347; Martinez MC, 2011, TRENDS PHARMACOL SCI, V32, P659, DOI 10.1016/j.tips.2011.06.005; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Membre A, 2008, HAEMATOLOGICA, V93, P566, DOI 10.3324/haematol.12364; Mercier N, 2006, CARDIOVASC RES, V72, P349, DOI 10.1016/j.cardiores.2006.08.008; Mesri C, 1998, J IMMUNOL, V161, P4382; Meziani F, 2006, AM J PATHOL, V169, P1473, DOI 10.2353/ajpath.2006.051304; MULSCH A, 1995, CIRCULATION, V92, P1876, DOI 10.1161/01.CIR.92.7.1876; Nakamura Y, 2006, AM J PATHOL, V169, P362, DOI 10.2353/ajpath.2006.051351; Ohlmann P, 2005, AM J PHYSIOL-HEART C, V289, pH2342, DOI 10.1152/ajpheart.00511.2004; Park JB, 2001, HYPERTENSION, V37, P1444, DOI 10.1161/01.HYP.37.6.1444; Pechanova O, 2004, J HYPERTENS, V22, P1551, DOI 10.1097/01.hjh.0000133734.32125.c7; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Priou P, 2010, AM J PATHOL, V177, P974, DOI 10.2353/ajpath.2010.091252; Savoia C, 2008, HYPERTENSION, V51, P432, DOI 10.1161/HYPERTENSIONAHA.107.103267; Schafer C, 2003, J MEMBRANE BIOL, V196, P157, DOI 10.1007/s00239-003-0634-7; Schiffrin EL, 2006, HYPERTENSION, V47, P312, DOI 10.1161/01.HYP.0000201443.63240.a7; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Sun Y, 1997, CARDIOVASC RES, V35, P138, DOI 10.1016/S0008-6363(97)00097-7; TARDY Y, 1991, CLIN PHYS PHYSIOL M, V12, P39, DOI 10.1088/0143-0815/12/1/003; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; Wang JM, 2009, J HUM HYPERTENS, V23, P307, DOI 10.1038/jhh.2008.137; Williams TA, 2006, ENDOCRINOLOGY, V147, P2496, DOI 10.1210/en.2005-1318; Zhao WY, 2006, AM J PHYSIOL-HEART C, V291, pH336, DOI 10.1152/ajpheart.01307.2005; Zhou XS, 2008, AM J PHYSIOL-HEART C, V295, pH1008, DOI 10.1152/ajpheart.00114.2008	50	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39235	10.1371/journal.pone.0039235	http://dx.doi.org/10.1371/journal.pone.0039235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808030	gold, Green Published			2022-12-25	WOS:000306355500008
J	Wang, Q; Dai, XQ; Li, Q; Wang, ZC; Cantero, MD; Li, S; Shen, J; Tu, JC; Cantiello, H; Chen, XZ				Wang, Qian; Dai, Xiao-Qing; Li, Qiang; Wang, Zuocheng; del Rocio Cantero, Maria; Li, Shu; Shen, Ji; Tu, Jian-Cheng; Cantiello, Horacio; Chen, Xing-Zhen			Structural Interaction and Functional Regulation of Polycystin-2 by Filamin	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; KIDNEY-DISEASE PROTEIN; ALPHA-ACTININ; CHANNEL ACTIVITY; INTRACELLULAR TRAFFICKING; HUMAN SYNCYTIOTROPHOBLAST; CD2-ASSOCIATED PROTEIN; SURFACE EXPRESSION; CATION CHANNEL; NMDA RECEPTOR	Filamins are important actin cross-linking proteins implicated in scaffolding, membrane stabilization and signal transduction, through interaction with ion channels, receptors and signaling proteins. Here we report the physical and functional interaction between filamins and polycystin-2, a TRP-type cation channel mutated in 10-15% patients with autosomal dominant polycystic kidney disease. Yeast two-hybrid and GST pull-down experiments demonstrated that the C-termini of filamin isoforms A, B and C directly bind to both the intracellular N- and C-termini of polycystin-2. Reciprocal co-immunoprecipitation experiments showed that endogenous polycystin-2 and filamins are in the same complexes in renal epithelial cells and human melanoma A7 cells. We then examined the effect of filamin on polycystin-2 channel function by electrophysiology studies with a lipid bilayer reconstitution system and found that filamin-A substantially inhibits polycystin-2 channel activity. Our study indicates that filamins are important regulators of polycystin-2 channel function, and further links actin cytoskeletal dynamics to the regulation of this channel protein.	[Wang, Qian; Dai, Xiao-Qing; Li, Qiang; Wang, Zuocheng; Li, Shu; Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [del Rocio Cantero, Maria; Cantiello, Horacio] Univ Buenos Aires, Fac Odontol, Catedra Biofis, Buenos Aires, DF, Argentina; [Shen, Ji; Tu, Jian-Cheng] Wuhan Univ, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China; [Cantiello, Horacio] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Charlestown, MA USA; [Cantiello, Horacio] Harvard Univ, Sch Med, Charlestown, MA USA	University of Alberta; University of Buenos Aires; Wuhan University; Harvard University; Massachusetts General Hospital; Harvard University	Wang, Q (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB, Canada.	cantiello@helix.mgh.harvard.edu; xzchen@ualberta.ca		Cantero, Maria del Rocio/0000-0002-9690-8413	Canadian Institutes of Health Research; Kidney Foundation of Canada; National Science Foundation of China [30770658]; National Institutes of Health ARRA [DK077079]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077079] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Canadian Institutes of Health Research and the Kidney Foundation of Canada (to XZC), and the National Science Foundation of China (to JCT, grant# 30770658). XZC is a Senior Scholar of the Alberta Heritage Foundation for Medical Research. MRC and HC are members of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) de Argentina. HC gratefully acknowledges partial support of this study by National Institutes of Health ARRA Award DK077079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar G, 2003, CANCER RES, V63, P2645; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Beekman JM, 2008, J IMMUNOL, V180, P3938, DOI 10.4049/jimmunol.180.6.3938; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chen XZ, 2008, FEBS J, V275, P4675, DOI 10.1111/j.1742-4658.2008.06616.x; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; de Wit MCY, 2009, J NEUROL NEUROSUR PS, V80, P426, DOI 10.1136/jnnp.2008.149419; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fiori JL, 2009, ENDOCRINOLOGY, V150, P2551, DOI 10.1210/en.2008-1344; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Harris PC, 2002, GENEREVIEWS; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2004, FEBS LETT, V576, P231, DOI 10.1016/j.febslet.2004.09.017; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montalbetti N, 2005, PFLUG ARCH EUR J PHY, V451, P294, DOI 10.1007/s00424-005-1458-7; Montalbetti N, 2005, J PHYSIOL-LONDON, V566, P309, DOI 10.1113/jphysiol.2005.087072; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Pirson Y, 2010, ADV CHRONIC KIDNEY D, V17, P173, DOI 10.1053/j.ackd.2010.01.003; Rycroft BK, 2004, J PHYSIOL-LONDON, V557, P795, DOI 10.1113/jphysiol.2003.059212; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0	45	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40448	10.1371/journal.pone.0040448	http://dx.doi.org/10.1371/journal.pone.0040448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802962	Green Published, gold, Green Submitted			2022-12-25	WOS:000306355500043
J	de Keijzer, J; van den Broek, LAM; Ketelaar, T; van Lammeren, AAM				de Keijzer, Jeroen; van den Broek, Lambertus A. M.; Ketelaar, Tijs; van Lammeren, Andre A. M.			Histological Examination of Horse Chestnut Infection by Pseudomonas syringae pv. aesculi and Non-Destructive Heat Treatment to Stop Disease Progression	PLOS ONE			English	Article							ALGINATE PRODUCTION; BACTERIAL POLYSACCHARIDES; SUBERIN DEPOSITION; ERWINIA-AMYLOVORA; BLEEDING CANKER; FIRE BLIGHT; TREE BARK; VIRULENCE; LIGNIN; LEAVES	Since its emergence in Northwest Europe as a pathogen that infects trunks and branches of Aesculus spp. (the horse chestnuts) approximately one decade ago, Pseudomonas syringae pv. aesculi has rapidly established itself as major threat to these trees. Infected trees exhibit extensive necrosis of phloem and cambium, which can ultimately lead to dieback. The events after host entry leading to extensive necrosis are not well documented. In this work, the histopathology of this interaction is investigated and heat-treatment is explored as method to eradicate bacteria associated with established infections. The early wound-repair responses of A. hippocastanum, both in absence and presence of P. s. pv. aesculi, included cell wall lignification by a distinct layer of phloem and cortex parenchyma cells. The same cells also deposited suberin lamellae later on, suggesting this layer functions in compartmentalizing healthy from disrupted tissues. However, monitoring bacterial ingress, its construction appeared inadequate to constrain pathogen spread. Microscopic evaluation of bacterial dispersal in situ using immunolabelling and GFP-tagging of P. s. pv. aesculi, revealed two discriminative types of bacterial colonization. The forefront of lesions was found to contain densely packed bacteria, while necrotic areas housed bacterial aggregates with scattered individuals embedded in an extracellular matrix of bacterial origin containing alginate. The endophytic localization and ability of P. s. pv aesculi to create a protective matrix render it poorly accessible for control agents. To circumvent this, a method based on selective bacterial lethality at 39 degrees C was conceived and successfully tested on A. hippocastanum saplings, providing proof of concept for controlling this disease by heat-treatment. This may be applicable for curing other tree cankers, caused by related phytopathogens.	[de Keijzer, Jeroen; Ketelaar, Tijs; van Lammeren, Andre A. M.] Univ Wageningen & Res Ctr, Cell Biol Lab, Wageningen, Netherlands; [van den Broek, Lambertus A. M.] Wageningen UR, Food & Biobased Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	de Keijzer, J (corresponding author), Univ Wageningen & Res Ctr, Cell Biol Lab, Wageningen, Netherlands.	andre.vanlammeren@wur.nl	van den Broek, Lambertus/K-4930-2012; van den Broek, Lambertus/O-1253-2019	van den Broek, Lambertus/0000-0002-4374-5753; van den Broek, Lambertus/0000-0002-4374-5753; de Keijzer, Jeroen/0000-0002-5175-9178	working group 'Aesculaap's; Dutch Ministry of Agriculture, Nature and Food Quality	working group 'Aesculaap's; Dutch Ministry of Agriculture, Nature and Food Quality	A. A. M. van Lammeren was supported by the working group 'Aesculaap's, financed by the Dutch Ministry of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Bassett CL, 2003, BIOTECHNOL LETT, V25, P199, DOI 10.1023/A:1022394716305; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BIGGS AR, 1986, J AM SOC HORTIC SCI, V111, P757; BIGGS AR, 1985, PHYTOPATHOLOGY, V75, P1191, DOI 10.1094/Phyto-75-1191; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BRASIER C M, 1976, European Journal of Forest Pathology, V6, P129; Bultreys A., 2008, PSEUDOMONAS SYRINGAE, P283; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; CHITNIS CE, 1993, MOL MICROBIOL, V8, P583, DOI 10.1111/j.1365-2958.1993.tb01602.x; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Dijkshoorn-Dekker M.W.C., 2005, EINDRAPPORT ONDERZOE; Dijkshoorn-Dekker MWC, 2008, EINDRAPPORT ONDERZ 2; Dijkshoorn-Dekker MWC, 2009, EINDRAPPORT ONDERZ 3; Dulla G, 2008, P NATL ACAD SCI USA, V105, P3082, DOI 10.1073/pnas.0711723105; Durgapal J. C., 1980, Indian Phytopathology, V33, P533; Elasri M, 2001, APPL ENVIRON MICROB, V67, P1198, DOI 10.1128/AEM.67.3.1198-1209.2001; FETT WF, 1986, APPL ENVIRON MICROB, V52, P466, DOI 10.1128/AEM.52.3.466-473.1986; FETT WF, 1989, PLANT PHYSIOL, V89, P5, DOI 10.1104/pp.89.1.5; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GARROD B, 1982, NEW PHYTOL, V90, P99, DOI 10.1111/j.1469-8137.1982.tb03245.x; Green S, 2009, PLANT PATHOL, V58, P731, DOI 10.1111/j.1365-3059.2009.02065.x; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harnik TY, 2004, HORTSCIENCE, V39, P1677, DOI 10.21273/HORTSCI.39.7.1677; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; KECK M, 1995, PLANT PATHOL, V44, P124, DOI 10.1111/j.1365-3059.1995.tb02724.x; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; Laue H, 2006, MICROBIOL-SGM, V152, P2909, DOI 10.1099/mic.0.28875-0; MACKAY JM, 1983, PLANT PATHOL, V32, P385, DOI 10.1111/j.1365-3059.1983.tb02852.x; Mullick D.B., 1977, Recent Advances in Phytochemistry, V11, P395; OSMAN SF, 1986, J BACTERIOL, V166, P66, DOI 10.1128/jb.166.1.66-71.1986; Penaloza-Vazquez A, 2004, MICROBIOL-SGM, V150, P2727, DOI 10.1099/mic.0.27199-0; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; RIDE JP, 1975, PHYSIOL PLANT PATHOL, V5, P125, DOI 10.1016/0048-4059(75)90016-8; RITTINGER PA, 1987, CAN J BOT, V65, P1886, DOI 10.1139/b87-258; Rodriguez-Moreno L, 2009, MICROB BIOTECHNOL, V2, P476, DOI 10.1111/j.1751-7915.2009.00101.x; RUDOLPH KWE, 1994, MOL MECH BACTERIAL V, P357; Schmidt O, 2008, FOREST PATHOL, V38, P124, DOI 10.1111/j.1439-0329.2007.00539.x; SCHOUTEN HJ, 1989, NETH J PLANT PATHOL, V95, P169, DOI 10.1007/BF01974296; SCHULTE R, 1992, PLANT CELL, V4, P79, DOI 10.1105/tpc.4.1.79; SHIGO AL, 1984, ANNU REV PHYTOPATHOL, V22, P189, DOI 10.1146/annurev.py.22.090184.001201; Simard M, 2001, PHYTOPATHOLOGY, V91, P1128, DOI 10.1094/PHYTO.2001.91.12.1128; Steele H, 2010, PLANT PATHOL, V59, P1005, DOI 10.1111/j.1365-3059.2010.02354.x; Stuurman N, 2000, MOL PLANT MICROBE IN, V13, P1163, DOI 10.1094/MPMI.2000.13.11.1163; Webber JF, 2008, PLANT PATHOL, V57, P368, DOI 10.1111/j.1365-3059.2007.01754.x; Woodward S, 1996, EUR J FOREST PATHOL, V26, P97; Yu J, 1999, MOL MICROBIOL, V33, P712, DOI 10.1046/j.1365-2958.1999.01516.x; Zamski E, 2006, ISR J PLANT SCI, V54, P301, DOI 10.1560/IJPS_54_4_301	52	11	12	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39604	10.1371/journal.pone.0039604	http://dx.doi.org/10.1371/journal.pone.0039604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808044	Green Submitted, Green Published, gold			2022-12-25	WOS:000306354700014
J	Koberle, M; Goppel, D; Grandl, T; Gaentzsch, P; Manncke, B; Berchtold, S; Muller, S; Luscher, B; Asselin-Labat, ML; Pallardy, M; Sorg, I; Langer, S; Barth, H; Zumbihl, R; Autenrieth, IB; Bohn, E				Koeberle, Martin; Goeppel, David; Grandl, Tanja; Gaentzsch, Peer; Manncke, Birgit; Berchtold, Susanne; Mueller, Steffen; Luescher, Bernhard; Asselin-Labat, Marie-Liesse; Pallardy, Marc; Sorg, Isabel; Langer, Simon; Barth, Holger; Zumbihl, Robert; Autenrieth, Ingo B.; Bohn, Erwin			Yersinia enterocolitica YopT and Clostridium difficile Toxin B Induce Expression of GILZ in Epithelial Cells	PLOS ONE			English	Article							INDUCED LEUCINE-ZIPPER; NF-KAPPA-B; PROTECTS T-LYMPHOCYTES; GENE-PRODUCT RHOB; DENDRITIC CELLS; THYMOCYTE APOPTOSIS; VIRULENCE PLASMID; SIGNALING PATHWAY; BINDING PROTEINS; INVASIN PROTEIN	Glucocorticoid induced-leucine zipper (GILZ) has been shown to be induced in cells by different stimuli such as glucocorticoids, IL-10 or deprivation of IL-2. GILZ has anti-inflammatory properties and may be involved in signalling modulating apoptosis. Herein we demonstrate that wildtype Yersinia enterocolitica which carry the pYV plasmid upregulated GILZ mRNA levels and protein expression in epithelial cells. Infection of HeLa cells with different Yersinia mutant strains revealed that the protease activity of YopT, which cleaves the membrane-bound form of Rho GTPases was sufficient to induce GILZ expression. Similarly, Clostridium difficile toxin B, another bacterial inhibitor of Rho GTPases induced GILZ expression. YopT and toxin B both increased transcriptional activity of the GILZ promoter in HeLa cells. GILZ expression could not be linked to the inactivation of an individual Rho GTPase by these toxins. However, forced expression of RhoA and RhoB decreased basal GILZ promoter activity. Furthermore, MAPK activation proved necessary for profound GILZ induction by toxin B. Promoter studies and gel shift analyses defined binding of upstream stimulatory factor (USF) 1 and 2 to a canonical c-Myc binding site (E-box) in the GILZ promoter as a crucial step of its trans-activation. In addition we could show that USF-1 and USF-2 are essential for basal as well as toxin B induced GILZ expression. These findings define a novel way of GILZ promoter trans-activation mediated by bacterial toxins and differentiate it from those mediated by dexamethasone or deprivation of IL-2.	[Koeberle, Martin; Goeppel, David; Grandl, Tanja; Gaentzsch, Peer; Manncke, Birgit; Berchtold, Susanne; Mueller, Steffen; Autenrieth, Ingo B.; Bohn, Erwin] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Luescher, Bernhard] Univ Klinikum RWTH Aachen, Inst Biochem & Mol Biol, Aachen, Germany; [Asselin-Labat, Marie-Liesse; Pallardy, Marc] Universud, INSERM, UMR S 996, Fac Pharm Paris Sud, Chatenay Malabry, France; [Asselin-Labat, Marie-Liesse] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Sorg, Isabel] Univ Basel, Biozentrum, Basel, Switzerland; [Langer, Simon; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Ulm, Germany; [Zumbihl, Robert] INRA, UMR1333, Lab Diversite Genomes & Interact Microorganismes, F-34060 Montpellier, France; [Zumbihl, Robert] Univ Montpellier 2, Montpellier, France	Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Walter & Eliza Hall Institute; University of Basel; Ulm University; INRAE; Universite de Montpellier; Universite de Montpellier	Koberle, M (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	erwin.bohn@med.uni-tuebingen.de	Köberle, Martin/HCI-8264-2022; Barth, Holger/E-7920-2013; Luscher, Bernhard/A-7330-2011	Köberle, Martin/0000-0001-6825-2667; Langer, Simon/0000-0002-9660-8058; Luscher, Bernhard/0000-0002-9622-8709	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins I, 2008, MICROBES INFECT, V10, P798, DOI 10.1016/j.micinf.2008.04.014; Adkins I, 2007, INT J MED MICROBIOL, V297, P235, DOI 10.1016/j.ijmm.2007.02.005; Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200; Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Ausiello CM, 2006, MICROBES INFECT, V8, P2640, DOI 10.1016/j.micinf.2006.07.009; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bohn E, 2004, CELL MICROBIOL, V6, P129, DOI 10.1046/j.1462-5822.2003.00346.x; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Castagliuolo I, 2001, AM J PHYSIOL-GASTR L, V280, pG539, DOI 10.1152/ajpgi.2001.280.4.G539; Chen L, 2006, J BIOL CHEM, V281, P10849, DOI 10.1074/jbc.M511237200; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Dach K, 2009, INFECT IMMUN, V77, P5583, DOI 10.1128/IAI.00121-09; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Desbarats L, 1996, GENE DEV, V10, P447, DOI 10.1101/gad.10.4.447; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Gerhard R, 2005, J BIOL CHEM, V280, P1499, DOI 10.1074/jbc.M406014200; Ghashghaeinia M, 2011, CELL PHYSIOL BIOCHEM, V27, P45, DOI 10.1159/000325204; Godot V, 2006, ALLERGY, V61, P886, DOI 10.1111/j.1398-9995.2006.01065.x; Grassl GA, 2003, CELL MICROBIOL, V5, P957, DOI 10.1046/j.1462-5822.2003.00339.x; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Jacobi CA, 1998, MOL MICROBIOL, V30, P865, DOI 10.1046/j.1365-2958.1998.01128.x; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Koberle M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000551; Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237; Lee JY, 2009, J MOL MED, V87, P169, DOI 10.1007/s00109-008-0415-2; Matte I, 2009, INFECT IMMUN, V77, P5400, DOI 10.1128/IAI.00485-09; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Mohammadi S, 2009, INFECT IMMUN, V77, P4771, DOI 10.1128/IAI.00850-09; Na X, 2005, GASTROENTEROLOGY, V128, P1002, DOI 10.1053/j.gastro.2005.01.053; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004; Schulte R, 1998, MED MICROBIOL IMMUN, V187, P53, DOI 10.1007/s004300050074; Schulte R, 1996, INFECT IMMUN, V64, P2106, DOI 10.1128/IAI.64.6.2106-2113.1996; Schulte R, 2000, FASEB J, V14, P1471, DOI 10.1096/fj.14.11.1471; Schulte R, 1998, INFECT IMMUN, V66, P1216, DOI 10.1128/IAI.66.3.1216-1224.1998; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219; Sorg I, 2003, INFECT IMMUN, V71, P4623, DOI 10.1128/IAI.71.8.4623-4632.2003; Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Suarez PE, 2012, MOL ENDOCRINOLOGY; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2006, CELL MICROBIOL, V8, P1504, DOI 10.1111/j.1462-5822.2006.00729.x; Vohra P, 2012, FEMS IMMUNOL MED MIC, V65, P96, DOI 10.1111/j.1574-695X.2012.00952.x; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wiedmaier N, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.06.001; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wu FQ, 2011, MED MICROBIOL IMMUN, V200, P203, DOI 10.1007/s00430-011-0196-z; Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289	74	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40730	10.1371/journal.pone.0040730	http://dx.doi.org/10.1371/journal.pone.0040730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792400	Green Published, gold			2022-12-25	WOS:000306354700065
J	Nikerel, E; Berkhout, J; Hu, FY; Teusink, B; Reinders, MJT; de Ridder, D				Nikerel, Emrah; Berkhout, Jan; Hu, Fengyuan; Teusink, Bas; Reinders, Marcel J. T.; de Ridder, Dick			Understanding Regulation of Metabolism through Feasibility Analysis	PLOS ONE			English	Article							YEAST GLYCOLYSIS; GENE-EXPRESSION; MODELS; ROBUSTNESS; PATHWAYS; DESIGN; ENZYME; CONSTRAINTS; PRINCIPLES; EVOLUTION	Understanding cellular regulation of metabolism is a major challenge in systems biology. Thus far, the main assumption was that enzyme levels are key regulators in metabolic networks. However, regulation analysis recently showed that metabolism is rarely controlled via enzyme levels only, but through non-obvious combinations of hierarchical (gene and enzyme levels) and metabolic regulation (mass action and allosteric interaction). Quantitative analyses relating changes in metabolic fluxes to changes in transcript or protein levels have revealed a remarkable lack of understanding of the regulation of these networks. We study metabolic regulation via feasibility analysis (FA). Inspired by the constraint-based approach of Flux Balance Analysis, FA incorporates a model describing kinetic interactions between molecules. We enlarge the portfolio of objectives for the cell by defining three main physiologically relevant objectives for the cell: function, robustness and temporal responsiveness. We postulate that the cell assumes one or a combination of these objectives and search for enzyme levels necessary to achieve this. We call the subspace of feasible enzyme levels the feasible enzyme space. Once this space is constructed, we can study how different objectives may (if possible) be combined, or evaluate the conditions at which the cells are faced with a trade-off among those. We apply FA to the experimental scenario of long-term carbon limited chemostat cultivation of yeast cells, studying how metabolism evolves optimally. Cells employ a mixed strategy composed of increasing enzyme levels for glucose uptake and hexokinase and decreasing levels of the remaining enzymes. This tradeoff renders the cells specialized in this low-carbon flux state to compete for the available glucose and get rid of over-overcapacity. Overall, we show that FA is a powerful tool for systems biologists to study regulation of metabolism, interpret experimental data and evaluate hypotheses.	[Nikerel, Emrah; Hu, Fengyuan; Reinders, Marcel J. T.; de Ridder, Dick] Delft Univ Technol, Delft Bioinformat Lab, Dept Intelligent Syst, Delft, Netherlands; [Berkhout, Jan; Teusink, Bas] Vrije Univ Amsterdam, Fac Earth & Life Sci, Syst Bioinformat IBIVU, Amsterdam, Netherlands; [Nikerel, Emrah; Berkhout, Jan; Teusink, Bas; Reinders, Marcel J. T.; de Ridder, Dick] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Nikerel, Emrah; Berkhout, Jan; Teusink, Bas; Reinders, Marcel J. T.; de Ridder, Dick] NCSB, Amsterdam, Netherlands; [Berkhout, Jan; Teusink, Bas] NISB, Amsterdam, Netherlands	Delft University of Technology; Vrije Universiteit Amsterdam	Nikerel, E (corresponding author), Delft Univ Technol, Delft Bioinformat Lab, Dept Intelligent Syst, Delft, Netherlands.	i.e.nikerel@tudelft.nl	Nikerel, Emrah/T-8664-2018; de Ridder, Dick/F-3169-2010	de Ridder, Dick/0000-0002-4944-4310; Nikerel, Emrah/0000-0002-9157-8662; Teusink, Bas/0000-0003-3929-0423	Netherlands Organization for Scientific Research (NWO-CLS); Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative	Netherlands Organization for Scientific Research (NWO-CLS)(Netherlands Organization for Scientific Research (NWO)); Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative	This work is supported by the Computational Life Science programme of the Netherlands Organization for Scientific Research (NWO-CLS), as well as by the Kluyver Centre for Genomics of Industrial Fermentation, part of the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barnes CP, 2011, P NATL ACAD SCI USA, V108, P15190, DOI 10.1073/pnas.1017972108; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Del Moral P, 2006, J R STAT SOC B, V68, P411, DOI 10.1111/j.1467-9868.2006.00553.x; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Guillen-Gosalbez G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-386; Hafner M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000534; Haunschild MD, 2005, BIOINFORMATICS, V21, P1617, DOI 10.1093/bioinformatics/bti225; Heijnen JJ, 2005, BIOTECHNOL BIOENG, V91, P534, DOI 10.1002/bit.20558; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Heinrich R., 1996, REGULATION CELLULAR; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hofmeyr JHS, 1996, J THEOR BIOL, V182, P371, DOI 10.1006/jtbi.1996.0176; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Ingalls BP, 2004, J PHYS CHEM B, V108, P1143, DOI 10.1021/jp036567u; INGALLS BP, 2006, SYSTEM MODELING CELL; Jansen MLA, 2005, MICROBIOL-SGM, V151, P1657, DOI 10.1099/mic.0.27577-0; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kim PJ, 2007, P NATL ACAD SCI USA, V104, P13638, DOI 10.1073/pnas.0703262104; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Machado D, 2012, METAB ENG, V14, P112, DOI 10.1016/j.ymben.2012.01.003; Mashego MR, 2005, FEMS YEAST RES, V5, P419, DOI 10.1016/j.femsyr.2004.11.008; Miskovic L, 2011, BIOTECHNOL BIOENG, V108, P413, DOI 10.1002/bit.22932; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nikerel IE, 2011, MATH COMP MODEL DYN, V17, P243, DOI 10.1080/13873954.2010.548167; Nikerel IE, 2009, THESIS DELFT U TECHN; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; POSTMA E, 1990, YEAST, V6, P149, DOI 10.1002/yea.320060209; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; Salvado B, 2011, MATH BIOSCI, V231, P3, DOI 10.1016/j.mbs.2011.02.005; Savageau M, 1976, BIOCH SYSTEMS ANAL S, V56; Savageau MA, 2009, FEBS LETT, V583, P3914, DOI 10.1016/j.febslet.2009.10.073; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Snoep JL, 2006, BIOSYSTEMS, V83, P207, DOI 10.1016/j.biosystems.2005.07.006; Sorribas A, 2010, J BIOTECHNOL, V149, P141, DOI 10.1016/j.jbiotec.2010.01.026; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2007, BIOINFORMATICS, V23, P1378, DOI 10.1093/bioinformatics/btm065; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; Tran LM, 2008, BIOPHYS J, V95, P5606, DOI 10.1529/biophysj.108.135442; VANGULIK WM, 1995, BIOTECHNOL BIOENG, V48, P681, DOI 10.1002/bit.260480617; Vilaprinyo E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-184; Visser D, 2004, METAB ENG, V6, P378, DOI 10.1016/j.ymben.2004.07.001; Visser D, 2003, METAB ENG, V5, P164, DOI 10.1016/S1096-7176(03)00025-9; Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103; Voit E. O., 2000, COMPUTATIONAL ANAL B; Wang LQ, 2006, METAB ENG, V8, P133, DOI 10.1016/j.ymben.2005.11.003; Wilhelm T., 2004, Systems Biology, V1, P114, DOI 10.1049/sb:20045004; Wu L, 2006, METAB ENG, V8, P160, DOI 10.1016/j.ymben.2005.09.005; Zamora-Sillero E, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-142	67	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39396	10.1371/journal.pone.0039396	http://dx.doi.org/10.1371/journal.pone.0039396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808034	Green Published, gold			2022-12-25	WOS:000306354700010
J	Curjuric, I; Imboden, M; Nadif, R; Kumar, A; Schindler, C; Haun, M; Kronenberg, F; Kunzli, N; Phuleria, H; Postma, DS; Russi, EW; Rochat, T; Demenais, F; Probst-Hensch, NM				Curjuric, Ivan; Imboden, Medea; Nadif, Rachel; Kumar, Ashish; Schindler, Christian; Haun, Margot; Kronenberg, Florian; Kuenzli, Nino; Phuleria, Harish; Postma, Dirkje S.; Russi, Erich W.; Rochat, Thierry; Demenais, Florence; Probst-Hensch, Nicole M.			Different Genes Interact with Particulate Matter and Tobacco Smoke Exposure in Affecting Lung Function Decline in the General Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OXIDATIVE STRESS; CIGARETTE-SMOKE; AIR-POLLUTION; FOLLOW-UP; MITOCHONDRIAL LOCALIZATION; PULMONARY-FUNCTION; DUST EXPOSURE; SWISS COHORT; LARGE-SCALE	Background: Oxidative stress related genes modify the effects of ambient air pollution or tobacco smoking on lung function decline. The impact of interactions might be substantial, but previous studies mostly focused on main effects of single genes. Objectives: We studied the interaction of both exposures with a broad set of oxidative-stress related candidate genes and pathways on lung function decline and contrasted interactions between exposures. Methods: For 12679 single nucleotide polymorphisms (SNP5), change in forced expiratory volume in one second (FEV1), FEV1 over forced vital capacity (FEV1/FVC), and mean forced expiratory flow between 25 and 75% of the FVC (FEF25-75) was regressed on interval exposure to particulate matter < 10 mu m in diameter (PM10) or packyears smoked (a), additive SNP effects (b), and interaction terms between (a) and (b) in 669 adults with GWAS data. Interaction p-values for 152 genes and 14 pathways were calculated by the adaptive rank truncation product (ARTP) method, and compared between exposures. Interaction effect sizes were contrasted for the strongest SNPs of nominally significant genes (p(interaction) < 0.05). Replication was attempted for SNPs with MAF > 10% in 3320 SAPALDIA participants without GWAS. Results: On the SNP-level, rs2035268 in gene SNCA accelerated FEV1/FVC decline by 3.8% (p(interaction) = 2.5 x 10(-6)), and rs12190800 in PARK2 attenuated FEV1 decline by 95.1 ml p(interaction) = 9.7 x 10(-8)) over 11 years, while interacting with PM10. Genes and pathways nominally interacting with PM10 and packyears exposure differed substantially. Gene CRISP2 presented a significant interaction with PM10 (p(interaction) = 3.0 x 10(-4)) on FEV1/FVC decline. Pathway interactions were weak. Replications for the strongest SNPs in PARK2 and CRISP2 were not successful. Conclusions: Consistent with a stratified response to increasing oxidative stress, different genes and pathways potentially mediate PM10 and tobacco smoke effects on lung function decline. Ignoring environmental exposures would miss these patterns, but achieving sufficient sample size and comparability across study samples is challenging.	[Curjuric, Ivan; Imboden, Medea; Kumar, Ashish; Schindler, Christian; Kuenzli, Nino; Phuleria, Harish; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst SwissTPH, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Curjuric, Ivan; Imboden, Medea; Kumar, Ashish; Schindler, Christian; Kuenzli, Nino; Phuleria, Harish; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Nadif, Rachel] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Resp & Environm Epidemiol Team, Villejuif, France; [Nadif, Rachel] Univ Paris 11, UMRS 1018, Villejuif, France; [Kumar, Ashish] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Haun, Margot; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, Groningen, Netherlands; [Russi, Erich W.] Univ Zurich Hosp, Div Pulm Med, CH-8091 Zurich, Switzerland; [Rochat, Thierry] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Demenais, Florence] INSERM, U946, Genet Variat & Human Dis Unit, Paris, France; [Demenais, Florence] Fdn Jean Dausset, CEPH, Paris, France; [Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol, Paris, France	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Wellcome Centre for Human Genetics; Medical University of Innsbruck; University of Groningen; University of Zurich; University Zurich Hospital; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Universite Paris Cite	Curjuric, I (corresponding author), Swiss Trop & Publ Hlth Inst SwissTPH, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	Nicole.Probst@unibas.ch	Kuenzli, Nino/F-7195-2014; Nadif, Rachel/R-2876-2016; Schindler, Christian/D-3472-2015; Russi, Erich/AGN-8387-2022; Demenais, Florence/G-3298-2013; Kronenberg, Florian/B-1736-2008	Kuenzli, Nino/0000-0001-8360-080X; Nadif, Rachel/0000-0003-4938-9339; Demenais, Florence/0000-0001-8361-0936; Kronenberg, Florian/0000-0003-2229-1120; Kumar, Ashish/0000-0002-7075-5930	Swiss National Science Foundation [33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171]; Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton government of Aargau; canton government of Basel-Stadt; canton government of Basel-Land; canton government of Geneva; canton government of Luzern; canton government of Ticino; canton government of Valais; canton government of Zurich; Swiss Lung League; canton Lung League of Basel Stadt; canton Lung League of Basel Landschaft; canton Lung League of Geneva; canton Lung League of Ticino; canton Lung League of Valais; canton Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics; European Commission [018996]; Wellcome Trust [WT 084703MA]; French National Research Agency (Bio2nea project) [ANR-CES 2009]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton government of Aargau; canton government of Basel-Stadt; canton government of Basel-Land; canton government of Geneva; canton government of Luzern; canton government of Ticino; canton government of Valais; canton government of Zurich; Swiss Lung League; canton Lung League of Basel Stadt; canton Lung League of Basel Landschaft; canton Lung League of Geneva; canton Lung League of Ticino; canton Lung League of Valais; canton Lung League of Zurich; Schweizerische Unfallversicherungsanstalt (SUVA); Freiwillige Akademische Gesellschaft; UBS Wealth Foundation; Talecris Biotherapeutics GmbH; Abbott Diagnostics(Abbott Laboratories); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); French National Research Agency (Bio2nea project)(French National Research Agency (ANR))	The Swiss Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) was supported by the Swiss National Science Foundation (grants no 33CS30_134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, 3233-054996, PDFMP3-123171), the Federal Office for Forest, Environment and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, Valais and Zurich, Schweizerische Unfallversicherungsanstalt (SUVA), Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH, and Abbott Diagnostics. Genotyping in the GABRIEL framework was supported by grants European Commission 018996 and Wellcome Trust WT 084703MA. Identification of pathways was supported by the French National Research Agency (Bio2nea project ANR-CES 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: The SAPALDIA study was supported by the UBS Wealth Foundation, Talecris Biotherapeutics GmbH, and Abbott Diagnostics in terms of unrestricted grants for personnel and genotyping. The support of these institutions did not influence the scientific work regarding study design, data collection, data analysis, interpretation of results, decision to publish, or preparation of the manuscript in any way. Also, this does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Ahsan MK, 2005, FREE RADICAL BIO MED, V39, P1549, DOI 10.1016/j.freeradbiomed.2005.07.016; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392, DOI 10.1152/ajplung.2001.281.6.L1392; Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Carta P, 1996, OCCUP ENVIRON MED, V53, P312, DOI 10.1136/oem.53.5.312; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Comandini A, 2010, PULM PHARMACOL THER, V23, P482, DOI 10.1016/j.pupt.2010.05.006; Curjuric I, 2010, EUR RESPIR J, V35, P505, DOI 10.1183/09031936.00044309; DAVIS GS, 1978, AM REV RESPIR DIS, V118, P7; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Eisner MD, 2007, ANN EPIDEMIOL, V17, P364, DOI 10.1016/j.annepidem.2006.10.008; Elliott NA, 2004, MOL CELL BIOL, V24, P3180, DOI 10.1128/MCB.24.8.3180-3187.2004; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hall IP, 2010, THORAX, V65, P760, DOI 10.1136/thx.2010.147173; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; He JQ, 2004, AM J RESP CRIT CARE, V170, P388, DOI 10.1164/rccm.200312-1763OC; Johnsen HL, 2010, AM J RESP CRIT CARE, V181, P1234, DOI 10.1164/rccm.200809-1381OC; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; KAUFFMANN F, 1982, BRIT J IND MED, V39, P221; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; KUNZLI N, 1995, EUR RESPIR J, V8, P371, DOI 10.1183/09031936.95.08030371; Kunzli N, 2005, SWISS MED WKLY, V135, P503; LANGE P, 1990, J CLIN EPIDEMIOL, V43, P867, DOI 10.1016/0895-4356(90)90070-6; Le Marchand L, 2008, CANCER EPIDEM BIOMAR, V17, P263, DOI 10.1158/1055-9965.EPI-07-0402; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Li N, 2002, INHAL TOXICOL, V14, P459, DOI 10.1080/089583701753678571; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nickel C, 2005, BIOL CHEM, V386, P1129, DOI 10.1515/BC.2005.129; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Siedlinski M, 2008, AM J RESP CRIT CARE, V178, P13, DOI 10.1164/rccm.200711-1749OC; Silverman Edwin K, 2009, Proc Am Thorac Soc, V6, P539, DOI 10.1513/pats.200904-021DS; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Stavem K, 2005, EUR RESPIR J, V25, P618, DOI 10.1183/09031936.05.00008504; Sunyer J, 2005, AM J RESP CRIT CARE, V172, P1139, DOI 10.1164/rccm.200504-648OC; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Tomita M, 2006, INT J MOL MED, V17, P37; Tseng CF, 2004, PROTEIN EXPRES PURIF, V33, P265, DOI 10.1016/j.pep.2003.09.006; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; van Durme YMTA, 2010, EUR RESPIR J, V36, P89, DOI 10.1183/09031936.00129509; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	64	33	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40175	10.1371/journal.pone.0040175	http://dx.doi.org/10.1371/journal.pone.0040175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792237	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800046
J	Lam, CY; Yip, CW; Poon, TCW; Cheng, CKC; Ng, EWY; Wong, NCL; Cheung, PFY; Lai, PBS; Ng, IOL; Fan, ST; Cheung, ST				Lam, Ching Yan; Yip, Chi Wai; Poon, Terence C. W.; Cheng, Christine K. C.; Ng, Eddy W. Y.; Wong, Nicholas C. L.; Cheung, Phyllis F. Y.; Lai, Paul B. S.; Ng, Irene O. L.; Fan, Sheung Tat; Cheung, Siu Tim			Identification and Characterization of Tropomyosin 3 Associated with Granulin-Epithelin Precursor in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; DOMINANT NEMALINE MYOPATHY; MESSENGER-RNA; GROWTH-FACTOR; TPM3; ISOFORMS; MUTATION; CANCER; TISSUE; CELLS	Background and Aim: Granulin-epithelin precursor (GEP) has previously been reported to control cancer growth, invasion, chemo-resistance, and served as novel therapeutic target for cancer treatment. However, the nature and characteristics of GEP interacting partner remain unclear. The present study aims to identify and characterize the novel predominant interacting partner of GEP using co-immunoprecipitation and mass spectrometry. Methods and Results: Specific anti-GEP monoclonal antibody was used to capture GEP and its interacting partner from the protein extract of the liver cancer cells Hep3B. The precipitated proteins were analyzed by SDS-PAGE, followed by mass spectrometry and the protein identity was demonstrated to be tropomyosin 3 (TPM3). The interaction has been validated in additional cell models using anti-TPM3 antibody and immunoblot to confirm GEP as the interacting partner. GEP and TPM3 expressions were then examined by real-time quantitative RT-PCR in clinical samples, and their transcript levels were significantly correlated. Elevated TPM3 levels were observed in liver cancer compared with the adjacent non-tumorous liver, and patients with elevated TPM3 levels were shown to have poor recurrence-free survival. Protein expression of GEP and TPM3 was observed only in the cytoplasm of liver cancer cells by immunohistochemical staining. Conclusions: TPM3 is an interacting partner of GEP and may play an important role in hepatocarcinogenesis.	[Lam, Ching Yan; Yip, Chi Wai; Cheng, Christine K. C.; Wong, Nicholas C. L.; Cheung, Phyllis F. Y.; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Cheung, Phyllis F. Y.; Ng, Irene O. L.; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene O. L.; Fan, Sheung Tat; Cheung, Siu Tim] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Poon, Terence C. W.; Ng, Eddy W. Y.] Chinese Univ Hong Kong, Dept Paediat, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Lai, Paul B. S.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene O. L.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Lam, CY (corresponding author), Govt Hong Kong SAR, Dept Hlth, Hong Kong, Hong Kong, Peoples R China.	stcheung@hku.hk	Cheung, Siu-Tim/C-4238-2009; Lai, Paul BS/K-8556-2015	Cheung, Siu-Tim/0000-0003-2147-315X; Lai, Paul BS/0000-0002-9469-6728; Ng, Irene Oi-lin/0000-0001-7532-2029	Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery, Hong Kong Research Grants Council (RGC) [GRF 764111, HKU7/CRG/09]; University of Hong Kong	Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery, Hong Kong Research Grants Council (RGC); University of Hong Kong(University of Hong Kong)	This study was supported in part by Sun C.Y. Research Foundation for Hepatobiliary and Pancreatic Surgery, Hong Kong Research Grants Council (RGC GRF 764111 and HKU7/CRG/09), Seed Funding Program for Basic Research and Small Project Funding of the University of Hong Kong. The sponsors had no role in study design as well as in data collection, analysis and interpretation.	Alaiya AA, 1997, INT J CANCER, V73, P678, DOI 10.1002/(SICI)1097-0215(19971127)73:5<678::AID-IJC11>3.0.CO;2-2; Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Cheung ST, 2002, CANCER RES, V62, P4711; Choi HS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-122; Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308; Cooley BC, 2001, ARCH BIOCHEM BIOPHYS, V390, P71, DOI 10.1006/abbi.2001.2347; CULOUSCOU JM, 1993, J BIOL CHEM, V268, P10458; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Franzen B, 1996, BRIT J CANCER, V73, P909, DOI 10.1038/bjc.1996.162; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Hoque M, 2005, J BIOL CHEM, V280, P13648, DOI 10.1074/jbc.M409575200; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lamant L, 1999, BLOOD, V93, P3088; Lehtokari VL, 2008, EUR J HUM GENET, V16, P1055, DOI 10.1038/ejhg.2008.60; LIN CS, 1988, MOL CELL BIOL, V8, P160, DOI 10.1128/MCB.8.1.160; MACLEOD AR, 1986, NUCLEIC ACIDS RES, V14, P8413, DOI 10.1093/nar/14.21.8413; Ng PC, 2010, J CLIN INVEST, V120, P2989, DOI 10.1172/JCI40196; Pawlak G, 2004, INT J CANCER, V110, P368, DOI 10.1002/ijc.20151; Pelham RJ, 1996, J CELL SCI, V109, P981; Penisson-Besnier I, 2007, NEUROMUSCULAR DISORD, V17, P330, DOI 10.1016/j.nmd.2007.01.017; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; PITTENGER MF, 1994, CURR OPIN CELL BIOL, V6, P96, DOI 10.1016/0955-0674(94)90122-8; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wang FL, 1996, CANCER RES, V56, P3634; WARREN KS, 1995, J CELL BIOL, V129, P697, DOI 10.1083/jcb.129.3.697; Wysocki PJ, 2010, EXPERT OPIN INV DRUG, V19, P265, DOI 10.1517/13543780903514110; Xia XM, 1998, BIOCHEM BIOPH RES CO, V245, P539, DOI 10.1006/bbrc.1998.8498; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200	37	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40324	10.1371/journal.pone.0040324	http://dx.doi.org/10.1371/journal.pone.0040324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792281	Green Published, gold			2022-12-25	WOS:000306461800070
J	Yoshida, T; Ozawa, K; Tanaka, S				Yoshida, Takamasa; Ozawa, Katsuya; Tanaka, Shigeru			Sensitivity Profile for Orientation Selectivity in the Visual Cortex of Goggle-Reared Mice	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; IN-VIVO; MONOCULAR DEPRIVATION; SINGLE ORIENTATION; RECEPTIVE-FIELDS; CRITICAL PERIOD; ADULT MICE; SELF-ORGANIZATION; CORTICAL-NEURONS	It has been widely accepted that ocular dominance in the responses of visual cortical neurons can change depending on visual experience in a postnatal period. However, experience-dependent plasticity for orientation selectivity, which is another important response property of visual cortical neurons, is not yet fully understood. To address this issue, using intrinsic signal imaging and two-photon calcium imaging we attempted to observe the alteration of orientation selectivity in the visual cortex of juvenile and adult mice reared with head-mounted goggles, through which animals can experience only the vertical orientation. After one week of goggle rearing, the density of neurons optimally responding to the exposed orientation increased, while that responding to unexposed orientations decreased. These changes can be interpreted as a reallocation of preferred orientations among visually responsive neurons. Our obtained sensitivity profile for orientation selectivity showed a marked peak at 5 weeks and sustained elevation at 12 weeks and later. These features indicate the existence of a critical period between 4 and 7 weeks and residual orientation plasticity in adult mice. The presence of a dip in the sensitivity profile at 10 weeks suggests that different mechanisms are involved in orientation plasticity in childhood and adulthood.	[Yoshida, Takamasa; Ozawa, Katsuya; Tanaka, Shigeru] RIKEN Brain Sci Inst, Lab Visual Neurocomp, Wako, Saitama, Japan	RIKEN	Yoshida, T (corresponding author), RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan.	shigeru@uec.ac.jp		Yoshida, Takamasa/0000-0002-5508-418X	Naito Foundation [2007-140]	Naito Foundation(Naito Memorial Foundation)	The Naito Foundation (2007-140); http://www.naito-f.or.jp/index.php?lang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLASDEL GG, 1977, J PHYSIOL-LONDON, V265, P615, DOI 10.1113/jphysiol.1977.sp011734; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; CARLSON M, 1986, DEV BRAIN RES, V25, P71, DOI 10.1016/0165-3806(86)90153-7; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gordon JA, 1996, J NEUROSCI, V16, P3274; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kreile AK, 2011, J NEUROSCI, V31, P13911, DOI 10.1523/JNEUROSCI.2143-11.2011; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; MAFFEI L, 1992, J NEUROSCI, V12, P4651; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MILLER KD, 1994, J NEUROSCI, V14, P409; MIYASHITA M, 1992, NEUROREPORT, V3, P69, DOI 10.1097/00001756-199201000-00018; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Hasi K, 2007, NEUROSCI RES, V58, P86, DOI 10.1016/j.neures.2007.01.005; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Ranson A, 2012, P NATL ACAD SCI US; RAUSCHECKER JP, 1981, J PHYSIOL-LONDON, V310, P215, DOI 10.1113/jphysiol.1981.sp013545; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Smith SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009925; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tanaka S, 2006, NEUROIMAGE, V30, P462, DOI 10.1016/j.neuroimage.2005.09.056; Tanaka S, 2004, NEURAL NETWORKS, V17, P1363, DOI 10.1016/j.neunet.2004.06.014; Tanaka S, 2007, J NEUROSCI METH, V160, P206, DOI 10.1016/j.jneumeth.2006.09.004; Tanaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005380; Trevino M, 2011, CEREB CORTE IN PRESS, P1; Tropea D, 2009, PHILOS T R SOC B, V364, P341, DOI 10.1098/rstb.2008.0269; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yoshida T., 2009, DEV LEARN IEEE INT C, P1	58	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40630	10.1371/journal.pone.0040630	http://dx.doi.org/10.1371/journal.pone.0040630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792390	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800111
J	Andrews-Zwilling, Y; Gillespie, AK; Kravitz, AV; Nelson, AB; Devidze, N; Lo, I; Yoon, SY; Bien-Ly, N; Ring, K; Zwilling, D; Potter, GB; Rubenstein, JLR; Kreitzer, AC; Huang, YD				Andrews-Zwilling, Yaisa; Gillespie, Anna K.; Kravitz, Alexxai V.; Nelson, Alexandra B.; Devidze, Nino; Lo, Iris; Yoon, Seo Yeon; Bien-Ly, Nga; Ring, Karen; Zwilling, Daniel; Potter, Gregory B.; Rubenstein, John L. R.; Kreitzer, Anatol C.; Huang, Yadong			Hilar GABAergic Interneuron Activity Controls Spatial Learning and Memory Retrieval	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL-NEOCORTICAL INTERACTIONS; SOMATOSTATIN-LIKE IMMUNOREACTIVITY; LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; RETROGRADE-AMNESIA; COGNITIVE NEUROSCIENCE; HOMOVANILLIC-ACID; SENILE-DEMENTIA; DENTATE GYRUS	Background: Although extensive research has demonstrated the importance of excitatory granule neurons in the dentate gyrus of the hippocampus in normal learning and memory and in the pathogenesis of amnesia in Alzheimer's disease (AD), the role of hilar GABAergic inhibitory interneurons, which control the granule neuron activity, remains unclear. Methodology and Principal Findings: We explored the function of hilar GABAergic interneurons in spatial learning and memory by inhibiting their activity through Cre-dependent viral expression of enhanced halorhodopsin (eNpHR3.0)-a light-driven chloride pump. Hilar GABAergic interneuron-specific expression of eNpHR3.0 was achieved by bilaterally injecting adeno-associated virus containing a double-floxed inverted open-reading frame encoding eNpHR3.0 into the hilus of the dentate gyrus of mice expressing Cre recombinase under the control of an enhancer specific for GABAergic interneurons. In vitro and in vivo illumination with a yellow laser elicited inhibition of hilar GABAergic interneurons and consequent activation of dentate granule neurons, without affecting pyramidal neurons in the CA3 and CA1 regions of the hippocampus. We found that optogenetic inhibition of hilar GABAergic interneuron activity impaired spatial learning and memory retrieval, without affecting memory retention, as determined in the Morris water maze test. Importantly, optogenetic inhibition of hilar GABAergic interneuron activity did not alter short-term working memory, motor coordination, or exploratory activity. Conclusions and Significance: Our findings establish a critical role for hilar GABAergic interneuron activity in controlling spatial learning and memory retrieval and provide evidence for the potential contribution of GABAergic interneuron impairment to the pathogenesis of amnesia in AD.	[Andrews-Zwilling, Yaisa; Gillespie, Anna K.; Kravitz, Alexxai V.; Nelson, Alexandra B.; Devidze, Nino; Lo, Iris; Yoon, Seo Yeon; Bien-Ly, Nga; Ring, Karen; Zwilling, Daniel; Kreitzer, Anatol C.; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Gillespie, Anna K.; Bien-Ly, Nga; Ring, Karen; Rubenstein, John L. R.; Kreitzer, Anatol C.; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Andrews-Zwilling, Yaisa; Nelson, Alexandra B.; Zwilling, Daniel; Kreitzer, Anatol C.; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Potter, Gregory B.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Andrews-Zwilling, Y (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	yhuang@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Kravitz, Alexxai/0000-0001-5983-0218; Potter, Gregory/0000-0002-0585-6575	J. David Gladstone Institutes; National Institutes of Health [P01 AG022074, P30 NS065780, C06RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the J. David Gladstone Institutes and National Institutes of Health Grants P01 AG022074, P30 NS065780, and C06RR18928, and a gift from the S. D. Bechtel, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; BAREGGI SR, 1982, ARCH NEUROL-CHICAGO, V39, P709, DOI 10.1001/archneur.1982.00510230035010; Bast T, 2011, CURR OPIN NEUROBIOL, V21, P492, DOI 10.1016/j.conb.2011.01.003; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Grouselle D, 1998, NEUROSCI LETT, V255, P21, DOI 10.1016/S0304-3940(98)00698-3; HARDY J, 1987, NEUROSCI LETT, V73, P192, DOI 10.1016/0304-3940(87)90016-4; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hu JH, 2004, NEUROREPORT, V15, P9, DOI 10.1097/00001756-200401190-00003; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Lopez J, 2011, HIPPOCAMPUS, V22, P827; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; Noulhiane M, 2007, BRAIN, V130, P3184, DOI 10.1093/brain/awm258; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Seidl R, 2001, N-S ARCH PHARMACOL, V363, P139, DOI 10.1007/s002100000346; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Winocur G, 2009, LEARN MEMORY, V16, P722, DOI 10.1101/lm.1447209; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; ZIMMER R, 1984, ARCH NEUROL-CHICAGO, V41, P602, DOI 10.1001/archneur.1984.04210080010005	49	65	66	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40555	10.1371/journal.pone.0040555	http://dx.doi.org/10.1371/journal.pone.0040555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792368	gold, Green Published			2022-12-25	WOS:000306436300071
J	Goulden, EF; Hall, MR; Pereg, LL; Hoj, L				Goulden, Evan F.; Hall, Michael R.; Pereg, Lily L.; Hoj, Lone			Identification of an Antagonistic Probiotic Combination Protecting Ornate Spiny Lobster (Panulirus ornatus) Larvae against Vibrio owensii Infection	PLOS ONE			English	Article							TROPICAL ROCK LOBSTER; BIOFILM FORMATION; MARINE BACTERIUM; ANTIBACTERIAL COMPOUNDS; TURBOT LARVAE; ANGUILLARUM; AQUACULTURE; ALTERNATIVES; ANTIBIOTICS; STRAINS	Vibrio owensii DY05 is a serious pathogen causing epizootics in the larviculture of ornate spiny lobster Panulirus ornatus. In the present study a multi-tiered probiotic screening strategy was used to identify a probiotic combination capable of protecting P. ornatus larvae (phyllosomas) from experimental V. owensii DY05 infection. From a pool of more than 500 marine bacterial isolates, 91 showed definitive in vitro antagonistic activity towards the pathogen. Antagonistic candidates were shortlisted based on phylogeny, strength of antagonistic activity, and isolate origin. Miniaturized assays used a green fluorescent protein labelled transconjugant of V. owensii DY05 to assess pathogen growth and biofilm formation in the presence of shortlisted candidates. This approach enabled rapid processing and selection of candidates to be tested in a phyllosoma infection model. When used in combination, strains Vibrio sp. PP05 and Pseudoalteromonas sp. PP107 significantly and reproducibly protected P. ornatus phyllosomas during vectored challenge with V. owensii DY05, with survival not differing significantly from unchallenged controls. The present study has shown the value of multispecies probiotic treatment and demonstrated that natural microbial communities associated with wild phyllosomas and zooplankton prey support antagonistic bacteria capable of in vivo suppression of a pathogen causing epizootics in phyllosoma culture systems.	[Goulden, Evan F.; Hall, Michael R.; Hoj, Lone] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Goulden, Evan F.; Pereg, Lily L.] Univ New England, Sch Sci & Technol, Res Ctr Mol Biol, Armidale, NSW, Australia	Australian Institute of Marine Science; University of New England	Goulden, EF (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	l.hoj@aims.gov.au	Hoj, Lone/A-1307-2008; Goulden, Evan/H-9691-2014	Hoj, Lone/0000-0002-7781-8754; Goulden, Evan/0000-0003-3991-5403	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	EFG was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN B, 1995, J FISH DIS, V18, P93, DOI 10.1111/j.1365-2761.1995.tb01271.x; Bourne D, 2007, AQUACULTURE, V268, P274, DOI 10.1016/j.aquaculture.2007.04.067; Bourne DG, 2006, AQUACULTURE, V260, P27, DOI 10.1016/j.aquaculture.2006.06.023; Bourne DG, 2004, AQUACULTURE, V242, P31, DOI 10.1016/j.aquaculture.2004.08.047; Brewster JD, 2003, J MICROBIOL METH, V53, P77, DOI 10.1016/S0167-7012(02)00226-9; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Cano-Gomez A, 2010, FEMS MICROBIOL LETT, V302, P175, DOI 10.1111/j.1574-6968.2009.01850.x; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Davies J, 2007, EMBO REP, V8, P616, DOI 10.1038/sj.embor.7401022; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Defoirdt T, 2011, CURR OPIN MICROBIOL, V14, P251, DOI 10.1016/j.mib.2011.03.004; Dheilly A, 2010, APPL ENVIRON MICROB, V76, P3452, DOI 10.1128/AEM.02632-09; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Fjellheim AJ, 2007, AQUACULTURE, V269, P98, DOI 10.1016/j.aquaculture.2007.04.021; Gatesoupe FJ, 1997, AQUAT LIVING RESOUR, V10, P239, DOI 10.1051/alr:1997026; Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005; Goulden EF, 2012, APPL ENVIRON MICROB, V78, P2841, DOI 10.1128/AEM.07274-11; Gram L, 1999, APPL ENVIRON MICROB, V65, P969; Gram L, 2010, MAR BIOTECHNOL, V12, P439, DOI 10.1007/s10126-009-9233-y; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Hjelm M, 2004, SYST APPL MICROBIOL, V27, P360, DOI 10.1078/0723-2020-00256; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Holmstrom C, 2002, FEMS MICROBIOL ECOL, V41, P47, DOI 10.1111/j.1574-6941.2002.tb00965.x; Isnansetyo A, 2009, WORLD J MICROB BIOT, V25, P1103, DOI 10.1007/s11274-009-9992-7; Jayaprakash NS, 2005, DIS AQUAT ORGAN, V68, P39, DOI 10.3354/dao068039; Jorquera M. A., 1999, Aquaculture International, V7, P433, DOI 10.1023/A:1009246007208; Karunasagar I, 1996, AQUACULTURE, V140, P241, DOI 10.1016/0044-8486(95)01180-3; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Kittaka J., 2000, SPINY LOBSTER FISHER, P465; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Longeon A, 2004, MAR BIOTECHNOL, V6, P633, DOI 10.1007/s10126-004-3009-1; Balcazar JL, 2007, J INVERTEBR PATHOL, V96, P147, DOI 10.1016/j.jip.2007.04.008; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Makridis P, 2005, AQUAC RES, V36, P1619, DOI 10.1111/j.1365-2109.2005.01388.x; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pasmore M, 2003, J IND MICROBIOL BIOT, V30, P407, DOI 10.1007/s10295-003-0069-6; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; Riquelme C, 1997, AQUACULTURE, V154, P17, DOI 10.1016/S0044-8486(97)00043-4; Sabatini P, 2010, GLOBEFISH COMMODITY; Smith G, 2009, AQUACULTURE, V295, P76, DOI 10.1016/j.aquaculture.2009.06.030; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012; Vaseeharan B, 2003, LETT APPL MICROBIOL, V36, P83, DOI 10.1046/j.1472-765X.2003.01255.x; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; Vine NG, 2006, FEMS MICROBIOL REV, V30, P404, DOI 10.1111/j.1574-6976.2006.00017.x; Webster NS, 2006, AQUACULTURE, V255, P173, DOI 10.1016/j.aquaculture.2006.01.019; Wietz M, 2010, MAR DRUGS, V8, P2946, DOI 10.3390/md8122946	53	27	27	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39667	10.1371/journal.pone.0039667	http://dx.doi.org/10.1371/journal.pone.0039667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792184	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300010
J	Matsumura, N; Kamei, M; Tsujikawa, M; Suzuki, M; Xie, P; Nishida, K				Matsumura, Nagakazu; Kamei, Motohiro; Tsujikawa, Motokazu; Suzuki, Mihoko; Xie, Ping; Nishida, Kohji			Low-Dose Lipopolysaccharide Pretreatment Suppresses Choroidal Neovascularization via IL-10 Induction	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CHLAMYDIA-PNEUMONIAE; MOLECULAR MIMICRY; MURINE MODEL; INFECTION; INFLAMMATION; ENDOTOXIN; THERAPY; TRANSLOCATION	Recent studies have suggested that some kinds of microbial infection may have a crucial role in the development of many diseases such as autoimmune diseases and certain types of cancer. It has been reported that some chronic infections, such as Chlamydia pneumoniae, and immunological dysfunctions are associated with age-related macular degeneration (AMD), a leading cause of blindness. To evaluate the association between systemic low-level inflammation induced by infection and AMD pathogenesis, we investigated whether intraperitoneal injection of lipopolysaccharide (LPS) can modulate the development of laser-induced choroidal neovascularization (CNV), a key feature of AMD. Contrary to our expectations, the sizes of CNV in mice with LPS pretreatment were approximately 65% smaller than those of the control mice. After LPS pretreatment, serum IL-10 concentration and IL-10 gene expression in peritoneal macrophages and in the posterior part of the eye increased. Peritoneal injection of anti-IL10 antibody reduced CNV suppression by LPS pretreatment. Moreover, adoptive transfer of the resident peritoneal macrophages from LPS-treated mice into control littermates resulted in an approximately 26% reduction in the size of CNV compared with PBS-treated mice. We concluded that CNV formation was suppressed by low-dose LPS pretreatment via IL-10 production by macrophages.	[Matsumura, Nagakazu; Kamei, Motohiro; Tsujikawa, Motokazu; Suzuki, Mihoko; Xie, Ping; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan	Osaka University	Matsumura, N (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan.	mkamei@ophthal.med.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610; Xie, Ping/0000-0003-4257-8970	Japan Society for the Promotion of Science [KAKENHI 21592231, 21592229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (KAKENHI 21592231, 21592229). http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Antoszyk AN, 2008, AM J OPHTHALMOL, V145, P862, DOI 10.1016/j.ajo.2007.12.029; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Epstein SE, 2000, ARTERIOSCL THROM VAS, V20, P1417, DOI 10.1161/01.ATV.20.6.1417; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Folk JC, 2010, NEW ENGL J MED, V363, P1648, DOI 10.1056/NEJMct1000495; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hasegawa E, 2012, J LEUKOCYTE BIOL, V91, P267, DOI 10.1189/jlb.1110603; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kaiser PK, 2006, GRAEF ARCH CLIN EXP, V244, P1132, DOI 10.1007/s00417-005-0199-9; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Kalayoglu MV, 2003, ARCH OPHTHALMOL-CHIC, V121, P478, DOI 10.1001/archopht.121.4.478; Kamei M, 2004, AM J OPHTHALMOL, V138, P574, DOI 10.1016/j.ajo.2004.05.029; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Machemer R, 1998, AM J OPHTHALMOL, V125, P698, DOI 10.1016/S0002-9394(98)00020-8; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; Miller DM, 2004, AM J OPHTHALMOL, V138, P323, DOI 10.1016/j.ajo.2004.03.018; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang JH, 2003, J IMMUNOL, V170, P14, DOI 10.4049/jimmunol.170.1.14	30	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39890	10.1371/journal.pone.0039890	http://dx.doi.org/10.1371/journal.pone.0039890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802947	Green Submitted, Green Published, gold			2022-12-25	WOS:000306186900021
J	Moss, BL; Elhammali, A; Fowlkes, T; Gross, S; Vinjamoori, A; Contag, CH; Piwnica-Worms, D				Moss, Britney L.; Elhammali, Adnan; Fowlkes, Tiffanie; Gross, Shimon; Vinjamoori, Anant; Contag, Christopher H.; Piwnica-Worms, David			Interrogation of Inhibitor of Nuclear Factor kappa B alpha/Nuclear Factor kappa B (I kappa B alpha/NF-kappa B) Negative Feedback Loop Dynamics FROM SINGLE CELLS TO LIVE ANIMALS IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TEMPORAL CONTROL; INDUCED STABILIZATION; SIGNALING PATHWAYS; LIVING CELLS; OSCILLATIONS; TNF; STIMULATION; SPECIFICITY; ACTIVATION	Full understanding of the biological significance of negative feedback processes requires interrogation at multiple scales as follows: in single cells, cell populations, and live animals in vivo. The transcriptionally coupled I kappa B alpha/NF-kappa B negative feedback loop, a pivotal regulatory node of innate immunity and inflammation, represents a model system for multiscalar reporters. Using a kappa B-5 -> I kappa B alpha-FLuc bioluminescent reporter, we rigorously evaluated the dynamics of I kappa B alpha degradation and subsequent NF-kappa B transcriptional activity in response to diverse modes of TNF alpha stimulation. Modulating TNF alpha concentration or pulse duration yielded complex, reproducible, and differential I kappa B alpha dynamics in both cell populations and live single cells. Tremendous heterogeneity in the transcriptional amplitudes of individual responding cells was observed, which was greater than the heterogeneity in the transcriptional kinetics of responsive cells. Furthermore, administration of various TNF alpha doses in vivo generated I kappa B alpha dynamic profiles in the liver resembling those observed in single cells and populations of cells stimulated with TNF alpha pulses. This suggested that dose modulation of circulating TNF alpha was perceived by hepatocytes in vivo as pulses of increasing duration. Thus, a robust bioluminescent reporter strategy enabled rigorous quantitation of NF-kappa B/I kappa B alpha dynamics in both live single cells and cell populations and furthermore, revealed reproducible behaviors that informed interpretation of in vivo studies.	[Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, Mol Imaging Ctr,Mallinckrodt Inst Radiol,Dept Cel, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, Mol Imaging Ctr,Mallinckrodt Inst Radiol,Dept Dev, St Louis, MO 63110 USA; [Vinjamoori, Anant; Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Pediat, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Radiol, Stanford, CA 94305 USA; [Vinjamoori, Anant; Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Washington University (WUSTL); Washington University (WUSTL); Stanford University; Stanford University; Stanford University	Piwnica-Worms, D (corresponding author), Washington Univ, Sch Med, BRIGHT Inst, Mol Imaging Ctr,Mallinckrodt Inst Radiol,Dept Cel, 510 S Kingshighway Blvd,Box 8225, St Louis, MO 63110 USA.	wormsd@mir.wustl.edu		fowlkes, tiffanie/0000-0001-8189-6838; Contag, Christopher/0000-0002-1011-8278; Moss, Britney/0000-0002-1037-5717	National Institutes of Health Grant [P50 CA94056]; National Science Foundation; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 CA94056. This work was also supported by a predoctoral fellowship Award from the National Science Foundation (to B.L.M.).	Alon U, 2007, NATURE, V446, P497, DOI 10.1038/446497a; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Harper CV, 2010, J CELL SCI, V123, P424, DOI 10.1242/jcs.060434; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Moss BL, 2008, J BIOL CHEM, V283, P8687, DOI 10.1074/jbc.M706831200; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nelson G, 2002, J CELL SCI, V115, P1137; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pichler A, 2005, CLIN CANCER RES, V11, P4487, DOI 10.1158/1078-0432.CCR-05-0038; Pichler A, 2008, P NATL ACAD SCI USA, V105, P15932, DOI 10.1073/pnas.0801075105; Place RF, 2003, J CELL PHYSIOL, V195, P470, DOI 10.1002/jcp.10262; Place RF, 2001, BIOCHEM BIOPH RES CO, V283, P813, DOI 10.1006/bbrc.2001.4883; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Sung MH, 2011, WIRES SYST BIOL MED, V3, P167, DOI 10.1002/wsbm.108; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Warrington NM, 2010, CANCER RES, V70, P5717, DOI 10.1158/0008-5472.CAN-09-3769; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	44	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31359	31370		10.1074/jbc.M112.364018	http://dx.doi.org/10.1074/jbc.M112.364018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807442	Green Published, hybrid			2022-12-25	WOS:000308791300047
J	Zhu, QL; Gibson, MP; Liu, QL; Liu, Y; Lu, YB; Wang, XF; Feng, JQ; Qin, CL				Zhu, Qinglin; Gibson, Monica Prasad; Liu, Qilin; Liu, Ying; Lu, Yongbo; Wang, Xiaofang; Feng, Jian Q.; Qin, Chunlin			Proteolytic Processing of Dentin Sialophosphoprotein (DSPP) Is Essential to Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALOPROTEIN; PHOSPHOPROTEIN; PROTEINS; MUTATION; SEQUENCE; BINDING; GENE; PHOSPHOPHORYN; SUBSTITUTION; PRODUCTS	DSPP, which plays a crucial role in dentin formation, is processed into the NH2-terminal and COOH-terminal fragments. We believe that the proteolytic processing of DSPP is an essential activation step for its biological function in biomineralization. We tested this hypothesis by analyzing transgenic mice expressing the mutant D452A-DSPP in the Dspp-knock-out (Dspp-KO) background (referred to as "Dspp-KO/D452A-Tg" mice). We employed multipronged approaches to characterize the dentin of the Dspp-KO/D452A-Tg mice, in comparison with Dspp-KOmice and mice expressing the normal DSPP transgene in the Dspp-KO background (named Dspp-KO/normal-Tg mice). Our analyses showed that 90% of the D452A-DSPP in the dentin of Dspp-KO/D452A-Tg mice was not cleaved, indicating that D452A substitution effectively blocked the proteolytic processing of DSPP in vivo. While the expression of the normal DSPP fully rescued the dentin defects of the Dspp-KO mice, expressing the D452A-DSPP failed to do so. These results indicate that the proteolytic processing of DSPP is an activation step essential to its biological function in dentinogenesis.	[Zhu, Qinglin; Gibson, Monica Prasad; Liu, Qilin; Liu, Ying; Lu, Yongbo; Wang, Xiaofang; Feng, Jian Q.; Qin, Chunlin] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA; [Zhu, Qinglin] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Air Force Military Medical University	Qin, CL (corresponding author), Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu		Wang, Xiaofang/0000-0002-7370-7192; Lu, Yongbo/0000-0003-3692-1736	National Institutes of Health [DE005092]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE005092 (to C. Q.).	Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Boskey A, 2000, CALCIFIED TISSUE INT, V67, P472, DOI 10.1007/s002230001169; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; Butler W T, 1995, Connect Tissue Res, V33, P59, DOI 10.3109/03008209509016983; BUTLER WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P178, DOI 10.1016/0003-9861(83)90021-8; BUTLER WT, 1981, COLLAGEN REL RES, V1, P187; BUTLER WT, 1992, MATRIX, V12, P343, DOI 10.1016/S0934-8832(11)80030-2; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; DICKSON IR, 1975, CALC TISS RES, V19, P51, DOI 10.1007/BF02563990; DIMUZIO MT, 1978, J BIOL CHEM, V253, P6845; Dong J, 2005, AM J MED GENET A, V132A, P305, DOI 10.1002/ajmg.a.30460; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Holappa H, 2006, EUR J ORAL SCI, V114, P381, DOI 10.1111/j.1600-0722.2006.00391.x; JONSSON M, 1978, J CHROMATOGR, V157, P235, DOI 10.1016/S0021-9673(00)92338-0; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026; LINDE A, 1989, ANAT REC, V224, P154, DOI 10.1002/ar.1092240206; MACDOUGALL M, 1985, BIOCHEM J, V232, P493, DOI 10.1042/bj2320493; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Malmgren B, 2004, HUM GENET, V114, P491, DOI 10.1007/s00439-004-1084-z; MARSH ME, 1989, BIOCHEMISTRY-US, V28, P346, DOI 10.1021/bi00427a047; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ritchie HH, 1996, J BIOL CHEM, V271, P21695, DOI 10.1074/jbc.271.36.21695; Ritchie HH, 2001, BBA-GENE STRUCT EXPR, V1520, P212, DOI 10.1016/S0167-4781(01)00274-3; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sugars RV, 2006, EUR J ORAL SCI, V114, P89, DOI 10.1111/j.1600-0722.2006.00271.x; Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Sun Y, 2010, INT J ORAL MAX SURG, V39, P272, DOI 10.1016/j.ijom.2009.12.017; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2005, J BIOL CHEM, V280, P1552, DOI 10.1074/jbc.M409606200; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhu Q, 2010, J DENT RES, V89, P808, DOI 10.1177/0022034510366902; Zhu QL, 2012, CONNECT TISSUE RES, V53, P307, DOI 10.3109/03008207.2011.650301	47	42	46	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30426	30435		10.1074/jbc.M112.388587	http://dx.doi.org/10.1074/jbc.M112.388587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798071	hybrid, Green Published			2022-12-25	WOS:000308579800035
J	Ha, YP; Hurt, LS; Tawiah-Agyemang, C; Kirkwood, BR; Edmond, KM				Ha, Yoonhee P.; Hurt, Lisa S.; Tawiah-Agyemang, Charlotte; Kirkwood, Betty R.; Edmond, Karen M.			Effect of Socioeconomic Deprivation and Health Service Utilisation on Antepartum and Intrapartum Stillbirth: Population Cohort Study from Rural Ghana	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MATERNAL SURVIVAL; SYSTEMATIC ANALYSIS; INFANT-MORTALITY; NEONATAL DEATHS; OBSTETRIC CARE; RISK-FACTORS; DISPARITIES; RATES	Background: No studies have examined the effect of socioeconomic deprivation on antepartum and intrapartum stillbirths in the poorest women in low income countries. Methodology/Principal Findings: This study used data from a prospective population based surveillance system involving all women of childbearing age and their babies in rural Ghana. The primary objective was to evaluate associations between household wealth and risk of antepartum and intrapartum stillbirth. The secondary objective was to assess whether any differences in risk were mediated by utilisation of health services during pregnancy. Data were analysed using multivariable logistic regression. Random effect models adjusted for clustering of women who delivered more than one infant. There were 80267 babies delivered from 1 July 2003 to 30 September 2008: 77666 live births and 2601 stillbirths. Of the stillbirths 1367 (52.6%) were antepartum, 989 (38.0%) were intrapartum and 245 (9.4%) had no data on the timing of death. 94.8% of the babies born in the study (76129/80267) had complete data on all covariates and outcomes. 36 878 (48.4%) of babies were born to women in the two poorest quintiles and 3697 (4.9%) had no pregnancy care. There was no association between wealth and antepartum stillbirths. There was a marked 'dose response' of increasing risk of intrapartum stillbirth with increasing levels of socioeconomic deprivation (adjOR 1.09 [1.03-1.16] p value 0.002). Women in the poorest two quintiles had greater risk of intrapartum stillbirth (adjOR 1.19 [1.02-1.38] p value 0.023) compared to the richest women. Adjusting for heath service utilisation and other variables did not alter results. Conclusions/Significance: Poor women had a high risk of intrapartum stillbirth and this risk was not influenced by health service utilisation. Health system strengthening is required to meet the needs of poor women in our study population.	[Ha, Yoonhee P.; Hurt, Lisa S.; Kirkwood, Betty R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Tawiah-Agyemang, Charlotte] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo, Ghana; [Edmond, Karen M.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia	University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre; University of Western Australia	Ha, YP (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Karen.Edmond@uwa.edu.au	Hurt, Lisa/GZG-4796-2022	Hurt, Lisa/0000-0002-2741-5383; Kirkwood, Betty/0000-0001-5274-6072	United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); Marshall Aid Commemoration Commission; Wellcome Trust; University of London Central Research Fund	United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Marshall Aid Commemoration Commission; Wellcome Trust(Wellcome TrustEuropean Commission); University of London Central Research Fund	This document is an output from a project supported by the United Kingdom Department for International Development (DFID) for the benefit of developing countries; the views expressed are not necessarily those of DFID. In addition, the United States Agency for International Development (USAID) contributed funding to the initial stages of the project. YPH was funded by a Marshall Scholarship from the Marshall Aid Commemoration Commission, a Dr. Gordon Smith Travelling Scholarship from the Wellcome Trust, and a grant from the University of London Central Research Fund. The researchers are fully independent from the funders. The study funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.	[Anonymous], 2010, SOCIOECONOMIC DIFFER; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF Macro, 2009, GHAN DEM HLTH SURV; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; McClure EM, 2009, J MATERN-FETAL NEO M, V22, P183, DOI 10.1080/14767050802559129; McClure EM, 2011, ACTA OBSTET GYNECOL; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Spong CY, 2011, LANCET, V377, P1635, DOI 10.1016/S0140-6736(11)60025-1; Spong CY, 2011, OBSTET GYNECOL, V117, P948, DOI 10.1097/AOG.0b013e318211726f; Stephansson O, 2001, INT J EPIDEMIOL, V30, P1296, DOI 10.1093/ije/30.6.1296; Sutan R, 2010, J PERINATOL, V30, P311, DOI 10.1038/jp.2009.158	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39050	10.1371/journal.pone.0039050	http://dx.doi.org/10.1371/journal.pone.0039050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808025	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000306406700007
J	Sato, A; Ikegami, M				Sato, Atsuyasu; Ikegami, Machiko			SP-B and SP-C Containing New Synthetic Surfactant for Treatment of Extremely Immature Lamb Lung	PLOS ONE			English	Article							NATURAL SURFACTANT; PREMATURE LAMBS; PROTEIN; VENTILATION; PHOSPHATIDYLCHOLINE; EXPRESSION; ANALOGS	Although superiority of synthetic surfactant over animal-driven surfactant has been known, there is no synthetic surfactant commercially available at present. Many trials have been made to develop synthetic surfactant comparable in function to animal-driven surfactant. The efficacy of treatment with a new synthetic surfactant (CHF5633) containing dipalmitoylphosphatidylcholine, phosphatidylglycerol, SP-B analog, and SP-C analog was evaluated using immature newborn lamb model and compared with animal lung tissue-based surfactant Survanta. Lambs were treated with a clinical dose of 200 mg/kg CHF5633, 100 mg/kg Survanta, or air after 15 min initial ventilation. All the lambs treated with air died of respiratory distress within 90 min of age. During a 5 h study period, Pco(2) was maintained at 55 mmHg with 24 cmH(2)O peak inspiratory pressure for both groups. The preterm newborn lamb lung functions were dramatically improved by CHF5633 treatment. Slight, but significant superiority of CHF5633 over Survanta was demonstrated in tidal volume at 20 min and dynamic lung compliance at 20 and 300 min. The ultrastructure of CHF5633 was large with uniquely aggregated lipid particles. Increased uptake of CHF5633 by alveolar monocytes for catabolism was demonstrated by microphotograph, which might be associated with the higher treatment dose of CHF5633. The higher catabolism of CHF5633 was also suggested by the similar amount of surfactant lipid in bronchoalveolar lavage fluid (BALF) between CHF5633 and Survanta groups, despite the 2-fold higher treatment dose of CHF5633. Under the present ventilation protocol, lung inflammation was minimal for both groups, evaluated by inflammatory cell numbers in BALF and expression of IL-1 beta, IL-6, IL-8, and TNF alpha mRNA in the lung tissue. In conclusion, the new synthetic surfactant CHF5633 was effective in treating extremely immature newborn lambs with surfactant deficiency during the 5 h study period.	[Sato, Atsuyasu; Ikegami, Machiko] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Sato, A (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA.	machiko.ikegami@cchmc.org	Sato, Atsuyasu/H-9690-2016	Sato, Atsuyasu/0000-0001-8068-9984	Chiesi Farmaceutici S.p.A.	Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc)	The study was supported by Chiesi Farmaceutici S.p.A. The surfactant CHF5633 was supplied by Chiesi Farmaceutici S.p.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS FH, 1978, PEDIATR RES, V12, P841, DOI 10.1203/00006450-197808000-00008; Akei H, 2006, AM J PHYSIOL-LUNG C, V291, pL572, DOI 10.1152/ajplung.00060.2006; Almlen A, 2010, NEONATOLOGY, V98, P91, DOI 10.1159/000276980; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHU J, 1967, PEDIATRICS, V40, P709; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Ding JQ, 2001, BIOPHYS J, V80, P2262, DOI 10.1016/S0006-3495(01)76198-X; DURAND DJ, 1985, J PEDIATR-US, V107, P775, DOI 10.1016/S0022-3476(85)80416-9; ENHORNING G, 1972, PEDIATRICS, V50, P58; Epaud R, 2003, AM J RESP CELL MOL, V28, P373, DOI 10.1165/rcmb.2002-0071OC; FUJIWARA T, 1980, LANCET, V1, P55; GROSS NJ, 1989, J APPL PHYSIOL, V66, P342, DOI 10.1152/jappl.1989.66.1.342; IKEGAMI M, 1983, J PEDIATR-US, V102, P443, DOI 10.1016/S0022-3476(83)80673-8; IKEGAMI M, 1981, J APPL PHYSIOL, V51, P306, DOI 10.1152/jappl.1981.51.2.306; IKEGAMI M, 1979, PEDIATR RES, V13, P777, DOI 10.1203/00006450-197906000-00012; Ikegami M, 2006, AM J RESP CRIT CARE, V173, P1342, DOI 10.1164/rccm.200509-1485OC; IKEGAMI M, 1993, AM REV RESPIR DIS, V148, P837, DOI 10.1164/ajrccm/148.4_Pt_1.837; Ikegami M, 1998, AM J RESP CRIT CARE, V157, P638, DOI 10.1164/ajrccm.157.2.9704006; Ikegami M, 2002, J APPL PHYSIOL, V92, P519, DOI 10.1152/japplphysiol.00459.2001; Ikegami M, 2005, AM J PHYSIOL-LUNG C, V289, pL962, DOI 10.1152/ajplung.00214.2005; Ikegami M, 2009, J APPL PHYSIOL, V106, P1545, DOI 10.1152/japplphysiol.91567.2008; JOBE A, 1978, AM J OBSTET GYNECOL, V132, P53, DOI 10.1016/0002-9378(78)90798-6; JOBE A, 1983, J APPL PHYSIOL, V55, P169, DOI 10.1152/jappl.1983.55.1.169; JOBE A, 1984, J CLIN INVEST, V73, P848, DOI 10.1172/JCI111280; Jobe AH, 1996, GENE THER, V3, P775; KING RJ, 1972, AM J PHYSIOL, V223, P707, DOI 10.1152/ajplegacy.1972.223.3.707; Kramer BW, 2000, AM J PHYSIOL-LUNG C, V279, pL842, DOI 10.1152/ajplung.2000.279.5.L842; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASON RJ, 1976, J LIPID RES, V17, P281; Michna J, 1999, AM J RESP CRIT CARE, V160, P634, DOI 10.1164/ajrccm.160.2.9902016; Morris RE, 1997, J ELECTRON MICROSC, V46, P315, DOI 10.1093/oxfordjournals.jmicro.a023525; Naik AS, 2001, AM J RESP CRIT CARE, V164, P494, DOI 10.1164/ajrccm.164.3.2010127; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; POULAIN FR, 1992, AM J PHYSIOL, V262, pL730, DOI 10.1152/ajplung.1992.262.6.L730; Poulain FR, 1999, AM J RESP CELL MOL, V20, P1049, DOI 10.1165/ajrcmb.20.5.3497; Ramanathan R, 2009, J PERINATOL, V29, pS38, DOI 10.1038/jp.2009.31; RICE WR, 1989, BIOCHIM BIOPHYS ACTA, V1006, P237, DOI 10.1016/0005-2760(89)90202-6; ROBILLARD E, 1964, CAN MED ASSOC J, V90, P55; Rodriguez-Capote K, 2001, AM J PHYSIOL-LUNG C, V281, pL231, DOI 10.1152/ajplung.2001.281.1.L231; Sato Atsuyasu, 2010, Am J Respir Crit Care Med, V181, P1098, DOI 10.1164/rccm.200912-1818OC; UEDA T, 1994, J APPL PHYSIOL, V76, P45, DOI 10.1152/jappl.1994.76.1.45; VORBROKER DK, 1995, AM J PHYSIOL-LUNG C, V268, pL647, DOI 10.1152/ajplung.1995.268.4.L647; Wada K, 1997, J APPL PHYSIOL, V83, P1054, DOI 10.1152/jappl.1997.83.4.1054; Walther FJ, 2002, BIOL NEONATE, V82, P181, DOI 10.1159/000063607	47	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39392	10.1371/journal.pone.0039392	http://dx.doi.org/10.1371/journal.pone.0039392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808033	Green Published, gold, Green Submitted			2022-12-25	WOS:000306406700008
J	Gerovasileiou, V; Voultsiadou, E				Gerovasileiou, Vasilis; Voultsiadou, Eleni			Marine Caves of the Mediterranean Sea: A Sponge Biodiversity Reservoir within a Biodiversity Hotspot	PLOS ONE			English	Article							MASS-MORTALITY; SUBMARINE CAVES; DIVERSITY; DEMOSPONGIAE; PORIFERA; AFFINITIES; BIOGEOGRAPHY; HOMOSCLEROMORPHA; INVERTEBRATES; ASSEMBLAGES	Marine caves are widely acknowledged for their unique biodiversity and constitute a typical feature of the Mediterranean coastline. Herein an attempt was made to evaluate the ecological significance of this particular ecosystem in the Mediterranean Sea, which is considered a biodiversity hotspot. This was accomplished by using Porifera, which dominate the rocky sublittoral substrata, as a reference group in a meta-analytical approach, combining primary research data from the Aegean Sea (eastern Mediterranean) with data derived from the literature. In total 311 species from all poriferan classes were recorded, representing 45.7% of the Mediterranean Porifera. Demospongiae and Homoscleromorpha are highly represented in marine caves at the family (88%), generic (70%), and species level (47.5%), the latter being the most favored group along with Dictyoceratida and Lithistida. Several rare and cave-exclusive species were reported from only one or few caves, indicating the fragmentation and peculiarity of this unique ecosystem. Species richness and phylogenetic diversity varied among Mediterranean areas; the former was positively correlated with research effort, being higher in the northern Mediterranean, while the latter was generally higher in caves than in the overall sponge assemblages of each area. Resemblance analysis among areas revealed that cavernicolous sponge assemblages followed a pattern quite similar to that of the overall Mediterranean assemblages. The same pattern was exhibited by the zoogeographic affinities of cave sponges: species with Atlanto-Mediterranean distribution and Mediterranean endemics prevailed (more than 40% each), 70% of them having warm-water affinities, since most caves were studied in shallow waters. According to our findings, Mediterranean marine caves appear to be important sponge biodiversity reservoirs of high representativeness and great scientific interest, deserving further detailed study and protection.	[Gerovasileiou, Vasilis; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki	Gerovasileiou, V (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, GR-54006 Thessaloniki, Greece.	vgerovas@bio.auth.gr	Voultsiadou, Eleni/P-9890-2017; Gerovasileiou, Vasilis/H-6376-2019	Voultsiadou, Eleni/0000-0003-3429-6754; Gerovasileiou, Vasilis/0000-0002-9143-7480	European Union; National Strategic Reference Framework - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund; Alexander S. Onassis Public Benefit Foundation	European Union(European Commission); National Strategic Reference Framework - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund; Alexander S. Onassis Public Benefit Foundation	This research has been co-financed (01/2011 up to date) by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. VG also benefited from "Alexander S. Onassis Public Benefit Foundation" fellowship for postgraduate studies (10/2009-12/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A., 2008, STATUS MARINE PROTEC; Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Aguilar Ricardo, 2011, Zootaxa, V2925, P33; Appeltans W, 2011, WORLD REGISTER MARIN; Bakran-Petricioli T, 2007, MAR ECOL-EVOL PERSP, V28, P10, DOI 10.1111/j.1439-0485.2007.00179.x; Bakran-Petricioli T, 2012, ZOOTAXA, P20, DOI 10.11646/zootaxa.3172.1.2; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2003, J MAR BIOL ASSOC UK, V83, P1199, DOI 10.1017/S002531540300849X; Bell JJ, 2000, HYDROBIOLOGIA, V440, P55, DOI 10.1023/A:1004145011422; Bell JJ, 2002, MAR ECOL-P S Z N I, V23, P297, DOI 10.1046/j.1439-0485.2002.02784.x; BenedettiCecchi L, 1997, J EXP MAR BIOL ECOL, V208, P153, DOI 10.1016/S0022-0981(96)02650-0; Bianchi Carlo Nike, 2010, Travaux Scientifiques du Parc National de Port-Cros, V24, P39; BIBILONI MA, 1989, MAR ECOL-P S Z N I, V10, P317, DOI 10.1111/j.1439-0485.1989.tb00076.x; Blanquer A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-13; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Boury-Esnault N., 2004, B MUS I BIOL U GEN, V68, P3; BOURYESNAULT N, 1971, VIE MILIEU B OCEANOG, V22, P159; BOURYESNAULT N, 1994, SPONGES IN TIME AND SPACE, P407; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Bussotti S, 2006, MAR ECOL PROG SER, V325, P109, DOI 10.3354/meps325109; Calcinai B, 2011, J MAR BIOL ASSOC UK, V91, P339, DOI 10.1017/S0025315410001050; Carballo JL, 1997, J BIOGEOGR, V24, P223, DOI 10.1046/j.1365-2699.1997.00082.x; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; Cicogna F., 2003, GROTTE MARINE CINQUA; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Corriero G, 2000, MAR ECOL-P S Z N I, V21, P85, DOI 10.1046/j.1439-0485.2000.00655.x; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; Denitto F, 2007, MAR ECOL-EVOL PERSP, V28, P35, DOI 10.1111/j.1439-0485.2007.00172.x; Di Franco A, 2009, ENVIRON CONSERV, V36, P32, DOI 10.1017/S0376892909005426; Dov Por Francis, 2009, BioRisk, V3, P5; DRACH P, 1948, CR HEBD ACAD SCI, V227, P1176; Ereskovsky AV, 2011, ZOOTAXA, P5, DOI 10.11646/zootaxa.2768.1.2; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Harmelin JG, 1997, VIE MILIEU, V47, P351; Harmelin Jean-Georges, 2003, Travaux Scientifiques du Parc National de Port-Cros, V19, P117; Harmelin JG, 1997, MAR ECOL PROG SER, V153, P139, DOI 10.3354/meps153139; HARMELIN JG, 1985, TETHYS, V11, P214; Hiscock K., 2007, MARINE BIODIVERSITY; HOBBS HH, 1994, HYDROBIOLOGIA, V287, P95, DOI 10.1007/BF00006899; Hooper J.N.A., 2002, SYSTEMA PORIFERA GUI, V1 & 2, DOI [10.1002/aqc.593, DOI 10.1002/AQC.593]; Hooper JNA, 2002, BIODIVERS CONSERV, V11, P851, DOI 10.1023/A:1015370312077; Hunter RL, 2008, J BIOGEOGR, V35, P65, DOI 10.1111/j.1365-2699.2007.01767.x; Iliffe Thomas M., 2009, Smithsonian Contributions to the Marine Sciences, P269; ILIFFE TM, 1983, NATURE, V302, P141, DOI 10.1038/302141a0; Labate M., 1965, Bollettino di Zoologia, V32, P541; Laborel J., 1958, Bulletin de l'Institut Oceanographique Monaco, V1120, P1; Lejeusne C, 2006, MOL ECOL, V15, P4123, DOI 10.1111/j.1365-294X.2006.03101.x; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; MALDONADO M, 1995, J BIOGEOGR, V22, P89, DOI 10.2307/2846075; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Manconi R, 2009, ITAL J ZOOL, V76, P306, DOI 10.1080/11250000802629471; Manconi R, 2006, J MAR BIOL ASSOC UK, V86, P691, DOI 10.1017/S0025315406013580; Manconi R, 2008, ZOOKEYS, P71, DOI 10.3897/zookeys.4.39; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; Marti R, 2004, J MAR BIOL ASSOC UK, V84, P557, DOI 10.1017/S0025315404009567h; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Olson DB, 2007, J PHYS OCEANOGR, V37, P1898, DOI 10.1175/JPO3028.1; Pansini M., 1983, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V50, P287; Pansini Maurizio, 2003, Biogeographia, V24, P59; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Peres J. M., 1949, Compte Rendu de la Societe de Biogeographie Paris, VNo. 227, P42; Peres J. M., 1958, Ann Inst Oceanogr Paris NS, V34, P213; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; PERES JM, 1966, EXPERIENTIA, V22, P417, DOI 10.1007/BF01900958; Perez T, 2004, J MAR BIOL ASSOC UK, V84, P15, DOI 10.1017/S0025315404008859h; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Pisera A, 2011, SCI MAR, V75, P17, DOI 10.3989/scsimar.2011.75n1017; POULIQUE.L, 1969, CR ACAD SCI D NAT, V268, P1324; Pouliquen L., 1972, Tethys, V3, P717; Price ARG, 2002, MAR ECOL PROG SER, V241, P23, DOI 10.3354/meps241023; RIEDL R, 1966, BIOL MEERESHOHLEN; Roberts CM, 2003, ECOL APPL, V13, pS199; Russ K., 1959, Pubblicazioni della Stazione Zoologica di Napoli Suppl, V30, P756; Rutzler, 1965, ZOOL ANZ, V176, P303; Samaai Toufiek, 2006, Zootaxa, V1358, P1; Sara M., 1962, Archivio Zoologico Italiano, V46, P1; Sara M., 1959, Archivio Zoologico Italiano Napoli, V43, P203; Sara M, 1973, SPONGIAIRES ANATOMIE, V3, P462; Sara M., 1968, RAPP COMM INT MER ME, V19, P83; Stewart IS, 2009, PHYS GEOGRAPHY MEDIT, P385; STOCK JH, 1986, STYGOLOGIA, V2, P90; STOCK JH, 1994, HYDROBIOLOGIA, V287, P105, DOI 10.1007/BF00006900; Terlizzi A, 2002, MAR POLLUT BULL, V44, P544, DOI 10.1016/S0025-326X(01)00282-X; Tunesi L., 1993, International Journal of Environmental Studies, V43, P253, DOI 10.1080/00207239308710832; URIZ MJ, 1992, PSZNI MAR ECOL, V13, P101; Vacelet J., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Ser A), V59, P145; Vacelet J., 1965, Recueil des Travaux de la Station Marine de l'Endoume Fasc Hors Ser Suppl, V4, P71; VACELET J, 1958, CR HEBD ACAD SCI, V246, P318; VACELET J, 1994, DEEP-SEA RES PT I, V41, P965, DOI 10.1016/0967-0637(94)90013-2; Vacelet J, 2007, J MAR BIOL ASSOC UK, V87, P1539, DOI 10.1017/S0025315407060687; Vacelet J, 2008, MAR ECOL-EVOL PERSP, V29, P237, DOI 10.1111/j.1439-0485.2007.00218.x; Vacelet Jean, 1998, Zoosystema, V20, P5; Vacelet Jean, 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V66, P109; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; van Soest RWM, 2011, HYDROBIOLOGIA; van Soest RWM, 2012, WORLD PORIFERA DATAB; VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213; VanStraalen NM, 2012, Introduction to Ecological Genomics, 2nd Edition, P1; Vishnyakov AE, 2009, MAR BIOL, V156, P1625, DOI 10.1007/s00227-009-1198-x; Voultsiadou E, 2005, HELGOLAND MAR RES, V59, P237, DOI 10.1007/s10152-005-0224-8; Voultsiadou E, 2005, ITAL J ZOOL, V72, P53, DOI 10.1080/11250000509356653; Voultsiadou E, 2011, REV FISH SCI, V19, P34, DOI 10.1080/10641262.2010.531794; Voultsiadou E, 2010, ESTUAR COAST SHELF S, V86, P598, DOI 10.1016/j.ecss.2009.11.035; Voultsiadou E, 2009, HYDROBIOLOGIA, V628, P1, DOI 10.1007/s10750-009-9725-9; Woodward J.C., 2009, PHYS GEOGRAPHY MEDIT, P287, DOI [10.1093/oso/9780199268030.003.0022, DOI 10.1093/OSO/9780199268030.003.0022]; ZERVAKIS V, 2005, STATE HELLENIC MARIN, P104; [No title captured]	118	94	95	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39873	10.1371/journal.pone.0039873	http://dx.doi.org/10.1371/journal.pone.0039873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808070	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400025
J	Pollack, JB; Cleveland, A; Palmer, TA; Reisinger, AS; Montagna, PA				Pollack, Jennifer Beseres; Cleveland, Andrew; Palmer, Terence A.; Reisinger, Anthony S.; Montagna, Paul A.			A Restoration Suitability Index Model for the Eastern Oyster (Crassostrea virginica) in the Mission-Aransas Estuary, TX, USA	PLOS ONE			English	Article							PERKINSUS-MARINUS; AMERICAN OYSTER; REEFS; POPULATIONS; CONSERVATION; HYPOXIA; GMELIN	Oyster reefs are one of the most threatened marine habitats on earth, with habitat loss resulting from water quality degradation, coastal development, destructive fishing practices, overfishing, and storm impacts. For successful and sustainable oyster reef restoration efforts, it is necessary to choose sites that support long-term growth and survival of oysters. Selection of suitable sites is critically important as it can greatly influence mortality factors and may largely determine the ultimate success of the restoration project. The application of Geographic Information Systems (GIS) provides an effective methodology for identifying suitable sites for oyster reef restoration and removes much of the uncertainty involved in the sometimes trial and error selection process. This approach also provides an objective and quantitative tool for planning future oyster reef restoration efforts. The aim of this study was to develop a restoration suitability index model and reef quality index model to characterize locations based on their potential for successful reef restoration within the Mission-Aransas Estuary, Texas, USA. The restoration suitability index model focuses on salinity, temperature, turbidity, dissolved oxygen, and depth, while the reef quality index model focuses on abundance of live oysters, dead shell, and spat. Size-specific Perkinsus marinus infection levels were mapped to illustrate general disease trends. This application was effective in identifying suitable sites for oyster reef restoration, is flexible in its use, and provides a mechanism for considering alternative approaches. The end product is a practical decision-support tool that can be used by coastal resource managers to improve oyster restoration efforts. As oyster reef restoration activities continue at small and large-scales, site selection criteria are critical for assisting stakeholders and managers and for maximizing long-term sustainability of oyster resources.	[Pollack, Jennifer Beseres] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA; [Cleveland, Andrew; Palmer, Terence A.; Reisinger, Anthony S.; Montagna, Paul A.] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX USA; [Reisinger, Anthony S.] Texas A&M Univ, Dept Phys & Environm Sci, Corpus Christi, TX USA	Texas A&M University System; Texas A&M University System; Texas A&M University System	Pollack, JB (corresponding author), Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA.	jennifer.pollack@tamucc.edu	Palmer, Terence Aaron/J-3427-2019; Montagna, Paul A./J-8208-2017	Montagna, Paul A./0000-0003-4199-3312; Palmer, Terence/0000-0001-6602-9760	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program [NA09NMF4720179]; Texas General Land Office Coastal Management Program [11-011-000-4309]; Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program; Texas General Land Office Coastal Management Program; Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi	This study was supported by grant number NA09NMF4720179 from the National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program, and grant number 11-011-000-4309 from the Texas General Land Office Coastal Management Program. Partial support was also provided by the Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN R L, 1989, Journal of Shellfish Research, V8, P95; Allen YC, 2005, ESTUARIES, V28, P435, DOI 10.1007/BF02693925; Andrews JD, 1988, AM FISH SOC SPEC PUB, V18, P257; Barnes TK, 2007, J SHELLFISH RES, V26, P949, DOI 10.2983/0730-8000(2007)26[949:AHSIMF]2.0.CO;2; Battista TA, 1999, THESIS U MARYLAND, P111; Beck M. W., 2009, SHELLFISH REEFS RISK; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Breitburg DL, 2000, J SHELLFISH RES, V19, P371; Brown Stephen K., 2000, North American Journal of Fisheries Management, V20, P408, DOI 10.1577/1548-8675(2000)020<0408:HSIMFE>2.3.CO;2; Brumbaugh RD, 2006, PRACTITIONERS GUIDE, P32; Buczkowski B.J., 2006, US GEOL SURV DATA SE; Cake EW, 1983, FWSOBS82105737 US DE; Carlsson J, 2008, J SHELLFISH RES, V27, P1117, DOI 10.2983/0730-8000-27.5.1117; Carnegie RB, 2011, MAR ECOL PROG SER, V432, P1, DOI 10.3354/meps09221; Chu FLE, 1996, J SHELLFISH RES, V15, P57; CRAIG A, 1989, ESTUARIES, V12, P82, DOI 10.2307/1351499; Curnutt JL, 2000, ECOL APPL, V10, P1849, DOI 10.2307/2641243; de Zwaan A., 1983, P137; Dellapenna TM, 2007, 11 TEX GEN LAND OFF; DORAN E, 1965, GEOGR REV, V55, P223, DOI 10.2307/212711; Economio VG, 2005, J SHELLFISH RES, V24, P143; Ford SE, 1996, E OYSTER CRASSOSTREA; Gribov A, 2011, STOCH ENV RES RISK A, V25, P1057, DOI 10.1007/s00477-011-0488-2; Grizzle RE, 2005, AM FISH S S, V41, P153; Haby MG, 2009, TAMUSG09201 COLL STA; Hargis W. J, 1999, OYSTER REEF HABITAT; Kennedy RJ, 1999, BIOL ENVIRON, V99B, P79; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; Levinton J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018849; Livingston RJ, 1997, ECOL APPL, V7, P277, DOI 10.1890/1051-0761(1997)007[0277:FITAGE]2.0.CO;2; Loosanoff V.L., 1953, P NATL SHELLFISH ASS, V43, P135; Loosanoff V.L., 1948, P NATL SHELLFISH ASS, V1947, P40; MACKENZIE CL, 1977, MAR FISH REV, V39, P1; MACKIN JOHN G., 1961, PUBL INST MAR SCI [PORT ARANSAS TEXAS], V7, P132; McKinley JCJ, 2009, TOUGH SEASON MAY FOR; Menzel R. W, 1958, P NATL SHELLFISH ASS, V48, P66; NOAA, 1990, EST US VIT STAT NAT; Orlando S.P., 1993, CHARACTERISTICS GULF; POWELL EN, 1995, FISH RES, V24, P199, DOI 10.1016/0165-7836(95)00370-P; Powell EN, 2007, N AM J FISH MANAGE, V27, P492, DOI 10.1577/M04-205.1; Ray S.M., 1966, P NATL SHELLFISH ASS, P55; Schoenbaechler C., 2011, COASTAL HYDROLOGY MI, P15; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Shumway S.E., 1996, E OYSTER CRASSOSTREA; Smith RW, 2001, ECOL APPL, V11, P1073, DOI 10.1890/1051-0761(2001)011[1073:BRIFAI]2.0.CO;2; Soniat TM, 1998, J SHELLFISH RES, V17, P1149; SONIAT TM, 1988, ESTUARIES, V11, P87, DOI 10.2307/1351995; Starke A, 2011, J SHELLFISH RES, V30, P671, DOI 10.2983/035.030.0309; Upton HF, 2011, R41640 CONGR RES SER; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; WIDDOWS J, 1989, BIOL BULL, V177, P154, DOI 10.2307/1541843; Williams N, 2010, CURR BIOL, V20, pR613, DOI 10.1016/j.cub.2010.07.019	52	46	47	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40839	10.1371/journal.pone.0040839	http://dx.doi.org/10.1371/journal.pone.0040839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792410	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400104
J	Widaa, A; Claro, T; Foster, TJ; O'Brien, FJ; Kerrigan, SW				Widaa, Amro; Claro, Tania; Foster, Timothy J.; O'Brien, Fergal J.; Kerrigan, Steven W.			Staphylococcus aureus Protein A Plays a Critical Role in Mediating Bone Destruction and Bone Loss in Osteomyelitis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FIBRONECTIN-BINDING PROTEINS; EXPERIMENTAL-MODEL; JOINT DESTRUCTION; EPITHELIAL-CELLS; OSTEOBLASTS; APOPTOSIS; MATRIX; INTERNALIZATION; MINERALIZATION	Staphylococcus aureus is the most frequent causative organism of osteomyelitis. It is characterised by widespread bone loss and bone destruction. Previously we demonstrated that S. aureus protein A (SpA) is capable of binding to tumour necrosis factor receptor-1 expressed on pre-osteoblastic cells, which results in signal generation that leads to cell apoptosis resulting in bone loss. In the current report we demonstrate that upon S. aureus binding to osteoblasts it also inhibits de novo bone formation by preventing expression of key markers of osteoblast growth and division such as alkaline phosphatase, collagen type I, osteocalcin, osteopontin and osteocalcin. In addition, S. aureus induces secretion of soluble RANKL from osteoblasts which in turn recruits and activates the bone resorbing cells, osteoclasts. A strain of S. aureus defective in SpA failed to affect osteoblast growth or proliferation and most importantly failed to recruit or activate osteoclasts. These results suggest that S. aureus SpA binding to osteoblasts provides multiple coordinated signals that accounts for bone loss and bone destruction seen in osteomyelitis cases. A better understanding of the mechanisms through which S. aureus leads to bone infection may improve treatment or lead to the development of better therapeutic agents to treat this notoriously difficult disease.	[Widaa, Amro; Claro, Tania; Kerrigan, Steven W.] Royal Coll Surgeons Ireland, Microbial Infect Grp, Dublin 2, Ireland; [Widaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland; [Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Kerrigan, Steven W.] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Widaa, A (corresponding author), Royal Coll Surgeons Ireland, Microbial Infect Grp, Dublin 2, Ireland.	skerrigan@rcsi.ie	O'Brien, Fergal/F-9485-2011	O'Brien, Fergal/0000-0003-2030-8005	Science Foundation of Ireland [BMT/2008/1709]	Science Foundation of Ireland(Science Foundation Ireland)	Science Foundation of Ireland Research Frontiers Programme awarded to SWK (no. BMT/2008/1709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Berendt T, 2004, CLIN MED, V4, P510, DOI 10.7861/clinmedicine.4-6-510; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Bu RF, 2003, BONE, V33, P760, DOI 10.1016/j.bone.2003.07.006; CEDERGREN L, 1993, PROTEIN ENG, V6, P441, DOI 10.1093/protein/6.4.441; Claro T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018748; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Evans CAW, 1998, J INFECT DIS, V177, P1582, DOI 10.1086/515313; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Garcia-Alvarez F, 2009, BIOGERONTOLOGY, V10, P649, DOI 10.1007/s10522-008-9211-1; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1016/S0378-1097(99)00079-8; Klosterhalfen B, 1996, J TRAUMA, V40, P372, DOI 10.1097/00005373-199603000-00008; Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; LI NG, 1991, BIOCHEM BIOPH RES CO, V179, P236, DOI 10.1016/0006-291X(91)91360-O; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; O'Seaghdha M, 2006, FEBS J, V273, P4831, DOI 10.1111/j.1742-4658.2006.05482.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PIVIROTTO LA, 1995, MOL CELL ENDOCRINOL, V111, P67, DOI 10.1016/0303-7207(95)03549-M; Rao NL, 2011, PLAST RECONSTR SURG, V127, p177S, DOI 10.1097/PRS.0b013e3182001f0f; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Redlich K, 2002, ARTHRITIS RHEUM, V46, P785, DOI 10.1002/art.10097; ROACH HI, 1994, CELL BIOL INT, V18, P617, DOI 10.1006/cbir.1994.1088; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Rosenquist JB, 1996, INFLAMM RES, V45, P457, DOI 10.1007/BF02252317; TAICHMAN RS, 1992, INFLAMMATION, V16, P587, DOI 10.1007/BF00919342; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tucker KA, 2000, FEMS MICROBIOL LETT, V186, P151, DOI 10.1016/S0378-1097(00)00125-7; UHLEN M, 1984, J BACTERIOL, V159, P713; Wesson CA, 2000, INFECT IMMUN, V68, P2998, DOI 10.1128/IAI.68.5.2998-3001.2000; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003; Yoshii T, 2002, CYTOKINE, V19, P59, DOI 10.1006/cyto.2002.1039	45	103	107	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40586	10.1371/journal.pone.0040586	http://dx.doi.org/10.1371/journal.pone.0040586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792377	gold, Green Published, Green Submitted			2022-12-25	WOS:000306362400075
J	Anand, V; Dogra, N; Singh, S; Kumar, SN; Jena, MK; Malakar, D; Dang, AK; Mishra, BP; Mukhopadhyay, TK; Kaushik, JK; Mohanty, AK				Anand, Vijay; Dogra, Nilambra; Singh, Surender; Kumar, Sudarshan N.; Jena, Manoj K.; Malakar, Dhruba; Dang, Ajay K.; Mishra, Bishnu P.; Mukhopadhyay, Tapas K.; Kaushik, Jai K.; Mohanty, Ashok K.			Establishment and Characterization of a Buffalo (Bubalus bubalis) Mammary Epithelial Cell Line	PLOS ONE			English	Article							GENE-EXPRESSION; MAC-T; BOVINE; CULTURE; DIFFERENTIATION; GLAND; MODEL; MORPHOGENESIS; SECRETION; PROTEIN	Background: The objective of this study was to establish the buffalo mammary epithelial cell line (BuMEC) and characterize its mammary specific functions. Methodology: Buffalo mammary tissue collected from the slaughter house was processed enzymatically to obtain a heterogenous population of cells containing both epithelial and fibroblasts cells. Epithelial cells were purified by selective trypsinization and were grown in a plastic substratum. The purified mammary epithelial cells (MECs) after several passages were characterized for mammary specific functions by immunocytochemistry, RT-PCR and western blot. Principal Findings: The established buffalo mammary epithelial cell line (BuMEC) exhibited epithelial cell characteristics by immunostaining positively with cytokeratin 18 and negatively with vimentin. The BuMEC maintained the characteristics of its functional differentiation by expression of beta-casein, kappa-casein, butyrophilin and lactoferrin. BuMEC had normal growth properties and maintained diploid chromosome number (2n = 50) before and after cryopreservation. A spontaneously immortalized buffalo mammary epithelial cell line was established after 20 passages and was continuously subcultured for more than 60 passages without senescence. Conclusions: We have established a buffalo mammary epithelial cell line that can be used as a model system for studying mammary gland functions.	[Anand, Vijay; Singh, Surender; Kumar, Sudarshan N.; Jena, Manoj K.; Malakar, Dhruba; Dang, Ajay K.; Kaushik, Jai K.; Mohanty, Ashok K.] NDRI, Karnal, Haryana, India; [Dogra, Nilambra; Mukhopadhyay, Tapas K.] Punjab Univ, NCHGSR, Chandigarh 160014, India; [Mishra, Bishnu P.] IVRI, Izatnagar, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Panjab University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Anand, V (corresponding author), NDRI, Karnal, Haryana, India.	ashokmohanty1@gmail.com	Jena, M/AGM-1989-2022; Anand, Vijay/GLT-5411-2022; Dang, Ajay Kumar/AAB-4090-2019	Dang, Ajay Kumar/0000-0002-7306-5302; Anand, Vijay/0000-0002-4061-9946; Kaushik, Jai/0000-0002-8872-0066; Jena, Manoj/0000-0003-3847-8539; Kumar, Sudarshan/0000-0002-9816-4307	"National Agriculture Innovation Project (NAIP)", Indian Council of Agricultural Research, Government of India; "Department of Biotechnology (DBT)", Ministry of Science and Technology, Government of India	"National Agriculture Innovation Project (NAIP)", Indian Council of Agricultural Research, Government of India; "Department of Biotechnology (DBT)", Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The research was supported jointly by "National Agriculture Innovation Project (NAIP)", Indian Council of Agricultural Research, Government of India and "Department of Biotechnology (DBT)", Ministry of Science and Technology, Government of India. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	AHN JY, 1995, BIOSCI BIOTECH BIOCH, V59, P59, DOI 10.1271/bbb.59.59; Aoki N, 2006, BIOSCI BIOTECH BIOCH, V70, P2019, DOI 10.1271/bbb.60142; BARTEK J, 1985, J CELL SCI, V75, P17; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; BERDICHEVSKY F, 1992, J CELL SCI, V102, P437; CIFRIAN E, 1994, J DAIRY SCI, V77, P970, DOI 10.3168/jds.S0022-0302(94)77033-8; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duchler M, 1998, BIOL CELL, V90, P199, DOI 10.1016/S0248-4900(98)80340-7; FRANKE WW, 1981, J CELL BIOL, V89, P485, DOI 10.1083/jcb.89.3.485; GIBSON CA, 1991, IN VITRO CELL DEV B, V27, P585, DOI 10.1007/BF02631290; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; HURLEY WL, 1989, J DAIRY SCI, V72, P1637, DOI 10.3168/jds.S0022-0302(89)79276-6; HUYNH H, 1995, IN VITRO CELL DEV-AN, V31, P25, DOI 10.1007/BF02631334; HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q; IANNUZZI L, 1994, CYTOGENET CELL GENET, V67, P102; Ilan N, 1998, IN VITRO CELL DEV-AN, V34, P326; Kim H, 2002, BIOCHEM J, V365, P765, DOI 10.1042/BJ20011848; KNIGHT CH, 1984, Q J EXP PHYSIOL CMS, V69, P331, DOI 10.1113/expphysiol.1984.sp002809; Kumura H, 2001, BIOSCI BIOTECH BIOCH, V65, P2098, DOI 10.1271/bbb.65.2098; Larson B. L., 1985, Lactation, P129; LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419; LEVINE JF, 1984, EXP CELL RES, V151, P112, DOI 10.1016/0014-4827(84)90361-6; Martinet J., 1999, BIOL LACTATION; MATHER IH, 1993, J DAIRY SCI, V76, P3832, DOI 10.3168/jds.S0022-0302(93)77726-7; MORK C, 1990, DIFFERENTIATION, V43, P146; Ouyang WQ, 1999, CHIN J VET SCI, V19, P561; Pantschenko AG, 2000, IN VITRO CELL DEV-AN, V36, P26, DOI 10.1290/1071-2690(2000)036<0026:EACOAC>2.0.CO;2; PARRY G, 1987, J CELL BIOL, V105, P2043, DOI 10.1083/jcb.105.5.2043; PETRITESMURPHY MB, 1992, VET PATHOL, V29, P552, DOI 10.1177/030098589202900614; PICKETT PB, 1975, J CELL BIOL, V66, P316, DOI 10.1083/jcb.66.2.316; Riley LG, 2010, ANIM GENET, V41, P55, DOI 10.1111/j.1365-2052.2009.01964.x; Rosen J. M., 1985, UCLA Symposia on Molecular and Cellular Biology, V23, P385; SCHMID E, 1983, J CELL BIOL, V96, P37, DOI 10.1083/jcb.96.1.37; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; STRANGE R, 1991, CELL GROWTH DIFFER, V2, P549; Sun YL, 2006, CELL BIOL INT, V30, P970, DOI 10.1016/j.cellbi.2006.06.023; TALHOUK RS, 1990, TISSUE CELL, V22, P583, DOI 10.1016/0040-8166(90)90057-G; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Tong HL, 2012, IN VITRO CELL DEV-AN, V48, P149, DOI 10.1007/s11626-012-9481-4; United Nations Food and Agriculture Organization, 2000, WAT BUFF ASS UND; WARBURTON MJ, 1981, EXP CELL RES, V132, P57, DOI 10.1016/0014-4827(81)90082-3; Wheeler TT, 2001, MOL CELL ENDOCRINOL, V176, P39, DOI 10.1016/S0303-7207(01)00481-6; Wilde CJ, 1999, J MAMMARY GLAND BIOL, V4, P129, DOI 10.1023/A:1018717006152; ZAVIZION B, 1992, J DAIRY SCI, V75, P3381, DOI 10.3168/jds.S0022-0302(92)78114-4; Zavizion B, 1996, IN VITRO CELL DEV-AN, V32, P138, DOI 10.1007/BF02723679; ZAVIZION B, 1995, J DAIRY SCI, V78, P515, DOI 10.3168/jds.S0022-0302(95)76662-0; Zavizion B., 1995, Methods in Cell Science, V17, P271, DOI 10.1007/BF00986233; Zhang K, 1998, SHENG WU GONG CHENG, V13, P271; Zhao CF, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-82; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023; Zheng YM, 2010, RES VET SCI, V89, P383, DOI 10.1016/j.rvsc.2010.03.023; Zucchi I, 2002, J MAMMARY GLAND BIOL, V7, P373, DOI 10.1023/A:1024081914634	54	37	41	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40469	10.1371/journal.pone.0040469	http://dx.doi.org/10.1371/journal.pone.0040469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792341	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700053
J	Hammerschmidt, A; Chatterji, B; Zeiser, J; Schroder, A; Genieser, HG; Pich, A; Kaever, V; Schwede, F; Wolter, S; Seifert, R				Hammerschmidt, Andreas; Chatterji, Bijon; Zeiser, Johannes; Schroeder, Anke; Genieser, Hans-Gottfried; Pich, Andreas; Kaever, Volkhard; Schwede, Frank; Wolter, Sabine; Seifert, Roland			Binding of Regulatory Subunits of Cyclic AMP-Dependent Protein Kinase to Cyclic CMP Agarose	PLOS ONE			English	Article							CYTIDINE 3',5'-MONOPHOSPHATE CCMP; MAMMALIAN-TISSUES; CYCLASE ACTIVITY; CAMP; CGMP; 5'-MONOPHOSPHATE; NUCLEOTIDES; ACTIVATION; MECHANISM; SYSTEM	The bacterial adenylyl cyclase toxins CyaA from Bordetella pertussis and edema factor from Bacillus anthracis as well as soluble guanylyl cyclase alpha(1)beta(1) synthesize the cyclic pyrimidine nucleotide cCMP. These data raise the question to which effector proteins cCMP binds. Recently, we reported that cCMP activates the regulatory subunits RI alpha and RII alpha of cAMP-dependent protein kinase. In this study, we used two cCMP agarose matrices as novel tools in combination with immunoblotting and mass spectrometry to identify cCMP-binding proteins. In agreement with our functional data, RI alpha and RII alpha were identified as cCMP-binding proteins. These data corroborate the notion that cAMP-dependent protein kinase may serve as a cCMP target.	[Hammerschmidt, Andreas; Kaever, Volkhard; Wolter, Sabine; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany; [Chatterji, Bijon; Zeiser, Johannes; Schroeder, Anke; Pich, Andreas] Hannover Med Sch, Inst Toxicol, D-3000 Hannover, Germany; [Genieser, Hans-Gottfried; Schwede, Frank] Biolog Life Sci Inst, Bremen, Germany	Hannover Medical School; Hannover Medical School	Hammerschmidt, A (corresponding author), Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany.	seifert.roland@mh-hannover.de	Kaever, Volkhard/G-3280-2013; Seifert, Roland/G-3189-2013	Zeiser, Johannes/0000-0001-5518-2137; Genieser, Hans-Gottfried/0000-0002-4904-5790	Hannover Biomedical Research School; Deutsche Forschungsgemeinschaft [Se 529/5-2]	Hannover Biomedical Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Hannover Biomedical Research School to A. H. and Deutsche Forschungsgemeinschaft grant Se 529/5-2 to R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TR, 1982, MOL CELL ENDOCRINOL, V28, P373, DOI 10.1016/0303-7207(82)90134-4; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; BLOCH A, 1974, BIOCHEM BIOPH RES CO, V59, P955, DOI 10.1016/S0006-291X(74)80072-0; Burhenne H, 2011, N-S ARCH PHARMACOL S, V38, pP096; CECH SY, 1977, SCIENCE, V198, P1063, DOI 10.1126/science.22127; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; CORRIE JET, 1992, PROTEIN EXPRES PURIF, V3, P417, DOI 10.1016/S1046-5928(05)80044-0; Desch M, 2010, FEBS LETT, V584, P3979, DOI 10.1016/j.febslet.2010.07.059; GAION RM, 1979, BIOCHEM BIOPH RES CO, V86, P105, DOI 10.1016/0006-291X(79)90387-5; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; Hanke SE, 2011, NEW BIOTECHNOL, V28, P294, DOI 10.1016/j.nbt.2010.12.001; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KUO JF, 1978, J BIOL CHEM, V253, P2518; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Reinecke D, 2011, FEBS LETT, V585, P3259, DOI 10.1016/j.febslet.2011.09.004; Sager G, 2009, MINI-REV MED CHEM, V9, P1009, DOI 10.2174/138955709788681654; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SCOFIELD RE, 1977, ANAL BIOCHEM, V77, P152, DOI 10.1016/0003-2697(77)90300-1; Taylor SS, 2004, BIOCHIM BIOPHYS ACTA, V697, P259; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093	25	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39848	10.1371/journal.pone.0039848	http://dx.doi.org/10.1371/journal.pone.0039848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808067	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700019
J	Pless-Petig, G; Singer, BB; Rauen, U				Pless-Petig, Gesine; Singer, Bernhard B.; Rauen, Ursula			Cold Storage of Rat Hepatocyte Suspensions for One Week in a Customized Cold Storage Solution - Preservation of Cell Attachment and Metabolism	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; HYPOTHERMIC PRESERVATION; CHELATABLE IRON; CULTURED-HEPATOCYTES; ORGAN PRESERVATION; HYPOXIC INJURY; GLYCINE; MEDIA; GLUTATHIONE	Background & Aims: Primary hepatocytes are of great importance for basic research as well as cell transplantation. However, their stability, especially in suspension, is very low. This feature severely compromises storage and shipment. Based on previous studies with adherent cells, we here assessed cold storage injury in rat hepatocyte suspensions and aimed to find a cold storage solution that preserves viability, attachment ability and functionality of these cells. Methods: Rat hepatocyte suspensions were stored in cell culture medium, organ preservation solutions and modified TiProtec solutions at 4 degrees C for one week. Viability and cell volume were determined by flow cytometry. Thereafter, cells were seeded and density and metabolic capacity (reductive metabolism, forskolin-induced glucose release, urea production) of adherent cells were assessed. Results: Cold storage injury in hepatocyte suspensions became evident as cell death occurring during cold storage or rewarming or as loss of attachment ability. Cell death during cold storage was not dependent on cell swelling and was almost completely inhibited in the presence of glycine and L-alanine. Cell attachment could be greatly improved by use of chloride-poor solutions and addition of iron chelators. Using a chloride-poor, potassium-rich storage solution containing glycine, alanine and iron chelators, cultures with 75% of the density of control cultures and with practically normal cell metabolism could be obtained after one week of cold storage. Conclusion: In the solution presented here, cold storage injury of hepatocyte suspensions, differing from that of adherent hepatocytes, was effectively inhibited. The components which acted on the different injurious processes were identified.	[Pless-Petig, Gesine; Rauen, Ursula] Univ Klinikum Essen, Inst Physiol Chem, Essen, Germany; [Singer, Bernhard B.] Univ Klinikum Essen, Inst Anat, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Pless-Petig, G (corresponding author), Univ Klinikum Essen, Inst Physiol Chem, Essen, Germany.	ursula.rauen@uni-duisburg-essen.de	Pless-Petig, Gesine/F-3639-2010; Rauen, Ursula/N-2137-2014; Singer, Bernhard B./AAP-9999-2020	Pless-Petig, Gesine/0000-0001-8843-6607; 	Deutsche Forschungsgemeinschaft [RA 960/1-3]; Franz Kohler Chemie GmbH, Bensheim, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Franz Kohler Chemie GmbH, Bensheim, Germany	This study was supported by the Deutsche Forschungsgemeinschaft (RA 960/1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; U. Rauen obtained consulting fees from Dr. Franz Kohler Chemie GmbH, Bensheim, Germany. Dr. F. Kohler Chemie GmbH holds a patent on a preservation solution, covering most of the modified solutions used in this study; U. Rauen is one of the inventors mentioned in the patent. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	Bakala A, 2007, POL J VET SCI, V10, P11; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; BRECHT M, 1994, AMINO ACIDS, V6, P25, DOI 10.1007/BF00808120; Carini R, 1997, HEPATOLOGY, V26, P107, DOI 10.1002/hep.510260114; DEGROOT H, 1991, BIOL CHEM H-S, V372, P35, DOI 10.1515/bchm3.1991.372.1.35; Frank A, 2000, J HEPATOL, V32, P58, DOI 10.1016/S0168-8278(00)80190-7; Fuckert O, 2000, TRANSPLANTATION, V70, P723, DOI 10.1097/00007890-200009150-00003; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Huang H, 2002, AM J TRANSPLANT, V2, P631, DOI 10.1034/j.1600-6143.2002.20708.x; Inuo H, 2007, J HEPATO-BILIARY-PAN, V14, P509, DOI 10.1007/s00534-007-1214-9; Gomez-Lechon MJ, 2008, CELL TRANSPLANT, V17, P887, DOI 10.3727/096368908786576534; Kerkweg U, 2003, TRANSPLANTATION, V76, P501, DOI 10.1097/01.TP.0000069830.78758.1C; Kerkweg U, 2002, HEPATOLOGY, V35, P560, DOI 10.1053/jhep.2002.31869; Mamprin ME, 2008, CRYOLETTERS, V29, P121; MARSH DC, 1990, CRYOBIOLOGY, V27, P1, DOI 10.1016/0011-2240(90)90047-8; MARSH DC, 1991, HEPATOLOGY, V13, P500, DOI 10.1016/0270-9139(91)90304-E; Ostrowska A, 2009, ARCH TOXICOL, V83, P493, DOI 10.1007/s00204-009-0419-x; Pahernik SA, 1996, CRYOBIOLOGY, V33, P552, DOI 10.1006/cryo.1996.0059; Pless G, 2012, CELL TRANSPLANT, V21, P23, DOI 10.3727/096368911X580509; Rauen U, 2007, CELL MOL LIFE SCI, V64, P192, DOI 10.1007/s00018-006-6456-1; Rauen U, 2000, FASEB J, V14, P1953, DOI 10.1096/fj.00-0071com; Rauen U, 2004, J INVEST MED, V52, P299, DOI 10.1136/jim-52-05-29; Rauen U, 2003, FREE RADICAL BIO MED, V35, P1664, DOI 10.1016/j.freeradbiomed.2003.09.018; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rauen U, 2007, CRYOBIOLOGY, V54, P77, DOI 10.1016/j.cryobiol.2006.11.008; RODRIGUEZ JV, 1995, CELL TRANSPLANT, V4, P245, DOI 10.1016/0963-6897(95)90036-5; ROSSER BG, 1995, GASTROENTEROLOGY, V108, P252, DOI 10.1016/0016-5085(95)90032-2; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Vairetti M, 2001, FREE RADICAL BIO MED, V31, P954, DOI 10.1016/S0891-5849(01)00670-0; Wille T, 2008, J VASC SURG, V47, P422, DOI 10.1016/j.jvs.2007.09.048	30	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40444	10.1371/journal.pone.0040444	http://dx.doi.org/10.1371/journal.pone.0040444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792326	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700050
J	Thomas, A; Lee, PJ; Dalton, JE; Nomie, KJ; Stoica, L; Costa-Mattioli, M; Chang, P; Nuzhdin, S; Arbeitman, MN; Dierick, HA				Thomas, Amanda; Lee, Pei-Jung; Dalton, Justin E.; Nomie, Krystle J.; Stoica, Loredana; Costa-Mattioli, Mauro; Chang, Peter; Nuzhdin, Sergey; Arbeitman, Michelle N.; Dierick, Herman A.			A Versatile Method for Cell-Specific Profiling of Translated mRNAs in Drosophila	PLOS ONE			English	Article							COMPLEX TISSUES; MELANOGASTER; SYSTEM; INVERTEBRATES; TRANSCRIPTOME; MAINTENANCE; EXPRESSION; PHENOTYPES; GROWTH; GENES	In Drosophila melanogaster few methods exist to perform rapid cell-type or tissue-specific expression profiling. A translating ribosome affinity purification (TRAP) method to profile actively translated mRNAs has been developed for use in a number of multicellular organisms although it has only been implemented to examine limited sets of cell-or tissue-types in these organisms. We have adapted the TRAP method for use in the versatile GAL4/UAS system of Drosophila allowing profiling of almost any tissue/cell-type with a single genetic cross. We created transgenic strains expressing a GFP-tagged ribosomal protein, RpL10A, under the control of the UAS promoter to perform cell-type specific translatome profiling. The GFP::RpL10A fusion protein incorporates efficiently into ribosomes and polysomes. Polysome affinity purification strongly enriches mRNAs from expected genes in the targeted tissues with sufficient sensitivity to analyze expression in small cell populations. This method can be used to determine the unique translatome profiles in different cell-types under varied physiological, pharmacological and pathological conditions.	[Thomas, Amanda; Lee, Pei-Jung; Nomie, Krystle J.; Dierick, Herman A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dalton, Justin E.; Arbeitman, Michelle N.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Stoica, Loredana; Costa-Mattioli, Mauro; Dierick, Herman A.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Stoica, Loredana; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Costa-Mattioli, Mauro; Dierick, Herman A.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Chang, Peter; Nuzhdin, Sergey] Univ So Calif, Dept Biol Sci, Sect Mol & Computat Biol, Los Angeles, CA 90089 USA; [Dierick, Herman A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; State University System of Florida; Florida State University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Southern California; Baylor College of Medicine	Thomas, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	michelle.arbeitman@med.fsu.edu; dierick@bcm.edu		Thomas-Wilson, Amanda/0000-0001-5875-8349; Arbeitman, Michelle/0000-0002-2437-4352	National Science Foundation [IOS-1119473]; National Institutes of Health [R01GM073039]; Naman Family Fund for Junior Faculty at BCM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073039] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Naman Family Fund for Junior Faculty at BCM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Science Foundation (IOS-1119473), National Institutes of Health (R01GM073039) and The Naman Family Fund for Junior Faculty at BCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; Halbeisen RE, 2009, METHODS, V48, P306, DOI 10.1016/j.ymeth.2009.04.003; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Jiang ZH, 2005, OBES RES, V13, P1898, DOI 10.1038/oby.2005.233; Jones WD, 2009, BMB REP, V42, P705, DOI 10.5483/BMBRep.2009.42.11.705; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/nmeth.1329, 10.1038/NMETH.1329]; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064	30	74	74	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40276	10.1371/journal.pone.0040276	http://dx.doi.org/10.1371/journal.pone.0040276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792260	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800060
J	Buggert, M; Norstrom, MM; Czarnecki, C; Tupin, E; Luo, M; Gyllensten, K; Sonnerborg, A; Lundegaard, C; Lund, O; Nielsen, M; Karlsson, AC				Buggert, Marcus; Norstrom, Melissa M.; Czarnecki, Chris; Tupin, Emmanuel; Luo, Ma; Gyllensten, Katarina; Sonnerborg, Anders; Lundegaard, Claus; Lund, Ole; Nielsen, Morten; Karlsson, Annika C.			Characterization of HIV-Specific CD4+T Cell Responses against Peptides Selected with Broad Population and Pathogen Coverage	PLOS ONE			English	Article							CD8(+) T-CELLS; EXON-2 DNA; EPITOPES; GAG; INFECTION; REPLICATION; VACCINATION; IMMUNITY; MEMORY	CD4+ T cells orchestrate immunity against viral infections, but their importance in HIV infection remains controversial. Nevertheless, comprehensive studies have associated increase in breadth and functional characteristics of HIV-specific CD4+ T cells with decreased viral load. A major challenge for the identification of HIV-specific CD4+ T cells targeting broadly reactive epitopes in populations with diverse ethnic background stems from the vast genomic variation of HIV and the diversity of the host cellular immune system. Here, we describe a novel epitope selection strategy, PopCover, that aims to resolve this challenge, and identify a set of potential HLA class II-restricted HIV epitopes that in concert will provide optimal viral and host coverage. Using this selection strategy, we identified 64 putative epitopes (peptides) located in the Gag, Nef, Env, Pol and Tat protein regions of HIV. In total, 73% of the predicted peptides were found to induce HIV-specific CD4+ T cell responses. The Gag and Nef peptides induced most responses. The vast majority of the peptides (93%) had predicted restriction to the patient's HLA alleles. Interestingly, the viral load in viremic patients was inversely correlated to the number of targeted Gag peptides. In addition, the predicted Gag peptides were found to induce broader polyfunctional CD4+ T cell responses compared to the commonly used Gag-p55 peptide pool. These results demonstrate the power of the PopCover method for the identification of broadly recognized HLA class II-restricted epitopes. All together, selection strategies, such as PopCover, might with success be used for the evaluation of antigen-specific CD4+ T cell responses and design of future vaccines.	[Buggert, Marcus; Norstrom, Melissa M.; Sonnerborg, Anders; Karlsson, Annika C.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Czarnecki, Chris; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Tupin, Emmanuel] Swedish Inst Infect Dis Control, Dept Virol, Stockholm, Sweden; [Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Gyllensten, Katarina] Stockholm S Gen Hosp Sodersjukhuset, Gay Mens Hlth Clin, Stockholm, Sweden; [Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Div Infect Dis, Stockholm, Sweden; [Lundegaard, Claus; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Karolinska Institutet; Public Health Agency of Canada; Swedish Institute for Infectious Disease Control; University of Manitoba; Karolinska Institutet; Technical University of Denmark	Buggert, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	mniel@cbs.dtu.dk	Karlsson, Annika/R-2255-2016; Sönnerborg, Anders/W-2011-2019; Lund, Ole/F-4437-2014; Nielsen, Morten/E-7754-2011; Buggert, Marcus/F-4663-2018; Nielsen, Morten/AAL-8700-2020	Karlsson, Annika/0000-0002-2028-8393; Sönnerborg, Anders/0000-0001-8928-3374; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Buggert, Marcus/0000-0003-0633-1719; Nielsen, Morten/0000-0001-7885-4311	Swedish Agency for International Development Cooperation-SIDA [2005-001756]; Swedish Research Council [K2010-56X-20345-04-3]; Karolinska Institutet; Ake Wibergs Foundation [40418186]; Swedish Physicians Against AIDS Research Foundation [FO2010-0019]; Swedish Society of Medicine [SLS-101021]; Clas Groschinskys Memorial fund [M10 33]	Swedish Agency for International Development Cooperation-SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Ake Wibergs Foundation; Swedish Physicians Against AIDS Research Foundation; Swedish Society of Medicine; Clas Groschinskys Memorial fund	This work was supported by grants from the Swedish Agency for International Development Cooperation-SIDA (2005-001756), the Swedish Research Council (K2010-56X-20345-04-3), Karolinska Institutet, Ake Wibergs Foundation (40418186), the Swedish Physicians Against AIDS Research Foundation (FO2010-0019), the Swedish Society of Medicine (SLS-101021) and the Clas Groschinskys Memorial fund (M10 33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; FRANKE EK, 1994, J VIROL, V68, P5300, DOI 10.1128/JVI.68.8.5300-5305.1994; Gloster SE, 2004, AIDS, V18, P749, DOI 10.1097/00002030-200403260-00005; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lindkvist Annica, 2009, AIDS Res Ther, V6, P15, DOI 10.1186/1742-6405-6-15; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Luo M, 2001, HUM IMMUNOL, V62, P1294, DOI 10.1016/S0198-8859(01)00339-1; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Owen RE, 2007, J IMMUNOL METHODS, V326, P93, DOI 10.1016/j.jim.2007.07.012; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Prendergast A, 2011, AIDS, V25, P1329, DOI 10.1097/QAD.0b013e3283478575; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; Ramduth D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005013; Ranasinghe S, 2011, J VIROL; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Riou C, 2012, J IMMUNOLOGY; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toussaint NC, 2009, NUCLEIC ACIDS RES, V37, pW617, DOI 10.1093/nar/gkp293; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19	38	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39874	10.1371/journal.pone.0039874	http://dx.doi.org/10.1371/journal.pone.0039874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792193	Green Published, gold			2022-12-25	WOS:000306436300012
J	Upadhyayula, SM; Mutheneni, SR; Kadiri, MR; Kumaraswamy, S; Nelaturu, SCB				Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Kadiri, Madhusudhan Rao; Kumaraswamy, Sriram; Nelaturu, Sarat Chandra Babu			Data Base Management System for Lymphatic Filariasis - A Neglected Tropical Disease	PLOS ONE			English	Article								Background: Researchers working in the area of Public Health are being confronted with large volumes of data on various aspects of entomology and epidemiology. To obtain the relevant information out of these data requires particular database management system. In this paper, we have described about the usages of our developed database on lymphatic filariasis. Methods: This database application is developed using Model View Controller (MVC) architecture, with MySQL as database and a web based interface. We have collected and incorporated the data on filariasis in the database from Karimnagar, Chittoor, East and West Godavari districts of Andhra Pradesh, India. Conclusion: The importance of this database is to store the collected data, retrieve the information and produce various combinational reports on filarial aspects which in turn will help the public health officials to understand the burden of disease in a particular locality. This information is likely to have an imperative role on decision making for effective control of filarial disease and integrated vector management operations.	[Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Kadiri, Madhusudhan Rao; Kumaraswamy, Sriram] CSIR Indian Inst Chem Technol, Div Biol, Hyderabad, Andhra Pradesh, India; [Nelaturu, Sarat Chandra Babu] Ctr Dev Adv Comp, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Centre for Development of Advanced Computing (C-DAC)	Upadhyayula, SM (corresponding author), CSIR Indian Inst Chem Technol, Div Biol, Hyderabad, Andhra Pradesh, India.	murty_usn@yahoo.com	Mutheneni, Srinivasa Rao/AAI-2262-2020	Mutheneni, Srinivasa Rao/0000-0003-3263-3905	Ministry of Communication and Information Technology (MC&IT), Govt. of India	Ministry of Communication and Information Technology (MC&IT), Govt. of India	The authors are thankful to Ministry of Communication and Information Technology (MC&IT), Govt. of India for sponsoring the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-86; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P221; Biswas G., 1996, REVISED STRATEGY CON; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; MARINEZ YN, 1984, STAT MED, V3, P101, DOI 10.1002/sim.4780030204; MCFADDEN ET, 1995, CONTROL CLIN TRIALS, V16, pS30; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; Roberts RJ, 2000, STAT MED, V19, P1645; Seim A R, 1999, Rev Soc Bras Med Trop, V32, P325, DOI 10.1590/S0037-86821999000300022; Upadhayula SM, 2010, ASIAN PAC J TROP MED, V3, P647, DOI 10.1016/S1995-7645(10)60156-3; vanEs GA, 1996, NETH J MED, V48, P38, DOI 10.1016/0300-2977(95)00036-4	12	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39970	10.1371/journal.pone.0039970	http://dx.doi.org/10.1371/journal.pone.0039970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792200	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300015
J	Haslinger, R; Pipa, G; Lima, B; Singer, W; Brown, EN; Neuenschwander, S				Haslinger, Robert; Pipa, Gordon; Lima, Bruss; Singer, Wolf; Brown, Emery N.; Neuenschwander, Sergio			Context Matters: The Illusive Simplicity of Macaque V1 Receptive Fields	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; GAMMA-BAND SYNCHRONIZATION; TIME-RESCALING THEOREM; NATURAL SCENES; RESPONSE VARIABILITY; NEURONAL CIRCUITS; CORTICAL-NEURONS; SPIKING ACTIVITY; CELL PROPERTIES; STRIATE CORTEX	Even in V1, where neurons have well characterized classical receptive fields (CRFs), it has been difficult to deduce which features of natural scenes stimuli they actually respond to. Forward models based upon CRF stimuli have had limited success in predicting the response of V1 neurons to natural scenes. As natural scenes exhibit complex spatial and temporal correlations, this could be due to surround effects that modulate the sensitivity of the CRF. Here, instead of attempting a forward model, we quantify the importance of the natural scenes surround for awake macaque monkeys by modeling it non-parametrically. We also quantify the influence of two forms of trial to trial variability. The first is related to the neuron's own spike history. The second is related to ongoing mean field population activity reflected by the local field potential (LFP). We find that the surround produces strong temporal modulations in the firing rate that can be both suppressive and facilitative. Further, the LFP is found to induce a precise timing in spikes, which tend to be temporally localized on sharp LFP transients in the gamma frequency range. Using the pseudo R 2 as a measure of model fit, we find that during natural scene viewing the CRF dominates, accounting for 60% of the fit, but that taken collectively the surround, spike history and LFP are almost as important, accounting for 40%. However, overall only a small proportion of V1 spiking statistics could be explained (R-2 similar to 5%), even when the full stimulus, spike history and LFP were taken into account. This suggests that under natural scene conditions, the dominant influence on V1 neurons is not the stimulus, nor the mean field dynamics of the LFP, but the complex, incoherent dynamics of the network in which neurons are embedded.	[Haslinger, Robert] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Haslinger, Robert; Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Pipa, Gordon] Univ Osnabruck, Dept Neuroinformat, Osnabruck, Germany; [Pipa, Gordon; Lima, Bruss; Singer, Wolf; Neuenschwander, Sergio] Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany; [Pipa, Gordon] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Neuenschwander, Sergio] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University Osnabruck; Max Planck Society; Harvard University; Massachusetts General Hospital; Universidade Federal do Rio Grande do Norte	Haslinger, R (corresponding author), Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	robhh@nmr.mgh.harvard.edu	Singer, Wolf/D-6874-2012; Pipa, Gordon/M-1813-2014; Lima, Bruss/I-9164-2016	Pipa, Gordon/0000-0002-3416-2652; Lima, Bruss/0000-0001-6865-2900; NEUENSCHWANDER, Sergio/0000-0001-7493-121X	National Institutes of Health [K25 NS052422-02, DP1 ODOO3646]; European Union [FP6-2005-NEST-Path-043309]; EC Project Phocus [240763]; Max Planck Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS052422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); EC Project Phocus; Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants K25 NS052422-02 (RH), and DP1 ODOO3646 (EB), as well as European Union Grant FP6-2005-NEST-Path-043309 (GP), EC Project Phocus Grant 240763 (GP) and the Max Planck Society (GP, BL, WS, SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison P. S., 2002, ILLUSTRATED WAVELET; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, J COMP NEUROL, V498, P330, DOI 10.1002/cne.21060; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berens P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.002.2008; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Chen G, 2005, J PHYSIOL-LONDON, V564, P233, DOI 10.1113/jphysiol.2004.080051; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Chisum HJ, 2004, NEURAL NETWORKS, V17, P681, DOI 10.1016/j.neunet.2004.05.002; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; El Boustani S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000519; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Freeman RD, 2001, PROG BRAIN RES, V134, P157; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; GILBERT CD, 1993, CEREB CORTEX, V3, P373, DOI 10.1093/cercor/3.5.373; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Guo K, 2005, EUR J NEUROSCI, V21, P536, DOI 10.1111/j.1460-9568.2005.03858.x; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Haslinger R, 2010, NEURAL COMPUT, V22, P2477, DOI 10.1162/NECO_a_00015; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kording KP, 2004, J NEUROPHYSIOL, V91, P206, DOI 10.1152/jn.00149.2003; KULIKOWSKI JJ, 1981, EXP BRAIN RES, V44, P371; Lee J, 2010, J NEUROPHYSIOL, V104, P2556, DOI 10.1152/jn.01040.2009; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Liu YJ, 2011, J NEUROPHYSIOL, V105, P1306, DOI 10.1152/jn.00692.2010; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; McCullagh P, 1989, GEN LINEAR MODELS; Mittlbock M, 1996, STAT MED, V15, P1987, DOI 10.1002/(SICI)1097-0258(19961015)15:19<1987::AID-SIM318>3.3.CO;2-0; Mittlbock M, 2001, J CLIN EPIDEMIOL, V54, P99, DOI 10.1016/S0895-4356(00)00292-4; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Muller JR, 2003, J NEUROPHYSIOL, V90, P822, DOI 10.1152/jn.00005.2003; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Szentagothai J, 1978, P R SOC LOND B, V201; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zipser K, 1996, J NEUROSCI, V16, P7376	95	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39699	10.1371/journal.pone.0039699	http://dx.doi.org/10.1371/journal.pone.0039699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802940	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900014
J	Soares, MC; Bshary, R; Cardoso, SC; Cote, IM; Oliveira, RF				Soares, Marta C.; Bshary, Redouan; Cardoso, Sonia C.; Cote, Isabelle M.; Oliveira, Rui F.			Face Your Fears: Cleaning Gobies Inspect Predators despite Being Stressed by Them	PLOS ONE			English	Article							THALASSOMA-BIFASCIATUM; ARGININE VASOTOCIN; GOBIOSOMA-EVELYNAE; BEHAVIOR; FISH; RISK; REPRODUCTION; PREFERENCES; AGGRESSION; DAMSELFISH	Social stressors typically elicit two distinct behavioural responses in vertebrates: an active response (i.e., "fight or flight") or behavioural inhibition (i.e., freezing). Here, we report an interesting exception to this dichotomy in a Caribbean cleaner fish, which interacts with a wide variety of reef fish clients, including predatory species. Cleaning gobies appraise predatory clients as potential threat and become stressed in their presence, as evidenced by their higher cortisol levels when exposed to predatory rather than to non-predatory clients. Nevertheless, cleaning gobies neither flee nor freeze in response to dangerous clients but instead approach predators faster (both in captivity and in the wild), and interact longer with these clients than with non-predatory clients (in the wild). We hypothesise that cleaners interrupt the potentially harmful physiological consequences elicited by predatory clients by becoming increasingly proactive and by reducing the time elapsed between client approach and the start of the interaction process. The activation of a stress response may therefore also be responsible for the longer cleaning service provided by these cleaners to predatory clients in the wild. Future experimental studies may reveal similar patterns in other social vertebrate species when, for instance, individuals approach an opponent for reconciliation after a conflict.	[Soares, Marta C.; Cardoso, Sonia C.; Oliveira, Rui F.] ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal; [Soares, Marta C.; Bshary, Redouan] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Oliveira, Rui F.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	Instituto Superior Psicologia Aplicada (ISPA); University of Neuchatel; Simon Fraser University; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Soares, MC (corresponding author), ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal.	msoares@ispa.pt	Soares, Marta C/J-4448-2013; Oliveira, Rui/A-3581-2013; Cote, Isabelle/ABD-5898-2021; Soares, Marta/GSM-7143-2022; Soares, Marta/J-4448-2013	Soares, Marta C/0000-0002-5213-2377; Oliveira, Rui/0000-0003-1528-618X; Soares, Marta/0000-0002-5213-2377; Cardoso, Sonia/0000-0002-5985-7792; Soares, Marta/0000-0001-5304-3424; Bshary, Redouan/0000-0001-7198-8472	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/MAR/105276/2008]; Natural Science and Engineering Research Council of Canada; Swiss Science Foundation	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swiss Science Foundation(Swiss National Science Foundation (SNSF))	MSC, SCC and RFO are supported by the Fundacao para a Ciencia e Tecnologia (Portugal; grant: PTDC/MAR/105276/2008). IMC is supported by the Natural Science and Engineering Research Council of Canada. RB is supported by the Swiss Science Foundation. All fieldwork expenses were financed by the Swiss Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2005, MONOGRAPHS BEHAV ECO; Aureli F., 2000, NATURAL CONFLICT RES; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bshary R, 2002, ECOL LETT, V5, P130, DOI 10.1046/j.1461-0248.2002.00295.x; Bshary R, 2011, ETHOLOGY, V117, P246, DOI 10.1111/j.1439-0310.2010.01872.x; Bshary Redouan, 2008, P563; Bshary Redouan, 2001, P146, DOI 10.1017/CBO9780511752421.010; Chapuis L, 2009, ANIM BEHAV, V78, P455, DOI 10.1016/j.anbehav.2009.06.001; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; DARCY GH, 1974, COPEIA, P375; De Boer SF, 2003, EUR J PHARMACOL, V463, P145, DOI 10.1016/S0014-2999(03)01278-0; Delisle H F, 1969, THESIS U PUERTO RICO; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; Francini RB, 2000, J FISH BIOL, V56, P802, DOI 10.1111/j.1095-8649.2000.tb00873.x; Galhardo Leonor, 2009, ARBS Annual Review of Biomedical Sciences, V11, P1; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; JOHNSON WS, 1988, ENVIRON BIOL FISH, V23, P225, DOI 10.1007/BF00004913; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; POTTS GW, 1973, ANIM BEHAV, V21, P250, DOI 10.1016/S0003-3472(73)80068-5; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Santangelo N, 2006, P ROY SOC B-BIOL SCI, V273, P3085, DOI 10.1098/rspb.2006.3683; Santangelo N, 2010, BRAIN BEHAV EVOLUT, V75, P282, DOI 10.1159/000316867; Sazima I, 1998, B MAR SCI, V63, P605; Scott AP, 2007, GEN COMP ENDOCR, V153, P392, DOI 10.1016/j.ygcen.2006.11.006; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Soares MC, 2008, ETHOLOGY, V114, P209, DOI 10.1111/j.1439-0310.2007.01471.x; Soares MC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1015, DOI 10.1007/s00265-006-0334-6; Soares MC, 2010, ETHOLOGY, V116, P1244, DOI 10.1111/j.1439-0310.2010.01838.x; Soares MC, 2012, PLOS ONE IN PRESS; Wicksten MK, 1998, J NAT HIST, V32, P13, DOI 10.1080/00222939800770021; WINBERG S, 1993, NEUROREPORT, V4, P399, DOI 10.1097/00001756-199304000-00014	39	24	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39781	10.1371/journal.pone.0039781	http://dx.doi.org/10.1371/journal.pone.0039781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22802925	Green Published, gold, Green Submitted			2022-12-25	WOS:000305825800069
J	Kasper, S; Breitenbuecher, F; Reis, H; Brandau, S; Worm, K; Kohler, J; Paul, A; Trarbach, T; Schmid, KW; Schuler, M				Kasper, S.; Breitenbuecher, F.; Reis, H.; Brandau, S.; Worm, K.; Koehler, J.; Paul, A.; Trarbach, T.; Schmid, K. W.; Schuler, M.			Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade	ONCOGENE			English	Article						cetuximab; colorectal cancer; RAS; ADCC; anti-EGFR antibodies; BCL-XL	GROWTH-FACTOR RECEPTOR; BCL-2 FAMILY PROTEINS; PLUS CETUXIMAB; LUNG-CANCER; APOPTOSIS; EXPRESSION; RESISTANCE; MUTATIONS; INHIBITOR; DEFECTS	Monoclonal antibodies against the epidermal growth factor receptor (EGFR) are effective cancer therapeutics, but tumors harboring RAS mutations are resistant. To functionally dissect RAS-mediated resistance, we have studied clinically approved anti-EGFR antibodies, cetuximab and panitumumab, in cancer models. Both antibodies were equally cytotoxic in vitro. However, cetuximab, which also triggers antibody-dependent cellular cytotoxicity (ADCC), was more effective than panitumumab in vivo. Oncogenic RAS neutralized the activity of both antibodies in vivo. Mechanistically, RAS upregulated BCL-XL in cancer cell lines and in primary colorectal cancers. Suppression of BCL-XL by short hairpin RNA or treatment with a BH3 mimetic overcame RAS-mediated antibody resistance. In conclusion, RAS-mutant tumors escape anti-EGFR antibody-mediated receptor blockade as well as ADCC in vivo. Pharmacological targeting of RAS effectors can restore sensitivity to antibody therapy.	[Kasper, S.; Breitenbuecher, F.; Koehler, J.; Trarbach, T.; Schuler, M.] Univ Duisburg Essen, West German Canc Ctr, Dept Med Oncol, Univ Hosp Essen, D-45147 Essen, Germany; [Reis, H.; Worm, K.; Schmid, K. W.] Univ Duisburg Essen, West German Canc Ctr, Dept Pathol & Neuropathol, Univ Hosp Essen, D-45147 Essen, Germany; [Brandau, S.] Univ Duisburg Essen, West German Canc Ctr, Dept Otorhinolaryngol, Univ Hosp Essen, D-45147 Essen, Germany; [Paul, A.] Univ Duisburg Essen, West German Canc Ctr, Dept Gen Visceral & Transplant Surg, Univ Hosp Essen, D-45147 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Schuler, M (corresponding author), Univ Duisburg Essen, West German Canc Ctr, Dept Med Oncol, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany.	martin.schuler@uk-essen.de	Reis, Henning/AAX-9545-2020; Trarbach, Tanja/F-4944-2019; Kasper, Stefan/I-4521-2015; Köhler, Jens/AAK-1541-2021	Reis, Henning/0000-0003-1373-5295; Trarbach, Tanja/0000-0002-1275-4040; Kasper, Stefan/0000-0002-5947-8733; Brandau, Sven/0000-0002-2702-4163	Merck Serono; Amgen; Wilhelm Sander-Stiftung [2005.136.3]; Deutsche Forschungsgemeinschaft [SCHU 1541/5-1]; Mercator Research Center Ruhr-MERCUR [An-2011-0031]; CESAR Research Fellowship; Wiedenfeld-Stiftung; IFORES program of the Medical Faculty of the University Duisburg-Essen; Pathology and Molecular Pathology Laboratories, University Hospital Essen	Merck Serono(Merck & Company); Amgen(Amgen); Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Mercator Research Center Ruhr-MERCUR; CESAR Research Fellowship; Wiedenfeld-Stiftung; IFORES program of the Medical Faculty of the University Duisburg-Essen; Pathology and Molecular Pathology Laboratories, University Hospital Essen	Martin Schuler has served as consultant to Amgen; Tanja Trarbach has received research funding, consulting and speaker honoraria from Merck Serono and Amgen. The other authors declare no conflict of interest.; We thank Sandra Hoffarth, Sarah-Luise Stergar, Kirsten Bruderek, Jeannette Markowetz, Anna Even, Miriam Backs, Ali Sak, Sabine Harde and the staff of the Central Animal Facility, and the Pathology and Molecular Pathology Laboratories, University Hospital Essen, for their support. Robert Coffey, Roman Thomas, Hyatt Balke-Want, Scott W Lowe, Gary P Nolan and Abbott are acknowledged for providing reagents. This work was funded by grants from the Wilhelm Sander-Stiftung (2005.136.3, MS), the Deutsche Forschungsgemeinschaft (SCHU 1541/5-1, MS), Mercator Research Center Ruhr-MERCUR (An-2011-0031, SK) a CESAR Research Fellowship (SK), the Wiedenfeld-Stiftung (SK) and the IFORES program of the Medical Faculty of the University Duisburg-Essen (MS).	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Barriere J, 2009, J CLIN ONCOL, V27; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Haehnel PS, 2008, CANCER RES, V68, P3899, DOI 10.1158/0008-5472.CAN-07-6286; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara M, 2008, CANCER SCI, V99, P1471, DOI 10.1111/j.1349-7006.2008.00821.x; Huber C, 2005, CELL DEATH DIFFER, V12, P317, DOI 10.1038/sj.cdd.4401563; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kasper S, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.5; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kurai J, 2007, CLIN CANCER RES, V13, P1552, DOI 10.1158/1078-0432.CCR-06-1726; Marques CA, 2008, BLOOD, V111, P1413, DOI 10.1182/blood-2007-05-089458; MAYER A, 1993, CANCER, V71, P2454, DOI 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Piloto O, 2006, CANCER RES, V66, P4843, DOI 10.1158/0008-5472.CAN-06-0018; Ravi R, 2006, CANCER RES, V66, P1730, DOI 10.1158/0008-5472.CAN-05-3377; REMMELE W, 1987, PATHOLOGE, V8, P138; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; SHULTZ LD, 1995, J IMMUNOL, V154, P180; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wesarg E, 2007, INT J CANCER, V121, P2387, DOI 10.1002/ijc.22977; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	34	31	31	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2013	32	23					2873	2881		10.1038/onc.2012.302	http://dx.doi.org/10.1038/onc.2012.302			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22797062				2022-12-25	WOS:000320369100007
J	Lim, DKY; Garg, S; Timmins, M; Zhang, ESB; Thomas-Hall, SR; Schuhmann, H; Li, Y; Schenk, PM				Lim, David K. Y.; Garg, Sourabh; Timmins, Matthew; Zhang, Eugene S. B.; Thomas-Hall, Skye R.; Schuhmann, Holger; Li, Yan; Schenk, Peer M.			Isolation and Evaluation of Oil-Producing Microalgae from Subtropical Coastal and Brackish Waters	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LIPID-ACCUMULATION; CELL-GROWTH; NANNOCHLOROPSIS-OCULATA; CHLORELLA-VULGARIS; BIODIESEL; TEMPERATURE; SALINITY; BIOFUELS; TRIACYLGLYCEROLS	Microalgae have been widely reported as a promising source of biofuels, mainly based on their high areal productivity of biomass and lipids as triacylglycerides and the possibility for cultivation on non-arable land. The isolation and selection of suitable strains that are robust and display high growth and lipid accumulation rates is an important prerequisite for their successful cultivation as a bioenergy source, a process that can be compared to the initial selection and domestication of agricultural crops. We developed standard protocols for the isolation and cultivation for a range of marine and brackish microalgae. By comparing growth rates and lipid productivity, we assessed the potential of subtropical coastal and brackish microalgae for the production of biodiesel and other oil-based bioproducts. This study identified Nannochloropsis sp., Dunaniella salina and new isolates of Chlorella sp. and Tetraselmis sp. as suitable candidates for a multiple-product algae crop. We conclude that subtropical coastal microalgae display a variety of fatty acid profiles that offer a wide scope for several oil-based bioproducts, including biodiesel and omega-3 fatty acids. A biorefinery approach for microalgae would make economical production more feasible but challenges remain for efficient harvesting and extraction processes for some species.	[Lim, David K. Y.; Garg, Sourabh; Timmins, Matthew; Zhang, Eugene S. B.; Thomas-Hall, Skye R.; Schuhmann, Holger; Li, Yan; Schenk, Peer M.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Timmins, Matthew] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Ctr Metabol, Sch Chem & Biochem, Nedlands, WA 6009, Australia	University of Queensland; University of Western Australia	Lim, DKY (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	p.schenk@uq.edu.au	Schenk, Peer/B-7879-2016; Li, Yan/A-5532-2008	Schenk, Peer/0000-0003-4878-3799; Li, Yan/0000-0002-9102-0917; Thomas-Hall, Skye/0000-0002-4208-5992; Li, Yan/0000-0002-9742-0081	Australian Research Council [LP0883380, LP0990558]; Pacific Seeds; Advanta India; North Queensland & Pacific Biodiesel; Queensland Sea Scallops Trading	Australian Research Council(Australian Research Council); Pacific Seeds; Advanta India; North Queensland & Pacific Biodiesel; Queensland Sea Scallops Trading	The authors wish to thank the Australian Research Council (LP0883380, LP0990558), Pacific Seeds, Advanta India, North Queensland & Pacific Biodiesel and Queensland Sea Scallops Trading for financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rezq TS, 1999, HYDROBIOLOGIA, V403, P97, DOI 10.1023/A:1003725626504; Ahmad AL, 2011, RENEW SUST ENERG REV, V15, P584, DOI 10.1016/j.rser.2010.09.018; Alonzo F, 1999, MAR CHEM, V67, P289, DOI 10.1016/S0304-4203(99)00075-4; Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; Araujo GS, 2011, BIORESOURCE TECHNOL, V102, P5248, DOI 10.1016/j.biortech.2011.01.089; Araujo SD, 2005, AQUACULTURE, V246, P405, DOI 10.1016/j.aquaculture.2005.02.051; Borowitzka M.A., 1988, P257; Bridgewater A, 2004, MOL GLOBAL PHOTOSYNT; Cavalli RO, 1999, AQUACULTURE, V179, P387, DOI 10.1016/S0044-8486(99)00173-8; Chen CY, 2010, BIOTECHNOL PROGR, V26, P679, DOI 10.1002/btpr.381; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Chiu SY, 2009, BIORESOURCE TECHNOL, V100, P833, DOI 10.1016/j.biortech.2008.06.061; Cho SH, 2007, FISHERIES SCI, V73, P1050, DOI 10.1111/j.1444-2906.2007.01435.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; de la Pena MR, 2005, AQUAC RES, V36, P1500, DOI 10.1111/j.1365-2109.2005.01371.x; Demirbas A, 2009, ENERG SOURCE PART B, V4, P310, DOI 10.1080/15567240701621166; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P163, DOI 10.1016/j.enconman.2010.06.055; Doroudi MS, 1999, AQUACULT INT, V7, P179, DOI 10.1023/A:1009207810808; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Emata AC, 2003, FISH PHYSIOL BIOCHEM, V28, P489, DOI 10.1023/B:FISH.0000030637.26086.ab; EMDADI D, 1989, MAR CHEM, V26, P215, DOI 10.1016/0304-4203(89)90004-2; Gong YM, 2011, BIOTECHNOL LETT, V33, P1269, DOI 10.1007/s10529-011-0574-z; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hu HH, 2003, BIOTECHNOL LETT, V25, P421, DOI 10.1023/A:1022489108980; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huerlimann R, 2010, BIOTECHNOL BIOENG, V107, P245, DOI 10.1002/bit.22809; Hur Byung-Ki, 2007, Korean Society for Biotechnology and Bioengineering Journal, V22, P37; Illman AM, 2000, ENZYME MICROB TECH, V27, P631, DOI 10.1016/S0141-0229(00)00266-0; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kliphuis AMJ, 2010, BIOTECHNOL PROGR, V26, P687, DOI 10.1002/btpr.379; Knothe G, 2005, FUEL PROCESS TECHNOL, V86, P1059, DOI 10.1016/j.fuproc.2004.11.002; Knothe G, 2005, BIODIESEL HDB, DOI [10.1201/9781003040262, DOI 10.1201/9781003040262]; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; Lee SJ, 2011, BIOTECHNOL BIOPROC E, V16, P561, DOI 10.1007/s12257-010-0360-0; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Lorenz M., 2005, ALGAL CULTURING TECH, P145, DOI DOI 10.1016/B978-012088426-1/50011-1; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; MIYAMOTO K, 1988, BIOTECHNOL LETT, V10, P703, DOI 10.1007/BF01025286; Okauchi M, 1997, HYDROBIOLOGIA, V358, P217, DOI 10.1023/A:1003157419675; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Patil V, 2007, AQUACULT INT, V15, P1, DOI 10.1007/s10499-006-9060-3; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Rocha JMS, 2003, BIOMOL ENG, V20, P237, DOI 10.1016/S1389-0344(03)00061-3; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; ROESSLER PG, 1990, J PHYCOL, V26, P393, DOI 10.1111/j.0022-3646.1990.00393.x; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; SHAMSUDIN L, 1992, J APPL PHYCOL, V4, P371, DOI 10.1007/BF02185795; Wang B, 2008, APPL MICROBIOL BIOT, V79, P707, DOI 10.1007/s00253-008-1518-y; Weyer KM, 2010, BIOENERG RES, V3, P204, DOI 10.1007/s12155-009-9046-x; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Malcata FX, 2011, TRENDS BIOTECHNOL, V29, P542, DOI 10.1016/j.tibtech.2011.05.005; ZEILER KG, 1995, ENERG CONVERS MANAGE, V36, P707, DOI 10.1016/0196-8904(95)00103-K	61	123	123	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40751	10.1371/journal.pone.0040751	http://dx.doi.org/10.1371/journal.pone.0040751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792403	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000306362400099
J	Takahashi, T; Muro, S; Tanabe, N; Terada, K; Kiyokawa, H; Sato, S; Hoshino, Y; Ogawa, E; Uno, K; Naruishi, K; Takashiba, S; Mishima, M				Takahashi, Tamaki; Muro, Shigeo; Tanabe, Naoya; Terada, Kunihiko; Kiyokawa, Hirofumi; Sato, Susumu; Hoshino, Yuma; Ogawa, Emiko; Uno, Kazuko; Naruishi, Koji; Takashiba, Shogo; Mishima, Michiaki			Relationship between Periodontitis-Related Antibody and Frequent Exacerbations in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							DENTAL HYGIENE EDUCATION; CORONARY-HEART-DISEASE; PORPHYROMONAS-GINGIVALIS; COPD EXACERBATIONS; NURSING-HOME; INFLAMMATORY MARKERS; RISK; PATHOGENS; SYMPTOMS; BACTERIA	Background: To identify patients with chronic obstructive pulmonary disease (COPD) who are susceptible to frequent exacerbations is important. Although periodontitis aggravated by poor oral hygiene might increase the risk of lower respiratory tract infection, the relationship between periodontitis and COPD exacerbations remains unknown. This prospective cohort study investigates the relationship between periodontitis-related antibody and exacerbation frequency over a one-year period. Methods: We assessed an IgG antibody titer against Porphyromonas gingivalis, which is a major pathogen of periodontitis, and then prospectively followed up 93 individuals over one year to detect exacerbations. Results: The numbers of exacerbations and the rate of individuals with frequent exacerbations (at least two per year) were significantly lower in patients with higher IgG titer than those with normal IgG titer (0.8 vs. 1.2 per year, p = 0.045 and 14.3 vs. 38.6%, p = 0.009, respectively). Multivariate logistic regression analysis showed that being normal-IgG titer for periodontitis-related antibody significantly increased the risk of frequent exacerbations (relative risk, 5.27, 95% confidence interval, 1.30-25.7; p = 0.019) after adjusting for other possible confounders, such as a history of exacerbations in the past year, disease severity, COPD medication and smoking status. Conclusions: Normal-IgG titer for periodontitis-related antibody can be an independent predictor of frequent exacerbations. Measuring periodontitis-related antibody titers might be useful to identify patients with susceptibility to frequent exacerbations so that an aggressive prevention strategy can be designed.	[Takahashi, Tamaki; Muro, Shigeo; Tanabe, Naoya; Terada, Kunihiko; Kiyokawa, Hirofumi; Sato, Susumu; Hoshino, Yuma; Mishima, Michiaki] Kyoto Univ, Dept Resp Med, Kyoto, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Shiga, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Kyoto, Japan; [Naruishi, Koji] Iwate Med Univ, Div Endodontol, Dept Conservat Dent & Oral Rehabil, Morioka, Iwate, Japan; [Takashiba, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol Periodontal Sci, Okayama 7008530, Japan	Kyoto University; Shiga University of Medical Science; Iwate Medical University; Okayama University	Takahashi, T (corresponding author), Kyoto Univ, Dept Resp Med, Kyoto, Japan.	smuro@kuhp.kyoto-u.ac.jp	Sato, Susumu/R-8976-2019; Takashiba, Shogo/C-9830-2010	Takashiba, Shogo/0000-0002-4712-6829	Ministry of Health, Labour and Welfare, Japan [16390234, 21590964]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid for scientific research (B) (No. 16390234) and (C) (No. 21590964) and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bascones-Martinez A, 2011, MED ORAL PATOL ORAL, V16, pE722, DOI 10.4317/medoral.17032; BASKAR P, 1990, J IMMUNOL, V144, P2321; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Bohnstedt S, 2010, J DENT RES, V89, P938, DOI 10.1177/0022034510370817; Brook I, 2003, CHEST, V124, P832, DOI 10.1378/chest.124.3.832; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deo Vikas, 2009, Indian J Dent Res, V20, P466, DOI 10.4103/0970-9290.59456; Drinka P, 2010, J AM MED DIR ASSOC, V11, P70, DOI 10.1016/j.jamda.2009.03.020; Garcia-Aymerich J, 2003, THORAX, V58, P100, DOI 10.1136/thorax.58.2.100; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kullberg E, 2010, J ADV NURS, V66, P1273, DOI 10.1111/j.1365-2648.2010.05298.x; Lamster IB, 1998, J CLIN PERIODONTOL, V25, P510, DOI 10.1111/j.1600-051X.1998.tb02480.x; Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; Murayama Y, 1988, Adv Dent Res, V2, P339; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Pussinen PJ, 2003, ARTERIOSCL THROM VAS, V23, P1250, DOI 10.1161/01.ATV.0000072969.71452.87; Renvert S, 2003, ORAL HLTH PREV DE S1, V1, P358; Renvert Stefan, 2003, Oral Health Prev Dent, V1 Suppl 1, P341; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sims TJ, 2001, ORAL MICROBIOL IMMUN, V16, P193, DOI 10.1034/j.1399-302X.2001.160401.x; Sjogren P, 2010, J ADV NURS, V66, P345, DOI 10.1111/j.1365-2648.2009.05181.x; Soler N, 1998, AM J RESP CRIT CARE, V157, P1498, DOI 10.1164/ajrccm.157.5.9711044; Stoller JK, 2002, NEW ENGL J MED, V346, P988, DOI 10.1056/NEJMcp012477; Sugi N, 2011, J CLIN LAB ANAL, V25, P25, DOI 10.1002/jcla.20381; Surendar J, 2011, DIABETES TECHNOL THE, V13, P477, DOI 10.1089/dia.2010.0178; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Terada K, 2008, THORAX, V63, P951, DOI 10.1136/thx.2007.092858; Terada K, 2010, CHEST, V137, P326, DOI 10.1378/chest.09-0482; Yamazaki K, 2007, CLIN EXP IMMUNOL, V149, P445, DOI 10.1111/j.1365-2249.2007.03450.x; Zhang M, 2010, EUR J CLIN MICROBIOL, V29, P1487, DOI 10.1007/s10096-010-1027-7	42	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40570	10.1371/journal.pone.0040570	http://dx.doi.org/10.1371/journal.pone.0040570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792372	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400071
J	Feng, Y; Ma, ZZ				Feng, Yun; Ma, Zhizhong			Transscleral Diode Photocoagulation of Large Retinal and Choroidal Vascular Lesions	PLOS ONE			English	Article							COATS-DISEASE; THRESHOLD RETINOPATHY; LASER; MANAGEMENT	Background: Transscleral retinal photocoagulation with a diode laser is used in glaucoma refractory to medical and surgical treatment. Our main research question was how the technique performed in large vascular lesions associated with hemangiomas of the retina and choroid. Methodology/Clinical Findings: Patient charts were retrieved from the hospital files for patients who underwent the procedure and were followed for at least 24 months. Five patients (6 eyes) fit the criteria. Cases included Von Hippel's disease (2 eyes), Coats' disease (1 eye) and choroidal hemangioma (3 cases). Transscleral diode laser treatment was performed under retrobulbar and topical anesthesia with a retinopexy probe (IRIS DioPexy, IRIS Medical Instruments, Mountain View, CA) applied transsclerally under indirect ophthalmoscope visualization. We found an improvement in best-corrected visual acuity at 24 months postoperatively. Conclusions/Significance: Transscleral photocoagulation may have a clinical application in these diseases as an alternate to the high cost of photodynamic therapy with photosensitizing agents.	[Feng, Yun] Peking Univ, Dept Ophthalmol, Hosp 3, Ctr Eye, Beijing 100871, Peoples R China; Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China	Peking University	Feng, Y (corresponding author), Peking Univ, Dept Ophthalmol, Hosp 3, Ctr Eye, Beijing 100871, Peoples R China.	puh3_yk@bjmu.edu.cn	Feng, Yun/L-7476-2019					Abramson DH, 1998, AM J OPHTHALMOL, V126, P733, DOI 10.1016/S0002-9394(98)00142-1; JACCOMA EH, 1985, ARCH OPHTHALMOL-CHIC, V103, P1728, DOI 10.1001/archopht.1985.01050110124039; Jones JH, 2001, INT OPHTHALMOL CLIN, V41, P189, DOI 10.1097/00004397-200110000-00017; McHugh DA, 1995, BRIT J OPHTHALMOL, V79, P1083, DOI 10.1136/bjo.79.12.1083; MCHUGH JDA, 1989, EYE, V3, P516, DOI 10.1038/eye.1989.83; Parvaresh MM, 2009, J AAPOS, V13, P535, DOI 10.1016/j.jaapos.2009.09.018; Paysse EA, 2002, OPHTHALMOLOGY, V109, P1662, DOI 10.1016/S0161-6420(02)01169-7; Schefler AC, 2008, RETINA-J RET VIT DIS, V28, pS38, DOI 10.1097/IAE.0b013e318163cd7c; Seiberth V, 1999, OPHTHALMOLOGY, V106, P1828, DOI 10.1016/S0161-6420(99)90367-6; Shapiro MJ, 2011, AM J OPHTHALMOL, V151, P725, DOI 10.1016/j.ajo.2010.10.024; Shields JA, 2002, RETINA-J RET VIT DIS, V22, P80, DOI 10.1097/00006982-200202000-00014; Shields JA, 2001, AM J OPHTHALMOL, V131, P572, DOI 10.1016/S0002-9394(01)00896-0; TARKKANEN A, 1983, BRIT J OPHTHALMOL, V67, P766, DOI 10.1136/bjo.67.11.766; Turell ME, 2010, MIDDLE EAST AFR J OP, V17, P191, DOI 10.4103/0974-9233.65486	14	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39340	10.1371/journal.pone.0039340	http://dx.doi.org/10.1371/journal.pone.0039340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792170	Green Submitted, Green Published, gold			2022-12-25	WOS:000306354700009
J	Giaime, E; Yamaguchi, H; Gautier, CA; Kitada, T; Shen, J				Giaime, Emilie; Yamaguchi, Hiroo; Gautier, Clement A.; Kitada, Tohru; Shen, Jie			Loss of DJ-1 Does Not Affect Mitochondrial Respiration but Increases ROS Production and Mitochondrial Permeability Transition Pore Opening	PLOS ONE			English	Article							DISEASE-ASSOCIATED PROTEIN; PARKINSONS-DISEASE; CELL-DEATH; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; DROSOPHILA DJ-1; IN-VIVO; MUTATIONS; DEGENERATION; PINK1	Background: Loss of function mutations in the DJ-1 gene have been linked to recessively inherited forms of Parkinsonism. Mitochondrial dysfunction and increased oxidative stress are thought to be key events in the pathogenesis of Parkinson's disease. Although it has been reported that DJ-1 serves as scavenger for reactive oxidative species (ROS) by oxidation on its cysteine residues, how loss of DJ-1 affects mitochondrial function is less clear. Methodology/Principal Findings: Using primary mouse embryonic fibroblasts (MEFs) or brains from DJ-1-/- mice, we found that loss of DJ-1 does not affect mitochondrial respiration. Specifically, endogenous respiratory activity as well as basal and maximal respiration are normal in intact DJ-1-/- MEFs, and substrate-specific state 3 and state 4 mitochondrial respiration are also unaffected in permeabilized DJ-1-/- MEFs and in isolated mitochondria from the cerebral cortex of DJ-1-/- mice at 3 months or 2 years of age. Expression levels and activities of all individual complexes composing the electron transport system are unchanged, but ATP production is reduced in DJ-1-/- MEFs. Mitochondrial transmembrane potential is decreased in the absence of DJ-1. Furthermore, mitochondrial permeability transition pore opening is increased, whereas mitochondrial calcium levels are unchanged in DJ-1-/- cells. Consistent with earlier reports, production of reactive oxygen species (ROS) is increased, though levels of antioxidative enzymes are unaltered. Interestingly, the decreased mitochondrial transmembrane potential and the increased mitochondrial permeability transition pore opening in DJ-1-/- MEFs can be restored by antioxidant treatment, whereas oxidative stress inducers have the opposite effects on mitochondrial transmembrane potential and mitochondrial permeability transition pore opening. Conclusions/Significance: Our study shows that loss of DJ-1 does not affect mitochondrial respiration or mitochondrial calcium levels but increases ROS production, leading to elevated mitochondrial permeability transition pore opening and reduced mitochondrial transmembrane potential.	[Giaime, Emilie; Yamaguchi, Hiroo; Gautier, Clement A.; Kitada, Tohru; Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Giaime, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Shen, Jie/GXH-9449-2022		National Institutes of Health [R01NS052745, R01NS041779]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041779, R01NS052745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (R01NS052745 and R01NS041779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo T, 2011, NEUROBIOL DIS, V41, P111, DOI 10.1016/j.nbd.2010.08.027; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braeckman BP, 1999, CURR BIOL, V9, P493, DOI 10.1016/S0960-9822(99)80216-4; BUCANA C, 1986, J HISTOCHEM CYTOCHEM, V34, P1109, DOI 10.1177/34.9.2426339; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7; Frezza Christian, 2007, Methods Mol Biol, V372, P405, DOI 10.1007/978-1-59745-365-3_29; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2012, MOL NEURODE IN PRESS; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Haugland RP, 1992, HDB FLUORESCENT PROB, P390; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016; LUNDIN A, 1975, ANAL BIOCHEM, V66, P47, DOI 10.1016/0003-2697(75)90723-X; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matsuura K, 1996, BRAIN RES, V733, P101, DOI 10.1016/S0006-8993(96)00686-5; McElroy W D, 1983, J Appl Biochem, V5, P197; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Seaton TA, 1998, BRAIN RES, V809, P12, DOI 10.1016/S0006-8993(98)00790-2; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wagenfeld A, 1998, BIOCHEM BIOPH RES CO, V251, P545, DOI 10.1006/bbrc.1998.9512; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhong N, 2008, HUM MOL GENET, V17, P3357, DOI 10.1093/hmg/ddn230; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	65	72	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40501	10.1371/journal.pone.0040501	http://dx.doi.org/10.1371/journal.pone.0040501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792356	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700057
J	Wolf, W; Kilic, A; Schrul, B; Lorenz, H; Schwappach, B; Seedorf, M				Wolf, Wendelin; Kilic, Annett; Schrul, Bianca; Lorenz, Holger; Schwappach, Blanche; Seedorf, Matthias			Yeast Ist2 Recruits the Endoplasmic Reticulum to the Plasma Membrane and Creates a Ribosome-Free Membrane Microcompartment	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; H+-ATPASE; CATION-TRANSPORT; PROTEIN; MUTATIONS; CALCIUM; HOMEOSTASIS; DOMAINS; PATHWAY; BINDING	The endoplasmic reticulum (ER) forms contacts with the plasma membrane. These contacts are known to function in non-vesicular lipid transport and signaling. Ist2 resides in specific domains of the ER in Saccharomyces cerevisiae where it binds phosphoinositide lipids at the cytosolic face of the plasma membrane. Here, we report that Ist2 recruits domains of the yeast ER to the plasma membrane. Ist2 determines the amount of cortical ER present and the distance between the ER and the plasma membrane. Deletion of IST2 resulted in an increased distance between ER and plasma membrane and allowed access of ribosomes to the space between the two membranes. Cells that overexpress Ist2 showed an association of the nucleus with the plasma membrane. The morphology of the ER and yeast growth were sensitive to the abundance of Ist2. Moreover, Ist2-dependent effects on cytosolic pH and genetic interactions link Ist2 to the activity of the H+ pump Pma1 in the plasma membrane during cellular adaptation to the growth phase of the culture. Consistently we found a partial colocalization of Ist2-containing cortical ER and Pma1-containing domains of the plasma membrane. Hence Ist2 may be critically positioned in domains that couple functions of the ER and the plasma membrane.	[Wolf, Wendelin; Kilic, Annett; Lorenz, Holger; Seedorf, Matthias] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany; [Schrul, Bianca; Schwappach, Blanche] Univ Med Gottingen, Dept Biochem 1, Gottingen, Germany; [Schrul, Bianca; Schwappach, Blanche] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Gottingen; Max Planck Society	Wolf, W (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany.	m.seedorf@zmbh.uni-heidelberg.de		Schwappach, Blanche/0000-0003-0225-6432	Deutsche Forschungsgemeinschaft [SE 811/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SE 811/5-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Brachmann CB, 1998, YEAST, V14, P115; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Franz A, 2007, FEBS LETT, V581, P401, DOI 10.1016/j.febslet.2006.12.048; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Getty AL, 2011, CELL MOL LIFE SCI, V68, P453, DOI 10.1007/s00018-010-0468-6; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Griffith J, 2008, TRAFFIC, V9, P1060, DOI 10.1111/j.1600-0854.2008.00753.x; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jennings ML, 2008, J GEN PHYSIOL, V131, P379, DOI 10.1085/jgp.200709905; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Juschke C, 2004, CURR BIOL, V14, P406, DOI 10.1016/j.cub.2004.02.034; Kama R, 2007, MOL CELL BIOL, V27, P605, DOI 10.1128/MCB.00699-06; Kim Y, 2005, EUKARYOT CELL, V4, P281, DOI 10.1128/EC.4.2.281-288.2005; KOLAROV J, 1988, J BIOL CHEM, V263, P10613; Lavieu G, 2010, P NATL ACAD SCI USA, V107, P6876, DOI 10.1073/pnas.1002536107; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; SIKORSKI RS, 1989, GENETICS, V122, P19; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stradalova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035132; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Withee JL, 1998, GENETICS, V149, P865; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002; ZIBIRRE R, 1986, J CELL PHYSIOL, V129, P85, DOI 10.1002/jcp.1041290113	60	60	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39703	10.1371/journal.pone.0039703	http://dx.doi.org/10.1371/journal.pone.0039703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808051	Green Published, gold			2022-12-25	WOS:000306354700017
J	Haneef, J; Parvathy, M; Thankayyan, RSK; Sithul, H; Sreeharshan, S				Haneef, Jazir; Parvathy, M.; Thankayyan, Santhosh Kumar R.; Sithul, Hima; Sreeharshan, Sreeja			Bax Translocation Mediated Mitochondrial Apoptosis and Caspase Dependent Photosensitizing Effect of Ficus religiosa on Cancer Cells	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; AQUEOUS EXTRACT; CLEAVAGE; ACTIVATION; PATHWAYS; THERAPY; STRESS; AGENTS; DEATH; CYCLE	The main aim of the present work was to investigate the potential effect of acetone extract of Ficus religosa leaf (FAE) in multiple apoptosis signalling in human breast cancer cells. FAE treatment significantly induced dose and time dependent, irreversible inhibition of breast cancer cell growth with moderate toxicity to normal breast epithelial cells. This observation was validated using Sulforhodamine B assay. Cell cycle analysis by Flow cytometry showed cell cycle arrest in G1 phase and induction of sub-G0 peak. FAE induced chromatin condensation and displayed an increase in apoptotic population in Annexin V-FITC/PI (Fluorescein isothiocyanate/Propidium iodide) double staining. FAE stimulated the loss of mitochondrial membrane potential in multiple breast cancer cell lines when compared to normal diploid cells. To understand the role of Bax in FAE induced apoptosis, we employed a sensitive cell based platform of MCF-7 cells expressing Bax-EGFP. Bax translocation to mitochondria was accompanied by the disruption of mitochondrial membrane potential and marked elevation in LEHDase activity (Caspase 9). Consistent with this data, FAE induced Caspase activation as evidenced by ratio change in FRET Caspase sensor expressing MCF-7 cell line and cleavage of prominent Caspases and PARP. Interestingly, FAE accelerated cell death in a mitochondrial dependent manner in continuous live cell imaging mode indicating its possible photosensitizing effect. Intracellular generation of reactive oxygen species (ROS) by FAE played a critical role in mediating apoptotic cell death and photosensitizing activity. FAE induced dose and time dependent inhibition of cancer cell growth which was associated with Bax translocation and mitochondria mediated apoptosis with the activation of Caspase 9 dependent Caspase cascade. FAE also possessed strong photosensitizing effect on cancer cell line that was mediated through rapid mitochondrial transmembrane potential loss and partial Caspase activation involving generation of intracellular ROS.	[Haneef, Jazir; Parvathy, M.; Thankayyan, Santhosh Kumar R.; Sithul, Hima; Sreeharshan, Sreeja] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Haneef, J (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram, Kerala, India.	trsanthosh@rgcb.res.in; sreejasreeharshan@yahoo.com			University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR), Government of India	University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from University Grants Commission (UGC) and Council of Scientific and Industrial Research (CSIR), Government of India, as Senior Research Fellowships to Dr. Haneef and Dr. Parvathy M respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aiyegoro OA, 2009, J MED PLANTS RES, V3, P1147; Aqil F, 2003, WORLD J MICROB BIOT, V19, P653, DOI 10.1023/A:1025128104056; Benjamin CW, 1998, MOL PHARMACOL, V53, P446, DOI 10.1124/mol.53.3.446; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Choi HY, 2009, J POLYM ENG, V29, P1, DOI 10.1515/POLYENG.2009.29.1-3.1; Choudhary G.P., 2006, PLANTA INDICA, V2, P17; Cisowska A, 2011, NAT PROD COMMUN, V6, P149; Denecker G, 2000, FEBS LETT, V465, P47, DOI 10.1016/S0014-5793(99)01702-0; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Grabley S, 2000, SPR DESKT EDIT CHEM, P3; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gulecha V, 2011, ASIAN PAC J TROP MED, V4, P526, DOI 10.1016/S1995-7645(11)60139-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Joseph J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020114; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Jung HW, 2008, PHYTOTHER RES, V22, P1064, DOI 10.1002/ptr.2442; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kirana H, 2009, INDIAN J EXP BIOL, V47, P822; Kwang SA, 2007, MOL PHARM, V71, P209; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lam M, 2001, J BIOL CHEM, V276, P47379, DOI 10.1074/jbc.M107678200; McDonald S, 2001, FOOD CHEM, V73, P73, DOI 10.1016/S0308-8146(00)00288-0; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Naira N., 2009, INTERNET J ALTERN ME, V6, P2; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Panchal RG, 1998, BIOCHEM PHARMACOL, V55, P247, DOI 10.1016/S0006-2952(97)00240-2; Pandit R, 2010, J ETHNOPHARMACOL, V128, P462, DOI 10.1016/j.jep.2010.01.025; Ratnasooriya WD, 1998, MED SCI RES, V26, P817; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Seervi M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.90; Sheetal A, 2008, INDIAN J PHARM SCI, V70, P31; Shishodia S., 2006, ANTICANCER POTENTIAL; Shoeb M., 2006, BANGL J PHARMACOL, V1, P35, DOI [10.3329/bjp.v1i2.486, DOI 10.3329/BJP.V1I2.486]; Singh D, 2011, J ETHNOPHARMACOL, V134, P565, DOI 10.1016/j.jep.2011.01.046; Singh D, 2009, J ETHNOPHARMACOL, V123, P330, DOI 10.1016/j.jep.2009.02.042; Sirisha N., 2010, International Journal of PharmTech Research, V2, P2174; Sreelekshmi R., 2007, Natural Product Radiance, V6, P377; Taskeen A, 2009, NEW YORK SCI J, V2, P32; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Trease G, 2002, PHARMACOGNOSY; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	51	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40055	10.1371/journal.pone.0040055	http://dx.doi.org/10.1371/journal.pone.0040055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792212	gold, Green Submitted, Green Published			2022-12-25	WOS:000306461800034
J	Sakhdari, A; Mujib, S; Vali, B; Yue, FY; MacParland, S; Clayton, K; Jones, RB; Liu, J; Lee, EY; Benko, E; Kovacs, C; Gommerman, J; Kaul, R; Ostrowski, MA				Sakhdari, Ali; Mujib, Shariq; Vali, Bahareh; Yue, Feng Yun; MacParland, Sonya; Clayton, Kiera; Jones, Richard Bradley; Liu, Jun; Lee, Erika Yue; Benko, Erika; Kovacs, Colin; Gommerman, Jennifer; Kaul, Rupert; Ostrowski, Mario A.			Tim-3 Negatively Regulates Cytotoxicity in Exhausted CD8(+) T Cells in HIV Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; NATURAL-KILLER-CELLS; MEDIATED CYTOTOXICITY; VIRUS-INFECTION; UP-REGULATION; DEPENDENT CYTOTOXICITY; PROLIFERATIVE CAPACITY; DISEASE PROGRESSION; GRANULE EXOCYTOSIS; IMPAIRED FUNCTION	Cytotoxic CD8(+) T cells (CTLs) contain virus infections through the release of granules containing both perforin and granzymes. T cell 'exhaustion' is a hallmark of chronic persistent viral infections including HIV. The inhibitory regulatory molecule, T cell Immunoglobulin and Mucin domain containing 3 (Tim-3) is induced on HIV-specific T cells in chronic progressive infection. These Tim-3 expressing T cells are dysfunctional in terms of their capacities to proliferate or to produce cytokines. In this study, we evaluated the effect of Tim-3 expression on the cytotoxic capabilities of CD8(+) T cells in the context of HIV infection. We investigated the cytotoxic capacity of Tim-3 expressing T cells by examining 1) the ability of Tim-3(+) CD8(+) T cells to make perforin and 2) the direct ability of Tim-3(+) CD8(+) T cells to kill autologous HIV infected CD4(+) target cells. Surprisingly, Tim-3(+) CD8(+) T cells maintain higher levels of perforin, which was mainly in a granule-associated (stored) conformation, as well as express high levels of T-bet. However, these cells were also defective in their ability to degranulate. Blocking the Tim-3 signalling pathway enhanced the cytotoxic capabilities of HIV specific CD8(+) T cells from chronic progressors by increasing; a) their degranulation capacity, b) their ability to release perforin, c) their ability to target activated granzyme B to HIV antigen expressing CD4(+) T cells and d) their ability to suppress HIV infection of CD4(+) T cells. In this latter effect, blocking the Tim-3 pathway enhances the cytotoxcity of CD8(+) T cells from chronic progressors to the level very close to that of T cells from viral controllers. Thus, the Tim-3 receptor, in addition to acting as a terminator for cytokine producing and proliferative functions of CTLs, can also down-regulate the CD8(+) T cell cytotoxic function through inhibition of degranulation and perforin and granzyme secretion.	[Sakhdari, Ali; Yue, Feng Yun; Clayton, Kiera; Jones, Richard Bradley; Liu, Jun; Lee, Erika Yue; Gommerman, Jennifer; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Mujib, Shariq; Vali, Bahareh; MacParland, Sonya; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Benko, Erika; Kovacs, Colin; Ostrowski, Mario A.] Maple Leaf Med Clin, Toronto, ON, Canada; [Ostrowski, Mario A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Sakhdari, A (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	ali.sakhdari@utoronto.ca	Sakhdari, Ali/AAD-9370-2019	Mujib, Shariq/0000-0002-6206-5622; MacParland, Sonya/0000-0002-8036-1425; Sakhdari, Ali/0000-0002-4610-7562; Kaul, Rupert/0000-0002-1586-4093; Gommerman, Jennifer/0000-0003-4576-6168	CIHR (Canadian Institutes of Health Research)	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	The funding source was CIHR (Canadian Institutes of Health Research) who provided funds for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, J ACQUIR IMMUNE DEFI; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Barker E, 1997, J IMMUNOL, V159, P5123; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blackbourn DJ, 1996, P NATL ACAD SCI USA, V93, P13125, DOI 10.1073/pnas.93.23.13125; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; Chun TW, 2001, P NATL ACAD SCI USA, V98, P253, DOI 10.1073/pnas.98.1.253; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Giorgi JV, 1999, IMMUNOL LETT, V66, P105, DOI 10.1016/S0165-2478(98)00170-9; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; HEINKELEIN M, 1995, J ACQ IMMUN DEF SYND, V10, P417, DOI 10.1097/00042560-199512000-00004; Heintel T, 2002, AIDS, V16, P1497, DOI 10.1097/00002030-200207260-00006; Hersperger AR, 2008, CYTOM PART A, V73A, P1050, DOI 10.1002/cyto.a.20596; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Hodgson PD, 1999, CLIN EXP IMMUNOL, V118, P63; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones N, 2006, AIDS RES HUM RETROV, V22, P1007, DOI 10.1089/aid.2006.22.1007; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2009, CELL MOL IMMUNOL, V6, P35, DOI 10.1038/cmi.2009.5; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KANE KP, 1993, J IMMUNOL, V150, P4788; Kuchroo VK, 2006, ADV IMMUNOL, V91, P227, DOI 10.1016/S0065-2776(06)91006-2; Lee SM, 2004, J MED GENET, V41, P137, DOI 10.1136/jmg.2003.011528; Liu HN, 2003, VIRAL IMMUNOL, V16, P381, DOI 10.1089/088282403322396172; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; Meng YR, 2006, J IMMUNOL, V177, P1981, DOI 10.4049/jimmunol.177.3.1981; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mujib S, 2012, J IMMUNOLOGY; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Pollack H, 1997, AIDS, V11, pF9, DOI 10.1097/00002030-199701000-00002; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sakuishi K, 2011, TRENDS IMMUNOL; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Shacklett BL, 2004, J IMMUNOL, V173, P641, DOI 10.4049/jimmunol.173.1.641; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SHIVER JW, 1991, CELL, V64, P1175, DOI 10.1016/0092-8674(91)90272-Z; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Tayade C, 2005, J LEUKOCYTE BIOL, V78, P1347, DOI 10.1189/jlb.0305142; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594; Tsuchie H, 1997, INT J STD AIDS, V8, P307, DOI 10.1258/0956462971920145; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; YOUNG JDE, 1988, IMMUNOL REV, V103, P161, DOI 10.1111/j.1600-065X.1988.tb00755.x; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zhu C, 2011, CURR TOP MICROBIOL, V350, P1, DOI 10.1007/82_2010_84	73	66	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40146	10.1371/journal.pone.0040146	http://dx.doi.org/10.1371/journal.pone.0040146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792231	Green Submitted, gold, Green Published			2022-12-25	WOS:000306436300031
J	Ward, Y; Lake, R; Martin, PL; Killian, K; Salerno, P; Wang, T; Meltzer, P; Merino, M; Cheng, SY; Santoro, M; Garcia-Rostan, G; Kelly, K				Ward, Y.; Lake, R.; Martin, P. L.; Killian, K.; Salerno, P.; Wang, T.; Meltzer, P.; Merino, M.; Cheng, S-Y; Santoro, M.; Garcia-Rostan, G.; Kelly, K.			CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model	ONCOGENE			English	Article						CD97; LPAR; thyroid cancer; metastasis; vascular invasion; anaplastic	LYSOPHOSPHATIDIC ACID; MAMMARY TUMORIGENESIS; TUMOR PROGRESSION; HORMONE RECEPTOR; EXPRESSION; AUTOTAXIN; INVASION; 7-TRANSMEMBRANE; METASTASIS; CARCINOMA	CD97, a member of the adhesion family of G-protein-coupled receptors (GPCRs), complexes with and potentiates lysophosphatidic acid (LPA) receptor signaling to the downstream effector RHOA. We show here that CD97 was expressed in a majority of thyroid cancers but not normal thyroid epithelium and that the level of CD97 expression was further elevated with progression to poorly differentiated and undifferentiated carcinoma. Intratumoral progression also showed that CD97 expression correlates with invasiveness and dedifferentiation. To determine the functional role of CD97, we produced a transgenic model of thyroglobulin promoter-driven CD97 expression. Transgenic CD97 in combination with Thrb(PV), an established mouse model of thyroid follicular cell carcinogenesis, significantly increased the occurrence of vascular invasion and lung metastasis. Expression of transgenic CD97 in thyroid epithelium led to elevated ERK phosphorylation and increased numbers of Ki67 + cells in developing tumors. In addition, tumor cell cultures derived from CD97 transgenic as compared with non-transgenic mice demonstrated enhanced, constitutive and LPA-stimulated ERK activation. In human thyroid cancer cell lines, CD97 depletion reduced RHO-GTP and decreased LPA-stimulated invasion but not EGF-stimulated invasion, further suggesting that CD97 influences an LPA-associated mechanism of progression. Consistent with the above, CD97 expression in human thyroid cancers correlated with LPA receptor and markers of aggressiveness including Ki67 and pAKT. This study shows an autonomous effect of CD97 on thyroid cancer progression and supports the investigation of this GPCR as a therapeutic target for these cancers.	[Ward, Y.; Lake, R.; Martin, P. L.; Kelly, K.] NCI, Cell & Canc Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Killian, K.; Meltzer, P.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Salerno, P.] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Wang, T.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Merino, M.] NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Cheng, S-Y] NCI, Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Santoro, M.] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Garcia-Rostan, G.] Univ Valladolid, Spanish Res Council, Inst Biol & Mol Genet, Valladolid, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Naples Federico II; Universidad de Valladolid	Kelly, K (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, Bldg 37 Room 1068, Bethesda, MD 20892 USA.	kellyka@mail.nih.gov	Rostan, Ginesa Garcia/E-4093-2018	Rostan, Ginesa Garcia/0000-0002-9238-1263	Intramural Research Program; Center for Cancer Research; National Cancer Institute; Programa Ramon y Cajal-Ministerio de Ciencia e Innovacion; Social EU Funds; Universidad de Valladolid, Spain; NATIONAL CANCER INSTITUTE [ZIABC011191, ZIASC009389, ZIABC011091] Funding Source: NIH RePORTER	Intramural Research Program; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Programa Ramon y Cajal-Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Social EU Funds; Universidad de Valladolid, Spain; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program, Center for Cancer Research, National Cancer Institute and the Programa Ramon y Cajal-Ministerio de Ciencia e Innovacion, Social EU Funds, Universidad de Valladolid, Spain. We acknowledge Barbara J Taylor, Subhadra Banerjee, William G Telford, and Veena Kapoor of the CCR FACS Core Facilities and Christopher D Heger of the CCR Antibody and Protein Purification Unit for their excellent technical support. We thank Drs Cameselle-Teijeiro, X Matias-Guiu, A Herrero and M Fresno-Forcelledo for providing human PDC and UC samples.	Adeniran AJ, 2006, AM J SURG PATHOL, V30, P216, DOI 10.1097/01.pas.0000176432.73455.1b; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Cheng SY, 2011, ONCOGENE; DeLellis R, 2004, PATHOLOGY GENETICS T; Gray JX, 1996, J IMMUNOL, V157, P5438; Guo R, 2006, ENDOCRINOLOGY, V147, P4883, DOI 10.1210/en.2005-1635; Gupte R, 2011, CHEMMEDCHEM, V6, P922, DOI 10.1002/cmdc.201000425; Horak CE, 2007, CANCER RES, V67, P11751, DOI 10.1158/0008-5472.CAN-07-3175; Jonkers J, 2009, CANCER CELL, V15, P457, DOI 10.1016/j.ccr.2009.05.003; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Kjellman P, 2003, THYROID, V13, P371, DOI 10.1089/105072503321669866; Kojic SL, 2011, EXPERT REV ANTICANC, V11, P387, DOI [10.1586/ERA.10.179, 10.1586/era.10.179]; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Loberg RD, 2005, UROLOGY, V66, P1321, DOI 10.1016/j.urology.2005.06.094; MEIER CA, 1993, J CLIN INVEST, V92, P1986, DOI 10.1172/JCI116793; Mustafa T, 2005, CANCER EPIDEM BIOMAR, V14, P108; Nagaiah G, 2011, J ONCOL, V2011, DOI 10.1155/2011/542358; Nikiforov YE, 2011, MODERN PATHOL, V24, pS34, DOI 10.1038/modpathol.2010.167; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Sipos JA, 2011, CLIN ONCOL-UK, V22, P395; Sobrinho-Simoes M, 2011, DIAGN HISTOPATHOL, V17, P114, DOI DOI 10.1016/J.MPDHP.2010.12.001; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Stortelers C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-387; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Wiseman SM, 2003, HEAD NECK-J SCI SPEC, V25, P662, DOI 10.1002/hed.10277; Ying H, 2003, CARCINOGENESIS, V24, P1467, DOI 10.1093/carcin/bgg111; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	33	47	48	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2726	2738		10.1038/onc.2012.301	http://dx.doi.org/10.1038/onc.2012.301			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22797060	Bronze, Green Accepted			2022-12-25	WOS:000319808000004
J	Xie, C; Jiang, XH; Zhang, JT; Sun, TT; Dong, JD; Sanders, AJ; Diao, RY; Wang, Y; Fok, KL; Tsang, LL; Yu, MK; Zhang, XH; Chung, YW; Ye, L; Zhao, MY; Guo, JH; Xiao, ZJ; Lan, HY; Ng, CF; Lau, KM; Cai, ZM; Jiang, WG; Chan, HC				Xie, C.; Jiang, X. H.; Zhang, J. T.; Sun, T. T.; Dong, J. D.; Sanders, A. J.; Diao, R. Y.; Wang, Y.; Fok, K. L.; Tsang, L. L.; Yu, M. K.; Zhang, X. H.; Chung, Y. W.; Ye, L.; Zhao, M. Y.; Guo, J. H.; Xiao, Z. J.; Lan, H. Y.; Ng, C. F.; Lau, K. M.; Cai, Z. M.; Jiang, W. G.; Chan, H. C.			CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer	ONCOGENE			English	Article						CFTR; miR-193b; uPA	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; NF-KAPPA-B; MESENCHYMAL TRANSITION; MUC4 EXPRESSION; CELL MIGRATION; MIR-200 FAMILY; BREAST-CANCER; RISK; METHYLATION	Cystic fibrosis (CF) transmembrane conductance regulator (CFTR) is expressed in the epithelial cells of a wide range of organs/tissues from which most cancers are derived. Although accumulating reports have indicated the association of cancer incidence with genetic variations in CFTR gene, the exact role of CFTR in cancer development and the possible underlying mechanism have not been elucidated. Here, we report that CFTR expression is significantly decreased in both prostate cancer cell lines and human prostate cancer tissue samples. Overexpression of CFTR in prostate cancer cell lines suppresses tumor progression (cell growth, adhesion and migration), whereas knockdown of CFTR leads to enhanced malignancies both in vitro and in vivo. In addition, we demonstrate that CFTR knockdown-enhanced cell proliferation, cell invasion and migration are significantly reversed by antibodies against either urokinase plasminogen activator (uPA) or uPA receptor (uPAR), which are known to be involved in various malignant traits of cancer development. More interestingly, overexpression of CFTR suppresses uPA by upregulating the recently described tumor suppressor microRNA-193b (miR-193b), and overexpression of pre-miR-193b significantly reverses CFTR knockdown-enhanced malignant phenotype and abrogates elevated uPA activity in prostate cancer cell line. Finally, we show that CFTR gene transfer results in significant tumor repression in prostate cancer xenografts in vivo. Taken together, the present study has demonstrated a previously undefined tumor-suppressing role of CFTR and its involvement in regulation of miR-193b in prostate cancer development.	[Xie, C.; Jiang, X. H.; Zhang, J. T.; Sun, T. T.; Dong, J. D.; Diao, R. Y.; Wang, Y.; Fok, K. L.; Tsang, L. L.; Yu, M. K.; Zhang, X. H.; Chung, Y. W.; Zhao, M. Y.; Guo, J. H.; Xiao, Z. J.; Chan, H. C.] Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Jiang, X. H.; Chan, H. C.] Chinese Univ Hong Kong, Minist Educ Peoples Republ China, Key Lab Regenerat Med, Jinan Univ, Guangzhou, Guangdong, Peoples R China; [Sanders, A. J.; Ye, L.; Jiang, W. G.] Cardiff Univ, Sch Med, Metastasis & Angiogenesis Res Grp, Dept Surg, Cardiff CF10 3AX, S Glam, Wales; [Diao, R. Y.; Cai, Z. M.] Peking Univ, Shenzhen Hosp, Shenzhen Key Lab Male Reprod Med & Genet, Shenzhen, Peoples R China; [Lan, H. Y.] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Ng, C. F.] Chinese Univ Hong Kong, Div Urol, Dept Surg, Shatin, Hong Kong, Peoples R China; [Lau, K. M.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Chan, H. C.] Sichuan Univ, Chinese Univ Hong Kong, West China Second Univ Hosp, Joint Lab Reprod Med, Chengdu 610064, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Jinan University; Ministry of Education, China; Cardiff University; Peking University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Sichuan University	Jiang, WG (corresponding author), Cardiff Univ, Sch Med, Metastasis & Angiogenesis Res Grp, Dept Surg, Cardiff CF10 3AX, S Glam, Wales.	jiangw@cf.ac.uk; hsiaocchan@cuhk.edu.hk	Fok, Kin Lam/G-2757-2017; Dong, Jianda/C-3338-2018; Chi-fai, NG/AAV-8270-2021; Jiang, Wen G/B-1293-2010; Lan, Hui Yao/C-9734-2015; jiang, wen/GYI-9662-2022; Jiang, Wen G./AAF-1876-2020; Ng, Chi-Fai/E-5134-2011; jiang, cynthia xiaohua/F-7580-2017; Sun, Tung-Tien/J-4425-2015; Chan, Hsiao Chang/E-1507-2016; Ye, Lin/G-9819-2016; Fok, Ellis/M-2784-2019	Fok, Kin Lam/0000-0003-3038-1337; Dong, Jianda/0000-0001-5583-0210; Jiang, Wen G/0000-0002-3283-1111; Lan, Hui Yao/0000-0003-4283-9755; Jiang, Wen G./0000-0002-3283-1111; Ng, Chi-Fai/0000-0002-1723-9646; jiang, cynthia xiaohua/0000-0002-7372-4961; Sun, Tung-Tien/0000-0002-6841-1063; Ye, Lin/0000-0002-0303-2409; Fok, Ellis/0000-0003-3038-1337; Zhang, Xiaohu/0000-0002-5329-1599; Sanders, Andrew/0000-0002-7997-5286; Lau, Kin-Mang/0000-0001-5888-1937	Focused Investment Scheme of the Chinese University of Hong Kong and National 973 project [2012CB944900]; Fundamental Research Funds for the Central Universities (JiNan University);  [GRF-CUHK466111]	Focused Investment Scheme of the Chinese University of Hong Kong and National 973 project; Fundamental Research Funds for the Central Universities (JiNan University); 	The work was supported by the Focused Investment Scheme of the Chinese University of Hong Kong and National 973 project (2012CB944900), GRF-CUHK466111, and the Fundamental Research Funds for the Central Universities (JiNan University). We are grateful to Professor Tzyh-Chang Hwang at Department of Biological Engineering, University of Missouri-Columbia, USA for providing CFTR-peGFP-C3 and control plasmids. The authors thank Mrs Huang Xiao ru and Mr Qin Wei from Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, for their helpful technical assistance.	Abraham EH, 1996, NAT MED, V2, P593, DOI 10.1038/nm0596-593; Boncoeur E, 2008, AM J PATHOL, V172, P1184, DOI 10.2353/ajpath.2008.070310; Chen JM, 2011, AM J PATHOL, V179, P2162, DOI 10.1016/j.ajpath.2011.07.010; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Cozzi PJ, 2006, HUM PATHOL, V37, P1442, DOI 10.1016/j.humpath.2006.05.002; Cuthbert AW, 2011, BRIT J PHARMACOL, V163, P173, DOI 10.1111/j.1476-5381.2010.01137.x; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Ding S, 2004, WORLD J GASTROENTERO, V10, P3433; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumano M, 2009, UROL ONCOL-SEMIN ORI, V27, P180, DOI 10.1016/j.urolonc.2008.01.012; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Li Y, 2010, LUNG CANCER, V70, P14, DOI 10.1016/j.lungcan.2010.01.005; Malinowsky K, 2010, CURR MED CHEM, V17, P4370, DOI 10.2174/092986710793361216; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; McWilliams RR, 2010, CANCER, V116, P203, DOI [10.1002/cncr.24697, 10.1002/cncr.25465]; McWilliams RR, 2005, CANCER, V104, P388, DOI 10.1002/cncr.21166; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; NEGLIA JP, 1995, NEW ENGL J MED, V332, P494, DOI 10.1056/NEJM199502233320803; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Padua RA, 1997, HUM MUTAT, V10, P45, DOI 10.1002/(SICI)1098-1004(1997)10:1<45::AID-HUMU6>3.0.CO;2-L; Qiao D, 2008, J CYST FIBROS, V7, P210, DOI 10.1016/j.jcf.2007.07.011; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Singh AP, 2007, ONCOGENE, V26, P30, DOI 10.1038/sj.onc.1209764; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Son JW, 2011, RESPIROLOGY, V16, P1203, DOI 10.1111/j.1440-1843.2011.01994.x; Southey MC, 1998, INT J CANCER, V79, P487, DOI 10.1002/(SICI)1097-0215(19981023)79:5<487::AID-IJC7>3.3.CO;2-X; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; WARREN N, 1991, BRIT MED J, V302, P760, DOI 10.1136/bmj.302.6779.760; Wiehe Melissa, 2010, AANA J, V78, P246; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	94	100	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2013	32	18					2282	2291		10.1038/onc.2012.251	http://dx.doi.org/10.1038/onc.2012.251			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22797075				2022-12-25	WOS:000318683600005
J	Ea, CK; Hao, SL; Yeo, KS; Baltimore, D				Ea, Chee-Kwee; Hao, ShengLi; Yeo, Kok Siong; Baltimore, David			EHMT1 Protein Binds to Nuclear Factor-kappa B p50 and Represses Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-H3 LYSINE-9 METHYLATION; INTERFERON RESPONSE; IMMUNE-RESPONSES; METHYLTRANSFERASE; CHROMATIN; SITE; G9A; H3; CELLS; HETEROCHROMATIN	Transcriptional homeostasis relies on the balance between positive and negative regulation of gene transcription. Methylation of histone H3 lysine 9 (H3K9) is commonly correlated with gene repression. Here, we report that a euchromatic H3K9 methyltransferase, EHMT1, functions as a negative regulator in both the NF-kappa B- and type I interferon-mediated gene induction pathways. EHMT1 catalyzes H3K9 methylation at promoters of NF-kappa B target genes. Moreover, EHMT1 interacts with p50, and, surprisingly, p50 appears to repress the expression of type I interferon genes and genes activated by type I interferons by recruiting EHMT1 to catalyze H3K9 methylation at their promoter regions. Silencing the expression of EHMT1 by RNA interference enhances expression of a subset NF-kappa B-regulated genes, augments interferon production, and augments antiviral immunity.	[Hao, ShengLi; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Ea, Chee-Kwee; Yeo, Kok Siong] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia	California Institute of Technology; Universiti Malaya	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	YEO, KOK SIONG/D-9910-2010; Yeo, Kok Siong/AAA-8345-2019	Yeo, Kok Siong/0000-0003-2430-2487	National Institutes of Health [2R01GM039458]; University of Malaya HIR [UM.C/625/1/HIR/MOHE/CHAN-02, H-50001-A000022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Malaya HIR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM039458. This work was also supported by the University of Malaya HIR Grant UM.C/625/1/HIR/MOHE/CHAN-02; H-50001-A000022.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; PLAKSIN D, 1993, J EXP MED, V177, P1651, DOI 10.1084/jem.177.6.1651; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	39	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31207	31217		10.1074/jbc.M112.365601	http://dx.doi.org/10.1074/jbc.M112.365601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801426	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000308791300033
J	Stahelin, RV; Kong, KF; Raha, S; Tian, W; Melowic, HR; Ward, KE; Murray, D; Altman, A; Cho, W				Stahelin, Robert V.; Kong, Kok-Fai; Raha, Sumita; Tian, Wen; Melowic, Heather R.; Ward, Katherine E.; Murray, Diana; Altman, Amnon; Cho, Wonhwa			Protein Kinase C theta C2 Domain Is a Phosphotyrosine Binding Module That Plays a Key Role in Its Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; KAPPA-B ACTIVATION; CYTOSOLIC PHOSPHOLIPASE A(2); MEMBRANE-BINDING; DIFFERENTIAL ROLES; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; PHORBOL ESTERS; ALPHA ACTIVITY; PKC-THETA	Protein kinase C theta (PKC theta) is a novel PKC that plays a key role in T lymphocyte activation. To understand how PKC theta is regulated in T cells, we investigated the properties of its N-terminal C2 domain that functions as an autoinhibitory domain. Our measurements show that a Tyr(P)-containing peptide derived from CDCP1 binds the C2 domain of PKC theta with high affinity and activates the enzyme activity of the intact protein. The Tyr(P) peptide also binds the C2 domain of PKC delta tightly, but no enzyme activation was observed with PKC delta. Mutations of PKC theta-C2 residues involved in Tyr(P) binding abrogated the enzyme activation and association of PKC theta with Tyr-phosphorylated full-length CDCP1 and severely inhibited the T cell receptor/CD28-mediated activation of a PKC theta-dependent reporter gene in T cells. Collectively, these studies establish the C2 domain of PKC theta as a Tyr(P)-binding domain and suggest that the domain may play a major role in PKC theta activation via its Tyr(P) binding.	[Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.; Raha, Sumita; Tian, Wen; Melowic, Heather R.; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Stahelin, Robert V.; Ward, Katherine E.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Murray, Diana] Columbia Univ, Dept Pharmacol, New York, NY 11032 USA; [Kong, Kok-Fai; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Cho, Wonhwa] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	Indiana University System; Indiana University South Bend; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Notre Dame; Columbia University; La Jolla Institute for Immunology; Pohang University of Science & Technology (POSTECH)	Stahelin, RV (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 1234 Notre Dame Ave, South Bend, IN 46617 USA.	rstaheli@iupui.edu; wcho@uic.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [CA035299, GM76581, AI081077]; World Class University Program through the National Research Foundation of Korea [R31-2008-000-10105-0]; Ministry of Education, Science, and Technology; American Heart Association Predoctoral Fellowship [AHA 11PRE7640028]; National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship [T32GM075762]; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762, R01GM076581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); American Heart Association Predoctoral Fellowship(American Heart Association); National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA035299 (to A. A.), CA035299 and GM76581 (to W. C.), and AI081077 (to R. S.). This work was also supported by the World Class University Program Grant R31-2008-000-10105-0 (to W. C.) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology.; Supported by American Heart Association Predoctoral Fellowship AHA 11PRE7640028 and National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship T32GM075762.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Corbalan-Garcia S, 2003, BIOCHEMISTRY-US, V42, P11661, DOI 10.1021/bi034850d; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Das J, 2004, J BIOL CHEM, V279, P37964, DOI 10.1074/jbc.M405137200; Das J, 2006, PROTEIN SCI, V15, P2107, DOI 10.1110/ps.062237606; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Kates M., 1986, TECHNIQUES LIPIDOLOG, P114; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Lopez-Andreo MJ, 2003, MOL BIOL CELL, V14, P4885, DOI 10.1091/mbc.E03-05-0295; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pepio AM, 1998, J BIOL CHEM, V273, P19040, DOI 10.1074/jbc.273.30.19040; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Slater SJ, 1997, J BIOL CHEM, V272, P6167, DOI 10.1074/jbc.272.10.6167; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Slater SJ, 2001, BBA-PROTEIN STRUCT M, V1544, P207, DOI 10.1016/S0167-4838(00)00222-3; Slater SJ, 2003, BIOCHEMISTRY-US, V42, P12105, DOI 10.1021/bi034860e; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	60	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30518	30528		10.1074/jbc.M112.391557	http://dx.doi.org/10.1074/jbc.M112.391557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787157	Green Published, hybrid			2022-12-25	WOS:000308579800044
J	Chen, WH; Zhou, W; Xia, T; Gu, X				Chen, Wenhai; Zhou, Wen; Xia, Tian; Gu, Xun			A Computational Analysis Framework for Molecular Cell Dynamics: Case-Study of Exocytosis	PLOS ONE			English	Article							SINGLE-MOLECULE; SYNAPTOTAGMIN; ACTIVATION; MECHANISMS; SNAREPINS; SENSOR	One difficulty in conducting biologically meaningful dynamic analysis at the systems biology level is that in vivo system regulation is complex. Meanwhile, many kinetic rates are unknown, making global system analysis intractable in practice. In this article, we demonstrate a computational pipeline to help solve this problem, using the exocytotic process as an example. Exocytosis is an essential process in all eukaryotic cells that allows communication in cells through vesicles that contain a wide range of intracellular molecules. During this process a set of proteins called SNAREs acts as an engine in this vesicle-membrane fusion, by forming four-helical bundle complex between (membrane) target-specific and vesicle-specific SNAREs. As expected, the regulatory network for exocytosis is very complex. Based on the current understanding of the protein-protein interaction network related to exocytosis, we mathematically formulated the whole system, by the ordinary differential equations (ODE). We then applied a mathematical approach (called inverse problem) to estimating the kinetic parameters in the fundamental subsystem (without regulation) from limited in vitro experimental data, which fit well with the reports by the conventional assay. These estimates allowed us to conduct an efficient stability analysis under a specified parameter space for the exocytotic process with or without regulation. Finally, we discuss the potential of this approach to explain experimental observations and to make testable hypotheses for further experimentation.	[Chen, Wenhai; Gu, Xun] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Chen, Wenhai; Gu, Xun] Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China; [Zhou, Wen] Iowa State Univ, Dept Math, Ames, IA USA; [Xia, Tian] Iowa State Univ, Elect & Comp Engn Dept, Ames, IA USA; [Xia, Tian] Northwestern Univ, Clin & Translat Sci Inst, Biomed Informat Ctr, Chicago, IL 60611 USA; [Gu, Xun] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Fudan University; Fudan University; Iowa State University; Iowa State University; Northwestern University; Iowa State University	Chen, WH (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	tianxia@northwestern.edu; xgu@iastate.edu						Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; DeVries G., 2006, COURSE MATH BIOL QUA; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Keener J., 2001, MATH PHYSL; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lorenzi A, 2014, INTRO IDENTIFICATION, P83; Lu XB, 2005, J BIOL CHEM, V280, P30538, DOI 10.1074/jbc.M506862200; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Mezer A, 2004, J NEUROSCI, V24, P8838, DOI 10.1523/JNEUROSCI.2815-04.2004; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; Perko L, 2000, DIFFER EQUAT DYN SYS; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Vogel C. R., 2002, FRONT APPL MATH, DOI DOI 10.1137/1.9780898717570; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Xia T, 2012, BMC SYSTEMS IN PRESS	29	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38699	10.1371/journal.pone.0038699	http://dx.doi.org/10.1371/journal.pone.0038699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808014	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400005
J	Ikeda, Y; Tajima, S; Izawa-Ishizawa, Y; Kihira, Y; Ishizawa, K; Tomita, S; Tsuchiya, K; Tamaki, T				Ikeda, Yasumasa; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Ishizawa, Keisuke; Tomita, Shuhei; Tsuchiya, Koichiro; Tamaki, Toshiaki			Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes	PLOS ONE			English	Article							IRON-METABOLISM; SERUM HEPCIDIN; MESSENGER-RNA; G-PROTEIN; RECEPTOR; MICE; CELLS; INFLAMMATION; ESTRADIOL; MECHANISM	Hepcidin, a liver-derived iron regulatory protein, plays a crucial role in iron metabolism. It is known that gender differences exist with respect to iron storage in the body; however, the effects of sex steroid hormones on iron metabolism are not completely understood. We focused on the effects of the female sex hormone estrogen on hepcidin expression. First, ovariectomized (OVX) and sham-operated mice were employed to investigate the effects of estrogen on hepcidin expression in an in vivo study. Hepcidin expression was decreased in the livers of OVX mice compared to the sham-operated mice. In OVX mice, bone morphologic protein-6 (BMP6), a regulator of hepcidin, was also found to be downregulated in the liver, whereas ferroportin (FPN), an iron export protein, was upregulated in the duodenum. Both serum and liver iron concentrations were elevated in OVX mice relative to their concentrations in sham-operated mice. In in vitro studies, 17 beta-estradiol (E-2) increased the mRNA expression of hepcidin in HepG2 cells in a concentration-dependent manner. E-2-induced hepatic hepcidin upregulation was not inhibited by ICI 182720, an inhibitor of the estrogen receptor; instead, hepcidin expression was increased by ICI 182720. E-2 and ICI 182720 exhibit agonist actions with G-protein coupled receptor 30 (GPR30), the 7-transmembrane estrogen receptor. G1, a GPR30 agonist, upregulated hepcidin expression, and GPR30 siRNA treatment abolished E-2-induced hepcidin expression. BMP6 expression induced by E-2 was abolished by GPR30 silencing. Finally, both E-2 and G1 supplementation restored reduced hepatic hepcidin and BMP6 expression and reversed the augmentation of duodenal FPN expression in the OVX mice. In contrast, serum hepcidin was elevated in OVX mice, which was reversed in these mice with E-2 and G1. Thus, estrogen is involved in hepcidin expression via a GPR30-BMP6-dependent mechanism, providing new insight into the role of estrogen in iron metabolism.	[Ikeda, Yasumasa; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Tomita, Shuhei; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Dept Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan; [Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Dept Med Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University; Tokushima University	Ikeda, Y (corresponding author), Univ Tokushima, Grad Sch, Dept Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan.	yasuike@basic.med.tokushima-u.ac.jp		Ikeda, Yasumasa/0000-0003-4318-7349	Grants for the Regional Innovation Cluster Program; Houansha Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Tokushima Shinbun Foundation; Akaeda Foundation for Medical Research; Grants-in-Aid for Scientific Research [23790089, 24590381] Funding Source: KAKEN	Grants for the Regional Innovation Cluster Program; Houansha Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokushima Shinbun Foundation; Akaeda Foundation for Medical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants for the Regional Innovation Cluster Program and Houansha Foundation (to TT.), Grants-in-Aid for Young Scientist B, the Uehara Memorial Foundation, Takeda Science Foundation, Tokushima Shinbun Foundation, and Akaeda Foundation for Medical Research (to YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Cheng XL, 2006, LIFE SCI, V79, P1988, DOI 10.1016/j.lfs.2006.06.044; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Floreani A, 2011, CLIN CHEM LAB MED, V49, P197, DOI 10.1515/CCLM.2011.055; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Itkonen O, 2011, CLIN CHIM ACTA; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Kijima H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-167; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Luque-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P846, DOI 10.1210/jc.2010-2211; Marino M, 2001, MOL CELL ENDOCRINOL, V182, P19, DOI 10.1016/S0303-7207(01)00556-1; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Milman N, 1996, INT J HEMATOL, V63, P103; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Solakidi S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P240; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Viatte L, 2005, BLOOD, V105, P4861, DOI 10.1182/blood-2004-12-4608; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205	35	81	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40465	10.1371/journal.pone.0040465	http://dx.doi.org/10.1371/journal.pone.0040465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792339	gold, Green Published, Green Submitted			2022-12-25	WOS:000306362400060
J	Lopez-Arbarello, A				Lopez-Arbarello, Adriana			Phylogenetic Interrelationships of Ginglymodian Fishes (Actinopterygii: Neopterygii)	PLOS ONE			English	Article							PECTORAL GIRDLE; SEMIONOTIFORM ACTINOPTERYGII; SWITZERLAND; EVOLUTION; REVISION; PROVINCE; GERMANY; PISCES; LEPISOSTEUS; HOMOLOGY	The Ginglymodi is one of the most common, though poorly understood groups of neopterygians, which includes gars, macrosemiiforms, and "semionotiforms." In particular, the phylogenetic relationships between the widely distributed "semionotiforms," and between them and other ginglymodians have been enigmatic. Here, the phylogenetic relationships between eight of the 11 "semionotiform" genera, five genera of living and fossil gars and three macrosemiid genera, are analysed through cladistic analysis, based on 90 morphological characters and 37 taxa, including 7 out-group taxa. The results of the analysis show that the Ginglymodi includes two main lineages: Lepisosteiformes and dagger Semionotiformes. The genera dagger Pliodetes, dagger Araripelepidotes, dagger Lepidotes, dagger Scheenstia, and dagger Isanichthys are lepisosteiforms, and not semionotiforms, as previously thought, and these taxa extend the stratigraphic range of the lineage leading to gars back up to the Early Jurassic. A monophyletic dagger Lepidotes is restricted to the Early Jurassic species, whereas the strongly tritoral species previously referred to dagger Lepidotes are referred to dagger Scheenstia. Other species previously referred to dagger Lepidotes represent other genera or new taxa. The macrosemiids are well nested within semionotiforms, together with dagger Semionotidae, here restricted to dagger Semionotus, and a new family including dagger Callipurbeckia n. gen. minor (previously referred to dagger Lepidotes), dagger Macrosemimimus, dagger Tlayuamichin, dagger Paralepidotus, and dagger Semiolepis. Due to the numerous taxonomic changes needed according to the phylogenetic analysis, this article also includes formal taxonomic definitions and diagnoses for all generic and higher taxa, which are new or modified. The study of Mesozoic ginglymodians led to confirm Patterson's observation that these fishes show morphological affinities with both halecomorphs and teleosts. Therefore, the compilation of large data sets including the Mesozoic ginglymodians and the re-evaluation of several hypotheses of homology are essential to test the hypotheses of the Halecostomi vs. the Holostei, which is one of the major topics in the evolution of Mesozoic vertebrates and the origin of modern fish faunas.	Bayer Staatssammlung Palaontol & Geol, Munich, Germany		Lopez-Arbarello, A (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	a.Lopez-Arbarello@lrz.uni-muenchen.de	Lopez-Arbarello, Adriana/N-1834-2018	Lopez-Arbarello, Adriana/0000-0002-2924-3319	German Research Foundation [DFG LO1405/1, LO1405/3]; European Commission's Research Infrastructure Action [SYNTHESYS FR-TAF 2079]; Volkswagen Foundation	German Research Foundation(German Research Foundation (DFG)); European Commission's Research Infrastructure Action(European CommissionEuropean Commission Joint Research Centre); Volkswagen Foundation(Volkswagen)	This work has been supported by the German Research Foundation (http://www.dfg.de/) through the projects DFG LO1405/1 and LO1405/3, the European Commission's Research Infrastructure Action (http://www.synthesys.info/) through the grant SYNTHESYS FR-TAF 2079, and the Volkswagen Foundation (http://www.volkswagenstiftung.de/) through the project "Die Dynamik des Solnhofener Archipels". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassiz L., 1841, EDINBURGH NEW PHILOS, V30, P82; Agassiz L., 1832, NEUES JB MINERALOGIE, V3, P139; Allis E. P., 1889, J MORPHOL, V2, DOI 10.1002/jmor.1050020303; Allis E. P., 1898, J MORPHOL, V14, DOI [10.1002/jmor.1050140303, DOI 10.1002/JMOR.1050140303]; Allis EP., 1909, ZOOLOGICA, V57, P96; [Anonymous], 1833, RECHERCHES POISSONS; Arambourg C, 1958, TRAITE ZOOL, V13, P2173; ARRATIA G, 1991, J MORPHOL, V208, P1, DOI 10.1002/jmor.1052080102; Arratia G, 2001, J VERTEBR PALEONTOL, V21, P767, DOI 10.1671/0272-4634(2001)021[0767:TSGOTC]2.0.CO;2; Arratia G, 2007, J VERTEBR PALEONTOL, V27, P838, DOI 10.1671/0272-4634(2007)27[838:ANHFFT]2.0.CO;2; Arratia Gloria, 1999, P265; Arratia Gloria, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P135; Arratia Gloria, 2000, Estudios Oceanologicos, V19, P19; Arratia G, 2008, GEOL SOC SPEC PUBL, V295, P71, DOI 10.1144/SP295.6; Aumonier FJ, 1941, Q J MICROSC SCI, V83, P1; Bartram A. W. H., 1977, Bulletin Br. Mus. nat. Hist. (Geol.), V29, P137; Beltan L.L., 1972, Cienc Artes Barcelona, V41, P281; Berg L. S., 1940, Travaux de l'Institut de Zoologie Acad Sci Leningrad, V5, P87; Bjerring H.C., 1971, Acta Zoologica Stockholm, V52, P189; Bjerring H.C., 1972, Zoologica Scr, V(5), P193; Bjerring H. C., 1968, P341; Bjerring H. C., 1967, P223; Blainville H.de., 1818, NOUVEAU DICT HIST NA, V27, P310; BOCCHINO R A, 1973, Ameghiniana, V10, P254; Branco W., 1885, JB K ONIGLICH PREUSS, V1884, P181; Brito Paulo M., 1997, Geodiversitas, V19, P681; BRITO PM, 1988, GEOBIOS-LYON, V21, P819, DOI 10.1016/S0016-6995(88)80098-6; Brough J., 1939, TRIASSIC FISHES BESA; Bryant HN, 1997, CLADISTICS, V13, P337, DOI 10.1111/j.1096-0031.1997.tb00323.x; Cavin L, 2006, PALAEONTOLOGY, V49, P339, DOI 10.1111/j.1475-4983.2006.00539.x; Cavin L, 2001, B SOC GEOL FR, V172, P661, DOI 10.2113/172.5.661; Cavin L, 2010, NATURWISSENSCHAFTEN, V97, P1035, DOI 10.1007/s00114-010-0722-7; Chang M.M., 1977, MEM I VERT PALEONTOL, V12, P1; Coates MI, 1999, PHILOS T R SOC B, V354, P435, DOI 10.1098/rstb.1999.0396; Cope E.D., 1872, P AM SOC ADVANCEMENT, V20, P317; Cuvier G, 1825, RECHERCHES OSSEMENS, V3; Danil'chenko PG, 1964, OSNOVY PALEONTOLOGII, P378; Deecke W., 1889, PALAEONTOGRAPHICA, V35, P13; DEPINNA MCC, 1991, CLADISTICS, V7, P367; DEQUEIROZ K, 1990, SYST ZOOL, V39, P307, DOI 10.2307/2992353; Forey P. L., 2011, PALAEONTOL ELECTRON, V14, P1; Gallo Valeria, 2004, P253; Gardiner B. G., 1967, Bulletin of the British Museum (Natural History) Geology, V14, P143; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; GARDINER BG, 1989, ZOOL J LINN SOC-LOND, V97, P135, DOI 10.1111/j.1096-3642.1989.tb00550.x; Gardiner Brian G., 1996, P117, DOI 10.1016/B978-012670950-6/50007-2; GARDINER BRIAN GEORGE, 1960, BULL BRIT MUS [NAT HIST] GEOL, V4, P239; Godefroit Pascal, 1994, Memoires pour Servir a l'Explication des Cartes Geologiques et Minieres de la Belgique, V39, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Gonzalez-Rodriguez K, 2004, J VERTEBR PALEONTOL, V24, P281, DOI 10.1671/1862; Gonzalez-Rodriguez Katia, 2004, P265; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande L, 2010, COPEIA, P1; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; HAMMARBERG FIGGE, 1937, ACTA ZOOLOGICA, V18, P209; Hay O. P., 1929, Vol I Carneg Inst Washington pub, V390, pUnpaginated; Hennig E., 1914, ARCH BIONTOLOGIE, V3, P293; Hilton Eric J., 2011, Fieldiana-Life and Earth Sciences, V3, P1; Hilton EJ, 2009, J SYST PALAEONTOL, V7, P427, DOI 10.1017/S1477201909002740; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Huxley TH., 1861, MEM GEOL SURV UK, V10, P1; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Jaekel O, 1929, MITTEILUNGEN MECKLEN, V3, P13; Jain S.L., 1985, Journal of the Palaeontological Society of India, V30, P18; Jain S.L., 1983, Journal of the Palaeontological Society of India, V28, P7; JAIN SOHAN LALL, 1963, PROC ZOOL SOC LONDON, V141, P119; JOLLIE M, 1986, CAN J ZOOL, V64, P365, DOI 10.1139/z86-058; JOLLIE M, 1984, COPEIA, P476, DOI 10.2307/1445204; JOLLIE M, 1975, J MORPHOL, V147, P61, DOI 10.1002/jmor.1051470106; Kriwet Juergen, 2005, Zitteliana Reihe A, V45, P135; L?pez-Arbarello A., 2008, REV ASOC GEOL ARGENT, V63, P586; Lacepede B. G. E., 1803, HIST NATURELLE POISS, V5; Lambers P.H, 1994, GEOBIOS, V27, P91, DOI 10.1016/S0016-6995(94)80024-3; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; LEHMAN JEAN-PIERRE, 1952, K SVENSKA VETENSKAPS AKAD HANDL, V2, P1; Lehman JP, 1966, ORIGINE VERTEBRES LE, VIV, P1; Lombardo C, 2001, RIV ITAL PALEONTOL S, V107, P345, DOI 10.13130/2039-4942/5439; Lombardo C., 2008, MESOZOIC FISHES, P129; Lopez-Arbarello A, 2008, PALAEONTOLOGY, V51, P1025, DOI 10.1111/j.1475-4983.2008.00806.x; Lopez-Arbarello A, 2008, PALAEONTOL Z, V82, P40; Lopez-Arbarello A, 2007, J VERTEBR PALEONTOL, V27, P811, DOI 10.1671/0272-4634(2007)27[811:SNSFTL]2.0.CO;2; Lopez-Arbarello A, 2006, J VERTEBR PALEONTOL, V26, p91A; Lopez-Arbarello A, 2011, ZOOTAXA, P1; Lopez-Arbarello A, 2011, J SYST PALAEONTOL, V9, P197, DOI 10.1080/14772019.2010.493751; Lopez-Arbarello Adriana, 2011, Zootaxa, V2749, P25; Lopez-Arbarello Adriana, 2004, P597; Lopez-Arbarello A, 2010, PALAEONTOLOGY, V53, P249, DOI 10.1111/j.1475-4983.2010.00931.x; MADDISON WP, 1984, SYST ZOOL, V33, P83, DOI 10.2307/2413134; Maddison WP, 2017, MESQUITE MODULAR SYS; Maisch Michael W., 2004, Palaeontologische Zeitschrift, V78, P161; Maisey JG, 1991, SANTANA FOSSILS ILLU; Malzahn E., 1963, Geologisches Jahrbuch, V80, P539; McAllister D.E., 1968, B NATL MUSEUM CANADA, V221, P1; MCCUNE AR, 1986, PALAEONTOLOGY, V29, P213; Micklich N., 2001, KAUPIA, V11, P73; Nelson JS, 1984, FISHES WORLD; Newberry J., 1888, US GEOLOGICAL SURVEY, V14, P1; NIELSEN E, 1942, MEDDELELSER GRONLAND, V138, P1; NIELSEN EIGIL, 1949, MEDDEL GRONLAND, V146, P1; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; NORMARK BB, 1991, MOL BIOL EVOL, V8, P819; Nybelin O., 1966, Bulletin of the British Museum (Natural History) Geology, V11, P351; Olsen P.E., 1991, Journal of Vertebrate Paleontology, V11, P269; Olsen PE., 1984, J VERTEBR PALEONTOL, V4, P481, DOI [10.1080/02724634.1984.10012024, DOI 10.1080/02724634.1984.10012024]; Owen R., 1860, PALAEONTOLOGY SYSTEM; PATTERSON C, 1982, AM ZOOL, V22, P241; Patterson C., 1973, Zoological J Linn Soc, V53, P233; PATTERSON C, 1975, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V88, P156; Patterson C, 1977, PROBLEMS VERTEBRATE, P1; Pehrson Torsten, 1940, ACTA ZOOL [STOCKHOLM], V21, P1; Piveteau J, 1935, ANN PALEONTOL, V23, P81; Poplin Cecile, 2004, P165; Quenstedt FA, 1847, UBER LEPIDOTUS LIAS; Rafinesque, 1820, W REV MISCELLANEOUS, V3, P165; Regan CT, 1923, P ZOOL SOC LOND, V1923, P445; Saint-Seine P.de., 1949, Nouvelles Archives du Museum d'Histoire Naturelle de Lyon Fasc, V2, P1; Sanford CPJ., 2000, THESES ZOOL, V33, P264; Santos R.daS., 1990, ANAIS ACAD BRASILEIR, V63, P239; Sauvage H.E., 1893, B SOC GEOLOGIQUE NOR, V14, P3; SCHAEFFER BOBB, 1950, AMER MUS NOVITATES, V1457, P1; Schroder KM, 2012, J VERTEBR PALEONTOL, V32, P512, DOI 10.1080/02724634.2012.649626; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Stensio E., 1921, TRIASSIC FISHES SPTI; STENSIo ERIE A., 1932, MEDDELEL OM GRONLAND, V83, P1; Stolley E., 1920, Palaeontographica Stuttgart, V63; Su Dezao, 1996, Vertebrata Palasiatica, V34, P91; SU DZ, 1981, VERTEBRAT PALASIATIC, V19, P107; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Teixeira C., 1947, Broteria Lisbon, V16, P53; Thies D, 1996, J VERTEBR PALEONTOL, V16, P369, DOI 10.1080/02724634.1996.10011326; Thies D., 1989, Journal of Vertebrate Paleontology, V9, P18; Thies Detlev, 2008, Geologica et Palaeontologica, V42, P23; Thiolliere V., 1858, B SOC GEOLOGIQUE FRA, V2, P782; Tintori A, 2007, RIV ITAL PALEONTOL S, V113, P369, DOI 10.13130/2039-4942/5881; Tintori Andrea, 1996, P167; Wagner A, 1863, ABHANDLUNGEN KONIGLI, VIII, P138; Wei F., 1976, VERTEBRAT PALASIATIC, V14, P154; Wen W, 2012, ACTA PALAEONTOL POL, V57, P149, DOI 10.4202/app.2010.0089; Wenz S, 2003, GEODIVERSITAS, V25, P481; WENZ S, 1992, CR ACAD SCI II, V314, P1519; Wenz S, 1968, CAHIERS PALEONTOLOGI, P1; Wenz S., 1999, MESOZOIC FISHES, P107; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; Wiley E.O., 1976, Miscellaneous Publs Mus nat Hist Univ Kans, VNo. 64, P1; Woodward, 1916, PALAEONTOGR SOC, V2, P49; Woodward A.S., 1895, MEMOIRS GEOLOGICAL S, V9, P1; Woodward A.S., 1888, Q J GEOL SOC LOND, V44, P138; Woodward AS, 1897, P YORKS GEOL SOC, V13, P325; WOODWARD AS, 1890, MEMOIRS GEOLOGICAL S, V4, P1, DOI DOI 10.1080/00222939008694061; Xu GH, 2011, ZOOL J LINN SOC-LOND, V161, P595, DOI 10.1111/j.1096-3642.2010.00645.x; Zambelli R., 1987, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V10, P1; [No title captured]; [No title captured]	156	103	108	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39370	10.1371/journal.pone.0039370	http://dx.doi.org/10.1371/journal.pone.0039370			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808031	Green Submitted, gold, Green Published			2022-12-25	WOS:000306362400010
J	Liu, YS; Feng, YP; Xie, JX; Luo, ZJ; Shen, CH; Niu, F; Zou, J; Tang, SF; Hao, J; Xu, JX; Xiao, LP; Xu, XM; Zhu, H				Liu, Yan-Sheng; Feng, Ya-Ping; Xie, Jia-Xin; Luo, Zhuo-Jing; Shen, Cai-Hong; Niu, Fang; Zou, Jian; Tang, Shao-Feng; Hao, Jiang; Xu, Jia-Xiang; Xiao, Li-Ping; Xu, Xiao-Ming; Zhu, Hui			A Novel First Aid Stretcher for Immobilization and Transportation of Spine Injured Patients	PLOS ONE			English	Article							LIFE-SUPPORT; BOARD; TRAUMA	Effective immobilization and transportation are vital to the life-saving acute medical care needed when treating critically injured people. However, the most common types of stretchers used today are wrought with problems that can lead to further medical complications, difficulty in employment and rescue, and ineffective transitions to hospital treatment. Here we report a novel first aid stretcher called the "emergency carpet'', which solves these problems with a unique design for spine injured patients. Polyurethane composite material, obtained by a novel process of manually mixing isocyanate and additives, can be poured into a specially designed fabric bag and allowed to harden to form a rigid human-shaped stretcher. The effectiveness of the emergency carpet was examined in the pre-hospital management of victims with spinal fractures. Additionally, it was tested on flat ground and complex terrain as well as in the sea and air. We demonstrated that the emergency carpet can be assembled and solidified on the scene in 5 minutes, providing effective immobilization to the entire injured body. With the protection of the emergency carpet, none of the 20 patients, who were finally confirmed to have spinal column fracture or dislocation, had any neurological deterioration during transportation. Furthermore, the carpet can be handled and transported by multiple means under differing conditions, without compromising immobilization. Finally, the emergency carpet allows the critically injured patient to receive multiple examinations such as X-ray, CT, and MRI without being removed from the carpet. Our results demonstrate that the emergency carpet has ideal capabilities for immobilization, extrication, and transportation of the spine injured patients. Compared with other stretchers, it allows for better mobility, effective immobilization, remarkable conformity to the body, and various means for transportation. The emergency carpet is promising for its intrinsic advantages in the pre-hospital management of accident victims.	[Liu, Yan-Sheng; Feng, Ya-Ping; Xie, Jia-Xin; Shen, Cai-Hong; Niu, Fang; Tang, Shao-Feng; Zhu, Hui] Kunming Gen Hosp Peoples Liberat Army, Peoples Liberat Army Clin Ctr Spinal Cord Injury, Kunming, Peoples R China; [Luo, Zhuo-Jing] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Orthopaed, Xian 710032, Peoples R China; [Zou, Jian] Nanjing Med Univ, Wuxi Affiliated Hosp 1, Dept Clin Lab Sci, Wuxi, Peoples R China; [Hao, Jiang] Kunming Gen Hosp Peoples Liberat Army, Emergency Dept, Kunming, Peoples R China; [Xu, Jia-Xiang; Xiao, Li-Ping] Yunnan Emergency Ctr, Kunming, Peoples R China; [Xu, Xiao-Ming] Indiana Univ, Sch Med, Dept Neurol Surg, Stark Neurosci Res Inst,Spinal Cord & Brain Injur, Indianapolis, IN USA	Air Force Military Medical University; Nanjing Medical University; Indiana University System; Indiana University-Purdue University Indianapolis	Liu, YS (corresponding author), Kunming Gen Hosp Peoples Liberat Army, Peoples Liberat Army Clin Ctr Spinal Cord Injury, Kunming, Peoples R China.	xu26@iupui.edu; kmzhuhui@sina.com		Xu, Xiao-ming/0000-0002-7229-0081				CHAN D, 1994, ANN EMERG MED, V23, P48, DOI 10.1016/S0196-0644(94)70007-9; CORDELL WH, 1995, ANN EMERG MED, V26, P31, DOI 10.1016/S0196-0644(95)70234-2; Fromm R E Jr, 1992, J Intensive Care Med, V7, P223; Johnson DR, 1996, AM J EMERG MED, V14, P369, DOI 10.1016/S0735-6757(96)90051-0; Johnson K, 2002, CRIT CARE, V6, P439, DOI 10.1186/cc1538; Kwan I, 2005, PREHOSP DISASTER MED, V20, P47, DOI 10.1017/S1049023X00002144; Lovell M E, 1993, J R Army Med Corps, V139, P98; LOVELL ME, 1994, INJURY, V25, P179, DOI 10.1016/0020-1383(94)90158-9; Luscombe MD, 2003, EMERG MED J, V20, P476, DOI 10.1136/emj.20.5.476; Main PW, 1996, J ACCID EMERG MED, V13, P34; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Velmahos GC, 2004, J AM COLL SURGEONS, V199, P62, DOI 10.1016/j.jamcollsurg.2004.02.022; Wang HE, 2009, QUAL SAF HEALTH CARE, V18, P213, DOI 10.1136/qshc.2007.024562	13	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39544	10.1371/journal.pone.0039544	http://dx.doi.org/10.1371/journal.pone.0039544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792181	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700012
J	Mollah, ZU; Graham, KL; Krishnamurthy, B; Trivedi, P; Brodnicki, TC; Trapani, JA; Kay, TW; Thomas, HE				Mollah, Zia U.; Graham, Kate L.; Krishnamurthy, Balasubramanian; Trivedi, Prerak; Brodnicki, Thomas C.; Trapani, Joseph A.; Kay, Thomas W.; Thomas, Helen E.			Granzyme B Is Dispensable in the Development of Diabetes in Non-Obese Diabetic Mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CYTOCHROME-C RELEASE; CD8 T-CELL; DEFICIENT MICE; NOD MICE; CASPASE ACTIVATION; INDUCED APOPTOSIS; MOUSE GRANZYME; PERFORIN; DEATH	Pancreatic beta cell destruction in type 1 diabetes is mediated by cytotoxic CD8(+) T lymphoctyes (CTL). Granzyme B is an effector molecule used by CTL to kill target cells. We previously showed that granzyme B-deficient allogeneic CTL inefficiently killed pancreatic islets in vitro. We generated granzyme B-deficient non-obese diabetic (NOD) mice to test whether granzyme B is an important effector molecule in spontaneous type 1 diabetes. Granzyme B-deficient islet antigen-specific CD8+ T cells had impaired homing into islets of young mice. Insulitis was reduced in granzyme B-deficient mice at 70 days of age (insulitis score 0.043 +/- 0.019 in granzyme B-deficient versus 0.139 +/- 0.034 in wild-type NOD mice p<0.05), but was similar to wild-type at 100 and 150 days of age. We observed a reduced frequency of CD3(+)CD8(+) T cells in the islets and peripheral lymphoid tissues of granzyme B-deficient mice (p<0.005 and p<0.0001 respectively), but there was no difference in cell proportions in the thymus. Antigen-specific CTL developed normally in granzyme B-deficient mice, and were able to kill NOD islet target cells as efficiently as wild-type CTL in vitro. The incidence of spontaneous diabetes in granzyme B-deficient mice was the same as wild-type NOD mice. We observed a delayed onset of diabetes in granzyme B-deficient CD8-dependent NOD8.3 mice (median onset 102.5 days in granzyme B-deficient versus 57.50 days in wild-type NOD8.3 mice), which may be due to the delayed onset of insulitis or inefficient priming at an earlier age in this accelerated model of diabetes. Our data indicate that granzyme B is dispensable for beta cell destruction in type 1 diabetes, but is required for efficient early activation of CTL.	[Mollah, Zia U.; Graham, Kate L.; Krishnamurthy, Balasubramanian; Trivedi, Prerak; Brodnicki, Thomas C.; Kay, Thomas W.; Thomas, Helen E.] St Vincents Inst, Fitzroy, Vic, Australia; [Trivedi, Prerak; Brodnicki, Thomas C.; Kay, Thomas W.; Thomas, Helen E.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Trapani, Joseph A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Mollah, ZU (corresponding author), St Vincents Inst, Fitzroy, Vic, Australia.	hthomas@svi.edu.au		Trapani, Joseph/0000-0003-0983-1532; Brodnicki, Thomas/0000-0003-2294-315X	National Health and Medical Research Council of Australia (NHMRC): NHMRC/JDRF special program grant in type 1 diabetes [APP466658]; NHMRC Career Development Fellowship [APP620232]; NHMRC [APP502605]; Juvenile Diabetes Research Foundation (JDRF): JDRF Postdoctoral Fellowship [4-2006-1025]; JDRF Postdoctoral Fellowship [4-2006-1025]; JDRF Career Development Award; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC): NHMRC/JDRF special program grant in type 1 diabetes(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation (JDRF): JDRF Postdoctoral Fellowship; JDRF Postdoctoral Fellowship(Juvenile Diabetes Research Foundation); JDRF Career Development Award(Juvenile Diabetes Research Foundation); Victorian Government's Operational Infrastructure Support Program	This work was funded by National Health and Medical Research Council of Australia (NHMRC) (http://www.nhmrc.gov.au/): NHMRC/JDRF special program grant in type 1 diabetes APP466658; NHMRC project grant APP502605; NHMRC Career Development Fellowship (HT) APP620232; Juvenile Diabetes Research Foundation (JDRF) http://www.jdrf.org/): JDRF Postdoctoral Fellowship (ZM) 4-2006-1025; JDRF Postdoctoral Fellowship (KG) 4-2006-1025; JDRF Career Development Award (BK); The Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Amrani A, 1999, J CLIN INVEST, V103, P1201, DOI 10.1172/JCI6266; Angstetra E, 2009, IMMUNOL CELL BIOL, V87, P178, DOI 10.1038/icb.2008.81; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Darwiche R, 2003, J IMMUNOL, V170, P6292, DOI 10.4049/jimmunol.170.12.6292; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Dudek NL, 2006, DIABETES, V55, P2412, DOI 10.2337/db06-0109; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Estella E, 2006, DIABETES, V55, P2212, DOI 10.2337/db06-0129; Graham KL, 2011, AM J PATHOL, V178, P2716, DOI 10.1016/j.ajpath.2011.02.015; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Kagi D, 1997, J EXP MED, V186, P989, DOI 10.1084/jem.186.7.989; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Leiter EH, 2009, DIABETES, V58, P1700, DOI 10.2337/db09-0120; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Nakayama M, 2007, J CLIN INVEST, V117, P1835, DOI 10.1172/JCI31368; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; SUMIDA T, 1994, INT IMMUNOL, V6, P1445, DOI 10.1093/intimm/6.9.1445; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Sutton VR, 2006, TRANSPLANTATION, V81, P146, DOI 10.1097/01.tp.0000191939.68451.d9; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Toso C, 2009, TRANSPLANTATION, V88, P1286, DOI 10.1097/TP.0b013e3181bc06b0; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Zajac AJ, 2003, VIROLOGY, V305, P1, DOI 10.1006/viro.2002.1754	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40357	10.1371/journal.pone.0040357	http://dx.doi.org/10.1371/journal.pone.0040357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792290	Green Published, gold			2022-12-25	WOS:000306354700038
J	Paul, D; Busireddy, A; Nagaraja, SB; Satyanarayana, S; Dewan, PK; Nair, SA; Sarkar, S; Ahmed, QT; Sarkar, S; Shamrao, SRM; Harries, AD; Oeltmann, JE				Paul, Durba; Busireddy, Arundhathi; Nagaraja, Sharath Burugina; Satyanarayana, Srinath; Dewan, Puneet Kumar; Nair, Sreenivas Achutan; Sarkar, Silajit; Ahmed, Quazi Toufique; Sarkar, Shakuntala; Shamrao, Sreenivas Rao Motta; Harries, Anthony David; Oeltmann, John Ethan			Factors Associated with Delays in Treatment Initiation after Tuberculosis Diagnosis in Two Districts of India	PLOS ONE			English	Article								Background: Excessive time between diagnosis and initiation of tuberculosis (TB) treatment contributes to ongoing TB transmission and should be minimized. In India, Revised National TB Control Programme (RNTCP) focuses on indicator start of treatment within 7 days of diagnosis for patients with sputum smear-positive PTB for monitoring DOTS implementation. Objectives: To determine length of time between diagnosis and initiation of treatment and factors associated with delays of more than 7 days in smear-positive pulmonary TB. Methods: Using existing programme records such as the TB Register, treatment cards, and the laboratory register, we conducted a retrospective cohort study of all patients with smear-positive pulmonary TB registered from July-September 2010 in two districts in India. A random sample of patients with pulmonary TB who experienced treatment delay of more than 7 days was interviewed using structured questionnaire. Results: 2027 of 3411 patients registered with pulmonary TB were smear-positive. 711(35%) patients had >7 days between diagnosis and treatment and 262(13%) had delays >15 days. Mean duration between TB diagnosis and treatment initiation was 8 days (range = 0-128 days). Odds of treatment delay >7 days was 1.8 times more likely among those who had been previously treated (95% confidence interval [CI] 1.5-2.3) and 1.6 (95% CI 1.3-1.8) times more likely among those diagnosed in health facilities without microscopy centers. The main factors associated with a delay >7 days were: patient reluctance to start a re-treatment regimen, patients seeking second opinions, delay in transportation of drugs to the DOT centers and delay in initial home visits. To conclude, treatment delay >7 days was associated with a number of factors that included history of previous treatment and absence of TB diagnostic services in the local health facility. Decentralized diagnostic facilities and improved referral procedures may reduce such treatment delays.	[Paul, Durba; Nagaraja, Sharath Burugina; Dewan, Puneet Kumar; Sarkar, Silajit; Ahmed, Quazi Toufique] WHO, Off WHO Representat India, New Delhi, India; [Busireddy, Arundhathi] Dist TB Off, Nalgonda, Andhra Pradesh, India; [Satyanarayana, Srinath; Nair, Sreenivas Achutan] Int Union TB & Lung Dis, SE Asia Off, New Delhi, India; [Sarkar, Shakuntala] Dist TB Ctr, Bardhaman, W Bengal, India; [Harries, Anthony David] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, London WC1, England; [Oeltmann, John Ethan] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA	Paul, D (corresponding author), WHO, Off WHO Representat India, New Delhi, India.	pauld@rntcp.org	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551; Nair, Sreenivas/0000-0002-2586-6797	Union from Global Fund Round 9 India TB Project funds; World Health Organization WHO-India from United States Agency for International Development (USAID)	Union from Global Fund Round 9 India TB Project funds; World Health Organization WHO-India from United States Agency for International Development (USAID)(United States Agency for International Development (USAID)World Health Organization)	Funding support was provided by The Union from Global Fund Round 9 India TB Project funds and by World Health Organization WHO-India from United States Agency for International Development (USAID) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division, 2011, TUB IND 2011 ANN REP; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; FAO, 2022, GLOB STRAT DIG HLTH; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; [Stop TB Partnership World Health Organization], 2006, GLOB PLAN STOP TB 20; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	9	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39040	10.1371/journal.pone.0039040	http://dx.doi.org/10.1371/journal.pone.0039040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792161	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000306354700006
J	Behrens, M; Born, S; Redel, U; Voigt, N; Schuh, V; Raguse, JD; Meyerhof, W				Behrens, Maik; Born, Stephan; Redel, Ulrike; Voigt, Nadine; Schuh, Vanessa; Raguse, Jan-Dirk; Meyerhof, Wolfgang			Immunohistochemical Detection of TAS2R38 Protein in Human Taste Cells	PLOS ONE			English	Article							BITTER TASTE; SWEET TASTE; RECEPTOR GENE; TRANSDUCTION; EXPRESSION; FAMILY; GUSTDUCIN; TASTANTS	The sense of taste plays an important role in the evaluation of the nutrient composition of consumed food. Bitter taste in particular is believed to serve a warning function against the ingestion of poisonous substances. In the past years enormous progress was made in the characterization of bitter taste receptors, including their gene expression patterns, pharmacological features and presumed physiological roles in gustatory as well as in non-gustatory tissues. However, due to a lack in TAS2R-specifc antibodies the localization of receptor proteins within gustatory tissues has never been analyzed. In the present study we have screened a panel of commercially available antisera raised against human bitter taste receptors by immunocytochemical experiments. One of these antisera was found to be highly specific for the human bitter taste receptor TAS2R38. We further demonstrate that this antibody is able to detect heterologously expressed TAS2R38 protein on Western blots. The antiserum is, however, not able to interfere significantly with TAS2R38 function in cell based calcium imaging analyses. Most importantly, we were able to demonstrate the presence of TAS2R38 protein in human gustatory papillae. Using double immunofluorescence we show that TAS2R38-positive cells form a subpopulation of PLCbeta2 expressing cells. On a subcellular level the localization of this bitter taste receptor is neither restricted to the cell surface nor particularly enriched at the level of the microvilli protruding into the pore region of the taste buds, but rather evenly distributed over the entire cell body.	[Behrens, Maik; Born, Stephan; Redel, Ulrike; Voigt, Nadine; Schuh, Vanessa; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany; [Raguse, Jan-Dirk] Campus Virchow Hosp, Charite, Clin & Polyclin Oral & Maxillofacial Surg, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Behrens, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Arthur Scheunert Allee 114-116, Nuthetal, Germany.	behrens@dife.de	Behrens, Maik/B-6753-2016	Behrens, Maik/0000-0003-2082-8860; Born, Stephan/0000-0001-6841-1410	German Research Foundation [Me 1024/3-2]	German Research Foundation(German Research Foundation (DFG))	The work was supported by a grant from the German Research Foundation (Me 1024/3-2, www.dfg.de) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Gimelbrant AA, 1999, J NEUROCHEM, V72, P2301, DOI 10.1046/j.1471-4159.1999.0722301.x; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kuhn C, 2010, CHEM SENSES, V35, P395, DOI 10.1093/chemse/bjq027; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nehring RB, 2000, J PHYSIOL-PARIS, V94, P185, DOI 10.1016/S0928-4257(00)00203-5; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ogura T, 1997, J NEUROSCI, V17, P3580; Peri I, 2000, AM J PHYSIOL-CELL PH, V278, pC17, DOI 10.1152/ajpcell.2000.278.1.C17; Reichling C, 2008, J NEUROCHEM, V106, P1138, DOI 10.1111/j.1471-4159.2008.05453.x; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zubare-Samuelov M, 2005, AM J PHYSIOL-CELL PH, V289, pC483, DOI 10.1152/ajpcell.00547.2004	40	32	33	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40304	10.1371/journal.pone.0040304	http://dx.doi.org/10.1371/journal.pone.0040304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792271	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800066
J	Flanagan, K; Fitzgerald, K; Baker, J; Regnstrom, K; Gardai, S; Bard, F; Mocci, S; Seto, P; You, M; Larochelle, C; Prat, A; Chow, S; Li, L; Vandevert, C; Zago, W; Lorenzana, C; Nishioka, C; Hoffman, J; Botelho, R; Willits, C; Tanaka, K; Johnston, J; Yednock, T				Flanagan, Ken; Fitzgerald, Kent; Baker, Jeanne; Regnstrom, Karin; Gardai, Shyra; Bard, Frederique; Mocci, Simonetta; Seto, Pui; You, Monica; Larochelle, Catherine; Prat, Alexandre; Chow, Samuel; Li, Lauri; Vandevert, Chris; Zago, Wagner; Lorenzana, Carlos; Nishioka, Christopher; Hoffman, Jennifer; Botelho, Raquel; Willits, Christopher; Tanaka, Kevin; Johnston, Jennifer; Yednock, Ted			Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; ADHESION MOLECULE; MULTIPLE-SCLEROSIS; MEMORY CELLS; IN-VITRO; EXPRESSION; RECEPTOR; LYMPHOCYTES; MIGRATION	TH17 cells enter tissues to facilitate pathogenic autoimmune responses, including multiple sclerosis (MS). However, the adhesion molecules involved in the unique migratory capacity of TH17 cells, into both inflamed and uninflamed tissues remain unclear. Herein, we characterize MCAM (CD146) as an adhesion molecule that defines human TH17 cells in the circulation; following in vitro restimulation of human memory T cells, nearly all of the capacity to secrete IL-17 is contained within the population of cells expressing MCAM. Furthermore, we identify the MCAM ligand as laminin 411, an isoform of laminin expressed within the vascular endothelial basement membranes under inflammatory as well as homeotstatic conditions. Purified MCAM-Fc binds to laminin 411 with an affinity of 27 nM, and recognizes vascular basement membranes in mouse and human tissue. MCAM-Fc binding was undetectable in tissue from mice with targeted deletion of laminin 411, indicating that laminin 411 is a major tissue ligand for MCAM. An anti-MCAM monoclonal antibody, selected for inhibition of laminin binding, as well as soluble MCAM-Fc, inhibited T cell adhesion to laminin 411 in vitro. When administered in vivo, the antibody reduced TH17 cell infiltration into the CNS and ameliorated disease in an animal model of MS. Our data suggest that MCAM and laminin 411 interact to facilitate TH17 cell entry into tissues and promote inflammation.	[Flanagan, Ken; Fitzgerald, Kent; Baker, Jeanne; Regnstrom, Karin; Gardai, Shyra; Bard, Frederique; Mocci, Simonetta; Seto, Pui; You, Monica; Chow, Samuel; Li, Lauri; Vandevert, Chris; Zago, Wagner; Lorenzana, Carlos; Nishioka, Christopher; Hoffman, Jennifer; Botelho, Raquel; Willits, Christopher; Tanaka, Kevin; Johnston, Jennifer; Yednock, Ted] Elan Pharmaceut, San Francisco, CA USA; [Larochelle, Catherine; Prat, Alexandre] Univ Montreal, CRCHUM, Ctr Excellence Neur, Neuroimmunol Res Lab, Montreal, PQ, Canada	Universite de Montreal	Flanagan, K (corresponding author), Elan Pharmaceut, San Francisco, CA USA.	kenneth.flanagan@elan.com		Johnston, Jennifer/0000-0002-4867-9230	Elan Pharmaceuticals	Elan Pharmaceuticals	Funding for all experiments was provided by Elan Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors are paid employees of Elan Pharmaceuticals, who funded this study: Ken Flanagan, Kent Fitzgerald, Jeanne Baker, Karin Regnstrom, Shyra Gardai, Frederique Bard, Simonetta Mocci, Pui Seto, Monica You, Samuel Chow, Lauri Li, Chris Vandevert, Wagner Zago, Carlos Lorenzana, Christopher Nishioka, Jennifer Hoffman, Raquel Botelho, Christopher Willits, Kevin Tanaka, Jennifer Johnston, and Ted Yednock. Elan Pharmaceuticals has an interest in exploring the biology herein for development of a therapeutic antibody. There are no patents, other products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2008, INT IMMUNOL, V20, P1361, DOI 10.1093/intimm/dxn106; Annunziato F, 2009, BLOOD, V114, P2213, DOI 10.1182/blood-2009-03-209189; Annunziato F, 2009, EUR J IMMUNOL, V39, P637, DOI 10.1002/eji.200839050; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Chen HB, 2001, ANTICANCER RES, V21, P505; CROFT M, 1994, J IMMUNOL, V152, P2675; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dagur PK, 2011, J AUTOIMMUN, V37, P319, DOI 10.1016/j.jaut.2011.09.003; Despoix N, 2008, EUR J IMMUNOL, V38, P2855, DOI 10.1002/eji.200838469; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Elshal MF, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-29; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnson JP, 1997, INT J CANCER, V73, P769; Kenne E, 2010, J LEUKOCYTE BIOL, V88, P523, DOI 10.1189/jlb.0110043; Kim Chang H., 2009, Inflammation & Allergy Drug Targets, V8, P221; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li J, 2007, J NEUROIMMUNOL, V192, P57, DOI 10.1016/j.jneuroim.2007.09.004; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Longbrake EE, 2009, EXPERT REV NEUROTHER, V9, P319, DOI 10.1586/14737175.9.3.319; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Mokkapati S, 2011, J BIOL CHEM, V286, P1911, DOI 10.1074/jbc.M110.149864; Pickl WF, 1997, J IMMUNOL, V158, P2107; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schlagbauer-Wadl H, 1999, INT J CANCER, V81, P951, DOI 10.1002/(SICI)1097-0215(19990611)81:6<951::AID-IJC18>3.0.CO;2-V; Shih IM, 1997, CANCER RES, V57, P3835; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Staquicini FI, 2008, CANCER RES, V68, P8419, DOI 10.1158/0008-5472.CAN-08-1242; TAIRA E, 1994, NEURON, V12, P861, DOI 10.1016/0896-6273(94)90338-7; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; Wondimu Z, 2006, MATRIX BIOL, V25, P89, DOI 10.1016/j.matbio.2005.10.001; Wu C, 2009, NAT MED, V15, P519, DOI 10.1038/nm.1957; Xie SH, 1997, CANCER RES, V57, P2295; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001	52	88	97	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40443	10.1371/journal.pone.0040443	http://dx.doi.org/10.1371/journal.pone.0040443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792325	gold, Green Submitted, Green Published			2022-12-25	WOS:000306461800086
J	Kim, SJ; Koo, HM; Lim, BJ; Oh, HJ; Yoo, DE; Shin, DH; Lee, MJ; Doh, FM; Park, JT; Yoo, TH; Kang, SW; Choi, KH; Jeong, HJ; Han, SH				Kim, Seung Jun; Koo, Hyang Mo; Lim, Beom Jin; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Doh, Fa Mee; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Jeong, Hyeon Joo; Han, Seung Hyeok			Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; COMPLEMENT ACTIVATION; GLOMERULAR DEPOSITION; ANOREXIA-NERVOSA; SYSTEMIC-LUPUS; SERUM IGA; DISEASE; GLOMERULONEPHRITIS; ERYTHEMATOSUS; INFLAMMATION	Background and Aims: Mesangial C3 deposition is frequently observed in patients with IgA nephropathy (IgAN). However, the role of complement in the pathogenesis or progression of IgAN is uncertain. In this observational cohort study, we aimed to identify the clinical implications of circulating C3 levels and mesangial C3 deposition and to investigate their utility as predictors of renal outcomes in patients with IgAN. Methods: A total of 343 patients with biopsy-proven IgAN were enrolled between January 2000 and December 2008. Decreased serum C3 level (hypoC3) was defined as C3 <90 mg/dl. The study endpoint was end-stage renal disease (ESRD) and a doubling of the baseline serum creatinine (D-SCr). Results: Of the patients, there were 66 patients (19.2%) with hypoC3. During a mean follow-up of 53.7 months, ESRD occurred in 5 patients (7.6%) with hypoC3 compared with 9 patients (3.2%) with normal C3 levels (P=0.11). However, 12 patients (18.2%) with hypoC3 reached D-SCr compared with 17 patients (6.1%) with normal C3 levels [Hazard ratio (HR), 3.59; 95% confidence interval (CI), 1.33-10.36; P=0.018]. In a multivariable model in which serum C3 levels were treated as a continuous variable, hypoC3 significantly predicted renal outcome of D-SCr (per 1 mg/dl increase of C3; HR, 0.95; 95% CI, 0.92-0.99; P=0.011). The risk of reaching renal outcome was significantly higher in patients with mesangial C3 deposition 2+ to 3+ than in patients without deposition (HR 9.37; 95% CI, 1.10-80.26; P=0.04). Conclusions: This study showed that hypoC3 and mesangial C3 deposition were independent risk factors for progression, suggesting that complement activation may play a pathogenic role in patients with IgAN.	[Kim, Seung Jun; Koo, Hyang Mo; Oh, Hyung Jung; Yoo, Dong Eun; Shin, Dong Ho; Lee, Mi Jung; Doh, Fa Mee; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Seung Hyeok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lim, Beom Jin] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kang, Shin-Wook; Jeong, Hyeon Joo] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	hansh@yuhs.ac	Kim, Seung Jun/N-5248-2019; Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Kim, Seung Jun/0000-0002-6913-6358; Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Lee, Mi Jung/0000-0001-8888-029X; Yoo, Tae-Hyun/0000-0002-9183-4507; Jeong, Hyeon Joo/0000-0002-9695-1227; Kang, Shin-Wook/0000-0002-5677-4756; Lim, Beom Jin/0000-0003-2856-0133; Choi, Kyu Hun/0000-0003-0095-9011; Park, Jung Tak/0000-0002-2325-8982; doh, fa mee/0000-0002-4780-6728	Brain Korea 21 Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF) grant; Korean government (MEST) [2011-0030711]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0030711), and by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammitzboll CG, 2011, RHEUMATOL INT; Birmingham DJ, 2010, LUPUS, V19, P1272, DOI 10.1177/0961203310371154; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chan Loretta Y Y, 2004, Clin Exp Nephrol, V8, P297; Cook HT, 2006, NAT CLIN PRACT RHEUM, V2, P330, DOI 10.1038/ncprheum0191; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; DAMICO G, 1987, SEMIN NEPHROL, V7, P355; DAMICO G, 1987, Q J MED, V64, P709; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Endo M, 1998, NEPHROL DIAL TRANSPL, V13, P1984, DOI 10.1093/ndt/13.8.1984; Espinosa M, 2009, NEPHROL DIAL TRANSPL, V24, P886, DOI 10.1093/ndt/gfn563; FEEHALLY J, 1986, KIDNEY INT, V30, P924, DOI 10.1038/ki.1986.274; Flierl MA, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-16; Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Giannakakis K, 2011, CLIN REV ALLERG IMMU, V40, P170, DOI 10.1007/s12016-010-8207-1; Hernandez-Mijares A, 2007, INT J OBESITY, V31, P927, DOI 10.1038/sj.ijo.0803543; HIEMSTRA PS, 1987, EUR J IMMUNOL, V17, P321, DOI 10.1002/eji.1830170304; Janssen U, 2000, AM J KIDNEY DIS, V35, P21, DOI 10.1016/S0272-6386(00)70296-4; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Komatsu H, 2004, INTERNAL MED, V43, P1023, DOI 10.2169/internalmedicine.43.1023; Kusaba G, 2012, MED MOL MORPHOL, V45, P29, DOI 10.1007/s00795-011-0538-3; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Myllymaki JM, 2007, KIDNEY INT, V71, P343, DOI 10.1038/sj.ki.5002046; Nakagawa H, 2000, AM J NEPHROL, V20, P122, DOI 10.1159/000013568; Nasr SH, 2011, NEPHRON CLIN PRACT, V119, pC18, DOI 10.1159/000324180; Ohsawa I, 2010, J CLIN LAB ANAL, V24, P113, DOI 10.1002/jcla.20372; Oortwijn BD, 2008, SEMIN NEPHROL, V28, P58, DOI 10.1016/j.semnephrol.2007.10.007; PALMBLAD J, 1979, ACTA PAEDIATR SCAND, V68, P617, DOI 10.1111/j.1651-2227.1979.tb05067.x; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Roufosse CA, 2009, CURR OPIN NEPHROL HY, V18, P212, DOI 10.1097/MNH.0b013e328329605c; SIGAL LH, 1989, AM J DIS CHILD, V143, P1391; STAD RK, 1993, CLIN EXP IMMUNOL, V92, P514; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Tomino Y, 2000, J CLIN LAB ANAL, V14, P220, DOI 10.1002/1098-2825(2000)14:5<220::AID-JCLA4>3.3.CO;2-U; Tsokos GC, 2004, ARTHRITIS RHEUM-US, V50, P3404, DOI 10.1002/art.20602; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2487, DOI 10.1093/ndt/gfh394; Walsh M, 2010, CLIN J AM SOC NEPHRO, V5, P425, DOI 10.2215/CJN.06530909; WYATT RJ, 1987, KIDNEY INT, V31, P1019, DOI 10.1038/ki.1987.101; Zwirner J, 1997, KIDNEY INT, V51, P1257, DOI 10.1038/ki.1997.171	43	78	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40495	10.1371/journal.pone.0040495	http://dx.doi.org/10.1371/journal.pone.0040495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792353	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800097
J	Chen, TJ; Wang, JQ; Zeng, LL; Li, RZ; Li, JC; Chen, YL; Lin, ZL				Chen, Tingjian; Wang, Jianqing; Zeng, Lingli; Li, Rizong; Li, Jicong; Chen, Yilu; Lin, Zhanglin			Significant Rewiring of the Transcriptome and Proteome of an Escherichia coli Strain Harboring a Tailored Exogenous Global Regulator IrrE	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DEINOCOCCUS-RADIODURANS; OUTER-MEMBRANE; SMALL RNAS; CLOSTRIDIUM-ACETOBUTYLICUM; NITROSATIVE STRESS; NITRIC-OXIDE; TOLERANCE; BACTERIA; RESISTANCE	Cell reprogramming for microorganisms via engineered or artificial transcription factors and RNA polymerase mutants has presented a powerful tool for eliciting complex traits that are practically useful particularly for industrial strains, and for understanding at the global level the regulatory network of gene transcription. We previously further showed that an exogenous global regulator IrrE (derived from the extreme radiation-resistant bacterium Deinococcus radiodurans) can be tailored to confer Escherichia coli (E. coli) with significantly enhanced tolerances to different stresses. In this work, based on comparative transcriptomic and proteomic analyses of the representative strains E1 and E0, harboring the ethanol-tolerant IrrE mutant E1 and the ethanol-intolerant wild type IrrE, respectively, we found that the transcriptome and proteome of E. coli were extensively rewired by the tailored IrrE protein. Overall, 1196 genes (or approximately 27% of E. coli genes) were significantly altered at the transcriptomic level, including notably genes in the nitrate-nitrite-nitric oxide (NO) pathway, and genes for non-coding RNAs. The proteomic profile revealed significant up-or downregulation of several proteins associated with syntheses of the cell membrane and cell wall. Analyses of the intracellular NO level and cell growth under reduced temperature supported a close correlation between NO and ethanol tolerance, and also suggests a role for membrane fluidity. The significantly different omic profiles of strain E1 indicate that IrrE functions as a global regulator in E. coli, and that IrrE may be evolved for other cellular tolerances. In this sense, it will provide synthetic biology with a practical and evolvable regulatory "part" that operates at a higher level of complexity than local regulators. This work also suggests a possibility of introducing and engineering other exogenous global regulators to rewire the genomes of microorganism cells.	[Chen, Tingjian; Wang, Jianqing; Zeng, Lingli; Li, Rizong; Li, Jicong; Lin, Zhanglin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China; [Chen, Yilu] Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, Nanjing 210009, Peoples R China	Tsinghua University; Nanjing Tech University	Chen, TJ (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	zhanglinlin@mail.tsinghua.edu.cn	Chen, Tingjian/L-2659-2013; Lin, Zhanglin/A-7232-2011	Chen, Tingjian/0000-0002-4458-4269; 	National Basic Research (973) program of China [2009CB724704, 2011CBA00800]	National Basic Research (973) program of China(National Basic Research Program of China)	This work was supported by grants from the National Basic Research (973) program of China (No. 2009CB724704 and No. 2011CBA00800). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldor IS, 2005, APPL ENVIRON MICROB, V71, P1717, DOI 10.1128/AEM.71.4.1717-1728.2005; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; Bauermeister A, 2009, ARCH MICROBIOL, V191, P913, DOI 10.1007/s00203-009-0522-7; Chen TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016228; Conrad TM, 2010, P NATL ACAD SCI USA, V107, P20500, DOI 10.1073/pnas.0911253107; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Frey AD, 2002, APPL ENVIRON MICROB, V68, P4835, DOI 10.1128/AEM.68.10.4835-4840.2002; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JY, 2011, BIOTECHNOL BIOENG, V108, P742, DOI 10.1002/bit.22989; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Ma RQ, 2011, CURR MICROBIOL, V62, P659, DOI 10.1007/s00284-010-9759-2; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Reyes LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017678; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Satoh K, 2006, MICROBIOL-SGM, V152, P3217, DOI 10.1099/mic.0.29139-0; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Xu CX, 2006, PROTEOMICS, V6, P462, DOI 10.1002/pmic.200500219; Yoon SH, 2003, BIOTECHNOL BIOENG, V81, P753, DOI 10.1002/bit.10626; Zhou ZF, 2011, MOL BIOSYST, V7, P1613, DOI 10.1039/c0mb00336k	58	19	22	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e37126	10.1371/journal.pone.0037126	http://dx.doi.org/10.1371/journal.pone.0037126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792156	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300003
J	Davis, IW; Benninger, C; Benfey, PN; Elich, T				Davis, Ian W.; Benninger, Christopher; Benfey, Philip N.; Elich, Tedd			POWRS: Position-Sensitive Motif Discovery	PLOS ONE			English	Article							REGULATE GENE-EXPRESSION; TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; BINDING SITES; CORE PROMOTER; CIS-ELEMENTS; IDENTIFICATION; SEQUENCES; PROFILES; MAP	Transcription factors and the short, often degenerate DNA sequences they recognize are central regulators of gene expression, but their regulatory code is challenging to dissect experimentally. Thus, computational approaches have long been used to identify putative regulatory elements from the patterns in promoter sequences. Here we present a new algorithm "POWRS" (POsition-sensitive WoRd Set) for identifying regulatory sequence motifs, specifically developed to address two common shortcomings of existing algorithms. First, POWRS uses the position-specific enrichment of regulatory elements near transcription start sites to significantly increase sensitivity, while providing new information about the preferred localization of those elements. Second, POWRS forgoes position weight matrices for a discrete motif representation that appears more resistant to over-generalization. We apply this algorithm to discover sequences related to constitutive, high-level gene expression in the model plant Arabidopsis thaliana, and then experimentally validate the importance of those elements by systematically mutating two endogenous promoters and measuring the effect on gene expression levels. This provides a foundation for future efforts to rationally engineer gene expression in plants, a problem of great importance in developing biotech crop varieties. Availability: BSD-licensed Python code at http://grassrootsbio.com/papers/powrs/.	[Davis, Ian W.; Benninger, Christopher; Benfey, Philip N.; Elich, Tedd] GrassRoots Biotechnol, Durham, NC USA; [Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC USA; [Benfey, Philip N.] Duke Univ, Ctr Syst Biol, Durham, NC USA	Duke University; Duke University	Davis, IW (corresponding author), GrassRoots Biotechnol, Durham, NC USA.	ian.davis@grassrootsbio.com			National Science Foundation [0957836]; Div Of Industrial Innovation & Partnersh [0957836] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by the National Science Foundation (0957836). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huggins P, 2011, BIOINFORMATICS, V27, P2361, DOI 10.1093/bioinformatics/btr412; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Keilwagen J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001070; Kim NK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-262; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Ma X, 2012, NUCL ACIDS RES; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Narang V, 2010, BIOINFORMATICS, V26, P1152, DOI 10.1093/bioinformatics/btq106; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sun HQ, 2011, BIOINFORMATICS, V27, P2641, DOI 10.1093/bioinformatics/btr459; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Tharakaraman K, 2005, BIOINFORMATICS, V21, pI440, DOI 10.1093/bioinformatics/bti1028; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Troukhan M, 2009, OMICS, V13, P139, DOI 10.1089/omi.2008.0034; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yan R, 2011, BIOINFORMATICS, V27, P2054, DOI 10.1093/bioinformatics/btr353; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yokoyama KD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp423	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40373	10.1371/journal.pone.0040373	http://dx.doi.org/10.1371/journal.pone.0040373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792292	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300059
J	Li, JZ; Gui, DY; Feng, CL; Wang, WZ; Du, BQ; Gan, T; Luo, YJ				Li, Jin-Zhen; Gui, Dan-Yang; Feng, Chun-Liang; Wang, Wen-Zhong; Du, Bo-Qi; Gan, Tian; Luo, Yue-Jia			Victims' Time Discounting 2.5 Years after the Wenchuan Earthquake: An ERP Study	PLOS ONE			English	Article							DECISION-MAKING; INTERTEMPORAL CHOICE; SELF-CONTROL; COGNITIVE CONTROL; BRAIN; REWARDS; PROBABILITY; RISK; RESOLUTION; INHIBITION	Background: Time discounting refers to the fact that the subjective value of a reward decreases as the delay until its occurrence increases. The present study investigated how time discounting has been affected in survivors of the magnitude-8.0 Wenchuan earthquake that occurred in China in 2008. Methodology: Nineteen earthquake survivors and 22 controls, all school teachers, participated in the study. Event-related brain potentials (ERPs) for time discounting tasks involving gains and losses were acquired in both the victims and controls. Findings: The behavioral data replicated our previous findings that delayed gains were discounted more steeply after a disaster. ERP results revealed that the P200 and P300 amplitudes were increased in earthquake survivors. There was a significant group (earthquake vs. non-earthquake) 6 task (gain vs. loss) interaction for the N300 amplitude, with a marginally significantly reduced N300 for gain tasks in the experimental group, which may suggest a deficiency in inhibitory control for gains among victims. Conclusions: The results suggest that post-disaster decisions might involve more emotional (System 1) and less rational thinking (System 2) in terms of a dual-process model of decision making. The implications for post-disaster intervention and management are also discussed.	[Li, Jin-Zhen; Gui, Dan-Yang; Feng, Chun-Liang; Du, Bo-Qi; Gan, Tian; Luo, Yue-Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wang, Wen-Zhong] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Li, JZ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	luoyj@bnu.edu.cn	Gan, Tian/AAV-7161-2021	Gui, Danyang/0000-0002-7940-1397	National Natural Science of China [91132704, 30930031]; Ministry of Sci & Tech (973 Program) [2011CB711000]; National Key Technologies R D Program [2009BAI77B01]; China Postdoctoral Science Foundation [20100480224]; Global Research Initiative Program, National Institutes of Health (NIH), USA [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Ministry of Sci & Tech (973 Program); National Key Technologies R D Program(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Global Research Initiative Program, National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the National Natural Science of China (91132704, 30930031), Ministry of Sci & Tech (973 Program, 2011CB711000), National Key Technologies R & D Program (2009BAI77B01), China Postdoctoral Science Foundation (No. 20100480224) and Global Research Initiative Program, National Institutes of Health (NIH), USA (1R01TW007897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Bal A, 2008, CHILD ADOL MENT H-UK, V13, P134, DOI 10.1111/j.1475-3588.2007.00469.x; Bechara A, 2002, BRAIN, V125, P1673, DOI 10.1093/brain/awf169; BENZION U, 1989, MANAGE SCI, V35, P270, DOI 10.1287/mnsc.35.3.270; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bland SH, 2005, J NERV MENT DIS, V193, P420, DOI 10.1097/01.nmd.0000165297.49452.41; Boettiger CA, 2007, J NEUROSCI, V27, P14383, DOI 10.1523/JNEUROSCI.2551-07.2007; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Dearstyne B, 2007, GOV INFORM Q, V24, P29, DOI 10.1016/j.giq.2006.03.004; Estle SJ, 2007, PSYCHOL SCI, V18, P58, DOI 10.1111/j.1467-9280.2007.01849.x; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JSBT, 1996, BRIT J PSYCHOL, V87, P223, DOI 10.1111/j.2044-8295.1996.tb02587.x; Fehr E, 2002, NATURE, V415, P269, DOI 10.1038/415269a; Ferreira MB, 2006, J PERS SOC PSYCHOL, V91, P797, DOI 10.1037/0022-3514.91.5.797; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frank MJ, 2009, CURR DIR PSYCHOL SCI, V18, P73, DOI 10.1111/j.1467-8721.2009.01612.x; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Ganderton PT, 2000, J RISK UNCERTAINTY, V20, P271, DOI 10.1023/A:1007871514658; Ganzel BL, 2008, NEUROIMAGE, V40, P788, DOI 10.1016/j.neuroimage.2007.12.010; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Glimcher PW, 2007, AM ECON REV, V97, P142, DOI 10.1257/aer.97.2.142; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Green L, 2004, J EXP ANAL BEHAV, V81, P39, DOI 10.1901/jeab.2004.81-39; GREEN L, 1993, BEHAV PHILOS, V21, P37; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; Hardman D, 2009, JUDGM DECIS MAK, P106; Havenaar JM, 2003, SOC SCI MED, V56, P569, DOI 10.1016/S0277-9536(02)00062-X; Kahneman D, 2011, THINKING FAST SLOW; Karakaya Isil, 2004, Turk Psikiyatri Derg, V15, P257; Li JZ, 2011, J APPL SOC PSYCHOL, V41, P2739, DOI 10.1111/j.1559-1816.2011.00847.x; Li JZ, 2011, APPL COGNITIVE PSYCH, V25, P104, DOI 10.1002/acp.1648; Li S, 2010, RISK ANAL, V30, P699, DOI 10.1111/j.1539-6924.2010.01371.x; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; LOGUE AW, 1988, BEHAV BRAIN SCI, V11, P665, DOI 10.1017/S0140525X00053978; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Ma QG, 2008, NEUROSCI LETT, V431, P57, DOI 10.1016/j.neulet.2007.11.022; MacKeigan L D, 1993, Pharmacoeconomics, V3, P374, DOI 10.2165/00019053-199303050-00005; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MISCHEL W, 1967, J PERS SOC PSYCHOL, V5, P24, DOI 10.1037/h0024180; Murphy JG, 2001, PSYCHOL REC, V51, P571; Myers DG, 2001, OBSERVER, V14, P3; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Ohmura Y, 2006, EXP CLIN PSYCHOPHARM, V14, P318, DOI 10.1037/1064-1297.14.3.318; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pavel, 2011, J COMP RES ANTHR SOC, V2, P117; Payne J.W., 2008, BLACKWELL HDB JUDGME, P110, DOI [10.1002/9780470752937.ch6, DOI 10.1002/9780470752937.CH6]; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Polezzi D, 2010, NEUROIMAGE, V49, P1886, DOI 10.1016/j.neuroimage.2009.08.068; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Read D., 2004, BLACKWELL HDB JUDGME, P424, DOI DOI 10.1002/9780470752937.CH21; REBER AS, 1992, PHILOS PSYCHOL, V5, P33, DOI 10.1080/09515089208573042; Rigoni D, 2010, BRAIN RES BULL, V81, P445, DOI 10.1016/j.brainresbull.2009.12.003; Sacco K, 2003, APPL COGNITIVE PSYCH, V17, P1113, DOI 10.1002/acp.989; Schoenfelder TE, 2003, J VOCAT BEHAV, V62, P43, DOI 10.1016/S0001-8791(02)00032-5; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SHELLEY MK, 1994, ORGAN BEHAV HUM DEC, V59, P124, DOI 10.1006/obhd.1994.1053; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; STEVENSON MK, 1986, J EXP PSYCHOL GEN, V115, P131, DOI 10.1037/0096-3445.115.2.131; Tamura H, 2000, EUR J OPER RES, V122, P461, DOI 10.1016/S0377-2217(99)00247-7; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Xu LJ, 2009, BRAIN RES, V1261, P65, DOI 10.1016/j.brainres.2008.12.061; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	74	22	24	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40316	10.1371/journal.pone.0040316	http://dx.doi.org/10.1371/journal.pone.0040316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974LI	22792277	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300052
J	Oda, Y; Onitsuka, T; Tsuchimoto, R; Hirano, S; Oribe, N; Ueno, T; Hirano, Y; Nakamura, I; Miura, T; Kanba, S				Oda, Yuko; Onitsuka, Toshiaki; Tsuchimoto, Rikako; Hirano, Shogo; Oribe, Naoya; Ueno, Takefumi; Hirano, Yoji; Nakamura, Itta; Miura, Tomofumi; Kanba, Shigenobu			Gamma Band Neural Synchronization Deficits for Auditory Steady State Responses in Bipolar Disorder Patients	PLOS ONE			English	Article							CORTEX IN-VITRO; RATING-SCALE; SODIUM VALPROATE; PLASMA GABA; SCHIZOPHRENIA; OSCILLATIONS; DEPRESSION; NETWORKS; INTERNEURONS; STIMULATION	Periodic auditory click stimulation has been reported to elicit an auditory steady state response (ASSR). The ASSR has been suggested to reflect the efficiency of gamma-amino butyric acid (GABA) inhibitory interneuronal activity. Although a potential role for GABAergic dysfunction has been previously proposed, the role of neural synchronization in the ASSR in people with bipolar disorder (BD) has received little attention. In the current study, we investigated ASSRs to 20 Hz, 30 Hz, 40 Hz and 80 Hz click trains in BD patients. A total of 14 (4 males) BD patients and 25 (10 males) healthy controls participated in this study. ASSRs were obtained using whole-head 306-channel magnetoencephalography to calculate, ASSR power values and phase locking factors (PLF). BD patients exhibited significantly reduced mean ASSR power and PLF values bilaterally at frequencies of 30, 40, and 80 Hz (p<0.05 for these frequencies). At 20 Hz, bipolar patients showed no significant reduction in mean ASSR power and PLF values. There was a significant negative correlation between 80 Hz-ASSR-power values obtained from the right hemisphere and scores on the Hamilton Depression Rating Scale (rho = -0.86, p=0.0003). The current study showed reduced low and high gamma band ASSR power and PLF bilaterally with no significant beta band ASSR reduction in BD patients. BD patients are characterized by deficits in gamma band oscillations, which may be associated with GABA inhibitory interneuronal activity dysfunction.	[Oda, Yuko; Onitsuka, Toshiaki; Tsuchimoto, Rikako; Hirano, Shogo; Oribe, Naoya; Ueno, Takefumi; Hirano, Yoji; Nakamura, Itta; Miura, Tomofumi; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan; [Oribe, Naoya; Hirano, Yoji] Boston VA Healthcare Syst, Dept Psychiat, Lab Neurosci, Clin Neurosci Div,Brockton Div, Brockton, MA USA; [Oribe, Naoya; Hirano, Yoji] Harvard Univ, Sch Med, Brockton, MA 02401 USA	Kyushu University; Harvard University	Oda, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan.	skanba@npsych.med.kyushu-u.ac.jp	Hirano, Yoji/AAR-5658-2021	Hirano, Yoji/0000-0001-6847-9677	Ministry of Education, Culture, Sports, Science and Technology, Japan [B22390226, C23591712]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan [H23 kokoro-ippan-002]; Mitsubishi Pharma Research Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Pharma Research Foundation	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan [B22390226 to SK, C23591712 to TO]; a grant by Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Japan Society for the Promotion of Science to SK and TO; a grant from Ministry of Health, Labour and Welfare, Japan (H23 kokoro-ippan-002 to SK); and a Research Grant from Mitsubishi Pharma Research Foundation to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernasconi R, 1982, EXCERPTA MED, V26, P183; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Clark L, 2005, BIOL PSYCHIAT, V57, P183, DOI 10.1016/j.biopsych.2004.11.007; Cunningham MO, 2000, NEUROPHARMACOLOGY, V39, P2139, DOI 10.1016/S0028-3908(00)00051-4; Cunningham MO, 2004, J PHYSIOL-LONDON, V559, P347, DOI 10.1113/jphysiol.2004.068973; EMRICH HM, 1980, ARCH PSYCHIAT NERVEN, V229, P1, DOI 10.1007/BF00343800; Furukawa TA, 2007, J CLIN PSYCHOPHARM, V27, P531, DOI 10.1097/JCP.0b013e31814f30b1; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Hamm JP, 2011, BIOL PSYCHIAT, V69, P989, DOI 10.1016/j.biopsych.2010.11.021; Hassel B, 2001, EPILEPSY RES, V43, P153, DOI 10.1016/S0920-1211(00)00196-0; Kaiser J, 2004, NEUROIMAGE, V23, P551, DOI 10.1016/j.neuroimage.2004.06.033; Konradi C, 2011, ARCH GEN PSYCHIAT, V68, P340, DOI 10.1001/archgenpsychiatry.2010.175; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; LOSCHER W, 1989, BRAIN RES, V501, P198, DOI 10.1016/0006-8993(89)91044-5; LOSCHER W, 1981, LIFE SCI, V28, P2383, DOI 10.1016/0024-3205(81)90504-X; LOSCHER W, 1980, EPILEPSIA, V21, P611, DOI 10.1111/j.1528-1157.1980.tb04314.x; Maharajh K., 2007, INT CONG SERI, V1300, P707, DOI [10.1016/j.ics.2006.12.073, DOI 10.1016/J.ICS.2006.12.073]; O'Donnell BF, 2004, NEUROREPORT, V15, P1369, DOI 10.1097/01.wnr.0000127348.64681.b2; Oke OO, 2010, EUR J NEUROSCI, V31, P1435, DOI 10.1111/j.1460-9568.2010.07171.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Rass O, 2010, BIPOLAR DISORD, V12, P793, DOI 10.1111/j.1399-5618.2010.00871.x; Reite M, 2009, BIPOLAR DISORD, V11, P371, DOI 10.1111/j.1399-5618.2009.00701.x; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Shiah IS, 2000, INT CLIN PSYCHOPHARM, V15, P221, DOI 10.1097/00004850-200015040-00005; Sohal VS, 2012, BIOL PSYCHIAT, V71, P1039, DOI 10.1016/j.biopsych.2012.01.024; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Spencer KM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-85; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Tsuchimoto R, 2011, SCHIZOPHR RES, V133, P99, DOI 10.1016/j.schres.2011.07.020; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wang AY, 2011, ACTA NEUROPATHOL, V122, P615, DOI 10.1007/s00401-011-0881-4; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	41	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39955	10.1371/journal.pone.0039955	http://dx.doi.org/10.1371/journal.pone.0039955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792199	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300014
J	Rapacciuolo, G; Roy, DB; Gillings, S; Fox, R; Walker, K; Purvis, A				Rapacciuolo, Giovanni; Roy, David B.; Gillings, Simon; Fox, Richard; Walker, Kevin; Purvis, Andy			Climatic Associations of British Species Distributions Show Good Transferability in Time but Low Predictive Accuracy for Range Change	PLOS ONE			English	Article							LAND-COVER DATA; DISTRIBUTION MODELS; ENVELOPE MODELS; EXTINCTION RISK; GLOBAL CHANGE; HABITAT; NICHE; BUTTERFLIES; IMPACTS; PLANTS	Conservation planners often wish to predict how species distributions will change in response to environmental changes. Species distribution models (SDMs) are the primary tool for making such predictions. Many methods are widely used; however, they all make simplifying assumptions, and predictions can therefore be subject to high uncertainty. With global change well underway, field records of observed range shifts are increasingly being used for testing SDM transferability. We used an unprecedented distribution dataset documenting recent range changes of British vascular plants, birds, and butterflies to test whether correlative SDMs based on climate change provide useful approximations of potential distribution shifts. We modelled past species distributions from climate using nine single techniques and a consensus approach, and projected the geographical extent of these models to a more recent time period based on climate change; we then compared model predictions with recent observed distributions in order to estimate the temporal transferability and prediction accuracy of our models. We also evaluated the relative effect of methodological and taxonomic variation on the performance of SDMs. Models showed good transferability in time when assessed using widespread metrics of accuracy. However, models had low accuracy to predict where occupancy status changed between time periods, especially for declining species. Model performance varied greatly among species within major taxa, but there was also considerable variation among modelling frameworks. Past climatic associations of British species distributions retain a high explanatory power when transferred to recent time - due to their accuracy to predict large areas retained by species - but fail to capture relevant predictors of change. We strongly emphasize the need for caution when using SDMs to predict shifts in species distributions: high explanatory power on temporally-independent records - as assessed using widespread metrics - need not indicate a model's ability to predict the future.	[Rapacciuolo, Giovanni; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Div Ecol & Evolut, Ascot, Berks, England; [Rapacciuolo, Giovanni; Roy, David B.] Ctr Ecol & Hydrol, Biol Records Ctr, Wallingford, Oxon, England; [Rapacciuolo, Giovanni; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England; [Gillings, Simon] British Trust Ornithol, Thetford, Norfolk, England; [Fox, Richard] Butterfly Conservat, Wareham, Dorset, England; [Walker, Kevin] Bot Soc British Isles, Harrogate, N Yorkshire, England	Imperial College London; UK Centre for Ecology & Hydrology (UKCEH); Imperial College London; British Trust for Ornithology	Rapacciuolo, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Ecol & Evolut, Ascot, Berks, England.	giovanni.rapacciuolo05@imperial.ac.uk	Roy, David/A-6619-2009; Purvis, Andy/A-7529-2008; Gillings, Simon/I-2727-2015	Roy, David/0000-0002-5147-0331; Purvis, Andy/0000-0002-8609-6204; Rapacciuolo, Giovanni/0000-0003-1494-9017; Fox, Richard/0000-0001-6992-3522; Gillings, Simon/0000-0002-9794-2357	Biotechnology and Biological Sciences Research Council (BBSRC); NERC (Natural Environment Research Council) (through the Centre for Ecology Hydrology); Joint Nature Conservation Committee (JNCC); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC (Natural Environment Research Council) (through the Centre for Ecology Hydrology)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Joint Nature Conservation Committee (JNCC); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Biotechnology and Biological Sciences Research Council (BBSRC), http://www.bbsrc.ac.uk/; Old Mutual plc, http://www.oldmutual.com/; NERC (Natural Environment Research Council) (through the Centre for Ecology & Hydrology), http://www.ceh.ac.uk/; and Joint Nature Conservation Committee (JNCC), http://jncc.defra.gov.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Asher J, 2001, MILLENNIUM ATLAS BUT; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fuller RM, 2002, CARTOGR J, V39, P15; Gibbons D. W., 1993, NEW ATLAS BREEDING B; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002; Heath J., 1984, ATLAS BUTTERFLIES BR; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hof AR, 2012, DIVERSITY D IN PRESS; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kharouba HM, 2009, ECOLOGY, V90, P2213, DOI 10.1890/08-1304.1; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Perring F.H., 1962, ATLAS BRIT FLORA; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Preston C, 2002, NEW ATLAS BRIT IRISH; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Sharrock J.T.R., 1976, ATLAS BREEDING BIRDS; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Stankowski PA, 2011, ECOL MODEL, V222, P567, DOI 10.1016/j.ecolmodel.2010.10.018; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; Telfer MG, 2002, BIOL CONSERV, V107, P99, DOI 10.1016/S0006-3207(02)00050-2; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; UNEPWCMC, 2011, UK NAT EC ASS SYNTH; Vanreusel W, 2007, CONSERV BIOL, V21, P201, DOI 10.1111/j.1523-1739.2006.00577.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	80	61	61	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40212	10.1371/journal.pone.0040212	http://dx.doi.org/10.1371/journal.pone.0040212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792243	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300036
J	Elashoff, MR; Nuttall, R; Beineke, P; Doctolero, MH; Dickson, M; Johnson, AM; Daniels, SE; Rosenberg, S; Wingrove, JA				Elashoff, Michael R.; Nuttall, Rachel; Beineke, Philip; Doctolero, Michael H.; Dickson, Mark; Johnson, Andrea M.; Daniels, Susan E.; Rosenberg, Steven; Wingrove, James A.			Identification of Factors Contributing to Variability in a Blood-Based Gene Expression Test	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; NONDIABETIC PATIENTS; MESSENGER-RNA; SIGNATURES; CELLS; INTERFERON; VALIDATION; CANCER; LUPUS	Background: Corus CAD is a clinically validated test based on age, sex, and expression levels of 23 genes in whole blood that provides a score (1-40 points) proportional to the likelihood of obstructive coronary disease. Clinical laboratory process variability was examined using whole blood controls across a 24 month period: Intra-batch variability was assessed using sample replicates; inter-batch variability examined as a function of laboratory personnel, equipment, and reagent lots. Methods/Results: To assess intra-batch variability, five batches of 132 whole blood controls were processed; inter-batch variability was estimated using 895 whole blood control samples. ANOVA was used to examine inter-batch variability at 4 process steps: RNA extraction, cDNA synthesis, cDNA addition to assay plates, and qRT-PCR. Operator, machine, and reagent lots were assessed as variables for all stages if possible, for a total of 11 variables. Intra-and inter-batch variations were estimated to be 0.092 and 0.059 Cp units respectively (SD); total laboratory variation was estimated to be 0.11 Cp units (SD). In a regression model including all 11 laboratory variables, assay plate lot and cDNA kit lot contributed the most to variability (p = 0.045; 0.009 respectively). Overall, reagent lots for RNA extraction, cDNA synthesis, and qRT-PCR contributed the most to inter-batch variance (52.3%), followed by operators and machines (18.9% and 9.2% respectively), leaving 19.6% of the variance unexplained. Conclusion: Intra-batch variability inherent to the PCR process contributed the most to the overall variability in the study while reagent lot showed the largest contribution to inter-batch variability.	[Elashoff, Michael R.; Nuttall, Rachel; Beineke, Philip; Doctolero, Michael H.; Dickson, Mark; Johnson, Andrea M.; Daniels, Susan E.; Rosenberg, Steven; Wingrove, James A.] CardioDx Inc, Palo Alto, CA 94303 USA		Elashoff, MR (corresponding author), CardioDx Inc, Palo Alto, CA 94303 USA.	jwingrove@cardiodx.com						Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Dumeaux V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000873; Elashoff MR, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-26; Goodison S, 2010, BIOANALYSIS, V2, P855, DOI 10.4155/BIO.10.35; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Lampe JW, 2004, CANCER EPIDEM BIOMAR, V13, P445; Llaverias G, 2008, PHARMACOGENOMICS, V9, P1035, DOI 10.2217/14622416.9.8.1035; McPhail S, 2005, DRUG DISCOV TODAY, V10, P1485, DOI 10.1016/S1359-6446(05)03644-5; Nakamura S, 2010, BIOCHEM BIOPH RES CO, V391, P846, DOI 10.1016/j.bbrc.2009.11.150; Park MY, 2007, BIOSTATISTICS, V8, P212, DOI 10.1093/biostatistics/kxl002; Rosenberg S, 2010, ANN INTERN MED, V153, P425, DOI 10.7326/0003-4819-153-7-201010050-00005; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730	18	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40068	10.1371/journal.pone.0040068	http://dx.doi.org/10.1371/journal.pone.0040068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802952	gold, Green Published, Green Submitted			2022-12-25	WOS:000306186900026
J	Assefa, N; Berhane, Y; Worku, A				Assefa, Nega; Berhane, Yemane; Worku, Alemayehu			Wealth Status, Mid Upper Arm Circumference (MUAC) and Ante Natal Care (ANC) Are Determinants for Low Birth Weight in Kersa, Ethiopia	PLOS ONE			English	Article							PREGNANCY	Background: Low Birth Weight (LBW) is one of the major risk factor for death in early life. However, little is known about predictors of LBW in sub-Saharan Africa. Therefore, the aim of this study was to measure the incidence and determinants of LBW in a rural population of Ethiopia. Methods: An observational cohort study on pregnant women was conducted from December 2009 to November 2010. During the study period 1295 live birth were registered and the weights of 956 children were measured within 24 hours after birth. Socio-demographic, economic, maternal and organizational factors were considered as a predicators of LBW, defined as birth weight below 2500g. Logistic regression was used to analyze the data, odds ratio (OR) and confidence intervals (CI) are reported. Result: The incidence of LBW was 28.3%. It is significantly associated with poverty [OR 2.1; 95% CI: 1.42, 3.05], maternal Mid Upper Arm Circumference (MUAC) less than 23 cm [OR 1.6; 95% CI: 1.19, 2.19], not attending ANC [OR 1.6; 95% CI: 1.12, 2.28], mother's experience of physical violence during pregnancy [OR 1.7; 95% CI: 1.12, 2.48], and longer time to walk to health facility [OR 1.6; 95% CI: 1.11, 2.40]. Conclusion and Recommendation: The incidence of LBW was high in Kersa. Babies born to women who were poor, undernourished, experienced physical violence during pregnancy and who had poor access to health services were more likely to be LBW in this part of the country. In this largely poor community where ANC coverage is low, to reduce the incidence of LBW, it is essential to improve access for maternal health care. The involvement of husbands and the community at large to seek collective action on LBW is essential.	[Assefa, Nega] Haramaya Univ, Coll Hlth Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Assefa, N (corresponding author), Haramaya Univ, Coll Hlth Sci, Harar, Ethiopia.	negaassefa@yahoo.com	Berhane, Yemane/ABB-8154-2020	Assefa, Nega/0000-0003-0341-2329; Berhane, Yemane/0000-0002-2527-1339	Haramaya University, Ethiopia	Haramaya University, Ethiopia	This work was funded by Haramaya University, Ethiopia, as part of Ph.D work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arokiasamy P, 2010, HLTH POLICY PLANNING, P1; Asefa M, 2004, ETHIOP J HLTH SCI, V14, P13; Assefa N, 2011, PREGNANCY R IN PRESS; Badshah S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-197; Basso O, 2000, INT J EPIDEMIOL, V29, P856, DOI 10.1093/ije/29.5.856; Dey AC, 2007, BANGLADISH J CHILD H, V31, P1; Dubois L, 2006, PEDIATR INT, V48, P470, DOI 10.1111/j.1442-200X.2006.02256.x; Enquoselassie F., 2000, Ethiopian Journal of Health Development, V14, P169; EpiDataAss, 2010, EPIDATA STAT APPL; Ethiopia CSA, 2006, DEM HLTH SURV 2005; Feresu SA, 2004, PAEDIATR PERINAT EP, V18, P154, DOI 10.1111/j.1365-3016.2003.00539.x; FMOH, 2007, HLTH EXT PROGR ETH P; FMOH, 2007, HLTH HLTH REL IND; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Janjua ZN, 2008, DETEMINATS LOW BIRTH; Kersa DHO, 2011, HLTH SERVICE COVERAG; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leal M, 2006, PARENTAL CHILDBIRTH, P40; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Macro O, 2002, UTILIZATION MATERNAL; Mbuagbaw LCE, 2011, MATERN CHILD HLTH J, V15, P1427, DOI 10.1007/s10995-010-0707-3; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; Mohanty C, 2005, MATERNAL ANTHROPOMET; Moss William, 2002, J Perinatol, V22, P484; Neeti R, 2011, ASIA PAC J PUBLIC HL; Nobile CGA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-192; OHLSSON A, 2008, DETERMINANTS PREVENT; PETHYBRIDGE RJ, 1974, BRIT J PREV SOC MED, V28, P10; Ricalde AE, 1998, REV SAUDE PUBL, V32, P112, DOI 10.1590/S0034-89101998000200002; Rosen D, 2007, J INTERPERS VIOLENCE, V22, P1305, DOI 10.1177/0886260507304551; Sarkar NN, 2008, J OBSTET GYNAECOL, V28, P266, DOI 10.1080/01443610802042415; Sellstrom E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-267; Sen J, 2010, J TROP PEDIATRICS, V56, P254, DOI 10.1093/tropej/fmp102; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; StataCorp, 2009, STAT STAT SOFTW REL; Tuniseranee P, 1999, WHO J EPIDEMIOLOGY C, V53, P624; Vahdaninia M, 2008, BMC PREGNANCY CHILDB, V8; Vyas S, 2006, CONSTRUCTING SOCIOEC; World Health Organization, 2005, RES VIOLENCE WOMEN P	41	78	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39957	10.1371/journal.pone.0039957	http://dx.doi.org/10.1371/journal.pone.0039957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792140	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100154
J	Jeong, JH; Lee, KH; Kim, YM; Kim, DH; Oh, BH; Kim, YG				Jeong, Jae-Hee; Lee, Kwang-Hoon; Kim, Young-Mi; Kim, Do-Hyung; Oh, Byung-Ha; Kim, Yeon-Gil			Crystal Structure of the Gtr1p(GTP)-Gtr2p(GDP) Protein Complex Reveals Large Structural Rearrangements Triggered by GTP-to-GDP Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; RAG GTPASES; ACTIVATION; TORC1	The heterodimeric Rag GTPases consisting of RagA (or RagB) and RagC (or RagD) are the key regulator activating the target of rapamycin complex 1 (TORC1) in response to the level of amino acids. The heterodimer between GTP-loaded RagA/B and GDP-loaded RagC/D is the most active form that binds Raptor and leads to the activation of TORC1. Here, we present the crystal structure of Gtr1pGTP-Gtr2pGDP, the active yeast Rag GTPase heterodimer. The structure reveals that GTP-to-GDP conversion on Gtr2p results in a large conformational transition of this subunit, including a large scale rearrangement of a long segment whose corresponding region in RagA is involved in binding to Raptor. In addition, the two GTPase domains of the heterodimer are brought to contact with each other, but without causing any conformational change of the Gtr1p subunit. These features explain how the nucleotide-bound statuses of the two GTPases subunits switch the Raptor binding affinity on and off.	[Jeong, Jae-Hee; Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea; [Lee, Kwang-Hoon; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, Inst Biocentury, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Young-Mi; Kim, Do-Hyung] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Pohang University of Science & Technology (POSTECH); Korea Advanced Institute of Science & Technology (KAIST); University of Minnesota System; University of Minnesota Twin Cities	Kim, YG (corresponding author), Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea.	ygkim76@postech.ac.kr	Oh, Byung-Ha/C-2061-2011	Kim, Do-Hyung/0000-0002-2924-4370	Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs; Basic Science Research Program through National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0007201]; Global Research Laboratory (GRL) Program, NRF of Korea [K20815000001]; American Diabetes Association [7-07-CD-08]; National Institutes of Health [DK072004, DK083474]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK072004, R01DK072004, R56DK083474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097057] Funding Source: NIH RePORTER	Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs; Basic Science Research Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Global Research Laboratory (GRL) Program, NRF of Korea(National Research Foundation of Korea); American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 2011-0007201) (to Y. G. K.), by the Global Research Laboratory (GRL) Program (Grant K20815000001) from the NRF of Korea (to B. H. O.), and by the American Diabetes Association (7-07-CD-08) (to D. H. K.) and by the National Institutes of Health (Grants DK072004 and DK083474) (to D. H. K.).	Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; RENSLAND H, 1991, BIOCHEMISTRY-US, V30, P11181, DOI 10.1021/bi00110a023; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1	20	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29648	29653		10.1074/jbc.C112.384420	http://dx.doi.org/10.1074/jbc.C112.384420			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22807443	hybrid, Green Published			2022-12-25	WOS:000308286900040
J	Stordal, B; Hamon, M; McEneaney, V; Roche, S; Gillet, JP; O'Leary, JJ; Gottesman, M; Clynes, M				Stordal, Britta; Hamon, Marion; McEneaney, Victoria; Roche, Sandra; Gillet, Jean-Pierre; O'Leary, John J.; Gottesman, Michael; Clynes, Martin			Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein	PLOS ONE			English	Article							ENERGY-DEPENDENT UPTAKE; MULTIDRUG-RESISTANCE; COLLATERAL SENSITIVITY; CROSS-RESISTANCE; MASS-SPECTROMETRY; INDUCED APOPTOSIS; DRUG-SENSITIVITY; IN-VITRO; EXPRESSION; GLUTATHIONE	The IGROVCDDP cisplatin-resistant ovarian cancer cell line is also resistant to paclitaxel and models the resistance phenotype of relapsed ovarian cancer patients after first-line platinum/taxane chemotherapy. A TaqMan low-density array (TLDA) was used to characterise the expression of 380 genes associated with chemotherapy resistance in IGROVCDDP cells. Paclitaxel resistance in IGROVCDDP is mediated by gene and protein overexpression of P-glycoprotein and the protein is functionally active. Cisplatin resistance was not reversed by elacridar, confirming that cisplatin is not a P-glycoprotein substrate. Cisplatin resistance in IGROVCDDP is multifactorial and is mediated in part by the glutathione pathway and decreased accumulation of drug. Total cellular glutathione was not increased. However, the enzyme activity of GSR and GGT1 were up-regulated. The cellular localisation of copper transporter CTR1 changed from membrane associated in IGROV-1 to cytoplasmic in IGROVCDDP. This may mediate the previously reported accumulation defect. There was decreased expression of the sodium potassium pump (ATP1A), MRP1 and FBP which all have been previously associated with platinum accumulation defects in platinum-resistant cell lines. Cellular localisation of MRP1 was also altered in IGROVCDDP shifting basolaterally, compared to IGROV-1. BRCA1 was also up-regulated at the gene and protein level. The overexpression of P-glycoprotein in a resistant model developed with cisplatin is unusual. This demonstrates that P-glycoprotein can be upregulated as a generalised stress response rather than as a specific response to a substrate. Mechanisms characterised in IGROVCDDP cells may be applicable to relapsed ovarian cancer patients treated with frontline platinum/taxane chemotherapy.	[Stordal, Britta; Hamon, Marion; Roche, Sandra; Clynes, Martin] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland; [Stordal, Britta; McEneaney, Victoria; O'Leary, John J.] St James Hosp, Dept Histopathol, Dublin 8, Ireland; [Stordal, Britta; McEneaney, Victoria; O'Leary, John J.] Trinity Coll Dublin, Dublin, Ireland; [Gillet, Jean-Pierre; Gottesman, Michael] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	Dublin City University; Trinity College Dublin; Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stordal, B (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland.	stordalb@tcd.ie	gillet, jean-pierre/A-3714-2012; gillet, jean-pierre/A-1419-2017; Roche, Sandra/AAM-9800-2021	gillet, jean-pierre/0000-0003-2453-590X; Roche, Sandra/0000-0002-4363-4607; Stordal, Britta/0000-0002-7892-951X; O'Leary, John/0000-0001-7311-9326	Marie Curie International Incoming Fellowship from the European Union FP7 programme; Irish Cancer Society Postdoctoral Fellowship; Travel Fellowship from the European Association of Cancer Research; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research	Marie Curie International Incoming Fellowship from the European Union FP7 programme; Irish Cancer Society Postdoctoral Fellowship; Travel Fellowship from the European Association of Cancer Research; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by a Marie Curie International Incoming Fellowship from the European Union FP7 programme, and an Irish Cancer Society Postdoctoral Fellowship (BS). The collaboration between Britta Stordal and the National Cancer Institute was supported by a Travel Fellowship from the European Association of Cancer Research. This research was also supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (JPG, MG). The funders had no role in study design, data collection and a nalysis, decision to publish, or preparation of the manuscript.	Bates SE, 2004, J PHARMACOL EXP THER, V310, P836, DOI 10.1124/jpet.103.063149; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568; CHAUDHARY PM, 1993, J NATL CANCER I, V85, P632, DOI 10.1093/jnci/85.8.632; Cheng LH, 2010, GYNECOL ONCOL, V117, P159, DOI 10.1016/j.ygyno.2010.01.041; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; DeLoia JA, 2011, GYNECOLOGIC ONCOLOGY; DREW R, 1984, BIOCHEM PHARMACOL, V33, P2989, DOI 10.1016/0006-2952(84)90598-7; Gillett JP, 2011, MOL PHARMACEUT, V8, P2080, DOI 10.1021/mp200240a; Gottesman MM, 2009, CANC DRUG DISC DEV, P83, DOI 10.1007/978-1-60327-459-3_11; HAMAGUCHI K, 1993, CANCER RES, V53, P5225; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; HYAFIL F, 1993, CANCER RES, V53, P4595; Ihnat MA, 1997, CLIN CANCER RES, V3, P1339; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Kishimoto S, 2006, CANCER CHEMOTH PHARM, V57, P84, DOI 10.1007/s00280-005-0003-x; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Le Moguen K, 2006, PROTEOMICS, V6, P5183, DOI 10.1002/pmic.200500925; Lee WK, 2011, TOXICOL SCI, V121, P343, DOI 10.1093/toxsci/kfr071; Lee YY, 2011, PROGNOSTIC VALUE COP, P135; Lewandowicz GM, 2002, CELLULAR GLUTATHIONE; Liang XJ, 2003, CANCER RES, V63, P5909; Locke VL, 1999, BRIT J HAEMATOL, V106, P86, DOI 10.1046/j.1365-2141.1999.01494.x; Ma JG, 1998, CANCER CHEMOTH PHARM, V41, P307, DOI 10.1007/s002800050744; Ma JG, 1998, CANCER CHEMOTH PHARM, V41, P186; MARTIN A, 1993, CYTOTECHNOLOGY, V11, P49, DOI 10.1007/BF00749057; Nakayama K, 2002, COPPER TRANSPORTING; O'Connor R, 2007, CANCER CHEMOTH PHARM, V59, P79, DOI 10.1007/s00280-006-0240-7; Ottone F, 1997, BRIT J CANCER, V76, P77, DOI 10.1038/bjc.1997.339; Parekh H, 1996, CANCER CHEMOTH PHARM, V37, P457, DOI 10.1007/s002800050412; Perego P, 1998, ANN ONCOL, V9, P423, DOI 10.1023/A:1008265012435; Pisano C, 2009, CANCER CHEMOTH PHARM, V64, P1021, DOI 10.1007/s00280-009-0958-0; Poulain L, 1998, INT J CANCER, V78, P454, DOI 10.1002/(SICI)1097-0215(19981109)78:4<454::AID-IJC11>3.0.CO;2-6; Quinn JE, 2003, CANCER RES, V63, P6221; Rahman Q, 1999, CRIT REV TOXICOL, V29, P543, DOI 10.1080/10408449991349276; RICHERT ND, 1988, BIOCHEMISTRY-US, V27, P7607, DOI 10.1021/bi00420a006; Rischin D, 2004, GYNECOL ONCOL, V93, P417, DOI 10.1016/j.ygyno.2004.01.037; Shen DW, 2000, J CELL PHYSIOL, V183, P108, DOI 10.1002/(SICI)1097-4652(200004)183:1<108::AID-JCP13>3.3.CO;2-W; Shen DW, 1998, CANCER RES, V58, P268; SILBER PM, 1986, ANAL BIOCHEM, V158, P68, DOI 10.1016/0003-2697(86)90590-7; Simon R, 2007, CANCER INFORM, V3, P11; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Stordal B, 2007, CANCER TREAT REV, V33, P688, DOI 10.1016/j.ctrv.2007.07.013; Stordal B, 2007, CANCER TREAT REV, V33, P347, DOI 10.1016/j.ctrv.2007.01.009; Stordal B, 2009, CURR CANCER DRUG TAR, V9, P354, DOI 10.2174/156800909788166592; Sun BY, 2007, MOL CELL PROTEOMICS, V6, P141, DOI 10.1074/mcp.T600046-MCP200; SUZUKAKE K, 1982, BIOCHEM PHARMACOL, V31, P121; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Wall R, 2007, TALANTA, V72, P145, DOI 10.1016/j.talanta.2006.10.010; Xu HD, 2005, BIOCHEM BIOPH RES CO, V328, P618, DOI 10.1016/j.bbrc.2005.01.015; Yang H, 2007, CANCER BIOL THER, V6, P942; YANG LY, 1993, INT J CANCER, V53, P478, DOI 10.1002/ijc.2910530321; Yang XW, 1995, ONCOL RES, V7, P619; Zhang XF, 2011, J SURG ONCOL, V104, P466, DOI 10.1002/jso.21958	57	75	77	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40717	10.1371/journal.pone.0040717	http://dx.doi.org/10.1371/journal.pone.0040717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792399	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000306362400095
J	Sokalingam, S; Raghunathan, G; Soundrarajan, N; Lee, SG				Sokalingam, Sriram; Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Lee, Sun-Gu			A Study on the Effect of Surface Lysine to Arginine Mutagenesis on Protein Stability and Structure Using Green Fluorescent Protein	PLOS ONE			English	Article							SALT BRIDGES; ELECTROSTATIC INTERACTIONS; INDUSTRIAL ENZYMES; HYDROPHOBIC CORE; TRANSITION-STATE; MECHANISM; THERMOSTABILITY; THERMOTOLERANCE; BINDING; SDS	Two positively charged basic amino acids, arginine and lysine, are mostly exposed to protein surface, and play important roles in protein stability by forming electrostatic interactions. In particular, the guanidinium group of arginine allows interactions in three possible directions, which enables arginine to form a larger number of electrostatic interactions compared to lysine. The higher pKa of the basic residue in arginine may also generate more stable ionic interactions than lysine. This paper reports an investigation whether the advantageous properties of arginine over lysine can be utilized to enhance protein stability. A variant of green fluorescent protein (GFP) was created by mutating the maximum possible number of lysine residues on the surface to arginines while retaining the activity. When the stability of the variant was examined under a range of denaturing conditions, the variant was relatively more stable compared to control GFP in the presence of chemical denaturants such as urea, alkaline pH and ionic detergents, but the thermal stability of the protein was not changed. The modeled structure of the variant indicated putative new salt bridges and hydrogen bond interactions that help improve the rigidity of the protein against different chemical denaturants. Structural analyses of the electrostatic interactions also confirmed that the geometric properties of the guanidinium group in arginine had such effects. On the other hand, the altered electrostatic interactions induced by the mutagenesis of surface lysines to arginines adversely affected protein folding, which decreased the productivity of the functional form of the variant. These results suggest that the surface lysine mutagenesis to arginines can be considered one of the parameters in protein stability engineering.	[Sokalingam, Sriram; Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Lee, Sun-Gu] Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea	Pusan National University	Sokalingam, S (corresponding author), Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea.	sungulee@pusan.ac.kr	Raghunathan, Govindan/T-5299-2019	Raghunathan, Govindan/0000-0002-1456-0768; Soundrarajan, Nagasundarapandian/0000-0001-5239-7992	Basic Science Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2011-0021222]	Basic Science Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0021222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bhuyan AK, 2010, BIOPOLYMERS, V93, P186, DOI 10.1002/bip.21318; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Boyle J., 2005, BIOCH MOL BIOL ED, V33, P74, DOI [10.1002/bmb.2005.494033010419, DOI 10.1002/BMB.2005.494033010419]; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Cormack P., 1996, GENE, V173, P33; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Gitlin I, 2006, J PHYS CHEM B, V110, P2372, DOI 10.1021/jp055699f; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang JR, 2008, HFSP J, V2, P378, DOI 10.2976/1.2976660; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; LATTMAN EE, 1993, P NATL ACAD SCI USA, V90, P439, DOI 10.1073/pnas.90.2.439; Makhatadze GI, 2004, J MOL BIOL, V336, P929, DOI 10.1016/j.jmb.2003.12.058; Marrs B, 1999, CURR OPIN MICROBIOL, V2, P241, DOI 10.1016/S1369-5274(99)80042-3; Matsutani M, 2011, BIOCHEM BIOPH RES CO, V409, P120, DOI 10.1016/j.bbrc.2011.04.126; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nielsen MM, 2007, BIOPHYS J, V92, P3674, DOI 10.1529/biophysj.106.101238; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Otzen DE, 1999, PROTEIN SCI, V8, P1878, DOI 10.1110/ps.8.9.1878; Pavoor TV, 2009, P NATL ACAD SCI USA, V106, P11895, DOI 10.1073/pnas.0902828106; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Strub Caroline, 2004, BMC Biochemistry, V5, P9, DOI 10.1186/1471-2091-5-9; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Tigerstrom A, 2004, BIOCHEMISTRY-US, V43, P12563, DOI 10.1021/bi048926x; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; Turunen O, 2002, PROTEIN ENG, V15, P141, DOI 10.1093/protein/15.2.141; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yokota K, 2006, SCI TECHNOL ADV MAT, V7, P255, DOI 10.1016/j.stam.2006.03.003	41	143	150	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40410	10.1371/journal.pone.0040410	http://dx.doi.org/10.1371/journal.pone.0040410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792305	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700042
J	Barboza, FR; Gomez, J; Lercari, D; Defeo, O				Barboza, Francisco R.; Gomez, Julio; Lercari, Diego; Defeo, Omar			Disentangling Diversity Patterns in Sandy Beaches along Environmental Gradients	PLOS ONE			English	Article							CRAB EMERITA-BRASILIENSIS; DE-LA-PLATA; LIFE-HISTORY; RICHNESS PATTERNS; POPULATIONS; MACROFAUNA; MORPHODYNAMICS; SALINITY; MACROINFAUNA; ADAPTATIONS	Species richness in sandy beaches is strongly affected by concurrent variations in morphodynamics and salinity. However, as in other ecosystems, different groups of species may exhibit contrasting patterns in response to these environmental variables, which would be obscured if only aggregate richness is considered. Deconstructing biodiversity, i.e. considering richness patterns separately for different groups of species according to their taxonomic affiliation, dispersal mode or mobility, could provide a more complete understanding about factors that drive species richness patterns. This study analyzed macroscale variations in species richness at 16 Uruguayan sandy beaches with different morphodynamics, distributed along the estuarine gradient generated by the Rio de la Plata over a 2 year period. Species richness estimates were deconstructed to discriminate among taxonomic groups, supralittoral and intertidal forms, and groups with different feeding habits and development modes. Species richness was lowest at intermediate salinities, increasing towards oceanic and inner estuarine conditions, mainly following the patterns shown for intertidal forms. Moreover, there was a differential tolerance to salinity changes according to the habitat occupied and development mode, which determines the degree of sensitivity of faunal groups to osmotic stress. Generalized (additive and linear) mixed models showed a clear increase of species richness towards dissipative beaches. All taxonomic categories exhibited the same trend, even though responses to grain size and beach slope were less marked for crustaceans and insects than for molluscs or polychaetes. However, supralittoral crustaceans exhibited the opposite trend. Feeding groups decreased from dissipative to reflective systems, deposit feeders being virtually absent in the latter. This deconstructive approach highlights the relevance of life history strategies in structuring communities, highlighting the relative importance that salinity and morphodynamic gradients have on macroscale diversity patterns in sandy beaches.	[Barboza, Francisco R.; Gomez, Julio; Lercari, Diego; Defeo, Omar] Univ Republica, Fac Sci, Dept Ecol & Evolut, UNDECIMAR, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Barboza, FR (corresponding author), Univ Republica, Fac Sci, Dept Ecol & Evolut, UNDECIMAR, Montevideo, Uruguay.	odefeo@dinara.gub.uy		Defeo, Omar/0000-0001-8318-528X; Lercari, Diego/0000-0001-7980-2193; Barboza, Francisco Rafael/0000-0002-9100-2962	Fondo Clemente Estable [4034]; Agencia Nacional de Investigacion e Innovacion [INI-X-2010-2-3002]; Global Environmental Facility [GCP URU 030 GFF]; Programa de Desarrollo de las Ciencias Basicas; Pew Charitable Trusts	Fondo Clemente Estable; Agencia Nacional de Investigacion e Innovacion; Global Environmental Facility; Programa de Desarrollo de las Ciencias Basicas; Pew Charitable Trusts	Financial support provided from Fondo Clemente Estable (4034), Agencia Nacional de Investigacion e Innovacion (INI-X-2010-2-3002), Global Environmental Facility (GCP URU 030 GFF), Programa de Desarrollo de las Ciencias Basicas and The Pew Charitable Trusts is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attrill MJ, 2002, J ANIM ECOL, V71, P262, DOI 10.1046/j.1365-2656.2002.00593.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Blamires D, 2008, ACTA OECOL, V33, P97, DOI 10.1016/j.actao.2007.09.006; Brazeiro A, 1999, REV CHIL HIST NAT, V72, P93; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Camus PA, 2002, REV CHIL HIST NAT, V75, P793; Cardoso RS, 2004, ESTUAR COAST SHELF S, V61, P559, DOI 10.1016/j.ecss.2004.06.021; Celentano E, 2010, MAR ECOL PROG SER, V398, P193, DOI 10.3354/meps08342; CHARMANTIER G, 1994, MAR ECOL PROG SER, V114, P93, DOI 10.3354/meps114093; Cisneros KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023724; Colombini I, 1996, REV CHIL HIST NAT, V69, P511; Contreras H, 2003, REV CHIL HIST NAT, V76, P543; DEFEO O, 1992, J COASTAL RES, V8, P830; Defeo O, 2003, J MAR BIOL ASSOC UK, V83, P331, DOI 10.1017/S0025315403007161h; Defeo O, 2001, MAR ECOL PROG SER, V212, P159, DOI 10.3354/meps212159; Defeo O, 1997, ESTUAR COAST SHELF S, V45, P453, DOI 10.1006/ecss.1996.0200; Defeo O, 2005, MAR ECOL PROG SER, V293, P143, DOI 10.3354/meps293143; DEFEO O, 1995, MAR ECOL PROG SER, V123, P73, DOI 10.3354/meps123073; Defeo O, 2011, MAR ECOL PROG SER, V433, P29, DOI 10.3354/meps09206; Defeo O, 2003, J COASTAL RES, P352; EMERY KO, 1961, LIMNOL OCEANOGR, V6, P90, DOI 10.4319/lo.1961.6.1.0090; ENDRASS U, 1976, MAR BIOL, V36, P47, DOI 10.1007/BF00388428; Fanini L, 2009, ECOL INDIC, V9, P167, DOI 10.1016/j.ecolind.2008.03.004; Folk R.L., 1974, PETROLOGY SEDIMENTAR; Gomez J, 1999, MAR ECOL PROG SER, V182, P209, DOI 10.3354/meps182209; Gomez J, 2012, ESTUAR COAST SHELF S, V98, P84, DOI 10.1016/j.ecss.2011.12.008; Guerrero RA, 1997, CONT SHELF RES, V17, P727, DOI 10.1016/S0278-4343(96)00061-1; Hastie TJ., 1990, GEN ADDITIVE MODELS; Herrick JE, 2002, SOIL SCI SOC AM J, V66, P1320, DOI 10.2136/sssaj2002.1320; Herrmann M, 2011, HELGOLAND MAR RES, V65, P285, DOI 10.1007/s10152-010-0222-3; JARAMILLO E, 1995, MAR ECOL PROG SER, V119, P311, DOI 10.3354/meps119311; KLAPOW LA, 1970, J ZOOL, V162, P359; Lercari D, 1999, ESTUAR COAST SHELF S, V49, P457, DOI 10.1006/ecss.1999.0521; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lozoya JP, 2006, MAR FRESHWATER RES, V57, P421, DOI 10.1071/MF05067; Marquet PA, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P191; MCARDLE SB, 1992, J COASTAL RES, V8, P398; MCARDLE SB, 1991, MAR ECOL PROG SER, V76, P91, DOI 10.3354/meps076091; MCLACHLAN A, 1981, ESTUAR COAST SHELF S, V13, P11, DOI 10.1016/S0302-3524(81)80102-8; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A, 2006, ECOLOGY SANDY SHORES; McLachlan A., 1993, J COASTAL RES, V15, P27, DOI DOI 10.2307/25735721; McLachlan A, 2013, ENCY BIODIVERSITY, DOI [10.1016/B978-0-12-384720-1.00294-3, DOI 10.1016/B978-0-12-384720-1.00294-3]; McLachlan Anton, 2001, P741; Lozoya JP, 2010, ESTUAR COAST SHELF S, V87, P472, DOI 10.1016/j.ecss.2010.02.005; Remane A., 1934, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V37, P34; Rodil IF, 2004, ESTUAR COAST SHELF S, V61, P37, DOI 10.1016/j.ecss.2004.03.016; Schoeman DS, 2002, J EXP MAR BIOL ECOL, V276, P67, DOI 10.1016/S0022-0981(02)00239-3; Short AD, 1996, REV CHIL HIST NAT, V69, P589; Simionato CG, 2001, GEOPHYS RES LETT, V28, P2641, DOI 10.1029/2000GL012478; Taskey HJ, 1991, INMATURE INSECTS KEN, P708; Terribile LC, 2009, GLOBAL ECOL BIOGEOGR, V18, P123, DOI 10.1111/j.1466-8238.2008.00440.x; Veloso VG, 2001, J MAR BIOL ASSOC UK, V81, P369, DOI 10.1017/S0025315401003976; Wood S., 2011, R PACKAGE VERSION, V0, P1; Zuur Alain F., 2009, P1	55	36	36	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40468	10.1371/journal.pone.0040468	http://dx.doi.org/10.1371/journal.pone.0040468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792340	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800091
J	Cheng, HLM				Cheng, Hai-Ling Margaret			Effect of Hyperoxia and Hypercapnia on Tissue Oxygen and Perfusion Response in the Normal Liver and Kidney	PLOS ONE			English	Article							RENAL BLOOD-FLOW; CARBON-DIOXIDE; RELAXATION-TIMES; RAT MODEL; BOLD-MRI; INHALATION; TUMORS; HEMODYNAMICS; R-2-ASTERISK; VALIDATION	Objective: Inhalation of air with altered levels of oxygen and carbon dioxide to manipulate tissue oxygenation and perfusion has both therapeutic and diagnostic value. These physiological responses can be measured non-invasively with magnetic resonance (MR) relaxation times. However, interpreting MR measurements is not straight-forward in extra-cranial organs where gas challenge studies have only begun to emerge. Inconsistent results have been reported on MR, likely because different organs respond differently. The objective of this study was to elucidate organ-specific physiological responses to gas challenge underlying MR measurements by investigating oxygenation and perfusion changes in the normal liver and kidney cortex. Materials and Methods: Gas challenges (100% O-2, 10% CO2, and carbogen [90% O-2+10% CO2]) interleaved with room air was delivered to rabbits to investigate their effect on tissue oxygenation and perfusion. Real-time fiber-optic measurements of absolute oxygen and relative blood flow were made in the liver and kidney cortex. Results: Only the liver demonstrated a vasodilatory response to CO2. Perfusion changes to other gases were minimal in both organs. Tissue oxygenation measurements showed the liver responding only when CO2 was present and the kidney only when O-2 was present. Conclusion: This study reveals distinct physiological response mechanisms to gas challenge in the liver and kidney. The detailed characterization of organ-specific responses is critical to improving our understanding and interpretation of MR measurements in various body organs, and will help broaden the application of MR for non-invasive studies of gas challenges.	[Cheng, Hai-Ling Margaret] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Cheng, Hai-Ling Margaret] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Cheng, HLM (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	Hai-Ling.Cheng@sickkids.ca	Cheng, Hai-Ling Margaret/E-5551-2011	Cheng, Hai-Ling Margaret/0000-0002-0733-9512	Natural Sciences and Engineering Research Council of Canada [484801]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for the study was provided by the Natural Sciences and Engineering Research Council of Canada (grant no. 484801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi R, 2009, BRIT J CANCER, V100, P644, DOI 10.1038/sj.bjc.6604903; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Baudelet C, 2004, MAGN RESON IMAGING, V22, P905, DOI 10.1016/j.mri.2004.02.005; Boss A, 2009, NMR BIOMED, V22, P638, DOI 10.1002/nbm.1378; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; DUTTON R, 1976, B EUR PHYSIOPATH RES, V12, P265; Edrei Y, 2011, NEOPLASIA, V13, P244, DOI 10.1593/neo.101354; Flemming B, 2000, J AM SOC NEPHROL, V11, P18, DOI 10.1681/ASN.V11118; Foadoddini M, 2011, EUR J CARDIO-THORAC, V39, P233, DOI 10.1016/j.ejcts.2010.05.036; FUJII H, 1985, JPN CIRC J, V49, P1185, DOI 10.1253/jcj.49.1185; Ganong WF, 1995, DYN BLOOD LYMPH FLOW, V30, P525; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Howe FA, 2001, NMR BIOMED, V14, P497, DOI 10.1002/nbm.716; HUGHES RL, 1979, PFLUG ARCH EUR J PHY, V381, P151, DOI 10.1007/BF00582346; Jones RA, 2002, MAGN RESON MED, V47, P728, DOI 10.1002/mrm.10127; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Lanzen JL, 1998, INT J RADIAT ONCOL, V42, P855, DOI 10.1016/S0360-3016(98)00312-5; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Liu SY, 2011, MAGN RESON MED, V66, P1722, DOI 10.1002/mrm.22968; Lu J, 2009, NEUROIMAGE, V45, P1126, DOI 10.1016/j.neuroimage.2008.11.037; Mark CI, 2011, NEUROIMAGE, V54, P1102, DOI 10.1016/j.neuroimage.2010.08.070; Meier J, 2005, CLIN PHYSIOL FUNCT I, V25, P158, DOI 10.1111/j.1475-097X.2005.00603.x; MOSELEY ME, 1992, MAGNET RESON MED, V23, P21, DOI 10.1002/mrm.1910230104; Neeman M, 2001, MAGNET RESON MED, V45, P887, DOI 10.1002/mrm.1118; Noseworthy MD, 1999, JMRI-J MAGN RESON IM, V9, P814, DOI 10.1002/(SICI)1522-2586(199906)9:6<814::AID-JMRI8>3.0.CO;2-5; O'Connor JPB, 2007, MAGN RESON MED, V58, P490, DOI 10.1002/mrm.21357; O'Connor JPB, 2009, MAGN RESON MED, V61, P75, DOI 10.1002/mrm.21815; Peschke P, 2003, ADV EXP MED BIOL, V530, P19; Prisman E, 2008, J MAGN RESON IMAGING, V27, P185, DOI 10.1002/jmri.21102; Robinson SP, 2001, MAGN RESON IMAGING, V19, P161, DOI 10.1016/S0730-725X(01)00230-2; ROBINSON SP, 1995, INT J RADIAT ONCOL, V33, P855, DOI 10.1016/0360-3016(95)00072-1; Sharkey RA, 1998, EUR RESPIR J, V12, P653, DOI 10.1183/09031936.98.12030653; STONE JE, 1958, AM J PHYSIOL, V194, P115, DOI 10.1152/ajplegacy.1958.194.1.115; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Thews O, 2002, RADIOTHER ONCOL, V62, P77, DOI 10.1016/S0167-8140(01)00401-7; Uematsu H, 2007, J COMPUT ASSIST TOMO, V31, P662, DOI 10.1097/rct.0b013e3180319114; Winter JD, 2011, ACAD RADIOL, V18, P1159, DOI 10.1016/j.acra.2011.04.016; Wise RG, 2007, J CEREBR BLOOD F MET, V27, P1521, DOI 10.1038/sj.jcbfm.9600465	40	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40485	10.1371/journal.pone.0040485	http://dx.doi.org/10.1371/journal.pone.0040485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792349	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800096
J	Enomoto, M; Kawazu, S; Kawai, S; Furuyama, W; Ikegami, T; Watanabe, J; Mikoshiba, K				Enomoto, Masahiro; Kawazu, Shin-ichiro; Kawai, Satoru; Furuyama, Wakako; Ikegami, Tohru; Watanabe, Jun-ichi; Mikoshiba, Katsuhiko			Blockage of Spontaneous Ca2+ Oscillation Causes Cell Death in Intraerythrocitic Plasmodium falciparum	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; MALARIA PARASITES; CONTINUOUS-CULTURE; TOXOPLASMA-GONDII; APICOMPLEXAN PARASITES; HOST-CELLS; INVASION; MELATONIN; ERYTHROCYTE	Malaria remains one of the world's most important infectious diseases and is responsible for enormous mortality and morbidity. Resistance to antimalarial drugs is a challenging problem in malaria control. Clinical malaria is associated with the proliferation and development of Plasmodium parasites in human erythrocytes. Especially, the development into the mature forms (trophozoite and schizont) of Plasmodium falciparum (P. falciparum) causes severe malaria symptoms due to a distinctive property, sequestration which is not shared by any other human malaria. Ca2+ is well known to be a highly versatile intracellular messenger that regulates many different cellular processes. Cytosolic Ca2+ increases evoked by extracellular stimuli are often observed in the form of oscillating Ca2+ spikes (Ca2+ oscillation) in eukaryotic cells. However, in lower eukaryotic and plant cells the physiological roles and the molecular mechanisms of Ca2+ oscillation are poorly understood. Here, we showed the observation of the inositol 1,4,5-trisphospate (IP3)-dependent spontaneous Ca2+ oscillation in P. falciparum without any exogenous extracellular stimulation by using live cell fluorescence Ca2+ imaging. Intraerythrocytic P. falciparum exhibited stage-specific Ca2+ oscillations in ring form and trophozoite stages which were blocked by IP3 receptor inhibitor, 2-aminoethyl diphenylborinate (2-APB). Analyses of parasitaemia and parasite size and electron micrograph of 2-APB-treated P. falciparum revealed that 2-APB severely obstructed the intraerythrocytic maturation, resulting in cell death of the parasites. Furthermore, we confirmed the similar lethal effect of 2-APB on the chloroquine-resistant strain of P. falciparum. To our best knowledge, we for the first time showed the existence of the spontaneous Ca2+ oscillation in Plasmodium species and clearly demonstrated that IP3-dependent spontaneous Ca2+ oscillation in P. falciparum is critical for the development of the blood stage of the parasites. Our results provide a novel concept that IP3/Ca2+ signaling pathway in the intraerythrocytic malaria parasites is a promising target for antimalarial drug development.	[Enomoto, Masahiro; Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Kawazu, Shin-ichiro; Furuyama, Wakako] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Kawai, Satoru] Dokkyo Med Univ, Lab Trop Med & Parasitol, Mibu, Tochigi, Japan; [Ikegami, Tohru; Watanabe, Jun-ichi] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Saitama, Japan	RIKEN; Obihiro University of Agriculture & Veterinary Medicine; Dokkyo Medical University; University of Tokyo; Japan Science & Technology Agency (JST)	Enomoto, M (corresponding author), Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON, Canada.	mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015; Enomoto, Masahiro/L-2209-2019	furuyama, wakako/0000-0001-7163-6960; Enomoto, Masahiro/0000-0002-9411-2999	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [2022007]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants to K.M. from the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology of Japan (2022007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2011, J BIOL CHEM, V286, P5905, DOI 10.1074/jbc.M110.188474; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Biagini GA, 2003, J BIOL CHEM, V278, P27910, DOI 10.1074/jbc.M304193200; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL; Bilmen JG, 2002, CELL SIGNAL, V14, P955, DOI 10.1016/S0898-6568(02)00042-6; Bola B, 2009, BIOCHEM SOC T, V37, P961, DOI 10.1042/BST0370961; BROCKELMAN CR, 1982, J PROTOZOOL, V29, P454, DOI 10.1111/j.1550-7408.1982.tb05432.x; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Ch'ng JH, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.97; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Gratraud P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006889; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; Inselburg J, 1983, STAGE SPECIFIC INHIB; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; KAUSHAL DC, 1980, NATURE, V286, P490, DOI 10.1038/286490a0; Kawai S, 1996, AM J TROP MED HYG, V55, P223, DOI 10.4269/ajtmh.1996.55.223; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; MAENO Y, 1993, AM J TROP MED HYG, V49, P485, DOI 10.4269/ajtmh.1993.49.485; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Moreno SNJ, 2011, ESSAYS BIOCHEM, V51, P97, DOI [10.1042/BSE0510097, 10.1042/bse0510097]; Mouray E, 2007, BIOCHIMIE, V89, P337, DOI 10.1016/j.biochi.2006.11.001; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nagamune Kisaburo, 2008, V47, P70; Nagata T, 2004, MOL BIOL EVOL, V21, P1855, DOI 10.1093/molbev/msh197; Passos APD, 1997, BIOCHEM MOL BIOL INT, V42, P919; READ LK, 1991, J PARASITOL, V77, P346, DOI 10.2307/3283117; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Talman AM, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-24; TRAGER W, 1989, J PROTOZOOL, V36, P451; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Schalkwyk DA, 2010, BIOCHEM PHARMACOL, V79, P1291, DOI 10.1016/j.bcp.2009.12.025; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; WHO, 2011, WORLD MALARIA REPORT 2011, P1	55	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39499	10.1371/journal.pone.0039499	http://dx.doi.org/10.1371/journal.pone.0039499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792177	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800014
J	Marcelli, A; Abbruzzetti, S; Bustamante, JP; Feis, A; Bonamore, A; Boffi, A; Gellini, C; Salvi, PR; Estrin, DA; Bruno, S; Viappiani, C; Foggi, P				Marcelli, Agnese; Abbruzzetti, Stefania; Pablo Bustamante, Juan; Feis, Alessandro; Bonamore, Alessandra; Boffi, Alberto; Gellini, Cristina; Salvi, Pier Remigio; Estrin, Dario A.; Bruno, Stefano; Viappiani, Cristiano; Foggi, Paolo			Following Ligand Migration Pathways from Picoseconds to Milliseconds in Type II Truncated Hemoglobin from Thermobifida fusca	PLOS ONE			English	Article							TIME-RESOLVED THERMODYNAMICS; MYCOBACTERIUM-TUBERCULOSIS; HEME-PROTEINS; PHOTOACOUSTIC CALORIMETRY; VIBRATIONAL-RELAXATION; HORSE CARBOXYMYOGLOBIN; PHOTOINDUCED PROCESSES; STRUCTURAL DYNAMICS; ULTRAFAST DYNAMICS; BINDING-PROPERTIES	CO recombination kinetics has been investigated in the type II truncated hemoglobin from Thermobifida fusca (Tf-trHb) over more than 10 time decades (from 1 ps to similar to 100 ms) by combining femtosecond transient absorption, nanosecond laser flash photolysis and optoacoustic spectroscopy. Photolysis is followed by a rapid geminate recombination with a time constant of similar to 2 ns representing almost 60% of the overall reaction. An additional, small amplitude geminate recombination was identified at similar to 100 ns. Finally, CO pressure dependent measurements brought out the presence of two transient species in the second order rebinding phase, with time constants ranging from similar to 3 to similar to 100 ms. The available experimental evidence suggests that the two transients are due to the presence of two conformations which do not interconvert within the time frame of the experiment. Computational studies revealed that the plasticity of protein structure is able to define a branched pathway connecting the ligand binding site and the solvent. This allowed to build a kinetic model capable of describing the complete time course of the CO rebinding kinetics to Tf-trHb.	[Marcelli, Agnese; Foggi, Paolo] LENS, European Lab Nonlinear Spect, Florence, Italy; [Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dept Phys, I-43100 Parma, Italy; [Pablo Bustamante, Juan; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Feis, Alessandro; Gellini, Cristina; Salvi, Pier Remigio] Univ Florence, Dept Chem Ugo Schiff, Florence, Italy; [Bonamore, Alessandra; Boffi, Alberto] Univ Roma La Sapienza, Dept Biochem Sci, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Bruno, Stefano] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Foggi, Paolo] Univ Perugia, Dept Chem, I-06100 Perugia, Italy; [Foggi, Paolo] INO CNR, Florence, Italy	University of Parma; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Florence; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Parma; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Marcelli, A (corresponding author), LENS, European Lab Nonlinear Spect, Florence, Italy.	marcelli@lens.unifi.it	Salvi, Pier Remigio/ABE-1408-2020; Foggi, Paolo/M-4596-2014; Bruno, Stefano/A-4582-2011; Viappiani, Cristiano/AAC-7579-2019; Feis, Alessandro/J-1724-2014; Bonamore, Alessandra/AAB-2587-2019; abbruzzetti, stefania/M-8640-2015; abbruzzetti, stefania/AAE-5518-2020; Foggi, Paolo/C-4532-2013; Estrin, Dario/AAY-7549-2020	Foggi, Paolo/0000-0002-2985-6721; Bruno, Stefano/0000-0002-7890-2472; Viappiani, Cristiano/0000-0001-7470-4770; Feis, Alessandro/0000-0003-3469-0647; Bonamore, Alessandra/0000-0002-3940-4657; abbruzzetti, stefania/0000-0001-7685-8554; abbruzzetti, stefania/0000-0001-7685-8554; Foggi, Paolo/0000-0002-2985-6721; Estrin, Dario/0000-0002-5006-7225; Bustamante, Juan/0000-0001-6546-2562	Regione Toscana under the project EPHODS	Regione Toscana under the project EPHODS	The authors acknowledge the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, 2008BFJ34R, Azioni Integrate Italia Spagna 2009, IT10L1M59M, and FIRB 2008 to Alessandra Bonamore), Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011-2013) and Istituto Pasteur Fondazione Cenci Bolognetti. One of the authors, A.M., wishes to acknowledge the grant financial support by Regione Toscana under the project EPHODS (POR FSE 2007-2013 obiettivo 2 Asse IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2005, J AM CHEM SOC, V127, P9865, DOI 10.1021/ja051702x; Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; Angeloni L, 2003, PHOTOCH PHOTOBIO SCI, V2, P730, DOI 10.1039/b301756g; ANSARI A, 1994, BIOCHEMISTRY-US, V33, P5128, DOI 10.1021/bi00183a017; Belogortseva N, 2007, J INORG BIOCHEM, V101, P977, DOI 10.1016/j.jinorgbio.2007.03.009; Benabbas A, 2010, J AM CHEM SOC, V132, P2811, DOI 10.1021/ja910005b; Bikiel DE, 2006, PHYS CHEM CHEM PHYS, V8, P5611, DOI 10.1039/b611741b; Boechi L, 2008, PROTEINS, V73, P372, DOI 10.1002/prot.22072; Boechi L, 2010, PROTEINS, V78, P962, DOI 10.1002/prot.22620; Bonamore A, 2005, FEBS J, V272, P4189, DOI 10.1111/j.1742-4658.2005.04831.x; BRASLAVSKY SE, 1992, CHEM REV, V92, P1381, DOI 10.1021/cr00014a007; Bruno S, 2007, J AM CHEM SOC, V129, P2880, DOI 10.1021/ja066638d; CALLIS JB, 1972, BIOCHIM BIOPHYS ACTA, V267, P348, DOI 10.1016/0005-2728(72)90122-3; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; DIXON DW, 1985, J AM CHEM SOC, V107, P808, DOI 10.1021/ja00290a012; Droghetti E, 2010, BIOCHEMISTRY-US, V49, P10394, DOI 10.1021/bi101452k; Dunietz BD, 2003, J PHYS CHEM B, V107, P5623, DOI 10.1021/jp0226376; Feis A, 2001, J PHYS CHEM B, V105, P2638, DOI 10.1021/jp002639v; Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f; Foggi P, 2003, J PHYS CHEM A, V107, P1689, DOI 10.1021/jp021313e; Forti F, 2011, J COMPUT CHEM, V32, P2219, DOI 10.1002/jcc.21805; FRANZEN S, 1995, BIOCHEMISTRY-US, V34, P1224, DOI 10.1021/bi00004a016; Franzen S, 2001, BIOPHYS J, V80, P2372, DOI 10.1016/S0006-3495(01)76207-8; Frey AD, 2005, TRENDS BIOTECHNOL, V23, P69, DOI 10.1016/j.tibtech.2004.12.002; Gensch T, 2003, PHOTOCH PHOTOBIO SCI, V2, P699, DOI 10.1039/b303177b; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; GROGAN TG, 1994, J PHYS CHEM-US, V98, P13791, DOI 10.1021/j100102a053; Guallar V, 2009, J BIOL CHEM, V284, P3106, DOI 10.1074/jbc.M806183200; HAGEN SJ, 1995, SCIENCE, V269, P959, DOI 10.1126/science.7638618; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Ilari A, 2007, ARCH BIOCHEM BIOPHYS, V457, P85, DOI 10.1016/j.abb.2006.09.033; Jasaitis A, 2012, CHEM PHYS, V396, P10, DOI 10.1016/j.chemphys.2011.04.003; JONES CM, 1992, BIOCHEMISTRY-US, V31, P6692, DOI 10.1021/bi00144a008; Kholodenko Y, 2000, CHEM PHYS, V259, P71, DOI 10.1016/S0301-0104(00)00182-8; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Larsen RW, 2007, COORDIN CHEM REV, V251, P1101, DOI 10.1016/j.ccr.2006.08.018; Lim MH, 1997, J BIOL INORG CHEM, V2, P531, DOI 10.1007/s007750050167; Lim MH, 1996, J PHYS CHEM-US, V100, P12043, DOI 10.1021/jp9536458; Marcelli A, 2008, J PHYS CHEM A, V112, P1864, DOI 10.1021/jp710132s; Marti MA, 2008, METHOD ENZYMOL, V437, P477, DOI 10.1016/S0076-6879(07)37024-9; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; MARTIN JL, 1992, ANNU REV BIOPH BIOM, V21, P199, DOI 10.1146/annurev.bb.21.060192.001215; MARTIN JL, 1983, P NATL ACAD SCI-BIOL, V80, P173, DOI 10.1073/pnas.80.1.173; Miksovska J, 2003, J BIOL INORG CHEM, V8, P621, DOI 10.1007/s00775-003-0457-4; MILLER RJD, 1991, ANNU REV PHYS CHEM, V42, P581, DOI 10.1146/annurev.physchem.42.1.581; Mizutani Y, 1997, SCIENCE, V278, P443, DOI 10.1126/science.278.5337.443; Nicoletti FP, 2011, J AM CHEM SOC, V133, P20970, DOI 10.1021/ja209312k; Nicoletti FP, 2010, BIOCHEMISTRY-US, V49, P2269, DOI 10.1021/bi901671d; NORRIS CL, 1993, BIOPHYS J, V65, P1660, DOI 10.1016/S0006-3495(93)81223-2; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200; PETERS KS, 1988, SCIENCE, V241, P1053, DOI 10.1126/science.3045967; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; PROJAHN HD, 1991, INORG CHEM, V30, P3288, DOI 10.1021/ic00017a014; RODRIGUEZ J, 1989, J AM CHEM SOC, V111, P6500, DOI 10.1021/ja00199a004; RODRIGUEZ J, 1991, J CHEM PHYS, V94, P6020, DOI 10.1063/1.460439; RUDZKI JE, 1985, J AM CHEM SOC, V107, P7849, DOI 10.1021/ja00312a007; Sakakura M, 2001, J AM CHEM SOC, V123, P4286, DOI 10.1021/ja9944655; Sakakura M, 2001, J PHYS CHEM B, V105, P10424, DOI 10.1021/jp0116252; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SHANK CV, 1976, SCIENCE, V193, P50, DOI 10.1126/science.935853; Silkstone G, 2005, DALTON T, P3489, DOI 10.1039/b508183c; SMALL JR, 1992, BIOPHYS CHEM, V42, P29, DOI 10.1016/0301-4622(92)80005-P; Small JR, 1992, NUMERICAL COMPUTER M, V210; Sottini S, 2005, J PHYS CHEM B, V109, P19523, DOI 10.1021/jp0540981; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; Steinbach PJ, 2002, J CHEM INF COMP SCI, V42, P1476, DOI 10.1021/ci025551i; Steinbach PJ, 2002, BIOPHYS J, V82, P2244, DOI 10.1016/S0006-3495(02)75570-7; Vetromile CM, 2011, BBA-PROTEINS PROTEOM, V1814, P1065, DOI 10.1016/j.bbapap.2011.01.009; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Vos MH, 1999, BBA-BIOENERGETICS, V1411, P1, DOI 10.1016/S0005-2728(99)00035-3; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n; Ye XO, 2003, J PHYS CHEM A, V107, P8156, DOI 10.1021/jp0276799	82	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39884	10.1371/journal.pone.0039884	http://dx.doi.org/10.1371/journal.pone.0039884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792194	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800024
J	Petrocelli, S; Tondo, ML; Daurelio, LD; Orellano, EG				Petrocelli, Silvana; Laura Tondo, Maria; Daurelio, Lucas D.; Orellano, Elena G.			Modifications of Xanthomonas axonopodis pv. citri Lipopolysaccharide Affect the Basal Response and the Virulence Process during Citrus Canker	PLOS ONE			English	Article							BIOFILM FORMATION; LIPID-A; NONHOST RESISTANCE; HOST-RANGE; O-ANTIGEN; PSEUDOMONAS-SOLANACEARUM; ARABIDOPSIS-THALIANA; EXPRESSION PATTERNS; INNATE IMMUNITY; BACTERIAL	Xanthomonas axonopodis pv. citri (Xac) is the phytopathogen responsible for citrus canker, one of the most devastating citrus diseases in the world. A broad range of pathogens is recognized by plants through so-called pathogen-associated molecular patterns (PAMPs), which are highly conserved fragments of pathogenic molecules. In plant pathogenic bacteria, lipopolisaccharyde (LPS) is considered a virulence factor and it is being recognized as a PAMP. The study of the participation of Xac LPS in citrus canker establishment could help to understand the molecular bases of this disease. In the present work we investigated the role of Xac LPS in bacterial virulence and in basal defense during the interaction with host and non host plants. We analyzed physiological features of Xac mutants in LPS biosynthesis genes (wzt and rfb303) and the effect of these mutations on the interaction with orange and tobacco plants. Xac mutants showed an increased sensitivity to external stresses and differences in bacterial motilities, in vivo and in vitro adhesion and biofilm formation. Changes in the expression levels of the LPS biosynthesis genes were observed in a medium that mimics the plant environment. Xacwzt exhibited reduced virulence in host plants compared to Xac wild-type and Xacrfb303. However, both mutant strains produced a lower increase in the expression levels of host plant defense-related genes respect to the parental strain. In addition, Xac LPS mutants were not able to generate HR during the incompatible interaction with tobacco plants. Our findings indicate that the structural modifications of Xac LPS impinge on other physiological attributes and lead to a reduction in bacterial virulence. On the other hand, Xac LPS has a role in the activation of basal defense in host and non host plants.	[Petrocelli, Silvana; Laura Tondo, Maria; Daurelio, Lucas D.; Orellano, Elena G.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut,Mol Biol Div, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Petrocelli, S (corresponding author), Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut,Mol Biol Div, Suipacha 531, RA-2000 Rosario, Argentina.	orellano@ibr.gov.ar	Daurelio, Lucas/AAT-6969-2020	Daurelio, Lucas Damian/0000-0002-1156-2266; Tondo, Maria Laura/0000-0002-0160-1882	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 01-12783]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 01-12783 to EGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EGO and LDD are staff members and SP and MLT are Fellows of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Atabek A, 2007, J BACTERIOL, V189, P8503, DOI 10.1128/JB.00769-07; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; Bishop RE, 2005, J ENDOTOXIN RES, V11, P174, DOI 10.1179/096805105X35242; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Braun SG, 2005, MOL PLANT MICROBE IN, V18, P674, DOI 10.1094/MPMI-18-0674; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Casabuono A, 2011, J BIOL CHEM, V286, P25628, DOI 10.1074/jbc.M110.186049; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daurelio Lucas D., 2009, P187; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768, DOI 10.1094/MPMI-8-0768; DRIGUES P, 1985, J BACTERIOL, V162, P504, DOI 10.1128/JB.162.2.504-509.1985; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Erbs G, 2012, MOL PLANT PATHOL, V13, P95, DOI 10.1111/j.1364-3703.2011.00730.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Gottwald TR, 2002, PHYTOPATHOLOGY, V92, P361, DOI 10.1094/PHYTO.2002.92.4.361; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; Ingle RA, 2006, BIOESSAYS, V28, P880, DOI 10.1002/bies.20457; Jofre E, 2004, FEMS MICROBIOL LETT, V231, P267, DOI 10.1016/S0378-1097(04)00003-5; Jones AME, 2006, PROTEOMICS, V6, P4155, DOI 10.1002/pmic.200500172; Kannenberg EL, 2001, MOL MICROBIOL, V39, P379, DOI 10.1046/j.1365-2958.2001.02225.x; KAO CC, 1991, J BACTERIOL, V173, P7841, DOI 10.1128/jb.173.24.7841-7847.1991; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; KINGSLEY MT, 1993, J BACTERIOL, V175, P5839, DOI 10.1128/JB.175.18.5839-5850.1993; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; KOMEDA Y, 1977, J BACTERIOL, V129, P908, DOI 10.1128/JB.129.2.908-915.1977; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lerner A, 2009, MICROBIOL-SGM, V155, P791, DOI 10.1099/mic.0.021824-0; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Lindhout T, 2009, MICROBIOL-SGM, V155, P3449, DOI 10.1099/mic.0.030510-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marolda Cristina L., 2006, V347, P237; Molinaro A, 2009, EUR J ORG CHEM, V2009, P5887, DOI 10.1002/ejoc.200900682; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Newman MA, 2001, EUR J PLANT PATHOL, V107, P95, DOI 10.1023/A:1008738817551; Newman MA, 2000, MOL PLANT PATHOL, V1, P25, DOI 10.1046/j.1364-3703.2000.00004.x; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oh SK, 2006, PLANTA, V223, P1101, DOI 10.1007/s00425-006-0232-1; OJANEN T, 1993, APPL ENVIRON MICROB, V59, P4143, DOI 10.1128/AEM.59.12.4143-4151.1993; Patil PB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-40; Patil PB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-243; Pimenta AD, 2003, MICROBES INFECT, V5, P1177, DOI 10.1016/j.micinf.2003.09.002; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHOONEJANS E, 1987, J BACTERIOL, V169, P4011, DOI 10.1128/jb.169.9.4011-4017.1987; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Silipo A, 2005, GLYCOBIOLOGY, V15, P561, DOI 10.1093/glycob/cwi029; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Titarenko E, 1997, J BACTERIOL, V179, P6699, DOI 10.1128/jb.179.21.6699-6704.1997; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vojnov AA, 1998, MICROBIOL-UK, V144, P1487, DOI 10.1099/00221287-144-6-1487; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Wang JC, 2011, PHYSIOL MOL PLANT P, V75, P129, DOI 10.1016/j.pmpp.2010.09.003; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Williams V, 1996, APPL ENVIRON MICROB, V62, P100, DOI 10.1128/AEM.62.1.100-104.1996; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	85	38	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40051	10.1371/journal.pone.0040051	http://dx.doi.org/10.1371/journal.pone.0040051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792211	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800033
J	Sanderson, SD; Thoman, ML; Kis, K; Virts, EL; Herrera, EB; Widmann, S; Sepulveda, H; Phillips, JA				Sanderson, Sam D.; Thoman, Marilyn L.; Kis, Kornelia; Virts, Elizabeth L.; Herrera, Edgar B.; Widmann, Stephanie; Sepulveda, Homero; Phillips, Joy A.			Innate Immune Induction and Influenza Protection Elicited by a Response-Selective Agonist of Human C5a	PLOS ONE			English	Article							CONFORMATIONALLY BIASED AGONIST; BRONCHIAL EPITHELIAL-CELLS; BACILLE CALMETTE-GUERIN; MOLECULAR ADJUVANT; DENDRITIC CELLS; VIRUS INFECTION; ALVEOLAR MACROPHAGES; RESPIRATORY-TRACT; NEURAMINIDASE INHIBITORS; COMPLEMENT FRAGMENTS	The anaphylatoxin C5a is an especially potent mediator of both local and systemic inflammation. However, C5a also plays an essential role in mucosal host defense against bacterial, viral, and fungal infection. We have developed a response-selective agonist of human C5a, termed EP67, which retains the immunoenhancing activity of C5a at the expense of its inflammatory, anaphylagenic properties. EP67 insufflation results in the rapid induction of pulmonary cytokines and chemokines. This is followed by an influx of innate immune effector cells, including neutrophils, NK cells, and dendritic cells. EP67 exhibits both prophylactic and therapeutic protection when tested in a murine model of influenza A infection. Mice treated with EP67 within a twenty-four hour window of non-lethal infection were significantly protected from influenza-induced weight loss. Furthermore, EP67 delivered twenty-four hours after lethal infection completely blocked influenza-induced mortality (0% vs. 100% survival). Since protection based on innate immune induction is not restricted to any specific pathogen, EP67 may well prove equally efficacious against a wide variety of possible viral, bacterial, and fungal pathogens. Such a strategy could be used to stop the worldwide spread of emergent respiratory diseases, including but not limited to novel strains of influenza.	[Sanderson, Sam D.] Univ Nebraska Med Ctr, Sch Allied Hlth Profess, Omaha, NE USA; [Thoman, Marilyn L.; Virts, Elizabeth L.; Phillips, Joy A.] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Thoman, Marilyn L.; Kis, Kornelia; Virts, Elizabeth L.; Herrera, Edgar B.; Phillips, Joy A.] San Diego State Univ, Biosci Ctr, San Diego, CA 92182 USA; [Widmann, Stephanie; Sepulveda, Homero] BD Biosci, San Diego, CA USA	University of Nebraska System; University of Nebraska Medical Center; California State University System; San Diego State University	Sanderson, SD (corresponding author), Univ Nebraska Med Ctr, Sch Allied Hlth Profess, Omaha, NE USA.	jphillips@sciences.sdsu.edu			National Institute of Allergy and Infectious Diseases [AI065712]; National Institute of General Medical Studies, National Institutes of Health [GM095884]; National Institute for Aging, National Institutes of Health [AG0278077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095884] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Studies, National Institutes of Health; National Institute for Aging, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supporting grants to Dr. Phillips were AI065712 from the National Institute of Allergy and Infectious Diseases and GM095884 from the National Institute of General Medical Studies, National Institutes of Health. Dr. Thoman is supported by AG0278077 from the National Institute for Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKOVIC ES, 1987, ANTIVIR RES, V8, P151, DOI 10.1016/0166-3542(87)90068-4; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Buchner RR, 1997, J IMMUNOL, V158, P1670; Buchweitz John P, 2007, Toxicol Pathol, V35, P424, DOI 10.1080/01926230701302558; CHELEN CJ, 1995, J CLIN INVEST, V95, P1415, DOI 10.1172/JCI117796; Cottey R, 2001, CURR PROTOC IMMUNOL, V42; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; DeForge LE, 2007, J IMMUNOL METHODS, V320, P58, DOI 10.1016/j.jim.2006.12.001; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; Diaz-Mitoma F, 2004, J CLIN VIROL, V31, P100, DOI 10.1016/j.jcv.2004.04.006; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Duryee MJ, 2009, VACCINE, V27, P2981, DOI 10.1016/j.vaccine.2009.02.105; Ernst D, 2003, APPL HDB; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Finch AM, 1997, J MED CHEM, V40, P877, DOI 10.1021/jm960727r; Floreani AA, 1998, J IMMUNOL, V160, P5073; FUJISAWA H, 1987, J GEN VIROL, V68, P425, DOI 10.1099/0022-1317-68-2-425; GLASGOW LA, 1977, J INFECT DIS, V135, P763, DOI 10.1093/infdis/135.5.763; GOODMAN MG, 1982, J IMMUNOL, V129, P70; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hegde GV, 2008, INT IMMUNOPHARMACOL, V8, P819, DOI 10.1016/j.intimp.2008.01.031; HICKS JT, 1978, J IMMUNOL, V121, P1437; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Hugli T E, 1978, Adv Immunol, V26, P1, DOI 10.1016/S0065-2776(08)60228-X; HUGLI TE, 1987, AM REV RESPIR DIS, V135, pS9; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Karachunski PI, 2000, J IMMUNOL, V164, P5236, DOI 10.4049/jimmunol.164.10.5236; Kim AHJ, 2004, J IMMUNOL, V173, P2524, DOI 10.4049/jimmunol.173.4.2524; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; MONTZ H, 1990, CELL IMMUNOL, V127, P337, DOI 10.1016/0008-8749(90)90137-G; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Morgan EL, 2010, VACCINE, V28, P8275, DOI 10.1016/j.vaccine.2010.10.008; Morgan EL, 2009, VACCINE, V28, P463, DOI 10.1016/j.vaccine.2009.10.029; MORGAN EL, 1983, J IMMUNOL, V130, P1257; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moulton RA, 2007, J LEUKOCYTE BIOL, V82, P956, DOI 10.1189/jlb.0206119; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Phillips JA, 2009, BIOCONJUGATE CHEM, V20, P1950, DOI 10.1021/bc9002794; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Sanderson SD, 2003, INT IMMUNOPHARMACOL, V3, P137, DOI 10.1016/S1567-5769(02)00260-6; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; SCHOLTISSEK C, 1991, ARCH VIROL, V119, P111, DOI 10.1007/BF01314327; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sheen TR, 2011, VACCINE, V30, P9, DOI 10.1016/j.vaccine.2011.10.054; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SPENCER JC, 1977, J INFECT DIS, V136, P171, DOI 10.1093/infdis/136.2.171; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Suresh M, 2003, J IMMUNOL, V170, P788, DOI 10.4049/jimmunol.170.2.788; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Taylor SM, 2001, CURR MED CHEM, V8, P675, DOI 10.2174/0929867013373156; Tempero RM, 1997, J IMMUNOL, V158, P1377; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Ulrich JT, 2000, J IMMUNOL, V164, P5492, DOI 10.4049/jimmunol.164.10.5492; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vogen SM, 2001, INT IMMUNOPHARMACOL, V1, P2151, DOI 10.1016/S1567-5769(01)00141-2; Vogen SM, 1999, J PEPT RES, V54, P74, DOI 10.1034/j.1399-3011.1999.00087.x; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; Wang K, 2012, COCHRANE DB SYST REV, V1	70	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40303	10.1371/journal.pone.0040303	http://dx.doi.org/10.1371/journal.pone.0040303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792270	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800065
J	Tcatchoff, L; Andersson, S; Utskarpen, A; Klokk, TI; Skanland, SS; Pust, S; Gerke, V; Sandvig, K				Tcatchoff, Lionel; Andersson, Sofia; Utskarpen, Audrun; Klokk, Tove Irene; Skanland, Sigrid S.; Pust, Sascha; Gerke, Volker; Sandvig, Kirsten			Annexin A1 and A2: Roles in Retrograde Trafficking of Shiga Toxin	PLOS ONE			English	Article							TO-GOLGI TRANSPORT; KINASE-C-DELTA; PHOSPHOLIPASE A(2); EARLY ENDOSOMES; CYTOSOLIC PHOSPHOLIPASE-A2; RECEPTOR; COMPLEX; RETROMER; CLATHRIN; LOCALIZATION	Annexins constitute a family of calcium and membrane binding proteins. As annexin A1 and A2 have previously been linked to various membrane trafficking events, we initiated this study to investigate the role of these annexins in the uptake and intracellular transport of the bacterial Shiga toxin (Stx) and the plant toxin ricin. Once endocytosed, both toxins are retrogradely transported from endosomes to the Golgi apparatus and the endoplasmic reticulum before being targeted to the cytosol where they inhibit protein synthesis. This study was performed to obtain new information both about toxin transport and the function of annexin A1 and annexin A2. Our data show that depletion of annexin A1 or A2 alters the retrograde transport of Stx but not ricin, without affecting toxin binding or internalization. Knockdown of annexin A1 increases Golgi transport of Stx, whereas knockdown of annexin A2 slightly decreases the same transport step. Interestingly, annexin A1 was found in proximity to cytoplasmic phospholipase A2 (cPLA(2)), and the basal as well as the increased Golgi transport of Stx upon annexin A1 knockdown is dependent on cPLA(2) activity. In conclusion, annexin A1 and A2 have different roles in Stx transport to the trans-Golgi network. The most prominent role is played by annexin A1 which normally works as a negative regulator of retrograde transport from the endosomes to the Golgi network, most likely by complex formation and inhibition of cPLA(2).	[Tcatchoff, Lionel; Andersson, Sofia; Utskarpen, Audrun; Klokk, Tove Irene; Skanland, Sigrid S.; Pust, Sascha; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed,Dept Biochem, Oslo, Norway; [Utskarpen, Audrun; Skanland, Sigrid S.; Sandvig, Kirsten] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Gerke, Volker] Univ Munster, Inst Med Chem, Ctr Mol Biol Inflammat, Munster, Germany	University of Oslo; University of Oslo; University of Munster	Tcatchoff, L (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed,Dept Biochem, Oslo, Norway.	ksandvig@radium.uio.no	Utskarpen, Audrun/GRS-0436-2022; Skånland, Sigrid S/AAW-4817-2021; Pust, Sascha/M-3201-2013	Pust, Sascha/0000-0002-0178-2206; Skanland, Sigrid S./0000-0003-1630-356X	Norwegian Cancer Society; Norwegian Research Council for Science and the Humanities; Norwegian Research Council - Functional Genomics (NFR-FUGE); German Research Council (DFG) [SFB 629]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council for Science and the Humanities; Norwegian Research Council - Functional Genomics (NFR-FUGE); German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Norwegian Cancer Society, the Norwegian Research Council for Science and the Humanities, the Norwegian Research Council - Functional Genomics (NFR-FUGE), and the German Research Council to VG (DFG, SFB 629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; Croxtall JD, 2003, BIOCHEM J, V371, P927, DOI 10.1042/BJ20021856; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; Doody AM, 2009, BIOCHEM BIOPH RES CO, V388, P695, DOI 10.1016/j.bbrc.2009.08.067; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Dyve AB, 2009, BIOCHEM BIOPH RES CO, V390, P109, DOI 10.1016/j.bbrc.2009.09.076; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Engedal N, 2011, MICROB BIOTECHNOL, V4, P32, DOI 10.1111/j.1751-7915.2010.00180.x; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Herbert SP, 2007, J BIOL CHEM, V282, P34468, DOI 10.1074/jbc.M701541200; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kim SW, 2001, FEBS LETT, V489, P243, DOI 10.1016/S0014-5793(00)02326-7; Klinger SC, 2011, J CELL SCI, V124, P1095, DOI 10.1242/jcs.072538; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Moes M, 2010, CELL MOL LIFE SCI, V67, P1547, DOI 10.1007/s00018-010-0267-0; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Popoff V, 2009, TRAFFIC, V10, P1868, DOI 10.1111/j.1600-0854.2009.00993.x; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Sakaguchi M, 2007, J BIOL CHEM, V282, P35679, DOI 10.1074/jbc.M707538200; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Skanland SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005935; Skanland SS, 2009, CELL MICROBIOL, V11, P796, DOI 10.1111/j.1462-5822.2009.01292.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spooner RA, 2008, BIOCHEM J, V414, P471, DOI 10.1042/BJ20080149; THIEL C, 1992, J CELL SCI, V103, P733; Tian W, 2008, J BIOL CHEM, V283, P3960, DOI 10.1074/jbc.M707345200; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Turpin E, 1998, BBA-MOL CELL RES, V1402, P115, DOI 10.1016/S0167-4889(97)00151-1; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; Utskarpen A, 2007, BIOCHEM BIOPH RES CO, V358, P566, DOI 10.1016/j.bbrc.2007.04.159; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387; Zobiack N, 2001, FEBS LETT, V500, P137, DOI 10.1016/S0014-5793(01)02604-7	72	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40429	10.1371/journal.pone.0040429	http://dx.doi.org/10.1371/journal.pone.0040429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792315	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800083
J	Schallenberg, M; Prokosch, V; Thanos, S				Schallenberg, Maurice; Prokosch, Verena; Thanos, Solon			Regulation of Retinal Proteome by Topical Antiglaucomatous Eye Drops in an Inherited Glaucoma Rat Model	PLOS ONE			English	Article							GANGLION-CELL DEATH; INTRAOCULAR-PRESSURE; INHIBITS APOPTOSIS; AXONAL-TRANSPORT; IN-VITRO; HEAT-SHOCK-PROTEIN-70; SURVIVAL; BDNF; CALCIUM/CALMODULIN; PHARMACOLOGY	Examination of the response of the retinal proteome to elevated intraocular pressure (IOP) and to the pharmacological normalization of IOP is crucial, in order to develop drugs with neuroptorective potential. We used a hereditary rat model of ocular hypertension to lower IOP with travaprost and dorzolamide applied topically on the eye surface, and examine changes of the retinal proteome. Our data demonstrate that elevated IOP causes alterations in the retinal protein profile, in particular in high-mobility-group-protein B1 (HMGB1), calmodulin, heat-shock-protein (HSP) 70 and carbonic anhydrase II expression. The changes of the retinal proteome by dorzolamide or travoprost are different and independent of the IOP lowering effect. This fact suggests that the eye drops exert a direct IOP-independent effect on retinal metabolism. Further investigations are required to elucidate the potential neuroprotective mechanisms signaled through changes of HMGB1, calmodulin, HSP70 and carbonic anhydrase II expression in glaucoma. The data may facilitate development of eye drops that exert neuroprotection through direct pharmacological effect.	[Schallenberg, Maurice; Prokosch, Verena; Thanos, Solon] Univ Clin Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany; [Schallenberg, Maurice; Prokosch, Verena; Thanos, Solon] Interdisciplinary Ctr Clin Res IZKF, Munster, Germany; [Schallenberg, Maurice] Univ Duisburg Essen, Univ Hosp Essen, Dept Ophthalmol, Essen, Germany	University of Munster; University of Duisburg Essen	Schallenberg, M (corresponding author), Univ Clin Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany.	solon@uni-muenster.de			Deutsche Forschungsgemeinschaft (DFG) [Th386/16-1, Th386/16-2]; IMF-Munster [NA 110503]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IMF-Munster	This work was supported by the Deutsche Forschungsgemeinschaft (DFG Grants Th386/16-1 and Th386/16-2 to Dr. Thanos) and the IMF-Munster (Grant NA 110503 to Dr. Thanos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Caprioli Joseph, 2003, Trans Am Ophthalmol Soc, V101, P39; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Davis TL, 1999, J OCUL PHARMACOL TH, V15, P323, DOI 10.1089/jop.1999.15.323; Drago F, 2001, EXP EYE RES, V72, P479, DOI 10.1006/exer.2000.0975; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; Fan W, 2007, INVEST OPHTH VIS SCI, V48, P3854, DOI 10.1167/iovs.06-1382; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hitchings R A, 1995, Curr Opin Ophthalmol, V6, P67; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kniep EM, 2006, INVEST OPHTH VIS SCI, V47, P1185, DOI 10.1167/iovs.05-0555; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; Levin LA, 2003, SURV OPHTHALMOL, V48, pS21, DOI 10.1016/S0039-6257(03)00007-9; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Martinez A, 2009, J OCUL PHARMACOL TH, V25, P239, DOI 10.1089/jop.2008.0114; Naskar R, 2006, MOL VIS, V12, P1199; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Osborne NN, 2004, EYE, V18, P1075, DOI 10.1038/sj.eye.6701588; Park HY, 2008, J OCUL PHARMACOL TH, V24, P563, DOI 10.1089/jop.2008.0039; Park KH, 2001, INVEST OPHTH VIS SCI, V42, P1522; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; Perez-Garcia MJ, 2004, J BIOL CHEM, V279, P6132, DOI 10.1074/jbc.M308367200; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Sugrue MF, 1996, J OCUL PHARMACOL TH, V12, P363, DOI 10.1089/jop.1996.12.363; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; Thanos S, 2004, EXP EYE RES, V79, P119, DOI 10.1016/j.exer.2004.02.005; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Yamagishi R, 2011, EXP EYE RES, V93, P265, DOI 10.1016/j.exer.2011.06.022; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	43	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e33593	10.1371/journal.pone.0033593	http://dx.doi.org/10.1371/journal.pone.0033593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792152	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300001
J	Wang, C; Chen, HF; Hao, QN; Sha, AH; Shan, ZH; Chen, LM; Zhou, R; Zhi, HJ; Zhou, XA				Wang, Cheng; Chen, HaiFeng; Hao, QingNan; Sha, AiHua; Shan, ZhiHui; Chen, LiMiao; Zhou, Rong; Zhi, HaiJian; Zhou, XinAn			Transcript Profile of the Response of Two Soybean Genotypes to Potassium Deficiency	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN-KINASE; K+ CHANNEL; MOLECULAR-MECHANISMS; SALT-STRESS; ARABIDOPSIS; METABOLISM; PLANTS; ACID; TRANSPORTERS	The macronutrient potassium (K) is essential to plant growth and development. Crop yield potential is often affected by lack of soluble K. The molecular regulation mechanism of physiological and biochemical responses to K starvation in soybean roots and shoots is not fully understood. In the present study, two soybean varieties were subjected to low-K stress conditions: a low-K-tolerant variety (You06-71) and a low-K-sensitive variety (HengChun04-11). Eight libraries were generated for analysis: 2 genotypes x2 tissues (roots and shoots) x2 time periods [short term (0.5 to 12 h) and long term (3 to 12 d)]. RNA derived from the roots and shoots of these two varieties across two periods (short term and long term) were sequenced and the transcriptomes were compared using high-throughput tag-sequencing. To this end, a large number of clean tags (tags used for analysis after removal of dirty tags) corresponding to distinct tags (all types of clean tags) were identified in eight libraries (L1, You06-71-root short term; L2, HengChun04-11-root short term; L3, You06-71-shoot short term; L4, HengChun04-11-shoot short term; L5, You06-71-root long term; L6, HengChun04-11-root long term; L7, You06-71-shoot long term; L8, HengChun04-11-shoot long term). All clean tags were mapped to the available soybean (Glycine max) transcript database (http://www.soybase.org). Many genes showed substantial differences in expression across the libraries. In total, 5,440 transcripts involved in 118 KEGG pathways were either up- or down-regulated. Fifteen genes were randomly selected and their expression levels were confirmed using quantitative RT-PCR. Our results provide preliminary information on the molecular mechanism of potassium absorption and transport under low-K stress conditions in different soybean tissues.	[Wang, Cheng; Zhi, HaiJian] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Wang, Cheng; Chen, HaiFeng; Hao, QingNan; Sha, AiHua; Shan, ZhiHui; Chen, LiMiao; Zhou, Rong; Zhou, XinAn] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol, Wuhan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wang, C (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China.	zhj@njau.edu.cn; zhouocri@sina.com			National Transgenic Project [2011ZX08004-005]; Modern Agricultural Technology System [CARS-040PS08]; Crop Germplasms Resource Protection Project [NB07-2130315-06, NB08-2130315-(25-31)06]	National Transgenic Project; Modern Agricultural Technology System; Crop Germplasms Resource Protection Project	The authors are grateful for financial support by special funds from the major issue of National Transgenic Project (2011ZX08004-005), the Modern Agricultural Technology System (CARS-040PS08) and grants from the Crop Germplasms Resource Protection Project (NB07-2130315-06, NB08-2130315-(25-31)06). The funders had no role in study design, data collection and analysis, preparation of the manuscript and decision to publish were determined by the author.	Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y; Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Adams F., 1974, The Plant Root and its Environment. Proceedings held at Virginia Polytechnic and State University, 1971. E.W.Carson (Editor), P441; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Assmann SM, 2003, TRENDS PLANT SCI, V8, P151, DOI 10.1016/S1360-1385(03)00052-9; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Becker D, 2003, FEBS LETT, V554, P119, DOI 10.1016/S0014-5793(03)01118-9; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Berger H, 2006, MOL MICROBIOL, V59, P433, DOI 10.1111/j.1365-2958.2005.04957.x; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Britto DT, 2008, PHYSIOL PLANTARUM, V133, P637, DOI 10.1111/j.1399-3054.2008.01067.x; Bryan J, 1999, BBA-BIOMEMBRANES, V1461, P285, DOI 10.1016/S0005-2736(99)00164-9; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2008, J INTEGR PLANT BIOL, V50, P835, DOI 10.1111/j.1744-7909.2008.00707.x; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Cullum R, 2011, RESPIROLOGY, V16, P210, DOI 10.1111/j.1440-1843.2010.01899.x; Deeken R, 2002, PLANTA, V216, P334, DOI 10.1007/s00425-002-0895-1; Duby G, 2008, PLANT J, V53, P115, DOI 10.1111/j.1365-313X.2007.03324.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; Gupta M, 2008, MOL GENET GENOMICS, V280, P437, DOI 10.1007/s00438-008-0377-7; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Jung JY, 2009, PLANT CELL, V21, P607, DOI 10.1105/tpc.108.063099; Jungk A, 1997, ADV AGRON, V61, P53, DOI 10.1016/S0065-2113(08)60662-8; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanneganti Vydehi, 2008, Physiology and Molecular Biology of Plants, V14, P109, DOI 10.1007/s12298-008-0010-6; Karam BS, 2002, CURR OPIN PLANT BIOL, V5, P430; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Libault M, 2010, PLANT PHYSIOL, V152, P541, DOI 10.1104/pp.109.148379; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Ma LG, 2005, PLANT PHYSIOL, V138, P80, DOI 10.1104/pp.104.054783; Marrush M, 1998, J AM SOC HORTIC SCI, V123, P925, DOI 10.21273/JASHS.123.5.925; Maser P, 2002, PLANT SOIL, V247, P43, DOI 10.1023/A:1021159130729; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; NAKAMURA RL, 1995, PLANT PHYSIOL, V109, P371, DOI 10.1104/pp.109.2.371; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pyo YJ, 2010, PLANT PHYSIOL, V153, P863, DOI 10.1104/pp.110.154369; Rapala-Kozik M, 2008, J EXP BOT, V59, P4133, DOI 10.1093/jxb/ern253; Ricarda D, 2001, J NEUROSCI, V21, P2058; Riechmann JL, 1998, BIOL CHEM, V379, P633; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Saijo Y, 2001, PLANT CELL PHYSIOL, V42, P1228, DOI 10.1093/pcp/pce158; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sudha G, 2002, PLANT CELL TISS ORG, V71, P181, DOI 10.1023/A:1020336626361; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Sutter JU, 2007, CURR BIOL, V17, P1396, DOI 10.1016/j.cub.2007.07.020; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tisdale S. L., 1993, SOIL FERTILITY FERTI, P109; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wang Y, 2010, CELL RES, V20, P826, DOI 10.1038/cr.2010.74; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Watanabe S, 2010, FEBS LETT, V584, P1181, DOI 10.1016/j.febslet.2010.02.023; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zhang GP, 1999, NUTR CYCL AGROECOSYS, V54, P41; Zhao J, 2008, PLANT PHYSIOL, V148, P796, DOI 10.1104/pp.108.124248	93	28	32	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39856	10.1371/journal.pone.0039856	http://dx.doi.org/10.1371/journal.pone.0039856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792192	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300011
J	Lu, JP; Huang, YQ; Wang, YX; Li, Y; Zhang, YJ; Wu, JJ; Zhao, FF; Meng, SJ; Yu, XW; Ma, QW; Song, MS; Chang, NB; Bittles, AH; Wang, W				Lu, Jiapeng; Huang, Yuqing; Wang, Youxin; Li, Yan; Zhang, Yujun; Wu, Jingjing; Zhao, Feifei; Meng, Shijiao; Yu, Xinwei; Ma, Qingwei; Song, Manshu; Chang, Naibai; Bittles, Alan H.; Wang, Wei			Profiling Plasma Peptides for the Identification of Potential Ageing Biomarkers in Chinese Han Adults	PLOS ONE			English	Article							OLDER PERSONS; SERUM-ALBUMIN; HUMAN LONGEVITY; RISK-FACTORS; AGE; FIBRINOGEN; MORTALITY; ASSOCIATION; POPULATION; PROTEIN	Advancing age is associated with cardiovascular disease, diabetes mellitus and cancer, and shows significant inter-individual variability. To identify ageing-related biomarkers we performed a proteomic analysis on 1890 Chinese Han individuals, 1136 males and 754 females, aged 18 to 82 years, using weak cation exchange magnetic bead based MALDI-TOF-MS analysis. The study identified 44 peptides which varied in concentration in different age groups. In particular, apolipoprotein A-I (ApoA1) concentration gradually increased between 18 to 50 years of age, the levels of fibrinogen alpha (FGA) decreased over the same age span, while albumin (ALB) was significantly degraded in middle-aged individuals. In addition, the plasma peptide profiles of FGA and four other unidentified proteins were found to be gender-dependent. Plasma proteins such as FGA, ALB and ApoA1 are significantly correlated with age in the Chinese Han population and could be employed as indicative ageing-related biomarkers.	[Lu, Jiapeng; Wang, Youxin; Wu, Jingjing; Zhao, Feifei; Meng, Shijiao; Yu, Xinwei; Song, Manshu; Wang, Wei] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Huang, Yuqing] Beijing Haidian Hosp, Dept Chest Surg, Beijing, Peoples R China; [Wang, Wei] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Bittles, Alan H.; Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Bittles, Alan H.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Li, Yan; Zhang, Yujun; Ma, Qingwei] Bioyong Technol Inc, Beijing, Peoples R China; [Chang, Naibai] Beijing Hosp, Dept Hematol, Beijing, Peoples R China; [Lu, Jiapeng; Wang, Youxin; Wu, Jingjing; Zhao, Feifei; Meng, Shijiao; Yu, Xinwei; Song, Manshu; Wang, Wei] Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Edith Cowan University; Murdoch University; Beijing Hospital	Lu, JP (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China.	songms@ccmu.edu.cn; wei6014@yahoo.com; wei.wang@ecu.edu.au	liu, li/HGC-0900-2022	Wang, Youxin/0000-0002-6574-6706; Huang, Yuqing/0000-0002-3182-1798; wang, wei/0000-0002-1430-1360; Song, Manshu/0000-0003-1433-7192; Bittles, Alan/0000-0002-8176-2730	National Science Technology Major Special Project on Major New Drug Innovation [2010ZX09401]; National "Twelfth Five-Year" Plan for Science and Technology Support [2012BAI37B03]; Major State Basic Research Program-973 of China [2011CB503806]; National Natural Science Foundation of China [30901238, 31070727, 81001281]	National Science Technology Major Special Project on Major New Drug Innovation; National "Twelfth Five-Year" Plan for Science and Technology Support; Major State Basic Research Program-973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by National Science Technology Major Special Project on Major New Drug Innovation (2010ZX09401) http://www.nmp.gov.cn/, National "Twelfth Five-Year" Plan for Science and Technology Support (2012BAI37B03) http://kjzc.jhgl.org/, Major State Basic Research Program-973 of China (No. 2011CB503806) http://program.most.gov.cn/, National Natural Science Foundation of China (30901238, 31070727 and 81001281) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred S, 2004, CLIN BIOCHEM, V37, P943, DOI 10.1016/j.clinbiochem.2004.09.002; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; BANERJEE AK, 1992, THROMB HAEMOSTASIS, V68, P261; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Bittles AH, 2005, HUMAN CLOCKS BIOCULT, P41; Bittles AH, 2008, OLD AGE PSYCHIAT, P3; Byerley LO, 2010, AGE, V32, P497, DOI 10.1007/s11357-010-9146-8; Capri M, 2006, ANN NY ACAD SCI, V1067, P252, DOI 10.1196/annals.1354.033; Choudhury A, 2004, BRIT J CANCER, V90, P657, DOI 10.1038/sj.bjc.6601604; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; FOLSOM AR, 1995, EUR HEART J, V16, P21, DOI 10.1093/eurheartj/16.suppl_A.21; Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Ishikawa S, 1997, THROMB HAEMOSTASIS, V77, P890; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; KLONOFFCOHEN H, 1992, J CLIN EPIDEMIOL, V45, P207, DOI 10.1016/0895-4356(92)90080-7; Ko GTC, 1997, ATHEROSCLEROSIS, V131, P211, DOI 10.1016/S0021-9150(97)06109-1; Kronenberg F, 2008, EXP GERONTOL, V43, P39, DOI 10.1016/j.exger.2007.09.005; Liu CB, 2011, INT J MED SCI, V8, P39, DOI 10.7150/ijms.8.39; LOWE GDO, 1995, EUR HEART J, V16, P2, DOI 10.1093/eurheartj/16.suppl_A.2; Lu JP, 2011, J PROTEOME RES, V10, P4959, DOI 10.1021/pr2004067; Miura Y, 2011, EXP GERONTOL, V46, P81, DOI 10.1016/j.exger.2010.10.002; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; SALIVE ME, 1992, J CLIN EPIDEMIOL, V45, P213, DOI 10.1016/0895-4356(92)90081-W; Sebastiani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008210; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; Shah GN, 1995, BBA-LIPID LIPID MET, V1259, P277, DOI 10.1016/0005-2760(95)00174-3; Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014; Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008; Stessman J, 2005, MECH AGEING DEV, V126, P333, DOI 10.1016/j.mad.2004.08.025; Thomas NE, 2005, AM J HUM BIOL, V17, P809, DOI 10.1002/ajhb.20447; Troen BR, 2003, MT SINAI J MED, V70, P3; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Villanueva J, 2006, NAT PROTOC, V1, P880, DOI 10.1038/nprot.2006.128; Visser M, 2005, AM J CLIN NUTR, V82, P531; Wu S, 2011, INT J CLIN ONCOL; Zhang Xinyi, 2004, J Biomol Tech, V15, P167; ZHOU ZJ, 2004, LING NAN XIN XUE GUA, V10, P10	44	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39726	10.1371/journal.pone.0039726	http://dx.doi.org/10.1371/journal.pone.0039726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802942	Green Published, gold			2022-12-25	WOS:000306186900016
J	Chau, WK; Ip, CK; Mak, ASC; Lai, HC; Wong, AST				Chau, W. K.; Ip, C. K.; Mak, A. S. C.; Lai, H-C; Wong, A. S. T.			c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/beta-catenin-ATP-binding cassette G2 signaling	ONCOGENE			English	Article						c-Kit; ovarian cancer; chemoresistance; beta-catenin; ABCG2	BETA-CATENIN; EPITHELIAL OVARIAN; IMATINIB MESYLATE; CLINICOPATHOLOGICAL FEATURES; GENE-EXPRESSION; STEM-CELLS; CARCINOMA; RESISTANCE; RECURRENT; BIOLOGY	Cisplatin and paclitaxel are standard chemotherapy for metastatic ovarian cancer, but with limited efficacy. Cancer stem/progenitor cells (or tumor-initiating cells, TICs) are hypothesized to be chemoresistant, and the existence of TICs in ovarian cancer has been previously demonstrated. However, the key signals and molecular events regulating the formation and expansion of ovarian tumor-initiating cells (OTICs) remain elusive. Here, we show that c-Kit is not just a marker of OTICs, but also a critical mediator of the phenotype that can be a viable target for the treatment of ovarian cancer. In contrast to non-OICs, c-Kit was overexpressed in OTICs. Moreover, the use of small interfering RNA to inhibit c-Kit expression markedly attenuated the number and size of OTIC subpopulations, inhibited the expression of stem cell markers and decreased the tumorigenic capabilities of OTICs. Imatinib (Gleevec), a clinical drug that blocks c-Kit kinase activity, also demonstrated its inhibition potency on OTICs. In addition, cisplatin/paclitaxel, which killed non-OTICs, with c-Kit knockdown or imatinib revealed that this was critically required for intervening ovarian cancer progression and recurrence in vitro and in xenograft tumors in vivo. Similar results were obtained with OTICs derived from ovarian carcinoma patients. Studies into the mechanisms suggest an important role for the activation of Wnt/beta-catenin and ATP-binding cassette G2 downstream of c-Kit. The tumor-promoting microenvironment, such as hypoxia, could promote OTICs via upregulation of c-Kit expression. These results unravel an integral role for c-Kit in ovarian neoplastic processes and shed light on its mechanisms of action.	[Chau, W. K.; Ip, C. K.; Mak, A. S. C.; Wong, A. S. T.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Lai, H-C] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	University of Hong Kong; National Defense Medical Center; Tri-Service General Hospital	Wong, AST (corresponding author), Univ Hong Kong, Sch Biol Sci, 4S-14 Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	awong1@hku.hk	Wong, Alice/AFJ-4595-2022	Wong, Alice/0000-0002-0676-6475; Ip, Carman K.M./0000-0002-6672-5982	National Health Research Institute of Taiwan [NHRI-EX100-9717NC]; HKU Strategic Research Theme Fund on Cancer, CRCG [201109176078, CUHK8/CRF/11R]; Croucher Senior Research Fellowship	National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan); HKU Strategic Research Theme Fund on Cancer, CRCG; Croucher Senior Research Fellowship	This study was supported by the National Health Research Institute of Taiwan (NHRI-EX100-9717NC) to H-C Lai, and by HKU Strategic Research Theme Fund on Cancer, CRCG (201109176078), CUHK8/CRF/11R, and Croucher Senior Research Fellowship to AST Wong.	Alberts DS, 2007, INT J GYNECOL CANCER, V17, P784, DOI 10.1111/j.1525-1438.2007.00882.x; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bailey-Dell KJ, 2001, BBA-GENE STRUCT EXPR, V1520, P234, DOI 10.1016/S0167-4781(01)00270-6; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Birner P, 2001, CLIN CANCER RES, V7, P1661; BROUDY VC, 1994, BLOOD, V83, P2145; Brustmann H, 2005, GYNECOL ONCOL, V98, P396, DOI 10.1016/j.ygyno.2005.04.035; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Coleman RL, 2006, GYNECOL ONCOL, V101, P126, DOI 10.1016/j.ygyno.2005.09.041; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; HEINRICH MC, 1993, BLOOD, V82, P771, DOI 10.1182/blood.V82.3.771.bloodjournal823771; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson SW, 1997, CANCER RES, V57, P850; Karlsson MO, 1999, DRUG METAB DISPOS, V27, P1220; Kildal W, 2005, EUR J CANCER, V41, P1127, DOI 10.1016/j.ejca.2005.01.022; Lee CM, 2003, GYNECOL ONCOL, V88, P363, DOI 10.1016/S0090-8258(02)00015-X; Luo LJ, 2011, EXP MOL PATHOL, V91, P596, DOI 10.1016/j.yexmp.2011.06.005; Matei D, 2008, CANCER-AM CANCER SOC, V113, P723, DOI 10.1002/cncr.23605; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Mundhenke C, 2008, J CANCER RES CLIN, V134, P1397, DOI 10.1007/s00432-008-0408-0; MUTCH DG, 1994, CLIN OBSTET GYNECOL, V37, P406, DOI 10.1097/00003081-199406000-00017; Nakayama K, 2002, CANCER LETT, V176, P215, DOI 10.1016/S0304-3835(01)00762-5; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Pon YL, 2006, MOL ENDOCRINOL, V20, P3336, DOI 10.1210/me.2006-0125; Posadas EM, 2007, CANCER-AM CANCER SOC, V110, P309, DOI 10.1002/cncr.22757; Raspollini AR, 2004, ANN ONCOL, V15, P594, DOI 10.1093/annonc/mdh139; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roberts KG, 2007, MOL CANCER THER, V6, P1159, DOI 10.1158/1535-7163.MCT-06-0641; Sattler M, 2004, LEUKEMIA RES, V28, pS11, DOI 10.1016/j.leukres.2003.10.004; Schilder RJ, 2008, J CLIN ONCOL, V26, P3418, DOI 10.1200/JCO.2007.14.3420; Schmandt RE, 2003, CANCER-AM CANCER SOC, V98, P758, DOI 10.1002/cncr.11561; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Shaw TJ, 2007, GYNECOL ONCOL, V105, P122, DOI 10.1016/j.ygyno.2006.10.052; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; WANG GL, 1993, BLOOD, V82, P3610; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Zajchowski DA, 2012, MOL CANCER THER, V11, P492, DOI 10.1158/1535-7163.MCT-11-0746; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	50	147	150	1	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2767	2781		10.1038/onc.2012.290	http://dx.doi.org/10.1038/onc.2012.290			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22797058				2022-12-25	WOS:000319808000008
J	Qi, QG; Gibson, A; Fu, XR; Zheng, MY; Kuehn, R; Wang, YC; Wang, YF; Navarro, S; Morrell, JA; Jiang, DM; Simmons, G; Bell, E; Ivleva, NB; McClerren, AL; Loida, P; Ruff, TG; Petracek, ME; Preuss, SB				Qi, Qungang; Gibson, Ann; Fu, Xiaoran; Zheng, Meiying; Kuehn, Rosemarie; Wang, Yongcheng; Wang, Yanfei; Navarro, Santiago; Morrell, James A.; Jiang, Dongming; Simmons, Grant; Bell, Erin; Ivleva, Natalia B.; McClerren, Amanda L.; Loida, Paul; Ruff, Thomas G.; Petracek, Marie E.; Preuss, Sasha B.			Involvement of the N-terminal B-box Domain of Arabidopsis BBX32 Protein in Interaction with Soybean BBX62 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SALT BRIDGES; CONSTANS; BINDING; TRANSCRIPTION; IDENTIFICATION; MOTIF	Previous studies have demonstrated that Arabidopsis thaliana BBX32 (AtBBX32) represses light signaling in A. thaliana and that expression of AtBBX32 in soybean increases grain yield in multiple locations and multiyear field trials. The BBX32 protein is a member of the B-box zinc finger family from A. thaliana and contains a single conserved Zn2+-binding B-box domain at the N terminus. Although the B-box domain is predicted to be involved in protein-protein interactions, the mechanism of interaction is poorly understood. Here, we provide in vitro and in vivo evidence demonstrating the physical and functional interactions of AtBBX32 with another B-box protein, soybean BBX62 (GmBBX62). Deletion analysis and characterization of the purified B-box domain indicate that the N-terminal B-box region of AtBBX32 interacts with GmBBX62. Computational modeling and site-directed mutagenesis of the AtBBX32 B-box region identified specific residues as critical for mediating the interaction between AtBBX32 and GmBBX62. This study defines the plant B-box as a protein interaction domain and offers novel insight into its role in mediating specific protein-protein interactions between different plant B-box proteins.	[Qi, Qungang; Gibson, Ann; Fu, Xiaoran; Zheng, Meiying; Kuehn, Rosemarie; Wang, Yongcheng; Wang, Yanfei; Navarro, Santiago; Morrell, James A.; Jiang, Dongming; Simmons, Grant; McClerren, Amanda L.; Loida, Paul; Ruff, Thomas G.; Petracek, Marie E.; Preuss, Sasha B.] Monsanto Co, Chesterfield, MO 63017 USA; [Bell, Erin; Ivleva, Natalia B.] Monsanto Co, St Louis, MO 63167 USA	Monsanto; Monsanto	Qi, QG (corresponding author), Monsanto Co, Chesterfield, MO 63017 USA.	qungang.qi@monsanto.com						ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Bagnasco L, 2007, FASEB J, V21, P1256, DOI 10.1096/fj.06-7082com; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; BORDEN KLB, 1995, EMBO J, V14, P5947, DOI 10.1002/j.1460-2075.1995.tb00283.x; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; Cao TY, 1997, J CELL SCI, V110, P1563; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Chang CSJ, 2008, PLANT J, V54, P205, DOI 10.1111/j.1365-313X.2008.03401.x; Craig TJ, 2004, J BIOCHEM BIOPH METH, V60, P49, DOI 10.1016/j.jbbm.2004.04.015; Datta S, 2008, PLANT CELL, V20, P2324, DOI 10.1105/tpc.108.061747; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frizzi A, 2010, PLANT MOL BIOL, V73, P569, DOI 10.1007/s11103-010-9644-1; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Holtan HE, 2011, PLANT PHYSIOL, V156, P2109, DOI 10.1104/pp.111.177139; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kohno Toshiyuki, 2007, V375, P257; Kumar S, 2000, PROTEINS, V38, P368, DOI 10.1002/(SICI)1097-0134(20000301)38:4<368::AID-PROT3>3.0.CO;2-R; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Poetz O, 2009, ANAL BIOCHEM, V395, P244, DOI 10.1016/j.ab.2009.08.002; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Qi QG, 2011, PLANT BIOTECHNOL J, V9, P193, DOI 10.1111/j.1467-7652.2010.00545.x; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Sindelar CV, 1998, PROTEIN SCI, V7, P1898, DOI 10.1002/pro.5560070906; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Vinarov DA, 2006, FEBS J, V273, P4160, DOI 10.1111/j.1742-4658.2006.05434.x; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Zhao Kate Qin, 2007, Journal of Structural and Functional Genomics, V8, P199, DOI 10.1007/s10969-007-9035-2	38	19	22	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31482	31493		10.1074/jbc.M112.346940	http://dx.doi.org/10.1074/jbc.M112.346940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801428	Green Published, hybrid			2022-12-25	WOS:000308791300061
J	Yu, J; Xing, XB; Zeng, LY; Sun, JH; Li, W; Sun, H; He, Y; Li, J; Zhang, GQ; Wang, C; Li, YX; Xie, L				Yu, Jian; Xing, Xiaobin; Zeng, Lingyao; Sun, Jiehuan; Li, Wei; Sun, Han; He, Ying; Li, Jing; Zhang, Guoqing; Wang, Chuan; Li, Yixue; Xie, Lu			SyStemCell: A Database Populated with Multiple Levels of Experimental Data from Stem Cell Differentiation Research	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; GENE-EXPRESSION; HISTONE H3; TRANSCRIPTIONAL NETWORK; MOUSE; 5-HYDROXYMETHYLCYTOSINE; PLURIPOTENCY; METHYLATION; MICRORNAS; REVEALS	Elucidation of the mechanisms of stem cell differentiation is of great scientific interest. Increasing evidence suggests that stem cell differentiation involves changes at multiple levels of biological regulation, which together orchestrate the complex differentiation process; many related studies have been performed to investigate the various levels of regulation. The resulting valuable data, however, remain scattered. Most of the current stem cell-relevant databases focus on a single level of regulation (mRNA expression) from limited stem cell types; thus, a unifying resource would be of great value to compile the multiple levels of research data available. Here we present a database for this purpose, SyStemCell, deposited with multi-level experimental data from stem cell research. The database currently covers seven levels of stem cell differentiation-associated regulatory mechanisms, including DNA CpG 5-hydroxymethylcytosine/methylation, histone modification, transcript products, microRNA-based regulation, protein products, phosphorylation proteins and transcription factor regulation, all of which have been curated from 285 peer-reviewed publications selected from PubMed. The database contains 43,434 genes, recorded as 942,221 gene entries, for four organisms (Homo sapiens, Mus musculus, Rattus norvegicus, and Macaca mulatta) and various stem cell sources (e.g., embryonic stem cells, neural stem cells and induced pluripotent stem cells). Data in SyStemCell can be queried by Entrez gene ID, symbol, alias, or browsed by specific stem cell type at each level of genetic regulation. An online analysis tool is integrated to assist researchers to mine potential relationships among different regulations, and the potential usage of the database is demonstrated by three case studies. SyStemCell is the first database to bridge multi-level experimental information of stem cell studies, which can become an important reference resource for stem cell researchers. The database is available at http://lifecenter.sgst.cn/SyStemCell/.	[Yu, Jian; Xing, Xiaobin; Zeng, Lingyao; Sun, Jiehuan; Li, Wei; Sun, Han; He, Ying; Li, Jing; Zhang, Guoqing; Wang, Chuan; Li, Yixue; Xie, Lu] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Xing, Xiaobin; Sun, Han; He, Ying; Li, Yixue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sun, Jiehuan; Li, Wei; Li, Jing] Huazhong Sci & Technol Univ, Wuhan, Hubei, Peoples R China; [Zeng, Lingyao] Tongji Univ, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Tongji University	Yu, J (corresponding author), Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China.	yxli@sibs.ac.cn; xielu@scbit.org	zhang, guoqing/GXG-4800-2022	Zhang, Guoqing/0000-0001-8827-7546	National Key Basic Research Program [2010CB912702]; State Key Basic Research Program [2011CB910204]; Key Infectious Disease Project [2012ZX10002012-014]; National Natural Science Foundation of China [31070752]; National Key Technology RD Program [2008BAI64B01]; National Scientific-Basic Special Fund [2009FY120100]	National Key Basic Research Program(National Basic Research Program of China); State Key Basic Research Program; Key Infectious Disease Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National Scientific-Basic Special Fund	Funding for open access charge: National Key Basic Research Program (2010CB912702); State Key Basic Research Program (2011CB910204); Key Infectious Disease Project (2012ZX10002012-014); National Natural Science Foundation of China (31070752); National Key Technology R&D Program (2008BAI64B01); National Scientific-Basic Special Fund (2009FY120100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arda HE, 2010, BRIEF FUNCT GENOMICS, V9, P4, DOI 10.1093/bfgp/elp049; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen H, 2009, NEUROL RES; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hatano A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar046; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2010, NUCLEIC ACIDS RES, V38, pD658, DOI 10.1093/nar/gkp933; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Miranda-Saavedra D, 2009, NUCLEIC ACIDS RES, V37, pD873, DOI 10.1093/nar/gkn854; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Oh IH, 2011, STEM CELLS; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pascal Laura E, 2007, BMC Urol, V7, P19, DOI 10.1186/1471-2490-7-19; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; SCACCHI R, 1991, ELECTROPHORESIS, V12, P667, DOI 10.1002/elps.1150120912; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smale ST, 2010, CURR OPIN GENET DEV, V20, P519, DOI 10.1016/j.gde.2010.06.010; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XY, 2010, INTEGR BIOL-UK, V2, P510, DOI 10.1039/c0ib00068j; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	60	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e35230	10.1371/journal.pone.0035230	http://dx.doi.org/10.1371/journal.pone.0035230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22807998	Green Submitted, gold, Green Published			2022-12-25	WOS:000306406700002
J	Arnold, EA; Hazelton, P; Lane, T; Christopoulos, KA; Galindo, GR; Steward, WT; Morin, SF				Arnold, Emily A.; Hazelton, Patrick; Lane, Tim; Christopoulos, Katerina A.; Galindo, Gabriel R.; Steward, Wayne T.; Morin, Stephen F.			A Qualitative Study of Provider Thoughts on Implementing Pre-Exposure Prophylaxis (PrEP) in Clinical Settings to Prevent HIV Infection	PLOS ONE			English	Article							UNITED-STATES; RISK; TRIALS; IMPACT	Background: A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabrine (TDF-FTC) can reduce HIV acquisition among men who have sex with men (MSM) and transgender (TG) women by 44%, and up to 90% if taken daily. We explored how medical and service providers understand research results and plan to develop clinical protocols to prescribe, support and monitor adherence for patients on PrEP in the United States. Methods: Using referrals from our community collaborators and snowball sampling, we recruited 22 healthcare providers in San Francisco, Oakland, and Los Angeles for in-depth interviews from May-December 2011. The providers included primary care physicians seeing high numbers of MSM and TG women, HIV specialists, community health clinic providers, and public health officials. We analyzed interviews thematically to produce recommendations for setting policy around implementing PrEP. Interview topics included: assessing clinician impressions of PrEP and CDC guidance, considerations of cost, office capacity, dosing schedules, and following patients over time. Results: Little or no demand for PrEP from patients was reported at the time of the interviews. Providers did not agree on the most appropriate patients for PrEP and believed that current models of care, which do not involve routine frequent office visits, were not well suited for prescribing PrEP. Providers detailed the need to build capacity and were concerned about monitoring side effects and adherence. PrEP was seen as potentially having impact on the epidemic but providers also noted that community education campaigns needed to be tailored to effectively reach specific vulnerable populations. Conclusions: While PrEP may be a novel and clinically compelling prevention intervention for MSM and TG women, it raises a number of important implementation challenges that would need to be addressed. Nonetheless, most providers expressed optimism that they eventually could prescribe and monitor PrEP in their practice.	[Arnold, Emily A.; Hazelton, Patrick; Lane, Tim; Galindo, Gabriel R.; Steward, Wayne T.; Morin, Stephen F.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Christopoulos, Katerina A.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Arnold, EA (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Emily.Arnold@ucsf.edu			California HIV/AIDS Research Program [RP08-SF-603]; Evelyn and Walter Haas, Jr. Fund [P0043126]; UCSF/Gladstone Institute of Virology and Immunology Center for AIDS Research [P30 AI027763]; Center for AIDS Prevention Studies [NIMH 2P30MH-062246]; Traineeship in AIDS Prevention Studies [NIMH T32 MH019105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092220, T32MH019105, P30MH062246] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; Evelyn and Walter Haas, Jr. Fund; UCSF/Gladstone Institute of Virology and Immunology Center for AIDS Research; Center for AIDS Prevention Studies; Traineeship in AIDS Prevention Studies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant to the UCSF AIDS Policy Research Center by the California HIV/AIDS Research Program (RP08-SF-603), the Evelyn and Walter Haas, Jr. Fund (P0043126), and special initiative funding from the UCSF/Gladstone Institute of Virology and Immunology Center for AIDS Research (P30 AI027763). Additional support was provided by the Center for AIDS Prevention Studies (NIMH 2P30MH-062246) and from the Traineeship in AIDS Prevention Studies (NIMH T32 MH019105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten J, 2012, ARV PREP HIV 1 PREV; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Cahill S, 2012, PREEXPOSURE PROPHYLA; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Flash C, 2012, CURR INFECT DIS REP; Forsyth AD, 2012, CURR OPIN HIV AIDS, V7, P111, DOI 10.1097/COH.0b013e32834fcff6; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Grady D, 2012, FDA ADVISORY PANEL B; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grant RM, 2010, CLIN INFECT DIS, V50, pS96, DOI 10.1086/651479; Hazelton P., 2011, FINANCING DELIVERY M; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Kelesidis Theodoros, 2011, Curr HIV/AIDS Rep, V8, P94, DOI 10.1007/s11904-011-0078-4; Leibowitz AA, 2011, AM J PUBLIC HEALTH, V101, P982, DOI 10.2105/AJPH.2010.300066; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Michael NL, 2010, NEW ENGL J MED, V363, P2663, DOI 10.1056/NEJMe1012929; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; MSN Money, 2012, US FDA GRANTS PRIOR; Muhr T., 1997, ATLAS TI 5 KNOWLEDGE; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pazella E, 2011, COMMENTS ED PAZELLA; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Thigpen MC, 2012, IAS C HIV PATH TREAT; Underhill Kristen, 2010, Curr HIV/AIDS Rep, V7, P210, DOI 10.1007/s11904-010-0062-4; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272	30	111	111	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40603	10.1371/journal.pone.0040603	http://dx.doi.org/10.1371/journal.pone.0040603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792384	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400081
J	Brugnara, L; Vinaixa, M; Murillo, S; Samino, S; Rodriguez, MA; Beltran, A; Lerin, C; Davison, G; Correig, X; Novials, A				Brugnara, Laura; Vinaixa, Maria; Murillo, Serafin; Samino, Sara; Angel Rodriguez, Miguel; Beltran, Antoni; Lerin, Carles; Davison, Gareth; Correig, Xavier; Novials, Anna			Metabolomics Approach for Analyzing the Effects of Exercise in Subjects with Type 1 Diabetes Mellitus	PLOS ONE			English	Article							ADIPOSE-TISSUE LIPOLYSIS; INTERMEDIATE POOL SIZE; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; ADOLESCENTS; GLUCOSE; METABOLISM; CAPACITY; SUPPRESSION	The beneficial effects of exercise in patients with type 1 diabetes (T1D) are not fully proven, given that it may occasionally induce acute metabolic disturbances. Indeed, the metabolic disturbances associated with sustained exercise may lead to worsening control unless great care is taken to adjust carbohydrate intake and insulin dosage. In this work, pre- and post-exercise metabolites were analyzed using a H-1-NMR and GC-MS untargeted metabolomics approach assayed in serum. We studied ten men with T1D and eleven controls matched for age, body mass index, body fat composition, and cardiorespiratory capacity, participated in the study. The participants performed 30 minutes of exercise on a cycle-ergometer at 80% VO(2)max. In response to exercise, both groups had increased concentrations of gluconeogenic precursors (alanine and lactate) and tricarboxylic acid cycle intermediates (citrate, malate, fumarate and succinate). The T1D group, however, showed attenuation in the response of these metabolites to exercise. Conversely to T1D, the control group also presented increases in a-ketoglutarate, alpha-ketoisocaproic acid, and lipolysis products (glycerol and oleic and linoleic acids), as well as a reduction in branched chain amino acids (valine and leucine) determinations. The T1D patients presented a blunted metabolic response to acute exercise as compared to controls. This attenuated response may interfere in the healthy performance or fitness of T1D patients, something that further studies should elucidate.	[Brugnara, Laura; Murillo, Serafin; Lerin, Carles; Novials, Anna] Hosp Clin Barcelona, Dept Endocrinol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Vinaixa, Maria; Samino, Sara; Angel Rodriguez, Miguel; Beltran, Antoni; Correig, Xavier] Univ Rovira & Virgili, Tarragona, Spain; [Samino, Sara; Beltran, Antoni; Correig, Xavier] Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain; [Davison, Gareth] Univ Ulster, Sport & Exercise Sci Res Inst, Newtownabbey, North Ireland; [Brugnara, Laura; Vinaixa, Maria; Murillo, Serafin; Angel Rodriguez, Miguel; Lerin, Carles; Correig, Xavier; Novials, Anna] Spanish Biomed Res Ctr Diabet & Assoc Metab Disor, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Ulster University	Brugnara, L (corresponding author), Hosp Clin Barcelona, Dept Endocrinol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	anovials@clinic.ub.es	Vinaixa, Maria/AAB-1176-2020; Lerin, Carles/AAP-9916-2020; Correig, Xavier/K-9836-2014; Vinaixa, Maria/L-7236-2014	Vinaixa, Maria/0000-0001-9804-0171; Lerin, Carles/0000-0003-0950-4363; Correig, Xavier/0000-0002-6902-3054; Vinaixa, Maria/0000-0001-9804-0171; Samino, Sara/0000-0001-8371-679X; Novials, Anna/0000-0003-0465-2949; Rodriguez-Gomez, Miguel Angel/0000-0001-9568-9821	CIBERDEM - Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); METADIAB (Metabolism and Diabetes Project)	CIBERDEM - Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); METADIAB (Metabolism and Diabetes Project)	This work was supported by CIBERDEM - Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); METADIAB (Metabolism and Diabetes Project) 12-12-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MJ, 2009, MAGN RESON MED, V61, P525, DOI 10.1002/mrm.21808; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Bergman BC, 2012, J CLIN ENDOCR METAB, V97, P1663, DOI 10.1210/jc.2011-3172; Biolo G, 1999, DIABETES, V48, P949, DOI 10.2337/diabetes.48.5.949; Bowtell JL, 2007, SPORTS MED, V37, P1071, DOI 10.2165/00007256-200737120-00005; Chatzinikolaou A, 2008, DIABETES CARE, V31, P1397, DOI 10.2337/dc08-0072; Davison GW, 2002, FREE RADICAL BIO MED, V33, P1543, DOI 10.1016/S0891-5849(02)01090-0; DEVLIN JT, 1994, DIABETOLOGIA, V37, P358, DOI 10.1007/BF00408471; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Divertie GD, 1997, AM J PHYSIOL-ENDOC M, V272, pE1130, DOI 10.1152/ajpendo.1997.272.6.E1130; Enea C, 2010, ANAL BIOANAL CHEM, V396, P1167, DOI 10.1007/s00216-009-3289-4; Farhy LS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00040; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; GELFAND RA, 1987, J CLIN INVEST, V80, P1, DOI 10.1172/JCI113033; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Gusso S, 2008, DIABETOLOGIA, V51, P1317, DOI 10.1007/s00125-008-1012-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; HENRIKSSON J, 1991, J EXP BIOL, V160, P149; Item F, 2011, AM J PHYSIOL-REG I, V301, pR60, DOI 10.1152/ajpregu.00747.2010; Jacob S, 1999, DIABETOLOGIA, V42, P1171, DOI 10.1007/s001250051288; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Komatsu WR, 2005, PEDIATR DIABETES, V6, P145, DOI 10.1111/j.1399-543X.2005.00120.x; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Leon AS, 2000, METABOLISM, V49, P513, DOI 10.1016/S0026-0495(00)80018-9; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Levin K, 2001, DIABETOLOGIA, V44, P824; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Lindon J. C., 2007, HDB METABONOMICS MET; Makinen VP, 2006, MAGN RESON MATER PHY, V19, P281, DOI 10.1007/s10334-006-0054-y; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Palazoglu M., 2009, AGIL APPL NOTE, V2009, P5990; Palmieri V, 2008, INT J CARDIOL, V127, P390, DOI 10.1016/j.ijcard.2007.04.035; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Perseghin G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1174, DOI 10.1152/ajpendo.00279.2003; SAHLIN K, 1990, ACTA PHYSIOL SCAND, V138, P259, DOI 10.1111/j.1748-1716.1990.tb08845.x; Schauer IE, 2011, DIABETES, V60, P306, DOI 10.2337/db10-0328; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stumvoll M, 2000, J CLIN ENDOCR METAB, V85, P3740, DOI 10.1210/jc.85.10.3740; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Valerio G, 2007, NUTR METAB CARDIOVAS, V17, P376, DOI 10.1016/j.numecd.2005.10.012; Vervoort G, 1999, HYPERTENSION, V34, P1080, DOI 10.1161/01.HYP.34.5.1080; YKIJARVINEN H, 1987, J CLIN INVEST, V80, P95, DOI 10.1172/JCI113069; YKIJARVINEN H, 1987, DIABETES, V36, P892, DOI 10.2337/diabetes.36.8.892; Zhang SC, 2009, ANAL CHEM, V81, P6080, DOI 10.1021/ac900424c	50	53	57	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40600	10.1371/journal.pone.0040600	http://dx.doi.org/10.1371/journal.pone.0040600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792382	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400079
J	Liu, JX; Xu, Y; Zheng, CH; Wang, Y; Yang, JY				Liu, Jin-Xing; Xu, Yong; Zheng, Chun-Hou; Wang, Yi; Yang, Jing-Yu			Characteristic Gene Selection via Weighting Principal Components by Singular Values	PLOS ONE			English	Article							MICROARRAY TECHNOLOGY; STRESS RESPONSES; DNA MICROARRAY; EXPRESSION; MATRIX; IDENTIFICATION; APPROXIMATION; ONTOLOGY; DROUGHT; COLD	Conventional gene selection methods based on principal component analysis (PCA) use only the first principal component (PC) of PCA or sparse PCA to select characteristic genes. These methods indeed assume that the first PC plays a dominant role in gene selection. However, in a number of cases this assumption is not satisfied, so the conventional PCA-based methods usually provide poor selection results. In order to improve the performance of the PCA-based gene selection method, we put forward the gene selection method via weighting PCs by singular values (WPCS). Because different PCs have different importance, the singular values are exploited as the weights to represent the influence on gene selection of different PCs. The ROC curves and AUC statistics on artificial data show that our method outperforms the state-of-the-art methods. Moreover, experimental results on real gene expression data sets show that our method can extract more characteristic genes in response to abiotic stresses than conventional gene selection methods.	[Liu, Jin-Xing; Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China; [Wang, Yi] Harbin Inst Technol, Sch Mech Engn & Automat, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Zheng, Chun-Hou] Anhui Univ, Coll Elect Engn & Automat, Hefei, Anhui, Peoples R China; [Yang, Jing-Yu] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Liu, Jin-Xing] Qufu Normal Univ, Coll Informat & Commun Technol, Rizhao, Shandong, Peoples R China; [Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Key Lab Network Oriented Intelligent Computat, Shenzhen, Guangdong, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; Harbin Institute of Technology; University Town of Shenzhen; Anhui University; Nanjing University of Science & Technology; Qufu Normal University; Harbin Institute of Technology; University Town of Shenzhen	Liu, JX (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China.	laterfall2@yahoo.com.cn	Liu, Jin-Xing/AAU-7257-2020		National Natural Science Foundation of China [90820306]; Program for New Century Excellent Talents in University [NCET-08-0156]; NSFC [61071179]; Provincial natural science research program of higher education institutions of Anhui province [KJ2012A005]; China Postdoctoral Science Foundation [2012M510148]; Foundation of Qufu Normal University [XJ200947]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NSFC(National Natural Science Foundation of China (NSFC)); Provincial natural science research program of higher education institutions of Anhui province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Qufu Normal University	This work was supported by fund for Key Research Project of National Natural Science Foundation of China under grant No. 90820306; Program for New Century Excellent Talents in University (No. NCET-08-0156), NSFC under grant No. 61071179; Provincial natural science research program of higher education institutions of Anhui province, No. KJ2012A005; China Postdoctoral Science Foundation Funded Project, No. 2012M510148; The Foundation of Qufu Normal University under grant, No. XJ200947. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blevins T, 2010, METHODS MOL BIOL, V631, P87, DOI 10.1007/978-1-60761-646-7_9; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; De Haan JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-158; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Josefsen K, 2011, METHODS MOL BIOL, V703, P87, DOI 10.1007/978-1-59745-248-9_7; Journee M, 2010, J MACH LEARN RES, V11, P517; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Lai ZH, 2011, NEUROCOMPUTING, V74, P629, DOI 10.1016/j.neucom.2010.09.010; Liu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002689; Liu J.X., 2012, COMPUT BIOL MED, DOI [10.1016/j.compbiomed.2012.1002.1002, DOI 10.1016/J.COMPBIOMED.2012.1002.1002]; Liu JX, 2011, LASSO LOGISTIC REGRE, p463~466; Luss R, 2010, OPTIM ENG, V11, P145, DOI 10.1007/s11081-008-9057-z; Ma S, 2009, BIOINFORMATICS, V25, P882, DOI 10.1093/bioinformatics/btp085; Maan NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012782; Musumarra G, 2004, J CHEMOMETR, V18, P125, DOI 10.1002/cem.846; Park MS, 2009, PATTERN RECOGN, V42, P2353, DOI 10.1016/j.patcog.2009.04.011; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sampson DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024973; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shen HP, 2008, J MULTIVARIATE ANAL, V99, P1015, DOI 10.1016/j.jmva.2007.06.007; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang H, 2003, PATTERN RECOGN, V36, P563, DOI 10.1016/S0031-3203(02)00048-1; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	34	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38873	10.1371/journal.pone.0038873	http://dx.doi.org/10.1371/journal.pone.0038873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808018	Green Published, gold			2022-12-25	WOS:000306355500005
J	Sustar, V; Zelko, J; Lopalco, P; Lobasso, S; Ota, A; Ulrih, NP; Corcelli, A; Kralj-iglic, V				Sustar, Vid; Zelko, Jasna; Lopalco, Patrizia; Lobasso, Simona; Ota, Ajda; Ulrih, Natasa Poklar; Corcelli, Angela; Kralj-iglic, Veronika			Morphology, Biophysical Properties and Protein-Mediated Fusion of Archaeosomes	PLOS ONE			English	Article							GIANT PHOSPHOLIPID-VESICLES; LIPID-MEMBRANES; BENDING ELASTICITY; PHASE-TRANSITION; FLUID MEMBRANES; POLAR LIPIDS; CURVATURE; BETA(2)-GLYCOPROTEIN-I; STABILITY; LIPOSOMES	As variance from standard phospholipids of eubacteria and eukaryotes, archaebacterial diether phospholipids contain branched alcohol chains (phytanol) linked to glycerol exclusively with ether bonds. Giant vesicles (GVs) constituted of different species of archaebacterial diether phospholipids and glycolipids (archaeosomes) were prepared by electroformation and observed under a phase contrast and/or fluorescence microscope. Archaebacterial lipids and different mixtures of archaebacterial and standard lipids formed GVs which were analysed for size, yield and ability to adhere to each other due to the mediating effects of certain plasma proteins. GVs constituted of different proportions of archaeal or standard phosphatidylcholine were compared. In nonarchaebacterial GVs ( in form of multilamellar lipid vesicles, MLVs) the main transition was detected at T-m=34.2 degrees C with an enthalpy of Delta H=0.68 kcal/mol, whereas in archaebacterial GVs (MLVs) we did not observe the main phase transition in the range between 10 and 70 degrees C. GVs constituted of archaebacterial lipids were subject to attractive interaction mediated by beta 2 glycoprotein I and by heparin. The adhesion constant of beta 2 glycoprotein I - mediated adhesion determined from adhesion angle between adhered GVs was in the range of 10(-8) J/m(2). In the course of protein mediated adhesion, lateral segregation of the membrane components and presence of thin tubular membranous structures were observed. The ability of archaebacterial diether lipids to combine with standard lipids in bilayers and their compatibility with adhesion-mediating molecules offer further evidence that archaebacterial lipids are appropriate for the design of drug carriers.	[Sustar, Vid; Zelko, Jasna] Univ Ljubljana, Fac Med, Chair Orthopaed, Lab Clin Biophys, Ljubljana, Slovenia; [Lopalco, Patrizia; Lobasso, Simona; Corcelli, Angela] Univ Bari Aldo Moro, Dept Med Biochem Biol & Phys, Bari, Italy; [Ota, Ajda; Ulrih, Natasa Poklar] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia; [Corcelli, Angela] IPCF CNR, Bari, Italy; [Kralj-iglic, Veronika] Univ Ljubljana, Fac Hlth Sci, Biomed Res Grp, Ljubljana, Slovenia	University of Ljubljana; Universita degli Studi di Bari Aldo Moro; University of Ljubljana; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); University of Ljubljana	Sustar, V (corresponding author), Univ Ljubljana, Fac Med, Chair Orthopaed, Lab Clin Biophys, Ljubljana, Slovenia.	veronika.kralj-iglic@fe.uni-lj.si	Ulrih, Natasa Poklar/B-2015-2008; LOBASSO, SIMONA/AAN-9109-2020	LOBASSO, SIMONA/0000-0003-3566-4547; Lopalco, Patrizia/0000-0003-3475-7485; Kralj-Iglic, Veronika/0000-0002-7496-2005; Ota, Ajda/0000-0001-6309-6669; Corcelli, Angela/0000-0001-9658-8520; Poklar Ulrih, Natasa/0000-0002-2731-9973	Italian Defense Ministry [9199, 2005]; Regione Puglia of Italy [15]; ARRS [P2-0232, J3-2120, J2-9219]	Italian Defense Ministry; Regione Puglia of Italy; ARRS(Slovenian Research Agency - Slovenia)	This work has been supported by the Italian Defense Ministry (contract 9199, 2005, http://www.difesa.it/default.htm) and Regione Puglia of Italy (Grant code 15, sens&MicroLab, http://www.regione.puglia.it/), and ARRS grants P2-0232, J3-2120 and J2-9219, http://www.arrs.gov.si/sl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2000, FRONT BIOSCI, V5, pD813; Alessandrini A, 2009, J PHYS CHEM B, V113, P3437, DOI 10.1021/jp809705d; Ambroic A, 2006, AUTOIMMUN REV, V6, P10, DOI 10.1016/j.autrev.2006.03.001; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Bagatolli L, 2000, BIOPHYS J, V79, P416, DOI 10.1016/S0006-3495(00)76303-X; Bagatolli LA, 2000, CHEM PHYS LIPIDS, V105, P135, DOI 10.1016/S0009-3084(00)00118-3; Bagatolli LA, 2010, PROG LIPID RES, V49, P378, DOI 10.1016/j.plipres.2010.05.001; Besnard M, 1997, J BIOL CHEM, V272, P992, DOI 10.1074/jbc.272.2.992; Bohinc K, 2004, EUROPHYS LETT, V68, P494, DOI 10.1209/epl/i2004-10250-2; BRIGHTON TA, 1994, BAILLIERE CLIN HAEM, V7, P541, DOI 10.1016/S0950-3536(05)80098-8; CAVAGNETTO F, 1992, BIOCHIM BIOPHYS ACTA, V1106, P273, DOI 10.1016/0005-2736(92)90006-8; Corcelli A, 2006, METHOD MICROBIOL, V35, P585, DOI 10.1016/S0580-9517(08)70028-X; DEULING HJ, 1976, J PHYS-PARIS, V37, P1335, DOI 10.1051/jphys:0197600370110133500; DUWE HP, 1990, PHYSICA A, V163, P410, DOI 10.1016/0378-4371(90)90349-W; ELFERINK MGL, 1993, EUR J BIOCHEM, V214, P917, DOI 10.1111/j.1432-1033.1993.tb17995.x; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; FAUCON JF, 1989, J PHYS-PARIS, V50, P2389, DOI 10.1051/jphys:0198900500170238900; Fosnaric M, 2005, J CHEM INF MODEL, V45, P1652, DOI 10.1021/ci050171t; Gambacorta A, 1985, WORLD J MICROB BIOT, V11, P115; Gamsjaeger R, 2005, BIOCHEM J, V389, P665, DOI 10.1042/BJ20050156; Genova J, 2009, J OPTOELECTRON ADV M, V11, P1222; Gmajner D, 2011, CHEM PHYS LIPIDS, V164, P236, DOI 10.1016/j.chemphyslip.2011.01.005; Gram GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006950; Hamdan R, 2007, BIOCHEMISTRY-US, V46, P10612, DOI 10.1021/bi700621j; Hammel M, 2001, BIOCHEMISTRY-US, V40, P14173, DOI 10.1021/bi0114372; Iglic A, 2010, BIOELECTROCHEMISTRY, V79, P223, DOI 10.1016/j.bioelechem.2010.05.003; Israelachvili J., 1997, INTERMOLECULAR SURFA; Julicher F, 1996, PHYS REV E, V53, P2670, DOI 10.1103/PhysRevE.53.2670; Kamath AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005771; KAS J, 1991, BIOPHYS J, V60, P825, DOI 10.1016/S0006-3495(91)82117-8; Kate M., 1993, BIOCH ARCHAEA ARCHAE, V26, P261, DOI DOI 10.1016/S0167-7306(08)60258-6; KATES M, 1968, CAN J BIOCHEM CELL B, V46, P971, DOI 10.1139/o68-145; KATES M, 1973, J LIPID RES, V14, P438; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Kralj-Iglic V, 1999, EUR PHYS J B, V10, P5, DOI 10.1007/s100510050822; Kralj-Iglic V, 2001, COLLOID SURFACE A, V181, P315, DOI 10.1016/S0927-7757(00)00802-5; Lamblet M, 2008, EUR PHYS J E, V26, P205, DOI 10.1140/epje/i2007-10317-x; Lobasso S, 2003, J LIPID RES, V44, P2120, DOI 10.1194/jlr.M300212-JLR200; Lobasso S, 2009, CHEM PHYS LIPIDS, V157, P12, DOI 10.1016/j.chemphyslip.2008.09.002; Lopalco P, 2004, J LIPID RES, V45, P194, DOI 10.1194/jlr.M300329-JLR200; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; Mares T, 2012, SCI WORLD J, DOI 10.1100/2012/146804; Mathai JC, 2001, J BIOL CHEM, V276, P27266, DOI 10.1074/jbc.M103265200; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; May S, 2008, J PHYS CHEM B, V112, P1685, DOI 10.1021/jp073355e; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; Patel GB, 2000, INT J PHARM, V194, P39, DOI 10.1016/S0378-5173(99)00331-2; Patel GB, 1999, CRIT REV BIOTECHNOL, V19, P317, DOI 10.1080/0738-859991229170; Pavliv JI, 2010, CR ACAD BULG SCI, V63, P497; Peterlin P, 2008, COLLOID SURFACE B, V64, P77, DOI 10.1016/j.colsurfb.2008.01.004; POLZ E, 1979, BIOCHEM BIOPH RES CO, V90, P1305, DOI 10.1016/0006-291X(79)91178-1; Rappolt M., 2008, STRUCTURE DYNAMICS M, P45; Rappolt M, 2008, CHEM PHYS LIPIDS, V154, P46, DOI 10.1016/j.chemphyslip.2008.02.006; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; SEIFERT U, 1990, PHYS REV A, V42, P4768, DOI 10.1103/PhysRevA.42.4768; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; SONG JB, 1993, BIOPHYS J, V64, P1967, DOI 10.1016/S0006-3495(93)81566-2; Sprott GD, 2008, GLYCOBIOLOGY, V18, P559, DOI 10.1093/glycob/cwn038; Sprott GD, 2009, GLYCOBIOLOGY, V19, P267, DOI 10.1093/glycob/cwn129; Sprott GD, 1997, FEMS MICROBIOL LETT, V154, P17, DOI 10.1016/S0378-1097(97)00294-2; Sustar V, 2009, BLOOD CELL MOL DIS, V42, P223, DOI 10.1016/j.bcmd.2009.01.012; Tomsie N, 2005, J CHEM INF MODEL, V45, P1676, DOI 10.1021/ci050188b; Ulrih NP, 2009, APPL MICROBIOL BIOT, V84, P249, DOI 10.1007/s00253-009-2102-9; Urbanija J, 2008, EUR BIOPHYS J BIOPHY, V37, P1085, DOI 10.1007/s00249-007-0252-1; Urbanija J, 2007, CHEM PHYS LIPIDS, V150, P49, DOI 10.1016/j.chemphyslip.2007.06.216; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Vitkova V, 2003, J MATER SCI-MATER EL, V14, P819, DOI 10.1023/A:1026129910215; Yaghmur A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000479; ZILKER A, 1987, J PHYS-PARIS, V48, P2139, DOI 10.1051/jphys:0198700480120213900; ZILKER A, 1992, PHYS REV A, V46, P7998, DOI 10.1103/PhysRevA.46.7998	70	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39401	10.1371/journal.pone.0039401	http://dx.doi.org/10.1371/journal.pone.0039401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792173	Green Submitted, gold, Green Published			2022-12-25	WOS:000306461800011
J	Xu, L; Wang, YX; Guo, Y; You, QS; Jonas, JB				Xu, Liang; Wang, Ya Xing; Guo, Yin; You, Qi Sheng; Jonas, Jost B.		Beijing Eye Study Grp	Prevalence and Associations of Steep Cornea/Keratoconus in Greater Beijing. The Beijing Eye Study	PLOS ONE			English	Article							KERATOCONUS; KERATOPLASTY; POPULATION	Purpose: To evaluate the prevalence and associated factors of steep cornea/keratoconus in the adult Chinese population. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic examination was performed including optical low-coherence reflectometry. Steep cornea/keratoconus were defined as an anterior corneal refractive power exceeding 48 diopters. Results: Mean refractive power of the cornea was 43.16 +/- 1.45 diopters (range: 36.51 to 48.46 diopters; flattest meridian) and 43.98 +/- 1.52 diopters (range: 37.00 to 52.88 diopters; steepest meridian). A steep cornea/keratoconus defined as corneal refractive power of >= 48 diopters and >= 49 diopters was detected in 27 subjects (prevalence rate: 0.9 +/- 0.2%) and 6 (0.2 +/- 0.1%) subjects, respectively. Presence of steep cornea/keratoconus was associated with shorter axial length (P<0.001), smaller interpupillary distance (P=0.038), lower best corrected visual acuity (P=0.021), higher cylindrical refractive error (P<0.001) and more myopic refractive error (P<0.001). It was not significantly associated with gender, body height, psychic depression, cognitive function, blood concentrations of glucose, lipids, creatinine and C-reactive protein, blood pressure and quality of life score, nor with intraocular pressure, dry eye feeling, and lens thickness. Conclusions: A steep cornea/keratoconus defined as corneal refractive power of 48+ diopters has a prevalence of 0.9 +/- 0.2% among Chinese aged 50 years and above. Its prevalence was significantly associated with the ocular parameters of shorter axial length, smaller interpupillary distance, higher cylindrical and myopic refractive error and lower best corrected visual acuity, however, with none of the systemic parameters tested.	[Xu, Liang; Wang, Ya Xing; Guo, Yin; You, Qi Sheng; Jonas, Jost B.; Beijing Eye Study Grp] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com	You, Qisheng/AAG-7153-2020; You, Qisheng/A-3619-2014; Guo, Yin/ABC-2134-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; Guo, Yin/0000-0003-3806-3771; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Towerki AE, 2004, CORNEA, V23, P584, DOI 10.1097/01.ico.0000121708.58571.5b; Assiri AA, 2005, BRIT J OPHTHALMOL, V89, P1403, DOI 10.1136/bjo.2005.074955; Claesson M, 2004, BRIT J OPHTHALMOL, V88, P858, DOI 10.1136/bjo.2003.035758; Dandona Lalit, 1997, Indian Journal of Ophthalmology, V45, P163; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024; LAWLESS M, 1989, AUST NZ J OPHTHALMOL, V17, P33; McMonnies Charles W, 2007, Eye Contact Lens, V33, P265, DOI 10.1097/ICL.0b013e31814fb64b; MCNAB AA, 1993, AUST NZ J OPHTHALMOL, V21, P1; Nielsen K, 2007, ACTA OPHTHALMOL SCAN, V85, P890, DOI 10.1111/j.1600-0420.2007.00981.x; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Poinard C, 2003, J FR OPHTALMOL, V26, P911; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Reeves SW, 2009, CORNEA, V28, P40, DOI 10.1097/ICO.0b013e3181839b06; Spoerl E, 2008, J REFRACT SURG, V24, pS737, DOI 10.3928/1081597X-20080901-18; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004	18	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39313	10.1371/journal.pone.0039313	http://dx.doi.org/10.1371/journal.pone.0039313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792169	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800008
J	Boulanger, A; Farge, M; Ramanoudjame, C; Wharton, K; Dura, JM				Boulanger, Ana; Farge, Morgane; Ramanoudjame, Christophe; Wharton, Kristi; Dura, Jean-Maurice			Drosophila Motor Neuron Retraction during Metamorphosis Is Mediated by Inputs from TGF-beta/BMP Signaling and Orphan Nuclear Receptors	PLOS ONE			English	Article							B ECDYSONE RECEPTOR; SYNAPTIC GROWTH; CELL-MIGRATION; II RECEPTOR; STABILIZATION; EXPRESSION; SYSTEM; AXONS; GENE; DEGENERATION	Larval motor neurons remodel during Drosophila neuro-muscular junction dismantling at metamorphosis. In this study, we describe the motor neuron retraction as opposed to degeneration based on the early disappearance of beta-Spectrin and the continuing presence of Tubulin. By blocking cell dynamics with a dominant-negative form of Dynamin, we show that phagocytes have a key role in this process. Importantly, we show the presence of peripheral glial cells close to the neuromuscular junction that retracts before the motor neuron. We show also that in muscle, expression of EcR-B1 encoding the steroid hormone receptor required for postsynaptic dismantling, is under the control of the ftz-f1/Hr39 orphan nuclear receptor pathway but not the TGF-beta signaling pathway. In the motor neuron, activation of EcR-B1 expression by the two parallel pathways (TGF-beta signaling and nuclear receptor) triggers axon retraction. We propose that a signal from a TGF-beta family ligand is produced by the dismantling muscle (postsynapse compartment) and received by the motor neuron (presynaptic compartment) resulting in motor neuron retraction. The requirement of the two pathways in the motor neuron provides a molecular explanation for the instructive role of the postsynapse degradation on motor neuron retraction. This mechanism insures the temporality of the two processes and prevents motor neuron pruning before postsynaptic degradation.	[Boulanger, Ana; Farge, Morgane; Ramanoudjame, Christophe; Wharton, Kristi; Dura, Jean-Maurice] Inst Human Genet, CNRS UPR1142, Dept Genet & Dev, Montpellier, France; [Wharton, Kristi] Brown Univ, Div Biol & Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Brown University	Boulanger, A (corresponding author), Inst Human Genet, CNRS UPR1142, Dept Genet & Dev, Montpellier, France.	ana.boulanger@igh.cnrs.fr; jmdura@igh.cnrs.fr			Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer [3744]; Association Francaise contre les Myopathies [MNM1 2007]; Agence Nationale de la Recherche [ANR-07-NEURO-034-01]; AFM; ANR; National Institutes of Health [GM068118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM068118, R01GM068118] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); AFM(Association Francaise contre les Myopathies); ANR(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Association pour la Recherche sur le Cancer (no 3744), the Association Francaise contre les Myopathies (MNM1 2007) and the Agence Nationale de la Recherche (ANR-07-NEURO-034-01). AB was supported by a postdoctoral fellowship from AFM and from ANR. MF was supported by ANR. CR was supported by AFM. Additional support was provided by National Institutes of Health GM068118 to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Awasaki T, 2011, NAT NEUROSCI, V14, P6, DOI 10.1038/nn0111-6; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Boulanger A, 2011, NAT NEUROSCI, V14, P37, DOI 10.1038/nn.2700; BROADIE KS, 1991, DEVELOPMENT, V113, P103; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Fernandes JJ, 1999, INT REV NEUROBIOL, V43, P221, DOI 10.1016/S0074-7742(08)60547-4; Fortier TA, 2003, DEV BIOL, V257, P153, DOI 10.1016/S0012-1606(03)00036-8; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Garbe DS, 2007, DEVELOPMENT, V134, P273, DOI 10.1242/dev.02653; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Hebbar S, 2010, DEV BIOL, V340, P344, DOI 10.1016/j.ydbio.2010.01.005; Kamiya Y, 2008, FEBS LETT, V582, P2496, DOI 10.1016/j.febslet.2008.05.052; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Liu ZW, 2010, J NEUROSCI, V30, P11624, DOI 10.1523/JNEUROSCI.0410-10.2010; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Parker L, 2006, DEVELOPMENT, V133, P4981, DOI 10.1242/dev.02673; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116; Ranjan R, 1998, J NEUROSCI, V18, P956; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	46	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40255	10.1371/journal.pone.0040255	http://dx.doi.org/10.1371/journal.pone.0040255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792255	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300041
J	Ferrer, IR; Wagener, ME; Song, MQ; Ford, ML				Ferrer, Ivana R.; Wagener, Maylene E.; Song, Mingqing; Ford, Mandy L.			CD154 Blockade Alters Innate Immune Cell Recruitment and Programs Alloreactive CD8(+) T Cells into KLRG-1 high Short-Lived Effector T Cells\	PLOS ONE			English	Article							DONOR-SPECIFIC TRANSFUSION; CARDIAC ALLOGRAFT-REJECTION; CD40 LIGAND; TRANSPLANTATION TOLERANCE; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; NONHUMAN-PRIMATES; ACUTE INFECTION; EXPRESSION; SKIN	CD154/CD40 blockade combined with donor specific transfusion remains one of the most effective therapies in prolonging allograft survival. Despite this, the mechanisms by which these pathways synergize to prevent rejection are not completely understood. Utilizing a BALB/c (H2-K-d) to B6 (H2-K-b) fully allogeneic skin transplant model system, we performed a detailed longitudinal analysis of the kinetics and magnitude of CD8(+) T cell expansion and differentiation in the presence of CD154/CD40 pathway blockade. Results demonstrated that treatment with anti-CD154 vs. DST had distinct and opposing effects on activated CD44(high) CD62L(low) CD8(+) T cells in skin graft recipients. Specifically, CD154 blockade delayed alloreactive CD8(+) T cell responses, while DST accelerated them. DST inhibited the differentiation of alloreactive CD8(+) T cells into multi-cytokine producing effectors, while CD40/CD154 blockade led to the diminution of the KLRG-1(low) long-lived memory precursor population compared with either untreated or DST treated animals. Moreover, only CD154 blockade effectively inhibited CXCL1 expression and neutrophil recruitment into the graft. When combined, anti-CD154 and DST acted synergistically to profoundly diminish the absolute number of IFN-gamma producing alloreactive CD8(+) T cells, and intra-graft expression of inflammatory chemokines. These findings demonstrate that the previously described ability of anti-CD154 and DST to result in alloreactive T cell deletion involves both delayed kinetics of T cell expansion and differentiation and inhibited development of KLRG-1(low) memory precursor cells.	[Ferrer, Ivana R.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA; Emory Univ, Dept Surg, Atlanta, GA 30322 USA	Emory University; Emory University	Ferrer, IR (corresponding author), Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.	mandy.ford@emory.edu			National Institutes of Health [AI073707, AI079409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI079409, R01AI073707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI073707 and AI079409 to Mandy L. Ford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badell IR, 2012, AM J TRANSPLANT, V12, P126, DOI 10.1111/j.1600-6143.2011.03736.x; El-Sawy T, 2005, CIRCULATION, V112, P320, DOI 10.1161/CIRCULATIONAHA.104.516708; Floyd TL, 2011, J IMMUNOL, V186, P2033, DOI 10.4049/jimmunol.1003015; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hancock WW, 1996, P NATL ACAD SCI USA, V93, P13967, DOI 10.1073/pnas.93.24.13967; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kondo T, 1996, TRANSPLANTATION, V61, P1750, DOI 10.1097/00007890-199606270-00015; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Margenthaler JA, 2003, TRANSPLANTATION, V75, P2119, DOI 10.1097/01.TP.0000069043.57679.85; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Pearl JP, 2007, TRANSPLANTATION, V83, P1219, DOI 10.1097/01.tp.0000259929.04596.d5; Pearson T, 2003, DIABETES, V52, P321, DOI 10.2337/diabetes.52.2.321; Phillips NE, 2003, J IMMUNOL, V170, P3015, DOI 10.4049/jimmunol.170.6.3015; Pluvinet R, 2004, BLOOD, V104, P3642, DOI 10.1182/blood-2004-03-0817; Preston EH, 2005, AM J TRANSPLANT, V5, P1032, DOI 10.1111/j.1600-6143.2005.00796.x; Quezada SA, 2003, BLOOD, V102, P1920, DOI 10.1182/blood-2003-02-0586; Ripoll E, 2011, GENE THER, V18, P945, DOI 10.1038/gt.2011.39; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shen X, 2010, AM J TRANSPLANT, V10, P1729, DOI 10.1111/j.1600-6143.2010.03205.x; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; van Maurik A, 2004, J IMMUNOL, V172, P2163, DOI 10.4049/jimmunol.172.4.2163; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhang T, 2011, AM J TRANSPLANT, V11, P1599, DOI 10.1111/j.1600-6143.2011.03624.x; Zheng XX, 1999, J IMMUNOL, V162, P4983	31	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40559	10.1371/journal.pone.0040559	http://dx.doi.org/10.1371/journal.pone.0040559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792369	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300072
J	Gaykalova, D; Vatapalli, R; Glazer, CA; Bhan, S; Shao, CB; Sidransky, D; Ha, PK; Califano, JA				Gaykalova, Daria; Vatapalli, Rajita; Glazer, Chad A.; Bhan, Sheetal; Shao, Chunbo; Sidransky, David; Ha, Patrick K.; Califano, Joseph A.			Dose-Dependent Activation of Putative Oncogene SBSN by BORIS	PLOS ONE			English	Article							CANCER-TESTIS GENE; TRANSCRIPTION FACTOR BORIS; LUNG-CANCER; CHROMOSOMAL-ABERRATIONS; HISTONE H3; LYSINE 9; EXPRESSION; CTCF; METHYLATION; CELLS	Testis-specific transcription factor BORIS (Brother of the Regulator of Imprinted Sites), a paralog and proposed functional antagonist of the widely expressed CTCF, is abnormally expressed in multiple tumor types and has been implicated in the epigenetic activation of cancer-testis antigens (CTAs). We have reported previously that suprabasin (SBSN), whose expression is restricted to the epidermis, is epigenetically derepressed in lung cancer. In this work, we establish that SBSN is a novel non-CTA target of BORIS epigenetic regulation. With the use of a doxycycline-inducible BORIS expressing vector, we demonstrate that relative BORIS dosage is critical for SBSN activation. At lower concentrations, BORIS induces demethylation of the SBSN CpG island and disruption and activation of chromatin around the SBSN transcription start site (TSS), resulting in a 35-fold increase in SBSN expression in the H358 human lung cancer cell line. Interestingly, increasing BORIS concentrations leads to a subsequent reduction in SBSN expression via chromatin repression. In a similar manner, increase in BORIS concentrations leads to eventual decrease of cell growth and colony formation. This is the first report demonstrating that different amount of BORIS defines its varied effects on the expression of a target gene via chromatin structure reorganization.	[Gaykalova, Daria; Vatapalli, Rajita; Glazer, Chad A.; Bhan, Sheetal; Shao, Chunbo; Sidransky, David; Ha, Patrick K.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Sidransky, David; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Sidransky, David; Ha, Patrick K.; Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Gaykalova, D (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu	Vatapalli, Rajita/AAN-1397-2021		National Cancer Institute Specialized Program of Research Excellence [5P50CA096784-05]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Dr. Califano and Dr. Gaykalova are supported by a National Cancer Institute Specialized Program of Research Excellence (5P50CA096784-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bazzi H, 2007, DEV DYNAM, V236, P961, DOI 10.1002/dvdy.21099; Bhan S, 2011, CLIN CANCER RES, V17, P4267, DOI 10.1158/1078-0432.CCR-11-0653; Buffart TE, 2009, VIRCHOWS ARCH, V455, P213, DOI 10.1007/s00428-009-0814-y; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Cuffel C, 2011, INT J CANCER, V128, P2625, DOI 10.1002/ijc.25607; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Fiorentino FP, 2012, J CELL PHYSIOL, V227, P479, DOI 10.1002/jcp.22780; Fiorentino FP, 2011, MOL CANCER RES, V9, P225, DOI 10.1158/1541-7786.MCR-10-0493; Formolo CA, 2011, J PROTEOME RES, V10, P3149, DOI 10.1021/pr200210w; Gaykalova Daria A., 2009, V523, P109, DOI 10.1007/978-1-59745-190-1_8; Glazer CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008189; Hines WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009738; Hoffmann MJ, 2006, BIOCHEM PHARMACOL, V72, P1577, DOI 10.1016/j.bcp.2006.06.020; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kang Y, 2007, ONCOGENE, V26, P4394, DOI 10.1038/sj.onc.1210218; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Kosaka-Suzuki N, 2011, J BIOL CHEM, V286, P27378, DOI 10.1074/jbc.M111.243576; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Mkrtichyan M, 2008, GENE THER, V15, P61, DOI 10.1038/sj.gt.3303044; Mkrtichyan M, 2011, CELL IMMUNOL, V270, P188, DOI 10.1016/j.cellimm.2011.05.007; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200; Park SY, 2004, CANCER GENET CYTOGEN, V152, P153, DOI 10.1016/j.cancergencyto.2003.10.016; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Renaud S, 2011, NUCLEIC ACIDS RES, V39, P862, DOI 10.1093/nar/gkq827; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Woloszynska-Read Anna, 2010, Cancer Immun, V10, P6; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Xu JH, 2010, BREAST CANCER RES TR, V120, P593, DOI 10.1007/s10549-009-0422-1	48	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40389	10.1371/journal.pone.0040389	http://dx.doi.org/10.1371/journal.pone.0040389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792300	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300062
J	Hu, HM; Zhang, SB; Lei, XH; Deng, ZL; Guo, WX; Qiu, ZF; Liu, S; Wang, XY; Zhang, H; Duan, EK				Hu, Hui-min; Zhang, Shou-bing; Lei, Xiao-hua; Deng, Zhi-li; Guo, Wei-xiang; Qiu, Zhi-fang; Liu, Shuang; Wang, Xin-yue; Zhang, He; Duan, En-kui			Estrogen Leads to Reversible Hair Cycle Retardation through Inducing Premature Catagen and Maintaining Telogen	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; STEM-CELLS; RECEPTOR-ALPHA; FOLLICLE; GROWTH; KERATINOCYTES; ENRICHMENT; INDUCTION; APOPTOSIS; INVIVO	Estrogen dysregulation causes hair disorder. Clinical observations have demonstrated that estrogen raises the telogen/anagen ratio and inhibits hair shaft elongation of female scalp hair follicles. In spite of these clinical insights, the properties of estrogen on hair follicles are poorly dissected. In the present study, we show that estrogen induced apoptosis of precortex cells and caused premature catagen by up-regulation of TGF beta 2. Immediately after the premature catagen, the expression of anagen chalone BMP4 increased. The up-regulation of BMP4 may further function to prevent anagen transition and maintain telogen. Interestingly, the hair follicle stem cell niche was not destructed during these drastic structural changes caused by estrogen. Additionally, dermal papilla cells, the estrogen target cells in hair follicles, kept their signature gene expressions as well as their hair inductive potential after estrogen treatment. Retention of the characteristics of both hair follicle stem cells and dermal papilla cells determined the reversibility of the hair cycle suppression. These results indicated that estrogen causes reversible hair cycle retardation by inducing premature catagen and maintaining telogen.	[Hu, Hui-min; Zhang, Shou-bing; Lei, Xiao-hua; Deng, Zhi-li; Guo, Wei-xiang; Qiu, Zhi-fang; Liu, Shuang; Wang, Xin-yue; Duan, En-kui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Hu, Hui-min; Zhang, Shou-bing; Deng, Zhi-li; Guo, Wei-xiang; Qiu, Zhi-fang; Liu, Shuang; Wang, Xin-yue] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhang, He] WN Agri Forestry Univ, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, HM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	duane@ioz.ac.cn	Lei, Xiaohua/J-7020-2019; Qiu, Zhifang/P-8313-2014	Lei, Xiaohua/0000-0001-8095-9008; Qiu, Zhifang/0000-0001-9196-032X	Strategic Priority Research Program of the Chinese academy of Sciences [XDA 01010202]; National Basic Research Program of China Grant [2011CB710905]; National Natural Science Foundation of China Grants [30971671]	Strategic Priority Research Program of the Chinese academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese academy of Sciences [grant number XDA 01010202], National Basic Research Program of China Grant [grant number 2011CB710905] and National Natural Science Foundation of China Grants [grant number 30971671]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Chanda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE202, DOI 10.1152/ajpendo.2000.278.2.E202; Conrad F, 2004, J INVEST DERMATOL, V122, P840, DOI 10.1111/j.0022-202X.2004.22344.x; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dawson HL, 1933, AM J ANAT, V53, P89, DOI 10.1002/aja.1000530104; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gharzi A, 2003, EXP DERMATOL, V12, P126, DOI 10.1034/j.1600-0625.2003.00106.x; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; JAHODA CAB, 1991, J CELL SCI, V99, P627; JAHODA CAB, 1984, J EMBRYOL EXP MORPH, V79, P211; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Kaufman KD, 2002, MOL CELL ENDOCRINOL, V198, P89, DOI 10.1016/S0303-7207(02)00372-6; Kim JY, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-2; KONDO S, 1990, ARCH DERMATOL RES, V282, P442, DOI 10.1007/BF00402619; Lin KK, 2004, P NATL ACAD SCI USA, V101, P15955, DOI 10.1073/pnas.0407114101; Lindner G, 1997, AM J PATHOL, V151, P1601; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; MONTAGNA W, 1962, STRUCTURE FUNCTION S; Moverare S, 2002, J INVEST DERMATOL, V119, P1053, DOI 10.1046/j.1523-1747.2002.00637.x; Nelson L.D., 2003, J INVEST DERMATOL, V121, p821a; Oh HS, 1996, P NATL ACAD SCI USA, V93, P12525, DOI 10.1073/pnas.93.22.12525; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Soma T, 1998, J INVEST DERMATOL, V111, P948, DOI 10.1046/j.1523-1747.1998.00408.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; WHITING DA, 1993, J AM ACAD DERMATOL, V28, P755, DOI 10.1016/0190-9622(93)70106-4; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544	41	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40124	10.1371/journal.pone.0040124	http://dx.doi.org/10.1371/journal.pone.0040124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792225	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300026
J	McHugh, BJ; Murdoch, A; Haslett, C; Sethi, T				McHugh, Brian J.; Murdoch, Amanda; Haslett, Christopher; Sethi, Tariq			Loss of the Integrin-Activating Transmembrane Protein Fam38A (Piezo1) Promotes a Switch to a Reduced Integrin-Dependent Mode of Cell Migration	PLOS ONE			English	Article							LUNG-CANCER; R-RAS; INVASION; MECHANISMS	Lung cancer is one of the most common fatal diseases in the developed world. The disease is rarely cured by currently available therapies, with an overall survival rate of similar to 10%. Characterizing novel proteins that offer crucial insights into the processes of lung tumour invasion and metastasis may therefore provide much-needed prognostic markers, and influence therapeutic strategies. Aberrant function of the integrin family of heterodimeric cell surface receptors is a common theme in cancer - investigation into novel integrin activity regulators may offer crucial insights into the processes of tumour invasion and metastasis and may reveal insights into potential therapeutic targets. We previously described that depletion of the novel multi-transmembrane domain protein Fam38A, located at the endoplasmic reticulum (ER), inactivates endogenous beta1 integrin affinity, reducing cell adhesion. We now show that depletion of Fam38A, also now known as Piezo1, causes anchorage independence and a switch to a reduced integrin-dependent mode of cell migration/invasion, a novel phenotype for this integrin-regulating protein. Normal lung epithelial cells show increased rates of migration by 2D time-lapse microscopy and increased capacity to invade into matrigel, despite having decreased integrin affinity. We confirm greatly depleted Fam38A expression in small cell lung cancer (SCLC) lines where a form of reduced integrin-dependent migration, i.e. amoeboid migration, is a known phenotype. We propose that loss of Fam38A expression may cause increased cell migration and metastasis in lung tumours.	[McHugh, Brian J.; Murdoch, Amanda; Haslett, Christopher] Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Sethi, Tariq] Kings Coll London, Dept Resp Med, London WC2R 2LS, England; [Sethi, Tariq] Kings Coll London, Dept Allergy, London WC2R 2LS, England	University of Edinburgh; University of London; King's College London; University of London; King's College London	McHugh, BJ (corresponding author), Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	Brian.McHugh@ed.ac.uk		McHugh, Brian/0000-0003-4747-0643	Chief Scientist Office of the Scottish Executive [CZB/4/691]; Medical Research Council [G0901697] Funding Source: researchfish; MRC [G0901697] Funding Source: UKRI	Chief Scientist Office of the Scottish Executive; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Chief Scientist Office of the Scottish Executive (http://www.cso.scot.nhs.uk/), grant number CZB/4/691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; COZENS AL, 1992, P NATL ACAD SCI USA, V89, P5171, DOI 10.1073/pnas.89.11.5171; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Girard L, 2000, CANCER RES, V60, P4894; Gregor A, 2001, THORAX, V56, P212, DOI 10.1136/thorax.56.3.212; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Levi F, 2004, INT J CANCER, V110, P155, DOI 10.1002/ijc.20097; McHugh B, 2004, J CELL BIOL, V167, P673, DOI 10.1083/jcb.200405155; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Mori Y, 1999, BRIT J CANCER, V80, P556, DOI 10.1038/sj.bjc.6690391; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Takeuchi T, 2006, PATHOL INT, V56, P434, DOI 10.1111/j.1440-1827.2006.01985.x; TSUDA H, 1994, CANCER RES, V54, P513	24	97	100	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40346	10.1371/journal.pone.0040346	http://dx.doi.org/10.1371/journal.pone.0040346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792288	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300058
J	Bonisch, U; Bohme, A; Kohajda, T; Mogel, I; Schutze, N; von Bergen, M; Simon, JC; Lehmann, I; Polte, T				Boenisch, Ulrike; Boehme, Alexander; Kohajda, Tibor; Moegel, Iljana; Schuetze, Nicole; von Bergen, Martin; Simon, Jan C.; Lehmann, Irina; Polte, Tobias			Volatile Organic Compounds Enhance Allergic Airway Inflammation in an Experimental Mouse Model	PLOS ONE			English	Article							NF-KAPPA-B; INDOOR RENOVATION ACTIVITIES; LUNG EPITHELIAL-CELLS; OXIDATIVE STRESS; ASTHMA; EXPOSURE; ASSOCIATION; CHILDREN; EMISSIONS; SCHOOLCHILDREN	Background: Epidemiological studies suggest an association between exposure to volatile organic compounds (VOCs) and adverse allergic and respiratory symptoms. However, whether VOCs exhibit a causal role as adjuvants in asthma development remains unclear. Methods: To investigate the effect of VOC exposure on the development of allergic airway inflammation Balb/c mice were exposed to VOCs emitted by new polyvinylchloride (PVC) flooring, sensitized with ovalbumin (OVA) and characterized in acute and chronic murine asthma models. Furthermore, prevalent evaporated VOCs were analyzed and mice were exposed to selected single VOCs. Results: Exposure of mice to PVC flooring increased eosinophilic lung inflammation and OVA-specific IgE serum levels compared to un-exposed control mice. The increased inflammation was associated with elevated levels of Th2-cytokines. Long-term exposure to PVC flooring exacerbated chronic airway inflammation. VOCs with the highest concentrations emitted by new PVC flooring were N-methyl-2-pyrrolidone (NMP) and 2,2,4-trimethyl-1,3-pentanediol diisobutyrate (TXIB). Exposure to NMP or TXIB also increased the allergic immune response in OVA-sensitized mice. In vitro or in vivo exposure to NMP or TXIB reduced IL-12 production in maturing dendritic cells (DCs) and enhanced airway inflammation after adoptive DC transfer into Balb/c mice. At higher concentrations both VOCs induced oxidative stress demonstrated by increased isoprostane and glutathione-S-transferase-pi1 protein levels in the lung of non-sensitized mice. Treatment of PVC flooring-exposed mice with N-acetylcysteine prevented the VOC-induced increase of airway inflammation. Conclusions: Our results demonstrate that exposure to VOCs may increase the allergic immune response by interfering with DC function and by inducing oxidative stress and has therefore to be considerate as risk factor for the development of allergic diseases.	[Boenisch, Ulrike; Boehme, Alexander; Moegel, Iljana; Schuetze, Nicole; Lehmann, Irina; Polte, Tobias] UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany; [Boenisch, Ulrike; Schuetze, Nicole; Simon, Jan C.; Polte, Tobias] Univ Leipzig, Dept Dermatol Venerol & Allergol, Leipzig Univ Med Ctr, Leipzig, Germany; [Kohajda, Tibor; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Metabol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Bonisch, U (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany.	tobias.polte@ufz.de	von Bergen, Martin/D-7960-2011	von Bergen, Martin/0000-0003-2732-2977; Lehmann, Irina/0000-0001-8875-5587	Helmholtz Association [VG-NG-337]	Helmholtz Association(Helmholtz Association)	The study was supported by the Helmholtz Association grant VG-NG-337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini F, 2009, AM J RESP CRIT CARE, V179, P984, DOI 10.1164/rccm.200807-1061OC; ANUNDI H, 1993, INT ARCH OCC ENV HEA, V65, P247, DOI 10.1007/BF00381198; Beaulieu HJ., 1991, APPL OCCUP ENVIRON H, V6, P874; Bowler RP, 2002, J ALLERGY CLIN IMMUN, V110, P349, DOI 10.1067/mai.2002.126780; Chan RCF, 2006, J ALLERGY CLIN IMMUN, V118, P455, DOI 10.1016/j.jaci.2006.06.006; Chen CM, 2007, NUTRITION, V23, P589, DOI 10.1016/j.nut.2007.05.004; Choi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013423; Cooke T. F., 1991, Reviews on Environmental Health, V9, P137; De Jong WH, 2009, TOXICOLOGY, V261, P103, DOI 10.1016/j.tox.2009.04.057; Diez U, 2000, INT J HYG ENVIR HEAL, V203, P23, DOI 10.1078/S1438-4639(04)70004-8; Dong GH, 2008, INT J ENVIRON HEAL R, V18, P267, DOI 10.1080/09603120701842864; Emenius G, 2004, INDOOR AIR, V14, P34, DOI 10.1046/j.1600-0668.2003.00207.x; Fei MJ, 2011, P NATL ACAD SCI USA, V108, P5360, DOI 10.1073/pnas.1015476108; Feltens R, 2010, TOXICOL APPL PHARM, V242, P100, DOI 10.1016/j.taap.2009.09.020; Fischader G, 2008, TOXICOL IN VITRO, V22, P359, DOI 10.1016/j.tiv.2007.09.015; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gu YH, 2008, HUM EXP TOXICOL, V27, P37, DOI 10.1177/0960327108088973; Hanninen M, 2005, U ALBERTA HLTH SCI J, V2, P11; Heinrich J, 2011, INT J HYG ENVIR HEAL, V214, P3, DOI 10.1016/j.ijheh.2010.08.009; Herbarth O, 2006, INT J HYG ENVIR HEAL, V209, P241, DOI 10.1016/j.ijheh.2006.01.003; Herberth G, 2009, PEDIAT ALLERG IMM-UK, V20, P563, DOI 10.1111/j.1399-3038.2008.00819.x; Huang RP, 1996, J CELL BIOL, V133, P211, DOI 10.1083/jcb.133.1.211; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jarnstrom H, 2008, ENVIRON INT, V34, P420, DOI 10.1016/j.envint.2007.09.011; Jouyban A, 2010, J PHARM PHARM SCI, V13, P524, DOI 10.18433/J3P306; Kato T, 2006, EUR J IMMUNOL, V36, P1199, DOI 10.1002/eji.200535140; Larsson M, 2010, INDOOR AIR, V20, P494, DOI 10.1111/j.1600-0668.2010.00671.x; Leech JA, 2002, J EXPO ANAL ENV EPID, V12, P427, DOI 10.1038/sj.jea.7500244; Lehmann I, 2001, INT J HYG ENVIR HEAL, V204, P211, DOI 10.1078/1438-4639-00100; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; Metiainen P., 2002, 9 INT C IND QUAL CLI, V2, P108; Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718; Morbt N, 2009, PROTEOMICS, V9, P4920, DOI 10.1002/pmic.200800836; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nielsen GD, 2007, INDOOR AIR, V17, P236, DOI 10.1111/j.1600-0668.2006.00468.x; Pearce N, 2006, INT J TUBERC LUNG D, V10, P125; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; Polte T, 2009, EUR J IMMUNOL, V39, P1736, DOI 10.1002/eji.200839004; Roder-Stolinski C, 2008, INHAL TOXICOL, V20, P813, DOI [10.1080/08958370802020810, 10.1080/08958370802020810 ]; Roder-Stolinski C, 2008, TOXICOL APPL PHARM, V231, P241, DOI 10.1016/j.taap.2008.04.010; Rumchev K, 2004, THORAX, V59, P746, DOI 10.1136/thx.2003.013680; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Smedje G, 1997, CLIN EXP ALLERGY, V27, P1270, DOI 10.1111/j.1365-2222.1997.tb01171.x; Solomon GM, 1996, J OCCUP ENVIRON MED, V38, P705, DOI 10.1097/00043764-199607000-00014; Sweet David G, 2002, Paediatr Respir Rev, V3, P140, DOI 10.1016/S1526-0550(02)00010-0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121; Wieslander G, 1997, INT ARCH OCC ENV HEA, V69, P115; Wieslander G, 1997, ANN OCCUP HYG, V41, P155, DOI 10.1016/S0003-4878(96)00039-7; Wilke O, 2004, INDOOR AIR, V14, P98, DOI 10.1111/j.1600-0668.2004.00314.x; Yang G, 2004, J CLIN INVEST, V114, P669, DOI 10.1172/JCI200419300	54	50	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39817	10.1371/journal.pone.0039817	http://dx.doi.org/10.1371/journal.pone.0039817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802943	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900017
J	Jensen, MH; Morris, EJ; Huang, RJ; Rebowski, G; Dominguez, R; Weitz, DA; Moore, JR; Wang, CLA				Jensen, Mikkel Herholdt; Morris, Eliza J.; Huang, Renjian; Rebowski, Grzegorz; Dominguez, Roberto; Weitz, David A.; Moore, Jeffrey R.; Wang, Chih-Lueh Albert			The Conformational State of Actin Filaments Regulates Branching by Actin-related Protein 2/3 (Arp2/3) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; DEPOLYMERIZING FACTOR; CALDESMON BINDING; TROPOMYOSIN; MOTILITY; COOPERATIVITY; ROLES	Actin is a highly ubiquitous protein in eukaryotic cells that plays a crucial role in cell mechanics and motility. Cell motility is driven by assembling actin as polymerizing actin drives cell protrusions in a process closely involving a host of other actin-binding proteins, notably the actin-related protein 2/3 (Arp2/3) complex, which nucleates actin and forms branched filamentous structures. The Arp2/3 complex preferentially binds specific actin networks at the cell leading edge and forms branched filamentous structures, which drive cell protrusions, but the exact regulatory mechanism behind this process is not well understood. Here we show using in vitro imaging and binding assays that a fragment of the actin-binding protein caldesmon added to polymerizing actin increases the Arp2/3-mediated branching activity, whereas it has no effect on branch formation when binding to aged actin filaments. Because this caldesmon effect is shown to be independent of nucleotide hydrolysis and phosphate release from actin, our results suggest a mechanism by which caldesmon maintains newly polymerized actin in a distinct state that has a higher affinity for the Arp2/3 complex. Our data show that this new state does not affect the level of cooperativity of binding by Arp2/3 complex or its distribution on actin. This presents a novel regulatory mechanism by which caldesmon, and potentially other actin-binding proteins, regulates the interactions of actin with its binding partners.	[Huang, Renjian; Wang, Chih-Lueh Albert] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Jensen, Mikkel Herholdt; Moore, Jeffrey R.] Boston Univ, Dept Physiol & Biophys, Boston, MA 02118 USA; [Jensen, Mikkel Herholdt] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Morris, Eliza J.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rebowski, Grzegorz; Dominguez, Roberto] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Wang, Chih-Lueh Albert] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan	Boston Biomedical Research Institute; Boston University; Boston University; Harvard University; University of Pennsylvania; China Medical University Taiwan	Wang, CLA (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	wang@bbri.org		Morris, Eliza/0000-0002-4658-502X; Moore, Jeffrey/0000-0001-7190-9332; Herholdt Jensen, Mikkel/0000-0002-4821-3318	National Institutes of Health [HL92252, HL86655]; National Science Foundation [DMR-1006546]; Harvard Materials Research Science and Engineering Center [DMR-0820484]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL092252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL92252 (to C. L. A. W.) and HL86655 (J. R. M., and R. D.). This work was also supported by the National Science Foundation (Grant DMR-1006546) and the Harvard Materials Research Science and Engineering Center (Grant DMR-0820484).	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Arias MP, 2001, BIOCHEMISTRY-US, V40, P12974, DOI 10.1021/bi010098+; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; BRETSCHER A, 1986, NATURE, V321, P726, DOI 10.1038/321726b0; BRETSCHER A, 1985, J CELL BIOL, V100, P1656, DOI 10.1083/jcb.100.5.1656; Bryan KE, 2005, J BIOL CHEM, V280, P1696, DOI 10.1074/jbc.M410180200; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; Collins Agnieszka, 2011, Bioarchitecture, V1, P127; EGELMAN EH, 1995, J STRUCT BIOL, V115, P159, DOI 10.1006/jsbi.1995.1040; Eves R, 2006, J CELL SCI, V119, P1691, DOI 10.1242/jcs.02881; Foster DB, 2004, J BIOL CHEM, V279, P53387, DOI 10.1074/jbc.M410109200; Galinska-Rakoczy A, 2009, J MOL BIOL, V387, P869, DOI 10.1016/j.jmb.2009.02.011; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; Huang RJ, 2010, J BIOL CHEM, V285, P71, DOI 10.1074/jbc.M109.065078; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jiang QF, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-6; Kordowska J, 2005, EXP CELL RES, V312, P95, DOI 10.1016/j.yexcr.2005.09.021; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Lin JJC, 2009, INT REV CEL MOL BIO, V274, P1, DOI 10.1016/S1937-6448(08)02001-7; MARSTON SB, 1996, BIOCH SMOOTH MUSCLE, P77; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; YANG YZ, 1979, J BIOL CHEM, V254, P7137; Yokouchi K, 2006, ARTERIOSCL THROM VAS, V26, P2231, DOI 10.1161/01.ATV.0000239441.29687.97	37	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31447	31453		10.1074/jbc.M112.350421	http://dx.doi.org/10.1074/jbc.M112.350421			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22791711	Green Published, hybrid			2022-12-25	WOS:000308791300055
J	Reinders, A; Sun, Y; Karvonen, KL; Ward, JM				Reinders, Anke; Sun, Ye; Karvonen, Kayla L.; Ward, John M.			Identification of Amino Acids Important for Substrate Specificity in Sucrose Transporters Using Gene Shuffling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROTEIN; PHLOEM; RICE; EXPRESSION; EVOLUTION; YEAST; TRANSFORMATION; AFFINITY; BARLEY	Plant sucrose transporters (SUTs) are H (+)-coupled uptake transporters. Type I and II (SUTs) are phylogenetically related but have different substrate specificities. Type I SUTs transport sucrose, maltose, and a wide range of natural and synthetic alpha- and beta-glucosides. Type II SUTs are more selective for sucrose and maltose. Here, we investigated the structural basis for this difference in substrate specificity. We used a novel gene shuffling method called synthetic template shuffling to introduce 62 differentially conserved amino acid residues from type I SUTs into OsSUT1, a type II SUT from rice. The OsSUT1 variants were tested for their ability to transport the fluorescent coumarin beta-glucoside esculin when expressed in yeast. Fluorescent yeast cells were selected using fluorescence-activated cell sorting (FACS). Substitution of five amino acids present in type I SUTs in OsSUT1 was found to be sufficient to confer esculin uptake activity. The changes clustered in two areas of the OsSUT1 protein: in the first loop and the top of TMS2 (T80L and A86K) and in TMS5 (S220A, S221A, and T224Y). The substrate specificity of this OsSUT1 variant was almost identical to that of type I SUTs. Corresponding changes in the sugarcane type II transporter ShSUT1 also changed substrate specificity, indicating that these residues contribute to substrate specificity in type II SUTs in general.	[Reinders, Anke; Sun, Ye; Karvonen, Kayla L.; Ward, John M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ward, JM (corresponding author), Univ Minnesota, Dept Plant Biol, 250 Biol Sci Ctr,1445 Gortner Ave, St Paul, MN 55108 USA.	jward@umn.edu		Ward, John/0000-0001-8185-0434; Reinders, Anke/0000-0001-5351-3940; Karvonen, Kayla/0000-0001-8213-6697	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy [DE-FG02-10ER15886]; National Institutes of Health [P30 CAO77598]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy Grant; We are grateful to Nisha Shah from the University Flow Cytometry Resource supported in part by National Institutes of Health Grant P30 CAO77598 for performing the cell sorting and to the College of Biological Sciences' Imaging Center at the University of Minnesota for assistance with fluorescence microscopy. We thank Dr. Robert Furbank (Commonwealth Scientific and Industrial Research Organisation) for supplying the OsSUT1 cDNA and Dr. Christopher P. Grof (University of Newcastle) for supplying the ShSUT1 cDNA.DE-FG02-10ER15886 (to J. M. W.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Aoki N, 2003, PLANT CELL PHYSIOL, V44, P223, DOI 10.1093/pcp/pcg030; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; BUSH DR, 1993, ARCH BIOCHEM BIOPHYS, V307, P355, DOI 10.1006/abbi.1993.1600; Chandran D, 2003, J BIOL CHEM, V278, P44320, DOI 10.1074/jbc.M308490200; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Eom JS, 2011, PLANT PHYSIOL, V157, P109, DOI 10.1104/pp.111.176982; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gora PJ, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-13; GRIFFIN SDJ, 1993, BIOCHIM BIOPHYS ACTA, V1152, P61, DOI 10.1016/0005-2736(93)90231-N; HITZ WD, 1986, J BIOL CHEM, V261, P1986; Inagaki K, 2006, PIGM CELL RES, V19, P451, DOI 10.1111/j.1600-0749.2006.00332.x; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Lu JMY, 1998, P NATL ACAD SCI USA, V95, P9025, DOI 10.1073/pnas.95.15.9025; Moore GL, 2001, P NATL ACAD SCI USA, V98, P3226, DOI 10.1073/pnas.051631498; Reinders A, 2001, MOL MICROBIOL, V39, P445, DOI 10.1046/j.1365-2958.2001.02237.x; Reinders A, 2008, PLANT MOL BIOL, V68, P289, DOI 10.1007/s11103-008-9370-0; Reinders A, 2006, PLANT CELL ENVIRON, V29, P1871, DOI 10.1111/j.1365-3040.2006.01563.x; Reinders A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00022; Rennie EA, 2009, P NATL ACAD SCI USA, V106, P14162, DOI 10.1073/pnas.0902279106; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schulze W, 2000, FEBS LETT, V485, P189, DOI 10.1016/S0014-5793(00)02180-3; Sivitz AB, 2005, PLANT CELL PHYSIOL, V46, P1666, DOI 10.1093/pcp/pci182; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Sun Y, 2012, BIOCHEMISTRY-US, V51, P3284, DOI 10.1021/bi201934h; Sun Y, 2010, PLANT CELL PHYSIOL, V51, P114, DOI 10.1093/pcp/pcp172	36	22	22	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30296	30304		10.1074/jbc.M112.372888	http://dx.doi.org/10.1074/jbc.M112.372888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807445	Green Published, hybrid			2022-12-25	WOS:000308579800022
J	Sawai, H; Yamanaka, M; Sugimoto, H; Shiro, Y; Aono, S				Sawai, Hitomi; Yamanaka, Masaru; Sugimoto, Hiroshi; Shiro, Yoshitsugu; Aono, Shigetoshi			Structural Basis for the Transcriptional Regulation of Heme Homeostasis in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TETR FAMILY; IRON; RESPIRATION; SEQUENCE; ACRR; IDENTIFICATION; REFINEMENT; EFFLUX; SYSTEM	Although heme is a crucial element for many biological processes including respiration, heme homeostasis should be regulated strictly due to the cytotoxicity of free heme molecules. Numerous lactic acid bacteria, including Lactococcus lactis, acquire heme molecules exogenously to establish an aerobic respiratory chain. A heme efflux system plays an important role for heme homeostasis to avoid cytotoxicity of acquired free heme, but its regulatory mechanism is not clear. Here, we report that the transcriptional regulator heme-regulated transporter regulator (HrtR) senses and binds a heme molecule as its physiological effector to regulate the expression of the heme-efflux system responsible for heme homeostasis in L. lactis. To elucidate the molecular mechanisms of how HrtR senses a heme molecule and regulates gene expression for the heme efflux system, we determined the crystal structures of the apo-HrtR.DNA complex, apo-HrtR, and holo-HrtR at a resolution of 2.0, 3.1, and 1.9 angstrom, respectively. These structures revealed that HrtR is a member of the TetR family of transcriptional regulators. The residue pair Arg-46 and Tyr-50 plays a crucial role for specific DNA binding through hydrogen bonding and a CH-pi interaction with the DNA bases. HrtR adopts a unique mechanism for its functional regulation upon heme sensing. Heme binding to HrtR causes a coil-to-helix transition of the alpha 4 helix in the heme-sensing domain, which triggers a structural change of HrtR, causing it to dissociate from the target DNA for derepression of the genes encoding the heme efflux system. HrtR uses a unique heme-sensing motif with bis-His (His-72 and His-149) ligation to the heme, which is essential for the coil-to-helix transition of the alpha 4 helix upon heme sensing.	[Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Sawai, Hitomi; Yamanaka, Masaru; Aono, Shigetoshi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Sawai, Hitomi; Yamanaka, Masaru; Aono, Shigetoshi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Sugimoto, H (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	sugimoto@spring8.or.jp; aono@ims.ac.jp	Shiro, Yoshitsugu Y/J-3757-2014; Sugimoto, Hiroshi/K-4041-2017; Aono, Shigetoshi/ABD-7618-2020; Sugimoto, Hiroshi/AAR-5442-2021; Sawai, Hitomi/AAU-2584-2020; Sawai, Hitomi/AAW-5541-2021; Asano, Yasuhisa/K-5898-2016	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Sugimoto, Hiroshi/0000-0002-3140-8362; Aono, Shigetoshi/0000-0002-2870-3694; Asano, Yasuhisa/0000-0003-3645-3952; Sawai, Hitomi/0000-0002-0714-8337	Japan Society for the Promotion of Science [23350084, 22870043]; Noda Institute for Scientific Research; Fumi Yamamura Memorial Foundation for Female Natural Scientists from Chuo Mitsui Trust and Banking; Shiseido Co., Ltd.; Grants-in-Aid for Scientific Research [23350084] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Noda Institute for Scientific Research(Noda Institute for Scientific Research); Fumi Yamamura Memorial Foundation for Female Natural Scientists from Chuo Mitsui Trust and Banking; Shiseido Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research B 23350084 (to S. A.) and Grant-in-aid for Research Activity Start-up 22870043 (to H. Sawai) from the Japan Society for the Promotion of Science, by the Noda Institute for Scientific Research (to S. A.), by the Fumi Yamamura Memorial Foundation for Female Natural Scientists from Chuo Mitsui Trust and Banking (to H. Sawai), and by the Shiseido Female Researcher Science Grant from Shiseido Co., Ltd. (to H. Sa).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brooijmans RJW, 2007, J BACTERIOL, V189, P5203, DOI 10.1128/JB.00361-07; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gu RY, 2008, ACTA CRYSTALLOGR F, V64, P584, DOI 10.1107/S1744309108016035; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kimura T, 2002, J AM CHEM SOC, V124, P11596, DOI 10.1021/ja026639f; Kokkinos A, 1998, LAIT, V78, P491, DOI 10.1051/lait:1998546; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lechardeur D, 2012, J BIOL CHEM, V287, P4752, DOI 10.1074/jbc.M111.297531; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Lunin VY, 2002, ACTA CRYSTALLOGR A, V58, P270, DOI 10.1107/S0108767302001046; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Schmitt MP, 1999, J BACTERIOL, V181, P5330, DOI 10.1128/JB.181.17.5330-5340.1999; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Stauff DL, 2009, CONTRIB MICROBIOL, V16, P120, DOI 10.1159/000219376; Su CC, 2007, BIOCHEM BIOPH RES CO, V361, P85, DOI 10.1016/j.bbrc.2007.06.175; Subramanian C, 2010, J BACTERIOL, V192, P280, DOI 10.1128/JB.00404-09; Sugahara M, 2006, ACTA CRYSTALLOGR D, V62, P520, DOI 10.1107/S0907444906009012; TAO X, 1994, MOL MICROBIOL, V14, P191, DOI 10.1111/j.1365-2958.1994.tb01280.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Umezawa Y, 2002, NUCLEIC ACIDS RES, V30, P2183, DOI 10.1093/nar/30.10.2183; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	44	44	44	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30755	30768		10.1074/jbc.M112.370916	http://dx.doi.org/10.1074/jbc.M112.370916			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798069	Green Published, hybrid			2022-12-25	WOS:000308579800064
J	Gimenez, LE; Vishnivetskiy, SA; Baameur, F; Gurevich, VV				Gimenez, Luis E.; Vishnivetskiy, Sergey A.; Baameur, Faiza; Gurevich, Vsevolod V.			Manipulation of Very Few Receptor Discriminator Residues Greatly Enhances Receptor Specificity of Non-visual Arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHORYLATION-RECOGNITION; NEOSTRIATAL NEURONS; CLATHRIN ADAPTER; BINDING STATE; LIVING CELLS	Based on the identification of residues that determine receptor selectivity of arrestins and the analysis of the evolution in the arrestin family, we introduced 10 mutations of "receptor discriminator" residues in arrestin-3. The recruitment of these mutants to M2 muscarinic (M2R), D1 (D1R) and D2 (D2R) dopamine, and beta(2)-adrenergic receptors (beta(2)AR) was assessed using bioluminescence resonance energy transfer-based assays in cells. Seven of 10 mutations differentially affected arrestin-3 binding to individual receptors. D260K and Q262P reduced the binding to beta(2)AR, much more than to other receptors. The combination D260K/Q262P virtually eliminated beta(2)AR binding while preserving the interactions with M2R, D1R, and D2R. Conversely, Y239T enhanced arrestin-3 binding to beta(2)AR and reduced the binding to M2R, D1R, and D2R, whereas Q256Y selectively reduced recruitment to D2R. The Y239T/Q256Y combination virtually eliminated the binding to D2R and reduced the binding to beta(2)AR and M2R, yielding a mutant with high selectivity for D1R. Eleven of 12 mutations significantly changed the binding to light-activated phosphorhodopsin. Thus, manipulation of key residues on the receptor-binding surface modifies receptor preference, enabling the construction of non-visual arrestins specific for particular receptor subtypes. These findings pave the way to the construction of signaling-biased arrestins targeting the receptor of choice for research or therapeutic purposes.	[Gimenez, Luis E.; Vishnivetskiy, Sergey A.; Baameur, Faiza; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM077561, GM081756, EY011500]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077561, GM081756, and EY011500 (to V.V.G.).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; FRANCES B, 1990, EUR J PHARM-MOLEC PH, V189, P1, DOI 10.1016/0922-4106(90)90224-L; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; JAGADEESH G, 1990, J PHARMACOL EXP THER, V252, P1184; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Macey TA, 2005, J NEUROCHEM, V93, P128, DOI 10.1111/j.1471-4159.2004.02998.x; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pantel J, 2011, EUR J PHARMACOL, V660, P139, DOI 10.1016/j.ejphar.2011.01.031; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; TIAN WN, 1994, MOL PHARMACOL, V45, P524; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	74	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29495	29505		10.1074/jbc.M112.366674	http://dx.doi.org/10.1074/jbc.M112.366674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787152	Green Published, hybrid			2022-12-25	WOS:000308286900026
J	Loiselle, AE; Frisch, BJ; Wolenski, M; Jacobson, JA; Calvi, LM; Schwarz, EM; Awad, HA; O'Keefe, RJ				Loiselle, Alayna E.; Frisch, Benjamin J.; Wolenski, Matthew; Jacobson, Justin A.; Calvi, Laura M.; Schwarz, Edward M.; Awad, Hani A.; O'Keefe, Regis J.			Bone Marrow-Derived Matrix Metalloproteinase-9 Is Associated with Fibrous Adhesion Formation after Murine Flexor Tendon Injury	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; RAT-BRAIN; TNF-ALPHA; MMP-9; INDUCTION; CELLS; REPAIR; INFLAMMATION; FIBROBLASTS	The pathogenesis of adhesions following primary tendon repair is poorly understood, but is thought to involve dysregulation of matrix metalloproteinases (Mmps). We have previously demonstrated that Mmp9 gene expression is increased during the inflammatory phase following murine flexor digitorum (FDL) tendon repair in association with increased adhesions. To further investigate the role of Mmp9, the cellular, molecular, and biomechanical features of healing were examined in WT and Mmp9(-/-) mice using the FDL tendon repair model. Adhesions persisted in WT, but were reduced in Mmp9(-/-) mice by 21 days without any decrease in strength. Deletion of Mmp9 resulted in accelerated expression of neotendon associated genes, Gdf5 and Smad8, and delayed expression of collagen I and collagen III. Furthermore, WT bone marrow cells (GFP(+)) migrated specifically to the tendon repair site. Transplanting myeloablated Mmp9(-/-) mice with WT marrow cells resulted in greater adhesions than observed in Mmp9(-/-) mice and similar to those seen in WT mice. These studies show that Mmp9 is primarily derived from bone marrow cells that migrate to the repair site, and mediates adhesion formation in injured tendons. Mmp9 is a potential target to limit adhesion formation in tendon healing.	[Loiselle, Alayna E.; Wolenski, Matthew; Jacobson, Justin A.; Schwarz, Edward M.; Awad, Hani A.; O'Keefe, Regis J.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14627 USA; [Frisch, Benjamin J.; Calvi, Laura M.] Univ Rochester, Sch Med & Dent, Dept Med, Div Endocrine, Rochester, NY 14642 USA; [Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Loiselle, AE (corresponding author), Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14627 USA.	regis_okeefe@urmc.rochester.edu	Awad, Hani A/G-6976-2014; Mostafa, Taymour/H-6834-2019; Calvi, Laura/P-6988-2019	Awad, Hani A/0000-0003-2197-2610; Mostafa, Taymour/0000-0003-3627-0662; Calvi, Laura/0000-0001-6969-239X; Frisch, Benjamin/0000-0003-0048-8491	National Institutes of Health from NIAMS [AR056696]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056696] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was partially supported by National Institutes of Health grant number AR056696 from NIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Beredjiklian PK, 2003, J BONE JOINT SURG AM, V85A, P539, DOI 10.2106/00004623-200303000-00025; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Corbel M, 2002, CELL BIOL TOXICOL, V18, P51, DOI 10.1023/A:1014471213371; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823; GELBERMAN RH, 1986, J HAND SURG-AM, V11A, P106, DOI 10.1016/S0363-5023(86)80115-0; GELBERMAN RH, 1982, J HAND SURG-AM, V7, P170, DOI 10.1016/S0363-5023(82)80083-X; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765, DOI 10.14670/HH-25.765; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Ingraham CA, 2011, J BIOL CHEM; Jozsa L.G., 1997, HUMAN TENDONS ANATOM; Kajikawa Y, 2007, J CELL PHYSIOL, V210, P684, DOI 10.1002/jcp.20876; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y; Katzel EB, 2011, J ORTHOP RES, V29, P684, DOI 10.1002/jor.21235; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; KULICK MI, 1986, J HAND SURG-AM, V11A, P110, DOI 10.1016/S0363-5023(86)80116-2; Lim DH, 2006, AM J PHYSIOL-LUNG C, V291, pL265, DOI 10.1152/ajplung.00305.2005; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Mukherjee R, 2010, FASEB J, V24, P3819, DOI 10.1096/fj.10-155531; Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34; Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40; Nee L, 2007, NEPHRON EXP NEPHROL, V107, pE73, DOI 10.1159/000108645; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Scabilloni JF, 2005, AM J PHYSIOL-LUNG C, V288, pL709, DOI 10.1152/ajplung.00034.2004; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sharma P, 2005, SURG-J R COLL SURG E, V3, P309, DOI 10.1016/S1479-666X(05)80109-X; Strickland, 1995, J Am Acad Orthop Surg, V3, P44; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; Tan RJ, 2006, AM J RESP CELL MOL, V35, P289, DOI 10.1165/rcmb.2005-0471OC; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Virchenko O, 2004, AM J SPORT MED, V32, P1743, DOI 10.1177/0363546504263403; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wang L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-14; Wang LY, 2010, J TOXICOL ENV HEAL A, V73, P410, DOI 10.1080/15287390903486550; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Woo SLY, 2000, ANNU REV BIOMED ENG, V2, P83, DOI 10.1146/annurev.bioeng.2.1.83; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Xia L, 2011, RHEUMATOLOGY INT; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098	50	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40602	10.1371/journal.pone.0040602	http://dx.doi.org/10.1371/journal.pone.0040602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792383	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400080
J	Mika, A; Reynolds, SL; Mohlin, FC; Willis, C; Swe, PM; Pickering, DA; Halilovic, V; Wijeyewickrema, LC; Pike, RN; Blom, AM; Kemp, DJ; Fischer, K				Mika, Angela; Reynolds, Simone L.; Mohlin, Frida C.; Willis, Charlene; Swe, Pearl M.; Pickering, Darren A.; Halilovic, Vanja; Wijeyewickrema, Lakshmi C.; Pike, Robert N.; Blom, Anna M.; Kemp, David J.; Fischer, Katja			Novel Scabies Mite Serpins Inhibit the Three Pathways of the Human Complement System	PLOS ONE			English	Article							TICK HAEMAPHYSALIS-LONGICORNIS; SERINE-PROTEASE PARALOGUES; IXODES-RICINUS TICKS; SALIVARY-GLANDS; SOFT TICK; SARCOPTES-SCABIEI; ANTICOMPLEMENT PROTEINS; TRANSCRIPTOME ANALYSIS; ORNITHODOROS-MOUBATA; ACARI IXODIDAE	Scabies is a parasitic infestation of the skin by the mite Sarcoptes scabiei that causes significant morbidity worldwide, in particular within socially disadvantaged populations. In order to identify mechanisms that enable the scabies mite to evade human immune defenses, we have studied molecules associated with proteolytic systems in the mite, including two novel scabies mite serine protease inhibitors (SMSs) of the serpin superfamily. Immunohistochemical studies revealed that within mite-infected human skin SMSB4 (54 kDa) and SMSB3 (47 kDa) were both localized in the mite gut and feces. Recombinant purified SMSB3 and SMSB4 did not inhibit mite serine and cysteine proteases, but did inhibit mammalian serine proteases, such as chymotrypsin, albeit inefficiently. Detailed functional analysis revealed that both serpins interfered with all three pathways of the human complement system at different stages of their activation. SMSB4 inhibited mostly the initial and progressing steps of the cascades, while SMSB3 showed the strongest effects at the C9 level in the terminal pathway. Additive effects of both serpins were shown at the C9 level in the lectin pathway. Both SMSs were able to interfere with complement factors without protease function. A range of binding assays showed direct binding between SMSB4 and seven complement proteins (C1, properdin, MBL, C4, C3, C6 and C8), while significant binding of SMSB3 occurred exclusively to complement factors without protease function (C4, C3, C8). Direct binding was observed between SMSB4 and the complement proteases C1s and C1r. However no complex formation was observed between either mite serpin and the complement serine proteases C1r, C1s, MASP-1, MASP-2 and MASP-3. No catalytic inhibition by either serpin was observed for any of these enzymes. In summary, the SMSs were acting at several levels mediating overall inhibition of the complement system and thus we propose that they may protect scabies mites from complement-mediated gut damage.	[Mika, Angela; Reynolds, Simone L.; Willis, Charlene; Swe, Pearl M.; Pickering, Darren A.; Halilovic, Vanja; Kemp, David J.; Fischer, Katja] Queensland Inst Med Res, Dept Biol, Program Infect Dis, Brisbane, Qld 4006, Australia; [Reynolds, Simone L.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Mohlin, Frida C.; Blom, Anna M.] Lund Univ, Dept Lab Med, Malmo, Sweden; [Wijeyewickrema, Lakshmi C.; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Lund University; Monash University	Mika, A (corresponding author), Queensland Inst Med Res, Dept Biol, Program Infect Dis, Brisbane, Qld 4006, Australia.	Katja.Fischer@qimr.edu.au	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022; Fischer, Katja/H-4989-2014; Wijeyewickrema, Lakshmi/A-9676-2015; Willis, Charlene/U-1344-2017	Blom, Anna/0000-0002-1348-1734; Fischer, Katja/0000-0003-3408-3337; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; , Simone/0000-0002-4902-2003; Pike, Robert/0000-0002-2083-0269	Australian National Health and Medical Research Council [496600, 613626]; Swedish Research Council [K2009-68X-14928-06-3]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Inga-Britt and Arne Lundberg Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg Foundation	This work was supported by the Australian National Health and Medical Research Council (http://www.nhmrc.gov.au/), Program Grant 496600, Project Grant 613626 and a fellowship to DJK. AB would like to acknowledge the financial support of the Swedish Research Council (K2009-68X-14928-06-3), the Swedish Foundation for Strategic Research and the Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; ALBERTI S, 1993, INFECT IMMUN, V61, P852; Aljamali MN, 2009, INSECT MOL BIOL, V18, P129, DOI 10.1111/j.1365-2583.2009.00863.x; Australian Government NHMRC, 2004, ACC BLOCK OV EM DEP, P1; Batista IFC, 2008, TOXICON, V51, P823, DOI 10.1016/j.toxicon.2007.12.011; Beckham SA, 2009, J BIOL CHEM, V284, P34413, DOI 10.1074/jbc.M109.061911; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOK I, 1995, J CLIN MICROBIOL, V33, P2139, DOI 10.1128/JCM.33.8.2139-2140.1995; Chalaire KC, 2011, J EXP BIOL, V214, P665, DOI 10.1242/jeb.052076; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Chmelar J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-233; Clucas DB, 2008, B WORLD HEALTH ORGAN, V86, P275, DOI 10.2471/BLT.07.043034; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; CROSSLEY LG, 1980, BIOCHEM J, V191, P173, DOI 10.1042/bj1910173; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Fischer K, 2003, AM J TROP MED HYG, V68, P61, DOI 10.4269/ajtmh.2003.68.1.0680061; Fischer K, 2009, J MOL BIOL, V390, P635, DOI 10.1016/j.jmb.2009.04.082; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; Francischetti IMB, 2008, INSECT BIOCHEM MOLEC, V38, P1, DOI 10.1016/j.ibmb.2007.09.009; Francischetti IMB, 2011, J PROTEOMICS, V74, P2892, DOI 10.1016/j.jprot.2011.07.015; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti IMB, 2008, J PROTEOMICS, V71, P493, DOI 10.1016/j.jprot.2008.07.006; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Hengge UR, 2006, LANCET INFECT DIS, V6, P769, DOI 10.1016/S1473-3099(06)70654-5; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Higgins WJ, 2010, J BIOL CHEM, V285, P3722, DOI 10.1074/jbc.M109.037358; Holt DC, 2003, J INVEST DERMATOL, V121, P1419, DOI 10.1046/j.1523-1747.2003.12621.x; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Kerr FK, 2008, MOL IMMUNOL, V45, P670, DOI 10.1016/j.molimm.2007.07.008; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LAWRENCE DA, 1994, J BIOL CHEM, V269, P27657; Lawrie CH, 2005, MOL IMMUNOL, V42, P31, DOI 10.1016/j.molimm.2004.07.001; Levi A, 2011, LASER MED SCI, V26, P291, DOI 10.1007/s10103-011-0894-1; Manderson GA, 2009, MOL IMMUNOL, V46, P3388, DOI 10.1016/j.molimm.2009.07.011; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; Mika A, 2011, PLOS NEGL T IN PRESS; Mika A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001331; Mounsey KE, 2008, FUTURE MICROBIOL, V3, P57, DOI 10.2217/17460913.3.1.57; Mulenga A, 2003, INSECT BIOCHEM MOLEC, V33, P267, DOI 10.1016/S0965-1748(02)00240-0; Mulenga A, 2001, J VET MED SCI, V63, P1063, DOI 10.1292/jvms.63.1063; Mulenga A, 2001, INSECT BIOCHEM MOLEC, V31, P817, DOI 10.1016/S0965-1748(00)00187-9; Mulenga A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-217; Nene V, 2004, INSECT BIOCHEM MOLEC, V34, P1117, DOI 10.1016/j.ibmb.2004.07.002; Nene V, 2002, INT J PARASITOL, V32, P1447, DOI 10.1016/S0020-7519(02)00159-5; Nicholson William L., 2009, P493; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Parola P, 2006, CLIN DERMATOL, V24, P191, DOI 10.1016/j.clindermatol.2005.11.007; Rapp CM, 2006, J MED ENTOMOL, V43, P539, DOI 10.1603/0022-2585(2006)43[539:POHIIT]2.0.CO;2; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Schroeder H, 2009, DEV COMP IMMUNOL, V33, P5, DOI 10.1016/j.dci.2008.07.010; Schroeder H, 2007, MICROBES INFECT, V9, P247, DOI 10.1016/j.micinf.2006.10.020; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Skelly PJ, 2004, TRENDS PARASITOL, V20, P370, DOI 10.1016/j.pt.2004.05.007; Steen NA, 2006, TOXICON, V47, P1, DOI 10.1016/j.toxicon.2005.09.010; STEWART GA, 1992, IMMUNOLOGY, V75, P29; Sugino M, 2003, VACCINE, V21, P2844, DOI 10.1016/S0264-410X(03)00167-1; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Tyson KR, 2008, J IMMUNOL, V180, P3964, DOI 10.4049/jimmunol.180.6.3964; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Willis C, 2006, AM J TROP MED HYG, V75, P683, DOI 10.4269/ajtmh.2006.75.683; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149	79	52	52	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40489	10.1371/journal.pone.0040489	http://dx.doi.org/10.1371/journal.pone.0040489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792350	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400062
J	Wang, B; Tan, YX; Jia, J; Digre, A; Zhang, X; Vlodavsky, I; Li, JP				Wang, Bo; Tan, Ying-xia; Jia, Juan; Digre, Andreas; Zhang, Xiao; Vlodavsky, Israel; Li, Jin-ping			Accelerated Resolution of AA Amyloid in Heparanase Knockout Mice Is Associated with Matrix Metalloproteases	PLOS ONE			English	Article							UP-REGULATION; PROTEIN; MATRIX-METALLOPROTEINASE-9; SULFATE	AA-amyloidosis is a disease characterized by abnormal deposition of serum A amyloid (SAA) peptide along with other components in various organs. The disease is a complication of inflammatory conditions that cause persistent high levels of the acute phase reactant SAA in plasma. In experimental animal models, the deposited amyloid is resolved when the inflammation is stopped, suggesting that there is an efficient clearance mechanism for the amyloid. As heparan sulfate (HS) is one of the major components in the amyloid, its metabolism is expected to affect the pathology of AA amyloidosis. In this study, we investigated the effect of heparanase, a HS degradation enzyme, in resolution of the AA amyloid. The transgenic mice deficient in heparanase (Hpa-KO) produced a similar level of SAA in plasma as the wildtype control (Ctr) mice upon induction by injection of AEF (amyloid enhancing factor) and inflammatory stimuli. The induction resulted in formation of SAA amyloid 7-days post treatment in the spleen that displayed a comparable degree of amyloid load in both groups. The amyloid became significantly less in the Hpa-KO spleen than in the Ctr spleen 10-days post treatment, and was completely resolved in the Hpa-KO spleen on day 21 post induction, while a substantial amount was still detected in the Ctr spleen. The rapid clearance of the amyloid in the Hpa-KO mice can be ascribed to upregulated matrix metalloproteases (MMPs) that are believed to contribute to degradation of the protein components in the AA amyloid. The results indicate that both heparanase and MMPs play important parts in the pathological process of AA amyloidosis.	[Wang, Bo; Tan, Ying-xia; Jia, Juan; Digre, Andreas; Li, Jin-ping] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Uppsala University; Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Wang, B (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	jin-pingli@imbim.uu.se			Swedish Science Council [K2009-67X-21128-01-3]; Swedish Cancer Foundation [090717]; Polysackaridforskning Foundation (Uppsala)	Swedish Science Council; Swedish Cancer Foundation; Polysackaridforskning Foundation (Uppsala)	This study is supported by the Swedish Science Council (K2009-67X-21128-01-3), Swedish Cancer Foundation (090717) and Polysackaridforskning Foundation (Uppsala). The funders had no role in data collection and analysis or preparation of the manuscript but they did have a role in design of the project and final decision to publish.	Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; AXELRAD MA, 1982, LAB INVEST, V47, P139; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Kisilevsky Robert, 2004, V299, P237; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Migita K, 1998, LAB INVEST, V78, P535; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sousa MM, 2004, FASEB J, V18, P124, DOI 10.1096/fj.04-2022fje; Stix B, 2001, AM J PATHOL, V159, P561, DOI 10.1016/S0002-9440(10)61727-0; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zitka O, 2010, CURR MED CHEM, V17, P3751, DOI 10.2174/092986710793213724	16	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39899	10.1371/journal.pone.0039899	http://dx.doi.org/10.1371/journal.pone.0039899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808071	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500015
J	Li, J; Sun, YA; Ye, JH				Li, Jing; Sun, Yanan; Ye, Jiang-Hong			Electroacupuncture Decreases Excessive Alcohol Consumption Involving Reduction of FosB/Delta FosB Levels in Reward-Related Brain Regions	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; RANDOMIZED-CONTROLLED-TRIAL; RECEPTOR AGONIST U50,488H; VOLUNTARY ETHANOL INTAKE; MESSENGER-RNA CONTENT; DELTA-FOSB; COGNITIVE DYSFUNCTION; PREFRONTAL CORTEX; DRUG-ADDICTION; GABAERGIC TAIL	New therapies are needed for alcohol abuse, a major public health problem in the U.S. and worldwide. There are only three FDA-approved drugs for treatment of alcohol abuse (naltrexone, acamprosate and disulfuram). On average these drugs yield only moderate success in reducing long-term alcohol consumption. Electroacupuncture has been shown to alleviate various drugs of abuse, including alcohol. Although previous studies have shown that electroacupuncture reduced alcohol consumption, the underlying mechanisms have not been fully elucidated. Delta FosB and FosB are members of the Fos family of transcription factors implicated in neural plasticity in drug addiction; a connection between electroacupuncture's treatment of alcohol abuse and the Fos family has not been established. In this study, we trained rats to drink large quantities of ethanol in a modified intermittent access two-bottle choice drinking procedure. When rats achieved a stable baseline of ethanol consumption, electroacupuncture (100 Hz or 2 Hz, 30 min each day) was administered at Zusanli (ST36) for 6 consecutive days. The level of FosB/Delta FosB in reward-related brain regions was assessed by immunohistochemistry. We found that the intake of and preference for ethanol in rats under 100 Hz, but not 2 Hz electroacupuncture regiment were sharply reduced. The reduction was maintained for at least 72 hours after the termination of electroacupuncture treatment. Conversely, 100 Hz electroacupuncture did not alter the intake of and preference for the natural rewarding agent sucrose. Additionally, FosB/Delta FosB levels in the prefrontal cortex, striatal region and the posterior region of ventral tegmental area were increased following excessive ethanol consumption, but were reduced after six-day 100 Hz electroacupuncture. Thus, this study demonstrates that six-day 100 Hz electroacupuncture treatment effectively reduces ethanol consumption and preference in rats that chronically drink excessive amount of ethanol. This effect of electroacupuncture may be mediated by down-regulation of FosB/Delta FosB in reward-related brain regions.	[Li, Jing; Ye, Jiang-Hong] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol Pharmacol & Physiol, Newark, NJ 07103 USA; [Sun, Yanan] Beijing Univ Chinese Med, Dong Zhi Men Hosp, Dept Neurol, Key Lab Internal Chinese Med,Minist Educ, Beijing, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Beijing University of Chinese Medicine	Li, J (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol Pharmacol & Physiol, 185 S Orange Ave, Newark, NJ 07103 USA.	ye@umdnj.edu			National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [AA016964, AA016618]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016964, R21AA016618] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [Grants AA016964 and AA016618]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Chen G, 2011, ALCOHOL CLIN EXP RES, V35, P1739, DOI 10.1111/j.1530-0277.2011.01520.x; Cui CL, 2008, NEUROCHEM RES, V33, P2013, DOI 10.1007/s11064-008-9784-8; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fadda P, 1999, ALCOHOL CLIN EXP RES, V23, P1296, DOI 10.1097/00000374-199908000-00002; Ford CP, 2007, J NEUROPHYSIOL, V97, P883, DOI 10.1152/jn.00963.2006; Han Jisheng, 2011, Front Med, V5, P141, DOI 10.1007/s11684-011-0136-8; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jindal V, 2008, J PEDIAT HEMATOL ONC, V30, P431, DOI 10.1097/MPH.0b013e318165b2cc; Karst M, 2002, ADDICT BIOL, V7, P415, DOI 10.1080/1355621021000006017; Kaufling J, 2010, BRIT J PHARMACOL, V161, P1677, DOI 10.1111/j.1476-5381.2010.00984.x; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kim YH, 2005, J ADDICT DIS, V24, P115, DOI 10.1300/J069v24n04_09; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kunz S, 2007, ALCOHOL CLIN EXP RES, V31, P436, DOI 10.1111/j.1530-0277.2006.00333.x; Li J, 2010, ALCOHOL CLIN EXP RES, V34; Li J, 2012, J PHARMACOL EXP THER, V341, P196, DOI 10.1124/jpet.111.190058; Li J, 2011, BRAIN RES BULL, V86, P428, DOI 10.1016/j.brainresbull.2011.08.013; Li J, 2011, ADDICT BIOL, V16, P600, DOI 10.1111/j.1369-1600.2011.00344.x; Lindholm S, 2001, BEHAV BRAIN RES, V120, P137, DOI 10.1016/S0166-4328(00)00368-5; Logrip ML, 2008, FASEB J, V22, P2393, DOI 10.1096/fj.07-099135; Logrip ML, 2009, ALCOHOL, V43, P359, DOI 10.1016/j.alcohol.2009.05.001; LU GW, 1983, AM J PHYSIOL, V245, pR606, DOI 10.1152/ajpregu.1983.245.4.R606; Mann K, 2004, ALCOHOL CLIN EXP RES, V28, P51, DOI 10.1097/01.ALC.0000108656.81563.05; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Marinelli PW, 2000, LIFE SCI, V66, P1915, DOI 10.1016/S0024-3205(00)00517-8; Meyers Robert J, 2003, Recent Dev Alcohol, V16, P183; Mitchell JM, 2005, PSYCHOPHARMACOLOGY, V182, P384, DOI 10.1007/s00213-005-0067-7; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nielsen CK, 2008, BIOL PSYCHIAT, V64, P974, DOI 10.1016/j.biopsych.2008.07.018; Overstreet DH, 2008, NEUROCHEM RES, V33, P2166, DOI 10.1007/s11064-008-9791-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; POKLIS A, 1982, CLIN CHEM, V28, P2125; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Shi XD, 2004, MOL BRAIN RES, V130, P124, DOI 10.1016/j.molbrainres.2004.07.016; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Stux G., 1987, ACUPUNCTURE TXB ATLA, V1st ed; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wang GB, 2011, PEPTIDES, V32, P713, DOI 10.1016/j.peptides.2010.12.006; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Winkler A, 1998, NEUROREPORT, V9, P1459, DOI 10.1097/00001756-199805110-00039; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Winstanley CA, 2009, PHARMACOL BIOCHEM BE, V93, P278, DOI 10.1016/j.pbb.2008.12.007; Wu LZ, 1999, BRAIN RES, V851, P290, DOI 10.1016/S0006-8993(99)02069-7; Xuei X, 2006, MOL PSYCHIATR, V11, P1016, DOI 10.1038/sj.mp.4001882; Yang CH, 2002, PHARMACOL BIOCHEM BE, V72, P847, DOI 10.1016/S0091-3057(02)00769-4; Yang CH, 2010, ALCOHOL CLIN EXP RES, V34, P2137, DOI 10.1111/j.1530-0277.2010.01310.x; Yoon SS, 2012, PSYCHOPHARMACOLOGY B; Yoshimoto K, 2001, ALCOHOL CLIN EXP RES, V25, p63S; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zhao RJ, 2006, NEUROSCI LETT, V395, P28, DOI 10.1016/j.neulet.2005.10.043	58	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40347	10.1371/journal.pone.0040347	http://dx.doi.org/10.1371/journal.pone.0040347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792289	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700037
J	Pulgarin-R, PC; Burg, TM				Pulgarin-R, Paulo C.; Burg, Theresa M.			Genetic Signals of Demographic Expansion in Downy Woodpecker (Picoides pubescens) after the Last North American Glacial Maximum	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; PHYLOGEOGRAPHIC STRUCTURE; CONTRASTING PATTERNS; ICE AGES; DIVERGENCE; FLOW; MICROSATELLITES; COALESCENT; SPECIATION	The glacial cycles of the Pleistocene have been recognized as important, large-scale historical processes that strongly influenced the demographic patterns and genetic structure of many species. Here we present evidence of a postglacial expansion for the Downy Woodpecker (Picoides pubescens), a common member of the forest bird communities in North America with a continental distribution. DNA sequences from the mitochondrial tRNA-Lys, and ATPase 6 and 8 genes, and microsatellite data from seven variable loci were combined with a species distribution model (SDM) to infer possible historical scenarios for this species after the last glacial maximum. Analyses of Downy Woodpeckers from 23 geographic areas suggested little differentiation, shallow genealogical relationships, and limited population structure across the species' range. Microsatellites, which have higher resolution and are able to detect recent differences, revealed two geographic groups where populations along the eastern edge of the Rocky Mountains (Montana, Utah, Colorado, and southern Alberta) were genetically isolated from the rest of the sampled populations. Mitochondrial DNA, an important marker to detect historical patterns, recovered only one group. However, populations in Idaho and southeast BC contained high haplotype diversity and, in general were characterized by the absence of the most common mtDNA haplotype. The SDM suggested several areas in the southern US as containing suitable Downy Woodpecker habitat during the LGM. The lack of considerable geographic structure and the starburst haplotype network, combined with several population genetic tests, suggest a scenario of demographic expansion during the last part of Pleistocene and early Holocene.	[Pulgarin-R, Paulo C.; Burg, Theresa M.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Pulgarin-R, PC (corresponding author), Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia.	pc.pulgarin51@uniandes.edu.co			NSERC; Alberta Innovates Tech Futures-New Scholars Award	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Tech Futures-New Scholars Award	Funding was provided by NSERC Discovery Grant (http://www.nserc-crsng.gc.ca/), and Alberta Innovates Tech Futures-New Scholars Award (http://www.albertatechfutures.ca/), both to Theresa M. Burg. There is no specific grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; BALL RM, 1988, P NATL ACAD SCI USA, V85, P1558, DOI 10.1073/pnas.85.5.1558; BALL RM, 1992, AUK, V109, P626; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barrowclough GF, 2004, MOL ECOL, V13, P1911, DOI 10.1111/j.1365-294X.2004.02215.x; Beadell JS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000636; Belkhir K, 1996, GENETIX V4 02 LOGICI; Brito PH, 2007, MOL ECOL, V16, P3423, DOI 10.1111/j.1365-294X.2007.03401.x; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; BROWNING MR, 1995, J FIELD ORNITHOL, V66, P12; Browning RM, 1997, ERA AR PHILLIPS FEST, P25; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Burg TM, 2006, MOL ECOL, V15, P2409, DOI 10.1111/j.1365-294X.2006.02957.x; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Carstens BC, 2005, MOL ECOL, V14, P255, DOI 10.1111/j.1365-294X.2004.02404.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drovetski SV, 2004, P ROY SOC B-BIOL SCI, V271, P545, DOI 10.1098/rspb.2003.2638; Edwards SV, 2000, EVOLUTION, V54, P1839; Ellegren H, 1999, HEREDITAS, V130, P291, DOI 10.1111/j.1601-5223.1999.00291.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Graham BA, 2012, J AVIAN BIOL, V43, P198, DOI 10.1111/j.1600-048X.2012.05604.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jackson J. A, 2002, BIRDS N AM; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; KIMURA M, 1964, GENETICS, V49, P561; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Klicka J, 1999, P ROY SOC B-BIOL SCI, V266, P695, DOI 10.1098/rspb.1999.0691; Knopp T, 2009, HEREDITY, V102, P174, DOI 10.1038/hdy.2008.91; Larsson LC, 2009, CONSERV GENET, V10, P1255, DOI 10.1007/s10592-008-9693-z; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Manthey JD, 2011, MOL PHYLOGENET EVOL, V58, P502, DOI 10.1016/j.ympev.2010.12.003; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Nei M, 1987, MOL EVOLUTIONARY GEN; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Ouellet H.R, 1977, THESIS MCGILL U; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pereira SL, 2008, GENET MOL BIOL, V31, P964, DOI 10.1590/S1415-47572008005000021; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIELOU EC, 1991, ICE AGE RETURN LIFE; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Runck AM, 2005, MOL ECOL, V14, P1445, DOI 10.1111/j.1365-294X.2005.02501.x; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; Scribner KT, 2003, AUK, V120, P889, DOI 10.1642/0004-8038(2003)120[0889:POCGBC]2.0.CO;2; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SLATKIN M, 1991, GENETICS, V129, P555; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Stenzler LM, 2009, CONDOR, V111, P470, DOI 10.1525/cond.2009.080052; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Swenson NG, 2004, EVOLUTION, V58, P2391; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valimaki K, 2008, MOL ECOL RESOUR, V8, P1152, DOI 10.1111/j.1755-0998.2008.02209.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila M, 2008, MOL ECOL RESOUR, V8, P415, DOI 10.1111/j.1471-8286.2007.01976.x; Walstrom VW, 2012, MOL ECOL, V21, P907, DOI 10.1111/j.1365-294X.2011.05384.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Zink Robert M., 1997, P301, DOI 10.1016/B978-012498315-1/50017-0	83	32	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40412	10.1371/journal.pone.0040412	http://dx.doi.org/10.1371/journal.pone.0040412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792306	Green Submitted, gold, Green Published			2022-12-25	WOS:000306354700043
J	Hamad, EA; Zhu, WZ; Chan, TO; Myers, V; Gao, E; Li, X; Zhang, J; Song, JL; Zhang, XQ; Cheung, JY; Koch, W; Feldman, AM				Hamad, Eman A.; Zhu, Weizhong; Chan, Tung O.; Myers, Valerie; Gao, Erhe; Li, Xue; Zhang, Jin; Song, Jianliang; Zhang, Xue-Qian; Cheung, Joseph Y.; Koch, Walter; Feldman, Arthur M.			Cardioprotection of Controlled and Cardiac-Specific Over-Expression of A(2A)-Adenosine Receptor in the Pressure Overload	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTOR; HEART-FAILURE; RESTRICTED OVEREXPRESSION; CARDIOMYOCYTE HYPERTROPHY; CONTRACTILE PERFORMANCE; A(1)-ADENOSINE RECEPTOR; MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES; REPERFUSION INJURY; IN-VITRO	Adenosine binds to three G protein-coupled receptors (R) located on the cardiomyocyte (A(1)-R, A(2A)-R and A(3)-R) and provides cardiac protection during both ischemic and load-induced stress. While the role of adenosine receptor-subtypes has been well defined in the setting of ischemia-reperfusion, far less is known regarding their roles in protecting the heart during other forms of cardiac stress. Because of its ability to increase cardiac contractility and heart rate, we hypothesized that enhanced signaling through A(2A)-R would protect the heart during the stress of transverse aortic constriction (TAC). Using a cardiac-specific and inducible promoter, we selectively over-expressed A(2A)-R in FVB mice. Echocardiograms were obtained at baseline, 2, 4, 8, 12, 14 weeks and hearts were harvested at 14 weeks, when WT mice developed a significant decrease in cardiac function, an increase in end systolic and diastolic dimensions, a higher heart weight to body weight ratio (HW/BW), and marked fibrosis when compared with sham-operated WT. More importantly, these changes were significantly attenuated by over expression of the A(2A)-R. Furthermore, WT mice also demonstrated marked increases in the hypertrophic genes beta-myosin heavy chain (beta-MHC), and atrial natriuretic factor (ANF) - changes that are mediated by activation of the transcription factor GATA-4. Levels of the mRNAs encoding beta-MHC, ANP, and GATA-4 were significantly lower in myocardium from A(2A)-R TG mice after TAC when compared with WT and sham-operated controls. In addition, three inflammatory factors genes encoding cysteine dioxygenase, complement component 3, and serine peptidase inhibitor, member 3N, were enhanced in WT TAC mice, but their expression was suppressed in A(2A)-R TG mice. A(2A)-R over-expression is protective against pressure-induced heart failure secondary to TAC. These cardioprotective effects are associated with attenuation of GATA-4 expression and inflammatory factors. The A(2A)-R may provide a novel new target for pharmacologic therapy in patients with cardiovascular disease.	[Hamad, Eman A.; Zhu, Weizhong; Myers, Valerie; Gao, Erhe; Song, Jianliang; Zhang, Xue-Qian; Cheung, Joseph Y.; Koch, Walter; Feldman, Arthur M.] Temple Univ, Sch Med, Cardiovasc Res Ctr, Dept Physiol, Philadelphia, PA 19122 USA; [Hamad, Eman A.; Chan, Tung O.; Li, Xue; Zhang, Jin] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University	Hamad, EA (corresponding author), Temple Univ, Sch Med, Cardiovasc Res Ctr, Dept Physiol, Philadelphia, PA 19122 USA.	Weizhong.Zhu@Temple.edu; Arthur.Feldman@Temple.edu		hamad, abdullah/0000-0003-4677-7686; Chan, Tung/0000-0001-6574-9555	NIH [R37 HL061690, R01 HL56205, P01 HL091799]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061690, P01HL091799, R01HL056205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported in part by NIH grants R37 HL061690 and R01 HL56205 (WJK), P01 HL091799 (WJK and AMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan TO, 2008, CTS-CLIN TRANSL SCI, V1, P126, DOI 10.1111/j.1752-8062.2008.00027.x; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chung ES, 1998, J HYPERTENS, V16, P1813, DOI 10.1097/00004872-199816120-00015; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Diedrichs H, 2004, EUR J HEART FAIL, V6, P3, DOI 10.1016/j.ejheart.2003.07.007; Dobson JG, 1997, CARDIOVASC RES, V34, P337, DOI 10.1016/S0008-6363(97)00023-0; DORN GW, 1994, AM J PHYSIOL, V267, pH400, DOI 10.1152/ajpheart.1994.267.1.H400; Dubey RK, 1997, CIRCULATION, V96, P2656, DOI 10.1161/01.CIR.96.8.2656; Fiser SM, 2002, J THORAC CARDIOV SUR, V124, P973, DOI 10.1067/mtc.2002.124886; Funakoshi H, 2007, CIRCULATION, V115, P2307, DOI 10.1161/CIRCULATIONAHA.107.694596; Funakoshi H, 2006, CIRCULATION, V114, P2240, DOI 10.1161/CIRCULATIONAHA.106.620211; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Gan XHT, 2005, J PHARMACOL EXP THER, V312, P27, DOI 10.1124/jpet.104.073122; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; GROSSMAN W, 1974, CIRC RES, V35, P793, DOI 10.1161/01.RES.35.5.793; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; Hamad EA, 2010, AM J PHYSIOL-HEART C, V298, pH1738, DOI 10.1152/ajpheart.00688.2009; Harada K, 1999, CIRCULATION, V100, P2093, DOI 10.1161/01.CIR.100.20.2093; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Headrick JP, 2003, AM J PHYSIOL-HEART C, V285, pH1797, DOI 10.1152/ajpheart.00407.2003; Headrick JP, 2003, J PHYSIOL-LONDON, V549, P823, DOI 10.1113/jphysiol.2003.041541; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; HOLUBARSCH C, 1985, BASIC RES CARDIOL, V80, P582, DOI 10.1007/BF01907857; HOLUBARSCH C, 1985, CIRC RES, V56, P78, DOI 10.1161/01.RES.56.1.78; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Impellizzeri D, 2011, EUR J PHARMACOL, V668, P305, DOI 10.1016/j.ejphar.2011.06.049; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liao YL, 2003, CIRC RES, V93, P759, DOI 10.1161/01.RES.0000094744.88220.62; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZB, 2008, CIRCULATION, V118, P1713, DOI 10.1161/CIRCULATIONAHA.108.788307; McPherson JA, 2001, ARTERIOSCL THROM VAS, V21, P791, DOI 10.1161/01.ATV.21.5.791; Modesti PA, 2002, J MOL CELL CARDIOL, V34, P1491, DOI 10.1006/jmcc.2002.2095; Morimoto T, 2001, J BIOL CHEM, V276, P34983, DOI 10.1074/jbc.M005498200; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Nagai T, 2011, HYPERTENSION, V57, P208, DOI 10.1161/HYPERTENSIONAHA.110.158915; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404, DOI 10.1152/ajprenal.1999.277.3.F404; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; Safran N, 2001, MOL CELL BIOCHEM, V217, P143, DOI 10.1023/A:1007209321969; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Todd J, 1996, ANN THORAC SURG, V62, P1364, DOI 10.1016/0003-4975(96)00495-X; Vinten-Johansen J, 1999, ANN THORAC SURG, V68, P1942, DOI 10.1016/S0003-4975(99)01018-8; Wagner DR, 1998, CIRCULATION, V97, P521; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5; Xu X, 2008, HYPERTENSION, V51, P1557, DOI 10.1161/HYPERTENSIONAHA.108.110833; Yan XH, 2008, AM J PHYSIOL-HEART C, V294, pH1274, DOI 10.1152/ajpheart.00174.2006; Yang DC, 2010, MOL MED REP, V3, P497, DOI 10.3892/mmr_00000287	54	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39919	10.1371/journal.pone.0039919	http://dx.doi.org/10.1371/journal.pone.0039919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792196	gold, Green Submitted, Green Published			2022-12-25	WOS:000306461800025
J	Lapchak, PH; Ioannou, A; Rani, P; Lieberman, LA; Yoshiya, K; Kannan, L; Lucca, JJD; Kowalska, MA; Tsokos, GC				Lapchak, Peter H.; Ioannou, Antonis; Rani, Poonam; Lieberman, Linda A.; Yoshiya, Kazuhisa; Kannan, Lakshmi; Lucca, Jurandir J. Dalle; Kowalska, M. Anna; Tsokos, George C.			The Role of Platelet Factor 4 in Local and Remote Tissue Damage in a Mouse Model of Mesenteric Ischemia/Reperfusion Injury	PLOS ONE			English	Article							CXC-CHEMOKINE PLATELET-FACTOR-4; INFLAMMATORY-BOWEL-DISEASE; HUMAN PLATELET FACTOR-4; ISCHEMIA-REPERFUSION; HUMAN MONOCYTES; FACTOR-IV; MICE; CELLS; ATHEROSCLEROSIS; DIFFERENTIATION	The robust inflammatory response that occurs during ischemia reperfusion (IR) injury recruits factors from both the innate and adaptive immune systems. However the contribution of platelets and their products such as Platelet Factor 4 (PF4; CXCL4), during the pathogenesis of IR injury has not been thoroughly investigated. We show that a deficiency in PF4 protects mice from local and remote tissue damage after 30 minutes of mesenteric ischemia and 3 hours of reperfusion in PF4-/- mice compared to control B6 mice. This protection was independent from Ig or complement deposition in the tissues. However, neutrophil and monocyte infiltration were decreased in the lungs of PF4-/- mice compared with B6 control mice. Platelet-depleted B6 mice transfused with platelets from PF4-/- mice displayed reduced tissue damage compared with controls. In contrast, transfusion of B6 platelets into platelet depleted PF4-/- mice reconstituted damage in both intestine and lung tissues. We also show that PF4 may modulate the release of IgA. Interestingly, we show that PF4 expression on intestinal epithelial cells is increased after IR at both the mRNA and protein levels. In conclusion, these findings demonstrate that may PF4 represent an important mediator of local and remote tissue damage.	[Lapchak, Peter H.; Ioannou, Antonis; Rani, Poonam; Lieberman, Linda A.; Yoshiya, Kazuhisa; Kannan, Lakshmi; Tsokos, George C.] Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA; [Lapchak, Peter H.; Ioannou, Antonis; Rani, Poonam; Lieberman, Linda A.; Yoshiya, Kazuhisa; Kannan, Lakshmi; Tsokos, George C.] Harvard Univ, Sch Med, Boston, MA USA; [Kowalska, M. Anna] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Lucca, Jurandir J. Dalle] USA, Inst Surg Res, San Antonio, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lapchak, PH (corresponding author), Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA.	aioannou@bicmc.harvard.edu; gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Lapchak, Peter H./B-3559-2009	tsokos, george C/0000-0001-9589-2360; Ioannou, Antonis/0000-0003-0064-5004; Lapchak, Peter/0000-0001-8597-088X	Medical Research and Material Command of the Department of the Army [W81XWH-09-1-0530, W81XWH-09-1-0536]	Medical Research and Material Command of the Department of the Army	The research presented herein was supported by Grant numbers W81XWH-09-1-0530 and W81XWH-09-1-0536 from Medical Research and Material Command of the Department of the Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin WM, 2010, CURR OPIN ORGAN TRAN; BEBAWY ST, 1986, J LEUKOCYTE BIOL, V39, P423, DOI 10.1002/jlb.39.4.423; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Chen J, 2009, J AUTOIMMUN, V32, P195, DOI 10.1016/j.jaut.2009.02.021; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Collins CE, 1997, ALIMENT PHARM THER, V11, P237, DOI 10.1046/j.1365-2036.1997.153328000.x; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; Ferroni Patrizia, 2003, Current Vascular Pharmacology, V1, P157, DOI 10.2174/1570161033476772; Fricke I, 2004, FASEB J, V18, P1588, DOI 10.1096/fj.03-1435fje; Fujimi S, 2006, BLOOD, V107, P4399, DOI 10.1182/blood-2005-09-3776; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Gushiken FC, 2009, J THROMB HAEMOST, V7, P865, DOI 10.1111/j.1538-7836.2009.03334.x; Han ZC, 1997, BLOOD, V89, P2328, DOI 10.1182/blood.V89.7.2328; HERMODSON M, 1977, J BIOL CHEM, V252, P6276; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Ioannou A, 2011, CLIN IMMUNOL, V141, P3, DOI 10.1016/j.clim.2011.07.001; Johansson C, 2005, CLIN EXP IMMUNOL, V141, P279, DOI 10.1111/j.1365-2249.2005.02843.x; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Lapchak PH, 2012, AM J PHYSIOL-GASTR L, V302, pG888, DOI 10.1152/ajpgi.00499.2011; Lasagni L, 2007, BLOOD, V109, P4127, DOI 10.1182/blood-2006-10-052035; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Matthijsen RA, 2007, AM J PATHOL, V171, P1743, DOI 10.2353/ajpath.2007.070184; Padilla ND, 2007, SURGERY, V142, P722, DOI 10.1016/j.surg.2007.05.015; Pervushina O, 2004, J IMMUNOL, V173, P2060, DOI 10.4049/jimmunol.173.3.2060; Petersen F, 1996, J IMMUNOL, V156, P1954; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schmitt-Sody M, 2007, SCAND J RHEUMATOL, V36, P311, DOI 10.1080/03009740701218741; Shenkman B, 2004, J THROMB HAEMOST, V2, P154, DOI 10.1111/j.1538-7836.2004.00527.x; Snoeck V, 2006, VET RES, V37, P455, DOI 10.1051/vetres:2006010; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; WALZ DA, 1977, THROMB RES, V11, P893, DOI 10.1016/0049-3848(77)90117-7; WATSON JB, 1994, J CLIN INVEST, V94, P261, DOI 10.1172/JCI117316; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Xia CQ, 2003, INT IMMUNOL, V15, P1007, DOI 10.1093/intimm/dxg100; Yoshida H, 2009, INFLAMM BOWEL DIS, V15, P1245, DOI 10.1002/ibd.20896; Yoshiya K, 2011, AM J PHYSIOL-GASTR L, V301, pG1020, DOI 10.1152/ajpgi.00239.2011; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2007, MOL IMMUNOL, V44, P103, DOI 10.1016/j.molimm.2006.06.022	51	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39934	10.1371/journal.pone.0039934	http://dx.doi.org/10.1371/journal.pone.0039934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792197	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800026
J	Chatterjee, A; Ghosh, SK; Adak, A; Singh, AK; Devara, PCS; Raha, S				Chatterjee, Abhijit; Ghosh, Sanjay K.; Adak, Anandamay; Singh, Ajay K.; Devara, Panuganti C. S.; Raha, Sibaji			Effect of Dust and Anthropogenic Aerosols on Columnar Aerosol Optical Properties over Darjeeling (2200 m asl), Eastern Himalayas, India	PLOS ONE			English	Article							VARIABILITY; ATHENS	Background: The loading of atmospheric particulate matter (aerosol) in the eastern Himalaya is mainly regulated by the locally generated anthropogenic aerosols from the biomass burning and by the aerosols transported from the distance sources. These different types of aerosol loading not only affect the aerosol chemistry but also produce consequent signature on the radiative properties of aerosol. Methodology/Principal Findings: An extensive study has been made to study the seasonal variations in aerosol components of fine and coarse mode aerosols and black carbon along with the simultaneous measurements of aerosol optical depth on clear sky days over Darjeeling, a high altitude station (2200 masl) at eastern Himalayas during the year 2008. We observed a heavy loading of fine mode dust component (Ca2+) during pre-monsoon (Apr - May) which was higher by 162% than its annual mean whereas during winter (Dec - Feb), the loading of anthropogenic aerosol components mainly from biomass burning (fine mode SO42- and black carbon) were higher (76% for black carbon and 96% for fine mode SO42-) from their annual means. These high increases in dust aerosols during pre-monsoon and anthropogenic aerosols during winter enhanced the aerosol optical depth by 25 and 40%, respectively. We observed that for every 1% increase in anthropogenic aerosols, AOD increased by 0.55% during winter whereas for every 1% increase in dust aerosols, AOD increased by 0.46% during pre-monsoon. Conclusion/Significance: The natural dust transport process (during pre-monsoon) plays as important a role in the radiation effects as the anthropogenic biomass burning (during winter) and their differential effects (rate of increase of the AOD with that of the aerosol concentration) are also very similar. This should be taken into account in proper modeling of the atmospheric environment over eastern Himalayas.	[Chatterjee, Abhijit; Adak, Anandamay; Raha, Sibaji] Bose Inst, Environm Sci Sect, Kolkata, India; [Chatterjee, Abhijit; Ghosh, Sanjay K.; Singh, Ajay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Darjeeling, India; [Chatterjee, Abhijit; Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Kolkata, India; [Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Dept Phys, Kolkata, India; [Devara, Panuganti C. S.] Indian Inst Trop Meteorol, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM)	Chatterjee, A (corresponding author), Bose Inst, Environm Sci Sect, Kolkata, India.	sibajiraha@bic.boseinst.ernet.in	Singh, Ajay/AAF-4414-2020		Science and Engineering Research Council, Department of Science and Technology, Government of India under the Intensification of Research in High Priority Areas (IRHPA) scheme [IR/S2/PF-01/2003]	Science and Engineering Research Council, Department of Science and Technology, Government of India under the Intensification of Research in High Priority Areas (IRHPA) scheme	This study was supported through a grant (No. IR/S2/PF-01/2003) of the Science and Engineering Research Council, Department of Science and Technology, Government of India under the Intensification of Research in High Priority Areas (IRHPA) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu SS, 2007, ANN GEOPHYS, V25, P2209; Beegum SN, 2009, J ATMOS SOL-TERR PHY, V71, P1846, DOI 10.1016/j.jastp.2009.07.004; Carrico CM, 2003, ATMOS ENVIRON, V37, P2811, DOI 10.1016/S1352-2310(03)00197-3; Chatterjee A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011122; Decesari S, 2009, ATMOS CHEM PHYS DISC, V9, P25487, DOI DOI 10.5194/ACPD-9-25487-2009; Eck TF, 1999, J GEOPHYS RES-ATMOS, V104, P31333, DOI 10.1029/1999JD900923; Gautam R, 2011, ATMOS CHEM PHYS, V11, P12841, DOI 10.5194/acp-11-12841-2011; Gautam R, 2009, ANN GEOPHYS-GERMANY, V27, P3691, DOI 10.5194/angeo-27-3691-2009; Gautam R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037641; Habib G, 2006, ATMOS ENVIRON, V40, P1909, DOI 10.1016/j.atmosenv.2005.07.077; Hess M, 1998, B AM METEOROL SOC, V79, P831, DOI 10.1175/1520-0477(1998)079<0831:OPOAAC>2.0.CO;2; Kaskaoutis DG, 2006, J ATMOS SOL-TERR PHY, V68, P2147, DOI 10.1016/j.jastp.2006.07.008; Kaskaoutis DG, 2006, ATMOS RES, V79, P67, DOI 10.1016/j.atmosres.2005.05.001; LI Y, 1993, REMOTE SENS ENVIRON, V44, P81, DOI 10.1016/0034-4257(93)90104-6; MAYEWSKI PA, 1979, ARCTIC ALPINE RES, V11, P267, DOI 10.2307/1550417; Momin GA, 1999, CURR SCI INDIA, V76, P985; Moorthy KK, 2007, ANN GEOPHYS-GERMANY, V25, P2293; O'Neill NT, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000877; Singh RP, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004966; Thompson LG, 2000, SCIENCE, V289, P1916, DOI 10.1126/science.289.5486.1916	20	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40286	10.1371/journal.pone.0040286	http://dx.doi.org/10.1371/journal.pone.0040286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792264	Green Published, gold			2022-12-25	WOS:000306436300047
J	Munk, M; Memon, AA; Goetze, JP; Nielsen, LB; Nexo, E; Sorensen, BS				Munk, Mathias; Memon, Ashfaque Ahmed; Goetze, Jens Peter; Nielsen, Lars Bo; Nexo, Ebba; Sorensen, Boe Sandahl			Hypoxia Changes the Expression of the Epidermal Growth Factor (EGF) System in Human Hearts and Cultured Cardiomyocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; MYOCARDIAL-INFARCTION; BREAST-CANCER; CELL-DEATH; NEUREGULIN; ERBB2; AKT; PROLIFERATION; CHEMOTHERAPY; TRASTUZUMAB	Background: The epidermal growth factor (EGF) receptors HER2 and HER4 and the ligands HB-EGF and NRG1 are crucial for heart development. The purpose of our study was to investigate the role of the complete EGF system in relation to hypoxia of the heart. Methodology/Principal Findings: We examined the mRNA expression by real time PCR of the 4 receptors and 12 ligands from the EGF-system in paired normoxic and hypoxic biopsies isolated from human hearts during coronary artery bypass operation. Compared to normoxic biopsies, hypoxic samples showed down-regulation of HER2 (P = 0.0005) and NRG1 (both alpha (P = 0.02) and beta (P = 0.03) isoforms). In contrast, HB-EGF (P = 0.0008), NRG2 beta (P = 0.01) and EGFR (P = 0.02) were up-regulated. As HER2 is essential for heart development and we find its expression reduced under hypoxia we investigated the effect of HER2 inhibition in hypoxic HL-1 cardiomyocytes by treatment with trastuzumab (20 nM). This resulted in inhibition of cardiomyocyte proliferation, but interestingly only in hypoxic cells. Co-treatment of HL-1 cells with HB-EGF (10 nM) but not with NRG-1 (5 ng/ml) rescued the cardiomyocytes from HER2 inhibition. HL-1 cardiomyocytes exposed to hypoxia revealed nuclear translocation of activated MAPK and the activity of this downstream signaling molecule was decreased by HER2 inhibition (20 nM trastuzumab), and re-established by HB-EGF (10 nM). Conclusions/Significance: Hypoxia in the human heart alters the expression of the EGF system. Mimicking the HER2 down-regulation seen in the human heart in cultured cardiomyocytes inhibited their proliferation under hypoxic conditions. Interestingly, HB-EGF is induced in the hypoxic human hearts, and rescues hypoxic cardiomyocytes from the effect of HER2 inhibition in the in vitro model. The results have implications for future treatment strategies of patients with ischemic heart disease.	[Munk, Mathias; Memon, Ashfaque Ahmed; Nexo, Ebba; Sorensen, Boe Sandahl] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Goetze, Jens Peter; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen	Munk, M (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	boesoere@rm.dk		Memon, Ashfaque/0000-0002-1081-3553; Nexo, Ebba/0000-0001-9406-9081; Sorensen, Boe/0000-0002-9472-8099; Goetze, Jens Peter/0000-0001-6356-3829	Danish Cancer Society	Danish Cancer Society(Danish Cancer Society)	This work was funded by the Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2001, BIOCHEM J, V358, P481, DOI 10.1042/0264-6021:3580481; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; FAVARA BE, 1972, AM J CARDIOL, V30, P423, DOI 10.1016/0002-9149(72)90576-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; Ky B, 2009, CIRCULATION, V120, P310, DOI 10.1161/CIRCULATIONAHA.109.856310; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nielsen LB, 2002, ARTERIOSCL THROM VAS, V22, P1489, DOI 10.1161/01.ATV.0000030199.06252.26; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schooler K, 2000, ANAL BIOCHEM, V277, P135, DOI 10.1006/abio.1999.4387; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611; Tanaka N, 2002, BIOCHEM BIOPH RES CO, V297, P375, DOI 10.1016/S0006-291X(02)02197-6; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	34	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40243	10.1371/journal.pone.0040243	http://dx.doi.org/10.1371/journal.pone.0040243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792252	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300039
J	Bron, PA; Wels, M; Bongers, RS; van Bokhorst-van de Veen, H; Wiersma, A; Overmars, L; Marco, ML; Kleerebezem, M				Bron, Peter A.; Wels, Michiel; Bongers, Roger S.; van Bokhorst-van de Veen, Hermien; Wiersma, Anne; Overmars, Lex; Marco, Maria L.; Kleerebezem, Michiel			Transcriptomes Reveal Genetic Signatures Underlying Physiological Variations Imposed by Different Fermentation Conditions in Lactobacillus plantarum	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; LACTIC-ACID BACTERIA; RIBONUCLEOTIDE REDUCTASE; LACTOCOCCUS-LACTIS; STATIONARY-PHASE; GROWTH; DIVERSITY; PATHWAYS; FLAVOR; IDENTIFICATION	Lactic acid bacteria (LAB) are utilized widely for the fermentation of foods. In the current post-genomic era, tools have been developed that explore genetic diversity among LAB strains aiming to link these variations to differential phenotypes observed in the strains investigated. However, these genotype-phenotype matching approaches fail to assess the role of conserved genes in the determination of physiological characteristics of cultures by environmental conditions. This manuscript describes a complementary approach in which Lactobacillus plantarum WCFS1 was fermented under a variety of conditions that differ in temperature, pH, as well as NaCl, amino acid, and O-2 levels. Samples derived from these fermentations were analyzed by full-genome transcriptomics, paralleled by the assessment of physiological characteristics, e. g., maximum growth rate, yield, and organic acid profiles. A data-storage and -mining suite designated FermDB was constructed and exploited to identify correlations between fermentation conditions and industrially relevant physiological characteristics of L. plantarum, as well as the associated transcriptome signatures. Finally, integration of the specific fermentation variables with the transcriptomes enabled the reconstruction of the gene-regulatory networks involved. The fermentation-genomics platform presented here is a valuable complementary approach to earlier described genotype-phenotype matching strategies which allows the identification of transcriptome signatures underlying physiological variations imposed by different fermentation conditions.	[Bron, Peter A.; Wels, Michiel; Bongers, Roger S.; van Bokhorst-van de Veen, Hermien; Wiersma, Anne; Overmars, Lex; Marco, Maria L.; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [Bron, Peter A.; Wels, Michiel; Bongers, Roger S.; van Bokhorst-van de Veen, Hermien; Wiersma, Anne; Overmars, Lex; Marco, Maria L.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Wels, Michiel; Overmars, Lex] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [van Bokhorst-van de Veen, Hermien; Kleerebezem, Michiel] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; NIZO Food Research; Radboud University Nijmegen; Wageningen University & Research	Bron, PA (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Michiel.Kleerebezem@nizo.nl	Marco, Maria/H-2322-2014; van Bokhorst-van de Veen, Hermien/K-2111-2013; Kleerebezem, Michiel/AAT-2078-2021	van Bokhorst-van de Veen, Hermien/0000-0003-4159-5955; Kleerebezem, Michiel/0000-0001-8552-2235	Kluyver Centre for Genomics of Industrial Fermentation of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Kluyver Centre for Genomics of Industrial Fermentation of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	PAB is partially funded by the research program of the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann H, 2009, APPL ENVIRON MICROB, V75, P5687, DOI 10.1128/AEM.00919-09; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bron Peter A, 2011, Bioeng Bugs, V2, P80, DOI 10.4161/bbug.2.2.13910; Brooijmans Rob, 2009, F1000 Biol Rep, V1, P34, DOI 10.3410/B1-34; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Corcoran BM, 2008, CURR PHARM DESIGN, V14, P1382, DOI 10.2174/138161208784480225; Derzelle S, 2003, APPL ENVIRON MICROB, V69, P4285, DOI 10.1128/AEM.69.7.4285-4290.2003; Dudley EG, 2005, J APPL MICROBIOL, V98, P14, DOI 10.1111/j.1365-2672.2004.02440.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fonseca F, 2006, APPL ENVIRON MICROB, V72, P6474, DOI 10.1128/AEM.00998-06; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Guinane CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018740; Hols P, 1999, J BACTERIOL, V181, P5521, DOI 10.1128/JB.181.17.5521-5526.1999; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Lacroix C, 2007, CURR OPIN BIOTECH, V18, P176, DOI 10.1016/j.copbio.2007.02.002; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V66, P209, DOI 10.1016/0378-1097(90)90284-W; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Liu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-36; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; McLeod A, 2008, SYST APPL MICROBIOL, V31, P393, DOI 10.1016/j.syapm.2008.06.002; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; MURPHY MG, 1985, ARCH MICROBIOL, V141, P75, DOI 10.1007/BF00446743; Pieterse B, 2006, J MICROBIOL METH, V64, P207, DOI 10.1016/j.mimet.2005.04.035; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; REICHARD P, 1993, J BIOL CHEM, V268, P8383; Rolain T, 2012, J BACTERIOL IN PRESS; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Smit BA, 2009, APPL MICROBIOL BIOT, V81, P987, DOI 10.1007/s00253-008-1758-x; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; STARRENBURG MJC, 1991, APPL ENVIRON MICROB, V57, P3535, DOI 10.1128/AEM.57.12.3535-3540.1991; Stevens MJA, 2008, APPL ENVIRON MICROB, V74, P4776, DOI 10.1128/AEM.00136-08; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Vrancken G, 2011, APPL ENVIRON MICROB, V77, P3406, DOI 10.1128/AEM.02668-10; Wang YY, 2011, J BACTERIOL, V193, P313, DOI 10.1128/JB.01159-10; Weckx S, 2010, APPL ENVIRON MICROB, V76, P5402, DOI 10.1128/AEM.00570-10; Wels M, 2011, MICROB BIOTECHNOL, V4, P333, DOI 10.1111/j.1751-7915.2010.00217.x; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang ZY, 2009, J BACTERIOL, V191, P5020, DOI 10.1128/JB.00587-09; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	54	42	42	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38720	10.1371/journal.pone.0038720	http://dx.doi.org/10.1371/journal.pone.0038720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802930	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900004
J	Elass-Rochard, E; Rombouts, Y; Coddeville, B; Maes, E; Blervaque, R; Hot, D; Kremer, L; Guerardel, Y				Elass-Rochard, Elisabeth; Rombouts, Yoann; Coddeville, Bernadette; Maes, Emmanuel; Blervaque, Renaud; Hot, David; Kremer, Laurent; Guerardel, Yann			Structural Determination and Toll-like Receptor 2-dependent Proinflammatory Activity of Dimycolyl-diarabino-glycerol from Mycobacterium marinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ACID-CONTAINING GLYCOLIPIDS; BACILLUS-CALMETTE-GUERIN; CELL-WALL COMPONENTS; MYCOLIC ACIDS; CORD FACTOR; INTRACELLULARE COMPLEX; ANTIGEN PRESENTATION; GRANULOMA-FORMATION; ZEBRAFISH EMBRYOS	Although it was identified in the cell wall of several pathogenic mycobacteria, the biological properties of dimycolyl-diarabino-glycerol have not been documented yet. In this study an apolar glycolipid, presumably corresponding to dimycolyl-diarabino-glycerol, was purified from Mycobacterium marinum and subsequently identified as a 5-O-mycolyl-beta-Araf-(1 -> 2)-5-O-mycolyl-alpha-Araf-(1 -> 1')-glycerol (designated Mma_DMAG) using a combination of nuclear magnetic resonance spectroscopy and mass spectrometry analyses. Lipid composition analysis revealed that mycolic acids were dominated by oxygenated mycolates over alpha-mycolates and devoid of trans-cyclopropane functions. Highly purified Mma_DMAG was used to demonstrate its immunomodulatory activity. Mma_DMAG was found to induce the secretion of proinflammatory cytokines (TNF-alpha, IL-8, IL-1 beta) in human macrophage THP-1 cells and to trigger the expression of ICAM-1 and CD40 cell surface antigens. This activation mechanism was dependent on TLR2, but not on TLR4, as demonstrated by (i) the use of neutralizing anti-TLR2 and -TLR4 antibodies and by (ii) the detection of secreted alkaline phosphatase in HEK293 cells co-transfected with the human TLR2 and secreted embryonic alkaline phosphatase reporter genes. In addition, transcriptomic analyses indicated that various genes encoding proinflammatory factors were up-regulated after exposure of THP-1 cells toMma_DMAG. Importantly, a wealth of other regulated genes related to immune and inflammatory responses, including chemokines/cytokines and their respective receptors, adhesion molecules, and metalloproteinases, were found to be modulated by Mma_DMAG. Overall, this study suggests that DMAG may be an active cell wall glycoconjugate driving host-pathogen interactions and participating in the immunopathogenesis of mycobacterial infections.	[Elass-Rochard, Elisabeth; Rombouts, Yoann; Coddeville, Bernadette; Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct, UGSF,IFR 147, F-59650 Villeneuve Dascq, France; [Elass-Rochard, Elisabeth; Rombouts, Yoann; Coddeville, Bernadette; Maes, Emmanuel; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Blervaque, Renaud; Hot, David] Inst Pasteur, Ctr Infect & Immun Lille, Lab Transcript & Genom Appl, U1019,UMR 8204, F-59019 Lille, France; [Kremer, Laurent] Univ Montpellier II & I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, DIMNP, F-34095 Montpellier 05, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Elass-Rochard, E (corresponding author), Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct, UGSF,IFR 147, F-59650 Villeneuve Dascq, France.	elisabeth.elass@univ-lille1.fr	Kremer, Laurent/M-4935-2017; Hot, David/M-6775-2016	Kremer, Laurent/0000-0002-6604-4458; Rombouts, Yoann/0000-0003-4482-2199; Hot, David/0000-0002-2361-0616; Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	National Research Agency [ANR-05-MIIM-025]; Ministere de l'Enseignement Superieur	National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur	This work was supported by National Research Agency Grant ANR-05-MIIM-025 (to Y.G. and L. K.) and a grant from the Ministere de l'Enseignement Superieur (to Y.R.).	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Andersen CAS, 2009, J IMMUNOL, V183, P2294, DOI 10.4049/jimmunol.0804091; Astarie-Dequeker C., 2010, DRUG DISCOV TODAY, pe33; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; CHENSUE SW, 1995, J IMMUNOL, V154, P5969; CHENSUE SW, 1986, INFECT IMMUN, V52, P341, DOI 10.1128/IAI.52.1.341-343.1986; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cosma Christine L, 2006, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/0471729256.mc10b02s3; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DAFFE M, 1991, RES MICROBIOL, V142, P397, DOI 10.1016/0923-2508(91)90109-N; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Ehrt S, 2007, NAT MED, V13, P284, DOI 10.1038/nm0307-284; Estrella JL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00067; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fujita Y, 2007, MICROB PATHOGENESIS, V43, P10, DOI 10.1016/j.micpath.2007.02.006; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; Hattori Y, 2011, BIOCHEM BIOPH RES CO, V409, P304, DOI 10.1016/j.bbrc.2011.04.146; HONDA I, 1993, RES MICROBIOL, V144, P229, DOI 10.1016/0923-2508(93)90048-7; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishiwata A, 2006, BIOORGAN MED CHEM, V14, P3049, DOI 10.1016/j.bmc.2005.12.037; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Khan AA, 2012, CARBOHYD RES, V356, P25, DOI 10.1016/j.carres.2012.03.010; Komori T, 2011, J BIOL CHEM, V286, P16800, DOI 10.1074/jbc.M110.217224; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Lebedeva T, 2005, CURR OPIN IMMUNOL, V17, P251, DOI 10.1016/j.coi.2005.04.008; Lonnstedt I, 2002, STAT SINICA, V12, P31; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Meena L.S., 2011, BIOTECHNOL RES INT; Miyauchi M, 2011, DRUG DISCOV THER, V5, P130, DOI 10.5582/ddt.2011.v5.3.130; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Petrini B, 2006, Eur J Clin Microbiol Infect Dis, V25, P609, DOI 10.1007/s10096-006-0201-4; Puttinaowarat S, 1999, AAHRI NEWSLETT, V8, P4; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Raja A, 2004, INDIAN J MED RES, V120, P213; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; ROUANET JM, 1983, ANN INST PASTEUR MIC, VB134, P233, DOI 10.1016/S0769-2609(83)80036-2; Roura-Mir C, 2005, J IMMUNOL, V175, P1758, DOI 10.4049/jimmunol.175.3.1758; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; SILVA CL, 1985, BRAZ J MED BIOL RES, V18, P327; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Watanabe M, 1997, EUR J BIOCHEM, V248, P93, DOI 10.1111/j.1432-1033.1997.00093.x; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; WATANABE M, 1992, BIOCHIM BIOPHYS ACTA, V1165, P53, DOI 10.1016/0005-2760(92)90075-7; Welsh KJ, 2008, MICROBIOL-SGM, V154, P1813, DOI 10.1099/mic.0.2008/016923-0; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	76	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34432	34444		10.1074/jbc.M112.378083	http://dx.doi.org/10.1074/jbc.M112.378083			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22798072	hybrid, Green Published			2022-12-25	WOS:000309654200045
J	Bchini, R; Dubourg-Gerecke, H; Rahuel-Clermont, S; Aubry, A; Branlant, G; Didierjean, C; Talfournier, F				Bchini, Raphael; Dubourg-Gerecke, Helene; Rahuel-Clermont, Sophie; Aubry, Andre; Branlant, Guy; Didierjean, Claude; Talfournier, Francois			Adenine Binding Mode Is a Key Factor in Triggering the Early Release of NADH in Coenzyme A-dependent Methylmalonate Semialdehyde Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; ACTIVE-SITE; STEM-CELLS; RAT-LIVER; PURIFICATION; SPECIFICITY; MECHANISM; ISOMERIZATION; INVOLVEMENT	Structural dynamics associated with cofactor binding have been shown to play key roles in the catalytic mechanism of hydrolytic NAD(P)-dependent aldehyde dehydrogenases (ALDH). By contrast, no information is available for their CoA-dependent counterparts. We present here the first crystal structure of a CoA-dependent ALDH. The structure of the methylmalonate semialdehyde dehydrogenase (MSDH) from Bacillus subtilis in binary complex with NAD(+) shows that, in contrast to what is observed for hydrolytic ALDHs, the nicotinamide ring is well defined in the electron density due to direct and H2O-mediated hydrogen bonds with the carboxamide. The structure also reveals that a conformational isomerization of the NMNH is possible in MSDH, as shown for hydrolytic ALDHs. Finally, the adenine ring is substantially more solvent-exposed, a result that could be explained by the presence of a Val residue at position 229 in helix alpha(F) that reduces the depth of the binding pocket and the absence of Gly-225 at the N-terminal end of helix alpha(F). Substitution of glycine for Val-229 and/or insertion of a glycine residue at position 225 resulted in a significant decrease of the rate constant associated with the dissociation of NADH from the NADH/thioacylenzyme complex, thus demonstrating that the weaker stabilization of the adenine ring is a key factor in triggering the early NADH release in the MSDH-catalyzed reaction. This study provides for the first time structural insights into the mechanism whereby the cofactor binding mode is responsible at least in part for the different kinetic behaviors of the hydrolytic and CoA-dependent ALDHs.	[Bchini, Raphael; Rahuel-Clermont, Sophie; Branlant, Guy; Talfournier, Francois] Unite Mixte Rech CNRS Univ Lorraine 7214 AREMS, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Fac Med, F-54506 Vandoeuvre Les Nancy, France; [Dubourg-Gerecke, Helene; Aubry, Andre; Didierjean, Claude] UMR 7036 CNRS Univ Lorraine, Fac Sci & Technol, Equipe Biocristallog, Unite Mixte Rech Cristallog Resonance Magnet & Mo, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine	Branlant, G (corresponding author), Unite Mixte Rech CNRS Univ Lorraine 7214 AREMS, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Fac Med, 9 Ave Foret Haye,BP 184, F-54506 Vandoeuvre Les Nancy, France.	guy.branlant@maem.uhp-nancy.fr; francois.talfournier@maem.uhp-nancy.fr	DIDIERJEAN, Claude/L-1493-2013; Rahuel-Clermont, Sophie/AAB-3451-2020	DIDIERJEAN, Claude/0000-0002-3176-8974; Rahuel-Clermont, Sophie/0000-0001-5143-0105; Bchini, Raphael/0000-0002-6017-3152	CNRS; University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine; French Research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine(Region Grand-Est); French Research Ministry(Ministry of Research, France)	This work was supported in part by the CNRS, the University of Nancy I, the Institut Federatif de Recherche 111 Bioingenierie, and local funds from the Region Lorraine.; Both authors contributed equally to this work and were supported by the French Research Ministry.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chambliss KL, 2000, J INHERIT METAB DIS, V23, P497, DOI 10.1023/A:1005616315087; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Dubourg H, 2004, ACTA CRYSTALLOGR D, V60, P1435, DOI 10.1107/S0907444904012533; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; GRAY RGF, 1987, BIOCHEM MED METAB B, V38, P121, DOI 10.1016/0885-4505(87)90069-7; Hammen PK, 2002, BIOCHEMISTRY-US, V41, P7156, DOI 10.1021/bi012197t; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUPIECKI FP, 1960, BIOCH PREP, V7, P69; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Marchal S, 1999, BIOCHEMISTRY-US, V38, P12950, DOI 10.1021/bi990453k; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; Munoz-Clares RA, 2011, CHEM-BIOL INTERACT, V191, P137, DOI 10.1016/j.cbi.2010.12.024; Ni L, 1997, J BIOL CHEM, V272, P18823, DOI 10.1074/jbc.272.30.18823; Pailot A, 2006, BIOCHEM J, V400, P521, DOI 10.1042/BJ20060843; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Rahuel-Clermont S, 2005, J BIOL CHEM, V280, P18590, DOI 10.1074/jbc.M414110200; Roussel P. A., 1991, TURBO FRODO SILICON; Sass JO, 2012, J INHERIT METAB DIS, V35, P437, DOI 10.1007/s10545-011-9381-x; SHONE CC, 1981, BIOCHEMISTRY-US, V20, P7494, DOI 10.1021/bi00529a026; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; Talfournier F, 2011, J BIOL CHEM, V286, P21971, DOI 10.1074/jbc.M110.213280; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Tsybovsky Y, 2011, J BIOL CHEM, V286, P23357, DOI 10.1074/jbc.M111.221069; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vedadi M, 1997, EUR J BIOCHEM, V246, P698, DOI 10.1111/j.1432-1033.1997.t01-1-00698.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997	41	5	5	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31095	31103		10.1074/jbc.M112.350272	http://dx.doi.org/10.1074/jbc.M112.350272			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782904	Green Published, hybrid			2022-12-25	WOS:000308791300022
J	Chen, R; Xu, M; Hogg, RT; Li, JW; Little, B; Gerard, RD; Garcia, JA				Chen, Rui; Xu, Min; Hogg, Richard T.; Li, Jiwen; Little, Bertis; Gerard, Robert D.; Garcia, Joseph A.			The Acetylase/Deacetylase Couple CREB-binding Protein/Sirtuin 1 Controls Hypoxia-inducible Factor 2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTIONAL ACTIVITY; FACTOR 1-ALPHA; GENE-EXPRESSION; TARGET GENE; HIF; ERYTHROPOIETIN; ACTIVATION; FAMILY; CELLS	Hypoxia-inducible factors (HIFs) are oxygen-sensitive transcription factors. HIF-1 alpha plays a prominent role in hypoxic gene induction. HIF-2 alpha target genes are more restricted but include erythropoietin (Epo), one of the most highly hypoxia-inducible genes in mammals. We previously reported that HIF-2 alpha is acetylated during hypoxia but is rapidly deacetylated by the stress-responsive deacetylase Sirtuin 1. We now demonstrate that the lysine acetyltransferases cAMP-response element-binding protein-binding protein (CBP) and p300 are required for efficient Epo induction during hypoxia. However, despite close structural similarity, the roles of CBP and p300 differ in HIF signaling. CBP acetylates HIF-2 alpha, is a major coactivator for HIF-2-mediated Epo induction, and is required for Sirt1 augmentation of HIF-2 signaling during hypoxia in Hep3B cells. In comparison, p300 is a major contributor for HIF-1 signaling as indicated by induction of Pgk1. Whereas CBP can bind with HIF-2 alpha independent of the HIF-2 alpha C-terminal activation domain via enzyme/substrate interactions, p300 only complexes with HIF-2 alpha through the C-terminal activation domain. Maximal CBP/HIF-2 signaling requires intact CBP acetyltransferase activity in both Hep3B cells as well as in mice.	[Chen, Rui; Garcia, Joseph A.] Vet Affairs N Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Rui; Xu, Min; Hogg, Richard T.; Li, Jiwen; Gerard, Robert D.; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Little, Bertis] Tarleton State Univ, Dept Math & Phys, Stephenville, TX 76402 USA; [Little, Bertis] Tarleton State Univ, Dept Engn, Stephenville, TX 76402 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Tarleton State University; Texas A&M University System; Tarleton State University	Garcia, JA (corresponding author), Vet Affairs N Texas Hlth Care Syst, Dept Med, 4600 S Lancaster Rd, Dallas, TX 75216 USA.	joseph.garcia@utsouthwestern.edu		Chen, Rui/0000-0002-7003-6602; Garcia, Joseph/0000-0002-5621-7538	National Institutes of Health [HL108104]; American Heart Association; Department of Veterans Affairs Award [IBX000446]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant HL108104 (to J. G.). This work was also supported by the American Heart Association and Department of Veterans Affairs Award IBX000446.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ruas JL, 2005, J CELL SCI, V118, P301, DOI 10.1242/jcs.01617; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010002; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wei LL, 2008, BIOCHEM BIOPH RES CO, V368, P279, DOI 10.1016/j.bbrc.2008.01.071; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	41	54	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30800	30811		10.1074/jbc.M111.244780	http://dx.doi.org/10.1074/jbc.M111.244780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807441	Green Published, hybrid			2022-12-25	WOS:000308579800068
J	Han, S; Kim, S; Bahl, S; Li, L; Burande, CF; Smith, N; James, M; Beauchamp, RL; Bhide, P; DiAntonio, A; Ramesh, V				Han, Sangyeul; Kim, Sun; Bahl, Samira; Li, Lin; Burande, Clara F.; Smith, Nicole; James, Marianne; Beauchamp, Roberta L.; Bhide, Pradeep; DiAntonio, Aaron; Ramesh, Vijaya			The E3 Ubiquitin Ligase Protein Associated with Myc (Pam) Regulates Mammalian/Mechanistic Target of Rapamycin Complex 1 (mTORC1) Signaling in Vivo through N- and C-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; SYNAPTIC GROWTH; E3-UBIQUITIN LIGASE; FORMATION REVEALS; ELEGANS RPM-1; HIGHWIRE; KINASE; MEMORY; PHR1; SPHINGOSINE-1-PHOSPHATE	Pam and its homologs (the PHR protein family) are large E3 ubiquitin ligases that function to regulate synapse formation and growth in mammals, zebrafish, Drosophila, and Caenorhabditis elegans. Phr1-deficient mouse models (Phr1(Delta 8,9) and Phr1(Magellan), with deletions in the N-terminal putative guanine exchange factor region and the C-terminal ubiquitin ligase region, respectively) exhibit axon guidance/outgrowth defects and striking defects of major axon tracts in the CNS. Our earlier studies identified Pam to be associated with tuberous sclerosis complex (TSC) proteins, ubiquitinating TSC2 and regulating mammalian/mechanistic target of rapamycin (mTOR) signaling. Here, we examine the potential involvement of the TSC/mTOR complex 1(mTORC1) signaling pathway in Phr1-deficient mouse models. We observed attenuation of mTORC1 signaling in the brains of both Phr1(Delta 8,9) and Phr1(Magellan) mouse models. Our results establish that Pam regulates TSC/mTOR signaling in vitro and in vivo through two distinct domains. To further address whether Pam regulates mTORC1 through two functionally independent domains, we undertook heterozygous mutant crossing between Phr1(Delta 8,9) and Phr1(Magellan) mice to generate a compound heterozygous model to determine whether these two domains can complement each other. mTORC1 signaling was not attenuated in the brains of double mutants (Phr1(Delta 8,9/Mag)), confirming that Pam displays dual regulation of the mTORC1 pathway through two functional domains. Our results also suggest that although dysregulation of mTORC1 signaling may be responsible for the corpus callosum defects, other neurodevelopmental defects observed with Phr1 deficiency are independent of mTORC1 signaling. The ubiquitin ligase complex containing Pam-Fbxo45 likely targets additional synaptic and axonal proteins, which may explain the overlapping neurodevelopmental defects observed in Phr1 and Fbxo45 deficiency.	[Han, Sangyeul; Kim, Sun; Bahl, Samira; Li, Lin; Burande, Clara F.; Smith, Nicole; James, Marianne; Beauchamp, Roberta L.; Ramesh, Vijaya] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Bhide, Pradeep] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [DiAntonio, Aaron] Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Washington University (WUSTL)	Ramesh, V (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Richard B Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	ramesh@helix.mgh.harvard.edu		Bhide, Pradeep/0000-0003-4236-9415	National Institutes of Health [NS024279, DA020812]; Autism Speaks, Simons Foundation for Autism Research Initiative; Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks, Simons Foundation for Autism Research Initiative; Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS024279 (to V. R.) and DA020812 (to A. D.). This work was also supported by a grant from Autism Speaks, Simons Foundation for Autism Research Initiative (to V. R.), and a fellowship from the Tuberous Sclerosis Alliance (to S. B.).	Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Han S, 2008, CELL SIGNAL, V20, P1084, DOI 10.1016/j.cellsig.2008.01.020; Hendricks M, 2009, J NEUROSCI, V29, P6593, DOI 10.1523/JNEUROSCI.1115-09.2009; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Santos TM, 2006, J NEUROSCI RES, V83, P222, DOI 10.1002/jnr.20723; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	42	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30063	30072		10.1074/jbc.M112.353987	http://dx.doi.org/10.1074/jbc.M112.353987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798074	hybrid, Green Published			2022-12-25	WOS:000308579800002
J	Singh, S; Dev, A; Verma, R; Pradeep, A; Sathyanarayana, P; Green, JM; Narayanan, A; Wojchowski, DM				Singh, Seema; Dev, Arvind; Verma, Rakesh; Pradeep, Anamika; Sathyanarayana, Pradeep; Green, Jennifer M.; Narayanan, Aishwarya; Wojchowski, Don M.			Defining an EPOR- Regulated Transcriptome for Primary Progenitors, including Tnfr-sf13c as a Novel Mediator of EPO- Dependent Erythroblast Formation	PLOS ONE			English	Article							ERYTHROPOIETIN RECEPTOR; BAFF-R; CELLS; APOPTOSIS; IDENTIFICATION; PROLIFERATION; MODULATION; INHIBITION; SUPPRESSOR; EXPRESSION	Certain concepts concerning EPO/EPOR action modes have been challenged by in vivo studies: Bcl-x levels are elevated in maturing erythroblasts, but not in their progenitors; truncated EPOR alleles that lack a major p85/PI3K recruitment site nonetheless promote polycythemia; and Erk1 disruption unexpectedly bolsters erythropoiesis. To discover novel EPO/EPOR action routes, global transcriptome analyses presently are applied to interrogate EPO/EPOR effects on primary bone marrow-derived CFUe-like progenitors. Overall, 160 EPO/EPOR target transcripts were significantly modulated 2-to 21.8-fold. A unique set of EPO-regulated survival factors included Lyl1, Gas5, Pim3, Pim1, Bim, Trib3 and Serpina 3g. EPO/EPOR-modulated cell cycle mediators included Cdc25a, Btg3, Cyclin-d2, p27-kip1, Cyclin-g2 and CyclinB1-IP-1. EPO regulation of signal transduction factors was also interestingly complex. For example, not only Socs3 plus Socs2 but also Spred2, Spred1 and Eaf1 were EPO-induced as negative-feedback components. Socs2, plus five additional targets, further proved to comprise new EPOR/Jak2/Stat5 response genes (which are important for erythropoiesis during anemia). Among receptors, an atypical TNF-receptor Tnfr-sf13c was up-modulated >5-fold by EPO. Functionally, Tnfr-sf13c ligation proved to both promote proerythroblast survival, and substantially enhance erythroblast formation. The EPOR therefore engages a sophisticated set of transcriptome response circuits, with Tnfr-sf13c deployed as one novel positive regulator of proerythroblast formation.	[Singh, Seema; Dev, Arvind; Verma, Rakesh; Pradeep, Anamika; Sathyanarayana, Pradeep; Wojchowski, Don M.] Maine Med Ctr, Res Inst, Ctr Excellence Stem Cell Biol & Regenerat Med, Scarborough, ME USA; [Green, Jennifer M.] Affymax Inc, Palo Alto, CA USA; [Narayanan, Aishwarya] Strand Life Sci, Bangalore, Karnataka, India	Maine Medical Center	Singh, S (corresponding author), Maine Med Ctr, Res Inst, Ctr Excellence Stem Cell Biol & Regenerat Med, Scarborough, ME USA.	wojchd@mmc.org			National Institutes of Health [NIH R01 DK089439, NIH R01 HL44491]; NIH/NCRR [P20 RR18789]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants NIH R01 DK089439 and NIH R01 HL44491 (principal investigator, Dr. Wojchowski). Core facility contributions (Flow Cytometry and Progenitor Cell Analysis, and Bioinformatics) were supported in part via NIH/NCRR P20 RR18789 (Dr. Wojchowski, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2005, BBA-MOL BASIS DIS, V1740, P17, DOI 10.1016/j.bbadis.2005.03.003; Barlow JL, 2010, CELL CYCLE, V9, P4286, DOI 10.4161/cc.9.21.13742; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Chung B, 2010, FASEB J, V24, P2093, DOI 10.1096/fj.09-152561; Dev A, 2010, BLOOD, V116, P5334, DOI 10.1182/blood-2009-12-258947; Dicato M, 2010, CURR OPIN ONCOL, V22, P307, DOI 10.1097/CCO.0b013e32833aa9de; Doherty L, 2010, AM J HUM GENET, V86, P222, DOI 10.1016/j.ajhg.2009.12.015; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huddleston H, 2003, BLOOD, V102, P142, DOI 10.1182/blood-2002-10-3245; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Klingmuller U, 1997, P NATL ACAD SCI USA, V94, P3016, DOI 10.1073/pnas.94.7.3016; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Krapf R, 2009, CLIN J AM SOC NEPHRO, V4, P470, DOI 10.2215/CJN.05040908; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Lombardero M, 2011, PATHOBIOLOGY, V78, P41, DOI 10.1159/000322975; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Mihalci SA, 2010, J IMMUNOL, V185, P1045, DOI 10.4049/jimmunol.1001120; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Mourtada-Maarabouni M, 2010, MOL PHARMACOL, V78, P19, DOI 10.1124/mol.110.064055; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Niu J, 2010, LEUK RES; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Ponassi R, 2008, CELL CYCLE, V7, P3211, DOI 10.4161/cc.7.20.6830; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Sathyanarayana P, 2007, BLOOD, V110, P509, DOI 10.1182/blood-2006-11-056465; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Suenobu S, 2002, BIOCHEM BIOPH RES CO, V293, P1124, DOI 10.1016/S0006-291X(02)00330-3; Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Wan ZH, 2010, J CLIN INVEST, V120, P3530, DOI 10.1172/JCI41805; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wojchowski DM, 2010, CURR OPIN HEMATOL, V17, P169, DOI 10.1097/MOH.0b013e328338008b; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	53	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e38530	10.1371/journal.pone.0038530	http://dx.doi.org/10.1371/journal.pone.0038530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22808010	Green Submitted, Green Published, gold			2022-12-25	WOS:000306406700004
J	Bernier, LP; Blais, D; Boue-Grabot, E; Seguela, P				Bernier, Louis-Philippe; Blais, Dominique; Boue-Grabot, Eric; Seguela, Philippe			A Dual Polybasic Motif Determines Phosphoinositide Binding and Regulation in the P2X Channel Family	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CRYSTAL-STRUCTURE; ION-CHANNEL; K+ CHANNELS; RECEPTOR; PIP2; MODULATION; DESENSITIZATION; IDENTIFICATION; ACTIVATION	Phosphoinositides modulate the function of several ion channels, including most ATP-gated P2X receptor channels in neurons and glia, but little is known about the underlying molecular mechanism. We identified a phosphoinositide-binding motif formed of two clusters of positively charged amino acids located on the P2X cytosolic C-terminal domain, proximal to the second transmembrane domain. For all known P2X subtypes, the specific arrangement of basic residues in these semi-conserved clusters determines their sensitivity to membrane phospholipids. Neutralization of these positive charges disrupts the functional properties of the prototypical phosphoinositide-binding P2X4 subtype, mimicking wortmannin-induced phosphoinositide depletion, whereas adding basic residues at homologous positions to the natively insensitive P2X5 subtype establishes de novo phosphoinositide-mediated regulation. Moreover, biochemical evidence of in vitro P2X subunit-phospholipid interaction and functional intracellular phosphoinositide-binding assays demonstrate that the dual polybasic cluster is necessary and sufficient for regulation of P2X signaling by phospholipids.	[Bernier, Louis-Philippe; Blais, Dominique; Seguela, Philippe] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada; [Boue-Grabot, Eric] Univ Bordeaux Segalen, Inst Malad Neurodegenerat, CNRS, UMR 5293, Bordeaux, France	McGill University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bernier, LP (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada.	philippe.seguela@mcgill.ca	Boué-Grabot, Eric/AAQ-2061-2020	Boué-Grabot, Eric/0000-0003-2187-9037; Bernier, Louis-Philippe/0000-0001-5063-2338	CIHR; NSERC; CNRS	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CNRS(Centre National de la Recherche Scientifique (CNRS))	Supported by CIHR and NSERC operating grants (PS) and CNRS (EBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ase AR, 2010, J NEUROCHEM, V113, P1676, DOI 10.1111/j.1471-4159.2010.06734.x; Bernier LP, 2008, MOL PHARMACOL, V74, P785, DOI 10.1124/mol.108.047019; Bernier LP, 2008, J NEUROSCI, V28, P12938, DOI 10.1523/JNEUROSCI.3038-08.2008; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Collo G, 1996, J NEUROSCI, V16, P2495; D'Arco M, 2009, J BIOL CHEM, V284, P21393, DOI 10.1074/jbc.M109.023051; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Koshimizu T, 2002, J BIOL CHEM, V277, P46891, DOI 10.1074/jbc.M205274200; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Mo G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-47; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Ruppelt A, 2001, J NEUROCHEM, V77, P1256, DOI 10.1046/j.1471-4159.2001.00348.x; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Toulme E, 2007, J NEUROCHEM, V102, P1357, DOI 10.1111/j.1471-4159.2007.04640.x; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Zhao Q, 2007, CHANNELS, V1, P46	33	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40595	10.1371/journal.pone.0040595	http://dx.doi.org/10.1371/journal.pone.0040595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792379	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400077
J	Bracciali, C; Campobello, D; Giacoma, C; Sara, G				Bracciali, Claudia; Campobello, Daniela; Giacoma, Cristina; Sara, Gianluca			Effects of Nautical Traffic and Noise on Foraging Patterns of Mediterranean Damselfish (Chromis chromis)	PLOS ONE			English	Article							FREQUENCY ACTIVE SONAR; HUMAN-GENERATED SOUND; ANTHROPOGENIC NOISE; FISH; BEHAVIOR; HEARING; AVOIDANCE; RESPONSES; NITROGEN; PREDATOR	Chromis chromis is a key species in the Mediterranean marine coastal ecosystems where, in summer, recreational boating and its associated noise overlap. Anthropogenic noise could induce behavioural modifications in marine organisms, thereby affecting population dynamics. In the case of an important species for the ecosystem like C. chromis, this could rebound on the community structure. Here, we measured nautical traffic during the summer of 2007 in a Southern Mediterranean Marine Protected Area (MPA) and simultaneously the feeding behaviour of C. chromis was video-recorded, within both the no-take A-zone and the B-zone where recreational use is allowed. Feeding frequencies, escape reaction and school density were analysed. C. chromis specimens were also collected from 2007 to 2008 to evaluate their physiological state using the Body Condition Index as a proxy of feeding efficiency. The MPA was more exploited by nautical tourism during holidays than on weekdays, particularly in the middle of the day. Greater traffic volume corresponded with lower feeding frequencies. The escape reaction was longer in duration (>1 min) when boat passed nearby, while moored boats did not induce an escape response. We found no differences in density between schools in the A-and B-zones and worse body conditions among those individuals inhabiting the B-zone in one area only. Overall, our findings revealed a significant modification of the daily foraging habits of C. chromis due to boat noise, which was slightly buffered by no-take zones established within the MPA.	[Bracciali, Claudia; Sara, Gianluca] Univ Palermo, Dipartimento Sci Terra & Mare, Palermo, Italy; [Bracciali, Claudia; Giacoma, Cristina] Univ Turin, Dipartimento Sci Vita & Biol Sistemi Life Sci & S, Turin, Italy; [Campobello, Daniela] Univ Palermo, Dept Environm Biol & Biodivers, Palermo, Italy	University of Palermo; University of Turin; University of Palermo	Bracciali, C (corresponding author), Univ Palermo, Dipartimento Sci Terra & Mare, Palermo, Italy.	daniela.campobello@unipa.it	Sara, Gianluca/AAG-7215-2020	Sara, Gianluca/0000-0002-7658-5274; GIACOMA, Cristina/0000-0002-8429-7723; Campobello, Daniela/0000-0003-4094-9395	DINAUTIS project by Italian Government	DINAUTIS project by Italian Government	Funds were provided by DINAUTIS project by the Environmental Minister of Italian Government (no numbers apply). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Amoser S, 2005, J EXP BIOL, V208, P3533, DOI 10.1242/jeb.01809; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Blumstein D.T., 2007, QUANTIFYING BEHAV JW, P211; BODDEKE R, 1963, NATURE, V197, P714, DOI 10.1038/197714b0; Buscaino G, 2010, MAR ENVIRON RES, V69, P136, DOI 10.1016/j.marenvres.2009.09.004; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; CHAPIN FS, 1992, TRENDS ECOL EVOL, V7, P107, DOI 10.1016/0169-5347(92)90141-W; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Davey AJH, 2007, FRESHWATER BIOL, V52, P1719, DOI 10.1111/j.1365-2427.2007.01800.x; De Robertis A, 2010, ICES J MAR SCI, V67, P985, DOI 10.1093/icesjms/fsp299; DULCIC J, 1995, FISH RES, V22, P255, DOI 10.1016/0165-7836(94)00318-Q; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Fasola M, 1997, MAR ECOL-P S Z N I, V18, P51, DOI 10.1111/j.1439-0485.1997.tb00426.x; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; Frid A, 2002, CONSERV ECOL, V6; Fuiman L. A., 1999, Journal of Fish Biology, V55, P215, DOI 10.1111/j.1095-8649.1999.tb01057.x; Gaucher L, 2012, J MORPHOL, V273, P49, DOI 10.1002/jmor.11005; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Halvorsen MB, 2012, J ACOUST SOC AM, V131, P599, DOI 10.1121/1.3664082; Handegard NO, 2003, AQUAT LIVING RESOUR, V16, P265, DOI 10.1016/S0990-7440(03)00020-2; Haviland-Howell G, 2007, J ACOUST SOC AM, V122, P151, DOI 10.1121/1.2717766; Holling C. S., 1959, Canadian Entomologist, V91, P385; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kastelein RA, 2008, MAR ENVIRON RES, V65, P369, DOI 10.1016/j.marenvres.2008.01.001; KENCHINGTON R, 1993, OCEAN COAST MANAGE, V21, P109, DOI 10.1016/0964-5691(93)90022-Q; Koen-Alonso Mariano, 2007, P1; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE, V3rd, P491, DOI [10.1017/CBO9780511805400, DOI 10.1017/CBO9780511805400]; KROHN MM, 1994, CAN J FISH AQUAT SCI, V51, P1119, DOI 10.1139/f94-111; La Manna G, 2010, CIENC MAR, V36, P71, DOI 10.7773/cm.v36i1.1457; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Lang B, 2011, J ANIM ECOL IN PRESS; Lehner PN, 1996, HDB ETHOLOGICAL METH, P672; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Magoulick DD, 2003, FRESHWATER BIOL, V48, P1186, DOI 10.1046/j.1365-2427.2003.01089.x; Miksis-Olds JL, 2011, MAR MAMMAL SCI, V27, P130, DOI 10.1111/j.1748-7692.2010.00381.x; Mussi M, 2005, J EXP BIOL, V208, P3037, DOI 10.1242/jeb.01750; MYRBERG AA, 1986, ANIM BEHAV, V34, P913, DOI 10.1016/S0003-3472(86)80077-X; Nash RDM, 2006, FISHERIES, V31, P236; Ona E, 2007, J ACOUST SOC AM, V121, pEL145, DOI 10.1121/1.2710741; Papale E, 2012, J MAR BIOL ASSOC UK, V92, P1877, DOI 10.1017/S002531541100083X; Picciulin Marta, 2002, Bioacoustics, V12, P236; Pinnegar JK, 2006, MAR BIOL, V148, P1089, DOI 10.1007/s00227-005-0141-z; Pinnegar JK, 2007, J EXP MAR BIOL ECOL, V352, P378, DOI 10.1016/j.jembe.2007.08.016; Pitcher TJ, 1993, BEHAV TELEOST FISHES, P439; Popper AN, 2003, FISHERIES, V28, P24, DOI 10.1577/1548-8446(2003)28[24:EOASOF]2.0.CO;2; Popper AN, 2004, ICES J MAR SCI, V61, P1057, DOI 10.1016/j.icesjms.2004.06.005; Popper AN, 2007, J ACOUST SOC AM, V122, P623, DOI 10.1121/1.2735115; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; Ruiz JM, 2010, MAR ENVIRON RES, V69, P118, DOI 10.1016/j.marenvres.2009.09.002; Sand O, 2000, ENVIRON BIOL FISH, V57, P327, DOI 10.1023/A:1007575426155; Sara G, 2007, MAR ECOL PROG SER, V331, P243, DOI 10.3354/meps331243; Sara G, 2011, MAR ENVIRON RES, V71, P317, DOI 10.1016/j.marenvres.2011.02.007; SCHOENER TW, 1986, AM ZOOL, V26, P81; Simpson SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016625; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Thetmeyer H, 1997, J EXP MAR BIOL ECOL, V218, P187, DOI 10.1016/S0022-0981(97)00073-7; THETMEYER H, 1995, MAR ECOL PROG SER, V126, P1, DOI 10.3354/meps126001; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Tyack PL, 2009, PHYS TODAY, V62, P39, DOI 10.1063/1.3265235; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Vabo R, 2002, FISH RES, V58, P59, DOI 10.1016/S0165-7836(01)00360-5; van Deurs M, 2011, MAR BIOL, V158, P1781, DOI 10.1007/s00227-011-1691-x; Wardle CS, 2001, CONT SHELF RES, V21, P1005, DOI 10.1016/S0278-4343(00)00122-9; Widmer WM, 2004, LANDSCAPE URBAN PLAN, V66, P173, DOI 10.1016/S0169-2046(03)00099-9; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562; Zar J.H., 1996, BIOSTAT ANAL, V5th; Zelick Randy, 1999, Springer Handbook of Auditory Research, V11, P363; ZUPO V., 2010, NATURAL SCI, V2, P1274, DOI DOI 10.4236/NS.2010.211154	73	51	51	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40582	10.1371/journal.pone.0040582	http://dx.doi.org/10.1371/journal.pone.0040582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792375	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400073
J	Stunkel, W; Pan, H; Chew, SB; Tng, E; Tan, JH; Chen, L; Joseph, R; Cheong, CY; Ong, ML; Lee, YS; Chong, YS; Saw, SM; Meaney, MJ; Kwek, K; Sheppard, AM; Gluckman, PD; Holbrook, JD				Stuenkel, Walter; Pan, Hong; Chew, Siew Boom; Tng, Emilia; Tan, Jun Hao; Chen, Li; Joseph, Roy; Cheong, Clara Y.; Ong, Mei-Lyn; Lee, Yung Seng; Chong, Yap-Seng; Saw, Seang Mei; Meaney, Michael J.; Kwek, Kenneth; Sheppard, Allan M.; Gluckman, Peter D.; Holbrook, Joanna D.		GUSTO Study Grp	Transcriptome Changes Affecting Hedgehog and Cytokine Signalling in the Umbilical Cord: Implications for Disease Risk	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; INTRAUTERINE GROWTH RESTRICTION; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DNA METHYLATION PATTERNS; PRETERM BIRTH; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; YOUNG-ADULTS	Background: Babies born at lower gestational ages or smaller birthweights have a greater risk of poorer health in later life. Both the causes of these sub-optimal birth outcomes and the mechanism by which the effects are transmitted over decades are the subject of extensive study. We investigated whether a transcriptomic signature of either birthweight or gestational age could be detected in umbilical cord RNA. Methods: The gene expression patterns of 32 umbilical cords from Singaporean babies of Chinese ethnicity across a range of birthweights (1698-4151 g) and gestational ages (35-41 weeks) were determined. We confirmed the differential expression pattern by gestational age for 12 genes in a series of 127 umbilical cords of Chinese, Malay and Indian ethnicity. Results: We found that the transcriptome is substantially influenced by gestational age; but less so by birthweight. We show that some of the expression changes dependent on gestational age are enriched in signal transduction pathways, such as Hedgehog and in genes with roles in cytokine signalling and angiogenesis. We show that some of the gene expression changes we report are reflected in the epigenome. Conclusions: We studied the umbilical cord which is peripheral to disease susceptible tissues. The results suggest that soma-wide transcriptome changes, preserved at the epigenetic level, may be a mechanism whereby birth outcomes are linked to the risk of adult metabolic and arthritic disease and suggest that greater attention be given to the association between premature birth and later disease risk.	[Stuenkel, Walter; Pan, Hong; Chew, Siew Boom; Tng, Emilia; Tan, Jun Hao; Chen, Li; Joseph, Roy; Cheong, Clara Y.; Ong, Mei-Lyn; Lee, Yung Seng; Meaney, Michael J.; Gluckman, Peter D.; Holbrook, Joanna D.] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Lee, Yung Seng; Chong, Yap-Seng; Saw, Seang Mei] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Sheppard, Allan M.; Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; University of Auckland	Stunkel, W (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.	Walter_Stunkel@sics.a-star.edu.sg; joanna_holbrook@sics.a-star.edu.sg	Hanson, Mark/AAE-8236-2019; Lee, Yung Seng/F-2169-2014; Inskip, Hazel/L-5467-2018; Venkatesh, Sudhakar/T-9385-2019	Hanson, Mark/0000-0002-6907-613X; Lee, Yung Seng/0000-0002-1253-0557; Godfrey, Keith/0000-0002-4643-0618; Shek, Lynette/0000-0001-9064-8983; TINT, Mya Thway/0000-0002-9548-7186; Inskip, Hazel/0000-0001-8897-1749; Kapur, Jeevesh/0000-0002-5696-0233; Ferguson-Smith, Anne/0000-0002-7608-5894; Chong, Yap Seng/0000-0002-7232-8473; Venkatesh, Sudhakar/0000-0002-7514-1030; Holbrook, Joanna/0000-0003-1791-6894; Yap, Fabian/0000-0003-1083-7958	Singapore National Medical Research council; Agency for Science Technology and Research; MRC [MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish	Singapore National Medical Research council(National Medical Research Council, Singapore); Agency for Science Technology and Research(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The GUSTO Cohort is supported by a Translational Clinical Research Flagship programme grant from the Singapore National Medical Research council. http://www.nmrc.gov.sg/content/nmrc_internet/home/our_research/tcr_flagship_programme.html. SICS Investigators are supported in part through Agency for Science Technology and Research funding. http://www.a-star.edu.sg/AboutASTAR/Overview/tabid/140/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2012, CHEM BIODIV IN PRESS; Alfaidy N, 2003, J CLIN ENDOCR METAB, V88, P5033, DOI 10.1210/jc.2002-021915; Alisi A, 2011, ANN MED; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Baird J, 2011, OSTEOPOROSIS INT, V22, P1323, DOI 10.1007/s00198-010-1344-9; Belkacemi L, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-105; Bell PA, 2011, LOSS MATRILIN DOES N; Benameur T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012688; Borish L, 2011, CURR ALLERGY ASTHM R, V11, P7, DOI 10.1007/s11882-010-0153-8; Breukhoven PE, 2011, EUR J ENDOCRINOL, V164, P133, DOI 10.1530/EJE-10-0573; Briana DD, 2011, INTRAUTERINE GROWTH; Briana DD, 2008, BONE, V42, P307, DOI 10.1016/j.bone.2007.10.002; Broekman BFP, 2009, PEDIATRICS, V123, pE1011, DOI 10.1542/peds.2008-3344; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Cohen J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r210; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Deckelbaum RA, 2002, J CELL SCI, V115, P3015; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; Duran-Gonzalez J, 2011, ARCH MED RES, V42, P523, DOI 10.1016/j.arcmed.2011.10.010; Fan JB, 2011, RHEUMATOL INT, V31, P629, DOI 10.1007/s00296-009-1341-5; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311; Gluckman PD, 2010, GENOME MED, V2, DOI 10.1186/gm135; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Hofman Paul L., 2006, Metabolic Syndrome and Related Disorders, V4, P101, DOI 10.1089/met.2006.4.101; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Holroyd C, 2012, OSTEOPOROSIS INT, V23, P401, DOI 10.1007/s00198-011-1671-5; Honma T, 2011, BIOGERONTOLOGY; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Hoyo C, 2011, EPIGENETICS, V6; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Kajantie E, 2002, CLIN ENDOCRINOL, V57, P635, DOI 10.1046/j.1365-2265.2002.01659.x; Kajantie E, 2010, DIABETES CARE, V33, P2623, DOI 10.2337/dc10-0912; Kanaka-Gantenbein C, 2010, ANN NY ACAD SCI, V1205, P99, DOI 10.1111/j.1749-6632.2010.05683.x; Kistner A, 2002, PEDIATR RES, V51, P675, DOI 10.1203/01.PDR.0000017482.64723.C4; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Krukier II, 2003, B EXP BIOL MED+, V136, P369, DOI 10.1023/B:BEBM.0000010954.15992.68; Leach L, 2011, MICROCIRCULATION, V18, P253, DOI 10.1111/j.1549-8719.2011.00097.x; Lewis RM, 2012, BONE, V50, P337, DOI 10.1016/j.bone.2011.11.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehata Y, 2010, FREE RADICAL RES, V44, P913, DOI 10.3109/10715762.2010.490836; Mason E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014479; Mauro A, 2011, FOLIA HISTOCHEM CYTO, V49, P211, DOI 10.5603/FHC.2011.0029; McTernan CL, 2001, J CLIN ENDOCR METAB, V86, P4979, DOI 10.1210/jc.86.10.4979; Moon SS, 2011, ENDOCR J, V58, P949, DOI 10.1507/endocrj.EJ11-0035; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Nanetti L, 2008, BJOG-INT J OBSTET GY, V115, P14, DOI 10.1111/j.1471-0528.2007.01567.x; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Picard C, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/BLO0b013e3180d09d9c; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Qiu AQ, 2012, NEUROIMAGE, V59, P1065, DOI 10.1016/j.neuroimage.2011.09.032; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Relton CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031821; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Schroeder JW, 2011, EPIGENETICS-US, V6, P1498, DOI 10.4161/epi.6.12.18296; Scott MN, 2011, J DEV BEHAV PEDIAT; Sebert S, 2011, AM J CLIN NUTR; Skilton MR, 2011, ARTERIOSCL THROM VAS, V31, P2975, DOI 10.1161/ATVBAHA.111.234757; Soh SE, 2012, COHORT PROFILE UNPUB; Sohi G, 2011, SEMIN REPROD MED, V29, P246, DOI 10.1055/s-0031-1275523; Takahashi M, 2007, BIOCHEM BIOPH RES CO, V364, P1037, DOI 10.1016/j.bbrc.2007.10.120; Tanegashima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010321; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Tu XL, 2012, DEV BIOL, V362, P76, DOI 10.1016/j.ydbio.2011.11.013; van der Kaay DCM, 2009, GROWTH HORM IGF RES, V19, P198, DOI 10.1016/j.ghir.2008.08.010; Wang K, 2011, J ENDOCRINOL; Wirbelauer J, 2011, EUR J OBSTET GYN R B, V155, P31, DOI 10.1016/j.ejogrb.2010.11.013; Zhang ZL, 2012, J BONE MINER METAB, V30, P69, DOI 10.1007/s00774-011-0284-6; Zuckerman-Levin N, 2011, PEDIATR RES, V70, P208, DOI 10.1203/PDR.0b013e3182226a0c	82	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39744	10.1371/journal.pone.0039744	http://dx.doi.org/10.1371/journal.pone.0039744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808055	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000306355500013
J	Dechet, AM; Parsons, M; Rambaran, M; Mohamed-Rambaran, P; Florendo-Cumbermack, A; Persaud, S; Baboolal, S; Ari, MD; Shadomy, SV; Zaki, SR; Paddock, CD; Clark, TA; Harris, L; Lyon, D; Mintz, ED				Dechet, Amy M.; Parsons, Michele; Rambaran, Madan; Mohamed-Rambaran, Pheona; Florendo-Cumbermack, Anita; Persaud, Shamdeo; Baboolal, Shirematee; Ari, Mary D.; Shadomy, Sean V.; Zaki, Sherif R.; Paddock, Christopher D.; Clark, Thomas A.; Harris, Lazenia; Lyon, Douglas; Mintz, Eric D.			Leptospirosis Outbreak following Severe Flooding: A Rapid Assessment and Mass Prophylaxis Campaign; Guyana, January-February 2005	PLOS ONE			English	Article							PULMONARY HEMORRHAGE; NICARAGUA; DIAGNOSIS; EPIDEMIC; DENGUE; TRIAL	Background: Leptospirosis is a zoonosis usually transmitted through contact with water or soil contaminated with urine from infected animals. Severe flooding can put individuals at greater risk for contracting leptospirosis in endemic areas. Rapid testing for the disease and large-scale interventions are necessary to identify and control infection. We describe a leptospirosis outbreak following severe flooding and a mass chemoprophylaxis campaign in Guyana. Methodology/Principal Findings: From January-March 2005, we collected data on suspected leptospirosis hospitalizations and deaths. Laboratory testing included anti-leptospiral dot enzyme immunoassay (DST), immunohistochemistry (IHC) staining, and microscopic agglutination testing (MAT). DST testing was conducted for 105 (44%) of 236 patients; 52 (50%) tested positive. Four (57%) paired serum samples tested by MAT were confirmed leptospirosis. Of 34 total deaths attributed to leptospirosis, postmortem samples from 10 (83%) of 12 patients were positive by IHC. Of 201 patients interviewed, 89% reported direct contact with flood waters. A 3-week doxycycline chemoprophylaxis campaign reached over 280,000 people. Conclusions: A confirmed leptospirosis outbreak in Guyana occurred after severe flooding, resulting in a massive chemoprophylaxis campaign to try to limit morbidity and mortality.	[Dechet, Amy M.; Parsons, Michele; Ari, Mary D.; Shadomy, Sean V.; Zaki, Sherif R.; Paddock, Christopher D.; Clark, Thomas A.; Harris, Lazenia; Mintz, Eric D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Dechet, Amy M.] Portland Providence Med Ctr, Portland, OR USA; [Rambaran, Madan; Mohamed-Rambaran, Pheona; Florendo-Cumbermack, Anita] Georgetown Publ Hosp Corp, Georgetown, Guyana; [Persaud, Shamdeo] Minist Hlth, Georgetown, Guyana; [Baboolal, Shirematee] Caribbean Epidemiol Ctr, Port Of Spain, Trinidad Tobago; [Lyon, Douglas] Ctr Dis Control & Prevent, Georgetown, Guyana; [Lyon, Douglas] La Clin Carino, Hood River, OR USA	Centers for Disease Control & Prevention - USA	Dechet, AM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	adechet@gmail.com	Shadomy, Sean/ABA-1234-2020					Alexander AD, 1986, MANUAL CLIN LAB IMMU, P435; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2006, CARIBBEAN NET NEWS; Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brett-Major DM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007342.pub2; CDC, 1995, MMWR-MORBID MORTAL W, V44, P841; Center CE, 2008, MORB REV COMM DIS CA; Chawla V, 2004, J Assoc Physicians India, V52, P619; COLE JR, 1973, APPL MICROBIOL, V25, P976, DOI 10.1128/AEM.25.6.976-980.1973; Drazen JM, 2005, NEW ENGL J MED, V352, P827, DOI 10.1056/NEJMe058031; Galloway RL, 2009, EPIDEMIOL INFECT, V137, P1323, DOI 10.1017/S0950268808001751; Gaynor K, 2007, AM J TROP MED HYG, V76, P882, DOI 10.4269/ajtmh.2007.76.882; Genrich GL, 2007, AM J TROP MED HYG, V76, P251, DOI 10.4269/ajtmh.2007.76.251; Gonsalez Claudio R., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P59, DOI 10.1590/S0036-46651998000100012; Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2003, MANUAL CLIN MICROBIO; Liverpool J, 2008, ANN TROP MED PARASIT, V102, P239, DOI 10.1179/136485908X278784; MOTIE A, 1986, TROP ANIM HEALTH PRO, V18, P113, DOI 10.1007/BF02359724; MYERS DM, 1985, TROP ANIM HEALTH PRO, V17, P239, DOI 10.1007/BF02356985; Pradutkanchana Jintana, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P175; Saenz R, 1995, Prehosp Disaster Med, V10, P154; Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Sehgal SC, 2000, INT J ANTIMICROB AG, V13, P249, DOI 10.1016/S0924-8579(99)00134-X; Silverman MS, 2004, ANN TROP MED PARASIT, V98, P851, DOI 10.1179/000349804X3216; Sun AH, 2011, BIOMED ENVIRON SCI, V24, P291, DOI 10.3967/0895-3988.2011.03.013; TAKAFUJI ET, 1984, NEW ENGL J MED, V310, P497, DOI 10.1056/NEJM198402233100805; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; White F, 1994, Bull Pan Am Health Organ, V28, P73; Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8	35	40	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39672	10.1371/journal.pone.0039672	http://dx.doi.org/10.1371/journal.pone.0039672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808049	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700016
J	Jiang, F; Yang, ML; Guo, W; Wang, XH; Kang, L				Jiang, Feng; Yang, Meiling; Guo, Wei; Wang, Xianhui; Kang, Le			Large-Scale Transcriptome Analysis of Retroelements in the Migratory Locust, Locusta migratoria	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; TRANSPOSABLE ELEMENTS; RNA-SEQ; GENE-EXPRESSION; PHASE-CHANGES; WEB SERVER; GENOME; EVOLUTION; FAMILIES; CLASSIFICATION	Background: Retroelements can successfully colonize eukaryotic genome through RNA-mediated transposition, and are considered to be some of the major mediators of genome size. The migratory locust Locusta migratoria is an insect with a large genome size, and its genome is probably subject to the proliferation of retroelements. An analysis of deep-sequencing transcriptome data will elucidate the structure, diversity and expression characteristics of retroelements. Results: We performed a de novo assembly from deep sequencing RNA-seq data and identified 105 retroelements in the locust transcriptome. Phylogenetic analysis of reverse transcriptase sequences revealed 1 copia, 1 BEL, 8 gypsy and 23 non-long terminal repeat (LTR) retroelements in the locust transcriptome. A novel approach was developed to identify full-length LTR retroelements. A total of 5 full-length LTR retroelements and 2 full-length non-LTR retroelements that contained complete structures for retrotransposition were identified. Structural analysis indicated that all these retroelements may have been activated or deprived of retrotransposition activities very recently. Expression profiling analysis revealed that the retroelements exhibited a unique expression pattern at the egg stage and showed differential expression profiles between the solitarious and gregarious phases at the fifth instar and adult stage. Conclusion: We hereby present the first de novo transcriptome analysis of retroelements in a species whose genome is not available. This work contributes to a comprehensive understanding of the landscape of retroelements in the locust transcriptome. More importantly, the results reveal that non-LTR retroelements are abundant and diverse in the locust transcriptome.	[Jiang, Feng; Yang, Meiling; Guo, Wei; Wang, Xianhui; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Yang, Meiling] Shanxi Univ, Coll Life Sci & Technol, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Shanxi University	Jiang, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022; Guo, Wei/A-7089-2008; Jiang, Feng/AHC-5102-2022	Kang, Le/0000-0003-4262-2329; Guo, Wei/0000-0001-9081-9754; Jiang, Feng/0000-0002-7407-7604	National Major Special Science and Technology Project [2009ZX08009-099B]; National Natural Science Foundation of China [30970407, 31100925]; Doctoral Program of Higher Education of China [20101401120008]	National Major Special Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Major Special Science and Technology Project (2009ZX08009-099B), National Natural Science Foundation of China (No. 30970407), National Natural Science Foundation of China (Grant No. 31100925) and Doctoral Program of Higher Education of China (20101401120008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova I, 2005, BIOESSAYS, V27, P76, DOI 10.1002/bies.20159; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Biedler J, 2003, MOL BIOL EVOL, V20, P1811, DOI 10.1093/molbev/msg189; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blumenstiel JP, 2011, TRENDS GENET, V27, P23, DOI 10.1016/j.tig.2010.10.003; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Capy P, 2005, CYTOGENET GENOME RES, V110, P457, DOI 10.1159/000084978; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clegg MT, 2000, P NATL ACAD SCI USA, V97, P7016, DOI 10.1073/pnas.97.13.7016; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Dufresne F, 2011, CHROMOSOME RES, P1; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eickbush TH, 2002, CURR OPIN GENET DEV, V12, P669, DOI 10.1016/S0959-437X(02)00359-3; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Faunes F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022569; Fernandez-Medina RD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-260; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Guo BC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-396; Guo W, 2010, J INSECT PHYSIOL, V56, P943, DOI 10.1016/j.jinsphys.2010.05.007; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Han JS, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-15; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hawkins JS, 2009, P NATL ACAD SCI USA, V106, P17811, DOI 10.1073/pnas.0904339106; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kapitonov VV, 2009, GENE, V448, P207, DOI 10.1016/j.gene.2009.07.019; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kojima KK, 2011, MOL BIOL EVOL, V28, P17, DOI 10.1093/molbev/msq220; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Malik HS, 1998, MOL BIOL EVOL, V15, P1123, DOI 10.1093/oxfordjournals.molbev.a026020; Mansour A, 2007, J CELL MOL BIOL, V6, P99; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Minervini CF, 2009, GENE, V440, P42, DOI 10.1016/j.gene.2009.03.021; Moczek AP, 2010, PHILOS T R SOC B, V365, P593, DOI 10.1098/rstb.2009.0263; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Novick PA, 2009, MOL BIOL EVOL, V26, P1811, DOI 10.1093/molbev/msp090; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; PARKHURST SM, 1987, EMBO J, V6, P419, DOI 10.1002/j.1460-2075.1987.tb04771.x; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Pons J, 2005, MOL BIOL EVOL, V22, P991, DOI 10.1093/molbev/msi085; Raghavan N, 2007, INT J PARASITOL, V37, P1307, DOI 10.1016/j.ijpara.2007.04.002; Rho MN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-425; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028167; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schon I, 2006, GENE, V371, P296, DOI 10.1016/j.gene.2005.12.007; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Tomilin NV, 2008, BIOESSAYS, V30, P338, DOI 10.1002/bies.20741; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; Wang SZ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r61; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Xu AG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000843; Zhao FQ, 2009, GENOME RES, V19, P1384, DOI 10.1101/gr.091363.109	77	25	30	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40532	10.1371/journal.pone.0040532	http://dx.doi.org/10.1371/journal.pone.0040532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792363	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800104
J	Nolan, MS; Podoll, AS; Hause, AM; Akers, KM; Finkel, KW; Murray, KO				Nolan, Melissa S.; Podoll, Amber S.; Hause, Anne M.; Akers, Katherine M.; Finkel, Kevin W.; Murray, Kristy O.			Prevalence of Chronic Kidney Disease and Progression of Disease Over Time among Patients Enrolled in the Houston West Nile Virus Cohort	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; GLOMERULAR-FILTRATION-RATE; INFECTION; URINE; PERSISTENCE; BIOMARKER; EQUATION; INJURY; NGAL	Introduction: In experimental models of West Nile virus (WNV) infection, animals develop chronic kidney infection with histopathological changes in the kidney up to 8-months post-infection. However, the long term pathologic effects of acute infection in humans are largely unknown. The purpose of this study was to assess renal outcomes following WNV infection, specifically the development of chronic kidney disease (CKD). Methods: In a cohort of 139 study participants with a previous diagnosis of WNV infection, we investigated the prevalence of CKD using the Kidney Disease Outcomes Quality Initiative (KDOQI) criteria based on the Modification of Diet in Renal Disease (MDRD) formula and urinary abnormalities, and assessed various risk factors and biomarkers. Results: Study participants were primarily male (60%) and non-Hispanic white (86%) with a mean age of 57 years. Most (83%) were four to nine years post-infection at the time of this study. Based on the KDOQI definition, 40% of participants had evidence of CKD, with 10% having Stage III or greater and 30% having Stage I-II. By urinary dipstick testing, 26% of patients had proteinuria and 23% had hematuria. Plasma NGAL levels were elevated in 14% of participants while MCP-1 levels were increased in 12%. Over 1.5 years, the average change in eGFR was -3.71 mL/min/1.73 m(2). Only a history of Neuroinvasive WNV disease was independently associated with CKD following multivariate analysis. Discussion: We found a high prevalence of CKD after long term follow-up in a cohort of participants previously infected with WNV. The majority of those with CKD are in Stage I-II indicating early stages of renal disease. Traditional risk factors were not associated with the presence of CKD in this population. Therefore, clinicians should regularly evaluate all patients with a history of WNV for evidence of CKD.	[Nolan, Melissa S.; Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Podoll, Amber S.; Akers, Katherine M.; Finkel, Kevin W.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Houston, TX USA; [Hause, Anne M.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Nolan, MS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	KMurray@bcm.edu			Gillson Longenbaugh Foundation; NIH/NIAID [5R01AI091816-01, K23AI057341, N01 AI 50027-03, U19AI089992-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050027, R01AI091816, K23AI057341, U19AI089992] Funding Source: NIH RePORTER	Gillson Longenbaugh Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was generously funded by the Gillson Longenbaugh Foundation and the NIH/NIAID (5R01AI091816-01, K23AI057341, N01 AI 50027-03, and U19AI089992-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemtam N, 2012, NEPHROL DIAL TRANSPL, V27, P1847, DOI 10.1093/ndt/gfr561; [Anonymous], 2002, KDOQI CLIN PRACT GUI; [Anonymous], 2010, DIR SERV; Baty SA, 2012, J INFECT DIS, V205, P1476, DOI 10.1093/infdis/jis221; Clark WF, 2011, J AM SOC NEPHROL, V22, P1729, DOI 10.1681/ASN.2010111217; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Haase-Fielitz A, 2009, NEPHROL DIAL TRANSPL, V24, P3349, DOI 10.1093/ndt/gfp234; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lindsey NP, 2012, VECTOR-BORNE ZOONOT, V12, P230, DOI 10.1089/vbz.2011.0721; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339; Murray KO, CLIN VACCINE I UNPUB; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Murray KO, 2008, VECTOR-BORNE ZOONOT, V8, P167, DOI 10.1089/vbz.2007.0109; Papa A, 2011, J MED VIROL, V83, P1857, DOI 10.1002/jmv.22190; Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238; Zhang XL, 2012, KIDNEY INT, V81, P401, DOI 10.1038/ki.2011.354	21	60	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40374	10.1371/journal.pone.0040374	http://dx.doi.org/10.1371/journal.pone.0040374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792293	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800073
J	Wong, IPL; Driessler, F; Khor, EC; Shi, YC; Hormer, B; Nguyen, AD; Enriquez, RF; Eisman, JA; Sainsbury, A; Herzog, H; Baldock, PA				Wong, Iris P. L.; Driessler, Frank; Khor, Ee Cheng; Shi, Yan-Chuan; Hoermer, Birgit; Nguyen, Amy D.; Enriquez, Ronaldo F.; Eisman, John A.; Sainsbury, Amanda; Herzog, Herbert; Baldock, Paul A.			Peptide YY Regulates Bone Remodeling in Mice: A Link between Gut and Skeletal Biology	PLOS ONE			English	Article							MINERAL DENSITY; BARIATRIC SURGERY; NEUROPEPTIDE-Y; WEIGHT-LOSS; RECEPTORS; MASS; APPETITE; ESTROGEN; WOMEN; LEADS	Background & Aims: Gastrointestinal peptides are increasingly being linked to processes controlling the maintenance of bone mass. Peptide YY (PYY), a gut-derived satiety peptide of the neuropeptide Y family, is upregulated in some states that also display low bone mass. Importantly, PYY has high affinity for Y-receptors, particularly Y1R and Y2R, which are known to regulate bone mass. Anorexic conditions and bariatric surgery for obesity influence circulating levels of PYY and have a negative impact on bone mass, but the precise mechanism behind this is unclear. We thus examined whether alterations in PYY expression affect bone mass. Methods: Bone microstructure and cellular activity were analyzed in germline PYY knockout and conditional adult-onset PYY over-expressing mice at lumbar and femoral sites using histomorphometry and micro-computed tomography. Results: PYY displayed a negative relationship with osteoblast activity. Male and female PYY knockout mice showed enhanced osteoblast activity, with greater cancellous bone mass. Conversely, PYY over-expression lowered osteoblast activity in vivo, via a direct Y1 receptor mediated mechanism involving MAPK stimulation evident in vitro. In contrast to PYY knockout mice, PYY over expression also altered bone resorption, as indicated by greater osteoclast surface, despite the lack of Y-receptor expression in osteoclastic cells. While evident in both sexes, cellular changes were generally more pronounced in females. Conclusions: These data demonstrate that the gut peptide PYY is critical for the control of bone remodeling. This regulatory axis from the intestine to bone has the potential to contribute to the marked bone loss observed in situations of extreme weight loss and higher circulating PYY levels, such as anorexia and bariatric obesity surgery, and may be important in the maintenance of bone mass in the general population.	[Wong, Iris P. L.; Driessler, Frank; Khor, Ee Cheng; Shi, Yan-Chuan; Nguyen, Amy D.; Enriquez, Ronaldo F.; Sainsbury, Amanda; Herzog, Herbert; Baldock, Paul A.] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Eisman, John A.; Herzog, Herbert; Baldock, Paul A.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Wong, IPL (corresponding author), Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia.	p.baldock@garvan.org.au	Eisman, John A/C-2886-2014; Shi, Yanchuan/H-5608-2012; Baldock, Paul/B-3840-2012; Salis, Amanda/A-3187-2011; Herzog, Herbert/B-8294-2008; Nguyen, Amy D/K-2588-2019	Shi, Yanchuan/0000-0002-8368-6735; Salis, Amanda/0000-0001-9176-1574; Nguyen, Amy D/0000-0003-4603-564X; , Herbert/0000-0002-1713-1029	National Health and Medical Research Council [427632]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Study funded by (in part) National Health and Medical Research Council grant 427632. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Bose M, 2010, OBESITY, V18, P1085, DOI 10.1038/oby.2009.473; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Ding KH, 2008, J BONE MINER RES, V23, P536, DOI 10.1359/JBMR.071202; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Fleischer J, 2008, J CLIN ENDOCR METAB, V93, P3735, DOI 10.1210/jc.2008-0481; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hegde SS, 1995, J PHARMACOL EXP THER, V275, P1261; Henriksen DB, 2009, BONE; Igwe JC, 2009, J CELL BIOCHEM, V108, P621, DOI 10.1002/jcb.22294; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Lee NJ, 2010, BONE; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Misra M, 2006, J CLIN ENDOCR METAB, V91, P1027, DOI 10.1210/jc.2005-1878; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Pournaras DJ, 2010, OBES SURG, V20, P56, DOI 10.1007/s11695-009-9989-1; Rapuri PB, 2004, J CLIN ENDOCR METAB, V89, P4954, DOI 10.1210/jc.2004-0434; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Russell M, 2009, BONE, V45, P104, DOI 10.1016/j.bone.2009.03.668; Scheid JL, 2011, BONE, V49, P194, DOI 10.1016/j.bone.2011.04.011; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Shi YC, 2012, NEUROPEPTID IN PRESS; Tsai WS, 2007, ARCH PEDIAT ADOL MED, V161, P217, DOI 10.1001/archpedi.161.3.217; Utz AL, 2008, BONE, V43, P135, DOI 10.1016/j.bone.2008.03.007; Valderas JP, 2010, J CLIN ENDOCR METAB, V95, P1069, DOI 10.1210/jc.2009-0983; Viegas M, 2010, ARQ BRAS ENDOCRINOL, V54, P158, DOI 10.1590/S0004-27302010000200011; von Mach MA, 2004, METABOLISM, V53, P918, DOI 10.1016/j.metabol.2004.01.015; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Wong IPL, 2010, CURR OPIN ENDOCRINOL, V17, P44, DOI 10.1097/MED.0b013e3283344a05; Wortley KE, 2007, GASTROENTEROLOGY, V133, P1534, DOI 10.1053/j.gastro.2007.08.024; Wucher H, 2008, OBES SURG, V18, P58, DOI 10.1007/s11695-007-9258-0; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yuzuriha H, 2007, FASEB J, V21, P2108, DOI 10.1096/fj.06-7621com	42	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40038	10.1371/journal.pone.0040038	http://dx.doi.org/10.1371/journal.pone.0040038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792209	Green Submitted, gold, Green Published			2022-12-25	WOS:000306461800032
J	Etxebeste, O; Herrero-Garcia, E; Cortese, MS; Garzia, A; Oiartzabal-Arano, E; de los Rios, V; Ugalde, U; Espeso, EA				Etxebeste, Oier; Herrero-Garcia, Erika; Cortese, Marc S.; Garzia, Aitor; Oiartzabal-Arano, Elixabet; de los Rios, Vivian; Ugalde, Unai; Espeso, Eduardo A.			GmcA Is a Putative Glucose-Methanol-Choline Oxidoreductase Required for the Induction of Asexual Development in Aspergillus nidulans	PLOS ONE			English	Article							DROSOPHILA-NINAG OXIDOREDUCTASE; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTORS; PROTEIN; FLBB; ESTABLISHMENT; DEGRADATION; MAINTENANCE; SPORULATION; EXPRESSION	Aspergillus nidulans asexual differentiation is induced by Upstream Developmental Activators (UDAs) that include the bZIP-type Transcription Factor (TF) FlbB. A 2D-PAGE/MS-MS-coupled screen for proteins differentially expressed in the presence and absence of FlbB identified 18 candidates. Most candidates belong to GO term classes involved in osmotic and/or oxidative stress response. Among these, we focused on GmcA, a putative glucose-methanol-choline oxidoreductase which is upregulated in a Delta flbB background. GmcA is not required for growth since no differences were detected in the radial extension upon deletion of gmcA. However, its activity is required to induce conidiation under specific culture conditions. A Delta gmcA strain conidiates profusely under acid conditions but displays a characteristic fluffy aconidial phenotype in alkaline medium. The absence of asexual development in a Delta gmcA strain can be suppressed, on one hand, using high concentrations of non-fermentable carbon sources like glycerol, and on the other hand, when the cMyb-type UDA TF flbD is overexpressed. Overall, the results obtained in this work support a role for GmcA at early stages of conidiophore initiation.	[Etxebeste, Oier; Cortese, Marc S.; Garzia, Aitor; Oiartzabal-Arano, Elixabet; Ugalde, Unai] Univ Basque Country Manuel de Lardizabal, Fac Chem, Dept Appl Chem, San Sebastian, Spain; [Herrero-Garcia, Erika; de los Rios, Vivian; Espeso, Eduardo A.] Ctr Invest Biol CSIC, Dept Med Celular & Mol, Madrid, Spain; [Cortese, Marc S.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Basque Foundation for Science	Etxebeste, O (corresponding author), Univ Basque Country Manuel de Lardizabal, Fac Chem, Dept Appl Chem, San Sebastian, Spain.	oier.echeveste@ehu.es	Espeso, Eduardo A/AAC-7238-2022; Espeso, Eduardo A/C-5259-2011; Etxebeste, Oier/H-8064-2019; Cortese, Marc/G-4026-2010	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Etxebeste, Oier/0000-0002-9786-6091; Garzia, Aitor/0000-0002-6270-1369; Cortese, Marc/0000-0002-5903-0525	Basque Government [SA-2010/00105, IT393-10]; Ministerio de Ciencia e Innovacion [BFU2010-17528, BFU2009-08701]; University of The Basque Country [BFU2010-17528]; Basque Government	Basque Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of The Basque Country; Basque Government(Basque Government)	This work has been supported by the Basque Government (SA-2010/00105 and IT393-10) and Ministerio de Ciencia e Innovacion (BFU2010-17528) to U.U. and to E.A.E. through grant BFU2009-08701. O.E was a contract researcher of The University of The Basque Country and is now associated to grant BFU2010-17528. E.H.-G. and A.G. held a predoctoral fellowship from the Basque Government, and M.S.C. was a contract researcher of the Ikerbasque program of the Basque Government (www.ikerbasque.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Ahmad ST, 2006, J BIOL CHEM, V281, P9205, DOI 10.1074/jbc.M510293200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atoui A, 2010, FUNGAL GENET BIOL, V47, P962, DOI 10.1016/j.fgb.2010.08.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CASTRILLO JI, 1995, YEAST, V11, P1353, DOI 10.1002/yea.320111404; Cortese MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017505; De Loof Arnold, 2006, Insect Science, V13, P325, DOI 10.1111/j.1744-7917.2006.00101.x; Dinan L, 2001, PHYTOCHEMISTRY, V57, P325, DOI 10.1016/S0031-9422(01)00078-4; Durbin R., 1998, BIOL SEQUENCE ANAL P; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Etxebeste O, 2008, EUKARYOT CELL, V7, P38, DOI 10.1128/EC.00207-07; Etxebeste O, 2010, CURR PROTEIN PEPT SC, V11, P704, DOI 10.2174/138920310794557682; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Ferreira P, 2009, J BIOL CHEM, V284, P24840, DOI 10.1074/jbc.M109.011593; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; Garzia A, 2009, MOL MICROBIOL, V71, P172, DOI 10.1111/j.1365-2958.2008.06520.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris SD, 2009, MOL MICROBIOL, V73, P733, DOI 10.1111/j.1365-2958.2009.06803.x; Herrero-Garcia E, 2011, FUNGAL BIOL-UK, V115, P393, DOI 10.1016/j.funbio.2011.02.005; Hervas-Aguilar A, 2010, EUKARYOT CELL, V9, P1504, DOI 10.1128/EC.00119-10; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; KAFER E, 1965, GENETICS, V52, P217; Kniemeyer O, 2011, PROTEOMICS, V11, P3232, DOI 10.1002/pmic.201100087; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; Lee AG, 1996, RHODOPSIN G PROTEIN; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Pontecorvo G, 1994, ASPERGILLUS 50 YEARS, P23; Pusztahelyi T, 2011, FUNGAL GENET BIOL, V48, P92, DOI 10.1016/j.fgb.2010.08.006; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Seki T, 1998, EUR J BIOCHEM, V257, P522, DOI 10.1046/j.1432-1327.1998.2570522.x; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SKROMNE I, 1995, MICROBIOL-SGM, V141, P21, DOI 10.1099/00221287-141-1-21; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Soid-Raggi G, 2006, MOL MICROBIOL, V59, P854, DOI 10.1111/j.1365-2958.2005.04996.x; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; WIESER J, 1994, CURR GENET, V27, P62, DOI 10.1007/BF00326580; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zamocky M, 2004, GENE, V338, P1, DOI 10.1016/j.gene.2004.04.025	65	18	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40292	10.1371/journal.pone.0040292	http://dx.doi.org/10.1371/journal.pone.0040292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792266	Green Published, gold			2022-12-25	WOS:000306436300049
J	Ikenaga, N; Ohuchida, K; Mizumoto, K; Akagawa, S; Fujiwara, K; Eguchi, D; Kozono, S; Ohtsuka, T; Takahata, S; Tanaka, M				Ikenaga, Naoki; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Akagawa, Shin; Fujiwara, Kenji; Eguchi, Daiki; Kozono, Shingo; Ohtsuka, Takao; Takahata, Shunichi; Tanaka, Masao			Pancreatic Cancer Cells Enhance the Ability of Collagen Internalization during Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CATHEPSIN-B; RECEPTOR ENDO180; PROMOTES; UPARAP/ENDO-180; IDENTIFICATION; INVASIVENESS; DEGRADATION; INTEGRINS	Background: Extracellular matrix (ECM) remodeling is predominantly mediated by fibroblasts using intracellular and extracellular pathways. Although it is well known that extracellular degradation of the ECM by proteases derived from cancer cells facilitates cellular invasion, the intracellular degradation of ECM components by cancer cells has not been clarified. The aim of this study was to characterize collagen internalization, which is the initial step of the intracellular degradation pathway in pancreatic cancer cells, in light of epithelial-mesenchymal transition (EMT). Methodology/Principal Findings: We analyzed the function of collagen internalization in two pancreatic cancer cell lines, SUIT-2 and KP-2, and pancreatic stellate cells (PSCs) using Oregon Green 488-gelatin. PSCs had a strong ability for collagen uptake, and the pancreatic cancer cells also internalized collagen although less efficiently. The collagen internalization abilities of SUIT-2 and KP-2 cells were promoted by EMT induced by human recombinant transforming growth factor beta 1 (P<0.05). Expression of Endo180, a collagen uptake receptor, was high in mesenchymal pancreatic cancer cell lines, as determined by EMT marker expression (P<0.01). Quantitative RT-PCR and western blot analyses showed that Endo180 expression was also increased by EMT induction in SUIT-2 and KP-2 cells. Endo180 knockdown by RNA interference attenuated the collagen uptake (P<0.01) and invasive abilities (P<0.05) of SUIT-2 and KP-2 cells. Conclusions/Significance: Pancreatic cancer cells are capable of collagen internalization, which is enhanced by EMT. This ECM clearance system may be a novel mechanism for cellular invasion and a potential therapeutic target in pancreatic cancer.	[Ikenaga, Naoki; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Akagawa, Shin; Fujiwara, Kenji; Eguchi, Daiki; Kozono, Shingo; Ohtsuka, Takao; Takahata, Shunichi; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Ikenaga, Naoki] Japan Soc Promot Sci, Tokyo, Japan; [Ohuchida, Kenoki] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka 812, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka 812, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University	Ikenaga, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan.	kenoki@surg1.med.kyushu-u.ac.jp; mizumoto@surg1.med.kyushu-u.ac.jp	Fujiwara, Kenji/AAI-8431-2021	Fujiwara, Kenji/0000-0001-5900-9382; Ohuchida, Kenoki/0000-0003-4792-1168	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Fukuoka Foundation for Sound Health; Grants-in-Aid for Scientific Research [24390318] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Uehara Memorial Foundation and the Fukuoka Foundation for Sound Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ikenaga N, 2011, GASTROENTEROLOGY, V139; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Menke A, 2001, CANCER RES, V61, P3508; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Niedergethmann M, 2004, PANCREAS, V29, P204, DOI 10.1097/00006676-200410000-00005; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Quintanilla-Dieck MJ, 2008, J INVEST DERMATOL, V128, P2281, DOI 10.1038/jid.2008.63; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sameni Mansoureh, 2003, Mol Imaging, V2, P159, DOI 10.1162/153535003322556903; Segal G, 2001, J CELL SCI, V114, P119; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Szpaderska AM, 2004, ANTICANCER RES, V24, P3887; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496	40	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40434	10.1371/journal.pone.0040434	http://dx.doi.org/10.1371/journal.pone.0040434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792318	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300066
J	Ortuno-Pineda, C; Galindo-Rosales, JM; Calderon-Salinas, JV; Villegas-Sepulveda, N; Saucedo-Cardenas, O; De Nova-Ocampo, M; Valdes, J				Ortuno-Pineda, Carlos; Manuel Galindo-Rosales, Jose; Victor Calderon-Salinas, Jose; Villegas-Sepulveda, Nicolas; Saucedo-Cardenas, Odila; De Nova-Ocampo, Monica; Valdes, Jesus			Binding of hnRNP H and U2AF65 to Respective G-codes and a Poly-Uridine Tract Collaborate in the N50-5 ' ss Selection of the REST N Exon in H69 Cells	PLOS ONE			English	Article							PRE-MESSENGER-RNA; 5' SPLICE SITES; LUNG-CANCER; U1 SNRNP; POLYPYRIMIDINE-TRACT; TARGET GENES; RICH MOTIFS; REPRESSOR; RECOGNITION; PROTEINS	The splicing of the N exon in the pre-mRNA coding for the RE1-silencing transcription factor (REST) results in a truncated protein that modifies the expression pattern of some of its target genes. A weak 3'ss, three alternative 5'ss (N4-, N50-, and N62-5'ss) and a variety of putative target sites for splicing regulatory proteins are found around the N exon; two GGGG codes (G2-G3) and a poly-Uridine tract (N-PU) are found in front of the N50-5'ss. In this work we analyzed some of the regulatory factors and elements involved in the preferred selection of the N50-5'ss (N50 activation) in the small cell lung cancer cell line H69. Wild type and mutant N exon/beta-globin minigenes recapitulated N50 exon splicing in H69 cells, and showed that the N-PU and the G2-G3 elements are required for N50 exon splicing. Biochemical and knockdown experiments identified these elements as U2AF65 and hnRNP H targets, respectively, and that they are also required for N50 exon activation. Compared to normal MRC5 cells, and in keeping with N50 exon activation, U2AF65, hnRNP H and other splicing factors were highly expressed in H69 cells. CLIP experiments revealed that hnRNP H RNA-binding occurs first and is a prerequisite for U2AF65 RNA binding, and EMSA and CLIP experiments suggest that U2AF65-RNA recognition displaces hnRNP H and helps to recruit other splicing factors (at least U1 70K) to the N50-5'ss. Our results evidenced novel hnRNP H and U2AF65 functions: respectively, U2AF65-recruiting to a 5'ss in humans and the hnRNP H-displacing function from two juxtaposed GGGG codes.	[Ortuno-Pineda, Carlos; Manuel Galindo-Rosales, Jose; Victor Calderon-Salinas, Jose; Valdes, Jesus] Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico; [Saucedo-Cardenas, Odila] Univ Autonoma Nuevo Leon, Fac Med, Dept Histol, Monterrey, NL, Mexico; [Saucedo-Cardenas, Odila] Inst Mexicano Seguro Social, Ctr Invest Biomed NE, Div Genet, Monterrey, NL, Mexico; [De Nova-Ocampo, Monica] Escuela Nacl Med & Homeopatia IPN, Programa Inst Biomed Mol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma de Nuevo Leon; Instituto Mexicano del Seguro Social	Ortuno-Pineda, C (corresponding author), Ctr Invest & Estudios Avanzados IPN, Dept Bioquim, Mexico City, DF, Mexico.	jvaldes@cinvestav.mx		Villegas-Sepulveda, Nicolas/0000-0001-9489-2545; De Nova Ocampo, Monica/0000-0002-0750-7977	CONACyT [49355-M, 127557-M]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported with funds from CONACyT (Grants Nos. 49355-M and 127557-M, and a Postgraduate Scholarship to COP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznarez I, 2008, GENOME RES, V18, P1247, DOI 10.1101/gr.073155.107; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Boehr DD, 2012, BIOESSAYS; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Chou MY, 1999, MOL CELL BIOL, V19, P69; Coulson JM, 1999, CANCER RES, V59, P5123; Coulson JM, 2000, CANCER RES, V60, P1840; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Forch P, 2003, BIOCHEM J, V372, P235, DOI 10.1042/BJ20021202; Grabowski PJ, 2004, BIOCHEM SOC T, V32, P924, DOI 10.1042/BST0320924; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; Immaneni A, 2000, NUCLEIC ACIDS RES, V28, P3403, DOI 10.1093/nar/28.17.3403; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kirschbaum-Slager Natanja, 2004, Genet Mol Res, V3, P512; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Magin A, 2002, NEUROCHEM INT, V40, P195, DOI 10.1016/S0197-0186(01)00091-2; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Scheer JM, 2001, ANAL BIOCHEM, V298, P130, DOI 10.1006/abio.2001.5384; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40315	10.1371/journal.pone.0040315	http://dx.doi.org/10.1371/journal.pone.0040315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792276	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000306436300051
J	Ditmer, MA; Stapleton, SP				Ditmer, Mark Allan; Stapleton, Seth Patrick			Factors Affecting Hatch Success of Hawksbill Sea Turtles on Long Island, Antigua, West Indies	PLOS ONE			English	Article							NEST-SITE SELECTION; ERETMOCHELYS-IMBRICATA; CARETTA-CARETTA; CLIMATE-CHANGE; LEATHERBACK; SAND; MORTALITY; PREFERENCES; TEMPERATURE; RECRUITMENT	Current understanding of the factors influencing hawksbill sea turtle (Eretmochelys imbricata) hatch success is disparate and based on relatively short-term studies or limited sample sizes. Because global populations of hawksbills are heavily depleted, evaluating the parameters that impact hatch success is important to their conservation and recovery. Here, we use data collected by the Jumby Bay Hawksbill Project (JBHP) to investigate hatch success. The JBHP implements saturation tagging protocols to study a hawksbill rookery in Antigua, West Indies. Habitat data, which reflect the varied nesting beaches, are collected at egg deposition, and nest contents are exhumed and categorized post-emergence. We analyzed hatch success using mixed-model analyses with explanatory and predictive datasets. We incorporated a random effect for turtle identity and evaluated environmental, temporal and individual-based reproductive variables. Hatch success averaged 78.6% (SD: 21.2%) during the study period. Highly supported models included multiple covariates, including distance to vegetation, deposition date, individual intra-seasonal nest number, clutch size, organic content, and sand grain size. Nests located in open sand were predicted to produce 10.4 more viable hatchlings per clutch than nests located >1.5 m into vegetation. For an individual first nesting in early July, the fourth nest of the season yielded 13.2 more viable hatchlings than the initial clutch. Generalized beach section and inter-annual variation were also supported in our explanatory dataset, suggesting that gaps remain in our understanding of hatch success. Our findings illustrate that evaluating hatch success is a complex process, involving multiple environmental and individual variables. Although distance to vegetation and hatch success were inversely related, vegetation is an important component of hawksbill nesting habitat, and a more complete assessment of the impacts of specific vegetation types on hatch success and hatchling sex ratios is needed. Future research should explore the roles of sand structure, nest moisture, and local weather conditions.	[Ditmer, Mark Allan; Stapleton, Seth Patrick] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Stapleton, Seth Patrick] Jumby Bay Hawksbill Project, St Johns, Bonaire, Netherlands	University of Minnesota System; University of Minnesota Twin Cities	Ditmer, MA (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	ditme004@umn.edu			Jumby Bay Island Company (JBIC)	Jumby Bay Island Company (JBIC)	All funding for the years of our study was provided by the Jumby Bay Island Company (JBIC - http://www.jumbybayisland.com/home.html). The Jumby Bay Hawksbill Project (JBHP) is a member of the Wider Caribbean Sea Turtle Conservation Network (WIDECAST). WIDECAST manages JBIC's annual contribution supporting the JBHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1981, COPEIA, P757; Barton BT, 2008, BIOL CONSERV, V141, P2139, DOI 10.1016/j.biocon.2008.06.013; BJORNDAL KA, 1985, COPEIA, P736, DOI 10.2307/1444767; Bourgeois S, 2009, BIOL CONSERV, V142, P85, DOI 10.1016/j.biocon.2008.09.028; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Burnham KP., 2002, MODEL SELECTION MULT, P496; Chouinard MP, 2007, AUK, V124, P1305, DOI 10.1642/0004-8038(2007)124[1305:SAHUOM]2.0.CO;2; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dobbs Kirstin A., 1999, Chelonian Conservation and Biology, V3, P344; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Eckert K., 2006, 2 WIDECAST, P40; Ficetola GF, 2007, ORYX, V41, P402, DOI 10.1017/S0030605307000543; Fish MR, 2005, CONSERV BIOL, V19, P482, DOI 10.1111/j.1523-1739.2005.00146.x; Glen F, 2004, GLOBAL CHANGE BIOL, V10, P2036, DOI 10.1111/j.1529-8817.2003.00865.x; Hamann M, 2003, CRC MAR BIOL SER, P135; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hays GC, 2001, OIKOS, V93, P87, DOI 10.1034/j.1600-0706.2001.930109.x; Hitchins PM, 2004, J ZOOL, V264, P383, DOI 10.1017/s0952836904005904; HORROCKS JA, 1991, MAR ECOL PROG SER, V69, P1, DOI 10.3354/meps069001; Kamel SJ, 2005, ANIM BEHAV, V70, P819, DOI 10.1016/j.anbehav.2005.01.006; Kamel SJ, 2006, ECOLOGY, V87, P2947, DOI 10.1890/0012-9658(2006)87[2947:IMOINS]2.0.CO;2; Kamel SJ, 2006, ECOL APPL, V16, P923, DOI 10.1890/1051-0761(2006)016[0923:DROSRD]2.0.CO;2; KRAEMER JE, 1980, HERPETOLOGICA, V36, P72; Levasseur K, 2011, MONITORING ERETMOCHE, P38; Marcovaldi MA, 1997, CAN J ZOOL, V75, P755, DOI 10.1139/z97-097; Marcovaldi Maria Angela, 2007, Endangered Species Research, V3, P133, DOI 10.3354/esr003133; Marcovaldi Maria Angela, 1999, Chelonian Conservation and Biology, V3, P301; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Mazaris AD, 2009, AMPHIBIA-REPTILIA, V30, P221, DOI 10.1163/156853809788201180; Mazerolle M.J., 2009, AICCMODAVG MODEL SEL; MCGINLEY MA, 1989, EVOL ECOL, V3, P150, DOI 10.1007/BF02270917; Meylan Anne B., 1999, Chelonian Conservation and Biology, V3, P200; Miller Jeffrey D., 1999, P124; Miller Jeffrey D., 1997, P51; MORTIMER J. A., 1982, BIOL CONSERVATION SE, P45; MORTIMER JA, 1990, COPEIA, P802, DOI 10.2307/1446446; Mortimer JA, 2008, IUCN 2010 IUCN RED L; Pike DA, 2006, J HERPETOL, V40, P91, DOI 10.1670/100-05N.1; Pike DA, 2008, ENVIRON MANAGE, V41, P461, DOI 10.1007/s00267-006-0434-0; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; Richardson James I., 1999, Chelonian Conservation and Biology, V3, P244; Stapleton SP, 2010, P 28 ANN S SEA TURTL, P189; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; Wallace BP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P423, DOI 10.1086/420951; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; West B, 2007, LINEAR MIXED MODELS, P376; WHITMORE CP, 1985, BIOL CONSERV, V34, P251, DOI 10.1016/0006-3207(85)90095-3; Wood DW, 2000, COPEIA, P119; WOOD VE, 1986, BIOL CONSERV, V37, P321, DOI 10.1016/0006-3207(86)90076-5; Zuur Alain F., 2009, P1	53	32	36	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38472	10.1371/journal.pone.0038472	http://dx.doi.org/10.1371/journal.pone.0038472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802928	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900002
J	Wang, XF; Liu, F; Zhou, S; Xu, ZP; Hoellwarth, J; Chen, XJ; He, L; Zhang, RB; Liu, F; Wang, J; Su, C				Wang, Xuefeng; Liu, Fan; Zhou, Sha; Xu, Zhipeng; Hoellwarth, Jason; Chen, Xiaojun; He, Lei; Zhang, Rongbo; Liu, Feng; Wang, Jun; Su, Chuan			Partial Regulatory T Cell Depletion Prior to Schistosomiasis Vaccination Does Not Enhance the Protection	PLOS ONE			English	Article							MEDIATED ANTITUMOR IMMUNITY; DNA VACCINE; IN-VIVO; JAPONICUM; RESPONSES; IL-10; INFECTION; MELANOMA; IMMUNOTHERAPY; CHEMOTHERAPY	CD4(+)CD25(+) regulatory T cells (Tregs) do not only influence self-antigen specific immune responses, but also dampen the protective effect induced by a number of vaccines. The impact of CD4(+)CD25(+) Tregs on vaccines against schistosomiasis, a neglected tropical disease that is a major public health concern, however, has not been examined. In this study, a DNA vaccine encoding a 26 kDa glutathione S-transferase of Schistosoma japonicum (pVAX1-Sj26GST) was constructed and its potential effects were evaluated by depleting CD25(+) cells prior to pVAX1-Sj26GST immunization. This work shows that removal of CD25(+) cells prior to immunization with the pVAX1-Sj26GST schistosomiasis DNA vaccine significantly increases the proliferation of splenocytes and IgG levels. However, CD25(+) cell-depleted mice immunized with pVAX1-Sj26GST show no improved protection against S. japonicum. Furthermore, depletion of CD25(+) cells causes an increase in both proinflammatory cytokines (e. g. IFN-gamma, GM-CSF and IL-4) and an anti-inflammatory cytokine (e. g. IL-10), with CD4(+)CD25(-) T cells being one of the major sources of both IFN-gamma and IL-10. These findings indicate that partial CD25(+) cell depletion fails to enhance the effectiveness of the schistosome vaccine, possibly due to IL-10 production by CD4(+)CD25(-) T cells, or other cell types, after CD25(+) cell depletion during vaccination.	[Wang, Xuefeng; Zhang, Rongbo; Wang, Jun] Anhui Univ Sci & Technol, Sch Med, Dept Pathogen Biol & Immunol, Huainan, Anhui, Peoples R China; [Liu, Fan] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Zhou, Sha; Xu, Zhipeng; Chen, Xiaojun; He, Lei; Liu, Feng; Su, Chuan] Nanjing Med Univ, Jiangsu Key Lab Pathogen Biol, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Hoellwarth, Jason] Univ So Calif, Keck Sch Med, Dept Educ Affairs, Los Angeles, CA 90033 USA	Anhui University of Science & Technology; Xiamen University; Nanjing Medical University; University of Southern California	Wang, XF (corresponding author), Anhui Univ Sci & Technol, Sch Med, Dept Pathogen Biol & Immunol, Huainan, Anhui, Peoples R China.	wangxxff1023@yahoo.com.cn	Chen, Xiaojun/P-8288-2017; He, Lei/L-4726-2019; Chen, Xiaojun/AAD-9401-2022; xu, zhipeng/M-7708-2019	Chen, Xiaojun/0000-0002-3698-2814; Chen, Xiaojun/0000-0002-3698-2814; xu, zhipeng/0000-0002-8853-5303; He, Lei/0000-0002-3821-2047	National Natural Science Foundation of China [30801046]; Anhui Academic and Technical Reserve Candidate Leaders; Anhui University of Science and Technology [2010YB004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Academic and Technical Reserve Candidate Leaders; Anhui University of Science and Technology	This work was supported by grant from the National Natural Science Foundation of China (No. 30801046), the grant from the Anhui Academic and Technical Reserve Candidate Leaders, and the grant 2010YB004 from Anhui University of Science and Technology to Xuefeng Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2009, PARASITOL RES, V104, P955, DOI 10.1007/s00436-009-1371-7; Aloysius MM, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-18; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bergquist NR, 2005, TRENDS PARASITOL, V21, P112, DOI 10.1016/j.pt.2005.01.001; Bhowmick S, 2009, INFECT IMMUN, V77, P1514, DOI 10.1128/IAI.01739-07; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Cabrera G, 2011, MEDICINA-BUENOS AIRE, V71, P243; Capron A, 2005, TRENDS PARASITOL, V21, P143, DOI 10.1016/j.pt.2005.01.003; Cardoso LS, 2010, CLIN EXP IMMUNOL, V160, P266, DOI 10.1111/j.1365-2249.2009.04084.x; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Cools N, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89195; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Fujio K, 2010, ADV IMMUNOL, V105, P99, DOI 10.1016/S0065-2776(10)05004-2; Furuichi Y, 2005, WORLD J GASTROENTERO, V11, P3772, DOI 10.3748/wjg.v11.i24.3772; Hong H, 2010, CLIN EXP IMMUNOL, V159, P93, DOI 10.1111/j.1365-2249.2009.04018.x; HOON DSB, 1990, CANCER RES, V50, P5358; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jing WQ, 2011, BLOOD, V117, P6952, DOI 10.1182/blood-2010-12-326108; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kim B, 2008, VACCINE, V26, P5601, DOI 10.1016/j.vaccine.2008.07.099; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Layland LE, 2010, J IMMUNOL, V184, P713, DOI 10.4049/jimmunol.0901435; Li MJ, 2011, EXP PARASITOL, V128, P427, DOI 10.1016/j.exppara.2011.05.012; Li YS, 1999, ACTA TROP, V73, P79, DOI 10.1016/S0001-706X(99)00019-4; Liu XS, 2009, J IMMUNOL, V183, P51, DOI 10.4049/jimmunol.0802047; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Maizels RM, 2011, ADV IMMUNOL, V112, P73, DOI 10.1016/B978-0-12-387827-4.00003-6; Matsushita N, 2008, J IMMUNOL METHODS, V333, P167, DOI 10.1016/j.jim.2008.01.012; McAleer JP, 2010, TRENDS IMMUNOL, V31, P429, DOI 10.1016/j.it.2010.08.005; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; McManus DP, 2005, PARASITE IMMUNOL, V27, P297, DOI 10.1111/j.1365-3024.2005.00784.x; Mikkelsen SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017183; Onizuka S, 1999, CANCER RES, V59, P3128; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; Tabbara KS, 2005, INFECT IMMUN, V73, P4714, DOI 10.1128/IAI.73.8.4714-4722.2005; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; TIU WU, 1988, PARASITE IMMUNOL, V10, P693, DOI 10.1111/j.1365-3024.1988.tb00255.x; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Toossi Z, 2011, CLIN EXP IMMUNOL, V163, P333, DOI 10.1111/j.1365-2249.2010.04269.x; Tuettenberg Andrea, 2007, J Dtsch Dermatol Ges, V5, P190, DOI 10.1111/j.1610-0387.2007.06179.x; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Wang XF, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-109; Wang XF, 2009, EUR J IMMUNOL, V39, P3052, DOI 10.1002/eji.200939335; Wei F, 2008, VACCINE, V26, P4145, DOI 10.1016/j.vaccine.2008.05.034; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Zhang L, 2008, MICROBES INFECT, V10, P251, DOI 10.1016/j.micinf.2007.11.009	60	4	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40359	10.1371/journal.pone.0040359	http://dx.doi.org/10.1371/journal.pone.0040359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802961	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900035
J	Adesso, L; Calabretta, S; Barbagallo, F; Capurso, G; Pilozzi, E; Geremia, R; Delle Fave, G; Sette, C				Adesso, L.; Calabretta, S.; Barbagallo, F.; Capurso, G.; Pilozzi, E.; Geremia, R.; Delle Fave, G.; Sette, C.			Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway	ONCOGENE			English	Article						eIF4E phosphorylation; MNK2 alternative splicing; drug resistance	INITIATION-FACTOR 4E; MAMMALIAN TARGET; EIF4E; PHOSPHORYLATION; TRANSLATION; MNK2; OVEREXPRESSION; PROLIFERATION; VARIANTS; KINASES	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive neoplastic disease. Gemcitabine, the currently used chemotherapeutic drug for PDAC, elicits only minor benefits, because of the development of escape pathways leading to chemoresistance. Herein, we aimed at investigating the involvement of the mitogen activating protein kinase interacting kinase (MNK)/eIF4E pathway in the acquired drug resistance of PDAC cells. Screening of a cohort of PDAC patients by immunohistochemistry showed that eIF4E phosphorylation correlated with disease grade, early onset of disease and worse prognosis. In PDAC cell lines, chemotherapeutic drugs induced MNK-dependent phosphorylation of eIF4E. Importantly, pharmacological inhibition of MNK activity synergistically enhanced the cytostatic effect of gemcitabine, by promoting apoptosis. RNA interference (RNAi) experiments indicated that MNK2 is mainly responsible for eIF4E phosphorylation and gemcitabine resistance in PDAC cells. Furthermore, we found that gemcitabine induced the expression of the oncogenic splicing factor SRSF1 and splicing of MNK2b, a splice variant that overrides upstream regulatory pathways and confers increased resistance to the drug. Silencing of SRSF1 by RNAi abolished this splicing event and recapitulated the effects of MNK pharmacological or genetic inhibition on eIF4E phosphorylation and apoptosis in gemcitabine-treated cells. Our results highlight a novel pro-survival pathway triggered by gemcitabine in PDAC cells, which leads to MNK2-dependent phosphorylation of eIF4E, suggesting that the MNK/eIF4E pathway represents an escape route utilized by PDAC cells to withstand chemotherapeutic treatments.	[Adesso, L.; Calabretta, S.; Barbagallo, F.; Geremia, R.; Delle Fave, G.; Sette, C.] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy; [Adesso, L.; Calabretta, S.; Capurso, G.; Pilozzi, E.; Delle Fave, G.] Univ Roma La Sapienza, Digest & Liver Dis Unit, Sch Med 2, I-00133 Rome, Italy; [Barbagallo, F.; Sette, C.] Fdn Santa Lucia, Lab Neuroembryol, Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome; IRCCS Santa Lucia	Delle Fave, G (corresponding author), Univ Roma La Sapienza, Digest & Liver Dis Unit, Sch Med 2, I-00133 Rome, Italy.	gianfranco.dellefave@uniroma1.it; claudio.sette@uniroma2.it	PILOZZI, Emanuela/AAC-1854-2022; Sette, Claudio/S-4307-2019; Barbagallo, Federica/K-1185-2018; Capurso, Gabriele/AAB-1389-2019; Adesso, Laura/AAA-7708-2020; Barbagallo, Federica/AAD-4903-2022	PILOZZI, Emanuela/0000-0002-7110-9172; Sette, Claudio/0000-0003-2864-8266; Barbagallo, Federica/0000-0002-2972-370X; Capurso, Gabriele/0000-0002-0019-8753; Adesso, Laura/0000-0003-2121-4924; Barbagallo, Federica/0000-0002-2972-370X; GEREMIA, Raffaele/0000-0001-9056-6603	Associazione Italiana Ricerca sul Cancro [AIRC IG10348]; Association for International Cancer Research (AICR); Worldwide Cancer Research [12-0150] Funding Source: researchfish	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research (AICR); Worldwide Cancer Research	We wish to thank Professor CG Proud for the generous gift of MNK2a and MNK2b plasmids, Professor A Scarpa for the gift of HPAF2 cells, Dr Enrica Bianchi for help with FACS analysis, Dr Maria Antonietta Talerico for technical support with immunohistochemistry and Dr Alessia Di Florio for helpful suggestions throughout the study. This work was supported by funds from the Associazione Italiana Ricerca sul Cancro (AIRC IG10348) and Association for International Cancer Research (AICR).	Altman JK, 2010, MOL PHARMACOL, V78, P778, DOI 10.1124/mol.110.064642; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Chrestensen CA, 2007, GENES CELLS, V12, P1133, DOI 10.1111/j.1365-2443.2007.01122.x; Culjkovic B, 2005, J CELL BIOL, V169, P245, DOI 10.1083/jcb.200501019; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Falasca M, 2011, ANTI-CANCER AGENT ME, V11, P455, DOI 10.2174/187152011795677382; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Goncalves V, 2009, MUTAT RES-FUND MOL M, V662, P33, DOI 10.1016/j.mrfmmm.2008.12.001; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kern SE, 2011, J PATHOL, V223, P295, DOI 10.1002/path.2813; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; O'Loghlen A, 2004, EXP CELL RES, V299, P343, DOI 10.1016/j.yexcr.2004.06.006; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Sanz DJ, 2010, CLIN CANCER RES, V16, P1957, DOI 10.1158/1078-0432.CCR-09-2564; Scheper GC, 2003, MOL CELL BIOL, V23, P5692, DOI 10.1128/MCB.23.16.5692-5705.2003; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zhang Y, 2008, BIOCHEM BIOPH RES CO, V367, P54, DOI 10.1016/j.bbrc.2007.12.118; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	32	87	93	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2013	32	23					2848	2857		10.1038/onc.2012.306	http://dx.doi.org/10.1038/onc.2012.306			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	22797067				2022-12-25	WOS:000320369100005
J	Jones, KB; Su, L; Jin, H; Lenz, C; Randall, RL; Underhill, TM; Nielsen, TO; Sharma, S; Capecchi, MR				Jones, K. B.; Su, L.; Jin, H.; Lenz, C.; Randall, R. L.; Underhill, T. M.; Nielsen, T. O.; Sharma, S.; Capecchi, M. R.			SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas	ONCOGENE			English	Article						synovial sarcoma; apoptosis; chemotherapy; targeted therapy; mouse model	CELL LINE; BCL-2; EXPRESSION; PROTEIN; INHIBITOR; INSIGHTS; MODEL	Synovial sarcoma is a deadly malignancy with limited sensitivity to traditional cytotoxic chemotherapy. SS18-SSX fusion oncogene expression characterizes human synovial sarcomas and drives oncogenesis in a mouse model. Elevated expression of BCL2 is considered a consistent feature of the synovial sarcoma expression profile. Our objective was to evaluate the expression of apoptotic pathway members in synovial sarcomas and interrogate the impact of modulating SS18-SSX expression on this pathway. We show in human and murine synovial sarcoma cells that SS18-SSX increases BCL2 expression, but represses other anti-apoptotic genes, including MCL1 and BCL2A1. This repression is achieved by directly suppressing expression via binding through activating transcription factor 2 (ATF2) to the cyclic adenosine monophosphate (AMP) response element (CRE) in the promoters of these genes and recruiting TLE1/Groucho. The suppression of these two anti-apoptotic pathways silences the typical routes by which other tumors evade BH3-domain peptidomimetic pharmacotherapy. We show that mouse and human synovial sarcoma cells are sensitive in vitro to ABT-263, a BH3-peptidomimetic, much more than the other tested cancer cell lines. ABT-263 also enhances the sensitivity of these cells to doxorubicin, a traditional cytotoxic chemotherapy used for synovial sarcoma. We also demonstrate the capacity of ABT-263 to stunt synovial sarcomagenesis in vivo in a genetic mouse model. These data recommend pursuit of BH3-peptidomimetic pharmacotherapy in human synovial sarcomas.	[Jones, K. B.; Jin, H.; Randall, R. L.] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Jones, K. B.; Jin, H.; Lenz, C.; Randall, R. L.; Sharma, S.; Capecchi, M. R.] Univ Utah, Ctr Childrens Canc Res, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Jones, K. B.; Jin, H.; Lenz, C.; Capecchi, M. R.] Univ Utah, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA; [Su, L.; Underhill, T. M.; Nielsen, T. O.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Su, L.; Underhill, T. M.; Nielsen, T. O.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Sharma, S.] Univ Utah, Dept Med, Div Hematol Oncol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of British Columbia; University of British Columbia; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Howard Hughes Med Inst, 15 North 2030 East Room 5440, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu			Huntsman Cancer Foundation; National Cancer Institute (NIH) [K08CA138764]; Canadian Cancer Society Research Institute [018355]; Terry Fox Foundation; CIHR Institute of Cancer [TFF 105265]; NATIONAL CANCER INSTITUTE [K08CA138764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021168] Funding Source: NIH RePORTER	Huntsman Cancer Foundation; National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; CIHR Institute of Cancer(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the support of the Paul Nabil Bustany Fund for Synovial Sarcoma Research, the Huntsman Cancer Foundation, and career development support from National Cancer Institute (NIH) K08CA138764. This work was also supported by grants from the Canadian Cancer Society Research Institute (Grant no. 018355) and the Terry Fox Foundation and CIHR Institute of Cancer (TFF 105265). We thank Matt Hockin, PhD, at the University of Utah for producing the TATCre protein.	Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Haldar M, 2009, CANCER RES, V69, P3657, DOI 10.1158/0008-5472.CAN-08-4127; Hirakawa N, 1996, HUM PATHOL, V27, P1060, DOI 10.1016/S0046-8177(96)90284-1; Joshi SK, 2002, GENESIS, V33, P48, DOI 10.1002/gene.10089; Joyner DE, 2006, J ORTHOP RES, V24, P474, DOI 10.1002/jor.20087; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Knosel T, 2010, EUR J CANCER, V46, P1170, DOI 10.1016/j.ejca.2010.01.032; Ladanyi M, 2002, CANCER RES, V62, P135; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu TM, 2011, ARTHRITIS RHEUM-US, V63, P2711, DOI 10.1002/art.30430; Mancuso T, 2000, LAB INVEST, V80, P805, DOI 10.1038/labinvest.3780085; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nakayama R, 2010, AM J SURG PATHOL, V34, P1599, DOI 10.1097/PAS.0b013e3181f7ce2c; Su L, 2010, ONCOGENE, V29, P4352, DOI 10.1038/onc.2010.204; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Sun BC, 2006, EUR J CANCER PREV, V15, P258, DOI 10.1097/01.cej.0000198896.02185.68; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304	21	26	26	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2013	32	18					2365	2371		10.1038/onc.2012.247	http://dx.doi.org/10.1038/onc.2012.247			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22797074	Green Accepted			2022-12-25	WOS:000318683600013
J	Makarava, N; Kovacs, GG; Savtchenko, R; Alexeeva, I; Budka, H; Rohwer, RG; Baskakov, IV				Makarava, Natallia; Kovacs, Gabor G.; Savtchenko, Regina; Alexeeva, Irina; Budka, Herbert; Rohwer, Robert G.; Baskakov, Ilia V.			Stabilization of a Prion Strain of Synthetic Origin Requires Multiple Serial Passages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; SCRAPIE AGENT; MOUSE SCRAPIE; HAMSTERS; PROTEIN; DISEASE; INFECTIVITY; RATS; MICE; REPLICATION	Transmission of prions to a new host is frequently accompanied by strain adaptation, a phenomenon that involves reduction of the incubation period, a change in neuropathological features and, sometimes, tissue tropism. Here we show that a strain of synthetic origin (SSLOW), although serially transmitted within the same species, displayed the key attributes of the strain adaptation process. At least four serial passages were required to stabilize the strain-specific SSLOW phenotype. The biological titration of SSLOW revealed a correlation between clinical signs and accumulation of PrPSc in brains of animals inoculated with high doses (10(-1)-10(-5) diluted brain material), but dissociation between the two processes at low dose inocula (10(-6)-10(-8) diluted brain material). At low doses, several asymptomatic animals harbored large amounts of PrPSc comparable with those seen in the brains of terminally ill animals, whereas one clinically ill animal had very little, if any, PrPSc. In summary, the current study illustrates that the phenomenon of prion strain adaptation is more common than generally thought and could be observed upon serial transmission without changing the host species. When PrPSc is seeded by recombinant PrP structures different from that of authentic PrPSc, PrPSc properties continued to evolve for as long as four serial passages.	[Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Rohwer, Robert G.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Kovacs, Gabor G.; Budka, Herbert] Med Univ Vienna, Inst Neurol, AKH 4J, A-1097 Vienna, Austria; [Alexeeva, Irina; Rohwer, Robert G.] Vet Affairs Maryland Hlth Care Syst, Med Res Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Medical University of Vienna	Baskakov, IV (corresponding author), 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu	Budka, Herbert/I-3486-2019; Kovacs, Gabor/A-7468-2013	Budka, Herbert/0000-0002-1933-1577; Kovacs, Gabor/0000-0003-3841-5511	National Institutes of Health [NS045585, NS074998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585, R56NS074998, R01NS074998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045585 and NS074998 (to I. V. B.).	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bailey JD, 2008, J ENDOCRINOL, V197, P251, DOI 10.1677/JOE-07-0516; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; CHANDLER R. L., 1963, RES VET SCI, V4, P276; CHANDLER RL, 1972, RES VET SCI, V31, P219, DOI 10.1016/S0034-5288(18)34031-1; CHANDLER RL, 1963, LANCET, V2, P1165; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collins SJ, 2005, NEUROBIOL DIS, V20, P336, DOI 10.1016/j.nbd.2005.03.014; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; Dickinson A G, 1976, Front Biol, V44, P209; Gonzalez-Montalban N, 2011, BIOCHEMISTRY-US, V50, P7933, DOI 10.1021/bi200950v; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; KIMBERLIN RH, 1979, J GEN VIROL, V42, P107, DOI 10.1099/0022-1317-42-1-107; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1730; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; PATTISON IH, 1968, RES VET SCI, V9, P408; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; SOMERVILLE RA, 1983, J GEN VIROL, V64, P2045, DOI 10.1099/0022-1317-64-9-2045; Thackray AM, 2012, J COMP PATHOL, V147, P316, DOI 10.1016/j.jcpa.2012.01.009; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; ZLOTNIK I, 1963, LANCET, V2, P1072	50	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30205	30214		10.1074/jbc.M112.392985	http://dx.doi.org/10.1074/jbc.M112.392985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807452	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000308579800015
J	Pehar, M; Jonas, MC; Hare, TM; Puglielli, L				Pehar, Mariana; Jonas, Mary Cabell; Hare, Theresa M.; Puglielli, Luigi			SLC33A1/AT-1 Protein Regulates the Induction of Autophagy Downstream of IRE1/XBP1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA TRANSPORTER; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; LYSINE ACETYLATION; MEMBRANE-PROTEIN; ER; STRESS; XBP1; LUMEN; YEAST	One of the main functions of the unfolded protein response is to ensure disposal of large protein aggregates that accumulate in the lumen of the endoplasmic reticulum (ER) whereas avoiding, at least under nonlethal levels of ER stress, cell death. When tightly controlled, autophagy-dependent ER-associated degradation (ERAD(II)) allows the cell to recover from the transient accumulation of protein aggregates; however, when unchecked, it can be detrimental and cause autophagic cell death/type 2 cell death. Here we show that IRE1/XBP1 controls the induction of autophagy/ERAD(II) during the unfolded protein response by activating the ER membrane transporter SLC33A1/AT-1, which ensures continuous supply of acetyl-CoA into the lumen of the ER. Failure to induce AT-1 leads to widespread autophagic cell death. Mechanistically, the regulation of the autophagic process involves N-epsilon-lysine acetylation of Atg9A.	[Puglielli, Luigi] Univ Wisconsin, Dept Med, VAH GRECC, Madison, WI 53705 USA; [Jonas, Mary Cabell; Puglielli, Luigi] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health from the NIA [AG028569, AG033514]; NATIONAL INSTITUTE ON AGING [R01AG028569, P50AG033514] Funding Source: NIH RePORTER	National Institutes of Health from the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG028569 and AG033514 from the NIA (to L. P.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Klionsky DJ, 2006, NATURE, V441, P819, DOI 10.1038/441819a; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matus S, 2009, AUTOPHAGY, V5, P1226, DOI 10.4161/auto.5.8.10247; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pehar M, 2012, J BIOL CHEM, V287, P22436, DOI 10.1074/jbc.C112.362871; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Tamura H, 2010, J HISTOCHEM CYTOCHEM, V58, P443, DOI 10.1369/jhc.2010.955690; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	36	56	58	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29921	29930		10.1074/jbc.M112.363911	http://dx.doi.org/10.1074/jbc.M112.363911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787145	Green Published, hybrid			2022-12-25	WOS:000308286900065
J	Desjardins, JK; Hofmann, HA; Fernald, RD				Desjardins, Julie K.; Hofmann, Hans A.; Fernald, Russell D.			Social Context Influences Aggressive and Courtship Behavior in a Cichlid Fish	PLOS ONE			English	Article							HAPLOCHROMIS-BURTONI; DECEIVE COMPETITORS; FIGHTING FISH; DOMINANCE; EVOLUTION; AUDIENCE; STRATEGY; RANK	Social interactions require knowledge of the environment and status of others, which can be acquired indirectly by observing the behavior of others. When being observed, animals can also alter their signals based on who is watching. Here we observed how male cichlid fish (Astatotilapia burtoni) behave when being watched in two different contexts. In the first, we show that aggressive and courtship behaviors displayed by subordinate males depends critically on whether dominant males can see them, and in the second, we manipulated who was watching aggressive interactions and showed that dominant males will change their behavior depending on audience composition. In both cases, when a more dominant individual is out of view and the audience consists of more subordinate individuals, those males signal key social information to females by displaying courtship and dominant behaviors. In contrast, when a dominant male is present, males cease both aggression and courtship. These data suggest that males are keenly aware of their social environment and modulate their aggressive and courtship behaviors strategically for reproductive and social advantage.	[Desjardins, Julie K.; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Inst Cellular & Mol Biol, Sect Integrat Biol, Austin, TX 78712 USA	Stanford University; University of Texas System; University of Texas Austin	Desjardins, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	desjarjk@stanford.edu	Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X	NSERC; National Science Foundation (NSF) [IOS-0923588]; Deutsche Forschungsgemeinschaft; NSF [IOS-0923588, IOS-0843712]; National Institutes of Health (NIH) [NS034950]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034950, R37NS034950, R01NS034950] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation (NSF)(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JKD was supported by an NSERC Post Doctoral Fellowship and National Science Foundation (NSF) IOS-0923588, HAH by a Deutsche Forschungsgemeinschaft postdoctoral fellowship and NSF IOS-0843712, and RDF by National Institutes of Health (NIH) NS034950 and NSF IOS-0923588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOULTON MJ, 1990, CHILD DEV, V61, P221; Chance MRA, 1976, SOCIAL STRUCTURE ATT; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; Fernald RD, 2003, INTEGR COMP BIOL, V43, P771, DOI 10.1093/icb/43.6.771; Getty T, 1997, TRENDS ECOL EVOL, V12, P159, DOI 10.1016/S0169-5347(97)89783-2; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Kustan JM, 2011, P ROY SOC B IN PRESS; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Maynard-Smith J, 1988, J THEOR BIOL, V177, P305; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; Mitchell RW, 1986, DECEPTION PERSPECTIV; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; PARKER GA, 1981, ANIM BEHAV, V29, P221, DOI 10.1016/S0003-3472(81)80170-4; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Peake TM, 2006, ANIM BEHAV, V72, P1013, DOI 10.1016/j.anbehav.2006.01.029; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Plath M, 2008, CURR BIOL, V18, P1138, DOI 10.1016/j.cub.2008.06.067; Plath M, 2008, BEHAVIOUR, V145, P931, DOI 10.1163/156853908784089225; Plath M, 2010, ACTA ETHOL, V13, P49, DOI 10.1007/s10211-010-0074-5; Plath Martin, 2008, Communicative & Integrative Biology, V1, P199; Raihani NJ, 2011, P ROY SOC B IN PRESS; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1994, ANN NY ACAD SCI, V746, P294; Summers CH, 2005, J COMP PHYSIOL A, V191, P241, DOI 10.1007/s00359-004-0554-z; VAUGHN BE, 1981, DEV PSYCHOL, V17, P275, DOI 10.1037/0012-1649.17.3.275; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; Whiten A., 1985, MACHIAVELLIAN INTELL; Whyte William Foote, 1993, STREET CORNER SOC; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	39	77	77	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e32781	10.1371/journal.pone.0032781	http://dx.doi.org/10.1371/journal.pone.0032781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22807996	Green Published, gold, Green Submitted			2022-12-25	WOS:000306366400001
J	Garvey, LJ; Pavese, N; Ramlackhansingh, A; Thomson, E; Allsop, JM; Politis, M; Kulasegaram, R; Main, J; Brooks, DJ; Taylor-Robinson, SD; Winston, A				Garvey, Lucy J.; Pavese, Nicola; Ramlackhansingh, Anil; Thomson, Emma; Allsop, Joanna M.; Politis, Marios; Kulasegaram, Ranjababu; Main, Janice; Brooks, David J.; Taylor-Robinson, Simon D.; Winston, Alan			Acute HCV/HIV Coinfection Is Associated with Cognitive Dysfunction and Cerebral Metabolite Disturbance, but Not Increased Microglial Cell Activation	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; CENTRAL-NERVOUS-SYSTEM; AIDS DEMENTIA COMPLEX; HIV-POSITIVE PATIENTS; BENZODIAZEPINE-RECEPTOR; BINDING-SITES; BRAIN; INFECTION; PET; IMPAIRMENT	Background: Microglial cell activation and cerebral function impairment are described in both chronic hepatitis C viral (HCV) and Human-Immune-Deficiency viral (HIV) infections. The aim of this study was to investigate the effect of acute HCV infection upon cerebral function and microglial cell activation in HIV-infected individuals. Methods: A case-control study was conducted. Subjects with acute HCV and chronic HIV coinfection (aHCV) were compared to matched controls with chronic HIV monoinfection (HIVmono). aHCV was defined as a new positive plasma HCV RNA within 12 months of a negative RNA test. Subjects underwent neuro-cognitive testing (NCT), cerebral proton magnetic resonance spectroscopy (H-1-MRS) and positron emission tomography (PET) using a C-11-radiolabeled ligand (PK11195), which is highly specific for translocator protein 18 kDA receptors on activated microglial cells. Differences between cases and controls were assessed using linear regression modelling. Results: Twenty-four aHCV cases completed NCT and H-1-MRS, 8 underwent PET. Of 57 HIVmono controls completing NCT, 12 underwent H-1-MRS and 8 PET. Subjects with aHCV demonstrated on NCT, significantly poorer executive function (mean (SD) error rate 26.50(17.87) versus 19.09(8.12), p = 0.001) and on H-1-MRS increased myo-inositol/ creatine ratios (mI/Cr, a marker of cerebral inflammation) in the basal ganglia (ratio of 0.71(0.22) versus 0.55(0.23), p = 0.03), compared to subjects with HIVmono. On PET imaging, no difference in C-11-PK11195 binding potential (BP) was observed between study groups (p > 0.10 all cerebral locations), however lower BPs were associated with combination antiretroviral therapy (cART) use in the parietal (p = 0.01) and frontal (p = 0.03) cerebral locations. Discussion: Poorer cognitive performance and disturbance of cerebral metabolites are observed in subjects with aHC, V compared to subjects with HIVmono. Higher C-11-PK11195 BP was not observed in subjects with aHCV, but was observed in subjects not on cART.	[Garvey, Lucy J.; Thomson, Emma; Main, Janice; Taylor-Robinson, Simon D.; Winston, Alan] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Garvey, Lucy J.; Thomson, Emma; Main, Janice; Winston, Alan] Imperial Coll Healthcare NHS Trust, Dept HIV & GU Med, London, England; [Pavese, Nicola; Ramlackhansingh, Anil; Politis, Marios; Brooks, David J.] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Neurosci Sect, London, England; [Allsop, Joanna M.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Imaging Sci Dept, London, England; [Kulasegaram, Ranjababu] Guys & St Thomas NHS Fdn Trust, Dept HIV & GU Med, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust	Garvey, LJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.	lucy.garvey@nhs.net	Politis, Marios/GYQ-9446-2022; Winston, Alan/AGZ-3015-2022; Thomson, Emma C/M-8690-2017	Winston, Alan/0000-0002-5847-8416; Thomson, Emma C/0000-0003-1482-0889; Brooks, David/0000-0003-2602-2518; Pavese, Nicola/0000-0002-6801-6194	NIHR Biomedical Facility at Imperial College London; Wellcome Trust; United Kingdom National Institute for Health Research (NIHR); British Medical Research Council; European Union; MRC [G1100810, MC_U120036861] Funding Source: UKRI; Medical Research Council [G1100810, MC_U120036861] Funding Source: researchfish	NIHR Biomedical Facility at Imperial College London; Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The NIHR Biomedical Facility at Imperial College London funded infrastructure support. SDT-R holds grants from the Wellcome Trust, the United Kingdom National Institute for Health Research (NIHR), the British Medical Research Council and the European Union (Framework 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Brown AK, 2007, J NUCL MED, V48, P2072, DOI 10.2967/jnumed.107.044842; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; Cagnin A, 2006, GUT, V55, P547, DOI 10.1136/gut.2005.075051; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Christensen JD, 1996, MAGNET RESON MED, V35, P658, DOI 10.1002/mrm.1910350506; Cysique LAJ, 2006, ARCH CLIN NEUROPSYCH, V21, P185, DOI 10.1016/j.acn.2005.07.011; Endres CJ, 2009, J NUCL MED, V50, P1276, DOI 10.2967/jnumed.109.062265; Forton DA, 2005, AIDS, V19, pS53, DOI 10.1097/01.aids.0000192071.72948.77; Forton DM, 2008, J HEPATOL, V49, P316, DOI 10.1016/j.jhep.2008.03.022; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; Forton DM, 2001, LANCET, V358, P38, DOI 10.1016/S0140-6736(00)05270-3; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grover VPB, 2012, J VIRAL HEPATITIS, V19, pE89, DOI 10.1111/j.1365-2893.2011.01510.x; Hammoud DA, 2005, J NEUROVIROL, V11, P346, DOI 10.1080/13550280500187351; Haussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Kim SJ, 2008, J NUCL MED, V49, P39, DOI 10.2967/jnumed.107.045724; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Laskus T, 2002, J VIROL, V76, P10064, DOI 10.1128/JVI.76.19.10064-10068.2002; Letendre SL, 2005, AIDS, V19, pS72, DOI 10.1097/01.aids.0000192073.18691.ff; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; Morgello S, 2005, AIDS, V19, pS116, DOI 10.1097/01.aids.0000192079.49185.f9; Murray J, 2008, J NEUROVIROL, V14, P17, DOI 10.1080/13550280701708427; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Richardson JL, 2005, AIDS, V19, P1659, DOI 10.1097/01.aids.0000186824.53359.62; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rojas S, 2007, J CEREBR BLOOD F MET, V27, P1975, DOI 10.1038/sj.jcbfm.9600500; Ryan EL, 2004, NEUROLOGY, V62, P957, DOI 10.1212/01.WNL.0000115177.74976.6C; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Tozzi V, 2005, AIDS RES HUM RETROV, V21, P706, DOI 10.1089/aid.2005.21.706; Tracey I, 1996, NEUROLOGY, V46, P783, DOI 10.1212/WNL.46.3.783; Turkheimer FE, 2007, J NUCL MED, V48, P158; Venneti S, 2008, J NEUROPATH EXP NEUR, V67, P1001, DOI 10.1097/NEN.0b013e318188b204; Vogel M, 2010, ANTIVIR THER, V15, P267, DOI 10.3851/IMP1501; Weissenborn K, 2004, J HEPATOL, V41, P845, DOI 10.1016/j.jhep.2004.07.022; Wiley CA, 2006, J NEUROVIROL, V12, P262, DOI 10.1080/13550280600873868; Winston A, 2010, J VIRAL HEPATITIS, V17, P419, DOI 10.1111/j.1365-2893.2009.01198.x; Winston A, 2010, CLIN INFECT DIS, V50, P920, DOI 10.1086/650743	44	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e38980	10.1371/journal.pone.0038980	http://dx.doi.org/10.1371/journal.pone.0038980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808022	Green Published, Green Submitted, gold			2022-12-25	WOS:000306366400006
J	Visovatti, SH; Hyman, MC; Bouis, D; Neubig, R; McLaughlin, VV; Pinsky, DJ				Visovatti, Scott H.; Hyman, Matthew C.; Bouis, Diane; Neubig, Richard; McLaughlin, Vallerie V.; Pinsky, David J.			Increased CD39 Nucleotidase Activity on Microparticles from Patients with Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ATP-DIPHOSPHOHYDROLASE; ADENOSINE-DIPHOSPHATE; EXTRACELLULAR ATP; NITRIC-OXIDE; ECTO-ATPASE; IN-VITRO; ACTIVATION; INHIBITION; RECEPTORS	Background: Idiopathic pulmonary arterial hypertension (IPAH) is a devastating disease characterized by increased pulmonary vascular resistance, smooth muscle and endothelial cell proliferation, perivascular inflammatory infiltrates, and in situ thrombosis. Circulating intravascular ATP, ADP, AMP and adenosine activate purinergic cell signaling pathways and appear to induce many of the same pathologic processes that underlie IPAH. Extracellular dephosphorylation of ATP to ADP and AMP occurs primarily via CD39 (ENTPD1), an ectonucleotidase found on the surface of leukocytes, platelets, and endothelial cells [1]. Microparticles are micron-sized phospholipid vesicles formed from the membranes of platelets and endothelial cells. Objectives: Studies here examine whether CD39 is an important microparticle surface nucleotidase, and whether patients with IPAH have altered microparticle-bound CD39 activity that may contribute to the pathophysiology of the disease. Methodology/ Principal Findings: Kinetic parameters, inhibitor blocking experiments, and immunogold labeling with electron microscopy support the role of CD39 as a major nucleotidase on the surface of microparticles. Comparison of microparticle surface CD39 expression and nucleotidase activity in 10 patients with advanced IPAH and 10 healthy controls using flow cytometry and thin layer chromatograph demonstrate the following: 1) circulating platelet (CD39(+) CD31(+) CD42b(+)) and endothelial (CD39(+) CD31(+) CD42b(+)) microparticle subpopulations in patients with IPAH show increased CD39 expression; 2) microparticle ATPase and ADPase activity in patients with IPAH is increased. Conclusions/ Significance: We demonstrate for the first time increased CD39 expression and function on circulating microparticles in patients with IPAH. Further research is needed to elucidate whether these findings identify an important trigger for the development of the disease, or reflect a physiologic response to IPAH.	[Visovatti, Scott H.; Bouis, Diane; McLaughlin, Vallerie V.; Pinsky, David J.] Univ Michigan, Dept Med, Div Cardiol, Ann Arbor, MI 48109 USA; [Hyman, Matthew C.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Neubig, Richard] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Michigan System; University of Michigan	Visovatti, SH (corresponding author), Univ Michigan, Dept Med, Div Cardiol, Ann Arbor, MI 48109 USA.	shv@med.umich.edu		Hyman, Matthew/0000-0002-4050-6925; Neubig, Richard/0000-0003-0501-0008	Pulmonary Hypertension Breakthrough Initiative; NIH [P01HL089407-04, R01HL086676-05, R01HL085149-04, T32HL007853-14]; Taubman Medical Research Institute of the University of Michigan; Cardiovascular Medical Research and Education Fund (CMREF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853, R01HL086676, R01HL085149, P01HL089407] Funding Source: NIH RePORTER	Pulmonary Hypertension Breakthrough Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taubman Medical Research Institute of the University of Michigan; Cardiovascular Medical Research and Education Fund (CMREF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Pulmonary Hypertension Breakthrough Initiative (DJP), and NIH grants P01HL089407-04 (DJP), R01HL086676-05 (DJP), R01HL085149-04 (DJP), T32HL007853-14 (SHV. and DJP), and the Taubman Medical Research Institute of the University of Michigan. Funding for the PHBI is provided by the Cardiovascular Medical Research and Education Fund (CMREF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Bakouboula B, 2008, AM J RESP CRIT CARE, V177, P536, DOI 10.1164/rccm.200706-840OC; Banz Y, 2008, BRIT J HAEMATOL, V142, P627, DOI 10.1111/j.1365-2141.2008.07230.x; Berchtold S, 1999, FEBS LETT, V458, P424, DOI 10.1016/S0014-5793(99)01197-7; Blaustein MP, 1998, CLIN EXP HYPERTENS, V20, P691, DOI 10.3109/10641969809053247; BOEYNAEMS JM, 1983, BIOCHEM BIOPH RES CO, V112, P290, DOI 10.1016/0006-291X(83)91829-6; BOGLE RG, 1991, BIOCHEM BIOPH RES CO, V180, P926, DOI 10.1016/S0006-291X(05)81154-4; BROOK MM, 1994, CIRCULATION, V90, P1287, DOI 10.1161/01.CIR.90.3.1287; BULLOUGH DA, 1994, J CLIN INVEST, V94, P1524, DOI 10.1172/JCI117493; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; CRACK BE, 1995, BRIT J PHARMACOL, V114, P475, DOI 10.1111/j.1476-5381.1995.tb13251.x; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; CROWLEY ST, 1994, CIRCULATION, V90, P1908, DOI 10.1161/01.CIR.90.4.1908; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dawicki DD, 1997, AM J PHYSIOL-LUNG C, V273, pL485, DOI 10.1152/ajplung.1997.273.2.L485; Distler JHW, 2005, ARTHRITIS RHEUM, V52, P3337, DOI 10.1002/art.21350; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dubey RK, 1998, HYPERTENSION, V31, P516, DOI 10.1161/01.HYP.31.1.516; Edmunds NJ, 2003, J VASC RES, V40, P68, DOI 10.1159/000068941; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Goepfert C, 2000, MOL MED, V6, P591, DOI 10.1007/BF03401797; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kiffer-Moreira T, 2010, FEMS YEAST RES, V10, P735, DOI 10.1111/j.1567-1364.2010.00641.x; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Marcus AJ, 2003, J THROMB HAEMOST, V1, P2497, DOI 10.1111/j.1538-7836.2003.00479.x; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; MCAUSLAN BR, 1983, MICROVASC RES, V26, P323, DOI 10.1016/0026-2862(83)90080-8; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; MeyerFernandes JR, 1997, ARCH BIOCHEM BIOPHYS, V341, P40, DOI 10.1006/abbi.1997.9933; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Wall MJ, 2008, NEUROPHARMACOLOGY, V55, P1251, DOI 10.1016/j.neuropharm.2008.08.005; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje; Zebisch M, 2007, BIOCHEMISTRY-US, V46, P11945, DOI 10.1021/bi701103y; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	41	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40829	10.1371/journal.pone.0040829	http://dx.doi.org/10.1371/journal.pone.0040829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792409	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400103
J	Jonker, RM; Zhang, Q; Van Hooft, P; Loonen, MJJE; Van der Jeugd, HP; Crooijmans, RPMA; Groenen, MAM; Prins, HHT; Kraus, RHS				Jonker, Rudy M.; Zhang, Qiong; Van Hooft, Pim; Loonen, Maarten J. J. E.; Van der Jeugd, Henk P.; Crooijmans, Richard P. M. A.; Groenen, Martien A. M.; Prins, Herbert H. T.; Kraus, Robert H. S.			The Development of a Genome Wide SNP Set for the Barnacle Goose Branta leucopsis	PLOS ONE			English	Article							BREEDING RANGE EXPANSION; MIGRATION; MARKERS; GEESE; RELATEDNESS; POPULATIONS; DIVERGENCE; SPREAD; BASE	Migratory birds are of particular interest for population genetics because of the high connectivity between habitats and populations. A high degree of connectivity requires using many genetic markers to achieve the required statistical power, and a genome wide SNP set can fit this purpose. Here we present the development of a genome wide SNP set for the Barnacle Goose Branta leucopsis, a model species for the study of bird migration. We used the genome of a different waterfowl species, Mallard Anas platyrhynchos, as a reference to align Barnacle Goose second generation sequence reads from an RRL library and detected 2188 SNPs genome wide. Furthermore, we used chimeric flanking sequences, merged from both Mallard and Barnacle Goose DNA sequence information, to create primers for validation by genotyping. Validation with a 384 SNP genotyping set resulted in 374 (97%) successfully typed SNPs in the assay, of which 358 (96%) were polymorphic. Additionally, we validated our SNPs on relatively old (30 years) museum samples, which resulted in a success rate of at least 80%. This shows that museum samples could be used in standard SNP genotyping assays. Our study also shows that the genome of a related species can be used as reference to detect genome wide SNPs in birds, because genomes of birds are highly conserved. This is illustrated by the use of chimeric flanking sequences, which showed that the incorporation of flanking nucleotides from Mallard into Barnacle Goose sequences lead to equal genotyping performance when compared to flanking sequences solely composed of Barnacle Goose sequence.	[Jonker, Rudy M.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Jonker, Rudy M.; Zhang, Qiong; Van Hooft, Pim; Prins, Herbert H. T.; Kraus, Robert H. S.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Zhang, Qiong] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Loonen, Maarten J. J. E.] Univ Groningen, Arctic Ctr, Groningen, Netherlands; [Van der Jeugd, Henk P.] Netherlands Inst Ecol, Dutch Ctr Avian Migrat & Demog, Wageningen, Netherlands; [Crooijmans, Richard P. M. A.; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Kraus, Robert H. S.] Senckenberg Res Inst, Conservat Genet Grp, Gelnhausen, Germany; [Kraus, Robert H. S.] Nat Hist Museum, Gelnhausen, Germany	University of Bielefeld; Wageningen University & Research; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Senckenberg Gesellschaft fur Naturforschung (SGN)	Jonker, RM (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	mrjonker@gmail.com	van der Jeugd, Henk/S-3159-2019; Vet, Louise E.M./B-1342-2009; van der Jeugd, Henk P/F-4891-2010; Jonker, Rudy/I-3979-2012; Groenen, Martien/D-8408-2012; Crooijmans, Richard PMA/E-2492-2012; Kraus, Robert/F-1188-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Jeugd, Henk/0000-0002-5332-9526; Vet, Louise E.M./0000-0002-2287-1128; van der Jeugd, Henk P/0000-0002-5332-9526; Groenen, Martien/0000-0003-0484-4545; Kraus, Robert/0000-0002-8743-7082; Prins, Herbert/0000-0003-1131-5107; Loonen, Maarten J.J.E./0000-0002-3426-4595; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Faunafund; Royal Netherlands Shooting Association; Leibniz Association [SAW-2011-SGN-3]; Netherlands Organization for Scientific Research (NWO)	Dutch Faunafund; Royal Netherlands Shooting Association; Leibniz Association; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding was provided by Dutch Faunafund and Royal Netherlands Shooting Association. RHSK was also funded by grant SAW-2011-SGN-3 from the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Bert Dibbits, who was of invaluable assistance in the lab. Martin Elferink assisted in the assignment of flanking sequences. Blood samples were collected as part of project BIRDHEALTH, funded by the Netherlands Organization for Scientific Research (NWO) on the occasion of the International Polar Year, Jouke Prop, Helmut Kruckenberg, Alexander Kondratyev and several students assisted in sample collection. We thank Kees Roselaar for access to the museum samples from the Zoological Museum Amsterdam. We thank Ning Li and Yinhua Huang and the Beijing Genomics Institute for providing the Mallard genome data.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderholm S, 2009, ANIM BEHAV, V78, P167, DOI 10.1016/j.anbehav.2009.04.011; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Eichhorn G, 2009, J ANIM ECOL, V78, P63, DOI 10.1111/j.1365-2656.2008.01485.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FILCHAGOV AV, 1992, POLAR RES, V11, P41, DOI 10.1111/j.1751-8369.1992.tb00411.x; FORSLUND P, 1991, ARDEA, V79, P342; Fowler AC, 2005, ANIM BEHAV, V69, P973, DOI 10.1016/j.anbehav.2004.07.014; Fowler AC, 2004, CONDOR, V106, P600, DOI 10.1650/7446; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Harrison XA, 2010, CONSERV GENET, P1; Harrison XA, 2010, MOL ECOL, V19, P5484, DOI 10.1111/j.1365-294X.2010.04852.x; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Jonker RM, 2011, BEHAV ECOL, V22, P326, DOI 10.1093/beheco/arq208; Jonker RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011369; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Kraus RHS, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-45; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; LARSSON K, 1988, ORNIS SCAND, V19, P182, DOI 10.2307/3676556; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Madsen J., 1999, GOOSE POPULATIONS W; Meininger Peter L., 1994, Limosa, V67, P1; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; R Development Core Team, 2009, R FDN STAT COMP; Shetty S, 1999, CHROMOSOME RES, V7, P289, DOI 10.1023/A:1009278914829; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Solexa I, 2006, BIOTECHNIQUES PROTOC, P29; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; van der Jeugd HP, 2006, ARDEA, V94, P421; van der Jeugd HP, 2003, POLAR BIOL, V26, P700, DOI 10.1007/s00300-003-0535-7; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wink M, 2006, J ORNITHOL, V147, P234, DOI 10.1007/s10336-006-0065-5	37	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38412	10.1371/journal.pone.0038412	http://dx.doi.org/10.1371/journal.pone.0038412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808008	gold, Green Published			2022-12-25	WOS:000306355500003
J	Thingnes, J; Lavelle, TJ; Hovig, E; Omholt, SW				Thingnes, Josef; Lavelle, Timothy J.; Hovig, Eivind; Omholt, Stig W.			Understanding the Melanocyte Distribution in Human Epidermis: An Agent-Based Computational Model Approach	PLOS ONE			English	Article							ETHNIC VARIATION; HUMAN SKIN; KERATINOCYTE; DENSITY; RULES; CELLS; FETAL	The strikingly even color of human skin is maintained by the uniform distribution of melanocytes among keratinocytes in the basal layer of the human epidermis. In this work, we investigated three possible hypotheses on the mechanism by which the melanocytes and keratinocytes organize themselves to generate this pattern. We let the melanocyte migration be aided by (1) negative chemotaxis due to a substance produced by the melanocytes themselves, or (2) positive chemotaxis due to a substance produced by keratinocytes lacking direct physical contact with a melanocyte, or (3) positive chemotaxis due to a substance produced by keratinocytes in a distance-to-melanocytes dependent manner. The three hypotheses were implemented in an agent-based computational model of cellular interactions in the basal layer of the human epidermis. We found that they generate mutually exclusive predictions that can be tested by existing experimental protocols. This model forms a basis for further understanding of the communication between melanocytes and other skin cells in skin homeostasis.	[Thingnes, Josef; Omholt, Stig W.] Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway; [Lavelle, Timothy J.; Hovig, Eivind] Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Hovig, Eivind] Univ Oslo, Inst Informat, Fac Math & Nat Sci, Oslo, Norway; [Hovig, Eivind] Norwegian Radium Hosp, Inst Med Informat, Oslo, Norway; [Omholt, Stig W.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	Norwegian University of Life Sciences; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Life Sciences	Thingnes, J (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway.	joseft@ifi.uio.no	Hovig, Eivind/H-2474-2011; Thingnes, Josef/I-9329-2018	Hovig, Eivind/0000-0002-9103-1077; 	National Programme for Research in Functional Genomics (FUGE) in the Research Council of Norway	National Programme for Research in Functional Genomics (FUGE) in the Research Council of Norway(Research Council of Norway)	This study was supported by The National Programme for Research in Functional Genomics (FUGE) in the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008511; Alaluf S, 2003, PIGM CELL RES, V16, P35, DOI 10.1034/j.1600-0749.2003.00005.x; Alaluf S, 2002, PIGM CELL RES, V15, P112, DOI 10.1034/j.1600-0749.2002.1o071.x; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Burns TF, 2004, ROOKS TSB DERMATOLOG; Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; FITZPATRICK T B, 1963, Dermatol Wochenschr, V147, P481; Fitzpatrick TB, 1987, DERMATOLOGY GEN MED; Hachiya A, 2005, J INVEST DERMATOL, V125, P364, DOI 10.1111/j.0022-202X.2005.23832.x; Hearing VJ, 2007, PIGM CELL RES, V20, P334, DOI 10.1111/j.1600-0749.2007.pcr402.x; HOLBROOK KA, 1989, ANAT EMBRYOL, V180, P443, DOI 10.1007/BF00305119; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Jorizzo JL, 2008, DERMATOLOGY; LEPOOLE IC, 1994, PIGM CELL RES, V7, P33; Madden K, 2011, J AM ACAD DERMATOL, V64, P548, DOI 10.1016/j.jaad.2010.05.021; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; ROSDAHL I, 1983, J INVEST DERMATOL, V81, P278, DOI 10.1111/1523-1747.ep12518318; SCOTT GA, 1991, J INVEST DERMATOL, V97, P776, DOI 10.1111/1523-1747.ep12486726; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Smallwood R, 2011, UNDERSTANDING THE DYNAMICS OF BIOLOGICAL SYSTEMS: LESSONS LEARNED FROM INTEGRATIVE SYSTEMS BIOLOGY, P175, DOI 10.1007/978-1-4419-7964-3_9; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Sun T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002129; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Walker DC, 2010, J THEOR BIOL, V262, P425, DOI 10.1016/j.jtbi.2009.10.002; Walker D, 2006, J THEOR BIOL, V242, P774, DOI 10.1016/j.jtbi.2006.04.020; Walker D, 2006, TISSUE ENG, V12, P2301, DOI 10.1089/ten.2006.12.2301; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Whiteman DC, 1999, ARCH DERMATOL RES, V291, P511, DOI 10.1007/s004030050446	35	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40377	10.1371/journal.pone.0040377	http://dx.doi.org/10.1371/journal.pone.0040377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792296	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700040
J	Hocher, B; Armbruster, FP; Stoeva, S; Reichetzeder, C; Gron, HJ; Lieker, I; Khadzhynov, D; Slowinski, T; Roth, HJ				Hocher, Berthold; Armbruster, Franz Paul; Stoeva, Stanka; Reichetzeder, Christoph; Groen, Hans Juergen; Lieker, Ina; Khadzhynov, Dmytro; Slowinski, Torsten; Roth, Heinz Juergen			Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress - Do We Need a Fourth Generation Parathyroid Hormone Assay?	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; INTRAVENOUS CALCITRIOL; HEMODIALYSIS-PATIENTS; RENAL OSTEODYSTROPHY; CALCIUM; UREMIA; IMMUNOASSAY; SECRETION; RESIDUES; RATS	Oxidation of PTH at methionine residues results in loss of biological activity. PTH may be oxidized in patients with renal disease. The aim of this study was to develop an assay considering oxidation of PTH. Oxidized hPTH was analyzed by high resolution nano-liquid chromatography coupled to ESI-FTT tandem mass spectrometry (nanoLC-ESI-FT-MS/MS) directly and after proteolytic cleavage. The oxidized hPTH(1-84) sample shows TIC-peaks at 18-20 min and several mass peaks due to mass shifts caused by oxidations. No significant signal for oxidized hPTH(1-84) species after removal of oxidized PTH molecules by a specific column with monoclonal antibodies (MAB) raised against the oxidized hPTH was detectable. By using this column in samples from 18 patients on dialysis we could demonstrate that measured PTH concentrations were substantially lower when considering oxidized forms of PTH. The relationship between PTH concentrations determined directly and those concentrations measured after removal of the oxidized PTH forms varies substantially. In some patients only 7% of traditionally measured PTH was free of oxidation, whereas in other patients 34% of the traditionally measured PTH was real intact PTH. In conclusion, a huge but not constant proportion of PTH molecules are oxidized in patients requiring dialysis. Since oxidized PTH is biologically inactive, the currently used methods to detect PTH in daily clinical practice may not adequately reflect PTH-related bone and cardiovascular abnormalities in patients on dialysis.	[Hocher, Berthold; Reichetzeder, Christoph] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Armbruster, Franz Paul; Stoeva, Stanka; Groen, Hans Juergen] Immundiagnostik AG, Bensheim, Germany; [Lieker, Ina; Khadzhynov, Dmytro; Slowinski, Torsten] Charite Mitte, Dept Nephrol, Berlin, Germany; [Roth, Heinz Juergen] Limbach Lab, Dept Endocrinol Oncol, Heidelberg, Germany	University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.	hocher@uni-potsdam.de	Armbruster, Franz Paul/D-7383-2014; Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Khadzhynov, Dmytro/0000-0001-5462-5776				BERSON SA, 1963, P NATL ACAD SCI USA, V49, P613, DOI 10.1073/pnas.49.5.613; BLIND E, 1987, CLIN CHEM, V33, P1376; Blind E, 2008, CLIN LAB, V54, P439; Brossard JH, 2000, CLIN CHEM, V46, P697; Chaykovska L, 2011, CLIN LAB, V57, P455; FELSENFELD AJ, 1991, NEPHROL DIAL TRANSPL, V6, P244, DOI 10.1093/ndt/6.4.244; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; GALCERAN T, 1984, ENDOCRINOLOGY, V115, P2375, DOI 10.1210/endo-115-6-2375; Garrett G, 2012, CLIN J AM SOC NEPHRO; Garrett G, 2012, ANN CLIN BIOCHEM, V49, P4, DOI 10.1258/acb.2011.011254; HORIUCHI N, 1988, J BONE MINER RES, V3, P353, DOI 10.1002/jbmr.5650030316; KEUTMANN HT, 1978, BIOCHEMISTRY-US, V17, P5723, DOI 10.1021/bi00619a019; Kumar V, 2010, CLIN CHEM, V56, P306, DOI 10.1373/clinchem.2009.134643; Lepage R, 1998, CLIN CHEM, V44, P805; Lopez MF, 2010, CLIN CHEM, V56, P281, DOI 10.1373/clinchem.2009.137323; MALBERTI F, 1992, NEPHROL DIAL TRANSPL, V7, P822; MESSA P, 1994, KIDNEY INT, V46, P1713, DOI 10.1038/ki.1994.473; ORIORDAN JL, 1974, J ENDOCRINOL, V63, P117, DOI 10.1677/joe.0.0630117; QUARLES LD, 1992, J CLIN ENDOCR METAB, V75, P145, DOI 10.1210/jc.75.1.145; RAMIREZ JA, 1993, J CLIN ENDOCR METAB, V76, P1489, DOI 10.1210/jc.76.6.1489; RODRIGUEZ M, 1991, J AM SOC NEPHROL, V2, P1014; SANCHEZ CP, 1995, KIDNEY INT, V48, P838, DOI 10.1038/ki.1995.359; Slatopolsky E, 2000, KIDNEY INT, V58, P753, DOI 10.1046/j.1523-1755.2000.00222.x; TAMPE J, 1992, J IMMUNOASSAY, V13, P1, DOI 10.1080/15321819208019821; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; ZULL JE, 1990, J BIOL CHEM, V265, P5671	27	56	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40242	10.1371/journal.pone.0040242	http://dx.doi.org/10.1371/journal.pone.0040242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792251	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800056
J	Linde, N; Gutschalk, CM; Hoffmann, C; Yilmaz, D; Mueller, MM				Linde, Nina; Gutschalk, Claudia M.; Hoffmann, Claudia; Yilmaz, Dilan; Mueller, Margareta M.			Integrating Macrophages into Organotypic Co-Cultures: A 3D In Vitro Model to Study Tumor-Associated Macrophages	PLOS ONE			English	Article							BASEMENT-MEMBRANE FORMATION; COLONY-STIMULATING FACTOR; SQUAMOUS-CELL CARCINOMAS; INTERFERON-GAMMA; PROGRESSION; SKIN; CULTURE; GROWTH; CANCER; DIFFERENTIATION	Tumor progression is controlled by signals from cellular and extra-cellular microenvironment including stromal cells and the extracellular matrix. Consequently, three-dimensional in vitro tumor models are essential to study the interaction of tumor cells with their microenvironment appropriately in a biologically relevant manner. We have previously used organotypic co-cultures to analyze the malignant growth of human squamous cell carcinoma (SCC) cell lines on a stromal equivalent in vitro. In this model, SCC cell lines are grown on a collagen-I gel containing fibroblasts. Since macrophages play a critical role in the progression of many tumor types, we now have expanded this model by integrating macrophages into the collagen gel of these organotypic tumor co-cultures. This model was established as a murine and a human system of skin SCCs. The effect of macrophages on tumor progression depends on their polarization. We demonstrate that macrophage polarization in organotypic co-cultures can be modulated towards and M1 or an M2 phenotype by adding recombinant IFN-gamma and LPS or IL-4 respectively to the growth medium. IL-4 stimulation of macrophage-containing cultures resulted in enhanced tumor cell invasion evidenced by degradation of the basement membrane, enhanced collagenolytic activity and increased MMP-2 and MMP-9. Interestingly, extended co-culture with tumor cells for three weeks resulted in spontaneous M2 polarization of macrophages without IL-4 treatment. Thus, we demonstrate that macrophages can be successfully integrated into organotypic co-cultures of murine or human skin SCCs and that this model can be exploited to analyze macrophage activation towards a tumor supporting phenotype.	[Linde, Nina; Gutschalk, Claudia M.; Yilmaz, Dilan; Mueller, Margareta M.] German Canc Res Ctr, Grp Tumor & Microenvironm, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Linde, N (corresponding author), German Canc Res Ctr, Grp Tumor & Microenvironm, Heidelberg, Germany.	muem@hs-furtwangen.de			Deutsche Forschungsgemeinschaft: DFG [SPP1190, MU1830/3-1]; DFG grant [GU791/2-1]	Deutsche Forschungsgemeinschaft: DFG(German Research Foundation (DFG)); DFG grant(German Research Foundation (DFG))	This work was financed by grants from the Deutsche Forschungsgemeinschaft: DFG grant SPP1190, project MU1830/3-1 and DFG grant GU791/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010; Bechetoille N, 2011, EXP DERMATOL, V20, P1035, DOI 10.1111/j.1600-0625.2011.01383.x; Brana C, 1999, J NEUROSCI METH, V90, P7, DOI 10.1016/S0165-0270(99)00045-X; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Fernandez-Bueno I, 2008, MOL VIS, V14, P2148; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; FUSENIG NE, 1983, J INVEST DERMATOL, V81, pS168, DOI 10.1111/1523-1747.ep12541032; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; HORNUNG J, 1987, J CANCER RES CLIN, V113, P325, DOI 10.1007/BF00397716; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KUEBLER JP, 1987, INVEST NEW DRUG, V5, P21; Lederle W, 2011, INT J CANCER, V128, P2803, DOI 10.1002/ijc.25621; Lederle W, 2010, AM J PATHOL, V176, P981, DOI 10.2353/ajpath.2010.080998; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mueller MM, 1999, INT J CANCER, V83, P780, DOI 10.1002/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.3.CO;2-3; Obermueller E, 2004, CANCER RES, V64, P7801, DOI 10.1158/0008-5472.CAN-03-3301; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Stacey A, 1997, Methods Mol Biol, V75, P305; Stark Hans-Jurgen, 2004, Biol Proced Online, V6, P55, DOI 10.1251/bpo72; Stark JJ, 2006, J INVEST DERM SYMP P, V11, P93, DOI 10.1038/sj.jidsymp.5650015; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; YIP I, 1995, J CLIN ENDOCR METAB, V80, P1664, DOI 10.1210/jc.80.5.1664	42	71	71	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40058	10.1371/journal.pone.0040058	http://dx.doi.org/10.1371/journal.pone.0040058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792213	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800035
J	Luo, YQ; Kong, QK; Yang, J; Mitra, A; Golden, G; Wanda, SY; Roland, KL; Jensen, RV; Ernst, PB; Curtiss, R				Luo, Yingqin; Kong, Qingke; Yang, Jiseon; Mitra, Arindam; Golden, Greg; Wanda, Soo-Young; Roland, Kenneth L.; Jensen, Roderick V.; Ernst, Peter B.; Curtiss, Roy, III			Comparative Genome Analysis of the High Pathogenicity Salmonella Typhimurium Strain UK-1	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PROVIDES ACQUIRED-RESISTANCE; IMMUNE-RESPONSES; III SECRETION; DNA REPEATS; VIRULENCE; IDENTIFICATION; SEQUENCE; VACCINE; CRISPR	Salmonella enterica serovar Typhimurium, a gram-negative facultative rod-shaped bacterium causing salmonellosis and foodborne disease, is one of the most common isolated Salmonella serovars in both developed and developing nations. Several S. Typhimurium genomes have been completed and many more genome-sequencing projects are underway. Comparative genome analysis of the multiple strains leads to a better understanding of the evolution of S. Typhimurium and its pathogenesis. S. Typhimurium strain UK-1 (belongs to phage type 1) is highly virulent when orally administered to mice and chickens and efficiently colonizes lymphoid tissues of these species. These characteristics make this strain a good choice for use in vaccine development. In fact, UK-1 has been used as the parent strain for a number of nonrecombinant and recombinant vaccine strains, including several commercial vaccines for poultry. In this study, we conducted a thorough comparative genome analysis of the UK-1 strain with other S. Typhimurium strains and examined the phenotypic impact of several genomic differences. Whole genomic comparison highlights an extremely close relationship between the UK-1 strain and other S. Typhimurium strains; however, many interesting genetic and genomic variations specific to UK-1 were explored. In particular, the deletion of a UK-1-specific gene that is highly similar to the gene encoding the T3SS effector protein NleC exhibited a significant decrease in oral virulence in BALB/c mice. The complete genetic complements in UK-1, especially those elements that contribute to virulence or aid in determining the diversity within bacterial species, provide key information in evaluating the functional characterization of important genetic determinants and for development of vaccines.	[Luo, Yingqin; Kong, Qingke; Yang, Jiseon; Mitra, Arindam; Golden, Greg; Wanda, Soo-Young; Roland, Kenneth L.; Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Luo, Yingqin] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA; [Jensen, Roderick V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Ernst, Peter B.] Univ Virginia, Div Gastroenterol & Hepatol, Dept Med, Charlottesville, VA USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Virginia Polytechnic Institute & State University; University of Virginia	Luo, YQ (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Mitra, Arindam/A-1379-2013; Kong, Qingke/K-3384-2019	Mitra, Arindam/0000-0002-1591-6164; Ernst, Peter/0000-0001-7777-1813; Yang, Jiseon/0000-0002-5393-7062	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI060557, AI08600, AI070491]; Bill and Melinda Gates Foundation [37863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070491, U01AI060557, R01AI060557] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants AI060557, AI08600 and AI070491, and the Bill and Melinda Gates Foundation grant 37863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrow PA, 2001, VACCINE, V19, P3432, DOI 10.1016/S0264-410X(01)00065-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chan K, 2005, INFECT IMMUN, V73, P5438, DOI 10.1128/IAI.73.9.5438-5449.2005; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Covone MG, 1998, INFECT IMMUN, V66, P224, DOI 10.1128/IAI.66.1.224-231.1998; CURTISS R, 1991, COLONIZATION CONTROL, P169; Curtiss R, 2009, INFECT IMMUN, V77, P1071, DOI 10.1128/IAI.00693-08; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Garcia-Quintanilla M, 2011, PLASMID, V65, P169, DOI 10.1016/j.plasmid.2010.12.001; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gotoh O, 2008, NUCLEIC ACIDS RES, V36, P2630, DOI 10.1093/nar/gkn105; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Gunn BM, 2010, CLIN VACCINE IMMUNOL, V17, P354, DOI 10.1128/CVI.00412-09; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; HASSAN J O, 1990, Research in Microbiology, V141, P839, DOI 10.1016/0923-2508(90)90119-B; Hassan JO, 1996, INFECT IMMUN, V64, P938, DOI 10.1128/IAI.64.3.938-944.1996; HASSAN JO, 1994, INFECT IMMUN, V62, P5519, DOI 10.1128/IAI.62.12.5519-5527.1994; HASSAN JO, 1993, AVIAN DIS, V37, P19, DOI 10.2307/1591452; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Izumiya H, 2011, ANTIMICROB AGENTS CH, V55, P623, DOI 10.1128/AAC.01215-10; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Kong QK, 2011, J IMMUNOL, V187, P412, DOI 10.4049/jimmunol.1100339; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANGE R, 1994, MOL MICROBIOL, V13, P733, DOI 10.1111/j.1365-2958.1994.tb00466.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Luo YQ, 2011, J BACTERIOL, V193, P4035, DOI 10.1128/JB.05224-11; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; McVey DS, 2002, VACCINE, V20, P1618, DOI 10.1016/S0264-410X(01)00516-3; Mohler VL, 2008, VACCINE, V26, P1751, DOI 10.1016/j.vaccine.2008.01.018; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; NEI M, 1986, MOL BIOL EVOL, V3, P418; Porter SB, 1997, AVIAN DIS, V41, P45, DOI 10.2307/1592442; PORTER SB, 1993, AVIAN DIS, V37, P265, DOI 10.2307/1591648; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Roland KL, 2005, CURR OPIN MOL THER, V7, P62; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; Rotger R, 1999, Int Microbiol, V2, P177; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sheoran AS, 2001, VACCINE, V19, P3591, DOI 10.1016/S0264-410X(01)00072-X; Shi HY, 2010, CLIN VACCINE IMMUNOL, V17, P363, DOI 10.1128/CVI.00413-09; SKURNIK M, 1989, MOL MICROBIOL, V3, P517, DOI 10.1111/j.1365-2958.1989.tb00198.x; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAKAYANAGI Y, 1994, MOL GEN GENET, V243, P525, DOI 10.1007/BF00284200; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Tsolis RM, 2008, NAT REV MICROBIOL, V6, P883, DOI 10.1038/nrmicro2012; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Varma JK, 2005, EMERG INFECT DIS, V11, P943; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zhang X, 1999, MICROB PATHOGENESIS, V26, P121, DOI 10.1006/mpat.1998.0245	98	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40645	10.1371/journal.pone.0040645	http://dx.doi.org/10.1371/journal.pone.0040645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792393	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800114
J	Trierweiler, C; Blum, HE; Hasselblatt, P				Trierweiler, Claudia; Blum, Hubert E.; Hasselblatt, Peter			The Transcription Factor c-Jun Protects against Liver Damage following Activated beta-Catenin Signaling	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATOCYTE PROLIFERATION; TUMOR-DEVELOPMENT; MYC DELETION; MOUSE-LIVER; APC; MICE; GROWTH; TUMORIGENESIS; REGENERATION	Background: The Wnt/beta-Catenin signaling pathway is central for liver functions and frequently deregulated in hepatocellular carcinoma (HCC). Analysis of the early phenotypes and molecular events following beta-Catenin activation is therefore essential for better understanding HCC pathogenesis. The AP-1 transcription factor c-Jun is a putative beta-Catenin target gene and promotes hepatocyte survival, proliferation, and liver tumorigenesis, suggesting that c-Jun may be a key target of beta-Catenin signaling in the liver. Methodology/Principal Findings: To address this issue, the immediate hepatic phenotypes following deletion of the tumor suppressor Apc and subsequent beta-Catenin activation were analyzed in mice. The contribution of c-Jun to these phenotypes was dissected in double mutant animals lacking both, Apc and c-Jun. beta-Catenin was rapidly activated in virtually all Apc mutant hepatocytes while c-Jun was induced only after several days, suggesting that its expression was rather a secondary event following Apc deletion in the liver. Loss of Apc resulted in increased hepatocyte proliferation, hepatomegaly, deregulated protein metabolism, and premature death. Interestingly, additional deletion of c-Jun did not affect hepatocyte proliferation but resulted in increased liver damage and mortality. This phenotype correlated with impaired expression of hepatoprotective genes such as Birc5, Egfr Igf1 and subsequently deregulated Akt signaling. Conclusions/Significance: These data indicate that c-Jun is not a primary target of beta-Catenin signaling in the liver, but rather protects against liver damage, which in turn may promote liver tumorigenesis.	[Trierweiler, Claudia; Blum, Hubert E.; Hasselblatt, Peter] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany; [Trierweiler, Claudia] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Trierweiler, C (corresponding author), Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany.	Peter.Hasselblatt@uniklinik-freiburg.de	Hasselblatt, Peter/AAF-3681-2021		German Research Foundation (DFG) [Ha4314/2-1, Ha4314/2-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG, www.dfg.de) grants Ha4314/2-1 and Ha4314/2-2 to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063; Cadoret A, 2001, CANCER RES, V61, P3245; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Fuest M, 2012, HEPATOLOGY, V55, P408, DOI 10.1002/hep.24699; Hasselblatt P, 2008, ONCOGENE, V27, P6102, DOI 10.1038/onc.2008.211; Hasselblatt P, 2007, P NATL ACAD SCI USA, V104, P17105, DOI 10.1073/pnas.0706272104; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Katiyar S, 2010, MOL BIOL CELL, V21, P4264, DOI 10.1091/mbc.E10-08-0705; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Reed KR, 2008, P NATL ACAD SCI USA, V105, P18919, DOI 10.1073/pnas.0805778105; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Torre C, 2011, J HEPATOL, V55, P86, DOI 10.1016/j.jhep.2010.10.021; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40638	10.1371/journal.pone.0040638	http://dx.doi.org/10.1371/journal.pone.0040638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792392	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800113
J	Veniant, MM; Hale, C; Helmering, J; Chen, MM; Stanislaus, S; Busby, J; Vonderfecht, S; Xu, J; Lloyd, DJ				Veniant, Murielle M.; Hale, Clarence; Helmering, Joan; Chen, Michelle M.; Stanislaus, Shanaka; Busby, Jim; Vonderfecht, Steven; Xu, Jing; Lloyd, David J.			FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice	PLOS ONE			English	Article							GROWTH-FACTOR 21; INSULIN SENSITIVITY; BETA-KLOTHO; DIABETES-MELLITUS; MOUSE MODELS; PPAR-ALPHA; RESISTANCE; TISSUE; OBESITY; FGF-21	Fibroblast growth factor 21 (FGF21) is a potent metabolic regulator, and pharmacological administration elicits glucose and lipid lowering responses in mammals. To delineate if adipose tissue is the predominant organ responsible for anti-diabetic effects of FGF21, we treated mice with reduced body fat (lipodystrophy mice with adipose specific expression of active sterol regulatory element binding protein 1c; Tg) with recombinant murine FGF21 (rmuFGF21). Unlike wildtype (WT) mice, Tg mice were refractory to the beneficial effects of rmuFGF21 on body weight, adipose mass, plasma insulin and glucose tolerance. To determine if adipose mass was critical for these effects, we transplanted WT white adipose tissue (WAT) into Tg mice and treated the mice with rmuFGF21. After transplantation, FGF21 responsiveness was completely restored in WAT transplanted Tg mice compared to sham Tg mice. Further, leptin treatment alone was sufficient to restore the anti-diabetic effects of rmuFGF21 in Tg mice. Molecular analyses of Tg mice revealed normal adipose expression of Fgfr1, Klb and an 8-fold over-expression of Fgf21. Impaired FGF21-induced signaling indicated that residual adipose tissue of Tg mice was resistant to FGF21, whilst normal FGF21 signaling was observed in Tg livers. Together these data suggest that adipose tissue is required for the triglyceride and glucose, but not the cholesterol lowering efficacy of FGF21, and that leptin and FGF21 exert additive anti-diabetic effects in Tg mice.	[Veniant, Murielle M.; Hale, Clarence; Helmering, Joan; Chen, Michelle M.; Stanislaus, Shanaka; Busby, Jim; Xu, Jing; Lloyd, David J.] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [Vonderfecht, Steven] Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Veniant, MM (corresponding author), Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA.	dlloyd@amgen.com		Lloyd, David/0000-0001-5924-0672	Amgen Inc.	Amgen Inc.(Amgen)	Amgen Inc. funded the study. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Amgen Inc. gave permission to publish.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Colombo C, 2003, J BIOL CHEM, V278, P3992, DOI 10.1074/jbc.M207665200; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Feng GS, 2006, EXPERT OPIN THER TAR, V10, P135, DOI 10.1517/14728222.10.1.135; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Gupte J, 2011, J MOL BIOL, V408, P491, DOI 10.1016/j.jmb.2011.03.003; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	28	112	113	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40164	10.1371/journal.pone.0040164	http://dx.doi.org/10.1371/journal.pone.0040164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792234	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800045
J	Adhikari, A; Gupta, G; Majumder, S; Banerjee, S; Bhattacharjee, S; Bhattacharya, P; Kumari, S; Haldar, S; Majumdar, SB; Saha, B; Majumdar, S				Adhikari, Anupam; Gupta, Gaurav; Majumder, Saikat; Banerjee, Sayantan; Bhattacharjee, Surajit; Bhattacharya, Parna; Kumari, Sangeeta; Haldar, Subhadra; Majumdar, Suchandra Bhattacharyya; Saha, Bhaskar; Majumdar, Subrata			Mycobacterium indicus pranii (Mw) Re-Establishes Host Protective Immune Response in Leishmania donovani Infected Macrophages: Critical Role of IL-12	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; NF-KAPPA-B; AMPHOTERICIN-B; MICE; ACTIVATION; TUBERCULOSIS; INVOLVEMENT; TOXICITY; SYNTHASE; LEPROSY	Leishmania donovani, a protozoan parasite, causes a strong immunosuppression in a susceptible host and inflicts the fatal disease visceral leishmaniasis. Relatively high toxicity, low therapeutic index, and failure in reinstating host-protective anti-leishmanial immune responses have made anti-leishmanial drugs patient non-compliant and an immuno-modulatory treatment a necessity. Therefore, we have tested the anti-leishmanial efficacy of a combination of a novel immunomodulator, Mycobacterium indicus pranii (Mw), and an anti-leishmanial drug, Amphotericin B (AmpB). We observe that Mw alone or with a suboptimal dose of AmpB offers significant protection against L. donovani infection by activating the macrophages. Our experiments examining the anti-leishmanial activity of Mw alone or with AmpB also indicate a p38MAPK and ERK-1/2 regulated pro-inflammatory responses. The Mw-AmpB combination induced nitric oxide production, restored Th1 response, and significantly reduced parasite burden in wild type macrophages but not in IL-12-deficient macrophages indicating a pivotal role for IL-12 in the induction of host-protection by Mw and AmpB treatments. In addition, we observed that Mw alone or in combination with suboptimal dose of AmpB render protection against L. donovani infection in susceptible BALB/c mice. However, these treatments failed to render protection in IL-12-deficient mice in vivo which added further support that IL-12 played a central role in this chemo immunotherapeutic approach. Thus, we demonstrate a novel chemo-immunotherapeutic approach-Mw and AmpB crosstalk eliminating the parasite-induced immunosuppression and inducing collateral host-protective effects.	[Adhikari, Anupam; Gupta, Gaurav; Majumder, Saikat; Banerjee, Sayantan; Bhattacharjee, Surajit; Bhattacharya, Parna; Majumdar, Suchandra Bhattacharyya; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Kumari, Sangeeta; Haldar, Subhadra; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Adhikari, A (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@bic.boseinst.ernet.in	Bhattacharjee, Surajit/B-5979-2012; Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019; Gupta, Gaurav/F-7519-2012	Bhattacharjee, Surajit/0000-0001-9233-4777; Majumder, Saikat/0000-0002-6591-9515; Gupta, Gaurav/0000-0003-4533-6272	Department of Biotechnology, Government of India, New Delhi; Bose Institute; National Centre for Cell science; council of Scientific and Industrial Research, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Bose Institute(Department of Science & Technology (India)); National Centre for Cell science; council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The Department of Biotechnology, Government of India, New Delhi provided the financial assistance to this work. Intramural funding has been provided by the Bose Institute (S.M., Corresponding Author) and National Centre for Cell science (B.S). The council of Scientific and Industrial Research, Government of India, New Delhi provided fellowships to A.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Arning M, 1995, MYCOSES, V38, P459, DOI 10.1111/j.1439-0507.1995.tb00020.x; AZUMA I, 1968, J BACTERIOL, V96, P1885, DOI 10.1128/JB.96.5.1885-1887.1968; BERMAN JD, 1992, ANTIMICROB AGENTS CH, V36, P1978, DOI 10.1128/AAC.36.9.1978; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; CHAKKALATH HR, 1994, J IMMUNOL, V153, P4378; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; DAVIDSON RN, 1991, LANCET, V337, P1061, DOI 10.1016/0140-6736(91)91708-3; Dey R, 2007, SCAND J IMMUNOL, V66, P671, DOI 10.1111/j.1365-3083.2007.02025.x; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Little J. R., 1987, Clinical Immunology Newsletter, V8, P183, DOI 10.1016/0197-1859(87)90048-3; LITTLE JR, 1978, IMMUNOCHEMISTRY, V15, P219, DOI 10.1016/0161-5890(78)90058-5; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Matsuo K, 2006, MICROBIOL IMMUNOL, V50, P337, DOI 10.1111/j.1348-0421.2006.tb03792.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray  H W, 2000, Int J Infect Dis, V4, P158, DOI 10.1016/S1201-9712(00)90078-X; REDDI PP, 1994, INT J LEPROSY, V62, P229; Rodrigues V, 1998, INFECT IMMUN, V66, P1233, DOI 10.1128/IAI.66.3.1233-1236.1998; SARTHOU P, 1986, J IMMUNOL, V137, P2156; Satoskar AR, 2000, EUR J IMMUNOL, V30, P834, DOI 10.1002/1521-4141(200003)30:3&lt;834::AID-IMMU834&gt;3.0.CO;2-9; SCHRECK R, 1994, METHOD ENZYMOL, V234, P151; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; Taylor AP, 1997, J EXP MED, V185, P1231, DOI 10.1084/jem.185.7.1231; ZAHEER SA, 1993, J INFECT DIS, V167, P401, DOI 10.1093/infdis/167.2.401	30	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40265	10.1371/journal.pone.0040265	http://dx.doi.org/10.1371/journal.pone.0040265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792256	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300042
J	Dalleau, G; Leroyer, P; Beaulieu, M; Verkindt, C; Rivard, CH; Allard, P				Dalleau, Georges; Leroyer, Pierre; Beaulieu, Marlene; Verkindt, Chantal; Rivard, Charles-Hilaire; Allard, Paul			Pelvis Morphology, Trunk Posture and Standing Imbalance and Their Relations to the Cobb Angle in Moderate and Severe Untreated AIS	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; NATURAL-HISTORY; CURVE TYPE; BALANCE; CHILDREN; ROTATION; STATURE; GROWTH; GIRLS	Adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis and usually affects young girls. Studies mostly describe the differences between scoliotic and non-scoliotic girls and focus primarily on a single set of parameters derived from spinal and pelvis morphology, posture or standing imbalance. No study addressed all these three biomechanical aspects simultaneously in pre-braced AIS girls of different scoliosis severity but with similar curve type and their interaction with scoliosis progression. The first objective of this study was to test if there are differences in these parameters between pre-braced AIS girls with a right thoracic scoliosis of moderate (less than 27 degrees) and severe (more than 27 degrees) deformity. The second objective was to identify which of these parameters are related to the Cobb angle progression either individually or in combination of thereof. Forty-five scoliotic girls, randomly selected by an orthopedic surgeon from the hospital scoliosis clinic, participated in this study. Parameters related to pelvis morphology, pelvis orientation, trunk posture and quiet standing balance were measured. Generally moderate pre-brace idiopathic scoliosis patients displayed lower values than the severe group characterized by a Cobb angle greater than 27 degrees. Only pelvis morphology and trunk posture were statistically different between the groups while pelvis orientation and standing imbalance were similar in both groups. Statistically significant Pearson coefficients of correlation between individual parameters and Cobb angle ranged between 0.32 and 0.53. Collectively trunk posture, pelvis morphology and standing balance parameters are correlated with Cobb angle at 0.82. The results suggest that spinal deformity progression is not only a question of trunk morphology distortion by itself but is also related to pelvis asymmetrical bone growth and standing neuromuscular imbalance.	[Dalleau, Georges; Leroyer, Pierre; Verkindt, Chantal] Univ Reunion, CURAPS DIMPS, Fac Sci Homme & Environm, Le Tampon, France; [Dalleau, Georges; Beaulieu, Marlene; Allard, Paul] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Rivard, Charles-Hilaire] St Justine Hosp, Dept Orthoped Surg, Montreal, PQ, Canada; [Beaulieu, Marlene; Rivard, Charles-Hilaire; Allard, Paul] St Justine Hosp, Res Ctr, Human Movement Lab, Montreal, PQ, Canada	University of La Reunion; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Dalleau, G (corresponding author), Univ Reunion, CURAPS DIMPS, Fac Sci Homme & Environm, Le Tampon, France.	georges.dalleau@univ-reunion.fr	Allard, Paul/ABA-3257-2021		Natural Science and Engineering Council of Canada (NSERC)	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Partial funding for this project was obtained from Natural Science and Engineering Council of Canada (NSERC). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2004, AM J PHYS MED REHAB, V83, P689, DOI 10.1097/01.PHM.0000137344.95784.15; AMENDT LE, 1990, PHYS THER, V70, P108, DOI 10.1093/ptj/70.2.108; ARCHER IA, 1985, J BONE JOINT SURG BR, V67, P185, DOI 10.1302/0301-620X.67B2.3980522; Beaulieu M, 2009, EUR SPINE J, V18, P38, DOI 10.1007/s00586-008-0831-6; BELLEFLEUR C, 1994, ANN CHIR, V48, P723; BUNNELL WP, 1986, SPINE, V11, P773, DOI 10.1097/00007632-198610000-00003; BURWELL RG, 1981, ANN ROY COLL SURG, V63, P209; Dalleau G, 2011, EUR SPINE J, V20, P123, DOI 10.1007/s00586-010-1554-z; Dalleau G, 2007, EUR SPINE J, V16, P1593, DOI 10.1007/s00586-007-0404-0; DICKSON RA, 1982, J BONE JOINT SURG BR, V64, P385; Gauchard GC, 2001, SPINE, V26, P1052, DOI 10.1097/00007632-200105010-00014; Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009; Gum JL, 2007, EUR SPINE J, V16, P1579, DOI 10.1007/s00586-007-0400-4; Haumont T, 2011, SPINE, V36, pE847, DOI 10.1097/BRS.0b013e3181ff5837; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; ISU T, 1992, CHILD NERV SYST, V8, P97, DOI 10.1007/BF00298449; LeBlanc R, 1997, SPINE, V22, P2532, DOI 10.1097/00007632-199711010-00013; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Mac-Thiong JM, 2003, SPINE, V28, P1404, DOI 10.1097/01.BRS.0000067118.60199.D1; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Masso PD, 2000, SPINE, V25, P457, DOI 10.1097/00007632-200002150-00011; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320, DOI 10.2106/00004623-199072030-00002; Mubarak SL, 1985, ORTHOP T, V9, P113; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; NICOLOPOULOS KS, 1985, J BONE JOINT SURG BR, V67, P594, DOI 10.1302/0301-620X.67B4.4030857; Pasha S, 2010, SPINE, V35, pE820, DOI 10.1097/BRS.0b013e3181e6856d; Ramirez L, 2006, IEEE T INF TECHNOL B, V10, P84, DOI 10.1109/TITB.2005.855526; SAHLSTRAND T, 1979, ACTA ORTHOP SCAND, V50, P275, DOI 10.3109/17453677908989768; Samuelsson L, 1997, ACTA ORTHOP SCAND, V68, P273, DOI 10.3109/17453679708996700; Simoneau M, 2006, EXP BRAIN RES, V170, P576, DOI 10.1007/s00221-005-0246-0; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Stylianides GA, 2011, EUROPEAN SP IN PRESS; THULBOURNE T, 1976, J BONE JOINT SURG BR, V58, P64, DOI 10.1302/0301-620X.58B1.1270497; Weinstein S., 1994, PEDIAT SPINE PRINCIP, P463; Wong HK, 2010, INDIAN J ORTHOP, V44, P9, DOI 10.4103/0019-5413.58601; Zabjek KF, 2005, CLIN BIOMECH, V20, P483, DOI 10.1016/j.clinbiomech.2005.01.003	38	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e36755	10.1371/journal.pone.0036755	http://dx.doi.org/10.1371/journal.pone.0036755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792155	gold, Green Published			2022-12-25	WOS:000306436300002
J	Harihar, A; Pandav, B				Harihar, Abishek; Pandav, Bivash			Influence of Connectivity, Wild Prey and Disturbance on Occupancy of Tigers in the Human-Dominated Western Terai Arc Landscape	PLOS ONE			English	Article							LEOPARD PANTHERA-PARDUS; EXTINCTION; TIGRIS; FRAMEWORK; ABUNDANCE; RECOVERY; DECLINE	Occupying only 7% of their historical range and confined to forested habitats interspersed in a matrix of human dominated landscapes, tigers (Panthera tigris) typify the problems faced by most large carnivores worldwide. With heads of governments of tiger range countries pledging to reverse the extinction process and setting a goal of doubling wild tiger numbers by 2022, achieving this target would require identifying existing breeding cores, potential breeding habitats and opportunities for dispersal. The Terai Arc Landscape (TAL) represents one region which has recently witnessed recovery of tiger populations following conservation efforts. In this study, we develop a spatially explicit tiger occupancy model with survey data from 2009-10 based on a priori knowledge of tiger biology and specific issues plaguing the western TAL (6,979 km 2), which occurs in two disjunct units (Tiger Habitat Blocks; THBs). Although the overall occupancy of tigers was 0.588 (SE 0.071), our results clearly indicate that loss in functionality of a regional corridor has resulted in tigers now occupying 17.58% of the available habitat in THB I in comparison to 88.5% in THB II. The current patterns of occupancy were best explained by models incorporating the interactive effect of habitat blocks (AIC w=0.883) on wild prey availability (AIC w=0.742) and anthropogenic disturbances (AIC w=0.143). Our analysis has helped identify areas of high tiger occupancy both within and outside existing protected areas, which highlights the need for a unified control of the landscape under a single conservation unit with the primary focus of managing tigers and associated wildlife. Finally, in the light of global conservation targets and recent legislations in India, our study assumes significance as we identify opportunities to secure (e.g. THB II) and increase (e.g. THB I) tiger populations in the landscape.	[Harihar, Abishek] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Harihar, Abishek; Pandav, Bivash] Wildlife Inst India, Dehra Dun, India	University of Kent; Wildlife Institute of India	Harihar, A (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	harihar.abishek@gmail.com	Harihar, Abishek/AAY-5092-2020	Harihar, Abishek/0000-0002-2446-6345	Kathryn Fuller Science for Nature Fellowships, WWF; Kaplan Graduate Awards, Panthera	Kathryn Fuller Science for Nature Fellowships, WWF; Kaplan Graduate Awards, Panthera	The work was supported in part by grants from the Kathryn Fuller Science for Nature Fellowships, WWF and Kaplan Graduate Awards, Panthera (to AH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asia Ministerial Conference on Tiger Conservation, 2010, 1 AS MIN C TIG CONS; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Bose J, 2011, INTERIM RELIEF SCHEM; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Champion HG, 1968, FOREST TYPE INDIA; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dinerstein E, 2006, SETTING PRIORITIES C; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Donovan T.M., 2007, EXERCISES OCCUPANCY; Fisher DO, 2003, P ROY SOC B-BIOL SCI, V270, P1801, DOI 10.1098/rspb.2003.2447; Goodrich JM, 2010, INTEGR ZOOL, V5, P300, DOI 10.1111/j.1749-4877.2010.00218.x; Government of India, 2011, CENS IND PROV POP TO; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Harihar A, 2009, ORYX, V43, P35, DOI 10.1017/S0030605307072043; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Harihar A, 2009, EUR J WILDLIFE RES, V55, P97, DOI 10.1007/s10344-008-0219-2; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines JE., 2006, PRESENCESOFTWARE EST; Jhala Y. V., 2011, STATUS TIGERS COPRED; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; Johnsingh A., 2004, RR04001 WILDL I IND; Kanagaraj R, 2011, ECOGRAPHY, V34, P970, DOI 10.1111/j.1600-0587.2010.06482.x; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 2000, J ZOOL, V250, P255; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; Rhodes J, 2011, ECOGRAPHY, V34, P141, DOI 10.1111/j.1600-0587.2010.05908.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sanderson E., 2006, SETTING PRIORITIES C; Seidensticker J., 2010, BIOL CONSERVATION WI; Seidensticker J, 2010, INTEGR ZOOL, V5, P285, DOI 10.1111/j.1749-4877.2010.00214.x; SMITH JLD, 1989, ANIM BEHAV, V37, P1; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Stokes EJ, 2010, INTEGR ZOOL, V5, P363, DOI 10.1111/j.1749-4877.2010.00223.x; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Sunquist M. E., 1981, SOCIAL ORG TIGERS PA; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Wikramanayake E, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P163, DOI 10.1016/B978-0-8155-1570-8.00010-4	52	67	67	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40105	10.1371/journal.pone.0040105	http://dx.doi.org/10.1371/journal.pone.0040105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792220	gold, Green Submitted, Green Published			2022-12-25	WOS:000306436300024
J	Jarviluoma, A; Strandin, T; Lulf, S; Bouchet, J; Makela, AR; Geyer, M; Benichou, S; Saksela, K				Jarviluoma, Annika; Strandin, Tomas; Luelf, Sebastian; Bouchet, Jerome; Makela, Anna R.; Geyer, Matthias; Benichou, Serge; Saksela, Kalle			High-Affinity Target Binding Engineered via Fusion of a Single-Domain Antibody Fragment with a Ligand-Tailored SH3 Domain	PLOS ONE			English	Article							HIV-1 NEF; ESCHERICHIA-COLI; VARIABLE DOMAINS; ANTIGEN-BINDING; PROTEIN; THERAPEUTICS; FAMILY; MULTIVALENT; STABILITY; EVOLUTION	Monoclonal and recombinant antibodies are ubiquitous tools in diagnostics, therapeutics, and biotechnology. However, their biochemical properties lack optimal robustness, their bacterial production is not easy, and possibilities to create multifunctional fusion proteins based on them are limited. Moreover, the binding affinities of antibodies towards their antigens are suboptimal for many applications where they are commonly used. To address these issues we have made use of the concept of creating high binding affinity based on multivalent target recognition via exploiting some of the best features of immunoglobulins (Ig) and non-Ig-derived ligand-binding domains. We have constructed a small protein, named Neffin, comprised of a 118 aa llama Ig heavy chain variable domain fragment (VHH) fused to a ligand-tailored 57 aa SH3 domain. Neffin could be readily produced in large amounts (>18 mg/L) in the cytoplasm of E. coli, and bound with a subpicomolar affinity (K-d 0.54 pM) to its target, the HIV-1 Nef protein. When expressed in human cells Neffin could potently inhibit Nef function. Similar VHH-SH3 fusion proteins could be targeted against many other proteins of interest and could have widespread use in diverse medical and biotechnology applications where biochemical robustness and strong binding affinity are required.	[Jarviluoma, Annika; Strandin, Tomas; Saksela, Kalle] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Luelf, Sebastian; Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44139 Dortmund, Germany; [Bouchet, Jerome; Benichou, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France; [Bouchet, Jerome; Benichou, Serge] INSERM, U1016, Paris, France; [Makela, Anna R.] NEXT Biomed Technol NBT Oy, Helsinki, Finland; [Saksela, Kalle] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland	University of Helsinki; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Helsinki; Helsinki University Central Hospital	Jarviluoma, A (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	kalle.saksela@helsinki.fi	Strandin, Tomas/K-5322-2019; bouchet, jerome/I-7716-2019	Strandin, Tomas/0000-0002-2454-7479; bouchet, jerome/0000-0002-6611-4380; Geyer, Matthias/0000-0002-7718-5002; Saksela, Kalle/0000-0003-0827-122X; Benichou, Serge/0000-0003-3602-3530	Academy of Finland [127197]; Helsinki University Central Hospital Research Council [TYH2008307]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Council; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants to KS from the Academy of Finland (127197), Helsinki University Central Hospital Research Council (TYH2008307), and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Bouchet J, 2011, BLOOD; Breuer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020033; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gmeiner WH, 2001, CELL BIOCHEM BIOPHYS, V35, P127, DOI 10.1385/CBB:35:2:127; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hiipakka M, 2002, J GEN VIROL, V83, P3147, DOI 10.1099/0022-1317-83-12-3147; Hiipakka M, 2001, VIROLOGY, V286, P152, DOI 10.1006/viro.2001.0973; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Hiipakka M, 2007, FEBS LETT, V581, P1735, DOI 10.1016/j.febslet.2007.03.044; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Honegger A., 2008, V181, P47; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Huang L, 2010, EXPERT REV MOL DIAGN, V10, P777, DOI 10.1586/ERM.10.62; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Koide A, 2007, METH MOL B, V352, P95; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Martineau P, 1999, J MOL BIOL, V292, P921, DOI 10.1006/jmbi.1999.3105; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Neri D, 1996, TRENDS BIOTECHNOL, V14, P465, DOI 10.1016/S0167-7799(96)10067-6; NERI D, 1995, J MOL BIOL, V246, P367, DOI 10.1006/jmbi.1994.0091; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Scolnik PA, 2009, MABS-AUSTIN, V1, P179, DOI 10.4161/mabs.1.2.7736; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Verheesen P, 2003, BBA-GEN SUBJECTS, V1624, P21, DOI 10.1016/j.bbagen.2003.09.006; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7	48	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40331	10.1371/journal.pone.0040331	http://dx.doi.org/10.1371/journal.pone.0040331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792285	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300056
J	Kouba, T; Danyi, I; Gunisova, S; Munzarova, V; Vlckova, V; Cuchalova, L; Neueder, A; Milkereit, P; Valasek, LS				Kouba, Tomas; Danyi, Istvan; Gunisova, Stanislava; Munzarova, Vanda; Vlckova, Vladislava; Cuchalova, Lucie; Neueder, Andreas; Milkereit, Philipp; Valasek, Leos Shivaya			Small Ribosomal Protein RPS0 Stimulates Translation Initiation by Mediating 40S-Binding of eIF3 via Its Direct Contact with the eIF3a/TIF32 Subunit	PLOS ONE			English	Article							RNA RECOGNITION MOTIF; P40/LAMININ RECEPTOR PRECURSOR; MULTIFACTOR COMPLEX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MESSENGER-RNAS; GCN4; REINITIATION; RESUMPTION; MATURATION	The ribosome translates information encoded by mRNAs into proteins in all living cells. In eukaryotes, its small subunit together with a number of eukaryotic initiation factors (eIFs) is responsible for locating the mRNA's translational start to properly decode the genetic message that it carries. This multistep process requires timely and spatially coordinated placement of eIFs on the ribosomal surface. In our long-standing pursuit to map the 40S-binding site of one of the functionally most complex eIFs, yeast multisubunit eIF3, we identified several interactions that placed its major body to the head, beak and shoulder regions of the solvent-exposed side of the 40S subunit. Among them is the interaction between the N-terminal domain (NTD) of the a/TIF32 subunit of eIF3 and the small ribosomal protein RPS0A, residing near the mRNA exit channel. Previously, we demonstrated that the N-terminal truncation of 200 residues in tif32-Delta 8 significantly reduced association of eIF3 and other eIFs with 40S ribosomes in vivo and severely impaired translation reinitiation that eIF3 ensures. Here we show that not the first but the next 200 residues of a/TIF32 specifically interact with RPS0A via its extreme C-terminal tail (CTT). Detailed analysis of the RPS0A conditional depletion mutant revealed a marked drop in the polysome to monosome ratio suggesting that the initiation rates of cells grown under non-permissive conditions were significantly impaired. Indeed, amounts of eIF3 and other eIFs associated with 40S subunits in the pre-initiation complexes in the RPS0A-depleted cells were found reduced; consistently, to the similar extent as in the tif32-Delta 8 cells. Similar but less pronounced effects were also observed with the viable CTT-less mutant of RPS0A. Together we conclude that the interaction between the flexible RPS0A-CTT and the residues 200-400 of the a/TIF32-NTD significantly stimulates attachment of eIF3 and its associated eIFs to small ribosomal subunits in vivo.	[Kouba, Tomas; Danyi, Istvan; Gunisova, Stanislava; Munzarova, Vanda; Vlckova, Vladislava; Cuchalova, Lucie; Valasek, Leos Shivaya] Inst Microbiol ASCR, Lab Regulat Gene Express, Vvi, Prague, Czech Republic; [Neueder, Andreas; Milkereit, Philipp] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Regensburg, Germany	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Regensburg	Kouba, T (corresponding author), Inst Microbiol ASCR, Lab Regulat Gene Express, Vvi, Prague, Czech Republic.	valasekl@biomed.cas.cz	Cuchalova, Lucie/H-4650-2014; Gunišová, Stanislava/I-1765-2014; Valášek, Leoš Shivaya/I-5743-2014; Neueder, Andreas/K-4319-2015; Hronová, Vladislava/J-9860-2014	Valášek, Leoš Shivaya/0000-0001-8123-8667; Neueder, Andreas/0000-0002-2389-5236; Hronová, Vladislava/0000-0001-6447-019X; Kouba, Tomas/0000-0001-8173-6930	Wellcome Trusts [076456/Z/05/Z, 090812/Z/09/Z]; Czech Science Foundation [P305-11-0172]	Wellcome Trusts(Wellcome Trust); Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by The Wellcome Trusts Grants 076456/Z/05/Z and 090812/Z/09/Z, and the Czech Science Foundation P305-11-0172 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ford CL, 1999, CANCER RES, V59, P704; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Lumsden T, 2010, NUCLEIC ACIDS RES, V38, P1261, DOI 10.1093/nar/gkp1113; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Munzarova V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002137; Nemoto N, 2010, J BIOL CHEM IN PRESS; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Nielsen KH, 2007, METHOD ENZYMOL, V431, P15, DOI 10.1016/S0076-6879(07)31002-1; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sokabe M, 2012, NUCLEIC ACIDS RES, V40, P905, DOI 10.1093/nar/gkr772; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Valasek LS, 2012, CURR PROTEI IN PRESS; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102	40	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40464	10.1371/journal.pone.0040464	http://dx.doi.org/10.1371/journal.pone.0040464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792338	Green Submitted, gold, Green Published			2022-12-25	WOS:000306436300068
J	Wang, AL; Xu, YQ; Ma, CQ; Gao, C; Li, LX; Wang, Y; Tao, F; Xu, P				Wang, Ailong; Xu, Youqiang; Ma, Cuiqing; Gao, Chao; Li, Lixiang; Wang, Yu; Tao, Fei; Xu, Ping			Efficient 2,3-Butanediol Production from Cassava Powder by a Crop-Biomass-Utilizer, Enterobacter cloacae subsp dissolvens SDM	PLOS ONE			English	Article							L-LACTIC ACID; FERMENTATION; ROOTS; BATCH	Background: 2,3-Butanediol (BD) is considered as one of the key platform chemicals used in a variety of industrial applications. It is crucial to find an efficient sugar-utilizing strain and feasible carbon source for the economical production of BD. Methodology/Principal Findings: Efficient BD production by a newly isolated Enterobacter cloacae subsp. dissolvens SDM was studied using crop-biomass cassava powder as substrate. The culture conditions and fermentation medium for BD production were optimized. Under the optimal conditions, 78.3 g l(-1) of BD was produced after 24 h in simultaneous saccharification and fermentation (SSF), with a yield of 0.42 g BD g(-1) cassava powder and a specific productivity of 3.3 g l(-1) h(-1). A higher BD concentration (93.9 g l(-1)) was produced after 47 h in fed-batch SSF. Conclusions/Significance: The results suggest that strain SDM is a good candidate for the BD production, and cassava powder could be used as an alternative substrate for the efficient production of BD.	[Wang, Ailong; Xu, Youqiang; Ma, Cuiqing; Gao, Chao; Li, Lixiang; Wang, Yu; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Tao, Fei; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University	Wang, AL (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn	Tao, Fei/E-5891-2010	Tao, Fei/0000-0002-5997-8770; Ma, Cuiqing/0000-0002-7468-1027; Gao, Chao/0000-0002-5205-0670; Wang, Yu/0000-0002-0957-9245	Chinese National Programs for High Technology Research and Development [2011AA02A207]; Chinese National Natural Science Foundation [30770064]	Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National Programs for High Technology Research and Development (2011AA02A207) and the Chinese National Natural Science Foundation (No. 30770064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; Cheng KK, 2010, PROCESS BIOCHEM, V45, P613, DOI 10.1016/j.procbio.2009.12.009; Choi GW, 2009, J CHEM TECHNOL BIOT, V84, P547, DOI 10.1002/jctb.2077; Djazuli M, 1999, FOOD CHEM, V65, P523, DOI 10.1016/S0308-8146(98)00218-0; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Ghofar A, 2005, J BIOSCI BIOENG, V100, P606, DOI 10.1263/jbb.100.606; Gu Y, 2009, J IND MICROBIOL BIOT, V36, P1225, DOI 10.1007/s10295-009-0604-1; Jansen N B, 1983, Adv Biochem Eng Biotechnol, V27, P85; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Ji XJ, 2011, APPL MICROBIOL BIOT, V89, P1119, DOI 10.1007/s00253-010-2940-5; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P5214, DOI 10.1016/j.biortech.2009.05.036; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P3410, DOI 10.1016/j.biortech.2009.02.031; Kostinek M, 2007, INT J FOOD MICROBIOL, V114, P342, DOI 10.1016/j.ijfoodmicro.2006.09.029; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Nie ZK, 2011, APPL BIOCHEM BIOTECH, V163, P946, DOI 10.1007/s12010-010-9098-6; Nitayavardhana S, 2010, BIORESOURCE TECHNOL, V101, P2741, DOI 10.1016/j.biortech.2009.10.075; Papong S, 2010, BIORESOURCE TECHNOL, V101, pS112, DOI 10.1016/j.biortech.2009.09.006; Petrov K, 2010, APPL MICROBIOL BIOT, V87, P943, DOI 10.1007/s00253-010-2545-z; Qin JY, 2006, CHINESE J CHEM ENG, V14, P132, DOI 10.1016/S1004-9541(06)60050-5; Roble ND, 2003, BIOTECHNOL LETT, V25, P1093, DOI 10.1023/A:1024192131343; Saha BC, 1999, APPL MICROBIOL BIOT, V52, P321, DOI 10.1007/s002530051526; Sun LH, 2009, APPL MICROBIOL BIOT, V82, P847, DOI 10.1007/s00253-008-1823-5; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Thang VH, 2010, APPL BIOCHEM BIOTECH, V161, P157, DOI 10.1007/s12010-009-8770-1; Wang AL, 2010, APPL MICROBIOL BIOT, V87, P965, DOI 10.1007/s00253-010-2557-8; Wang LM, 2010, BIORESOURCE TECHNOL, V101, P7895, DOI 10.1016/j.biortech.2010.05.018; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Xu YQ, 2012, J BACTERIOL, V194, P897, DOI 10.1128/JB.06495-11; Zeng AP, 2011, CURR OPIN BIOTECH, V22, P749, DOI 10.1016/j.copbio.2011.05.005; Zhang LY, 2010, J IND MICROBIOL BIOT, V37, P857, DOI 10.1007/s10295-010-0733-6	31	42	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40442	10.1371/journal.pone.0040442	http://dx.doi.org/10.1371/journal.pone.0040442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792324	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300067
J	Weinberg, SH; Tung, L				Weinberg, Seth H.; Tung, Leslie			Oscillation in Cycle Length Induces Transient Discordant and Steady-State Concordant Alternans in the Heart	PLOS ONE			English	Article							MONOMORPHIC VENTRICULAR-TACHYCARDIA; SMALL-SIGNAL AMPLIFICATION; MECHANISM; INITIATION	Alternans is a beat-to-beat alternation of the cardiac action potential duration (APD) or intracellular calcium (Ca-i) transient. In cardiac tissue, alternans can be spatially concordant or discordant, of which the latter has been shown to increase dispersion of repolarization and promote a substrate for initiation of ventricular fibrillation. Alternans has been studied almost exclusively under constant cycle length pacing conditions. However, heart rate varies greatly on a beat-by-beat basis in normal and pathological conditions. The purpose of this study was to determine if applying a repetitive but non-constant pacing pattern, specifically cycle length oscillation (CLO), promotes or suppresses a proarrhythmic substrate. We performed computational simulations and optical mapping experiments to investigate the potential consequences of CLO. In a single cell computational model, CLO induced APD and Ca-i alternans, which became "phase-matched" with the applied oscillation. As a consequence of the phase-matching, in one-dimensional cable simulations, neonatal rat ventricular myocyte monolayers, and isolated adult guinea pig hearts CLO could transiently induce spatial and electromechanical discordant alternans followed by a steady-state of concordance. Our results demonstrated that under certain conditions, CLO can initiate ventricular fibrillation in the isolated hearts. On the other hand, CLO can also exert an antiarrhythmic effect by converting an existing state of discordant alternans to concordant alternans.	[Weinberg, Seth H.; Tung, Leslie] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Weinberg, SH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	sweinbe9@jhmi.edu; ltung@jhu.edu		Weinberg, Seth/0000-0003-1170-0419	National Institutes of Health [R01 HL066239, S10 RR025544]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025544] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by National Institutes of Health grants R01 HL066239 (LT) and S10 RR025544 (LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistrup GL, 2009, CIRCULATION RES; Berger CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058101; BINKLEY PF, 1995, ANN INTERN MED, V122, P115, DOI 10.7326/0003-4819-122-2-199501150-00007; Christini DJ, 2001, P NATL ACAD SCI USA, V98, P5827, DOI 10.1073/pnas.091553398; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Gratadour P, 2008, INT J CARDIOL, V127, pE138, DOI 10.1016/j.ijcard.2007.04.138; Hall GM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.198102; Heldstab J, 1983, Z PHYS B, P141; Huikuri HV, 1996, CIRCULATION, V93, P1836, DOI 10.1161/01.CIR.93.10.1836; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Otani NF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021910; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Qu ZL, 2000, CIRCULATION, V102, P1664, DOI 10.1161/01.CIR.102.14.1664; ROELKE M, 1994, J AM COLL CARDIOL, V23, P117, DOI 10.1016/0735-1097(94)90509-6; RUBENSTEIN DS, 1995, CIRCULATION, V91, P201, DOI 10.1161/01.CIR.91.1.201; Saeed M, 2000, AM J CARDIOL, V85, P580, DOI 10.1016/S0002-9149(99)00815-2; Shiferaw Y, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021903; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Tandri H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002445; Tung L, 2006, J ELECTROCARDIOL, V39, pS2, DOI 10.1016/j.jelectrocard.2006.04.010; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x; Weinberg S, 2008, BIOPHYS J, V95, P1138, DOI 10.1529/biophysj.107.128207; Weinberg S, 2010, METHODS MOL BIOL, V660, P215, DOI 10.1007/978-1-60761-705-1_14; Weinberg S, 2010, AM J PHYSIOL-HEART C, V298, pH1727, DOI 10.1152/ajpheart.01036.2009; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; WIESENFELD K, 1986, PHYS REV A, V33, P629, DOI 10.1103/PhysRevA.33.629; Wu RZ, 2006, J CARDIOVASC ELECTR, V17, P87, DOI 10.1111/j.1540-8167.2005.00319.x; Zhao XP, 2007, NONLINEAR DYNAM, V48, P381, DOI 10.1007/s11071-006-9092-2; Zhao X, 2008, J COMPUT NONLIN DYN, V3, DOI 10.1115/1.2960467	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40477	10.1371/journal.pone.0040477	http://dx.doi.org/10.1371/journal.pone.0040477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792346	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300069
J	Yu, HP; Zhao, H; Wang, LE; Liu, ZS; Li, DH; Wei, QY				Yu, Hongping; Zhao, Hui; Wang, Li-E; Liu, Zhensheng; Li, Donghui; Wei, Qingyi			Correlation between Base-Excision Repair Gene Polymorphisms and Levels of In-Vitro BPDE-Induced DNA Adducts in Cultured Peripheral Blood Lymphocytes	PLOS ONE			English	Article							LUNG-CANCER RISK; POLYCYCLIC AROMATIC-HYDROCARBONS; SQUAMOUS-CELL CARCINOMA; DIOL EPOXIDE; BREAST-CANCER; ESCHERICHIA-COLI; REDOX REGULATION; NUCLEOTIDE; APE1; BENZO<A>PYRENE	In vitro benzo[a]pyrene diol epoxide (BPDE)-induced DNA adducts in cultured peripheral lymphocytes have been shown to be a phenotypic biomarker of individual's DNA repair phenotype that is associated with cancer risk. In this study, we explored associations between genotypes of base-excision repair genes (PARP1 Val762Ala, APEX1 Asp148Glu, and XRCC1 Arg399Gln) and in vitro BPDE-induced DNA adducts in cultured peripheral blood lymphocytes in 706 cancer-free non-Hispanic white subjects. We found that levels of BPDE-induced DNA adducts were significantly higher in ever smokers than in never smokers and that individuals with the Glu variant genotypes (i.e., Asp/Glu and Glu/Glu) exhibited lower levels of BPDE-induced DNA adducts than did individuals with the common Asp/Asp homozygous genotype (median RAL levels: 32.0 for Asp/Asp, 27.0 for Asp/Glu, and 17.0 for Glu/Glu, respectively; P-trend = 0.030). Further stratified analysis showed that compared with individuals with the common APEX1-148 homozygous Asp/Asp genotype, individuals with the APEX1-148Asp/Glu genotype or the Glu/Glu genotype had a lower risk of having higher-level adducts (adjusted OR = 0.60, 95% CI: 0.36-0.98 and adjusted OR = 0.47, 95% CI: 0.26-0.86, respectively; P-trend = 0.012) among smokers. Such an effect was not observed in non-smokers. However, there was no significant interaction between the APEX1 Asp148Glu polymorphism and smoking exposure in this study population (P = 0.512). Additional genotype-phenotype analysis found that the APEX1-148Glu allele had significantly increased expression of APEX1 mRNA in 270 Epstein-Barr virus-transformed lymphoblastoid cell lines, which is likely associated with more active repair activity. Our findings suggest that the functional APEX1-148Glu allele is associated with reduced risk of having high levels of BPDE-induced DNA adducts mediated with high levels of mRNA expression.	[Yu, Hongping] Guiling Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guilin, Peoples R China; [Yu, Hongping; Zhao, Hui; Wang, Li-E; Liu, Zhensheng; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yu, HP (corresponding author), Guiling Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guilin, Peoples R China.	yuhongping@hotmail.com; qwei@mdanderson.org	Zhao, Hui/AAS-7145-2020		National Institutes of Health [R01 ES-11740, R01 CA-131274, P30 CA-16672]; National Natural Science Foundation of China [30660162]; Natural Science Foundation of Guangxi [0719006]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA131274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (R01 ES-11740 and R01 CA-131274 to Dr. Wei, and P30 CA-16672 to The University of Texas M.D. Anderson Cancer Center), the National Natural Science Foundation of China (30660162), and the Natural Science Foundation of Guangxi (0719006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Alexandrov K, 2010, TOXICOL LETT, V198, P63, DOI 10.1016/j.toxlet.2010.04.009; Ali MF, 2008, ONCOL REP, V19, P1033; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Benhamou S, 2000, MUTAT RES-REV MUTAT, V462, P149, DOI 10.1016/S1383-5742(00)00032-6; BLAKEY DH, 1990, MUTAT RES, V236, P35, DOI 10.1016/0921-8777(90)90030-9; Bonn D, 1998, LANCET, V351, P42, DOI 10.1016/S0140-6736(05)78079-X; Braithwaite E, 1998, CARCINOGENESIS, V19, P1239, DOI 10.1093/carcin/19.7.1239; Canbay E, 2010, ANTICANCER RES, V30, P1359; Casale GP, 2001, CHEM RES TOXICOL, V14, P192, DOI 10.1021/tx000012y; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; DAY RS, 1978, MUTAT RES, V50, P383, DOI 10.1016/0027-5107(78)90043-X; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Deng Q, 2011, MED ONCOL; DEVANESAN PD, 1992, CHEM RES TOXICOL, V5, P302, DOI 10.1021/tx00026a024; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fritz G, 2000, INT J BIOCHEM CELL B, V32, P925, DOI 10.1016/S1357-2725(00)00045-5; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HALL J, 1994, INT J CANCER, V58, P179, DOI 10.1002/ijc.2910580206; HELZLSOUER KJ, 1995, INT J CANCER, V64, P14, DOI 10.1002/ijc.2910640105; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Houtgraaf JH, 2006, CARDIOVASC REVASCULA, V7, P165, DOI 10.1016/j.carrev.2006.02.002; JEFFREY AM, 1979, SCIENCE, V206, P1309, DOI 10.1126/science.316186; Jin XM, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-38; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; KING HWS, 1979, CHEM-BIOL INTERACT, V24, P345, DOI 10.1016/0009-2797(79)90082-6; Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042; Li DH, 2001, INT J CANCER, V93, P436, DOI 10.1002/ijc.1347.abs; Li DH, 2007, CANCER RES, V67, P5628, DOI 10.1158/0008-5472.CAN-07-0983; Li HH, 2009, BREAST, V18, P183, DOI 10.1016/j.breast.2009.03.008; Li Z, 2011, ARCH MED RES, V42, P226, DOI 10.1016/j.arcmed.2011.04.005; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; Lo YL, 2009, CANCER EPIDEM BIOMAR, V18, P223, DOI 10.1158/1055-9965.EPI-08-0749; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; Manvilla BA, 2010, BIOMOL NMR ASSIGN, V4, P5, DOI 10.1007/s12104-009-9196-y; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; O'Brien TJ, 2005, MOL CELL BIOCHEM, V279, P85, DOI 10.1007/s11010-005-8225-0; OSBORNE M, 1985, CHEM-BIOL INTERACT, V53, P183, DOI 10.1016/S0009-2797(85)80095-8; OSBORNE MR, 1981, CARCINOGENESIS, V2, P553, DOI 10.1093/carcin/2.6.553; PELTONEN K, 1995, J OCCUP ENVIRON MED, V37, P52, DOI 10.1097/00043764-199501000-00008; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Shekari M, 2008, CANCER BIOMARK, V4, P63, DOI 10.3233/CBM-2008-4202; STIERUM RH, 1994, CARCINOGENESIS, V15, P745, DOI 10.1093/carcin/15.4.745; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; STRAUB KM, 1977, P NATL ACAD SCI USA, V74, P5285, DOI 10.1073/pnas.74.12.5285; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; VANHOUTEN B, 1986, CARCINOGENESIS, V7, P83, DOI 10.1093/carcin/7.1.83; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; WEI QY, 1994, AM J EPIDEMIOL, V140, P598, DOI 10.1093/oxfordjournals.aje.a117297; Wei QY, 1997, CANCER METAST REV, V16, P295, DOI 10.1023/A:1005852211430; Wei QY, 1996, CANCER RES, V56, P4103; Wei QY, 2000, J NATL CANCER I, V92, P1764; WEI QY, 1993, P NATL ACAD SCI USA, V90, P1614, DOI 10.1073/pnas.90.4.1614; WEINSTEIN IB, 1976, SCIENCE, V193, P592, DOI 10.1126/science.959820; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Yosunkaya E, 2010, BRIT J NEUROSURG, V24, P561, DOI 10.3109/02688697.2010.489655; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653; Zhao H, 2008, CARCINOGENESIS, V29, P1560, DOI 10.1093/carcin/bgn089; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	65	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40131	10.1371/journal.pone.0040131	http://dx.doi.org/10.1371/journal.pone.0040131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792228	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300029
J	Amigo-Correig, M; Barcelo-Batllori, S; Soria, G; Krezymon, A; Benani, A; Penicaud, L; Tudela, R; Planas, AM; Fernandez, E; Carmona, MD; Gomis, R				Amigo-Correig, Marta; Barcelo-Batllori, Silvia; Soria, Guadalupe; Krezymon, Alice; Benani, Alexandre; Penicaud, Luc; Tudela, Raul; Maria Planas, Anna; Fernandez, Eduardo; del Carmen Carmona, Maria; Gomis, Ramon			Anti-Obesity Sodium Tungstate Treatment Triggers Axonal and Glial Plasticity in Hypothalamic Feeding Centers	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-2; WATER DIFFUSION; AGENT TUNGSTATE; ARCUATE NUCLEUS; NERVOUS-SYSTEM; ADIPOSE-TISSUE; FOOD-INTAKE; PHOSPHORYLATION; CRMP-2; RATS	Objective: This study aims at exploring the effects of sodium tungstate treatment on hypothalamic plasticity, which is known to have an important role in the control of energy metabolism. Methods: Adult lean and high-fat diet-induced obese mice were orally treated with sodium tungstate. Arcuate and paraventricular nuclei and lateral hypothalamus were separated and subjected to proteomic analysis by DIGE and mass spectrometry. Immunohistochemistry and in vivo magnetic resonance imaging were also performed. Results: Sodium tungstate treatment reduced body weight gain, food intake, and blood glucose and triglyceride levels. These effects were associated with transcriptional and functional changes in the hypothalamus. Proteomic analysis revealed that sodium tungstate modified the expression levels of proteins involved in cell morphology, axonal growth, and tissue remodeling, such as actin, CRMP2 and neurofilaments, and of proteins related to energy metabolism. Moreover, immunohistochemistry studies confirmed results for some targets and further revealed tungstate-dependent regulation of SNAP25 and HPC-1 proteins, suggesting an effect on synaptogenesis as well. Functional test for cell activity based on c-fos-positive cell counting also suggested that sodium tungstate modified hypothalamic basal activity. Finally, in vivo magnetic resonance imaging showed that tungstate treatment can affect neuronal organization in the hypothalamus. Conclusions: Altogether, these results suggest that sodium tungstate regulates proteins involved in axonal and glial plasticity. The fact that sodium tungstate could modulate hypothalamic plasticity and networks in adulthood makes it a possible and interesting therapeutic strategy not only for obesity management, but also for other neurodegenerative illnesses like Alzheimer's disease.	[Amigo-Correig, Marta; Barcelo-Batllori, Silvia; del Carmen Carmona, Maria; Gomis, Ramon] Hosp Clin Barcelona, Diabet & Obes Lab, Inst Invest Biomed August Pi & Sunyer, Endocrinol & Nutr Unit, Barcelona, Spain; [Amigo-Correig, Marta; Barcelo-Batllori, Silvia; del Carmen Carmona, Maria; Gomis, Ramon] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Tudela, Raul] Univ Barcelona, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Grp Biomed Imaging, Barcelona, Spain; [Soria, Guadalupe; Maria Planas, Anna] Inst Invest Biomed August Pi & Sunyer, CSIC, Inst Invest Biomed Barcelona, Dept Brain Ischemia & Neurodegenerat, Barcelona, Spain; [Soria, Guadalupe; Tudela, Raul; Maria Planas, Anna] Inst Invest Biomed August Pi & Sunyer, Expt MRI Unit 7T, Barcelona, Spain; [Krezymon, Alice; Benani, Alexandre; Penicaud, Luc] Univ Bourgogne, INRA 1324, UMR CNRS 6265, Taste & Food Sci Ctr, Dijon, France; [Fernandez, Eduardo] Miguel Hernandez Univ, Bioengn Inst, Elche, Spain; [Fernandez, Eduardo] Miguel Hernandez Univ, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Elche, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad Miguel Hernandez de Elche	Amigo-Correig, M (corresponding author), Hosp Clin Barcelona, Diabet & Obes Lab, Inst Invest Biomed August Pi & Sunyer, Endocrinol & Nutr Unit, Barcelona, Spain.	CARMONA@clinic.ub.es; RGOMIS@clinic.ub.es	Tudela, Raúl/K-8261-2017; Soria, Guadalupe/AAG-4658-2021; Soria, Guadalupe/GXH-4792-2022; Planas, Anna M/J-5991-2014; Fernandez, Eduardo/S-8206-2016; Benani, Alexandre/F-4002-2012	Tudela, Raúl/0000-0001-5134-4784; Soria, Guadalupe/0000-0002-8344-0479; Planas, Anna M/0000-0002-6147-1880; Fernandez, Eduardo/0000-0002-7052-6011; Carmona Orozco, Mamen/0000-0001-5911-6938; Benani, Alexandre/0000-0003-2046-0162; Barcelo-Batllori, Silvia/0000-0002-5352-9747	Spanish Ministry of Education of Science [SAF 2006-07382, BES-2007-17284]; Carlos III Health Institute (ISCIII) [CP07/00152]	Spanish Ministry of Education of Science(Spanish Government); Carlos III Health Institute (ISCIII)(Instituto de Salud Carlos III)	This work was supported by project no SAF 2006-07382 and grant no BES-2007-17284, both awarded by the Spanish Ministry of Education of Science, and by project noCP07/00152, financed by the Carlos III Health Institute (ISCIII). Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas is an initiative of ISCIII (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo-Correig M, 2011, DIABETES OBES METAB, V13, P235, DOI 10.1111/j.1463-1326.2010.01339.x; Amigo-Correig M, DIABETES OB IN PRESS; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Banas SM, 2009, CELL MOL NEUROBIOL, V29, P157, DOI 10.1007/s10571-008-9307-9; BARBERA A, 1994, J BIOL CHEM, V269, P20047; Barbera AGR, 2001, DIABETOLOGIA, V44; Barcelo-Batllori S, 2005, PROTEOMICS, V5, P4927, DOI 10.1002/pmic.200500050; Barcelo-Batllori S, 2002, PROTEOMICS, V2, P551, DOI 10.1002/1615-9861(200205)2:5<551::AID-PROT551>3.0.CO;2-O; Barcelo-Batllori S, 2008, MOL CELL PROTEOMICS, V7, P378, DOI 10.1074/mcp.M700198-MCP200; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becskei C, 2009, NEUROENDOCRINOLOGY, V90, P371, DOI 10.1159/000251723; Bernabeu A, 2009, NEUROIMAGE, V47, P1172, DOI 10.1016/j.neuroimage.2009.04.080; Bouret S, 2004, SCIENCE, V304, P63; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; Canals I, 2009, ENDOCRINOLOGY, V150, P642, DOI 10.1210/en.2008-0881; Carmona MC, 2009, INT J OBES; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Claret M, 2005, ENDOCRINOLOGY, V146, P4362, DOI 10.1210/en.2005-0385; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Evans J, 2002, J NEUROPHYSIOL, V87, P1076, DOI 10.1152/jn.00088.2001; Felley-Bosco E, 1999, ELECTROPHORESIS, V20, P3508, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3508::AID-ELPS3508>3.0.CO;2-7; Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gomez-Ramos A, 2006, J NEUROSCI RES, V83, P264, DOI 10.1002/jnr.20726; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; HARRIS RBS, 1986, J NUTR, V116, P2536, DOI 10.1093/jn/116.12.2536; Hasan KM, 2006, MAGN RESON MED, V56, P130, DOI 10.1002/mrm.20935; Horvath TL, 2004, NEUROSCIENTIST, V10, P235, DOI 10.1177/1073858403262151; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kanninen K, 2004, NEUROSCI LETT, V367, P235, DOI 10.1016/j.neulet.2004.06.013; Kletzin A, 1996, FEMS MICROBIOL REV, V18, P5, DOI 10.1016/0168-6445(95)00025-9; Lazar M, 2005, MAGN RESON MED, V54, P860, DOI 10.1002/mrm.20653; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Morisaki S, 2011, J MAGN RESON IMAGING, V33, P535, DOI 10.1002/jmri.22442; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mungarndee SS, 2008, AM J PHYSIOL-REG I, V295, pR751, DOI 10.1152/ajpregu.90344.2008; Munoz MC, 2001, DIABETES, V50, P131, DOI 10.2337/diabetes.50.1.131; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Piquer S, 2007, BIOCHEM BIOPH RES CO, V358, P385, DOI 10.1016/j.bbrc.2007.04.143; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Stankiewiez PaG MJ, 1988, BIOCHEMISTRY-US, V27, P206; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; Tobin JE, 2011, J NEUROPATH EXP NEUR, V70, P157, DOI 10.1097/NEN.0b013e31820937e4; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Veeranna GJ, 2000, MOL BRAIN RES, V76, P229, DOI 10.1016/S0169-328X(00)00003-6; Verty ANA, 2010, ENDOCRINOLOGY, V151, P4236, DOI 10.1210/en.2009-1235; Vianna CR, 2011, ENDOCRINOLOGY, V152, P11, DOI 10.1210/en.2010-0778; Yamashita N, 2012, J NEUROSCI, V32, P1360, DOI 10.1523/JNEUROSCI.5563-11.2012; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zheng HY, 2008, PHYSIOLOGY, V23, P75, DOI 10.1152/physiol.00047.2007	61	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39087	10.1371/journal.pone.0039087	http://dx.doi.org/10.1371/journal.pone.0039087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802935	Green Published, gold			2022-12-25	WOS:000306186900009
J	Miller, AK; Britten, RD; Nielsen, PMF				Miller, Andrew K.; Britten, Randall D.; Nielsen, Poul M. F.			Declarative Representation of Uncertainty in Mathematical Models	PLOS ONE			English	Article							CELLML	An important aspect of multi-scale modelling is the ability to represent mathematical models in forms that can be exchanged between modellers and tools. While the development of languages like CellML and SBML have provided standardised declarative exchange formats for mathematical models, independent of the algorithm to be applied to the model, to date these standards have not provided a clear mechanism for describing parameter uncertainty. Parameter uncertainty is an inherent feature of many real systems. This uncertainty can result from a number of situations, such as: when measurements include inherent error; when parameters have unknown values and so are replaced by a probability distribution by the modeller; when a model is of an individual from a population, and parameters have unknown values for the individual, but the distribution for the population is known. We present and demonstrate an approach by which uncertainty can be described declaratively in CellML models, by utilising the extension mechanisms provided in CellML. Parameter uncertainty can be described declaratively in terms of either a univariate continuous probability density function or multiple realisations of one variable or several (typically non-independent) variables. We additionally present an extension to SED-ML (the Simulation Experiment Description Markup Language) to describe sampling sensitivity analysis simulation experiments. We demonstrate the usability of the approach by encoding a sample model in the uncertainty markup language, and by developing a software implementation of the uncertainty specification (including the SED-ML extension for sampling sensitivty analyses) in an existing CellML software library, the CellML API implementation. We used the software implementation to run sampling sensitivity analyses over the model to demonstrate that it is possible to run useful simulations on models with uncertainty encoded in this form.	[Miller, Andrew K.; Britten, Randall D.; Nielsen, Poul M. F.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Nielsen, Poul M. F.] Univ Auckland, Dept Engn Sci, Fac Engn, Auckland, New Zealand	University of Auckland; University of Auckland	Miller, AK (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand.	ak.miller@auckland.ac.nz			Virtual Physiological Human Share project under European Framework 7	Virtual Physiological Human Share project under European Framework 7	This work was funded by the Virtual Physiological Human Share project (http://www.vph-share.eu), under European Framework 7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS JH, 1982, COMMUN ACM, V25, P47, DOI 10.1145/358315.358390; Apt K, 2003, LECT N BIOINFORMAT; Carlisle D., 2000, SIGSAM Bulletin, V34, P6, DOI 10.1145/362001.362011; Devroye L., 1986, NONUNIFORM RANDOM VA, V4; Gilks W.R., 1994, LANGUAGE PROGRAM COM, P169; Hedley WJ, 2001, PHILOS T ROY SOC A, V359, P1073, DOI 10.1098/rsta.2001.0817; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Josey A, 2004, 10031 IEEE OP GROUP, P20; Kinderman A, 1976, J AM STAT ASSOC, P893; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Lloyd CM, 2004, PROG BIOPHYS MOL BIO, V85, P433, DOI 10.1016/j.pbiomolbio.2004.01.004; Lourakis M, 2008, LEVMAR LEVENBERG MAR; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Miller AK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-178; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Thomas A, 1992, BAYESIAN STATISTICS, P837; Von Neumann J., 1951, APPL MATH SER, V12, P36	19	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39721	10.1371/journal.pone.0039721	http://dx.doi.org/10.1371/journal.pone.0039721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802941	gold, Green Submitted, Green Published			2022-12-25	WOS:000306186900015
J	Monchy, S; Grattepanche, JD; Breton, E; Meloni, D; Sanciu, G; Chabe, M; Delhaes, L; Viscogliosi, E; Sime-Ngando, T; Christaki, U				Monchy, Sebastien; Grattepanche, Jean-David; Breton, Elsa; Meloni, Dionigia; Sanciu, Giovanna; Chabe, Magali; Delhaes, Laurence; Viscogliosi, Eric; Sime-Ngando, Telesphore; Christaki, Urania			Microplanktonic Community Structure in a Coastal System Relative to a Phaeocystis Bloom Inferred from Morphological and Tag Pyrosequencing Methods	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SEQUENCE ALIGNMENT; MOLECULAR ECOLOGY; MYRIONECTA-RUBRA; LIFE-CYCLE; EUKARYOTES; RARE; SIZE; PHYTOPLANKTON; BIODIVERSITY	Background: Massive phytoplankton blooms, like the recurrent Phaeocystis proliferation observed every year in the Eastern English Channel (EEC), have a significant influence on the overall planktonic community structure and their food web dynamics. As well as being an important area for local fisheries, the EEC is an ideal ecosystem for work on microbial diversity. This is because, although its environmental context is relatively complex, it is reasonably well understood due to several years of monitoring and morphological observations of its planktonic organisms. The objective of our study was to better understand the under-explored microbial eukaryotic diversity relative to the Phaeocystis bloom. Methodology and Principal Findings: The community structure of microplankton (diatoms, haptophytes, ciliates and dinoflagellates) was studied through morphological observations and tag pyrosequencing. During the annual Phaeocystis spring bloom, the phytoplankton biomass increased by 34-fold, while the microzooplankton biomass showed a 4-fold increase, representing on average about 4.6% of the biomass of their phytoplankton prey. Tag pyrosequencing unveiled an extensive diversity of Gymnodiniaceae, with G. spirale and G. fusiformis representing the most abundant reads. An extended diversity of Phaeocystales, with partial 18S rDNA genes sequence identity as low as 85% was found, with taxa corresponding to P. globosa, but also to unknown Phaeocystaceae. Conclusions: Morphological analyses and pyrosequencing were generally in accordance with capturing frequency shifts of abundant taxa. Tag pyrosequencing allowed highlighting the maintenance of microplankton diversity during the Phaeocystis bloom and the increase of the taxa presenting low number of reads (minor taxa) along with the dominant ones in response to biotic and/or abiotic changing conditions. Although molecular approaches have enhanced our perception on diversity, it has come to light that the challenge of modelling and predicting ecological change requires the use of different complementary approaches, to link taxonomic data with the functional roles of microbes in biogeochemical cycles.	[Monchy, Sebastien; Grattepanche, Jean-David; Breton, Elsa; Christaki, Urania] Univ Lille Nord, Univ Littoral Cote Opale, LOG, CNRS,UMR 8187, Wimereux, France; [Meloni, Dionigia; Sanciu, Giovanna; Chabe, Magali; Delhaes, Laurence; Viscogliosi, Eric] Univ Lille Nord France, CIIL, Inst Pasteur Lille, Inserm,U1019,CNRS,UMR 8204,EA4547, Lille, France; [Meloni, Dionigia; Sanciu, Giovanna] Univ Sassari, Dept Biol Sci, Div Expt & Clin Microbiol, I-07100 Sassari, Italy; [Sime-Ngando, Telesphore] Univ Blaise Pascal, LMGE, CNRS, UMR 6023, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Sassari; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Monchy, S (corresponding author), Univ Lille Nord, Univ Littoral Cote Opale, LOG, CNRS,UMR 8187, Wimereux, France.	sebmonchy@gmail.com	Meloni, Dionigia/K-4840-2015; Sime-Ngando, Télesphore/M-4134-2019; Delhaes, Laurence/AAD-6930-2020; elsa, Breton/J-4996-2013; Grattepanche, Jean-David/C-7101-2013; Chabe, Magali/H-6045-2017	Meloni, Dionigia/0000-0003-0188-5747; Sime-Ngando, Télesphore/0000-0002-7240-5803; Grattepanche, Jean-David/0000-0002-1854-3762; Breton, Elsa/0000-0002-9569-5436; Viscogliosi, Eric/0000-0002-5805-7179; Christaki, Urania/0000-0002-2061-5278; MONCHY, Sebastien/0000-0001-5808-4700; Chabe, Magali/0000-0002-6732-6772	INSU (Institut National des Sciences de l'Univers) - CNRS (Centre National de la Recherche Scientifique) EC2CO; ANR (Agence Nationale de la Recherche) [DREP 07 BLANC 0372-01]; SOMLIT network (Service d'Observation du Milieu Littoral)	INSU (Institut National des Sciences de l'Univers) - CNRS (Centre National de la Recherche Scientifique) EC2CO; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); SOMLIT network (Service d'Observation du Milieu Littoral)	This study was supported by the INSU (Institut National des Sciences de l'Univers) - CNRS (Centre National de la Recherche Scientifique) EC2CO, and ANR (Agence Nationale de la Recherche) - DREP 07 BLANC 0372-01 projects and the SOMLIT network (Service d'Observation du Milieu Littoral). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler L, 2010, LIFE WORLDS OCEANS D; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Breton E, 2006, LIMNOL OCEANOGR, V51, P1401, DOI 10.4319/lo.2006.51.3.1401; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Capnulo GM, 1983, MAR ECOL PROG SER, V10, P277; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; CHAO A, 1984, SCAND J STAT, V11, P265; Christaki U, 1999, MAR ECOL PROG SER, V181, P297, DOI 10.3354/meps181297; Christaki U, 2009, AQUAT MICROB ECOL, V57, P263, DOI 10.3354/ame01339; Creer S, 2010, MOL ECOL, V19, P2829, DOI 10.1111/j.1365-294X.2010.04670.x; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Duffy JE, 2006, MAR ECOL PROG SER, V311, P179, DOI 10.3354/meps311179; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Gaebler-Schwarz S, 2010, J PHYCOL, V46, P1006, DOI 10.1111/j.1529-8817.2010.00875.x; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Genitsaris S, 2009, FEMS MICROBIOL ECOL, V69, P75, DOI 10.1111/j.1574-6941.2009.00686.x; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gomez F, 2008, CR BIOL, V331, P678, DOI 10.1016/j.crvi.2008.06.005; Gomez F, 2007, CR BIOL, V330, P231, DOI 10.1016/j.crvi.2007.02.002; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grattepanche JD, 2011, J EXP MAR BIOL ECOL, V404, P87, DOI 10.1016/j.jembe.2011.04.004; Grattepanche JD, 2011, J PLANKTON RES, V33, P37, DOI 10.1093/plankt/fbq097; Gribble KE, 2006, J PHYCOL, V42, P1081, DOI 10.1111/j.1529-8817.2006.00267.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Johnson MD, 2004, PROTIST, V155, P347, DOI 10.1078/1434461041844222; Jurgens K, 2000, AQUAT MICROB ECOL, V22, P57, DOI 10.3354/ame022057; Karakousis A, 2006, J MICROBIOL METH, V65, P38, DOI 10.1016/j.mimet.2005.06.008; Karayanni H, 2005, J GEOPHYS RES, V10; Ki JS, 2005, J APPL PHYCOL, V17, P147, DOI 10.1007/s10811-005-7211-y; Kirchman DL, 2007, OCEANOGRAPHY, V20, P166, DOI 10.5670/oceanog.2007.62; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Lange M, 2002, EUR J PHYCOL, V37, P77, DOI 10.1017/S0967026201003481; Lange M, 1997, THESIS U BREMEN BREM; Lepere C, 2006, APPL ENVIRON MICROB, V72, P2971, DOI 10.1128/AEM.72.4.2971-2981.2006; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; Marie D, 2010, FEMS MICROBIOL ECOL, V72, P165, DOI 10.1111/j.1574-6941.2010.00842.x; Martin LA, 2002, PROTIST, V153, P275, DOI 10.1078/1434-4610-00104; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; MEDLIN LK, 1994, PHYCOLOGIA, V33, P199, DOI 10.2216/i0031-8884-33-3-199.1; Medlin LK, 1995, NATO ADV SCI INST SE, V38, P133; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Oikonomou A, 2012, SCI WORLD J, DOI 10.1100/2012/504135; Park JS, 2007, AQUAT MICROB ECOL, V48, P83, DOI 10.3354/ame048083; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Quiroga I, 2004, BOT MAR, V47, P341, DOI 10.1515/BOT.2004.040; Rappe MS, 1998, APPL ENVIRON MICROB, V64, P294; Reiss J, 2010, ADV ECOL RES, V43, P45, DOI 10.1016/S0065-2504(10)43002-0; ROUSSEAU V, 1990, MAR BIOL, V107, P305, DOI 10.1007/BF01319830; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Schapira M, 2008, J MAR BIOL ASS UK, P88; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; SIMEK K, 1995, LIMNOL OCEANOGR, V40, P1077, DOI 10.4319/lo.1995.40.6.1077; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spatharis S, 2011, ECOL INDIC, V11, P697, DOI 10.1016/j.ecolind.2010.09.009; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; STOECKER DK, 1994, MAR ECOL PROG SER, V110, P293, DOI 10.3354/meps110293; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; VAULOT D, 1994, J PHYCOL, V30, P1022, DOI 10.1111/j.0022-3646.1994.01022.x; VERITY PG, 1985, LIMNOL OCEANOGR, V30, P1268, DOI 10.4319/lo.1985.30.6.1268	84	50	52	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39924	10.1371/journal.pone.0039924	http://dx.doi.org/10.1371/journal.pone.0039924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792138	Green Published, Green Submitted, gold			2022-12-25	WOS:000305892100140
J	Umezu, T; Ohyashiki, K; Kuroda, M; Ohyashiki, JH				Umezu, T.; Ohyashiki, K.; Kuroda, M.; Ohyashiki, J. H.			Leukemia cell to endothelial cell communication via exosomal miRNAs	ONCOGENE			English	Article						exosomal miRNAs; cell-to-cell communication; endothelial migration; tube formation	BONE MORPHOGENETIC PROTEINS; MICRORNAS; EXPRESSION; ANGIOGENESIS; MECHANISM; NOTCH; DICER; FATE	Recent findings indicate that specific microRNAs (miRNAs), such as those of the miR-17-92 cluster, may be responsible for regulating endothelial gene expression during tumor angiogenesis. Secreted miRNAs enclosed in exosomes also have an important role in cell-cell communication. To elucidate whether miRNAs secreted from neoplastic cells transfer into endothelial cells and are functionally active in the recipient cells, we investigated the effect of exosomal miRNAs derived from leukemia cells (K562) on human umbilical vein endothelial cells (HUVECs). As K562 cells released the miR-17-92 cluster, especially miR-92a, into the extracellular environment, K562 cells, transfected with Cy3-labeled pre-miR-92a, were co-cultured with HUVECs. Cy3-miR-92a derived from K562 cells was detected in the cytoplasm of HUVECs, and the Cy3-miR-92a co-localized with the signals of an exosomal marker, CD63. The expression of integrin alpha 5, a target gene for miR-92a, was significantly reduced in HUVECs by exosomal miR-92a, indicating that exogenous miRNA via exosomal transport can function like endogenous miRNA in HUVECs. The most salient feature of this study is the exosome, derived from K562 cells with enforced miR-92a expression, did not affect the growth of HUVECs but did enhance endothelial cell migration and tube formation. Our results support the idea that exosomal miRNAs have an important role in neoplasia-to-endothelial cell communication.	[Umezu, T.; Ohyashiki, K.] Tokyo Med Univ, Dept Mol Sci, Tokyo 1600023, Japan; [Ohyashiki, K.] Tokyo Med Univ, Dept Internal Med 1, Tokyo 1600023, Japan; [Kuroda, M.] Tokyo Med Univ, Dept Mol Pathol, Tokyo 1600023, Japan; [Ohyashiki, J. H.] Tokyo Med Univ, Inst Med Sci, Tokyo 1600023, Japan	Tokyo Medical University; Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Umezu, T (corresponding author), Tokyo Med Univ, Dept Mol Sci, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	t_umezu@tokyo-med.ac.jp	Umezu, Tomohiro/AAK-9711-2020	Umezu, Tomohiro/0000-0002-0123-8921	Private University Strategic Research-Based Support Project: Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Tokyo, Japan; Grants-in-Aid for Scientific Research [23659626] Funding Source: KAKEN	Private University Strategic Research-Based Support Project: Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Private University Strategic Research-Based Support Project: Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Tokyo, Japan.	Anand S, 2011, CURR OPIN HEMATOL, V18, P171, DOI 10.1097/MOH.0b013e328345a180; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; AUFDERHEIDE E, 1987, J CELL BIOL, V105, P599, DOI 10.1083/jcb.105.1.599; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; CABRERA CV, 1990, DEVELOPMENT, V110, P733; Chen AL, 2004, J ORTHOP RES, V22, P1188, DOI 10.1016/j.orthres.2004.02.013; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Ebara S, 2002, SPINE, V27, pS10, DOI 10.1097/00007632-200208151-00004; Heusschen R, 2010, BBA-REV CANCER, V1805, P87, DOI 10.1016/j.bbcan.2009.09.005; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Ohyashiki Junko H, 2010, BMC Res Notes, V3, P347, DOI 10.1186/1756-0500-3-347; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Scott WJ, 2005, REPROD TOXICOL, V19, P479, DOI 10.1016/j.reprotox.2004.11.013; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	25	341	366	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2013	32	22					2747	2755		10.1038/onc.2012.295	http://dx.doi.org/10.1038/onc.2012.295			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	156FU	22797057				2022-12-25	WOS:000319808000006
J	Bugg, CW; Isas, JM; Fischer, T; Patterson, PH; Langen, R				Bugg, Charles W.; Isas, J. Mario; Fischer, Torsten; Patterson, Paul H.; Langen, Ralf			Structural Features and Domain Organization of Huntingtin Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; BETA-SHEET STRUCTURE; IN-VITRO; POLYGLUTAMINE AGGREGATION; INTRANUCLEAR INCLUSIONS; EXPANDED GLUTAMINE; MUTANT HUNTINGTIN; ALPHA-SYNUCLEIN; CAG REPEAT	Misfolding and aggregation of huntingtin is one of the hallmarks of Huntington disease, but the overall structure of these aggregates and the mechanisms by which huntingtin misfolds remain poorly understood. Here we used site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy to study the structural features of huntingtin exon 1 (HDx1) containing 46 glutamine residues in its polyglutamine ( polyQ) region. Despite some residual structuring in the N terminus, we find that soluble HDx1 is highly dynamic. Upon aggregation, the polyQ domain becomes strongly immobilized indicating significant tertiary or quaternary packing interactions. Analysis of spin-spin interactions does not show the close contact between same residues that is characteristic of the parallel, in-register structure commonly found in amyloids. Nevertheless, the same residues are still within 20 angstrom of each other, suggesting that polyQ domains from different molecules come into proximity in the fibrils. The N terminus has previously been found to take up a helical structure in fibrils. We find that this domain not only becomes structured, but that it also engages in tertiary or quaternary packing interactions. The existence of spin-spin interactions in this region suggests that such contacts could be made between N-terminal domains from different molecules. In contrast, the C-terminal domain is dynamic, contains polyproline II structure, and lacks pronounced packing interactions. This region must be facing away from the core of the fibrils. Collectively, these data provide new constraints for building structural models of HDx1 fibrils.	[Isas, J. Mario; Fischer, Torsten; Langen, Ralf] Univ So Calif, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90089 USA; [Bugg, Charles W.; Patterson, Paul H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Southern California; California Institute of Technology	Langen, R (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Keck Sch Med, 1501 San Pablo St,ZNI 119, Los Angeles, CA 90089 USA.	langen@usc.edu			National Institutes of Health through NINDS; Hereditary Disease Foundation	National Institutes of Health through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hereditary Disease Foundation	This work was supported, in whole or in part, by a grant from the National Institutes of Health through the NINDS (to P. H. P.). This work was also supported by grants from the Hereditary Disease Foundation (to R. L. and P. H. P.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hollenbach B, 1999, PHILOS T ROY SOC B, V354, P991, DOI 10.1098/rstb.1999.0450; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Langen R, 1999, BIOCHEMISTRY-US, V38, P7918, DOI 10.1021/bi990010g; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2003, BIOCHEMISTRY-US, V42, P4009, DOI 10.1021/bi027437z; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mishra R, 2012, J MOL BIOL, V415, P900, DOI 10.1016/j.jmb.2011.12.011; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rosas HD, 2001, NEUROLOGY, V57, P1025, DOI 10.1212/WNL.57.6.1025; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sharma D, 2005, PROTEINS, V61, P398, DOI 10.1002/prot.20602; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Woody R. W., 1992, ADV BIOPHYS CHEM, V2, P37; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	59	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31739	31746		10.1074/jbc.M112.353839	http://dx.doi.org/10.1074/jbc.M112.353839			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22801429	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-25	WOS:000309059400015
J	Komori, H; Watanabe, H; Shuto, T; Kodama, A; Maeda, H; Watanabe, K; Kai, H; Otagiri, M; Maruyama, T				Komori, Hisakazu; Watanabe, Hiroshi; Shuto, Tsuyoshi; Kodama, Azusa; Maeda, Hitoshi; Watanabe, Kenji; Kai, Hirofumi; Otagiri, Masaki; Maruyama, Toru			alpha(1)-Acid Glycoprotein Up-regulates CD163 via TLR4/CD14 Protein Pathway POSSIBLE PROTECTION AGAINST HEMOLYSIS-INDUCED OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE SCAVENGER RECEPTOR; ACUTE-PHASE PROTEINS; TOLL-LIKE RECEPTORS; HUMAN MONOCYTES; ALPHA-1-ACID GLYCOPROTEIN; DIFFERENTIATION ANTIGEN; HEMOGLOBIN; ACTIVATION; INDUCTION; BINDING	CD163, a scavenger receptor that is expressed at high levels in the monocyte-macrophage system, is a critical factor for the efficient extracellular hemoglobin (Hb) clearance during hemolysis. Because of the enormous detrimental effect of liberated Hb on our body by its ability to induce pro-inflammatory signals and tissue damage, an understanding of the molecular mechanisms associated with CD163 expression during the acute phase response is a central issue. We report here that alpha(1)-acid glycoprotein (AGP), an acute phase protein, the serum concentration of which is elevated under various inflammatory conditions, including hemolysis, up-regulates CD163 expression in both macrophage-like differentiated THP-1 (dTHP-1) cells and peripheral blood mononuclear cells in a time- and concentration-dependent manner. Moreover, the subsequent induction of Hb uptake was also observed in AGP-treated dTHP-1 cells. Among representative acute phase proteins such as AGP, alpha(1)-antitrypsin, C-reactive protein, and haptoglobin, only AGP increased CD163 expression, suggesting that AGP plays a specific role in the regulation of CD163. Consistently, the physiological concentrations of AGP induced CD163, and the subsequent induction of Hb uptake as well as the reduction of oxidative stress in plasma were observed in phenylhydrazine-induced hemolytic model mice, confirming the in vivo role of AGP. Finally, AGP signaling through the toll-like receptor-4 (TLR4) and CD14, the common innate immune receptor complex that normally recognizes bacterial components, was identified as a crucial stimulus that induces the autocrine regulatory loops of IL-6 and/or IL-10 via NF-kappa B, p38, and JNK pathways, which leads to an enhancement in CD163 expression. These findings provide possible insights into how AGP exerts anti-inflammatory properties against hemolysis-induced oxidative stress.	[Otagiri, Masaki; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Shuto, Tsuyoshi; Watanabe, Kenji; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Komori, Hisakazu] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028471, Japan; [Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600822, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Japan Society for the Promotion of Science; Sojo University	Maruyama, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tomaru@kumamoto-u.ac.jp	Komori, Hisakazu/AAQ-2590-2020		Japan Society for the Promotion of Science [20390161, 23458100]; Grants-in-Aid for Scientific Research [24659076] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-aid for Scientific Research 20390161 and 23458100 from Japan Society for the Promotion of Science.	Barrabes S, 2010, ELECTROPHORESIS, V31, P2903, DOI 10.1002/elps.200900764; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Grinshtein N, 2003, BIOCHEMISTRY-US, V42, P6977, DOI 10.1021/bi020647r; HARALDSSON B, 1987, ACTA PHYSIOL SCAND, V129, P127, DOI 10.1111/j.1748-1716.1987.tb08047.x; HARALDSSON BS, 1992, KIDNEY INT, V41, P310, DOI 10.1038/ki.1992.43; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kagaya N, 2005, J BIOSCI BIOENG, V99, P81, DOI 10.1263/jbb.99.81; Kato GJ, 2009, J CLIN INVEST, V119, P2140, DOI 10.1172/JCI40258; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kuzuhara H, 2006, EUR J PHARMACOL, V541, P205, DOI 10.1016/j.ejphar.2006.05.003; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Maru Y, 2009, CANCER SCI, V100, P2006, DOI 10.1111/j.1349-7006.2009.01300.x; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pioli PA, 2004, J LEUKOCYTE BIOL, V76, P500, DOI 10.1189/jlb.1203617; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ritter M, 1999, BIOCHEM BIOPH RES CO, V260, P466, DOI 10.1006/bbrc.1999.0866; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Schaer DJ, 2002, BRIT J HAEMATOL, V119, P239, DOI 10.1046/j.1365-2141.2002.03790.x; SCHMID K, 1973, BIOCHEMISTRY-US, V12, P2711, DOI 10.1021/bi00738a026; SCHNITZER JE, 1992, AM J PHYSIOL, V263, pH48, DOI 10.1152/ajpheart.1992.263.1.H48; Schroder NWJ, 2008, IMMUNOBIOLOGY, V213, P329, DOI 10.1016/j.imbio.2007.11.003; Shapiro RA, 1997, INFECT IMMUN, V65, P293, DOI 10.1128/IAI.65.1.293-297.1997; SHNYRA A, 1995, INFECT IMMUN, V63, P865, DOI 10.1128/IAI.63.3.865-873.1995; Su SJ, 1999, IMMUNOPHARMACOLOGY, V41, P21, DOI 10.1016/S0162-3109(98)00048-4; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; TILG H, 1993, J EXP MED, V178, P1629, DOI 10.1084/jem.178.5.1629; Vallelian F, 2010, BLOOD, V116, P5347, DOI 10.1182/blood-2010-04-277319; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Van Molle W, 1999, J IMMUNOL, V163, P5235; VanMolle W, 1997, J IMMUNOL, V159, P3555; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Weaver LK, 2007, J LEUKOCYTE BIOL, V81, P663, DOI 10.1189/jlb.0706428; Williams L, 2002, J LEUKOCYTE BIOL, V72, P800; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	49	34	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30688	30700		10.1074/jbc.M112.353771	http://dx.doi.org/10.1074/jbc.M112.353771			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807450	Green Published, hybrid			2022-12-25	WOS:000308579800058
J	Magnacca, A; Persiconi, I; Nurzia, E; Caristi, S; Meloni, F; Barnaba, V; Paladini, F; Raimondo, D; Fiorillo, MT; Sorrentino, R				Magnacca, Adriana; Persiconi, Irene; Nurzia, Elisa; Caristi, Silvana; Meloni, Francesca; Barnaba, Vincenzo; Paladini, Fabiana; Raimondo, Domenico; Fiorillo, Maria Teresa; Sorrentino, Rosa			Characterization of a Proteasome and TAP-independent Presentation of Intracellular Epitopes by HLA-B27 Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HLA CLASS-I; TRANS-GOLGI NETWORK; T-CELL RECOGNITION; ANKYLOSING-SPONDYLITIS; SELF-PEPTIDE; SUBTYPES; SUSCEPTIBILITY; RESIDUE; HLA-B-ASTERISK-2705; MECHANISM	Nascent HLA-class I molecules are stabilized by proteasome-derived peptides in the ER and the new complexes proceed to the cell surface through the post-ER vesicles. It has been shown, however, that less stable complexes can exchange peptides in the Trans Golgi Network (TGN). HLA-B27 are the most studied HLA-class I molecules due to their association with Ankylosing Spondylitis (AS). Chimeric proteins driven by TAT of HIV have been exploited by us to deliver viral epitopes, whose cross-presentation by the HLA-B27 molecules was proteasome and TAP-independent and not restricted to Antigen-Presenting Cells (APC). Here, using these chimeric proteins as epitope suppliers, we compared with each other and with the HLA-A2 molecules, the two HLA-B*2705 and B*2709 alleles differing at residue 116 (D116H) and differentially associated with AS. We found that the antigen presentation by the two HLA-B27 molecules was proteasome-, TAP-, and APC-independent whereas the presentation by the HLA-A2 molecules required proteasome, TAP and professional APC. Assuming that such difference could be due to the unpaired, highly reactive Cys-67 distinguishing the HLA-B27 molecules, C67S mutants in HLA-B*2705 and B*2709 and V67C mutant in HLA-A*0201 were also analyzed. The results showed that this mutation did not influence the HLA-A2-restricted antigen presentation while it drastically affected the HLA-B27-restricted presentation with, however, remarkable differences between B*2705 and B*2709. The data, together with the occurrence on the cell surface of unfolded molecules in the case of C67S-B*2705 mutant but not in that of C67SB*2709 mutant, indicates that Cys-67 has a more critical role in stabilizing the B*2705 rather than the B*2709 complexes.	[Sorrentino, Rosa] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Meloni, Francesca; Barnaba, Vincenzo] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00185 Rome, Italy; [Raimondo, Domenico] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Sorrentino, R (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, Via Sardi 70, I-00185 Rome, Italy.	rosa.sorrentino@uniroma1.it	Barnaba, Vincenzo/AAB-1945-2019; Sorrentino, Rosa/G-5472-2012; raimondo, domenico/J-1704-2012	Sorrentino, Rosa/0000-0002-9632-2383; PERSICONI, IRENE/0000-0002-2924-7256; Paladini, Fabiana/0000-0003-1040-452X; FIORILLO, Maria Teresa/0000-0002-6859-5851; raimondo, domenico/0000-0002-1780-7295; caristi, silvana/0000-0002-0016-7498	Italian Ministry of Education, University and Research (MIUR) through PRIN [2008C33HRL-004]; Istituto Pasteur-Fondazione Cenci Bolognetti; King Abdullah University of Science and Technology (KAUST) Fondazione Roma [KUK-11-012-43]; Sapienza through Progetti di Ateneo [C26A10CT9F]	Italian Ministry of Education, University and Research (MIUR) through PRIN(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); King Abdullah University of Science and Technology (KAUST) Fondazione Roma; Sapienza through Progetti di Ateneo	This work was supported by the Italian Ministry of Education, University and Research (MIUR) through PRIN (grant no2008C33HRL-004), by the Istituto Pasteur-Fondazione Cenci Bolognetti, King Abdullah University of Science and Technology (KAUST) (Award No. KUK-11-012-43) Fondazione Roma and by Sapienza through Progetti di Ateneo (Grant noC26A10CT9F).	Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Alvarez I, 2001, J BIOL CHEM, V276, P48740, DOI 10.1074/jbc.M108882200; Appel H, 2004, J IMMUNOL, V173, P6564, DOI 10.4049/jimmunol.173.11.6564; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Bettosini F, 2005, J VIROL, V79, P15537, DOI 10.1128/JVI.79.24.15537-15546.2005; Blanco-Gelaz MA, 2001, HUM IMMUNOL, V62, P1042, DOI 10.1016/S0198-8859(01)00299-3; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Campbell EC, 2012, IMMUNOLOGY, V136, P380, DOI 10.1111/j.1365-2567.2012.03593.x; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Fiorillo MT, 1997, EUR J IMMUNOL, V27, P368, DOI 10.1002/eji.1830270205; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 1998, EUR J IMMUNOL, V28, P2508, DOI 10.1002/(SICI)1521-4141(199808)28:08<2508::AID-IMMU2508>3.0.CO;2-1; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Garcia-Fernandez S, 2001, TISSUE ANTIGENS, V58, P259, DOI 10.1034/j.1399-0039.2001.580407.x; Hendel H, 1999, J IMMUNOL, V162, P6942; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Mear JP, 1999, J IMMUNOL, V163, P6665; Montserrat V, 2003, J IMMUNOL, V170, P5778, DOI 10.4049/jimmunol.170.11.5778; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nurzia E, 2010, CLIN IMMUNOL, V135, P476, DOI 10.1016/j.clim.2010.01.009; Paladini F, 2005, ARTHRITIS RHEUM-US, V52, P3319, DOI 10.1002/art.21308; Propato A, 2001, NAT MED, V7, P807, DOI 10.1038/89930; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Santos SG, 2006, J IMMUNOL, V176, P2942, DOI 10.4049/jimmunol.176.5.2942; Sesma L, 2002, J BIOL CHEM, V277, P16744, DOI 10.1074/jbc.M200371200; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Taurog JD, 2009, ADV EXP MED BIOL, V649, P245; Tran TM, 2004, J IMMUNOL, V172, P5110, DOI 10.4049/jimmunol.172.8.5110; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	43	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30358	30367		10.1074/jbc.M112.384339	http://dx.doi.org/10.1074/jbc.M112.384339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807446	hybrid, Green Published			2022-12-25	WOS:000308579800028
J	Puts, CF; Panatala, R; Hennrich, H; Tsareva, A; Williamson, P; Holthuis, JCM				Puts, Catheleyne F.; Panatala, Radhakrishnan; Hennrich, Hanka; Tsareva, Alina; Williamson, Patrick; Holthuis, Joost C. M.			Mapping Functional Interactions in a Heterodimeric Phospholipid Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSPORT; SUBCELLULAR-LOCALIZATION; CRYSTAL-STRUCTURE; CDC50 PROTEINS; YEAST; TRANSLOCATION; ASYMMETRY; ROLES	Type 4 P-type ATPases (P-4-ATPases) catalyze phospholipid transport to generate phospholipid asymmetry across membranes of late secretory and endocytic compartments, but their kinship to cation-transporting P-type transporters raised doubts about whether P-4-ATPases alone are sufficient to mediate flippase activity. P-4-ATPases form heteromeric complexes with Cdc50 proteins. Studies of the enzymatic properties of purified P-4-ATPase.Cdc50 complexes showed that catalytic activity depends on direct and specific interactions between Cdc50 subunit and transporter, whereas in vivo interaction assays suggested that the binding affinity for each other fluctuates during the transport reaction cycle. The structural determinants that govern this dynamic association remain to be established. Using domain swapping, site-directed, and random mutagenesis approaches, we here show that residues throughout the subunit contribute to forming the heterodimer. Moreover, we find that a precise conformation of the large ectodomain of Cdc50 proteins is crucial for the specificity and functionality to transporter/subunit interactions. We also identified two highly conserved disulfide bridges in the Cdc50 ectodomain. Functional analysis of cysteine mutants that disrupt these disulfide bridges revealed an inverse relationship between subunit binding and P-4-ATPase-catalyzed phospholipid transport. Collectively, our data indicate that a dynamic association between subunit and transporter is crucial for the transport reaction cycle of the heterodimer.	[Holthuis, Joost C. M.] Univ Osnabruck, Mol Cell Biol Div, D-49076 Osnabruck, Germany; [Puts, Catheleyne F.; Panatala, Radhakrishnan; Hennrich, Hanka; Holthuis, Joost C. M.] Univ Utrecht, Bijvoet Ctr, Dept Membrane Enzymol, NL-3508 TC Utrecht, Netherlands; [Puts, Catheleyne F.; Panatala, Radhakrishnan; Hennrich, Hanka; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3508 TC Utrecht, Netherlands; [Tsareva, Alina; Williamson, Patrick] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	University Osnabruck; Utrecht University; Utrecht University; Amherst College	Holthuis, JCM (corresponding author), Univ Osnabruck, Mol Cell Biol Div, Barbarastr 13, D-49076 Osnabruck, Germany.	holthuis@uos.de	Holthuis, Joost/AAL-9157-2020; Panatala, Radhakrishnan/AAH-7284-2021	Panatala, Radhakrishnan/0000-0003-3663-8236; Holthuis, Joost/0000-0001-8912-1586	European Union; Dutch Organization of Sciences (NWO-CW); Utrecht High Potential Program; National Science Foundation	European Union(European Commission); Dutch Organization of Sciences (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Utrecht High Potential Program; National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the European Union Framework V Program (the Flippase Project), the Dutch Organization of Sciences (NWO-CW), the Utrecht High Potential Program (to J. C. M. H.), and the National Science Foundation (to P. W.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Grefen C., 2007, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0527S41; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	36	26	26	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30529	30540		10.1074/jbc.M112.371088	http://dx.doi.org/10.1074/jbc.M112.371088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22791719	Green Published, hybrid			2022-12-25	WOS:000308579800045
J	Akiyama, Y; Hoshino, T; Iwabuchi, K; Morishima, K				Akiyama, Yoshitake; Hoshino, Takayuki; Iwabuchi, Kikuo; Morishima, Keisuke			Room Temperature Operable Autonomously Moving Bio-Microrobot Powered by Insect Dorsal Vessel Tissue	PLOS ONE			English	Article							CULTURED CARDIOMYOCYTES; LONG-TERM; FABRICATION; STIMULATION	Living muscle tissues and cells have been attracting attention as potential actuator candidates. In particular, insect dorsal vessel tissue (DVT) seems to be well suited for a bio-actuator since it is capable of contracting autonomously and the tissue itself and its cells are more environmentally robust under culturing conditions compared with mammalian tissues and cells. Here we demonstrate an autonomously moving polypod microrobot (PMR) powered by DVT excised from an inchworm. We fabricated a prototype of the PMR by assembling a whole DVT onto an inverted two-row micropillar array. The prototype moved autonomously at a velocity of 3.5610(-2) mu m/s, and the contracting force of the whole DVT was calculated as 20 mu N. Based on the results obtained by the prototype, we then designed and fabricated an actual PMR. We were able to increase the velocity significantly for the actual PMR which could move autonomously at a velocity of 3.5 mu m/s. These results indicate that insect DVT has sufficient potential as the driving force for a bio-microrobot that can be utilized in microspaces.	[Akiyama, Yoshitake; Hoshino, Takayuki; Morishima, Keisuke] Osaka Univ, Dept Mech Engn, Suita, Osaka, Japan; [Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Dept Appl Mol Biol & Biochem, Fuchu, Tokyo, Japan; [Akiyama, Yoshitake; Hoshino, Takayuki; Morishima, Keisuke] Tokyo Univ Agr & Technol, Dept Bioapplicat & Syst Engn, Tokyo, Japan	Osaka University; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology	Akiyama, Y (corresponding author), Osaka Univ, Dept Mech Engn, Suita, Osaka, Japan.	morishima@mech.eng.osaka-u.ac.jp	Iwabuchi, Kikuo/I-7530-2012; Morishima, Keisuke/AAZ-8751-2021; Hoshino, Takayuki/O-6226-2015; Morishima, Keisuke/L-2873-2016	Morishima, Keisuke/0000-0003-1146-3900; Hoshino, Takayuki/0000-0003-4376-7853; Morishima, Keisuke/0000-0003-1146-3900	Ministry of Education, Culture, Sports, Science and Technology in Japan [20034017, 21676002, 21111503, 21225007]; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Moritani Scholarship Foundation; TORAY Science Foundation; CASIO Science Promotion Foundation	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Moritani Scholarship Foundation; TORAY Science Foundation(Toray Industries, Inc.); CASIO Science Promotion Foundation	The present work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan Nos. 20034017, 21676002, 21111503, and 21225007, the Industrial Technology Research Grant Program (2006) from the New Energy and Industrial Technology Development Organization (NEDO) of Japan, The Moritani Scholarship Foundation, TORAY Science Foundation and CASIO Science Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Yoshitake, 2010, Journal of Biomechanical Science and Engineering, V5, P236, DOI 10.1299/jbse.5.236; Akiyama Y, 2008, P 12 INT C MIN SYST, P1669; Akiyama Y, 2008, J BIOTECHNOL, V133, P261, DOI 10.1016/j.jbiotec.2007.08.042; Akiyama Yoshitake, 2006, Conf Proc IEEE Eng Med Biol Soc, VSuppl, P6565; Akiyama Y, 2010, IN VITRO CELL DEV-AN, V46, P411, DOI 10.1007/s11626-009-9268-4; Akiyama Y, 2008, P IEEE RAS-EMBS INT, P501, DOI 10.1109/BIOROB.2008.4762909; Akiyama Y, 2009, LAB CHIP, V9, P140, DOI 10.1039/b809299k; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Horiguchi H, 2009, IEEE T NANOBIOSCI, V8, P349, DOI 10.1109/TNB.2009.2035282; Hunter I.W., 1992, IEEE SOL STAT SENS A, P178, DOI DOI 10.1109/SOLSEN.1992.228297; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Ishisaka T., 2007, TRANSDUCERS '07 & Eurosensors XXI. 2007 14th International Conference on Solid-State Sensors, Actuators and Microsystems, P903, DOI 10.1109/SENSOR.2007.4300277; Kim DH, 2006, SENSOR ACTUAT B-CHEM, V117, P391, DOI 10.1016/j.snb.2005.11.051; Kim J, 2007, LAB CHIP, V7, P1504, DOI 10.1039/b705367c; Madden JD, 2007, SCIENCE, V318, P1094, DOI 10.1126/science.1146351; Mitsuhashi J, 2002, SPRING LAB MAN; Morishima K, 2006, SENSOR ACTUAT B-CHEM, V119, P345, DOI 10.1016/j.snb.2005.11.063; Park JY, 2007, LAB CHIP, V7, P1367, DOI 10.1039/b703900j; Shimizu K, 2010, INT C P MIN SYST CHE, P1229; Suzumura K, 2011, PROC IEEE MICR ELECT, P149, DOI 10.1109/MEMSYS.2011.5734383; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tanaka Y, 2006, LAB CHIP, V6, P362, DOI 10.1039/b515149j; Tanaka Y, 2006, LAB CHIP, V6, P230, DOI 10.1039/b512099c; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Yamasaki K, 2009, J ARTIF ORGANS, V12, P131, DOI 10.1007/s10047-009-0457-4	27	44	44	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e38274	10.1371/journal.pone.0038274	http://dx.doi.org/10.1371/journal.pone.0038274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808004	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400001
J	Llupia, A; Garcia-Basteiro, AL; Mena, G; Rios, J; Puig, J; Bayas, JM; Trilla, A				Llupia, Anna; Garcia-Basteiro, Alberto L.; Mena, Guillermo; Rios, Jose; Puig, Joaquim; Bayas, Jose M.; Trilla, Antoni			Vaccination Behaviour Influences Self-Report of Influenza Vaccination Status: A Cross-Sectional Study among Health Care Workers	PLOS ONE			English	Article							ELDERLY OUTPATIENTS; COVERAGE; VALIDATION; PROGRAM; QUESTIONNAIRE; PERSONNEL; ACCURACY; VALIDITY	Background: Published influenza vaccination coverage in health care workers (HCW) are calculated using two sources: self-report and vaccination records. The objective of this study was to determine whether self-report is a good proxy for recorded vaccination in HCW, as the degree of the relationship is not known, and whether vaccine behaviour influences self-reporting. Methods: A cross-sectional study was conducted using a self-administered survey during September 2010. Considering the vaccination record as the gold standard of vaccination, the properties of self-report as a proxy of the record (sensitivity, specificity, positive predictive value, negative predictive value) were calculated. Concordance between the vaccination campaigns studied (2007-2010) was made using the Kappa index, and discordance was analyzed using McNemar's test. Results: 248 HCW responded. The 95% confidence intervals of coverage according to the vaccination record and to self-report overlapped, except for 2007, and the Kappa index showed a substantial concordance, except for 2007. McNemar's test suggested that differences between discordant cases were not due to chance and it was found that the proportion of unvaccinated discordant cases was higher than that of vaccinated discordant cases. Conclusions: In our study population, self-reported influenza vaccination coverage in HCW in the previous two years is a good proxy of the vaccination record. However, vaccination behaviour influences the self-report and explains a trend to overestimate coverage in self-reporting compared to the vaccination record. The sources of coverage should be taken into account whenever comparisons are made.	[Llupia, Anna; Garcia-Basteiro, Alberto L.; Mena, Guillermo; Bayas, Jose M.; Trilla, Antoni] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Prevent Med & Epidemiol Unit, Barcelona, Catalonia, Spain; [Rios, Jose] Hosp Clin Barcelona, Clin Pharmacol Serv, Barcelona, Catalonia, Spain; [Rios, Jose] Univ Autonoma Barcelona, Biostat Unit, E-08193 Barcelona, Catalonia, Spain; [Puig, Joaquim] Univ Politecn Cataluna, Dept Appl Math 1, Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Universitat Politecnica de Catalunya	Llupia, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Prevent Med & Epidemiol Unit, Barcelona, Catalonia, Spain.	annallupia@gmail.com	Llupià, Anna/AAD-2093-2021; Trilla, Antoni/G-2446-2018; Ríos, José/AAZ-2341-2020; Puig, Joaquim/G-1573-2015	Ríos, José/0000-0002-0716-8784; Puig, Joaquim/0000-0003-0600-1023; Llupia, Anna/0000-0001-8284-7560; MENA PINILLA, GUILLERMO/0000-0003-0147-6302	Solvay-Abbott Influenza Research Grant; GlaxoSmithKline; Sanofi Pasteur MSD;  [MTM2009-06973]	Solvay-Abbott Influenza Research Grant; GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur MSD; 	This study was funded by the Solvay-Abbott Influenza Research Grant 2010. J Puig is funded by MTM2009-06973. The investigators were contracted by their institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JMB has received fees for lectures, advice and participation in working groups funded by the pharmaceutical industry. He has participated as principal investigator in clinical trials of vaccines (influenza vaccines, and others) promoted by GlaxoSmithKline and Sanofi Pasteur MSD. All other authors declare they have no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrews RM, 2005, VACCINE, V23, P2756, DOI 10.1016/j.vaccine.2004.11.039; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bertin M, 2007, AM J INFECT CONTROL, V35, P33, DOI 10.1016/j.ajic.2006.10.005; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Bryant KA, 2004, INFECT CONT HOSP EP, V25, P912, DOI 10.1086/502319; de Juanes JR, 2007, VACCINE, V25, P201, DOI 10.1016/j.vaccine.2005.10.057; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Greene SK, 2009, AM J PREV MED, V37, P552, DOI 10.1016/j.amepre.2009.08.022; HUTCHISON BG, 1989, CAN J PUBLIC HEALTH, V80, P271; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Llupia A, 2010, AM J INFECT CONTROL, V38, P476, DOI 10.1016/j.ajic.2010.01.013; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2007, EPIDEMIOL INFECT, V135, P139, DOI 10.1017/S0950268806006479; National Health and Medical Research Council (Australia), 1997, AUSTR IMM HDB; NICHOL KL, 1991, AM J PREV MED, V7, P199, DOI 10.1016/S0749-3797(18)30913-9; Russell ML, 2003, AM J INFECT CONTROL, V31, P457, DOI 10.1016/S0196-6553(03)00085-3; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; Sartor C, 2004, INFECT CONT HOSP EP, V25, P918, DOI 10.1086/502320; Skull SA, 2007, VACCINE, V25, P4775, DOI 10.1016/j.vaccine.2007.04.015; Sy LS, 2010, VACCINE, V28, P5254, DOI 10.1016/j.vaccine.2010.05.061; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4	24	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39496	10.1371/journal.pone.0039496	http://dx.doi.org/10.1371/journal.pone.0039496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808039	Green Published, gold, Green Submitted			2022-12-25	WOS:000306362400011
J	Kelly, JD; Dudderidge, TJ; Wollenschlaeger, A; Okoturo, O; Burling, K; Tulloch, F; Halsall, I; Prevost, T; Prevost, AT; Vasconcelos, JC; Robson, W; Leung, HY; Vasdev, N; Pickard, RS; Williams, GH; Stoeber, K				Kelly, John D.; Dudderidge, Tim J.; Wollenschlaeger, Alex; Okoturo, Odu; Burling, Keith; Tulloch, Fiona; Halsall, Ian; Prevost, Teresa; Prevost, Andrew Toby; Vasconcelos, Joana C.; Robson, Wendy; Leung, Hing Y.; Vasdev, Nikhil; Pickard, Robert S.; Williams, Gareth H.; Stoeber, Kai			Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; MINICHROMOSOME MAINTENANCE PROTEIN-2; PHOTODYNAMIC DIAGNOSIS; 5-AMINOLEVULINIC ACID; UROTHELIAL CANCER; DNA-REPLICATION; FOLLOW-UP; EXPRESSION; MARKERS; NMP22	Background: Urinary biomarkers for bladder cancer detection are constrained by inadequate sensitivity or specificity. Here we evaluate the diagnostic accuracy of Mcm5, a novel cell cycle biomarker of aberrant growth, alone and in combination with NMP22. Methods: 1677 consecutive patients under investigation for urinary tract malignancy were recruited to a prospective blinded observational study. All patients underwent ultrasound, intravenous urography, cystoscopy, urine culture and cytologic analysis. An immunofluorometric assay was used to measure Mcm5 levels in urine cell sediments. NMP22 urinary levels were determined with the FDA-approved NMP22 (R) Test Kit. Results: Genito-urinary tract cancers were identified in 210/1564 (13%) patients with an Mcm5 result and in 195/1396 (14%) patients with an NMP22 result. At the assay cut-point where sensitivity and specificity were equal, the Mcm5 test detected primary and recurrent bladder cancers with 69% sensitivity (95% confidence interval = 62-75%) and 93% negative predictive value (95% CI = 92-95%). The area under the receiver operating characteristic curve for Mcm5 was 0.75 (95% CI = 0.71-0.79) and 0.72 (95% CI = 0.67-0.77) for NMP22. Importantly, Mcm5 combined with NMP22 identified 95% (79/83; 95% CI = 88-99%) of potentially life threatening diagnoses (i.e. grade 3 or carcinoma in situ or stage >= pT1) with high specificity (72%, 95% CI = 69-74%). Conclusions: The Mcm5 immunoassay is a non-invasive test for identifying patients with urothelial cancers with similar accuracy to the FDA-approved NMP22 ELISA Test Kit. The combination of Mcm5 plus NMP22 improves the detection of UCC and identifies 95% of clinically significant disease. Trials of a commercially developed Mcm5 assay suitable for an end-user laboratory alongside NMP22 are required to assess their potential clinical utility in improving diagnostic and surveillance care pathways.	[Kelly, John D.; Dudderidge, Tim J.; Williams, Gareth H.; Stoeber, Kai] UCL, Dept Pathol, London, England; [Kelly, John D.; Dudderidge, Tim J.; Williams, Gareth H.; Stoeber, Kai] UCL, Inst Canc, London, England; [Dudderidge, Tim J.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Wollenschlaeger, Alex; Williams, Gareth H.; Stoeber, Kai] UCL, Wolfson Inst Biomed Res, London, England; [Okoturo, Odu] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Burling, Keith; Tulloch, Fiona; Halsall, Ian] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; [Prevost, Teresa; Vasconcelos, Joana C.] Univ Cambridge, Inst Publ Hlth, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge, England; [Prevost, Andrew Toby] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Robson, Wendy; Vasdev, Nikhil; Pickard, Robert S.] Freeman Rd Hosp, Dept Urol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Leung, Hing Y.] Univ Glasgow, Beatson Inst Canc Res, Glasgow, Lanark, Scotland	University of London; University College London; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; University College London; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; King's College London; Newcastle Freeman Hospital; Newcastle University - UK; Beatson Institute; University of Glasgow	Kelly, JD (corresponding author), UCL, Dept Pathol, London, England.	gareth.williams@ucl.ac.uk	Vasdev, Nikhil/AAG-3878-2020; Dudderidge, Tim/AAO-1430-2020	Vasdev, Nikhil/0000-0002-3966-5734; Dudderidge, Tim/0000-0001-6373-3613; Leung, Hing Y./0000-0002-3933-3975; Prevost, A. Toby/0000-0003-1723-0796	Cancer Research UK [C428/A3441]; Cancer Research UK [15151] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (grant number C428/A3441 to KS and GHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almallah YZ, 2000, UROLOGY, V56, P37, DOI 10.1016/S0090-4295(00)00555-0; American Cancer Society, 2012, CANC FACTS FIG 2012; Ayaru L, 2008, BRIT J CANCER, V98, P1548, DOI 10.1038/sj.bjc.6604342; Babjuk M, 2012, GUIDELINES NONMUSCLE; Barkley LR, 2007, EXP CELL RES, V313, P3789, DOI 10.1016/j.yexcr.2007.07.004; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Burger M, 2007, BRIT J CANCER, V96, P1711, DOI 10.1038/sj.bjc.6603784; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; Eward KL, 2004, J CELL SCI, V117, P5875, DOI 10.1242/jcs.01503; Gakis G, 2010, CURR OPIN UROL, V20, P388, DOI 10.1097/MOU.0b013e32833cc9f4; Gaston KE, 2010, METHODS MOL BIOL, V641, P303, DOI 10.1007/978-1-60761-711-2_17; Going JJ, 2002, GUT, V50, P373, DOI 10.1136/gut.50.3.373; Grossman HB, 2006, JAMA-J AM MED ASSOC, V295, P299, DOI 10.1001/jama.295.3.299; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Korkolopoulou P, 2005, HUM PATHOL, V36, P899, DOI 10.1016/j.humpath.2005.06.008; Kriegmair M, 1996, J UROLOGY, V155, P105, DOI 10.1016/S0022-5347(01)66559-5; Kruger S, 2003, EUR UROL, V43, P138, DOI 10.1016/S0302-2838(02)00580-8; Ku JH, 2012, BJU INT, V110, P630, DOI 10.1111/j.1464-410X.2011.10884.x; Lotan Y, 2008, BJU INT, V101, P1362, DOI 10.1111/j.1464-410X.2008.07473.x; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mostofi FK, 1973, HISTOLOGICAL TYPING; Mowatt G, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14040; Ponsky LE, 2001, J UROLOGY, V166, P75, DOI 10.1016/S0022-5347(05)66080-6; Redorta JP, 2011, NEPHROUROL MON, V3, P182; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Saad A, 2002, BJU INT, V89, P369, DOI 10.1046/j.1464-4096.2001.01699.x; Sanchez-Carbayo M, 1999, BJU INT, V84, P706; Schneeweiss S, 1999, J UROLOGY, V161, P1116, DOI 10.1016/S0022-5347(01)61605-7; Shariat SF, 2006, J UROLOGY, V176, P919, DOI 10.1016/j.juro.2006.04.017; Shelfo SW, 1997, WORLD J UROL, V15, P107, DOI 10.1007/BF02201981; SHULTZ EK, 1995, CLIN CHEM, V41, P1248; Stoeber K, 2002, J NATL CANCER I, V94, P1071; UICC International Union Against Cancer, 2009, TNM CLASS MAL TUM; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Williams GH, 2007, CURR OPIN CELL BIOL, V19, P672, DOI 10.1016/j.ceb.2007.10.005; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Zaak D, 2001, UROLOGY, V57, P690, DOI 10.1016/S0090-4295(00)01053-0; Zippe C, 1999, J UROLOGY, V161, P62, DOI 10.1016/S0022-5347(01)62063-9	38	31	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40305	10.1371/journal.pone.0040305	http://dx.doi.org/10.1371/journal.pone.0040305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792272	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700033
J	Nakajima, Y; Yamada, M; Taguchi, R; Shibusawa, N; Ozawa, A; Tomaru, T; Hashimoto, K; Saito, T; Tsuchiya, T; Okada, S; Satoh, T; Mori, M				Nakajima, Yasuyo; Yamada, Masanobu; Taguchi, Ryo; Shibusawa, Nobuyuki; Ozawa, Atsushi; Tomaru, Takuya; Hashimoto, Koshi; Saito, Tsugumichi; Tsuchiya, Takafumi; Okada, Shuichi; Satoh, Tetsurou; Mori, Masatomo			NR4A1 (Nur77) Mediates Thyrotropin-Releasing Hormone-Induced Stimulation of Transcription of the Thyrotropin beta Gene: Analysis of TRH Knockout Mice	PLOS ONE			English	Article							NUCLEAR RECEPTOR NUR77; THYROID-HORMONE; GLUCOCORTICOID-RECEPTOR; TERTIARY HYPOTHYROIDISM; SUBUNIT GENE; TUMOR-CELLS; PITUITARY; EXPRESSION; KINASE; GROWTH	Thyrotropin-releasing hormone (TRH) is a major stimulator of thyrotropin-stimulating hormone (TSH) synthesis in the anterior pituitary, though precisely how TRH stimulates the TSH beta gene remains unclear. Analysis of TRH-deficient mice differing in thyroid hormone status demonstrated that TRH was critical for the basal activity and responsiveness to thyroid hormone of the TSH beta gene. cDNA microarray and K-means cluster analyses with pituitaries from wild-type mice, TRH-deficient mice and TRH-deficient mice with thyroid hormone replacement revealed that the largest and most consistent decrease in expression in the absence of TRH and on supplementation with thyroid hormone was shown by the TSH beta gene, and the NR4A1 gene belonged to the same cluster as and showed a similar expression profile to the TSH beta gene. Immunohistochemical analysis demonstrated that NR4A1 was expressed not only in ACTH-and FSH-producing cells but also in thyrotrophs and the expression was remarkably reduced in TRH-deficient pituitary. Furthermore, experiments in vitro demonstrated that incubation with TRH in GH4C1 cells increased the endogenous NR4A1 mRNA level by approximately 50-fold within one hour, and this stimulation was inhibited by inhibitors for PKC and ERK1/2. Western blot analysis confirmed that TRH increased NR4A1 expression within 2 h. A series of deletions of the promoter demonstrated that the region between bp -138 and +37 of the TSH beta gene was responsible for the TRH-induced stimulation, and Chip analysis revealed that NR4A1 was recruited to this region. Conversely, knockdown of NR4A1 by siRNA led to a significant reduction in TRH-induced TSH beta promoter activity. Furthermore, TRH stimulated NR4A1 promoter activity through the TRH receptor. These findings demonstrated that 1) TRH is a highly specific regulator of the TSH beta gene, and 2) TRH mediated induction of the TSH beta gene, at least in part by sequential stimulation of the NR4A1-TSH beta genes through a PKC and ERK1/2 pathway.	[Nakajima, Yasuyo; Yamada, Masanobu; Taguchi, Ryo; Shibusawa, Nobuyuki; Ozawa, Atsushi; Tomaru, Takuya; Hashimoto, Koshi; Saito, Tsugumichi; Tsuchiya, Takafumi; Okada, Shuichi; Satoh, Tetsurou; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan	Gunma University	Nakajima, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan.	myamada@gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	Health and Labor Sciences Research Grants; Research on Measures for Intractable Disease Hyptahalamo-Pituitary Dysfunction Research Group; Japan Society for the Promotion of Science	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Research on Measures for Intractable Disease Hyptahalamo-Pituitary Dysfunction Research Group(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by grant from Health and Labor Sciences Research Grants, Research on Measures for Intractable Disease Hyptahalamo-Pituitary Dysfunction Research Group (MM), and Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (MY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; Bassett MH, 2004, ENDOCR RES, V30, P567, DOI 10.1081/ERC-200043715; BOLER J, 1969, BIOCHEM BIOPH RES CO, V37, P705, DOI 10.1016/0006-291X(69)90868-7; BURGUS R, 1969, CR ACAD SCI D NAT, V268, P2116; CARR FE, 1993, ENDOCRINOLOGY, V133, P1700, DOI 10.1210/en.133.4.1700; CARR FE, 1989, MOL ENDOCRINOL, V3, P717, DOI 10.1210/mend-3-4-717; Charles MA, 2006, MOL ENDOCRINOL, V20, P1366, DOI 10.1210/me.2005-0378; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Cohen LE, 2002, ENDOCR REV, V23, P431, DOI 10.1210/er.2001-0030; CRAWFORD PA, 1995, MOL CELL BIOL, V15, P4331; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Fernandez PM, 2000, ENDOCRINOLOGY, V141, P2392, DOI 10.1210/en.141.7.2392; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GERSHENGORN MC, 1989, ANN NY ACAD SCI, V553, P191; GORDON DF, 1993, MOL CELL ENDOCRINOL, V96, P75, DOI 10.1016/0303-7207(93)90097-4; Gordon DF, 2002, MOL CELL ENDOCRINOL, V196, P53, DOI 10.1016/S0303-7207(02)00223-X; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; GUMBINER B, 1982, CELL, V28, P51, DOI 10.1016/0092-8674(82)90374-9; Hashimoto K, 2000, J BIOL CHEM, V275, P33365, DOI 10.1074/jbc.M006819200; Hashimoto K, 2005, MOL CELL ENDOCRINOL, V229, P11, DOI 10.1016/j.mce.2004.10.005; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; Inaoka Y, 2008, MOL REPROD DEV, V75, P931, DOI 10.1002/mrd.20788; Ishii S, 2004, MOL ENDOCRINOL, V18, P1708, DOI 10.1210/me.2004-0067; JACKSON IMD, 1982, NEW ENGL J MED, V306, P145, DOI 10.1056/NEJM198201213060305; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Kakar SS, 2003, GENE, V308, P67, DOI 10.1016/S0378-1119(03)00446-3; KANDA Y, 1994, BIOCHEM BIOPH RES CO, V199, P1447, DOI 10.1006/bbrc.1994.1393; Kashiwabara Y, 2009, J MOL ENDOCRINOL, V42, P225, DOI 10.1677/JME-08-0099; Kelly SN, 2005, J ENDOCRINOL, V186, P33, DOI 10.1677/joe.1.06005; KILEY SC, 1991, J BIOL CHEM, V266, P23761; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Lavoie PL, 2008, MOL ENDOCRINOL, V22, P1647, DOI 10.1210/me.2007-0567; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Maira M, 1999, MOL CELL BIOL, V19, P7549; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; Martin LJ, 2008, MOL ENDOCRINOL, V22, P2021, DOI 10.1210/me.2007-0370; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MORI M, 1988, NEUROENDOCRINOLOGY, V48, P153, DOI 10.1159/000125003; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nakajima Y, 2010, THYROID, V20, P917, DOI 10.1089/thy.2009.0389; Nikrodhanond AA, 2006, J BIOL CHEM, V281, P5000, DOI 10.1074/jbc.M511530200; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; OHMICHI M, 1994, J BIOL CHEM, V269, P3783; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Santelli G, 1999, AM J PATHOL, V155, P799, DOI 10.1016/S0002-9440(10)65178-4; Satoh T, 1996, J BIOL CHEM, V271, P27919, DOI 10.1074/jbc.271.44.27919; Satoh T, 1999, ENDOCRINOLOGY, V140, P5004, DOI 10.1210/en.140.11.5004; Shibusawa N, 2003, J CLIN INVEST, V112, P588, DOI 10.1172/JCI200318377; Shibusawa N, 2000, MOL ENDOCRINOL, V14, P137, DOI 10.1210/me.14.1.137; SHUPNIK MA, 1989, ENDOCR REV, V10, P459, DOI 10.1210/edrv-10-4-459; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; STEINFELDER HJ, 1992, P NATL ACAD SCI USA, V89, P5942, DOI 10.1073/pnas.89.13.5942; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Stocco CO, 2000, J BIOL CHEM, V275, P37202, DOI 10.1074/jbc.M006016200; Sun Y, 2003, J MOL ENDOCRINOL, V30, P87, DOI 10.1677/jme.0.0300087; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; Takano T, 2002, JPN J CLIN ONCOL, V32, P229, DOI 10.1093/jjco/hyf054; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Umezawa R, 2009, ENDOCRINOLOGY; Wansa KDSA, 2005, J MOL ENDOCRINOL, V34, P835, DOI 10.1677/jme.1.01739; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Yamada M, 1997, P NATL ACAD SCI USA, V94, P10862, DOI 10.1073/pnas.94.20.10862; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848	80	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40437	10.1371/journal.pone.0040437	http://dx.doi.org/10.1371/journal.pone.0040437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792320	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700048
J	Empey, KM; Orend, JG; Peebles, RS; Egana, L; Norris, KA; Oury, TD; Kolls, JK				Empey, Kerry M.; Orend, Jacob G.; Peebles, R. Stokes, Jr.; Egana, Loreto; Norris, Karen A.; Oury, Tim D.; Kolls, Jay K.			Stimulation of Immature Lung Macrophages with Intranasal Interferon Gamma in a Novel Neonatal Mouse Model of Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							HUMAN ALVEOLAR MACROPHAGES; CD8 T-CELLS; FUNCTIONAL PLASTICITY; VIRAL LOAD; RSV; BRONCHIOLITIS; ACTIVATION; RESPONSES; DISEASE; PATHOGENESIS	Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and viral death in infants. Reduced CD8 T-cells and negligible interferon gamma (IFN gamma) in the airway are associated with severe infant RSV disease, yet there is an abundance of alveolar macrophages (AM) and neutrophils. However, it is unclear, based on our current understanding of macrophage functional heterogeneity, if immature AM improve viral clearance or contribute to inflammation and airway obstruction in the IFN gamma-deficient neonatal lung environment. The aim of the current study was to define the age-dependent AM phenotype during neonatal RSV infection and investigate their differentiation to classically activated macrophages (CAM) using i.n. IFN gamma in the context of improving viral clearance. Neonatal and adult BALB/cJ mice were infected with 1x10(6) plaque forming units (PFU)/gram (g) RSV line 19 and their AM responses compared. Adult mice showed a rapid and robust CAM response, indicated by increases in major histocompatibility complex class II (MHC II), CD86, CCR7, and a reduction in mannose receptor (MR). Neonatal mice showed a delayed and reduced CAM response, likely due to undetectable IFN gamma production. Intranasal (i.n.) treatment with recombinant mouse IFN gamma (rIFN gamma) increased the expression of CAM markers on neonatal AM, reduced viral lung titers, and improved weight gain compared to untreated controls with no detectable increase in CD4 or CD8 T-cell infiltration. In vitro infection of J774A. 1 macrophages with RSV induced an alternatively activated macrophage (AAM) phenotype however, when macrophages were first primed with IFN gamma, a CAM phenotype was induced and RSV spread to adjacent Hep-2 cells was reduced. These studies demonstrate that the neonatal AM response to RSV infection is abundant and immature, but can be exogenously stimulated to express the antimicrobial phenotype, CAM, with i.n. rIFN gamma.	[Empey, Kerry M.; Orend, Jacob G.; Egana, Loreto] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Kolls, Jay K.] Childrens Hosp Pittsburgh, Dept Pediat, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15213 USA; [Norris, Karen A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Empey, KM (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA.	kme33@pitt.edu; jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304	National Institutes of Health [KL2 RR024154, KL2TR000146]; Central Research Development Fund from the University of Pittsburgh Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062052, R37HL079142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Research Development Fund from the University of Pittsburgh Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The project described was supported by the National Institutes of Health through Grant Numbers KL2 RR024154 and KL2TR000146, Central Research Development Fund from the University of Pittsburgh Research Council, and resources provided by the University Of Pittsburgh School Of Pharmacy, Pittsburgh, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Benoit A, 2006, CLIN EXP IMMUNOL, V145, P147, DOI 10.1111/j.1365-2249.2006.03114.x; CIRINO NM, 1993, J GEN VIROL, V74, P1527, DOI 10.1099/0022-1317-74-8-1527; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Empey KM, 2007, INFECT IMMUN, V75, P3382, DOI 10.1128/IAI.00174-07; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GORDON S, IMMUNITY, V32, P593; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harker JA, 2010, J VIROL, V84, P5294, DOI 10.1128/JVI.02503-09; Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004; Heidema J, 2004, J GEN VIROL, V85, P2365, DOI 10.1099/vir.0.80131-0; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Kaiko GE, 2010, J IMMUNOL, V185, P4681, DOI 10.4049/jimmunol.1001758; Lanson NA, 2003, CANCER RES, V63, P7936; Larranaga CL, 2009, PEDIAT INFECT DIS J; Lee YM, 2008, AM J RESP CRIT CARE, V177, P208, DOI 10.1164/rccm.200612-1890OC; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; MIDULLA F, 1989, AM REV RESPIR DIS, V140, P771, DOI 10.1164/ajrccm/140.3.771; MOKOENA T, 1985, J CLIN INVEST, V75, P624, DOI 10.1172/JCI111740; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; PANUSKA JR, 1995, J CLIN INVEST, V96, P2445, DOI 10.1172/JCI118302; PANUSKA JR, 1990, J CLIN INVEST, V86, P113, DOI 10.1172/JCI114672; PANUSKA JR, 1992, AM REV RESPIR DIS, V145, P934, DOI 10.1164/ajrccm/145.4_Pt_1.934; Qureshi MH, 2001, J IMMUNOL, V166, P5704, DOI 10.4049/jimmunol.166.9.5704; Reed JL, 2008, J INFECT DIS, V198, P1783, DOI 10.1086/593173; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Stout RD, 2005, IMMUNOL REV, V205, P60, DOI 10.1111/j.0105-2896.2005.00260.x; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; WOODSIDE KH, 1983, J APPL PHYSIOL, V54, P94, DOI 10.1152/jappl.1983.54.1.94; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107	42	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40499	10.1371/journal.pone.0040499	http://dx.doi.org/10.1371/journal.pone.0040499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792355	Green Published, gold, Green Accepted			2022-12-25	WOS:000306461800099
J	Heitmann, ER; Lankachandra, KM; Wall, J; Harris, GD; McKinney, HJ; Jalali, GR; Verma, Y; Kershnar, E; Kilpatrick, MW; Tsipouras, P; Harper, DM				Heitmann, Erica R.; Lankachandra, Kamani M.; Wall, Jeff; Harris, George D.; McKinney, Hollie J.; Jalali, G. Reza; Verma, Yogita; Kershnar, Eric; Kilpatrick, Michael W.; Tsipouras, Petros; Harper, Diane M.			3q26 Amplification Is an Effective Negative Triage Test for LSIL: A Historical Prospective Study	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; TELOMERASE GENE TERC; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS INFECTION; GENOMIC AMPLIFICATION; INTEROBSERVER REPRODUCIBILITY; EUROPEAN GUIDELINES; QUALITY-ASSURANCE; RANDOMIZED-TRIAL; PAP-SMEARS	Background: Women with low grade squamous intraepithelial lesions (LSIL) at cervical cancer screening are currently referred for further diagnostic work up despite 80% having no precancerous lesion. The primary purpose of this study is to measure the test characteristics of 3q26 chromosome gain (3q26 gain) as a host marker of carcinogenesis in women with LSIL. A negative triage test may allow these women to be followed by cytology alone without immediate referral to colposcopy. Methods and Findings: A historical prospective study was designed to measure 3q26 gain from the archived liquid cytology specimens diagnosed as LSIL among women attending colposcopy between 2007 and 2009. 3q26 gain was assessed on the index liquid sample; and sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were measured at immediate triage and at 6-16 months after colposcopic biopsy. The sensitivity of 3q26 gain measured at immediate triage from automated and manually reviewed tests in 65 non-pregnant unique women was 70% (95% CI: 35, 93) with a NPV of 89% (95% CI: 78, 96). The sensitivity and NPV increased to 80% (95% CI: 28, 99) and 98% (95% CI: 87, 100), respectively, when only the automated method of detecting 3q26 gain was used. Conclusions: 3q26 gain demonstrates high sensitivity and NPV as a negative triage test for women with LSIL, allowing possible guideline changes to routine surveillance instead of immediate colposcopy. Prospective studies are ongoing to establish the sensitivity, specificity, PPV and NPV of 3q26 gain for LSIL over time.	[Heitmann, Erica R.; Harper, Diane M.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Heitmann, Erica R.; Wall, Jeff; Harper, Diane M.] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Lankachandra, Kamani M.] Univ Missouri, Sch Med, Dept Pathol, Kansas City, MO 64108 USA; [Harris, George D.; McKinney, Hollie J.; Harper, Diane M.] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64108 USA; [Heitmann, Erica R.; Harper, Diane M.] Univ Missouri, Sch Med, Ctr Excellence, Kansas City, MO 64108 USA; [Jalali, G. Reza; Verma, Yogita; Kershnar, Eric; Kilpatrick, Michael W.; Tsipouras, Petros] Ikonisys Inc, New Haven, CT USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Ikonisys Inc	Heitmann, ER (corresponding author), Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA.	Diane.M.Harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X	Ikonisys	Ikonisys	UPA and Truman Medical Centers received monies from Ikonisys to conduct this trial. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameda F, 2009, HUM PATHOL, V40, P1474, DOI 10.1016/j.humpath.2009.03.013; Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Andersson S, 2009, AM J PATHOL, V175, P1831, DOI 10.2353/ajpath.2009.090122; Arbyn M, 2010, BJOG-INT J OBSTET GY, V117, P641, DOI 10.1111/j.1471-0528.2010.02521.x; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Arbyn M, 2009, INT J CANCER, V125, P2489, DOI 10.1002/ijc.24774; Arbyn M, 2009, J CELL MOL MED, V13, P648, DOI 10.1111/j.1582-4934.2008.00631.x; Aulmann S, 2008, J CLIN PATHOL, V61, P1034, DOI 10.1136/jcp.2008.056275; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Caraway NP, 2008, GYNECOL ONCOL, V110, P37, DOI 10.1016/j.ygyno.2008.01.040; Castle PE, 2010, AM J EPIDEMIOL, V171, P155, DOI 10.1093/aje/kwp390; Castle PE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.049; Cotton S, 2010, BJOG-INT J OBSTET GY, V117, P645, DOI 10.1111/j.1471-0528.2010.02519.x; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Dalstein W, 2003, INT J CANCER, V106, P396, DOI 10.1002/ijc.11222; Eversole GM, 2010, ARCH PATHOL LAB MED, V134, P331, DOI 10.1043/1543-2165-134.3.331; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hellsten C, 2008, BJOG-INT J OBSTET GY, V115, P212, DOI 10.1111/j.1471-0528.2007.01609.x; Herbert A, 2007, CYTOPATHOLOGY, V18, P213, DOI 10.1111/j.1365-2303.2007.00469.x; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; Heselmeyer-Haddad K, 2005, AM J PATHOL, V166, P1229, DOI 10.1016/S0002-9440(10)62341-3; Heselmeyer-Haddad K, 2003, AM J PATHOL, V163, P1405, DOI 10.1016/S0002-9440(10)63498-0; Hopman AHN, 2006, J PATHOL, V210, P412, DOI 10.1002/path.2070; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Hsu CP, 2005, WORLD J GASTROENTERO, V11, P6941, DOI 10.3748/wjg.v11.i44.6941; Huang KF, 2007, J FORMOS MED ASSOC, V106, P894, DOI 10.1016/S0929-6646(08)60059-5; Insinga RP, 2011, CANCER EPIDEM BIOMAR, V20, P287, DOI 10.1158/1055-9965.EPI-10-0791; Jalali GR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.016; Jin GA, 2011, CANCER SCI, V102, P144, DOI 10.1111/j.1349-7006.2010.01782.x; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Safont MJ, 2011, CLIN TRANSL ONCOL, V13, P396, DOI 10.1007/s12094-011-0673-2; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kokalj-Vokac N, 2009, CANCER GENET CYTOGEN, V195, P19, DOI 10.1016/j.cancergencyto.2009.01.005; Le T, 2006, INT J GYNECOL CANCER, V16, P1089, DOI 10.1111/j.1525-1438.2006.00599.x; Li Y, 2010, INT J GYNECOL CANCER, V20, P631, DOI 10.1111/IGC.0b013e3181c50c7e; Liu Z, 2011, CANC EPIDEM IN PRESS; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Massad LS, 2004, OBSTET GYNECOL, V104, P1077, DOI 10.1097/01.AOG.0000143256.63961.c0; Nayar Ritu, 2004, Cytojournal, V1, P4, DOI 10.1186/1742-6413-1-4; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Rijkaart DC, 2012, INT J CANCER, V130, P602, DOI 10.1002/ijc.26056; Schiffman M, 2007, CANCER CYTOPATHOL, V111, P145, DOI 10.1002/cncr.22751; Schlecht NF, 2003, JNCI-J NATL CANCER I, V95, P1336, DOI 10.1093/jnci/djg037; Seppo A, 2009, GYNECOL ONCOL, V114, P80, DOI 10.1016/j.ygyno.2009.03.031; Sherman ME, 2007, CANCER CYTOPATHOL, V111, P15, DOI 10.1002/cncr.22423; Sokolova I, 2007, J MOL DIAGN, V9, P604, DOI 10.2353/jmoldx.2007.070007; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; StatSoft Inc, 2010, STATISTICA DAT AN SO; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Suso EMI, 2011, CANCER IMMUNOL IMMUN, V60, P809, DOI 10.1007/s00262-011-0991-9; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Tavassoeli FA, 2003, PATHOLOGY GENETICS T; Tu Z, 2009, CANCER GENET CYTOGEN, V191, P10, DOI 10.1016/j.cancergencyto.2009.01.004; Umayahara K, 2002, GENE CHROMOSOME CANC, V33, P98, DOI 10.1002/gcc.1215; Verri A, 2011, LABMEDICINE, V42, P134, DOI 10.1309/LMZXH9BYHV1XVOUH; Wilting S, 2006, J PATHOL, V209, P220, DOI 10.1002/path.1966; Wilting SM, 2009, CANCER RES, V69, P647, DOI 10.1158/0008-5472.CAN-08-2478; Wong G, 2008, CLIN J AM SOC NEPHRO, V3, pS87, DOI 10.2215/CJN.03320807; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; Zhang A, 2002, INT J CANCER, V101, P427, DOI 10.1002/ijc.10627; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6	64	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39101	10.1371/journal.pone.0039101	http://dx.doi.org/10.1371/journal.pone.0039101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792164	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800006
J	Helmstadter, M; Luthy, K; Godel, M; Simons, M; Ashish; Nihalani, D; Rensing, SA; Fischbach, KF; Huber, TB				Helmstaedter, Martin; Luethy, Kevin; Goedel, Markus; Simons, Matias; Ashish; Nihalani, Deepak; Rensing, Stefan A.; Fischbach, Karl-Friedrich; Huber, Tobias B.			Functional Study of Mammalian Neph Proteins in Drosophila melanogaster	PLOS ONE			English	Article							IRREC-RST PROTEIN; SLIT DIAPHRAGM; AXONAL PROJECTIONS; ROLLING PEBBLES; MYOBLAST FUSION; CELL; ADHESION; GENE; MORPHOGENESIS; RECOGNITION	Neph molecules are highly conserved immunoglobulin superfamily proteins (IgSF) which are essential for multiple morphogenetic processes, including glomerular development in mammals and neuronal as well as nephrocyte development in D. melanogaster. While D. melanogaster expresses two Neph-like proteins (Kirre and IrreC/Rst), three Neph proteins (Neph1-3) are expressed in the mammalian system. However, although these molecules are highly abundant, their molecular functions are still poorly understood. Here we report on a fly system in which we overexpress and replace endogenous Neph homologs with mammalian Neph1-3 proteins to identify functional Neph protein networks required for neuronal and nephrocyte development. Misexpression of Neph1, but neither Neph2 nor Neph3, phenocopies the overexpression of endogenous Neph molecules suggesting a functional diversity of mammalian Neph family proteins. Moreover, structure-function analysis identified a conserved and specific Neph1 protein motif that appears to be required for the functional replacement of Kirre. Hereby, we establish D. melanogaster as a genetic system to specifically model molecular Neph1 functions in vivo and identify a conserved amino acid motif linking Neph1 to Drosophila Kirre function.	[Helmstaedter, Martin; Goedel, Markus; Simons, Matias; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Helmstaedter, Martin; Luethy, Kevin; Rensing, Stefan A.; Fischbach, Karl-Friedrich] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Rensing, Stefan A.; Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Simons, Matias; Rensing, Stefan A.] Univ Freiburg, Ctr Syst Biol, D-79106 Freiburg, Germany; [Ashish] CSIR Inst Microbial Technol, Chandigarh, India; [Nihalani, Deepak] Univ Penn, Philadelphia, PA 19104 USA	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Pennsylvania	Helmstadter, M (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	kff@uni-freiburg.de; tobias.huber@uniklinik-freiburg.de	nihalani, deepak/AAK-9453-2020; Simons, Matias/I-2038-2017	Simons, Matias/0000-0003-3959-6350; Luthy, Kevin/0000-0002-4510-3826; Huber, Tobias B./0000-0001-7175-5062	Bundesministerium fur Bildung und Forschung Gerontosys II - NephAge [031 5896A]; DFG and Else Kroner Foundation [Fef2 406614]; MS (BMBF Gerontosys II - NephAge) [031 5896A]; Excellence Initiative of the German Federal and State Governments [EXC 294]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956] Funding Source: NIH RePORTER	Bundesministerium fur Bildung und Forschung Gerontosys II - NephAge; DFG and Else Kroner Foundation; MS (BMBF Gerontosys II - NephAge); Excellence Initiative of the German Federal and State Governments; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grants to TBH (Fef2 406614; Bundesministerium fur Bildung und Forschung Gerontosys II - NephAge [031 5896A]; DFG and Else Kroner Foundation), to KFF (Fef2 406614) and MS (BMBF Gerontosys II - NephAge [031 5896A]), as well as by the Excellence Initiative of the German Federal and State Governments (TBH; EXC 294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulchand S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009374; Cagan RL, 2011, CURR OPIN NEPHROL HY, V20, P409, DOI 10.1097/MNH.0b013e328347ae02; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Kreiskother N, 2006, J MUSCLE RES CELL M, V27, P93, DOI 10.1007/s10974-006-9060-y; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Mallik L, 2012, J BIOL CHEM, V287, P9441, DOI 10.1074/jbc.M111.284927; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Reiter C, 1996, DEVELOPMENT, V122, P1931; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Simons M, 2009, CURR OPIN NEPHROL HY, V18, P324, DOI 10.1097/MNH.0b013e32832e316d; Simons M, 2009, KIDNEY INT, V75, P455, DOI 10.1038/ki.2008.653; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Wanner N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023598; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	40	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40300	10.1371/journal.pone.0040300	http://dx.doi.org/10.1371/journal.pone.0040300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792268	Green Submitted, gold, Green Published			2022-12-25	WOS:000306461800064
J	Henrick, BM; Nag, K; Yao, XD; Drannik, AG; Aldrovandi, GM; Rosenthal, KL				Henrick, Bethany M.; Nag, Kakon; Yao, Xiao-Dan; Drannik, Anna G.; Aldrovandi, Grace M.; Rosenthal, Kenneth L.			Milk Matters: Soluble Toll-Like Receptor 2 (sTLR2) in Breast Milk Significantly Inhibits HIV-1 Infection and Inflammation	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CHILD TRANSMISSION; TLR2 ACTIVATION; RECOGNITION; TOLL-LIKE-RECEPTOR-2; RESPONSES; PROTEIN; EXPRESSION; PATHWAYS; SALIVA	The majority of infants who breastfeed from their HIV-positive mothers remain uninfected despite constant and repeated exposure to virus over weeks to years. This phenomenon is not fully understood but has been closely linked to innate factors in breast milk (BM). Most recently we have focused on one such innate factor, soluble Toll-like receptor 2 (sTLR2) for its significant contribution as an inhibitor of inflammation triggered by bacterial and viral antigens. We hypothesized that sTLR2 in BM inhibits immune activation/inflammation and HIV-1 infection. sTLR2 protein profiles were analyzed in HIV-uninfected BM and showed dramatic variability in expression concentration and predominant sTLR2 forms between women. sTLR2 immunodepleted BM, versus mock-depleted BM, incubated with Pam(3)CSK(4) lead to significant increases in IL-8 production in a TLR2-dependant fashion in U937, HEK293-TLR2, and Caco-2. Importantly, TLR2-specific polyclonal and monoclonal antibody addition to BM prior to cell-free R5 HIV-1 addition led to significantly (P < 0.01, P < 0.001, respectively) increased HIV-1 infection in TZM-bl reporter cells. To confirm these findings, sTLR2-depletion in BM led to significantly (P < 0.001) increased HIV-1 infection in TZM-bl cells. Notably, immunodepletion does not allow for the complete removal of sTLR2 from BM, thus functional testing shown here may underestimate the total effect elicited by sTLR2 against HIV-1 and synthetic bacterial ligand. This study provides evidence for the first time that sTLR2 in BM may provide a dual protective role for infants breastfeeding from their HIV-infected mothers by; (1) immunomodulating pro-inflammatory responses to bacterial ligands, and (2) directly inhibiting cell-free HIV-1 infection. Thus, sTLR2 in BM may be critical to infant health and prove beneficial in decreasing vertical HIV-1 transmission to infants.	[Henrick, Bethany M.; Nag, Kakon; Yao, Xiao-Dan; Drannik, Anna G.; Rosenthal, Kenneth L.] McMaster Univ, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat, Los Angeles, CA 90027 USA; [Aldrovandi, Grace M.] Childrens Hosp Los Angeles, Saban Res Inst, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA	McMaster University; Children's Hospital Los Angeles; Children's Hospital Los Angeles	Henrick, BM (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada.	rosenthl@mcmaster.ca	Henrick, Bethany/P-7388-2016	Henrick, Bethany/0000-0003-1883-6749	Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC); Antibody Immune Monitoring Consortium (CA-VIMC); National Institute of Child Health and Human Development [RO1 HD 39611, RO1 HD 40777]; Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040777, R01HD039611] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC); Antibody Immune Monitoring Consortium (CA-VIMC); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (CAVD)/Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) and Antibody Immune Monitoring Consortium (CA-VIMC) as well as grants from the National Institute of Child Health and Human Development (RO1 HD 39611, RO1 HD 40777). Bethany M. Henrick and Anna G. Drannik were supported by Studentship Awards and Kenneth L. Rosenthal by a Career Scientist Award from the Ontario HIV Treatment Network (OHTN). Kakon Nag was supported by a Postdoctoral Award from the Canadian Institutes of Health Research (CIHR). Grace M. Aldrovandi is an Elizabeth Glaser Pediatric AIDS Foundation Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2011, LIFE SCI, V88, P980, DOI 10.1016/j.lfs.2010.09.023; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BEAUDRY M, 1995, J PEDIATR-US, V126, P191, DOI 10.1016/S0022-3476(95)70544-9; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; Coutsoudis A, 2002, AIDS, V16, P498, DOI 10.1097/00002030-200202150-00028; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Dulay AT, 2009, J IMMUNOL, V182, P7244, DOI 10.4049/jimmunol.0803517; Greene CM, 2004, INFECT IMMUN, V72, P3684, DOI 10.1128/IAI.72.6.3684-3687.2004; Grulee CG, 1935, JAMA-J AM MED ASSOC, P1; Heggelund L, 2004, AIDS, V18, P2437; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jain S, 2011, MUCOSAL IMMUNOL, V4, P539, DOI 10.1038/mi.2011.21; Kataoka H, 2006, CELL MICROBIOL, V8, P1199, DOI 10.1111/j.1462-5822.2006.00702.x; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005; Kuhn L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001363; Kuroishi T, 2007, MOL IMMUNOL, V44, P1969, DOI 10.1016/j.molimm.2006.09.028; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; LeBouder E, 2006, J IMMUNOL, V176, P3742, DOI 10.4049/jimmunol.176.6.3742; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lyimo MA, 2009, JAIDS-J ACQ IMM DEF, V51, P117, DOI 10.1097/QAI.0b013e3181a3908d; Matala E, 2001, AIDS RES HUM RETROV, V17, P1725, DOI 10.1089/08892220152741423; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Michaud F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013742; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Padua E, 2009, AIDS RES HUM RETROV, V25, P1171, DOI 10.1089/aid.2009.0103; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; Plummer FA, 1998, AIDS RES HUM RETROV, V14, pS5; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P3546, DOI 10.1128/AAC.49.8.3546-3549.2005; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Salvatori F, 2001, AIDS RES HUM RETROV, V17, P925, DOI 10.1089/088922201750290041; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Verhasselt V, 2010, CURR OPIN IMMUNOL, V22, P623, DOI 10.1016/j.coi.2010.08.008; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Yoshimura A, 1999, J IMMUNOL, V163, P1	51	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40138	10.1371/journal.pone.0040138	http://dx.doi.org/10.1371/journal.pone.0040138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792230	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800043
J	Kingsbury, JM; Heitman, J; Pinnell, SR				Kingsbury, Joanne M.; Heitman, Joseph; Pinnell, Sheldon R.			Calcofluor White Combination Antifungal Treatments for Trichophyton rubrum and Candida albicans	PLOS ONE			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; NIKKOMYCIN-Z; CONGO RED; RYLUX BSU; TESTING SUSCEPTIBILITIES; ASPERGILLUS-FUMIGATUS; SPORE GERMINATION; CLSI M38-A; CELL-WALLS	Superficial mycoses caused by dermatophyte fungi are among the most common infections worldwide, yet treatment is restricted by limited effective drugs available, drug toxicity, and emergence of drug resistance. The stilbene fluorescent brightener calcofluor white (CFW) inhibits fungi by binding chitin in the cell wall, disrupting cell wall integrity, and thus entails a different mechanism of inhibition than currently available antifungal drugs. To identify novel therapeutic options for the treatment of skin infections, we compared the sensitivity of representative strains of the dermatophyte Trichophyton rubrum and Candida albicans to CFW and a panel of fluorescent brighteners and phytoalexin compounds. We identified the structurally related stilbene fluorescent brighteners 71, 85, 113 and 134 as fungicidal to both T. rubrum and C. albicans to a similar degree as CFW, and the stilbene phytoalexins pinosylvan monomethyl ether and pterostilbene inhibited to a lesser degree, allowing us to develop a structure-activity relationship for fungal inhibition. Given the abilities of CFW to absorb UV365 (nm) and bind specifically to fungal cell walls, we tested whether CFW combined with UV365 nm irradiation would be synergistic to fungi and provide a novel photodynamic treatment option. However, while both treatments individually were cytocidal, UV365 nm irradiation reduced sensitivity to CFW, which we attribute to CFW photoinactivation. We also tested combination treatments of CFW with other fungal inhibitors and identified synergistic interactions between CFW and some ergosterol biosynthesis inhibitors in C. albicans. Therefore, our studies identify novel fungal inhibitors and drug interactions, offering promise for combination topical treatment regimes for superficial mycoses.	[Kingsbury, Joanne M.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Pinnell, Sheldon R.] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC USA; [Pinnell, Sheldon R.] Skin Sci Inst Inc, Durham, NC USA	Duke University; Duke University	Kingsbury, JM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	jokingsb@duke.edu	Heitman, Joseph/ABC-6006-2021	Kingsbury, Joanne/0000-0002-5939-7255	National Institutes of Health National Institute of Allergy and Infectious Diseases [R01 AI50438-08]; Small Business Innovation Research [2R44 AR0496086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050438] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Small Business Innovation Research(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health National Institute of Allergy and Infectious Diseases R01 AI50438-08 awarded to JH, and Small Business Innovation Research 2R44 AR0496086 awarded to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALY R, 1994, J AM ACAD DERMATOL, V31, pS21, DOI 10.1016/S0190-9622(08)81262-5; Andrade AC, 2000, MICROBIOL-SGM, V146, P1987, DOI 10.1099/00221287-146-8-1987; Anliker R, 1975, FLUORESCENT WHITENIN; ASM, 2012, ANTIMICROBIAL AGENTS, pi; BARTNICKIGARCIA S, 1994, ARCH BIOCHEM BIOPHYS, V310, P6, DOI 10.1006/abbi.1994.1133; Benedict FG, 1919, P NATL ACAD SCI USA, V5, P218, DOI 10.1073/pnas.5.6.218; Blankenship Jill R, 2003, Curr Opin Investig Drugs, V4, P192; Brasch J, 2003, MYCOSES, V46, P120, DOI 10.1046/j.1439-0507.2003.00857.x; Canton E, 2009, EXPERT REV ANTI-INFE, V7, P107, DOI 10.1586/14787210.7.1.107; Chalupova V, 2002, FOLIA MICROBIOL, V47, P152, DOI 10.1007/BF02817673; CLSI, 2008, M38A2 CLSI; CLSI, 2008, M27A3 CLSI; Dannaoui E, 2009, ANTIMICROB AGENTS CH, V53, P3549, DOI 10.1128/AAC.00184-09; DARKEN MA, 1963, APPL MICROBIOL, V11, P154, DOI 10.1128/AEM.11.2.154-156.1963; Djeridane A, 2006, MYCOSES, V49, P190, DOI 10.1111/j.1439-0507.2006.01230.x; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Espinel-Ingroff A, 2005, J CLIN MICROBIOL, V43, P3884, DOI 10.1128/JCM.43.8.3884-3889.2005; FINLAY AY, 1994, BRIT J DERMATOL, V130, P1, DOI 10.1111/j.1365-2133.1994.tb06082.x; Garcia-Rodriguez LJ, 2000, J BACTERIOL, V182, P2428, DOI 10.1128/JB.182.9.2428-2437.2000; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Ghannoum MA, 2006, J CLIN MICROBIOL, V44, P4353, DOI 10.1128/JCM.00688-06; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gupta AK, 1998, DRUGS, V55, P645, DOI 10.2165/00003495-199855050-00004; Gupta AK, 1998, LANCET, V351, P541, DOI 10.1016/S0140-6736(05)78552-4; Gupta AK, 1998, CUTIS, V62, P189; Haneke E, 1999, INT J DERMATOL, V38, P7, DOI 10.1046/j.1365-4362.1999.00015.x; HAPLOVA J, 1994, ARCH MICROBIOL, V161, P340, DOI 10.1007/BF00303590; HECTOR RF, 1992, ANTIMICROB AGENTS CH, V36, P1284, DOI 10.1128/AAC.36.6.1284; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HEJTMANEK M, 1990, FOLIA MICROBIOL, V35, P437, DOI 10.1007/BF02821413; Idnurm A, 2010, FUNGAL GENET BIOL, V47, P881, DOI 10.1016/j.fgb.2010.04.009; Jorgensen KB, 2010, MOLECULES, V15, P4334, DOI 10.3390/molecules15064334; Jun JH, 2007, J MICROBIOL BIOTECHN, V17, P1324; Jung HJ, 2005, ARCH PHARM RES, V28, P557, DOI 10.1007/BF02977758; KEPLINGER ML, 1974, TOXICOL APPL PHARM, V27, P494, DOI 10.1016/0041-008X(74)90029-5; Kim DH, 2004, BIOTECHNOL BIOENG, V87, P849, DOI 10.1002/bit.20189; Lee SK, 2005, FITOTERAPIA, V76, P258, DOI 10.1016/j.fitote.2004.12.004; Li RK, 1999, ANTIMICROB AGENTS CH, V43, P1401, DOI 10.1128/AAC.43.6.1401; Likhtenshtein G., 2009, STILBENES APPL CHEM; MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660; MARINES HM, 1987, OPHTHALMOLOGY, V94, P23, DOI 10.1016/S0161-6420(87)33516-X; Martinez-Rossi NM, 2008, MYCOPATHOLOGIA, V166, P369, DOI 10.1007/s11046-008-9110-7; MILEWSKI S, 1991, J GEN MICROBIOL, V137, P2155, DOI 10.1099/00221287-137-9-2155; MONHEIT JE, 1984, ARCH PATHOL LAB MED, V108, P616; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nweze EI, 2010, J CLIN MICROBIOL, V48, P3750, DOI 10.1128/JCM.01357-10; Olesen BW, 1982, BRUEL KJAER TECHNICA, P1; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Onyewu Chiatogu, 2007, Anti-Infective Agents in Medicinal Chemistry, V6, P3; Ozkutuk A, 2007, MYCOSES, V50, P125, DOI 10.1111/j.1439-0507.2006.01333.x; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Pezet R, 1995, HDB PHYTOALEXIN META; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P1274, DOI 10.1128/JCM.02437-10; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P845, DOI 10.1128/JCM.02441-10; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P630, DOI 10.1128/JCM.02161-10; PFALLER MA, 1990, DIAGN MICR INFEC DIS, V13, P31, DOI 10.1016/0732-8893(90)90050-6; Raclavsky V, 1999, FOLIA MICROBIOL, V44, P663, DOI 10.1007/BF02825658; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; RUCHEL R, 1993, MYCOSES, V36, P239, DOI 10.1111/j.1439-0507.1993.tb00757.x; Sadeghi G, 2009, J DERMATOL TREAT, V20, P120, DOI 10.1080/09546630802449070; Santos DA, 2006, J CLIN MICROBIOL, V44, P98, DOI 10.1128/JCM.44.1.98-101.2006; Schmidt CL, 1999, YEAST, V15, P1503, DOI 10.1002/(SICI)1097-0061(199910)15:14<1503::AID-YEA481>3.3.CO;2-N; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Seppanen SK, 2004, PLANT CELL REP, V22, P584, DOI 10.1007/s00299-003-0728-0; Singh J, 2007, MED MYCOL, V45, P595, DOI 10.1080/13693780701549364; Siqueira ER, 2008, REV INST MED TROP SP, V50, P1, DOI 10.1590/S0036-46652008000100001; Smijs TGM, 2011, PHOTOCHEM PHOTOBIOL, V87, P2, DOI 10.1111/j.1751-1097.2010.00848.x; Smijs TGM, 2009, PHOTOCHEM PHOTOBIOL, V85, P733, DOI 10.1111/j.1751-1097.2008.00468.x; SURARIT R, 1987, J MED VET MYCOL, V25, P403; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Weber K, 2011, MYCOSES, V54, P30, DOI 10.1111/j.1439-0507.2009.01763.x; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240; Welsh O, 2010, CLIN DERMATOL, V28, P151, DOI 10.1016/j.clindermatol.2009.12.006; Zhang J, 2010, CHINESE MED J-PEKING, V123, P1909, DOI 10.3760/cma.j.issn.0366-6999.2010.14.015	75	33	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39405	10.1371/journal.pone.0039405	http://dx.doi.org/10.1371/journal.pone.0039405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792174	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800012
J	Shelton, DN; Fornalik, H; Neff, T; Park, SY; Bender, D; DeGeest, K; Liu, XM; Xie, WL; Meyerholz, DK; Engelhardt, JF; Goodheart, MJ				Shelton, Dawne N.; Fornalik, Hubert; Neff, Traci; Park, Soo Yeun; Bender, David; DeGeest, Koen; Liu, Xiaoming; Xie, Weiliang; Meyerholz, David K.; Engelhardt, John F.; Goodheart, Michael J.			The Role of LEF1 in Endometrial Gland Formation and Carcinogenesis	PLOS ONE			English	Article							BETA-CATENIN EXPRESSION; METHYL-N-NITROSOUREA; EPITHELIAL-MESENCHYMAL INTERACTIONS; CYCLIN D1 GENE; OVARIAN CARCINOMAS; MATRIX METALLOPROTEINASE-7; MICROSATELLITE INSTABILITY; ESTROGEN-RECEPTOR; SIGNALING PATHWAY; MUTATIONS	Endometrial carcinoma is the most common gynecologic cancer, yet the mechanisms underlying this disease process are poorly understood. We hypothesized that Lef1 is required for endometrial gland formation within the uterus and is overexpressed in endometrial cancer. Using Lef1 knockout (KO) mice, we compared uterine gland development to wild-type (WT) controls, with respect to both morphology and expression of the Lef1 targets, cyclin D1 and MMP7. We characterized the dynamics of Lef1 protein expression during gland development and the mouse estrus cycle, by immunostaining and Western blot. Finally, we investigated the roles of cyclin D1 and MMP7 in gland and cancer formation in the mouse, and assessed the relevance of Lef1 to human cancer by comparing expression levels in cancerous and normal endometrial tissues. Lef1 upregulation in mouse endometrium correlates with the proliferative stages of the estrus cycle and gland development during the neonatal period. WT mice endometrial glands began to develop by day 5 and were easily identified by day 9, whereas Lef1 KO mice endometrial glands had not developed by day 9 although the endometrial lining was intact. We found that during gland development cyclin D1 is elevated and localized to the gland buds, and that this requires the presence of Lef1. We also noted that Lef1 protein was expressed at higher levels in endometrial cancers within mice and humans when compared to normal endometrium. Our loss-of-function data indicate that Lef1 is required for the formation of endometrial glands in the mouse uterus. Lef1 protein elevation corresponds to gland formation during development, and varies cyclically with the mouse estrus cycle, in parallel with gland regeneration. Finally, Lef1 is overexpressed in human and mouse endometrial tumors, consistent with it playing a role in gland proliferation.	[Shelton, Dawne N.; Fornalik, Hubert; Neff, Traci; Park, Soo Yeun; Bender, David; DeGeest, Koen; Goodheart, Michael J.] Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Liu, Xiaoming; Xie, Weiliang; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Meyerholz, David K.] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Shelton, DN (corresponding author), Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.	michael-goodheart@uiowa.edu	Meyerholz, David/J-8131-2019; xie, weiliang/E-6551-2013	Meyerholz, David/0000-0003-1552-3253; Bender, David/0000-0002-9192-510X; LIU, XIAOMING/0000-0002-3902-9105; Goodheart, Michael/0000-0003-3498-8945; Engelhardt, John/0000-0003-2389-9277; xie, weiliang/0000-0002-4887-3711	Reproductive Scientist Development Program National Institutes of Health [5K12HD00849]; American Board of Obstetrics and Gynecology, National Cancer Institute [P30CA086862]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047967, P30DK054759] Funding Source: NIH RePORTER	Reproductive Scientist Development Program National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Board of Obstetrics and Gynecology, National Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support to MJG: Reproductive Scientist Development Program National Institutes of Health grant 5K12HD00849 and The American Board of Obstetrics and Gynecology, National Cancer Institute P30CA086862. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Bircan S, 2005, PATHOL ONCOL RES, V11, P32, DOI 10.1007/BF03032403; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; BRODY JR, 1989, AM J ANAT, V186, P1, DOI 10.1002/aja.1001860102; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; Duan DS, 1999, DEVELOPMENT, V126, P4441; EVANS GS, 1990, CELL TISSUE KINET, V23, P619, DOI 10.1111/j.1365-2184.1990.tb01350.x; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Fukuchi T, 1998, CANCER RES, V58, P3526; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Hai B, 2010, STEM CELLS DEV, V19, P1793, DOI 10.1089/scd.2009.0499; Horree N, 2008, J CLIN PATHOL, V61, P36, DOI 10.1136/jcp.2006.043794; Horst D, 2009, EUR J CANCER, V45, P2034, DOI 10.1016/j.ejca.2009.04.004; Horst D, 2009, CANCER, V115, P2063, DOI 10.1002/cncr.24254; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jesse S, 2010, INT J CANCER, V126, P1109, DOI 10.1002/ijc.24802; Jung HC, 2005, LIFE SCI, V77, P1249, DOI 10.1016/j.lfs.2005.02.009; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Konopka B, 2007, J CANCER RES CLIN, V133, P361, DOI 10.1007/s00432-006-0179-4; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kriegl L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-123; Machin P, 2002, HUM PATHOL, V33, P206, DOI 10.1053/hupa.2002.30723; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Moreno-Bueno G, 2001, DIAGN MOL PATHOL, V10, P116, DOI 10.1097/00019606-200106000-00008; Nei H, 1999, MOL CARCINOGEN, V25, P207, DOI 10.1002/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.3.CO;2-W; Nikaido T, 1996, CANCER, V78, P1248, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1248::AID-CNCR12>3.3.CO;2-U; NIWA K, 1991, JPN J CANCER RES, V82, P1391, DOI 10.1111/j.1349-7006.1991.tb01811.x; Niwa K, 1996, CANCER LETT, V104, P115, DOI 10.1016/0304-3835(96)04240-1; NIWA K, 1993, JPN J CANCER RES, V84, P951, DOI 10.1111/j.1349-7006.1993.tb00183.x; Putti R, 1979, Basic Appl Histochem, V23, P25; Ray S, 2008, MOL ENDOCRINOL, V22, P1125, DOI 10.1210/me.2007-0445; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1997, CANCER RES, V57, P4624; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Saegusa M, 2001, BRIT J CANCER, V84, P209, DOI 10.1054/bjoc.2000.1581; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Spencer TE, 2006, MOL B INT U, P186; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; WHITTEN WK, 1968, SCIENCE, V161, P584, DOI 10.1126/science.161.3841.584; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Yi YC, 2010, CLIN CHEM LAB MED, V48, P337, DOI 10.1515/CCLM.2010.082; Zaino RJ, 2011, BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT, SIXTH EDITION, P105, DOI 10.1007/978-1-4419-0489-8_3; Zysow BR, 1997, ARTERIOSCL THROM VAS, V17, P1741, DOI 10.1161/01.ATV.17.9.1741	53	30	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40312	10.1371/journal.pone.0040312	http://dx.doi.org/10.1371/journal.pone.0040312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792274	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800068
J	Eisenhardt, M; Glassner, A; Kramer, B; Korner, C; Sibbing, B; Kokordelis, P; Nischalke, HD; Sauerbruch, T; Spengler, U; Nattermann, J				Eisenhardt, Marianne; Glaessner, Andreas; Kraemer, Benjamin; koerner, Christian; Sibbing, Bernhard; Kokordelis, Pavlos; Nischalke, Hans Dieter; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob			The CXCR3(+)CD56Bright Phenotype Characterizes a Distinct NK Cell Subset with Anti-Fibrotic Potential That Shows Dys-Regulated Activity in Hepatitis C	PLOS ONE			English	Article							LIVER FIBROSIS; STELLATE CELLS; LIGAND; CXCL10; HEPATOCYTES; ASSOCIATION; EXPRESSION; PROTEIN-10; CHEMOKINES; RIBAVIRIN	Background: In mouse models, natural killer (NK) cells have been shown to exert anti-fibrotic activity via killing of activated hepatic stellate cells (HSC). Chemokines and chemokine receptors critically modulate hepatic recruitment of NK cells. In hepatitis C, the chemokine receptor CXCR3 and its ligands have been shown to be associated with stage of fibrosis suggesting a role of these chemokines in HCV associated liver damage by yet incompletely understood mechanisms. Here, we analyzed phenotype and function of CXCR3 expressing NK cells in chronic hepatitis C. Methods: Circulating NK cells from HCV-infected patients (n = 57) and healthy controls (n = 27) were analyzed with respect to CXCR3 and co-expression of different maturation markers. Degranulation and interferon-gamma secretion of CXCR3(+) and CXCR3(-) NK cell subsets were studied after co-incubation with primary human hepatic stellate cells (HSC). In addition, intra-hepatic frequency of CXCR3(+) NK cells was correlated with stage of liver fibrosis (n = 15). Results: We show that distinct NK cell subsets can be distinguished based on CXCR3 surface expression. In healthy controls CXCR3(+)CD56Bright NK cells displayed strongest activity against HSC. Chronic hepatitis C was associated with a significantly increased frequency of CXCR3(+)CD56Bright NK cells which showed impaired degranulation and impaired IFN-gamma secretion in response to HSC. Of note, we observed intra-hepatic accumulation of this NK cell subset in advanced stages of liver fibrosis. Conclusion: We show that distinct NK cell subsets can be distinguished based on CXCR3 surface expression. Intra-hepatic accumulation of the functionally impaired CXCR3(+) CD56Bright NK cell subset might be involved in HCV-induced liver fibrosis.	[Eisenhardt, Marianne; Glaessner, Andreas; Kraemer, Benjamin; koerner, Christian; Sibbing, Bernhard; Kokordelis, Pavlos; Nischalke, Hans Dieter; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany	University of Bonn	Eisenhardt, M (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jacob.nattermann@ukb.uni-bonn.de	Körner, Christian/ABB-8335-2020; Krämer, Benjamin/AAC-9618-2019	Körner, Christian/0000-0002-3431-7319; Krämer, Benjamin/0000-0002-1385-9709; Nischalke, Hans Dieter/0000-0002-3457-0023	German Research Foundation [DFG SFB/TRR 57]; H. W. and J. Hector Foundation [M42]; BMBF (German Ministry for Science and Education) [01KI0791]	German Research Foundation(German Research Foundation (DFG)); H. W. and J. Hector Foundation; BMBF (German Ministry for Science and Education)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (DFG SFB/TRR 57), the H. W. and J. Hector Foundation [grant number M42], and by a grant from the BMBF (German Ministry for Science and Education) [01KI0791]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Cruise MW, 2006, J IMMUNOL, V176, P6235, DOI 10.4049/jimmunol.176.10.6235; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Gao Bin, 2007, Expert Rev Gastroenterol Hepatol, V1, P173, DOI 10.1586/17474124.1.1.173; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Jeong WI, 2008, J GASTROEN HEPATOL, V23, pS112, DOI 10.1111/j.1440-1746.2007.05274.x; Jeong WI, 2008, GASTROENTEROLOGY, V134, P248, DOI 10.1053/j.gastro.2007.09.034; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136; Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Radaeva S, 2007, AM J PHYSIOL-GASTR L, V293, pG809, DOI 10.1152/ajpgi.00212.2007; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sene D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184; Tacke F, 2011, LIVER INT, V31, P842, DOI 10.1111/j.1478-3231.2011.02504.x; Varchetta S, 2009, J HEPATOL, V50, P314, DOI 10.1016/j.jhep.2008.10.018; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614	26	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e38846	10.1371/journal.pone.0038846	http://dx.doi.org/10.1371/journal.pone.0038846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792160	gold, Green Published, Green Submitted			2022-12-25	WOS:000306436300004
J	Lunova, M; Zizer, E; Kucukoglu, O; Schwarz, C; Dillmann, WH; Wagner, M; Strnad, P				Lunova, Mariia; Zizer, Eugen; Kucukoglu, Ozlem; Schwarz, Carolin; Dillmann, Wolfgang H.; Wagner, Martin; Strnad, Pavel			Hsp72 Overexpression Accelerates the Recovery from Caerulein-Induced Pancreatitis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TRYPSINOGEN ACTIVATION; MOLECULAR CHAPERONES; THERAPEUTIC TOOLS; EXOCRINE PANCREAS; STRESS; PROTECTION; DISEASES; INJURY; EXPRESSION	Background and Aims: Heat shock protein (Hsp) 72 is a molecular chaperone which is upregulated in response to a variety of stress situations and has a general cytoprotective function. Increased Hsp72 levels were implicated in protection from acute pancreatitis; a hypothesis which was not tested in a transgenic mouse model yet. Methods: To analyze the role of Hsp72 during acute pancreatitis, well-characterized transgenic animals overexpressing rat Hsp72 (Hsp72 mice) under the control of the beta-actin promoter were subjected to caerulein- and L-arginine-induced acute pancreatitis. The severity of experimental pancreatitis was determined via serum lipase levels, morphometric evaluation and quantification of pancreatic edema/inflammation. Results: Hsp72 mice displayed similar to 100-times Hsp72 overexpression, but no changes in the remaining chaperones. Robust Hsp72 signal was observed in pancreatic acini, but not in islets or ductal cells. In both models, elevated Hsp72 did not protect from development of acute pancreatitis and the pancreatitis-associated lung injury, but accelerated recovery from caerulein- induced tissue injury (lower lipase levels, edema, inflammation and necrosis 36 h after caerulein administration). The observed protective function of Hsp72 in caerulein- induced pancreatitis is likely due to an attenuated NF-kappa B signalling. Conclusions: Hsp72 overexpression accelerates the recovery from acute pancreatitis and may represent a potential treatment strategy.	[Lunova, Mariia; Zizer, Eugen; Kucukoglu, Ozlem; Schwarz, Carolin; Wagner, Martin; Strnad, Pavel] Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany; [Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, San Diego, CA 92103 USA	Ulm University; University of California System; University of California San Diego	Lunova, M (corresponding author), Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany.	Mariia.Lunova@uniklinik-ulm.de; Pavel.Strnad@uniklinik-ulm.de	Kucukoglu, Ozlem/J-4713-2019; Lunova, Mariia/G-8447-2014	Kucukoglu, Ozlem/0000-0002-4217-9075; Lunova, Mariia/0000-0002-5795-7781	Emmy Noether program of the German Research Foundation [STR 1095/2-1]	Emmy Noether program of the German Research Foundation(German Research Foundation (DFG))	This work was supported by the Emmy Noether program of the German Research Foundation STR 1095/2-1 (P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MB, 2011, BIOMED PHARMACOTHER, V65, P239, DOI 10.1016/j.biopha.2011.04.025; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Bhagat L, 2002, GASTROENTEROLOGY, V122, P156, DOI 10.1053/gast.2002.30314; Bhagat L, 2000, J CLIN INVEST, V106, P81, DOI 10.1172/JCI8706; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Czako L, 2009, PANCREATOLOGY, V9, P351, DOI 10.1159/000181169; Dudeja V, 2009, GUT, V58, P1000, DOI 10.1136/gut.2007.140194; Feng JY, 2010, J DIGEST DIS, V11, P277, DOI 10.1111/j.1751-2980.2010.00450.x; Fetaud-Lapierre V, 2010, J PROTEOME RES, V9, P5929, DOI 10.1021/pr100695d; Gao HK, 2005, WORLD J GASTROENTERO, V11, P661, DOI 10.3748/wjg.v11.i5.661; Gupta KWB, 2010, ANN INTERN MED; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Oruc N, 2004, PANCREAS, V28, pE1, DOI 10.1097/00006676-200401000-00020; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Rakonczay Z, 2003, J CELL PHYSIOL, V195, P383, DOI 10.1002/jcp.10268; Saluja A, 2008, J GASTROEN HEPATOL, V23, pS42, DOI 10.1111/j.1440-1746.2007.05272.x; SCHMIDT J, 1992, INT J PANCREATOL, V12, P41; Vege SS, 2007, GI EPIDEMIOLOGY, P221, DOI 10.1002/9780470692189.ch30; Wagner ACC, 1996, GASTROENTEROLOGY, V111, P1333, DOI 10.1053/gast.1996.v111.pm8898648; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Zhong BH, 2007, MOL BIOL CELL, V18, P4969, DOI 10.1091/mbc.E07-02-0180	29	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39972	10.1371/journal.pone.0039972	http://dx.doi.org/10.1371/journal.pone.0039972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792201	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300016
J	Schaffhauser, DF; Patti, M; Goda, T; Miyahara, Y; Forster, IC; Dittrich, PS				Schaffhauser, Daniel Felix; Patti, Monica; Goda, Tatsuro; Miyahara, Yuji; Forster, Ian Cameron; Dittrich, Petra Stephanie			An Integrated Field-Effect Microdevice for Monitoring Membrane Transport in Xenopus laevis Oocytes via Lateral Proton Diffusion	PLOS ONE			English	Article							CELL-MEMBRANE; PHOSPHATE COTRANSPORTER; SODIUM-CHANNEL; CLAMP; EXPRESSION; MECHANISM; FLOUNDER; KINETICS; SURFACE; SYSTEM	An integrated microdevice for measuring proton-dependent membrane activity at the surface of Xenopus laevis oocytes is presented. By establishing a stable contact between the oocyte vitelline membrane and an ion-sensitive field-effect (ISFET) sensor inside a microperfusion channel, changes in surface pH that are hypothesized to result from facilitated proton lateral diffusion along the membrane were detected. The solute diffusion barrier created between the sensor and the active membrane area allowed detection of surface proton concentration free from interference of solutes in bulk solution. The proposed sensor mechanism was verified by heterologously expressing membrane transport proteins and recording changes in surface pH during application of the specific substrates. Experiments conducted on two families of phosphate-sodium cotransporters (SLC20 & SLC34) demonstrated that it is possible to detect phosphate transport for both electrogenic and electroneutral isoforms and distinguish between transport of different phosphate species. Furthermore, the transport activity of the proton/amino acid cotransporter PAT1 assayed using conventional whole cell electrophysiology correlated well with changes in surface pH, confirming the ability of the system to detect activity proportional to expression level.	[Schaffhauser, Daniel Felix] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Patti, Monica; Forster, Ian Cameron] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Goda, Tatsuro; Miyahara, Yuji; Dittrich, Petra Stephanie] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Tokyo Medical & Dental University (TMDU)	Schaffhauser, DF (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland.	miyahara.bsr@tmd.ac.jp; iforster@access.uzh.ch; dittrich@org.chem.eth.ch	Dittrich, Petra S/C-6717-2008; Goda, Tatsuro/B-6484-2011	Dittrich, Petra S/0000-0001-5359-8403; Goda, Tatsuro/0000-0003-2688-8186; Forster, Ian/0000-0003-3087-9952	European Research Council [203428]; National Institute for Materials Science (NIMS, Tsukuba, JPN); JST-CREST (JPN)	European Research Council(European Research Council (ERC)European Commission); National Institute for Materials Science (NIMS, Tsukuba, JPN); JST-CREST (JPN)	Main funding: European Research Council (ERC Starting Grant, nu-LIPIDS, No. 203428); National Institute for Materials Science (NIMS, Tsukuba, JPN): Research visit grant; JST-CREST (JPN): Partial financial support of materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Antonenko YN, 1998, FEBS LETT, V429, P197, DOI 10.1016/S0014-5793(98)00590-0; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; Bacconi A, 2005, P NATL ACAD SCI USA, V102, P12606, DOI 10.1073/pnas.0505882102; Baumann WH, 1999, SENSOR ACTUAT B-CHEM, V55, P77, DOI 10.1016/S0925-4005(99)00116-1; BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; Blanchard MG, 2008, AM J PHYSIOL-CELL PH, V295, pC1464, DOI 10.1152/ajpcell.00560.2007; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P78, DOI 10.1007/BF00378644; Casans S, 2000, EDN, V45, P164; Cucu D, 2004, PFLUG ARCH EUR J PHY, V447, P934, DOI 10.1007/s00424-003-1171-3; Dahan E, 2007, BIOSENS BIOELECTRON, V22, P3196, DOI 10.1016/j.bios.2007.02.017; DUMONT JN, 1978, J MORPHOL, V155, P73, DOI 10.1002/jmor.1051550106; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Foltz M, 2005, BIOCHEM J, V386, P607, DOI 10.1042/BJ20041519; Forster IC, 1999, AM J PHYSIOL-RENAL, V276, pF644, DOI 10.1152/ajprenal.1999.276.4.F644; GEORGE AL, 1989, P NATL ACAD SCI USA, V86, P7295, DOI 10.1073/pnas.86.18.7295; GUNDERSEN CB, 1982, PROC R SOC SER B-BIO, V216, P369, DOI 10.1098/rspb.1982.0080; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lehmann M, 2000, BIOSENS BIOELECTRON, V15, P117, DOI 10.1016/S0956-5663(00)00065-8; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Medvedev ES, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/23/234103; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; OLIVARES W, 1975, BIOPHYS J, V15, P143, DOI 10.1016/S0006-3495(75)85798-5; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Sakata T, 2008, ANAL CHEM, V80, P1493, DOI 10.1021/ac701977e; Schaffhauser DF, 2011, LAB CHIP, V11, P3471, DOI 10.1039/c0lc00729c; Schnizler K, 2003, RECEPTOR CHANNEL, V9, P41, DOI 10.1080/10606820308253; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; STRICKHOLM A, 1961, J GEN PHYSIOL, V44, P1073, DOI 10.1085/jgp.44.6.1073; Taylor PM, 1996, J EXP BIOL, V199, P923; VANHAL REG, 1995, SENSOR ACTUAT B-CHEM, V24, P201, DOI 10.1016/0925-4005(95)85043-0; WERNER A, 1994, AM J PHYSIOL, V267, pF311, DOI 10.1152/ajprenal.1994.267.2.F311	39	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39238	10.1371/journal.pone.0039238	http://dx.doi.org/10.1371/journal.pone.0039238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792166	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000306436300005
J	Vargas, S; Schuster, A; Sacher, K; Buttner, G; Schatzle, S; Lauchli, B; Hall, K; Hooper, JNA; Erpenbeck, D; Worheide, G				Vargas, Sergio; Schuster, Astrid; Sacher, Katharina; Buettner, Gabrielle; Schaetzle, Simone; Laeuchli, Benjamin; Hall, Kathryn; Hooper, John N. A.; Erpenbeck, Dirk; Woerheide, Gert			Barcoding Sponges: An Overview Based on Comprehensive Sampling	PLOS ONE			English	Article							DNA ISOLATION; DEMOSPONGIAE; PORIFERA; PHYLOGENIES; BACTERIA; PROTOCOL	Background: Phylum Porifera includes,8,500 valid species distributed world-wide in aquatic ecosystems ranging from ephemeral fresh-water bodies to coastal environments and the deep-sea. The taxonomy and systematics of sponges is complicated, and morphological identification can be both time consuming and erroneous due to phenotypic convergence and secondary losses, etc. DNA barcoding can provide sponge biologists with a simple and rapid method for the identification of samples of unknown taxonomic membership. The Sponge Barcoding Project (www.spongebarcoding.org), the first initiative to barcode a non-bilaterian metazoan phylum, aims to provide a comprehensive DNA barcode database for Phylum Porifera. Methodology/Principal Findings: similar to 7,400 sponge specimens have been extracted, and amplification of the standard COI barcoding fragment has been attempted for approximately 3,300 museum samples with similar to 25% mean amplification success. Based on this comprehensive sampling, we present the first report on the workflow and progress of the sponge barcoding project, and discuss some common pitfalls inherent to the barcoding of sponges. Conclusion: A DNA-barcoding workflow capable of processing potentially large sponge collections has been developed and is routinely used for the Sponge Barcoding Project with success. Sponge specific problems such as the frequent co-amplification of non-target organisms have been detected and potential solutions are currently under development. The initial success of this innovative project have already demonstrated considerable refinement of sponge systematics, evaluating morphometric character importance, geographic phenotypic variability, and the utility of the standard barcoding fragment for Porifera (despite its conserved evolution within this basal metazoan phylum).	[Vargas, Sergio; Schuster, Astrid; Sacher, Katharina; Buettner, Gabrielle; Schaetzle, Simone; Laeuchli, Benjamin; Erpenbeck, Dirk; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Hall, Kathryn; Hooper, John N. A.] Queensland Museum, Brisbane, Qld, Australia; [Hooper, John N. A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Erpenbeck, Dirk; Woerheide, Gert] GeoBioctr LMU, Munich, Germany; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, Munich, Germany	University of Munich; Queensland Museum; Griffith University; University of Munich	Vargas, S (corresponding author), Univ Munich, Dept Earth & Environm Sci, Munich, Germany.	woerheide@lmu.de	Wörheide, Gert/C-1080-2008; Hall, Kathryn/A-2402-2009; Vargas, Sergio/A-5678-2011; Hall, Kathryn/GVS-0464-2022	Wörheide, Gert/0000-0002-6380-7421; Hall, Kathryn/0000-0002-8785-4513; Vargas, Sergio/0000-0001-8704-1339; Schuster, Astrid/0000-0001-8978-3256; Hooper, John/0000-0003-1722-5954; Erpenbeck, Dirk/0000-0003-2716-1085	Alfred P. Sloan Foundation; GeoBio-CenterLMU; German Science Foundation (DFG) [Wo896/9-1, Wo896/9-2]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); GeoBio-CenterLMU; German Science Foundation (DFG)(German Research Foundation (DFG))	The Sponge Barcoding Project thanks the Marine Barcoding of Life Initiative (MarBol), funded by the Alfred P. Sloan Foundation and the GeoBio-CenterLMU, for financing the subsampling and extraction of 17,000 sponge specimens within the custodianship of the Queensland Museum, Brisbane, Australia, and the Taxonomic Research Informatics Network (TRIN) and Atlas of Living Australia (ALA) project for supporting the development of the morphometric database/wiki that provides complementary taxonomic verification for these sequence data. The authors also acknowledge funding of the German Science Foundation (DFG), through grants Wo896/9-1,2 to G. Worheide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Boom R, 1999, J CLIN MICROBIOL, V37, P615, DOI 10.1128/JCM.37.3.615-619.1999; Cardenas P, 2009, ZOOTAXA, P1; Chelossi E, 2004, J EXP MAR BIOL ECOL, V309, P21, DOI 10.1016/j.jembe.2004.03.006; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Erpenbeck D, 2006, MOL PHYLOGENET EVOL, V38, P293, DOI 10.1016/j.ympev.2005.11.001; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erpenbeck D, 2012, ORG DIVERS EVOL, P1; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1; Erpenbeck D, 2007, MAR BIOTECHNOL, V9, P2, DOI 10.1007/s10126-005-6109-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gatti S, 2002, BERICHTE POLAR MEERE, V434, P1, DOI DOI 10.2312/BZPM_0434_2002; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0021326, 10.1371/journal.pone.0018318]; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Sambrook E., 1989, MOL CLONING; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Siddall ME, 2009, SYST BIOL, V58, P445, DOI 10.1093/sysbio/syp033; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; van Soest RWM, 2012, WORLD PORIFERA DATAB; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Worheide G, 2008, PORIFERA RES BIODIVE, P123; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1	32	50	53	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39345	10.1371/journal.pone.0039345	http://dx.doi.org/10.1371/journal.pone.0039345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802937	Green Published, gold, Green Submitted			2022-12-25	WOS:000306186900011
J	Garcia, AG; Nedev, H; Bijian, K; Su, J; Alaoui-Jamali, MA; Saragovi, HU				Garcia, A. Galan; Nedev, H.; Bijian, K.; Su, J.; Alaoui-Jamali, M. A.; Saragovi, H. U.			Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs	ONCOGENE			English	Article						therapeutic window; chemotherapy; herceptin; conjugate; metastasis	MONOCLONAL-ANTIBODY; ADJUVANT CHEMOTHERAPY; DOXORUBICIN; RESISTANCE; HER2; TRASTUZUMAB; EFFICACY; RECEPTOR; THERAPY; MECHANISMS	Anthracyclines and taxanes have remarkable anticancer efficacy, but have poor selectivity and high toxicity. Targeted delivery of chemotherapeutics has emerged as a strategy to achieve higher drug levels at the tumor site, to spare noncancerous tissue and potentially to use lower systemic drug doses, thus preventing side effects. In this study, we targeted the HER2 receptor using the monoclonal antibody (mAb) Herceptin (Trastuzumab) chemically conjugated to Doxorubicin or Taxol. In vitro, drug-Herceptin conjugates exhibited cytotoxicity comparable to equimolar concentrations of free drugs, with the benefit that the cytotoxicity of the conjugates was selective for cells expressing the HER2 target. In vivo, treatment of tumor-bearing mice with Taxol-Herceptin conjugates had a reduction of primary tumors comparable to equivalent doses of free drugs. However, Taxol-Herceptin conjugates significantly reduced metastasis compared with equivalent doses of free drugs. Thus, the data support the concept that conjugates might target metastasis better than primary tumors. This would offer a potential therapeutic approach for management of metastatic breast cancer.	[Garcia, A. Galan; Nedev, H.; Bijian, K.; Su, J.; Alaoui-Jamali, M. A.; Saragovi, H. U.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Alaoui-Jamali, M. A.; Saragovi, H. U.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3T 1E2, Canada; [Alaoui-Jamali, M. A.; Saragovi, H. U.] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Alaoui-Jamali, M. A.; Saragovi, H. U.] McGill Univ, Ctr Canc, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, 3755 Cote St Catherine E 535, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca			McGill Center for Experimental Therapeutics in Cancer Fund; Canadian Institutes of Health Research (CIHR); Quebec Breast Cancer Foundation	McGill Center for Experimental Therapeutics in Cancer Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Quebec Breast Cancer Foundation	We are thankful to Amrit Kirpalani for help with in vivo assays. This work was funded by the McGill Center for Experimental Therapeutics in Cancer Fund to Cure Breast Cancer, and by the Canadian Institutes of Health Research (CIHR), and in part by the Quebec Breast Cancer Foundation.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Anhorn MG, 2008, BIOCONJUGATE CHEM, V19, P2321, DOI 10.1021/bc8002452; Barros FFT, 2010, HISTOPATHOLOGY, V56, P560, DOI 10.1111/j.1365-2559.2010.03494.x; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Cooley S, 1999, EXP HEMATOL, V27, P1533, DOI 10.1016/S0301-472X(99)00089-2; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; Danesi R, 2002, CLIN PHARMACOKINET, V41, P431, DOI 10.2165/00003088-200241060-00004; de Azambuja E, 2009, TARGET ONCOL, V4, P77, DOI 10.1007/s11523-009-0112-2; Dean-Colomb W, 2008, EUR J CANCER, V44, P2806, DOI 10.1016/j.ejca.2008.09.013; El Bayoumil T, 2009, CLIN CANCER RES, V15, P1973, DOI 10.1158/1078-0432.CCR-08-2392; Freudenberg JA, 2009, EXP MOL PATHOL, V87, P1, DOI 10.1016/j.yexmp.2009.05.001; Guillemard V, 2005, DNA CELL BIOL, V24, P350, DOI 10.1089/dna.2005.24.351; Guillemard V, 2004, CURR CANCER DRUG TAR, V4, P313, DOI 10.2174/1568009043332989; Guillemard V, 2004, ONCOGENE, V23, P3613, DOI 10.1038/sj.onc.1207463; Guillemard V, 2001, CANCER RES, V61, P694; Harris M, 2004, LANCET ONCOL, V5, P292, DOI 10.1016/S1470-2045(04)01467-6; KATO H, 1993, J BIOL CHEM, V268, P2655; Kojic LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003597; Krop IE, 2010, J CLIN ONCOL, V28, P2698, DOI 10.1200/JCO.2009.26.2071; Lyass O, 2000, CANCER, V89, P1037, DOI 10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z; MENZIN AW, 1994, GYNECOL ONCOL, V54, P103; Monneret C, 2001, EUR J MED CHEM, V36, P483, DOI 10.1016/S0223-5234(01)01244-2; Nabholtz JM, 2005, EXPERT OPIN PHARMACO, V6, P1073, DOI 10.1517/14656566.6.7.1073; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Omelyanenko V, 1996, J DRUG TARGET, V3, P357, DOI 10.3109/10611869608996827; Paik S, 2000, J NATL CANCER I, V92, P1991, DOI 10.1093/jnci/92.24.1991; Paik SM, 1998, JNCI-J NATL CANCER I, V90, P1361, DOI 10.1093/jnci/90.18.1361; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Rayson D, 2008, ANN ONCOL, V19, P1530, DOI 10.1093/annonc/mdn292; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stan AC, 1999, CANCER RES, V59, P115; Stockmeyer B, 2003, J IMMUNOL, V171, P5124, DOI 10.4049/jimmunol.171.10.5124; Tai WY, 2010, J CONTROL RELEASE, V146, P264, DOI 10.1016/j.jconrel.2010.04.009; TEWEY KM, 1984, J BIOL CHEM, V259, P9182; Tubiana-Hulin M, 2005, CANCER TREAT REV, V31, pS3, DOI 10.1016/S0305-7372(05)80002-7; Windebank AJ, 1999, CURR OPIN NEUROL, V12, P565, DOI 10.1097/00019052-199910000-00010; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Yen L, 2002, MOL BIOL CELL, V13, P4029, DOI 10.1091/mbc.e02-02-0084; Yu DH, 2001, SEMIN ONCOL, V28, P12	46	7	9	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2013	32	20					2527	2533		10.1038/onc.2012.283	http://dx.doi.org/10.1038/onc.2012.283			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	148UY	22797066				2022-12-25	WOS:000319274300004
J	Faresse, N; Vitagliano, JJ; Staub, O				Faresse, Nourdine; Vitagliano, Jean-Jacques; Staub, Olivier			Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation	FASEB JOURNAL			English	Article						aldosterone; ubiquitin; post-translational modifications; turnover	GLUCOCORTICOID-RECEPTOR; ALDOSTERONE; EXPRESSION; ACTIVATION; CELLS; DEGRADATION; TRANSPORT; ELEMENT	Aldosterone stimulation of the mineralocorticoid receptor (MR) is involved in numerous physiological responses, including Na+ homeostasis, blood pressure control, and heart failure. Aldosterone binding to MR promotes different post-translational modifications that regulate MR nuclear translocation, gene expression, and finally receptor degradation. Here, we show that aldosterone stimulates rapid phosphorylation of MR via ERK1/2 in a dose-dependent manner (from 0.1 to 10 nM) in renal epithelial cells. This phosphorylation induces an increase of MR apparent molecular weight, with a maximal upward shift of 30 kDa. Strikingly, these modifications are critical for the regulation of the MR ubiquitylation state. Indeed, we find that MR is monoubiquitylated in its basal state, and this status is sustained by the tumor suppressor gene 101 (Tsg101). Phosphorylation leads to disruption of MR/Tsg101 association and monoubiquitin removal. These events prompt polyubiquitin-dependent destabilization of MR and degradation. Preventing MR phosphorylation by ERK1/2 inhibition or mutation of target serines affects the sequential mechanisms of MR ubiquitylation and inhibits the aldosterone-mediated degradation. Our data provide a novel model of negative feedback of aldosterone signaling, involving sequential phosphorylation, monoubiquitin removal and subsequent polyubiquitylation/degradation of MR.-Faresse, N., Vitagliano, J.-J., Staub, O. Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation. FASEB J. 26, 4373-4382 (2012). www.fasebj.org	[Faresse, Nourdine; Vitagliano, Jean-Jacques; Staub, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Staub, O (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	olivier.staub@unil.ch			Leducq Foundation (Transatlantic Network on Hypertension); Swiss National Science Foundation [31003A_125422/1]; Swiss National Centre of Competence in Research Kidney.ch; European Molecular Biology Organization long-term fellowship	Leducq Foundation (Transatlantic Network on Hypertension)(Leducq Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Centre of Competence in Research Kidney.ch; European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO))	The authors thank Dr. N. Farman for providing the experiment on MR phosphorylation in rCCD cells. The authors also thank Dr. N. Farman, Dr. D. Diviani, and Dr. P. Shaw for critically reading the manuscript and for stimulating discussions. The authors also thank I. Perez Lopez for the cardiomyocyte preparation. This work was supported by the Leducq Foundation (Transatlantic Network on Hypertension), Swiss National Science Foundation (31003A_125422/1), the Swiss National Centre of Competence in Research Kidney.ch, and a European Molecular Biology Organization long-term fellowship to N.F.	ALNEMRI ES, 1991, J BIOL CHEM, V266, P18072; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Djelidi S, 2001, J AM SOC NEPHROL, V12, P1805, DOI 10.1681/ASN.V1291805; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Geller DS, 1998, NAT GENET, V19, P279, DOI 10.1038/966; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; Grossmann C, 2005, MOL ENDOCRINOL, V19, P1697, DOI 10.1210/me.2004-0469; Grossmann C, 2008, STEROIDS, V73, P973, DOI 10.1016/j.steroids.2007.12.008; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Ismaili N, 2005, J BIOL CHEM, V280, P11120, DOI 10.1074/jbc.M500059200; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kodadek T, 2010, J BIOL CHEM, V285, P2221, DOI 10.1074/jbc.R109.077883; Krug AW, 2003, J BIOL CHEM, V278, P43060, DOI 10.1074/jbc.M308134200; Krug AW, 2002, J BIOL CHEM, V277, P45892, DOI 10.1074/jbc.M208851200; La Rosa P, 2011, CELL SIGNAL, V23, P1128, DOI 10.1016/j.cellsig.2011.02.006; La Rosa P, 2011, IUBMB LIFE, V63, P49, DOI 10.1002/iub.414; Le Moellic C, 2004, J AM SOC NEPHROL, V15, P1145; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pearce D, 2003, VITAM HORM, V66, P29, DOI 10.1016/S0083-6729(03)01002-1; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Rogerson FM, 2003, MOL CELL ENDOCRINOL, V200, P45, DOI 10.1016/S0303-7207(02)00413-6; Rogerson FM, 1999, J BIOL CHEM, V274, P36305, DOI 10.1074/jbc.274.51.36305; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Verrey F., 2008, KIDNEY PHYSL PATHOPH, P889, DOI DOI 10.1016/B978-012088488-9.50035-8; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Yang J, 2012, MOL CELL ENDOCRINOL, V350, P196, DOI 10.1016/j.mce.2011.07.001; Yokota K, 2004, ENDOCR RES, V30, P611, DOI 10.1081/ERC-200043783	36	35	35	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4373	4382		10.1096/fj.12-209924	http://dx.doi.org/10.1096/fj.12-209924			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22798426				2022-12-25	WOS:000309704000041
J	Cotsaftis, O; Plett, D; Shirley, N; Tester, M; Hrmova, M				Cotsaftis, Olivier; Plett, Darren; Shirley, Neil; Tester, Mark; Hrmova, Maria			A Two-Staged Model of Na+ Exclusion in Rice Explained by 3D Modeling of HKT Transporters and Alternative Splicing	PLOS ONE			English	Article							SALINITY TOLERANCE; DURUM-WHEAT; STRUCTURE PREDICTION; SODIUM TRANSPORTER; PROTEIN-SEQUENCE; SALT TOLERANCE; GENE FAMILY; NAX2; ARABIDOPSIS; PROFILES	The HKT family of Na+ and Na+/K+ transporters is implicated in plant salinity tolerance. Amongst these transporters, the cereal HKT1;4 and HKT1;5 are responsible for Na+ exclusion from photosynthetic tissues, a key mechanism for plant salinity tolerance. It has been suggested that Na+ is retrieved from the xylem transpiration stream either in the root or the leaf sheath, protecting the leaf blades from excessive Na+ accumulation. However, direct evidence for this scenario is scarce. Comparative modeling and evaluation of rice (Oryza sativa) HKT-transporters based on the recent crystal structure of the bacterial TrkH K+ transporter allowed to reconcile transcriptomic and physiological data. For OsHKT1;5, both transcript abundance and protein structural features within the selectivity filter could control shoot Na+ accumulation in a range of rice varieties. For OsHKT1;4, alternative splicing of transcript and the anatomical complexity of the sheath needed to be taken into account. Thus, Na+ accumulation in a specific leaf blade seems to be regulated by abundance of a correctly spliced OsHKT1;4 transcript in a corresponding sheath. Overall, allelic variation of leaf blade Na+ accumulation can be explained by a complex interplay of gene transcription, alternative splicing and protein structure.	[Cotsaftis, Olivier; Plett, Darren; Shirley, Neil; Tester, Mark; Hrmova, Maria] Univ Adelaide, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia	University of Adelaide	Cotsaftis, O (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia.	oliv.cotsaftis@gmail.com	Tester, Mark/J-2368-2017; Hrmova, Maria/AAH-3951-2020	Tester, Mark/0000-0002-5085-8801; Plett, Darren/0000-0002-9551-8755; Hrmova, Maria/0000-0002-3545-0605; Shirley, Neil/0000-0001-8114-9891; Cotsaftis, Olivier/0000-0002-9635-326X	Australian Research Council	Australian Research Council(Australian Research Council)	This work was financed through two Australian Research Council (www.arc.gov.au) grants to M. T. and M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Domene C, 2012, BIOCHEMISTRY-US, V51, P1559, DOI 10.1021/bi201586n; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012571; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zeng LH, 2005, PLANT SOIL, V268, P51, DOI 10.1007/s11104-004-0180-0	30	132	138	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39865	10.1371/journal.pone.0039865	http://dx.doi.org/10.1371/journal.pone.0039865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808069	Green Published, gold			2022-12-25	WOS:000306362400024
J	Anderson, JL; Mari, AR; Braasch, I; Amores, A; Hohenlohe, P; Batzel, P; Postlethwait, JH				Anderson, Jennifer L.; Mari, Adriana Rodriguez; Braasch, Ingo; Amores, Angel; Hohenlohe, Paul; Batzel, Peter; Postlethwait, John H.			Multiple Sex-Associated Regions and a Putative Sex Chromosome in Zebrafish Revealed by RAD Mapping and Population Genomics	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; RIBOSOMAL-RNA GENES; GERM-CELLS; Y-CHROMOSOME; OOCYTE APOPTOSIS; LINKAGE ANALYSIS; DIFFERENTIATION; TEMPERATURE; EXPRESSION; MEDAKA	Within vertebrates, major sex determining genes can differ among taxa and even within species. In zebrafish (Danio rerio), neither heteromorphic sex chromosomes nor single sex determination genes of large effect, like Sry in mammals, have yet been identified. Furthermore, environmental factors can influence zebrafish sex determination. Although progress has been made in understanding zebrafish gonad differentiation (e.g. the influence of germ cells on gonad fate), the primary genetic basis of zebrafish sex determination remains poorly understood. To identify genetic loci associated with sex, we analyzed F2 offspring of reciprocal crosses between Oregon *AB and Nadia (NA) wild-type zebrafish stocks. Genome-wide linkage analysis, using more than 5,000 sequence-based polymorphic restriction site associated (RAD-tag) markers and population genomic analysis of more than 30,000 single nucleotide polymorphisms in our *ABxNA crosses revealed a sex-associated locus on the end of the long arm of chr-4 for both cross families, and an additional locus in the middle of chr-3 in one cross family. Additional sequencing showed that two SNPs in dmrt1 previously suggested to be functional candidates for sex determination in a cross of ABxIndia wild-type zebrafish, are not associated with sex in our AB fish. Our data show that sex determination in zebrafish is polygenic and that different genes may influence sex determination in different strains or that different genes become more important under different environmental conditions. The association of the end of chr-4 with sex is remarkable because, unique in the karyotype, this chromosome arm shares features with known sex chromosomes: it is highly heterochromatic, repetitive, late replicating, and has reduced recombination. Our results reveal that chr-4 has functional and structural properties expected of a sex chromosome.	[Anderson, Jennifer L.; Mari, Adriana Rodriguez; Braasch, Ingo; Amores, Angel; Batzel, Peter; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Hohenlohe, Paul] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	University of Oregon; Idaho; University of Idaho	Anderson, JL (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	jpostle@uoneuro.uoregon.edu	Hohenlohe, Paul/AAE-7744-2019; Anderson, Jennifer L/I-5435-2012; Braasch, Ingo/A-6948-2010	Hohenlohe, Paul/0000-0002-7616-0161; Anderson, Jennifer L/0000-0002-0713-6897; Braasch, Ingo/0000-0003-4766-611X; Amores, Angel/0000-0002-9307-3609	National Institutes of Health (NIH) grant [R01GM085318]; NIH grant [P01HD22486]; Alexander von Humboldt Foundation; Volkswagen Foundation; National Science Foundation, Office of Cyber Infrastructure [OCI-0960354]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Volkswagen Foundation(Volkswagen); National Science Foundation, Office of Cyber Infrastructure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by National Institutes of Health (NIH) grant R01GM085318 (to JHP), NIH grant P01HD22486 (to JHP), a Feodor-Lynen-Fellowship of the Alexander von Humboldt Foundation (to IB), and a grant from the Volkswagen Foundation (to IB). The research was also supported by a Major Research Instrumentation grant from the National Science Foundation, Office of Cyber Infrastructure, "MRI-R2: Acquisition of an Applied Computational Instrument for Scientific Synthesis (ACISS)", Grant #: OCI-0960354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozaid H, 2012, SEX DEV, V6, P201, DOI 10.1159/000336297; Abozaid H, 2011, SEX DEV, V5, P259, DOI 10.1159/000330120; ALVAREZ MC, 1991, J FISH BIOL, V39, P817, DOI 10.1111/j.1095-8649.1991.tb04411.x; Amores A, 1999, METHOD CELL BIOL, V60, P323; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baroiller JF, 2001, EXS, V91, P177; Barske LA, 2008, CURR OPIN GENET DEV, V18, P499, DOI 10.1016/j.gde.2008.11.004; Baumgartner-Parzer SM, 2001, J CLIN ENDOCR METAB, V86, P4771, DOI 10.1210/jc.86.10.4771; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown KH, 2012, P NATL ACAD SCI USA, V109, P529, DOI 10.1073/pnas.1112163109; BULL JJ, 1979, SCIENCE, V206, P1186, DOI 10.1126/science.505003; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; CHAN STH, 1983, FISH PHYSIOL, V9, P171; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Craves JAM, 2008, ANNU REV GENET, V42, P565, DOI 10.1146/annurev.genet.42.110807.091714; Crews D, 2003, EVOL DEV, V5, P50, DOI 10.1046/j.1525-142X.2003.03008.x; CREWS D, 1989, GEN COMP ENDOCR, V76, P159, DOI 10.1016/0016-6480(89)90042-7; Daga RR, 1996, CHROMOSOME RES, V4, P29, DOI 10.1007/BF02254941; Davidson WS, 2009, SEX DEV, V3, P78, DOI 10.1159/000223073; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Drummond A., 2011, GENEIOUS V5 5; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Fan J, 2007, BIOCHEM BIOPH RES CO, V363, P757, DOI 10.1016/j.bbrc.2007.09.047; FERGUSON MWJ, 1982, NATURE, V296, P850, DOI 10.1038/296850a0; Freeman JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-195; Gornung E, 2000, CHROMOSOME RES, V8, P362, DOI 10.1023/A:1009252017097; Gornung E, 1997, CHROMOSOME RES, V5, P40, DOI 10.1023/A:1018441402370; Goudet J, 1996, GENETICS, V144, P1933; GRUMBACH MM, 1963, P NATL ACAD SCI USA, V49, P581, DOI 10.1073/pnas.49.5.581; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Herpin A, 2009, NUCLEIC ACIDS RES, V37, P1510, DOI 10.1093/nar/gkn1065; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Ings JS, 2006, MOL REPROD DEV, V73, P943, DOI 10.1002/mrd.20490; JOHNSON SL, 1995, GENETICS, V139, P1727; Johnson SL, 1996, GENETICS, V142, P1277; Kallman K.D., 1984, P95; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; KAUFFMAN EJ, 1995, GENOMICS, V30, P337, DOI 10.1006/geno.1995.9869; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Kondo M, 2004, CURR BIOL, V14, P1664, DOI 10.1016/j.cub.2004.09.026; Kondo M, 2006, GENOME RES, V16, P815, DOI 10.1101/gr.5016106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis ZR, 2008, J MORPHOL, V269, P909, DOI 10.1002/jmor.10608; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Loukovitis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016599; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Martinez P, 2009, GENETICS, V183, P1443, DOI 10.1534/genetics.109.107979; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mindnich R, 2004, MOL CELL ENDOCRINOL, V215, P19, DOI 10.1016/j.mce.2003.11.010; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Mohideen MAPK, 2000, GENOMICS, V67, P102, DOI 10.1006/geno.2000.6233; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nanda I, 2000, CHROMOSOMA, V109, P173, DOI 10.1007/s004120050425; NAYUDU PL, 1979, COPEIA, P225, DOI 10.2307/1443407; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pelegri F, 1999, METHOD CELL BIOL, V60, P1; Phillips RB, 2006, CYTOGENET GENOME RES, V114, P155, DOI 10.1159/000093332; Pieau C, 1999, CELL MOL LIFE SCI, V55, P887, DOI 10.1007/s000180050342; PIJNACKER LP, 1995, GENOME, V38, P1052, DOI 10.1139/g95-140; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Poutanen M, 1995, J STEROID BIOCHEM, V55, P525, DOI 10.1016/0960-0760(95)00201-4; QUIRK JG, 1973, SCIENCE, V180, P963, DOI 10.1126/science.180.4089.963; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2011, METHOD CELL BIOL, V105, P461, DOI 10.1016/B978-0-12-381320-6.00020-5; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Rosler A, 1996, J CLIN ENDOCR METAB, V81, P1827, DOI 10.1210/jc.81.5.1827; Ross JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000391; Sato T, 2005, ZOOL SCI, V22, P985, DOI 10.2108/zsj.22.985; SAWETAWAN C, 1994, MOL CELL ENDOCRINOL, V99, P161, DOI 10.1016/0303-7207(94)90004-3; Schultheis C, 2009, SEX DEV, V3, P68, DOI 10.1159/000223072; Ser JR, 2010, EVOLUTION, V64, P486, DOI 10.1111/j.1558-5646.2009.00871.x; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; Shive HR, 2010, P NATL ACAD SCI USA, V107, P19350, DOI 10.1073/pnas.1011630107; Siegfried KR, 2010, J FISH BIOL, V76, P1879, DOI 10.1111/j.1095-8649.2010.02594.x; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Singer A, 2002, GENETICS, V160, P649; Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Sola L, 2001, GENETICA, V111, P397, DOI 10.1023/A:1013776323077; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Tripathi N, 2009, GENETICS, V182, P365, DOI 10.1534/genetics.108.098541; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; Uchida D, 2002, J EXP BIOL, V205, P711; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whiteley AR, 2011, MOL ECOL; Winge O, 1930, J GENET, V23, P69, DOI 10.1007/BF03052594; Yoshimoto S, 2011, FEBS J, V278, P1020, DOI 10.1111/j.1742-4658.2011.08031.x; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108	112	165	169	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40701	10.1371/journal.pone.0040701	http://dx.doi.org/10.1371/journal.pone.0040701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792396	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700064
J	McLaughlan, JM; Liti, G; Sharp, S; Maslowska, A; Louis, EJ				McLaughlan, Jenny M.; Liti, Gianni; Sharp, Sarah; Maslowska, Agnieszka; Louis, Edward J.			Apparent Ploidy Effects on Silencing Are Post-Transcriptional at HML and Telomeres in Saccharomyces cerevisiae	PLOS ONE			English	Article							RESOLUTION STRUCTURAL-ANALYSIS; TRANSCRIPTIONAL STATES; TRANSLATIONAL RESPONSE; CHROMATIN; YEAST; LOCUS; SIZE; RECOMBINATION; ESTABLISHMENT; INHERITANCE	The repression of genes in regions of heterochromatin is known as transcriptional silencing. It occurs in a wide range of organisms and can have importance in adaptation to the environment, developmental changes and disease. The model organism Saccharomyces cerevisiae has been used for many years to study transcriptional silencing, but until recently no study has been made in relation to ploidy. The aim of this work was to compare transcriptional silencing in haploids and diploids at both telomeres and the hidden mating-type (HM) loci. Transcriptional silencing was assayed, by growth on 5-fluoroorotic acid (5-FOA) media or by flow cytometry, on strains where a telomere or HM locus was marked. RNA levels were measured by quantitative RT-PCR to confirm that effects were transcriptional. 5-FOA assays and flow cytometry were consistent with transcriptional silencing at telomeres and at HML being reduced as ploidy increases which agreed with conclusions in previous publications. However, QRT-PCR revealed that transcriptional silencing was unaffected by ploidy and thus protein levels were increasing independently of RNA levels. At telomere XI left (XI-L), changes in protein level were strongly influenced by mating-type, whereas at HML mating-type had much less influence. The post-transcriptional effects seen in this study, illustrate the often ignored need to measure RNA levels when assaying transcriptional silencing in Saccharomyces cerevisiae.	[McLaughlan, Jenny M.; Liti, Gianni; Sharp, Sarah; Maslowska, Agnieszka; Louis, Edward J.] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2RD, England	University of Nottingham	McLaughlan, JM (corresponding author), Novozymes Biopharma UK Ltd, Nottingham, England.	jfml@novozymes.com; Ed.Louis@nottingham.ac.uk	Liti, Gianni/I-9929-2014; Louis, Edward/B-7920-2008	Louis, Edward/0000-0003-1157-3608; Liti, Gianni/0000-0002-2318-0775	Wellcome Trust [WT084507]; CRUK [C6950/A9435]; BBSRC Biotechnology and Biological Sciences Research Council [BB/F015216/1]; BBSRC [BB/F015216/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F015216/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); BBSRC Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Wellcome Trust (WT084507) http://www.wellcome.ac.uk/, CRUK (C6950/A9435) http://www.cancerresearchuk.org/, the BBSRC Biotechnology and Biological Sciences Research Council(BB/F015216/1) http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brachmann CB, 1998, YEAST, V14, P115; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Collart MA, 2001, PREPARATION YEAST RN; Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006; Fairhead C, 1996, YEAST, V12, P1439; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000659; Loney ER, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-18; Lundberg E, 2008, J PROTEOMICS, V71, P448, DOI 10.1016/j.jprot.2008.06.014; Mazor Y, 2009, NUCLEIC ACIDS RES, V37, P4839, DOI 10.1093/nar/gkp512; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Mercier G, 2005, NUCLEIC ACIDS RES, V33, P6635, DOI 10.1093/nar/gki959; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trcek T, 2010, GENE DEV, V24, P1827, DOI 10.1101/gad.1972810; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39044	10.1371/journal.pone.0039044	http://dx.doi.org/10.1371/journal.pone.0039044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792162	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700007
J	Iacona, GD; Kirkman, LK; Bruna, EM				Iacona, Gwenllian D.; Kirkman, L. Katherine; Bruna, Emilio M.			Experimental Test for Facilitation of Seedling Recruitment by the Dominant Bunchgrass in a Fire-Maintained Savanna	PLOS ONE			English	Article							LONGLEAF PINE; POSITIVE INTERACTIONS; PLANT-COMMUNITIES; SPECIES RICHNESS; SHRUB; WATER; AVAILABILITY; INTERFERENCE; COMPETITION; DIVERSITY	Facilitative interactions between neighboring plants can influence community composition, especially in locations where environmental stress is a factor limiting competitive effects. The longleaf pine savanna of the southeastern United States is a threatened and diverse system where seedling recruitment success and understory species richness levels are regulated by the availability of moist microsites. We hypothesized that the dominant bunch grass species (Aristida stricta Michx.) would facilitate moist seedling microsites through shading, but that the effect would depend on stress gradients. Here, we examined the environmental properties modified by the presence of wiregrass and tested the importance of increased shade as a potential facilitative mechanism promoting seedling recruitment across spatial and temporal stress gradients. We showed that environmental gradients, season, and experimental water manipulation influence seedling success. Environmental properties were modified by wiregrass proximity in a manner that could facilitate seedling success, but we showed that shade alone does not provide a facilitative benefit to seedlings in this system.	[Iacona, Gwenllian D.; Kirkman, L. Katherine] JW Jones Ecol Res Ctr, Newton, GA USA; [Iacona, Gwenllian D.; Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Bruna, Emilio M.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Iacona, GD (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	giacona@utk.edu	Bruna, Emilio M/H-2769-2012; Iacona, Gwenllian/G-6567-2016	Bruna, Emilio M/0000-0003-3381-8477; Iacona, Gwenllian/0000-0002-7408-3895	J.W. Jones Ecological Research Center; The Robert Woodruff Foundation; The University of Florida College of Agricultural and Life Sciences	J.W. Jones Ecological Research Center; The Robert Woodruff Foundation; The University of Florida College of Agricultural and Life Sciences	Funding was provided by the J.W. Jones Ecological Research Center, The Robert Woodruff Foundation, and The University of Florida College of Agricultural and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Butterfield BJ, 2009, J ECOL, V97, P1192, DOI 10.1111/j.1365-2745.2009.01569.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Drew Mark B., 1998, Castanea, V63, P1; Freestone AL, 2006, ECOLOGY, V87, P2728, DOI 10.1890/0012-9658(2006)87[2728:FDLAAR]2.0.CO;2; Fulbright TE, 1995, ACTA OECOL, V16, P621; Goebel P. C., 1997, 971 JW JON EC RES CT; Greenlee JT, 1996, AM NAT, V148, P386, DOI 10.1086/285931; Hacker SD, 1997, ECOLOGY, V78, P1990, DOI 10.1890/0012-9658(1997)078[1990:SIODPI]2.0.CO;2; HACKER SD, 1995, ECOLOGY, V76, P2165, DOI 10.2307/1941690; Hacker SD, 1999, ECOLOGY, V80, P2064, DOI 10.1890/0012-9658(1999)080[2064:EEFFMP]2.0.CO;2; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Iacona G, 2008, THESIS U FLORDIA GAI; Iacona GD, 2010, OECOLOGIA, V163, P171, DOI 10.1007/s00442-009-1502-y; Keddy PA, 2006, APPL VEG SCI, V9, P17, DOI 10.1658/1402-2001(2006)9[17:POHPDI]2.0.CO;2; Kikvidze Z, 2006, J VEG SCI, V17, P77, DOI 10.1111/j.1654-1103.2006.tb02425.x; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; MACMAHON J.A., 1981, WATER DESERT ECOSYST, V11, P114; Manson RH, 1998, OIKOS, V82, P37, DOI 10.2307/3546915; McNab WH, 1994, ADM PUBL; Mitchell RJ, 1999, CAN J FOREST RES, V29, P743, DOI 10.1139/cjfr-29-6-743; Olness A, 2005, SOIL SCI, V170, P90, DOI 10.1097/00010694-200502000-00002; Pecot SD, 2007, CAN J FOREST RES, V37, P634, DOI 10.1139/X06-247; Peet RK, 1993, LONGLEAF PINE VEGETA; RAHMAN AAAE, 1965, J ECOL, V53, P267, DOI 10.2307/2257974; Shreve F, 1931, ECOLOGY, V12, P96, DOI 10.2307/1932935; Shumway SW, 2000, OECOLOGIA, V124, P138, DOI 10.1007/s004420050033; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; VINTON MA, 1995, ECOLOGY, V76, P1116, DOI 10.2307/1940920; Weedon JT, 2008, J ECOL, V96, P1230, DOI 10.1111/j.1365-2745.2008.01427.x; West JB, 2004, J TORREY BOT SOC, V131, P120, DOI 10.2307/4126913; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	36	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39108	10.1371/journal.pone.0039108	http://dx.doi.org/10.1371/journal.pone.0039108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792165	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800007
J	Wang, LJ; Zuo, B; Xu, DQ; Ren, ZQ; Zhang, HP; Li, XW; Lei, MG; Xiong, YZ				Wang, Linjie; Zuo, Bo; Xu, Dequan; Ren, Zuqing; Zhang, Hongping; Li, Xuewei; Lei, Minggang; Xiong, Yuanzhu			Alternative Splicing of the Porcine Glycogen Synthase Kinase 3 beta (GSK-3 beta) Gene with Differential Expression Patterns and Regulatory Functions	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CATENIN; SKELETAL-MUSCLE; SUBSTRATE-SPECIFICITY; QUIESCENT CELLS; PHOSPHORYLATION; INSULIN; GSK3; KINASE-3-BETA; BINDING	Background: Glycogen synthase kinase 3 (GSK3 alpha and GSK3 beta) are serine/threonine kinases involved in numerous cellular processes and diverse diseases including mood disorders, Alzheimer's disease, diabetes, and cancer. However, in pigs, the information on GSK3 is very limited. Identification and characterization of pig GSK3 are not only important for pig genetic improvement, but also contribute to the understanding and development of porcine models for human disease prevention and treatment. Methodology: Five different isoforms of GSK3 beta were identified in porcine different tissues, in which three isoforms are novel. These isoforms had differential expression patterns in the fetal and adult of the porcine different tissues. The mRNA expression level of GSK3 beta isoforms was differentially regulated during the course of the insulin treatment, suggesting that different GSK3 beta isoforms may have different roles in insulin signaling pathway. Moreover, GSK3 beta 5 had a different role on regulating the glycogen synthase activity, phosphorylation and the expression of porcine GYS1 and GYS2 gene compared to other GSK3 beta isoforms. Conclusions: We are the first to report five different isoforms of GSK3 beta identified from the porcine different tissues. Splice variants of GSK3 beta exhibit differential activity towards glycogen synthase. These results provide new insight into roles of the GSK3 beta on regulating glycogen metabolism.	[Wang, Linjie; Zhang, Hongping; Li, Xuewei] Sichuan Agr Univ, Inst Genet & Anim Breeding, Yaan, Sichuan, Peoples R China; [Zuo, Bo; Xu, Dequan; Ren, Zuqing; Lei, Minggang; Xiong, Yuanzhu] Huazhong Agr Univ, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China; [Zuo, Bo; Xu, Dequan; Ren, Zuqing; Lei, Minggang; Xiong, Yuanzhu] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Sichuan Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Wang, LJ (corresponding author), Sichuan Agr Univ, Inst Genet & Anim Breeding, Yaan, Sichuan, Peoples R China.	wanglinjie@sicau.edu.cn; yuanzhu010@yahoo.com.cn			National Natural Science Foundation of China [31101699]; Key Project of National Basic Research and Developmental Plan of China [2006CB102102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of National Basic Research and Developmental Plan of China	This study was supported by the grants from National Natural Science Foundation of China (31101699) and the Key Project of National Basic Research and Developmental Plan (2006CB102102) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Castano Z, 2010, J NEUROCHEM, V113, P117, DOI 10.1111/j.1471-4159.2010.06581.x; Ciaraldi TP, 2010, MOL CELL ENDOCRINOL, V315, P153, DOI 10.1016/j.mce.2009.05.020; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; RYLATT DB, 1980, EUR J BIOCHEM, V107, P529; Saeki K, 2011, BIOL PHARM BULL, V34, P146, DOI 10.1248/bpb.34.146; Schaffer B, 2003, GENE, V302, P73, DOI 10.1016/S0378-1119(02)01092-2; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020150; Wang LJ, 2012, MOL CELL BIOCHEM, V360, P169, DOI 10.1007/s11010-011-1054-4; Wood-Kaczmar A, 2009, MOL CELL NEUROSCI, V42, P184, DOI 10.1016/j.mcn.2009.07.002; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40250	10.1371/journal.pone.0040250	http://dx.doi.org/10.1371/journal.pone.0040250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792253	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800057
J	Nicolaidou, V; Wong, MM; Redpath, AN; Ersek, A; Baban, DF; Williams, LM; Cope, AP; Horwood, NJ				Nicolaidou, Vicky; Wong, Mei Mei; Redpath, Andia N.; Ersek, Adel; Baban, Dilair F.; Williams, Lynn M.; Cope, Andrew P.; Horwood, Nicole J.			Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation	PLOS ONE			English	Article							MARROW STROMAL CELLS; SIGNAL-TRANSDUCTION PATHWAY; ONCOSTATIN-M; ALKALINE-PHOSPHATASE; PARATHYROID-HORMONE; BONE-FORMATION; IMMUNE-SYSTEM; JAK-STAT; DIFFERENTIATION; GROWTH	A major therapeutic challenge is how to replace bone once it is lost. Bone loss is a characteristic of chronic inflammatory and degenerative diseases such as rheumatoid arthritis and osteoporosis. Cells and cytokines of the immune system are known to regulate bone turnover by controlling the differentiation and activity of osteoclasts, the bone resorbing cells. However, less is known about the regulation of osteoblasts (OB), the bone forming cells. This study aimed to investigate whether immune cells also regulate OB differentiation. Using in vitro cell cultures of human bone marrow-derived mesenchymal stem cells (MSC), it was shown that monocytes/macrophages potently induced MSC differentiation into OBs. This was evident by increased alkaline phosphatase (ALP) after 7 days and the formation of mineralised bone nodules at 21 days. This monocyte-induced osteogenic effect was mediated by cell contact with MSCs leading to the production of soluble factor(s) by the monocytes. As a consequence of these interactions we observed a rapid activation of STAT3 in the MSCs. Gene profiling of STAT3 constitutively active (STAT3C) infected MSCs using Illumina whole human genome arrays showed that Runx2 and ALP were up-regulated whilst DKK1 was down-regulated in response to STAT3 signalling. STAT3C also led to the up-regulation of the oncostatin M (OSM) and LIF receptors. In the co-cultures, OSM that was produced by monocytes activated STAT3 in MSCs, and neutralising antibodies to OSM reduced ALP by 50%. These data indicate that OSM, in conjunction with other mediators, can drive MSC differentiation into OB. This study establishes a role for monocyte/macrophages as critical regulators of osteogenic differentiation via OSM production and the induction of STAT3 signalling in MSCs. Inducing the local activation of STAT3 in bone cells may be a valuable tool to increase bone formation in osteoporosis and arthritis, and in localised bone remodelling during fracture repair.	[Nicolaidou, Vicky; Wong, Mei Mei; Redpath, Andia N.; Ersek, Adel; Williams, Lynn M.; Horwood, Nicole J.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London, England; [Baban, Dilair F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Cope, Andrew P.] Kings Coll Sch Med, Acad Dept Rheumatol, Div Immunol Infect & Inflammatory Dis, Ctr Mol & Cellular Biol Inflammat, London, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London	Nicolaidou, V (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London, England.	nicole.horwood@kennedy.ox.ac.uk	Nicolaidou, Vicky/AAX-4756-2021	Cope, Andrew/0000-0001-6735-5496; Redpath, Andia/0000-0002-3620-4983; Ersek, Adel/0000-0001-7963-2980; nicolaidou, vicky/0000-0003-1017-2677; Horwood, Nicole/0000-0002-6344-1677	Arthritis Research UK; MRC [G0900160, G0700128] Funding Source: UKRI; Medical Research Council [G0700128] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Arthritis Research UK (http://www.arthritisresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; ALLAN EH, 1991, J CELL PHYSIOL, V149, P34, DOI 10.1002/jcp.1041490106; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Arthur A, 2011, BONE, V48, P533, DOI 10.1016/j.bone.2010.10.180; Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Batten P, 2006, TISSUE ENG, V12, P2263, DOI 10.1089/ten.2006.12.2263; Bellido T, 1996, J CLIN INVEST, V97, P431, DOI 10.1172/JCI118432; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CENTRELLA M, 1989, ENDOCRINOLOGY, V125, P13, DOI 10.1210/endo-125-1-13; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; de Hooge ASK, 2002, AM J PATHOL, V160, P1733, DOI 10.1016/S0002-9440(10)61120-0; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082; FUJITANI Y, 1994, BIOCHEM BIOPH RES CO, V202, P1181, DOI 10.1006/bbrc.1994.2053; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; GARGOSKY SE, 1990, J ENDOCRINOL, V127, P391, DOI 10.1677/joe.0.1270391; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; Ge C, 2011, J BONE MINER RES; GIMBLE JM, 1994, J CELL BIOCHEM, V54, P122, DOI 10.1002/jcb.240540113; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Guihard P, 2012, STEM CELLS; Gur-Wahnon D, 2007, EXP HEMATOL, V35, P426, DOI 10.1016/j.exphem.2006.11.001; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; HENRICHSEN E, 1956, EXP CELL RES, V11, P115, DOI 10.1016/0014-4827(56)90196-3; Holder N, 1999, DEVELOPMENT, V126, P2033; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Horwood N, 2008, AUTOIMMUNITY, V41, P230, DOI 10.1080/08916930701694766; Huang HC, 2010, J BONE MINER RES, V25, P819, DOI 10.1359/jbmr.091019; IKEDA E, 1988, CALCIFIED TISSUE INT, V43, P162, DOI 10.1007/BF02571314; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Katoh M, 2007, INT J MOL MED, V19, P273; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kovacevic A, 2008, J CELL BIOCHEM, V103, P994, DOI 10.1002/jcb.21472; Levi B, 2010, PLAST RECONSTR SURG, V126, P41, DOI 10.1097/PRS.0b013e3181da8858; Levy JB, 1996, ENDOCRINOLOGY, V137, P1159, DOI 10.1210/en.137.4.1159; Levy O, 2010, INT J BIOCHEM CELL B, V42, P1823, DOI 10.1016/j.biocel.2010.07.017; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Malaval L, 2005, J CELL PHYSIOL, V204, P585, DOI 10.1002/jcp.20312; MALIK N, 1995, MOL CELL BIOL, V15, P2349; Mikami Y, 2010, J CELL PHYSIOL, V223, P123, DOI 10.1002/jcp.22017; MIYAHARA T, 1991, TOXICOL LETT, V57, P257, DOI 10.1016/0378-4274(91)90200-P; Morgan JM, 2011, J CELL BIOCHEM, V112, P3354, DOI 10.1002/jcb.23265; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; OHMORI Y, 1988, BIOCHIM BIOPHYS ACTA, V970, P22, DOI 10.1016/0167-4889(88)90218-2; OWEN M, 1988, CIBA F SYMP, V136, P42; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Rauner M, 2011, J BONE MINER RES; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Repovic P, 2002, J NEUROSCI, V22, P5334; RICKARD DJ, 1993, CALCIFIED TISSUE INT, V52, P227, DOI 10.1007/BF00298724; Rifas L, 2003, J CELL BIOCHEM, V88, P650, DOI 10.1002/jcb.10436; Rifas L, 2006, J CELL BIOCHEM, V98, P706, DOI 10.1002/jcb.20933; SCHMID C, 1984, FEBS LETT, V173, P48, DOI 10.1016/0014-5793(84)81015-7; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	99	165	172	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39871	10.1371/journal.pone.0039871	http://dx.doi.org/10.1371/journal.pone.0039871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802946	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000306186900020
J	Azuma, M; Koyama, D; Kikuchi, J; Yoshizawa, H; Thasinas, D; Shiizaki, K; Kuro-o, M; Furukawa, Y; Kusano, E				Azuma, Masahiro; Koyama, Daisuke; Kikuchi, Jiro; Yoshizawa, Hiromichi; Thasinas, Dissayabutra; Shiizaki, Kazuhiro; Kuro-o, Makoto; Furukawa, Yusuke; Kusano, Eiji			Promoter methylation confers kidney-specific expression of the Klotho gene	FASEB JOURNAL			English	Article						CpG island; VISTA analysis; aging; kl/ kl mouse	DNA DEMETHYLATION; FUNCTIONAL VARIANT; ANTIAGING GENE; TET PROTEINS; CPG-ISLANDS; 5-METHYLCYTOSINE; IDENTIFICATION; PLURIPOTENT; SUPPRESSION; ASSOCIATION	The aging suppressor geneKlotho is predominantly expressed in the kidney irrespective of species. Because Klotho protein is an essential component of an endocrine axis that regulates renal phosphate handling, the kidney-specific expression is biologically relevant; however, little is known about its underlying mechanisms. Here we provide in vitro and in vivo evidence indicating that promoter methylation restricts the expression of the Klotho gene in the kidney. Based on evolutionary conservation and histone methylation patterns, the region up to - 1200 bp was defined as a major promoter element of the human Klotho gene. This region displayed promoter activity equally in Klotho-expressing and -nonexpressing cells in transient reporter assays, but the activity was reduced to similar to 20% when the constructs were integrated into the chromatin in the latter. Both endogenous and transfected Klotho promoters were 30-40% methylated in Klotho-nonexpressing cells, but unmethylated in Klotho-expressing renal tubular cells. DNA demethylating agents increased Klotho expression 1.5- to 3.0-fold in nonexpressing cells and restored the activity of silenced reporter constructs. Finally, we demonstrated that a severe hypomorphic allele of Klotho had aberrant CpG methylation in kl/kl mice. These findings might be useful in therapeutic intervention for accelerated aging and several complications caused by Klotho downregulation.- Azuma, M., Koyama, D., Kikuchi, J., Yoshizawa, H., Thasinas, D., Shiizaki, K., Kuro-o, M., Furukawa, Y., Kusano, E. Promoter methylation confers kidney-specific expression of the Klotho gene. FASEB J. 26, 4264-4274 (2012). www.fasebj.org	[Azuma, Masahiro; Koyama, Daisuke; Kikuchi, Jiro; Furukawa, Yusuke] Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Azuma, Masahiro; Yoshizawa, Hiromichi; Thasinas, Dissayabutra; Shiizaki, Kazuhiro; Kusano, Eiji] Jichi Med Univ, Dept Internal Med, Div Nephrol, Shimotsuke, Tochigi 3290498, Japan; [Shiizaki, Kazuhiro; Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	Jichi Medical University; Jichi Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Furukawa, Y (corresponding author), Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	Ministry of Education, Culture, Sports, Science and Technology of Japan; U.S. National Institutes of Health [R01-DK091392 to M.K]; JKA Foundation from Keirin Race;  [C22591047 to Y.F]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091392] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JKA Foundation from Keirin Race; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant-in-aid for scientific research (C22591047 to Y.F.) and the Support Program for Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a grant from the U.S. National Institutes of Health (R01-DK091392 to M.K.). This publication was subsidized by the JKA Foundation through its promotion funds from Keirin Race. The authors declare no conflicts of interest.	Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Friedman DJ, 2009, J BONE MINER RES, V24, P1847, DOI [10.1359/JBMR.090516, 10.1359/jbmr.090516]; Furukawa Y, 2005, MOL CANCER RES, V3, P325, DOI 10.1158/1541-7786.MCR-04-0105; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; King GD, 2012, BIOCHEM J, V441, P453, DOI 10.1042/BJ20101909; Kobayashi T, 2009, KIDNEY INT, V75, P1173, DOI 10.1038/ki.2009.44; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuro-O M, 2011, KIDNEY INT, V79, pS20, DOI 10.1038/ki.2011.26; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusano E, 2011, CLIN EXP NEPHROL, V15, P627, DOI 10.1007/s10157-011-0461-x; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Narumiya H, 2004, CARDIOVASC RES, V64, P331, DOI 10.1016/j.cardiores.2004.07.011; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Oshiro MM, 2005, NEOPLASIA, V7, P799, DOI 10.1593/neo.05274; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pan J, 2011, TUMOR BIOL, V32, P729, DOI 10.1007/s13277-011-0174-5; Rubinek T, 2012, BREAST CANCER RES TR, V133, P649, DOI 10.1007/s10549-011-1824-4; Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Wada T, 2012, EMBO REP, V13, P142, DOI 10.1038/embor.2011.247; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; Wang LJ, 2011, AM J CANCER RES, V1, P111; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yoon HE, 2011, NEPHROL DIAL TRANSPL, V26, P800, DOI 10.1093/ndt/gfq537; Zhang H, 2008, KIDNEY INT, V74, P732, DOI 10.1038/ki.2008.244	60	63	68	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4264	4274		10.1096/fj.12-211631	http://dx.doi.org/10.1096/fj.12-211631			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22782974	Green Published			2022-12-25	WOS:000309704000031
J	Hernandez-Rocamora, VM; Reija, B; Garcia, C; Natale, P; Alfonso, C; Minton, AP; Zorrilla, S; Rivas, G; Vicente, M				Hernandez-Rocamora, Victor M.; Reija, Belen; Garcia, Concepcion; Natale, Paolo; Alfonso, Carlos; Minton, Allen P.; Zorrilla, Silvia; Rivas, German; Vicente, Miguel			Dynamic Interaction of the Escherichia coli Cell Division ZipA and FtsZ Proteins Evidenced in Nanodiscs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; MEMBRANE; RECONSTITUTION; RING; ASSOCIATION; MONOMER	The full-length ZipA protein from Escherichia coli, one of the essential components of the division proto-ring that provides membrane tethering to the septation FtsZ protein, has been incorporated in single copy into nanodiscs formed by a membrane scaffold protein encircling an E. coli phospholipid mixture. This is an acellular system that reproduces the assembly of part of the cell division components. ZipA contained in nanodiscs (Nd-ZipA) retains the ability to interact with FtsZ oligomers and with FtsZ polymers. Interactions with FtsZ occur at similar strengths as those involved in the binding of the soluble form of ZipA, lacking the transmembrane region, suggesting that the transmembrane region of ZipA has little influence on the formation of the ZipA.FtsZ complex. Peptides containing partial sequences of the C terminus of FtsZ compete with FtsZ polymers for binding to Nd-ZipA. The affinity of Nd-ZipA for the FtsZ polymer formed with GTP or GMPCPP (a slowly hydrolyzable analog of GTP) is moderate (micromolar range) and of similar magnitude as for FtsZ-GDP oligomers. Polymerization does not stabilize the binding of FtsZ to ZipA. This supports the role of ZipA as a passive anchoring device for the proto-ring with little implication, if any, in the regulation of its assembly. Furthermore, it indicates that the tethering of FtsZ to the membrane shows sufficient plasticity to allow for its release from noncentral regions of the cytoplasmic membrane and its subsequent relocation to midcell when demanded by the assembly of a division ring.	[Hernandez-Rocamora, Victor M.; Garcia, Concepcion; Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, E-28006 Madrid, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Natale, Paolo; Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, E-28006 Madrid, Spain; [Minton, Allen P.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rivas, G (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.	grivas@cib.csic.es; mvicente@cnb.csic.es	Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Natale, Paolo/E-9326-2012; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Natale, Paolo/0000-0002-4759-0816; Minton, Allen/0000-0001-8459-1247; Zorrilla, Silvia/0000-0002-6309-9058; Hernandez-Rocamora, Victor M./0000-0003-2517-5707	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2008-04478-C03, CSIC-PIE-201020I001, BFU2010-14910, BIO2011-28941-C03]; NIDDK, National Institutes of Health	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Human Frontier Science Program through Grant RGP0050/2010, the European Commission through Contract HEALTH-F3-2009-223431 (both to M. V. and G. R.), and the Spanish Government through Grants BIO2008-04478-C03 (to M. V. and G. R.), CSIC-PIE-201020I001 (to C. A.), BFU2010-14910 (to S. Z.), and BIO2011-28941-C03 (to M. V., G. R., and S. Z.).; Supported by the Intramural Research Program of the NIDDK, National Institutes of Health.	Arumugam S, 2011, WIRES SYST BIOL MED, V3, P269, DOI 10.1002/wsbm.119; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Rico AI, 2010, MOL MICROBIOL, V76, P760, DOI 10.1111/j.1365-2958.2010.07134.x; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Kenny CH, 2003, ANAL BIOCHEM, V323, P224, DOI 10.1016/j.ab.2003.08.033; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Martos A, 2010, BIOCHEMISTRY-US, V49, P10780, DOI 10.1021/bi101495x; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P9146, DOI 10.1021/bi0009690; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Ohashi T, 2002, J BACTERIOL, V184, P4313, DOI 10.1128/JB.184.15.4313-4315.2002; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Skoog K, 2012, BIOCHEMISTRY-US, V51, P1407, DOI 10.1021/bi2015647; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	24	36	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30097	30104		10.1074/jbc.M112.388959	http://dx.doi.org/10.1074/jbc.M112.388959			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787144	hybrid, Green Published			2022-12-25	WOS:000308579800005
J	Saito, S; Nakatsuka, K; Takahashi, K; Fukuta, N; Imagawa, T; Ohta, T; Tominaga, M				Saito, Shigeru; Nakatsuka, Kazumasa; Takahashi, Kenji; Fukuta, Naomi; Imagawa, Toshiaki; Ohta, Toshio; Tominaga, Makoto			Analysis of Transient Receptor Potential Ankyrin 1 (TRPA1) in Frogs and Lizards Illuminates Both Nociceptive Heat and Chemical Sensitivities and Coexpression with TRP Vanilloid 1 (TRPV1) in Ancestral Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; XENOPUS-TROPICALIS; CAPSAICIN RECEPTOR; MOLECULAR-CLONING; SENSORY NEURONS; COLD; EVOLUTION; THERMOSENSATION; MECHANISMS; EXPRESSION	Transient receptor potential ankyrin 1 (TRPA1) and TRP vanilloid 1 (V1) perceive noxious temperatures and chemical stimuli and are involved in pain sensation in mammals. Thus, these two channels provide a model for understanding how different genes with similar biological roles may influence the function of one another during the course of evolution. However, the temperature sensitivity of TRPA1 in ancestral vertebrates and its evolutionary path are unknown as its temperature sensitivities vary among different vertebrate species. To elucidate the functional evolution of TRPA1, TRPA1s of the western clawed (WC) frogs and green anole lizards were characterized. WC frog TRPA1 was activated by heat and noxious chemicals that activate mammalian TRPA1. These stimuli also activated native sensory neurons and elicited nocifensive behaviors in WC frogs. Similar to mammals, TRPA1 was functionally co-expressed with TRPV1, another heat- and chemical-sensitive nociceptive receptor, in native sensory neurons of the WC frog. Green anole TRPA1 was also activated by heat and noxious chemical stimulation. These results suggest that TRPA1 was likely a noxious heat and chemical receptor and co-expressed with TRPV1 in the nociceptive sensory neurons of ancestral vertebrates. Conservation of TRPV1 heat sensitivity throughout vertebrate evolution could have changed functional constraints on TRPA1 and influenced the functional evolution of TRPA1 regarding temperature sensitivity, whereas conserving its noxious chemical sensitivity. In addition, our results also demonstrated that two mammalian TRPA1 inhibitors elicited different effect on the TRPA1s of WC frogs and green anoles, which can be utilized to clarify the structural bases for inhibition of TRPA1.	[Saito, Shigeru; Fukuta, Naomi; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Nakatsuka, Kazumasa; Takahashi, Kenji; Ohta, Toshio] Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan; [Imagawa, Toshiaki] Hokkaido Univ, Grad Sch Sci, Div Chem, Dept Biol Chem, Sapporo, Hokkaido 0600810, Japan; [Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Tottori University; Hokkaido University; Graduate University for Advanced Studies - Japan	Saito, S (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	sshigeru@nips.ac.jp; tominaga@nips.ac.jp	Saito, Shigeru/B-4698-2015	Saito, Shigeru/0000-0002-6237-8979	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas (to M. T.), a Grant-in-aid for Young Scientists (B) (to S. S.), and a Grant-in-aid for Scientific Research (to T. O.) from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Dowland LK, 2000, J BIOL CHEM, V275, P37765, DOI 10.1074/jbc.M004840200; Goodman RM, 2007, J EXP ZOOL PART A, V307A, P439, DOI 10.1002/jez.397; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Ohkita M, 2012, J BIOL CHEM, V287, P2388, DOI 10.1074/jbc.M111.305698; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	45	56	60	1	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30743	30754		10.1074/jbc.M112.362194	http://dx.doi.org/10.1074/jbc.M112.362194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22791718	hybrid, Green Published			2022-12-25	WOS:000308579800063
J	Shan, B; Li, DW; Bruschweiler-Li, L; Bruschweiler, R				Shan, Bing; Li, Da-Wei; Brueschweiler-Li, Lei; Brueschweiler, Rafael			Competitive Binding between Dynamic p53 Transactivation Subdomains to Human MDM2 Protein IMPLICATIONS FOR REGULATING THE p53.MDM2/MDMX INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; ACTIVATION DOMAIN; FORCE-FIELDS; INHIBITION; PHOSPHORYLATION; MECHANISM; SEQUENCE; PATHWAY; COMPLEX; AMPLIFICATION	The interaction between the transactivation domain of p53 (p53TAD) and the N-terminal domain of MDM2 and MDMX plays an essential role for cell function. Mutations in these proteins have been implicated in many forms of cancer. The intrinsically disordered p53TAD contains two subdomains, TAD1 and TAD2. Using NMR spectroscopy, site-directed mutagenesis, and molecular dynamics simulations, we demonstrate that TAD2 directly interacts with MDM2, adopting transient structures that bind to the same hydrophobic pocket of MDM2 as TAD1. Our data show that binding of TAD1 and TAD2 to MDM2 is competitive, which is further supported by the observation that the interaction of TAD2 with MDM2 can be blocked by the small molecule inhibitor nutlin-3. Our data further indicate that TAD2 interacts with MDMX in a fashion very similar to MDM2. Because TAD2 is known to have transcriptional activity, the interaction of TAD2 with MDM2/MDMX may play a direct role in the inhibition of p53 transactivation.	[Brueschweiler, Rafael] Florida State Univ, Dept Chem & Biochem, Chem Sci Lab, Tallahassee, FL 32306 USA; Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bruschweiler, R (corresponding author), Florida State Univ, Dept Chem & Biochem, Chem Sci Lab, CSL 3006, Tallahassee, FL 32306 USA.	bruschweiler@magnet.fsu.edu	Shan, Bing/G-5460-2011; Bruschweiler, Rafael/F-6624-2015; Dawei, Li/F-7233-2010	Dawei, Li/0000-0002-3266-5272	National Science Foundation [MCB-0918362]; National High Magnetic Field Laboratory at Florida State University; Florida Department of Health; Bankhead-Coley Cancer Research Program	National Science Foundation(National Science Foundation (NSF)); National High Magnetic Field Laboratory at Florida State University; Florida Department of Health; Bankhead-Coley Cancer Research Program	This work was supported by National Science Foundation Grant MCB-0918362 and the National High Magnetic Field Laboratory at Florida State University.; Recipient of a postdoctoral research fellowship supported by the Florida Department of Health and the Bankhead-Coley Cancer Research Program.	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Chene P, 2004, MOL CANCER RES, V2, P20; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Khoury K, 2011, MEDCHEMCOMM, V2, P246, DOI 10.1039/c0md00248h; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li DW, 2011, J CHEM THEORY COMPUT, V7, P1773, DOI 10.1021/ct200094b; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Marx J, 2007, SCIENCE, V315, P1211, DOI 10.1126/science.315.5816.1211; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Romer L, 2006, ANGEW CHEM INT EDIT, V45, P6440, DOI 10.1002/anie.200600611; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sanchez MC, 2010, FEBS LETT, V584, P3035, DOI 10.1016/j.febslet.2010.05.058; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	60	20	20	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30376	30384		10.1074/jbc.M112.369793	http://dx.doi.org/10.1074/jbc.M112.369793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807444	hybrid, Green Published			2022-12-25	WOS:000308579800030
J	Halabi, A; Ditch, S; Wang, J; Grabczyk, E				Halabi, Anasheh; Ditch, Scott; Wang, Jeffrey; Grabczyk, Ed			DNA Mismatch Repair Complex MutS beta Promotes GAA.TTC Repeat Expansion in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAA TRIPLET-REPEAT; HISTONE DEACETYLASE INHIBITORS; KNOCK-IN MICE; FRIEDREICH ATAXIA; CAG REPEAT; TRINUCLEOTIDE REPEATS; SOMATIC INSTABILITY; MYOTONIC-DYSTROPHY; HMUTS-BETA; WEB SERVER	While DNA repair has been implicated in CAG.CTG repeat expansion, its role in the GAA.TTC expansion of Friedreich ataxia (FRDA) is less clear. We have developed a human cellular model that recapitulates the DNA repeat expansion found in FRDA patient tissues. In this model, GAA.TTC repeats expand incrementally and continuously. We have previously shown that the expansion rate is linked to transcription within the repeats. Our working hypothesis is that structures formed within the GAA.TTC repeat during transcription attract DNA repair enzymes that then facilitate the expansion process. MutS beta, a heterodimer of MSH2 and MSH3, is known to have a role in CAG.CTG repeat expansion. We now show that shRNA knockdown of either MSH2 or MSH3 slowed GAA.TTC expansion in our system. We further characterized the role of MutS beta in GAA.TTC expansion using a functional assay in primary FRDA patient-derived fibroblasts. These fibroblasts have no known propensity for instability in their native state. Ectopic expression of MSH2 and MSH3 induced GAA.TTC repeat expansion in the native FXN gene. MSH2 is central to mismatch repair and its absence or reduction causes a predisposition to cancer. Thus, despite its essential role in GAA.TTC expansion, MSH2 is not an attractive therapeutic target. The absence or reduction of MSH3 is not strongly associated with cancer predisposition. Accordingly, MSH3 has been suggested as a therapeutic target for CAG.CTG repeat expansion disorders. Our results suggest that MSH3 may also serve as a therapeutic target to slow the expansion of GAA.TTC repeats in the future.	[Halabi, Anasheh; Ditch, Scott; Wang, Jeffrey; Grabczyk, Ed] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Grabczyk, E (corresponding author), LSU Hlth Sci Ctr, Dept Genet, 533 Bolivar St, New Orleans, LA USA.	egrabc@lsuhsc.edu			National Institutes of Health [R01NS046567, F30AG042263]; Friedreich's Ataxia Research Alliance; LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG042263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich's Ataxia Research Alliance; LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the National Institutes of Health (R01NS046567) (F30AG042263, to A. H.), the Friedreich's Ataxia Research Alliance, and the LSUHSC Research Enhancement Fund (to E. G.).	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Calmels N, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-46; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chang DK, 2000, J BIOL CHEM, V275, P18424, DOI 10.1074/jbc.M001140200; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; COGGINS LW, 1989, NUCLEIC ACIDS RES, V17, P7417, DOI 10.1093/nar/17.18.7417; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Darlow JM, 1998, J MOL BIOL, V275, P17, DOI 10.1006/jmbi.1997.1452; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; Debacker K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001257; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Dowen JM, 2010, MOL CELL BIOL, V30, P3321, DOI 10.1128/MCB.01558-09; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; GACY AM, 1995, CELL, V81, P533; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Grabczyk E, 1999, ANAL BIOCHEM, V267, P241, DOI 10.1006/abio.1998.2962; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; KOLODNER RD, 1994, COLD SPRING HARB SYM, V59, P331, DOI 10.1101/SQB.1994.059.01.037; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marino Michael P, 2003, Methods Mol Biol, V229, P43; Montermini L, 1997, NEUROLOGY, V49, P606, DOI 10.1212/WNL.49.2.606; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1996, J BIOL CHEM, V271, P16773, DOI 10.1074/jbc.271.28.16773; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Pabla N, 2011, J BIOL CHEM, V286, P10411, DOI 10.1074/jbc.M110.210989; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Plotz G, 2002, NUCLEIC ACIDS RES, V30, P711, DOI 10.1093/nar/30.3.711; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Reiser J, 2000, J VIROL, V74, P10589, DOI 10.1128/JVI.74.22.10589-10599.2000; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SMITH GK, 1995, NUCLEIC ACIDS RES, V23, P4303; Soragni E, 2011, METHODS MOL BIOL, V793, P495, DOI 10.1007/978-1-61779-328-8_32; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; YU A, 1995, NUCLEIC ACIDS RES, V23, P4055, DOI 10.1093/nar/23.20.4055; Zhang H, 1999, CANCER RES, V59, P3021; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29958	29967		10.1074/jbc.M112.356758	http://dx.doi.org/10.1074/jbc.M112.356758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787155	Green Published, hybrid			2022-12-25	WOS:000308286900069
J	Basturea, GN; Harris, TK; Deutscher, MP				Basturea, Georgeta N.; Harris, Thomas K.; Deutscher, Murray P.			Growth of a Bacterium That Apparently Uses Arsenic Instead of Phosphorus Is a Consequence of Massive Ribosome Breakdown	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DEGRADATION	A recent study (Wolfe-Simon, F., Switzer Blum, J., Kulp, T. R., Gordon, G. W., Hoeft, S. E., Pett-Ridge, J., Stolz, J. F., Webb, S. M., Weber, P. K., Davies, P. C., Anbar, A. D., and Oremland, R. S. (2011) Science 332, 1163-1166) described the isolation of a special bacterial strain, GFAJ-1, that could grow in medium containing arsenate, but lacking phosphate, and that supposedly could substitute arsenic for phosphorus in its biological macromolecules. Here, we provide an alternative explanation for these observations and show that they can be reproduced in a laboratory strain of Escherichia coli. We find that arsenate induces massive ribosome degradation, which provides a source of phosphate. A small number of arsenate-tolerant cells arise during the long lag period prior to initiation of growth in +As/-P medium, and it is this population that undergoes the very slow, limited growth observed for both E. coli and GFAJ-1. These results provide a simple explanation for the reported growth of GFAJ-1 in arsenate without invoking replacement of phosphorus by arsenic in biological macromolecules.	[Basturea, Georgeta N.; Harris, Thomas K.; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Basturea, Georgeta/A-3116-2011		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M. P. D.).	Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Bremer H, 1996, ESCHERICHIA COLI SAL; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Erb T. J., 2012, AIDS RES HUM RETRO S, DOI [10.1126/science.1218455, DOI 10.1126/SCIENCE.1218455]; Hayden EC, 2011, NATURE, V474, P19, DOI 10.1038/474019a; Reaves M. L., 2012, AIDS RES HUM RETRO S, DOI [10.1126/science.1219861, DOI 10.1126/SCIENCE.1219861]; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	11	14	14	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28816	28819		10.1074/jbc.C112.394403	http://dx.doi.org/10.1074/jbc.C112.394403			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22798070	Green Published, hybrid			2022-12-25	WOS:000308074600054
J	Vashisht, R; Mondal, AK; Jain, A; Shah, A; Vishnoi, P; Priyadarshini, P; Bhattacharyya, K; Rohira, H; Bhat, AG; Passi, A; Mukherjee, K; Choudhary, KS; Kumar, V; Arora, A; Munusamy, P; Subramanian, A; Venkatachalam, A; Gayathri, S; Raj, S; Chitra, V; Verma, K; Zaheer, S; Balaganesh, J; Gurusamy, M; Razeeth, M; Raja, I; Thandapani, M; Mevada, V; Soni, R; Rana, S; Ramanna, GM; Raghavan, S; Subramanya, SN; Kholia, T; Patel, R; Bhavnani, V; Chiranjeevi, L; Sengupta, S; Singh, PK; Atray, N; Gandhi, S; Avasthi, TS; Nisthar, S; Anurag, M; Sharma, P; Hasija, Y; Dash, D; Sharma, A; Scaria, V; Thomas, Z; Chandra, N; Brahmachari, SK; Bhardwaj, A				Vashisht, Rohit; Mondal, Anupam Kumar; Jain, Akanksha; Shah, Anup; Vishnoi, Priti; Priyadarshini, Priyanka; Bhattacharyya, Kausik; Rohira, Harsha; Bhat, Ashwini G.; Passi, Anurag; Mukherjee, Keya; Choudhary, Kumari Sonal; Kumar, Vikas; Arora, Anshula; Munusamy, Prabhakaran; Subramanian, Ahalyaa; Venkatachalam, Aparna; Gayathri, S.; Raj, Sweety; Chitra, Vijaya; Verma, Kaveri; Zaheer, Salman; Balaganesh, J.; Gurusamy, Malarvizhi; Razeeth, Mohammed; Raja, Ilamathi; Thandapani, Madhumohan; Mevada, Vishal; Soni, Raviraj; Rana, Shruti; Ramanna, Girish Muthagadhalli; Raghavan, Swetha; Subramanya, Sunil N.; Kholia, Trupti; Patel, Rajesh; Bhavnani, Varsha; Chiranjeevi, Lakavath; Sengupta, Soumi; Singh, Pankaj Kumar; Atray, Naresh; Gandhi, Swati; Avasthi, Tiruvayipati Suma; Nisthar, Shefin; Anurag, Meenakshi; Sharma, Pratibha; Hasija, Yasha; Dash, Debasis; Sharma, Arun; Scaria, Vinod; Thomas, Zakir; Chandra, Nagasuma; Brahmachari, Samir K.; Bhardwaj, Anshu		OSDD Consortium	Crowd Sourcing a New Paradigm for Interactome Driven Drug Target Identification in Mycobacterium tuberculosis	PLOS ONE			English	Article							ANTI-SIGMA-FACTOR; BINDING-SITES; DATABASE; NETWORK; BIOLOGY; INHIBITOR; ALGORITHM; PROTEINS	A decade since the availability of Mycobacterium tuberculosis (Mtb) genome sequence, no promising drug has seen the light of the day. This not only indicates the challenges in discovering new drugs but also suggests a gap in our current understanding of Mtb biology. We attempt to bridge this gap by carrying out extensive re-annotation and constructing a systems level protein interaction map of Mtb with an objective of finding novel drug target candidates. Towards this, we synergized crowd sourcing and social networking methods through an initiative 'Connect to Decode' (C2D) to generate the first and largest manually curated interactome of Mtb termed '3interactome pathway' (IPW), encompassing a total of 1434 proteins connected through 2575 functional relationships. Interactions leading to gene regulation, signal transduction, metabolism, structural complex formation have been catalogued. In the process, we have functionally annotated 87% of the Mtb genome in context of gene products. We further combine IPW with STRING based network to report central proteins, which may be assessed as potential drug targets for development of drugs with least possible side effects. The fact that five of the 17 predicted drug targets are already experimentally validated either genetically or biochemically lends credence to our unique approach.	[Vashisht, Rohit; Mondal, Anupam Kumar; Shah, Anup; Vishnoi, Priti; Bhattacharyya, Kausik; Mukherjee, Keya; Choudhary, Kumari Sonal; Anurag, Meenakshi; Dash, Debasis; Scaria, Vinod; Brahmachari, Samir K.] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Vashisht, Rohit; Bhat, Ashwini G.; Chandra, Nagasuma] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Rohira, Harsha; Arora, Anshula; Raj, Sweety] Univ Delhi, Acharya Narendra Dev Coll, Delhi 110007, India; [Kumar, Vikas] Goethe Univ Frankfurt, Frankfurt, Germany; [Munusamy, Prabhakaran] PSG Coll Technol, Coimbatore, Tamil Nadu, India; [Subramanian, Ahalyaa; Venkatachalam, Aparna] SASTRA Univ, Thanjavur, Tamilnadu, India; [Gayathri, S.] SDM Coll, Ujire, Karnataka, India; [Chitra, Vijaya] Sree Narayan Guru Coll, Coimbatore, Tamil Nadu, India; [Verma, Kaveri] Maharshi Dayanand Univ, Rohtak, Haryana, India; [Zaheer, Salman] Amity Univ, Amity Inst Biotechnol, Lucknow, Uttar Pradesh, India; [Balaganesh, J.] Bharathiar Univ, Coimbatore, Tamil Nadu, India; [Gurusamy, Malarvizhi; Razeeth, Mohammed; Raja, Ilamathi; Thandapani, Madhumohan] Bharathidasan Univ, Tiruchirappall, Tamil Nadu, India; [Mevada, Vishal; Soni, Raviraj; Rana, Shruti] Hem N Gujarat Univ, Patan, Gujarat, India; [Ramanna, Girish Muthagadhalli; Raghavan, Swetha; Subramanya, Sunil N.] Business Intelligence Technol India Pvt Ltd, Bangalore, Karnataka, India; [Kholia, Trupti] Saurashtra Univ, Christ Coll, Rajkot 360005, Gujarat, India; [Patel, Rajesh] Hemchandracharya N Gujarat Univ, Dept Life Sci, Patan, Gujarat, India; [Bhavnani, Varsha] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Chiranjeevi, Lakavath] CSIR, Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Sengupta, Soumi] Indian Stat Inst, Kolkata, W Bengal, India; [Singh, Pankaj Kumar] Maulana Azad Natl Inst Technol, Bhopal, Madhya Pradesh, India; [Atray, Naresh] Shri Ram Coll Pharm, Karnal, Haryana, India; [Gandhi, Swati] Maharaj Sayajirao Univ Baroda, Baroda, Gujarat, India; [Avasthi, Tiruvayipati Suma] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Nisthar, Shefin] Univ Kerala, Thiruvananthapuram 695034, Kerala, India; [Sharma, Pratibha] All India Inst Med Sci, New Delhi, India; [Hasija, Yasha] Delhi Technol Univ, Dept Biotechnol, Delhi, India; [Sharma, Arun] CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Avasthi, Tiruvayipati Suma] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Institute of Science (IISC) - Bangalore; University of Delhi; Goethe University Frankfurt; PSG College Technology; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Maharshi Dayanand University; Bharathiar University; Bharathidasan University; Hemchandracharya North Gujarat University; Saurashtra University; Hemchandracharya North Gujarat University; Savitribai Phule Pune University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Indian Statistical Institute; Indian Statistical Institute Kolkata; National Institute of Technology (NIT System); Maulana Azad National Institute of Technology Bhopal; Maharaja Sayajirao University Baroda; University of Hyderabad; University of Kerala; All India Institute of Medical Sciences (AIIMS) New Delhi; Delhi Technological University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Universiti Malaya	Vashisht, R (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	nchandra@biochem.iisc.ernet.in; skb@igib.res.in; anshu@csir.res.in	Mevada, Vishal/N-4048-2014; Patel, Rajesh/X-4517-2018; Vashisht, Rohit/K-6181-2019; Choudhary, Kumari Sonal/M-4517-2017; Basheera, Shefin/ABI-1878-2020; chitra, Vijaya/ABD-2593-2021; Scaria, Vinod/AAS-3151-2021; Scaria, Vinod/B-2819-2008; Patel, Rajesh/G-5669-2012; Kumari, Sonal/AAW-7588-2020; Passi, Anurag/AAN-5309-2021; Tiruvayipati, Suma/AAF-8331-2021; Shait Mohammed, Mohammed Razeeth/AAY-3154-2020; Dash, Debasis/F-3137-2012	Mevada, Vishal/0000-0003-0739-026X; Vashisht, Rohit/0000-0002-2938-7259; Choudhary, Kumari Sonal/0000-0001-9527-7958; Basheera, Shefin/0000-0002-4368-2764; Patel, Rajesh/0000-0002-4712-1921; Passi, Anurag/0000-0002-0448-794X; Tiruvayipati, Suma/0000-0003-0195-1097; S, Gayathri/0000-0002-2776-1307; Scaria, Vinod/0000-0001-7644-7181; Sharma, Arun/0000-0003-3854-7944; Raghavan, Swetha/0000-0001-6951-0592; S, Gayathri/0000-0003-2431-9553; Shah, Anup/0000-0002-3793-1998; bhardwaj, anshu/0000-0001-5830-2616; Mondal, Anupam/0000-0002-3572-6392; Janakiraman, Balaganesh/0000-0002-5893-8961; Dash, Debasis/0000-0002-5647-3785; Kumar, Vikas/0000-0002-5263-9303; Shait Mohammed, Mohammed Razeeth/0000-0002-4711-1483; Bhattacharyya, Kausik/0000-0002-4033-676X; Subramanian, Ahalyaa/0000-0001-9669-8260; Chandra, Nagasuma/0000-0002-9939-8439	Council of Scientific and Industrial Research, India [HCP0001]; Hewlett-Packard; Sun Microsystems	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Hewlett-Packard; Sun Microsystems	This work was supported by the Council of Scientific and Industrial Research, India, Funding (Grant No. HCP0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Vipin Singh, Assistant Professor, Amity University, Noida, for very constructive and detailed comments on the manuscript. We also thank Dr. TS Balganesh, CSIR, and Dr. Vani Brahmachari, ACBR, for fruitful discussions on the manuscript. We acknowledge India 800 foundation for support towards rewarding the best contributors with net books, Hewlett-Packard and Sun Microsystems for providing financial and logistics support for the on-site phase of C2D. We would also like to thank Mahanagar Telephone Nigam Limited, Delhi, India, for providing connectivity and the National Knowledge Network (NKN) for providing high-bandwidth support for C2D on-site phase activities. We also acknowledge School of Information Technology, Jawaharlal Nehru University, Delhi, India, for hosting the on-site phase and Dr. Andrew Michael Lynn and his group, School of Information Technology, Jawaharlal Nehru University, and Dr. S Ramachandran, CSIR-Institute of Genomics and Integrative Biology and his group, Delhi, for providing logistics support. We also thank Dr. GPS Raghava, CSIR-Institute of Microbial Technology, Chandigarh, for hosting the IPW web server. The authors thank all the OSDD members for their active participation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anurag M, 2009, MOL BIOSYST, V5, P1752, DOI [10.1039/b905518p, 10.1039/B905518p]; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhardwaj A, 2011, TUBERCULOSIS, V91, P479, DOI 10.1016/j.tube.2011.06.004; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chandra N, 2011, TUBERCULOSIS, V91, P487, DOI 10.1016/j.tube.2011.02.008; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grigorov MG, 2005, DRUG DISCOV TODAY, V10, P365, DOI 10.1016/S1359-6446(05)03369-6; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hey A. J. G., 2009, 4 PARADIGM DATA INTE; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kalidas Y, 2008, J STRUCT BIOL, V161, P31, DOI 10.1016/j.jsb.2007.09.005; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitano H, 2011, NAT CHEM BIOL, V7, P323, DOI 10.1038/nchembio.574; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Munos B, 2010, CLIN PHARMACOL THER, V87, P534, DOI 10.1038/clpt.2010.26; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Prakash T, 2005, J MOL BIOL, V345, P937, DOI 10.1016/j.jmb.2004.11.008; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Raman Karthik, 2010, Autom Exp, V2, P2, DOI 10.1186/1759-4499-2-2; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Singh S, 2008, CELL, V133, P201, DOI 10.1016/j.cell.2008.04.003; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams Antony J, 2011, COLLABORATIVE TOOLS; World Health Organization, 2010, WHOHTMTB20107; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543	48	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39808	10.1371/journal.pone.0039808	http://dx.doi.org/10.1371/journal.pone.0039808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808064	gold, Green Published, Green Submitted			2022-12-25	WOS:000306362400021
J	Brecht, I; Weissbrich, B; Braun, J; Toyka, KV; Weishaupt, A; Buttmann, M				Brecht, Isabel; Weissbrich, Benedikt; Braun, Julia; Toyka, Klaus Viktor; Weishaupt, Andreas; Buttmann, Mathias			Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; DIFFERENTIAL-DIAGNOSIS; NERVOUS-SYSTEM; CRITERIA; SERUM; MS	Background: Oligoclonal bands (OCB) are detected in the cerebrospinal fluid (CSF) in more than 95% of patients with multiple sclerosis (MS) in the Western hemisphere. Here we evaluated the intrathecal, polyspecific antiviral immune response as a potential diagnostic CSF marker for OCB-negative MS patients. Methodology/Principal Findings: We tested 46 OCB-negative German patients with paraclinically well defined, definite MS. Sixteen OCB-negative patients with a clear diagnosis of other autoimmune CNS disorders and 37 neurological patients without evidence for autoimmune CNS inflammation served as control groups. Antibodies against measles, rubella, varicella zoster and herpes simplex virus in paired serum and CSF samples were determined by ELISA, and virus-specific immunoglobulin G antibody indices were calculated. An intrathecal antibody synthesis against at least one neurotropic virus was detected in 8 of 26 (31%) patients with relapsing-remitting MS, 8 of 12 (67%) with secondary progressive MS and 5 of 8 (63%) with primary progressive MS, in 3 of 16 (19%) CNS autoimmune and 3 of 37 (8%) non-autoimmune control patients. Antibody synthesis against two or more viruses was found in 11 of 46 (24%) MS patients but in neither of the two control groups. On average, MS patients with a positive antiviral immune response were older and had a longer disease duration than those without. Conclusion: Determination of the intrathecal, polyspecific antiviral immune response may allow to establish a CSF-supported diagnosis of MS in OCB-negative patients when two or more of the four virus antibody indices are elevated.	[Brecht, Isabel; Toyka, Klaus Viktor; Weishaupt, Andreas; Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Weissbrich, Benedikt; Braun, Julia] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Brecht, I (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	m.buttmann@uni-wuerzburg.de	Buttmann, Mathias/AAD-7488-2021; Buttmann, Mathias/R-7301-2019	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685	Merck Serono Germany; University of Wurzburg; Merck Serono; Abbott; Dade Behring; Siemens; Sanofi Aventis; Teva Pharmaceutical Industries Ltd.; DFG (German National Research Foundation); BMBF (German Federal Ministry of Education and Science); State of Bavaria Research Funds; University Research Funds; Gemeinnutzige Hertie Stiftung; German MS Society; Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg; Biogen Idec	Merck Serono Germany; University of Wurzburg; Merck Serono(Merck & Company); Abbott(Abbott Laboratories); Dade Behring; Siemens(Siemens AG); Sanofi Aventis(Sanofi-Aventis); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); DFG (German National Research Foundation)(German Research Foundation (DFG)); BMBF (German Federal Ministry of Education and Science)(Federal Ministry of Education & Research (BMBF)); State of Bavaria Research Funds; University Research Funds; Gemeinnutzige Hertie Stiftung; German MS Society; Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg; Biogen Idec(Biogen)	This work was supported by an educational grant from Merck Serono Germany (to M. B.) and the University Research Fund at the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by Merck Serono Germany. None of the authors nor Merck Serono has commercial interests related to the content of this manuscript. I. B. received a travel grant from Merck Serono. B. W. received research grants from Abbott, Dade Behring and Siemens, and lecture fees from Dade Behring. J.B. reports no disclosures. K. V. T. served on a scientific advisory board for Merck Serono; has received travel expenses and/or speaker honoraria from Lundbeck Inc. and Teva Pharmaceutical Industries Ltd., and for lectures or educational activities not funded by industry; serves on the editorial boards of Current Treatment Options in Neurology and Therapeutic Advances in Neurological Disorders; serves as a consultant to Teva Pharmaceutical Industries Ltd., and served as a consultant to Merck Serono and Ebewe Neuro Pharma GmbH; and received research support from Sanofi Aventis and Teva Pharmaceutical Industries Ltd., Merck Serono, the DFG (German National Research Foundation), the BMBF (German Federal Ministry of Education and Science), State of Bavaria Research Funds, University Research Funds, the Gemeinnutzige Hertie Stiftung, and the German MS Society Research Fund. A. W. received research grants from the Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg and from the Gemeinnutzige Hertie Stiftung. M. B. received a travel grant from Biogen Idec; travel grants, speaker's fees and a research grant from Merck Serono; served on an advisory board for Almirall Hermal GmbH; and received research grants from Sanofi Aventis and Teva Pharmaceutical Industries Ltd., Novartis, and the Interdisciplinary Center for Clinical Research (IZKF) at the University of Wurzburg. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bednarova J, 2005, ACTA NEUROL SCAND, V112, P97, DOI 10.1111/j.1600-0404.2005.00418.x; FELGENHAUER K, 1992, CLIN INVESTIGATOR, V70, P28, DOI 10.1007/BF00422934; Jarius S, 2008, J NEUROL NEUROSUR PS, V79, P1134, DOI 10.1136/jnnp.2007.133330; Jarius S, 2009, J NEUROL SCI, V280, P98, DOI 10.1016/j.jns.2008.08.002; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; PUCCIONISOHLER M, 1995, ARQ NEURO-PSIQUIAT, V53, P760, DOI 10.1590/S0004-282X1995000500008; REIBER H, 1995, CLIN CHEM, V41, P256; REIBER H, 1991, CLIN CHEM, V37, P1153; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Schubert J, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-12; SINDIC CJM, 1994, J NEUROIMMUNOL, V54, P75, DOI 10.1016/0165-5728(94)90233-X; Thompson A, 2004, MULT SCLER J, V10, pS2, DOI 10.1191/1352458504ms1024oa	16	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40431	10.1371/journal.pone.0040431	http://dx.doi.org/10.1371/journal.pone.0040431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792316	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700047
J	Nagao, H; Setoguchi, T; Kitamoto, S; Ishidou, Y; Nagano, S; Yokouchi, M; Abematsu, M; Kawabata, N; Maeda, S; Yonezawa, S; Komiya, S				Nagao, Hiroko; Setoguchi, Takao; Kitamoto, Sho; Ishidou, Yasuhiro; Nagano, Satoshi; Yokouchi, Masahiro; Abematsu, Masahiko; Kawabata, Naoya; Maeda, Shingo; Yonezawa, Suguru; Komiya, Setsuro			RBPJ Is a Novel Target for Rhabdomyosarcoma Therapy	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; NOTCH; CELL; PATHWAY; GROWTH; CANCER; EXPRESSION; INTEGRATION; ACTIVATION; MECHANISM	The Notch pathway regulates a broad spectrum of cell fate decisions and differentiation processes during fetal and postnatal development. In addition, the Notch pathway plays an important role in controlling tumorigenesis. However, the role of RBPJ, a transcription factor in the Notch pathway, in the development of tumors is largely unknown. In this study, we focused on the role of RBPJ in the pathogenesis of rhabdomyosarcoma (RMS). Our data showed that Notch pathway genes were upregulated and activated in human RMS cell lines and patient samples. Inhibition of the Notch pathway by a gamma-secretase inhibitor (GSI) decreased the in vitro proliferation of RMS cells. Knockdown of RBPJ expression by RNAi inhibited the anchorage-independent growth of RMS cells and the growth of xenografts in vivo. Additionally, overexpression of RBPJ promoted the anchorage-independent growth of RMS cells. Further, we revealed that RBPJ regulated the cell cycle in RMS xenograft tumors and decreased proliferation. Our findings suggest that RBPJ regulates the RMS growth, and that the inhibition of RBPJ may be an effective therapeutic approach for patients with RMS.	[Nagao, Hiroko; Nagano, Satoshi; Yokouchi, Masahiro; Abematsu, Masahiko; Kawabata, Naoya; Komiya, Setsuro] Kagoshima Univ, Dept Orthopaed Surg, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Nagao, Hiroko; Setoguchi, Takao; Abematsu, Masahiko] Kagoshima Univ, Near Future Locomotor Organ Med Creat Course Kusu, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kitamoto, Sho; Yonezawa, Suguru] Kagoshima Univ, Dept Human Pathol, Grad Sch Med & Dent Sci, Field Oncol, Kagoshima 890, Japan; [Ishidou, Yasuhiro; Maeda, Shingo] Kagoshima Univ, Dept Med Joint Mat, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima University	Nagao, H (corresponding author), Kagoshima Univ, Dept Orthopaed Surg, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	setoro@m2.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647; Nagano, Satoshi/0000-0003-2015-1730	KAKENHI [19591725, 20591786, 21591919, 21591920, 22591663, 24592238, 23592195]; Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer;  [201201976]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer; 	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) (C) 19591725, (C) 20591786, (C) 21591919, (C) 21591920, (C) 22591663, (C) 24592238 and (C) 23592195 and a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer, and Scientific Research on Priority Areas 201201976 to HN from the Grant-in-Aid for JSPS Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Belyea BC, 2011, CLIN CANCER RES, V17, P7324, DOI 10.1158/1078-0432.CCR-11-1004; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gupta AA, 2011, CANCER, V118, P1130; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Kawabata N, 2011, INT J ONCOL, V39, P899, DOI 10.3892/ijo.2011.1076; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Matsunoshita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016234; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nagao H, 2011, J PATHOL, V224, P169, DOI 10.1002/path.2880; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Perez EA, 2011, J SURG RES, V170, pE243, DOI 10.1016/j.jss.2011.03.001; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rodeberg David, 2006, Semin Pediatr Surg, V15, P57, DOI 10.1053/j.sempedsurg.2005.11.009; Roma J, 2011, CLIN CANCER RES, V17, P505, DOI 10.1158/1078-0432.CCR-10-0166; Sana J, 2011, ANAL CELL PATHOL, V34, P303, DOI [10.1155/2011/939457, 10.3233/ACP-2011-0018]; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Sasaki H, 2010, ONCOL REP, V23, P677, DOI 10.3892/or_00000684; Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sivasankaran B, 2009, CANCER RES, V69, P458, DOI 10.1158/0008-5472.CAN-08-2610; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Tohda S, 2006, LEUKEMIA RES, V30, P1385, DOI 10.1016/j.leukres.2006.05.003; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	48	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39268	10.1371/journal.pone.0039268	http://dx.doi.org/10.1371/journal.pone.0039268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792167	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700008
J	Terao, C; Ohmura, K; Ikari, K; Kochi, Y; Maruya, E; Katayama, M; Yurugi, K; Shimada, K; Murasawa, A; Honjo, S; Takasugi, K; Matsuo, K; Tajima, K; Suzuki, A; Yamamoto, K; Momohara, S; Yamanaka, H; Yamada, R; Saji, H; Matsuda, F; Mimori, T				Terao, Chikashi; Ohmura, Koichiro; Ikari, Katsunori; Kochi, Yuta; Maruya, Etsuko; Katayama, Masaki; Yurugi, Kimiko; Shimada, Kota; Murasawa, Akira; Honjo, Shigeru; Takasugi, Kiyoshi; Matsuo, Keitaro; Tajima, Kazuo; Suzuki, Akari; Yamamoto, Kazuhiko; Momohara, Shigeki; Yamanaka, Hisashi; Yamada, Ryo; Saji, Hiroo; Matsuda, Fumihiko; Mimori, Tsuneyo			ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; HLA-DRB1 SHARED EPITOPE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; RISK LOCUS; SUSCEPTIBILITY; ASSOCIATION; ALLELES; POPULATION; METAANALYSIS	HLA-DRB1, especially the shared epitope (SE), is strongly associated with rheumatoid arthritis (RA). However, recent studies have shown that SE is at most weakly associated with RA without anti-citrullinated peptide/protein antibody (ACPA). We have recently reported that ACPA-negative RA is associated with specific HLA-DRB1 alleles and diplotypes. Here, we attempted to detect genetically different subsets of ACPA-negative RA by classifying ACPA-negative RA patients into two groups based on their positivity for rheumatoid factor (RF). HLA-DRB1 genotyping data for totally 954 ACPA-negative RA patients and 2,008 healthy individuals in two independent sets were used. HLA-DRB1 allele and diplotype frequencies were compared among the ACPA-negative RF-positive RA patients, ACPA-negative RF-negative RA patients, and controls in each set. Combined results were also analyzed. A similar analysis was performed in 685 ACPA-positive RA patients classified according to their RF positivity. As a result, HLA-DRB1*04:05 and *09:01 showed strong associations with ACPA-negative RF-positive RA in the combined analysis (p = 8.86 x 10(-6) and 0.0011, OR: 1.57 (1.28-1.91) and 1.37 (1.13-1.65), respectively). We also found that HLA-DR14 and the HLA-DR8 homozygote were associated with ACPA-negative RF-negative RA (p = 0.00022 and 0.00013, OR: 1.52 (1.21-1.89) and 3.08 (1.68-5.64), respectively). These association tendencies were found in each set. On the contrary, we could not detect any significant differences between ACPA-positive RA subsets. As a conclusion, ACPA-negative RA includes two genetically distinct subsets according to RF positivity in Japan, which display different associations with HLA-DRB1. ACPA-negative RF-positive RA is strongly associated with HLA-DRB1*04:05 and *09:01. ACPA-negative RF-negative RA is associated with DR14 and the HLA-DR8 homozygote.	[Terao, Chikashi; Ohmura, Koichiro; Katayama, Masaki; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Ikari, Katsunori; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Kochi, Yuta; Suzuki, Akari] RIKEN, Lab Autoimmune Dis, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Maruya, Etsuko; Saji, Hiroo] HLA Lab, Kyoto, Japan; [Yurugi, Kimiko] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Shimada, Kota] Natl Hosp Org, Sagamihara Natl Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Murasawa, Akira] Niigata Rheumat Ctr, Dept Rheumatol, Niigata, Japan; [Honjo, Shigeru] Saiseikai Takaoka Hosp, Rheumatoid Arthrit Ctr, Toyama, Japan; [Takasugi, Kiyoshi] Dohgo Spa Hosp, Dept Internal Med, Ctr Rheumat Dis, Matsuyama, Ehime, Japan; [Matsuo, Keitaro; Tajima, Kazuo] Aichi Canc Ctr Hosp & Res Inst, Nagoya, Aichi, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Matsuda, Fumihiko] Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, Unite U852, Kyoto, Japan	Kyoto University; Kyoto University; Tokyo Women's Medical University; RIKEN; Kyoto University; Aichi Cancer Center; University of Tokyo; Japan Science & Technology Agency (JST); Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	a0001101@kuhp.kyoto-u.ac.jp; ohmurako@kuhp.kyoto-u.ac.jp	Matsuo, Keitaro/H-6758-2019; Yamamoto, Kazuhiko/N-5096-2015; Suzuki, Akari/N-5389-2015	Matsuo, Keitaro/0000-0003-1761-6314; Yamada, Ryo/0000-0002-1587-630X	Kyoto University; Genetics and Allied research in Rheumatic diseases Networking (GARNET) consortium; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Rheumatism Foundation; Waksman Foundation; Mitsubishi Pharma Research Foundation; Grants-in-Aid for Scientific Research [24659274, 24390360] Funding Source: KAKEN	Kyoto University; Genetics and Allied research in Rheumatic diseases Networking (GARNET) consortium; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Rheumatism Foundation(Japan Rheumatism Foundation); Waksman Foundation; Mitsubishi Pharma Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank Dr. Naoichiro Yukawa, Dr. Hajime Yoshifuji, Dr. Daisuke Kawabata, Dr. Takaki Nojima, Dr. Takashi Usui, and Dr. Takao Fujii of Kyoto University for collecting the DNA samples. We would also like to thank Mr. Taishi Shigeki for developing the clinical database software used at Dohgo Spa hospital. We would like to thank Dr. Yasuo Miura and Dr. Taira Maekawa of Kyoto University for their support of HLA-DRB1 genotyping. Moreover, we wish to thank all of the doctors and medical staff who collected the samples. This study was performed with the support of the Genetics and Allied research in Rheumatic diseases Networking (GARNET) consortium.; This study was supported by Grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, as well as by research grants from the Japan Rheumatism Foundation, the Waksman Foundation, and the Mitsubishi Pharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Furuya T, 2007, CLIN EXP RHEUMATOL, V25, P219; Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P400, DOI 10.1002/art.20006; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mackie SL, 2012, GENES IMMUN, V13, P120, DOI 10.1038/gene.2011.60; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Morgan AW, 2009, ARTHRITIS RHEUM-US, V60, P2565, DOI 10.1002/art.24752; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Okada Y, 2010, ANN RHEUM DIS, V69, P1569, DOI 10.1136/ard.2009.118018; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Queiro-Silva R, 2004, SCAND J RHEUMATOL, V33, P318, DOI 10.1080/03009740410005953; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Terao C, 2012, ANN RHEUM DIS, V71, P1095, DOI 10.1136/annrheumdis-2011-200907; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Terao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020457; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302	43	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40067	10.1371/journal.pone.0040067	http://dx.doi.org/10.1371/journal.pone.0040067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792215	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800037
J	van Loon, JE; Sanders, YV; de Wee, EM; Kruip, MJHA; de Maat, MPM; Leebeek, FWG				van Loon, Janine E.; Sanders, Yvonne V.; de Wee, Eva M.; Kruip, Marieke J. H. A.; de Maat, Moniek P. M.; Leebeek, Frank W. G.			Effect of Genetic Variation in STXBP5 and STX2 on von Willebrand Factor and Bleeding Phenotype in Type 1 von Willebrand Disease Patients	PLOS ONE			English	Article							MCMDM-1VWD; DIAGNOSIS; GENOTYPE	Background: In type 1 von Willebrand Disease (VWD) patients, von Willebrand Factor (VWF) levels and bleeding symptoms are highly variable. Recently, the association between genetic variations in STXBP5 and STX2 with VWF levels has been discovered in the general population. We assessed the relationship between genetic variations in STXBP5 and STX2, VWF levels, and bleeding phenotype in type 1 VWD patients. Methods: In 158 patients diagnosed with type 1 VWD according to the current ISTH guidelines, we genotyped three tagging-SNPs in STXBP5 and STX2 and analyzed their relationship with VWF:Ag levels and the severity of the bleeding phenotype, as assessed by the Tosetto bleeding score. Results: In STX2, rs7978987 was significantly associated with VWF:Ag levels (beta-coefficient (beta) = -0.04 IU/mL per allele, [95%CI -0.07;-0.001], p = 0.04) and VWF:CB activity (beta = -0.12 IU/mL per allele, [95%CI -0.17;-0.06], p<0.0001). For rs1039084 in STXBP5 a similar trend with VWF:Ag levels was observed: (beta = -0.03 IU/mL per allele [95% CI -0.06;0.003], p = 0.07). In women, homozygous carriers of the minor alleles of both SNPs in STXBP5 had a significantly higher bleeding score than homozygous carriers of the major alleles. (Rs1039084 p = 0.01 and rs9399599 p = 0.02). Conclusions: Genetic variation in STX2 is associated with VWF: Ag levels in patients diagnosed with type 1 VWD. In addition, genetic variation in STXBP5 is associated with bleeding phenotype in female VWD patients. Our findings may partly explain the variable VWF levels and bleeding phenotype in type 1 VWD patients.	[van Loon, Janine E.; Sanders, Yvonne V.; de Wee, Eva M.; Kruip, Marieke J. H. A.; de Maat, Moniek P. M.; Leebeek, Frank W. G.] Erasmus MC, Dept Haematol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Loon, JE (corresponding author), Erasmus MC, Dept Haematol, Rotterdam, Netherlands.	f.leebeek@erasmusmc.nl		Sanders, Yvonne/0000-0002-3603-737X	CSL Behring Prof. Heimburger Award; Dutch Haemophilia Foundation	CSL Behring Prof. Heimburger Award; Dutch Haemophilia Foundation	This work was supported by the CSL Behring Prof. Heimburger Award 2011 and the Dutch Haemophilia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cumming A, 2006, THROMB HAEMOSTASIS, V96, P630, DOI 10.1160/TH06-07-0383; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; James PD, 2007, BLOOD, V109, P145, DOI 10.1182/blood-2006-05-021105; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; MACFARLANE DE, 1975, THROMB DIATH HAEMOST, V34, P306, DOI 10.1055/s-0038-1651343; Ruggeri ZM, 2000, J CLIN INVEST, V105, P699, DOI 10.1172/JCI9604; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler J Evan, 2009, Hematology Am Soc Hematol Educ Program, P106, DOI 10.1182/asheducation-2009.1.106; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tosetto A, 2007, J THROMB HAEMOST, V5, P715, DOI 10.1111/j.1538-7836.2007.02444.x; van Loon JE, 2010, CIRC-CARDIOVASC GENE, V3, P507, DOI 10.1161/CIRCGENETICS.110.957407; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200	14	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40624	10.1371/journal.pone.0040624	http://dx.doi.org/10.1371/journal.pone.0040624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792389	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800110
J	Hatfaludi, T; Al-Hasani, K; Gong, L; Boyce, JD; Ford, M; Wilkie, IW; Quinsey, N; Dunstone, MA; Hoke, DE; Adler, B				Hatfaludi, Tamas; Al-Hasani, Keith; Gong, Lan; Boyce, John D.; Ford, Mark; Wilkie, Ian W.; Quinsey, Noelene; Dunstone, Michelle A.; Hoke, David E.; Adler, Ben			Screening of 71 P-multocida Proteins for Protective Efficacy in a Fowl Cholera Infection Model and Characterization of the Protective Antigen PlpE	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; GROUP-B STREPTOCOCCUS; HAEMOLYTICA SEROTYPE-1; HEMORRHAGIC SEPTICEMIA; SUBCELLULAR-LOCALIZATION; VACCINE DEVELOPMENT; BINDING-PROTEINS; LIVE VACCINE; VIRULENCE; IDENTIFICATION	Background: There is a strong need for a recombinant subunit vaccine against fowl cholera. We used a reverse vaccinology approach to identify putative secreted or cell surface associated P. multocida proteins that may represent potential vaccine candidate antigens. Principal Findings: A high-throughput cloning and expression protocol was used to express and purify 71 recombinant proteins for vaccine trials. Of the 71 proteins tested, only one, PlpE in denatured insoluble form, protected chickens against fowl cholera challenge. PlpE also elicited comparable levels of protection in mice. PlpE was localized by immunofluorescence to the bacterial cell surface, consistent with its ability to elicit a protective immune response. To explore the role of PlpE during infection and immunity, a plpE mutant was generated. The plpE mutant strain retained full virulence for mice. Conclusion: These studies show that PlpE is a surface exposed protein and was the only protein of 71 tested that was able to elicit a protective immune response. However, PlpE is not an essential virulence factor. This is the first report of a denatured recombinant protein stimulating protection against fowl cholera.	[Al-Hasani, Keith; Gong, Lan; Boyce, John D.; Quinsey, Noelene; Adler, Ben] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Gen, Clayton, Vic, Australia; [Hatfaludi, Tamas; Gong, Lan; Quinsey, Noelene; Dunstone, Michelle A.; Hoke, David E.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Al-Hasani, Keith; Boyce, John D.; Dunstone, Michelle A.; Adler, Ben] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Ford, Mark] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Wilkie, Ian W.] Univ Queensland, Brisbane, Qld, Australia	Monash University; Monash University; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Hatfaludi, T (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Gen, Clayton, Vic, Australia.	tamas.hatfaludi@monash.edu	Gong, Lan/J-6368-2016; Boyce, John D/F-5058-2012; Gong, Lan/O-7886-2019; Dunstone, Michelle/I-2895-2014	Gong, Lan/0000-0003-3136-1565; Boyce, John D/0000-0002-8614-3074; Gong, Lan/0000-0003-3136-1565; Dunstone, Michelle/0000-0002-6026-648X; Hatfaludi, Tamas/0000-0001-6605-9556; Al-Hasani, Keith/0000-0001-6109-5603	Australian Research Council, Canberra, Australia	Australian Research Council, Canberra, Australia(Australian Research Council)	This research was supported by the Australian Research Council, Canberra, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 1996, J BIOTECHNOL, V44, P139, DOI 10.1016/0168-1656(95)00113-1; Al-Hasani K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-3; APVMA, 2011, PUBL CHEM REG INF SY; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boyce J, 2009, PATHOGENESIS BACTERI; BOYCE J, 2004, PATHOGENESIS BACTERI, P273, DOI DOI 10.1002/9780470344903.CH20; Boyce JD, 2006, PROTEOMICS, V6, P870, DOI 10.1002/pmic.200401342; Boyce JD, 2001, INFECT IMMUN, V69, P1943, DOI 10.1128/IAI.69.3.1943-1946.2001; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Cardenas M, 2001, VET MICROBIOL, V80, P53, DOI 10.1016/S0378-1135(00)00372-2; Carter G R, 1967, Adv Vet Sci, V11, P321; Confer AW, 2006, VACCINE, V24, P2248, DOI 10.1016/j.vaccine.2005.11.036; Confer AW, 2003, VACCINE, V21, P2821, DOI 10.1016/S0264-410X(03)00213-5; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hansson M, 2000, BIOTECHNOL APPL BIOC, V32, P95, DOI 10.1042/BA20000034; Harper M, 2004, INFECT IMMUN, V72, P3436, DOI 10.1128/IAI.72.6.3436-3443.2004; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Hatfaludi T, 2008, ANTIMICROB AGENTS CH, V52, P4166, DOI 10.1128/AAC.00245-08; Hatfaludi T, 2010, VET MICROBIOL, V144, P1, DOI 10.1016/j.vetmic.2010.01.027; HEDDLESTON KL, 1972, AVIAN DIS, V16, P925, DOI 10.2307/1588773; HEDDLESTON KL, 1972, AVIAN DIS, V16, P578, DOI 10.2307/1588675; Hopkins BA, 1998, AVIAN DIS, V42, P265, DOI 10.2307/1592476; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kristensen K, 1996, PEDIATR INFECT DIS J, V15, P525, DOI 10.1097/00006454-199606000-00010; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lee J, 2007, J MICROBIOL, V45, P179; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Luo YG, 1997, J BACTERIOL, V179, P7856, DOI 10.1128/jb.179.24.7856-7864.1997; Magyar T, 2002, VACCINE, V20, P1797, DOI 10.1016/S0264-410X(02)00023-3; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; MAKELA PH, 1980, LANCET, V2, P547; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moore DD, 1995, GLOB MOB SURV; Movahedi A, 2008, VET MICROBIOL, V131, P1, DOI 10.1016/j.vetmic.2008.02.011; MYINT A, 1989, VET REC, V124, P508, DOI 10.1136/vr.124.19.508; MYINT A, 1987, VET REC, V120, P500, DOI 10.1136/vr.120.21.500; Nagy G, 2008, INT J MED MICROBIOL, V298, P379, DOI 10.1016/j.ijmm.2008.01.012; Pandher K, 1998, INFECT IMMUN, V66, P5613, DOI 10.1128/IAI.66.12.5613-5619.1998; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Scott PV, 1999, AVIAN DIS, V43, P83, DOI 10.2307/1592765; Seib KL, 2009, INFECT IMMUN, V77, P292, DOI 10.1128/IAI.01071-08; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Singh AP, 2010, J VET SCI, V11, P227, DOI 10.4142/jvs.2010.11.3.227; Sthitmatee N, 2008, VACCINE, V26, P2398, DOI 10.1016/j.vaccine.2008.02.051; Tatum FM, 2009, AVIAN DIS, V53, P169, DOI 10.1637/8471-092308-Reg.1; Van Overbeke I, 2001, J VET MED B, V48, P15, DOI 10.1046/j.1439-0450.2001.00419.x; Verma R, 1997, VACCINE, V15, P1254, DOI 10.1016/S0264-410X(97)00025-X; Wilkie IW, 2000, VET MICROBIOL, V72, P57, DOI 10.1016/S0378-1135(99)00187-X; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Wu JR, 2007, VACCINE, V25, P4140, DOI 10.1016/j.vaccine.2007.03.005	58	23	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e39973	10.1371/journal.pone.0039973	http://dx.doi.org/10.1371/journal.pone.0039973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792202	Green Submitted, Green Published, gold			2022-12-25	WOS:000306436300017
J	Gao, YX; Feng, J; Ma, KY; Zhou, Z; Zhu, Y; Xu, QB; Wang, X				Gao, Yanxiang; Feng, Juan; Ma, Kongyang; Zhou, Zhou; Zhu, Yi; Xu, Qingbo; Wang, Xian			8,9-Epoxyeicosatrienoic Acid Inhibits Antibody Production of B Lymphocytes in Mice	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; EPOXYGENASE-DERIVED EICOSANOIDS; PLASMA-CELL DIFFERENTIATION; EPOXYEICOSATRIENOIC ACIDS; ARACHIDONIC-ACID; HYPERPOLARIZING FACTORS; ENDOTHELIAL-CELLS; PROSTAGLANDIN E-2; IMMUNE-RESPONSES; GENE-EXPRESSION	Epoxyeicosatrienoic acids (EETs), synthesized from arachidonic acid by cytochrome P450 epoxygenases, are converted to dihydroxyeicosatrienoic acids by soluble epoxide hydrolase. EETs exert anti-inflammatory effects. However, the effect of EETs on humoral immunity is poorly understood. The present study is to investigate the potential role of EETs on B cell function and mechanisms. We examined the role of EETs on antibody production of splenic B cells from C57BL/6 and apolipoprotein E-deficient (ApoE-/-) mice by means of ELISA. Of the 4 EET regioisomers, 8,9-EET decreased basal and activation-induced B cell antibody secretion. As well, 8,9-EET significantly inhibited B-cell proliferation and survival, plasma cell differentiation and class-switch recombination. Western blot analysis revealed that lipopolysaccharide-induced nuclear translocation of NF-kappa B could be attenuated by 8,9-EET. Furthermore, germinal center formation was impaired by 8,9-EET in mice in vivo. 8,9-EET may inhibit B-cell function in vitro and in vivo, which suggests a new therapeutic strategy for diseases with excess B cell activation.	[Gao, Yanxiang; Feng, Juan; Ma, Kongyang; Zhou, Zhou; Zhu, Yi; Wang, Xian] Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Qingbo] Kings Coll London, BHF Ctr, Cardiovasc Div, London WC2R 2LS, England	Peking University; University of London; King's College London	Gao, YX (corresponding author), Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing 100871, Peoples R China.	xwang@bjmu.edu.cn	gao, yi/HCI-8298-2022; Zhou, Zhou/R-7788-2016; Gao, Yu/HGE-1937-2022; Ma, Kongyang/AAW-9433-2020; Gao, Y./GWZ-3665-2022	Ma, Kongyang/0000-0002-9739-7686	National Basic Research Program of China [2010CB912504, 2011CB503904]; National Natural Science Foundation of China [81121061, 81000115]; Fund of the Chinese Ministry of Education [20100001120049]; Programme of Introducing Talents of Discipline to Universities [B07001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of the Chinese Ministry of Education(Ministry of Education, China); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (URL: www.973.gov.cn/AreaAppl.aspx) [2010CB912504 and 2011CB503904] to X. Wang, the National Natural Science Foundation of China (URL: www.nsfc.gov.cn/Portal0/default124.htm) [81121061 to X. Wang; 81000115 to J. Feng], Fund of the Chinese Ministry of Education (URL: www.cutech.edu.cn/cn/kyjj/A0103index_1.htm) [20100001120049] to J. Feng, and the Programme of Introducing Talents of Discipline to Universities (URL: www.cutech.edu.cn/cn/kyjj/A0103index_1.htm) [B07001] to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit C, 2001, AM J PHYSIOL-LUNG C, V280, pL965, DOI 10.1152/ajplung.2001.280.5.L965; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Cheng MK, 2004, BRIT J PHARMACOL, V141, P441, DOI 10.1038/sj.bjp.0705640; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; JUNIER MP, 1990, ENDOCRINOLOGY, V126, P1534, DOI 10.1210/endo-126-3-1534; KATOH T, 1991, AM J PHYSIOL, V261, pF578, DOI 10.1152/ajprenal.1991.261.4.F578; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Liu XH, 2006, AM J PHYSIOL-CELL PH, V290, pC873, DOI 10.1152/ajpcell.00229.2005; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; Michaelis UR, 2005, ARTERIOSCL THROM VAS, V25, P321, DOI 10.1161/01.ATV.0000151648.58516.eb; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Okunishi K, 2004, J IMMUNOL, V173, P6393, DOI 10.4049/jimmunol.173.10.6393; OLIW EH, 1994, PROG LIPID RES, V33, P329, DOI 10.1016/0163-7827(94)90029-9; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Smith KR, 2005, P NATL ACAD SCI USA, V102, P2186, DOI 10.1073/pnas.0409591102; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; Wray J, 2008, EXP PHYSIOL, V93, P148, DOI 10.1113/expphysiol.2007.038612; Zhang LN, 2009, ARTERIOSCL THROM VAS, V29, P1265, DOI 10.1161/ATVBAHA.109.186064; Zhu PM, 2005, J IMMUNOL, V175, P4981, DOI 10.4049/jimmunol.175.8.4981	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40258	10.1371/journal.pone.0040258	http://dx.doi.org/10.1371/journal.pone.0040258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802958	Green Published, gold, Green Submitted			2022-12-25	WOS:000306186900032
J	Light, GA; Swerdlow, NR; Rissling, AJ; Radant, A; Sugar, CA; Sprock, J; Pela, M; Geyer, MA; Braff, DL				Light, Gregory A.; Swerdlow, Neal R.; Rissling, Anthony J.; Radant, Allen; Sugar, Catherine A.; Sprock, Joyce; Pela, Marlena; Geyer, Mark A.; Braff, David L.			Characterization of Neurophysiologic and Neurocognitive Biomarkers for Use in Genomic and Clinical Outcome Studies of Schizophrenia	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; MISMATCH NEGATIVITY DEFICITS; CONSENSUS COGNITIVE BATTERY; PREPULSE INHIBITION; P50 SUPPRESSION; ANTIPSYCHOTIC MEDICATIONS; TREATING SCHIZOPHRENIA; 1ST-DEGREE RELATIVES; SKILLS ASSESSMENT; BIPOLAR DISORDER	Background: Endophenotypes are quantitative, laboratory-based measures representing intermediate links in the pathways between genetic variation and the clinical expression of a disorder. Ideal endophenotypes exhibit deficits in patients, are stable over time and across shifts in psychopathology, and are suitable for repeat testing. Unfortunately, many leading candidate endophenotypes in schizophrenia have not been fully characterized simultaneously in large cohorts of patients and controls across these properties. The objectives of this study were to characterize the extent to which widely-used neurophysiological and neurocognitive endophenotypes are: 1) associated with schizophrenia, 2) stable over time, independent of state-related changes, and 3) free of potential practice/maturation or differential attrition effects in schizophrenia patients (SZ) and nonpsychiatric comparison subjects (NCS). Stability of clinical and functional measures was also assessed. Methods: Participants (SZ n = 341; NCS n = 205) completed a battery of neurophysiological (MMN, P3a, P50 and N100 indices, PPI, startle habituation, antisaccade), neurocognitive (WRAT-3 Reading, LNS-forward, LNS-reorder, WCST-64, CVLT-II). In addition, patients were rated on clinical symptom severity as well as functional capacity and status measures (GAF, UPSA, SOF). 223 subjects (SZ n = 163; NCS n = 58) returned for retesting after 1 year. Results: Most neurophysiological and neurocognitive measures exhibited medium-to-large deficits in schizophrenia, moderate-to-substantial stability across the retest interval, and were independent of fluctuations in clinical status. Clinical symptoms and functional measures also exhibited substantial stability. A Longitudinal Endophenotype Ranking System (LERS) was created to rank neurophysiological and neurocognitive biomarkers according to their effect sizes across endophenotype criteria. Conclusions: The majority of neurophysiological and neurocognitive measures exhibited deficits in patients, stability over a 1-year interval and did not demonstrate practice or time effects supporting their use as endophenotypes in neural substrate and genomic studies. These measures hold promise for informing the "gene-to-phene gap" in schizophrenia research.	[Light, Gregory A.; Sprock, Joyce; Geyer, Mark A.; Braff, David L.] San Diego VA Hlth Care Syst, VISN Mental Illness Res Educ & Clin Ctr MIRECC 22, La Jolla, CA 92161 USA; [Light, Gregory A.; Swerdlow, Neal R.; Rissling, Anthony J.; Sprock, Joyce; Pela, Marlena; Geyer, Mark A.; Braff, David L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Radant, Allen] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sugar, Catherine A.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Sugar, Catherine A.] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Light, GA (corresponding author), San Diego VA Hlth Care Syst, VISN Mental Illness Res Educ & Clin Ctr MIRECC 22, La Jolla, CA 92161 USA.	glight@ucsd.edu	Swerdlow, Neal/AAU-4912-2020; Light, Gregory/AAA-5696-2020	Light, Gregory/0000-0003-4730-8646	National Institute of Mental Health [MH042228, MH079777, MH065571]; Department of Veteran Affairs (VISN 22 Mental Illness Research, Education, and Clinical Center); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065571, R01MH042228, R01MH079777, R37MH042228] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Veteran Affairs (VISN 22 Mental Illness Research, Education, and Clinical Center); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from National Institute of Mental Health (MH042228, MH079777, and MH065571) and supported by the Department of Veteran Affairs (VISN 22 Mental Illness Research, Education, and Clinical Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2007, SCHIZOPHRENIA BULL, V33, P665, DOI 10.1093/schbul/sbl075; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Adler LE, 2004, AM J PSYCHIAT, V161, P1822, DOI 10.1176/appi.ajp.161.10.1822; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Bearden CE, 2006, TRENDS GENET, V22, P306, DOI 10.1016/j.tig.2006.04.004; BOUTROS NN, 1991, PSYCHIAT RES, V39, P181, DOI 10.1016/0165-1781(91)90086-5; Braff DL, 2007, BIOL PSYCHIAT, V61, P1204, DOI 10.1016/j.biopsych.2006.08.015; Braff David L, 2005, Dialogues Clin Neurosci, V7, P125; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Braff DL, 2004, PSYCHOPHARMACOLOGY, V174, P75, DOI 10.1007/s00213-004-1848-0; Calkins ME, 2003, INT J PSYCHOPHYSIOL, V49, P139, DOI 10.1016/S0167-8760(03)00101-6; Cho RY, 2005, SCHIZOPHRENIA BULL, V31, P865, DOI 10.1093/schbul/sbi050; CLEMENTZ BA, 1994, PSYCHOPHYSIOLOGY, V31, P486, DOI 10.1111/j.1469-8986.1994.tb01052.x; Clementz BA, 1997, BIOL PSYCHIAT, V41, P1035, DOI 10.1016/S0006-3223(96)00208-9; First M. B., 2002, STRUCTURED CLIN INTE; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Glahn DC, 2007, AM J MED GENET B, V144B, P242, DOI 10.1002/ajmg.b.30446; Glahn DC, 2012, BIOL PSYCHIAT, V71, P6, DOI 10.1016/j.biopsych.2011.08.022; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Green MF, 2008, AM J PSYCHIAT, V165, P221, DOI 10.1176/appi.ajp.2007.07010089; Green MF, 2009, SCHIZOPHRENIA BULL, V35, P163, DOI 10.1093/schbul/sbn156; Greenwood TA, 2011, AM J PSYCHIAT; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Greenwood TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029630; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hall MH, 2009, PSYCHOL MED, V39, P1277, DOI 10.1017/S0033291709005261; Hall MH, 2006, BEHAV GENET, V36, P845, DOI 10.1007/s10519-006-9091-6; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Hetrick WP, 1996, BIOL PSYCHIAT, V39, P51, DOI 10.1016/0006-3223(95)00067-4; Horan WP, 2008, SCHIZOPHR RES, V103, P218, DOI 10.1016/j.schres.2008.02.014; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Jahshan C, 2011, PSYCHOL MED, V41, P1; Jahshan C, 2010, NEUROPSYCHOLOGY, V24, P109, DOI 10.1037/a0016791; Kawakubo Y, 2007, PSYCHIAT RES, V152, P261, DOI 10.1016/j.psychres.2006.02.010; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Kurtz MM, 2005, SCHIZOPHR RES, V74, P15, DOI 10.1016/j.schres.2004.07.005; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Leifker FR, 2010, SCHIZOPHR RES, V119, P246, DOI 10.1016/j.schres.2010.03.021; Light G A, 1999, Curr Psychiatry Rep, V1, P31, DOI 10.1007/s11920-999-0008-y; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2000, AM J PSYCHIAT, V157, P767, DOI 10.1176/appi.ajp.157.5.767; Light GA, 1999, BIOL PSYCHIAT, V46, P990, DOI 10.1016/S0006-3223(99)00034-7; Light GA, 2001, AM J PSYCHIAT, V158, P2066, DOI 10.1176/appi.ajp.158.12.2066; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Marder SR, 2004, SCHIZOPHR RES, V72, P5, DOI 10.1016/j.schres.2004.09.010; Mathalon DH, 2000, BIOL PSYCHIAT, V47, P434, DOI 10.1016/S0006-3223(99)00277-2; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; Maxwell E, 1992, MANUAL FIGS; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Meincke U, 2004, PSYCHIAT RES, V126, P51, DOI 10.1016/j.psychres.2004.01.003; Nagamoto HT, 1996, BIOL PSYCHIAT, V40, P181, DOI 10.1016/0006-3223(95)00371-1; Olincy A, 2010, SCHIZOPHR RES; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Perry W, 2001, SCHIZOPHRENIA BULL, V27, P157, DOI 10.1093/oxfordjournals.schbul.a006854; Radant AD, 2007, SCHIZOPHR RES, V89, P320, DOI 10.1016/j.schres.2006.08.010; Rapaport MH, 1996, AM J GERIAT PSYCHIAT, V4, P218, DOI 10.1097/00019442-199622430-00005; Rentzsch J, 2008, INT J PSYCHOPHYSIOL, V67, P81, DOI 10.1016/j.ijpsycho.2007.10.006; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SMITH DA, 1994, PSYCHOPHYSIOLOGY, V31, P495, DOI 10.1111/j.1469-8986.1994.tb01053.x; Stone WS, IMPAIRED LEARN UNPUB; Swerdlow NR, 2009, NEUROPSYCHOPHARMACOL, V34, P1854, DOI 10.1038/npp.2009.7; Swerdlow NR, 2007, SCHIZOPHR RES, V92, P237, DOI 10.1016/j.schres.2007.01.012; Swerdlow NR, 2011, SCHIZOPHR RES, V130, P1, DOI 10.1016/j.schres.2011.05.004; SWERDLOW NR, 1994, ARCH GEN PSYCHIAT, V51, P139; SWERDLOW NR, 1993, BIOL PSYCHIAT, V34, P253, DOI 10.1016/0006-3223(93)90079-S; Thompson A, 2011, SCHIZOPHR RES, V126, P51, DOI 10.1016/j.schres.2010.09.024; Turetsky B, 1998, BIOL PSYCHIAT, V43, P31, DOI 10.1016/S0006-3223(97)00261-8; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Turetsky BI, 2008, BIOL PSYCHIAT, V64, P1051, DOI 10.1016/j.biopsych.2008.06.018; Twamley EW, 2008, AM J PSYCHIATR REHAB, V11, P144, DOI 10.1080/15487760801963678; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Wynn JK, 2007, SCHIZOPHR RES, V95, P134, DOI 10.1016/j.schres.2007.05.039	84	131	133	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39434	10.1371/journal.pone.0039434	http://dx.doi.org/10.1371/journal.pone.0039434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802938	Green Submitted, Green Published, gold			2022-12-25	WOS:000306186900012
J	Ribeiro, RJT; Monteiro, CPD; Azevedo, ASM; Cunha, VFM; Ramanakumar, AV; Fraga, AM; Pina, FM; Lopes, CMS; Medeiros, RM; Franco, EL				Ribeiro, Ricardo J. T.; Monteiro, Catia P. D.; Azevedo, Andreia S. M.; Cunha, Virginia F. M.; Ramanakumar, Agnihotram V.; Fraga, Avelino M.; Pina, Francisco M.; Lopes, Carlos M. S.; Medeiros, Rui M.; Franco, Eduardo L.			Performance of an Adipokine Pathway-Based Multilocus Genetic Risk Score for Prostate Cancer Risk Prediction	PLOS ONE			English	Article							LEPTIN RECEPTOR; BINDING PROTEIN-3; ADIPOSE-TISSUE; GROWTH-FACTORS; POLYMORPHISM; OBESITY; ASSOCIATION; EXPRESSION; OSTEOPONTIN; RECLASSIFICATION	Few biomarkers are available to predict prostate cancer risk. Single nucleotide polymorphisms (SNPs) tend to have weak individual effects but, in combination, they have stronger predictive value. Adipokine pathways have been implicated in the pathogenesis. We used a candidate pathway approach to investigate 29 functional SNPs in key genes from relevant adipokine pathways in a sample of 1006 men eligible for prostate biopsy. We used stepwise multivariate logistic regression and bootstrapping to develop a multilocus genetic risk score by weighting each risk SNP empirically based on its association with disease. Seven common functional polymorphisms were associated with overall and high-grade prostate cancer (Gleason >= 7), whereas three variants were associated with high metastatic-risk prostate cancer (PSA >= 20 ng/mL and/or Gleason >= 8). The addition of genetic variants to age and PSA improved the predictive accuracy for overall and high-grade prostate cancer, using either the area under the receiver-operating characteristics curves (P<0.02), the net reclassification improvement (P<0.001) and integrated discrimination improvement (P<0.001) measures. These results suggest that functional polymorphisms in adipokine pathways may act individually and cumulatively to affect risk and severity of prostate cancer, supporting the influence of adipokine pathways in the pathogenesis of prostate cancer. Use of such adipokine multilocus genetic risk score can enhance the predictive value of PSA and age in estimating absolute risk, which supports further evaluation of its clinical significance.	[Ribeiro, Ricardo J. T.; Monteiro, Catia P. D.; Azevedo, Andreia S. M.; Cunha, Virginia F. M.; Fraga, Avelino M.; Medeiros, Rui M.] Portuguese Inst Oncol, Mol Oncol Grp CI, Oporto, Portugal; [Ribeiro, Ricardo J. T.; Fraga, Avelino M.; Lopes, Carlos M. S.; Medeiros, Rui M.] Univ Porto, Abel Salazar Biomed Sci Inst, P-4100 Oporto, Portugal; [Ribeiro, Ricardo J. T.; Ramanakumar, Agnihotram V.; Franco, Eduardo L.] McGill Univ, Dept Oncol, Div Canc Epidemiol, Montreal, PQ, Canada; [Ribeiro, Ricardo J. T.; Monteiro, Catia P. D.; Azevedo, Andreia S. M.; Cunha, Virginia F. M.; Medeiros, Rui M.] LPCC Portuguese League Canc NRNorte, Oporto, Portugal; [Fraga, Avelino M.] D Pedro V Mil Hosp, Dept Urol, Oporto, Portugal; [Pina, Francisco M.] S Joao Hosp, Dept Urol, Oporto, Portugal	Universidade de Coimbra; Universidade do Porto; McGill University; Sao Joao Hospital	Ribeiro, RJT (corresponding author), Portuguese Inst Oncol, Mol Oncol Grp CI, Oporto, Portugal.	oriebir.r@gmail.com	Ribeiro, Ricardo Jorge Teixeira/S-6419-2017; Medeiros, Rui/C-7938-2009; Monteiro, Cátia/L-5409-2014; Franco, Eduardo/C-6445-2014	Ribeiro, Ricardo Jorge Teixeira/0000-0001-9785-857X; Medeiros, Rui/0000-0003-3010-8373; Monteiro, Cátia/0000-0002-0828-4541; Franco, Eduardo/0000-0002-4409-8084; Ferreira, Avelino/0000-0002-2999-0963; Azevedo, Andreia Sofia/0000-0002-0521-2841; Cunha, Virginia/0000-0003-1896-3318	Portuguese Foundation for Science and Technology [PTDC/SAL-FCF/71552/2006]; Research Centre on Environment, Genetics and Oncobiology of the University of Coimbra [CIMAGO 07/09]; Portuguese League Against Cancer - North Centre; Novartis Oncology Portugal; Programa Operacional Potencial Humano/Fundo social Europeu (POPH/FSE) [SFRH/BD/30021/2006]; Union for International Cancer Control (UICC-ICRETT) [ICR/10/079/2010]; Cancer Research Society	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Research Centre on Environment, Genetics and Oncobiology of the University of Coimbra; Portuguese League Against Cancer - North Centre; Novartis Oncology Portugal; Programa Operacional Potencial Humano/Fundo social Europeu (POPH/FSE); Union for International Cancer Control (UICC-ICRETT); Cancer Research Society	This work was supported by the Portuguese Foundation for Science and Technology (PTDC/SAL-FCF/71552/2006); the Research Centre on Environment, Genetics and Oncobiology of the University of Coimbra (CIMAGO 07/09); the Portuguese League Against Cancer - North Centre; and by an unrestricted educational grant for basic research in Molecular Oncology from Novartis Oncology Portugal. RR is the recipient of a PhD grant from Programa Operacional Potencial Humano/Fundo social Europeu (POPH/FSE, SFRH/BD/30021/2006) and of an International Cancer Technology Transfer Fellowship from the Union for International Cancer Control (UICC-ICRETT, ICR/10/079/2010). AVR was supported by funding from the Cancer Research Society to the Division of Cancer Epidemiology at McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; Aly M, 2011, EUR UROL, V60, P21, DOI 10.1016/j.eururo.2011.01.017; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Cavadas V, 2010, EUR UROL, V58, P551, DOI 10.1016/j.eururo.2010.06.023; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen WS, 2009, EUR J HUM GENET, V17, P1668, DOI 10.1038/ejhg.2009.86; Cronauer MV, 2003, EUR UROL, V43, P309, DOI 10.1016/S0302-2838(03)00005-8; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; da Silva BA, 1998, ENDOCRINOLOGY, V139, P3681, DOI 10.1210/en.139.9.3681; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Danforth KN, 2008, PROSTATE, V68, P400, DOI 10.1002/pros.20694; de Alencar SA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/715139; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dossus L, 2010, CARCINOGENESIS, V31, P455, DOI 10.1093/carcin/bgp307; Fall K, 2008, PROSTATE, V68, P1416, DOI 10.1002/pros.20797; Febbo PG, 2009, CANCER-AM CANCER SOC, V115, P3046, DOI 10.1002/cncr.24350; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Harnden P, 2007, LANCET ONCOL, V8, P411, DOI 10.1016/S1470-2045(07)70136-5; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Hsing AW, 2007, AM J CLIN NUTR, V86, p843S, DOI 10.1093/ajcn/86.3.843S; Hummelshoj T, 2006, MOL IMMUNOL, V43, P980, DOI 10.1016/j.molimm.2005.05.012; Jacobs EJ, 2008, CANCER EPIDEM BIOMAR, V17, P972, DOI 10.1158/1055-9965.EPI-07-2787; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kote-Jarai Z, 2003, BJU INT, V92, P109, DOI 10.1046/j.1464-410X.2003.04272.x; Li L, 2010, MOL BIOL REP, V37, P127, DOI 10.1007/s11033-009-9552-0; Lindstrom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017142; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Moore SC, 2009, INT J CANCER, V124, P869, DOI 10.1002/ijc.24043; Morote J, 2002, EUR UROL, V42, P333, DOI 10.1016/S0302-2838(02)00318-4; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Park J, 2011, ENDOCR REV; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Quinton ND, 2001, HUM GENET, V108, P233, DOI 10.1007/s004390100468; Ribeiro R, 2006, PROSTATE CANCER P D, V9, P19, DOI 10.1038/sj.pcan.4500844; Ribeiro R, 2004, PROSTATE, V59, P268, DOI 10.1002/pros.20004; Santer FR, 2010, ENDOCR-RELAT CANCER, V17, P241, DOI 10.1677/ERC-09-0200; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schulz S, 2005, INT J CARDIOL, V101, P265, DOI 10.1016/j.ijcard.2004.03.049; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Sun Q, 2010, HUM MOL GENET, V19, P1846, DOI 10.1093/hmg/ddq056; Sundstrom J, 2011, SCAND J PUBLIC HEALT, V39, P439, DOI 10.1177/1403494810396556; Tan DF, 2005, J UROLOGY, V174, P753, DOI 10.1097/01.ju.0000168723.42824.40; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Vickers AJ, 2011, ANN REV MED; von Hafe P, 2004, OBES RES, V12, P1930, DOI 10.1038/oby.2004.242; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834	54	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39236	10.1371/journal.pone.0039236	http://dx.doi.org/10.1371/journal.pone.0039236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22792137	gold, Green Published, Green Submitted			2022-12-25	WOS:000305892100035
J	Serrano, MA; Li, Z; Dangeti, M; Musich, PR; Patrick, S; Roginskaya, M; Cartwright, B; Zou, Y				Serrano, M. A.; Li, Z.; Dangeti, M.; Musich, P. R.; Patrick, S.; Roginskaya, M.; Cartwright, B.; Zou, Y.			DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair	ONCOGENE			English	Article						p53-RPA interaction; DNA-PK; ATM; ATR; homologous recombination repair; nonhomologous recombination end joining	REPLICATION-PROTEIN-A; DOUBLE-STRAND BREAKS; DAMAGE-INDUCED PHOSPHORYLATION; RPA PHOSPHORYLATION; INDUCED HYPERPHOSPHORYLATION; COMPLEX-FORMATION; P53; BINDING; RAD52; TRANSACTIVATION	Homologous recombination (HR) and nonhomologous end joining (NHEJ) are two distinct DNA double-stranded break (DSB) repair pathways. Here, we report that DNA-dependent protein kinase (DNA-PK), the core component of NHEJ, partnering with DNA-damage checkpoint kinases ataxia telangiectasia mutated (ATM) and ATM-and Rad3-related (ATR), regulates HR repair of DSBs. The regulation was accomplished through modulation of the p53 and replication protein A (RPA) interaction. We show that upon DNA damage, p53 and RPA were freed from a p53-RPA complex by simultaneous phosphorylations of RPA at the N-terminus of RPA32 subunit by DNA-PK and of p53 at Ser37 and Ser46 in a Chk1/Chk2-independent manner by ATR and ATM, respectively. Neither the phosphorylation of RPA nor of p53 alone could dissociate p53 and RPA. Furthermore, disruption of the release significantly compromised HR repair of DSBs. Our results reveal a mechanism for the crosstalk between HR repair and NHEJ through the co-regulation of p53-RPA interaction by DNA-PK, ATM and ATR.	[Serrano, M. A.; Li, Z.; Musich, P. R.; Roginskaya, M.; Cartwright, B.; Zou, Y.] E Tennessee State Univ, Dept Biochem & Mol Biol, James H Quillen Coll Med, Johnson City, TN 37614 USA; [Dangeti, M.; Patrick, S.] Univ Toledo, Med Ctr, Biochem & Canc Biol Dept, Toledo, OH 43606 USA	East Tennessee State University; University System of Ohio; University of Toledo	Zou, Y (corresponding author), E Tennessee State Univ, Dept Biochem & Mol Biol, James H Quillen Coll Med, Johnson City, TN 37614 USA.	zouy@etsu.edu	Roginskaya, Marina/ABD-3144-2021; Zou, Yue/ABA-8429-2020; Li, Zhengke/J-8527-2016	Li, Zhengke/0000-0001-5560-343X; Serrano, Moises/0000-0002-1037-9304; Musich, Phillip/0000-0001-8816-4242	National Institutes of Health [CA86927, GM083307, ES017214]; NATIONAL CANCER INSTITUTE [R56CA086927, R01CA086927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES017214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088249, R15GM083307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Dr Xiaohua Wu for providing U2OS cells expressing RPA32-WT and PD-RPA proteins. We also gratefully acknowledge Dr Carl W Anderson for providing the p53-expression constructs (pCAG3.1-WT, -S15A, -S20A, -S37A and -S46A) and Dr Karen Vousden for the pCB6 expression vectors p53-WT and p53-S15A. This work is supported by National Institutes of Health grants CA86927 and GM083307 (to YZ) as well as ES017214 (to MAS).	Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 2000, GENE DEV, V14, P278; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hass CS, 2010, MOL CANCER RES, V8, P1017, DOI 10.1158/1541-7786.MCR-10-0161; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kuhn C, 1999, ONCOGENE, V18, P769, DOI 10.1038/sj.onc.1202327; Leiter LM, 1996, ONCOGENE, V12, P2661; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Miller SD, 1997, MOL CELL BIOL, V17, P2194, DOI 10.1128/MCB.17.4.2194; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Patrick SM, 2005, BIOCHEMISTRY-US, V44, P8438, DOI 10.1021/bi048057b; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Robison JG, 2007, CELL CYCLE, V6, P2408, DOI 10.4161/cc.6.19.4773; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakasai R, 2010, DNA REPAIR, V9, P76, DOI 10.1016/j.dnarep.2009.10.008; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shell SM, 2009, MOL MECH ATAXIA TELA, P42; Shi W, 2010, CARCINOGENESIS, V31, P994, DOI 10.1093/carcin/bgq035; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sommers JA, 2005, CANCER RES, V65, P1223, DOI 10.1158/0008-5472.CAN-03-0231; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Sun JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013554; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; VIRSHUP DM, 1990, UCLA SYM BI, V127, P303; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wood JL, 2008, TRENDS CELL BIOL, V18, P451, DOI 10.1016/j.tcb.2008.07.006; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	63	67	72	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2013	32	19					2452	2462		10.1038/onc.2012.257	http://dx.doi.org/10.1038/onc.2012.257			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140ZL	22797063	Green Accepted			2022-12-25	WOS:000318694900009
J	Maheshwari, M; Samanta, A; Godavarthi, SK; Mukherjee, R; Jana, NR				Maheshwari, Megha; Samanta, Ananya; Godavarthi, Swetha K.; Mukherjee, Rajarshi; Jana, Nihar Ranjan			Dysfunction of the Ubiquitin Ligase Ube3a May Be Associated with Synaptic Pathophysiology in a Mouse Model of Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; ANGELMAN-SYNDROME; TRANSGENIC MICE; POLYGLUTAMINE PROTEIN; TRINUCLEOTIDE REPEAT; DECREASED EXPRESSION; PLASTICITY; GENE; DEGRADATION; PROMOTES	Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by progressive cognitive, psychiatric, and motor symptoms. The disease is caused by abnormal expansion of CAG repeats in the gene encoding huntingtin, but how mutant huntingtin leads to early cognitive deficits in HD is poorly understood. Here, we demonstrate that the ubiquitin ligase Ube3a, which is implicated in synaptic plasticity and involved in the clearance of misfolded polyglutamine protein, is strongly recruited to the mutant huntingtin nuclear aggregates, resulting in significant loss of its functional pool in different regions of HD mouse brain. Interestingly, Arc, one of the substrates of Ube3a linked with synaptic plasticity, is also associated with nuclear aggregates, although its synaptic level is increased in the hippocampus and cortex of HD mouse brain. Different regions of HD mouse brain also exhibit decreased levels of AMPA receptors and various pre- and postsynaptic proteins, which could be due to the partial loss of function of Ube3a. Transient expression of mutant huntingtin in mouse primary cortical neurons further demonstrates recruitment of Ube3a into mutant huntingtin aggregates, increased accumulation of Arc, and decreased numbers of GluR1 puncta in the neuronal processes. Altogether, our results suggest that the loss of function of Ube3a might be associated with the synaptic abnormalities observed in HD.	[Maheshwari, Megha; Samanta, Ananya; Godavarthi, Swetha K.; Mukherjee, Rajarshi; Jana, Nihar Ranjan] Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Gurgaon 122050, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Gurgaon 122050, Haryana, India.	nihar@nbrc.ac.in		Jana, Nihar/0000-0002-6549-4211; Godavarthi, Swetha/0000-0003-4665-4627	Department of Biotechnology [BT/HRD/34/18/2008]	Department of Biotechnology	This work was supported in part by a core grant from the Department of Biotechnology to the National Brain Research Centre, Government of India.; Recipient of National Bioscience Award for Career Development BT/HRD/34/18/2008 from the Department of Biotechnology. To whom correspondence should be addressed. Tel.: 91-124-284-5217; Fax: 91-124-233-8910; E-mail: nihar@nbrc.ac.in.	Andre VM, 2006, J NEUROPHYSIOL, V95, P2108, DOI 10.1152/jn.01118.2005; Browne SE, 1999, BRAIN PATHOL, V9, P147; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; FOROUD T, 1995, ANN NEUROL, V37, P657, DOI 10.1002/ana.410370516; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jana NR, 2003, J CHEM NEUROANAT, V26, P95, DOI 10.1016/S0891-0618(03)00029-2; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2003, NEUROBIOL DIS, V14, P624, DOI 10.1016/j.nbd.2003.08.024; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandal M, 2011, J BIOL CHEM, V286, P33719, DOI 10.1074/jbc.M111.236521; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Milnerwood AJ, 2006, HUM MOL GENET, V15, P1690, DOI 10.1093/hmg/ddl092; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mulherkar SA, 2010, NEUROBIOL DIS, V40, P586, DOI 10.1016/j.nbd.2010.08.002; Mulherkar SA, 2009, J NEUROCHEM, V110, P1955, DOI 10.1111/j.1471-4159.2009.06293.x; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Peavy GM, 2010, MOVEMENT DISORD, V25, P1163, DOI 10.1002/mds.22953; Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	47	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29949	29957		10.1074/jbc.M112.371724	http://dx.doi.org/10.1074/jbc.M112.371724			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787151	hybrid, Green Published			2022-12-25	WOS:000308286900068
J	Schelkle, B; Faria, PJ; Johnson, MB; van Oosterhout, C; Cable, J				Schelkle, Bettina; Faria, Patricia J.; Johnson, Mireille B.; van Oosterhout, Cock; Cable, Joanne			Mixed Infections and Hybridisation in Monogenean Parasites	PLOS ONE			English	Article							GYRODACTYLID INFECTIONS; POECILIA-RETICULATA; SEXUAL REPRODUCTION; HOST SWITCH; EVOLUTION; FISH; STRAINS; PLATYHELMINTHES; POPULATIONS; SPECIATION	Theory predicts that sexual reproduction promotes disease invasion by increasing the evolutionary potential of the parasite, whereas asexual reproduction tends to enhance establishment success and population growth rate. Gyrodactylid monogeneans are ubiquitous ectoparasites of teleost fish, and the evolutionary success of the specious Gyrodactylus genus is thought to be partly due to their use of various modes of reproduction. Gyrodactylus turnbulli is a natural parasite of the guppy (Poecilia reticulata), a small, tropical fish used as a model for behavioural, ecological and evolutionary studies. Using experimental infections and a recently developed microsatellite marker, we conclusively show that monogenean parasites reproduce sexually. Conservatively, we estimate that sexual recombination occurs and that between 3.7-10.9% of the parasites in our experimental crosses are hybrid genotypes with ancestors from different laboratory strains of G. turnbulli. We also provide evidence of hybrid vigour and/ or inter-strain competition, which appeared to lead to a higher maximum parasite load in mixed infections. Finally, we demonstrate inbreeding avoidance for the first time in platyhelminths which may influence the distribution of parasites within a host and their subsequent exposure to the host's localized immune response. Combined reproductive modes and inbreeding avoidance may explain the extreme evolutionary diversification success of parasites such as Gyrodactylus, where host-parasite coevolution is punctuated by relatively frequent host switching.	[Schelkle, Bettina; Faria, Patricia J.; Johnson, Mireille B.; Cable, Joanne] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Cardiff University; University of East Anglia	Schelkle, B (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	cablej@cardiff.ac.uk	Schelkle, Bettina/D-9835-2013; Cable, Joanne/A-4360-2010	Cable, Joanne/0000-0002-8510-7055; van Oosterhout, Cock/0000-0002-5653-738X	European Community [MTKD-CT-2005-030018]; Biotechnology and Biological Sciences Research Council [BB/D526137/1]	European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a European Community Framework Programme 6 Marie Curie Host Fellowship for Transfer of Knowledge (MTKD-CT-2005-030018) to JC and a Biotechnology and Biological Sciences Research Council (BB/D526137/1) studentship to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2004, MOL ECOL, V13, P997, DOI 10.1111/j.1365-294X.2004.02145.x; Badaraco JL, 2008, EXP PARASITOL, V119, P453, DOI 10.1016/j.exppara.2008.02.004; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bakke TA, 2002, INT J PARASITOL, V32, P281, DOI 10.1016/S0020-7519(01)00331-9; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Beukeboom LW, 2007, HEREDITY, V98, P123, DOI 10.1038/sj.hdy.6800926; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; BREMOND P, 1989, PARASITOL RES, V76, P138, DOI 10.1007/BF00930836; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Bukowski TC, 2002, CAN J ZOOL, V80, P193, DOI 10.1139/Z01-220; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2002, INT J PARASITOL, V32, P255, DOI 10.1016/S0020-7519(01)00330-7; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; COHEN J, 1977, REPRODUCTION; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Davies CM, 2002, PARASITOLOGY, V124, P31, DOI 10.1017/S0031182001008873; Detwiler JT, 2010, GENES-BASEL, V1, P102, DOI 10.3390/genes1010102; Faria PJ, 2011, CONSERV GENET RESOUR, V3, P177, DOI 10.1007/s12686-010-9317-z; FRANDSEN F, 1978, J HELMINTHOL, V52, P11, DOI 10.1017/S0022149X0000506X; HARRIS PD, 1989, PARASITOLOGY, V98, P245, DOI 10.1017/S0031182000062156; Harris PD, 2004, SYST PARASITOL, V59, P1, DOI 10.1023/B:SYPA.0000038447.52015.e4; Harris PD, 1998, INT J PARASITOL, V28, P1595, DOI 10.1016/S0020-7519(98)00086-1; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Hedrick PW, 2002, EVOLUTION, V56, P654; Karvonen A, 2007, PARASITOLOGY, V134, P1237, DOI 10.1017/S0031182007002636; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; Kirkman T. W., 1996, STAT USE; Kirkpatrick M, 2000, AM NAT, V155, P154, DOI 10.1086/303312; Kuusela J, 2007, MOL ECOL, V16, P5234, DOI 10.1111/j.1365-294X.2007.03562.x; Laird AR, 2003, J CLIN MICROBIOL, V41, P4400, DOI 10.1128/JCM.41.9.4400-4403.2003; Lawrence E., 2005, HENDERSONS DICT BIOL; MacCarthy T, 2007, P NATL ACAD SCI USA, V104, P12801, DOI 10.1073/pnas.0705455104; MACDONALD S, 1975, Z PARASITENKD, V45, P323, DOI 10.1007/BF00329822; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; MUTANI A, 1985, ACTA TROP, V42, P319; NEI M, 1968, P NATL ACAD SCI USA, V60, P517, DOI 10.1073/pnas.60.2.517; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; OHTA T, 1974, GENET RES, V23, P191, DOI 10.1017/S0016672300014816; Peck JR, 2000, J EVOLUTION BIOL, V13, P63, DOI 10.1046/j.1420-9101.2000.00142.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; ROLLINSON D, 1990, ACTA TROP, V47, P101, DOI 10.1016/0001-706X(90)90072-8; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schelkle B, 2009, DIS AQUAT ORGAN, V86, P65, DOI 10.3354/dao02087; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; SCOTT ME, 1982, PARASITOLOGY, V85, P217, DOI 10.1017/S0031182000055207; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seridi N, 2008, MICROBES INFECT, V10, P1309, DOI 10.1016/j.micinf.2008.07.031; Smoot LM, 2002, INFECT IMMUN, V70, P2694, DOI 10.1128/IAI.70.5.2694-2699.2002; Steinauer ML, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000222; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Trouve S, 1998, PARASITOLOGY, V117, P133, DOI 10.1017/S0031182098002947; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; van Oosterhout C, 2007, INT J PARASITOL, V37, P805, DOI 10.1016/j.ijpara.2006.12.016; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Webster RG, 2001, SCIENCE, V293, P1773; Zietara MS, 2006, HEREDITAS, V143, P84; Zietara MS, 2002, EVOLUTION, V56, P2445, DOI 10.1111/j.0014-3820.2002.tb00170.x	65	28	28	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39506	10.1371/journal.pone.0039506	http://dx.doi.org/10.1371/journal.pone.0039506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808040	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000306362400012
J	Drayton, JM; Hall, MD; Hunt, J; Jennions, MD				Drayton, Jean M.; Hall, Matthew D.; Hunt, John; Jennions, Michael D.			Sexual Signaling and Immune Function in the Black Field Cricket Teleogryllus commodus	PLOS ONE			English	Article							COURTSHIP SONG; TRADE-OFFS; IMMUNOCOMPETENCE HANDICAP; GRYLLODES-SIGILLATUS; GRYLLUS-BIMACULATUS; REPRODUCTIVE EFFORT; NATURAL-POPULATION; MALE ADVERTISEMENT; GENETIC VARIANCE; WILD POPULATION	The immunocompetence handicap hypothesis predicts that male sexual trait expression should be positively correlated with immunocompetence. Here we investigate if immune function in the cricket, Teleogryllus commodus, is related to specific individual components of male sexual signals, as well as to certain multivariate combinations of these components that females most strongly prefer. Male T. commodus produce both advertisement and courtship calls prior to mating. We measured fine-scale structural parameters of both call types and also recorded nightly advertisement calling effort. We then measured two standard indices of immune function: lysozyme-like activity of the haemolymph and haemocyte counts. We found a weak, positive relationship between advertisement calling effort and lysozyme-like activity. There was, however, little evidence that individual structural call components or the net multivariate attractiveness of either call type signalled immune function. The relationships between immunity and sexual signaling did not differ between inbred and outbred males. Our data suggest that it is unlikely that females assess overall male immune function using male calls.	[Drayton, Jean M.; Jennions, Michael D.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Hall, Matthew D.] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Hunt, John] Univ Exeter Cornwall, Ctr Ecol & Conservat, Coll Life & Environm Sci, Penryn, England	Australian National University; University of Basel; University of Exeter	Drayton, JM (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	Jean.Drayton@anu.edu.au	Jennions, Michael D/C-7560-2009; Hall, Matthew D/A-2006-2009; Hunt, John/F-1279-2014	Jennions, Michael D/0000-0001-9221-2788; Hall, Matthew D/0000-0002-4738-203X; Hunt, John/0000-0002-4962-8750	Australian Research Council [DP0555943]; Natural Environment Research Council; Royal Society; Australian Postgraduate Award; Natural Environment Research Council [NE/G016399/1] Funding Source: researchfish; NERC [NE/G016399/1] Funding Source: UKRI	Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Australian Postgraduate Award(Australian Government); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Australian Research Council (DP0555943 to M.D.J.). J.H. was funded by the Natural Environment Research Council and a Royal Society Fellowship. J.M.D. was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; Ahtiainen JJ, 2005, J EVOLUTION BIOL, V18, P985, DOI 10.1111/j.1420-9101.2005.00907.x; Ahtiainen JJ, 2004, BEHAV ECOL, V15, P602, DOI 10.1093/beheco/arh062; BENTLEY DR, 1972, ANIM BEHAV, V20, P478, DOI 10.1016/S0003-3472(72)80012-5; Bentsen CL, 2006, AM NAT, V167, pE102, DOI 10.1086/501376; Blows MW, 2007, J EVOLUTION BIOL, V20, P1, DOI 10.1111/j.1420-9101.2006.01164.x; Boonekamp JJ, 2008, BIOL LETTERS, V4, P741, DOI 10.1098/rsbl.2008.0347; Brooks R, 2005, EVOLUTION, V59, P871, DOI 10.1111/j.0014-3820.2005.tb01760.x; Bussiere LF, 2006, EVOLUTION, V60, P792, DOI 10.1554/05-378.1; Chenoweth SF, 2005, AM NAT, V165, P281, DOI 10.1086/427271; Contreras-Garduno J, 2006, J ETHOL, V24, P165, DOI 10.1007/s10164-005-0177-z; Drayton JM, 2007, J EVOLUTION BIOL, V20, P1138, DOI 10.1111/j.1420-9101.2006.01286.x; Drayton JM, 2011, J EVOLUTION BIOL, V24, P47, DOI 10.1111/j.1420-9101.2010.02135.x; Drayton JM, 2011, BEHAV ECOL, V22, P486, DOI 10.1093/beheco/arr005; Drayton JM, 2010, EVOLUTION, V64, P3069, DOI 10.1111/j.1558-5646.2010.01053.x; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Freitak D, 2003, P ROY SOC B-BIOL SCI, V270, pS220, DOI 10.1098/rsbl.2003.0069; Gershman SN, 2010, J EVOLUTION BIOL, V23, P829, DOI 10.1111/j.1420-9101.2010.01951.x; Getty T, 2006, TRENDS ECOL EVOL, V21, P83, DOI 10.1016/j.tree.2005.10.016; Gonzalez-Santoyo I, 2010, BEHAVIOUR, V147, P1285, DOI 10.1163/000579510X516777; Gonzalez-Tokman DM, 2010, J ETHOL, V28, P29, DOI 10.1007/s10164-009-0151-2; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hall MD, 2008, EVOLUTION, V62, P2305, DOI 10.1111/j.1558-5646.2008.00436.x; Hall MD, 2010, MOL ECOL, V19, P610, DOI 10.1111/j.1365-294X.2009.04496.x; HILL K G, 1972, Australian Journal of Zoology, V20, P153, DOI 10.1071/ZO9720153; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; KAVANAGH MW, 1987, J EXP BIOL, V130, P107; Kelly NB, 2009, P ROY SOC B-BIOL SCI, V276, P3175, DOI 10.1098/rspb.2009.0599; Kerr AM, 2010, BEHAV ECOL, V21, P647, DOI 10.1093/beheco/arq035; Ketola T, 2009, EVOL ECOL RES, V11, P1131; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Kurtz J, 1999, P ROY SOC B-BIOL SCI, V266, P2515, DOI 10.1098/rspb.1999.0954; Kurtz J, 2000, DEV COMP IMMUNOL, V24, P1, DOI 10.1016/S0145-305X(99)00057-9; Kurtz J, 2007, ZOOLOGY, V110, P336, DOI 10.1016/j.zool.2007.07.001; Lawniczak MKN, 2007, TRENDS ECOL EVOL, V22, P48, DOI 10.1016/j.tree.2006.09.012; Luong LT, 2007, EVOLUTION, V61, P1391, DOI 10.1111/j.1558-5646.2007.00116.x; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Moreno-Garcia M, 2010, J MED ENTOMOL, V47, P111, DOI 10.1603/ME08267; Murai M, 2009, EVOLUTION, V63, P2363, DOI 10.1111/j.1558-5646.2009.00726.x; Pomfret JC, 2006, BEHAV ECOL, V17, P466, DOI 10.1093/beheco/arj050; PRESTWICH KN, 1981, J COMP PHYSIOL, V143, P199; Rantala MJ, 2003, BIOL J LINN SOC, V79, P503, DOI 10.1046/j.1095-8312.2003.00202.x; Rantala MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2453, DOI 10.1098/rspb.2000.1305; Rantala MJ, 2005, FUNCT ECOL, V19, P323, DOI 10.1111/j.1365-2435.2005.00979.x; Rantala MJ, 2002, P ROY SOC B-BIOL SCI, V269, P1681, DOI 10.1098/rspb.2002.2056; Rantala MJ, 2003, FUNCT ECOL, V17, P534, DOI 10.1046/j.1365-2435.2003.00764.x; Rantala MJ, 2004, BEHAV ECOL, V15, P187, DOI 10.1093/beheco/arg103; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Ryder JJ, 2000, P ROY SOC B-BIOL SCI, V267, P1171, DOI 10.1098/rspb.2000.1125; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Simmons LW, 2010, BEHAV ECOL, V21, P1330, DOI 10.1093/beheco/arq154; Simmons LW, 2005, ANIM BEHAV, V69, P1235, DOI 10.1016/j.anbehav.2004.09.011; Simmons LW, 2005, SCIENCE, V309, P2031, DOI 10.1126/science.1114500; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Tomkins JL, 2010, SCIENCE, V328, P892, DOI 10.1126/science.1188013; Tregenza T, 2006, ANIM BEHAV, V72, P809, DOI 10.1016/j.anbehav.2006.01.019; Westneat DF, 1998, P ROY SOC B-BIOL SCI, V265, P1065, DOI 10.1098/rspb.1998.0400; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zajitschek F, 2009, FUNCT ECOL, V23, P602, DOI 10.1111/j.1365-2435.2008.01520.x	70	6	6	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39631	10.1371/journal.pone.0039631	http://dx.doi.org/10.1371/journal.pone.0039631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808047	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700015
J	Khalife, N; Glover, V; Hartikainen, AL; Taanila, A; Ebeling, H; Jarvelin, MR; Rodriguez, A				Khalife, Natasha; Glover, Vivette; Hartikainen, Anna-Liisa; Taanila, Anja; Ebeling, Hanna; Jarvelin, Marjo-Riitta; Rodriguez, Alina			Placental Size Is Associated with Mental Health in Children and Adolescents	PLOS ONE			English	Article							HYPERACTIVITY SYMPTOMS; MIXED-HANDEDNESS; BIRTH-WEIGHT; PREGNANCY; DISEASE; STRESS; GROWTH; ORIGINS; NEURODEVELOPMENT; INATTENTION	Background: The role of the placenta in fetal programming has been recognized as a highly significant, yet often neglected area of study. We investigated placental size in relation to psychopathology, in particular attention deficit hyperactivity disorder (ADHD) symptoms, in children at 8 years of age, and later as adolescents at 16 years. Methodology/Principal Findings: Prospective data were obtained from The Northern Finland Birth Cohort (NFBC) 1986. Placental weight, surface area and birth weight were measured according to standard procedures, within 30 minutes after birth. ADHD symptoms, probable psychiatric disturbance, antisocial disorder and neurotic disorder were assessed at 8 years (n = 8101), and ADHD symptoms were assessed again at 16 years (n = 6607), by teachers and parents respectively. We used logistic regression analyses to investigate the association between placental size and mental health outcomes, and controlled for gestational age, birth weight, socio-demographic factors and medical factors, during gestation. There were significant positive associations between placental size (weight, surface area and placental-to-birth-weight ratio) and mental health problems in boys at 8 and 16 years of age. Increased placental weight was linked with overall probable psychiatric disturbance (at 8y, OR = 1.14 [95% CI = 1.04-1.25]), antisocial behavior (at 8 y, OR = 1.14 [95% CI = 1.03-1.27]) and ADHD symptoms (inattention-hyperactivity at 16y, OR = 1.19 [95% CI = 1.02-1.38]). No significant associations were detected among girls. Conclusions/Significance: Compensatory placental growth may occur in response to prenatal insults. Such overgrowth may affect fetal development, including brain development, and ultimately contribute to psychopathology.	[Khalife, Natasha; Jarvelin, Marjo-Riitta; Rodriguez, Alina] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Glover, Vivette] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Oulu, Finland; [Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Taanila, Anja] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Ebeling, Hanna] Oulu Univ Hosp, Clin Child Psychiat, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Med Res Council, Hlth Protect Agcy, Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Rodriguez, Alina] Mid Sweden Univ, Dept Social Sci Psychol, Ostersund, Sweden; [Rodriguez, Alina] Kings Coll London, Med Res Council, Social Genet Dev Psychiat Ctr, London WC2R 2LS, England	Imperial College London; Imperial College London; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Health Protection Agency; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Finland National Institute for Health & Welfare; University of Oulu; Mid-Sweden University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London	Khalife, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England.	a.rodriguez@imperial.ac.uk	Rodriguez, Alina/B-3541-2015; Glover, Vivette/M-2711-2016	Rodriguez, Alina/0000-0003-1209-8802; Glover, Vivette/0000-0001-6543-1651; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Academy of Finland [103451]; Sigrid Juselius Foundation, Finland; Thule Institute; University of Oulu, Finland; National Institute of Mental Health [MH63706]; EURO-BLCS; VINNMER [P32925-1]; Medical Research Council [G0801056B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation, Finland(Sigrid Juselius Foundation); Thule Institute; University of Oulu, Finland; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EURO-BLCS; VINNMER; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Academy of Finland (103451); Sigrid Juselius Foundation, Finland; Thule Institute; University of Oulu, Finland; the National Institute of Mental Health (MH63706); and EURO-BLCS. Dr Rodriguez received support from VINNMER (P32925-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Baptiste-Roberts Kesha, 2008, BMC Pregnancy Childbirth, V8, P44, DOI 10.1186/1471-2393-8-44; Barker DJP, 2010, J DEV ORIG HLTH DIS, V1, P360, DOI 10.1017/S2040174410000280; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; Clifton VL, 2005, CELL TISSUE RES, V322, P63, DOI 10.1007/s00441-005-1117-5; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; Glover V, 2004, EARLY HUM DEV, V79, P107, DOI 10.1016/j.earlhumdev.2004.04.012; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey K M, 2001, Public Health Nutr, V4, P611; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017071; KRUGER H, 1970, AM J OBSTET GYNECOL, V106, P586; Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42; L'Abee C, 2011, J PERINAT MED, V39, P27, DOI 10.1515/jpm.2010.119; Lahti J, 2009, BRIT J PSYCHIAT, V195, P132, DOI 10.1192/bjp.bp.108.054387; Lewis R, 2006, REV GYNECOL PERINAT, V6, P70, DOI DOI 10.1016/J.RIGAPP.2005.12.001; Lumey LH, 1998, PLACENTA, V19, P105; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Obel C, 2003, DEV MED CHILD NEUROL, V45, P557; Pedersen JF, 1981, OBSTET GYNECOLOGICAL, V36, P305; Raatikainen K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-268; Rees S, 2004, NEUROSCI LETT, V361, P111, DOI 10.1016/j.neulet.2004.02.002; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Rodriguez A, 2009, J CHILD PSYCHOL PSYC, V50, P1073, DOI 10.1111/j.1469-7610.2009.02071.x; Rodriguez A, 2008, J CHILD PSYCHOL PSYC, V49, P967, DOI 10.1111/j.1469-7610.2008.01923.x; Rodriguez A, 2010, PEDIATRICS, V125, pE340, DOI 10.1542/peds.2009-1165; Rodriguez A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-327; Roseboom TJ, 2011, PLACENTA, V32, P395, DOI 10.1016/j.placenta.2011.03.001; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Smalley SL, 2007, J AM ACAD CHILD PSY, V46, P1575, DOI 10.1097/chi.0b013e3181573137; Swanson J, 2005, CATEGORICAL DIMENSIO; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tegethoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014478; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	48	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40534	10.1371/journal.pone.0040534	http://dx.doi.org/10.1371/journal.pone.0040534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792364	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000306354700058
J	Amigo, I; Traba, J; Satrustegui, J; del Arco, A				Amigo, Ignacio; Traba, Javier; Satrustegui, Jorgina; del Arco, Araceli			SCaMC-1Like a Member of the Mitochondrial Carrier (MC) Family Preferentially Expressed in Testis and Localized in Mitochondria and Chromatoid Body	PLOS ONE			English	Article							MALE GERM-CELLS; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; NUAGE FORMATION; CALCIUM; PROTEIN; ATP; SPERMATOGENESIS; IDENTIFICATION; BODIES	Mitochondrial carriers (MC) form a highly conserved family involved in solute transport across the inner mitochondrial membrane in eukaryotes. In mammals, ATP-Mg/Pi carriers, SCaMCs, form the most complex subgroup with four paralogs, SCaMC-1, - 2, - 3 and - 3L, and several splicing variants. Here, we report the tissue distribution and subcellular localization of a mammalian-specific SCaMC paralog, 4930443G12Rik/SCaMC-1Like (SCaMC-1L), which displays unanticipated new features. SCaMC-1L proteins show higher amino acid substitution rates than its closest paralog SCaMC-1. In mouse, SCaMC-1L expression is restricted to male germ cells and regulated during spermatogenesis but unexpectedly its localization is not limited to mitochondrial structures. In mature spermatids SCaMC-1L is detected in the mitochondrial sheath but in previous differentiation stages appears associated to cytosolic granules which colocalize with specific markers of the chromatoid body (CB) in post-meiotic round spermatids and inter-mitochondrial cement (IMC) in spermatocytes. The origin of this atypical distribution was further investigated by transient expression in cell lines. Similarly to male germ cells, in addition to mitochondrial and cytosolic distribution, a fraction of SCaMC-1L-expressing COS-7 cells display cytosolic SCaMC-1L-aggregates which exhibit aggresomal-like features as the CB. Our results indicate that different regions of SCaMC-1L hinder its import into mitochondria and this apparently favours the formation of cytosolic aggregates in COS-7 cells. This mechanism could be also operational in male germ cells and explain the incorporation of SCaMC-1L into germinal granules.	[Amigo, Ignacio; Traba, Javier; Satrustegui, Jorgina] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain; [Amigo, Ignacio; Traba, Javier; Satrustegui, Jorgina] Univ Autonoma Madrid, CIBER Enfermedades Raras CIBERER, Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, CRIB, Fac Ciencias Ambientales & Bioquim, Area Bioquim, Toledo, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de Castilla-La Mancha	Amigo, I (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain.	Araceli.Arco@uclm.es	Traba, Javier/AAA-9287-2020; Satrustegui, Jorgina/R-6732-2019; del Arco, Araceli/R-5653-2019	Traba, Javier/0000-0002-7855-3540; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667; del Arco, Araceli/0000-0002-6839-542X; Amigo, Ignacio/0000-0003-0527-5954	Instituto de Salud Carlos III (ISCIII) [PI080610]; Ministerio de Educacion y Ciencia [BFU2008-04084/BMC]; institutional grant from the Fundacion Ramon Areces; Ministerio de Educacion y Ciencia (MEC); Comunidad de Madrid	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion y Ciencia(Spanish Government); institutional grant from the Fundacion Ramon Areces; Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) PI080610 (to AdA), Ministerio de Educacion y Ciencia, BFU2008-04084/BMC (to JS) and by an institutional grant from the Fundacion Ramon Areces to the CBMSO CSIC-UAM. The CIBER de Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank I. Manso for help with animal handling. The expert technical advice of the Optical and Confocal Microscopy Unit of the Centro de Biologia Molecular is also acknowledged. I. Amigo is a recipient of a FPI predoctoral fellowship from Ministerio de Educacion y Ciencia (MEC), J. Traba is a recipient of a fellowship from the Comunidad de Madrid.	Aihara T, 2009, BIOL REPROD, V80, P762, DOI 10.1095/biolreprod.108.074013; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Bonilla E, 2008, MOL HUM REPROD, V14, P137, DOI 10.1093/molehr/gan002; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7185.2004; Cavero S, 2005, BIOCHEM J, V392, P537, DOI 10.1042/BJ20050806; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; del Arco A, 2005, BIOCHEM J, V389, P647, DOI 10.1042/BJ20050283; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; del Arco A, 2000, BIOCHEM J, V345, P725, DOI 10.1042/0264-6021:3450725; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Esaki M, 2003, NAT STRUCT BIOL, V10, P988, DOI 10.1038/nsb1008; Fawcett D. W, 1970, Biology Reprod., V2, P129, DOI 10.1095/biolreprod2.1.129; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Force A, 1999, GENETICS, V151, P1531; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Haraguchi CM, 2005, J HISTOCHEM CYTOCHEM, V53, P455, DOI 10.1369/jhc.4A6520.2005; Haraguchi CM, 2003, BIOL REPROD, V69, P885, DOI 10.1095/biolreprod.102.013524; HESS RA, 1993, BIOL REPROD, V48, P1299, DOI 10.1095/biolreprod48.6.1299; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Hughes J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-306; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lynch M, 2000, GENETICS, V154, P459; Mazurek MP, 2010, EMBO REP, V11, P431, DOI 10.1038/embor.2010.51; Mosevitsky MI, 2012, ACTA HISTOCHEM, V114, P237, DOI 10.1016/j.acthis.2011.06.009; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Pan JY, 2005, DEVELOPMENT, V132, P4029, DOI 10.1242/dev.02003; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Roesch K, 2004, HUM MOL GENET, V13, P2101, DOI 10.1093/hmg/ddh217; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Seitz J, 1995, INT J ANDROL, V18, P7; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; SODERSTROM KO, 1976, MOL CELL ENDOCRINOL, V5, P181, DOI 10.1016/0303-7207(76)90082-4; Sun Q, 2009, J CELL SCI, V122, P1563, DOI 10.1242/jcs.047738; Szklarczyk R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r135; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; Traba J, 2011, CELL MOL LIFE SCI, V68, P1183, DOI 10.1007/s00018-010-0612-3; Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokota S, 2008, ACTA HISTOCHEM CYTOC, V41, P65, DOI 10.1267/ahc.08010	70	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40470	10.1371/journal.pone.0040470	http://dx.doi.org/10.1371/journal.pone.0040470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792342	Green Published, gold, Green Accepted			2022-12-25	WOS:000306461800092
J	Hasan, S; Danishuddin, M; Adil, M; Singh, K; Verma, PK; Khan, AU				Hasan, Sadaf; Danishuddin, Mohd; Adil, Mohd; Singh, Kunal; Verma, Praveen K.; Khan, Asad U.			Efficacy of E. officinalis on the Cariogenic Properties of Streptococcus mutans: A Novel and Alternative Approach to Suppress Quorum-Sensing Mechanism	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; BIOFILM FORMATION; ACID PRODUCTION; ADHERENCE; CARIES; HYDROPHOBICITY; IDENTIFICATION; INHIBITION; PROTEINS; EXTRACTS	The present study was focused on evaluating the potential of Emblica officinalis against cariogenic properties of Streptococcus mutans, a causative microorganism for caries. The effect of crude extract and ethanolic fraction from Emblica officinalis fruit was analysed against S. mutans. The sub-MIC concentrations of crude and ethanolic fraction of E. officinalis were evaluated for its cariogenic properties such as acid production, biofilm formation, cell-surface hydrophobicity, glucan production, sucrose-dependent and independent adherence. Its effect on biofilm architecture was also investigated with the help of confocal and scanning electron microscopy (SEM). Moreover, expression of genes involved in biofilm formation was also studied by quantitative RT-PCR. This study showed 50% reduction in adherence at concentrations 156 mu g/and 312.5 mu g/ml of crude extract and ethanolic fraction respectively. However, the biofilm was reduced to 50% in the presence of crude extract (39.04 mu g/ml) and ethanolic fraction (78.08 mu g/ml). Furthermore, effective reduction was observed in the glucan synthesis and cell surface hydrophobicity. The qRT-PCR revealed significant suppression of the genes involved in its virulence. Confocal and scanning electron microscopy clearly depicted the obliteration of biofilm structure with reference to control. Hence, this study reveals the potential of E. officinalis fruit extracts as an alternative and complementary medicine for dental caries by inhibiting the virulence factors of Streptococcus mutans.	[Hasan, Sadaf; Danishuddin, Mohd; Adil, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India; [Singh, Kunal; Verma, Praveen K.] Natl Inst Plant Genome Res, New Delhi, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Hasan, S (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Singh, Kunal/AAS-1975-2021; Khan, Asad U/K-8157-2013; hasan, sadaf/J-4050-2019	Singh, Kunal/0000-0001-9375-1070; Khan, Asad U/0000-0001-9191-9423; 	(Interdisciplinary Biotechnology Unit) IBU; Aligarh Muslim University (AMU); Indian Council of Medical Research (ICMR) [531 59/6/2009/BMS/TRM]	(Interdisciplinary Biotechnology Unit) IBU; Aligarh Muslim University (AMU); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This study was supported by internal funds of (Interdisciplinary Biotechnology Unit) IBU, Aligarh Muslim University (AMU) and Indian Council of Medical Research (ICMR) grant no. 531 59/6/2009/BMS/TRM to AUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	CIARDI JE, 1981, J DENT RES, V60, P756, DOI 10.1177/00220345810600031701; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; HAMADA S, 1978, INFECT IMMUN, V20, P592, DOI 10.1128/IAI.20.3.592-599.1978; HARDIE JM, 1992, BRIT DENT J, V172, P271, DOI 10.1038/sj.bdj.4807849; Hazra B, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-20; IIO M, 1984, AGR BIOL CHEM TOKYO, V48, P2143, DOI 10.1080/00021369.1984.10866463; Islam B, 2009, J APPL MICROBIOL, V106, P1682, DOI 10.1111/j.1365-2672.2008.04135.x; Islam B, 2008, J ANTIMICROB CHEMOTH, V62, P751, DOI 10.1093/jac/dkn253; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Khan R, 2010, J APPL MICROBIOL, V109, P2151, DOI 10.1111/j.1365-2672.2010.04847.x; Khan R, 2009, MOLECULES, V14, P586, DOI 10.3390/molecules14020586; Koo H, 2000, ARCH ORAL BIOL, V45, P141, DOI 10.1016/S0003-9969(99)00117-X; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; MARTIN MA, 1989, AM J INFECT CONTROL, V17, P130, DOI 10.1016/0196-6553(89)90199-5; Matsumoto M, 1999, CARIES RES, V33, P441, DOI 10.1159/000016549; MCBRIDE BC, 1984, INFECT IMMUN, V44, P68, DOI 10.1128/IAI.44.1.68-75.1984; Miller-Torbert TA, 2008, MICROB PATHOGENESIS, V45, P53, DOI 10.1016/j.micpath.2008.02.001; Nascimento MM, 2004, J BACTERIOL, V186, P6383, DOI 10.1128/JB.186.19.6383-6390.2004; Nostro A, 2004, LETT APPL MICROBIOL, V38, P423, DOI 10.1111/j.1472-765X.2004.01509.x; Pecharki D, 2005, ORAL MICROBIOL IMMUN, V20, P366, DOI 10.1111/j.1399-302X.2005.00244.x; Perianayagam JB, 2004, J ETHNOPHARMACOL, V95, P83, DOI 10.1016/j.jep.2004.06.020; Prabu GR, 2006, J APPL MICROBIOL, V101, P487, DOI 10.1111/j.1365-2672.2006.02912.x; Razak Fathilah Abdul, 2003, J Oral Sci, V45, P201; Ribeiro DA, 2004, J PERIODONTAL RES, V39, P358, DOI 10.1111/j.1600-0765.2004.00759.x; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; ULLMAN RF, 1988, HEART LUNG, V17, P209; VANDERHOEVEN JS, 1984, INFECT IMMUN, V45, P356, DOI 10.1128/IAI.45.2.356-359.1984; Wakabayashi H, 2010, BIOMETALS, V23, P419, DOI 10.1007/s10534-010-9304-6; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993	36	51	55	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40319	10.1371/journal.pone.0040319	http://dx.doi.org/10.1371/journal.pone.0040319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792279	Green Published, gold, Green Submitted			2022-12-25	WOS:000306436300054
J	Uto-Konomi, A; Miyauchi, K; Ozaki, N; Motomura, Y; Suzuki, Y; Yoshimura, A; Suzuki, S; Cua, D; Kubo, M				Uto-Konomi, Ayako; Miyauchi, Kosuke; Ozaki, Naoko; Motomura, Yasutaka; Suzuki, Yoshie; Yoshimura, Akihiko; Suzuki, Shinobu; Cua, Daniel; Kubo, Masato			Dysregulation of Suppressor of Cytokine Signaling 3 in Keratinocytes Causes Skin Inflammation Mediated by Interleukin-20 Receptor-Related Cytokines	PLOS ONE			English	Article							NF-KAPPA-B; PERMEABILITY BARRIER; PSORIASIS; STAT3; SOCS3; MICE; HOMEOSTASIS; ROLES; IL-20; GENE	Homeostatic regulation of epidermal keratinocytes is controlled by the local cytokine milieu. However, a role for suppressor of cytokine signaling (SOCS), a negative feedback regulator of cytokine networks, in skin homeostasis remains unclear. Keratinocyte specific deletion of Socs3 (Socs3 cKO) caused severe skin inflammation with hyper-production of IgE, epidermal hyperplasia, and S100A8/9 expression, although Socs1 deletion caused no inflammation. The inflamed skin showed constitutive STAT3 activation and up-regulation of IL-6 and IL-20 receptor (IL-20R) related cytokines, IL-19, IL-20 and IL-24. Disease development was rescued by deletion of the Il6 gene, but not by the deletion of Il23, Il4r, or Rag1 genes. The expression of IL-6 in Socs3 cKO keratinocytes increased expression of IL-20R-related cytokines that further facilitated STAT3 hyperactivation, epidermal hyperplasia and neutrophilia. These results demonstrate that skin homeostasis is strictly regulated by the IL-6-STAT3-SOCS3 axis. Moreover, the SOCS3-mediated negative feedback loop in keratinocytes has a critical mechanistic role in the prevention of skin inflammation caused by hyperactivation of STAT3.	[Uto-Konomi, Ayako; Miyauchi, Kosuke; Motomura, Yasutaka; Suzuki, Yoshie; Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan; [Uto-Konomi, Ayako; Ozaki, Naoko; Suzuki, Shinobu] Nippon Boehringer Ingelheim Co Ltd, Kobe Pharma Res Inst, Dept Mol & Cellular Biol, Kobe, Hyogo, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Cua, Daniel] Schering Plough Biopharma, Palo Alto, CA USA; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Noda, Chiba 278, Japan	RIKEN; Boehringer Ingelheim; Keio University; Merck & Company; Tokyo University of Science	Uto-Konomi, A (corresponding author), RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan.	raysolfc@rcai.riken.jp	Yoshimura, Akihiko/K-5515-2013; Kubo, Masato/A-5918-2016		Ministry of Education, Culture, Sports, Science, and Technology (Japan); National Institute of Biomedical Innovation (NIBIO)	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This work was supported by a grant from Grant in Aid for Scientific Research (B) and Grant in Aid for Scientific Research on Priority Areas of the Ministry of Education, Culture, Sports, Science, and Technology (Japan) and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boniface K, 2005, EUR CYTOKINE NETW, V16, P309; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Hara K, 2008, INT J PHARM, V356, P267, DOI 10.1016/j.ijpharm.2007.12.041; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kingo K, 2004, GENES IMMUN, V5, P117, DOI 10.1038/sj.gene.6364046; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Leng RX, EXPERT OPIN THER TAR, V15, P119; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Mohrs M, 1999, J IMMUNOL, V162, P7302; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Park YM, 1999, J DERMATOL SCI, V22, P17, DOI 10.1016/S0923-1811(99)00038-9; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Stenderup K, 2007, ANN NY ACAD SCI, V1110, P368, DOI 10.1196/annals.1423.039; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Wang XP, 2004, J INVEST DERMATOL, V123, P124, DOI 10.1111/j.0022-202X.2004.22736.x; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhu BM, 2008, J INVEST DERMATOL, V128, P1821, DOI 10.1038/sj.jid.5701224	37	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40343	10.1371/journal.pone.0040343	http://dx.doi.org/10.1371/journal.pone.0040343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792286	Green Submitted, gold, Green Published			2022-12-25	WOS:000306436300057
J	Vullo, R; Marugan-Lobon, J; Kellner, AWA; Buscalioni, AD; Gomez, B; de la Fuente, M; Moratalla, JJ				Vullo, Romain; Marugan-Lobon, Jesus; Kellner, Alexander W. A.; Buscalioni, Angela D.; Gomez, Bernard; de la Fuente, Montserrat; Moratalla, Jose J.			A New Crested Pterosaur from the Early Cretaceous of Spain: The First European Tapejarid (Pterodactyloidea: Azhdarchoidea)	PLOS ONE			English	Article							LAS HOYAS; HUAXIAPTERUS PTEROSAURIA; DIVERSITY PATTERNS; EARLY ANGIOSPERMS; SAMPLING BIASES; IBERIAN RANGES; CHINA; EVOLUTION; PALEOECOLOGY; LAGERSTATTE	Background: The Tapejaridae is a group of unusual toothless pterosaurs characterized by bizarre cranial crests. From a paleoecological point of view, frugivorous feeding habits have often been suggested for one of its included clades, the Tapejarinae. So far, the presence of these intriguing flying reptiles has been unambiguously documented from Early Cretaceous sites in China and Brazil, where pterosaur fossils are less rare and fragmentary than in similarly-aged European strata. Methodology/Principal Findings: Europejara olcadesorum gen. et sp. nov. is diagnosed by a unique combination of characters including an unusual caudally recurved dentary crest. It represents the oldest known member of Tapejaridae and the oldest known toothless pterosaur. The new taxon documents the earliest stage of the acquisition of this anatomical feature during the evolutionary history of the Pterodactyloidea. This innovation may have been linked to the development of new feeding strategies. Conclusion/Significance: The discovery of Europejara in the Barremian of the Iberian Peninsula reveals an earlier and broader global distribution of tapejarids, suggesting a Eurasian origin of this group. It adds to the poorly known pterosaur fauna of the Las Hoyas locality and contributes to a better understanding of the paleoecology of this Konservat-Lagerstatte. Finally, the significance of a probable contribution of tapejarine tapejarids to the early angiosperm dispersal is discussed.	[Vullo, Romain] Univ Rennes 1, CNRS, UMR 6118, Lab Geosci Rennes, Rennes, France; [Vullo, Romain; Marugan-Lobon, Jesus; Buscalioni, Angela D.; de la Fuente, Montserrat] Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Madrid, Spain; [Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Lab Systemat & Taphon Fossil Vertebrates, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil; [Gomez, Bernard] Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Plantes Environm, F-69622 Villeurbanne, France; [Moratalla, Jose J.] Inst Geol & Min Espana, Museo Geominero, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Autonomous University of Madrid; Universidade Federal do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vullo, R (corresponding author), Univ Rennes 1, CNRS, UMR 6118, Lab Geosci Rennes, Rennes, France.	romain.vullo@gmail.com	Kellner, Alexander W/H-1023-2015; Marugán-Lobón, Jesús/AAA-7614-2019; Moratalla, Jose Joaquin/E-3995-2018; Buscalioni, Angela D./AAA-5874-2019; Gomez, Bernard/B-1394-2012; Kellner, Alexander/ABE-9591-2020	Kellner, Alexander W/0000-0001-7174-9447; Moratalla, Jose Joaquin/0000-0002-4949-7666; Gomez, Bernard/0000-0003-1691-0634; Kellner, Alexander/0000-0001-7174-9447	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.779/2008, E-26/111.273/2010]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307276/2009-0]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-11838BTE]; Junta de Castilla-La Mancha	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla-La Mancha	AWAK acknowledges the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ nos. E-26/102.779/2008 and E-26/111.273/2010) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq no. 307276/2009-0) for supporting research on pterosaurs, including the examination of the Las Hoyas specimen. This study was supported by the Project CGL2009-11838BTE of the Spanish Ministerio de Ciencia e Innovacion and the Junta de Castilla-La Mancha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Archangelsky S, 2009, CRETACEOUS RES, V30, P1073, DOI 10.1016/j.cretres.2009.03.001; Barral A, 2009, MESOZOIC TERRESTRIAL, P125; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Buscalioni AD, 2008, CRETACEOUS RES, V29, P687, DOI 10.1016/j.cretres.2008.02.004; Buscalioni AD, 2010, J IBER GEOL, V36, P297, DOI 10.5209/rev_JIGE.2010.v36.n2.13; Buscalioni Angela D., 2006, P9; Butler RJ, 2009, J EVOLUTION BIOL, V22, P446, DOI 10.1111/j.1420-9101.2008.01680.x; Butler RJ, 2012, EVOLUTION, V66, P147, DOI 10.1111/j.1558-5646.2011.01415.x; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Coiffard C, 2007, ANN BOT-LONDON, V100, P545, DOI 10.1093/aob/mcm160; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Dyke GJ, 2009, J EVOLUTION BIOL, V22, P890, DOI 10.1111/j.1420-9101.2008.01682.x; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Elgin RA, 2012, HIST BIOL IN PRESS, V24; Eriksson O, 2000, INT J PLANT SCI, V161, P319, DOI 10.1086/314248; FLEMING TH, 1991, AM NAT, V138, P1058, DOI 10.1086/285269; Fregenal-Martinez M.A., 2000, AAPG STUDIES GEOLOGY, V46, P303; Frey Eberhard, 2003, Geological Society Special Publication, V217, P65, DOI 10.1144/GSL.SP.2003.217.01.06; Frey E, 2011, SWISS J GEOSCI, V104, pS35, DOI 10.1007/s00015-011-0073-1; Friis EM, 2010, REV PALAEOBOT PALYNO, V162, P341, DOI 10.1016/j.revpalbo.2009.11.009; Gomez B, 2001, PALAEOGEOGR PALAEOCL, V170, P133, DOI 10.1016/S0031-0182(01)00232-2; Heimhofer U, 2010, REV PALAEOBOT PALYNO, V161, P105, DOI 10.1016/j.revpalbo.2010.03.010; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; Kellner A, 2007, J VERTEBR PALEONTOL, V27, p98A; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2010, AN ACAD BRAS CIENC, V82, P1063, DOI 10.1590/S0001-37652010000400025; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P453; Lu Junchang, 2005, Geological Review (Beijing), V51, P458; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P683; Mohr BAR, 2000, INT J PLANT SCI, V161, pS155, DOI 10.1086/317580; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osi A, 2011, CRETACEOUS RES, V32, P456, DOI 10.1016/j.cretres.2011.01.011; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Prentice KC, 2011, J SYST PALAEONTOL, V9, P337, DOI 10.1080/14772019.2011.565081; SANZ JL, 1988, GEOBIOS-LYON, V21, P611, DOI 10.1016/S0016-6995(88)80072-X; Sanz JL, 2001, PALAEOBIOLOGY, VII, P356; Stecher R, 2008, SWISS J GEOSCI, V101, P185, DOI 10.1007/s00015-008-1252-6; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Sun G, 2002, REV PALAEOBOT PALYNO, V121, P91, DOI 10.1016/S0034-6667(02)00083-0; Sun Ge, 2008, Palaeoworld, V17, P166, DOI 10.1016/j.palwor.2008.10.002; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Vullo R, 2009, GEOL MAG, V146, P931, DOI 10.1017/S0016756809990525; Wang XL, 2006, GEOL J, V41, P405, DOI 10.1002/gj.1046; Wang XL, 2012, NATURWISSENSCHAFTEN, V99, P249, DOI 10.1007/s00114-012-0889-1; Wang XL, 2009, AN ACAD BRAS CIENC, V81, P793, DOI 10.1590/S0001-37652009000400016; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Webb Colin J., 1998, Plant Species Biology, V13, P57, DOI 10.1111/j.1442-1984.1998.tb00248.x; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379; Witton MP, 2009, CRETACEOUS RES, V30, P676, DOI 10.1016/j.cretres.2008.12.004; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	67	47	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e38900	10.1371/journal.pone.0038900	http://dx.doi.org/10.1371/journal.pone.0038900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802931	gold, Green Published			2022-12-25	WOS:000306186900005
J	Gray, LW; Peng, FY; Molloy, SA; Pendyala, VS; Muchenditsi, A; Muzik, O; Lee, J; Kaplan, JH; Lutsenko, S				Gray, Lawrence W.; Peng, Fangyu; Molloy, Shannon A.; Pendyala, Venkata S.; Muchenditsi, Abigael; Muzik, Otto; Lee, Jaekwon; Kaplan, Jack H.; Lutsenko, Svetlana			Urinary Copper Elevation in a Mouse Model of Wilson's Disease Is a Regulated Process to Specifically Decrease the Hepatic Copper Load	PLOS ONE			English	Article							TRANSPORTING ATPASE; BIOLOGICAL SAMPLES; MAMMALIAN-CELLS; VIRAL-HEPATITIS; MENKES DISEASE; LIVER-DISEASE; GENE; HOMEOSTASIS; EXCRETION; ACCUMULATION	Body copper homeostasis is regulated by the liver, which removes excess copper via bile. In Wilson's disease (WD), this function is disrupted due to inactivation of the copper transporter ATP7B resulting in hepatic copper overload. High urinary copper is a diagnostic feature of WD linked to liver malfunction; the mechanism behind urinary copper elevation is not fully understood. Using Positron Emission Tomography-Computed Tomography (PET-CT) imaging of live Atp7b(-/-) mice at different stages of disease, a longitudinal metal analysis, and characterization of copper-binding molecules, we show that urinary copper elevation is a specific regulatory process mediated by distinct molecules. PET-CT and atomic absorption spectroscopy directly demonstrate an age-dependent decrease in the capacity of Atp7b(-/-) livers to accumulate copper, concomitant with an increase in urinary copper. This reciprocal relationship is specific for copper, indicating that cell necrosis is not the primary cause for the initial phase of metal elevation in the urine. Instead, the urinary copper increase is associated with the down-regulation of the copper-transporter Ctr1 in the liver and appearance of a 2 kDa Small Copper Carrier, SCC, in the urine. SCC is also elevated in the urine of the liver-specific Ctr1(-/-) knockouts, which have normal ATP7B function, suggesting that SCC is a normal metabolite carrying copper in the serum. In agreement with this hypothesis, partially purified SCC-Cu competes with free copper for uptake by Ctr1. Thus, hepatic down-regulation of Ctr1 allows switching to an SCC-mediated removal of copper via kidney when liver function is impaired. These results demonstrate that the body regulates copper export through more than one mechanism; better understanding of urinary copper excretion may contribute to an improved diagnosis and monitoring of WD.	[Gray, Lawrence W.; Pendyala, Venkata S.; Muchenditsi, Abigael; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Peng, Fangyu] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Molloy, Shannon A.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Muzik, Otto] Wayne State Univ, Sch Med, Carman & Ann Adams Dept Pediat, Detroit, MI USA; [Muzik, Otto] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68583 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wayne State University; Wayne State University; University of Nebraska System; University of Nebraska Lincoln	Gray, LW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Peng, Fangyu/D-1079-2015	Peng, Fangyu/0000-0002-3142-3845; Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [5F31DK084730, 5R01DK079209, 5P01GM067166, S10-RR025512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675, S10RR025512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK084730, R01DK079209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants 5F31DK084730 to LWG, 5R01DK079209 to JL, and 5P01GM067166 to SL and JHK. The mass-spectrometry work was done at the Metal Ion Core (Oregon Health and Science University), supported by NIH instrumentation grant S10-RR025512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2011, CLIN LAB, V57, P847; Afridi HI, 2009, BIOL TRACE ELEM RES, V129, P78, DOI 10.1007/s12011-008-8297-2; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Burkhead JL, 2011, BIOMETALS, V24, P455, DOI 10.1007/s10534-011-9430-9; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; ELMES ME, 1989, J PATHOL, V158, P131, DOI 10.1002/path.1711580208; FROMMER DJ, 1981, DIGESTION, V21, P169, DOI 10.1159/000198559; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Huster D, 2010, BEST PRACT RES CL GA, V24, P531, DOI 10.1016/j.bpg.2010.07.014; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; Linz R, 2008, AM J PHYSIOL-RENAL, V294, pF53, DOI 10.1152/ajprenal.00314.2007; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; MELICHAR B, 1994, J TRACE ELEM ELECT H, V8, P209; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Peng F., 2011, MOL IMAGING BIOL; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Pfeiffer Ronald F, 2011, Handb Clin Neurol, V100, P681, DOI 10.1016/B978-0-444-52014-2.00049-5; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Walshe JM, 2011, QJM-INT J MED, V104, P775, DOI 10.1093/qjmed/hcr073; WILKEN H, 1961, KLIN WOCHENSCHR, V39, P147, DOI 10.1007/BF01485365; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401	33	51	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2012	7	6							e38327	10.1371/journal.pone.0038327	http://dx.doi.org/10.1371/journal.pone.0038327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964XV	22802922	Green Published, gold			2022-12-25	WOS:000305730900009
J	Luo, SQ; Hu, JP; Qu, Q; Li, J; Ren, W; Zhang, JM; Zhong, Y; Hu, WX				Luo, Sai-Qun; Hu, Jing-Ping; Qu, Qiang; Li, Jiang; Ren, Wei; Zhang, Jia-Ming; Zhong, Yan; Hu, Wei-Xin			The Effects of Promoter Methylation on Downregulation of DAZAP2 in Multiple Myeloma Cell Lines	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DEPENDENT KINASE INHIBITOR; MARROW STROMAL CELLS; NF-KAPPA-B; DNA METHYLATION; MYELOGENOUS LEUKEMIA; BONE-DISEASE; EXPRESSION; GENE; INTERLEUKIN-6	Our previous studies had shown that DAZAP2 was profoundly downregulated in bone marrow mononuclear cells from multiple myeloma patients. In this report, we analyzed epigenetic changes in multiple myeloma cell lines to understand the molecular mechanisms underlying the downregulation of DAZAP2. Four multiple myeloma cell lines, KM3, MM. 1S, OPM-2 and ARH-77, were studied. The results of methylation specific PCR (MSP) showed that the promoter of DAZAP2 was methylated for KM3, MM. 1S, OPM-2 and unmethylated for ARH-77. The DAZAP2 promoter region was amplified to obtain a series of different length sequences. All of the amplified sequences were inserted to luciferase reporter vector. The constructs were transfected into COS-7 cells and the luciferase activities were measured to search for the core region of DAZAP2 promoter. Two CpG islands were found in DAZAP2 promoter region. The results of luciferase assay showed that CpG island 1 displayed weak transcriptional activity, whereas CpG island 2 exhibited strong transcriptional activity (273 folds) compared to the control. The sequence that covered both CpG islands 1 and 2 showed higher activity (1,734 folds) compared to the control, suggesting that the two islands had synergistic effect on regulating DAZAP2 expression. We also found that M. Sss I methylase could inhibit the luciferase activity, whereas demethylation using 5-aza-29-deoxycytidine treatment rescued the expression of DAZAP2 for multiple myeloma cell lines. These data revealed that methylation of DAZAP2 promoter was involved in downregulation of DAZAP2 in multiple myeloma cells.	[Luo, Sai-Qun; Hu, Jing-Ping; Qu, Qiang; Li, Jiang; Ren, Wei; Zhang, Jia-Ming; Zhong, Yan; Hu, Wei-Xin] Cent S Univ, Xiangya Sch Med, Mol Biol Res Ctr, Changsha, Hunan, Peoples R China	Central South University	Hu, WX (corresponding author), Cent S Univ, Xiangya Sch Med, Mol Biol Res Ctr, Changsha, Hunan, Peoples R China.	weixinhu@yahoo.com.cn	Zhang, Jiaming/GSD-8224-2022	Hu, Jingping/0000-0001-5548-1241	National Natural Science Foundation of China [81071947, 30770906, 30270750, 39880021]; Science Foundation from Ministry of Education of China [200805330049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation from Ministry of Education of China	This work was supported with grants from the National Natural Science Foundation of China (no. 81071947, 30770906, 30270750 and 39880021) and the Science Foundation from Ministry of Education of China (no. 200805330049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Kenneth C, 2002, Hematology Am Soc Hematol Educ Program, P214; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Choi SH, 2011, NUCLEIC ACIDS RES, V39, P104, DOI 10.1093/nar/gkq774; Choi SJ, 2001, J CLIN INVEST, V108, P1833, DOI 10.1172/JCI13116; Corn PG, 1999, CANCER RES, V59, P3352; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Dewan MZ, 2004, CANCER SCI, V95, P564, DOI 10.1111/j.1349-7006.2004.tb02487.x; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Galm O, 2005, ANN HEMATOL, V84, P39, DOI 10.1007/s00277-005-0005-0; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kulkarni MS, 2002, LEUKEMIA, V16, P127, DOI 10.1038/sj.leu.2402328; Link PA, 2008, CANCER RES, V68, P9358, DOI 10.1158/0008-5472.CAN-08-1860; Liu H, 2004, BLOOD, V104, P2505, DOI 10.1182/blood-2004-02-0483; Lukas J, 2009, NUCLEIC ACIDS RES, V37, P3007, DOI 10.1093/nar/gkp179; Mateos MV, 2002, BRIT J HAEMATOL, V118, P1034, DOI 10.1046/j.1365-2141.2002.03749.x; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Pei JH, 2011, TUMOR BIOL, V32, P1133, DOI 10.1007/s13277-011-0215-0; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Rasmussen T, 2005, BLOOD, V105, P317, DOI 10.1182/blood-2004-03-0833; Roche DD, 2009, DEV BIOL, V333, P26, DOI 10.1016/j.ydbio.2009.06.019; Roman-Gomez J, 2009, J CLIN ONCOL, V27, P1316, DOI 10.1200/JCO.2008.19.3441; Schmelz K, 2005, INT J CANCER, V114, P683, DOI 10.1002/ijc.20797; Shaughnessy J, 2000, BLOOD, V96, P1505, DOI 10.1182/blood.V96.4.1505.h8001505_1505_1511; Shi YW, 2007, CHINESE MED J-PEKING, V120, P1659, DOI 10.1097/00029330-200710010-00003; Shi Yiwu, 2004, Genomics Proteomics & Bioinformatics, V2, P47; Siu LLP, 2003, BRIT J HAEMATOL, V122, P70, DOI 10.1046/j.1365-2141.2003.04396.x; Sossey-Alaoui K, 2002, GENOMICS, V80, P5, DOI 10.1006/geno.2002.6792; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tsui SL, 2000, GENOMICS, V65, P266, DOI 10.1006/geno.2000.6169; Wang MC, 2006, CHINESE MED J-PEKING, V119, P1226, DOI 10.1097/00029330-200607020-00018; Wijermans PW, 2005, ANN HEMATOL, V84, P9, DOI 10.1007/s00277-005-0012-1; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	41	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40475	10.1371/journal.pone.0040475	http://dx.doi.org/10.1371/journal.pone.0040475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792345	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700055
J	Xu, Y; Wang, SH; Chao, HJ; Liu, SJ; Zhou, NY				Xu, Ying; Wang, Song-He; Chao, Hong-Jun; Liu, Shuang-Jiang; Zhou, Ning-Yi			Biochemical and Molecular Characterization of the Gentisate Transporter GenK in Corynebacterium glutamicum	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; PSEUDOMONAS-ALCALIGENES NCIMB-9867; SP STRAIN U2; LACTOSE PERMEASE; NAG GENES; DEGRADATION; PATHWAY; PROTEIN; PUTIDA; PCAK	Background: Gentisate (2,5-dihydroxybenzoate) is a key ring-cleavage substrate involved in various aromatic compounds degradation. Corynebacterium glutamicum ATCC13032 is capable of growing on gentisate and genK was proposed to encode a transporter involved in this utilization by its disruption in the restriction-deficient mutant RES167. Its biochemical characterization by uptake assay using [C-14]-labeled gentisate has not been previously reported. Methodology/Principal Findings: In this study, biochemical characterization of GenK by uptake assays with [C-14]-labeled substrates demonstrated that it specifically transported gentisate into the cells with V-max and K-m of 3.06 +/- 0.16 nmol/min/mg of dry weight and 10.71 +/- 0.11 mu M respectively, and no activity was detected for either benzoate or 3-hydoxybenzoate. When GenK was absent in strain RES167 Delta genK, it retained 85% of its original transport activity at pH 6.5 compared to that of strain RES167. However, it lost 79% and 88% activity at pH 7.5 and 8.0, respectively. A number of competing substrates, including 3-hydroxybenzoate, benzoate, protocatechuate and catechol, significantly inhibited gentisate uptake by more than 40%. Through site-directed mutagenesis, eight amino acid residues of GenK, Asp-54, Asp-57 and Arg-386 in the hydrophobic transmembrane regions and Arg-103, Trp-309, Asp-312, Arg-313 and Ile-317 in the hydrophilic cytoplasmic loops were shown to be important for gentisate transport. When conserved residues Asp-54 and Asp-57 respectively were changed to glutamate, both mutants retained approximately 50% activity and were able to partially complement the ability of strain RES167 Delta genK to grow on gentisate. Conclusions/Significance: Our results demonstrate that GenK is an active gentisate transporter in Corynebacterium glutamicum ATCC13032. The GenK-mediated gentisate transport was also shown to be a limiting step for the gentisate utilization by this strain. This enhances our understanding of gentisate transport in the microbial degradation of aromatic compounds.	[Xu, Ying; Wang, Song-He; Chao, Hong-Jun; Zhou, Ning-Yi] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China; [Liu, Shuang-Jiang] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Xu, Y (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China.	n.zhou@pentium.whiov.ac.cn	Chao, Hongjun/O-6252-2014; Liu, Shuang-Jiang/E-5756-2013; Chao, Hong-Jun/GPT-1718-2022	Chao, Hongjun/0000-0002-2481-8056; 	National Natural Science Foundation of China [30730002, 30900014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30730002 and 30900014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; Collier LS, 1997, J BACTERIOL, V179, P5943, DOI 10.1128/jb.179.18.5943-5946.1997; Ditty JL, 2002, J BACTERIOL, V184, P1444, DOI 10.1128/JB.184.5.1444-1448.2002; Ditty JL, 1999, J BACTERIOL, V181, P5068, DOI 10.1128/JB.181.16.5068-5074.1999; Gao XL, 2005, J BACTERIOL, V187, P7696, DOI 10.1128/JB.187.22.7696-7702.2005; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Jakoby M, 1999, BIOTECHNOL TECH, V13, P437, DOI 10.1023/A:1008968419217; Jeon CO, 2006, APPL ENVIRON MICROB, V72, P1086, DOI 10.1128/AEM.72.2.1086-1095.2006; JessenMarshall AE, 1997, J BACTERIOL, V179, P2616, DOI 10.1128/jb.179.8.2616-2622.1997; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; KONOPKA A, 1993, FEMS MICROBIOL LETT, V111, P93, DOI 10.1111/j.1574-6968.1993.tb06367.x; LACK L, 1959, BIOCHIM BIOPHYS ACTA, V34, P117, DOI 10.1016/0006-3002(59)90239-2; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Leveau JHJ, 1998, J BACTERIOL, V180, P2237, DOI 10.1128/JB.180.8.2237-2243.1998; Liu TT, 2011, APPL MICROBIOL BIOT, V90, P671, DOI 10.1007/s00253-010-3033-1; Nichols NN, 1997, J BACTERIOL, V179, P5056, DOI 10.1128/jb.179.16.5056-5061.1997; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Tauch A, 2002, CURR MICROBIOL, V45, P362, DOI 10.1007/s00284-002-3728-3; Wang SH, 2011, INT BIODETER BIODEGR, V65, P527, DOI 10.1016/j.ibiod.2011.02.004; Xu Y, 2006, BIOCHEM BIOPH RES CO, V346, P555, DOI 10.1016/j.bbrc.2006.05.143; Yeo CC, 2003, GENE, V312, P239, DOI 10.1016/S0378-1119(03)00619-X; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Youn JW, 2009, J BACTERIOL, V191, P5480, DOI 10.1128/JB.00640-09; Zhou NY, 2002, J BACTERIOL, V184, P1547, DOI 10.1128/JB.184.6.1547-1555.2002; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	31	76	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38701	10.1371/journal.pone.0038701	http://dx.doi.org/10.1371/journal.pone.0038701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808015	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700004
J	Adilakshmi, T; Sudol, I; Tapinos, N				Adilakshmi, Tadepalli; Sudol, Ida; Tapinos, Nikos			Combinatorial Action of miRNAs Regulates Transcriptional and Post-Transcriptional Gene Silencing following in vivo PNS Injury	PLOS ONE			English	Article							SCHWANN-CELLS; RNA CLEAVAGE; NERVE INJURY; MICRORNAS; MYELINATION; IDENTIFICATION; BIOGENESIS; ARGONAUTE2; SIGNALS; TARGETS	Injury response in the peripheral nervous system (PNS) is characterized by rapid alterations in the genetic program of Schwann cells. However, the epigenetic mechanisms modulating these changes remain elusive. Here we show that sciatic nerve injury in mice induces a cohort of 22 miRNAs, which coordinate Schwann cell differentiation and dedifferentiation through a combinatorial modulation of their positive and negative gene regulators. These miRNAs and their targeted mRNAs form functional complexes with the Argonaute-2 protein to mediate post-transcriptional gene silencing. MiR-138 and miR-709 show the highest affinity amongst the cohort, for binding and regulation of Egr2, Sox-2 and c-Jun expression following injury. Moreover, miR-709 participates in the formation of epigenetic silencing complexes with H3K27me3 and Argonaute-1 to induce transcriptional gene silencing of the Egr2 promoter. Collectively, we identified a discrete cohort of miRNAs as the central epigenetic regulators of the transition between differentiation and dedifferentiation during the acute phase of PNS injury.	[Adilakshmi, Tadepalli; Sudol, Ida; Tapinos, Nikos] Geisinger Med Clin, Weis Ctr Res, Mol Neurosci Lab, Danville, PA 17822 USA	Geisinger Medical Center	Adilakshmi, T (corresponding author), Geisinger Med Clin, Weis Ctr Res, Mol Neurosci Lab, 100 N Acad Ave, Danville, PA 17822 USA.	ntapinos1@geisinger.edu			Geisinger Clinic	Geisinger Clinic	The study was supported by internal funds from Geisinger Clinic to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Castanotto D, 2005, MOL THER, V12, P179, DOI 10.1016/j.ymthe.2005.03.003; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Ghislain J, 2002, DEVELOPMENT, V129, P155; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hannon GJ, 2006, COLD SPRING HARB SYM, V71, P551, DOI 10.1101/sqb.2006.71.064; Jang SW, 2010, J NEUROCHEM, V115, P1409, DOI 10.1111/j.1471-4159.2010.07045.x; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Muller HW, 1998, CURR OPIN NEUROL, V11, P557; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Radtke Christine, 2009, Eplasty, V9, pe47; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171	44	53	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39674	10.1371/journal.pone.0039674	http://dx.doi.org/10.1371/journal.pone.0039674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792185	Green Submitted, gold, Green Published			2022-12-25	WOS:000306461800016
J	Hall, ZJ; MacDougall-Shackleton, SA				Hall, Zachary J.; MacDougall-Shackleton, Scott A.			Influence of Testosterone Metabolites on Song-Control System Neuroplasticity during Photostimulation in Adult European Starlings (Sturnus vulgaris)	PLOS ONE			English	Article							HIGH VOCAL CENTER; CONTROL NUCLEI VOLUMES; SEASONAL-LIKE GROWTH; NEURONAL RECRUITMENT; ZEBRA FINCHES; ESTROGEN-RECEPTOR; CONTROL-CIRCUITS; FEMALE CANARIES; AVIAN BRAIN; ANDROGEN	The song-control system is a network of discrete nuclei in the songbird brain that controls the production and learning of birdsong and exhibits some of the best-studied neuroplasticity found in the adult brain. Photoperiodic growth of the song-control system during the breeding season is driven, at least in part, by the gonadal steroid testosterone. When acting on neural tissue, however, testosterone can be metabolized into 5 alpha-dihydrotestosterone (DHT) or 17 beta-estradiol (E2), which activate different hormonal signaling pathways. By treating adult starlings with both testosterone metabolites and metabolite antagonists, we attempted to isolate the effects of androgen and estrogen treatment on neuroplasticity during photostimulation in male and female European starlings (Sturnus vulgaris). Photostimulation resulted in a large HVC volume typical of the breeding season in all treatments independent of hormone treatment. E2 had additional effects on HVC growth by reducing neuron density and enhancing early survival of new neurons recruited to HVC in females but did not significantly affect HVC volume. Conversely, DHT reduced the migration of new neurons, assessed by the expression of doublecortin, to HVC. DHT also increased syrinx mass and maintained RA (robust nucleus of the arcopallium) cytoarchitecture in the presence of aromatase inhibitors. In addition, we document the first evidence of sex-specific neuroplastic responses of the song-control system to androgens and estrogens. These findings suggest that the contributions of DHT and E2 signaling in songbird neuroplasticity may be regulated by photoperiod and that future studies should account for species and sex differences in the brain.	[Hall, Zachary J.] Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON, Canada; [MacDougall-Shackleton, Scott A.] Univ Western Ontario, Dept Psychol, Adv Facil Avian Res, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Hall, ZJ (corresponding author), Univ St Andrews, St Marys Coll, Sch Psychol, St Andrews, Fife, Scotland.	zjh2@st-andrews.ac.uk	MacDougall-Shackleton, Scott A/C-6622-2008	MacDougall-Shackleton, Scott A/0000-0001-8518-765X	Natural Sciences and Engineering Research Council of Canada [217831]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (Grant # 217831; http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil P, 2003, BEHAV BRAIN RES, V143, P15, DOI 10.1016/S0166-4328(03)00006-8; Ball GF, 2004, ANN NY ACAD SCI, V1016, P586, DOI 10.1196/annals.1298.043; Ball GF, 1999, BRAIN BEHAV EVOLUT, V54, P28, DOI 10.1159/000006609; Balthazart J, 2008, EUR J NEUROSCI, V27, P801, DOI 10.1111/j.1460-9568.2008.06059.x; Bentley GE, 2003, GEN COMP ENDOCR, V134, P187, DOI 10.1016/S0016-6480(03)00261-2; Bernard DJ, 1997, GEN COMP ENDOCR, V105, P276, DOI 10.1006/gcen.1996.6829; Bernard DJ, 1997, BRAIN RES, V760, P163, DOI 10.1016/S0006-8993(97)00277-1; BERNARD DJ, 1995, J COMP NEUROL, V360, P726, DOI 10.1002/cne.903600415; Boseret G, 2007, J CHEM NEUROANAT, V33, P140, DOI 10.1016/j.jchemneu.2007.02.002; Brenowitz EA, 2002, P NATL ACAD SCI USA, V99, P12421, DOI 10.1073/pnas.192308799; Brenowitz EA, 2001, J NEUROSCI, V21, P2320, DOI 10.1523/JNEUROSCI.21-07-02320.2001; Chen TT, 2010, POULTRY SCI, V89, P558, DOI 10.3382/ps.2009-00429; DAWSON A, 1983, J ENDOCRINOL, V97, P253, DOI 10.1677/joe.0.0970253; DEVOOGD T, 1981, SCIENCE, V214, P202, DOI 10.1126/science.7280692; Fair J., 2010, ORNITHOLOGICAL COUNC; Fusani L, 2007, HORM BEHAV, V51, P62, DOI 10.1016/j.yhbeh.2006.08.005; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Grisham W, 2007, NEUROSCI LETT, V418, P92, DOI 10.1016/j.neulet.2007.03.002; Gulledge CC, 1997, J NEUROBIOL, V32, P391, DOI 10.1002/(SICI)1097-4695(199704)32:4<391::AID-NEU3>3.0.CO;2-1; Hall ZJ, 2010, BRAIN BEHAV EVOLUT, V76, P168, DOI 10.1159/000320971; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; Kafitz KW, 1999, GLIA, V27, P88; KIRN J, 1994, P NATL ACAD SCI USA, V91, P7844, DOI 10.1073/pnas.91.17.7844; KIRN JR, 1989, J NEUROSCI, V9, P3176; Kirn JR, 1999, J COMP NEUROL, V411, P487; London SE, 2009, FRONT NEUROENDOCRIN, V30, P302, DOI 10.1016/j.yfrne.2009.05.001; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; MacDougall-Shackleton SA, 2003, NEUROSCI LETT, V340, P165, DOI 10.1016/S0304-3940(03)00109-5; MacDougall-Shackleton SA, 2001, BRAIN BEHAV EVOLUT, V58, P38, DOI 10.1159/000047260; Meitzen J, 2007, J COMP PHYSIOL A, V193, P677, DOI 10.1007/s00359-007-0222-1; Metzdorf R, 1999, J COMP NEUROL, V407, P115; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Newman AEM, 2009, EUR J NEUROSCI, V29, P1905, DOI 10.1111/j.1460-9568.2009.06748.x; NORDEEN EJ, 1988, J NEUROSCI, V8, P2869; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Pavlova DZ, 2007, BEHAVIOUR, V144, P663, DOI 10.1163/156853907781347835; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; RASIKA S, 1994, P NATL ACAD SCI USA, V91, P7854, DOI 10.1073/pnas.91.17.7854; Riebel K, 2003, ADV STUD BEHAV, V33, P49, DOI 10.1016/S0065-3454(03)33002-5; Riters LV, 2001, J NEUROENDOCRINOL, V13, P985, DOI 10.1046/j.1365-2826.2001.00723.x; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SCHLINGER BA, 1992, P NATL ACAD SCI USA, V89, P7650, DOI 10.1073/pnas.89.16.7650; Schlinger BA, 1997, J NEUROBIOL, V33, P619, DOI 10.1002/(SICI)1097-4695(19971105)33:5<619::AID-NEU9>3.0.CO;2-7; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Smith GT, 1997, J NEUROSCI, V17, P6001; Soma KK, 1999, GEN COMP ENDOCR, V115, P442, DOI 10.1006/gcen.1999.7334; Soma KK, 2004, J NEUROBIOL, V58, P413, DOI 10.1002/neu.10288; Stevenson TJ, 2008, GEN COMP ENDOCR, V156, P385, DOI 10.1016/j.ygcen.2008.01.015; Thompson CK, 2005, J COMP NEUROL, V481, P276, DOI 10.1002/cne.20381; Tramontin AD, 2003, J NEUROBIOL, V57, P130, DOI 10.1002/neu.10263; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Tramontin AD, 1998, J COMP NEUROL, V396, P186, DOI 10.1002/(SICI)1096-9861(19980629)396:2<186::AID-CNE4>3.0.CO;2-X; Vellema M, 2010, J COMP NEUROL, V518, P1442, DOI 10.1002/cne.22281; Wade J, 2000, J COMP NEUROL, V426, P154; Yamamura T, 2011, J NEUROSCI, V31, P9649, DOI 10.1523/JNEUROSCI.0088-11.2011	56	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40060	10.1371/journal.pone.0040060	http://dx.doi.org/10.1371/journal.pone.0040060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792214	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800036
J	Hammers, M; Richardson, DS; Burke, T; Komdeur, J				Hammers, Martijn; Richardson, David S.; Burke, Terry; Komdeur, Jan			Age-Dependent Terminal Declines in Reproductive Output in a Wild Bird	PLOS ONE			English	Article							SEYCHELLES WARBLER; TERRITORY QUALITY; SENESCENCE; PERFORMANCE; EVOLUTION; RATES; POPULATION; RESTRAINT; PATTERNS; SURVIVAL	In many iteroparous species individual fitness components, such as reproductive output, first increase with age and then decline during late-life. However, individuals differ greatly in reproductive lifespan, but reproductive declines may only occur in the period just before their death as a result of an age-independent decline in physiological condition. To fully understand reproductive senescence it is important to investigate to what extent declines in late-life reproduction can be explained by age, time until death, or both. However, the study of late-life fitness performance in natural populations is challenging as the exact birth and death dates of individuals are often not known, and most individuals succumb to extrinsic mortality before reaching old age. Here, we used an exceptional long-term longitudinal dataset of individuals from a natural, closed, and predator-free population of the Seychelles warbler (Acrocephalus sechellensis) to investigate reproductive output, both in relation to age and to the time until the death of an individual (reverse-age approach). We observed an initial age-dependent increase in reproductive output that was followed by a decline in old age. However, we found no significant decline in reproductive output in the years directly preceding death. Although post-peak reproductive output declined with age, this pattern differed between terminal and non-terminal reproductive attempts, and the age-dependence of the terminal breeding attempt explained much of the variation in age-specific reproductive output. In fact, terminal declines in reproductive output were steeper in very old individuals. These results indicate that not only age-dependent, but also age-independent factors, such as physiological condition, need to be considered to understand reproductive senescence in wild-living animals.	[Hammers, Martijn; Komdeur, Jan] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Hammers, Martijn; Richardson, David S.] Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; [Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Richardson, David S.] Nat Seychelles, Victoria, Mahe, Seychelles	University of Groningen; University of East Anglia; University of Sheffield	Hammers, M (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	martijnhammers@gmail.com	Richardson, David S/A-5082-2010; Burke, Terry/B-3196-2011; Komdeur, Jan/X-1261-2019	Richardson, David S/0000-0001-7226-9074; Burke, Terry/0000-0003-3848-1244; Komdeur, Jan/0000-0002-9241-0124	UK Natural Environment Research Council; The Netherlands Organisation for Scientific Research; Natural Environment Research Council [NE/F02083X/1, NE/B504106/1] Funding Source: researchfish; NERC [NE/F02083X/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants from the UK Natural Environment Research Council and The Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, IME4 LINEAR MIXED EF; Bouwhuis S, 2009, P ROY SOC B-BIOL SCI, V276, P2769, DOI 10.1098/rspb.2009.0457; Bouwhuis S, 2010, J ANIM ECOL, V79, P1251, DOI 10.1111/j.1365-2656.2010.01730.x; Brouwer L, 2006, J ANIM ECOL, V75, P1321, DOI 10.1111/j.1365-2656.2006.01155.x; Brouwer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033167; Brouwer L, 2010, MOL ECOL, V19, P3444, DOI 10.1111/j.1365-294X.2010.04750.x; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Catry P, 2006, P ROY SOC B-BIOL SCI, V273, P1625, DOI 10.1098/rspb.2006.3482; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Coulson JC, 2001, J AVIAN BIOL, V32, P146, DOI 10.1034/j.1600-048X.2001.320207.x; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Komdeur J, 2005, J ORNITHOL, V146, P305, DOI 10.1007/s10336-005-0008-6; Komdeur J, 2005, BIOL CONSERV, V124, P15, DOI 10.1016/j.biocon.2004.12.009; Komdeur J, 2004, IBIS, V146, P298, DOI 10.1046/j.1474-919X.2004.00255.x; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/BF00167742; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Komdeur J, 1996, BEHAV ECOL, V7, P417, DOI 10.1093/beheco/7.4.417; Komdeur J, 1996, J BIOL RHYTHM, V11, P333, DOI 10.1177/074873049601100407; KOMDEUR J, 1995, ANIM BEHAV, V49, P695; Komdeur J., 1991, TRENDS ECOLOGY EVOLU, V7, P330; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Martin JGA, 2011, ECOL LETT, V14, P576, DOI 10.1111/j.1461-0248.2011.01621.x; McCleery RH, 2008, P R SOC B, V275, P963, DOI 10.1098/rspb.2007.1418; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Newton I, 1989, LIFETIME REPROD SUCC; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rattiste K, 2004, P ROY SOC B-BIOL SCI, V271, P2059, DOI 10.1098/rspb.2004.2832; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Richardson DS, 2007, EVOLUTION, V61, P2790, DOI 10.1111/j.1558-5646.2007.00222.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Stearns S.C., 1992, pi; Torres R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027245; van de Crommenacker J, 2011, J ANIM ECOL, V80, P668, DOI 10.1111/j.1365-2656.2010.01792.x; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	52	45	45	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40413	10.1371/journal.pone.0040413	http://dx.doi.org/10.1371/journal.pone.0040413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792307	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000306461800078
J	Pearce, MS; Mann, KD; Martin-Ruiz, C; Parker, L; White, M; von Zglinicki, T; Adams, J				Pearce, Mark S.; Mann, Kay D.; Martin-Ruiz, Carmen; Parker, Louise; White, Martin; von Zglinicki, Thomas; Adams, Jean			Childhood Growth, IQ and Education as Predictors of White Blood Cell Telomere Length at Age 49-51 Years: The Newcastle Thousand Families Study	PLOS ONE			English	Article							BIRTH-WEIGHT; DYSFUNCTION; ATTAINMENT	Background: Telomere length is emerging as a potential factor in the pathogenesis of cardiovascular disease. We investigated whether birth weight, infant growth, childhood cognition and adult height, as well as a range of lifestyle, socioeconomic and educational factors, were associated with white blood cell telomere length at age 49-51 years. Methods: The study included 318 members of the Newcastle Thousand Families Study, a prospectively followed birth cohort which includes all individuals born in Newcastle, England in May and June 1947, who attended for clinical examination at age 49-51 years, and had telomere length successfully measured using real-time PCR analyses of DNA extracted from peripheral blood mononuclear cells. Results: No association was found between birth weight and later telomere length. However, associations were seen with other factors from early life. Education level was the only predictor in males, while telomere length in females was associated with gestational age at birth, childhood growth and childhood IQ. Conclusions: While these findings may be due to chance, in particular where differing associations were seen between males and females, they do provide evidence of early life associations with telomere length much later in life. Our findings of sex differences in the education association may reflect the sex differences in achieved education levels in this generation where few women went to university regardless of their intelligence. Our findings do not support the concept of telomere length being on the pathway between very early growth and later disease risk.	[Pearce, Mark S.; Mann, Kay D.; White, Martin; Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Martin-Ruiz, Carmen; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Parker, Louise] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Parker, Louise] Dalhousie Univ, Dept Paediat, Halifax, NS, Canada	Newcastle University - UK; Newcastle University - UK; Dalhousie University; Dalhousie University	Pearce, MS (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mark.pearce@ncl.ac.uk	Mann, Kay/T-4406-2019; Adams, Jean/G-2402-2010	Mann, Kay/0000-0003-0115-5293; Adams, Jean/0000-0002-5733-7830; Pearce, Mark/0000-0002-0583-3779; PARKER, LOUISE/0000-0002-5188-8113; Martin-Ruiz, Carmen/0000-0002-3361-6974; White, Martin/0000-0002-1861-6757; von Zglinicki, Thomas/0000-0002-5939-0248	Faculty of Public Health Medicine/BUPA research fellowship; Research into Aging programme grant; Fuse - the Centre for Translational Research in Public Health; UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute of Health Research; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI	Faculty of Public Health Medicine/BUPA research fellowship; Research into Aging programme grant; Fuse - the Centre for Translational Research in Public Health; UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was partly supported by funding from the Faculty of Public Health Medicine/BUPA research fellowship (2001-4) awarded to JA and by a Research into Aging programme grant awarded to TvZ. JA is funded in full and MW in part by Fuse - the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding for Fuse is provided by the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and National Institute of Health Research. The views expressed in this paper do not necessarily represent those of the funders or UKCRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2007, AGING CELL, V6, P125, DOI 10.1111/j.1474-9726.2006.00258.x; Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davy P, 2009, PLACENTA, V30, P539, DOI 10.1016/j.placenta.2009.03.005; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; Forrest LF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-895; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Friedrich U, 2001, PEDIATR RES, V49, P252, DOI 10.1203/00006450-200102000-00020; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Fyhrquist F, 2011, J Hum Hypertens, V25, P711, DOI 10.1038/jhh.2011.57; Harris SE, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.013; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Mann KD, 2011, J HYPERTENS, V29, P1077, DOI 10.1097/HJH.0b013e328346d76c; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Mayer S, 2006, CYTOGENET GENOME RES, V112, P194, DOI 10.1159/000089870; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pearce MS, 2009, INT J EPIDEMIOL, V38, P932, DOI 10.1093/ije/dyn184; Raqib R, 2007, AM J CLIN NUTR, V85, P845, DOI 10.1093/ajcn/85.3.845; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Surtees PG, 2012, BRAIN BEHAV IMMUN, V26, P414, DOI 10.1016/j.bbi.2011.11.009; Thomas P, 2008, MECH AGEING DEV, V129, P183, DOI 10.1016/j.mad.2007.12.004; Valdes AM, 2010, NEUROBIOL AGING, V31, P986, DOI 10.1016/j.neurobiolaging.2008.07.012; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Bonsdorff MB, 2011, AM J EPIDEMIOL, V174, P1336, DOI 10.1093/aje/kwr270; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; World Health Organisation, 1990, ORG MON TRENDS DET 3; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012	36	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40116	10.1371/journal.pone.0040116	http://dx.doi.org/10.1371/journal.pone.0040116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792222	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800040
J	Tsai, J; Grosse, SD; Grant, AM; Reyes, NL; Hooper, WC; Atrash, HK				Tsai, James; Grosse, Scott D.; Grant, Althea M.; Reyes, Nimia L.; Hooper, W. Craig; Atrash, Hani K.			Correlates of In-Hospital Deaths among Hospitalizations with Pulmonary Embolism: Findings from the 2001-2008 National Hospital Discharge Survey	PLOS ONE			English	Article							CASE-FATALITY RATE; VENOUS THROMBOEMBOLISM RISK; QUALITY-OF-LIFE; THROMBOLYTIC THERAPY; UNITED-STATES; EPIDEMIOLOGY; DIAGNOSIS; MORTALITY; CARE; MULTIMORBIDITY	Background: Deep vein thrombosis and pulmonary embolism (PE) are responsible for substantial mortality, morbidity, and impaired health-related quality of life. The aim of this study was to evaluate the correlates of in-hospital deaths among hospitalizations with a diagnosis of PE in the United States. Methods: By using data from the 2001-2008 National Hospital Discharge Survey, we assessed the correlates of in-hospital deaths among 14,721 hospitalizations with a diagnosis of PE and among subgroups stratified by age, sex, race, days of hospital stay, type of admission, cancer, pneumonia, and fractures. We produced adjusted rate ratios (aRR) and 95% confidence intervals using log-linear multivariate regression models. Results: Regardless of the listing position of diagnostic codes, we observed an increased likelihood of in-hospital death in subgroups of hospitalizations with ages 50 years and older (aRR = 1.82-8.48), less than 7 days of hospital stay (aRR = 1.43-1.57), cancer (aRR = 2.10-2.28), pneumonia (aRR = 1.79-2.20), or fractures (aRR = 2.18) (except for first-listed PE), when compared to the reference groups with ages 1-49 years, 7 days or more of hospital stay, without cancer, pneumonia, or fractures while adjusting for covariates. In addition, we observed an increased likelihood of in-hospital death for first-listed PE in hospitalizations of women, when compared to those of men (aRR = 1.45). Conclusions: The results of this study provide support for identifying, developing, and implementing effective, evidence-based clinical assessment and management strategies to reduce PE-related morbidity and mortality among hospitalized PE patients who may have concurrent health conditions including cancer, pneumonia, and fractures.	[Tsai, James; Grosse, Scott D.; Grant, Althea M.; Reyes, Nimia L.; Hooper, W. Craig; Atrash, Hani K.] Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tsai, J (corresponding author), Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	jxt9@cdc.gov		Grosse, Scott/0000-0003-1078-6855; Tsai, James/0000-0002-3114-124X				Abunasser Jafar, 2012, Conn Med, V76, P5; Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Alikhan R, 2004, J CLIN PATHOL, V57, P1254, DOI 10.1136/jcp.2003.013581; [Anonymous], 2010, MULT CHRON COND STRA; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Brogan D, 2005, ENCY BIOSTATISTICS, V8-Set, P5057; CDC, 2010, NAT HLTH STAT REP; CDC/National Center for Health Statistics, 2011, NAT HOSP DISCH SURV; Chughtai HL, 2011, CLIN APPL THROMB-HEM, V17, P656, DOI 10.1177/1076029611405033; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Cushman M, 2007, SEMIN HEMATOL, V44, P62, DOI 10.1053/j.seminhematol.2007.02.004; DeMonaco NA, 2008, AM J MED, V121, P611, DOI 10.1016/j.amjmed.2008.02.035; DHHS, 2008, SURG GEN CALL ACT PR; Douma RA, 2010, NAT REV CARDIOL, V7, P585, DOI 10.1038/nrcardio.2010.106; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Geerts W, 2009, J THROMB HAEMOST, V7, P1, DOI 10.1111/j.1538-7836.2009.03384.x; Goldhaber SZ, 2010, J AM COLL CARDIOL, V56, P1, DOI 10.1016/j.jacc.2010.01.057; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; Klok FA, 2010, J THROMB HAEMOST, V8, P523, DOI 10.1111/j.1538-7836.2009.03726.x; Klok FA, 2010, CHEST, V138, P1432, DOI 10.1378/chest.09-2482; Korn E. L., 1999, ANAL HLTH SURVEYS; Kozak LJ, 1995, NATL CTR HLTH STAT N, V10; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Prasad V, 2012, ARCH INTERN MED, V172, P955, DOI 10.1001/archinternmed.2012.195; Rosendaal Frits R, 2005, Hematology Am Soc Hematol Educ Program, P1; Rubenfire M, 2007, CRIT CARE CLIN, V23, P801, DOI 10.1016/j.ccc.2007.07.006; Smith SB, 2012, J EMERG MED, V42, P1, DOI 10.1016/j.jemermed.2011.06.004; Smith SM, 2007, BRIT J GEN PRACT, V57, P268; Stein PD, 2012, AM J MED, V125, P465, DOI 10.1016/j.amjmed.2011.10.015; Stein PD, 2012, AM J MED, V125, P471, DOI 10.1016/j.amjmed.2011.12.003; Stein PD, 2012, AM J MED, V125, P478, DOI 10.1016/j.amjmed.2011.05.025; Stein PD, 2011, CLIN APPL THROMB-HEM, V17, P140, DOI 10.1177/1076029610389027; Stein PD, 2010, CLIN CHEST MED, V31, P611, DOI 10.1016/j.ccm.2010.07.001; Stein PD, 2006, AM J MED, V119, P163, DOI 10.1016/j.amjmed.2005.02.028; Stein PD, 2004, AM J CARDIOL, V93, P1194, DOI 10.1016/j.amjcard.2004.01.061; Stein PD, 2004, AM J CARDIOL, V93, P1197, DOI 10.1016/j.amjcard.2004.01.058; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Tsai J, 2012, ARCH INTERN MED, V172, P960, DOI 10.1001/archinternmed.2012.198; Van Es J, 2010, NAT REV CARDIOL, V7, P613, DOI 10.1038/nrcardio.2010.141; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428	47	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e34048	10.1371/journal.pone.0034048	http://dx.doi.org/10.1371/journal.pone.0034048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792153	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800001
J	Wernike, K; Breithaupt, A; Keller, M; Hoffmann, B; Beer, M; Eschbaumer, M				Wernike, Kerstin; Breithaupt, Angele; Keller, Markus; Hoffmann, Bernd; Beer, Martin; Eschbaumer, Michael			Schmallenberg Virus Infection of Adult Type I Interferon Receptor Knock-Out Mice	PLOS ONE			English	Article							PROTECTION; DEFICIENT; CATTLE; LETHAL; CELLS	Schmallenberg virus (SBV), a novel orthobunyavirus, was discovered in Europe in late 2011. It causes mild and transient disease in adult ruminants, but fetal infection can lead to abortion or severe malformations. There is considerable demand for SBV research, but in vivo studies in large animals are complicated by their long gestation periods and the cost of high containment housing. The goal of this study was to investigate whether type I interferon receptor knock-out (IFNAR(-/-)) mice are a suitable small animal model for SBV. Twenty IFNAR(-/-) mice were inoculated with SBV, four were kept as controls. After inoculation, all were observed and weighed daily; two mice per day were sacrificed and blood, brain, lungs, liver, spleen, and intestine were harvested. All but one inoculated mouse lost weight, and two mice died spontaneously at the end of the first week, while another two had to be euthanized. Real-time RT-PCR detected large amounts of SBV RNA in all dead or sick mice; the controls were healthy and PCR-negative. IFNAR(-/-) mice are susceptible to SBV infection and can develop fatal disease, making them a handy and versatile tool for SBV vaccine research.	[Wernike, Kerstin; Hoffmann, Bernd; Beer, Martin; Eschbaumer, Michael] FLI, Inst Diagnost Virol, Greifswald, Germany; [Breithaupt, Angele] FLI, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Keller, Markus] FLI, Inst Novel & Emerging Infect Dis, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Wernike, K (corresponding author), FLI, Inst Diagnost Virol, Greifswald, Germany.	kerstin.wernike@fli.bund.de	Breithaupt, Angele/GON-7227-2022; Breithaupt, Angele/B-6155-2013	Breithaupt, Angele/0000-0002-6373-5923; Eschbaumer, Michael/0000-0002-1104-0695				Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Bilk S, 2012, VET MICROBI IN PRESS; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Eschbaumer M, 2012, VET MICROBIOL, V155, P417, DOI 10.1016/j.vetmic.2011.08.019; Franceschi V, 2011, VACCINE, V29, P3074, DOI 10.1016/j.vaccine.2011.01.075; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; KUROGI H, 1976, ARCH VIROL, V51, P67, DOI 10.1007/BF01317835; Lorenzo G, 2010, VACCINE, V28, P2937, DOI 10.1016/j.vaccine.2010.02.018; Ma GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034425; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Oem JK, 2012, VET MICROBI IN PRESS; Operschall E, 1999, J CLIN VIROL, V13, P17, DOI 10.1016/S1386-6532(99)00008-6; Schuh T, 1999, HUM GENE THER, V10, P1649, DOI 10.1089/10430349950017653; WECHSLER SJ, 1991, J INVERTEBR PATHOL, V57, P200, DOI 10.1016/0022-2011(91)90117-9	16	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40380	10.1371/journal.pone.0040380	http://dx.doi.org/10.1371/journal.pone.0040380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792298	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800074
J	Winter, JM; Tang, LH; Klimstra, DS; Brennan, MF; Brody, JR; Rocha, FG; Jia, XY; Qin, LX; D'Angelica, MI; DeMatteo, RP; Fong, Y; Jarnagin, WR; O'Reilly, EM; Allen, PJ				Winter, Jordan M.; Tang, Laura H.; Klimstra, David S.; Brennan, Murray F.; Brody, Jonathan R.; Rocha, Flavio G.; Jia, Xiaoyu; Qin, Li-Xuan; D'Angelica, Michael I.; DeMatteo, Ronald P.; Fong, Yuman; Jarnagin, William R.; O'Reilly, Eileen M.; Allen, Peter J.			A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DUCTAL ADENOCARCINOMA; INTRAEPITHELIAL NEOPLASIA; TRANSLATIONAL RESEARCH; ADJUVANT CHEMOTHERAPY; SINGLE-INSTITUTION; CARCINOMA-CELLS; GROWTH-FACTOR; EXPRESSION; RESECTION	Background: One-fifth of patients with seemingly 'curable' pancreatic ductal adenocarcinoma (PDA) experience an early recurrence and death, receiving no definable benefit from a major operation. Some patients with advanced stage tumors are deemed 'unresectable' by conventional staging criteria (e.g. liver metastasis), yet progress slowly. Effective biomarkers that stratify PDA based on biologic behavior are needed. To help researchers sort through the maze of biomarker data, a compendium of similar to 2500 published candidate biomarkers in PDA was compiled (PLoS Med, 2009. 6(4) p. e1000046). Methods and Findings: Building on this compendium, we constructed a survival tissue microarray (termed s-TMA) comprised of short-term (cancer-specific death < 12 months, n = 58) and long-term survivors (> 30 months, n = 79) who underwent resection for PDA (total, n = 137). The s-TMA functions as a biological filter to identify bona fide prognostic markers associated with survival group extremes (at least 18 months separate survival groups). Based on a stringent selection process, 13 putative PDA biomarkers were identified from the public biomarker repository. Candidates were tested against the s-TMA by immunohistochemistry to identify the best markers of tumor biology. In a multivariate model, MUC1 (odds ratio, OR = 28.95, 3+ vs. negative expression, p = 0.004) and MSLN (OR = 12.47, 3+ vs. negative expression, p = 0.01) were highly predictive of early cancer-specific death. By comparison, pathologic factors (size, lymph node metastases, resection margin status, and grade) had ORs below three, and none reached statistical significance. ROC curves were used to compare the four pathologic prognostic features (ROC area = 0.70) to three univariate molecular predictors (MUC1, MSLN, MUC2) of survival group (ROC area = 0.80, p = 0.07). Conclusions: MUC1 and MSLN were superior to pathologic features and other putative biomarkers as predicting survival group. Molecular assays comparing cancers from short and long survivors are an effective strategy to screen biomarkers and prioritize candidate cancer genes for diagnostic and therapeutic studies.	[Winter, Jordan M.; Brody, Jonathan R.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA; [Tang, Laura H.; Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Brennan, Murray F.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Fong, Yuman] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Rocha, Flavio G.; Jarnagin, William R.] Virginia Mason Med Ctr, Dept Surg, Seattle, WA 98101 USA; [Jia, Xiaoyu; Qin, Li-Xuan; Allen, Peter J.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [O'Reilly, Eileen M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Jefferson University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Virginia Mason Medical Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Winter, JM (corresponding author), Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA.	allenp@mskcc.org	Rocha, Flavio/AAV-3411-2020	O'Reilly, Eileen M./0000-0002-8076-9199; Brennan, Murray/0000-0003-2358-4371	Marshall and Therese Sonenshine Foundation;  [U01 CA152653]; NATIONAL CANCER INSTITUTE [U01CA152653] Funding Source: NIH RePORTER	Marshall and Therese Sonenshine Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funds for the study were derived from U01 CA152653, PI Allen. In addition, funds were provided by the Marshall and Therese Sonenshine Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2003, AM J SURG PATHOL, V27, P571, DOI 10.1097/00000478-200305000-00002; Argani P, 2001, CLIN CANCER RES, V7, P3862; Arnaoutakis GJ, 2011, J GASTROINTEST SURG, V15, P1611, DOI 10.1007/s11605-011-1605-8; Barton JG, 2009, J GASTROINTEST SURG, V13, P2050, DOI 10.1007/s11605-009-0849-z; Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Berger AC, 2008, J CLIN ONCOL, V26, P5918, DOI 10.1200/JCO.2008.18.6288; Boeck S, 2007, ONCOLOGY-BASEL, V72, P314, DOI 10.1159/000113054; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; Cantile M, 2009, INT J CANCER, V125, P1532, DOI 10.1002/ijc.24438; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Cardillo TM, 2001, CLIN CANCER RES, V7, P3186; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen L, 1996, J CLIN INVEST, V98, P2539, DOI 10.1172/JCI119072; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chung GG, 2006, CANCER, V106, P1677, DOI 10.1002/cncr.21783; Coppola D, 2011, PANCREAS, V40, P433, DOI 10.1097/MPA.0b013e318205eb03; Einama T, 2011, PANCREAS, V40, P1276, DOI 10.1097/MPA.0b013e318221bed8; Feng Y, 2009, MOL CANCER THER, V8, P1113, DOI 10.1158/1535-7163.MCT-08-0945; Garcea G, 2008, J PANCREAS, V9, P99; Gray PJ, 2004, MOL CANCER THER, V3, P641; Gray RG, 2011, J CLIN ONCOL, V29, P4611, DOI 10.1200/JCO.2010.32.8732; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Hinoda Y, 2003, J GASTROENTEROL, V38, P1162, DOI 10.1007/s00535-003-1224-6; Hollevoet K, 2012, J CLIN ONCOL, V30, P1541, DOI 10.1200/JCO.2011.39.6671; Huang JJ, 2000, ANN SURG, V231, P890, DOI 10.1097/00000658-200006000-00014; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023344; Jhala N, 2006, AM J CLIN PATHOL, V126, P572, DOI 10.1309/CEV30BE088CBDQD9; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Karamitopoulou E, 2010, PATHOLOGY, V42, P229, DOI 10.3109/00313021003631379; Kondo N, 2010, ANN SURG ONCOL, V17, P2321, DOI 10.1245/s10434-010-1033-0; Kurihara T, 2000, J CLIN INVEST, V106, P763, DOI 10.1172/JCI9180; Leao IC, 2008, CTS-CLIN TRANSL SCI, V1, P228, DOI 10.1111/j.1752-8062.2008.00070.x; Levi E, 2004, J CLIN PATHOL, V57, P456, DOI 10.1136/jcp.2003.013292; Lisovsky M, 2010, HUM PATHOL, V41, P902, DOI 10.1016/j.humpath.2009.12.004; Marsh WL, 2009, APPL IMMUNOHISTO M M, V17, P216, DOI 10.1097/PAI.0b013e31818c1aa6; Matros E, 2006, CANCER-AM CANCER SOC, V106, P693, DOI 10.1002/cncr.21609; Morse DL, 2010, BIOCHEM PHARMACOL, V80, P748, DOI 10.1016/j.bcp.2010.05.018; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pham NA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-43; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Sharon E, 2011, CLIN CHEM LAB MED; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shi CJ, 2012, HUM PATHOL, V43, P1, DOI 10.1016/j.humpath.2011.04.003; Showalter SL, 2008, CANCER BIOL THER, V7, P1584, DOI 10.4161/cbt.7.10.6562; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Tanaka M, 2011, J HISTOCHEM CYTOCHEM, V59, P942, DOI 10.1369/0022155411420569; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; Wegener W, 2008, SAFETY EFFICACY STUD; Wen J, 2010, PANCREAS, V39, P622, DOI 10.1097/MPA.0b013e3181c75f5e; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Winter JM, 2006, CANCER BIOL THER, V5, P360, DOI 10.4161/cbt.5.4.2552; Winter JM, 2012, ANN SURG ONCOL, V19, P169, DOI 10.1245/s10434-011-1900-3; Yang Wen-bin, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2135; Yang Wen-bin, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1908; Yu Guan-Zhen, 2005, Ai Zheng, V24, P1398; Yu GZ, 2004, PANCREAS, V28, P421, DOI 10.1097/00006676-200405000-00011	67	30	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40157	10.1371/journal.pone.0040157	http://dx.doi.org/10.1371/journal.pone.0040157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792233	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800044
J	Wolf, J; Armstrong, B				Wolf, Jennyfer; Armstrong, Ben			The Association of Season and Temperature with Adverse Pregnancy Outcome in Two German States, a Time-Series Analysis	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; LOW-BIRTH-WEIGHT; DISSIPATION LIMIT THEORY; HEAT-SHOCK RESPONSE; OF-THE-LITERATURE; PRETERM BIRTH; GESTATION LENGTH; RESIDENTIAL-MOBILITY; OUTDOOR TEMPERATURE; INFECTIOUS-DISEASES	Background: A seasonality of low birth weight (LBW) and preterm birth (PTB) has been described for most regions and there is evidence that this pattern is caused by ambient outdoor temperature. However, the association as such, the direction of effect and the critical time of exposure remain controversial. Methods: Logistic, time-series regression was performed on nearly 300,000 births from two German states to study the association between season and daily mean temperature and changes in daily proportions of term LBW (tLBW) or PTB. Analyses were adjusted for time-varying factors. Temperature exposures were examined during different periods of pregnancy. Results: Weak evidence for an association between season of conception, season of birth or ambient outdoor temperature and tLBW or PTB was found. Results of analyses of temperature were not consistent between the two states. Different sources of bias which would have artificially led to stronger findings were detected and are described. Conclusions: No clear evidence for an association between season of conception, season of birth or temperature and tLBW or PTB was found. In the study of pregnancy outcome different sources of bias can be identified which can potentially explain heterogeneous findings of the past.	[Wolf, Jennyfer; Armstrong, Ben] London Sch Hyg & Trop Med, Dept Social & Environm Hlth, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Wolf, J (corresponding author), WHO, Dept Publ Hlth & Environm, CH-1211 Geneva, Switzerland.	jennyfer.wolf@googlemail.com		armstrong, benedict/0000-0003-4407-0409	German Academic Exchange Office (DAAD)	German Academic Exchange Office (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Jennyfer Wolf received a scholarship of the German Academic Exchange Office (DAAD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Andrews WW, 1995, INFECT AGENT DIS, V4, P196; ANIELLO C, 1995, COMPUT GEOSCI-UK, V21, P965, DOI 10.1016/0098-3004(95)00033-5; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; BANTJE H, 1987, SOC SCI MED, V24, P733, DOI 10.1016/0277-9536(87)90110-9; Basu R, 2010, AM J EPIDEMIOL, V172, P1108, DOI 10.1093/aje/kwq170; Bodnar LM, 2008, PAEDIATR PERINAT EP, V22, P538, DOI 10.1111/j.1365-3016.2008.00971.x; Carson C, 2006, AM J EPIDEMIOL, V164, P77, DOI 10.1093/aje/kwj147; Chodick G, 2007, ANN EPIDEMIOL, V17, P440, DOI 10.1016/j.annepidem.2006.10.013; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; COOPERSTOCK M, 1986, AM J EPIDEMIOL, V124, P234, DOI 10.1093/oxfordjournals.aje.a114381; Dadvand P, 2011, ENVIRON HEALTH PERSP, V119, P1449, DOI 10.1289/ehp.1003241; Darrow LA, 2009, EPIDEMIOLOGY, V20, P699, DOI 10.1097/EDE.0b013e3181a66e96; Darrow LA, 2009, EPIDEMIOLOGY, V20, P689, DOI 10.1097/EDE.0b013e3181a7128f; Deschenes O, 2009, AM ECON REV, V99, P211, DOI 10.1257/aer.99.2.211; Duncan TC, 2009, STAT METHODS ENV EPI, P158; Edwards MJ, 1998, CELL STRESS CHAPERON, V3, P213, DOI 10.1379/1466-1268(1998)003<0213:ATHSRH>2.3.CO;2; Edwards MJ, 1997, INT J DEV BIOL, V41, P345; Elter K, 2004, AUST NZ J OBSTET GYN, V44, P553, DOI 10.1111/j.1479-828X.2004.00314.x; Fellman J, 2000, HUM BIOL, V72, P851; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Flouris AD, 2009, AM J HUM BIOL, V21, P214, DOI 10.1002/ajhb.20818; Gouveia N, 2003, INT J EPIDEMIOL, V32, P390, DOI 10.1093/ije/dyg077; HOLMES JHG, 1986, TROP ANIM HEALTH PRO, V18, P185, DOI 10.1007/BF02359533; HOWELL CE, 1951, J ANIM SCI, V10, P789, DOI 10.2527/jas1951.104789x; KELLER CA, 1983, AM J EPIDEMIOL, V118, P689, DOI 10.1093/oxfordjournals.aje.a113679; KHOURY MJ, 1988, J CLIN EPIDEMIOL, V41, P15, DOI 10.1016/0895-4356(88)90004-2; Laaidi M, 2011, ENVIRON RISQUE SANTE, V10, P128, DOI 10.1684/ers.2011.0432; Lackland D T, 2003, J Clin Hypertens (Greenwich), V5, P133, DOI 10.1111/j.1524-6175.2003.01353.x; Lajinian S, 1997, AM J PUBLIC HEALTH, V87, P1205, DOI 10.2105/AJPH.87.7.1205; Lawlor DA, 2005, BJOG-INT J OBSTET GY, V112, P647, DOI 10.1111/j.1471-0528.2004.00488.x; Lee MC, 1998, FAM PRACT, V15, P336, DOI 10.1093/fampra/15.4.336; Lee SJ, 2006, BJOG-INT J OBSTET GY, V113, P1280, DOI 10.1111/j.1471-0528.2006.01055.x; Lee SJ, 2005, THESIS LONDON SCH HY; Lee SJ, 2008, ENVIRON RES, V106, P185, DOI 10.1016/j.envres.2007.10.003; Lisonkova S, 2010, J OBSTET GYNAECOL CA, V32, P541, DOI 10.1016/S1701-2163(16)34522-4; Madsen C, 2010, ENVIRON RES, V110, P363, DOI 10.1016/j.envres.2010.02.005; Magnus P, 2001, BRIT J OBSTET GYNAEC, V108, P1116, DOI 10.1111/j.1471-0528.2003.00273.x; MANGOLD WD, 1981, AM J PUBLIC HEALTH, V71, P601, DOI 10.2105/AJPH.71.6.601; MATSUDA S, 1993, HUM BIOL, V65, P481; MATSUDA S, 1995, HUM BIOL, V67, P641; MATSUDA S, 1992, INT J EPIDEMIOL, V21, P91, DOI 10.1093/ije/21.1.91; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McGrath JJ, 2005, ANN HUM BIOL, V32, P547, DOI 10.1080/03014460500154699; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Murray LJ, 2000, OBSTET GYNECOL, V96, P689, DOI 10.1016/S0029-7844(00)01022-X; Porter KR, 1999, AM J PUBLIC HEALTH, V89, P1090, DOI 10.2105/AJPH.89.7.1090; Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134; RIOPELLE AJ, 1975, AM J CLIN NUTR, V28, P1170, DOI 10.1093/ajcn/28.10.1170; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Rousham EK, 1998, AUST NZ J PUBL HEAL, V22, P669, DOI 10.1111/j.1467-842X.1998.tb01467.x; Ruff CB, 1994, AM J PHYS ANTHROPOL, V37, P65, DOI DOI 10.1002/AJPA.1330370605; Scott IC, 2008, ANIM REPROD SCI, V109, P206, DOI 10.1016/j.anireprosci.2007.11.025; SELVIN S, 1971, BRIT J PREV SOC MED, V25, P12; Simons MJP, 2011, J EXP BIOL, V214, P38, DOI 10.1242/jeb.044230; Speakman JR, 2010, INTEGR COMP BIOL, V50, P793, DOI 10.1093/icb/icq049; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Strand LB, 2011, ENVIRON RES, V111, P451, DOI 10.1016/j.envres.2011.01.023; Strand LB, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-49; Tam WH, 2008, GYNECOL OBSTET INVES, V66, P22, DOI 10.1159/000114252; Thornton J G, 2001, Eur J Obstet Gynecol Reprod Biol, V95, P5, DOI 10.1016/S0301-2115(00)00381-X; Tustin K, 2004, DEV PSYCHOBIOL, V45, P221, DOI 10.1002/dev.20030; US EPA, 2006, HLTH CLIM CHANG HLTH; Wells JCK, 2002, AM J PHYS ANTHROPOL, V119, P276, DOI 10.1002/ajpa.10137; Wells JCK, 2002, J THEOR BIOL, V214, P413, DOI 10.1006/jtbi.2001.2465; Wier ML, 2007, PAEDIATR PERINAT EP, V21, P4, DOI 10.1111/j.1365-3016.2007.00856.x; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Wohlfahrt J, 1998, LANCET, V352, P1990, DOI 10.1016/S0140-6736(05)61336-0; World Health Organization, TOP 10 CAUS DEATH; Yackerson NS, 2007, CLIN EXP OBSTET GYN, V34, P27; Yamauchi F, 2010, EMPIRICAL STUDY GROW; YEATES N. T. M., 1956, AUSTRALIAN JOUR AGRIC RES, V7, P435, DOI 10.1071/AR9560435	73	47	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40228	10.1371/journal.pone.0040228	http://dx.doi.org/10.1371/journal.pone.0040228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974UB	22792247	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000306461800052
J	Smith, LJ; Stapleton, MR; Buxton, RS; Green, J				Smith, Laura J.; Stapleton, Melanie R.; Buxton, Roger S.; Green, Jeffrey			Structure-Function Relationships of the Mycobacterium tuberculosis Transcription Factor WhiB1	PLOS ONE			English	Article							NITRIC-OXIDE; 4FE-4S CLUSTER; PROTEIN	Background: Members of the WhiB-like (Wbl) protein family possess iron-sulfur clusters and are implicated in the regulation of developmental processes in Actinomycetes. Mycobacterium tuberculosis possesses seven Wbl proteins. The [4Fe-4S] cluster of M. tuberculosis WhiB1 is relatively insensitive to O-2 but very sensitive to nitric oxide (NO). Nitric oxide nitrosylates the WhiB1 iron-sulfur cluster and promotes DNA-binding; the apo-forms of WhiB1 also bind DNA. However, the molecular requirements for iron-sulfur cluster acquisition and for DNA-binding by WhiB1 are poorly characterized. Methods and Findings: WhiB1 variants were created by site-directed mutagenesis and the abilities of the corresponding proteins to acquire an iron-sulfur cluster and/or bind to whiB1 promoter DNA were assessed. All four Cys residues (Cys9, 37, 40, and 46) in the N-terminal region of WhiB1 were required for incorporation of a [4Fe-4S] cluster, whereas a possible alternative cluster ligand Asp13 (by analogy with M. smegmatis WhiB2) was not. The C-terminal region of WhiB1 is predicted to house the DNA-binding domain of the protein consisting of a predicted beta-turn ((58)GVWGG(62)) followed by two amino acid motifs ((KRRN75)-K-72 and (78)TKAR(81)) that are conserved in WhiB1 proteins. Gly residues (Gly58, 61 and 62) in the b-turn and positively-charged residues (Lys72, Arg73, Arg74, Lys79 and Arg81) in the downstream conserved regions were required for binding of WhiB1 DNA. Conclusions: Site-directed mutagenesis of M. tuberculosis whiB1 and characterization of the corresponding proteins has been used to explore structure-function relationships of the NO-responsive transcription factor WhiB1. This showed that all four conserved Cys residues in the N-terminal region are required for incorporation of iron-sulfur clusters but not for DNA-binding. Analysis of variants with amino acid substitutions in the C-terminal region revealed the crucial roles played by a predicted b-turn and two conserved positively-charged motifs in facilitating DNA-binding, but not iron-sulfur cluster acquisition, by WhiB1.	[Smith, Laura J.; Stapleton, Melanie R.; Green, Jeffrey] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Buxton, Roger S.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	University of Sheffield; MRC National Institute for Medical Research	Smith, LJ (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	mbp08ljs@sheffield.ac.uk			Biotechnology and Biological Sciences Research Council UK;  [BB/G018960/1]; Biotechnology and Biological Sciences Research Council [BB/G018960/1] Funding Source: researchfish; Medical Research Council [MC_U117585867] Funding Source: researchfish; BBSRC [BB/G018960/1] Funding Source: UKRI; MRC [MC_U117585867] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Biotechnology and Biological Sciences Research Council UK studentship to LJS and Project Grant BB/G018960/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Erht S, 2009, CELL MICROBIOL, V11, P1170; Flynn JL, 1998, J IMMUNOL, V160, P1796; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Ragahund TR, 2006, J BACTERIOL, V188, P6966; Ralph AP, 2008, TRENDS MICROBIOL, V16, P336, DOI 10.1016/j.tim.2008.04.003; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Stapleton MR, 2012, TUBERCULOSIS EDINB, DOI [10.1016/j.tube2012.03.001, DOI 10.1016/J.TUBE2012.03.001]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; World Health Organisation, 2011, WHOHTMTB201116	15	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40407	10.1371/journal.pone.0040407	http://dx.doi.org/10.1371/journal.pone.0040407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792304	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000306436300064
J	Schon, I; Pinto, RL; Halse, S; Smith, AJ; Martens, K; Birky, CW				Schon, Isa; Pinto, Ricardo L.; Halse, Stuart; Smith, Alison J.; Martens, Koen; Birky, C. William, Jr.			Cryptic Species in Putative Ancient Asexual Darwinulids (Crustacea, Ostracoda)	PLOS ONE			English	Article							GLOBAL DIVERSITY; SEMITERRESTRIAL HABITATS; DNA TAXONOMY; GENUS; EVOLUTION; ORIBATIDA; ROTIFERA; ACARI; DIVERSIFICATION; DELIMITATION	Background: Fully asexually reproducing taxa lack outcrossing. Hence, the classic Biological Species Concept cannot be applied. Methodology/Principal Findings: We used DNA sequences from the mitochondrial COI gene and the nuclear ITS2 region to check species boundaries according to the evolutionary genetic (EG) species concept in five morphospecies in the putative ancient asexual ostracod genera, Penthesilenula and Darwinula, from different continents. We applied two methods for detecting cryptic species, namely the K/h method and the General Mixed Yule Coalescent model (GMYC). We could confirm the existence of species in all five darwinulid morphospecies and additional cryptic diversity in three morphospecies, namely in Penthesilenula brasiliensis, Darwinula stevensoni and in P. aotearoa. The number of cryptic species within one morphospecies varied between seven (P. brasiliensis), five to six (D. stevensoni) and two (P. aotearoa), respectively, depending on the method used. Cryptic species mainly followed continental distributions. We also found evidence for coexistence at the local scale for Brazilian cryptic species of P. brasiliensis and P. aotearoa. Our ITS2 data confirmed that species exist in darwinulids but detected far less EG species, namely two to three cryptic species in P. brasiliensis and no cryptic species at all in the other darwinulid morphospecies. Conclusions/Significance: Our results clearly demonstrate that both species and cryptic diversity can be recognized in putative ancient asexual ostracods using the EG species concept, and that COI data are more suitable than ITS2 for this purpose. The discovery of up to eight cryptic species within a single morphospecies will significantly increase estimates of biodiversity in this asexual ostracod group. Which factors, other than long-term geographic isolation, are important for speciation processes in these ancient asexuals remains to be investigated.	[Schon, Isa; Martens, Koen] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Schon, Isa] Univ Hasselt, Dept Biol, Diepenbeek, Belgium; [Pinto, Ricardo L.] Univ Brasilia, Inst Geosci, Brasilia, DF, Brazil; [Halse, Stuart] Bennelongia Pty Ltd, Wembley, WA, Australia; [Smith, Alison J.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Martens, Koen] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Birky, C. William, Jr.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Royal Belgian Institute of Natural Sciences; Hasselt University; Universidade de Brasilia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Ghent University; University of Arizona	Schon, I (corresponding author), Royal Belgian Inst Nat Sci, Brussels, Belgium.	isa.schoen@naturalsciences.be	Halse, Stuart/GXF-7832-2022; Pinto, Ricardo/I-4814-2012; Martens, Koen RLM/A-8171-2010	Pinto, Ricardo/0000-0002-4128-8405; 	FAPESP [Proc: 03/13510-5]; CAPES [Proc: BEX3406/04-0]; Belgian OSTC [MO/36/005, MO/36/015]; Flemish FWO [1.5.172.09N]; Department of Environment and Conservation (Western Australia)	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Belgian OSTC; Flemish FWO(FWO); Department of Environment and Conservation (Western Australia)	Fellowships to RP: FAPESP (Proc: 03/13510-5); CAPES (Proc: BEX3406/04-0). Research Founding to IS & KM: Belgian OSTC (MO/36/005 & MO/36/015). Research Founding to KM: Flemish FWO (krediet voor navorsers 1.5.172.09N). Scientific Stay of IS & KM: Department of Environment and Conservation (Western Australia). Visiting Fellowship to IS: Edit-Cowan-University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artheau M, 2007, INVERTEBR SYST, V21, P471, DOI 10.1071/IS05058; Barraclough TG, 2003, EVOLUTION, V57, P2166; Bell G., 1982, MASTERPIECE NATURE E; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Bode SNS, 2010, MOL PHYLOGENET EVOL, V54, P542, DOI 10.1016/j.ympev.2009.08.022; Bromham L, 2000, J MOL EVOL, V50, P296, DOI 10.1007/s002399910034; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; COYNE JA, 1994, EVOLUTION, V48, P19, DOI 10.1111/j.1558-5646.1994.tb01290.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023969; Fontaneto D, 2011, HYDROBIOLOGIA, V662, P27, DOI 10.1007/s10750-010-0481-7; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Foottit R. G., 1997, V54, P291; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hay WW, 1999, GEOL S AM S, P1; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Heethoff M, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-2; Heethoff M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P241, DOI 10.1007/978-90-481-2770-2_12; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Martens K, 2003, P ROY SOC B-BIOL SCI, V270, P723, DOI 10.1098/rspb.2002.2270; Martens K, 2005, HYDROBIOLOGIA, V538, P153, DOI 10.1007/s10750-004-4945-5; Martens K, 2002, INVERTEBR SYST, V16, P195, DOI 10.1071/IT01022; Martens K, 1998, SEX AND PARTHENOGENESIS, P295; Martens K, 1998, SEX AND PARTHENOGENESIS, P197; Martens K, 2008, NATURE, V453, P587, DOI 10.1038/453587b; Martens K, 2008, HYDROBIOLOGIA, V595, P185, DOI 10.1007/s10750-007-9245-4; Martens K, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P187, DOI 10.1007/978-90-481-2770-2_9; Maynard Smith, 1998, EVOL GENET; MAYR E, 1970, P453; Molostovskaya II, 2000, HYDROBIOLOGIA, V419, P125, DOI 10.1023/A:1003982517547; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Neiman M, 2009, ANN NY ACAD SCI, V1168, P185, DOI 10.1111/j.1749-6632.2009.04572.x; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pinto RL, 2005, CRUSTACEANA, V78, P975, DOI 10.1163/156854005775197244; Pinto RL, 2005, ZOOL J LINN SOC-LOND, V145, P145, DOI 10.1111/j.1096-3642.2005.00185.x; Pinto RL, 2004, J NAT HIST, V38, P2567, DOI 10.1080/00222930310001647424; Pinto RL, 2003, ZOOL J LINN SOC-LOND, V139, P305, DOI 10.1046/j.1096-3642.2003.00070.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2022, R LANG ENV STAT COMP; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Rossetti G, 2011, BELG J ZOOL, V141, P55; Rossetti Giampaolo, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V68, P55; Rossetti Giampaolo, 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V66, P73; Schatz H, 2008, HYDROBIOLOGIA, V595, P323, DOI 10.1007/s10750-007-9027-z; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P217, DOI 10.1007/978-90-481-2770-2_11; Schoen Isa, 2008, V3, P341, DOI 10.1007/7050_2007_032; Schon I, 2007, HYDROBIOLOGIA, V575, P33, DOI 10.1007/s10750-006-0276-z; Schon I, 1998, J NAT HIST, V32, P943, DOI 10.1080/00222939800770481; Schon I, 2003, BIOL J LINN SOC, V79, P93, DOI 10.1046/j.1095-8312.2003.00186.x; Schon I, 1998, P ROY SOC B-BIOL SCI, V265, P235, DOI 10.1098/rspb.1998.0287; Schon I, 2003, P ROY SOC B-BIOL SCI, V270, P827, DOI 10.1098/rspb.2002.2314; Schwander T, 2011, CURR BIOL, V21, P1129, DOI 10.1016/j.cub.2011.05.026; Schwander T, 2009, MOL ECOL, V18, P28, DOI 10.1111/j.1365-294X.2008.03992.x; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Smith RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1569, DOI 10.1098/rspb.2005.3452; Subias L. S., 2004, Graellsia, V60, P3; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Van Doninck K, 2003, FRESHWATER BIOL, V48, P1285, DOI 10.1046/j.1365-2427.2003.01078.x; Van Doninck K, 2002, OECOLOGIA, V132, P205, DOI 10.1007/s00442-002-0939-z; Welch DBM, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P259, DOI 10.1007/978-90-481-2770-2_13; White T., 1990, PCR PROTOCOLS GUIDE, P315	85	43	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39844	10.1371/journal.pone.0039844	http://dx.doi.org/10.1371/journal.pone.0039844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802945	Green Published, Green Submitted, gold			2022-12-25	WOS:000306186900019
J	Neilsen, PM; Noll, JE; Mattiske, S; Bracken, CP; Gregory, PA; Schulz, RB; Lim, SP; Kumar, R; Suetani, RJ; Goodall, GJ; Callen, DF				Neilsen, P. M.; Noll, J. E.; Mattiske, S.; Bracken, C. P.; Gregory, P. A.; Schulz, R. B.; Lim, S. P.; Kumar, R.; Suetani, R. J.; Goodall, G. J.; Callen, D. F.			Mutant p53 drives invasion in breast tumors through up-regulation of miR-155	ONCOGENE			English	Article						breast cancer; invasion; miR-155; mutant p53; ZNF652	CANCER PATIENTS; GENE; EXPRESSION; MICRORNA-155; METASTASIS; GROWTH; TRANSITION; CARCINOMA; CELLS; PDCD4	Loss of p53 function is a critical event during tumorigenesis, with half of all cancers harboring mutations within the TP53 gene. Such events frequently result in the expression of a mutated p53 protein with gain-of-function properties that drive invasion and metastasis. Here, we show that the expression of miR-155 was up-regulated by mutant p53 to drive invasion. The miR-155 host gene was directly repressed by p63, providing the molecular basis for mutant p53 to drive miR-155 expression. Significant overlap was observed between miR-155 targets and the molecular profile of mutant p53-expressing breast tumors in vivo. A search for cancer-related target genes of miR-155 revealed ZNF652, a novel zinc-finger transcriptional repressor. ZNF652 directly repressed key drivers of invasion and metastasis, such as TGFB1, TGFB2, TGFBR2, EGFR, SMAD2 and VIM. Furthermore, silencing of ZNF652 in epithelial cancer cell lines promoted invasion into matrigel. Importantly, loss of ZNF652 expression in primary breast tumors was significantly correlated with increased local invasion and defined a population of breast cancer patients with metastatic tumors. Collectively, these findings suggest that miR-155 targeted therapies may provide an attractive approach to treat mutant p53-expressing tumors.	[Neilsen, P. M.; Noll, J. E.; Mattiske, S.; Schulz, R. B.; Lim, S. P.; Kumar, R.; Suetani, R. J.; Callen, D. F.] Univ Adelaide, Ctr Personalised Canc Med, Adelaide, SA 5005, Australia; [Neilsen, P. M.; Noll, J. E.; Mattiske, S.; Bracken, C. P.; Gregory, P. A.; Schulz, R. B.; Lim, S. P.; Kumar, R.; Suetani, R. J.; Goodall, G. J.; Callen, D. F.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [Bracken, C. P.; Gregory, P. A.; Goodall, G. J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Goodall, G. J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide; Centre for Cancer Biology; SA Pathology; University of Adelaide	Neilsen, PM (corresponding author), Univ Adelaide, Ctr Personalised Canc Med, Sarcoma Res Grp, Adelaide, SA 5005, Australia.	Paul.Neilsen@health.sa.gov.au	Callen, David F/G-1975-2012; Gregory, Philip/F-4089-2013; Kumar, Raman/AHE-0538-2022	Gregory, Philip/0000-0002-0999-0632; Kumar, Raman/0000-0001-7976-8386; Neilsen, Paul/0000-0001-7937-3675; Noll, Jacqueline/0000-0001-7375-635X; Goodall, Gregory/0000-0003-1294-0692; Callen, David/0000-0002-6189-9991; Bracken, Cameron/0000-0001-7722-625X	National Health and Medical Research Council (NHMRC) of Australia [1009447]; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	We thank Dr Erik Flemington for his kind gift of the pMSCV-Puro-GFP-miR-155 plasmid. We also thank Dr Emily Paterson and Bee Suan Tay for technical assistance. This study was supported by the National Health and Medical Research Council (NHMRC) of Australia (project # 1009447).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; DAVIDOFF AM, 1991, J SURG ONCOL, V48, P260, DOI 10.1002/jso.2930480409; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Huang Y, 2011, CELL DEATH DIFFER, V18, P1220, DOI 10.1038/cdd.2010.188; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kumar R, 2008, J BIOL CHEM, V283, P19026, DOI 10.1074/jbc.M709136200; Kumar R, 2006, MOL CANCER RES, V4, P655, DOI 10.1158/1541-7786.MCR-05-0249; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nieves-Alicea R, 2009, BREAST CANCER RES TR, V114, P203, DOI 10.1007/s10549-008-9993-5; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pishas KI, 2011, CLIN CANCER RES, V17, P494, DOI 10.1158/1078-0432.CCR-10-1587; Santhanam AN, 2010, ONCOGENE, V29, P3921, DOI 10.1038/onc.2010.158; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Utku Y, 2006, MOL BIOSYST, V2, P312, DOI 10.1039/b603229j; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wen YH, 2007, ONCOL REP, V18, P1387; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yu Q, 2004, CLIN EXP METASTAS, V21, P235, DOI 10.1023/B:CLIN.0000037705.25256.d3	38	121	125	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2013	32	24					2992	3000		10.1038/onc.2012.305	http://dx.doi.org/10.1038/onc.2012.305			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22797073	Green Published			2022-12-25	WOS:000320369700009
J	McCallum, M; Shaw, SD; Shaw, GS; Creuzenet, C				McCallum, Matthew; Shaw, Steven D.; Shaw, Gary S.; Creuzenet, Carole			Complete 6-Deoxy-D-altro-heptose Biosynthesis Pathway from Campylobacter jejuni MORE COMPLEX THAN ANTICIPATED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-L-FUCOSE; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; ACTIVE-SITE; YERSINIA-PSEUDOTUBERCULOSIS; 6-DEOXYHEXOSE SYNTHESIS; PROTEIN GLYCOSYLATION; HELICOBACTER-PYLORI; LIPOOLIGOSACCHARIDE; RESISTANCE	The Campylobacter jejuni capsule is important for colonization and virulence in various infection models. In most strains, the capsule includes a modified heptose whose biological role and biosynthetic pathway are unknown. To decipher the biosynthesis pathway for the 6-deoxy-D-altro-heptose of strain 81-176, we previously showed that the 4,6-dehydratase WcbK and the reductase WcaG generated GDP-6-deoxy-D-manno-heptose, but the C3 epimerase necessary to form GDP-6-deoxy-D-altro-heptose was not identified. Herein, we characterized the putative C3/C5 epimerase Cjj1430 and C3/C5 epimerase/C4 reductase Cjj1427 from the capsular cluster. We demonstrate that GDP-6-deoxy-D-altro-heptose biosynthesis is more complex than anticipated and requires the sequential action of WcbK, Cjj1430, and Cjj1427. We show that Cjj1430 serves as C3 epimerase devoid of C5 epimerization activity and that Cjj1427 has no epimerization activity and only serves as a reductase to produce GDP-6-deoxy-D-altro-heptose. Cjj1430 and Cjj1427 are the only members of the C3/C5 epimerases and C3/C5 epimerase/C4 reductase families shown to have activity on a heptose substrate and to exhibit only one of their two to three potential activities, respectively. Furthermore, we show that although the reductase WcaG is not part of the main pathway, its presence and its product affect the outcome of the pathway in a complex regulatory loop involving Cjj1427. This work provides the grounds for the elucidation of similar pathways found in other C. jejuni strains and other pathogens. It provides new molecular tools for the synthesis of carbohydrate antigens useful for vaccination and for the screening of enzymatic inhibitors that may have antibacterial effects.	[McCallum, Matthew; Shaw, Steven D.; Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, London, ON N6A 5C1, Canada; [Shaw, Steven D.; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Creuzenet, C (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, DSB 3031, London, ON N6A 5C1, Canada.	ccreuzen@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625	Natural Sciences and Engineering Research Council of Canada [RGPIN 240762-2010]; Canadian Institutes of Health Research [MOP 93520]; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by Natural Sciences and Engineering Research Council of Canada Operating Grant RGPIN 240762-2010 (to C. C.) and Canadian Institutes of Health Research Grant MOP 93520 and the Canada Research Chairs Program (to G. S. S.).	ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; ASPINALL GO, 1992, CARBOHYD RES, V231, P13, DOI 10.1016/0008-6215(92)84003-B; Aspinall GO, 1995, CARBOHYD RES, V279, P227, DOI 10.1016/0008-6215(95)00283-9; Bachtiar BM, 2007, FEMS IMMUNOL MED MIC, V49, P149, DOI 10.1111/j.1574-695X.2006.00182.x; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Butty FD, 2009, BIOCHEMISTRY-US, V48, P7764, DOI 10.1021/bi901065t; Chen YH, 2008, CARBOHYD RES, V343, P1034, DOI 10.1016/j.carres.2008.02.024; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; GABRIEL O, 1968, J BIOL CHEM, V243, P1479; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Hegeman AD, 2002, BIOCHEMISTRY-US, V41, P2797, DOI 10.1021/bi011748c; Ho N, 2008, MOL MICROBIOL, V68, P424, DOI 10.1111/j.1365-2958.2008.06163.x; Ito S, 2009, APPL MICROBIOL BIOT, V84, P1053, DOI 10.1007/s00253-009-2179-1; Jarvinen N, 2001, EUR J BIOCHEM, V268, P6458, DOI 10.1046/j.0014-2956.2001.02601.x; JOHN BK, 1993, J MAGN RESON SER A, V101, P113, DOI 10.1006/jmra.1993.1019; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keo T, 2011, VIRULENCE, V2, P30, DOI 10.4161/viru.2.1.14752; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Kittl S, 2011, J APPL MICROBIOL, V110, P513, DOI 10.1111/j.1365-2672.2010.04906.x; Kneidinger B, 2001, J BIOL CHEM, V276, P20935, DOI 10.1074/jbc.M100378200; Kondakova AN, 2008, CARBOHYD RES, V343, P1383, DOI 10.1016/j.carres.2008.04.003; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; Lin J, 2007, ANTIMICROB AGENTS CH, V51, P1678, DOI 10.1128/AAC.01411-06; Lindow JC, 2010, J CLIN MICROBIOL, V48, P3012, DOI 10.1128/JCM.00768-10; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; MELO A, 1968, J BIOL CHEM, V243, P1475; MELO A, 1968, J BIOL CHEM, V243, P1467; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Peng WJ, 2011, ORG LETT, V13, P5290, DOI 10.1021/ol202152r; Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Rizzi M, 1998, STRUCTURE, V6, P1453, DOI 10.1016/S0969-2126(98)00144-0; Shashkov AS, 2001, CARBOHYD RES, V330, P289, DOI 10.1016/S0008-6215(00)00309-8; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; Stern RJ, 1999, MICROBIOL-UK, V145, P663, DOI 10.1099/13500872-145-3-663; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; XIANG SH, 1993, J BACTERIOL, V175, P4877, DOI 10.1128/JB.175.15.4877-4884.1993; YAO ZJ, 1994, J BACTERIOL, V176, P4133, DOI 10.1128/JB.176.13.4133-4143.1994; Zhao S, 2010, APPL ENVIRON MICROB, V76, P7949, DOI 10.1128/AEM.01297-10	53	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29776	29788		10.1074/jbc.M112.390492	http://dx.doi.org/10.1074/jbc.M112.390492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787156	hybrid, Green Published			2022-12-25	WOS:000308286900053
J	Musante, L; Saraswat, M; Duriez, E; Byrne, B; Ravida, A; Domon, B; Holthofer, H				Musante, Luca; Saraswat, Mayank; Duriez, Elodie; Byrne, Barry; Ravida, Alessandra; Domon, Bruno; Holthofer, Harry			Biochemical and Physical Characterisation of Urinary Nanovesicles following CHAPS Treatment	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; EXOSOMES; SOLUBILIZATION; BIOMARKERS; CLONING; IDENTIFICATION; ENKEPHALINASE; BIOGENESIS; EXPRESSION; PROTEOMICS	Urinary exosomes represent a precious source of potential biomarkers for disease biology. Currently, the methods for vesicle isolation are severely restricted by the tendency of vesicle entrapment, e. g. by the abundant Tamm-Horsfall protein (THP) polymers. Treatment by reducing agents such as dithiothreitol (DTT) releases entrapped vesicles, thus increasing the final yield. However, this harsh treatment can cause remodelling of all those proteins which feature extra-vesicular domains stabilized by internal disulfide bridges and have detrimental effects on their biological activity. In order to optimize exosomal yield, we explore two vesicle treatment protocols-dithiothreitol (DTT) and 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic (CHAPS)-applied to the differential centrifugation protocol for exosomal vesicle isolation. The results show that CHAPS treatment does not affect vesicle morphology or exosomal marker distribution, thus eliminating most of THP interference. Moreover, the recovery and preservation of catalytic activity of two trans-membrane proteases, dipeptidyl peptidase IV and nephrilysin, was examined and found to be clearly superior after CHAPS treatment compared to DTT. Finally, proteomic profiling by mass spectrometry (MS) revealed that 76.2% of proteins recovered by CHAPS are common to those seen for DTT treatment, which illustrates underlining similarities between the two approaches. In conclusion, we provide a major improvement to currently-utilized urinary vesicle isolation strategies to allow recovery of urinary vesicles without the deleterious interference of abundant urinary proteins, while preserving typical protein folding and, consequently, the precious biological activity of urinary proteins which serve as valuable biomarkers.	[Musante, Luca; Saraswat, Mayank; Byrne, Barry; Ravida, Alessandra; Holthofer, Harry] Dublin City Univ, Ctr BioAnalyt Sci CBAS, Dublin 9, Ireland; [Duriez, Elodie; Domon, Bruno] CRP Sante, Luxembourg Clin Prote Ctr LCP, Strassen, Luxembourg	Dublin City University; Luxembourg Institute of Health	Musante, L (corresponding author), Dublin City Univ, Ctr BioAnalyt Sci CBAS, Dublin 9, Ireland.	harry.holthofer@dcu.ie	Saraswat, Mayank/F-2985-2015; Musante, Luca/F-5086-2017; Musante, Luca/A-8460-2015	Saraswat, Mayank/0000-0002-5021-8150; Musante, Luca/0000-0003-0845-275X; Musante, Luca/0000-0002-6225-8598; Duriez, Elodie/0000-0001-8780-3479; Ravida, Alessandra/0000-0001-8547-2039	Luxembourg Fonds National de la Recherche (FNR) (PEARL grant); Health Research Board (HRB) [HRA/09/62]	Luxembourg Fonds National de la Recherche (FNR) (PEARL grant)(Luxembourg National Research Fund); Health Research Board (HRB)	This work was funded by The Luxembourg Fonds National de la Recherche (FNR) (PEARL grant). We acknowledge the financial support of the Health Research Board (HRB), grant number HRA/09/62. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; Ahola H, 1999, AM J PATHOL, V155, P907, DOI 10.1016/S0002-9440(10)65190-5; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; Busek P, 2004, INT J BIOCHEM CELL B, V36, P408, DOI 10.1016/S1357-2725(03)00262-0; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; ERDOS EG, 1989, FASEB J, V3, P145, DOI 10.1096/fasebj.3.2.2521610; FAIRLEY JK, 1983, BRIT MED J, V287, P1838, DOI 10.1136/bmj.287.6408.1838; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; FLORENTIN D, 1984, ANAL BIOCHEM, V141, P62, DOI 10.1016/0003-2697(84)90425-1; Garner AE, 2008, BIOPHYS J, V94, P1326, DOI 10.1529/biophysj.107.114108; Gonzales PA, 2010, METHODS MOL BIOL, V641, P89, DOI 10.1007/978-1-60761-711-2_6; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hara M, 2010, HUM PATHOL, V41, P1265, DOI 10.1016/j.humpath.2010.02.004; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; HJELMELAND LM, 1980, P NATL ACAD SCI-BIOL, V77, P6368, DOI 10.1073/pnas.77.11.6368; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kentsis A, 2009, PROTEOM CLIN APPL, V3, P1052, DOI 10.1002/prca.200900008; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kobayashi K, 2001, ARCH BIOCHEM BIOPHYS, V388, P113, DOI 10.1006/abbi.2000.2265; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; KUMAR S, 1985, HISTOCHEM J, V17, P1251, DOI 10.1007/BF01002506; LABETA MO, 1988, J IMMUNOL METHODS, V112, P133, DOI 10.1016/0022-1759(88)90043-9; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; LIU WJ, 1995, ENDOCRINOLOGY, V136, P779, DOI 10.1210/en.136.2.779; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; MCQUEEN EG, 1966, J CLIN PATHOL, V19, P392, DOI 10.1136/jcp.19.4.392; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Patari A, 2003, DIABETES, V52, P2969, DOI 10.2337/diabetes.52.12.2969; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; SHIMADA K, 1994, J BIOL CHEM, V269, P18275; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sustar V, 2011, INT J NANOMED, V6, P2737, DOI 10.2147/IJN.S24537; TAMM I, 1952, J EXP MED, V95, P71, DOI 10.1084/jem.95.1.71; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Watanabe T, 2005, CELL TISSUE RES, V321, P185, DOI 10.1007/s00441-005-1148-y; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Wenk R E, 1981, Pathobiol Annu, V11, P229; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206	59	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e37279	10.1371/journal.pone.0037279	http://dx.doi.org/10.1371/journal.pone.0037279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808001	Green Submitted, Green Published, gold			2022-12-25	WOS:000306366400002
J	Villers, A; Godaux, E; Ris, L				Villers, Agnes; Godaux, Emile; Ris, Laurence			Long-Lasting LTP Requires Neither Repeated Trains for Its Induction Nor Protein Synthesis for Its Development	PLOS ONE			English	Article							BETA-ADRENERGIC-RECEPTORS; KINASE M-ZETA; TERM POTENTIATION; LATE-PHASE; D-SERINE; SYNAPTIC PLASTICITY; AMPA RECEPTORS; HIPPOCAMPAL SLICES; CA1 REGION; REPEATED TETANIZATION	Current thinking about LTP triggered in the area CA1 of hippocampal slices is ruled by two "dogmas'': (1) A single train of high-frequency stimulation is sufficient to trigger short-lasting LTP (1 - 3 h), whereas multiple trains are required to induce long-lasting LTP (L-LTP, more than 4 h). (2) The development of the late phase of L-LTP requires the synthesis of new proteins. In this study, we found that a single high-frequency train could trigger an LTP lasting more than 8 h that was not affected by either anisomycin or cycloheximide (two inhibitors of protein synthesis). We ascertained that the induction of this L-LTP made use of the same mechanisms as those usually reported to be involved in LTP induction: it was dependent on NMDA receptors and on the activation of two "core'' kinases, CaMKII and PI3K. These findings call into question the two "dogmas'' about LTP.	[Villers, Agnes; Godaux, Emile; Ris, Laurence] Univ Mons, Dept Neurosci, B-7000 Mons, Belgium	University of Mons	Villers, A (corresponding author), Univ Mons, Dept Neurosci, B-7000 Mons, Belgium.	laurence.ris@umons.ac.be	VILLERS, Arnauld/K-6629-2016	VILLERS, Arnauld/0000-0002-6298-7758	Belgian Fund for Scientific Research (F.R.S-FNRS); Queen Elisabeth Fund for Medical Research	Belgian Fund for Scientific Research (F.R.S-FNRS)(Fonds de la Recherche Scientifique - FNRS); Queen Elisabeth Fund for Medical Research	The work was support by the Belgian Fund for Scientific Research (F.R.S-FNRS) and by the Queen Elisabeth Fund for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2009, NEUROSCI RES, V63, P59, DOI 10.1016/j.neures.2008.10.008; Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Appleby VJ, 2011, J NEUROCHEM, V116, P530, DOI 10.1111/j.1471-4159.2010.07133.x; Bagayogo IP, 2009, ASN NEURO, V1, DOI 10.1042/AN20090006; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bortolotto ZA, 1998, NEUROPHARMACOLOGY, V37, P535, DOI 10.1016/S0028-3908(98)00058-6; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; Bortolotto ZA, 2008, NEUROPHARMACOLOGY, V55, P454, DOI 10.1016/j.neuropharm.2008.06.020; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Capron B, 2006, LEARN MEMORY, V13, P271, DOI 10.1101/lm.135406; Chan CB, 2011, EMBO J, V30, P4274, DOI 10.1038/emboj.2011.281; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Connor SA, 2011, J PHYSIOL-LONDON, V589, P4321, DOI 10.1113/jphysiol.2011.209379; Damiani CL, 2007, J NEUROCHEM, V100, P720, DOI 10.1111/j.1471-4159.2006.04321.x; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fonseca R, 2012, EUR J NEUROSCI, V35, P195, DOI 10.1111/j.1460-9568.2011.07955.x; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; French PJ, 2001, EUR J NEUROSCI, V13, P968, DOI 10.1046/j.0953-816x.2001.01467.x; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hernandez RV, 2005, BRAIN RES PROTOC, V15, P6, DOI 10.1016/j.brainresprot.2005.02.003; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 2005, LEARN MEMORY, V12, P587, DOI 10.1101/lm.98905; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LIPTON P, 1977, J NEUROCHEM, V28, P1347, DOI 10.1111/j.1471-4159.1977.tb12330.x; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021568; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Navakkode S, 2010, LEARN MEMORY, V17, P605, DOI 10.1101/lm.1991910; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Raymond M, 2011, J NEUROSCI, V31, P17864, DOI 10.1523/JNEUROSCI.3179-11.2011; Redondo RL, 2010, FENS ABSTR, V4, P1613; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Ris L, 2007, LEARN MEMORY, V14, P185, DOI 10.1101/lm.451507; Ris L, 2009, NEUROREPORT, V20, P1572, DOI 10.1097/WNR.0b013e328332e021; Rudy JW, 2008, NEUROBIOL LEARN MEM, V89, P219, DOI 10.1016/j.nlm.2007.08.014; Rudy JW, 2006, LEARN MEMORY, V13, P1, DOI 10.1101/lm.157806; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sajikumar S, 2005, CURR OPIN NEUROBIOL, V15, P607, DOI 10.1016/j.conb.2005.08.009; Sajikumar S, 2008, LEARN MEMORY, V15, P46, DOI 10.1101/lm.816908; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sharma AV, 2012, J NEUROSCI, V32, P2377, DOI 10.1523/JNEUROSCI.3543-11.2012; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Squire LR., 1999, MEMORY MIND MOL; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tenorio G, 2010, LEARN MEMORY, V17, P627, DOI 10.1101/lm.1974510; Thalhammer A, 2006, EMBO J, V25, P5873, DOI 10.1038/sj.emboj.7601420; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; Villers A, 2010, NEUROREPORT, V21, P210, DOI 10.1097/WNR.0b013e328335c311; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Young JZ, 2006, EUR J NEUROSCI, V23, P1784, DOI 10.1111/j.1460-9568.2006.04707.x	80	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40823	10.1371/journal.pone.0040823	http://dx.doi.org/10.1371/journal.pone.0040823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792408	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400102
J	Zhang, H; Hu, XX; Wang, ZP; Zhang, YD; Wang, SZ; Wang, N; Ma, L; Leng, L; Wang, SW; Wang, QG; Wang, YX; Tang, ZQ; Li, N; Da, Y; Li, H				Zhang, Hui; Hu, Xiaoxiang; Wang, Zhipeng; Zhang, Yuandan; Wang, Shouzhi; Wang, Ning; Ma, Li; Leng, Li; Wang, Shengwen; Wang, Qigui; Wang, Yuxiang; Tang, Zhiquan; Li, Ning; Da, Yang; Li, Hui			Selection Signature Analysis Implicates the PC1/PCSK1 Region for Chicken Abdominal Fat Content	PLOS ONE			English	Article							QUANTITATIVE TRAITS; POSITIVE SELECTION; GENE POLYMORPHISM; GENOME; OBESITY; ASSOCIATION; LOCI; VARIANTS; SEQUENCE	We conducted a selection signature analysis using the chicken 60k SNP chip in two chicken lines that had been divergently selected for abdominal fat content (AFC) for 11 generations. The selection signature analysis used multiple signals of selection, including long-range allele frequency differences between the lean and fat lines, long-range heterozygosity changes, linkage disequilibrium, haplotype frequencies, and extended haplotype homozygosity. Multiple signals of selection identified ten signatures on chromosomes 1, 2, 4, 5, 11, 15, 20, 26 and Z. The 0.73 Mb PC1/PCSK1 region of the Z chromosome at 55.43-56.16 Mb was the most heavily selected region. This region had 26 SNP markers and seven genes, Mar-03, SLC12A2, FBN2, ERAP1, CAST, PC1/PCSK1 and ELL2, where PC1/PCSK1 are the chicken/human names for the same gene. The lean and fat lines had two main haplotypes with completely opposite SNP alleles for the 26 SNP markers and were virtually line-specific, and had a recombinant haplotype with nearly equal frequency (0.193 and 0.196) in both lines. Other haplotypes in this region had negligible frequencies. Nine other regions with selection signatures were PAH-IGF1, TRPC4, GJD4-CCNY, NDST4, NOVA1, GALNT9, the ESRP2-GALR1 region with five genes, the SYCP2-CADH4 with six genes, and the TULP1-KIF21B with 14 genes. Genome-wide association analysis showed that nearly all regions with evidence of selection signature had SNP effects with genome-wide significance (P<10(-6)) on abdominal fat weight and percentage. The results of this study provide specific gene targets for the control of chicken AFC and a potential model of AFC in human obesity.	[Zhang, Hui; Wang, Zhipeng; Wang, Shouzhi; Wang, Ning; Leng, Li; Wang, Qigui; Wang, Yuxiang; Tang, Zhiquan; Li, Hui] Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China; [Zhang, Hui; Wang, Zhipeng; Wang, Shouzhi; Wang, Ning; Leng, Li; Wang, Qigui; Wang, Yuxiang; Tang, Zhiquan; Li, Hui] NE Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhang, Yuandan] Univ New England, Anim Genet & Breeding Unit, Armidale, NSW, Australia; [Ma, Li; Wang, Shengwen; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; China Agricultural University; University of New England; University of Minnesota System; University of Minnesota Twin Cities	Zhang, H (corresponding author), Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China.	yda@umn.edu; lihui@neau.edu.cn	ma, li/C-1585-2014; Ma, Li/B-1844-2010		China Agriculture Research System [CARS-42]; National 863 project of China [2010AA10A102]; National 973 Project of China [2009CB941604]	China Agriculture Research System; National 863 project of China; National 973 Project of China(National Basic Research Program of China)	This research was supported by China Agriculture Research System (No. CARS-42), National 863 project of China (No. 2010AA10A102) and National 973 Project of China (No. 2009CB941604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Chambers JR, 1990, POULTRY BREEDING GEN; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Choquet H, 2011, METHODS MOL BIOL, V768, P247, DOI 10.1007/978-1-61779-204-5_13; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Han DH, 2008, KOREAN J PHYSIOL PHA, V12, P125, DOI 10.4196/kjpp.2008.12.3.125; HAVENSTEIN GB, 1994, POULTRY SCI, V73, P1795, DOI 10.3382/ps.0731795; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Ikeobi CON, 2002, ANIM GENET, V33, P428, DOI 10.1046/j.1365-2052.2002.00911.x; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Kessler AM, 2000, AN C APINCO CIENC TE; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mao YC, 2006, PHYSIOL GENOMICS, V28, P46, DOI 10.1152/physiolgenomics.00096.2006; Methot J, 2010, EXPERT REV CARDIOVAS, V8, P639, DOI 10.1586/ERC.10.38; Morgan Angharad R, 2011, BMC Res Notes, V4, P253, DOI 10.1186/1756-0500-4-253; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; Nones K, 2006, ANIM GENET, V37, P95, DOI 10.1111/j.1365-2052.2005.01387.x; Parikh RM, 2007, MED HYPOTHESES, V68, P1272, DOI 10.1016/j.mehy.2006.10.038; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2011, OBESITY, V19, P2436, DOI 10.1038/oby.2011.237; Zhou H, 2005, POULTRY SCI, V84, P212, DOI 10.1093/ps/84.2.212	31	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40736	10.1371/journal.pone.0040736	http://dx.doi.org/10.1371/journal.pone.0040736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792402	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400098
J	Kemeny, S; Dery, D; Loboda, Y; Rovner, M; Lev, T; Zuri, D; Finberg, JPM; Larisch, S				Kemeny, Stav; Dery, Dikla; Loboda, Yelena; Rovner, Marshall; Lev, Tali; Zuri, Dotan; Finberg, John P. M.; Larisch, Sarit			Parkin Promotes Degradation of the Mitochondrial Pro-Apoptotic ARTS Protein	PLOS ONE			English	Article							RECESSIVE JUVENILE PARKINSONISM; LEWY-BODY FORMATION; CELL-DEATH; ALPHA-SYNUCLEIN; NEURONAL DEATH; MOLECULAR PATHWAYS; BINDING PROTEIN; GROWTH-FACTOR; DISEASE; P53	Parkinson's disease (PD) is associated with excessive cell death causing selective loss of dopaminergic neurons. Dysfunction of the Ubiquitin Proteasome System (UPS) is associated with the pathophysiology of PD. Mutations in Parkin which impair its E3-ligase activity play a major role in the pathogenesis of inherited PD. ARTS (Sept4_i2) is a mitochondrial protein, which initiates caspase activation upstream of cytochrome c release in the mitochondrial apoptotic pathway. Here we show that Parkin serves as an E3-ubiquitin ligase to restrict the levels of ARTS through UPS-mediated degradation. Though Parkin binds equally to ARTS and Sept4_i1 (H5/PNUTL2), the non-apoptotic splice variant of Sept4, Parkin ubiquitinates and degrades only ARTS. Thus, the effect of Parkin on ARTS is specific and probably related to its pro-apoptotic function. High levels of ARTS are sufficient to promote apoptosis in cultured neuronal cells, and rat brains treated with 6-OHDA reveal high levels of ARTS. However, over-expression of Parkin can protect cells from ARTS-induced apoptosis. Furthermore, Parkin loss-of-function experiments reveal that reduction of Parkin causes increased levels of ARTS and apoptosis. We propose that in brain cells in which the E3-ligase activity of Parkin is compromised, ARTS levels increase and facilitate apoptosis. Thus, ARTS is a novel substrate of Parkin. These observations link Parkin directly to a pro-apoptotic protein and reveal a novel connection between Parkin, apoptosis, and PD.	[Kemeny, Stav; Dery, Dikla; Rovner, Marshall; Lev, Tali; Zuri, Dotan; Larisch, Sarit] Univ Haifa, Dept Biol, Fac Sci, Cell Death Res Lab, IL-31999 Haifa, Israel; [Kemeny, Stav; Loboda, Yelena; Finberg, John P. M.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Mol Pharmacol, Haifa, Israel	University of Haifa; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Kemeny, S (corresponding author), Univ Haifa, Dept Biol, Fac Sci, Cell Death Res Lab, IL-31999 Haifa, Israel.	saritlarisch@gmail.com		Kemeny, Stav/0000-0002-5292-215X	Aubrey and Ella Brown Fellowship; Muriel Edith Rickman Trust (UK); Johnson Johnson	Aubrey and Ella Brown Fellowship; Muriel Edith Rickman Trust (UK); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	This work was supported by funds from "The Aubrey and Ella Brown Fellowship'' (supporting a stipend for Dr. Kemeny), The Muriel Edith Rickman Trust (UK) (supporting equipment purchase for Dr. Finberg) and Johnson & Johnson (Focused Giving Program COSAT grant to Dr. Larisch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2007, DEV CELL, V13, P464, DOI 10.1016/j.devcel.2007.09.008; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bornstein B, 2011, APOPTOSIS       0623; Bornstein B, 2012, INT J BIOCHEM CELL B, V44, P489, DOI 10.1016/j.biocel.2011.12.005; Braak H, 1996, J NEURAL TRANSM-SUPP, P1; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Carp MJ, 2008, SEPTINS, P281; Chan NC, 2011, HUM MOL GENET; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dawson TM, 2002, NATURE NEUROSCIENCE; Dawson V L, 1995, Adv Pharmacol, V34, P323; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Edison N, 2012, CLIN CANC RES; Edison N, 2011, CELL DEATH DIFFER; Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Finberg JPM, 2010, RESTOR NEUROL NEUROS, V28, P803, DOI 10.3233/RNN-2010-0551; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Garcia-Fernandez M, 2010, GENE DEV, V24, P2282, DOI 10.1101/gad.1970110; Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goetz CG, 2007, MOVEMENT DISORD, V22, P179, DOI 10.1002/mds.21226; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Gottfried Y, 2007, SCHIZOPHR RES, V96, P257, DOI 10.1016/j.schres.2007.05.031; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Kuroda Y, 2006, BIOCHEM BIOPH RES CO, V348, P787, DOI 10.1016/j.bbrc.2006.06.201; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Larisch-Bloch S, 2000, CELL GROWTH DIFFER, V11, P1; Lee TV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002261; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liang ZQ, 2007, BRAIN RES, V1145, P190, DOI 10.1016/j.brainres.2007.01.130; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Lotan R, 2005, J BIOL CHEM, V280, P25802, DOI 10.1074/jbc.M501955200; Lu BW, 2004, MOL PSYCHIATR, V9, P6, DOI 10.1038/sj.mp.4001417; Matsumine H, 2001, METH MOLEC MED, V62, P13, DOI 10.1385/1-59259-142-6:13; McCarthy N, 2010, NAT REV CANCER, V10, P816, DOI 10.1038/nrc2969; Morley JF, 2010, NEUROLOGY, V75, pS9, DOI 10.1212/WNL.0b013e3181fb3628; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Mouatt-Prigent A, 2004, J NEURAL TRANSM, V111, P1209, DOI 10.1007/s00702-004-0144-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; PEREZPOLO JR, 1982, DEV NEUROSCI-BASEL, V5, P418, DOI 10.1159/000112702; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Prunell GF, 2004, J NEUROSCI RES, V78, P1, DOI 10.1002/jnr.20252; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Ron I, 2010, HUM MOL GENET, V19, P3771, DOI 10.1093/hmg/ddq292; Rosen KM, 2010, J NEUROSCI RES, V88, P167, DOI 10.1002/jnr.22178; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Shehadeh L, 2009, MOVEMENT DISORD, V24, P204, DOI 10.1002/mds.22306; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4; Turmel H, 2001, MOVEMENT DISORD, V16, P185, DOI 10.1002/mds.1037; Ulusoy A, 2008, EXP NEUROL, V212, P258, DOI 10.1016/j.expneurol.2008.04.026; Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Xie H, 1999, CELL MOTIL CYTOSKEL, V43, P52, DOI 10.1002/(SICI)1097-0169(1999)43:1<52::AID-CM6>3.0.CO;2-5; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zieger B, 2000, GENE, V261, P197, DOI 10.1016/S0378-1119(00)00527-8	93	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38837	10.1371/journal.pone.0038837	http://dx.doi.org/10.1371/journal.pone.0038837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792159	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700005
J	Zhang, Y; Xu, JY; Wang, ZW; Zhang, XL; Liang, XM; Civelli, O				Zhang, Yan; Xu, Junyan; Wang, Zhiwei; Zhang, Xiuli; Liang, Xinmiao; Civelli, Olivier			BmK-YA, an Enkephalin-Like Peptide in Scorpion Venom	PLOS ONE			English	Article							BUTHUS-MARTENSII KARSCH; MOLECULAR CHARACTERIZATION; OPIOID RECEPTOR; 3-FINGER TOXIN; IDENTIFICATION; NEUROTOXINS; PROENKEPHALIN; ANTAGONIST; EXENDIN-4; CHANNELS	By screening extracts of venom from the Asian scorpion Buthus martensii Karsch (BmK) for their abilities to activate opioid receptors, we have identified BmK-YA, an amidated peptide containing an enkephalin-like sequence. BmK-YA is encoded by a precursor that displays a signal sequence and contains four copies of BmK-YA sequences and four of His(4)-BmK-YA, all flanked by single amino acid residues. BmK-YA and His(4)-BmK-YA are amidated and thus fulfill the characteristics expected of bioactive peptides. BmK-YA can activate mammalian opioid receptors with selectivity for the delta subtype while His(4)-BmK-YA is inactive at opioid receptors. The discovery of BmK-YA suggests that scorpion venom may represent a novel source of bioactive molecules targeting G protein-coupled receptors (GPCRs) and reveal additional insights on the evolution of the opioid precursors.	[Zhang, Yan; Wang, Zhiwei; Civelli, Olivier] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Xu, Junyan; Zhang, Xiuli; Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Civelli, Olivier] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Civelli, Olivier] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA	University of California System; University of California Irvine; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of California System; University of California Irvine; University of California System; University of California Irvine	Zhang, Y (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	liangxm@dicp.ac.cn; ocivelli@uci.edu	Civelli, Olivier/A-8392-2012		National Institute of Health [MH60231, DA024746]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Tourette Syndrome Association; National Natural Science Funds for Distinguished Young Scholar to Xinmiao Liang in China [20825518]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024746] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Tourette Syndrome Association; National Natural Science Funds for Distinguished Young Scholar to Xinmiao Liang in China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health (www.nih.gov/) Grants MH60231 and DA024746, an Established Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) and a Tourette Syndrome Association (www.tsa-usa.org/) award to Olivier Civelli. This work was also supported by National Natural Science Funds (http://www.nsfc.gov.cn) for Distinguished Young Scholar to Xinmiao Liang in China (20825518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal KM, 2003, CELL BIOCHEM BIOPHYS, V38, P215, DOI 10.1385/CBB:38:2:215; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; Cao ZY, 2004, J PEPT RES, V64, P33, DOI 10.1111/j.1399-3011.2004.00164.x; CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Ducancel F, 2005, CELL MOL LIFE SCI, V62, P2828, DOI 10.1007/s00018-005-5286-x; EGBERTSON MS, 1994, J MED CHEM, V37, P2537, DOI 10.1021/jm00042a007; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; ENG J, 1992, J BIOL CHEM, V267, P7402; ESNOUF MP, 1967, BRIT J HAEMATOL, V13, P581, DOI 10.1111/j.1365-2141.1967.tb00765.x; Fox JW, 2007, CURR PHARM DESIGN, V13, P2927, DOI 10.2174/138161207782023739; Gazarian KG, 2005, VACCINE, V23, P3357, DOI 10.1016/j.vaccine.2004.12.027; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Guan RJ, 2001, BBA-PROTEIN STRUCT M, V1549, P9, DOI 10.1016/S0167-4838(01)00241-2; Guan RJ, 2000, ACTA CRYSTALLOGR D, V56, P1012, DOI 10.1107/S0907444900006004; Guo ZM, 2007, CHEM COMMUN, P2491, DOI 10.1039/b701831b; Khalap A, 2005, ANN NY ACAD SCI, V1040, P22, DOI 10.1196/annals.1327.003; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koivula K, 2010, TOXICON, V56, P440, DOI 10.1016/j.toxicon.2010.05.001; Lan ZD, 1999, TOXICON, V37, P815, DOI 10.1016/S0041-0101(98)00221-9; LEUNG MK, 1984, P NATL ACAD SCI-BIOL, V81, P955, DOI 10.1073/pnas.81.3.955; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Li F., 1997, CHIN J PHARM TOXIN, V11, P154; Liu DW, 2008, INT J PEPT RES THER, V14, P137, DOI 10.1007/s10989-008-9122-7; Liu YF, 2003, PROTEIN EXPRES PURIF, V27, P253, DOI 10.1016/S1046-5928(02)00609-5; Maiga A, 2012, TOXICON, V59, P487, DOI 10.1016/j.toxicon.2011.03.009; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; Quinton L, 2010, BRIT J PHARMACOL, V159, P316, DOI 10.1111/j.1476-5381.2009.00532.x; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; RomiLebrun R, 1997, EUR J BIOCHEM, V245, P457, DOI 10.1111/j.1432-1033.1997.00457.x; Rouget C, 2010, BRIT J PHARMACOL, V161, P1361, DOI 10.1111/j.1476-5381.2010.00966.x; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Salzet M, 1997, BRAIN RES, V768, P224, DOI 10.1016/S0006-8993(97)00646-X; SEIZINGER BR, 1985, NATURE, V313, P57, DOI 10.1038/313057a0; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Sharpe IA, 2003, J BIOL CHEM, V278, P34451, DOI 10.1074/jbc.M305410200; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; STEFANO GB, 1992, P NATL ACAD SCI USA, V89, P9316, DOI 10.1073/pnas.89.19.9316; Toombs CF, 2001, HAEMOSTASIS, V31, P141; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; VandeCraen M, 1997, EUR J IMMUNOL, V27, P1296, DOI 10.1002/eji.1830270535; Wang CY, 2000, BRAIN RES BULL, V53, P335, DOI 10.1016/S0361-9230(00)00355-5; WEBER E, 1983, P NATL ACAD SCI-BIOL, V80, P7362, DOI 10.1073/pnas.80.23.7362; WOLLEMANN M, 1990, J NEUROCHEM, V54, P1095, DOI 10.1111/j.1471-4159.1990.tb01934.x; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Zhang Y, 2011, NEUROCHEM RES, V36, P2104, DOI 10.1007/s11064-011-0534-y; Zhu MM, 2009, BRIT J PHARMACOL, V158, P1895, DOI 10.1111/j.1476-5381.2009.00471.x	49	12	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40417	10.1371/journal.pone.0040417	http://dx.doi.org/10.1371/journal.pone.0040417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792309	Green Published, gold			2022-12-25	WOS:000306354700045
J	Zhang, Y; Wang, LL; Wang, LL; Wu, N; Zhou, Z; Song, LS				Zhang, Ying; Wang, Leilei; Wang, Lingling; Wu, Ning; Zhou, Zhi; Song, Linsheng			An Integrin from Shrimp Litopenaeus vannamei Mediated Microbial Agglutination and Cell Proliferation	PLOS ONE			English	Article							BETA-INTEGRIN; CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; ALPHA-V-BETA-3; EXPRESSION; HEMOCYTES; SUBUNITS; WSSV	Background: Integrins are a family of adhesion receptors which regulate cell proliferation, differentiation, leukocyte migration, and complement receptor-dependent phagocytosis. In invertebrates, as a cell adhesion receptor, beta integrins play an important role for the balanced activation of immune defense responses especially during the encounter of infections. The present study attempts to characterize the immune functions of shrimp integrin (LvIntegrin) to have better understanding on the immune system and its regulation mechanisms in shrimps. Methodology: A shrimp integrin was identified from the Pacific white shrimp Litopenaeus vannamei (designated as LvIntegrin). Its full-length cDNA was of 2621 bp with an open reading frame (ORF) of 2439 bp encoding a polypeptide of 812 amino acids. The mRNA expression of LvIntegrin was significantly up-regulated at 3, 6 and 12 h after Listonella anguillarum challenge. The cDNA fragment encoding beta integrin domains (beta A and hybrid domain) of LvIntegrin was recombined and expressed in Escherichia coli BL21(DE3)-pLysS. The recombinant protein (rLvIntegrin) could significantly agglutinate the tested microbe including E. coli JM109, L. anguillarum, Micrococcus luteus and Candida dattiladattila in the presence of divalent cations. Moreover, when NIH3T3 cells were cultured with rLvIntegrin, the proliferation rate increased significantly in a dose-dependent manner. Conclusions: LvIntegrin, a shrimp beta integrin was identified from L. vannamei, shared several highly conserved features. LvIntegrin exhibited broad-spectrum agglutination activity towards both bacteria and fungi and could improve the proliferation of NIH3T3 cells, indicating that LvIntegrin is involved in the immune response against microbe challenge and regulation of cell proliferation as a cell adhesion receptor in shrimp.	[Zhang, Ying; Wang, Leilei; Wang, Lingling; Wu, Ning; Zhou, Zhi; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Ying] Shandong Marine Fisheries Res Inst, Res Ctr Fishery Resources & Ecol, Yantai, Peoples R China; [Wang, Leilei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China (973 program) from the Chinese Ministry of Science and Technology [2012CB114405]; Shandong Provincial Natural Science Foundation [JQ201110, ZR2011CQ017]	National Basic Research Program of China (973 program) from the Chinese Ministry of Science and Technology(National Basic Research Program of China); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This research was supported by National Basic Research Program of China (973 program, No. 2012CB114405) from the Chinese Ministry of Science and Technology http://www.973.gov.cn/, and Grants (No. JQ201110 to L. Wang and No. ZR2011CQ017 to Y. Zhang) from Shandong Provincial Natural Science Foundation (http://www.sdnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Burke RD, 1999, INT REV CYTOL, V191, P257, DOI 10.1016/S0074-7696(08)60161-8; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Dinkins MB, 2008, DEV DYNAM, V237, P3927, DOI 10.1002/dvdy.21802; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hu JA, 2010, J INSECT PHYSIOL, V56, P1846, DOI 10.1016/j.jinsphys.2010.08.001; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Levin DM, 2005, INSECT BIOCHEM MOLEC, V35, P369, DOI 10.1016/j.ibmb.2005.01.003; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Luo T, 2007, MOL IMMUNOL, V44, P1516, DOI 10.1016/j.molimm.2006.09.015; Lutz KL, 1997, CURR TOP PEPT PROT R, V2, P69; Marsden M, 1997, DEV BIOL, V181, P234, DOI 10.1006/dbio.1996.8451; Miyazawa S, 2004, IMMUNOGENETICS, V55, P836, DOI 10.1007/s00251-004-0651-8; Moita LF, 2006, INSECT BIOCHEM MOLEC, V36, P282, DOI 10.1016/j.ibmb.2006.01.004; O'Reilly AM, 2008, J CELL BIOL, V182, P801, DOI 10.1083/jcb.200710141; Okada Y, 2011, BIOCHEM PHARMACOL, V81, P866, DOI 10.1016/j.bcp.2011.01.010; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; WILCOX M, 1989, DEVELOPMENT, V107, P891; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang HJ, 2007, FISH SHELLFISH IMMUN, V22, P88, DOI 10.1016/j.fsi.2006.03.015; YEE GH, 1993, DEVELOPMENT, V118, P845; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P418, DOI 10.1016/j.dci.2009.11.012; Zhang Y, 2009, FISH SHELLFISH IMMUN, V26, P183, DOI 10.1016/j.fsi.2008.03.008; Zhuang S, 2008, DEV COMP IMMUNOL, V32, P365, DOI 10.1016/j.dci.2007.07.007	37	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40615	10.1371/journal.pone.0040615	http://dx.doi.org/10.1371/journal.pone.0040615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792387	gold, Green Published, Green Submitted			2022-12-25	WOS:000306354700061
J	Meng, Y; Sohar, I; Wang, LL; Sleat, DE; Lobel, P				Meng, Yu; Sohar, Istvan; Wang, Lingling; Sleat, David E.; Lobel, Peter			Systemic Administration of Tripeptidyl Peptidase I in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis: Effect of Glycan Modification	PLOS ONE			English	Article							ENZYME-REPLACEMENT-THERAPY; BLOOD-BRAIN-BARRIER; RECEPTOR-MEDIATED TRANSPORT; MANNOSE 6-PHOSPHATE; INTRACEREBROVENTRICULAR INFUSION; ACID SPHINGOMYELINASE; LYSOSOMAL DISEASES; STORAGE; VII; MICE	Late-infantile neuronal ceroid lipofuscinosis (LINCL) is a recessive genetic disease of childhood caused by deficiencies in the lysosomal protease tripeptidyl peptidase I (TPP1). Disease is characterized by progressive and extensive neuronal death. One hurdle towards development of enzyme replacement therapy is delivery of TPP1 to the brain. In this study, we evaluated the effect of modifying N-linked glycans on recombinant human TPP1 on its pharmacokinetic properties after administration via tail vein injection to a mouse model of LINCL. Unmodified TPP1 exhibited a dose-dependent serum half-life of 12 min (0.12 mg) to 45 min (2 mg). Deglycosylation or modification using sodium metaperiodate oxidation and reduction with sodium borohydride increased the circulatory half-life but did not improve targeting to the brain compared to unmodified TPP1. Analysis of liver, brain, spleen, kidney and lung demonstrated that for all preparations, >95% of the recovered activity was in the liver. Interestingly, administration of a single 2 mg dose (80 mg/kg) of unmodified TPP1 resulted in similar to 10% of wild-type activity in brain. This suggests that systemic administration of unmodified recombinant enzyme merits further exploration as a potential therapy for LINCL.	[Meng, Yu; Sohar, Istvan; Sleat, David E.; Lobel, Peter] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Wang, Lingling] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Vivarium, Piscataway, NJ 08854 USA; [Sleat, David E.; Lobel, Peter] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Meng, Y (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu			National Institutes of Health Grant [NS037918]; Batten Disease Support & Research Association Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Batten Disease Support & Research Association Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS037918 (PL) and by a Batten Disease Support & Research Association Fellowship (YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair D, 2010, MOL GENET METAB, V99, P132, DOI 10.1016/j.ymgme.2009.10.002; Blanz J, 2008, HUM MOL GENET, V17, P3437, DOI 10.1093/hmg/ddn237; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Dickson P, 2007, MOL GENET METAB, V91, P61, DOI 10.1016/j.ymgme.2006.12.012; Dickson PI, 2010, MOL GENET METAB, V101, P115, DOI 10.1016/j.ymgme.2010.06.020; Dierenfeld AD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001380; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Elliger SS, 1999, GENE THER, V6, P1175, DOI 10.1038/sj.gt.3300931; Gliddon BL, 2004, PEDIATR RES, V56, P65, DOI 10.1203/01.PDR.0000129661.40499.12; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; Guhaniyogi J, 2009, J BIOL CHEM, V284, P3985, DOI 10.1074/jbc.M806943200; Kakkis E, 2004, MOL GENET METAB, V83, P163, DOI 10.1016/j.ymgme.2004.07.003; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; NAKAJIMA M, 1988, J CELL BIOCHEM, V36, P157, DOI 10.1002/jcb.240360207; Rozaklis T, 2011, EXP NEUROL, V230, P123, DOI 10.1016/j.expneurol.2011.04.004; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Sohar I, 2000, CLIN CHEM, V46, P1005; Tsuji D, 2011, ANN NEUROL, V69, P691, DOI 10.1002/ana.22262; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Urayama A, 2008, MOL THER, V16, P1261, DOI 10.1038/mt.2008.84; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Vogler C, 1999, PEDIATR RES, V45, P838, DOI 10.1203/00006450-199906000-00010; Vogler C, 2005, P NATL ACAD SCI USA, V102, P14777, DOI 10.1073/pnas.0506892102; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; Xu S, 2011, MOL THER, V19, P1842, DOI 10.1038/mt.2011.130; Ziegler RJ, 2011, EXP NEUROL, V231, P261, DOI 10.1016/j.expneurol.2011.06.019	33	28	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40509	10.1371/journal.pone.0040509	http://dx.doi.org/10.1371/journal.pone.0040509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792360	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800101
J	Sawall, Y; Richter, C; Ramette, A				Sawall, Yvonne; Richter, Claudio; Ramette, Alban			Effects of Eutrophication, Seasonality and Macrofouling on the Diversity of Bacterial Biofilms in Equatorial Coral Reefs	PLOS ONE			English	Article							LARVAL SETTLEMENT; MULTIVARIATE ANALYSES; MICROBIAL DIVERSITY; COMMUNITY; BIODIVERSITY; SEDIMENTS; DYNAMICS; ANTIBACTERIAL; METAMORPHOSIS; PRODUCTIVITY	Biofilms play an important role as a settlement cue for invertebrate larvae and significantly contribute to the nutrient turnover in aquatic ecosystems. Nevertheless, little is known about how biofilm community structure generally responds to environmental changes. This study aimed to identify patterns of bacterial dynamics in coral reef biofilms in response to associated macrofouling community structure, microhabitat (exposed vs. sheltered), seasonality, and eutrophication. Settlement tiles were deployed at four reefs along a cross-shelf eutrophication gradient and were exchanged every 4 months over 20 months. The fouling community composition on the tiles was recorded and the bacterial community structure was assessed with the community fingerprinting technique Automated Ribosomal Intergenic Spacer Analysis (ARISA). Bacterial operational taxonomic unit (OTU) number was higher on exposed tiles, where the fouling community was homogenous and algae-dominated, than in sheltered habitats, which were occupied by a variety of filter feeders. Furthermore, OTU number was also highest in eutrophied near-shore reefs, while seasonal variations in community structure were most pronounced in the oligotrophic mid-shelf reef. In contrast, the macrofouling community structure did not change significantly with seasons. Changes in bacterial community patterns were mostly affected by microhabitat, seasonal and anthropogenically derived changes in nutrient availability, and to a lesser extent by changes in the macrofouling community structure. Path analysis revealed a complex interplay of various environmental and biological factors explaining the spatial and temporal variations in bacterial biofilm communities under natural conditions.	[Sawall, Yvonne] Leibniz Ctr Trop Marine Ecol, Bremen, Germany; [Richter, Claudio] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Ramette, Alban] Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society	Sawall, Y (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Res Unit Benth Ecol, Kiel, Germany.	aramette@mpi-bremen.de	Richter, Claudio/AAT-1212-2020; Ramette, Alban/E-9197-2016	Richter, Claudio/0000-0002-8182-6896; Ramette, Alban/0000-0002-3437-4639	German Federal Ministry of Education and Research (BMBF) under a bilateral German-Indonesian project (SPICE) [03F0472A]; Bremen International Graduate School for Marine Sciences (GLOMAR); German Research Foundation (DFG); Max Planck Society	German Federal Ministry of Education and Research (BMBF) under a bilateral German-Indonesian project (SPICE)(Federal Ministry of Education & Research (BMBF)); Bremen International Graduate School for Marine Sciences (GLOMAR); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This study was funded by the German Federal Ministry of Education and Research (BMBF) under a bilateral German-Indonesian project (SPICE, grant number 03F0472A). Further support was given by the Bremen International Graduate School for Marine Sciences (GLOMAR) funded by the German Research Foundation (DFG). AR was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2012, FEMS MICROBIOL ECOL, V80, P294, DOI 10.1111/j.1574-6941.2011.01289.x; Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; ALOGILY SM, 1977, NATURE, V265, P728, DOI 10.1038/265728a0; Armstrong E, 2001, HYDROBIOLOGIA, V461, P37, DOI 10.1023/A:1012756913566; Belliveau SA, 2002, MAR ECOL PROG SER, V232, P105, DOI 10.3354/meps232105; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; BOTO KG, 1978, ANAL CHEM, V50, P392, DOI 10.1021/ac50025a009; BUSS LW, 1981, J EXP MAR BIOL ECOL, V49, P151, DOI 10.1016/0022-0981(81)90067-8; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Claret C, 1998, AQUAT SCI, V60, P33, DOI 10.1007/s000270050025; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; DELGADO O, 1994, CORAL REEFS, V13, P151, DOI 10.1007/BF00301191; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; English S, 1997, SURVEY MANUAL TROPIC, V2; Fairfull SJL, 1999, MAR FRESHWATER RES, V50, P235, DOI 10.1071/MF97267; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Gillan DC, 1998, APPL ENVIRON MICROB, V64, P3464; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hewson I, 2006, MICROB ECOL, V51, P147, DOI 10.1007/s00248-005-0144-9; Hewson I, 2006, MAR ECOL PROG SER, V306, P79, DOI 10.3354/meps306079; Hoeksema Bert W., 2007, V29, P117; HOEKSEMA BW, 1989, NETH J SEA RES, V23, P149, DOI 10.1016/0077-7579(89)90009-4; Huang YL, 2007, APPL ENVIRON MICROB, V73, P6284, DOI 10.1128/AEM.00578-07; Hung OS, 2005, MAR ECOL PROG SER, V304, P155, DOI 10.3354/meps304155; Jin T, 2005, MAR ECOL PROG SER, V297, P169, DOI 10.3354/meps297169; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kinkade C, 1997, DEEP-SEA RES PT I, V44, P581, DOI 10.1016/S0967-0637(97)00002-2; Lau SCK, 2005, AQUAT MICROB ECOL, V38, P41, DOI 10.3354/ame038041; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1998, NUMERICAL ECOLOGY, V2; Meyer-Reil LA, 2000, MAR POLLUT BULL, V41, P255, DOI 10.1016/S0025-326X(00)00114-4; MOLL H, 1983, THESIS LEIDEN U; Moss JA, 2006, APPL ENVIRON MICROB, V72, P5679, DOI 10.1128/AEM.02773-05; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nocker A, 2004, APPL ENVIRON MICROB, V70, P6834, DOI 10.1128/AEM.70.11.6834-6845.2004; Poltak SR, 2011, ISME J, V5, P369, DOI 10.1038/ismej.2010.136; Pringault O, 2008, MICROB ECOL, V55, P247, DOI 10.1007/s00248-007-9272-8; Qian PY, 2009, SPRINGER SER BIOFILM, V4, P315, DOI 10.1007/7142_2008_19; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Renema W, 2001, PALAEOGEOGR PALAEOCL, V175, P125, DOI 10.1016/S0031-0182(01)00389-3; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Schottner S, 2011, ENVIRON MICROBIOL, V13, P1815, DOI 10.1111/j.1462-2920.2011.02494.x; SLATTERY M, 1995, J EXP MAR BIOL ECOL, V190, P61, DOI 10.1016/0022-0981(95)00032-M; Stirk WA, 2007, J APPL PHYCOL, V19, P271, DOI 10.1007/s10811-006-9134-7; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Uthicke S, 2007, ESTUAR COAST SHELF S, V72, P188, DOI 10.1016/j.ecss.2006.10.017; WALLS JT, 1993, J EXP MAR BIOL ECOL, V169, P1, DOI 10.1016/0022-0981(93)90039-Q; Webster NS, 2006, ENVIRON MICROBIOL, V8, P1177, DOI 10.1111/j.1462-2920.2006.01007.x; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wieczorek SK, 1998, BIOFOULING, V12, P81, DOI 10.1080/08927019809378348; [No title captured], DOI DOI 10.1023/A:1009971414055	63	36	38	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39951	10.1371/journal.pone.0039951	http://dx.doi.org/10.1371/journal.pone.0039951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792198	Green Published, gold, Green Accepted			2022-12-25	WOS:000306461800027
J	Pazos, MA; Kraus, TA; Munoz-Fontela, C; Moran, TM				Pazos, Michael A.; Kraus, Thomas A.; Munoz-Fontela, Cesar; Moran, Thomas M.			Estrogen Mediates Innate and Adaptive Immune Alterations to Influenza Infection in Pregnant Mice	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; COLLAGEN-INDUCED ARTHRITIS; CD8(+) T-CELLS; MULTIPLE-SCLEROSIS; VIRUS INFECTION; POSTPARTUM WOMEN; VIRAL-INFECTION; HORMONE ESTRIOL; PRETERM LABOR; CUTTING EDGE	Pregnancy is a leading risk factor for severe complications during an influenza virus infection. Women infected during their second and third trimesters are at increased risk for severe cardiopulmonary complications, premature delivery, and death. Here, we establish a murine model of aerosolized influenza infection during pregnancy. We find significantly altered innate antiviral responses in pregnant mice, including decreased levels of IFN-beta, IL-1 alpha, and IFN-gamma at early time points of infection. We also find reduced cytotoxic T cell activity and delayed viral clearance. We further demonstrate that pregnancy levels of the estrogen 17-beta-estradiol are able to induce key anti-inflammatory phenotypes in immune responses to the virus independently of other hormones or pregnancy-related stressors. We conclude that elevated estrogen levels result in an attenuated anti-viral immune response, and that pregnancy-associated morbidities occur in the context of this anti-inflammatory phenotype.	[Pazos, Michael A.; Kraus, Thomas A.; Moran, Thomas M.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Kraus, Thomas A.] Mt Sinai Sch Med, Dept Obstet Gynecol & Reprod Sci, New York, NY USA; [Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Heinrich Pette Institute	Pazos, MA (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	Thomas.Moran@mssm.edu		Munoz-Fontela, Cesar/0000-0002-7725-2586	National Institutes of Health (NIH) [RO1 AI41111, NO1 AI50028, U19 AI062623, F31 AI086197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI086197, R01AI041111, N01AI050028, U19AI062623] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The following National Institutes of Health (NIH) grants contributed to this work: RO1 AI41111, NO1 AI50028, U19 AI062623, F31 AI086197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Biswas Debajit K, 2005, Sci STKE, V2005, ppe27, DOI 10.1126/stke.2882005pe27; Blanchard-Rohner G, 2011, VACCINE, V29, P7542, DOI 10.1016/j.vaccine.2011.08.013; Borderia AV, 2008, J IMMUNOL, V181, P6872, DOI 10.4049/jimmunol.181.10.6872; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CASEY ML, 1989, J CLIN INVEST, V83, P430, DOI 10.1172/JCI113901; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Dulos J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3032; Elloso MM, 2005, J ENDOCRINOL, V185, P243, DOI 10.1677/joe.1.06063; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Escribese MM, 2008, BLOOD, V112, P4574, DOI 10.1182/blood-2008-04-148692; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; GELLIN BG, 1991, AM J EPIDEMIOL, V133, P392, DOI 10.1093/oxfordjournals.aje.a115893; Harger JH, 2002, J INFECT DIS, V185, P422, DOI 10.1086/338832; Harris J, 1919, JAMA; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hermesh T, 2010, CELL HOST MICROBE, V7, P343, DOI 10.1016/j.chom.2010.04.006; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jansson L, 2001, ARTHRITIS RHEUM, V44, P2168, DOI 10.1002/1529-0131(200109)44:9<2168::AID-ART370>3.0.CO;2-2; Jara LJ, 2011, CLIN REV ALLERG IMMU, V40, P50, DOI 10.1007/s12016-009-8185-3; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim S, 1999, NEUROLOGY, V52, P1230, DOI 10.1212/WNL.52.6.1230; Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006; Klein Sabra L, 2010, Biol Sex Differ, V1, P5, DOI 10.1186/2042-6410-1-5; KLIPPLE GL, 1989, RHEUM DIS CLIN N AM, V15, P213; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lopez CB, 2000, CELL IMMUNOL, V206, P107, DOI 10.1006/cimm.2000.1736; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Luft T, 1998, J IMMUNOL, V161, P1947; Marcelin G, 2011, J VIROL, V85, P11208, DOI 10.1128/JVI.00654-11; MATTSSON R, 1991, CLIN EXP IMMUNOL, V85, P41, DOI 10.1111/j.1365-2249.1991.tb05679.x; Mattsson R, 1998, AM J REPROD IMMUNOL, V40, P383, DOI 10.1111/j.1600-0897.1998.tb00422.x; McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Munoz-Fontela C, 2011, J IMMUNOL, V187, P6428, DOI 10.4049/jimmunol.1101459; Nesin M, 2000, AM J PERINAT, V17, P393, DOI 10.1055/s-2000-13457; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Robertson CA, 2004, EMERG INFECT DIS, V10, P345, DOI 10.3201/eid1002.030736; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Ruder C, 2009, J CLIN INVEST, V119, P2184, DOI 10.1172/JCI37760; SCHULMAN JL, 1963, J EXP MED, V118, P257, DOI 10.1084/jem.118.2.257; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; SIEM RA, 1960, J NEUROPATH EXP NEUR, V19, P125, DOI 10.1097/00005072-196001000-00013; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; STGEME JW, 1970, CALIF MED, V112, P25; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Svensson T, 2011, PHARMACOEPIDEM DR S, V20, P1030, DOI 10.1002/pds.2194; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Thomas IJ, 2007, J IMMUNOL, V179, P5936, DOI 10.4049/jimmunol.179.9.5936; Varner MW, 2011, OBSTET GYNECOL, V118, P593, DOI 10.1097/AOG.0b013e318229e484; WILLIAMS K, 1977, J HYG-CAMBRIDGE, V79, P249, DOI 10.1017/S0022172400053067; Wong SF, 2003, BJOG-INT J OBSTET GY, V110, P641, DOI 10.1046/j.1471-0528.2003.03008.x; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503	74	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2012	7	7							e40502	10.1371/journal.pone.0040502	http://dx.doi.org/10.1371/journal.pone.0040502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974LI	22792357	Green Published, Green Submitted, gold			2022-12-25	WOS:000306436300070
J	Ribeiro, FS; da Silva, ICD; Carneiro, VC; Belgrano, FD; Mohana-Borges, R; Rosa, ID; Benchimol, M; Souza, NRQ; Mesquita, RD; Sorgine, MHF; Gazos-Lopes, F; Vicentino, ARR; Wu, WJ; Maciel, RD; da Silva-Neto, MAC; Fantappie, MR				Ribeiro, Fabio Schneider; de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Belgrano, Fabricio dos Santos; Mohana-Borges, Ronaldo; Rosa, Ivone de Andrade; Benchimol, Marlene; Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias; Ferreira Sorgine, Marcos Henrique; Gazos-Lopes, Felipe; Revoredo Vicentino, Amanda Roberta; Wu, Wenjie; Maciel, Renata de Moraes; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado			The Dengue Vector Aedes aegypti Contains a Functional High Mobility Group Box 1 (HMGB1) Protein with a Unique Regulatory C-Terminus	PLOS ONE			English	Article							DNA-BINDING PROPERTIES; ACIDIC TAIL; CHROMATIN PROTEIN; IN-VITRO; DSP1; DOMAINS; GENE; RECEPTORS; COMPLEXES; INTERACT	The mosquito Aedes aegypti can spread the dengue, chikungunya and yellow fever viruses. Thus, the search for key molecules involved in the mosquito survival represents today a promising vector control strategy. High Mobility Group Box (HMGB) proteins are essential nuclear factors that maintain the high-order structure of chromatin, keeping eukaryotic cells viable. Outside the nucleus, secreted HMGB proteins could alert the innate immune system to foreign antigens and trigger the initiation of host defenses. In this work, we cloned and functionally characterized the HMGB1 protein from Aedes aegypti (AaHMGB1). The AaHMGB1 protein typically consists of two HMG-box DNA binding domains and an acidic C-terminus. Interestingly, AaHMGB1 contains a unique alanine/glutamine-rich (AQ-rich) C-terminal region that seems to be exclusive of dipteran HMGB proteins. AaHMGB1 is localized to the cell nucleus, mainly associated with heterochromatin. Circular dichroism analyses of AaHMGB1 or the C-terminal truncated proteins revealed a-helical structures. We showed that AaHMGB1 can effectively bind and change the topology of DNA, and that the AQ-rich and the C-terminal acidic regions can modulate its ability to promote DNA supercoiling, as well as its preference to bind supercoiled DNA. AaHMGB1 is phosphorylated by PKA and PKC, but not by CK2. Importantly, phosphorylation of AaHMGB1 by PKA or PKC completely abolishes its DNA bending activity. Thus, our study shows that a functional HMGB1 protein occurs in Aedes aegypt and we provide the first description of a HMGB1 protein containing an AQ-rich regulatory C-terminus.	[Ribeiro, Fabio Schneider; de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Gazos-Lopes, Felipe; Revoredo Vicentino, Amanda Roberta; Maciel, Renata de Moraes; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Belgrano, Fabricio dos Santos; Mohana-Borges, Ronaldo; Rosa, Ivone de Andrade] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, Rio De Janeiro, Brazil; [Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias; Ferreira Sorgine, Marcos Henrique; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil; [Rosa, Ivone de Andrade; Benchimol, Marlene] Univ Santa Ursula, Rio De Janeiro, Brazil; [Wu, Wenjie] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Roswell Park Cancer Institute	Ribeiro, FS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	fantappie@bioqmed.ufrj.br	Borges, Ronaldo S Mohana/C-5575-2013; Mesquita, Rafael Dias/AAH-4352-2022; Silva-Neto, Mario A C/C-1211-2013; Mesquita, Rafael Dias/AFP-3693-2022; de Moraes Maciel, Renata/E-1426-2014	Mesquita, Rafael Dias/0000-0002-2882-3362; Silva-Neto, Mario A C/0000-0003-2273-194X; Mesquita, Rafael Dias/0000-0002-2882-3362; Carneiro, Vitor/0000-0003-1518-7667; Belgrano, Fabricio/0000-0002-0411-7244	INCT-EM; CNPq; Faperj	INCT-EM; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by INCT-EM (http://www.inctem.bioqmed.ufrj.br/), CNPq (http://www.cnpq.br/), and Faperj (http://www.faperj.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar MM, 2008, EUKARYOT CELL, V7, P1565, DOI 10.1128/EC.00123-08; Aleporou-Marinou V, 2003, BIOCHEM GENET, V41, P291, DOI 10.1023/B:BIGI.0000006030.05308.04; de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Briquet S, 2006, EUKARYOT CELL, V5, P672, DOI 10.1128/EC.5.4.672-682.2006; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Chen YH, 2011, MOL IMMUNOL, V48, P793, DOI 10.1016/j.molimm.2010.11.020; da Silva ICD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023572; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hagedorn HH, 1989, PHYSL ROLES HEMOLYMP; Kiilerich B, 2008, GENE, V407, P86, DOI 10.1016/j.gene.2007.09.025; Kirov NC, 1996, EMBO J, V15, P7079, DOI 10.1002/j.1460-2075.1996.tb01099.x; Lamiable O, 2010, GENESIS, V48, P244, DOI 10.1002/dvg.20609; Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Martin D, 2003, J BIOCHEM, V134, P583, DOI 10.1093/jb/mvg177; Mosrin-Huaman C, 1998, DEV GENET, V23, P324; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; NER SS, 1993, NUCLEIC ACIDS RES, V21, P4369, DOI 10.1093/nar/21.18.4369; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782; Pfaffl MW, 2001, APMIS, V109, P345, DOI 10.1034/j.1600-0463.2001.090503.x; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Retief J D, 2000, Methods Mol Biol, V132, P243; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9; Seabra-Junior E.S., 2011, FAT FUNCTIONAL ANAL; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x; Stros M, 1998, J BIOL CHEM, V273, P10355; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Thomsen MS, 2004, BIOCHEMISTRY-US, V43, P8029, DOI 10.1021/bi0499009; WAGNER CR, 1992, MOL CELL BIOL, V12, P1915, DOI 10.1128/MCB.12.5.1915; Wang SF, 1998, J BIOL CHEM, V273, P27531, DOI 10.1074/jbc.273.42.27531; WARD LD, 1985, METHOD ENZYMOL, V117, P400; WISNIEWSKI JR, 1992, J BIOL CHEM, V267, P17170; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P10713; WISNIEWSKI JR, 1994, EUR J BIOCHEM, V225, P687, DOI 10.1111/j.1432-1033.1994.00687.x; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	55	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e40192	10.1371/journal.pone.0040192	http://dx.doi.org/10.1371/journal.pone.0040192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802955	Green Submitted, gold, Green Published			2022-12-25	WOS:000306186900029
J	van Bokhorst-van de Veen, H; Lee, IC; Marco, ML; Wels, M; Bron, PA; Kleerebezem, M				van Bokhorst-van de Veen, Hermien; Lee, I-Chiao; Marco, Maria L.; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel			Modulation of Lactobacillus plantarum Gastrointestinal Robustness by Fermentation Conditions Enables Identification of Bacterial Robustness Markers	PLOS ONE			English	Article							STRESS-RESPONSE; IN-VITRO; GENETIC-CHARACTERIZATION; BILE-SALT; STRAINS; LACTOCOCCUS; SURVIVAL; REUTERI; GROWTH; WCFS1	Background: Lactic acid bacteria (LAB) are applied worldwide in the production of a variety of fermented food products. Additionally, specific Lactobacillus species are nowadays recognized for their health-promoting effects on the consumer. To optimally exert such beneficial effects, it is considered of great importance that these probiotic bacteria reach their target sites in the gut alive. Methodology/Principal Findings: In the accompanying manuscript by Bron et al. the probiotic model organism Lactobacillus plantarum WCFS1 was cultured under different fermentation conditions, which was complemented by the determination of the corresponding molecular responses by full-genome transcriptome analyses. Here, the gastrointestinal (GI) survival of the cultures produced was assessed in an in vitro assay. Variations in fermentation conditions led to dramatic differences in GI-tract survival (up to 7-log) and high robustness could be associated with low salt and low pH during the fermentations. Moreover, random forest correlation analyses allowed the identification of specific transcripts associated with robustness. Subsequently, the corresponding genes were targeted by genetic engineering, aiming to enhance robustness, which could be achieved for 3 of the genes that negatively correlated with robustness and where deletion derivatives displayed enhanced survival compared to the parental strain. Specifically, a role in GI-tract survival could be confirmed for the lp_1669-encoded AraC-family transcription regulator, involved in capsular polysaccharide remodeling, the penicillin-binding protein Pbp2A involved in peptidoglycan biosynthesis, and the Na+/H+ antiporter NapA3. Moreover, additional physiological analysis established a role for Pbp2A and NapA3 in bile salt and salt tolerance, respectively. Conclusion: Transcriptome trait matching enabled the identification of biomarkers for bacterial (gut-) robustness, which is important for our molecular understanding of GI-tract survival and could facilitate the design of culture conditions aimed to enhance probiotic culture robustness.	[van Bokhorst-van de Veen, Hermien; Lee, I-Chiao; Marco, Maria L.; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [van Bokhorst-van de Veen, Hermien; Lee, I-Chiao; Marco, Maria L.; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [van Bokhorst-van de Veen, Hermien; Kleerebezem, Michiel] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands; [Wels, Michiel] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Top Institute Food & Nutrition; NIZO Food Research; Wageningen University & Research; Radboud University Nijmegen	van Bokhorst-van de Veen, H (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Michiel.Kleerebezem@nizo.nl	van Bokhorst-van de Veen, Hermien/K-2111-2013; Kleerebezem, Michiel/AAT-2078-2021; Marco, Maria/H-2322-2014	van Bokhorst-van de Veen, Hermien/0000-0003-4159-5955; Kleerebezem, Michiel/0000-0001-8552-2235				Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bron PA, 2006, J APPL MICROBIOL, V100, P728, DOI 10.1111/j.1365-2672.2006.02891.x; Bron PA, 2004, J BACTERIOL, V186, P7829, DOI 10.1128/JB.186.23.7829-7835.2004; Bron PA, 2011, FOOD MICROBIOL FOOD, P369, DOI 10.1007/978-0-387-92771-8_16; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Corcoran BM, 2008, CURR PHARM DESIGN, V14, P1382, DOI 10.2174/138161208784480225; Corcoran BM, 2004, J APPL MICROBIOL, V96, P1024, DOI 10.1111/j.1365-2672.2004.02219.x; Eijsink VGH, 1996, J BACTERIOL, V178, P2232, DOI 10.1128/jb.178.8.2232-2237.1996; FAO/WHO, 2001, EV HLTH NUTR PROP PO; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Georgieva RN, 2008, J BASIC MICROB, V48, P234, DOI 10.1002/jobm.200700355; Gobbetti M, 2010, CRIT REV FOOD SCI, V50, P716, DOI 10.1080/10408398.2010.499770; GOVERS MJAP, 1994, J LIPID RES, V35, P741; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Ingham CJ, 2008, APPL ENVIRON MICROB, V74, P7750, DOI 10.1128/AEM.00982-08; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kim WS, 2001, CURR MICROBIOL, V43, P346, DOI 10.1007/s002840010314; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Looijesteijn PJ, 1999, J BIOSCI BIOENG, V88, P178, DOI 10.1016/S1389-1723(99)80198-4; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Marteau P, 1997, J DAIRY SCI, V80, P1031, DOI 10.3168/jds.S0022-0302(97)76027-2; Matto J, 2004, J APPL MICROBIOL, V97, P459, DOI 10.1111/j.1365-2672.2004.02340.x; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Pfeiler EA, 2007, J BACTERIOL, V189, P4624, DOI 10.1128/JB.00337-07; Prasad J, 2003, APPL ENVIRON MICROB, V69, P917, DOI 10.1128/AEM.69.2.917-925.2003; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Succi M, 2005, FEMS MICROBIOL LETT, V244, P129, DOI 10.1016/j.femsle.2005.01.037; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; van Bokhorst-van de Veen H, 2011, APPL ENVIRON MICROB, V77, P5247, DOI 10.1128/AEM.00515-11; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Watson D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-176; Weckx S, 2010, APPL ENVIRON MICROB, V76, P5402, DOI 10.1128/AEM.00570-10; Wegkamp A, 2008, MODULATION FOLATE PR; Wegkamp A, 2009, FEMS MICROBIOL LETT, V297, P261, DOI 10.1111/j.1574-6968.2009.01690.x; Wels M, 2006, NUCLEIC ACIDS RES, V34, P1947, DOI 10.1093/nar/gkl138; Whitehead K, 2008, APPL ENVIRON MICROB, V74, P1812, DOI 10.1128/AEM.02259-07; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173	55	50	51	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e39053	10.1371/journal.pone.0039053	http://dx.doi.org/10.1371/journal.pone.0039053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	22802934	gold, Green Published			2022-12-25	WOS:000306186900008
J	Mutt, SJ; Karhu, T; Lehtonen, S; Lehenkari, P; Carlberg, C; Saarnio, J; Sebert, S; Hypponen, E; Jarvelin, MR; Herzig, KH				Mutt, Shivaprakash J.; Karhu, Toni; Lehtonen, Siri; Lehenkari, Petri; Carlberg, Carsten; Saarnio, Juha; Sebert, Sylvain; Hyppoenen, Elina; Jarvelin, Marjo-Ritta; Herzig, Karl-Heinz			Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D-3 via the NF-kappa B pathway	FASEB JOURNAL			English	Article						obesity; vitamin D; interleukin 6; chronic inflammation	VITAMIN-D SUPPLEMENTATION; NECROSIS-FACTOR-ALPHA; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; D DEFICIENCY; STEM-CELLS; RISK; INTERLEUKIN-6; 1-ALPHA,25(OH)(2)D-3; RECRUITMENT; EXPRESSION	Adipose tissue inflammation is an important pathological process in obese people, associated with diabetes and cardiovascular disease. We hypothesized that 1,25-dihydroxyvitamin D-3 [1,25(OH)2D(3)] inhibits cytokine secretion from adipocytes via direct inhibition of transcription factor nuclear factor-kappa B (NF-kappa B). We utilized two different human models. Bone marrow-derived human mesenchymal stromal cells (hMSCs) differentiated into adipocytes, and adipocytes isolated from biopsies stimulated with lipopolysaccharide (LPS) were treated with or without 1,25(OH) 2D(3). Expression and secretion of interleukin-6 (IL-6) were measured by quantitative RT-PCR analysis and ELISA. Assessment of NF-kappa B nuclear translocation, DNA binding activity was performed by immunofluorescence (IF) and electrophoretic mobility assay (EMSA). Inhibitor kappa B (I kappa B) and its phosphorylation were detected by Western blot (WB) analysis. Simultaneous 1,25(OH) 2D(3) cotreatment significantly re-duced LPS-stimulated (10 ng/ml) IL-6 secretion dose dependently by 15% at 10(-10) M and 26% at 10(-7) M (P<0.05) in hMSCs, while preincubation with 1,25(OH) 2D(3) (10(-7) M) for 24 h reduced IL-6 secretion by 24 and 35% (P<0.001) and mRNA levels by 34 and 30% (P<0.05) in hMSCs and isolated adipocytes, respectively. 1,25(OH) 2D(3) suppressed LPS-stimulated I kappa B phosphorylation-mediated NF-kappa B translocation into the nucleus were evident from WB, IF, and EMSA. 1,25(OH) 2D(3) inhibits LPS-stimulated IL-6 secretion in two human adipocyte models via interference with NF-kappa B signaling.-Mutt, S.J., Karhu, T., Lehtonen, S., Lehenkari, P., Carlberg, C., Saarnio, J., Sebert, S., Hypponen, E., Jorvelin, M.-R., Herzig, K.-H. Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D-3 via the NF-kappa B pathway. FASEB J. 26, 4400-4407 (2012). www.fasebj.org	[Mutt, Shivaprakash J.; Karhu, Toni; Lehtonen, Siri; Lehenkari, Petri; Herzig, Karl-Heinz] Univ Oulu, Dept Physiol, Inst Biomed, FIN-90014 Oulu, Finland; [Mutt, Shivaprakash J.; Karhu, Toni; Jarvelin, Marjo-Ritta; Herzig, Karl-Heinz] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Lehtonen, Siri; Lehenkari, Petri] Univ Oulu, Dept Anat, FIN-90014 Oulu, Finland; [Lehtonen, Siri; Lehenkari, Petri; Saarnio, Juha] Univ Oulu, Oulu Univ Hosp, Dept Surg, FIN-90014 Oulu, Finland; [Jarvelin, Marjo-Ritta] Univ Oulu, Inst Hlth Sci, FIN-90014 Oulu, Finland; [Lehtonen, Siri; Lehenkari, Petri] Clin Res Ctr, Oulu, Finland; [Carlberg, Carsten] Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Ritta] Natl Inst Hlth & Welf, Dept Life Course & Serv, Oulu, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Ritta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Sebert, Sylvain; Jarvelin, Marjo-Ritta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Med Res Council Hlth Protect Agcy Ctr, London, England; [Hyppoenen, Elina] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Herzig, Karl-Heinz] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; Finland National Institute for Health & Welfare; Imperial College London; Imperial College London; University of London; University College London; Kuopio University Hospital; University of Eastern Finland	Herzig, KH (corresponding author), Univ Oulu, Dept Physiol, Inst Biomed, POB 5000, FIN-90014 Oulu, Finland.	karl-heinz.herzig@oulu.fi	Lehenkari, Petri/O-3009-2016; Hypponen, Elina/B-2596-2014; Carlberg, Carsten/C-9075-2011; Mutt, Shivaprakash Jagalur/AAC-9768-2019	Lehenkari, Petri/0000-0002-0055-5183; Hypponen, Elina/0000-0003-3670-9399; Carlberg, Carsten/0000-0003-2633-0684; Mutt, Shivaprakash Jagalur/0000-0001-8285-551X; Sebert, Sylvain/0000-0001-6681-6983; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Lehtonen, Siri/0000-0002-5578-8232	Academy of Finland [104781, 120315, 129269, 1114194]; Academy of Finland [Responding to Public Health Challenges Research Programme (SALVE)]; University Hospital Oulu; Biocenter of Oulu; University of Oulu, Finland [75617]; Medical Research Council, UK (PrevMetSyn/SALVE); Medical Research Council [G0801056B] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish	Academy of Finland(Academy of Finland); Academy of Finland [Responding to Public Health Challenges Research Programme (SALVE)]; University Hospital Oulu; Biocenter of Oulu; University of Oulu, Finland; Medical Research Council, UK (PrevMetSyn/SALVE)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the grants from the Academy of Finland [project grants 104781, 120315, 129269, 1114194, and Responding to Public Health Challenges Research Programme (SALVE)], University Hospital Oulu, Biocenter of Oulu, University of Oulu, Finland (75617), and the Medical Research Council, UK (PrevMetSyn/SALVE). The authors declare no conflicts of interest.	Adorini L, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P631; Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038/sj.ejcn.1602108; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Baroni E, 2007, J LEUKOCYTE BIOL, V81, P250, DOI 10.1189/jlb.0506322; Calvo MS, 2003, NUTR REV, V61, P107, DOI 10.1301/nr.2003.marr.107-113; Canning MO, 2001, EUR J ENDOCRINOL, V145, P351, DOI 10.1530/eje.0.1450351; Carlberg C, 2010, CHROMOSOMA, V119, P479, DOI 10.1007/s00412-010-0283-8; Carlin Arthur M, 2006, Surg Obes Relat Dis, V2, P98, DOI 10.1016/j.soard.2005.12.001; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Cohen-Lahav M., 2007, J STEROID BIOCHEM, V103, P558; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Fain JN, 1998, METABOLISM, V47, P1455, DOI 10.1016/S0026-0495(98)90069-5; Giarratana N, 2004, J IMMUNOL, V173, P2280, DOI 10.4049/jimmunol.173.4.2280; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hoareau L, 2006, CYTOKINE, V34, P291, DOI 10.1016/j.cyto.2006.06.005; Hoch M, 2008, CYTOKINE, V41, P29, DOI 10.1016/j.cyto.2007.10.008; HOLICK MF, 1989, LANCET, V2, P1104; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huotari A, 2008, INT J CIRCUMPOL HEAL, V67, P164, DOI 10.3402/ijch.v67i2-3.18258; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Jenab Mazda, 2010, BMJ, V340, pb5500, DOI 10.1136/bmj.b5500; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jorde R, 2000, AM J CLIN NUTR, V71, P1530; Joyner JM, 2000, J ENDOCRINOL, V166, P145, DOI 10.1677/joe.0.1660145; Kodiha M., 2009, NAT NETW PROTOC, DOI [10.1038/nprot.2009.16, DOI 10.1038/NPROT.2009.16]; Konradsen S, 2008, EUR J NUTR, V47, P87, DOI 10.1007/s00394-008-0700-4; Lamberg-Allardt CJE, 2001, J BONE MINER RES, V16, P2066, DOI 10.1359/jbmr.2001.16.11.2066; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lorente-Cebrian S, 2012, EUR J NUTR, V51, P335, DOI 10.1007/s00394-011-0218-z; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; MAXWELL JD, 1994, P NUTR SOC, V53, P533, DOI 10.1079/PNS19940063; Perakyla M, 2005, MOL ENDOCRINOL, V19, P2060, DOI 10.1210/me.2004-0417; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Rapuri PB, 2002, J CLIN ENDOCR METAB, V87, P2024, DOI 10.1210/jc.87.5.2024; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Samuelson G, 2000, EUR J CLIN NUTR, V54, pS21, DOI 10.1038/sj.ejcn.1600980; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Suzuki Y, 2009, J STEROID BIOCHEM, V113, P134, DOI 10.1016/j.jsbmb.2008.12.004; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Vlasova M, 2010, ACTA PHYSIOL, V200, P107, DOI 10.1111/j.1748-1716.2010.02171.x; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wu SP, 2010, INT J BIOCHEM CELL B, V42, P329, DOI 10.1016/j.biocel.2009.11.012; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	54	68	71	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4400	4407		10.1096/fj.12-210880	http://dx.doi.org/10.1096/fj.12-210880			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22798425				2022-12-25	WOS:000310574200004
J	Di Costanzo, A; Troiano, A; di Martino, O; Cacace, A; Natale, CF; Ventre, M; Netti, P; Caserta, S; Pollice, A; La Mantia, G; Calabro, V				Di Costanzo, Antonella; Troiano, Annaelena; di Martino, Orsola; Cacace, Andrea; Natale, Carlo F.; Ventre, Maurizio; Netti, Paolo; Caserta, Sergio; Pollice, Alessandra; La Mantia, Girolama; Calabro, Viola			The p63 Protein Isoform Delta Np63 alpha Modulates Y-box Binding Protein 1 in Its Subcellular Distribution and Regulation of Cell Survival and Motility Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; MESSENGER-RNA; P53 HOMOLOG; YB-1; KERATINOCYTES; EXPRESSION; CARCINOMA; GROWTH; PROLIFERATION	The Y-box binding protein 1 (YB-1) belongs to the cold-shock domain protein superfamily, one of the most evolutionarily conserved nucleic acid-binding proteins currently known. YB-1 performs a wide variety of cellular functions, including transcriptional and translational regulation, DNA repair, drug resistance, and stress responses to extracellular signals. Inasmuch as the level of YB-1 drastically increases in tumor cells, this protein is considered to be one of the most indicative markers of malignant tumors. Here, we present evidence that Delta Np63 alpha, the predominant p63 protein isoform in squamous epithelia and YB-1, can physically interact. Into the nucleus, Delta Np63 alpha and YB-1 cooperate in PI3KCA gene promoter activation. Moreover, Delta Np63 alpha promotes YB-1 nuclear accumulation thereby reducing the amount of YB-1 bound to its target transcripts such as that encoding the SNAIL1 protein. Accordingly, Delta Np63 alpha enforced expression was associated with a reduction of the level of SNAIL1, a potent inducer of epithelial to mesenchymal transition. Furthermore, Delta Np63 alpha depletion causes morphological change and enhanced formation of actin stress fibers in squamous cancer cells. Mechanistic studies indicate that alpha Np63 Delta affects cell movement and can reverse the increase of cell motility induced by YB-1 overexpression. These data thus suggest that Delta Np63 alpha provides inhibitory signals for cell motility. Deficiency of Delta Np63 alpha gene expression promotes cell mobilization, at least partially, through a YB-1-dependent mechanism.	[Di Costanzo, Antonella; Troiano, Annaelena; di Martino, Orsola; Cacace, Andrea; Pollice, Alessandra; La Mantia, Girolama; Calabro, Viola] Univ Naples Federico II, Dept Struct & Mol Biol, Ist Italiano Tecnol, I-80126 Naples, Italy; [Natale, Carlo F.; Ventre, Maurizio; Netti, Paolo] Univ Naples Federico II, Ctr Adv Biomat Hlth Care, Ist Italiano Tecnol, I-80126 Naples, Italy; [Natale, Carlo F.; Ventre, Maurizio; Netti, Paolo] Univ Naples Federico II, Interdisciplinary Res Ctr Biomat, I-80126 Naples, Italy; [Caserta, Sergio] Univ Naples Federico II, Dept Chem Engn, I-80125 Naples, Italy	Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Calabro, V (corresponding author), Univ Naples Federico II, Dept Biol Strutturale & Funzionale, Via Cinzia Monte S Angelo, I-80126 Naples, Italy.	vcalabro@unina.it	Ventre, Maurizio/M-8029-2019; Caserta, Sergio/E-4602-2012; Calabro, Viola/H-6156-2013	Ventre, Maurizio/0000-0003-3375-9112; Caserta, Sergio/0000-0002-4400-0059; di Martino, Orsola/0000-0002-7620-0290; Calabro, Viola/0000-0002-6508-8889; NETTI, PAOLO/0000-0002-2435-7181	MIUR [PRIN 2009KFS94X_003]	MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR Grant PRIN 2009KFS94X_003 (to V. C.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Amoresana A, 2010, J PROTEOME RES, V9, P2042, DOI 10.1021/pr9011156; Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Chernov K. G., 2008, BMC BIOCH, P9; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Danilov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026815; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fukunishi N, 2010, NEOPLASIA, V12, P969, DOI 10.1593/neo.101054; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Ha LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021877; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Higashi K, 2011, J BIOL CHEM, V286, P4485, DOI 10.1074/jbc.M110.151936; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Lo Iacono M, 2006, CELL CYCLE, V5, P78; Matsumoto Ken, 2005, J Mol Genet Med, V1, P11; Moll UM, 2004, MOL CANCER RES, V2, P371; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Sou PW, 2010, INT J BIOCHEM CELL B, V42, P1940, DOI 10.1016/j.biocel.2010.08.021; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Wu Joyce, 2007, Transl Oncogenomics, V2, P49; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang YF, 2003, ONCOGENE, V22, P2782, DOI 10.1038/sj.onc.1206357	40	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30170	30180		10.1074/jbc.M112.349951	http://dx.doi.org/10.1074/jbc.M112.349951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787154	Green Published, hybrid			2022-12-25	WOS:000308579800012
J	Du, JT; Campau, E; Soragni, E; Ku, S; Puckett, JW; Dervan, PB; Gottesfeld, JM				Du, Jintang; Campau, Erica; Soragni, Elisabetta; Ku, Sherman; Puckett, James W.; Dervan, Peter B.; Gottesfeld, Joel M.			Role of Mismatch Repair Enzymes in GAA.TTC Triplet-repeat Expansion in Friedreich Ataxia Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOT-TTC REPEATS; SOMATIC INSTABILITY; NEURAL CONVERSION; IPS CELLS; DNA; TRANSCRIPTION; INHIBITION; SEQUENCE; REPLICATION; HUNTINGTONS	The genetic mutation in Friedreich ataxia (FRDA) is a hyper-expansion of the triplet-repeat sequence GAA.TTC within the first intron of the FXN gene. Although yeast and reporter construct models for GAA.TTC triplet-repeat expansion have been reported, studies on FRDA pathogenesis and therapeutic development are limited by the availability of an appropriate cell model in which to study the mechanism of instability of the GAA.TTC triplet repeats in the human genome. Herein, induced pluripotent stem cells (iPSCs) were generated from FRDA patient fibroblasts after transduction with the four transcription factors Oct4, Sox2, Klf4, and c-Myc. These cells were differentiated into neurospheres and neuronal precursors in vitro, providing a valuable cell model for FRDA. During propagation of the iPSCs, GAA.TTC triplet repeats expanded at a rate of about two GAA.TTC triplet repeats/replication. However, GAA.TTC triplet repeats were stable in FRDA fibroblasts and neuronal stem cells. The mismatch repair enzymes MSH2, MSH3, and MSH6, implicated in repeat instability in other triplet-repeat diseases, were highly expressed in pluripotent stem cells compared with fibroblasts and neuronal stem cells and occupied FXN intron 1. In addition, shRNA silencing of MSH2 and MSH6 impeded GAA.TTC triplet-repeat expansion. A specific pyrrole-imidazole polyamide targeting GAA.TTC triplet-repeat DNA partially blocked repeat expansion by displacing MSH2 from FXN intron 1 in FRDA iPSCs. These studies suggest that in FRDA, GAA.TTC triplet-repeat instability occurs in embryonic cells and involves the highly active mismatch repair system.	[Du, Jintang; Campau, Erica; Soragni, Elisabetta; Ku, Sherman; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Puckett, James W.; Dervan, Peter B.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Scripps Research Institute; California Institute of Technology	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-27,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joelg@scripps.edu		Gottesfeld, Joel/0000-0002-4643-5777	National Institutes Health from NINDS [NS062856]; NIGMS [GM275681]; Friedreich's Ataxia Research Alliance; California Institute for Regenerative Medicine (CIRM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	National Institutes Health from NINDS; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Friedreich's Ataxia Research Alliance; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes Health Grant NS062856 from NINDS (to J. M. G.) and Grant GM275681 from NIGMS (to P. B. D.). This work was also supported by a postdoctoral fellowship from the Friedreich's Ataxia Research Alliance (to J. D.) and by a grant from the California Institute for Regenerative Medicine (CIRM).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; Dickinson LA, 1998, P NATL ACAD SCI USA, V95, P12890, DOI 10.1073/pnas.95.22.12890; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Dottori Mirella, 2008, V438, P19, DOI 10.1007/978-1-59745-133-8_3; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Dudouet B, 2003, CHEM BIOL, V10, P859, DOI 10.1016/j.chembiol.2003.09.001; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; Fujimoto J, 2008, BIOORGAN MED CHEM, V16, P5899, DOI 10.1016/j.bmc.2008.04.060; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Gomes-Pereira Mario, 2004, V277, P61; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Liu J, 2011, STEM CELL REV REP, V7, P703, DOI 10.1007/s12015-010-9210-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Napierala M, 2004, J BIOL CHEM, V279, P6444, DOI 10.1074/jbc.M309596200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pollard LM, 2008, NUCLEIC ACIDS RES, V36, P489, DOI 10.1093/nar/gkm1066; Rindler PM, 2011, NUCLEIC ACIDS RES, V39, P526, DOI 10.1093/nar/gkq788; Rindler PM, 2006, NUCLEIC ACIDS RES, V34, P6352, DOI 10.1093/nar/gkl846; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; Urbach AR, 2002, J MOL BIOL, V320, P55, DOI 10.1016/S0022-2836(02)00430-8; Urbach AR, 2001, P NATL ACAD SCI USA, V98, P4343, DOI 10.1073/pnas.081070798; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	46	80	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29861	29872		10.1074/jbc.M112.391961	http://dx.doi.org/10.1074/jbc.M112.391961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22798143	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000308286900060
J	Woolley, JF; Naughton, R; Stanicka, J; Gough, DR; Bhatt, L; Dickinson, BC; Chang, CJ; Cotter, TG				Woolley, John F.; Naughton, Ruth; Stanicka, Joanna; Gough, David R.; Bhatt, Lavinia; Dickinson, Bryan C.; Chang, Christopher J.; Cotter, Thomas G.			H2O2 Production Downstream of FLT3 Is Mediated by p22phox in the Endoplasmic Reticulum and Is Required for STAT5 Signalling	PLOS ONE			English	Article							IMAGING HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PLASMA-MEMBRANE; DNA-DAMAGE; ACTIVATION; NOX4; KINASE; DEGRADATION; EXPRESSION; MECHANISM	The internal tandem duplication (ITD) of the juxtamembrane region of the FLT3 receptor has been associated with increased reactive oxygen species (ROS) generation in acute myeloid leukemia (AML). How this elevated level of ROS contributes to the leukemic phenotype, however, remains poorly understood. In this work we show that ROS in the FLT3-ITD expressing AML cell line MV4-11 is reduced by treatment with PKC412, an inhibitor of FLT3, DPI, a flavoprotein inhibitor, and VAS2870, a Nox specific inhibitor, suggesting that ROS production is both FLT3 and NADPH oxidase dependent. The majority of these ROS co-localize to the endoplasmic reticulum (ER), as determined with the H2O2-specific aryl-boronate dye Peroxyorange 1, which also corresponds to co-localization of p22phox. Moreover, knocking down p22phox dramatically reduces H2O2 after 24 hours in the ER, without affecting mitochondrial ROS. Significantly, the FLT3 inhibitor PKC412 reduces H2O2 in FLT3-ITD expressing cell lines (MV4-11, MOLM-13) through reduction of p22phox over 24 hours. Reduced p22phox is achieved by proteasomal degradation and is prevented upon GSK3-b inhibition. Knockdown of p22phox resulted in reduced STAT5 signalling and reduced Pim-1 levels in the cells after 24 hours. Thus, we have shown that FLT3 driven H2O2 production in AML cells is mediated by p22phox and is critical for STAT5 signalling.	[Woolley, John F.; Naughton, Ruth; Stanicka, Joanna; Gough, David R.; Bhatt, Lavinia; Cotter, Thomas G.] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland; [Dickinson, Bryan C.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University College Cork; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Woolley, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland.	t.cotter@ucc.ie		Cotter, Thomas/0000-0003-4626-5613; Woolley, John/0000-0001-7885-8515	Children's Leukemia Research Project, Cancer Research Ireland and Science Foundation Ireland; National Institutes of Health [GM 79465, T32 GM066698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM066698] Funding Source: NIH RePORTER	Children's Leukemia Research Project, Cancer Research Ireland and Science Foundation Ireland(Science Foundation Ireland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Children's Leukemia Research Project, Cancer Research Ireland and Science Foundation Ireland (SFI). The authors thank the National Institutes of Health (GM 79465 to C.J.C.) for funding. C.J.C. is an Investigator with the Howard Hughes Medical Institute. B.C.D. was partially supported by a Chemical Biology Training Grant from the National Institutes of Health (T32 GM066698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira D, 2011, J BIOL CHEM, V286, P32313, DOI 10.1074/jbc.M111.249060; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Birkenkamp KU, 2001, LEUKEMIA, V15, P1923, DOI 10.1038/sj.leu.2402317; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Edderkaoui M, 2011, J BIOL CHEM, V286, P7779, DOI 10.1074/jbc.M110.200063; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Kayser S, 2009, BLOOD, V114, P2386, DOI 10.1182/blood-2009-03-209999; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Lee CF, 2010, CIRC RES, V106, P1489, DOI 10.1161/CIRCRESAHA.109.215392; Li J, 2007, J CLIN INVEST, V117, P3283, DOI 10.1172/JCI31772; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sattler M, 1999, BLOOD, V93, P2928; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Small D, 2008, SEMIN HEMATOL, V45, pS17, DOI 10.1053/j.seminhematol.2008.07.007; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454	53	43	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e34050	10.1371/journal.pone.0034050	http://dx.doi.org/10.1371/journal.pone.0034050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	22807997	Green Published, gold, Green Submitted			2022-12-25	WOS:000306406700001
J	Otte, WM; Dijkhuizen, RM; van Meer, MPA; van der Hel, WS; Verlinde, SAMW; van Nieuwenhuizen, O; Viergever, MA; Stam, CJ; Braun, KPJ				Otte, Willem M.; Dijkhuizen, Rick M.; van Meer, Maurits P. A.; van der Hel, Wilhelmina S.; Verlinde, Suzanne A. M. W.; van Nieuwenhuizen, Onno; Viergever, Max A.; Stam, Cornelis J.; Braun, Kees P. J.			Characterization of Functional and Structural Integrity in Experimental Focal Epilepsy: Reduced Network Efficiency Coincides with White Matter Changes	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD NETWORKS; SUBJECT DIFFUSION DATA; TETANUS TOXIN; SPATIAL STATISTICS; STATUS EPILEPTICUS; VOXELWISE ANALYSIS; RAT MODEL; MRI DATA	Background: Although focal epilepsies are increasingly recognized to affect multiple and remote neural systems, the underlying spatiotemporal pattern and the relationships between recurrent spontaneous seizures, global functional connectivity, and structural integrity remain largely unknown. Methodology/Principal Findings: Here we utilized serial resting-state functional MRI, graph-theoretical analysis of complex brain networks and diffusion tensor imaging to characterize the evolution of global network topology, functional connectivity and structural changes in the interictal brain in relation to focal epilepsy in a rat model. Epileptic networks exhibited a more regular functional topology than controls, indicated by a significant increase in shortest path length and clustering coefficient. Interhemispheric functional connectivity in epileptic brains decreased, while intrahemispheric functional connectivity increased. Widespread reductions of fractional anisotropy were found in white matter regions not restricted to the vicinity of the epileptic focus, including the corpus callosum. Conclusions/Significance: Our longitudinal study on the pathogenesis of network dynamics in epileptic brains reveals that, despite the locality of the epileptogenic area, epileptic brains differ in their global network topology, connectivity and structural integrity from healthy brains.	[Otte, Willem M.; van Meer, Maurits P. A.; van der Hel, Wilhelmina S.; Verlinde, Suzanne A. M. W.; van Nieuwenhuizen, Onno; Braun, Kees P. J.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Otte, Willem M.; Dijkhuizen, Rick M.; van Meer, Maurits P. A.; Viergever, Max A.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Otte, WM (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	wim@invivonmr.uu.nl	Otte, Willem M/I-1228-2013; Otte, Willem M./J-6140-2019; Viergever, Max A/J-1215-2014	Otte, Willem M/0000-0003-1511-6834; Otte, Willem M./0000-0003-1511-6834; Stam, Cornelis/0000-0001-9163-7274; Dijkhuizen, Rick/0000-0002-4623-4078	Dutch National Epilepsy Fund (NEF) [08-10]; Utrecht University's High Potential program	Dutch National Epilepsy Fund (NEF); Utrecht University's High Potential program	This research was supported by the Dutch National Epilepsy Fund (NEF nr. 08-10) and Utrecht University's High Potential program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barkmeier DT, 2009, CLIN EEG NEUROSCI, V40, P234, DOI 10.1177/155005940904000405; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; BRENER K, 1991, EUR J NEUROSCI, V3, P47, DOI 10.1111/j.1460-9568.1991.tb00810.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058; Chavez M, 2006, CHAOS, V16, DOI 10.1063/1.2180467; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Coan AC, 2009, NEUROLOGY, V73, P834, DOI 10.1212/WNL.0b013e3181b783dd; Duncan J, 2009, CURR OPIN NEUROL, V22, P179, DOI 10.1097/WCO.0b013e328328f260; Dupont S, 2000, BRAIN, V123, P1722, DOI 10.1093/brain/123.8.1722; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; ITO BM, 1988, NEUROLOGY, V38, P924, DOI 10.1212/WNL.38.6.924; Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones R. H., 1993, LONGITUDINAL DATA SE; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Klein S, 2009, IEEE T MED IMAGING; Koepp MJ, 2005, LANCET NEUROL, V4, P42, DOI 10.1016/S1474-4422(04)00965-2; Kotloski R, 2002, PROG BRAIN RES, V135, P95; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; LOUIS ED, 1990, ELECTROEN CLIN NEURO, V75, P548, DOI 10.1016/0013-4694(90)90141-6; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Marsh ED, 2006, EPILEPSIA, V47, P1999, DOI 10.1111/j.1528-1167.2006.00894.x; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mirsattari SM, 2004, ARCH NEUROL-CHICAGO, V61, P1254, DOI 10.1001/archneur.61.8.1254; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; MORRELL F, 1989, J CLIN NEUROPHYSIOL, V6, P227, DOI 10.1097/00004691-198907000-00002; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nilsen KE, 2006, EPILEPSIA, V47, P1169, DOI 10.1111/j.1528-1167.2006.00540.x; Nilsen KE, 2005, EPILEPSIA, V46, P179, DOI 10.1111/j.0013-9580.2005.26004.x; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Otte WM, 2012, EPILEPSIA, P1; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Percha B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031909; Pinheiro J., 2007, R PACKAGE VERSION, V3, P57; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; RUBINOV M, 2009, NEUROIMAGE; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Siek J, 2002, BOOST GRAPH LIB USER, P112; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stam CJ, 2012, CLIN NEUROPHYSIOL; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Sutula TP, 2003, CURR OPIN NEUROL, V16, P189, DOI 10.1097/00019052-200304000-00012; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Vaessen M.J., 2011, CEREB CORTEX; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Wang K, 2010, NMR BIOMED; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007	76	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39078	10.1371/journal.pone.0039078	http://dx.doi.org/10.1371/journal.pone.0039078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808026	Green Published, Green Submitted, gold			2022-12-25	WOS:000306366400008
J	Boyden, AW; Legge, KL; Waldschmidt, TJ				Boyden, Alexander W.; Legge, Kevin L.; Waldschmidt, Thomas J.			Pulmonary Infection with Influenza A Virus Induces Site-Specific Germinal Center and T Follicular Helper Cell Responses	PLOS ONE			English	Article							MEMORY B-CELLS; ANTIBODY-SECRETING CELLS; LYMPHOID-TISSUE; DENDRITIC CELLS; IMMUNE-RESPONSES; CUTTING EDGE; MICE; EXPRESSION; IL-21; LUNG	Protection from influenza A virus (IAV) challenge requires switched, high affinity Abs derived from long-lived memory B cells and plasma cells. These B cell subsets are generated in germinal centers (GCs), hallmark structures of T helper cell-driven B cell immunity. A full understanding of the GC reaction after respiratory IAV infection is lacking, as is the characterization of T follicular helper (T-FH) cells that support GCs. Here, GC B cell and T-FH cell responses were studied in mice following pulmonary challenge with IAV. Marked GC reactions were induced in draining lymph nodes (dLNs), lung, spleen and nasal-associated lymphoid tissue (NALT), although the magnitude and kinetics of the response was site-specific. Examination of switching within GCs demonstrated IgG2(+) cells to compose the largest fraction in dLNs, lung and spleen. IgA(+) GC B cells were infrequent in these sites, but composed a significant subset of the switched GC population in NALT. Further experiments demonstrated splenectomized mice to withstand a lethal recall challenge, suggesting the spleen to be unnecessary for long-term protection in spite of strong GC responses in this organ. Final studies showed that T-FH cell numbers were highest in dLNs and spleen, and peaked in all sites prior to the height of the GC reaction. T-FH cells purified from dLNs generated IL-21 and IFN gamma upon activation, although CD4(+)CXCR5(-) T effector cells produced higher levels of all cytokines. Collectively, these findings reveal respiratory IAV infection to induce strong T helper cell-driven B cell responses in various organs, with each site displaying unique attributes.	[Boyden, Alexander W.; Legge, Kevin L.; Waldschmidt, Thomas J.] Univ Iowa, Interdisciplinary Grad Program Immunol, Carver Coll Med, Iowa City, IA 52242 USA; [Boyden, Alexander W.; Legge, Kevin L.; Waldschmidt, Thomas J.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Legge, Kevin L.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Boyden, AW (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Carver Coll Med, Iowa City, IA 52242 USA.	thomas-waldschmidt@uiowa.edu		Waldschmidt, Thomas/0000-0001-6147-6991; Legge, Kevin/0000-0001-9800-6854; Boyden, Alexander/0000-0003-3440-7848	National Institutes of Health [R01AI071085, R01AA019438]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants R01AI071085 and R01AA019438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2011, IMMUNOLOGY, V133, P452, DOI 10.1111/j.1365-2567.2011.03456.x; Arulanandam BP, 2001, J IMMUNOL, V166, P226, DOI 10.4049/jimmunol.166.1.226; Asanuma H, 1998, VACCINE, V16, P1257, DOI 10.1016/S0264-410X(98)00048-6; Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Baumgarth N, 2008, CURR TOP MICROBIOL, V319, P41; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Brydak LB, 2004, J CLIN IMMUNOL, V24, P225, DOI 10.1023/B:JOCI.0000025444.24160.d5; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Elgueta R, 2010, IMMUNOL REV, V236, P139, DOI 10.1111/j.1600-065X.2010.00924.x; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; FAZEKAS G, 1994, EUR J IMMUNOL, V24, P3063, DOI 10.1002/eji.1830241222; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; HOCART MJ, 1989, J GEN VIROL, V70, P2439, DOI 10.1099/0022-1317-70-9-2439; HYLAND L, 1994, J VIROL, V68, P6083, DOI 10.1128/JVI.68.9.6083-6086.1994; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES PD, 1986, J VIROL, V60, P614, DOI 10.1128/JVI.60.2.614-619.1986; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kopf M, 2002, EUR J IMMUNOL, V32, P2229, DOI 10.1002/1521-4141(200208)32:8<2229::AID-IMMU2229>3.0.CO;2-T; Langley JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-219; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Liang B, 2001, J VIROL, V75, P5416, DOI 10.1128/JVI.75.11.5416-5420.2001; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lund FE, 2002, J IMMUNOL, V169, P5236, DOI 10.4049/jimmunol.169.9.5236; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Rangel-Moreno J, 2005, J IMMUNOL, V175, P4904, DOI 10.4049/jimmunol.175.8.4904; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sealy R, 2003, IMMUNOLOGY, V108, P431, DOI 10.1046/j.1365-2567.2003.01615.x; Shen CH, 2010, P NATL ACAD SCI USA, V107, P22587, DOI 10.1073/pnas.1016350108; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Swain SL, 2004, VIRAL IMMUNOL, V17, P197, DOI 10.1089/0882824041310577; Tamura S, 1998, J GEN VIROL, V79, P291, DOI 10.1099/0022-1317-79-2-291; Topham DJ, 1997, J IMMUNOL, V159, P5197; Tripp RA, 1997, J IMMUNOL, V158, P3716; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Wolf AI, 2011, J CLIN INVEST, V121, P3954, DOI 10.1172/JCI57362; Wolniak KL, 2004, CRIT REV IMMUNOL, V24, P39, DOI 10.1615/CritRevImmunol.v24.20; Wolniak KL, 2006, J IMMUNOL, V177, P2072, DOI 10.4049/jimmunol.177.4.2072; Xiao YL, 2004, J IMMUNOL, V172, P7432, DOI 10.4049/jimmunol.172.12.7432; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yoo JK, 2010, J EXP MED, V207, P1435, DOI 10.1084/jem.20091373; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zeng JW, 2009, J IMMUNOL, V182, P4721, DOI 10.4049/jimmunol.0802833; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	81	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40733	10.1371/journal.pone.0040733	http://dx.doi.org/10.1371/journal.pone.0040733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792401	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400097
J	Glaab, E; Bacardit, J; Garibaldi, JM; Krasnogor, N				Glaab, Enrico; Bacardit, Jaume; Garibaldi, Jonathan M.; Krasnogor, Natalio			Using Rule-Based Machine Learning for Candidate Disease Gene Prioritization and Sample Classification of Cancer Gene Expression Data	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR EXPRESSION; NON-HODGKINS-LYMPHOMAS; PARTIAL LEAST-SQUARES; PROSTATE-CANCER; FEATURE-SELECTION; MICROARRAY DATA; BREAST-CANCER; OUTCOME PREDICTION; COA RACEMASE; HEPSIN	Microarray data analysis has been shown to provide an effective tool for studying cancer and genetic diseases. Although classical machine learning techniques have successfully been applied to find informative genes and to predict class labels for new samples, common restrictions of microarray analysis such as small sample sizes, a large attribute space and high noise levels still limit its scientific and clinical applications. Increasing the interpretability of prediction models while retaining a high accuracy would help to exploit the information content in microarray data more effectively. For this purpose, we evaluate our rule-based evolutionary machine learning systems, BioHEL and GAssist, on three public microarray cancer datasets, obtaining simple rule-based models for sample classification. A comparison with other benchmark microarray sample classifiers based on three diverse feature selection algorithms suggests that these evolutionary learning techniques can compete with state-of-the-art methods like support vector machines. The obtained models reach accuracies above 90% in two-level external cross-validation, with the added value of facilitating interpretation by using only combinations of simple if-then-else rules. As a further benefit, a literature mining analysis reveals that prioritizations of informative genes extracted from BioHEL's classification rule sets can outperform gene rankings obtained from a conventional ensemble feature selection in terms of the pointwise mutual information between relevant disease terms and the standardized names of top-ranked genes.	[Glaab, Enrico; Bacardit, Jaume; Krasnogor, Natalio] Univ Nottingham, Interdisciplinary Comp & Complex Syst ICOS Res Gr, Nottingham NG7 2RD, England; [Garibaldi, Jonathan M.] Univ Nottingham, Intelligent Modeling & Anal IMA Res Grp, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Glaab, E (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.	Natalio.Krasnogor@Nottingham.ac.uk	Bacardit, Jaume/F-9293-2014; Glaab, Enrico/A-9136-2012	Bacardit, Jaume/0000-0002-2692-7205; Glaab, Enrico/0000-0003-3977-7469; Garibaldi, Jonathan/0000-0002-9690-7074	Marie-Curie Early-Stage-Training programme [MEST-CT-2004-007597]; United Kingdom Engineering and Physical Sciences Research Council [EP/E017215/1, EP/H016597/1, EP/J004111/1]; Biotechnology and Biological Sciences Research Council [BB/F01855X/1]; Engineering and Physical Sciences Research Council [EP/E017215/1, EP/J004111/1, EP/H016597/1] Funding Source: researchfish; BBSRC [BB/F01855X/1] Funding Source: UKRI; EPSRC [EP/H016597/1, EP/J004111/1, EP/E017215/1] Funding Source: UKRI	Marie-Curie Early-Stage-Training programme(European Commission); United Kingdom Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge support by the Marie-Curie Early-Stage-Training programme (grant MEST-CT-2004-007597), by the United Kingdom Engineering and Physical Sciences Research Council (EP/E017215/1, EP/H016597/1 and EP/J004111/1) and the Biotechnology and Biological Sciences Research Council (BB/F01855X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuff HB, 2006, CANCER RES, V66, P7968, DOI 10.1158/0008-5472.CAN-05-4279; Aguilar-Ruiz JS, 2003, IEEE T SYST MAN CY B, V33, P324, DOI 10.1109/TSMCB.2002.805696; Alexe Gabriela, 2006, Breast Cancer Res, V8, pR41, DOI 10.1186/bcr1512; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bacardit J, 2008, LECT NOTES COMPUTER, V4998, P255; Bacardit J, 2004, THESIS RAMON LLULL U; Bacardit J, 2008, GECCO 08, P1421; Bacardit J., 2009, MEMET COMPUT, V1, P55, DOI DOI 10.1007/S12293-008-0005-4; Bacardit J, 2007, LECT NOTES ARTIF INT, V4399, P282, DOI 10.1007/978-3-540-71231-2_19; Bacardit J, 2007, LECT NOTES ARTIF INT, V4399, P59, DOI 10.1007/978-3-540-71231-2_5; Bacardit J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-6; Bassel GW, 2011, PLANT CELL, V23, P3101, DOI 10.1105/tpc.111.088153; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Bende RJ, 2007, LEUKEMIA, V21, P18, DOI 10.1038/sj.leu.2404426; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Blanco R, 2004, INT J PATTERN RECOGN, V18, P1373, DOI 10.1142/S0218001404003800; Boulesteix A.-L., 2004, STAT APPL GENET MOL, V3, P1075, DOI DOI 10.2202/1544-6115.1075; Boulesteix AL, 2008, BIOINFORMATICS, V24, P1698, DOI 10.1093/bioinformatics/btn262; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Bray GA, 2002, J NUTR, V132, p3451S, DOI 10.1093/jn/132.11.3451S; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calle M Luz, 2011, Brief Bioinform, V12, P86, DOI 10.1093/bib/bbq011; Chen ZX, 2003, J UROLOGY, V169, P1316, DOI 10.1097/01.ju.0000050648.40164.0d; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chu W, 2005, BIOINFORMATICS, V21, P3385, DOI 10.1093/bioinformatics/bti526; Conover W. J., 1971, PRACTICAL NONPARAMET; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dani C, 1997, J CELL SCI, V110, P1279; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch JM, 2003, BIOINFORMATICS, V19, P45, DOI 10.1093/bioinformatics/19.1.45; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; DiLella AG, 2001, J HISTOCHEM CYTOCHEM, V49, P669, DOI 10.1177/002215540104900517; Divina F, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P385; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Fano R M, 1961, AM J PHYS, V29, P793, DOI DOI 10.1119/1.1937609; FASOLA G, 1984, ACTA HAEMATOL-BASEL, V72, P231, DOI 10.1159/000206395; Ferdinandusse S, 2000, J LIPID RES, V41, P1890; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gerhold DL, 2002, NAT GENET, V32, P547, DOI 10.1038/ng1042; Gilbert R, 2000, P GEN EV COMP C GECC, P551; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Glaab E., 2010, LECT NOTES INFORM, V173, P123; Glaab E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-597; Glaab E, 2010, J STAT SOFTW, V36, P1; Glaab E, 2010, BIOINFORMATICS, V26, P1271, DOI 10.1093/bioinformatics/btq131; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Goh L., 2004, P 2 C AS PAC BIOINF, P161; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Ha CM, 2008, NEUROENDOCRINOLOGY, V88, P199, DOI 10.1159/000139579; Habashy HO, 2010, EJC SUPPL, V8, P91, DOI 10.1016/S1359-6349(10)70143-9; Habashy HO, 2011, BREAST CANCER RES TR, V128, P315, DOI 10.1007/s10549-010-1073-y; HABESHAW JA, 1983, LANCET, V1, P498; Hall M. A., 2000, P 17 INT C MACH LEAR; Hastie T.J., 2017, STAT SCI; Holland J.H., 2000, LNCS LNAI, V1813, P3, DOI [10.1007/3-540-45027-01, DOI 10.1007/3-540-45027-01]; Hu YJ, 2008, LECT NOTES COMPUT SC, V4985, P846; Jayasurya A, 2000, CANCER LETT, V155, P99, DOI 10.1016/S0304-3835(00)00414-6; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Kuefer R, 2002, AM J PATHOL, V161, P841, DOI 10.1016/S0002-9440(10)64244-7; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lecocke M, 2006, CANCER INFORM, V2, P313; Lee JY, 2003, GENOMICS, V82, P78, DOI 10.1016/S0888-7543(03)00098-3; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Li L., 2002, METHODS MICROARRAY D, P81, DOI [10.1007/978-1-4615-0873-1_7, DOI 10.1007/978-1-4615-0873-1_7]; Li W, 2001, METHODS MICROARRAY D, P137; Lin BY, 2008, CLIN CANCER RES, V14, P1397, DOI 10.1158/1078-0432.CCR-07-1535; Lin BY, 2003, GENOMICS, V82, P331, DOI 10.1016/S0888-7543(03)00151-4; Liu J, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2275, DOI 10.1109/ICMLC.2003.1259886; Luo J, 2001, CANCER RES, V61, P4683; Luo J, 2002, CANCER RES, V62, P2220; Ma PCH, 2006, IEEE T EVOLUT COMPUT, V10, P296, DOI 10.1109/TEVC.2005.859371; Magee JA, 2001, CANCER RES, V61, P5692; MEDEIROS LJ, 1988, CANCER, V61, P1844; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moore JH, 2002, GENET EPIDEMIOL, V23, P57, DOI 10.1002/gepi.1117; Mosca E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-76; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Nakashima M, 2008, ANTICANCER RES, V28, P609; Nicodemus KK, 2011, BRIEF BIOINFORM, V12, P369, DOI 10.1093/bib/bbr016; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Paul TK, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P453; PILERI S, 1984, BRIT J HAEMATOL, V58, P501, DOI 10.1111/j.1365-2141.1984.tb03997.x; Popovici V, 2011, BIOINFORMATICS, V27, P1729, DOI 10.1093/bioinformatics/btr233; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; RISSANEN J, 1983, ANN STAT, V11, P416, DOI 10.1214/aos/1176346150; Rivest R. L., 1987, Machine Learning, V2, P229, DOI 10.1007/BF00058680; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Sheng WG, 2006, J HEURISTICS, V12, P447, DOI 10.1007/s10732-006-7284-z; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Srikantan V, 2002, CANCER RES, V62, P6812; Stephan C, 2004, J UROLOGY, V171, P187, DOI 10.1097/01.ju.0000101622.74236.94; Stojanov M, 2007, THESIS DTSCH KREBSF; Stout M, 2009, SOFT COMPUT, V13, P245, DOI 10.1007/s00500-008-0318-8; Stout M, 2008, BIOINFORMATICS, V24, P916, DOI 10.1093/bioinformatics/btn050; Sun YJ, 2007, BIOINFORMATICS, V23, P30, DOI 10.1093/bioinformatics/btl543; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Theocharis SE, 2004, HISTOPATHOLOGY, V45, P103, DOI 10.1111/j.1365-2559.2004.01922.x; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tokuda Y, 2003, BJU INT, V91, P716, DOI 10.1046/j.1464-410X.2003.04218.x; Toyota M, 1999, CANCER RES, V59, P4535; Tsuruoka Y, 2008, BIOINFORMATICS, V24, P2559, DOI 10.1093/bioinformatics/btn469; Vanpoucke G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r213; Vapnik V.N., 1974, THEORY PATTERN RECOG; Venturini G., 1993, Machine Learning: ECML-93. European Conference on Machine Learning Proceedings, P280; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Wold H., 1975, PERSPECTIVES PROBABI, V12, P117, DOI [10.1017/s0021900200047604, DOI 10.1017/S0021900200047604, 10.1017/S0021900200047604]; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wood IA, 2007, BIOINFORMATICS, V23, P1363, DOI 10.1093/bioinformatics/btm117; Zervakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-53; Zhang CL, 2006, IEEE ACM T COMPUT BI, V3, P312, DOI 10.1109/TCBB.2006.42; Zhang H, 2010, BREAST CANCER RES TR, V121, P41, DOI 10.1007/s10549-009-0450-x; Zhang SQ, 2011, BMC BIOINFORMATICS, V12, DOI [10.1186/1471-2105-12-238, 10.1186/1471-2105-12-450]	128	70	72	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39932	10.1371/journal.pone.0039932	http://dx.doi.org/10.1371/journal.pone.0039932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808075	gold, Green Published, Green Submitted			2022-12-25	WOS:000306362400027
J	Maezawa, S; Fukushima, R; Matsushita, T; Kato, T; Takagaki, Y; Nishiyama, Y; Ando, S; Matsumoto, T; Kouda, K; Hayano, T; Suzuki, M; Koiwai, K; Koiwai, O				Maezawa, So; Fukushima, Rie; Matsushita, Toyofumi; Kato, Tomoyoshi; Takagaki, Yoshiki; Nishiyama, Yoshihiro; Ando, Sachiko; Matsumoto, Takuro; Kouda, Kousuke; Hayano, Takahide; Suzuki, Masahiro; Koiwai, Kotaro; Koiwai, Osamu			Ubiquitylation of Terminal Deoxynucleotidyltransferase Inhibits Its Activity	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYMES; DNA-REPAIR; PHYSICAL INTERACTION; LIGASE COMPLEX; PROTEIN; PATHWAY; MONOUBIQUITINATION; IDENTIFICATION; GENE; E2	Terminal deoxynucleotidyltransferase (TdT), which template-independently synthesizes DNA during V(D)J recombination in lymphoid cells, is ubiquitylated by a BPOZ-2/Cul3 complex, as the ubiquitin ligase, and then degraded by the 26 S proteasome. We show here that TdT is ubiquitylated by the Cul3-based ubiquitylation system in vitro. Because TdT could also be ubiquitylated in the absence of Cul/BPOZ-2, we determined that it could also be directly ubiquitylated by the E2 proteins UbcH5a/b/c and UbcH6, E3-independently. Furthermore, the ubiquitylated TdT inhibited its nucleotidyltransferase activity.	[Maezawa, So; Fukushima, Rie; Matsushita, Toyofumi; Kato, Tomoyoshi; Takagaki, Yoshiki; Nishiyama, Yoshihiro; Ando, Sachiko; Matsumoto, Takuro; Kouda, Kousuke; Hayano, Takahide; Suzuki, Masahiro; Koiwai, Kotaro; Koiwai, Osamu] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan	Tokyo University of Science	Maezawa, S (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	maezws@rs.noda.tus.ac.jp		Koiwai, Kotaro/0000-0002-9684-3699				Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Bollum F J, 1974, Methods Enzymol, V29, P70; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hong S, 2008, BIOCHEM BIOPH RES CO, V371, P256, DOI 10.1016/j.bbrc.2008.04.066; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KOIWAI O, 1988, BIOCHEM BIOPH RES CO, V154, P91, DOI 10.1016/0006-291X(88)90654-7; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lucero P, 2000, J BACTERIOL, V182, P241, DOI 10.1128/JB.182.1.241-243.2000; Maezawa S, 2008, GENES CELLS, V13, P439, DOI 10.1111/j.1365-2443.2008.01179.x; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V372, P708, DOI 10.1016/j.bbrc.2008.05.113; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	41	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39511	10.1371/journal.pone.0039511	http://dx.doi.org/10.1371/journal.pone.0039511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808041	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400013
J	Zhu, F; Ma, XH; Qin, C; Tao, L; Liu, X; Shi, Z; Zhang, CL; Tan, CY; Chen, YZ; Jiang, YY				Zhu, Feng; Ma, Xiao Hua; Qin, Chu; Tao, Lin; Liu, Xin; Shi, Zhe; Zhang, Cun Long; Tan, Chun Yan; Chen, Yu Zong; Jiang, Yu Yang			Drug Discovery Prospect from Untapped Species: Indications from Approved Natural Product Drugs	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; TYROSINE KINASE; INHIBITORS; METABOLITES; STAUROSPORINE; ANTIBIOTICS; IMATINIB; DESIGN	Due to extensive bioprospecting efforts of the past and technology factors, there have been questions about drug discovery prospect from untapped species. We analyzed recent trends of approved drugs derived from previously untapped species, which show no sign of untapped drug-productive species being near extinction and suggest high probability of deriving new drugs from new species in existing drug-productive species families and clusters. Case histories of recently approved drugs reveal useful strategies for deriving new drugs from the scaffolds and pharmacophores of the natural product leads of these untapped species. New technologies such as cryptic gene-cluster exploration may generate novel natural products with highly anticipated potential impact on drug discovery.	[Zhu, Feng; Zhang, Cun Long; Tan, Chun Yan; Chen, Yu Zong; Jiang, Yu Yang] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China; [Zhu, Feng] Chongqing Univ, Innovat Drug Res Ctr, Chongqing 630044, Peoples R China; [Zhu, Feng] Chongqing Univ, Coll Chem & Chem Engn, Chongqing 630044, Peoples R China; [Zhu, Feng; Ma, Xiao Hua; Qin, Chu; Tao, Lin; Liu, Xin; Shi, Zhe; Chen, Yu Zong] Natl Univ Singapore, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117548, Singapore; [Zhu, Feng; Ma, Xiao Hua; Qin, Chu; Tao, Lin; Liu, Xin; Shi, Zhe; Chen, Yu Zong] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore; [Qin, Chu; Tao, Lin] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chongqing University; Chongqing University; National University of Singapore; National University of Singapore; National University of Singapore	Zhu, F (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China.	phacyz@nus.edu.sg; Jiangyy@sz.tsinghua.edu.cn	Zhu, Feng/F-1489-2011; Tan, Chunyan/F-2785-2012; MA, XIAO/HHN-5611-2022; ZHU, Feng/X-2659-2018; jiang, yu/HGU-0029-2022; Liu, Xin/U-5451-2019; ZHU, Feng/ABF-5843-2021	Tan, Chunyan/0000-0002-4263-2175; ZHU, Feng/0000-0001-8069-0053; Liu, Xin/0000-0002-6542-3181; ZHU, Feng/0000-0001-8069-0053; Chen, Yu Zong/0000-0002-5473-8022; Tao, Lin/0000-0001-7494-4758	National University of Singapore Research Scholarship; Ministry of Science and Technology; 863 Hi-Tech Program [2007AA02Z160]; Key Special Project Grant, China [2009ZX09501-004]	National University of Singapore Research Scholarship(National University of Singapore); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Hi-Tech Program(National High Technology Research and Development Program of China); Key Special Project Grant, China	We acknowledge support from the National University of Singapore Research Scholarship, Ministry of Science and Technology, 863 Hi-Tech Program (2007AA02Z160), Key Special Project Grant 2009ZX09501-004, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Chiang YM, 2011, CURR OPIN CHEM BIOL, V15, P137, DOI 10.1016/j.cbpa.2010.10.011; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; DANN JG, 1986, BIOCHEM BIOPH RES CO, V134, P71, DOI 10.1016/0006-291X(86)90528-0; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Furet P, 1995, J COMPUT AID MOL DES, V9, P465, DOI 10.1007/BF00124317; Gambacorti-Passerini C, 2008, LANCET ONCOL, V9, P600, DOI 10.1016/S1470-2045(08)70152-9; Harvey AL, 1999, TRENDS PHARMACOL SCI, V20, P196, DOI 10.1016/S0165-6147(99)01346-2; Hunt JT, 2009, MOL CANCER THER, V8, P275, DOI 10.1158/1535-7163.MCT-08-0999; Kingston DGI, 2009, J NAT PROD, V72, P507, DOI 10.1021/np800568j; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lydon NB, 2004, LEUKEMIA RES, V28, pS29, DOI 10.1016/j.leukres.2003.10.002; MCQUADE TJ, 1990, SCIENCE, V247, P454, DOI 10.1126/science.2405486; Nakano H, 2009, J ANTIBIOT, V62, P17, DOI 10.1038/ja.2008.4; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Piel J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/annurev-micro-090110-102805; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Pullen CB, 2003, PHYTOCHEMISTRY, V62, P377, DOI 10.1016/S0031-9422(02)00550-2; RALPH RK, 1972, BIOCHEM J, V130, P901, DOI 10.1042/bj1300901a; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; ROBERTS NA, 1990, SCIENCE, V248, P358, DOI 10.1126/science.2183354; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Traxler PM, 1996, J MED CHEM, V39, P2285, DOI 10.1021/jm960118j; Tulp M, 2005, TRENDS PHARMACOL SCI, V26, P175, DOI 10.1016/j.tips.2005.02.001; Tulp M, 2002, TRENDS PHARMACOL SCI, V23, P225, DOI 10.1016/S0165-6147(02)02007-2; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; WALL ME, 1995, CANCER RES, V55, P753; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Zhu F, 2011, P NATL ACAD SCI USA, V108, P12943, DOI 10.1073/pnas.1107336108	37	36	37	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e39782	10.1371/journal.pone.0039782	http://dx.doi.org/10.1371/journal.pone.0039782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808057	gold, Green Published, Green Submitted			2022-12-25	WOS:000306362400017
J	Flanagan, TP; Letendre, K; Burnside, WR; Fricke, GM; Moses, ME				Flanagan, Tatiana P.; Letendre, Kenneth; Burnside, William R.; Fricke, G. Matthew; Moses, Melanie E.			Quantifying the Effect of Colony Size and Food Distribution on Harvester Ant Foraging	PLOS ONE			English	Article							POGONOMYRMEX-OCCIDENTALIS; FORMICA-RUFA; FIDELITY; BEHAVIOR; AVAILABILITY; ECOLOGY; HYMENOPTERA; RECRUITMENT; STRATEGIES; PATTERNS	Desert seed-harvester ants, genus Pogonomyrmex, are central place foragers that search for resources collectively. We quantify how seed harvesters exploit the spatial distribution of seeds to improve their rate of seed collection. We find that foraging rates are significantly influenced by the clumpiness of experimental seed baits. Colonies collected seeds from larger piles faster than randomly distributed seeds. We developed a method to compare foraging rates on clumped versus random seeds across three Pogonomyrmex species that differ substantially in forager population size. The increase in foraging rate when food was clumped in larger piles was indistinguishable across the three species, suggesting that species with larger colonies are no better than species with smaller colonies at collecting clumped seeds. These findings contradict the theoretical expectation that larger groups are more efficient at exploiting clumped resources, thus contributing to our understanding of the importance of the spatial distribution of food sources and colony size for communication and organization in social insects.	[Flanagan, Tatiana P.; Letendre, Kenneth; Burnside, William R.; Moses, Melanie E.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Flanagan, Tatiana P.; Letendre, Kenneth; Fricke, G. Matthew; Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Moses, Melanie E.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of New Mexico; University of New Mexico; The Santa Fe Institute	Flanagan, TP (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	tpaz@unm.edu		Fricke, George/0000-0002-4466-8649	Defense Advanced Research Projects Agency (DARPA) [P-1070-113237]; National Institutes of Health (NIH) [P20 RR-018754]; National Science Foundation Emerging Frontiers (NSF EF) [1038682]; Microsoft Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Emerging Frontiers (NSF EF); Microsoft Research(Microsoft); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors gratefully acknowledge support from Defense Advanced Research Projects Agency (DARPA) grant P-1070-113237, www.darpa.mil; National Institutes of Health (NIH) grant P20 RR-018754, www.nih.gov; National Science Foundation Emerging Frontiers (NSF EF) grant 1038682, www.nsf.gov; and a gift from Microsoft Research, research.microsoft.com; from Sandia National Laboratories LDRD 09-1292 to KL, www.sandia.gov; and from the Sevilleta LTER to WB and MEM, sev.lternet.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been funded in part by a gift from Microsoft Research (research.microsoft.com). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ABRAMSKY Z, 1983, OECOLOGIA, V57, P328, DOI 10.1007/BF00377176; Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; [Anonymous], PASW STAT REL 18 0 1; ARON S, 1989, BIOL BEHAV, V14, P207; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; BERNSTEIN RA, 1975, ECOLOGY, V56, P213, DOI 10.2307/1935314; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Buchkremer EM, 2008, BEHAV ECOL, V19, P984, DOI 10.1093/beheco/arn057; CARACO T, 1975, AM NAT, V109, P343, DOI 10.1086/283001; Cole AC, 1968, POGONOMYMEX HARVESTE; CRIST TO, 1991, ENVIRON ENTOMOL, V20, P265, DOI 10.1093/ee/20.1.265; CRIST TO, 1992, ECOLOGY, V73, P1768, DOI 10.2307/1940028; DAVIDSON DW, 1977, ECOLOGY, V58, P725, DOI 10.2307/1936209; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Denny AJ, 2001, ANIM BEHAV, V62, P139, DOI 10.1006/anbe.2001.1718; Edelman A, 2010, THESIS U NEW MEXICO; FEWELL JH, 1990, OECOLOGIA, V82, P45, DOI 10.1007/BF00318532; FEWELL JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P401, DOI 10.1007/BF00294977; FRESNEAU D, 1985, INSECT SOC, V32, P109, DOI 10.1007/BF02224226; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; HILL K, 1987, ETHOL SOCIOBIOL, V8, P1, DOI 10.1016/0162-3095(87)90055-0; HOBBS RJ, 1985, OECOLOGIA, V67, P519, DOI 10.1007/BF00790023; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; HOLLDOBLER B, 1970, Psyche (Cambridge), V77, P385, DOI 10.1155/1970/38470; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; Johnson RA, 2000, SOCIOBIOLOGY, V36, P89; KUNIN WE, 1994, OECOLOGIA, V98, P328, DOI 10.1007/BF00324221; MEHLHOP P, 1983, ECOL ENTOMOL, V8, P69, DOI 10.1111/j.1365-2311.1983.tb00484.x; Moses ME, 2005, THESIS U NEW MEXICO; Mull JF, 1997, AM MIDL NAT, V138, P1, DOI 10.2307/2426649; Paz Flanagan Tatiana, 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P178, DOI 10.1109/ALIFE.2011.5954650; REICHMAN OJ, 1984, J BIOGEOGR, V11, P1, DOI 10.2307/2844771; ROSENGREN R, 1986, INSECT SOC, V33, P306, DOI 10.1007/BF02224248; RYER CH, 1995, ANIM BEHAV, V49, P411, DOI 10.1006/anbe.1995.0054; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; TAYLOR F, 1977, BEHAV ECOL SOCIOBIOL, V2, P147, DOI 10.1007/BF00361899; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; WHITFORD WG, 1975, ENVIRON ENTOMOL, V4, P689, DOI 10.1093/ee/4.5.689; WHITFORD WG, 1978, ECOLOGY, V59, P185, DOI 10.2307/1936647; Wilby A, 2000, OECOLOGIA, V125, P495, DOI 10.1007/s004420000478; Wilson E.O., 1971, INSECT SOC	45	25	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39427	10.1371/journal.pone.0039427	http://dx.doi.org/10.1371/journal.pone.0039427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808035	Green Published, gold, Green Submitted			2022-12-25	WOS:000306355500010
J	Meng, J; Cheng, XL; Liu, J; Zhang, WQ; Li, XJ; Kong, H; Xu, HY				Meng, Jie; Cheng, Xuelian; Liu, Jian; Zhang, Weiqi; Li, Xiaojin; Kong, Hua; Xu, Haiyan			Effects of Long and Short Carboxylated or Aminated Multiwalled Carbon Nanotubes on Blood Coagulation	PLOS ONE			English	Article							PROTEIN ADSORPTION; CALCIUM-ENTRY; IN-VITRO; PLATELET; COMPATIBILITY; SIRNA; CYTOTOXICITY; ACTIVATION; CELLS	In this work the effects of four different multiwalled carbon nanotubes (MWCNTs), including long carboxylated (L-COOH), short carboxylated (S-COOH), long aminated (L-NH2) and short aminated (S-NH2) ones, on the integrity of red blood cells, coagulation kinetics and activation of platelets were investigated with human whole blood. We found that the four MWCNTs induced different degrees of red blood cell damage as well as a mild level of platelet activation (10-25%). L-COOH and L-NH2 induced a higher level of platelet activation than S-COOH and S-NH2 respectively; meanwhile L-NH2 caused marked reductions in platelet viability. The presence of the four MWCNTs led to earlier fibrin formation, L-NH2 increased the clots hardness significantly, while L-COOH and S-NH2 made the clots become softer. It was concluded that the four MWCNTs affected blood coagulation process and the clots mechanical properties; they also altered the integrity of the red blood cells and the viability of the platelets, as well as induced platelets activation. The effects of MWCNTs depended on the size and chemistry of the nanotubes and the type of cells they contacted.	[Meng, Jie] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Meng, J (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	xuhy@pumc.edu.cn	Zhang, Weiqi/J-3974-2019	Zhang, Weiqi/0000-0003-4315-6809	National Key Program of China (973 program) [2011CB933504]; National Natural Science Foundation of China [81000665]; Beijing Municipal Natural Science Foundation [7092063]	National Key Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	The authors thank National Key Program of China (973 program 2011CB933504), National Natural Science Foundation of China (81000665) and Beijing Municipal Natural Science Foundation (7092063) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Bihari P, 2010, TOXICOLOGY, V269, P148, DOI 10.1016/j.tox.2009.08.011; Bomboi F, 2011, J COLLOID INTERF SCI, V355, P342, DOI 10.1016/j.jcis.2010.12.026; Burke AR, 2011, BIOMATERIALS, V32, P5970, DOI 10.1016/j.biomaterials.2011.04.059; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Jia FM, 2009, J MATER CHEM, V19, P8950, DOI 10.1039/b916219d; Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k; Koh LB, 2008, J BIOMED MATER RES A, V86A, P394, DOI 10.1002/jbm.a.31605; Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003; Lacerda SHD, 2011, ACS NANO, V5, P5808, DOI 10.1021/nn2015369; Ladeira MS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385101; Ling WL, 2011, ACS NANO, V5, P730, DOI 10.1021/nn102400w; Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020; Meng J, 2005, J BIOMED MATER RES A, V74A, P208, DOI 10.1002/jbm.a.30315; Meng J, 2005, NANOMED-NANOTECHNOL, V1, P136, DOI 10.1016/j.nano.2005.03.003; Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468; Nemmar A, 2007, J THROMB HAEMOST, V5, P1217, DOI 10.1111/j.1538-7836.2007.02557.x; Radomski A, 2005, BRIT J PHARMACOL, V146, P882, DOI 10.1038/sj.bjp.0706386; Rossi NAA, 2009, BIOMATERIALS, V30, P638, DOI 10.1016/j.biomaterials.2008.09.057; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Semberova J, 2009, NANO LETT, V9, P3312, DOI 10.1021/nl901603k; Sobhani Z, 2011, INT J NANOMED, V6, P705, DOI 10.2147/IJN.S17336; Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095; Tang AM, 2011, CONTRAST MEDIA MOL I, V6, P93, DOI 10.1002/cmmi.410; Vinante M, 2009, J NANOSCI NANOTECHNO, V9, P3785, DOI 10.1166/jnn.2009.NS68; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wu W, 2011, METHODS MOL BIOL, V751, P565, DOI 10.1007/978-1-61779-151-2_35; Yang M, 2010, J NANOSCI NANOTECHNO, V10, P7550, DOI 10.1166/jnn.2010.2825; Zemp RJ, 2009, NAT NANOTECHNOL, V4, P798, DOI 10.1038/nnano.2009.367	30	41	42	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e38995	10.1371/journal.pone.0038995	http://dx.doi.org/10.1371/journal.pone.0038995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808023	gold, Green Submitted, Green Published			2022-12-25	WOS:000306355500006
J	Ohkura, M; Sasaki, T; Kobayashi, C; Ikegaya, Y; Nakai, J				Ohkura, Masamichi; Sasaki, Takuya; Kobayashi, Chiaki; Ikegaya, Yuji; Nakai, Junichi			An Improved Genetically Encoded Red Fluorescent Ca2+ Indicator for Detecting Optically Evoked Action Potentials	PLOS ONE			English	Article							IN-VIVO; CALCIUM INDICATORS; SIGNALS; PROTEIN; RESOLUTION; ELEGANS; NEURONS; SENSOR; BRAIN	Genetically encoded Ca2+ indicators (GECIs) are powerful tools to image activities of defined cell populations. Here, we developed an improved red fluorescent GECI, termed R-CaMP1.07, by mutagenizing R-GECO1. In HeLa cell assays, R-CaMP1.07 exhibited a 1.5-2-fold greater fluorescence response compared to R-GECO1. In hippocampal pyramidal neurons, R-CaMP1.07 detected Ca2+ transients triggered by single action potentials (APs) with a probability of 95% and a signal-to-noise ratio >7 at a frame rate of 50 Hz. The amplitudes of Ca2+ transients linearly correlated with the number of APs. The expression of R-CaMP1.07 did not significantly alter the electrophysiological properties or synaptic activity patterns. The co-expression of R-CaMP1.07 and channelrhodpsin-2 (ChR2), a photosensitive cation channel, in pyramidal neurons demonstrated that R-CaMP1.07 was applicable for the monitoring of Ca2+ transients in response to optically evoked APs, because the excitation light for R-CaMP1.07 hardly activated ChR2. These technical advancements provide a novel strategy for monitoring and manipulating neuronal activity with single cell resolution.	[Ohkura, Masamichi; Sasaki, Takuya; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Kobayashi, Chiaki; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan	Saitama University; University of Tokyo	Ohkura, M (corresponding author), Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan.	mohkura@mail.saitama-u.ac.jp; jnakai@mail.saitama-u.ac.jp	Nakai, Junichi/GQZ-6415-2022; Sasaki, Takuya/J-3283-2015; Ohkura, Masamichi/J-6976-2012	Ohkura, Masamichi/0000-0002-3659-7780; Ikegaya, Yuji/0000-0003-2260-8191	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22500285, 24111509, 10J05408, 21500379]	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Regional Innovation Cluster Program (City Area Type, Central Saitama Area) and grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to M.O. (nos. 22500285 and 24111509), T. S. (no. 10J05408) and J.N. (no. 21500379). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi N, 2011, CURR PROTOC NEUROSCI; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	33	91	94	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39933	10.1371/journal.pone.0039933	http://dx.doi.org/10.1371/journal.pone.0039933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808076	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500017
J	Short, MK; Hallett, JP; Tar, K; Dange, T; Schmidt, M; Moir, R; Willis, IM; Jubinsky, PT				Short, Mary K.; Hallett, Joshua P.; Tar, Krisztina; Dange, Thomas; Schmidt, Marion; Moir, Robyn; Willis, Ian M.; Jubinsky, Paul T.			The Yeast Magmas Ortholog Pam16 Has an Essential Function in Fermentative Growth That Involves Sphingolipid Metabolism	PLOS ONE			English	Article							PHOSPHOSPHINGOLIPID PHOSPHOLIPASE-C; PROTEIN IMPORT MOTOR; SACCHAROMYCES-CEREVISIAE; ACID SYNTHESIS; PRESEQUENCE TRANSLOCASE; CERAMIDE SYNTHESIS; J-DOMAIN; MITOCHONDRIA; GENE; CARDIOLIPIN	Magmas is a growth factor responsive gene encoding an essential mitochondrial protein in mammalian cells. Pam16, the Magmas ortholog in Saccharomyces cerevisiae, is a component of the presequence translocase-associated motor. A temperature-sensitive allele (pam16-I61N) was used to query an array of non-essential gene-deletion strains for synthetic genetic interactions. The pam16-I61N mutation at ambient temperature caused synthetic lethal or sick phenotypes with genes involved in lipid metabolism, perixosome synthesis, histone deacetylation and mitochondrial protein import. The gene deletion array was also screened for suppressors of the pam16-I61N growth defect to identify compensatory pathways. Five suppressor genes were identified (SUR4, ISC1, IPT1, SKN1, and FEN1) and all are involved in sphingolipid metabolism. pam16-I61N cells cultured in glucose at non-permissive temperatures resulted in rapid growth inhibition and G1 cell cycle arrest, but cell viability was maintained. Altered mitochondria morphology, reduced peroxisome induction in glycerol/ethanol and oleate, and changes in the levels of several sphingolipids including C18 alpha-hydroxy-phytoceramide, were also observed in the temperature sensitive strain. Deletion of SUR4, the strongest suppressor, reversed the temperature sensitive fermentative growth defect, the morphological changes and the elevated levels of C18 alpha-hydroxy phytoceramide in pam16-I61N. Deletion of the other four suppressor genes had similar effects on C18 alpha-hydroxy-phytoceramide levels and restored proliferation to the pam16-I61N strain. In addition, pam16-I61N inhibited respiratory growth, likely by reducing cardiolipin, which is essential for mitochondrial function. Our results suggest that the pleiotropic effects caused by impaired Pam16/Magmas function are mediated in part by changes in lipid metabolism.	[Short, Mary K.; Hallett, Joshua P.; Jubinsky, Paul T.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Tar, Krisztina; Dange, Thomas; Schmidt, Marion; Moir, Robyn; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Jubinsky, Paul T.] Yale Univ, Sch Med, Dept Pediat, Hematol Oncol Sect, New Haven, CT 06510 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yale University	Short, MK (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	ian.willis@einstein.yu.edu; paul.jubinsky@yale.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health [NIH GM084228]; National Institute of General Medical Sciences [NIGMS GM085177]; James B. Ax Family Foundation; SAS Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085177, R01GM084228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); James B. Ax Family Foundation; SAS Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH GM084228)-MS, National Institute of General Medical Sciences (NIGMS GM085177)-IMW, James B. Ax Family Foundation, the SAS Foundation for Cancer Research, and support from Donna Alex and Mary and Robert Cancilla to PTJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Becker S, 2001, GENE, V262, P15, DOI 10.1016/S0378-1119(00)00548-5; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bleve G, 2011, BBA-BIOMEMBRANES, V1808, P733, DOI 10.1016/j.bbamem.2010.12.005; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; de Avalos SV, 2005, J BIOL CHEM, V280, P7170, DOI 10.1074/jbc.M411058200; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dickson RC, 2010, ADV EXP MED BIOL, V688, P217; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Elsner S, 2009, INT J MOL SCI, V10, P2041, DOI 10.3390/ijms10052041; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Jubinsky PT, 2011, BIOORG MED CHEM LETT, V21, P3479, DOI 10.1016/j.bmcl.2011.03.050; Jubinsky PT, 2005, J MOL HISTOL, V36, P69, DOI 10.1007/s10735-004-3840-8; Jubinsky PT, 2003, J HISTOCHEM CYTOCHEM, V51, P585, DOI 10.1177/002215540305100504; Jubinsky PT, 2001, EXP HEMATOL, V29, P1392, DOI 10.1016/S0301-472X(01)00749-4; Kawano T, 2008, BIOL PHARM BULL, V31, P998, DOI 10.1248/bpb.31.998; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Mokranjac D, 2007, J BIOL CHEM, V282, P18037, DOI 10.1074/jbc.M701895200; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Pais JE, 2011, MOL BIOL CELL, V22, P4740, DOI 10.1091/mbc.E11-08-0715; Peng Jianbin, 2005, In Silico Biology, V5, P251; Perkins GA, 2001, EUR J CELL BIOL, V80, P139, DOI 10.1078/0171-9335-00149; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; PIPER PW, 1986, EUR J BIOCHEM, V161, P525, DOI 10.1111/j.1432-1033.1986.tb10474.x; Plesofsky NS, 2008, EUKARYOT CELL, V7, P2147, DOI 10.1128/EC.00147-08; Roy S, 2012, FASEB J; Saleem RA, 2010, MOL CELL PROTEOMICS, V9, P2076, DOI 10.1074/mcp.M000116-MCP201; Saleem RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011953; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Scatena R, 2012, ADV EXP MED BIOL, V942, P287, DOI 10.1007/978-94-007-2869-1_13; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Shechtman CF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215038; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Tagliati F, 2010, ENDOCRINOLOGY, V151, P4635, DOI 10.1210/en.2010-0441; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Thevissen K, 2005, FEBS LETT, V579, P1973, DOI 10.1016/j.febslet.2005.02.043; Thevissen K, 2010, FEMS MICROBIOL LETT, V303, P163, DOI 10.1111/j.1574-6968.2009.01869.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; Vizeacoumar FJ, 2004, MOL BIOL CELL, V15, P665, DOI 10.1091/mbc.E03-09-0681; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu BX, 2011, J BIOL CHEM, V286, P22362, DOI 10.1074/jbc.M110.156471; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	93	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39428	10.1371/journal.pone.0039428	http://dx.doi.org/10.1371/journal.pone.0039428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808036	gold, Green Submitted, Green Published			2022-12-25	WOS:000306355500011
J	Cameron, DJ; Galvin, C; Alkam, T; Sidhu, H; Ellison, J; Luna, S; Ethell, DW				Cameron, D. Joshua; Galvin, Cooper; Alkam, Tursun; Sidhu, Harpreet; Ellison, John; Luna, Salvadore; Ethell, Douglas W.			Alzheimer's-Related Peptide Amyloid-beta Plays a Conserved Role in Angiogenesis	PLOS ONE			English	Article							GAMMA-SECRETASE; DISEASE; TRIALS; DIFFERENTIATION; PRESENILIN-1; PLAQUES; CELLS	Alzheimer's disease research has been at an impasse in recent years with lingering questions about the involvement of Amyloid-beta (A beta). Early versions of the amyloid hypothesis considered A beta something of an undesirable byproduct of APP processing that wreaks havoc on the human neocortex, yet evolutionary conservation - over three hundred million years - indicates this peptide plays an important biological role in survival and reproductive fitness. Here we describe how A beta regulates blood vessel branching in tissues as varied as human umbilical vein and zebrafish hindbrain. High physiological concentrations of A beta monomer induced angiogenesis by a conserved mechanism that blocks gamma-secretase processing of a Notch intermediate, NEXT, and reduces the expression of downstream Notch target genes. Our findings allude to an integration of signaling pathways that utilize gamma-secretase activity, which may have significant implications for our understanding of Alzheimer's pathogenesis vis-a-vis vascular changes that set the stage for ensuing neurodegeneration.	[Cameron, D. Joshua] Western Univ Hlth Sci, Coll Optometry, Pomona, CA USA; [Alkam, Tursun; Luna, Salvadore; Ethell, Douglas W.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA; [Ethell, Douglas W.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences	Cameron, DJ (corresponding author), Western Univ Hlth Sci, Coll Optometry, Pomona, CA USA.	dougeth64@gmail.com	Alkam, Tursun/AAG-5503-2019	Ethell, Douglas/0000-0002-9237-0265; Sidhu, Harpreet/0000-0001-8767-3897	Western University of Health Sciences College of Optometry; College of Biomedical Sciences; California Institute for Regenerative Medicine [RN1-00538]; 5-College Neuroscience Summer Fellowship through the Claremont Colleges	Western University of Health Sciences College of Optometry; College of Biomedical Sciences; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); 5-College Neuroscience Summer Fellowship through the Claremont Colleges	Funding provided by the Western University of Health Sciences College of Optometry to DJC, College of Biomedical Sciences to DWE, and a grant from the California Institute for Regenerative Medicine (RN1-00538) to DWE. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John Dowling for critical comments on the manuscript. CG received a 5-College Neuroscience Summer Fellowship through the Claremont Colleges.	Alzheimers Assoc, 2011, ALZHEIMERS DEMENT, V7, P208, DOI 10.1016/j.jalz.2011.02.004; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Cechetto David F, 2008, Expert Rev Neurother, V8, P743, DOI 10.1586/14737175.8.5.743; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Ethell DW, 2010, NEUROSCIENTIST, V16, P614, DOI 10.1177/1073858410366162; Ethell DW, 2002, CURR BIOL, V12, P1595, DOI 10.1016/S0960-9822(02)01140-5; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hayashi H, 2007, BIOCHEM BIOPH RES CO, V363, P584, DOI 10.1016/j.bbrc.2007.09.003; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Liao YF, 2007, MOL PHARMACOL, V71, P588, DOI 10.1124/mol.106.024299; Malinda KM, 1998, J IMMUNOL, V160, P1001; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Nagase H, 2011, CURR STEM CELL RES T, V6, P131, DOI 10.2174/157488811795495459; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Westerfield M, 2007, ZEBRAFISH BOOK; Wilcock DM, 2009, CNS NEUROL DISORD-DR, V8, P50, DOI 10.2174/187152709787601858; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	35	37	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e39598	10.1371/journal.pone.0039598	http://dx.doi.org/10.1371/journal.pone.0039598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792182	Green Submitted, Green Published, gold			2022-12-25	WOS:000306354700013
J	de Timary, P; Cani, PD; Duchemin, J; Neyrinck, AM; Gihousse, D; Laterre, PF; Badaoui, A; Leclercq, S; Delzenne, NM; Starkel, P				de Timary, Philippe; Cani, Patrice D.; Duchemin, Julie; Neyrinck, Audrey M.; Gihousse, Dominique; Laterre, Pierre-Francois; Badaoui, Abdenor; Leclercq, Sophie; Delzenne, Nathalie M.; Starkel, Peter			The Loss of Metabolic Control on Alcohol Drinking in Heavy Drinking Alcohol-Dependent Subjects	PLOS ONE			English	Article							RESEARCH CLINICS PREVALENCE; NERVOUS-SYSTEM CONTROL; HABITUAL FOOD-INTAKE; GHRELIN LEVELS; BODY-WEIGHT; ENERGY-EXPENDITURE; NUTRIENT INTAKE; LEPTIN LEVELS; SERUM LEPTIN; CONSUMPTION	Background: Most physiological studies interested in alcohol-dependence examined ethanol as a pharmacological agent rather than a nutrient. We conducted two studies, which assessed the metabolic and endocrine factors involved in the regulation of alcohol and nutrient intake in alcohol-dependent (AD) subjects. We also examined the potential role of a disruption in energy balance in alcohol-dependence. Methods and Results: In Study-1, quantitative dietetic interviews of eating and drinking habits were conducted with 97 AD subjects. The population was split around a median alcohol intake value of 12.5 kcal/kg/day. The results showed that the "low alcohol'' drinking AD subjects had high Body Mass Index (BMI) and Fat Mass (FM) and alcohol intake was compensated for by a decrease in non-alcoholic intakes. "High alcohol'' drinking AD subjects, on the other hand, had low BMI and FM and the total caloric intakes were largely above norms. In Study-2, 24 AD inpatients were submitted to dietetic interviews, calorimetry and blood samplings for the measurement of biomarkers of the regulation of metabolism and satiety, on day 2, 5 and 16 of abstinence. These patients were compared with 20 controls matched for age and gender. We observed in AD patients an increase in cortisol, leptin and PYY plasma levels and a decrease in ghrelin, which might explain the observed decrease in non-alcoholic intakes. However, alcoholic and non-alcoholic intakes correlated positively with basal metabolism and negatively with leptin and leptin/BMI. Conclusion: For individuals consuming below 12.5 kcal/kg/day of alcohol, alcohol intake is compensated for by a decrease in non-alcoholic nutrient intakes, probably due to changes in metabolic and satiety factors. For individuals consuming above 12.5 kcal/kg/day of alcohol, alcohol accelerates metabolism and decreases fat mass and leptin levels, and the total caloric intake largely exceeds norms. A dual model for regulation of energy intake in AD subjects is proposed.	[de Timary, Philippe; Duchemin, Julie; Leclercq, Sophie] Catholic Univ Louvain, Dept Adult Psychiat, St Luc Acad Hosp, Brussels, Belgium; [de Timary, Philippe; Duchemin, Julie; Leclercq, Sophie] Catholic Univ Louvain, Psychol Dev CSDP Res Unit, Inst Neurosci, Brussels, Belgium; [de Timary, Philippe; Duchemin, Julie; Leclercq, Sophie] Catholic Univ Louvain, Inst Psychol, Brussels, Belgium; [Cani, Patrice D.; Neyrinck, Audrey M.; Leclercq, Sophie; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium; [Gihousse, Dominique] Catholic Univ Louvain, Dept Dietet, St Luc Acad Hosp, Brussels, Belgium; [Laterre, Pierre-Francois] Catholic Univ Louvain, Dept Anestesiol, St Luc Acad Hosp, Brussels, Belgium; [Laterre, Pierre-Francois; Badaoui, Abdenor; Starkel, Peter] Catholic Univ Louvain, Inst Clin Res, Brussels, Belgium; [Badaoui, Abdenor; Starkel, Peter] Catholic Univ Louvain, Dept Gastroenterol, St Luc Acad Hosp, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel	de Timary, P (corresponding author), Catholic Univ Louvain, Dept Adult Psychiat, St Luc Acad Hosp, Brussels, Belgium.	Philippe.detimary@uclouvain.be	D., Cani Patrice/M-8055-2016; Neyrinck, Audrey/AAE-7929-2019; Stärkel, Peter/AAC-6400-2019; Delzenne, Nathalie/AAC-4628-2019	D., Cani Patrice/0000-0003-2040-2448; Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082; Leclercq, Sophie/0000-0002-2894-5220	FNRS-FRS, FSR [3.4.585.07F]; Fonds Speciaux de Recherche pour l'Agriculture et l'Industrie; Fondation Saint-Luc	FNRS-FRS, FSR(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherche pour l'Agriculture et l'Industrie; Fondation Saint-Luc	This work was supported by grant 3.4.585.07F from FNRS-FRS, FSR 2004, by Fonds Speciaux de Recherche pour l'Agriculture et l'Industrie and a grant from Fondation Saint-Luc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 2000, AM J GASTROENTEROL, V95, P2323; Addolorato G, 1998, J INTERN MED, V244, P387; Addolorato G, 1998, AM J GASTROENTEROL, V93, P2476, DOI 10.1111/j.1572-0241.1998.00707.x; Addolorato G, 2006, ALCOHOL CLIN EXP RES, V30, P1933, DOI 10.1111/j.1530-0277.2006.00238.x; Ahima RS, 2008, J CLIN INVEST, V118, P2380, DOI 10.1172/JCI36284; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Badaoui A, 2008, EUR J CLIN INVEST, V38, P397, DOI 10.1111/j.1365-2362.2008.01947.x; BEBB HT, 1971, AM J CLIN NUTR, V24, P1042; Berneis K, 1997, METABOLISM, V46, P750, DOI 10.1016/S0026-0495(97)90118-9; BLOCK G, 1985, AM J EPIDEMIOL, V122, P27, DOI 10.1093/oxfordjournals.aje.a114084; BLOCK G, 1982, AM J EPIDEMIOL, V115, P492, DOI 10.1093/oxfordjournals.aje.a113331; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; CAMARGO CA, 1987, J AM COLL NUTR, V6, P271; de Castro JM, 2006, J NUTR, V136, P1382, DOI 10.1093/jn/136.5.1382; DENNIS BH, 1985, AM J CLIN NUTR, V41, P312, DOI 10.1093/ajcn/41.5.1103; FISHER M, 1985, AM J CLIN NUTR, V41, P623, DOI 10.1093/ajcn/41.3.623; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; GORDON T, 1986, ARCH INTERN MED, V146, P262, DOI 10.1001/archinte.146.2.262; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Goris AHC, 2001, BRIT J NUTR, V85, P629, DOI 10.1079/BJN2001322; GRUCHOW HW, 1985, AM J CLIN NUTR, V42, P289, DOI 10.1093/ajcn/42.2.289; Hillemacher T, 2007, PSYCHONEUROENDOCRINO, V32, P87, DOI 10.1016/j.psyneuen.2006.09.013; HILLERS VN, 1985, AM J CLIN NUTR, V41, P356, DOI 10.1093/ajcn/41.2.356; Horvath B, 2002, BIOCHEM PHARMACOL, V64, P369, DOI 10.1016/S0006-2952(02)01167-X; JACOBSEN BK, 1987, J CHRON DIS, V40, P795, DOI 10.1016/0021-9681(87)90131-7; Jahn H, 2001, ARCH GEN PSYCHIAT, V58, P509, DOI 10.1001/archpsyc.58.5.509; JONES BR, 1982, AM J CLIN NUTR, V35, P135, DOI 10.1093/ajcn/35.1.135; Kiefer F, 2001, BIOL PSYCHIAT, V49, P782, DOI 10.1016/S0006-3223(01)01081-2; Kim DJ, 2005, ALCOHOL ALCOHOLISM, V40, P76, DOI 10.1093/alcalc/agh108; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Kraus T, 2005, ALCOHOL CLIN EXP RES, V29, P2154, DOI 10.1097/01.alc.0000191753.82554.7e; Kraus T, 2004, ADDICT BIOL, V9, P213, DOI 10.1111/j.1369-1600.2004.tb00535.x; Lagiou P, 1999, ANN NUTR METAB, V43, P23, DOI 10.1159/000012763; Leggio L, 2008, ALCOHOL CLIN EXP RES, V32, P450, DOI 10.1111/j.1530-0277.2007.00589.x; LIEBER CS, 1973, RES COMMUN CHEM PATH, V6, P983; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; LIEBER CS, 1991, AM J CLIN NUTR, V54, P976, DOI 10.1093/ajcn/54.6.976; MAISTO SA, 1982, ADDICT BEHAV, V7, P33, DOI 10.1016/0306-4603(82)90022-3; Mantzoros CS, 1998, OBES RES, V6, P179, DOI 10.1002/j.1550-8528.1998.tb00335.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NACE EP, 1984, ANNU REV MED, V35, P293, DOI 10.1146/annurev.me.35.020184.001453; Nicolas JM, 2001, ALCOHOL CLIN EXP RES, V25, P83; PIROLA RC, 1972, PHARMACOLOGY, V7, P185, DOI 10.1159/000136288; Rosenbaum M, 2002, J CLIN ENDOCR METAB, V87, P2391, DOI 10.1210/jc.87.5.2391; Santolaria F, 2003, ALCOHOL ALCOHOLISM, V38, P60, DOI 10.1093/alcalc/agg015; Santolaria F, 2000, DRUG ALCOHOL DEPEN, V59, P295, DOI 10.1016/S0376-8716(99)00129-5; SCHATZKIN A, 1987, NEW ENGL J MED, V316, P1169, DOI 10.1056/NEJM198705073161901; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SEPPA K, 1992, ARCH INTERN MED, V152, P297, DOI 10.1001/archinte.152.2.297; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; WEATHERALL R, 1988, EUR J CLIN NUTR, V42, P221; WINDHAM CT, 1983, J AM DIET ASSOC, V82, P364; Windham CT, 1983, J AM DIET ASSOC, V82, P373; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmet P, 1998, NUTRITION, V14, P653	56	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e38682	10.1371/journal.pone.0038682	http://dx.doi.org/10.1371/journal.pone.0038682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22808013	Green Published, Green Submitted, gold			2022-12-25	WOS:000306354700003
J	Peters, HL; Pitt, JJ; Wood, LR; Hamilton, NJ; Sarsero, JP; Buck, NE				Peters, Heidi L.; Pitt, James J.; Wood, Leonie R.; Hamilton, Natasha J.; Sarsero, Joseph P.; Buck, Nicole E.			Mouse Models for Methylmalonic Aciduria	PLOS ONE			English	Article							COA MUTASE; PROPIONIC ACIDEMIA; IN-VITRO; METABOLISM; INTEGRATION; MANAGEMENT; DISORDERS; NUTRITION; GROWTH; ENZYME	Methylmalonic aciduria (MMA) is a disorder of organic acid metabolism resulting from a functional defect of methylmalonyl-CoA mutase (MCM). MMA is associated with significant morbidity and mortality, thus therapies are necessary to help improve quality of life and prevent renal and neurological complications. Transgenic mice carrying an intact human MCM locus have been produced. Four separate transgenic lines were established and characterised as carrying two, four, five or six copies of the transgene in a single integration site. Transgenic mice from the 2-copy line were crossed with heterozygous knockout MCM mice to generate mice hemizygous for the human transgene on a homozygous knockout background. Partial rescue of the uniform neonatal lethality seen in homozygous knockout mice was observed. These rescued mice were significantly smaller than control littermates (mice with mouse MCM gene). Biochemically, these partial rescue mice exhibited elevated methylmalonic acid levels in urine, plasma, kidney, liver and brain tissue. Acylcarnitine analysis of blood spots revealed elevated propionylcarnitine levels. Analysis of mRNA expression confirms the human transgene is expressed at higher levels than observed for the wild type, with highest expression in the kidney followed closely by brain and liver. Partial rescue mouse fibroblast cultures had only 20% of the wild type MCM enzyme activity. It is anticipated that this humanised partial rescue mouse model of MMA will enable evaluation of long-term pathophysiological effects of elevated methylmalonic acid levels and be a valuable model for the investigation of therapeutic strategies, such as cell transplantation.	[Peters, Heidi L.; Wood, Leonie R.; Hamilton, Natasha J.; Sarsero, Joseph P.; Buck, Nicole E.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Pitt, James J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, VCGS Pathol, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Peters, HL (corresponding author), Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia.	heidi.peters@mcri.edu.au	peters, heidi/GWD-0358-2022	Peters, Heidi/0000-0001-7189-5874	Murdoch Childrens Research Institute; National Health and Medical Research Council [491256]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award	Murdoch Childrens Research Institute; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Murdoch Childrens Research Institute, National Health and Medical Research Council (#491256) and the Victorian Government's Operational Infrastructure Support Program. HP was the recipient of an National Health and Medical Research Council clinical Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Essa M, 1998, CLIN GENET, V54, P90; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Buck NE, 2009, MOL GENET METAB, V97, P244, DOI 10.1016/j.ymgme.2009.04.004; Chace DH, 2001, CLIN CHEM, V47, P2040; CHURCH JA, 1984, J INHERIT METAB DIS, V7, P12, DOI 10.1007/BF01805612; Corazza F, 1996, BIOL NEONATE, V70, P304; Feillet F, 2000, J PEDIATR-US, V136, P659, DOI 10.1067/mpd.2000.104290; Howden SE, 2008, GENE THER, V15, P1372, DOI 10.1038/gt.2008.84; Hu RM, 2009, J GENE MED, V11, P361, DOI 10.1002/jgm.1297; HYMAN SL, 1987, J PEDIATR-US, V111, P558, DOI 10.1016/S0022-3476(87)80121-X; INOUE S, 1981, PEDIATR RES, V15, P95, DOI 10.1203/00006450-198102000-00001; KAHLER SG, 1989, J PEDIATR-US, V115, P235, DOI 10.1016/S0022-3476(89)80071-X; KAHLER SG, 1994, J PEDIATR-US, V124, P239, DOI 10.1016/S0022-3476(94)70311-6; Le Saux A, 2010, TRANSGENIC RES, V19, P923, DOI 10.1007/s11248-010-9368-7; Leonard JV, 2003, EUR J PEDIATR, V162, pS21, DOI 10.1007/s00431-003-1345-1; LEONARD JV, 1995, J INHERIT METAB DIS, V18, P430, DOI 10.1007/BF00710054; LINDBLAD B, 1968, ACTA PAEDIATR SCAND, V57, P417, DOI 10.1111/j.1651-2227.1968.tb07314.x; Magera MJ, 2000, CLIN CHEM, V46, P1804; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; Nagy A., 2003, MANIPULATING MOUSE E; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; THREADGILL DW, 1990, CYTOGENET CELL GENET, V53, P112, DOI 10.1159/000132907; WILKEMEYER MF, 1993, BIOCHEM J, V296, P663, DOI 10.1042/bj2960663; WILKEMEYER MF, 1990, BIOCHEM J, V271, P449, DOI 10.1042/bj2710449; WILLARD HF, 1980, J CLIN INVEST, V65, P690, DOI 10.1172/JCI109715; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; Yannicelli S, 2003, MOL GENET METAB, V80, P181, DOI 10.1016/j.ymgme.2003.08.012	28	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40609	10.1371/journal.pone.0040609	http://dx.doi.org/10.1371/journal.pone.0040609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792386	gold, Green Published			2022-12-25	WOS:000306354700060
J	Comeau, AM; Tremblay, D; Moineau, S; Rattei, T; Kushkina, AI; Tovkach, FI; Krisch, HM; Ackermann, HW				Comeau, Andre M.; Tremblay, Denise; Moineau, Sylvain; Rattei, Thomas; Kushkina, Alla I.; Tovkach, Fedor I.; Krisch, Henry M.; Ackermann, Hans-Wolfgang			Phage Morphology Recapitulates Phylogeny: The Comparative Genomics of a New Group of Myoviruses	PLOS ONE			English	Article							VIBRIO-CHOLERAE; TEMPERATE BACTERIOPHAGES; SEQUENCE; DNA; CLASSIFICATION; PROTEOME	Among dsDNA tailed bacteriophages (Caudovirales), members of the Myoviridae family have the most sophisticated virion design that includes a complex contractile tail structure. The Myoviridae generally have larger genomes than the other phage families. Relatively few "dwarf'' myoviruses, those with a genome size of less than 50 kb such as those of the Mu group, have been analyzed in extenso. Here we report on the genome sequencing and morphological characterization of a new group of such phages that infect a diverse range of Proteobacteria, namely Aeromonas salmonicida phage 56, Vibrio cholerae phages 138 and CP-T1, Bdellovibrio phage phi 1422, and Pectobacterium carotovorum phage ZF40. This group of dwarf myoviruses shares an identical virion morphology, characterized by usually short contractile tails, and have genome sizes of approximately 45 kb. Although their genome sequences are variable in their lysogeny, replication, and host adaption modules, presumably reflecting differing lifestyles and hosts, their structural and morphogenesis modules have been evolutionarily constrained by their virion morphology. Comparative genomic analysis reveals that these phages, along with related prophage genomes, form a new coherent group within the Myoviridae. The results presented in this communication support the hypothesis that the diversity of phages may be more structured than generally believed and that the innumerable phages in the biosphere all belong to discrete lineages or families.	[Comeau, Andre M.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Comeau, Andre M.] Univ Laval, IBIS, Quebec City, PQ, Canada; [Tremblay, Denise; Moineau, Sylvain; Ackermann, Hans-Wolfgang] Univ Laval, Fac Med Dent, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale, Quebec City, PQ, Canada; [Moineau, Sylvain] Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Rattei, Thomas] Univ Vienna, Dept Computat Syst Biol, Vienna, Austria; [Kushkina, Alla I.; Tovkach, Fedor I.] DK Zabolotny Inst Microbiol & Virol, Kiev, Ukraine; [Krisch, Henry M.] CNRS, Lab Microbiol & Genet Mol, Toulouse, France; [Krisch, Henry M.] Univ Toulouse Paul Sabatier, Lab Microbiol & Genet Mol, Toulouse, France; [Ackermann, Hans-Wolfgang] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University; University of Vienna; National Academy of Sciences Ukraine; Zabolotny Institute of Microbiology & Virology of NASU; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Laval University	Comeau, AM (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	andre.comeau@ibis.ulaval.ca	Rattei, Thomas/F-1366-2011; Kushkina, Alla/AAS-2804-2020; Moineau, Sylvain/N-3578-2013; Kushkina, Alla/AAC-2224-2020; Moineau, Sylvain/I-7231-2019	Rattei, Thomas/0000-0002-0592-7791; Kushkina, Alla/0000-0002-2206-7324; Moineau, Sylvain/0000-0002-2832-5101	Institute of Biological Sciences (INSB) of the Centre National de la Recherche Scientifique (CNRS); Kribu Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada (Major Resources Support Program)	Institute of Biological Sciences (INSB) of the Centre National de la Recherche Scientifique (CNRS); Kribu Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada (Major Resources Support Program)(Natural Sciences and Engineering Research Council of Canada (NSERC))	HMK's research was supported by intramural funding from the Institute of Biological Sciences (INSB) of the Centre National de la Recherche Scientifique (CNRS) and by supplementary funding from the Kribu Foundation. SM acknowledges funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Major Resources Support Program). SM holds a Tier 1 Canada Research Chair in Bacteriophages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Ackermann Hans-W, 2011, Bacteriophage, V1, P138; ACKERMANN HW, 1985, ANN INST PASTEUR VIR, V136E, P175, DOI 10.1016/S0769-2617(85)80044-7; ACKERMANN HW, 1983, ANN INST PASTEUR VIR, V134, P387, DOI 10.1016/S0769-2617(83)80011-2; ALTHAUSER M, 1972, J VIROL, V10, P516, DOI 10.1128/JVI.10.3.516-523.1972; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Chaconas G, 1999, BIOCHEM CELL BIOL, V77, P487, DOI 10.1139/bcb-77-6-487; CHATTERJ.SN, 1965, INDIAN J MED RES, V53, P934; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Comeau AM, 2007, VIROLOGY, V362, P384, DOI 10.1016/j.virol.2006.12.031; Deveau H, 2002, APPL ENVIRON MICROB, V68, P4364, DOI 10.1128/AEM.68.9.4364-4369.2002; Grigoriev PS, 2001, MOL MICROBIOL, V42, P355, DOI 10.1046/j.1365-2958.2001.02632.x; GUIDOLIN A, 1984, J VIROL, V51, P163, DOI 10.1128/JVI.51.1.163-169.1984; Hauser R, 2011, J BACTERIOL, V193, P3135, DOI 10.1128/JB.01481-10; Hardies SC, 2003, VIROLOGY, V310, P359, DOI 10.1016/S0042-6822(03)00172-7; Hidaka T, 1971, MEM FAC FISH KAGOSHI, V20, P141; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Leblanc C, 2009, ENV MICROBIOL REP, V1, P499, DOI 10.1111/j.1758-2229.2009.00055.x; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; OGG JE, 1981, INFECT IMMUN, V31, P737, DOI 10.1128/IAI.31.2.737-741.1981; OGG JE, 1978, INFECT IMMUN, V19, P231, DOI 10.1128/IAI.19.1.231-238.1978; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; POPOFF M, 1971, Annales de Recherches Veterinaires, V2, P33; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Resch G, 2004, J BACTERIOL, V186, P5523, DOI 10.1128/JB.186.16.5523-5528.2004; Sabri M, 2011, J BACTERIOL, V193, P551, DOI 10.1128/JB.01117-10; Schwudke D, 2008, J BACTERIOL, V190, P332, DOI 10.1128/JB.01402-07; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Shelton CB, 2000, J BACTERIOL, V182, P6130, DOI 10.1128/JB.182.21.6130-6136.2000; Shingler V, 2011, FEMS MICROBIOL REV, V35, P425, DOI 10.1111/j.1574-6976.2010.00255.x; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tovkach F. I., 2002, Mikrobiologiya, V71, P75; VARON M, 1972, J VIROL, V9, P519, DOI 10.1128/JVI.9.3.519-525.1972; WILLI K, 1993, MED MICROBIOL LETT, V2, P419; Willi K, 1997, ORAL MICROBIOL IMMUN, V12, P40, DOI 10.1111/j.1399-302X.1997.tb00365.x	41	43	45	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40102	10.1371/journal.pone.0040102	http://dx.doi.org/10.1371/journal.pone.0040102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792219	Green Submitted, gold, Green Published			2022-12-25	WOS:000306461800039
J	Puill-Stephan, E; Seneca, FO; Miller, DJ; van Oppen, MJH; Willis, BL				Puill-Stephan, Eneour; Seneca, Francois O.; Miller, David J.; van Oppen, Madeleine J. H.; Willis, Bette L.			Expression of Putative Immune Response Genes during Early Ontogeny in the Coral Acropora millepora	PLOS ONE			English	Article							INVERTEBRATE CUCUMARIA-ECHINATA; LECTIN CEL-III; RECOGNITION; SYSTEM; ALLORECOGNITION; ENDOSYMBIONT; SETTLEMENT; CNIDARIA; ANCIENT; GROWTH	Background: Corals, like many other marine invertebrates, lack a mature allorecognition system in early life history stages. Indeed, in early ontogeny, when corals acquire and establish associations with various surface microbiota and dinoflagellate endosymbionts, they do not efficiently distinguish between closely and distantly related individuals from the same population. However, very little is known about the molecular components that underpin allorecognition and immunity responses or how they change through early ontogeny in corals. Methodology/Principal Findings: Patterns in the expression of four putative immune response genes (apextrin, complement C3, and two CELIII type lectin genes) were examined in juvenile colonies of Acropora millepora throughout a six-month post-settlement period using quantitative real-time PCR (qPCR). Expression of a CELIII type lectin gene peaked in the fourth month for most of the coral juveniles sampled and was significantly higher at this time than at any other sampling time during the six months following settlement. The timing of this increase in expression levels of putative immune response genes may be linked to allorecognition maturation which occurs around this time in A. millepora. Alternatively, the increase may represent a response to immune challenges, such as would be involved in the recognition of symbionts (such as Symbiodinium spp. or bacteria) during winnowing processes as symbioses are fine-tuned. Conclusions/Significance: Our data, although preliminary, are consistent with the hypothesis that lectins may play an important role in the maturation of allorecognition responses in corals. The co-expression of lectins with apextrin during development of coral juveniles also raises the possibility that these proteins, which are components of innate immunity in other invertebrates, may influence the innate immune systems of corals through a common pathway or system. However, further studies investigating the expression of these genes in alloimmune-challenged corals are needed to further clarify emerging evidence of a complex innate immunity system in corals.	[Puill-Stephan, Eneour; Miller, David J.; van Oppen, Madeleine J. H.; Willis, Bette L.] James Cook Univ, AIMS JCU, Townsville, Qld, Australia; [Puill-Stephan, Eneour; Seneca, Francois O.; Miller, David J.; van Oppen, Madeleine J. H.; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Puill-Stephan, Eneour; Seneca, Francois O.; van Oppen, Madeleine J. H.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Puill-Stephan, Eneour; Seneca, Francois O.; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Puill-Stephan, Eneour] Univ Bretagne Occidentale, Lab Optimisat Regulat Physiol, Brest, France; [Seneca, Francois O.; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld, Australia; [Seneca, Francois O.] Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	James Cook University; James Cook University; James Cook University; Australian Institute of Marine Science; Universite de Bretagne Occidentale; James Cook University; Stanford University	Puill-Stephan, E (corresponding author), James Cook Univ, AIMS JCU, Townsville, Qld, Australia.	Bette.Willis@jcu.edu.au	Seneca, Francois/F-9040-2010; van Oppen, Madeleine JH/C-3261-2008	Seneca, Francois/0000-0002-8908-1227; PUILL-STEPHAN, Eneour/0000-0003-0618-8051; van Oppen, Madeleine/0000-0003-4607-0744	Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies; AIMS@JCU; Australian Institute of Marine Science; James Cook University	Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); AIMS@JCU; Australian Institute of Marine Science; James Cook University	This study was supported by the Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies (www.coralcoe.org.au), AIMS@JCU (aims.jcu.edu.au), the Australian Institute of Marine Science (www.aims.gov.au), and James Cook University (www.jcu.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Barki Y, 2002, MAR ECOL PROG SER, V231, P91, DOI 10.3354/meps231091; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Frank U, 1997, P ROY SOC B-BIOL SCI, V264, P99, DOI 10.1098/rspb.1997.0015; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hughes RN, 2004, EVOL DEV, V6, P431, DOI 10.1111/j.1525-142X.2004.04051.x; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020140; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kouzuma Y, 2003, J BIOCHEM, V134, P395, DOI 10.1093/jb/mvg157; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Littman RA, 2009, MAR ECOL PROG SER, V389, P45, DOI 10.3354/meps08180; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Nozawa Y, 2005, MAR ECOL PROG SER, V286, P115, DOI 10.3354/meps286115; Oren M, 2007, DEV COMP IMMUNOL, V31, P889, DOI 10.1016/j.dci.2006.12.009; Puill-Stephan E, 2012, CORAL REEFS, V31, P1019, DOI 10.1007/s00338-012-0912-1; Puill-Stephan E, 2012, P ROY SOC B-BIOL SCI, V279, P699, DOI 10.1098/rspb.2011.1035; Rebrikov DV, 2006, APPL BIOCHEM MICRO+, V42, P455, DOI 10.1134/S0003683806050024; Rinkevich B, 2011, ISJ-INVERT SURVIV J, V8, P153; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rosengarten RD, 2011, CURR BIOL, V21, pR82, DOI 10.1016/j.cub.2010.11.061; SALTERCID L, 1991, BIOL BULL-US, V181, P127, DOI 10.2307/1542495; Sekine H, 2001, J IMMUNOL, V167, P4504, DOI 10.4049/jimmunol.167.8.4504; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilson ACC, 2004, BEHAV ECOL SOCIOBIOL, V57, P40, DOI 10.1007/s00265-004-0831-4; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x	34	19	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39099	10.1371/journal.pone.0039099	http://dx.doi.org/10.1371/journal.pone.0039099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792163	Green Published, Green Accepted, gold			2022-12-25	WOS:000306461800005
J	Schabussova, I; Hufnagl, K; Tang, MLK; Hoflehner, E; Wagner, A; Loupal, G; Nutten, S; Zuercher, A; Mercenier, A; Wiedermann, U				Schabussova, Irma; Hufnagl, Karin; Tang, Mimi L. K.; Hoflehner, Elisabeth; Wagner, Angelika; Loupal, Gerhard; Nutten, Sophie; Zuercher, Adrian; Mercenier, Annick; Wiedermann, Ursula			Perinatal Maternal Administration of Lactobacillus paracasei NCC 2461 Prevents Allergic Inflammation in a Mouse Model of Birch Pollen Allergy	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GENE-ENVIRONMENT INTERACTIONS; REGULATORY T-CELLS; IMMUNE-RESPONSES; INTESTINAL MICROFLORA; AIRWAY INFLAMMATION; MURINE MODEL; BET V-1; ASTHMA; INFANTS	Background: The hygiene hypothesis implies that microbial agents including probiotic bacteria may modulate foetal/neonatal immune programming and hence offer effective strategies for primary allergy prevention; however their mechanisms of action are poorly understood. We investigated whether oral administration of Lactobacillus paracasei NCC 2461 to mothers during gestation/lactation can protect against airway inflammation in offspring in a mouse model of birch pollen allergy, and examined the immune mechanisms involved. Methods: BALB/c mice were treated daily with L. paracasei in drinking water or drinking water alone in the last week of gestation and during lactation. Their offspring were sensitized with recombinant Bet v 1, followed by aerosol challenge with birch pollen extract. Results: Maternal exposure to L. paracasei prevented the development of airway inflammation in offspring, as demonstrated by attenuation of eosinophil influx in the lungs; reduction of IL-5 levels in bronchoalveolar lavage, and in lung and mediastinal lymph node cell cultures; and reduced peribronchial inflammatory infiltrate and mucus hypersecretion. While allergen-specific IgE and IgG antibody levels remained unchanged by the treatment, IL-4 and IL-5 production in spleen cell cultures were significantly reduced upon allergen stimulation in offspring of L. paracasei treated mice. Offspring of L. paracasei supplemented mothers had significantly reduced Bet v 1-specific as well as Concanavalin A-induced responses in spleen and mesenteric lymph node cell cultures, suggesting the modulation of both antigen-specific and mitogen-induced immune responses in offspring. These effects were associated with increased Foxp3 mRNA expression in the lungs and increased TGF-beta in serum. Conclusion: Our data show that in a mouse model of birch pollen allergy, perinatal administration of L. paracasei NCC 2461 to pregnant/lactating mothers protects against the development of airway inflammation in offspring by activating regulatory pathways, likely through TLR2/4 signalling.	[Schabussova, Irma; Hufnagl, Karin; Hoflehner, Elisabeth; Wagner, Angelika; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Tang, Mimi L. K.] Univ Melbourne, Royal Childrens Hosp, Dept Allergy & Immunol, Melbourne, Vic, Australia; [Tang, Mimi L. K.] Murdoch Childrens Res Inst, Dept Allergy & Immune Disorders, Melbourne, Vic, Australia; [Tang, Mimi L. K.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Loupal, Gerhard] Univ Vet Med Vienna, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Nutten, Sophie; Mercenier, Annick] Nestle Res Ctr, Nutr & Hlth Dept, CH-1000 Lausanne, Switzerland; [Zuercher, Adrian] CSL Behring AG, Bern, Switzerland	Medical University of Vienna; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Veterinary Medicine Vienna; Nestle SA; CSL	Schabussova, I (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at	Tang, Mimi/ABD-8350-2020	Tang, Mimi/0000-0002-3839-5293; Schabussova, Irma/0000-0002-2109-2640; Wiedermann, Ursula/0000-0002-1302-3223; Wagner, Angelika/0000-0002-5447-9534	Nestle (Investor Initiated Study; "Prenatal- and perinatal interventions against allergic sensitization''); SFB grant ("Mucosal tolerance induction, a strategy for prevention and therapy of type I allergy,'' from the Austrian Science Fund [F0814]	Nestle (Investor Initiated Study; "Prenatal- and perinatal interventions against allergic sensitization''); SFB grant ("Mucosal tolerance induction, a strategy for prevention and therapy of type I allergy,'' from the Austrian Science Fund	This work was financially supported by Nestle (Investor Initiated Study; "Prenatal- and perinatal interventions against allergic sensitization'') and by a SFB grant ("Mucosal tolerance induction, a strategy for prevention and therapy of type I allergy,'' F0814) from the Austrian Science Fund. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Blumer N, 2007, CLIN EXP ALLERGY, V37, P348, DOI 10.1111/j.1365-2222.2007.02671.x; Bortolatto J, 2008, CLIN EXP ALLERGY, V38, P1668, DOI 10.1111/j.1365-2222.2008.03036.x; Brand S, 2011, J ALLERGY CLIN IMMUN, V128, P618, DOI 10.1016/j.jaci.2011.04.035; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Daniel C, 2006, ALLERGY, V61, P812, DOI 10.1111/j.1398-9995.2006.01071.x; de Roock S, 2010, CLIN EXP ALLERGY, V40, P103, DOI 10.1111/j.1365-2222.2009.03344.x; Dotterud CK, 2010, BRIT J DERMATOL, V163, P616, DOI 10.1111/j.1365-2133.2010.09889.x; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Latvala S, 2011, CLIN EXP IMMUNOL, V165, P94, DOI 10.1111/j.1365-2249.2011.04408.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinez-Canavate A, 2009, PEDIAT ALLERG IMM-UK, V20, P592, DOI 10.1111/j.1399-3038.2008.00833.x; Matsuzaki T, 1998, J DAIRY SCI, V81, P48, DOI 10.3168/jds.S0022-0302(98)75549-3; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006474.pub2; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Renz H, 2011, ALLERGY, V66, P10, DOI 10.1111/j.1398-9995.2011.02622.x; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Repa A, 2003, VACCINE, V22, P87, DOI 10.1016/S0264-410X(03)00528-0; Savino F, 2004, ACTA PAEDIATR, V93, P825, DOI [10.1080/08035250410027625, 10.1111/j.1651-2227.2004.tb03025.x]; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Schabussova I, 2011, VACCINE, V29, P1981, DOI 10.1016/j.vaccine.2010.12.101; Schaub B, 2009, J ALLERGY CLIN IMMUN, V123, p[774, e775]; Schwarzer M, 2011, ALLERGY, V66, P368, DOI 10.1111/j.1398-9995.2010.02488.x; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Suzuki S, 2007, CLIN EXP ALLERGY, V37, P506, DOI 10.1111/j.1365-2222.2007.02676.x; Tang MLK, 2010, CURR OPIN PEDIATR, V22, P626, DOI 10.1097/MOP.0b013e32833d9728; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Velasco G, 2005, AM J RESP CELL MOL, V32, P218, DOI 10.1165/rcmb.2003-0435OC; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; von der Weid T, 2001, CLIN DIAGN LAB IMMUN, V8, P695, DOI 10.1128/CDLI.8.4.695-701.2001; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x	39	31	35	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40271	10.1371/journal.pone.0040271	http://dx.doi.org/10.1371/journal.pone.0040271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792257	gold, Green Published			2022-12-25	WOS:000306461800058
J	Catry, FX; Moreira, F; Pausas, JG; Fernandes, PM; Rego, F; Cardillo, E; Curt, T				Catry, Filipe X.; Moreira, Francisco; Pausas, Juli G.; Fernandes, Paulo M.; Rego, Francisco; Cardillo, Enrique; Curt, Thomas			Cork Oak Vulnerability to Fire: The Role of Bark Harvesting, Tree Characteristics and Abiotic Factors	PLOS ONE			English	Article							QUERCUS-SUBER; PHYTOPHTHORA-CINNAMOMI; SLOPE ASPECT; DAMAGE; CLIMATE; IMPACT; FOREST; SURVIVAL; PERFORMANCE; MANAGEMENT	Forest ecosystems where periodical tree bark harvesting is a major economic activity may be particularly vulnerable to disturbances such as fire, since debarking usually reduces tree vigour and protection against external agents. In this paper we asked how cork oak Quercus suber trees respond after wildfires and, in particular, how bark harvesting affects post-fire tree survival and resprouting. We gathered data from 22 wildfires ( 4585 trees) that occurred in three southern European countries (Portugal, Spain and France), covering a wide range of conditions characteristic of Q. suber ecosystems. Post-fire tree responses (tree mortality, stem mortality and crown resprouting) were examined in relation to management and ecological factors using generalized linear mixed-effects models. Results showed that bark thickness and bark harvesting are major factors affecting resistance of Q. suber to fire. Fire vulnerability was higher for trees with thin bark (young or recently debarked individuals) and decreased with increasing bark thickness until cork was 3-4 cm thick. This bark thickness corresponds to the moment when exploited trees are debarked again, meaning that exploited trees are vulnerable to fire during a longer period. Exploited trees were also more likely to be top-killed than unexploited trees, even for the same bark thickness. Additionally, vulnerability to fire increased with burn severity and with tree diameter, and was higher in trees burned in early summer or located in drier south-facing aspects. We provided tree response models useful to help estimating the impact of fire and to support management decisions. The results suggested that an appropriate management of surface fuels and changes in the bark harvesting regime (e. g. debarking coexisting trees in different years or increasing the harvesting cycle) would decrease vulnerability to fire and contribute to the conservation of cork oak ecosystems.	[Catry, Filipe X.; Moreira, Francisco; Fernandes, Paulo M.; Rego, Francisco] Tech Univ Lisbon CEABN ISA UTL, Ctr Appl Ecol, Sch Agr, Lisbon, Portugal; [Pausas, Juli G.] Spanish Natl Res Council CIDE CSIC, Desertificat Res Ctr, Valencia, Spain; [Fernandes, Paulo M.] Univ Tras Os Montes & Alto Douro CIFAP UTAD, Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal; [Cardillo, Enrique] Inst Wood Cork & Charcoal IPROCOR, Badajoz, Spain; [Curt, Thomas] Natl Res Inst Sci & Technol Environm & Agr EMAX I, Mediterranean Ecosyst & Risks Res Unit, Aix En Provence, France	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); University of Tras-os-Montes & Alto Douro; INRAE	Catry, FX (corresponding author), Tech Univ Lisbon CEABN ISA UTL, Ctr Appl Ecol, Sch Agr, Lisbon, Portugal.	fcatry@isa.utl.pt	Fernandes, Paulo M./A-6948-2008; Moreira, Francisco/B-2873-2008; Catry, Filipe/F-5338-2010; Pausas, Juli/C-5794-2008; Castro Rego, Francisco/H-9155-2013	Fernandes, Paulo M./0000-0003-0336-4398; Moreira, Francisco/0000-0003-4393-8018; Catry, Filipe/0000-0003-0668-9323; Pausas, Juli/0000-0003-3533-5786; Cardillo, Enrique/0000-0002-9148-7090; Castro Rego, Francisco/0000-0003-0060-5192	Portuguese government (Fundacao para a Ciencia e a Tecnologia) [POCI/AGR/61407/2004, SFRH/BD/65991/2009]; European Union [COST FP0701, TRANZFOR]; Spanish government [VARQUS, GL2004-04325/BOS, VIRRA, CGL2009-12048/BOS]; French government (Ministry for Ecology) [MEEDATT/DEB/2006]; Provence region [PACA DEB 09-716]; Fundação para a Ciência e a Tecnologia [POCI/AGR/61407/2004, SFRH/BD/114843/2016] Funding Source: FCT	Portuguese government (Fundacao para a Ciencia e a Tecnologia); European Union(European Commission); Spanish government(Spanish GovernmentEuropean Commission); French government (Ministry for Ecology); Provence region; Fundação para a Ciência e a Tecnologia	This work was funded by the Portuguese government (Fundacao para a Ciencia e a Tecnologia: project POCI/AGR/61407/2004 and PhD grant SFRH/BD/65991/2009; Fundo Florestal Permanente: project Recuperacao de Areas Ardidas), the European Union (projects: COST FP0701 and TRANZFOR), the Spanish government (projects: VARQUS, CGL2004-04325/BOS and VIRRA, CGL2009-12048/BOS), and the French government (Ministry for Ecology: project MEEDATT/DEB/2006; Provence region: project PACA DEB 09-716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, DIG MAP EUR EC REG; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1950, DIRECAO GERAL SERVIC; [Anonymous], 2009, ECOLOGY SILVICULTURE; APCOR, 2009, APCOR YB 2009; Barberis A, 2003, J ARID ENVIRON, V54, P565, DOI 10.1006/jare.2002.1079; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bergot M, 2004, GLOBAL CHANGE BIOL, V10, P1539, DOI 10.1111/j.1365-2486.2004.00824.x; Bond WJ, 1994, FIRE PLANTS; Botha J, 2004, BIODIVERS CONSERV, V13, P1675, DOI 10.1023/B:BIOC.0000029333.72945.b0; Branco M, 2009, CORK OAK WOODLANDS E, P103; Brando PM, 2012, GLOBAL CHANGE BIOL, V18, P630, DOI 10.1111/j.1365-2486.2011.02533.x; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Cardillo E, 2007, ALCORNOCAL FUEGO; Catry FX, 2010, FOREST ECOL MANAG, V260, P1184, DOI 10.1016/j.foreco.2010.07.010; Catry FX, 2012, MANAG FOR ECOSYST, V24, P195, DOI 10.1007/978-94-007-2208-8_9; Catry FX, 2009, EUR J FOREST RES, V128, P231, DOI 10.1007/s10342-009-0259-5; Correia O.A., 1992, SCI GERUND, V18, P195; Costa A, 2004, FORESTRY, V77, P1, DOI 10.1093/forestry/77.1.1; DeBano LF, 1998, FIRES EFFECTS ECOSYS; Delvaux C, 2010, BIOL CONSERV, V143, P2664, DOI 10.1016/j.biocon.2010.07.009; Delvaux C, 2009, J APPL ECOL, V46, P703, DOI 10.1111/j.1365-2664.2009.01639.x; DUMERLE P, 1992, ANN SCI FOREST, V49, P571, DOI 10.1051/forest:19920602; FAO, 2006, GLOB FOR RES ASS 200; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Gaoue OG, 2008, J APPL ECOL, V45, P34, DOI 10.1111/j.1365-2664.2007.01381.x; Gaoue OG, 2010, CONSERV BIOL, V24, P605, DOI 10.1111/j.1523-1739.2009.01345.x; Giannakopoulos C, 2009, GLOBAL PLANET CHANGE, V68, P209, DOI 10.1016/j.gloplacha.2009.06.001; Guedje NM, 2007, FOREST ECOL MANAG, V240, P1, DOI 10.1016/j.foreco.2006.09.029; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jackson JF, 1999, AM NAT, V153, P614, DOI 10.1086/303201; Kutiel P, 1999, ISRAEL J PLANT SCI, V47, P169, DOI 10.1080/07929978.1999.10676770; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; MARQUES MA, 1992, CATENA, V19, P333, DOI 10.1016/0341-8162(92)90007-X; Martin J, 2005, FOREST ECOL MANAG, V216, P166, DOI 10.1016/j.foreco.2005.05.027; Mendes AMSC, 2009, CORK OAK WOODLANDS E, P59; Miller M, 2000, US FOR SERV RMRS-P, P9; Moreira AC, 2005, FOREST PATHOL, V35, P145, DOI 10.1111/j.1439-0329.2005.00397.x; Moreira F, 2009, PLANT ECOL, V201, P77, DOI 10.1007/s11258-008-9476-0; Moreira F, 2007, FOREST ECOL MANAG, V253, P30, DOI 10.1016/j.foreco.2007.07.001; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; OLIVEIRA G, 1992, VEGETATIO, V100, P199; Paula S., 2009, ECOLOGY, V90, P1420, DOI DOI 10.1890/08-1309.1; Pausas J.G., 2009, CORK OAK WOODLANDS E, P11; Pausas JG, 1997, J VEG SCI, V8, P703, DOI 10.2307/3237375; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JS, 2009, CORK OAK WOODLANDS E, P219; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pereira H., 2011, CORK BIOL PRODUCTION; Pereira PM, 2003, CONSERV ECOL, V7; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Purohit A, 2001, CURR SCI INDIA, V81, P586; RUNDEL PW, 1973, ECOLOGY, V54, P210, DOI 10.2307/1934393; RYAN KC, 1988, CAN J FOREST RES, V18, P1291, DOI 10.1139/x88-199; Silva J. S., 2006, International Journal of Environmental Studies, V63, P235, DOI 10.1080/00207230600720829; Silva SP, 2005, INT MATER REV, V50, P345, DOI 10.1179/174328005X41168; Sternberg M, 2001, ECOL RES, V16, P335, DOI 10.1046/j.1440-1703.2001.00393.x; Stewart K, 2009, FOREST ECOL MANAG, V258, P1121, DOI 10.1016/j.foreco.2009.05.039; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wargo PM, 1996, ANN SCI FOREST, V53, P359, DOI 10.1051/forest:19960218; Whelan R.J.., 1995, ECOLOGY FIRE; Zuur Alain F., 2009, P1	64	42	42	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39810	10.1371/journal.pone.0039810	http://dx.doi.org/10.1371/journal.pone.0039810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22787521	Green Published, gold			2022-12-25	WOS:000305826400040
J	Li, B; Wang, C; Zhang, Y; Zhao, XY; Huang, B; Wu, PF; Li, Q; Li, H; Liu, YS; Cao, LY; Dai, WM; Fang, WG; Shang, DS; Cao, L; Zhao, WD; Chen, YH				Li, B.; Wang, C.; Zhang, Y.; Zhao, X. Y.; Huang, B.; Wu, P. F.; Li, Q.; Li, H.; Liu, Y. S.; Cao, L. Y.; Dai, W. M.; Fang, W. G.; Shang, D. S.; Cao, L.; Zhao, W. D.; Chen, Y. H.			Elevated PLGF contributes to small-cell lung cancer brain metastasis	ONCOGENE			English	Article						blood-brain barrier; brain metastasis; PLGF; Rho kinase; small-cell lung cancer	ENDOTHELIAL GROWTH-FACTOR; TIGHT JUNCTION PROTEINS; BREAST-CANCER; VASCULAR-PERMEABILITY; DIABETIC-RETINOPATHY; KINASE; OCCLUDIN; BARRIER; PHOSPHORYLATION; ACTIVATION	Brain metastasis (BM) is a major cause of mortality in small-cell lung cancer (SCLC) patients; however, the molecular pathway of SCLC BM remains largely unknown because of a lack of investigation. Here we screen the levels of some candidate-soluble factors in the serum of SCLC patients and find that SCLC patients with high levels of placental growth factor (PLGF) are prone to BM. Using in vitro blood-brain barrier model, we show that PLGF derived from SCLC cells triggers vascular endothelial growth factor receptor1- Rho-extracellular regulated protein kinase 1/2 signaling axis activation, results in disassembly of tight junction in brain endothelial cells and promotes SCLC cell transendothelial migration. Furthermore, the downregulation of PLGF suppresses SCLC cell metastasis to the brain in an experimental BM model. These data suggest that PLGF is a potential signature of SCLC BM and a prospective therapeutic target for SCLC BM.	[Li, B.; Wang, C.; Zhang, Y.; Zhao, X. Y.; Liu, Y. S.; Cao, L. Y.; Dai, W. M.; Fang, W. G.; Shang, D. S.; Zhao, W. D.; Chen, Y. H.] China Med Univ, Dept Dev Biol, Minist Publ Hlth, Key Lab Cell Biol, Shenyang 110001, Peoples R China; [Li, B.; Wang, C.; Zhang, Y.; Zhao, X. Y.; Liu, Y. S.; Cao, L. Y.; Dai, W. M.; Fang, W. G.; Shang, D. S.; Cao, L.; Zhao, W. D.; Chen, Y. H.] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang 110001, Peoples R China; [Wang, C.] Liaoning Univ Tradit Chinese Med, Dept Cell Biol, Shenyang, Peoples R China; [Zhao, X. Y.] Shenyang Pharmaceut Univ, Dept Cell Biol, Shenyang, Peoples R China; [Huang, B.] Liaoning Canc Hosp & Inst, Dept Pathol, Shenyang, Peoples R China; [Wu, P. F.] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Peoples R China; [Li, Q.] China Med Univ, Shengjing Hosp, Dept Med Examinat, Shenyang 110001, Peoples R China; [Li, H.] China Med Univ, Shengjing Hosp, Dept Geriatr Med, Shenyang 110001, Peoples R China; [Cao, L.] China Med Univ, Minist Educ, Minist Publ Hlth, Inst Translat Med,Key Lab Cell Biol, Shenyang 110001, Peoples R China	China Medical University; China Medical University; Liaoning University of Traditional Chinese Medicine; Shenyang Pharmaceutical University; China Medical University; China Medical University; China Medical University; China Medical University	Chen, YH (corresponding author), China Med Univ, Dept Dev Biol, Minist Publ Hlth, Key Lab Cell Biol, 92 Bei Er Rd, Shenyang 110001, Peoples R China.	yhchen@mail.cmu.edu.cn	Liu, Yongshuo/GRX-6416-2022	Liu, Yongshuo/0000-0001-8190-0139	Trans-Century Training Program Foundation for Talents; Ministry of Education of China [JJH2002-48]; Innovation Team Program Foundation of Liaoning Province [2006T131, LT2011011]; National Natural Science Foundation of China [30600270]; Science and Technology Foundation of Liaoning Province [20102291]	Trans-Century Training Program Foundation for Talents; Ministry of Education of China(Ministry of Education, China); Innovation Team Program Foundation of Liaoning Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Liaoning Province	We are grateful to Drs Monique Stins and Kwang Sik Kim (Department of Pediatrics, John Hopkins University School of Medicine) for providing HBMEC and Dr Shuh Narumiya (Kyoto University Faculty of Medicine, Kyoto, Japan) for providing pCAGmyc, pCAG-myc-ROCK-WT and pCAG-myc-ROCK-KDIA. This work was supported by the Trans-Century Training Program Foundation for Talents, Ministry of Education of China (JJH2002-48), the Innovation Team Program Foundation of Liaoning Province (2006T131, LT2011011), the National Natural Science Foundation of China (30600270) and the Science and Technology Foundation of Liaoning Province (20102291).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; CARNEY DN, 1985, CANCER RES, V45, P2913; Casalou C, 2007, LEUKEMIA, V21, P1590, DOI 10.1038/sj.leu.2404668; Castrucci WA, 2008, CANCER J, V14, P138, DOI 10.1097/PPO.0b013e318172d6e1; Chen CN, 2004, CANCER LETT, V213, P73, DOI 10.1016/j.canlet.2004.05.020; Chen JF, 2008, J CELL BIOCHEM, V105, P313, DOI 10.1002/jcb.21831; Cipolla MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P777, DOI 10.2741/1282; Clarke H, 2000, J CELL SCI, V113, P3187; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Dowell JE, 2010, AM J MED SCI, V339, P68, DOI 10.1097/MAJ.0b013e3181bccef5; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; FUJIMAKI T, 1993, INT J ONCOL, V3, P789; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; Khan NA, 2009, INT J PARASITOL, V39, P1611, DOI 10.1016/j.ijpara.2009.06.004; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Meyer TN, 2003, AM J PHYSIOL-CELL PH, V285, pC1281, DOI 10.1152/ajpcell.00548.2002; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Parr C, 2005, EUR J CANCER, V41, P2819, DOI 10.1016/j.ejca.2005.07.022; Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200; Phelps RM, 1996, J CELL BIOCHEM, P32; Ribatti D, 2008, ANGIOGENESIS, V11, P215, DOI 10.1007/s10456-008-9114-4; Rottbauer W, 2005, GENE DEV, V19, P1624, DOI 10.1101/gad.1319405; Schreurs MPH, 2012, FASEB J, V26, P355, DOI 10.1096/fj.11-191916; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Taylor AP, 2010, BRIT J CANCER, V103, P82, DOI 10.1038/sj.bjc.6605746; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Vogel C, 2007, J CELL PHYSIOL, V212, P236, DOI 10.1002/jcp.21022; Wang X, 2011, BIOCHEM BIOPH RES CO, V410, P258, DOI 10.1016/j.bbrc.2011.05.128; Wei SC, 2005, GUT, V54, P666, DOI 10.1136/gut.2004.050831; Willis CL, 2010, J CEREBR BLOOD F MET, V30, P1847, DOI 10.1038/jcbfm.2010.119; Zhang CY, 2009, CANCER RES, V69, P828, DOI 10.1158/0008-5472.CAN-08-2588; Zhao WD, 2010, INFECT IMMUN, V78, P4809, DOI 10.1128/IAI.00377-10	47	60	66	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2013	32	24					2952	2962		10.1038/onc.2012.313	http://dx.doi.org/10.1038/onc.2012.313			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22797069				2022-12-25	WOS:000320369700005
J	Chan, NLS; Hou, CX; Zhang, TY; Yuan, FH; Machwe, A; Huang, J; Orren, DK; Gu, LY; Li, GM				Chan, Nelson L. S.; Hou, Caixia; Zhang, Tianyi; Yuan, Fenghua; Machwe, Amrita; Huang, Jian; Orren, David K.; Gu, Liya; Li, Guo-Min			The Werner Syndrome Protein Promotes CAG/CTG Repeat Stability by Resolving Large (CAG)(n)/(CTG)(n) Hairpins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; EUKARYOTIC REPLICATION FORK; TRINUCLEOTIDE REPEATS; TRIPLET REPEATS; MISMATCH REPAIR; RECQ HELICASES; IN-VITRO; SYNDROME GENE; HUMAN-DISEASE; INSTABILITY	Expansion of CAG/CTG repeats causes certain neurological and neurodegenerative disorders, and the formation and subsequent persistence of stable DNA hairpins within these repeats are believed to contribute to CAG/CTG repeat instability. Human cells possess a DNA hairpin repair (HPR) pathway, which removes various (CAG)(n) and (CTG)(n) hairpins in a nick-directed and strand-specific manner. Interestingly, this HPR system processes a (CTG)(n) hairpin on the template DNA strand much less efficiently than a (CAG)(n) hairpin on the same strand (Hou, C., Chan, N. L., Gu, L., and Li, G. M. (2009) Incision-dependent and error-free repair of (CAG)(n)/(CTG)(n) hairpins in human cell extracts. Nat. Struct. Mol. Biol. 16, 869-875), suggesting the involvement of an additional component for (CTG)(n) HPR. To identify this activity, a functional in vitro HPR assay was used to screen partially purified HeLa nuclear fractions for their ability to stimulate (CTG)(n) HPR. We demonstrate here that the stimulating activity is the Werner syndrome protein (WRN). Although WRN contains both a 3'-> 5' helicase activity and a 3'-> 5' exonuclease activity, the stimulating activity was found to be the helicase activity, as a WRN helicase mutant failed to enhance (CTG)(n) HPR. Consistently, WRN efficiently unwound large (CTG)(n) hairpins and promoted DNA polymerase delta-catalyzed DNA synthesis using a (CTG)(n) hairpin as a template. We, therefore, conclude that WRN stimulates (CTG)(n) HPR on the template DNA strand by resolving the hairpin so that it can be efficiently used as a template for repair or replicative synthesis.	[Chan, Nelson L. S.; Hou, Caixia; Zhang, Tianyi; Yuan, Fenghua; Machwe, Amrita; Orren, David K.; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Chan, Nelson L. S.; Hou, Caixia; Zhang, Tianyi; Yuan, Fenghua; Machwe, Amrita; Orren, David K.; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Zhang, Tianyi; Huang, Jian; Li, Guo-Min] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei Province, Peoples R China	University of Kentucky; University of Kentucky; Wuhan University	Li, GM (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [GM089684, CA104333, AG027258]; Chinese 111 Project [B06018]; NATIONAL CANCER INSTITUTE [R01CA113371, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 111 Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM089684 (to G. M. L.), CA104333 (to L. G.), and AG027258 (to D. K. O.). This work was also supported by Chinese 111 Project B06018.	Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bhattacharyya S, 2005, J BIOL CHEM, V280, P33311, DOI 10.1074/jbc.M503325200; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GACY AM, 1995, CELL, V81, P533; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hou CX, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-11; Hou CX, 2009, NAT STRUCT MOL BIOL, V16, P869, DOI 10.1038/nsmb.1638; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kerrest A, 2009, NAT STRUCT MOL BIOL, V16, P159, DOI 10.1038/nsmb.1544; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Mankouri HW, 2012, MOL CELL, V45, P6, DOI 10.1016/j.molcel.2011.12.015; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Orren DK, 2006, FRONT BIOSCI-LANDMRK, V11, P2657, DOI 10.2741/1999; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Szekely AM, 2000, P NATL ACAD SCI USA, V97, P11365, DOI 10.1073/pnas.97.21.11365; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhang TY, 2012, DNA REPAIR, V11, P201, DOI 10.1016/j.dnarep.2011.10.020; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	43	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30151	30156		10.1074/jbc.M112.389791	http://dx.doi.org/10.1074/jbc.M112.389791			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787159	Green Published, hybrid			2022-12-25	WOS:000308579800010
J	Channappanavar, R; Twardy, BS; Suvas, S				Channappanavar, Rudragouda; Twardy, Brandon S.; Suvas, Susmit			Blocking of PDL-1 Interaction Enhances Primary and Secondary CD8 T Cell Response to Herpes Simplex Virus-1 Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; PD-1 EXPRESSION; LISTERIA-MONOCYTOGENES; TRIGEMINAL GANGLIA; PROGRAMMED DEATH-1; DENDRITIC CELLS; EXHAUSTION; BLOCKADE; LATENCY; B7-H1	The blocking of programmed death ligand-1 (PDL-1) has been shown to enhance virus-specific CD8 T cell function during chronic viral infections. Though, how PDL-1 blocking at the time of priming affects the quality of CD8 T cell response to acute infections is not well understood and remains controversial. This report demonstrates that the magnitude of the primary and secondary CD8 T cell responses to herpes simplex virus-1 (HSV-1) infection is subject to control by PDL-1. Our results showed that after footpad HSV-1 infection, PD-1 expression increases on immunodominant SSIEFARL peptide specific CD8 T cells. Additionally, post-infection, the level of PDL-1 expression also increases on CD11c+ dendritic cells. Intraperitoneal administration of anti-PDL-1 monoclonal antibody given one day prior to and three days after cutaneous HSV-1 infection, resulted in a marked increase in effector and memory CD8 T cell response to SSIEFARL peptide. This was shown by measuring the quantity and quality of SSIEFARL-specific CD8 T cells by making use of ex-vivo assays that determine antigen specific CD8 T cell function, such as intracellular cytokine assay, degranulation assay to measure cytotoxicity and viral clearance. Our results are discussed in terms of the beneficial effects of blocking PDL-1 interactions, while giving prophylactic vaccines, to generate a more effective CD8 T cell response to viral infection.	[Channappanavar, Rudragouda; Twardy, Brandon S.; Suvas, Susmit] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	Oakland University	Channappanavar, R (corresponding author), Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA.	suvas@oakland.edu			American Federation for Aging Research (AFAR) Grant; National Eye Institute [R21EY020625]; Oakland University Research Excellence Fund (REF); NATIONAL EYE INSTITUTE [R21EY020625] Funding Source: NIH RePORTER	American Federation for Aging Research (AFAR) Grant; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oakland University Research Excellence Fund (REF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by an American Federation for Aging Research (AFAR) Grant, National Eye Institute grant R21EY020625, and the Oakland University Research Excellence Fund (REF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; Allie SR, 2011, J IMMUNOL, V186, P6280, DOI 10.4049/jimmunol.1003870; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bryant-Hudson KM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/924619; Chentoufi AA, 2011, J VIROL, V85, P9127, DOI 10.1128/JVI.00587-11; Chentoufi AA, 2012, VIRAL IMMUNOL, V25, P204, DOI 10.1089/vim.2011.0091; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Crawford A, 2009, CURR OPIN IMMUNOL, V21, P179, DOI 10.1016/j.coi.2009.01.010; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Hokey DA, 2008, EUR J IMMUNOL, V38, P1435, DOI 10.1002/eji.200737857; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jun H, 2005, FEBS LETT, V579, P6259, DOI 10.1016/j.febslet.2005.09.098; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lafon M, 2008, J IMMUNOL, V180, P7506, DOI 10.4049/jimmunol.180.11.7506; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Mott KR, 2009, J VIROL, V83, P2246, DOI 10.1128/JVI.02234-08; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; Seo SK, 2008, IMMUNOLOGY, V123, P90, DOI 10.1111/j.1365-2567.2007.02708.x; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Talay O, 2009, P NATL ACAD SCI USA, V106, P2741, DOI 10.1073/pnas.0813367106; Telcian AG, 2011, J INFECT DIS, V203, P85, DOI 10.1093/infdis/jiq020; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Zelinskyy G, 2011, J IMMUNOL, V187, P3730, DOI 10.4049/jimmunol.1101612	35	34	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e39757	10.1371/journal.pone.0039757	http://dx.doi.org/10.1371/journal.pone.0039757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22808056	Green Submitted, Green Published, gold			2022-12-25	WOS:000306366400011
J	Bosse, JB; Bauerfeind, R; Popilka, L; Marcinowski, L; Taeglich, M; Jung, C; Striebinger, H; von Einem, J; Gaul, U; Walther, P; Koszinowski, UH; Ruzsics, Z				Bosse, Jens B.; Bauerfeind, Rudolf; Popilka, Leonhard; Marcinowski, Lisa; Taeglich, Martina; Jung, Christophe; Striebinger, Hannah; von Einem, Jens; Gaul, Ulrike; Walther, Paul; Koszinowski, Ulrich H.; Ruzsics, Zsolt			A Beta-Herpesvirus with Fluorescent Capsids to Study Transport in Living Cells	PLOS ONE			English	Article							SIMPLEX-VIRUS; HUMAN CYTOMEGALOVIRUS; VIRAL REPLICATION; ESCHERICHIA-COLI; NUCLEAR EGRESS; PROTEIN; TEGUMENT; VISUALIZATION; LOCALIZATION; GLYCOPROTEIN	Fluorescent tagging of viral particles by genetic means enables the study of virus dynamics in living cells. However, the study of beta-herpesvirus entry and morphogenesis by this method is currently limited. This is due to the lack of replication competent, capsid-tagged fluorescent viruses. Here, we report on viable recombinant MCMVs carrying ectopic insertions of the small capsid protein (SCP) fused to fluorescent proteins (FPs). The FPs were inserted into an internal position which allowed the production of viable, fluorescently labeled cytomegaloviruses, which replicated with wild type kinetics in cell culture. Fluorescent particles were readily detectable by several methods. Moreover, in a spread assay, labeled capsids accumulated around the nucleus of the newly infected cells without any detectable viral gene expression suggesting normal entry and particle trafficking. These recombinants were used to record particle dynamics by live-cell microscopy during MCMV egress with high spatial as well as temporal resolution. From the resulting tracks we obtained not only mean track velocities but also their mean square displacements and diffusion coefficients. With this key information, we were able to describe particle behavior at high detail and discriminate between particle tracks exhibiting directed movement and tracks in which particles exhibited free or anomalous diffusion.	[Bosse, Jens B.; Popilka, Leonhard; Marcinowski, Lisa; Striebinger, Hannah; Koszinowski, Ulrich H.; Ruzsics, Zsolt] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Bauerfeind, Rudolf] Hannover Med Sch, Dept Cell Biol, D-3000 Hannover, Germany; [von Einem, Jens] Univ Med Ctr Ulm, Inst Virol, Ulm, Germany; [Taeglich, Martina; Jung, Christophe; Gaul, Ulrike] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany; [Walther, Paul] Univ Ulm, Cent Unit Electron Microscopy, Ulm, Germany	University of Munich; Hannover Medical School; Ulm University; University of Munich; Ulm University	Bosse, JB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ruzsics@lmb.uni-muenchen.de	Bosse, Jens Bernhard/D-7336-2011; Ruzsics, Zsolt/D-6284-2014; von Einem, Jens/ABB-4480-2021	Bosse, Jens Bernhard/0000-0001-7252-5541; von Einem, Jens/0000-0001-7508-4702	German Research Foundation; Bayerisch-FranzosischesHochschulzentrum/Centre de Cooperation Universitaire Franco-Bavarois (BFHZ-CCUFB) [FK20-10]; German National Academic Foundation (Studienstiftung des deutschenVolkes)	German Research Foundation(German Research Foundation (DFG)); Bayerisch-FranzosischesHochschulzentrum/Centre de Cooperation Universitaire Franco-Bavarois (BFHZ-CCUFB); German National Academic Foundation (Studienstiftung des deutschenVolkes)	This work was supported by the German Research Foundation as part of the "Schwerpunktprogramm 1175" (SPP1175) and the Bayerisch-FranzosischesHochschulzentrum/Centre de Cooperation Universitaire Franco-Bavarois (BFHZ-CCUFB) through the project FK20-10. JBB was supported by a PhD studentship from the German National Academic Foundation (Studienstiftung des deutschenVolkes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Antinone SE, 2006, J VIROL, V80, P11235, DOI 10.1128/JVI.01441-06; Bohannon KP, 2012, J GEN VIROL, V93, P124, DOI 10.1099/vir.0.036145-0; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Borst EM, 2001, J VIROL, V75, P1450, DOI 10.1128/JVI.75.3.1450-1458.2001; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Chaudhuri V, 2008, J VIROL, V82, P10231, DOI 10.1128/JVI.01890-07; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cockrell SK, 2011, J VIROL, V85, P4875, DOI 10.1128/JVI.00242-11; Conway JF, 2010, J MOL BIOL, V397, P575, DOI 10.1016/j.jmb.2010.01.043; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Desai P, 1998, VIROLOGY, V247, P115, DOI 10.1006/viro.1998.9230; Desai P, 1998, J VIROLOGY; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; Donnelly M, 2001, J VIROL, V75, P2575, DOI 10.1128/JVI.75.6.2575-2583.2001; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Endress T, 2008, EUR BIOPHYS J BIOPHY, V37, P1291, DOI 10.1007/s00249-008-0322-z; Finke S, 2004, J VIROL, V78, P12333, DOI 10.1128/JVI.78.22.12333-12343.2004; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Frampton AR, 2010, VET MICROBIOL, V141, P12, DOI 10.1016/j.vetmic.2009.07.035; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327; Henson BW, 2009, J VIROL, V83, P3877, DOI 10.1128/JVI.01733-08; Hutchinson I, 2002, J VIROL, V76, P10365, DOI 10.1128/JVI.76.20.10365-10373.2002; Kirstein J, 2005, J AM CHEM SOC, V130, P1638; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Krautwald M, 2008, J GEN VIROL, V89, P1346, DOI 10.1099/vir.0.83652-0; Lai LL, 2003, J VIROL, V77, P2730, DOI 10.1128/JVI.77.4.2730-2735.2003; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Maninger S, 2011, J VIROL, V85, P9254, DOI 10.1128/JVI.00443-11; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; NII S, 1968, J VIROL, V2, P517, DOI 10.1128/JVI.2.5.517-536.1968; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliveira SA, 2002, J VIROL, V76, P885, DOI 10.1128/JVI.76.2.885-894.2002; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Potel C, 2002, J VIROL METHODS, V105, P13, DOI 10.1016/S0166-0934(02)00027-7; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Roberts KL, 2010, J VIROL, V84, P9889, DOI 10.1128/JVI.00732-10; Rupp B, 2005, J VIROL, V79, P486, DOI 10.1128/JVI.79.1.486-494.2005; Rupp B, 2007, J VIROL, V81, P5508, DOI 10.1128/JVI.02796-06; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schaffer P A, 1975, Curr Top Microbiol Immunol, V70, P51; Scrivano L, 2010, J VIROL, V84, P4469, DOI 10.1128/JVI.02441-09; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Sugimoto K, 2008, J VIROL, V82, P5198, DOI 10.1128/JVI.02681-07; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001	62	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40585	10.1371/journal.pone.0040585	http://dx.doi.org/10.1371/journal.pone.0040585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22792376	Green Published, Green Submitted, gold			2022-12-25	WOS:000306362400074
J	Alevra, M; Schwartz, P; Schild, D				Alevra, Mihai; Schwartz, Peter; Schild, Detlev			Direct Measurement of Diffusion in Olfactory Cilia Using a Modified FRAP Approach	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; MOLECULAR-DIFFUSION; FROG; COEFFICIENT; NEURONS	The diffusion coefficient of fluorescein in detached cilia of Xenopus laevis olfactory receptor neurons was measured using spatially-resolved FRAP, where the dye along half of the ciliary length was photobleached and its spatiotemporal fluorescence redistribution recorded. Fitting a one-dimensional numerical simulation of diffusion and photobleaching for 35 cilia resulted in a mean value of the diffusion coefficient (1.20 +/- 0.23).10(-10)m(2)/s and thus a reduction by a factor of 3.4 compared to free diffusion in aqueous solution.	[Alevra, Mihai; Schild, Detlev] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany; [Alevra, Mihai; Schild, Detlev] German Res Fdn Res Ctr Mol Physiol Brain, Gottingen, Germany; [Schild, Detlev] German Res Fdn Cluster Excellence 171, Gottingen, Germany; [Schwartz, Peter] Univ Gottingen, Dept Anat & Embryol, Gottingen, Germany	University of Gottingen; University of Gottingen	Alevra, M (corresponding author), Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany.	malevra@gwdg.de	Alevra, Mihai/AAL-2679-2021	Alevra, Mihai/0000-0002-1384-0071	"Deutsche Forschungsgemeinschaft" Research Center Molecular Physiology of the Brain (CMPB); Cluster of Excellence 171	"Deutsche Forschungsgemeinschaft" Research Center Molecular Physiology of the Brain (CMPB); Cluster of Excellence 171	This work was supported by grants of the "Deutsche Forschungsgemeinschaft" Research Center Molecular Physiology of the Brain (CMPB, http://cmpb.de/) to DS and MA, and the Cluster of Excellence 171 (http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=32501626) to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANHOLT RRH, 1986, J NEUROSCI, V6, P1962; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chen CH, 1999, BIOPHYS J, V76, P2861, DOI 10.1016/S0006-3495(99)77440-0; CHEN Z, 1986, J NEUROSCI, V6, P2146; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gennerich A, 2000, BIOPHYS J, V79, P3294, DOI 10.1016/S0006-3495(00)76561-1; Gennerich A, 2002, BIOPHYS J, V83, P510, DOI 10.1016/S0006-3495(02)75187-4; Hansen A, 1998, J COMP NEUROL, V398, P273, DOI 10.1002/(SICI)1096-9861(19980824)398:2<273::AID-CNE8>3.0.CO;2-Y; Junek S, 2009, BIOPHYS J, V96, P3801, DOI 10.1016/j.bpj.2008.12.3962; Kim SA, 2010, J NEUROSCI, V30, P16409, DOI 10.1523/JNEUROSCI.3063-10.2010; KLEENE SJ, 1994, J EXP BIOL, V195, P307; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/S0006-3495(98)77978-0; SONG LL, 1995, BIOPHYS J, V68, P2588, DOI 10.1016/S0006-3495(95)80442-X; Takao D, 2008, J EXP BIOL, V211, P3594, DOI 10.1242/jeb.021923; Takeuchi H, 2008, J NEUROSCI, V28, P766, DOI 10.1523/JNEUROSCI.3531-07.2008; Weickert J, 1998, IEEE T IMAGE PROCESS, V7, P398, DOI 10.1109/83.661190	17	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e39628	10.1371/journal.pone.0039628	http://dx.doi.org/10.1371/journal.pone.0039628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22808046	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500012
J	Benito-Miguel, M; Garcia-Carmona, Y; Balsa, A; Bautista-Caro, MB; Arroyo-Villa, I; Cobo-Ibanez, T; Bonilla-Hernan, MG; de Ayala, CP; Sanchez-Mateos, P; Martin-Mola, E; Miranda-Carus, ME				Benito-Miguel, Marta; Garcia-Carmona, Yolanda; Balsa, Alejandro; Bautista-Caro, Maria-Belen; Arroyo-Villa, Irene; Cobo-Ibanez, Tatiana; Gema Bonilla-Hernan, Maria; Perez de Ayala, Carlos; Sanchez-Mateos, Paloma; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia			IL-15 Expression on RA Synovial Fibroblasts Promotes B Cell Survival	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; FOLLICULAR DENDRITIC CELLS; T-CELL; NECROSIS-FACTOR; BETA-CHAIN; SYNOVIOCYTES; PROLIFERATION; RECEPTOR; DISEASE; DIFFERENTIATION	Introduction: The purpose of this study was to examine the role of RA Synovial Fibroblast (RASFib) IL-15 expression on B cell survival. Methods: Magnetically sorted peripheral blood memory B cells from 15 healthy subjects were cocultured with RASFib. Results: RASFib constitutively expressed membrane IL-15. Survival of isolated B cells cultured for 6 days, below 5%, was extended in coculture with RASFib to 52+/28% (p<0.001). IL-15 neutralizing agents but not isotype controls, reduced this rate to 31+/26% (p<0.05). Interestingly, rhIL-15 had no effect on isolated B cells but significantly increased their survival in coculture with RASFib. In parallel, B cell IL-15R chains were upregulated in cocultures. BAFF and VCAM-1, that are expressed on RASFib, were tested as potential candidates involved in upregulating B cell IL-15R. Culture of B cells in the presence of rhBAFF or rhVCAM-1 resulted in significantly increased survival, together with upregulation of all three IL-15R chains; in parallel, rhIL-15 potentiated the anti-apoptotic effect of BAFF and VCAM-1. Both BAFF and VCAM-1 neutralizing agents downmodulated the effect of RASFib on B cell survival and IL-15R expression. In parallel, rhIL-15 had a lower effect on the survival of B cells cocultured with RASFib in the presence of BAFF or VCAM-1 neutralizing agents. Peripheral blood B cells from 15 early RA patients demonstrated an upregulated IL-15R and increased survival in cocultures. Conclusion: IL-15 expression on RASFib significantly contributes to the anti-apoptotic effect of RASFib on B cells. IL-15 action is facilitated by BAFF and VCAM-1 expressed on RASFib, through an upregulation of IL-15R chains.	[Benito-Miguel, Marta; Garcia-Carmona, Yolanda; Balsa, Alejandro; Bautista-Caro, Maria-Belen; Arroyo-Villa, Irene; Cobo-Ibanez, Tatiana; Gema Bonilla-Hernan, Maria; Perez de Ayala, Carlos; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain; [Sanchez-Mateos, Paloma] Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Madrid, Spain	Hospital Universitario La Paz; General University Gregorio Maranon Hospital	Benito-Miguel, M (corresponding author), Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain.	mmiranda.hulp@salud.madrid.org	Miranda-Carus, Maria-Eugenia/S-7403-2019; Balsa, Alejandro/ABF-6456-2020; Benito Miguel, Marta/O-8776-2014; Sanchez-Mateos, Paloma/E-8931-2013; Clemente-Suarez, Vicente Javier/K-7980-2014	Benito Miguel, Marta/0000-0002-2023-1063; Garcia-Carmona, Yolanda/0000-0003-2562-4752; Sanchez-Mateos, Paloma/0000-0001-6589-4445; Clemente-Suarez, Vicente Javier/0000-0002-2397-2801	Roche Pharmaceuticals; Ministerio de Ciencia e Innovacion grant [SAF 2009-07100]; RETICS Program from "Instituto de Salud Carlos III" (ISCIII) [RD08/0075]	Roche Pharmaceuticals(Roche Holding); Ministerio de Ciencia e Innovacion grant(Spanish Government); RETICS Program from "Instituto de Salud Carlos III" (ISCIII)	This work was supported by an unrestricted research grant from Roche Pharmaceuticals,(www.roche.com) by Ministerio de Ciencia e Innovacion grant SAF 2009-07100, (www.micinn.es) and by RETICS Program, RD08/0075 (RIER) from "Instituto de Salud Carlos III" (ISCIII) (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh G, 2011, EUR J IMMUNOL, V41, P2113, DOI 10.1002/eji.201041194; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balsa A, 2004, J RHEUMATOL, V31, P40; Benito-Miguel M, 2009, J IMMUNOL, V183, P8268, DOI 10.4049/jimmunol.0900007; Briard D, 2002, J IMMUNOL, V168, P4326, DOI 10.4049/jimmunol.168.9.4326; Buckley CD, 2003, RHEUMATOLOGY, V42, P1433, DOI 10.1093/rheumatology/keg413; Burger JA, 2001, J CLIN INVEST, V107, P305, DOI 10.1172/JCI11092; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Catalan D, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2985; CHOMARAT P, 1993, ARTHRITIS RHEUM-US, V36, P234, DOI 10.1002/art.1780360215; Dorner T, 2003, CURR OPIN RHEUMATOL, V15, P246, DOI 10.1097/00002281-200305000-00011; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Edwards JCW, 1997, CLIN EXP IMMUNOL, V108, P407, DOI 10.1046/j.1365-2249.1997.4061306.x; Ernestam S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1871; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; Hayashida K, 2000, J IMMUNOL, V164, P1110, DOI 10.4049/jimmunol.164.2.1110; Hopken UE, 2010, J LEUKOCYTE BIOL, V87, P671, DOI 10.1189/jlb.0709505; Kim YS, 1998, J IMMUNOL, V160, P5742; Kurowska M, 2002, J IMMUNOL, V169, P1760, DOI 10.4049/jimmunol.169.4.1760; Li WX, 2005, INT IMMUNOL, V17, P429, DOI 10.1093/intimm/dxh223; Lindhout E, 1999, J IMMUNOL, V162, P5949; McInnes IB, 1998, IMMUNOL TODAY, V19, P75, DOI 10.1016/S0167-5699(97)01205-X; Miranda-Carus ME, 2004, J IMMUNOL, V173, P1463, DOI 10.4049/jimmunol.173.2.1463; Ohata J, 2005, J IMMUNOL, V174, P864, DOI 10.4049/jimmunol.174.2.864; Park CS, 2004, J IMMUNOL, V173, P6676, DOI 10.4049/jimmunol.173.11.6676; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Prokopec KE, 2010, CLIN IMMUNOL, V137, P322, DOI 10.1016/j.clim.2010.08.006; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Reparon-Schuijt CC, 2000, ARTHRITIS RHEUM, V43, P1115, DOI 10.1002/1529-0131(200005)43:5<1115::AID-ANR22>3.0.CO;2-A; Rochas C, 2009, ARTHRITIS RHEUM-US, V60, P1261, DOI 10.1002/art.24498; Saalbach A, 2000, J INVEST DERMATOL, V115, P882, DOI 10.1046/j.1523-1747.2000.00104.x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weyand CM, 2003, CURR OPIN RHEUMATOL, V15, P259, DOI 10.1097/00002281-200305000-00013; ZVAIFLER NJ, 1974, ARTHRITIS RHEUM, V17, P297, DOI 10.1002/art.1780170315; ZVAIFLER NJ, 1994, SEMIN ARTHRITIS RHEU, V23, P11, DOI 10.1016/0049-0172(94)90080-9	42	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40620	10.1371/journal.pone.0040620	http://dx.doi.org/10.1371/journal.pone.0040620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792388	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700062
J	Yang, WB; Liang, QL; Ye, ZJ; Niu, CM; Ma, WL; Xiong, XZ; Du, RH; Zhou, Q; Zhang, JC; Shi, HZ				Yang, Wei-Bing; Liang, Qiu-Li; Ye, Zhi-Jian; Niu, Chun-Mi; Ma, Wan-Li; Xiong, Xian-Zhi; Du, Rong-Hui; Zhou, Qiong; Zhang, Jian-Chu; Shi, Huan-Zhong			Cell Origins and Diagnostic Accuracy of Interleukin 27 in Pleural Effusions	PLOS ONE			English	Article							REGULATORY T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; TH17 CELLS; IL-27; RESPONSES; METAANALYSIS; INFECTION; CCL22; WSX-1	The objective of the present study was to investigate the presence of interleukin (IL)-27 in pleural effusions and to evaluate the diagnostic significance of pleural IL-27. The concentrations of IL-27 were determined in pleural fluids and sera from 68 patients with tuberculous pleural effusion, 63 malignant pleural effusion, 22 infectious pleural effusion, and 21 transudative pleural effusion. Flow cytometry was used to identify which pleural cell types expressed IL-27. It was found that the concentrations of pleural IL-27 in tuberculous group were significantly higher than those in malignant, infectious, and transudative groups, respectively. Pleural CD4(+) T cells, CD8(+) T cells, NK cells, NKT cells, B cells, monocytes, macrophages, and mesothelial cells might be the cell sources for IL-27. IL-27 levels could be used for diagnostic purpose for tuberculous pleural effusion, with the cut off value of 1,007 ng/L, IL-27 had a sensitivity of 92.7% and specificity of 99.1% for differential diagnosing tuberculous pleural effusion from non-tuberculous pleural effusions. Therefore, compared to non-tuberculous pleural effusions, IL-27 appeared to be increased in tuberculous pleural effusion. IL-27 in pleural fluid is a sensitive and specific biomarker for the differential diagnosing tuberculous pleural effusion from pleural effusions with the other causes.	[Yang, Wei-Bing; Ye, Zhi-Jian; Niu, Chun-Mi; Ma, Wan-Li; Xiong, Xian-Zhi; Zhou, Qiong; Zhang, Jian-Chu; Shi, Huan-Zhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Resp & Crit Care Med, Key Lab Pulm Dis,Hlth Minist,Union Hosp, Wuhan 430074, Peoples R China; [Liang, Qiu-Li] Guangxi Med Univ, Affiliated Hosp 1, Inst Resp Dis, Nanning, Peoples R China; [Du, Rong-Hui] Wuhan Inst TB Prevent & Control, Dept Internal Med, Wuhan, Peoples R China	Huazhong University of Science & Technology; Guangxi Medical University	Yang, WB (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Resp & Crit Care Med, Key Lab Pulm Dis,Hlth Minist,Union Hosp, Wuhan 430074, Peoples R China.	zsn0928@163.com; shihuanzhong@sina.com		Zhang, Jianchu/0000-0002-8731-6600	National Basic Research Program of China (973 Program) [National Basic Research Program of China (973 Program 2012CB518706]; National Science Fund for Distinguished Young Scholars of China [30925032]; 12th Five-Year National Science and Technology Program of Social Development, Ministry of Science and Technology, China [2012BAI05B02]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 12th Five-Year National Science and Technology Program of Social Development, Ministry of Science and Technology, China	This work was supported in part by a grant from National Basic Research Program of China (973 Program 2012CB518706); in part by a grant from National Science Fund for Distinguished Young Scholars (No. 30925032) of China; and in part by a grant from the 12th Five-Year National Science and Technology Program of Social Development, Ministry of Science and Technology, China (No. 2012BAI05B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONY VB, 1985, J CLIN INVEST, V76, P1514, DOI 10.1172/JCI112131; ANTONY VB, 1983, ACTA CYTOL, V27, P355; BARNES PF, 1989, J IMMUNOL, V142, P1114; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; O'Dwyer MJ, 2008, INTENS CARE MED, V34, P683, DOI 10.1007/s00134-007-0968-5; Pearl JE, 2004, J IMMUNOL, V173, P7490, DOI 10.4049/jimmunol.173.12.7490; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Qin XJ, 2009, CLIN CANCER RES, V15, P2231, DOI 10.1158/1078-0432.CCR-08-2641; Robinson CM, 2008, J INFECT DIS, V198, P359, DOI 10.1086/589774; Sahn SA, 2008, TXB PLEURAL DIS, P209; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; Villena V, 2002, ARCH BRONCONEUMOL, V38, P21, DOI 10.1016/S0300-2896(02)75142-9; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Ye ZJ, 2011, CLIN VACCINE IMMUNOL, V18, P1608, DOI 10.1128/CVI.05214-11; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445; Zhang JD, 2011, J IMMUNOL, V186, P5885, DOI 10.4049/jimmunol.1003447	30	43	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40450	10.1371/journal.pone.0040450	http://dx.doi.org/10.1371/journal.pone.0040450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	22792330	Green Published, gold, Green Submitted			2022-12-25	WOS:000306354700052
J	Chia, BS; Lanzas, F; Rifat, D; Herrera, A; Kim, EY; Sailer, C; Torres-Chavolla, E; Narayanaswamy, P; Einarsson, V; Bravo, J; Pascale, JM; Ioerger, TR; Sacchettini, JC; Karakousis, PC				Chia, Bing-Shao; Lanzas, Fedora; Rifat, Dalin; Herrera, Aubrey; Kim, Elizabeth Y.; Sailer, Christine; Torres-Chavolla, Edith; Narayanaswamy, Purvaja; Einarsson, Viktor; Bravo, Jaime; Pascale, Juan M.; Ioerger, Thomas R.; Sacchettini, James C.; Karakousis, Petros C.			Use of Multiplex Allele-Specific Polymerase Chain Reaction (MAS-PCR) to Detect Multidrug-Resistant Tuberculosis in Panama	PLOS ONE			English	Article							ARYLAMINE N-ACETYLTRANSFERASE; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; DRUG-RESISTANCE; RIFAMPIN-RESISTANT; RPOB MUTATIONS; GENE; KATG; PREVALENCE; STRAINS	The frequency of individual genetic mutations conferring drug resistance (DR) to Mycobacterium tuberculosis has not been studied previously in Central America, the place of origin of many immigrants to the United States. The current gold standard for detecting multidrug-resistant tuberculosis (MDR-TB) is phenotypic drug susceptibility testing (DST), which is resource-intensive and slow, leading to increased MDR-TB transmission in the community. We evaluated multiplex allele-specific polymerase chain reaction (MAS-PCR) as a rapid molecular tool to detect MDR-TB in Panama. Based on DST, 67 MDR-TB and 31 drug-sensitive clinical isolates were identified and cultured from an archived collection. Primers were designed to target five mutation hotspots that confer resistance to the first-line drugs isoniazid and rifampin, and MAS-PCR was performed. Whole-genome sequencing confirmed DR mutations identified by MAS-PCR, and provided frequencies of genetic mutations. DNA sequencing revealed 70.1% of MDR strains to have point mutations at codon 315 of the katG gene, 19.4% within mabA-inhA promoter, and 98.5% at three hotspots within rpoB. MAS-PCR detected each of these mutations, yielding 82.8% sensitivity and 100% specificity for isoniazid resistance, and 98.4% sensitivity and 100% specificity for rifampin resistance relative to DST. The frequency of individual DR mutations among MDR strains in Panama parallels that of other TB-endemic countries. The performance of MAS-PCR suggests that it may be a relatively inexpensive and technically feasible method for rapid detection of MDR-TB in developing countries.	[Chia, Bing-Shao; Rifat, Dalin; Herrera, Aubrey; Sailer, Christine; Torres-Chavolla, Edith; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lanzas, Fedora; Bravo, Jaime; Pascale, Juan M.] ICGES, Dept Genom & Prote, Panama City, Panama; [Kim, Elizabeth Y.; Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Narayanaswamy, Purvaja; Einarsson, Viktor; Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci, College Stn, TX 77843 USA; [Sacchettini, James C.] Texas A&M Univ, Dept Biochem Biophys, College Stn, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Chia, BS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Chia, Bing Shao/GYJ-4068-2022; Karakousis, Petros Constantine/AAR-7899-2020	Chia, Bing Shao/0000-0003-0101-5805; Rifat, Dalin/0000-0002-8918-5173	Johns Hopkins Center for Global Health faculty pilot grant; NIH [AI083125, HL106786]	Johns Hopkins Center for Global Health faculty pilot grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Johns Hopkins Center for Global Health faculty pilot grant and NIH grants AI083125 and HL106786 to PCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev MV, 2007, J ANTIMICROB CHEMOTH, V59, P1057, DOI 10.1093/jac/dkm086; [Anonymous], 2008, TECHN P BACT DIAGN T; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Cavusoglu C, 2002, J CLIN MICROBIOL, V40, P4435, DOI 10.1128/JCM.40.12.4435-4438.2002; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; DeVito JA, 2003, ANTIMICROB AGENTS CH, V47, P188, DOI 10.1128/AAC.47.1.188-195.2003; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gegia M, 2008, ANTIMICROB AGENTS CH, V52, P725, DOI 10.1128/AAC.01124-07; Hofling CC, 2005, INT J TUBERC LUNG D, V9, P87; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Karakousis PC, 2009, INFECT DIS-SER, P271, DOI 10.1007/978-1-59745-180-2_24; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; O'Brien RJ, 2001, AM J RESP CRIT CARE, V163, P1055, DOI 10.1164/ajrccm.163.5.2007122; Pan American Health Organization, MAN BACT DIAGN TUB S; Park YK, 2005, J MICROBIOL METH, V63, P165, DOI 10.1016/j.mimet.2005.03.002; Payton M, 1999, J BACTERIOL, V181, P1343, DOI 10.1128/JB.181.4.1343-1347.1999; Qian LS, 2002, J CLIN MICROBIOL, V40, P1091, DOI 10.1128/JCM.40.3.1091-1094.2002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2004, J MED MICROBIOL, V53, P107, DOI 10.1099/jmm.0.05343-0; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sandy J, 2002, J MOL BIOL, V318, P1071, DOI 10.1016/S0022-2836(02)00141-9; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Tho DQ, 2008, INT J TUBERC LUNG D, V12, P1306; US Census Bureau, C2010BR04 US CENS BU; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; World Health Organisation, 2011, WHOHTMTB201116; Yang ZH, 2005, DIAGN MICR INFEC DIS, V53, P201, DOI 10.1016/j.diagmicrobio.2005.06.007; Yue J, 2003, J CLIN MICROBIOL, V41, P2209, DOI 10.1128/JCM.41.5.2209-2212.2003; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	34	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40456	10.1371/journal.pone.0040456	http://dx.doi.org/10.1371/journal.pone.0040456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792333	Green Published, gold, Green Submitted			2022-12-25	WOS:000306461800089
J	Markovic, D; Freyhof, J; Wolter, C				Markovic, Danijela; Freyhof, Joerg; Wolter, Christian			Where Are All the Fish: Potential of Biogeographical Maps to Project Current and Future Distribution Patterns of Freshwater Species	PLOS ONE			English	Article							CLIMATE-CHANGE; IMPACTS; TEMPERATURE; RESOLUTION; MODELS; SHIFTS; RANGE	The dendritic structure of river networks is commonly argued against use of species atlas data for modeling freshwater species distributions, but little has been done to test the potential of grid-based data in predictive species mapping. Using four different niche-based models and three different climate change projections for the middle of the 21st century merged pairwise as well as within a consensus modeling framework, we studied the variability in current and future distribution patterns of 38 freshwater fish species across Germany. We used grid-based (11 x 11 km) fish distribution maps and numerous climatic, topographic, hydromorphologic, and anthropogenic factors derived from environmental maps at a finer scale resolution (250 m-1 km). Apart from the explicit predictor selection, our modeling framework included uncertainty estimation for all phases of the modeling process. We found that the predictive performance of some niche-based models is excellent independent of the predictor data set used, emphasizing the importance of a well-grounded predictor selection process. Though important, climate was not a primary key factor for any of the studied fish species groups, in contrast to substrate preferences, hierarchical river structure, and topography. Generally, distribution ranges of cold-water and warm-water species are expected to change significantly in the future; however, the extent of changes is highly uncertain. Finally, we show that the mismatch between the current and future ranges of climatic variables of more than 90% is the most limiting factor regarding reliability of our future estimates. Our study highlighted the underestimated potential of grid cell information in biogeographical modeling of freshwater species and provides a comprehensive modeling framework for predictive mapping of species distributions and evaluation of the associated uncertainties.	[Markovic, Danijela; Freyhof, Joerg; Wolter, Christian] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Markovic, D (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany.	markovic@igb-berlin.de	Wolter, Christian/F-6210-2014	Wolter, Christian/0000-0002-2819-2900	European Commission BIOFRESH project - Biodiversity of Freshwater Ecosystems: Status, Trends, Pressures, and Conservation Priorities (7th FWP) [226874]	European Commission BIOFRESH project - Biodiversity of Freshwater Ecosystems: Status, Trends, Pressures, and Conservation Priorities (7th FWP)	Current research is funded by the European Commission BIOFRESH project - Biodiversity of Freshwater Ecosystems: Status, Trends, Pressures, and Conservation Priorities (7th FWP ref. 226874), http://www.freshwaterbiodiversity.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; Borgstrom R, 2005, ECOL FRESHW FISH, V14, P375, DOI 10.1111/j.1600-0633.2005.00112.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Buisson L, 2008, ECOL FRESHW FISH, V17, P244, DOI 10.1111/j.1600-0633.2007.00276.x; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Buisson L, 2009, DIVERS DISTRIB, V15, P613, DOI 10.1111/j.1472-4642.2009.00565.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x; Daufresne M, 2007, GLOBAL CHANGE BIOL, V13, P2467, DOI 10.1111/j.1365-2486.2007.01449.x; de Jager AL, 2010, HYDROLOG SCI J, V55, P661, DOI 10.1080/02626667.2010.490786; Franklin J, 2009, MAPPING SPECIES DIST; Goldstein RM, 2004, T AM FISH SOC, V133, P971, DOI 10.1577/T03-080.1; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kottelat M, 2007, HDB EUROPEAN FRESHWA; Lassalle G, 2009, FRESHWATER BIOL, V54, P587, DOI 10.1111/j.1365-2427.2008.02135.x; Lassalle G, 2008, BIOL CONSERV, V141, P1105, DOI 10.1016/j.biocon.2008.02.010; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Limburg KE, 2009, BIOSCIENCE, V59, P955, DOI 10.1525/bio.2009.59.11.7; Logez M, 2012, ECOL FRESHW FISH, V21, P266, DOI 10.1111/j.1600-0633.2011.00545.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Nelson KC, 2009, J APPL ECOL, V46, DOI 10.1111/j.1365-2664.2008.01599.x; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Pankhurst NW, 2010, J FISH BIOL, V76, P69, DOI 10.1111/j.1095-8649.2009.02484.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pottgiesser T, 2004, HDB LIMNOLOGIE, V19, p[; Rahel FJ, 2008, CONSERV BIOL, V22, P551, DOI 10.1111/j.1523-1739.2008.00953.x; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; TURC L., 1961, Annales Agronomiques, V12, P13; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wang LZ, 2006, AM FISH S S, V48, P1; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	47	40	40	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40530	10.1371/journal.pone.0040530	http://dx.doi.org/10.1371/journal.pone.0040530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792361	Green Published, Green Submitted, gold			2022-12-25	WOS:000306461800102
J	Seo, M; Oh, S				Seo, Minseok; Oh, Sejong			CBFS: High Performance Feature Selection Algorithm Based on Feature Clearness	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; CANCER; CLASSIFICATION	Background: The goal of feature selection is to select useful features and simultaneously exclude garbage features from a given dataset for classification purposes. This is expected to bring reduction of processing time and improvement of classification accuracy. Methodology: In this study, we devised a new feature selection algorithm (CBFS) based on clearness of features. Feature clearness expresses separability among classes in a feature. Highly clear features contribute towards obtaining high classification accuracy. CScore is a measure to score clearness of each feature and is based on clustered samples to centroid of classes in a feature. We also suggest combining CBFS and other algorithms to improve classification accuracy. Conclusions/Significance: From the experiment we confirm that CBFS is more excellent than up-to-date feature selection algorithms including FeaLect. CBFS can be applied to microarray gene selection, text categorization, and image classification.	[Seo, Minseok] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; Dankook Univ, WCU Res Ctr Nanobiomed Sci, Cheonan, South Korea	Dankook University; Dankook University	Seo, M (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.	sejongoh@dankook.ac.kr			World Class University (WCU) project of the Ministry of Education, Science & Technology (MEST) [R31-2008-000-10069-0]; Korea Science and Engineering Foundation (KOSEF)	World Class University (WCU) project of the Ministry of Education, Science & Technology (MEST); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	This study was supported by grant No. R31-2008-000-10069-0 from the World Class University (WCU) project of the Ministry of Education, Science & Technology (MEST) and the Korea Science and Engineering Foundation (KOSEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengio Y, 2004, J MACH LEARN RES, V5, P1089; BERRAR D. P., 2009, PRACTICAL APPROACH M; Blake C.L., 1998, UCI REPOSITORY MACHI; Chang C.C., 2005, LIBSVM LIB SUPPORT V; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Ding C., 2003, P IEEE COMP SOC C BI, V523; Fawcett T., 2004, ROC GRAPHS NOTES PRA; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GORMAN RP, 1988, NEURAL NETWORKS, V1, P75, DOI 10.1016/0893-6080(88)90023-8; Guyon I, 2007, PATTERN RECOGN LETT, V28, P1438, DOI 10.1016/j.patrec.2007.02.014; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Kononenko I, 1995, CISM COURSES LECT, V363; Liang JN, 2008, PATTERN RECOGN, V41, P1429, DOI 10.1016/j.patcog.2007.10.018; Notterman DA, 2001, CANCER RES, V61, P3124; Oh S, 2011, COMPUT BIOL MED, V41, P115, DOI 10.1016/j.compbiomed.2010.12.006; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Wainwright MJ, 2009, IEEE T INFORM THEORY, V55, P2183, DOI 10.1109/TIT.2009.2016018; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Winarko E, DATA MINING; Zare H., 2010, FEALECT FEATURE SELE	23	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40419	10.1371/journal.pone.0040419	http://dx.doi.org/10.1371/journal.pone.0040419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792310	gold, Green Published, Green Submitted			2022-12-25	WOS:000306461800079
J	Yan, P; Zhu, XZ; Li, HM; Shrubsole, MJ; Shi, HM; Zhang, MZ; Harris, RC; Hao, CM; Dai, Q				Yan, Ping; Zhu, Xiangzhu; Li, Haiming; Shrubsole, Martha J.; Shi, Haiming; Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming; Dai, Qi			Association of High Blood Pressure with Renal Insufficiency: Role of Albuminuria, from NHANES, 1999-2006	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CREATININE; NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; POSITION STATEMENT; HYPERTENSION; PROGRESSION; PROTEINURIA; PREVALENCE; MORTALITY	Background: The relationship between hypertension and kidney disease is complicated. Clinical trials found intense blood pressure control was not associated with alterations in glomerular filtration rate (GFR) in all patients but did slow the rate of GFR decline among those with a higher baseline proteinuria. However, the underlying mechanism has been unclear. Methods: We tested the hypothesis that the association between high blood pressure and renal function is modified by albuminuria status by conducting analyses in a cross-sectional study with 12,440 adult participants without known kidney diseases, diabetes or cardiovascular diseases, participating in the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Results: 1226 out of 12440 were found to have unknown high blood pressure and 4494 were found to have reduced renal function. Overall, a moderate association was found between high blood pressure and renal function insufficiency in all participants analyzed. However, among participants with albuminuria, the prevalence of moderate-severe renal insufficiency substantially and progressively increased from normal subjects to prehypertensive and undiagnosed hypertensive subjects (1.43%, 3.44%, 10.96%, respectively, P for trend <0.0001); on the other hand, the prevalence of undiagnosed hypertension was also significantly higher among subjects with moderate-severe renal insufficiency than those with mild renal insufficiency (35.54% Vs 19.09%, P value <0.05), supporting an association between hypertension and renal function damage. In contrast, no association between hypertension and renal insufficiency was observed among those without albuminuria in this population. Similar findings were observed when the CKD-EPI equation was used. Conclusions: The association between high blood pressure and reduced renal function could be dependent upon the albuminuria status. This finding may provide a possible explanation for results observed in clinical trials of intensive blood pressure control. Further studies are warranted to confirm our findings.	[Yan, Ping; Shi, Haiming] Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China; [Li, Haiming; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Yan, Ping; Zhu, Xiangzhu; Shrubsole, Martha J.; Dai, Qi] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN USA	Fudan University; Fudan University; Vanderbilt University; Vanderbilt University	Yan, P (corresponding author), Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China.	qi.dai@vanderbilt.edu	Shrubsole, Martha J/K-5052-2015; Zhu, Xiangzhu/ABB-5787-2021; Zhu, Xiao-Shan/B-2179-2015	Shrubsole, Martha J/0000-0002-5591-7575; Zhu, Xiangzhu/0000-0002-4462-8815; Zhu, Xiao-Shan/0000-0003-1223-1415	International Society of Nephrology; Vanderbilt Epidemiology Center	International Society of Nephrology; Vanderbilt Epidemiology Center	This work is partially supported by the International Fellowship Program of the International Society of Nephrology (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Drs. Qi Dai and Xiangzhu Zhu's effort was supported by the Vanderbilt Epidemiology Center's development fund. No additional external funding received for this study.	[Anonymous], 2004, AM J KIDNEY DIS, V43, pS14, DOI 10.1053/j/ajkd.2004.03.004; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Barri Yousri M, 2006, Curr Cardiol Rep, V8, P411, DOI 10.1007/s11886-006-0098-7; Bidani AK, 2011, NAT REV NEPHROL, V7, P128, DOI 10.1038/nrneph.2010.168; CHAVERS BM, 1984, KIDNEY INT, V25, P576, DOI 10.1038/ki.1984.57; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Di Angelantonio Emanuele, 2010, BMJ, V341, pc4986, DOI 10.1136/bmj.c4986; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P308, DOI 10.1097/MNH.0b013e328337bbbe; Hamm LL, 2010, AM J MED SCI, V340, P30, DOI 10.1097/MAJ.0b013e3181e590f0; Islam TM, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-17; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; Kalaitzidis RG, 2010, KIDNEY INT, V77, P194, DOI 10.1038/ki.2009.439; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; National Center for Health Statistics. Centers for Disease Control and Prevention, CTR DIS CONTR PREV N; National Health and Nutrition Examination Survey, 2003, PHYS EX PROC MAN; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Population Division US Census Bureau, 2007, NCEST200601 US BUR C; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Sabanayagam C, 2011, ASIA-PAC J PUBLIC HE, V23, P936, DOI 10.1177/1010539510361637; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Segura J, 2011, ADV CHRONIC KIDNEY D, V18, P23, DOI 10.1053/j.ackd.2010.11.001; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; Upadhyay A, 2011, ANN INTERN MED, V154, P541, DOI 10.7326/0003-4819-154-8-201104190-00335; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572	46	81	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e37837	10.1371/journal.pone.0037837	http://dx.doi.org/10.1371/journal.pone.0037837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	23029464	gold, Green Published, Green Submitted			2022-12-25	WOS:000306186900001
J	Borges, JC; Seraphim, TV; Mokry, DZ; Almeida, FCL; Cyr, DM; Ramos, CHI				Borges, Julio C.; Seraphim, Thiago V.; Mokry, David Z.; Almeida, Fabio C. L.; Cyr, Douglas M.; Ramos, Carlos H. I.			Identification of Regions Involved in Substrate Binding and Dimer Stabilization within the Central Domains of Yeast Hsp40 Sis1	PLOS ONE			English	Article							MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; DNAK CHAPERONE; HSP70; PROTEIN; YDJ1; ULTRACENTRIFUGATION; SPECTROSCOPY; AGGREGATION; SPECIFICITY	Protein folding, refolding and degradation are essential for cellular life and are regulated by protein homeostatic processes such those that involve the molecular chaperone DnaK/Hsp70 and its co-chaperone DnaJ. Hsp70 action is initiated when proteins from the DnaJ family bind an unfolded protein for delivery purposes. In eukaryotes, the DnaJ family can be divided into two main groups, Type I and Type II, represented by yeast cytosolic Ydj1 and Sis1, respectively. Although sharing some unique features both members of the DnaJ family, Ydj1 and Sis1 are structurally and functionally distinct as deemed by previous studies, including the observation that their central domains carry the structural and functional information even in switched chimeras. In this study, we combined several biophysical tools for evaluating the stability of Sis1 and mutants that had the central domains (named Gly/Met rich domain and C-terminal Domain I) deleted or switched to those of Ydj1 to gain insight into the role of these regions in the structure and function of Sis1. The mutants retained some functions similar to full length wild-type Sis1, however they were defective in others. We found that: 1) Sis1 unfolds in at least two steps as follows: folded dimer to partially folded monomer and then to an unfolded monomer. 2) The Gly/Met rich domain had intrinsically disordered characteristics and its deletion had no effect on the conformational stability of the protein. 3) The deletion of the C-terminal Domain I perturbed the stability of the dimer. 4) Exchanging the central domains perturbed the conformational stability of the protein. Altogether, our results suggest the existence of two similar subdomains in the C-terminal domain of DnaJ that could be important for stabilizing each other in order to maintain a folded substrate-binding site as well as the dimeric state of the protein.	[Seraphim, Thiago V.; Mokry, David Z.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil; [Borges, Julio C.; Seraphim, Thiago V.] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil; [Seraphim, Thiago V.] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil; [Almeida, Fabio C. L.] Natl Ctr Nucl Magnet Resonance Macromol UFRJ, Inst Med Biochem, Rio De Janeiro, Brazil; [Almeida, Fabio C. L.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Cyr, Douglas M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of North Carolina; University of North Carolina Chapel Hill	Ramos, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil.	cramos@iqm.unicamp.br	Ramos, CH/C-1571-2012; Almeida, Fabio/O-4989-2018; Borges, Julio C/C-6160-2008; Seraphim, Thiago V/J-9949-2013; Portes Santos, Claudia/D-5093-2009	Ramos, CH/0000-0002-7246-9081; Almeida, Fabio/0000-0001-6046-7006; Borges, Julio C/0000-0003-4856-748X; Santos, Helena/0000-0002-5240-5662; Monteiro-Neto, Cassiano/0000-0001-9342-8089; Cyr, Douglas/0000-0002-4928-3414; Vargas Seraphim, Thiago/0000-0002-8682-8962; Portes Santos, Claudia/0000-0001-5165-0853	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981, R01GM067785] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the agencies that funded this work through grants, namely, the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - www.fapesp.br) and Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq - www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges JC, 2011, CURR MED CHEM, V18, P1276; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; da Silva KP, 2011, PROTEIN PEPTIDE LETT, V18, P132; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156; Ramos CHI, 1999, BIOCHEMISTRY-US, V38, P9783, DOI 10.1021/bi9828627; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]	31	41	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50927	10.1371/journal.pone.0050927	http://dx.doi.org/10.1371/journal.pone.0050927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	22792329	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200082
J	Sim, SC; Durstewitz, G; Plieske, J; Wieseke, R; Ganal, MW; Van Deynze, A; Hamilton, JP; Buell, CR; Causse, M; Wijeratne, S; Francis, DM				Sim, Sung-Chur; Durstewitz, Gregor; Plieske, Joerg; Wieseke, Ralf; Ganal, Martin W.; Van Deynze, Allen; Hamilton, John P.; Buell, C. Robin; Causse, Mathilde; Wijeratne, Saranga; Francis, David M.			Development of a Large SNP Genotyping Array and Generation of High-Density Genetic Maps in Tomato	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; LYCOPERSICON-PENNELLII; DISEASE RESISTANCE; CULTIVATED TOMATO; GENOMIC SELECTION; LINKAGE MAPS; DISCOVERY; MARKERS; POLYMORPHISM; LOCI	The concurrent development of high-throughput genotyping platforms and next generation sequencing (NGS) has increased the number and density of genetic markers, the efficiency of constructing detailed linkage maps, and our ability to overlay recombination and physical maps of the genome. We developed an array for tomato with 8,784 Single Nucleotide Polymorphisms (SNPs) mainly discovered based on NGS-derived transcriptome sequences. Of the SNPs, 7,720 (88%) passed manufacturing quality control and could be scored in tomato germplasm. The array was used to generate high-density linkage maps for three interspecific F-2 populations: EXPEN 2000 (Solanum lycopersicum LA0925 x S. pennellii LA0716, 79 individuals), EXPEN 2012 (S. lycopersicum Moneymaker x S. pennellii LA0716, 160 individuals), and EXPIM 2012 (S. lycopersicum Moneymaker x S. pimpinellifolium LA0121, 183 individuals). The EXPEN 2000-SNP and EXPEN 2012 maps consisted of 3,503 and 3,687 markers representing 1,076 and 1,229 unique map positions (genetic bins), respectively. The EXPEN 2000-SNP map had an average marker bin interval of 1.6 cM, while the EXPEN 2012 map had an average bin interval of 0.9 cM. The EXPIM 2012 map was constructed with 4,491 markers (1,358 bins) and an average bin interval of 0.8 cM. All three linkage maps revealed an uneven distribution of markers across the genome. The dense EXPEN 2012 and EXPIM 2012 maps showed high levels of colinearity across all 12 chromosomes, and also revealed evidence of small inversions between LA0716 and LA0121. Physical positions of 7,666 SNPs were identified relative to the tomato genome sequence. The genetic and physical positions were mostly consistent. Exceptions were observed for chromosomes 3, 10 and 12. Comparing genetic positions relative to physical positions revealed that genomic regions with high recombination rates were consistent with the known distribution of euchromatin across the 12 chromosomes, while very low recombination rates were observed in the heterochromatic regions.	[Sim, Sung-Chur; Francis, David M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Durstewitz, Gregor; Plieske, Joerg; Wieseke, Ralf; Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Van Deynze, Allen] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Causse, Mathilde] INRA, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France; [Wijeratne, Saranga] Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol Cellular & Imagining Ctr, Wooster, OH 44691 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; Michigan State University; INRAE; University System of Ohio; Ohio State University	Sim, SC (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	francis.77@osu.edu	Panthee, Dilip/AAH-2974-2022; Francis, David/B-7262-2012; Panthee, Dilip/CAF-8991-2022; Wijeratne, Saranga/I-5341-2016; Causse, Mathilde/AAF-6555-2020; Panthee, Dilip/AFM-0574-2022; Hamilton, John P/G-1379-2016	Panthee, Dilip/0000-0002-8736-512X; Wijeratne, Saranga/0000-0002-9782-4406; Panthee, Dilip/0000-0002-8736-512X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Sim, Sung-Chur/0000-0001-7672-6260; Stoffel, Karl/0000-0003-4431-3626; Francis, David/0000-0003-2016-1357	United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA) [2008-55300-04757, 2009-85606-05673]; German Federal Ministry of Education and Research (BMBF) [0315639A]; Agropolis Fondation; French foundation for Agricultural Sciences and Sustainable Development	United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA)(United States Department of Agriculture (USDA)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Agropolis Fondation; French foundation for Agricultural Sciences and Sustainable Development	This work was supported by a grant from the United States Department of Agriculture/National Institute of Food and Agriculture (USDA/NIFA) (2008-55300-04757 and 2009-85606-05673). Work at TraitGenetics was supported by the German Federal Ministry of Education and Research (BMBF) through grant number 0315639A. INRA SNPs were obtained from the INRA AIP Bioresources and from the ARCAD sub-project "Comparative population genomics''. ARCAD (Agropolis Resource Center for Crop Conservation, Adaptation and Diversity) is funded (2009-2013) by the Agropolis Fondation, the French foundation for Agricultural Sciences and Sustainable Development (www.arcad-project.org and www.agropolis-fondation.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2010, CYTOGENET GENOME RES, V129, P24, DOI 10.1159/000313850; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bundock PC, 2009, PLANT BIOTECHNOL J, V7, P347, DOI 10.1111/j.1467-7652.2009.00401.x; CHETELAT RT, 1991, THEOR APPL GENET, V82, P704, DOI 10.1007/BF00227314; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; ESHED Y, 1995, GENETICS, V141, P1147; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Frary A, 1996, MOL GEN GENET, V250, P295, DOI 10.1007/BF02174387; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Meuwissen THE, 2001, GENETICS, V157, P1819; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHERMAN JD, 1992, GENOME, V35, P354, DOI 10.1139/g92-054; Shirasawa K, 2010, DNA RES, V17, P381, DOI 10.1093/dnares/dsq024; Sim SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-466; Stack SM, 2009, CYTOGENET GENOME RES, V124, P339, DOI 10.1159/000218137; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; TANKSLEY SD, 1992, GENETICS, V132, P1141; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; van der Knaap E, 2004, GENETICS, V168, P2127, DOI 10.1534/genetics.104.031013; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y	48	272	283	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40563	10.1371/journal.pone.0040563	http://dx.doi.org/10.1371/journal.pone.0040563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22802968	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500057
J	Villani, A; Frigessi, A; Liljeros, F; Nordvik, MK; de Blasio, BF				Villani, Antonella; Frigessi, Arnoldo; Liljeros, Fredrik; Nordvik, Monica K.; de Blasio, Birgitte Freiesleben			A Characterization of Internet Dating Network Structures among Nordic Men Who Have Sex with Men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; PARTNERS; ONLINE; RISK; PREFERENCES	Background: The Internet has become an important venue for seeking sexual partners and may facilitate transmission of sexually transmitted infections. Methods: We examined a 64-day data log of flirt messages expressing sexual interest among MSM within the Qruiser. com community. We used logistic regression to analyze characteristics of MSM sending and receiving flirt messages and negative binomial regression to examine individual activity and popularity. The structural properties, including the core structure of the flirt network, were analyzed. Results: The MSM population consisted of approximately 40% homosexuals and 37% bisexuals, while the remaining 23% included men who identified as heterosexual but searched for sex with men and "experimental". MSM were more likely to send flirt messages if they were homosexual and aged 40+ years; young people aged, 30 years were more likely to receive a flirt. Possession of a webcam was strongly associated with both sending flirt messages and being a flirt target. The distributions of flirts sent (max k(out) = 2162) and received (max k(in) = 84) were highly heterogeneous. Members in central cores were more likely homosexuals, singles, and aged 31-40 years. The probability of a matched flirt (flirt returned from target) increased from 1% in the outer core to 18% in the central core (core size = 4). Discussion: The flirt network showed high degree heterogeneity similar to the structural properties of real sexual contact networks with a single central core. Further studies are needed to explore use of webcam for Internet dating.	[Villani, Antonella] Univ Aquila, Dept Math, I-67100 Laquila, Italy; [Frigessi, Arnoldo; de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Liljeros, Fredrik; Nordvik, Monica K.] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Liljeros, Fredrik] Inst Future Studies, Stockholm, Sweden; [Nordvik, Monica K.] Mid Sweden Univ, Dept Social Work, Ostersund, Sweden; [de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway	University of L'Aquila; University of Oslo; Stockholm University; Institute for Futures Studies; Mid-Sweden University; Norwegian Institute of Public Health (NIPH)	Villani, A (corresponding author), Univ Aquila, Dept Math, I-67100 Laquila, Italy.	birgitte.deblasio@basalmed.uio.no	Liljeros, Fredrik G I/I-2667-2018	Liljeros, Fredrik G I/0000-0001-8642-6624; Frigessi, Arnoldo/0000-0001-7103-7589; Norkko, Joanna/0000-0001-9885-8408; Villnas, Anna/0000-0003-3077-929X	Norwegian Research Council [166056/V50]; Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Norwegian Research Council(Research Council of NorwayEuropean Commission); Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Birgitte Freiesleben de Blasio was supported by the Norwegian Research Council (Projects 166056/V50). Fredrik Liljeros was supported by Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no external funding sources for this study.	Al-Tayyib AA, 2009, SEX TRANSM INFECT, V85, P216, DOI 10.1136/sti.2008.032631; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bull SS, 2000, SEX TRANSM DIS, V27, P545, DOI 10.1097/00007435-200010000-00008; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Daneback K, 2005, ARCH SEX BEHAV, V34, P321, DOI 10.1007/s10508-005-3120-z; Daneback K, 2007, CYBERPSYCHOL BEHAV, V10, P100, DOI 10.1089/cpb.2006.9986; de Nooy W, 2005, EXPLORATIVE SOCIAL N; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Fiore ART, 2004, THESIS MIT; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Gobrogge KL, 2007, ARCH SEX BEHAV, V36, P717, DOI 10.1007/s10508-007-9216-x; Kim AA, 2001, J ACQ IMMUN DEF SYND, V28, P89; Klausner JD, 2000, JAMA-J AM MED ASSOC, V284, P447, DOI 10.1001/jama.284.4.447; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mustanski BS, 2007, AIDS CARE, V19, P822, DOI 10.1080/09540120701237244; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ross MW, 2005, CYBERPSYCHOL BEHAV, V8, P131, DOI 10.1089/cpb.2005.8.131; Sautter JM, 2010, SOC SCI QUART, V91, P554, DOI 10.1111/j.1540-6237.2010.00707.x; Silverthorne ZA, 2000, ARCH SEX BEHAV, V29, P67, DOI 10.1023/A:1001886521449; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295	22	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39717	10.1371/journal.pone.0039717	http://dx.doi.org/10.1371/journal.pone.0039717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808052	Green Submitted, Green Published, gold			2022-12-25	WOS:000306406700011
J	Lee, MS; Jung, JI; Kwon, SH; Lee, SM; Morita, K; Her, S				Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Lee, Sang-Mok; Morita, Kyoji; Her, Song			TIMP-2 Fusion Protein with Human Serum Albumin Potentiates Anti-Angiogenesis-Mediated Inhibition of Tumor Growth by Suppressing MMP-2 Expression	PLOS ONE			English	Article							TISSUE INHIBITOR; IN-VIVO; MATRIX-METALLOPROTEINASE; CELL-PROLIFERATION; ESCHERICHIA-COLI; DOWN-REGULATION; APOPTOSIS; ACTIVATION; CANCER; THERAPY	TIMP-2 protein has been intensively studied as a promising anticancer candidate agent, but the in vivo mechanism underlying its anticancer effect has not been clearly elucidated by previous works. In this study, we investigated the mechanism underlying the anti-tumor effects of a TIMP-2 fusion protein conjugated with human serum albumin (HSA/TIMP-2). Systemic administration of HSA/TIMP-2 effectively inhibited tumor growth at a minimum effective dose of 60 mg/kg. The suppressive effect of HSA/TIMP-2 was accompanied by a marked reduction of in vivo vascularization. The anti-angiogenic activity of HSA/TIMP-2 was directly confirmed by CAM assays. In HSA/TIMP-2-treated tumor tissues, MMP-2 expression was profoundly decreased without a change in MT1-MMP expression of PECAM-1-positive cells. MMP-2 mRNA was also decreased by HSA/TIMP-2 treatment of human umbilical vein endothelial cells. Zymographic analysis showed that HSA/TIMP-2 substantially decreased extracellular pro-MMP-2 activity (94-99% reduction) and moderately decreased active MMP-2 activity (10-24% reduction), suggesting MT1-MMP-independent MMP-2 modulation. Furthermore, HSA/TIMP-2 had no effect on in vitro active MMP-2 activity and in vivo MMP-2 activity. These studies show that HSA/TIMP-2 potentiates anti-angiogenic activity by modulating MMP-2 expression, but not MMP-2 activity, to subsequently suppress tumor growth, suggesting an important role for MMP-2 expression rather than MMP-2 activity in anti-angiogenesis.	[Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Her, Song] Korea Basic Sci Inst, Chuncheon Ctr, Div Bioimaging, Chunchon, South Korea; [Lee, Sang-Mok] BiocurePharm, Daejeon Bio Venture Town, Taejon, South Korea; [Morita, Kyoji] Shikoku Univ, Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima, Japan	Korea Basic Science Institute (KBSI)	Lee, MS (corresponding author), Kyung Hee Univ, Coll Oriental Med, Dept Basic Oriental Med Sci, Seoul, South Korea.	swher@kbsi.re.kr		CORBETTA, MAURIZIO/0000-0001-8295-3304	Korea Basic Science Institute grant [T31901]	Korea Basic Science Institute grant	This study was supported by a Korea Basic Science Institute grant (T31901) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JS, 1992, J CLIN PATHOL, V45, P1116, DOI 10.1136/jcp.45.12.1116; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hajitou A, 2001, CANCER RES, V61, P3450; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Imren S, 1996, CANCER RES, V56, P2891; Itoh T, 1998, CANCER RES, V58, P1048; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kang WK, 2007, PROTEIN EXPRES PURIF, V53, P331, DOI 10.1016/j.pep.2007.02.001; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kwon GT, 2011, J NUTR BIOCH; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee Mi-Sook, 2010, [Journal of Life Science, 생명과학회지], V20, P1738; Lee MS, 2011, J PHARM PHARM SCI, V14, P368, DOI 10.18433/J3H88D; Lee MS, 2010, BIOCHEM BIOPH RES CO, V394, P348, DOI 10.1016/j.bbrc.2010.03.009; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Morita K, 2009, J MOL NEUROSCI, V38, P31, DOI 10.1007/s12031-008-9156-5; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; NEGRO A, 1995, FEBS LETT, V360, P52, DOI 10.1016/0014-5793(95)00073-I; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Park JY, 2009, ANAL BIOCHEM, V394, P217, DOI 10.1016/j.ab.2009.07.040; Preaux AM, 2002, HEPATOLOGY, V36, P615, DOI 10.1053/jhep.2002.35279; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shapiro S, 2010, AM J PHYSIOL-CELL PH, V298, pC942, DOI 10.1152/ajpcell.00305.2009; Steinbrenner H, 2003, BIOCHEM BIOPH RES CO, V308, P486, DOI 10.1016/S0006-291X(03)01430-X; STETLERSTEVENSON WG, 1990, J BIOL CHEM, V265, P13933; Storgard Chris, 2004, V294, P123; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617; VAUPEL P, 1989, CANCER RES, V49, P6449; Williamson RA, 2000, METH MOL B, V151, P257, DOI 10.1385/1-59259-046-2:257; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yi Y, 2005, CURR GENE THER, V5, P25, DOI 10.2174/1566523052997514	57	152	154	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35710	10.1371/journal.pone.0035710	http://dx.doi.org/10.1371/journal.pone.0035710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22792291	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343200051
J	Li, ZH; Lu, CX; Peng, B; Zeng, H; Zhou, ZG; Wu, YM; Zhong, GM				Li, Zhihong; Lu, Chunxue; Peng, Bo; Zeng, Hao; Zhou, Zhiguan; Wu, Yimou; Zhong, Guangming			Induction of Protective Immunity against Chlamydia muridarum Intravaginal Infection with a Chlamydial Glycogen Phosphorylase	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CLASS-II COMPLEXES; TRACHOMATIS INFECTION; ACQUIRED-IMMUNITY; VACCINATION; INHIBITION; CELLS; MICE; IMMUNIZATION; HYDROSALPINX	We evaluated 7 C. muridarum ORFs for their ability to induce protection against chlamydial infection in a mouse intravaginal infection model. These antigens, although encoded in C. muridarum genome, are transcriptionally regulated by a cryptic plasmid that is known to contribute to C. muridarum pathogenesis. Of the 7 plasmid-regulated ORFs, the chlamydial glycogen phosphorylase or GlgP, when delivered into mice intramuscularly, induced the most pronounced protective immunity against C. muridarum intravaginal infection. The GlgP-immunized mice displayed a significant reduction in vaginal shedding of live organisms on day 14 after infection. The protection correlated well with a robust C. muridarum-specific antibody and a Th1-dominant T cell responses, which significantly reduced the severity but not overall incidence of hydrosalpinx. The GlgP-induced partial protection against upper genital tract pathology suggests that GlgP may be considered a component for a multi-subunit vaccine. These results have demonstrated that intramuscular immunization of mice with purified proteins can be used to identify vaccine antigens for preventing intravaginal infection with C. trachomatis in humans.	[Li, Zhihong; Lu, Chunxue; Peng, Bo; Zeng, Hao; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Li, Zhihong; Zhou, Zhiguan] Cent S Univ, Xiangya Hosp 2, Dept Surg, Changsha, Hunan, Peoples R China; [Lu, Chunxue; Peng, Bo; Wu, Yimou] Univ S China, Dept Pathol & Microbiol, Hengyang, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; Central South University; University of South China	Li, ZH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@uthscsa.edu			National Institutes of Health [R01AI64537]; Merck-UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck-UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number R01AI64537 and a Merck-UT sponsorship (2009-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; [Centers for Disease Control and Prevention C Services USDoHaH], 2009, SEX TRANSM DIS SURV; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; EISSENBERG LG, 1981, INFECT IMMUN, V32, P889, DOI 10.1128/IAI.32.2.889-896.1981; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; GRAYSTON JT, 1962, ANN NY ACAD SCI, V98, P352, DOI 10.1111/j.1749-6632.1962.tb30558.x; Greene W, 2004, INFECT IMMUN, V72, P451, DOI 10.1128/IAI.72.1.451-460.2004; Johnson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002125.pub3; Karunakaran KP, 2008, J IMMUNOL, V180, P2459, DOI 10.4049/jimmunol.180.4.2459; Kinnunen AH, 2002, HUM REPROD, V17, P2073, DOI 10.1093/humrep/17.8.2073; Lei L, 2011, MICROB PATHOGENESIS, V51, P101, DOI 10.1016/j.micpath.2011.05.002; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Olivares-Zavaleta N, 2010, VACCINE, V28, P1454, DOI 10.1016/j.vaccine.2009.11.073; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Pal S, 2002, INFECT IMMUN, V70, P4812, DOI 10.1128/IAI.70.9.4812-4817.2002; Pal S, 1999, VACCINE, V17, P459, DOI 10.1016/S0264-410X(98)00219-9; Peterman TA, 2006, ANN INTERN MED, V145, P564, DOI 10.7326/0003-4819-145-8-200610170-00005; Qi ML, 2011, J BACTERIOL, V193, P2498, DOI 10.1128/JB.01301-10; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Rodgers AK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.005; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; SHERMAN KJ, 1990, SEX TRANSM DIS, V17, P115, DOI 10.1097/00007435-199007000-00001; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Strandell A, 2000, HUM REPROD UPDATE, V6, P387, DOI 10.1093/humupd/6.4.387; Strandell A, 1999, HUM REPROD, V14, P2762, DOI 10.1093/humrep/14.11.2762; Strandell A, 2004, J ASSIST REPROD GEN, V21, P241, DOI 10.1023/B:JARG.0000042009.93520.15; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wang J, 2009, VACCINE, V27, P2967, DOI 10.1016/j.vaccine.2009.02.095; Xiao YM, 2005, J IMMUNOL, V174, P1701, DOI 10.4049/jimmunol.174.3.1701; Zhong G, 2011, CURR CHEM BIOL, V5, P9; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007	41	133	150	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32997	10.1371/journal.pone.0032997	http://dx.doi.org/10.1371/journal.pone.0032997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22792223	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500072
J	Peng, XJ; Zhao, Y; Cao, JG; Zhang, W; Jiang, HY; Li, XY; Ma, Q; Zhu, SW; Cheng, BJ				Peng, Xiaojian; Zhao, Yang; Cao, Jiangang; Zhang, Wei; Jiang, Haiyang; Li, Xiaoyu; Ma, Qing; Zhu, Suwen; Cheng, Beijiu			CCCH-Type Zinc Finger Family in Maize: Genome-Wide Identification, Classification and Expression Profiling under Abscisic Acid and Drought Treatments	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA-BINDING PROTEINS; ANKYRIN REPEAT; MESSENGER-RNA; STRESS RESPONSES; GENE FAMILIES; ARABIDOPSIS; TOLERANCE; ELEMENTS; TRISTETRAPROLIN	Background: CCCH-type zinc finger proteins comprise a large protein family. Increasing evidence suggests that members of this family are RNA-binding proteins with regulatory functions in mRNA processing. Compared with those in animals, functions of CCCH-type zinc finger proteins involved in plant growth and development are poorly understood. Methodology/Principal Findings: Here, we performed a genome-wide survey of CCCH-type zinc finger genes in maize (Zea mays L.) by describing the gene structure, phylogenetic relationships and chromosomal location of each family member. Promoter sequences and expression profiles of putative stress-responsive members were also investigated. A total of 68 CCCH genes (ZmC3H1-68) were identified in maize and divided into seven groups by phylogenetic analysis. These 68 genes were found to be unevenly distributed on 10 chromosomes with 15 segmental duplication events, suggesting that segmental duplication played a major role in expansion of the maize CCCH family. The Ka/Ks ratios suggested that the duplicated genes of the CCCH family mainly experienced purifying selection with limited functional divergence after duplication events. Twelve maize CCCH genes grouped with other known stress-responsive genes from Arabidopsis were found to contain putative stress-responsive cis-elements in their promoter regions. Seven of these genes chosen for further quantitative real-time PCR analysis showed differential expression patterns among five representative maize tissues and over time in response to abscisic acid and drought treatments. Conclusions: The results presented in this study provide basic information on maize CCCH proteins and form the foundation for future functional studies of these proteins, especially for those members of which may play important roles in response to abiotic stresses.	[Peng, Xiaojian; Zhao, Yang; Cao, Jiangang; Zhang, Wei; Jiang, Haiyang; Li, Xiaoyu; Ma, Qing; Zhu, Suwen; Cheng, Beijiu] Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China	Anhui Agricultural University	Peng, XJ (corresponding author), Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China.	bjchengahau@163.com			National Natural Science Foundation of China [31071423, 11075001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Natural Science Foundation of China (No. 31071423 and 11075001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kosarev P, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-4-research0016; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; PLA M, 1993, PLANT MOL BIOL, V21, P259, DOI 10.1007/BF00019942; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Seong ES, 2007, J BIOCHEM MOL BIOL, V40, P952; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	55	133	150	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40120	10.1371/journal.pone.0040120	http://dx.doi.org/10.1371/journal.pone.0040120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792223	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800041
J	Xu, JY; Qi, X; Gong, JF; Yu, MY; Zhang, FX; Sha, HB; Gao, X				Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Zhang, Fangxiong; Sha, Haibo; Gao, Xiang			Fstl1 Antagonizes BMP Signaling and Regulates Ureter Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; URINARY-TRACT DEVELOPMENT; SONIC-HEDGEHOG; CONGENITAL-ANOMALIES; MOUSE URETER; BRANCHING MORPHOGENESIS; PERISTALTIC MACHINERY; VESICOURETERAL REFLUX; KIDNEY DEVELOPMENT; EXPRESSION	Bone morphogenetic protein (BMP) signaling pathway plays important roles in urinary tract development although the detailed regulation of its activity in this process remains unclear. Here we report that follistatiri-like 1 (Fstl1), encoding a secreted extracellular glycoprotein, is expressed in developing ureter and antagonizes BMP signaling activity. Mouse embryos carrying disrupted Fstl1 gene displayed prominent hydroureter arising from proximal segment and tireterovesical junction defects. These defects were associated with significant reduction in ureteric epithelial cell proliferation at E15.5 and E16.5 as well as absence of subepithelial ureteral mesenchymal cells in the urinary tract at E16.5 and E18.5. At the molecular level, increased BMP signaling was found in Fstl1 deficient ureters, indicated by elevated pSmad1/5/8 activity. in vitro study also indicated that Fstl1 can directly bind to ALK6 which is specifically expressed in ureteric epithelial cells in developing ureter. Furthermore, Sonic hedgehog (SHH) signaling, which is crucial for differentiation of ureteral subepithelial cell proliferation, was also impaired in Fstl1(-/-) ureter. Altogether, our data suggest that Fstl1 is essential in maintaining normal ureter development by antagonizing BMP signaling.	[Xu, Jingyue; Qi, Xin; Gong, Jianfeng; Yu, Mingyan; Sha, Haibo; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China; [Zhang, Fangxiong] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Life Sci, Shanghai, Peoples R China	Nanjing University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xu, JY (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China.	gaoxiang@nju.edu.cn			MOST (The Ministry of Science and Technology) [2011CB944104, 2011BAI15B02, 2011ZX09307-302-02]; NSFC (The National Science Foundation of China) [30825024]	MOST (The Ministry of Science and Technology); NSFC (The National Science Foundation of China)	This work is supported in part by grants from MOST (The Ministry of Science and Technology) (2011CB944104, 2011BAI15B02, 2011ZX09307-302-02) and NSFC (The National Science Foundation of China) (30825024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Bellusci S, 1996, DEVELOPMENT, V122, P1693; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; BOBER E, 1994, DEVELOPMENT, V120, P603; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Bush KT, 2006, DEV BIOL, V298, P571, DOI 10.1016/j.ydbio.2006.07.006; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hoshino T, 2008, GENES CELLS, V13, P159, DOI 10.1111/j.1365-2443.2007.01158.x; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Liem KF, 2000, DEVELOPMENT, V127, P4855; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Mendelsohn C, 2004, J CLIN INVEST, V113, P957, DOI 10.1172/JCI21402; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Mitchell EKL, 2006, GENE EXPR PATTERNS, V6, P519, DOI 10.1016/j.modgep.2005.10.008; Miyazaki Y, 1998, J CLIN INVEST, V102, P1489, DOI 10.1172/JCI4401; Miyazaki Y, 2003, PEDIATR INT, V45, P598, DOI 10.1046/j.1442-200X.2003.01777.x; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Monsoro-Burq AH, 2001, MOL CELL, V7, P789, DOI 10.1016/S1097-2765(01)00223-4; Murawski IJ, 2007, AM J PHYSIOL-RENAL, V293, pF1736, DOI 10.1152/ajprenal.00221.2007; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Okabayashi K, 1999, BIOCHEM BIOPH RES CO, V254, P42, DOI 10.1006/bbrc.1998.9892; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Schedl A, 2000, CURR OPIN GENET DEV, V10, P543, DOI 10.1016/S0959-437X(00)00125-8; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Towers P, 1999, DEV BIOL, V214, P298, DOI 10.1006/dbio.1999.9421; Uetani N, 2009, CLIN GENET, V75, P307, DOI 10.1111/j.1399-0004.2009.01175.x; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Umezu T, 2010, P NATL ACAD SCI USA, V107, P4601, DOI 10.1073/pnas.0909501107; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	58	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e32554	10.1371/journal.pone.0032554	http://dx.doi.org/10.1371/journal.pone.0032554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22808012	Green Submitted, Green Published, gold			2022-12-25	WOS:000304780500008
J	Sim, SC; Van Deynze, A; Stoffel, K; Douches, DS; Zarka, D; Ganal, MW; Chetelat, RT; Hutton, SF; Scott, JW; Gardner, RG; Panthee, DR; Mutschler, M; Myers, JR; Francis, DM				Sim, Sung-Chur; Van Deynze, Allen; Stoffel, Kevin; Douches, David S.; Zarka, Daniel; Ganal, Martin W.; Chetelat, Roger T.; Hutton, Samuel F.; Scott, John W.; Gardner, Randolph G.; Panthee, Dilip R.; Mutschler, Martha; Myers, James R.; Francis, David M.			High-Density SNP Genotyping of Tomato (Solanum lycopersicum L.) Reveals Patterns of Genetic Variation Due to Breeding	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM ANALYSIS; LATE BLIGHT RESISTANCE; SELF-PRUNING GENE; MAP-BASED CLONING; DISEASE RESISTANCE; CULTIVATED TOMATO; PHYTOPHTHORA-INFESTANS; BACTERIAL SPOT; COMPLEX TRAITS	The effects of selection on genome variation were investigated and visualized in tomato using a high-density single nucleotide polymorphism (SNP) array. 7,720 SNPs were genotyped on a collection of 426 tomato accessions (410 inbreds and 16 hybrids) and over 97% of the markers were polymorphic in the entire collection. Principal component analysis (PCA) and pairwise estimates of F-st supported that the inbred accessions represented seven sub-populations including processing, large-fruited fresh market, large-fruited vintage, cultivated cherry, landrace, wild cherry, and S. pimpinellifolium. Further divisions were found within both the contemporary processing and fresh market sub-populations. These sub-populations showed higher levels of genetic diversity relative to the vintage sub-population. The array provided a large number of polymorphic SNP markers across each sub-population, ranging from 3,159 in the vintage accessions to 6,234 in the cultivated cherry accessions. Visualization of minor allele frequency revealed regions of the genome that distinguished three representative sub-populations of cultivated tomato (processing, fresh market, and vintage), particularly on chromosomes 2, 4, 5, 6, and 11. The PCA loadings and F-st outlier analysis between these three sub-populations identified a large number of candidate loci under positive selection on chromosomes 4, 5, and 11. The extent of linkage disequilibrium (LD) was examined within each chromosome for these sub-populations. LD decay varied between chromosomes and sub-populations, with large differences reflective of breeding history. For example, on chromosome 11, decay occurred over 0.8 cM for processing accessions and over 19.7 cM for fresh market accessions. The observed SNP variation and LD decay suggest that different patterns of genetic variation in cultivated tomato are due to introgression from wild species and selection for market specialization.	[Sim, Sung-Chur; Francis, David M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Van Deynze, Allen; Stoffel, Kevin] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Douches, David S.; Zarka, Daniel] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA; [Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Chetelat, Roger T.] Univ Calif Davis, CM Rick Tomato Genet Resource Ctr, Davis, CA 95616 USA; [Hutton, Samuel F.; Scott, John W.] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL USA; [Gardner, Randolph G.; Panthee, Dilip R.] N Carolina State Univ, Mt Hort Crops Res & Extens Ctr, Dept Hort Sci, Mills River, NC USA; [Mutschler, Martha] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Myers, James R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; Michigan State University; University of California System; University of California Davis; State University System of Florida; University of Florida; University of North Carolina; North Carolina State University; Cornell University; Oregon State University	Francis, DM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	francis.77@osu.edu	Panthee, Dilip/AAH-2974-2022; Francis, David/B-7262-2012; Panthee, Dilip/CAF-8991-2022; Wijeratne, Saranga/I-5341-2016; Causse, Mathilde/AAF-6555-2020; Panthee, Dilip/AFM-0574-2022; Hamilton, John P/G-1379-2016	Panthee, Dilip/0000-0002-8736-512X; Wijeratne, Saranga/0000-0002-9782-4406; Panthee, Dilip/0000-0002-8736-512X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Sim, Sung-Chur/0000-0001-7672-6260; Stoffel, Karl/0000-0003-4431-3626; Francis, David/0000-0003-2016-1357	United States Department of Agriculture/National Institute of Food and Agriculture [2008-55300-04757, 2009-85606-05673]; German Federal Ministry of Education and Research (BMBF) [0315639A]	United States Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the United States Department of Agriculture/National Institute of Food and Agriculture (2008-55300-04757 and 2009-85606-05673). Work at TraitGenetics was supported by the German Federal Ministry of Education and Research (BMBF) through grant number 0315639A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LJ, 1934, OHIO AGR EXP STA B, V539; [Anonymous], MICROSATELLITE ANAL; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Barry CS, 2008, PLANT PHYSIOL, V147, P179, DOI 10.1104/pp.108.118430; Bates D., 1988, NONLINEAR REGRESSION; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BERRY SZ, 1991, HORTSCIENCE, V26, P1093, DOI 10.21273/HORTSCI.26.8.1093; BOHN G. W., 1939, SCIENCE, V89, P603, DOI 10.1126/science.89.2322.603; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Budiman MA, 2004, THEOR APPL GENET, V108, P190, DOI 10.1007/s00122-003-1429-3; Carmel-Goren L, 2003, PLANT MOL BIOL, V52, P1215, DOI 10.1023/B:PLAN.0000004333.96451.11; Chunwongse J, 2002, J HORTIC SCI BIOTECH, V77, P281, DOI 10.1080/14620316.2002.11511493; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; ESHED Y, 1995, GENETICS, V141, P1147; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; GARDNER RG, 1992, HORTSCIENCE, V27, P1233, DOI 10.21273/HORTSCI.27.11.1233; George WL, 1983, TOMATO PRODUCTION PR, P48; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham E. B., 2004, REP TOMATO GENET COO, V54, P22; Graham TO, 1959, TOM GEN COOP REP, V9, P37; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hemming MN, 2004, THEOR APPL GENET, V109, P409, DOI 10.1007/s00122-004-1646-4; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Jones CM, 2007, AM J BOT, V94, P935, DOI 10.3732/ajb.94.6.935; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kim MJ, 2005, J AM SOC HORTIC SCI, V130, P877, DOI 10.21273/JASHS.130.6.877; Labate JA, 2005, MOL BREEDING, V16, P343, DOI 10.1007/s11032-005-1911-5; Labate JA, 2010, HORTSCIENCE, V45, pS145; Labate JA, 2009, THEOR APPL GENET, V118, P1005, DOI 10.1007/s00122-008-0957-2; Lanfermeijer FC, 2003, PLANT MOL BIOL, V52, P1037, DOI 10.1023/A:1025434519282; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Merk HL, 2012, J AM SOC HORTIC SCI, V137, P427, DOI 10.21273/JASHS.137.6.427; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; NEI M, 1974, GENETICS, V76, P379; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Park YH, 2004, GENOME, V47, P510, DOI [10.1139/g04-004, 10.1139/G04-004]; Pei CC, 2012, THEOR APPL GENET, V124, P533, DOI 10.1007/s00122-011-1726-1; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2016, R FDN STAT COMP; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; RASMUSSEN W. D., 1968, Technology Cult., Chicago., V9, P531, DOI 10.2307/3101894; RAY J, 1992, PLANT MOL BIOL, V19, P401, DOI 10.1007/BF00023387; Rick C. M., 1976, Evolution of crop plants., P268; RICK CHARLES M., 1958, ECON BOT, V12, P346, DOI 10.1007/BF02860023; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Robbins MD, 2010, HORTSCIENCE, V45, P1424, DOI 10.21273/HORTSCI.45.10.1424; Robbins MD, 2009, PHYTOPATHOLOGY, V99, P1037, DOI 10.1094/PHYTO-99-9-1037; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scott JW, 2008, HORTSCIENCE, V43, P2228, DOI 10.21273/HORTSCI.43.7.2228; Scott JW, 2004, J AM SOC HORTIC SCI, V129, P394, DOI 10.21273/JASHS.129.3.0394; Sim SC, 2011, HEREDITY, V106, P927, DOI 10.1038/hdy.2010.139; Sim SC, 2011, DOWNSTREAM ANAL SNPS; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Sim SC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-466; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Spassova MI, 2001, MOL BREEDING, V7, P151, DOI 10.1023/A:1011363119763; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stevens MA., 1986, TOMATO CROP SCI BASI, P35; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; United States Department of Agriculture States Relations Service Office of Experiment Stations, 1919, EXP STAT REC, V39; van Berloo R, 2008, THEOR APPL GENET, V117, P89, DOI 10.1007/s00122-008-0755-x; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; WATTS VM, 1947, P AM SOC HORTIC SCI, V49, P233; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMS CE, 1993, GENOME, V36, P619, DOI 10.1139/g93-083; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yang WC, 2005, PHYTOPATHOLOGY, V95, P519, DOI 10.1094/PHYTO-95-0519; Yang WC, 2004, MOL BREEDING, V14, P21, DOI 10.1023/B:MOLB.0000037992.03731.a5; Yuan DJ, 2008, SCI HORTIC-AMSTERDAM, V118, P20, DOI 10.1016/j.scienta.2008.05.011; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	102	272	283	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45520	10.1371/journal.pone.0045520	http://dx.doi.org/10.1371/journal.pone.0045520			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	22802968	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900068
J	Choi, YH; Jit, M; Flasche, S; Gay, N; Miller, E				Choi, Yoon Hong; Jit, Mark; Flasche, Stefan; Gay, Nigel; Miller, Elizabeth			Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales	PLOS ONE			English	Article							CONJUGATE VACCINE; SEROTYPE REPLACEMENT; CARRIAGE; IMPACT	Introduction: England and Wales recently replaced the 7-valent pneumococcal conjugate vaccine (PCV7) with its 13-valent equivalent (PCV13), partly based on projections from mathematical models of the long-term impact of such a switch compared to ceasing pneumococcal conjugate vaccination altogether. Methods: A compartmental deterministic model was used to estimate parameters governing transmission of infection and competition between different groups of pneumococcal serotypes prior to the introduction of PCV13. The best-fitting parameters were used in an individual based model to describe pneumococcal transmission dynamics and effects of various options for the vaccination programme change in England and Wales. A number of scenarios were conducted using (i) different assumptions about the number of invasive pneumococcal disease cases adjusted for the increasing trend in disease incidence prior to PCV7 introduction in England and Wales, and (ii) a range of values representing serotype replacement induced by vaccination of the additional six serotypes in PCV13. Results: Most of the scenarios considered suggest that ceasing pneumococcal conjugate vaccine use would cause an increase in invasive pneumococcal disease incidence, while replacing PCV7 with PCV13 would cause an overall decrease. However, the size of this reduction largely depends on the level of competition induced by the additional serotypes in PCV13. The model estimates that over 20 years of PCV13 vaccination, around 5000-62000 IPD cases could be prevented compared to stopping pneumococcal conjugate vaccination altogether. Conclusion: Despite inevitable uncertainty around serotype replacement effects following introduction of PCV13, the model suggests a reduction in overall invasive pneumococcal disease incidence in all cases. Our results provide useful evidence on the benefits of PCV13 to countries replacing or considering replacing PCV7 with PCV13, as well as data that can be used to evaluate the cost-effectiveness of such a switch.	[Choi, Yoon Hong; Jit, Mark; Flasche, Stefan; Miller, Elizabeth] Hlth Protect Agcy, Hlth Protect Serv Colindale, London, England; [Jit, Mark] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Flasche, Stefan] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Gay, Nigel] Fu Consulting, Hungerford, Berks, England	Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; University of Strathclyde	Choi, YH (corresponding author), Hlth Protect Agcy, Hlth Protect Serv Colindale, London, England.	yoon.choi@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Choi, Yongwook/0000-0003-4017-9669; Chan, Agnes/0000-0003-2373-9580; Miller, Jason/0000-0002-6912-2925; Jit, Mark/0000-0001-6658-8255; Flasche, Stefan/0000-0002-5808-2606	NHGRI NIH HHS [R01 HG004701, 5R01HG004701-03] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Boccalini S, 2011, VACCINE, V29, P9521, DOI 10.1016/j.vaccine.2011.10.013; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; De Wals P, 2009, CLIN THER, V31, P2152, DOI 10.1016/j.clinthera.2009.10.014; Flasche S, 2011, EUROSURVEILLANCE, V16, P13; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Robberstad B, 2011, VACCINE, V29, P8564, DOI 10.1016/j.vaccine.2011.09.025; Strutton DR, 2012, J INFECTION, V64, P54, DOI 10.1016/j.jinf.2011.10.015; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	16	748	772	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39927	10.1371/journal.pone.0039927	http://dx.doi.org/10.1371/journal.pone.0039927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	23056405	Green Published, Green Accepted, gold			2022-12-25	WOS:000306406700015
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
